data_2lqm_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lqm _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.486 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.32 158.42 39.15 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.006 1.322 . . . . 0.0 111.282 -173.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -63.71 148.68 48.48 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.879 0.872 . . . . 0.0 113.079 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -61.46 -22.6 65.2 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.615 1.566 . . . . 0.0 113.805 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -76.17 -14.99 60.14 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.348 1.459 . . . . 0.0 112.406 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.5 m -64.23 136.99 57.71 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.426 1.091 . . . . 0.0 112.548 -175.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -77.94 147.96 34.72 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.357 1.063 . . . . 0.0 112.703 169.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.6 p -144.85 159.88 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.269 1.028 . . . . 0.0 112.373 -171.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -129.55 135.43 48.58 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.606 1.963 . . . . 0.0 108.883 -177.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -155.83 175.19 14.25 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.079 0.854 . . . . 0.0 112.155 168.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -136.13 139.26 42.8 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.452 1.101 . . . . 0.0 111.86 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -156.76 150.79 24.98 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.987 1.315 . . . . 0.0 110.633 173.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.8 t0 49.96 42.08 23.93 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.656 1.182 . . . . 0.0 112.66 -173.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.1 m 55.75 36.17 26.74 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 126.401 1.881 . . . . 0.0 114.609 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.3 p -149.0 139.88 13.81 Favored Pre-proline 0 CA--C 1.54 0.579 0 O-C-N 120.419 -1.426 . . . . 0.0 111.242 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.33 150.29 32.42 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.708 2.938 . . . . 0.0 113.309 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -126.78 140.22 52.53 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.775 2.03 . . . . 0.0 109.894 172.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -148.03 113.2 5.53 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.098 0.959 . . . . 0.0 110.039 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -164.33 -175.51 3.97 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.428 1.891 . . . . 0.0 110.249 -174.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 m -72.09 146.32 47.61 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 120.872 -1.142 . . . . 0.0 109.928 173.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.407 HG12 ' CG ' ' A' ' 152' ' ' TYR . 9.1 tp -56.84 -37.99 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 O-C-N 121.593 -0.692 . . . . 0.0 112.29 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -63.83 -26.27 68.54 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.104 0.866 . . . . 0.0 112.451 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -78.31 -40.64 36.13 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.841 1.257 . . . . 0.0 111.112 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -73.0 -32.58 65.24 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.422 -0.799 . . . . 0.0 111.725 173.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -59.62 -49.18 78.77 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.842 0.857 . . . . 0.0 111.026 169.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.2 t -65.95 -31.5 72.45 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.438 0.695 . . . . 0.0 111.968 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -67.85 -53.52 26.13 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.04 1.336 . . . . 0.0 110.983 173.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -70.4 -33.29 71.2 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.33 -31.88 72.94 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.684 0.794 . . . . 0.0 111.943 173.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.3 t -78.52 -29.98 46.82 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 121.199 -0.938 . . . . 0.0 112.011 174.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 65.5 mtm -81.08 -49.96 10.23 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.113 0.965 . . . . 0.0 113.454 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 -111.8 -20.28 12.12 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.639 1.576 . . . . 0.0 114.295 -168.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.55 158.31 33.56 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 124.553 1.073 . . . . 0.0 114.613 -178.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -104.68 126.42 51.75 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.279 1.032 . . . . 0.0 110.475 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 11.1 mp -99.82 148.51 34.89 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 126.406 1.882 . . . . 0.0 110.517 177.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -72.4 154.92 55.95 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.118 2.546 . . . . 0.0 111.668 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -134.37 167.81 20.05 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.566 1.146 . . . . 0.0 111.202 168.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -51.57 -58.08 7.33 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.036 1.335 . . . . 0.0 111.453 171.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -96.57 -8.79 30.93 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -171.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -175.16 -131.08 1.38 Allowed Glycine 0 CA--C 1.535 1.294 0 N-CA-C 114.871 0.708 . . . . 0.0 114.871 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -136.81 159.7 41.07 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.206 1.802 . . . . 0.0 111.211 176.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.44 149.03 42.07 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.209 1.404 . . . . 0.0 111.213 -177.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.2 t -123.5 116.97 27.94 Favored Pre-proline 0 N--CA 1.482 1.154 0 C-N-CA 125.432 1.493 . . . . 0.0 109.912 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.72 140.97 40.25 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 124.23 3.287 . . . . 0.0 111.78 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 87.5 mt -109.47 169.68 8.55 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.386 1.074 . . . . 0.0 113.309 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -148.29 123.01 9.89 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.723 1.609 . . . . 0.0 110.022 174.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 50.17 40.59 22.31 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.543 1.537 . . . . 0.0 114.022 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.9 t -102.12 122.74 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 121.243 -0.91 . . . . 0.0 110.048 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -121.25 150.9 40.67 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.281 1.032 . . . . 0.0 113.115 -171.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.4 m -138.19 155.49 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 126.862 2.065 . . . . 0.0 111.634 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -69.06 132.55 46.8 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.328 0.651 . . . . 0.0 109.682 167.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.2 t -132.28 148.48 52.44 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.585 1.954 . . . . 0.0 110.654 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 55.9 tp -104.98 134.35 48.23 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.457 1.103 . . . . 0.0 109.654 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -78.1 105.57 9.41 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.59 0.756 . . . . 0.0 109.071 167.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 29.5 mm -66.75 -23.51 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 119.656 1.116 . . . . 0.0 111.633 -176.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.57 -48.22 49.8 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.661 1.184 . . . . 0.0 114.093 -177.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.2 m -114.87 -3.12 12.76 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.214 1.006 . . . . 0.0 113.435 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.59 28.85 68.63 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.293 1.425 . . . . 0.0 113.479 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -95.04 141.58 28.52 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.508 1.123 . . . . 0.0 112.039 -173.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.9 mp -89.81 128.02 42.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 C-N-CA 125.106 1.362 . . . . 0.0 109.501 -176.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -151.53 170.39 19.75 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.331 1.052 . . . . 0.0 112.645 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -114.23 135.12 54.4 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.82 1.248 . . . . 0.0 111.23 -177.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.6 t -134.58 153.87 51.76 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.219 1.008 . . . . 0.0 112.769 -174.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -80.42 140.9 35.77 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 175.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -93.45 143.0 26.7 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.387 1.075 . . . . 0.0 110.92 167.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 96.0 p -85.56 -53.95 4.86 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.81 1.244 . . . . 0.0 112.269 -174.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -152.1 158.82 43.51 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.964 1.705 . . . . 0.0 112.669 177.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.2 mt -85.66 152.51 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 163.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -143.56 148.05 35.35 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.103 1.361 . . . . 0.0 111.466 -177.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.1 ptt-85 -144.11 150.8 38.69 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 168.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -148.62 172.16 15.0 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.293 1.837 . . . . 0.0 110.586 175.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp -101.32 143.87 30.85 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.131 0.973 . . . . 0.0 112.186 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.6 m -145.35 146.57 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.464 1.506 . . . . 0.0 110.815 173.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -92.81 -34.46 13.86 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.731 1.212 . . . . 0.0 111.729 173.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -114.86 124.4 51.63 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.876 1.67 . . . . 0.0 110.224 -170.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.5 tp -134.29 158.5 43.61 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.61 1.564 . . . . 0.0 109.746 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 14.4 mt -109.61 130.83 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.324 1.049 . . . . 0.0 108.762 173.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -100.12 123.83 44.8 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.188 1.395 . . . . 0.0 110.083 168.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -113.3 115.79 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.557 1.543 . . . . 0.0 108.269 173.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.2 tttt -87.82 148.52 24.64 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.444 1.098 . . . . 0.0 110.966 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 85.8 mt -115.06 158.41 22.16 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.17 1.388 . . . . 0.0 112.347 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.1 t -65.04 -23.02 67.07 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 121.881 -0.512 . . . . 0.0 112.077 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 96.1 p -63.35 -22.26 66.77 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.697 1.599 . . . . 0.0 115.031 170.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.83 1.22 61.78 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 125.275 1.417 . . . . 0.0 115.198 -171.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -85.7 161.67 19.1 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.633 1.217 . . . . 0.0 111.194 172.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.2 p -134.49 135.34 42.35 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.359 1.076 . . . . 0.0 112.79 172.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 63.4 tp -97.76 115.09 27.32 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.659 1.584 . . . . 0.0 108.797 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -111.09 109.48 19.58 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.637 1.575 . . . . 0.0 109.878 -177.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.2 m -149.81 154.18 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 126.157 1.783 . . . . 0.0 113.254 -161.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.9 p -66.7 149.75 98.03 Favored Pre-proline 0 N--CA 1.471 0.587 0 O-C-N 121.072 -1.017 . . . . 0.0 113.244 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -60.5 -21.62 68.92 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 124.316 3.344 . . . . 0.0 114.685 -175.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.6 p -76.95 -23.08 52.4 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 128.318 2.647 . . . . 0.0 114.704 175.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 44.0 t60 -75.19 121.19 84.7 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-O 118.349 -0.834 . . . . 0.0 112.671 -162.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -75.13 126.28 9.78 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.881 2.387 . . . . 0.0 112.866 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.8 t -106.08 145.01 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 126.011 1.725 . . . . 0.0 109.175 175.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 18.0 tp -79.46 109.86 14.22 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.4 0.545 . . . . 0.0 110.363 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.1 mp -107.35 161.05 15.16 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.252 1.821 . . . . 0.0 111.556 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -117.91 112.16 19.97 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 174.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.1 mtt-85 -139.62 91.1 2.45 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.76 1.224 . . . . 0.0 109.162 165.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 56.28 -2.68 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 128.25 2.62 . . . . 0.0 116.984 -167.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.76 164.66 37.39 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 125.515 1.531 . . . . 0.0 112.682 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 67.6 mt -71.5 114.86 10.02 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.884 1.674 . . . . 0.0 110.403 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -138.35 136.59 36.52 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -174.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -92.21 112.41 24.34 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.57 1.148 . . . . 0.0 110.85 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 60.5 t -124.32 127.4 25.3 Favored Pre-proline 0 N--CA 1.478 0.962 0 C-N-CA 123.95 0.9 . . . . 0.0 110.233 -172.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -64.22 143.35 83.4 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.487 2.125 . . . . 0.0 111.584 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.14 -30.52 26.91 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 177.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.61 -22.06 66.63 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 173.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -105.43 -6.52 19.43 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.334 1.454 . . . . 0.0 112.486 175.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 84.8 t -68.51 142.25 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 O-C-N 121.292 -0.88 . . . . 0.0 109.594 166.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.61 154.65 80.92 Favored Pre-proline 0 N--CA 1.469 0.505 0 C-N-CA 128.289 2.636 . . . . 0.0 109.496 -178.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.46 132.49 31.36 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.994 1.796 . . . . 0.0 111.05 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 104.04 -6.06 46.81 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.166 1.365 . . . . 0.0 114.221 175.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.33 162.28 28.85 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 118.734 1.267 . . . . 0.0 112.439 177.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 50.5 t -91.12 121.59 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.071 1.348 . . . . 0.0 110.661 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.1 t -94.87 137.69 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.853 1.261 . . . . 0.0 110.233 169.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 41.1 t -89.58 137.82 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.14 0.976 . . . . 0.0 110.473 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -164.99 -149.01 5.67 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.245 0.926 . . . . 0.0 113.002 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.9 p -148.44 166.15 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 127.404 2.281 . . . . 0.0 108.486 175.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 . . . . . 0 N--CA 1.472 0.664 0 C-N-CA 123.67 0.788 . . . . 0.0 111.909 174.649 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 0 CA--C 1.536 0.415 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 95.7 mt -137.13 164.83 27.5 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.674 1.99 . . . . 0.0 109.634 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -142.09 134.73 28.3 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.207 1.403 . . . . 0.0 111.83 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -90.59 143.54 26.64 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.557 1.543 . . . . 0.0 111.702 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -131.65 136.07 47.42 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.35 1.46 . . . . 0.0 110.917 -173.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -87.33 130.65 34.54 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 119.011 0.823 . . . . 0.0 112.394 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 82.8 t -68.35 122.15 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 121.77 0.795 . . . . 0.0 110.573 167.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 45.5 t -76.92 -50.29 13.63 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.823 1.649 . . . . 0.0 112.602 176.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.4 t -158.8 164.99 35.28 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.474 1.51 . . . . 0.0 110.552 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.8 m -132.61 149.5 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 124.486 1.114 . . . . 0.0 111.543 170.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -155.34 154.37 31.93 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.247 1.019 . . . . 0.0 113.565 171.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 71.2 mt -90.25 130.6 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.561 1.144 . . . . 0.0 109.26 169.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 16.1 pt -126.39 159.04 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.925 1.69 . . . . 0.0 112.496 -174.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -95.38 96.53 9.19 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 122.24 1.019 . . . . 0.0 111.534 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -76.01 -52.02 11.11 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.064 0.945 . . . . 0.0 113.2 176.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 50.89 33.12 8.18 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.954 1.301 . . . . 0.0 113.952 -176.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -141.04 172.97 11.95 Favored 'General case' 0 CA--C 1.549 0.928 0 O-C-N 120.775 -1.203 . . . . 0.0 112.471 -170.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -74.01 137.89 43.75 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.262 -0.899 . . . . 0.0 112.091 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 12.2 m -122.35 154.5 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.399 1.88 . . . . 0.0 110.141 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.407 ' CG ' HG12 ' A' ' 21' ' ' ILE . 1.5 p90 -113.06 159.73 18.88 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -174.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -137.68 145.29 42.43 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.256 1.422 . . . . 0.0 109.092 158.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 67.1 tp -120.89 103.99 9.49 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.829 1.252 . . . . 0.0 109.426 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 57.6 t -87.71 131.66 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -150.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.4 mm -124.62 85.78 56.21 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 124.536 1.134 . . . . 0.0 110.793 -176.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -65.48 -10.3 25.7 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.561 2.174 . . . . 0.0 114.216 177.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -72.15 -47.74 48.69 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 119.816 1.189 . . . . 0.0 113.0 172.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 71.1 p -135.32 -15.2 1.93 Allowed 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -171.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . 0.295 68.6 m80 56.78 25.9 10.83 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 128.079 2.552 . . . . 0.0 116.03 -170.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.92 146.85 26.55 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 120.796 -1.19 . . . . 0.0 113.548 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -147.56 166.05 28.49 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.299 1.439 . . . . 0.0 112.302 -176.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.9 mp -109.82 135.59 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.82 1.248 . . . . 0.0 111.663 177.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -85.81 159.05 55.67 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 124.315 1.046 . . . . 0.0 112.624 171.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.0 -23.19 74.06 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.69 2.926 . . . . 0.0 112.582 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.74 8.22 2.05 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.548 1.139 . . . . 0.0 113.176 171.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 90.68 -20.61 37.59 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 127.098 2.285 . . . . 0.0 116.048 169.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 47.2 mt -70.87 151.76 44.41 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.279 1.432 . . . . 0.0 112.889 -173.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.41 124.72 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 124.565 1.146 . . . . 0.0 111.926 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.96 144.07 43.68 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.738 2.015 . . . . 0.0 111.96 -173.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -100.27 146.52 26.81 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.563 0.745 . . . . 0.0 111.98 166.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 22.8 m120 . . . . . 0 CA--C 1.538 0.483 0 O-C-N 121.562 -0.711 . . . . 0.0 110.832 168.388 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.667 0 CA-C-O 121.023 0.44 . . . . 0.0 112.031 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.414 ' HB2' ' CE1' ' A' ' 152' ' ' TYR . 0.0 OUTLIER -146.6 164.45 32.59 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.645 1.578 . . . . 0.0 111.058 -172.419 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.74 143.58 57.43 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.66 1.184 . . . . 0.0 113.725 -175.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? -58.71 -25.22 62.69 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.182 1.393 . . . . 0.0 114.238 177.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -87.02 1.03 54.19 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.924 1.29 . . . . 0.0 113.399 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.1 m -69.35 142.06 54.07 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.592 1.157 . . . . 0.0 113.099 175.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -79.32 148.06 32.23 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.436 1.494 . . . . 0.0 113.464 171.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.0 p -147.19 158.52 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.648 1.179 . . . . 0.0 111.904 -173.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -126.35 139.86 52.96 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.444 1.898 . . . . 0.0 108.807 178.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -155.28 177.21 11.61 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.608 0.718 . . . . 0.0 111.379 165.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -134.9 143.1 46.75 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.135 0.974 . . . . 0.0 110.181 173.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -159.53 143.12 14.56 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.483 1.113 . . . . 0.0 109.826 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.4 t70 48.49 50.28 17.07 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.927 1.291 . . . . 0.0 113.595 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.4 m 68.71 11.06 8.22 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 128.38 2.672 . . . . 0.0 116.145 174.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.6 p -134.71 136.87 26.22 Favored Pre-proline 0 CA--C 1.545 0.756 0 O-C-N 120.279 -1.513 . . . . 0.0 112.871 -176.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -73.0 154.39 52.82 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 123.793 2.996 . . . . 0.0 112.597 174.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -135.31 136.86 41.92 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.739 2.016 . . . . 0.0 109.147 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 50.6 ttm -152.95 104.01 2.8 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.749 0.82 . . . . 0.0 110.277 -176.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -162.29 -176.86 5.34 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.138 1.375 . . . . 0.0 111.067 -169.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.4 m -71.6 143.75 49.71 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 120.855 -1.153 . . . . 0.0 110.673 171.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.1 tp -55.02 -38.29 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -62.64 -24.04 67.39 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.365 -0.834 . . . . 0.0 113.02 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -80.55 -39.39 27.83 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.08 0.952 . . . . 0.0 111.313 176.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -73.18 -33.23 65.32 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.079 0.854 . . . . 0.0 111.72 174.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -56.96 -51.73 68.02 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.701 1.2 . . . . 0.0 111.908 169.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.1 t -62.17 -40.42 95.97 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.631 0.772 . . . . 0.0 111.423 -177.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -61.05 -53.01 62.49 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.756 1.223 . . . . 0.0 110.425 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -72.07 -33.28 67.8 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.0 -31.58 72.56 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.254 1.022 . . . . 0.0 112.513 175.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.7 t -79.81 -33.07 40.69 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 118.796 0.725 . . . . 0.0 111.878 174.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 69.8 mtm -75.99 -48.15 22.22 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.566 0.747 . . . . 0.0 112.665 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 35.7 m-20 -116.86 -19.88 9.67 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.437 1.495 . . . . 0.0 113.887 -166.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.75 159.17 34.89 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 125.087 1.327 . . . . 0.0 114.755 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -104.19 124.33 48.92 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.703 1.201 . . . . 0.0 109.435 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.3 mp -106.24 141.4 22.67 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 125.777 1.631 . . . . 0.0 110.613 -178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.12 146.23 57.35 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.505 2.803 . . . . 0.0 112.09 -173.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -134.25 154.73 51.1 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.42 1.088 . . . . 0.0 112.234 177.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -42.17 -47.45 4.65 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.897 1.679 . . . . 0.0 114.673 -176.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -116.3 7.65 14.04 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.13 -137.43 2.44 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 116.097 1.199 . . . . 0.0 116.097 -172.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -145.35 157.0 44.13 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 127.562 2.345 . . . . 0.0 111.062 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.09 151.98 47.15 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.376 1.071 . . . . 0.0 112.306 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.4 t -123.96 116.96 27.31 Favored Pre-proline 0 N--CA 1.48 1.046 0 C-N-CA 125.393 1.477 . . . . 0.0 110.284 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.43 141.63 31.96 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 124.529 3.486 . . . . 0.0 111.584 -176.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 77.2 mt -115.54 171.21 7.87 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.822 1.249 . . . . 0.0 112.682 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -148.92 135.02 19.16 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.843 1.657 . . . . 0.0 109.479 165.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 52.17 50.28 18.78 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.971 1.308 . . . . 0.0 113.562 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 67.0 t -113.05 107.67 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.075 0.95 . . . . 0.0 110.48 177.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -103.71 137.66 41.43 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.603 1.161 . . . . 0.0 113.335 -167.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.8 m -134.74 149.84 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.574 1.549 . . . . 0.0 112.599 175.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -65.44 141.95 58.34 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.648 0.779 . . . . 0.0 111.028 169.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.9 t -144.78 154.17 42.42 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.609 1.564 . . . . 0.0 111.259 -174.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 54.0 tp -114.05 138.88 49.8 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.06 1.344 . . . . 0.0 110.821 -175.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -86.6 120.69 28.19 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.17 1.388 . . . . 0.0 108.987 161.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 24.2 mm -78.87 -28.85 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 O-C-N 121.256 -0.903 . . . . 0.0 111.154 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.05 -36.19 80.86 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.437 1.095 . . . . 0.0 113.492 -171.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.9 m -121.54 -21.26 6.28 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.217 1.407 . . . . 0.0 112.998 171.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.49 31.01 20.19 Favored Glycine 0 N--CA 1.474 1.232 0 CA-C-N 118.878 0.763 . . . . 0.0 113.099 -173.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -91.92 143.68 26.24 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.819 1.248 . . . . 0.0 112.05 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.0 144.23 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.482 1.113 . . . . 0.0 110.6 -176.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.3 ptpt -154.0 176.91 11.65 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.901 1.68 . . . . 0.0 112.367 -177.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -121.45 147.82 45.24 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.792 1.637 . . . . 0.0 111.567 174.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.7 t -143.61 160.4 40.72 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.013 1.325 . . . . 0.0 111.187 175.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -97.88 132.36 43.54 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 170.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.33 142.2 39.51 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.056 0.943 . . . . 0.0 111.004 175.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.6 t -89.96 -46.14 8.72 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -169.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -153.53 160.55 42.52 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.684 1.193 . . . . 0.0 112.272 174.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.7 mt -88.79 152.81 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.481 1.112 . . . . 0.0 108.423 165.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -139.69 148.04 41.8 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.459 1.504 . . . . 0.0 110.537 -177.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.4 ptt85 -143.32 150.16 38.81 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.099 0.96 . . . . 0.0 113.155 169.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -151.66 166.08 32.36 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.988 1.715 . . . . 0.0 109.984 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -94.09 151.93 19.14 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.036 0.834 . . . . 0.0 111.459 172.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.7 m -148.74 143.12 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 124.879 1.272 . . . . 0.0 110.333 170.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -90.22 -30.14 17.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 117.632 -1.175 . . . . 0.0 112.019 175.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.7 mttt -131.95 130.43 41.51 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.274 0.943 . . . . 0.0 110.915 -174.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.8 tp -139.93 162.78 34.37 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.804 2.042 . . . . 0.0 110.158 -168.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.7 mt -116.46 127.58 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.604 1.162 . . . . 0.0 110.138 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -96.62 126.45 41.8 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.139 0.975 . . . . 0.0 110.625 166.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -111.0 129.03 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.436 1.094 . . . . 0.0 109.835 169.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -97.65 143.73 28.02 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.025 1.73 . . . . 0.0 111.301 173.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.3 mt -104.55 157.35 17.23 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 127.094 2.158 . . . . 0.0 110.317 -176.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.3 t -66.88 -23.6 66.02 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -173.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.7 t -66.84 -20.05 65.85 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.251 -0.905 . . . . 0.0 113.415 167.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 108.13 -5.52 34.08 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 127.575 2.512 . . . . 0.0 115.71 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -82.85 161.07 22.05 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.166 1.387 . . . . 0.0 110.831 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 65.2 p -141.46 159.83 41.41 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 24.3 tp -129.41 138.89 51.74 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.461 1.904 . . . . 0.0 110.324 177.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -111.22 121.63 45.79 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.876 1.27 . . . . 0.0 112.113 177.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.12 153.41 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.728 1.611 . . . . 0.0 112.85 -166.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.2 p -68.55 148.57 98.11 Favored Pre-proline 0 N--CA 1.472 0.64 0 O-C-N 120.944 -1.098 . . . . 0.0 112.573 173.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -60.84 -30.32 89.9 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 123.069 2.513 . . . . 0.0 114.366 -168.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 95.9 p -85.19 -6.56 59.27 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -61.5 119.21 44.75 Favored Pre-proline 0 CA--C 1.544 0.747 0 CA-C-N 119.635 1.107 . . . . 0.0 111.548 -177.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -73.47 127.38 11.75 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.415 2.077 . . . . 0.0 113.097 178.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.1 t -109.38 141.04 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.389 1.876 . . . . 0.0 109.374 174.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 20.2 tp -84.12 116.06 22.71 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.935 -0.478 . . . . 0.0 110.369 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.4 mp -115.67 148.28 39.88 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.961 1.704 . . . . 0.0 111.358 -173.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -107.0 81.54 1.56 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.877 0.846 . . . . 0.0 112.662 -173.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -119.0 78.81 1.32 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.691 1.196 . . . . 0.0 110.055 -169.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.6 t70 64.54 -14.79 0.09 Allowed 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 128.697 2.799 . . . . 0.0 115.602 -160.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.58 179.45 43.32 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 126.471 1.986 . . . . 0.0 111.506 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 73.0 mt -71.49 127.38 32.36 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.501 1.12 . . . . 0.0 109.981 178.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -153.33 144.93 23.34 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.902 0.881 . . . . 0.0 112.387 174.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -89.83 128.13 36.11 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.163 0.985 . . . . 0.0 110.879 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.0 t -131.65 128.94 21.93 Favored Pre-proline 0 N--CA 1.473 0.698 0 C-N-CA 124.584 1.154 . . . . 0.0 110.801 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -65.21 144.57 81.61 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.08 1.854 . . . . 0.0 110.974 175.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.44 -29.9 17.72 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 176.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.81 -23.0 67.19 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 173.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -108.83 0.76 20.49 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.302 1.841 . . . . 0.0 112.178 178.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.7 t -78.37 142.92 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.478 1.111 . . . . 0.0 110.014 166.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.74 154.94 73.24 Favored Pre-proline 0 N--CA 1.469 0.478 0 C-N-CA 126.202 1.801 . . . . 0.0 111.127 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -63.69 122.5 10.62 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.188 1.926 . . . . 0.0 109.978 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 102.08 5.27 50.23 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 124.355 0.979 . . . . 0.0 115.316 -176.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -64.38 165.08 10.23 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 118.956 1.378 . . . . 0.0 112.302 164.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.1 p -113.48 125.03 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.171 1.388 . . . . 0.0 111.744 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.3 t -101.64 142.92 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 127.938 2.495 . . . . 0.0 110.652 -173.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 43.8 t -99.99 143.35 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.842 1.257 . . . . 0.0 112.314 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -162.9 -152.12 6.67 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.826 1.679 . . . . 0.0 112.63 175.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.4 p -138.82 157.01 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 127.519 2.328 . . . . 0.0 108.873 -177.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 . . . . . 0 N--CA 1.476 0.834 0 C-N-CA 123.068 0.547 . . . . 0.0 110.815 179.029 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 N--CA 1.477 0.893 0 CA-C-O 122.4 1.095 . . . . 0.0 113.637 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 98.8 mt -66.03 138.98 58.16 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.003 1.721 . . . . 0.0 113.838 -177.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -131.11 149.88 52.4 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.439 1.496 . . . . 0.0 112.98 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -130.95 136.13 48.28 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.895 0.878 . . . . 0.0 113.142 -170.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -125.9 142.41 51.53 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.42 1.088 . . . . 0.0 111.297 -175.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -88.99 138.46 31.38 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.55 0.74 . . . . 0.0 110.894 174.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 71.9 t -72.41 126.26 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 O-C-N 120.705 -1.247 . . . . 0.0 110.115 172.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 28.2 t -77.71 -48.55 16.43 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.412 1.485 . . . . 0.0 111.629 172.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.72 170.54 20.57 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.412 -0.805 . . . . 0.0 111.588 176.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 11.1 m -132.81 155.24 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.772 1.229 . . . . 0.0 110.255 169.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -153.9 153.9 32.89 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.201 1.001 . . . . 0.0 112.391 168.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 96.3 mt -94.14 135.99 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.949 1.3 . . . . 0.0 108.091 168.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 28.2 pt -132.56 148.21 31.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 125.147 1.379 . . . . 0.0 111.029 -178.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -84.39 96.01 8.94 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 170.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -74.12 -45.95 45.68 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.096 -1.003 . . . . 0.0 112.105 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 47.12 40.51 9.97 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.559 1.143 . . . . 0.0 112.498 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -148.41 172.3 14.66 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.244 1.418 . . . . 0.0 110.763 -170.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -76.94 142.55 40.0 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 122.052 0.93 . . . . 0.0 112.638 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.36 157.53 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 126.557 1.943 . . . . 0.0 109.344 177.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.414 ' CE1' ' HB2' ' A' ' 2' ' ' PHE . 7.8 p90 -110.51 161.44 15.69 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.973 0.909 . . . . 0.0 112.016 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -137.38 154.03 50.08 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.865 0.866 . . . . 0.0 108.944 158.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.0 tt -129.05 108.99 10.82 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.738 -1.226 . . . . 0.0 108.823 -172.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.7 t -90.87 127.47 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -153.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 28.8 mm -124.18 85.84 54.7 Favored Pre-proline 0 N--CA 1.47 0.571 0 C-N-CA 125.627 1.571 . . . . 0.0 109.705 -172.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -64.65 -16.92 57.74 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.098 1.866 . . . . 0.0 113.816 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -78.45 -45.03 23.18 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.742 1.156 . . . . 0.0 113.089 -176.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 76.6 p -131.65 -8.52 3.62 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.338 1.455 . . . . 0.0 114.288 -172.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 54.73 15.68 1.17 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.555 1.542 . . . . 0.0 114.773 -165.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -143.45 142.48 31.22 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 121.248 1.84 . . . . 0.0 114.951 -175.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -141.74 162.91 34.31 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.383 1.473 . . . . 0.0 112.069 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 95.2 mt -112.29 130.62 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.281 1.032 . . . . 0.0 110.568 -173.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -77.74 160.1 75.18 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 124.151 0.981 . . . . 0.0 111.866 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -62.19 -20.12 68.91 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.577 2.185 . . . . 0.0 112.719 177.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -73.81 -12.21 60.62 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.039 1.336 . . . . 0.0 113.226 175.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 102.61 -22.43 37.38 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.851 1.691 . . . . 0.0 115.446 177.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 72.2 mt -72.14 148.12 45.98 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 119.479 1.639 . . . . 0.0 113.087 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.9 p -99.89 134.38 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.396 1.079 . . . . 0.0 112.48 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 41.4 mt -119.47 133.75 55.54 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.498 1.919 . . . . 0.0 110.913 -171.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 31.6 t-80 -86.23 126.56 34.36 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.606 -0.684 . . . . 0.0 110.379 165.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.542 0.655 0 C-N-CA 124.069 0.948 . . . . 0.0 109.464 170.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.878 0 CA-C-O 121.085 0.469 . . . . 0.0 111.983 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -131.01 160.26 35.1 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 127.014 2.126 . . . . 0.0 111.196 -175.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -55.46 145.86 21.57 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.379 1.071 . . . . 0.0 112.615 175.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -26.26 67.89 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -79.21 -8.26 58.88 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 175.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.0 m -63.11 134.8 56.63 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 121.063 -1.023 . . . . 0.0 111.29 -175.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -76.78 149.32 36.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 122.268 1.033 . . . . 0.0 113.719 175.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.0 p -145.35 152.14 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 124.595 1.158 . . . . 0.0 111.675 -173.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -122.06 143.26 49.62 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.766 2.026 . . . . 0.0 107.284 176.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -150.86 -175.88 5.31 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.427 0.691 . . . . 0.0 111.132 164.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -136.15 142.24 44.18 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.258 1.423 . . . . 0.0 110.624 174.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -164.04 151.21 11.95 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.879 2.071 . . . . 0.0 108.109 176.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.2 t0 50.95 43.18 28.86 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.791 1.237 . . . . 0.0 113.698 -177.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.5 m 56.66 35.18 25.76 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.625 1.57 . . . . 0.0 114.523 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.1 p -154.66 140.8 12.85 Favored Pre-proline 0 CA--C 1.538 0.482 0 O-C-N 120.505 -1.372 . . . . 0.0 112.012 177.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.35 144.87 57.67 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.588 2.192 . . . . 0.0 112.194 173.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -123.34 142.21 51.19 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 128.819 2.848 . . . . 0.0 108.806 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 41.6 ttm -153.29 120.43 5.8 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.678 -0.639 . . . . 0.0 111.634 -175.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -160.44 -172.43 3.55 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.47 1.908 . . . . 0.0 110.56 -176.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.4 m -76.16 150.08 37.21 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 120.639 -1.288 . . . . 0.0 110.541 167.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.2 tp -59.22 -36.36 62.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 O-C-N 121.019 -1.051 . . . . 0.0 111.985 177.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -59.71 -27.64 66.62 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.202 0.91 . . . . 0.0 113.455 173.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -81.46 -47.51 13.08 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.542 0.737 . . . . 0.0 110.194 -176.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.9 ppp? -68.27 -33.26 74.04 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 176.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -58.46 -50.05 75.1 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.428 0.691 . . . . 0.0 111.6 170.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.4 t -66.18 -29.61 69.93 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 121.646 -0.659 . . . . 0.0 111.973 -173.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -69.53 -57.13 5.6 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 126.39 1.876 . . . . 0.0 110.731 173.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -69.7 -34.86 74.51 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.282 -0.886 . . . . 0.0 112.89 -176.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.57 -24.79 64.65 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.303 1.041 . . . . 0.0 113.616 174.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 30.9 t -82.38 -35.27 27.91 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.765 0.712 . . . . 0.0 111.975 172.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 63.8 mtm -77.55 -58.08 3.46 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.85 0.86 . . . . 0.0 111.793 -178.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 47.2 m-20 -98.53 -20.02 17.29 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.828 1.251 . . . . 0.0 112.555 -171.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.7 159.35 33.2 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-O 121.941 0.745 . . . . 0.0 114.008 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -105.01 124.2 49.12 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.223 1.009 . . . . 0.0 110.577 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.6 mp -98.46 151.31 37.41 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 125.225 1.41 . . . . 0.0 110.488 174.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -69.09 156.12 66.05 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.834 2.356 . . . . 0.0 111.624 176.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -140.6 169.54 17.45 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.988 1.715 . . . . 0.0 110.26 174.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -48.93 -49.48 39.99 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -176.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -107.4 -13.43 15.1 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 177.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -161.21 -134.96 1.73 Allowed Glycine 0 CA--C 1.528 0.847 0 O-C-N 121.507 -0.745 . . . . 0.0 113.935 -167.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -140.69 154.72 46.49 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.284 1.034 . . . . 0.0 111.891 -177.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -135.95 145.4 46.17 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.774 1.23 . . . . 0.0 112.454 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 52.1 t -118.53 116.78 34.85 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 125.642 1.577 . . . . 0.0 110.758 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -71.34 138.23 32.54 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 124.091 3.194 . . . . 0.0 111.603 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 82.2 mt -107.18 158.13 17.34 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.974 1.31 . . . . 0.0 112.507 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -139.12 124.37 19.11 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.316 1.446 . . . . 0.0 109.444 174.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 51.33 51.2 17.35 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.797 1.639 . . . . 0.0 113.98 -178.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.4 t -116.41 128.71 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.408 1.483 . . . . 0.0 109.981 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -129.25 158.28 39.5 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.603 1.161 . . . . 0.0 113.364 -170.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.1 m -146.12 152.48 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 126.784 2.034 . . . . 0.0 112.269 176.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -61.7 131.45 49.99 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.402 1.481 . . . . 0.0 110.45 161.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.6 t -134.84 153.09 52.18 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.201 2.2 . . . . 0.0 111.565 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 37.6 tp -106.63 136.2 46.84 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.032 0.933 . . . . 0.0 112.169 -176.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -82.61 93.56 7.35 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.733 1.613 . . . . 0.0 110.173 170.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 31.7 mm -59.92 -21.82 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 O-C-N 120.854 -1.154 . . . . 0.0 112.888 -175.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.26 -50.12 64.84 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.081 -1.012 . . . . 0.0 113.455 175.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -111.91 -15.28 13.37 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.917 0.887 . . . . 0.0 112.652 -168.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.86 36.27 91.93 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.395 0.998 . . . . 0.0 112.105 -172.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -103.67 150.0 24.43 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.529 1.932 . . . . 0.0 111.084 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 mp -95.41 135.47 29.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 124.774 1.23 . . . . 0.0 110.801 -173.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.05 163.5 38.0 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.679 1.592 . . . . 0.0 112.569 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.4 150.19 20.65 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.232 1.413 . . . . 0.0 111.695 172.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.8 t -143.25 165.1 28.39 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.616 1.167 . . . . 0.0 111.787 167.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -91.58 153.38 19.78 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.142 1.377 . . . . 0.0 112.639 172.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -107.39 144.06 34.83 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.397 1.079 . . . . 0.0 111.487 170.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.6 t -97.64 -44.19 6.89 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.699 0.999 . . . . 0.0 113.699 -170.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -153.83 159.13 41.72 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.402 1.081 . . . . 0.0 112.761 173.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.2 mt -90.21 153.02 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.268 1.427 . . . . 0.0 108.398 164.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -137.41 148.42 46.16 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.051 1.34 . . . . 0.0 112.614 -177.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 37.3 ptt85 -138.29 145.89 41.8 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.836 1.254 . . . . 0.0 114.105 174.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -152.63 168.35 25.89 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.942 2.097 . . . . 0.0 110.314 177.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -110.26 139.56 45.31 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.285 1.434 . . . . 0.0 112.602 -175.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.1 m -148.48 146.82 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 124.794 1.238 . . . . 0.0 112.133 -176.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -104.32 -25.32 12.91 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 126.188 1.795 . . . . 0.0 112.923 174.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -122.23 118.05 27.63 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.64 1.109 . . . . 0.0 111.021 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.9 tp -128.03 159.15 35.92 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.813 2.045 . . . . 0.0 108.388 -175.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.1 mt -113.37 129.58 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 119.727 1.149 . . . . 0.0 109.146 177.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -103.76 117.24 33.9 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.769 0.828 . . . . 0.0 110.978 170.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.2 mp -102.84 125.58 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 C-N-CA 125.399 1.479 . . . . 0.0 108.241 175.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.4 tttt -95.46 147.75 23.2 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.057 1.343 . . . . 0.0 110.67 171.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 54.3 mt -117.67 160.57 21.09 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.364 1.466 . . . . 0.0 112.149 -172.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.7 t -64.76 -16.86 63.58 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.571 1.148 . . . . 0.0 112.979 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.2 p -70.37 -11.16 60.72 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.974 1.71 . . . . 0.0 114.214 167.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.76 -4.17 84.95 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 126.193 1.854 . . . . 0.0 113.985 -174.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -88.72 165.76 14.52 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.236 1.814 . . . . 0.0 112.151 -175.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.9 p -131.2 152.78 50.14 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 174.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 61.8 tp -127.94 129.28 46.56 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.63 1.972 . . . . 0.0 109.394 178.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -114.09 113.31 24.56 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.262 1.425 . . . . 0.0 111.15 -177.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.9 m -141.72 155.39 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 125.634 1.574 . . . . 0.0 113.036 -170.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.4 p -64.25 147.18 97.22 Favored Pre-proline 0 N--CA 1.469 0.513 0 O-C-N 121.212 -0.93 . . . . 0.0 112.677 175.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -62.83 -29.81 77.01 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.864 2.376 . . . . 0.0 113.589 -170.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.8 p -72.04 -10.93 60.46 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.196 1.798 . . . . 0.0 114.768 174.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -78.38 119.19 76.41 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 119.524 1.056 . . . . 0.0 112.787 -164.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -68.74 137.85 39.66 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.847 2.365 . . . . 0.0 113.207 -177.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.9 t -120.25 140.81 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 126.388 1.875 . . . . 0.0 109.156 175.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 39.5 tp -81.83 110.43 17.13 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 122.848 0.459 . . . . 0.0 110.158 178.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.0 mp -105.12 150.53 24.96 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.972 1.709 . . . . 0.0 111.801 -175.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -108.74 102.06 11.14 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.641 0.776 . . . . 0.0 111.792 171.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 59.0 mtt-85 -139.61 80.52 1.78 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.312 1.045 . . . . 0.0 111.6 174.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.9 t0 64.5 1.05 1.21 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 127.728 2.411 . . . . 0.0 115.148 -167.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 179.32 165.63 33.83 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 124.764 1.173 . . . . 0.0 113.018 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 39.6 mt -72.43 117.58 14.27 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.174 0.99 . . . . 0.0 111.133 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -145.63 137.09 25.06 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.22 1.008 . . . . 0.0 112.609 -176.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -91.79 121.85 33.79 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.209 1.004 . . . . 0.0 110.902 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 71.3 t -134.0 130.27 20.4 Favored Pre-proline 0 N--CA 1.48 1.039 0 C-N-CA 125.472 1.509 . . . . 0.0 109.561 -175.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.05 151.53 77.43 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 122.815 2.343 . . . . 0.0 112.797 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.47 -31.91 16.57 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 174.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.09 -23.31 67.28 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 173.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -106.07 -5.01 19.77 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.027 1.731 . . . . 0.0 112.082 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 89.9 t -69.53 147.07 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.592 1.157 . . . . 0.0 110.26 166.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.53 154.13 80.64 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 127.78 2.432 . . . . 0.0 110.625 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.56 116.15 3.93 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.431 2.087 . . . . 0.0 111.043 -178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.65 0.37 24.6 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.677 1.132 . . . . 0.0 114.948 -177.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -60.21 157.04 14.08 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 119.682 1.741 . . . . 0.0 112.119 169.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.6 t -95.65 126.05 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.542 1.137 . . . . 0.0 110.574 168.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.1 t -101.08 142.51 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 126.92 2.088 . . . . 0.0 110.09 173.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.1 t -90.63 137.62 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.852 0.861 . . . . 0.0 111.111 175.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -166.48 -150.87 6.54 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.298 0.951 . . . . 0.0 113.533 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.0 p -152.81 172.86 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 127.25 2.22 . . . . 0.0 109.895 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 . . . . . 0 N--CA 1.473 0.714 0 C-N-CA 125.051 1.34 . . . . 0.0 112.7 174.583 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 . . . . . 0 N--CA 1.481 1.076 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 43.4 mt -147.31 154.42 40.92 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.584 1.554 . . . . 0.0 111.968 172.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -149.7 127.75 11.95 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.101 1.76 . . . . 0.0 110.836 177.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -88.14 148.6 24.35 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.309 -0.869 . . . . 0.0 111.54 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -130.2 133.39 46.53 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.925 1.29 . . . . 0.0 109.622 -170.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -90.82 140.77 29.49 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 119.812 1.187 . . . . 0.0 111.847 175.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 78.4 t -74.8 139.65 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.16 0.984 . . . . 0.0 111.271 175.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.1 t -94.58 -48.27 6.17 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.503 1.921 . . . . 0.0 112.29 175.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 13.1 t -156.61 161.63 39.91 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.352 1.061 . . . . 0.0 111.551 -177.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.6 m -139.52 149.38 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 125.365 1.466 . . . . 0.0 111.512 168.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -161.85 168.76 22.49 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 160.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 43.9 mt -93.09 128.06 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.006 1.322 . . . . 0.0 110.004 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 31.6 pt -120.78 154.8 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 127.159 2.184 . . . . 0.0 112.485 -174.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -100.48 75.51 1.78 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.182 1.393 . . . . 0.0 111.159 -168.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -66.97 -47.89 70.17 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.26 -0.9 . . . . 0.0 112.465 -169.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 49.5 41.5 21.23 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.09 1.756 . . . . 0.0 111.941 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -146.17 176.62 9.61 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.114 1.366 . . . . 0.0 111.34 -171.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -74.42 147.0 42.44 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.008 0.923 . . . . 0.0 112.067 170.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 6.8 m -127.98 150.17 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.087 1.755 . . . . 0.0 109.484 175.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -118.34 156.8 28.29 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.526 0.73 . . . . 0.0 112.74 -173.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -155.64 151.41 27.43 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.481 1.113 . . . . 0.0 109.485 -165.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 38.0 tp -128.68 128.34 43.91 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.067 0.947 . . . . 0.0 111.782 -173.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 59.6 t -98.99 118.95 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.537 0.684 . . . . 0.0 112.742 -166.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 16.2 mm -124.41 86.87 54.63 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 127.451 2.3 . . . . 0.0 108.754 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -64.3 -17.82 61.04 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.837 2.358 . . . . 0.0 114.192 175.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -72.18 -55.62 6.95 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.705 1.139 . . . . 0.0 112.6 -177.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 67.7 p -124.97 -10.18 7.16 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.238 1.415 . . . . 0.0 113.9 -172.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 53.43 29.25 8.57 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -171.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -156.94 147.47 21.41 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 120.024 -1.673 . . . . 0.0 113.562 175.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -150.38 161.15 43.05 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.403 1.081 . . . . 0.0 112.076 176.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.7 mp -101.03 136.56 32.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 123.911 0.885 . . . . 0.0 111.486 -176.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -82.55 159.21 64.56 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 125.745 1.618 . . . . 0.0 112.456 173.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.01 -16.65 40.88 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.91 2.407 . . . . 0.0 113.68 -177.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -79.68 -1.09 36.8 Favored 'General case' 0 CA--C 1.556 1.194 0 O-C-N 121.398 -0.814 . . . . 0.0 112.487 170.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 97.91 -14.52 62.72 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.999 1.761 . . . . 0.0 115.65 175.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 57.9 mt -74.19 145.47 44.16 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.831 1.252 . . . . 0.0 111.953 -177.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.4 p -91.09 137.5 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 118.796 0.725 . . . . 0.0 112.318 174.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 67.5 mt -116.45 155.63 28.24 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.177 2.191 . . . . 0.0 110.78 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -100.87 155.44 17.94 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.935 0.894 . . . . 0.0 111.075 177.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 25.6 t30 . . . . . 0 CA--C 1.543 0.674 0 O-C-N 121.051 -1.031 . . . . 0.0 109.336 161.97 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -132.29 163.9 27.61 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 127.557 2.343 . . . . 0.0 111.183 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.3 145.09 54.69 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.64 1.176 . . . . 0.0 113.587 177.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -61.26 -24.28 66.27 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.545 1.138 . . . . 0.0 113.292 173.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -86.33 4.68 38.12 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.697 1.599 . . . . 0.0 113.658 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.6 m -74.25 141.06 45.39 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.047 0.939 . . . . 0.0 111.915 171.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -81.34 155.75 25.83 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.03 0.932 . . . . 0.0 113.038 169.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.0 p -148.07 155.8 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.957 0.903 . . . . 0.0 111.724 -173.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.47 139.22 54.24 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.151 1.78 . . . . 0.0 108.016 175.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -152.03 -179.06 7.16 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.951 0.9 . . . . 0.0 111.236 167.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -135.23 142.14 45.93 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.211 1.404 . . . . 0.0 111.082 177.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -164.14 159.08 19.92 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 127.618 2.367 . . . . 0.0 107.359 174.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.7 t0 53.49 32.94 15.03 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 m 58.73 33.21 22.91 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.894 1.278 . . . . 0.0 113.399 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.6 p -154.39 140.57 12.77 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 125.133 1.373 . . . . 0.0 112.527 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -70.02 150.85 67.2 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 123.13 2.553 . . . . 0.0 113.489 176.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -130.31 133.12 46.23 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 127.903 2.481 . . . . 0.0 108.744 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 39.9 ttm -145.75 113.11 6.23 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.074 0.95 . . . . 0.0 112.298 -175.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -162.79 -177.07 5.3 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.515 1.526 . . . . 0.0 112.606 -174.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.9 m -69.96 137.81 51.78 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.289 -0.882 . . . . 0.0 110.531 170.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.6 tp -55.68 -36.5 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 121.378 -0.826 . . . . 0.0 113.1 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -60.8 -26.93 67.64 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.522 1.129 . . . . 0.0 112.596 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -81.49 -42.83 19.69 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.477 1.111 . . . . 0.0 111.191 178.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.6 ptm -68.65 -32.21 71.9 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.331 0.969 . . . . 0.0 111.591 174.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -57.67 -48.97 78.01 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.562 0.745 . . . . 0.0 110.632 171.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.6 t -62.79 -38.07 89.21 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.629 0.772 . . . . 0.0 111.829 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -64.32 -52.37 58.82 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.004 1.321 . . . . 0.0 110.585 177.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -71.08 -34.3 71.03 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.409 -0.807 . . . . 0.0 113.018 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.21 -35.32 80.7 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.788 0.835 . . . . 0.0 111.535 172.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 66.7 m -74.54 -29.34 61.33 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.115 0.966 . . . . 0.0 112.647 178.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 66.5 mtm -86.86 -47.31 9.14 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.068 1.347 . . . . 0.0 113.237 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -116.92 -13.76 10.66 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.835 1.254 . . . . 0.0 113.825 -165.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.46 163.72 39.56 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 124.4 1.0 . . . . 0.0 114.4 175.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -113.75 126.21 54.97 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.885 1.274 . . . . 0.0 110.452 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.6 mp -105.42 151.33 39.69 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 127.247 2.219 . . . . 0.0 110.54 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -76.91 155.91 34.44 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 123.558 2.839 . . . . 0.0 112.973 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.75 162.92 34.28 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.197 1.399 . . . . 0.0 110.519 163.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.36 -54.1 36.16 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 120.854 -1.154 . . . . 0.0 113.496 -176.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -96.96 -6.91 34.44 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 177.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -163.17 -140.5 2.89 Favored Glycine 0 CA--C 1.534 1.244 0 N-CA-C 116.602 1.401 . . . . 0.0 116.602 -172.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -149.0 157.13 43.18 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.752 1.621 . . . . 0.0 112.958 -171.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.83 148.75 41.07 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.434 1.094 . . . . 0.0 113.531 -176.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 51.4 t -129.18 121.72 20.75 Favored Pre-proline 0 N--CA 1.48 1.056 0 C-N-CA 126.085 1.754 . . . . 0.0 111.534 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -80.55 132.99 9.24 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 124.379 3.386 . . . . 0.0 113.227 -175.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 78.0 mt -97.77 165.76 11.8 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.042 1.337 . . . . 0.0 113.682 179.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -148.97 121.21 8.36 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.94 1.296 . . . . 0.0 111.079 176.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 46.14 52.77 9.97 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.782 1.633 . . . . 0.0 112.823 -173.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.7 t -112.46 128.43 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.44 1.096 . . . . 0.0 108.577 174.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -134.4 161.29 35.41 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -168.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.1 p -152.84 148.66 13.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 124.306 1.042 . . . . 0.0 112.18 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -64.41 133.45 52.58 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 122.348 1.07 . . . . 0.0 109.93 166.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.7 t -138.38 153.59 48.92 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.803 2.041 . . . . 0.0 110.49 -171.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.0 tp -113.95 145.02 42.11 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.322 -0.861 . . . . 0.0 111.537 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -96.8 118.02 32.34 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 124.485 1.114 . . . . 0.0 110.845 164.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mp -80.53 -20.65 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 124.135 0.974 . . . . 0.0 112.457 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.65 -36.93 85.12 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.206 1.003 . . . . 0.0 113.459 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.4 m -121.11 -16.97 7.89 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.565 1.146 . . . . 0.0 112.827 173.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.21 23.69 39.82 Favored Glycine 0 N--CA 1.475 1.293 0 C-N-CA 124.173 0.892 . . . . 0.0 113.667 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -100.02 137.75 38.04 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.862 1.665 . . . . 0.0 112.745 -169.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 mp -75.7 144.83 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 125.636 1.575 . . . . 0.0 111.866 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -155.6 176.19 12.92 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 127.093 2.157 . . . . 0.0 111.629 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -129.08 141.86 51.08 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 125.14 1.376 . . . . 0.0 111.151 175.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -139.83 168.98 18.57 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.398 1.079 . . . . 0.0 113.287 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -92.2 147.95 22.54 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.178 1.391 . . . . 0.0 112.563 173.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.88 138.31 37.13 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.245 1.018 . . . . 0.0 110.311 167.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.0 t -94.28 -48.69 6.06 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -167.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.17 156.03 40.11 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.657 1.183 . . . . 0.0 111.629 175.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.7 mt -89.94 145.05 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.43 1.092 . . . . 0.0 108.414 165.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -128.52 150.65 50.08 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.949 1.7 . . . . 0.0 111.004 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.3 ptt-85 -143.63 151.35 40.02 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.201 1.0 . . . . 0.0 113.578 168.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -147.45 167.89 23.26 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.928 1.691 . . . . 0.0 110.938 175.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.54 146.89 23.8 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.621 0.768 . . . . 0.0 112.131 173.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.8 m -149.15 147.97 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 125.784 1.634 . . . . 0.0 111.522 171.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -100.31 -29.06 12.64 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.788 1.635 . . . . 0.0 112.36 175.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -122.23 128.76 51.54 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.513 1.125 . . . . 0.0 110.582 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 12.2 tp -135.45 160.86 37.13 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.841 1.657 . . . . 0.0 109.503 -174.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.7 mt -109.04 126.65 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 119.836 1.198 . . . . 0.0 109.653 175.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -102.46 119.93 39.66 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.775 1.23 . . . . 0.0 110.792 169.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -105.65 125.01 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.063 1.345 . . . . 0.0 108.478 173.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.6 tttt -92.33 146.54 23.61 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.675 1.19 . . . . 0.0 110.623 172.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 78.5 mt -106.57 160.48 15.4 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.769 1.627 . . . . 0.0 111.475 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.5 t -67.78 -11.42 58.43 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.626 1.17 . . . . 0.0 112.591 -176.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.6 p -81.44 -8.78 59.78 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 128.63 2.772 . . . . 0.0 114.947 168.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.65 -7.9 80.65 Favored Glycine 0 CA--C 1.54 1.632 0 C-N-CA 125.752 1.644 . . . . 0.0 115.362 -173.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -74.04 162.67 28.78 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.544 1.538 . . . . 0.0 111.201 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 86.3 p -140.41 146.02 37.79 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 66.8 tp -121.96 132.51 54.57 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.485 1.914 . . . . 0.0 110.068 176.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -117.03 116.5 27.47 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.871 1.668 . . . . 0.0 111.522 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.5 m -141.61 153.08 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.327 1.451 . . . . 0.0 113.082 -169.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.7 p -68.08 148.97 98.33 Favored Pre-proline 0 N--CA 1.466 0.372 0 O-C-N 121.258 -0.901 . . . . 0.0 111.66 171.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.22 -28.32 83.74 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.409 2.739 . . . . 0.0 114.346 -166.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.8 m -85.21 -4.96 59.34 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.39 1.255 . . . . 0.0 114.39 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 63.8 t60 -65.92 118.53 52.93 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 119.909 1.231 . . . . 0.0 111.918 -176.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -76.36 132.63 13.83 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.758 2.305 . . . . 0.0 113.441 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.3 t -111.33 143.82 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 126.111 1.765 . . . . 0.0 109.798 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 25.6 tp -81.31 102.0 10.14 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.014 0.526 . . . . 0.0 110.78 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.1 mp -98.96 153.64 18.68 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.971 1.709 . . . . 0.0 111.434 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -108.7 107.94 18.59 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.413 0.625 . . . . 0.0 112.593 176.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.414 ' C ' ' H ' ' A' ' 101' ' ' GLY . 36.4 mtp-105 -136.24 80.05 1.8 Allowed 'General case' 0 N--CA 1.479 1.004 0 O-C-N 120.861 -1.149 . . . . 0.0 110.211 -178.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 53.43 -3.25 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 127.657 2.383 . . . . 0.0 115.584 -156.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 99' ' ' ARG . . . -171.81 171.27 44.02 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 125.591 1.567 . . . . 0.0 113.206 -178.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 82.1 mt -76.3 115.16 15.77 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.45 1.9 . . . . 0.0 111.007 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -146.83 147.93 31.36 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -99.4 117.06 32.97 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.183 1.393 . . . . 0.0 111.375 -173.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.4 t -124.49 128.45 24.97 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 123.862 0.865 . . . . 0.0 109.908 -176.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -64.56 147.34 90.22 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.575 2.184 . . . . 0.0 111.419 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.26 -30.78 18.8 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 175.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.54 -21.36 66.16 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 173.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -105.06 4.02 31.09 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.84 2.056 . . . . 0.0 112.436 175.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.6 t -84.12 143.84 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.166 1.386 . . . . 0.0 111.099 169.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.34 155.17 81.07 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 126.995 2.118 . . . . 0.0 111.33 -177.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.52 118.45 5.6 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.006 2.47 . . . . 0.0 111.681 -175.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.74 5.88 35.63 Favored Glycine 0 CA--C 1.538 1.516 0 CA-C-O 119.12 -0.822 . . . . 0.0 115.139 -176.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -61.43 166.11 4.24 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.251 1.421 . . . . 0.0 112.474 166.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.3 p -116.79 131.69 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 125.84 1.656 . . . . 0.0 111.546 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.5 t -117.22 140.67 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 126.147 1.779 . . . . 0.0 110.632 -172.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.1 t -89.03 134.42 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 123.818 0.847 . . . . 0.0 110.943 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -160.05 -151.52 6.2 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 121.674 -0.641 . . . . 0.0 113.66 174.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.3 p -139.52 159.87 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 127.051 2.14 . . . . 0.0 108.981 173.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 . . . . . 0 N--CA 1.473 0.687 0 C-N-CA 123.84 0.856 . . . . 0.0 109.833 173.229 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 . . . . . 0 CA--C 1.541 0.632 0 CA-C-O 119.423 -0.323 . . . . 0.0 110.969 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 96.0 mt -139.32 163.14 33.28 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.923 1.289 . . . . 0.0 112.84 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -153.66 154.26 33.82 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.824 1.65 . . . . 0.0 112.658 172.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -78.15 153.39 32.11 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 120.961 -1.087 . . . . 0.0 113.848 178.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 43.9 m80 -131.27 158.21 41.21 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.992 1.717 . . . . 0.0 108.385 166.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -120.29 142.24 49.27 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 121.259 -0.901 . . . . 0.0 111.464 -173.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 99.3 t -76.36 132.96 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 121.767 -0.583 . . . . 0.0 110.885 172.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.6 t -91.3 -46.07 8.25 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.89 2.076 . . . . 0.0 111.725 172.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.4 t -158.36 169.54 24.24 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.04 -1.038 . . . . 0.0 111.284 175.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.5 m -133.68 148.95 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.086 1.354 . . . . 0.0 110.745 167.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -154.27 154.82 34.07 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.681 0.792 . . . . 0.0 112.686 167.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 96.9 mt -84.16 130.7 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 166.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 16.3 pt -123.95 158.6 30.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 126.362 1.865 . . . . 0.0 112.299 -174.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -94.46 94.5 8.27 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.127 1.371 . . . . 0.0 112.246 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -83.4 -56.29 3.83 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.459 -0.776 . . . . 0.0 112.771 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 51.82 36.83 18.97 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.081 0.953 . . . . 0.0 112.449 -177.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -150.98 172.97 14.87 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.142 1.377 . . . . 0.0 110.837 -172.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -75.04 138.83 42.44 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.997 0.903 . . . . 0.0 112.962 -176.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 15.5 m -120.25 153.97 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 126.046 1.738 . . . . 0.0 109.57 177.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -114.05 160.79 18.5 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.081 0.952 . . . . 0.0 112.568 -175.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -142.63 148.63 37.75 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.612 -0.68 . . . . 0.0 109.856 157.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 55.1 tp -108.5 119.58 39.92 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.684 1.193 . . . . 0.0 109.965 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 50.7 t -88.35 120.25 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -166.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 27.9 mm -118.66 86.93 30.76 Favored Pre-proline 0 N--CA 1.471 0.592 0 C-N-CA 125.833 1.653 . . . . 0.0 109.375 -177.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -70.9 -9.75 26.32 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.271 2.647 . . . . 0.0 113.995 -174.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -81.32 -60.57 2.23 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 118.898 0.772 . . . . 0.0 112.203 175.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 73.7 p -118.61 -10.67 10.0 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -171.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 66.6 m80 53.33 27.36 6.14 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.306 1.442 . . . . 0.0 114.692 -172.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.6 149.96 30.55 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 120.629 -1.294 . . . . 0.0 113.237 178.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -153.01 162.8 40.89 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.358 1.463 . . . . 0.0 111.415 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.8 mp -103.66 137.99 29.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 124.053 0.941 . . . . 0.0 110.945 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.76 156.82 64.51 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 123.944 0.898 . . . . 0.0 111.839 173.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -64.78 -23.76 62.41 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.553 2.169 . . . . 0.0 112.641 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -79.41 3.91 17.0 Favored 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 124.931 1.292 . . . . 0.0 112.711 174.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 105.96 -21.6 33.5 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.645 1.593 . . . . 0.0 116.612 164.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 64.4 mt -77.7 149.33 34.63 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.832 1.816 . . . . 0.0 113.818 -171.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 4.6 t -89.41 123.81 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.175 0.99 . . . . 0.0 110.646 174.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 54.6 mt -116.08 148.48 40.21 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.56 1.944 . . . . 0.0 111.629 -174.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -96.62 136.79 36.64 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.756 0.823 . . . . 0.0 110.873 170.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 . . . . . 0 CA--C 1.535 0.372 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 162.544 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.686 0 CA-C-O 121.063 0.459 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -140.01 164.78 29.11 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.369 1.468 . . . . 0.0 112.303 -178.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.3 151.3 47.73 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -172.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.65 -22.03 43.36 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 177.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -73.9 -21.63 60.0 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.392 1.477 . . . . 0.0 113.639 177.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.4 m -64.68 126.41 27.81 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.091 0.957 . . . . 0.0 112.017 -166.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -74.14 150.48 40.44 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 174.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.2 p -148.33 153.19 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.114 0.966 . . . . 0.0 111.683 -170.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -126.49 120.77 30.53 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.85 1.66 . . . . 0.0 108.79 -173.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -150.2 168.12 24.92 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -176.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -134.17 144.21 48.37 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.807 1.243 . . . . 0.0 111.041 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -160.92 136.56 8.01 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.175 0.99 . . . . 0.0 111.172 176.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.7 t70 54.53 47.62 22.31 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.1 1.36 . . . . 0.0 113.541 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.9 m 60.47 38.88 18.92 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 127.538 2.335 . . . . 0.0 114.127 176.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.4 p -154.12 140.18 12.57 Favored Pre-proline 0 CA--C 1.547 0.858 0 O-C-N 121.098 -1.001 . . . . 0.0 112.025 173.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -83.31 151.69 13.71 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 124.818 3.679 . . . . 0.0 113.625 175.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -133.91 145.5 49.66 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.472 2.309 . . . . 0.0 111.514 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 43.4 ttm -147.67 95.95 2.59 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.823 0.849 . . . . 0.0 111.503 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -148.64 -178.71 6.49 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.647 1.579 . . . . 0.0 111.952 -171.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.3 m -71.23 148.48 47.19 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 120.74 -1.225 . . . . 0.0 110.238 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.4 tp -57.17 -35.48 48.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 O-C-N 121.368 -0.832 . . . . 0.0 112.418 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -65.68 -29.76 70.36 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.577 1.08 . . . . 0.0 112.792 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -74.86 -42.83 57.15 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.316 1.046 . . . . 0.0 110.037 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -71.93 -40.2 68.92 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.56 -0.713 . . . . 0.0 111.666 176.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -54.27 -48.57 71.05 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.745 0.818 . . . . 0.0 110.939 175.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.0 t -66.59 -32.04 73.12 Favored 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -174.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.2 ttpt -65.53 -50.73 64.16 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.192 0.997 . . . . 0.0 110.131 177.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -70.38 -33.98 72.05 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.607 -0.683 . . . . 0.0 112.287 177.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.52 -22.46 63.58 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.226 -0.921 . . . . 0.0 113.198 173.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.7 m -92.88 -14.96 26.96 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.332 1.453 . . . . 0.0 113.475 176.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 72.6 mtm -97.06 -57.91 2.15 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.068 1.747 . . . . 0.0 112.005 174.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -94.27 -27.49 16.11 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.638 1.575 . . . . 0.0 111.985 -170.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.95 158.85 13.37 Favored Glycine 0 C--N 1.341 0.837 0 C-N-CA 125.248 1.404 . . . . 0.0 114.07 -177.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -104.91 150.49 24.83 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.683 1.193 . . . . 0.0 111.851 -170.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.2 mp -121.97 145.02 42.57 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 127.026 2.13 . . . . 0.0 111.569 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.32 156.35 37.19 Favored 'Trans proline' 0 C--O 1.24 0.616 0 C-N-CA 124.718 3.612 . . . . 0.0 112.848 -176.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -145.85 165.85 27.69 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -177.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -47.56 -53.81 13.48 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.5 1.92 . . . . 0.0 114.054 177.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -106.55 0.71 24.78 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 115.051 1.501 . . . . 0.0 115.051 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 177.78 -122.49 0.83 Allowed Glycine 0 CA--C 1.53 1.019 0 N-CA-C 115.966 1.146 . . . . 0.0 115.966 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -145.36 159.84 42.44 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.025 1.73 . . . . 0.0 111.28 -177.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.68 154.27 48.6 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.076 1.351 . . . . 0.0 111.998 -178.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 67.9 t -127.87 118.12 20.94 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 125.133 1.373 . . . . 0.0 110.44 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.49 138.55 42.5 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.986 3.124 . . . . 0.0 111.34 177.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 87.4 mt -111.49 157.84 19.84 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.673 1.189 . . . . 0.0 112.559 175.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -142.0 129.57 21.44 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.993 1.317 . . . . 0.0 111.023 169.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 59.97 33.03 21.38 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 126.692 1.997 . . . . 0.0 114.673 -177.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.1 t -100.19 137.74 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 O-C-N 120.359 -1.463 . . . . 0.0 111.309 176.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -132.99 154.53 50.42 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.328 1.851 . . . . 0.0 112.851 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.8 m -141.06 162.6 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 126.714 2.006 . . . . 0.0 110.84 174.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -89.36 145.86 25.07 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.328 -0.858 . . . . 0.0 111.847 172.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.5 t -148.47 152.16 36.44 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.259 1.824 . . . . 0.0 111.311 -167.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 48.3 tp -102.22 138.63 38.91 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.773 1.229 . . . . 0.0 109.963 173.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -87.92 130.69 34.85 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.794 0.837 . . . . 0.0 111.347 161.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 43.8 mm -77.21 -25.46 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 120.941 -1.099 . . . . 0.0 112.546 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.99 -42.68 31.94 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -169.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.4 m -112.99 -9.5 13.59 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.928 1.291 . . . . 0.0 112.861 174.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.05 28.71 66.01 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 123.659 0.647 . . . . 0.0 113.987 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -89.51 136.52 32.98 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.999 1.319 . . . . 0.0 110.685 -177.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 mp -88.54 126.85 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 174.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -147.92 169.74 19.19 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.612 1.165 . . . . 0.0 112.661 -173.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.5 ttmt -92.7 149.35 21.37 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.42 1.488 . . . . 0.0 110.438 174.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.1 t -146.21 158.93 43.91 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.199 1.0 . . . . 0.0 111.171 171.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.73 159.91 22.46 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 121.27 -0.894 . . . . 0.0 112.83 177.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.28 135.56 54.96 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.285 0.634 . . . . 0.0 111.38 168.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.8 t -88.78 -46.28 9.1 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.565 1.146 . . . . 0.0 112.676 -167.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -155.25 157.31 37.09 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.494 1.518 . . . . 0.0 111.398 174.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.4 mt -88.81 151.41 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.772 1.229 . . . . 0.0 108.53 167.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -140.27 149.82 43.31 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.857 1.263 . . . . 0.0 112.426 -175.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.9 ptp85 -132.39 155.73 47.94 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.696 1.198 . . . . 0.0 112.714 171.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -150.29 163.26 38.77 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.803 1.241 . . . . 0.0 110.338 167.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -96.94 145.21 26.12 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.351 1.06 . . . . 0.0 110.973 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.4 m -150.13 141.08 16.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 124.862 1.265 . . . . 0.0 110.297 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -83.1 -34.41 26.13 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.955 1.302 . . . . 0.0 110.921 171.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -131.93 132.35 43.48 Favored 'General case' 0 C--N 1.345 0.393 0 C-N-CA 123.942 0.897 . . . . 0.0 112.33 -169.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.5 tp -131.88 164.95 24.95 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.311 1.844 . . . . 0.0 109.678 -173.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.1 mt -112.16 123.83 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 119.587 1.085 . . . . 0.0 109.167 175.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -96.08 123.32 39.65 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.416 0.686 . . . . 0.0 111.489 166.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -108.77 123.18 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.083 1.353 . . . . 0.0 108.621 170.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.1 tttt -92.86 147.87 22.49 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.664 1.586 . . . . 0.0 109.952 173.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 87.8 mt -118.91 158.32 25.93 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.615 1.566 . . . . 0.0 112.337 -175.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.7 t -66.93 -10.41 48.69 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.694 1.198 . . . . 0.0 113.264 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 88.6 p -77.62 0.59 22.6 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 127.625 2.37 . . . . 0.0 114.899 165.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.58 -3.1 56.28 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 125.126 1.346 . . . . 0.0 114.522 -173.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -76.81 163.95 26.3 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.041 1.736 . . . . 0.0 111.957 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 60.4 p -142.2 144.67 33.5 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 165.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.8 tp -118.29 131.55 56.34 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.449 1.899 . . . . 0.0 110.02 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -111.23 114.93 28.49 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.385 1.474 . . . . 0.0 111.515 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.2 m -138.01 153.83 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 126.337 1.855 . . . . 0.0 112.215 -171.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.2 p -67.27 150.48 97.87 Favored Pre-proline 0 N--CA 1.471 0.618 0 O-C-N 120.906 -1.121 . . . . 0.0 112.354 171.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -60.21 -31.38 93.0 Favored 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 123.103 2.535 . . . . 0.0 114.32 -168.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.2 m -84.07 -0.96 53.9 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 49.5 t60 -73.85 117.11 58.43 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.927 1.291 . . . . 0.0 111.177 -175.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -68.35 132.06 24.81 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.04 2.494 . . . . 0.0 112.892 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.0 t -110.74 137.0 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 126.078 1.751 . . . . 0.0 109.422 174.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.13 112.39 19.77 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.7 mp -105.58 149.68 26.06 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.802 1.641 . . . . 0.0 112.212 -175.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -101.99 112.01 24.5 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.033 0.933 . . . . 0.0 112.454 172.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -143.49 80.43 1.67 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.645 1.178 . . . . 0.0 111.024 170.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 59.74 -15.16 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 128.203 2.601 . . . . 0.0 116.759 -164.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -162.67 168.06 37.39 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 126.026 1.775 . . . . 0.0 113.89 177.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.5 mt -72.01 116.11 12.03 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.104 1.762 . . . . 0.0 110.98 -176.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -144.87 139.79 27.92 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.65 0.78 . . . . 0.0 112.786 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -96.53 123.64 40.26 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.251 1.02 . . . . 0.0 112.052 -177.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 57.3 t -128.2 129.84 23.62 Favored Pre-proline 0 N--CA 1.48 1.044 0 C-N-CA 124.928 1.291 . . . . 0.0 109.738 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -64.68 148.37 90.24 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.856 2.371 . . . . 0.0 112.057 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.67 -32.14 18.35 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.28 -25.48 67.88 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 173.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -107.85 -1.34 20.89 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.777 1.631 . . . . 0.0 113.158 178.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 74.9 t -70.1 144.17 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 124.368 1.067 . . . . 0.0 109.655 166.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.86 156.95 77.01 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 127.098 2.159 . . . . 0.0 110.324 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -65.48 125.3 14.18 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.74 1.627 . . . . 0.0 110.776 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 103.22 0.42 47.57 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.649 1.119 . . . . 0.0 114.931 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -57.95 153.73 13.75 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.176 0.991 . . . . 0.0 111.309 167.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.4 t -97.64 122.2 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.062 0.945 . . . . 0.0 109.957 172.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.2 t -94.12 141.48 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 126.68 1.992 . . . . 0.0 110.016 173.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 59.4 t -92.62 131.59 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.959 0.904 . . . . 0.0 110.399 172.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -155.08 -150.86 5.67 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.028 1.299 . . . . 0.0 111.644 176.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.8 p -143.8 169.28 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.227 1.411 . . . . 0.0 111.118 177.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 . . . . . 0 N--CA 1.472 0.673 0 C-N-CA 127.332 2.253 . . . . 0.0 110.153 177.492 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 . . . . . 0 N--CA 1.472 0.645 0 CA-C-O 120.763 0.316 . . . . 0.0 111.796 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 97.0 mt -136.9 157.47 46.66 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.689 1.596 . . . . 0.0 112.062 -172.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -132.66 132.78 42.79 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.372 1.469 . . . . 0.0 112.007 174.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -87.49 143.61 27.13 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.593 1.157 . . . . 0.0 112.518 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -131.11 136.57 48.5 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.739 1.616 . . . . 0.0 110.115 -174.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -85.36 137.12 33.15 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.97 -1.081 . . . . 0.0 112.828 176.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 97.6 t -69.93 122.51 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.101 0.961 . . . . 0.0 111.372 163.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.4 t -81.77 -53.04 6.53 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.791 1.636 . . . . 0.0 112.329 176.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.5 m -154.92 156.3 35.84 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.346 1.058 . . . . 0.0 111.921 177.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.4 m -128.63 148.13 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.043 0.937 . . . . 0.0 111.33 176.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -157.93 156.13 30.76 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.849 0.86 . . . . 0.0 112.015 169.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 74.6 mt -80.58 145.43 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 160.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 44.8 pt -131.25 153.49 39.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 126.515 1.926 . . . . 0.0 110.076 177.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -88.29 108.02 19.11 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 122.581 1.182 . . . . 0.0 109.904 169.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -83.35 -50.48 8.31 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.363 1.865 . . . . 0.0 112.355 174.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 42.23 51.5 4.54 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.847 1.659 . . . . 0.0 111.76 -172.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -155.84 177.28 11.58 Favored 'General case' 0 CA--C 1.552 1.037 0 O-C-N 121.257 -0.902 . . . . 0.0 113.099 -175.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -77.65 134.95 38.06 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.182 1.393 . . . . 0.0 112.928 174.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 5.9 m -114.29 153.63 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.34 1.456 . . . . 0.0 109.664 175.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -119.81 159.62 24.21 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -171.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -155.04 157.59 37.81 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 113.614 -1.63 . . . . 0.0 110.289 -172.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 41.5 tp -134.82 119.07 17.69 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.92 0.888 . . . . 0.0 109.391 -175.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 51.9 t -86.93 118.03 32.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.154 0.502 . . . . 0.0 111.749 -165.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 29.7 mm -115.29 94.09 38.1 Favored Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 124.944 1.297 . . . . 0.0 109.194 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.4 -12.47 33.66 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.732 2.288 . . . . 0.0 113.339 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -79.45 -64.04 1.28 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 119.039 0.836 . . . . 0.0 112.586 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 76.0 p -114.48 -13.7 12.19 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.174 1.39 . . . . 0.0 114.459 -173.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 63.05 15.01 8.1 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -169.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -150.79 151.93 33.05 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 120.21 1.368 . . . . 0.0 113.257 -175.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -152.55 179.67 8.38 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.788 1.235 . . . . 0.0 112.241 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 85.1 mt -123.62 138.88 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.689 1.196 . . . . 0.0 111.473 -170.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -93.32 154.6 41.4 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.931 1.292 . . . . 0.0 112.302 173.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -66.76 -16.21 49.58 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.789 2.992 . . . . 0.0 114.054 -174.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -72.42 -3.55 24.86 Favored 'General case' 0 CA--C 1.556 1.179 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 170.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.9 -8.92 68.18 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.555 1.55 . . . . 0.0 114.919 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 66.9 mt -79.55 144.66 33.7 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.886 1.274 . . . . 0.0 111.99 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.2 p -89.86 139.07 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.135 0.974 . . . . 0.0 111.035 173.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 74.1 mt -118.19 152.21 36.11 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.855 2.062 . . . . 0.0 111.114 178.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -120.33 148.56 43.58 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.89 0.876 . . . . 0.0 112.93 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.545 0.773 0 C-N-CA 124.112 0.965 . . . . 0.0 113.47 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.93 0 N-CA-C 110.763 -0.088 . . . . 0.0 110.763 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.03 162.57 33.78 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.775 1.23 . . . . 0.0 112.615 -173.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -55.91 145.3 25.37 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.946 1.699 . . . . 0.0 113.317 176.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.0 ppt_? -63.75 -22.71 67.04 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 172.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -83.19 3.66 30.03 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.6 m -69.75 150.97 46.35 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.797 1.239 . . . . 0.0 112.883 170.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -101.52 155.35 18.13 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.16 1.784 . . . . 0.0 113.169 174.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 p -148.15 158.35 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.511 0.724 . . . . 0.0 112.484 -168.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -127.34 126.36 42.4 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.387 1.875 . . . . 0.0 108.698 -174.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -153.32 173.41 15.64 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -128.15 144.43 51.12 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.588 1.155 . . . . 0.0 111.378 168.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -165.19 154.01 12.19 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.62 1.568 . . . . 0.0 110.052 174.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.9 t70 48.98 44.38 22.5 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.83 1.252 . . . . 0.0 114.181 -175.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.9 m 58.06 37.32 26.51 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.544 1.538 . . . . 0.0 114.023 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.2 p -157.7 142.47 11.96 Favored Pre-proline 0 CA--C 1.551 0.992 0 O-C-N 120.562 -1.336 . . . . 0.0 112.964 176.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.24 152.31 39.53 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 124.567 3.511 . . . . 0.0 113.516 174.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -136.62 142.63 43.28 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.742 2.017 . . . . 0.0 111.371 -175.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 52.2 ttm -147.35 86.39 1.62 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.208 1.003 . . . . 0.0 110.979 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -137.46 -179.2 5.59 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.532 1.533 . . . . 0.0 112.491 -174.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.9 m -73.17 140.91 47.33 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 120.759 -1.213 . . . . 0.0 110.637 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.405 HG12 ' CD2' ' A' ' 152' ' ' TYR . 9.3 tp -58.0 -36.12 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 O-C-N 121.303 -0.873 . . . . 0.0 112.958 -178.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.01 -24.77 68.07 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.758 -0.589 . . . . 0.0 112.455 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -79.09 -49.25 12.93 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.028 0.931 . . . . 0.0 109.916 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 20.7 ptm -65.85 -33.0 74.84 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.606 -0.684 . . . . 0.0 112.114 175.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -54.88 -49.87 70.12 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.295 0.952 . . . . 0.0 111.207 172.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 39.9 t -61.29 -39.48 90.59 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.348 1.059 . . . . 0.0 111.486 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -65.32 -53.46 43.43 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.319 1.447 . . . . 0.0 110.932 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -72.84 -31.5 64.81 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.249 -0.907 . . . . 0.0 112.473 -177.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.43 -32.26 73.52 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.129 -0.982 . . . . 0.0 111.907 170.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 60.4 m -79.2 -26.03 42.63 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.664 0.786 . . . . 0.0 112.864 178.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 61.2 mtm -91.53 -46.61 7.87 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.24 1.416 . . . . 0.0 113.264 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -112.22 -13.91 13.43 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.034 1.334 . . . . 0.0 113.572 -169.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.9 163.75 35.94 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.849 1.214 . . . . 0.0 114.573 178.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -111.38 134.85 52.67 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.189 1.395 . . . . 0.0 110.014 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.5 mp -116.75 148.46 42.07 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 126.14 1.776 . . . . 0.0 111.617 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -70.65 143.44 46.55 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.38 2.72 . . . . 0.0 111.349 175.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -130.07 169.53 15.18 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.876 1.67 . . . . 0.0 111.149 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.91 -52.8 62.83 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 120.975 -1.078 . . . . 0.0 113.538 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -99.86 -8.86 23.56 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.98 -134.25 1.76 Allowed Glycine 0 CA--C 1.53 0.994 0 CA-C-N 119.137 0.88 . . . . 0.0 114.235 -172.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -135.27 151.3 50.45 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.14 1.776 . . . . 0.0 112.066 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.25 142.59 39.89 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.4 1.08 . . . . 0.0 112.784 -174.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.9 t -116.38 111.62 41.99 Favored Pre-proline 0 N--CA 1.474 0.74 0 C-N-CA 126.653 1.981 . . . . 0.0 109.638 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -65.17 139.69 61.72 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.867 3.044 . . . . 0.0 110.931 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.0 mt -110.06 165.13 11.98 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.601 1.16 . . . . 0.0 111.941 176.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -144.16 127.0 16.28 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.75 1.62 . . . . 0.0 110.123 169.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 50.5 46.81 25.01 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.387 1.075 . . . . 0.0 113.306 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.8 t -111.4 116.92 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.18 0.992 . . . . 0.0 108.797 173.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -113.63 151.8 31.24 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -167.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.6 m -135.82 154.13 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.494 1.518 . . . . 0.0 111.565 174.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -66.74 133.25 49.78 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 161.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.0 t -135.52 145.28 46.9 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.737 1.615 . . . . 0.0 110.54 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.4 tp -99.87 136.51 39.68 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.792 0.837 . . . . 0.0 110.351 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -85.46 91.43 8.22 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.755 1.222 . . . . 0.0 109.422 171.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.7 mm -58.97 -25.22 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 119.372 0.987 . . . . 0.0 112.282 -171.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.69 -45.92 87.86 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.63 1.172 . . . . 0.0 114.108 175.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 m -107.67 -22.75 12.38 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.632 1.173 . . . . 0.0 112.61 -173.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.44 25.16 66.26 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.642 1.592 . . . . 0.0 113.281 -169.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -90.49 141.39 28.8 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.177 1.391 . . . . 0.0 112.061 -175.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.2 mp -90.83 122.41 42.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 125.042 1.337 . . . . 0.0 110.681 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -146.91 179.23 7.74 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.773 1.629 . . . . 0.0 112.093 -177.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -110.89 152.27 26.91 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.886 1.674 . . . . 0.0 111.358 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.3 t -147.65 162.08 39.87 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.61 -0.681 . . . . 0.0 110.852 165.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -94.41 142.78 27.03 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.091 0.957 . . . . 0.0 112.335 173.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.41 143.8 26.77 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.555 0.742 . . . . 0.0 111.311 174.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 84.4 p -84.5 -48.34 9.69 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.437 1.095 . . . . 0.0 112.454 -172.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -151.86 159.95 43.69 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.306 1.842 . . . . 0.0 112.191 173.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.5 mt -86.73 146.98 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 160.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -132.9 148.11 52.29 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 125.246 1.418 . . . . 0.0 110.927 -175.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -146.13 150.23 35.51 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 165.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -146.99 165.97 28.23 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.183 1.793 . . . . 0.0 110.878 173.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.45 146.78 23.84 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.194 -0.941 . . . . 0.0 112.8 -177.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.1 m -147.53 151.36 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.366 1.066 . . . . 0.0 112.299 173.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -113.36 -5.37 13.56 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.988 2.115 . . . . 0.0 113.184 177.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -138.43 119.21 14.14 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.792 1.637 . . . . 0.0 109.992 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.6 tp -133.24 159.35 40.46 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.812 1.645 . . . . 0.0 109.601 -175.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 13.5 mt -110.48 127.72 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 119.245 0.93 . . . . 0.0 109.492 176.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -98.68 127.63 44.67 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.406 1.082 . . . . 0.0 111.048 167.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.8 mp -112.9 126.07 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.152 1.381 . . . . 0.0 109.77 172.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -91.68 143.41 26.58 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.662 1.585 . . . . 0.0 110.48 171.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 83.9 mt -113.32 156.45 23.36 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.091 1.357 . . . . 0.0 112.113 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.1 t -59.55 -26.4 65.34 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.251 1.42 . . . . 0.0 112.005 174.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 94.2 p -64.57 -16.72 63.11 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.207 1.403 . . . . 0.0 114.477 171.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.33 4.04 74.55 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 125.919 1.723 . . . . 0.0 114.505 -174.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -85.22 158.73 20.27 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.889 1.675 . . . . 0.0 110.729 172.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 84.5 p -137.66 142.64 41.13 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 165.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.8 tp -121.48 140.62 51.94 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.73 2.012 . . . . 0.0 110.09 -172.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -121.16 116.56 25.19 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.189 1.396 . . . . 0.0 112.165 -174.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.1 m -139.81 154.78 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.286 1.434 . . . . 0.0 112.899 -167.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.1 p -65.79 148.1 98.41 Favored Pre-proline 0 N--CA 1.471 0.598 0 O-C-N 120.912 -1.117 . . . . 0.0 111.572 173.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.08 -29.47 87.16 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.166 2.578 . . . . 0.0 113.535 -173.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 32.9 p -84.62 0.2 51.03 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.178 2.191 . . . . 0.0 114.875 177.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -73.95 116.47 52.49 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 119.89 1.223 . . . . 0.0 112.023 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -77.9 127.13 8.41 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.681 2.254 . . . . 0.0 112.468 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 38.4 t -107.0 142.08 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 126.095 1.758 . . . . 0.0 109.43 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 22.4 tp -80.68 113.29 18.78 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 122.588 0.355 . . . . 0.0 110.693 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.8 mp -109.38 147.54 32.59 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.655 1.582 . . . . 0.0 112.701 -172.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -96.18 95.21 7.98 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.55 1.54 . . . . 0.0 109.569 170.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -130.35 71.88 1.47 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.288 1.435 . . . . 0.0 109.662 174.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.9 t70 63.37 -15.88 0.07 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 128.712 2.805 . . . . 0.0 115.866 -163.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -168.51 159.34 32.46 Favored Glycine 0 CA--C 1.522 0.524 0 O-C-N 121.189 -0.945 . . . . 0.0 114.09 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 59.6 mt -61.21 112.72 2.24 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.786 1.634 . . . . 0.0 110.95 -175.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -145.85 145.33 30.71 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -93.15 119.62 32.55 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.571 1.148 . . . . 0.0 110.895 -178.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 57.7 t -127.61 130.08 23.72 Favored Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 124.073 0.949 . . . . 0.0 110.081 -178.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -65.37 147.88 87.72 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.872 2.382 . . . . 0.0 111.82 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.1 -31.89 20.63 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 174.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.52 -18.42 65.36 Favored 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 173.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -108.57 2.09 21.86 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.237 1.815 . . . . 0.0 112.477 173.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.5 t -78.26 143.32 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 120.875 -1.141 . . . . 0.0 109.993 168.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.65 151.54 78.23 Favored Pre-proline 0 N--CA 1.471 0.596 0 C-N-CA 127.505 2.322 . . . . 0.0 110.682 -177.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -65.22 116.19 3.73 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.418 2.079 . . . . 0.0 110.798 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.7 2.22 34.69 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 124.571 1.082 . . . . 0.0 115.543 -173.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -56.59 159.94 3.54 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.804 1.302 . . . . 0.0 111.912 162.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.6 t -116.78 125.4 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 123.936 0.894 . . . . 0.0 110.042 175.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.6 t -100.78 145.19 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 126.774 2.03 . . . . 0.0 110.279 -178.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 44.1 t -86.05 135.99 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.818 1.247 . . . . 0.0 109.926 175.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -166.68 -149.56 6.02 Favored Glycine 0 CA--C 1.529 0.915 0 O-C-N 121.952 -0.468 . . . . 0.0 113.837 178.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.3 p -151.07 162.43 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 125.403 1.481 . . . . 0.0 110.579 175.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 42.4 mtm105 . . . . . 0 N--CA 1.465 0.302 0 C-N-CA 124.696 1.198 . . . . 0.0 111.065 172.479 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 91.3 mt -140.46 163.49 32.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.219 1.807 . . . . 0.0 111.73 -177.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -146.35 161.8 39.55 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.443 1.897 . . . . 0.0 111.882 -176.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -107.12 149.17 27.94 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.924 0.89 . . . . 0.0 112.096 170.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -128.48 119.05 24.15 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.354 1.061 . . . . 0.0 108.497 173.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -85.22 144.19 28.29 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 120.94 -1.1 . . . . 0.0 111.786 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 97.1 t -76.36 142.87 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 125.418 1.487 . . . . 0.0 111.027 174.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 26.0 t -100.76 -50.03 3.98 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.438 1.895 . . . . 0.0 112.506 174.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 13.9 m -149.5 156.37 41.88 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.134 1.373 . . . . 0.0 111.035 -175.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.4 m -134.97 147.09 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.893 0.877 . . . . 0.0 111.97 169.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -154.99 156.87 36.76 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 176.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 90.9 mt -92.27 138.42 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.69 1.196 . . . . 0.0 108.499 168.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 16.0 pt -132.83 155.87 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 126.388 1.875 . . . . 0.0 111.587 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -96.07 94.54 7.61 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 122.122 0.963 . . . . 0.0 112.491 173.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -72.34 -43.47 64.03 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 8.0 m120 49.22 38.79 14.18 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.849 1.66 . . . . 0.0 113.583 -178.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -154.15 175.62 13.24 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.627 1.171 . . . . 0.0 111.109 -170.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -72.28 141.53 48.89 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.157 0.983 . . . . 0.0 113.218 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.8 m -122.53 153.96 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 126.465 1.906 . . . . 0.0 109.614 173.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.405 ' CD2' HG12 ' A' ' 21' ' ' ILE . 3.4 p90 -113.59 164.66 13.38 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -174.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -140.07 159.98 40.96 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.547 151.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.1 tt -127.06 98.86 5.47 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.182 0.993 . . . . 0.0 108.796 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 98.9 t -82.73 128.25 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -148.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 23.3 mm -116.59 100.61 53.54 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 124.767 1.227 . . . . 0.0 109.445 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -73.16 -13.33 25.87 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.356 2.037 . . . . 0.0 113.101 176.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 76.7 tt0 -74.0 -67.76 0.58 Allowed 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.815 1.188 . . . . 0.0 111.97 174.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 68.6 p -109.83 -7.97 14.95 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.928 1.291 . . . . 0.0 114.215 -169.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 56.42 21.23 5.36 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.929 1.291 . . . . 0.0 114.468 -169.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.37 145.56 26.18 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 -178.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -138.66 166.84 23.33 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.04 1.336 . . . . 0.0 112.416 176.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.8 mp -110.21 135.45 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.731 1.212 . . . . 0.0 111.634 177.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -86.5 156.62 56.32 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.091 0.956 . . . . 0.0 112.568 171.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -67.3 -11.99 34.22 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.826 3.017 . . . . 0.0 113.875 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -70.27 -17.82 63.11 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 121.767 -0.583 . . . . 0.0 112.443 168.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 115.23 -24.69 10.42 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 126.46 1.981 . . . . 0.0 115.069 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 50.0 mt -68.73 151.82 46.16 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.807 1.643 . . . . 0.0 113.63 -170.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 4.1 t -104.02 122.82 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 124.977 1.311 . . . . 0.0 111.96 176.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.8 144.27 43.77 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.355 1.862 . . . . 0.0 112.868 -170.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 62.7 t60 -96.61 150.48 20.61 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.136 0.975 . . . . 0.0 113.183 169.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 16.9 m120 . . . . . 0 CA--C 1.546 0.795 0 N-CA-C 115.533 1.679 . . . . 0.0 115.533 177.628 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.7 166.51 22.77 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.446 1.898 . . . . 0.0 111.772 -174.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.45 146.88 54.06 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.244 1.418 . . . . 0.0 114.608 -176.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -67.85 -21.22 65.19 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.748 1.219 . . . . 0.0 113.96 175.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -84.76 -3.66 58.7 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 174.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.2 m -65.16 141.65 58.61 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 119.363 0.983 . . . . 0.0 113.233 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -79.35 147.89 32.25 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.581 1.152 . . . . 0.0 112.917 170.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 p -146.39 156.77 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.498 1.119 . . . . 0.0 112.328 -172.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -126.28 135.19 51.24 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.844 2.058 . . . . 0.0 108.088 177.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -153.59 176.09 12.47 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.493 0.717 . . . . 0.0 112.249 169.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -131.85 140.98 49.29 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.148 1.379 . . . . 0.0 110.819 174.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -162.12 166.19 26.06 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.713 2.005 . . . . 0.0 108.328 174.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.4 t70 58.99 24.73 12.98 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 120.176 1.353 . . . . 0.0 113.2 170.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 63.55 29.81 15.22 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.158 1.783 . . . . 0.0 114.8 -171.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.8 p -152.78 141.75 14.31 Favored Pre-proline 0 CA--C 1.548 0.884 0 O-C-N 119.678 -1.889 . . . . 0.0 113.473 -176.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.33 152.96 50.38 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.713 2.942 . . . . 0.0 112.595 173.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -135.75 142.59 44.99 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.033 2.133 . . . . 0.0 109.96 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 35.9 ttm -153.24 106.21 2.96 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.035 0.534 . . . . 0.0 111.555 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -157.14 -179.54 8.3 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.444 1.898 . . . . 0.0 111.682 -172.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.7 m -67.73 138.49 56.29 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.219 -0.926 . . . . 0.0 110.013 170.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.6 tp -55.9 -37.33 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -176.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -69.53 -16.67 63.48 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.84 1.2 . . . . 0.0 112.755 -178.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -80.44 -46.55 15.75 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.416 1.086 . . . . 0.0 109.836 177.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -67.92 -34.62 76.96 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 122.015 -0.428 . . . . 0.0 112.079 173.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -58.59 -49.97 75.52 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.497 0.719 . . . . 0.0 110.835 172.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.5 t -68.99 -30.3 68.68 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.263 0.625 . . . . 0.0 111.513 -176.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -64.67 -54.04 37.89 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.43 1.492 . . . . 0.0 110.514 172.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -69.4 -33.85 73.63 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.203 -0.936 . . . . 0.0 112.347 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.33 -19.1 64.64 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 121.104 -0.997 . . . . 0.0 113.309 174.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.0 m -96.04 -7.64 35.69 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.874 1.669 . . . . 0.0 113.855 174.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 59.2 mtm -113.08 -49.51 2.92 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.756 1.623 . . . . 0.0 112.895 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -102.33 -19.59 14.94 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.175 1.79 . . . . 0.0 112.021 -174.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.96 166.59 42.33 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.589 1.09 . . . . 0.0 114.103 174.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -112.89 130.19 56.2 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.731 1.212 . . . . 0.0 110.465 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.2 mp -119.38 148.87 46.44 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 126.431 1.893 . . . . 0.0 110.808 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -72.06 162.31 42.18 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.452 2.768 . . . . 0.0 113.977 -173.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -145.45 170.07 17.1 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.047 1.739 . . . . 0.0 110.847 175.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -60.03 -58.23 9.42 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.546 1.138 . . . . 0.0 113.151 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -90.56 -3.87 57.28 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 176.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.93 -128.31 1.15 Allowed Glycine 0 CA--C 1.534 1.239 0 CA-C-N 120.322 1.419 . . . . 0.0 116.504 -177.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -139.56 161.07 38.39 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.092 1.757 . . . . 0.0 111.668 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.6 159.74 41.54 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.571 1.148 . . . . 0.0 112.691 177.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 81.6 t -127.17 113.47 21.63 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 125.782 1.633 . . . . 0.0 109.855 176.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -65.71 142.42 70.18 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 124.25 3.3 . . . . 0.0 111.263 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.2 mt -116.12 151.97 34.58 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 122.608 1.194 . . . . 0.0 112.853 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -133.84 129.74 36.9 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.824 1.249 . . . . 0.0 110.581 170.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 57.84 33.68 23.49 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.209 1.404 . . . . 0.0 114.157 176.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.3 t -101.68 133.7 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.492 1.517 . . . . 0.0 110.031 174.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -132.39 154.18 50.06 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.927 1.691 . . . . 0.0 112.912 -174.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.3 m -146.68 158.6 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 127.725 2.41 . . . . 0.0 110.542 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -79.32 149.06 31.87 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.013 -1.054 . . . . 0.0 112.232 170.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.0 t -148.24 157.17 43.34 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.904 1.682 . . . . 0.0 111.81 -169.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 38.6 tp -112.35 134.22 54.01 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.05 1.34 . . . . 0.0 110.226 176.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -83.46 104.12 13.36 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 163.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 mm -63.32 -29.94 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-N 120.935 1.698 . . . . 0.0 111.546 -177.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.77 -45.31 90.36 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.071 1.348 . . . . 0.0 113.241 -177.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.8 m -101.84 -20.24 14.98 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.918 0.887 . . . . 0.0 112.465 177.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.25 37.72 81.16 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.981 1.277 . . . . 0.0 112.42 -170.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -103.01 136.33 43.02 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.393 1.877 . . . . 0.0 110.644 -177.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 mp -93.7 127.69 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.7 pttt -144.86 169.65 17.64 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.987 1.315 . . . . 0.0 112.072 -177.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -103.5 143.46 32.69 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.959 0.904 . . . . 0.0 110.887 175.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.6 t -142.44 162.08 36.38 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.017 1.327 . . . . 0.0 112.62 -175.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -81.74 151.73 27.34 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 173.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -107.69 138.66 43.51 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.778 0.831 . . . . 0.0 110.942 164.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.9 t -91.86 -46.83 7.65 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.978 1.311 . . . . 0.0 113.255 -169.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -150.73 158.49 44.21 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.868 1.267 . . . . 0.0 111.559 172.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.1 mt -87.25 153.22 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 162.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -139.05 149.65 44.87 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.304 1.441 . . . . 0.0 111.715 -175.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 21.6 ptt-85 -139.12 150.5 45.74 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.769 1.228 . . . . 0.0 113.547 169.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -144.53 159.56 42.57 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.152 1.781 . . . . 0.0 109.445 172.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -102.91 136.43 42.74 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.133 0.879 . . . . 0.0 110.788 -176.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.9 m -144.87 145.48 20.97 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-O 122.324 1.059 . . . . 0.0 111.962 -176.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -97.48 -28.64 13.89 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 125.987 1.715 . . . . 0.0 111.867 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -120.28 128.69 53.54 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.544 1.138 . . . . 0.0 110.385 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.8 tp -131.89 160.69 34.97 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.342 1.457 . . . . 0.0 109.781 178.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.0 mt -113.4 126.21 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 119.858 1.208 . . . . 0.0 109.123 175.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -97.15 120.6 37.81 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.465 1.106 . . . . 0.0 111.119 169.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -109.55 122.22 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.496 1.518 . . . . 0.0 109.266 173.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -90.68 146.09 24.3 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.254 1.822 . . . . 0.0 110.601 175.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.6 mt -115.92 158.63 22.72 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.497 1.519 . . . . 0.0 111.74 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.5 t -61.71 -20.0 63.02 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.396 1.079 . . . . 0.0 113.561 -176.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 78.1 p -85.3 4.76 33.51 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.27 1.828 . . . . 0.0 115.619 172.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.78 10.04 86.49 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 124.306 0.955 . . . . 0.0 114.652 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -76.52 152.82 35.91 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.996 1.319 . . . . 0.0 109.829 166.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 80.5 p -135.68 135.62 40.26 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 165.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.9 tp -109.42 137.22 47.6 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.906 1.682 . . . . 0.0 109.755 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt -119.64 117.83 29.33 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.86 1.264 . . . . 0.0 111.105 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.5 m -139.15 153.49 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.994 1.318 . . . . 0.0 112.479 -168.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.8 p -64.87 145.66 98.9 Favored Pre-proline 0 N--CA 1.468 0.462 0 O-C-N 121.098 -1.001 . . . . 0.0 111.003 170.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -59.09 -24.81 75.4 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.381 2.721 . . . . 0.0 113.322 -173.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 61.7 p -76.3 -12.77 60.13 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 128.033 2.533 . . . . 0.0 115.539 175.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -70.96 116.68 48.92 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 124.344 1.058 . . . . 0.0 111.886 -174.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -78.52 120.81 4.93 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 123.253 2.636 . . . . 0.0 111.966 177.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.2 t -92.89 142.95 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 126.689 1.996 . . . . 0.0 110.124 178.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.74 101.08 6.5 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.534 0.683 . . . . 0.0 109.395 173.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.6 tp -98.76 152.77 19.32 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.015 1.726 . . . . 0.0 111.735 -173.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -111.85 113.2 25.4 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.056 0.542 . . . . 0.0 111.932 167.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -130.67 77.47 1.79 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.876 0.871 . . . . 0.0 109.274 165.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.2 t70 62.99 -7.92 0.14 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 128.634 2.774 . . . . 0.0 116.335 -166.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -165.32 163.36 36.5 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 125.628 1.585 . . . . 0.0 112.722 -177.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 78.2 mt -70.28 119.35 14.33 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.627 1.571 . . . . 0.0 110.594 -174.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -149.63 149.86 31.3 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -103.16 121.82 43.44 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.427 1.091 . . . . 0.0 111.028 -177.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 54.4 t -136.59 129.47 17.53 Favored Pre-proline 0 N--CA 1.481 1.104 0 C-N-CA 124.185 0.994 . . . . 0.0 110.87 -174.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -66.31 146.71 81.68 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.081 2.521 . . . . 0.0 112.811 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.11 -32.05 21.37 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 175.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.29 -19.43 65.41 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 173.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -107.8 -3.88 18.61 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.29 1.836 . . . . 0.0 112.824 177.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 92.6 t -73.47 146.23 10.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 C-N-CA 124.987 1.315 . . . . 0.0 110.479 168.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.78 159.26 72.03 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 127.762 2.425 . . . . 0.0 109.387 177.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -65.64 127.78 18.7 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 121.637 1.558 . . . . 0.0 110.724 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 99.14 7.81 54.41 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.238 0.923 . . . . 0.0 114.756 -178.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -67.15 165.65 15.55 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 118.301 1.05 . . . . 0.0 112.21 162.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.56 132.37 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 124.242 1.017 . . . . 0.0 111.211 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.0 t -107.26 134.1 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 126.367 1.867 . . . . 0.0 110.521 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 49.5 t -91.26 143.02 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.905 0.882 . . . . 0.0 111.355 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -169.1 -149.38 6.2 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.424 1.488 . . . . 0.0 111.846 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.6 p -136.88 162.99 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 125.388 1.475 . . . . 0.0 111.096 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 . . . . . 0 N--CA 1.469 0.478 0 C-N-CA 126.705 2.002 . . . . 0.0 110.427 179.356 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 . . . . . 0 N--CA 1.471 0.606 0 CA-C-O 119.107 -0.473 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.1 mt -146.83 153.36 40.08 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.221 1.009 . . . . 0.0 113.508 -177.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -135.8 151.47 50.11 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.156 1.782 . . . . 0.0 113.11 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -124.16 130.57 52.77 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.989 1.715 . . . . 0.0 110.701 -175.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -129.43 126.48 38.85 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.075 0.95 . . . . 0.0 110.411 -164.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -84.71 134.03 34.36 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.322 0.965 . . . . 0.0 112.152 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 75.0 t -67.41 129.41 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 124.142 0.977 . . . . 0.0 110.259 170.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.0 t -88.48 -42.94 11.8 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.412 1.485 . . . . 0.0 113.059 176.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.8 t -159.84 161.17 34.43 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.834 0.854 . . . . 0.0 111.426 -177.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 10.7 m -136.92 154.99 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.639 1.175 . . . . 0.0 112.555 170.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -162.36 162.11 27.73 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.428 1.091 . . . . 0.0 112.809 156.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 64.9 mt -76.05 141.34 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.953 0.901 . . . . 0.0 108.827 163.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 35.8 pt -130.67 156.67 42.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 126.988 2.115 . . . . 0.0 111.16 176.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -100.15 85.84 3.1 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 122.354 1.073 . . . . 0.0 111.382 -175.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -72.12 -46.45 56.57 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 121.308 -0.87 . . . . 0.0 112.862 -173.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 48.21 37.54 8.45 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.468 1.507 . . . . 0.0 113.097 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -145.47 174.52 11.08 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.503 1.121 . . . . 0.0 111.165 -170.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -74.64 132.81 42.03 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 123.553 0.741 . . . . 0.0 111.826 173.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 5.7 m -102.24 170.78 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.945 1.298 . . . . 0.0 109.474 169.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -123.0 161.47 24.2 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.973 0.909 . . . . 0.0 112.6 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -144.48 154.99 43.5 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.628 0.771 . . . . 0.0 110.184 158.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 40.8 tp -116.27 122.69 45.69 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.013 1.325 . . . . 0.0 110.232 175.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 99.7 t -91.83 121.25 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -165.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 25.1 mm -118.08 88.58 32.33 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 125.747 1.619 . . . . 0.0 110.227 -176.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -68.29 -13.69 38.43 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.47 2.113 . . . . 0.0 113.547 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -76.53 -46.39 26.73 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.326 0.966 . . . . 0.0 112.637 -177.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 81.3 p -138.78 -4.02 1.61 Allowed 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 126.077 1.751 . . . . 0.0 114.782 -169.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 31.0 m170 60.39 18.45 8.13 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 -177.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.15 148.51 25.02 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 120.095 -1.628 . . . . 0.0 113.582 177.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -132.66 170.9 14.56 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.939 1.696 . . . . 0.0 112.365 176.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 81.1 mt -121.54 132.99 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.471 1.108 . . . . 0.0 110.925 -175.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -80.36 161.74 63.76 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 125.102 1.361 . . . . 0.0 113.439 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.44 -18.35 62.71 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 122.869 2.379 . . . . 0.0 112.158 174.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.74 10.85 10.27 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.116 0.966 . . . . 0.0 113.181 172.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.21 -14.43 27.94 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.6 1.571 . . . . 0.0 116.559 176.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 78.6 mt -69.65 144.94 52.77 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 118.947 1.373 . . . . 0.0 112.833 -177.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 19.7 t -85.23 132.21 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.732 0.813 . . . . 0.0 110.629 171.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 77.1 mt -118.15 138.22 52.43 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.957 2.103 . . . . 0.0 110.061 177.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 42.3 t60 -137.76 141.85 40.93 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -168.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 . . . . . 0 CA--C 1.548 0.884 0 C-N-CA 124.977 1.311 . . . . 0.0 111.078 158.232 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.835 0 CA-C-O 119.474 -0.298 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.0 162.18 25.86 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.358 1.463 . . . . 0.0 112.238 -178.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.72 148.94 41.18 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.901 1.28 . . . . 0.0 113.697 177.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -12.54 31.98 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.047 1.339 . . . . 0.0 113.724 171.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.79 -24.19 64.38 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.187 2.195 . . . . 0.0 111.411 175.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.4 m -66.64 139.28 57.86 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.429 1.092 . . . . 0.0 113.62 -170.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -88.34 152.26 22.05 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.929 1.291 . . . . 0.0 113.427 171.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 p -148.17 153.3 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.122 0.969 . . . . 0.0 112.543 -169.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -132.88 127.22 33.92 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.175 1.79 . . . . 0.0 107.767 -173.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -153.0 177.7 10.49 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.111 0.964 . . . . 0.0 111.562 -175.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -134.48 141.79 46.87 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.036 -1.04 . . . . 0.0 111.275 173.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -154.51 162.38 41.17 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.774 1.63 . . . . 0.0 108.72 171.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.9 t70 51.28 29.74 5.28 Favored 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -174.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.1 m 57.34 39.74 28.14 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.703 1.601 . . . . 0.0 113.675 -171.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.0 p -153.58 141.13 13.53 Favored Pre-proline 0 CA--C 1.545 0.785 0 O-C-N 120.395 -1.441 . . . . 0.0 112.452 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.18 143.87 45.15 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.526 2.817 . . . . 0.0 113.871 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.5 m80 -128.45 141.67 51.33 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 128.294 2.637 . . . . 0.0 109.194 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 52.6 ttm -149.55 106.31 3.55 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.054 -1.029 . . . . 0.0 111.48 -174.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -153.95 179.39 8.95 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.115 0.966 . . . . 0.0 112.514 -171.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.9 m -74.86 141.08 44.25 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.028 -1.045 . . . . 0.0 109.479 168.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.4 tp -53.63 -36.28 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -176.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -63.44 -27.27 69.18 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.198 0.908 . . . . 0.0 112.564 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -74.85 -44.09 50.97 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.506 -0.746 . . . . 0.0 110.426 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 20.2 ptm -69.32 -37.44 77.74 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 119.371 -0.347 . . . . 0.0 111.3 172.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -59.78 -52.16 66.64 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.093 0.86 . . . . 0.0 110.874 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.7 t -65.51 -28.47 69.21 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.851 1.261 . . . . 0.0 111.773 -175.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -72.04 -56.78 5.03 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 127.373 2.269 . . . . 0.0 111.378 171.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -71.72 -33.77 69.02 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 120.919 -1.113 . . . . 0.0 112.791 -175.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.33 -23.07 65.59 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 121.288 -0.883 . . . . 0.0 112.663 172.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.2 t -89.67 -23.88 21.76 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.156 0.982 . . . . 0.0 113.316 174.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 70.5 mtm -86.44 -52.09 5.8 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.0 0.92 . . . . 0.0 112.013 176.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -106.65 -18.44 13.95 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.344 1.458 . . . . 0.0 112.724 -168.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.95 161.75 35.57 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.303 0.954 . . . . 0.0 114.05 176.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -109.42 126.89 53.94 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.954 0.902 . . . . 0.0 111.104 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.5 mp -98.6 144.94 29.04 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 125.32 1.448 . . . . 0.0 110.589 176.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -72.91 146.19 41.63 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 123.838 3.026 . . . . 0.0 112.199 -177.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.41 154.37 49.98 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.114 1.366 . . . . 0.0 111.941 178.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -52.55 -46.67 66.89 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.649 1.18 . . . . 0.0 113.745 -177.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -88.81 -9.98 49.77 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 172.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 173.81 -123.3 0.96 Allowed Glycine 0 CA--C 1.532 1.099 0 N-CA-C 116.958 1.543 . . . . 0.0 116.958 -168.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -142.7 159.25 42.59 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.007 1.723 . . . . 0.0 111.953 -177.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.25 150.66 46.91 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.522 1.529 . . . . 0.0 111.997 176.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.9 t -125.79 118.27 24.24 Favored Pre-proline 0 N--CA 1.486 1.34 0 C-N-CA 125.302 1.441 . . . . 0.0 111.29 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.62 140.89 40.41 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 124.186 3.257 . . . . 0.0 112.157 -178.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 73.3 mt -111.1 165.79 11.6 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.084 1.354 . . . . 0.0 112.568 176.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -145.59 124.09 12.43 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.881 1.272 . . . . 0.0 111.534 169.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 51.18 44.66 28.63 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.421 1.889 . . . . 0.0 113.856 -177.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.7 t -106.81 130.75 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.857 1.663 . . . . 0.0 109.884 173.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -130.15 159.19 37.57 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.948 1.299 . . . . 0.0 113.014 -169.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.5 m -144.78 150.63 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.951 1.7 . . . . 0.0 112.13 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -65.31 132.57 49.37 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.962 1.305 . . . . 0.0 108.027 164.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.4 t -141.37 154.9 45.9 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.335 1.054 . . . . 0.0 112.005 -169.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 56.8 tp -115.64 133.41 56.06 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.957 1.303 . . . . 0.0 110.785 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.426 ' HB2' ' HE3' ' A' ' 61' ' ' LYS . 8.2 t0 -79.51 117.02 20.08 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.223 0.609 . . . . 0.0 111.255 163.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.4 mm -70.15 -16.64 20.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 O-C-N 121.056 -1.028 . . . . 0.0 113.261 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.48 -46.87 24.92 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.545 -1.347 . . . . 0.0 113.92 -177.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.0 m -121.36 -8.73 9.14 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 179.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.4 29.06 54.27 Favored Glycine 0 CA--C 1.535 1.291 0 O-C-N 121.388 -0.82 . . . . 0.0 114.016 -176.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -77.83 131.59 37.63 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.142 0.971 . . . . 0.0 110.933 175.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 mp -81.74 139.57 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 170.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.426 ' HE3' ' HB2' ' A' ' 54' ' ' ASP . 5.9 mttt -141.12 173.13 11.78 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.567 1.547 . . . . 0.0 110.485 174.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -111.53 128.53 56.05 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.476 0.71 . . . . 0.0 110.433 162.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.9 t -131.41 164.54 25.48 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.202 1.001 . . . . 0.0 112.601 -174.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.8 ppt_? -86.09 139.59 30.99 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.231 1.013 . . . . 0.0 112.772 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -93.8 144.01 25.81 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.063 0.945 . . . . 0.0 109.587 166.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.7 t -101.01 -45.88 5.27 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -172.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -153.78 155.55 36.06 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.767 1.227 . . . . 0.0 112.551 175.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.9 mt -87.23 159.88 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.855 1.262 . . . . 0.0 108.85 167.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -142.54 151.03 41.19 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.178 1.791 . . . . 0.0 111.106 -176.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 42.9 ptt85 -145.5 159.41 43.14 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 167.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -152.09 159.42 43.67 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.333 1.853 . . . . 0.0 110.663 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -97.28 140.95 30.98 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.632 1.173 . . . . 0.0 112.526 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.1 m -148.12 141.62 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.073 0.949 . . . . 0.0 113.25 -176.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -99.66 -24.34 14.75 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.269 1.428 . . . . 0.0 113.226 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -127.86 126.83 42.33 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.451 1.101 . . . . 0.0 110.994 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.7 tp -136.84 167.11 22.08 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.947 2.099 . . . . 0.0 109.29 -173.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 20.2 mt -119.82 126.95 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.75 1.22 . . . . 0.0 108.816 176.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -99.31 116.63 31.93 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.917 0.887 . . . . 0.0 111.073 170.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.0 mp -101.4 122.33 53.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 125.175 1.39 . . . . 0.0 108.416 172.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -90.37 148.91 22.52 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.782 1.233 . . . . 0.0 110.791 174.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 65.2 mt -116.38 157.78 24.52 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.436 1.494 . . . . 0.0 111.831 178.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.1 t -64.65 -27.17 68.75 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.665 -0.647 . . . . 0.0 112.469 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 84.3 p -59.82 -22.43 62.22 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.374 1.469 . . . . 0.0 114.354 172.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 86.27 19.0 58.09 Favored Glycine 0 CA--C 1.537 1.452 0 O-C-N 121.284 -0.885 . . . . 0.0 113.806 -167.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -93.67 158.32 15.74 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.082 0.941 . . . . 0.0 111.062 161.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 83.8 p -138.21 137.53 37.66 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.52 1.528 . . . . 0.0 110.785 177.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.6 tp -115.97 130.65 56.91 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.93 1.292 . . . . 0.0 109.79 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -111.53 113.53 26.01 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.484 1.514 . . . . 0.0 109.929 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.8 m -137.41 153.82 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.16 1.384 . . . . 0.0 113.504 -169.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.6 p -66.71 143.25 98.0 Favored Pre-proline 0 N--CA 1.472 0.644 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 176.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -62.43 -22.26 73.83 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.713 2.942 . . . . 0.0 113.454 -178.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.6 p -88.55 -1.67 58.18 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.324 1.85 . . . . 0.0 114.215 176.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -87.74 124.28 67.69 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 119.158 0.89 . . . . 0.0 112.583 -175.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -70.97 129.75 16.79 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.607 2.872 . . . . 0.0 111.215 176.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.1 t -108.03 140.35 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 125.679 1.591 . . . . 0.0 110.337 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 51.9 tp -81.51 104.67 12.1 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.493 0.717 . . . . 0.0 110.812 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.1 mp -104.5 158.38 16.52 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.431 1.893 . . . . 0.0 112.119 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -106.14 127.02 52.91 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 169.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 72.4 mtp85 -138.23 74.87 1.49 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.981 0.912 . . . . 0.0 111.009 162.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 50.97 21.14 0.92 Allowed 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 125.44 1.496 . . . . 0.0 113.173 -164.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 179.27 149.02 8.06 Favored Glycine 0 CA--C 1.521 0.455 0 O-C-N 120.536 -1.352 . . . . 0.0 111.447 -170.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 60.6 mt -75.01 120.89 21.15 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.34 1.456 . . . . 0.0 109.523 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -150.34 151.68 33.27 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -177.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -105.76 121.12 43.37 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.458 1.103 . . . . 0.0 112.106 -172.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 78.5 t -139.07 132.56 15.92 Favored Pre-proline 0 N--CA 1.484 1.257 0 C-N-CA 124.916 1.286 . . . . 0.0 110.563 -178.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -66.82 145.29 74.38 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.827 2.352 . . . . 0.0 113.333 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.01 -34.03 19.89 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 175.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.84 -23.99 67.56 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 174.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -98.02 -15.49 20.03 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.552 1.141 . . . . 0.0 112.94 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.7 t -63.02 149.95 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.565 1.546 . . . . 0.0 111.416 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.427 ' HZ2' ' CG ' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -129.8 154.3 81.02 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 126.094 1.757 . . . . 0.0 111.389 178.168 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -65.98 130.3 24.09 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.311 2.007 . . . . 0.0 111.513 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.62 4.09 54.88 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.775 1.179 . . . . 0.0 114.073 -176.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.427 ' CG ' ' HZ2' ' A' ' 111' ' ' LYS . 70.5 m-20 -65.06 168.76 6.15 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.668 1.187 . . . . 0.0 112.291 165.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.3 t -115.54 124.23 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.949 1.3 . . . . 0.0 111.069 -173.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.0 t -95.71 143.38 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.74 1.616 . . . . 0.0 110.31 175.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.5 t -89.56 133.71 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.706 0.803 . . . . 0.0 110.507 177.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -158.28 -158.52 9.05 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.139 0.876 . . . . 0.0 113.053 178.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.439 ' CG2' ' H ' ' A' ' 120' ' ' ARG . 4.1 p -141.38 -179.71 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 126.589 1.955 . . . . 0.0 111.746 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.439 ' H ' ' CG2' ' A' ' 119' ' ' VAL . 64.8 mtt-85 . . . . . 0 N--CA 1.468 0.449 0 C-N-CA 126.489 1.916 . . . . 0.0 111.459 -175.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 92.5 mt -138.41 159.74 41.3 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.71 2.004 . . . . 0.0 111.353 168.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -150.73 127.05 10.65 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.473 2.309 . . . . 0.0 110.452 174.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -84.67 146.37 27.49 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.401 1.08 . . . . 0.0 112.227 -177.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 52.0 m80 -129.63 137.89 50.92 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.297 1.039 . . . . 0.0 111.479 -174.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -89.48 136.61 32.93 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.293 1.037 . . . . 0.0 113.529 -174.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 77.5 t -74.27 120.0 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.407 1.083 . . . . 0.0 111.379 171.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.8 t -87.68 -29.62 21.0 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.034 1.733 . . . . 0.0 114.105 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.1 m -164.93 164.54 20.73 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.693 1.197 . . . . 0.0 111.291 172.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.9 m -132.79 145.69 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.235 1.014 . . . . 0.0 111.221 165.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -151.21 154.56 37.08 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.78 1.232 . . . . 0.0 112.281 170.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 97.0 mt -76.59 141.89 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 160.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 24.7 pt -131.05 159.37 43.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 125.288 1.435 . . . . 0.0 110.898 169.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -98.54 101.49 12.94 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.731 0.776 . . . . 0.0 111.942 169.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -80.21 -47.71 14.23 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.609 -0.682 . . . . 0.0 112.281 -177.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 55.66 32.51 19.43 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.346 1.058 . . . . 0.0 113.095 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -144.65 178.2 8.15 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.0 1.32 . . . . 0.0 111.814 -170.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -80.51 139.94 36.12 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.115 1.366 . . . . 0.0 112.753 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.8 m -125.88 154.7 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 125.841 1.656 . . . . 0.0 110.063 177.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -115.67 162.92 16.56 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -171.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -140.87 150.78 43.67 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 125.8 1.64 . . . . 0.0 108.633 160.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 56.5 tp -119.19 115.26 23.85 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.326 -1.484 . . . . 0.0 109.677 175.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 35.0 t -86.0 120.47 35.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -163.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 13.1 mm -119.6 84.64 30.71 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 125.384 1.474 . . . . 0.0 109.424 -177.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -65.77 -8.14 18.68 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.777 2.984 . . . . 0.0 114.371 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -84.56 -42.15 15.74 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.03 1.332 . . . . 0.0 113.212 177.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 68.9 p -142.26 -11.93 0.83 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -170.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . 0.25 92.0 m-70 57.36 24.13 9.72 Favored 'General case' 0 CA--C 1.553 1.079 0 N-CA-C 116.782 2.141 . . . . 0.0 116.782 -176.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -157.36 150.53 23.64 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 119.929 -1.732 . . . . 0.0 114.169 175.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -148.18 142.69 26.44 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.526 1.53 . . . . 0.0 112.43 -174.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.8 mp -92.7 137.04 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 O-C-N 120.477 -1.389 . . . . 0.0 112.162 -175.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -91.97 159.42 37.91 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 126.698 1.999 . . . . 0.0 113.386 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.25 -13.76 33.81 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.95 3.1 . . . . 0.0 113.885 -177.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -72.85 -7.69 52.0 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.28 0.632 . . . . 0.0 112.049 168.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 98.54 -20.17 51.49 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 126.749 2.119 . . . . 0.0 113.902 -177.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 74.7 mt -69.72 144.57 52.75 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.043 1.422 . . . . 0.0 112.844 -174.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 56.8 t -74.49 125.73 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 165.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 47.0 mt -106.53 166.27 10.67 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.081 1.752 . . . . 0.0 110.487 167.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -132.31 155.04 49.07 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.153 0.981 . . . . 0.0 112.446 -157.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 . . . . . 0 CA--C 1.541 0.634 0 C-N-CA 124.268 1.027 . . . . 0.0 111.499 172.191 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.948 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -140.02 156.58 46.55 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.044 1.737 . . . . 0.0 111.239 -171.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.88 146.33 55.06 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 120.491 -1.381 . . . . 0.0 114.21 -177.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.87 -14.49 15.55 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.226 1.411 . . . . 0.0 114.605 165.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -69.87 -14.9 62.96 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.167 0.987 . . . . 0.0 112.24 170.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.8 m -80.5 143.55 33.23 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -170.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -80.17 152.69 29.06 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.604 1.562 . . . . 0.0 112.741 168.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.6 p -146.99 158.35 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.505 1.122 . . . . 0.0 112.534 -172.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -124.92 137.59 54.27 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.621 1.968 . . . . 0.0 108.749 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -156.27 177.13 11.79 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 118.863 0.756 . . . . 0.0 111.96 168.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -135.78 144.71 45.93 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.037 1.335 . . . . 0.0 110.206 171.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -150.77 -63.31 0.19 Allowed 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 176.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -76.6 45.07 0.38 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.815 1.246 . . . . 0.0 112.722 -175.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.4 m 49.56 45.12 24.37 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.321 1.448 . . . . 0.0 110.706 -168.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.9 p -165.98 144.23 4.8 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 127.021 2.128 . . . . 0.0 110.126 -173.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.2 161.3 23.21 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 124.013 3.142 . . . . 0.0 113.855 175.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -142.23 143.93 33.11 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.57 2.348 . . . . 0.0 111.337 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 40.7 ttm -145.83 120.34 9.72 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.15 1.38 . . . . 0.0 110.02 172.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -165.77 -179.03 5.09 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.217 1.407 . . . . 0.0 110.628 -172.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.7 m -76.82 142.94 40.09 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 120.83 -1.168 . . . . 0.0 110.635 171.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.426 HG12 ' CG ' ' A' ' 152' ' ' TYR . 8.4 tp -56.0 -36.64 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -177.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -69.71 -18.0 63.5 Favored 'General case' 0 CA--C 1.549 0.909 0 O-C-N 121.673 -0.642 . . . . 0.0 112.529 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -75.3 -46.9 30.53 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.156 -0.965 . . . . 0.0 110.465 172.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.7 ptm -71.95 -35.83 69.7 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -57.93 -53.59 56.54 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 118.921 0.782 . . . . 0.0 110.709 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.2 t -64.68 -33.68 76.52 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.318 1.047 . . . . 0.0 111.509 -176.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -65.12 -52.66 53.99 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.209 1.404 . . . . 0.0 110.683 175.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -70.1 -32.38 70.4 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.321 -0.862 . . . . 0.0 112.671 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.01 -27.68 67.63 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.999 0.92 . . . . 0.0 113.176 172.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.7 t -79.86 -35.46 38.11 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.469 1.107 . . . . 0.0 112.073 173.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 46.0 mtm -85.13 -43.47 13.83 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.157 0.983 . . . . 0.0 113.395 -174.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -107.5 -31.86 7.95 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.289 1.435 . . . . 0.0 111.404 -172.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 102.05 165.36 26.82 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.016 1.293 . . . . 0.0 113.508 -177.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -114.44 135.65 53.87 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.675 1.59 . . . . 0.0 111.136 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.6 mp -100.43 148.29 34.74 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 125.878 1.671 . . . . 0.0 109.833 166.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -75.79 159.34 38.56 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.328 2.685 . . . . 0.0 111.615 175.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -135.59 161.36 35.75 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.461 1.505 . . . . 0.0 109.861 164.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -42.9 -48.55 5.84 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -117.14 3.94 12.69 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -160.89 -145.64 4.36 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 115.515 0.966 . . . . 0.0 115.515 -172.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -150.53 155.53 39.65 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.388 1.875 . . . . 0.0 112.378 -175.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.72 143.43 41.22 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.459 1.504 . . . . 0.0 112.095 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 86.7 t -125.71 111.65 25.16 Favored Pre-proline 0 N--CA 1.484 1.233 0 C-N-CA 125.16 1.384 . . . . 0.0 110.787 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.63 127.74 13.5 Favored 'Trans proline' 0 C--N 1.351 0.686 1 C-N-CA 125.348 4.032 . . . . 0.0 112.307 -174.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 68.6 mt -106.64 156.4 18.65 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.183 0.993 . . . . 0.0 113.152 -177.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -134.98 132.66 38.63 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.91 1.684 . . . . 0.0 111.046 168.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 50.13 45.84 25.23 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.347 1.859 . . . . 0.0 113.244 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 49.1 t -109.07 127.76 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.69 0.796 . . . . 0.0 109.604 175.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -127.99 155.34 44.44 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.268 1.027 . . . . 0.0 113.471 -168.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.5 m -141.94 151.88 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 126.543 1.937 . . . . 0.0 112.25 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -72.25 136.35 46.3 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.298 1.839 . . . . 0.0 108.137 169.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.2 t -151.33 154.65 37.12 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.186 -0.946 . . . . 0.0 113.323 -170.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 60.2 tp -107.09 129.04 54.88 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.758 1.623 . . . . 0.0 110.579 177.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -79.78 102.35 9.01 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.602 -0.686 . . . . 0.0 109.876 168.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.5 mm -59.31 -23.36 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.318 1.047 . . . . 0.0 112.586 -175.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.81 -39.77 69.6 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.428 1.891 . . . . 0.0 114.746 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.3 m -108.4 -24.65 11.35 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.971 1.309 . . . . 0.0 112.94 -173.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.13 29.4 68.8 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.234 1.397 . . . . 0.0 113.161 -169.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -103.38 137.23 41.76 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.69 1.596 . . . . 0.0 111.386 -176.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.3 mp -93.33 135.58 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.111 0.965 . . . . 0.0 109.088 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -153.27 172.2 17.37 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.796 1.638 . . . . 0.0 111.192 -176.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt -90.58 144.11 26.09 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.842 0.857 . . . . 0.0 111.146 165.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.8 t -136.48 166.38 23.64 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.056 1.342 . . . . 0.0 111.41 170.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.6 ptp85 -97.64 146.88 24.88 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.773 1.229 . . . . 0.0 112.939 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -103.13 146.21 28.74 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.468 1.107 . . . . 0.0 111.19 170.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.7 t -98.13 -43.35 7.05 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -174.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -153.9 159.01 41.58 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.062 0.945 . . . . 0.0 112.789 173.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.8 mt -89.42 151.48 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.08 0.952 . . . . 0.0 108.465 164.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -137.46 146.71 44.62 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.778 1.631 . . . . 0.0 110.31 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -144.07 151.55 39.78 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 119.833 1.197 . . . . 0.0 113.482 166.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -152.05 169.99 21.02 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.013 1.725 . . . . 0.0 110.597 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -103.35 140.13 37.84 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.689 1.195 . . . . 0.0 111.605 -175.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.1 m -146.88 142.22 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.649 1.18 . . . . 0.0 111.795 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -104.99 -11.15 16.78 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.639 1.575 . . . . 0.0 113.451 175.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -123.75 121.21 34.86 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.969 1.308 . . . . 0.0 109.908 173.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.0 tp -136.9 161.03 37.14 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.43 1.492 . . . . 0.0 109.419 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.4 mt -114.5 128.11 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 120.982 -1.074 . . . . 0.0 109.348 178.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -100.6 113.61 26.58 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.559 1.143 . . . . 0.0 110.518 171.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.2 mp -100.79 122.11 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.174 1.39 . . . . 0.0 108.526 172.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -91.6 148.75 22.05 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.548 1.139 . . . . 0.0 111.108 176.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 82.8 mt -115.34 158.74 21.98 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.876 1.27 . . . . 0.0 112.822 -176.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.8 t -66.31 -39.71 89.5 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.993 1.317 . . . . 0.0 112.205 -175.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.7 m -75.29 0.28 17.19 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 172.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 105.99 -2.53 38.28 Favored Glycine 0 CA--C 1.534 1.268 0 N-CA-C 117.089 1.596 . . . . 0.0 117.089 162.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -81.48 171.64 14.47 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.529 1.664 . . . . 0.0 111.654 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 85.2 p -139.73 135.55 33.24 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.993 0.917 . . . . 0.0 112.926 174.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 68.4 tp -105.41 126.0 51.62 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.126 1.77 . . . . 0.0 109.468 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -114.52 110.62 20.1 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.422 1.489 . . . . 0.0 110.54 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.6 m -140.69 154.09 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.586 1.554 . . . . 0.0 112.34 -167.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.49 150.36 97.32 Favored Pre-proline 0 N--CA 1.468 0.427 0 C-N-CA 123.761 0.824 . . . . 0.0 113.115 177.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -63.51 -35.58 59.31 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.598 2.198 . . . . 0.0 114.951 -167.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.7 m -89.5 3.06 53.63 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -67.65 119.36 65.49 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 124.539 1.135 . . . . 0.0 110.928 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -80.12 126.47 6.35 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.914 2.409 . . . . 0.0 112.347 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.6 t -106.32 146.23 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 125.938 1.695 . . . . 0.0 109.537 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 21.6 tp -78.8 105.17 9.92 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.081 0.467 . . . . 0.0 110.221 177.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.6 mp -104.19 158.94 16.1 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.475 1.51 . . . . 0.0 111.508 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -103.35 122.81 45.6 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.186 0.594 . . . . 0.0 112.202 168.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.402 ' C ' ' H ' ' A' ' 101' ' ' GLY . 44.9 mtp180 -143.36 85.42 1.85 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.528 1.531 . . . . 0.0 109.366 170.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 54.56 -3.72 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 127.464 2.305 . . . . 0.0 115.855 -160.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 99' ' ' ARG . . . -175.21 174.81 46.99 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 126.933 2.206 . . . . 0.0 113.059 -178.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 37.1 mt -64.58 122.33 16.56 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.965 1.706 . . . . 0.0 110.673 173.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -151.94 152.04 32.0 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.08 0.952 . . . . 0.0 113.4 170.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -97.96 118.48 34.64 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.297 1.439 . . . . 0.0 111.126 -173.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.3 t -130.09 130.59 23.11 Favored Pre-proline 0 N--CA 1.48 1.046 0 C-N-CA 124.001 0.921 . . . . 0.0 110.872 -172.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -65.71 140.36 61.59 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.67 2.246 . . . . 0.0 111.877 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.36 -31.52 14.88 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 176.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.25 -29.28 69.75 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 174.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -101.32 -2.71 30.38 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.241 1.416 . . . . 0.0 112.169 178.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 89.9 t -72.95 142.9 14.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 O-C-N 121.064 -1.022 . . . . 0.0 110.328 167.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.46 154.57 76.98 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 127.108 2.163 . . . . 0.0 109.804 -177.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.21 136.07 42.61 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.778 1.652 . . . . 0.0 111.147 -170.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 93.37 3.65 64.84 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.812 1.196 . . . . 0.0 114.222 -176.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -62.54 158.64 17.53 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.441 1.096 . . . . 0.0 111.096 164.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.0 t -106.05 119.24 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.997 1.319 . . . . 0.0 110.16 -177.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.6 t -91.88 140.47 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.158 1.383 . . . . 0.0 109.694 174.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 38.2 t -90.64 135.67 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 123.739 0.816 . . . . 0.0 110.644 177.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -164.44 -145.29 4.34 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 114.268 0.467 . . . . 0.0 114.268 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.9 p -156.07 169.77 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 126.263 1.825 . . . . 0.0 109.545 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 74.1 mtm-85 . . . . . 0 N--CA 1.469 0.508 0 C-N-CA 125.18 1.392 . . . . 0.0 111.946 175.967 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.3 mt -140.76 160.28 40.38 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.622 1.569 . . . . 0.0 112.103 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -144.05 165.15 28.61 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.409 1.484 . . . . 0.0 111.248 174.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -110.73 152.28 26.77 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.727 1.211 . . . . 0.0 111.91 174.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 64.1 m-70 -135.36 137.81 42.73 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.493 1.117 . . . . 0.0 109.635 -176.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -103.52 135.29 45.4 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.453 -0.78 . . . . 0.0 112.475 -169.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 91.4 t -73.86 125.64 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 121.631 0.729 . . . . 0.0 111.352 177.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 21.2 t -88.28 -37.77 15.75 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.734 1.614 . . . . 0.0 113.403 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.2 m -154.47 159.67 41.15 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.824 1.25 . . . . 0.0 111.327 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.5 m -138.2 148.94 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 123.434 0.693 . . . . 0.0 111.193 163.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -163.16 159.65 23.25 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.309 1.044 . . . . 0.0 113.41 165.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 89.9 mt -79.22 135.57 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 164.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 16.3 pt -124.54 163.49 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 127.589 2.355 . . . . 0.0 109.828 173.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . 0.328 1.6 p-10 -114.13 65.98 0.67 Allowed 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 -172.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -56.27 -39.93 73.42 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.794 1.637 . . . . 0.0 115.335 -160.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 47.9 36.02 5.57 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.81 2.044 . . . . 0.0 113.461 -175.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -146.48 175.52 10.5 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 120.841 -1.162 . . . . 0.0 112.458 -170.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -67.21 133.74 50.33 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 122.396 1.093 . . . . 0.0 113.433 -176.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.7 m -114.45 150.83 16.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.437 164.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.426 ' CG ' HG12 ' A' ' 21' ' ' ILE . 2.8 p90 -111.78 163.88 13.67 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.987 1.315 . . . . 0.0 111.656 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -143.84 147.99 34.87 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.348 0.659 . . . . 0.0 109.844 160.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 34.6 tp -107.15 122.18 45.99 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.687 1.195 . . . . 0.0 110.271 174.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 36.1 t -87.47 118.04 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 O-C-N 121.948 -0.47 . . . . 0.0 111.911 -168.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 12.7 mm -123.19 84.78 51.53 Favored Pre-proline 0 N--CA 1.472 0.66 0 C-N-CA 125.29 1.436 . . . . 0.0 110.416 -176.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -70.04 -12.08 31.68 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 122.646 2.231 . . . . 0.0 113.835 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -74.34 -40.5 62.12 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.066 1.346 . . . . 0.0 113.83 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 70.9 p -139.73 -13.9 1.09 Allowed 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -170.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 77.4 m80 56.11 20.69 4.58 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.984 1.713 . . . . 0.0 115.179 -164.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -150.13 151.0 32.45 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.618 -1.301 . . . . 0.0 114.476 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -145.87 173.84 11.77 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.307 1.843 . . . . 0.0 111.065 177.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 79.4 mt -122.26 138.29 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.01 0.924 . . . . 0.0 110.534 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -89.0 158.18 47.43 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 124.087 0.955 . . . . 0.0 112.438 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -65.7 -18.69 59.05 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.136 2.557 . . . . 0.0 112.751 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -74.57 7.92 2.66 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.868 1.267 . . . . 0.0 112.812 170.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 91.55 -25.11 16.78 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 126.968 2.223 . . . . 0.0 115.644 175.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 41.3 mt -75.19 144.37 42.72 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.553 1.176 . . . . 0.0 113.79 -166.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.9 t -86.1 127.66 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.012 0.925 . . . . 0.0 111.079 174.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 52.9 mt -117.29 150.35 38.94 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.113 2.165 . . . . 0.0 112.169 -174.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -109.24 145.52 35.76 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.632 1.173 . . . . 0.0 112.809 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 . . . . . 0 CA--C 1.547 0.858 0 O-C-N 121.21 -0.931 . . . . 0.0 111.811 169.793 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.638 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -135.04 162.04 33.59 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.673 1.989 . . . . 0.0 111.098 -174.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.46 141.7 57.5 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.1 0.96 . . . . 0.0 111.673 172.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -11.58 38.66 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 176.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -81.43 -13.11 58.62 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.565 1.946 . . . . 0.0 113.306 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.3 m -64.47 136.92 57.55 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.153 0.981 . . . . 0.0 112.253 -177.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -81.32 151.64 27.93 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.662 0.744 . . . . 0.0 112.073 171.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 p -144.14 160.68 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 123.611 0.764 . . . . 0.0 111.038 -170.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -132.09 124.78 29.85 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.167 1.387 . . . . 0.0 108.929 -175.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -149.58 174.87 12.06 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 118.921 0.782 . . . . 0.0 112.73 176.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -131.03 142.43 50.32 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.117 1.367 . . . . 0.0 110.879 170.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -162.91 141.98 8.73 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.996 1.319 . . . . 0.0 110.533 174.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.2 t70 61.34 38.21 16.45 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.38 1.472 . . . . 0.0 113.448 -173.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.8 m 59.41 40.6 20.66 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.317 1.447 . . . . 0.0 112.651 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.2 p -158.85 140.51 9.8 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 124.866 1.266 . . . . 0.0 110.873 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -75.46 155.82 40.89 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 123.791 2.994 . . . . 0.0 113.806 176.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 39.1 m-70 -137.0 142.99 42.53 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 127.072 2.149 . . . . 0.0 110.767 176.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 43.1 ttm -154.29 82.64 1.12 Allowed 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.764 0.792 . . . . 0.0 112.432 -170.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -143.49 -176.34 4.91 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.238 1.415 . . . . 0.0 112.085 -173.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.9 m -69.37 138.47 53.7 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 120.955 -1.091 . . . . 0.0 110.755 174.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.5 tp -55.06 -36.34 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -66.73 -17.91 65.1 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.338 -0.851 . . . . 0.0 113.127 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -75.43 -51.76 12.31 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.354 1.061 . . . . 0.0 109.927 172.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 22.2 ptm -68.08 -36.21 79.46 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.43 -0.794 . . . . 0.0 112.034 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -56.17 -51.83 66.58 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.5 0.72 . . . . 0.0 111.299 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.1 m -57.27 -40.16 77.16 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 125.324 1.449 . . . . 0.0 111.727 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -69.51 -50.93 40.43 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.017 0.927 . . . . 0.0 111.173 178.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -68.19 -33.66 74.84 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 121.338 -0.851 . . . . 0.0 112.213 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.68 -23.46 65.31 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.59 0.756 . . . . 0.0 112.782 172.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.57 -11.94 38.54 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.957 1.303 . . . . 0.0 114.112 174.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 67.0 mtm -103.66 -52.2 3.03 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.103 1.361 . . . . 0.0 111.669 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -105.14 -16.53 14.76 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.972 1.309 . . . . 0.0 112.346 -171.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.36 161.97 32.21 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 124.234 0.921 . . . . 0.0 113.271 175.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -104.96 140.58 37.97 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.913 0.885 . . . . 0.0 109.845 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.3 mp -118.51 149.09 45.47 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 126.375 1.87 . . . . 0.0 110.611 176.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -81.44 151.24 17.43 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.074 3.183 . . . . 0.0 112.222 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -138.9 163.35 32.54 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.308 1.843 . . . . 0.0 111.097 -175.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -50.76 -55.88 14.66 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.844 1.258 . . . . 0.0 113.573 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -95.54 -7.45 37.91 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.47 -134.23 1.84 Allowed Glycine 0 CA--C 1.533 1.167 0 N-CA-C 115.507 0.963 . . . . 0.0 115.507 -170.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -138.98 160.23 40.26 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.623 1.969 . . . . 0.0 111.05 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.98 155.71 45.45 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.205 1.002 . . . . 0.0 113.311 176.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.8 t -126.46 115.97 23.13 Favored Pre-proline 0 N--CA 1.48 1.059 0 C-N-CA 126.09 1.756 . . . . 0.0 110.457 175.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.95 139.3 29.87 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 124.63 3.554 . . . . 0.0 112.296 -176.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 78.4 mt -107.76 163.98 12.63 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.65 1.18 . . . . 0.0 112.752 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -147.93 128.41 14.04 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.686 1.594 . . . . 0.0 109.345 168.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 55.04 41.31 31.9 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.865 1.666 . . . . 0.0 114.264 -176.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.4 t -108.32 118.43 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 O-C-N 121.308 -0.87 . . . . 0.0 109.618 175.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -114.52 148.33 38.07 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.458 1.103 . . . . 0.0 112.166 -171.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.9 m -139.44 153.97 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.091 1.357 . . . . 0.0 111.431 175.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -76.27 147.21 38.42 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.726 0.775 . . . . 0.0 111.557 172.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.6 t -154.96 167.08 31.53 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.69 1.596 . . . . 0.0 111.316 -165.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 36.9 tp -124.76 139.11 54.15 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.453 1.501 . . . . 0.0 110.326 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -87.14 112.96 22.46 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.363 1.065 . . . . 0.0 109.652 164.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.1 mm -71.62 -21.39 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 121.049 -1.032 . . . . 0.0 112.513 -175.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.47 -45.62 21.66 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -174.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.2 m -101.89 -15.63 16.81 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.266 1.027 . . . . 0.0 112.681 173.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.55 23.33 75.62 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.045 0.831 . . . . 0.0 113.524 -174.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -82.41 133.66 35.22 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.501 1.12 . . . . 0.0 111.519 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.3 mp -80.67 136.06 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 174.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -142.92 171.08 14.54 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.444 1.898 . . . . 0.0 111.528 -174.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -117.56 144.98 44.58 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.911 1.684 . . . . 0.0 110.118 167.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.7 t -143.68 153.29 42.32 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.221 1.008 . . . . 0.0 112.492 -174.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.3 137.07 37.88 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.362 1.065 . . . . 0.0 112.198 172.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.83 136.78 36.89 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.16 0.984 . . . . 0.0 110.984 172.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 91.4 p -89.02 -47.25 8.25 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.862 0.865 . . . . 0.0 113.267 -167.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -154.12 156.97 38.21 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.393 1.477 . . . . 0.0 112.356 173.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.7 mt -87.19 153.57 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 124.683 1.193 . . . . 0.0 107.941 164.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -138.6 152.61 48.29 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.858 1.663 . . . . 0.0 111.581 -173.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -146.52 152.88 39.69 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 164.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -150.39 167.22 27.72 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 127.453 2.301 . . . . 0.0 110.574 177.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -106.33 138.63 42.16 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.079 1.351 . . . . 0.0 113.779 -173.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.8 m -145.97 145.28 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 C-N-CA 124.764 1.226 . . . . 0.0 111.881 -176.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -96.22 -30.86 13.24 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 125.867 1.667 . . . . 0.0 112.26 175.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -129.41 133.25 47.25 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.144 0.978 . . . . 0.0 111.822 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.9 tp -136.39 158.45 44.4 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.15 2.18 . . . . 0.0 109.161 -170.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.2 mt -110.17 127.66 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 O-C-N 121.241 -0.912 . . . . 0.0 109.617 176.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -102.91 119.08 38.21 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.321 1.048 . . . . 0.0 111.648 168.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -104.86 123.65 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.694 1.598 . . . . 0.0 108.547 174.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -91.54 143.93 26.07 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.431 1.092 . . . . 0.0 111.142 173.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.4 mt -109.73 151.94 26.29 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.231 1.812 . . . . 0.0 110.706 175.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.9 t -66.53 -22.8 66.16 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -168.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.9 m -76.9 -10.29 59.27 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.863 1.265 . . . . 0.0 114.159 172.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 107.03 2.28 36.19 Favored Glycine 0 CA--C 1.54 1.634 0 N-CA-C 116.731 1.452 . . . . 0.0 116.731 175.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -80.86 153.81 27.43 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.41 1.484 . . . . 0.0 110.841 172.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 39.1 p -131.06 144.32 51.35 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 168.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 60.0 tp -111.72 126.35 54.95 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.168 2.187 . . . . 0.0 109.566 177.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -118.61 107.8 14.17 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.823 1.649 . . . . 0.0 110.556 -173.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.3 m -143.42 151.49 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.83 1.252 . . . . 0.0 113.174 -161.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.4 p -67.9 149.07 98.37 Favored Pre-proline 0 N--CA 1.467 0.402 0 O-C-N 121.43 -0.794 . . . . 0.0 111.93 174.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -59.5 -29.81 90.93 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 123.144 2.563 . . . . 0.0 114.09 -168.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.3 p -81.04 -9.42 59.83 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 55.6 t60 -69.38 120.81 79.39 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 119.717 1.144 . . . . 0.0 111.637 -178.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -79.31 129.49 8.65 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.019 2.479 . . . . 0.0 113.687 178.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.4 t -103.95 143.13 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 126.112 1.765 . . . . 0.0 109.544 175.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.05 109.32 15.51 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.181 0.515 . . . . 0.0 110.729 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.4 mp -106.23 153.84 21.57 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.417 1.887 . . . . 0.0 111.33 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -108.65 107.72 18.3 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.403 ' C ' ' H ' ' A' ' 101' ' ' GLY . 40.8 mtp180 -139.83 89.71 2.33 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 120.9 -1.125 . . . . 0.0 109.842 174.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 59.76 -13.84 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 128.154 2.581 . . . . 0.0 116.049 -163.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 99' ' ' ARG . . . -174.2 -176.36 42.53 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 126.163 1.839 . . . . 0.0 113.329 174.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 95.1 mt -72.37 117.51 14.11 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.796 2.038 . . . . 0.0 111.738 -174.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -146.59 141.84 27.35 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -95.96 120.92 37.09 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.428 1.491 . . . . 0.0 111.225 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 83.9 t -123.5 128.03 25.35 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 123.652 0.781 . . . . 0.0 109.945 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -62.87 142.93 90.42 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.283 1.989 . . . . 0.0 111.147 176.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.0 -31.89 19.46 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 176.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.42 -11.29 57.43 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 174.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -112.71 -4.62 14.03 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.144 1.378 . . . . 0.0 113.552 171.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.4 t -71.63 149.35 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.067 1.347 . . . . 0.0 111.712 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.14 152.04 79.47 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 126.26 1.824 . . . . 0.0 111.747 178.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -67.56 125.24 13.04 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.271 2.647 . . . . 0.0 111.093 -175.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 96.93 9.58 55.99 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-O 119.673 -0.515 . . . . 0.0 114.266 -173.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -65.52 161.37 20.28 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 118.183 0.991 . . . . 0.0 111.587 159.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.4 p -106.59 126.96 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.617 1.567 . . . . 0.0 111.604 178.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.9 t -106.2 136.41 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.791 1.636 . . . . 0.0 111.199 -177.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.3 t -89.78 134.74 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.081 0.952 . . . . 0.0 110.9 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -158.49 -153.11 6.64 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.533 1.064 . . . . 0.0 111.522 172.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.6 p -131.88 162.5 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.766 1.226 . . . . 0.0 110.294 167.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 40.3 mtt-85 . . . . . 0 N--CA 1.472 0.639 0 C-N-CA 126.47 1.908 . . . . 0.0 112.556 -165.654 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 . . . . . 0 N--CA 1.475 0.816 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.7 mt -137.94 158.56 44.09 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.276 1.83 . . . . 0.0 111.4 173.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -142.02 150.41 41.27 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.429 1.492 . . . . 0.0 112.339 177.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -91.52 148.87 21.98 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.944 1.697 . . . . 0.0 113.25 176.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -137.09 139.4 41.24 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.438 1.495 . . . . 0.0 109.911 -177.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -91.5 130.21 37.36 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.844 0.747 . . . . 0.0 111.843 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 71.1 t -67.94 125.47 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 O-C-N 121.498 -0.751 . . . . 0.0 109.758 168.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.4 t -85.62 -42.64 14.15 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.944 1.698 . . . . 0.0 112.635 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.5 t -159.93 165.41 32.16 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.602 1.161 . . . . 0.0 111.108 174.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.9 m -135.11 149.94 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.671 1.188 . . . . 0.0 110.936 168.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -156.02 160.31 39.91 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.964 0.906 . . . . 0.0 112.65 167.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 87.8 mt -81.67 143.44 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 161.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 43.2 pt -131.91 152.33 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.949 2.1 . . . . 0.0 111.383 173.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -87.12 97.21 10.62 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.004 -1.06 . . . . 0.0 110.769 174.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -76.94 -46.63 23.48 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.554 -1.341 . . . . 0.0 112.59 177.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 50.84 31.94 6.65 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.59 1.156 . . . . 0.0 114.077 -176.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -139.19 172.59 12.61 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.808 -1.183 . . . . 0.0 111.61 -176.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -71.18 141.35 50.7 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.34 1.056 . . . . 0.0 111.562 173.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.9 m -123.53 153.26 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 126.219 1.808 . . . . 0.0 109.551 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -109.72 161.92 14.94 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.169 0.587 . . . . 0.0 112.258 -173.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -143.19 157.59 44.37 Favored 'General case' 0 CA--C 1.55 0.949 0 O-C-N 121.722 -0.612 . . . . 0.0 111.366 158.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 44.1 tp -114.76 127.88 55.99 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.056 1.342 . . . . 0.0 110.555 174.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 37.8 t -98.26 132.73 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 121.689 0.757 . . . . 0.0 112.415 -169.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 20.8 mm -132.66 92.61 26.59 Favored Pre-proline 0 N--CA 1.47 0.535 0 C-N-CA 126.08 1.752 . . . . 0.0 108.599 -173.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -70.41 -13.25 32.86 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.404 2.069 . . . . 0.0 113.469 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -72.88 -45.66 57.03 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 118.725 0.693 . . . . 0.0 112.368 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 82.5 p -140.74 -10.21 1.04 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.807 1.643 . . . . 0.0 114.55 -171.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 45.8 m80 55.66 21.46 4.6 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 -169.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -143.7 148.57 35.93 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 120.74 -1.225 . . . . 0.0 113.955 177.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -143.3 167.62 21.72 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.346 1.458 . . . . 0.0 112.449 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 92.5 mt -115.18 131.12 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.416 1.486 . . . . 0.0 110.501 -172.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -81.31 160.23 65.69 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 123.914 0.886 . . . . 0.0 112.543 177.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.92 -12.34 32.4 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.741 2.294 . . . . 0.0 113.421 174.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -94.11 24.13 4.54 Favored 'General case' 0 CA--C 1.555 1.141 0 CA-C-N 118.785 0.72 . . . . 0.0 111.576 165.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 83.42 -23.31 6.45 Favored Glycine 0 CA--C 1.528 0.905 0 O-C-N 120.051 -1.655 . . . . 0.0 117.102 166.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 72.7 mt -61.84 142.03 57.59 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.897 1.348 . . . . 0.0 112.797 -175.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.2 t -98.02 124.95 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.96 0.904 . . . . 0.0 110.525 174.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 27.4 mt -119.37 139.69 51.58 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.856 1.662 . . . . 0.0 111.77 -168.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -97.87 139.75 33.26 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.007 0.923 . . . . 0.0 112.794 172.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 . . . . . 0 CA--C 1.544 0.723 0 C-N-CA 124.705 1.202 . . . . 0.0 111.883 176.367 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -137.42 155.78 48.95 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.422 1.889 . . . . 0.0 110.988 -172.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -55.28 141.46 35.53 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.203 1.001 . . . . 0.0 112.364 174.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -59.92 -21.09 60.65 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.012 0.925 . . . . 0.0 113.367 172.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -77.53 -3.68 41.84 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.493 1.517 . . . . 0.0 112.635 175.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.8 m -79.22 145.0 33.85 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 122.443 1.116 . . . . 0.0 112.689 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -73.64 158.74 34.19 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.726 1.61 . . . . 0.0 114.112 171.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.3 p -149.2 153.64 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 124.325 1.05 . . . . 0.0 111.599 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -122.91 130.71 53.18 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.69 1.996 . . . . 0.0 107.466 175.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -150.61 179.49 8.14 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.994 0.917 . . . . 0.0 111.287 169.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -140.77 143.69 35.05 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.447 1.499 . . . . 0.0 110.565 178.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -158.28 -39.95 0.06 Allowed 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -100.01 41.1 1.18 Allowed 'General case' 0 N--CA 1.479 1.023 0 O-C-N 120.999 -1.063 . . . . 0.0 112.936 -172.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.6 m 53.26 33.49 15.58 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.247 1.419 . . . . 0.0 112.434 -167.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.6 p -159.44 146.32 12.62 Favored Pre-proline 0 C--O 1.24 0.559 0 C-N-CA 126.8 2.04 . . . . 0.0 107.799 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -74.1 161.01 41.78 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.282 2.655 . . . . 0.0 111.596 171.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -137.75 125.33 22.18 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 126.416 1.886 . . . . 0.0 109.58 -175.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -127.75 112.78 15.17 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.458 1.503 . . . . 0.0 109.023 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -155.45 -175.64 5.54 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.293 1.437 . . . . 0.0 110.704 -177.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.5 m -78.07 148.05 34.44 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 120.9 -1.125 . . . . 0.0 110.045 168.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.466 HG12 ' CG ' ' A' ' 152' ' ' TYR . 7.3 tp -58.05 -38.71 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 O-C-N 121.508 -0.745 . . . . 0.0 111.831 177.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -61.09 -20.1 62.22 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 178.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -85.34 -46.07 11.32 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.87 1.268 . . . . 0.0 111.217 175.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -73.29 -33.59 65.3 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 121.202 -0.936 . . . . 0.0 112.158 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -59.95 -46.96 87.7 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.795 0.838 . . . . 0.0 111.1 176.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.9 t -63.04 -36.03 82.2 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.41 1.084 . . . . 0.0 111.551 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -65.23 -53.61 41.82 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.342 1.457 . . . . 0.0 110.395 175.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -72.29 -34.13 67.94 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.006 -1.059 . . . . 0.0 113.382 -178.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.16 -28.01 66.92 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.964 0.906 . . . . 0.0 112.748 176.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 51.3 m -75.89 -41.89 50.7 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.406 0.682 . . . . 0.0 111.479 172.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 45.5 mtm -78.71 -45.02 22.2 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.44 1.096 . . . . 0.0 113.006 -172.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 23.5 m-20 -111.44 -26.36 9.14 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.124 1.37 . . . . 0.0 112.238 -170.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.19 163.47 27.55 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.85 1.214 . . . . 0.0 114.424 176.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -110.79 126.6 54.79 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.575 1.15 . . . . 0.0 111.167 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.3 mp -95.69 147.68 33.39 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 127.077 2.151 . . . . 0.0 110.988 174.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -73.1 151.15 49.27 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.243 2.629 . . . . 0.0 111.125 174.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -133.73 160.67 36.88 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.318 1.447 . . . . 0.0 111.155 165.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -46.76 -49.03 20.38 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.058 1.343 . . . . 0.0 113.852 177.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -101.18 -5.93 24.94 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 177.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.49 -129.64 1.28 Allowed Glycine 0 CA--C 1.528 0.865 0 CA-C-N 119.75 1.159 . . . . 0.0 115.148 -173.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -144.64 156.32 44.05 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.684 1.194 . . . . 0.0 112.738 -174.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.34 150.45 47.74 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.547 1.139 . . . . 0.0 111.814 177.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.5 t -126.01 120.18 23.96 Favored Pre-proline 0 N--CA 1.48 1.065 0 C-N-CA 125.437 1.495 . . . . 0.0 110.027 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -76.05 139.19 21.42 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 124.13 3.22 . . . . 0.0 111.482 -176.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.3 mt -108.36 155.6 20.36 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.56 0.744 . . . . 0.0 112.516 178.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -138.11 132.5 32.11 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.098 1.359 . . . . 0.0 110.056 167.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 57.5 33.89 23.87 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.503 1.521 . . . . 0.0 113.896 -178.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.8 t -107.88 127.84 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 121.074 -1.016 . . . . 0.0 111.473 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -132.79 160.95 35.38 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.08 1.352 . . . . 0.0 113.905 -172.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.9 p -151.5 155.83 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 125.8 1.64 . . . . 0.0 112.467 -178.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -65.51 132.41 48.84 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.841 0.856 . . . . 0.0 110.153 168.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.8 t -132.81 140.17 47.85 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.711 1.605 . . . . 0.0 109.937 173.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.5 tp -91.15 134.1 34.81 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 171.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -79.73 105.32 10.94 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 164.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 23.2 mm -63.29 -24.74 36.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 O-C-N 121.647 -0.658 . . . . 0.0 111.566 -174.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -81.47 -37.21 28.31 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.307 1.843 . . . . 0.0 115.784 -178.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.0 m -106.13 -18.53 13.99 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.658 1.183 . . . . 0.0 112.483 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.4 25.73 73.67 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 125.324 1.44 . . . . 0.0 113.52 -168.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -79.52 131.28 35.99 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.899 1.68 . . . . 0.0 111.093 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.8 mp -92.37 113.47 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 173.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -138.38 172.81 12.35 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.079 1.352 . . . . 0.0 112.019 -174.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -103.9 148.05 26.61 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.66 1.184 . . . . 0.0 111.009 173.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.6 t -140.66 151.85 44.91 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.393 1.077 . . . . 0.0 111.178 173.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -72.89 157.58 37.17 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.252 1.021 . . . . 0.0 111.967 171.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -115.81 143.4 45.45 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.308 1.443 . . . . 0.0 110.942 168.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -88.67 -48.5 7.49 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.229 1.012 . . . . 0.0 112.933 -173.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -157.35 157.35 33.95 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.686 1.194 . . . . 0.0 112.043 177.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.5 mt -88.1 153.14 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 124.918 1.287 . . . . 0.0 108.265 166.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -135.22 151.31 50.5 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.025 1.73 . . . . 0.0 111.27 -178.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 26.8 ptt-85 -147.34 156.65 43.1 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 167.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -152.36 163.07 40.23 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.508 1.923 . . . . 0.0 108.945 176.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.17 143.44 26.37 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.36 -0.838 . . . . 0.0 110.577 176.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.0 m -143.28 143.81 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 122.417 1.103 . . . . 0.0 111.641 175.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -101.82 -15.23 16.98 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.657 1.183 . . . . 0.0 113.009 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -132.22 125.44 31.13 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.549 1.54 . . . . 0.0 110.903 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.1 tp -140.26 159.85 41.27 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.012 1.725 . . . . 0.0 109.538 -173.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.2 mt -112.53 128.52 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.372 1.069 . . . . 0.0 109.177 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -102.51 119.67 39.22 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.225 1.01 . . . . 0.0 110.696 169.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -104.16 127.9 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 124.821 1.249 . . . . 0.0 108.556 173.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -94.19 148.35 22.27 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.865 1.266 . . . . 0.0 110.719 172.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 70.6 mt -114.87 156.89 24.12 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.545 1.938 . . . . 0.0 111.367 -177.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 36.3 t -68.38 -20.1 64.67 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -163.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 37.2 m -93.86 4.76 53.45 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 173.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 102.08 11.57 36.52 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.129 1.347 . . . . 0.0 116.254 171.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -96.23 167.99 10.86 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.977 1.311 . . . . 0.0 111.706 177.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 97.1 p -142.46 157.76 44.41 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -176.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.1 tp -135.8 127.8 29.62 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.989 1.716 . . . . 0.0 110.337 177.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -108.7 115.81 30.79 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.491 1.516 . . . . 0.0 111.949 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.4 m -142.33 153.55 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.721 1.608 . . . . 0.0 113.142 -169.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.2 p -67.56 147.96 98.67 Favored Pre-proline 0 N--CA 1.465 0.314 0 O-C-N 121.308 -0.87 . . . . 0.0 112.305 174.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -55.5 -33.77 87.38 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.673 2.916 . . . . 0.0 114.102 -174.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.9 p -81.76 -6.96 59.52 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 30.1 t60 -76.27 120.18 80.54 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 124.737 1.215 . . . . 0.0 112.333 -174.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -75.65 129.78 12.06 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.869 2.379 . . . . 0.0 113.436 176.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.72 144.98 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 126.499 1.92 . . . . 0.0 109.256 174.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 21.2 tp -80.88 106.62 13.02 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.343 0.519 . . . . 0.0 110.561 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.5 mp -107.49 165.63 11.26 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.859 2.063 . . . . 0.0 112.272 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -119.86 119.43 33.52 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.447 1.099 . . . . 0.0 113.05 176.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 33.6 mtm180 -132.59 77.86 1.77 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.176 1.39 . . . . 0.0 108.486 164.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.2 t70 59.23 8.49 1.11 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 126.862 2.065 . . . . 0.0 115.501 -169.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.34 169.01 42.12 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.953 1.739 . . . . 0.0 111.228 -174.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 71.7 mt -76.58 119.23 20.12 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.512 1.125 . . . . 0.0 110.639 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -133.55 131.76 40.12 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.127 0.971 . . . . 0.0 110.915 -176.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -88.32 122.29 31.67 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 172.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 67.0 t -132.2 127.11 20.79 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 123.87 0.868 . . . . 0.0 110.301 -175.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -65.89 142.72 70.31 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.378 2.052 . . . . 0.0 111.239 176.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.97 -30.85 16.07 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 176.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.08 -18.44 65.31 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 173.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -111.74 -3.97 14.81 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.151 1.38 . . . . 0.0 112.248 175.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 89.3 t -71.16 144.49 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.833 1.253 . . . . 0.0 110.316 169.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.12 156.66 78.92 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 126.407 1.883 . . . . 0.0 110.895 -177.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.36 126.24 13.99 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.337 2.025 . . . . 0.0 112.404 -172.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 108.07 -2.85 33.4 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.03 1.3 . . . . 0.0 114.814 -178.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -59.81 160.38 7.66 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.938 1.295 . . . . 0.0 113.221 174.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.8 t -102.56 118.35 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.139 1.375 . . . . 0.0 109.975 177.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.4 t -93.79 141.55 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.698 1.599 . . . . 0.0 110.058 173.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.5 t -91.38 138.66 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.259 1.024 . . . . 0.0 110.555 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -164.7 -149.13 5.7 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 123.402 0.525 . . . . 0.0 114.339 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.7 p -150.33 159.44 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 127.008 2.123 . . . . 0.0 108.573 175.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 N--CA 1.472 0.671 0 C-N-CA 123.91 0.884 . . . . 0.0 112.249 176.724 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 . . . . . 0 N--CA 1.477 0.896 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 96.7 mt -139.58 174.25 10.7 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 127.864 2.465 . . . . 0.0 111.907 -177.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -142.25 170.85 14.94 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 127.437 2.295 . . . . 0.0 110.604 169.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -126.04 147.0 49.67 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.103 1.761 . . . . 0.0 110.805 172.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -135.76 134.79 39.37 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.257 1.023 . . . . 0.0 110.313 -168.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -95.13 138.95 32.15 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.523 -0.736 . . . . 0.0 112.916 -174.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 71.0 t -74.15 132.67 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.351 1.06 . . . . 0.0 111.012 174.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 36.1 t -91.64 -40.36 11.35 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.211 1.804 . . . . 0.0 113.082 176.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.5 t -162.08 165.97 26.45 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.18 0.992 . . . . 0.0 110.643 176.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.2 m -131.93 148.23 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.491 1.116 . . . . 0.0 109.986 166.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -152.0 154.46 36.05 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.377 1.071 . . . . 0.0 112.766 172.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 87.7 mt -94.32 129.21 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.414 1.086 . . . . 0.0 108.537 169.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 16.8 pt -123.02 165.4 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 126.393 1.877 . . . . 0.0 112.131 -177.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -108.24 68.21 0.69 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.463 1.905 . . . . 0.0 112.509 -173.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -62.21 -43.88 97.84 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 121.097 -1.002 . . . . 0.0 113.24 -164.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 50.97 33.27 8.59 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.338 1.455 . . . . 0.0 113.894 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -141.5 177.64 7.99 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.853 1.261 . . . . 0.0 111.962 -174.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -77.65 142.07 39.06 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.161 0.985 . . . . 0.0 113.055 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 14.8 m -126.76 151.04 33.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 125.666 1.586 . . . . 0.0 109.671 177.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.466 ' CG ' HG12 ' A' ' 21' ' ' ILE . 1.2 p90 -111.04 164.18 13.08 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.678 0.791 . . . . 0.0 112.463 -175.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -144.31 155.4 43.8 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 122.439 0.296 . . . . 0.0 110.761 154.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 46.6 tp -107.49 124.39 49.83 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.568 1.147 . . . . 0.0 110.329 175.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 23.1 t -91.98 117.44 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 121.768 0.794 . . . . 0.0 111.887 -171.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 13.7 mm -120.73 83.25 35.52 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 126.396 1.879 . . . . 0.0 109.063 -177.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -63.24 -19.31 68.21 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.123 1.882 . . . . 0.0 113.808 178.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -76.13 -30.38 58.16 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 120.533 -1.355 . . . . 0.0 113.944 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 69.7 p -141.43 -18.1 0.79 Allowed 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . 0.253 75.6 m80 56.82 21.89 6.47 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.077 2.151 . . . . 0.0 115.165 -168.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -147.32 145.66 29.42 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.618 1.099 . . . . 0.0 113.767 -179.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -148.66 164.79 33.27 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.085 1.354 . . . . 0.0 111.709 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.2 mp -111.39 136.3 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.296 1.038 . . . . 0.0 111.466 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -81.88 157.64 68.82 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 124.033 0.933 . . . . 0.0 112.374 175.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -64.92 -22.71 62.67 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.815 2.344 . . . . 0.0 112.76 178.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -77.27 -5.48 49.58 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.559 0.744 . . . . 0.0 112.856 173.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 112.55 -21.68 18.65 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 125.955 1.74 . . . . 0.0 116.566 165.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 58.3 mt -76.87 149.89 36.09 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.097 1.448 . . . . 0.0 113.88 -171.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.9 t -96.78 123.84 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.761 1.224 . . . . 0.0 111.818 -178.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 25.4 mt -117.47 142.88 46.63 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.323 1.849 . . . . 0.0 112.577 -169.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -102.72 140.42 37.02 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.266 1.026 . . . . 0.0 112.369 170.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 . . . . . 0 CA--C 1.545 0.783 0 C-N-CA 123.944 0.897 . . . . 0.0 111.649 174.057 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.676 0 CA-C-O 120.832 0.349 . . . . 0.0 111.481 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.11 161.75 32.51 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.702 2.401 . . . . 0.0 110.684 -177.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.84 141.68 56.85 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.338 1.055 . . . . 0.0 112.59 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.2 ppt_? -56.54 -28.55 60.33 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.016 1.327 . . . . 0.0 113.166 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -81.74 -6.89 59.45 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.725 2.01 . . . . 0.0 114.599 -177.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.1 m -69.02 144.04 54.17 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.159 1.384 . . . . 0.0 112.856 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -82.06 152.02 26.8 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.438 1.495 . . . . 0.0 113.88 171.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.7 p -148.19 162.57 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.698 1.599 . . . . 0.0 111.685 -173.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -134.89 130.02 35.28 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.685 1.594 . . . . 0.0 109.823 -173.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -157.3 -178.53 7.42 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 118.924 0.784 . . . . 0.0 112.793 175.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -135.3 138.86 43.87 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.399 1.479 . . . . 0.0 111.43 172.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -169.0 146.92 3.8 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.139 1.376 . . . . 0.0 111.374 174.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.5 t0 62.92 36.93 12.38 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 115.321 1.601 . . . . 0.0 115.321 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 m 62.59 37.51 13.0 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.579 1.552 . . . . 0.0 113.504 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.8 p -157.29 137.08 8.58 Favored Pre-proline 0 CA--C 1.543 0.703 0 O-C-N 121.329 -0.857 . . . . 0.0 111.499 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.26 147.4 32.94 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.962 3.108 . . . . 0.0 111.111 171.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -127.35 135.97 51.26 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.812 1.245 . . . . 0.0 112.02 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 52.1 ttm -143.79 88.29 1.97 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.736 1.215 . . . . 0.0 109.789 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -146.31 -176.42 5.16 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.729 2.012 . . . . 0.0 111.645 -168.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -73.64 150.98 40.96 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.472 -1.392 . . . . 0.0 111.893 176.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.8 tp -58.34 -37.25 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 O-C-N 121.527 -0.733 . . . . 0.0 111.927 173.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -64.5 -30.44 71.47 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.215 0.916 . . . . 0.0 113.003 174.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -73.76 -41.39 62.51 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.587 -0.696 . . . . 0.0 110.301 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 20.0 ptm -69.47 -39.51 77.67 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.654 171.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -57.41 -52.41 65.49 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.975 0.807 . . . . 0.0 111.756 -178.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.8 t -71.55 -29.13 64.4 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 122.718 0.407 . . . . 0.0 111.503 -173.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -65.19 -53.01 51.17 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.363 1.465 . . . . 0.0 110.634 173.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -68.26 -32.77 73.18 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.376 -0.827 . . . . 0.0 112.015 177.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.74 -28.54 66.9 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.495 1.118 . . . . 0.0 113.658 174.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.4 t -83.83 -31.49 25.79 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.416 -0.802 . . . . 0.0 111.736 174.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 67.1 mtm -81.33 -42.75 20.09 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -114.27 -23.11 9.59 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.193 1.397 . . . . 0.0 113.875 -171.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.98 161.74 37.01 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.836 1.208 . . . . 0.0 114.647 -178.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -112.83 128.43 56.44 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.566 1.547 . . . . 0.0 110.406 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.8 mp -105.54 142.56 25.01 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 125.393 1.477 . . . . 0.0 111.789 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.24 146.27 40.25 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 124.04 3.16 . . . . 0.0 112.349 -177.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -141.12 159.55 41.98 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.083 1.753 . . . . 0.0 111.346 -178.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -61.42 -52.07 66.12 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 120.203 -1.56 . . . . 0.0 114.578 -178.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -79.84 -15.34 57.59 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 172.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -179.05 -125.99 0.98 Allowed Glycine 0 CA--C 1.539 1.549 0 N-CA-C 117.177 1.631 . . . . 0.0 117.177 -175.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -143.6 161.89 37.32 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.897 1.679 . . . . 0.0 111.003 178.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.19 148.52 41.7 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.952 1.301 . . . . 0.0 112.486 -176.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 54.5 t -124.11 120.99 26.28 Favored Pre-proline 0 N--CA 1.481 1.113 0 C-N-CA 125.756 1.623 . . . . 0.0 110.861 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -75.9 141.91 24.65 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 124.245 3.297 . . . . 0.0 112.317 -178.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.3 mt -106.45 164.58 11.93 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.52 1.128 . . . . 0.0 113.692 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -146.65 125.71 12.87 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.297 1.439 . . . . 0.0 111.009 173.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 54.46 32.96 17.74 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 125.758 1.623 . . . . 0.0 114.251 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.2 t -96.31 122.38 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 120.849 -1.157 . . . . 0.0 110.179 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -124.12 155.04 39.14 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.488 1.115 . . . . 0.0 113.508 -174.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.5 p -150.49 152.19 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.663 1.185 . . . . 0.0 111.976 -176.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -63.31 129.83 41.95 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 122.026 0.917 . . . . 0.0 110.228 167.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.2 t -131.22 152.17 50.76 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.624 1.97 . . . . 0.0 111.248 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.6 tp -105.0 135.0 47.15 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.428 1.091 . . . . 0.0 110.211 175.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -80.8 116.04 20.59 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.769 0.828 . . . . 0.0 110.404 164.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 39.4 mm -71.9 -21.43 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.634 0.774 . . . . 0.0 112.473 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.8 -43.11 31.61 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.91 0.884 . . . . 0.0 113.305 -176.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -107.28 -23.67 12.16 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.405 1.082 . . . . 0.0 111.882 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.9 34.25 38.95 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.519 1.056 . . . . 0.0 113.272 -170.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -99.27 147.18 25.43 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.747 1.274 . . . . 0.0 113.502 -175.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.4 mp -91.95 130.88 40.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 C-N-CA 125.999 1.72 . . . . 0.0 110.025 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -157.5 171.43 20.37 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.367 1.467 . . . . 0.0 112.374 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -102.86 141.65 35.32 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.075 1.35 . . . . 0.0 111.047 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.1 t -141.5 166.44 24.74 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.094 0.958 . . . . 0.0 112.373 176.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -93.61 150.79 20.13 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.941 1.296 . . . . 0.0 112.809 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.56 139.16 46.07 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.563 1.145 . . . . 0.0 111.556 173.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 93.1 p -91.0 -51.93 5.1 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -165.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -155.07 159.56 40.35 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.494 1.517 . . . . 0.0 112.95 177.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.3 mt -96.66 151.59 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 125.803 1.641 . . . . 0.0 109.117 170.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -137.6 148.5 45.9 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.347 1.459 . . . . 0.0 111.569 -174.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.51 149.12 52.38 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.399 1.48 . . . . 0.0 112.423 176.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -155.6 162.41 40.64 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.945 1.298 . . . . 0.0 110.386 176.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -101.74 140.92 35.38 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.08 0.952 . . . . 0.0 110.983 -176.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.8 m -149.05 144.47 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 124.527 1.131 . . . . 0.0 111.522 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -93.01 -36.16 12.88 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 126.278 1.831 . . . . 0.0 111.384 170.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -118.38 130.61 56.09 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.355 1.062 . . . . 0.0 110.981 -171.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.3 tp -139.02 159.14 42.86 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.648 1.979 . . . . 0.0 109.403 -173.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.4 mt -113.07 126.05 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.884 0.874 . . . . 0.0 109.209 176.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -97.03 127.82 43.38 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.08 0.952 . . . . 0.0 111.268 167.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -113.79 133.02 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.467 1.507 . . . . 0.0 109.474 173.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -103.78 146.47 28.58 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 126.753 2.021 . . . . 0.0 111.957 -179.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 68.2 mt -119.48 156.72 29.7 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.785 1.634 . . . . 0.0 113.08 -173.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.9 t -57.45 -29.39 64.16 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.312 1.445 . . . . 0.0 113.913 -178.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 55.7 m -75.44 1.38 14.17 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 173.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.63 43.26 19.4 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-N 119.608 1.095 . . . . 0.0 112.596 -178.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -130.48 152.78 49.5 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.15 1.78 . . . . 0.0 109.667 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 54.3 p -132.37 149.68 52.3 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 174.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 67.3 tp -122.19 134.18 54.72 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 126.501 1.92 . . . . 0.0 110.791 176.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -113.26 117.29 31.44 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.286 1.435 . . . . 0.0 111.962 -178.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.0 m -140.59 158.33 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.275 1.43 . . . . 0.0 112.913 -174.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.6 p -65.61 147.56 98.63 Favored Pre-proline 0 N--CA 1.471 0.61 0 O-C-N 120.975 -1.078 . . . . 0.0 112.766 174.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -59.5 -32.7 96.69 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.385 2.723 . . . . 0.0 113.763 -172.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 64.6 p -75.66 -1.64 25.66 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.774 2.03 . . . . 0.0 114.9 177.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 53.6 t60 -91.07 122.11 66.98 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 124.497 1.119 . . . . 0.0 113.022 -165.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -73.22 142.28 33.67 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.929 2.419 . . . . 0.0 114.425 -177.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.2 t -125.89 143.14 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 126.73 2.012 . . . . 0.0 109.479 174.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.1 tt -81.21 105.52 12.48 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.703 0.763 . . . . 0.0 110.087 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.8 mp -99.73 159.58 14.95 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.335 1.854 . . . . 0.0 111.381 177.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -113.54 133.31 55.32 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.675 -0.641 . . . . 0.0 111.89 174.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -153.46 96.86 2.08 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.942 1.697 . . . . 0.0 110.224 155.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 56.27 -3.33 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 127.328 2.251 . . . . 0.0 116.898 -167.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.83 163.43 34.52 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.372 1.463 . . . . 0.0 113.333 177.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 67.5 mt -67.93 115.16 7.14 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.066 2.146 . . . . 0.0 110.943 -177.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -141.73 139.81 32.97 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -178.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -98.37 124.53 43.09 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.919 0.887 . . . . 0.0 112.157 -175.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 62.1 t -131.58 131.28 22.74 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 125.196 1.398 . . . . 0.0 110.258 -172.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.43 145.62 77.67 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.583 2.188 . . . . 0.0 111.878 177.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.57 -30.95 14.4 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 176.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.27 -25.93 68.27 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 173.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -102.59 -4.95 24.45 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.032 1.733 . . . . 0.0 112.737 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 98.5 t -69.69 148.76 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.024 0.929 . . . . 0.0 109.647 166.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.92 155.22 71.09 Favored Pre-proline 0 N--CA 1.471 0.585 0 C-N-CA 127.252 2.221 . . . . 0.0 109.987 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.89 119.48 6.51 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.041 1.827 . . . . 0.0 111.577 -177.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.24 6.87 33.45 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.158 1.361 . . . . 0.0 114.705 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -61.15 155.62 20.22 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.275 1.037 . . . . 0.0 111.654 163.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.6 t -93.04 128.46 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.421 1.088 . . . . 0.0 110.071 169.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 28.0 t -103.03 139.03 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 126.381 1.872 . . . . 0.0 109.695 171.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.6 t -91.68 141.34 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.531 0.732 . . . . 0.0 110.772 176.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -168.38 -150.52 6.66 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 121.728 -0.607 . . . . 0.0 114.188 -177.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.4 p -140.33 168.36 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 126.253 1.821 . . . . 0.0 109.979 175.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 35.9 mtp180 . . . . . 0 N--CA 1.467 0.383 0 C-N-CA 125.584 1.554 . . . . 0.0 112.607 -175.441 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 . . . . . 0 N--CA 1.472 0.663 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 60.9 mt -128.93 174.18 9.74 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.652 1.981 . . . . 0.0 112.297 178.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -140.05 169.53 17.53 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.885 2.474 . . . . 0.0 109.279 171.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -135.5 156.18 49.32 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 119.992 -1.693 . . . . 0.0 111.627 164.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.29 140.09 52.07 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.589 1.156 . . . . 0.0 110.862 -172.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -89.28 133.69 34.36 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.51 0.724 . . . . 0.0 110.985 170.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 79.4 t -72.15 122.58 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 123.433 0.693 . . . . 0.0 110.229 174.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 47.9 t -77.76 -41.98 35.68 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.652 1.181 . . . . 0.0 112.478 174.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.7 t -160.8 164.67 31.26 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.458 -0.777 . . . . 0.0 112.376 -177.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.7 m -135.72 150.71 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.485 1.114 . . . . 0.0 110.999 167.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -152.68 155.94 38.24 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.397 1.079 . . . . 0.0 112.943 173.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 80.5 mt -93.01 130.82 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 168.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 36.3 pt -122.33 149.37 25.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 124.63 1.172 . . . . 0.0 112.371 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.53 102.47 12.88 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.421 1.088 . . . . 0.0 110.069 168.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -84.34 -50.38 7.87 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.211 0.604 . . . . 0.0 111.715 172.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 44.57 57.17 4.62 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.978 1.311 . . . . 0.0 112.504 -173.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -151.63 175.71 12.08 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.712 0.805 . . . . 0.0 112.176 -177.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -67.67 144.42 55.5 Favored 'General case' 0 N--CA 1.463 0.189 0 O-C-N 121.727 -0.608 . . . . 0.0 110.79 162.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.1 m -122.5 152.16 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.521 1.128 . . . . 0.0 109.466 169.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -114.47 157.2 23.25 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 121.781 0.801 . . . . 0.0 112.09 -178.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -155.59 153.94 30.89 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.777 0.831 . . . . 0.0 109.784 -165.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 32.3 tp -136.51 139.44 42.27 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.174 -0.954 . . . . 0.0 111.788 -170.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 28.9 t -113.17 130.04 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.763 0.825 . . . . 0.0 112.608 -168.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 11.0 mm -134.08 85.55 39.51 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 125.728 1.611 . . . . 0.0 109.535 -175.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.98 -13.71 39.08 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.006 2.471 . . . . 0.0 113.766 -177.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -79.43 -40.18 30.58 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.383 0.882 . . . . 0.0 113.383 -177.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 59.1 p -140.14 -6.41 1.24 Allowed 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -171.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 58.01 13.35 2.15 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.203 1.801 . . . . 0.0 115.851 -174.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.03 147.55 24.15 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 120.96 1.709 . . . . 0.0 114.983 -176.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -146.85 159.24 43.76 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.369 1.068 . . . . 0.0 113.539 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.7 mp -99.7 137.96 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.466 1.106 . . . . 0.0 112.643 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -91.0 156.26 44.32 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 126.664 1.986 . . . . 0.0 112.428 172.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -67.75 -19.83 46.85 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.763 2.976 . . . . 0.0 113.74 -174.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 47.6 p30 -73.18 -0.94 15.67 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.063 1.345 . . . . 0.0 113.418 171.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.2 -5.63 68.28 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 126.391 1.948 . . . . 0.0 115.385 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 66.8 mt -84.94 153.54 22.76 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.231 1.516 . . . . 0.0 111.846 -175.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.7 p -110.55 133.04 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.785 0.834 . . . . 0.0 111.798 175.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 24.4 mt -116.2 154.33 30.26 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.831 2.052 . . . . 0.0 110.844 -172.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 8.3 t-80 -111.64 149.75 31.09 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.081 0.952 . . . . 0.0 112.86 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 3.4 t30 . . . . . 0 CA--C 1.55 0.976 0 C-N-CA 123.474 0.709 . . . . 0.0 111.161 162.351 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.608 0 CA-C-O 120.819 0.343 . . . . 0.0 111.6 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.12 156.32 45.37 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.704 1.602 . . . . 0.0 110.748 -169.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.08 145.3 31.3 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.825 1.25 . . . . 0.0 114.203 -177.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -60.64 -23.39 64.73 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.474 1.509 . . . . 0.0 114.216 177.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -92.79 4.37 53.93 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.792 0.837 . . . . 0.0 112.973 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.8 m -71.47 140.14 49.89 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.027 -1.045 . . . . 0.0 111.603 174.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -65.67 155.61 35.44 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.241 1.417 . . . . 0.0 113.648 167.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.7 p -148.11 151.93 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.331 1.052 . . . . 0.0 111.341 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -128.08 126.22 40.78 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.544 1.538 . . . . 0.0 108.254 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -156.92 176.98 12.03 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.396 0.678 . . . . 0.0 111.616 -177.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -134.83 138.36 44.15 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.683 1.193 . . . . 0.0 110.08 178.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -161.66 158.79 26.61 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.425 1.09 . . . . 0.0 110.213 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.3 t0 50.27 37.87 16.14 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.063 0.945 . . . . 0.0 113.26 -175.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.7 m 53.39 41.85 32.07 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.398 1.079 . . . . 0.0 113.372 -176.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.0 p -157.92 142.19 11.61 Favored Pre-proline 0 CA--C 1.545 0.753 0 O-C-N 120.968 -1.083 . . . . 0.0 111.216 174.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.14 149.26 64.21 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 123.003 2.468 . . . . 0.0 112.604 174.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -137.11 139.82 41.5 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 127.209 2.203 . . . . 0.0 109.629 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 42.6 ttm -153.08 106.1 2.98 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.361 -0.837 . . . . 0.0 110.775 -174.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -159.55 -179.3 7.78 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.006 1.322 . . . . 0.0 111.963 -165.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.4 m -71.03 138.02 49.51 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.099 -1.0 . . . . 0.0 110.565 169.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.458 HG12 ' CG ' ' A' ' 152' ' ' TYR . 6.6 tp -55.13 -38.75 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 O-C-N 121.251 -0.906 . . . . 0.0 112.606 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -66.29 -16.78 64.31 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.389 0.995 . . . . 0.0 113.104 -177.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -87.2 -41.13 13.97 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.846 1.258 . . . . 0.0 111.178 173.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 2.1 ppp? -73.4 -36.93 66.09 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 120.914 -1.116 . . . . 0.0 112.062 176.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -55.42 -45.7 76.73 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.447 1.099 . . . . 0.0 110.673 175.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.2 t -60.98 -34.67 75.14 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.1 0.96 . . . . 0.0 111.156 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -65.47 -53.08 47.78 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.457 1.103 . . . . 0.0 110.513 174.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -73.28 -35.36 66.15 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 121.495 -0.753 . . . . 0.0 112.739 -173.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.01 -35.67 80.45 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.262 0.625 . . . . 0.0 110.686 172.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 54.5 m -76.9 -24.08 52.51 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 121.049 -1.032 . . . . 0.0 113.538 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 33.1 mtm -90.54 -52.98 4.63 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.844 1.258 . . . . 0.0 112.062 177.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -100.31 -21.33 15.49 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.34 1.456 . . . . 0.0 112.049 -167.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.84 161.09 31.58 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.632 1.111 . . . . 0.0 113.049 -177.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -102.76 138.38 39.73 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.663 1.185 . . . . 0.0 111.155 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.6 mp -107.4 148.21 36.73 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 128.925 2.89 . . . . 0.0 110.212 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.85 155.68 43.68 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 123.516 2.811 . . . . 0.0 112.53 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -142.46 175.95 9.38 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.857 1.263 . . . . 0.0 112.524 169.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.61 -55.96 25.95 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.555 1.142 . . . . 0.0 112.119 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -105.94 -4.19 20.91 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -175.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -169.7 -135.69 1.95 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 114.61 0.604 . . . . 0.0 114.61 -172.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -144.65 165.37 28.23 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.086 1.754 . . . . 0.0 111.334 -175.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.29 159.33 42.33 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.687 1.595 . . . . 0.0 111.617 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 54.2 t -131.52 117.18 16.47 Favored Pre-proline 0 N--CA 1.48 1.061 0 C-N-CA 125.747 1.619 . . . . 0.0 111.102 178.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -82.46 123.3 3.81 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 124.233 3.289 . . . . 0.0 112.664 -172.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 90.5 mt -97.74 157.48 16.04 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -171.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -134.49 127.04 30.62 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.731 1.613 . . . . 0.0 112.588 171.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 52.32 40.95 30.23 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.246 1.418 . . . . 0.0 113.578 178.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.7 t -104.26 126.62 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.974 1.31 . . . . 0.0 109.543 172.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -126.46 158.74 35.26 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.927 1.291 . . . . 0.0 112.305 -175.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.8 m -143.09 150.18 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 126.334 1.853 . . . . 0.0 111.457 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -69.56 133.07 47.21 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 122.925 1.345 . . . . 0.0 109.666 164.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.3 t -137.13 164.68 27.87 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.7 2.4 . . . . 0.0 110.345 -173.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.3 tp -119.22 135.37 54.72 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.389 1.076 . . . . 0.0 109.194 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -79.1 105.99 10.83 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 163.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.2 mm -70.62 -24.63 25.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.685 0.794 . . . . 0.0 111.579 -175.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.97 -47.56 71.2 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.439 1.496 . . . . 0.0 113.391 -177.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.1 m -107.98 -19.27 13.56 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.599 1.16 . . . . 0.0 112.745 178.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.62 36.87 15.14 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.018 0.818 . . . . 0.0 112.318 -176.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -101.63 134.5 44.67 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.875 1.67 . . . . 0.0 112.591 -177.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 mp -76.64 136.53 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 O-C-N 121.798 -0.564 . . . . 0.0 109.934 178.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.1 ptpt -146.94 168.09 22.36 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.559 1.544 . . . . 0.0 111.781 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -116.05 147.71 40.98 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.414 1.486 . . . . 0.0 109.349 170.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.3 t -147.12 161.3 41.15 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.714 0.806 . . . . 0.0 111.866 -178.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -83.75 137.92 33.51 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.727 1.211 . . . . 0.0 112.027 175.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.34 132.18 44.03 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.229 1.011 . . . . 0.0 109.707 169.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.3 t -94.63 -41.09 9.48 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -163.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -150.51 156.23 41.03 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.923 1.289 . . . . 0.0 110.842 173.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.4 mt -88.49 149.4 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 162.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -126.95 149.2 49.96 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 126.324 1.85 . . . . 0.0 109.742 175.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.52 142.67 47.09 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.661 1.184 . . . . 0.0 111.71 167.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -141.98 153.22 44.13 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.595 1.158 . . . . 0.0 109.868 171.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.5 mmtt -84.06 144.36 29.12 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.813 -0.555 . . . . 0.0 110.661 171.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 20.5 m -143.09 140.51 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 122.457 1.122 . . . . 0.0 111.883 173.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -102.05 -9.11 20.87 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.594 1.558 . . . . 0.0 112.453 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -139.46 131.3 27.6 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.076 1.35 . . . . 0.0 109.952 175.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 13.0 tp -139.52 160.28 40.22 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.996 1.318 . . . . 0.0 109.513 -176.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.9 mt -111.63 127.5 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.851 0.861 . . . . 0.0 109.451 179.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -98.51 120.02 38.21 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.091 0.956 . . . . 0.0 110.786 167.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.4 mp -102.16 127.47 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.316 1.046 . . . . 0.0 108.473 168.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -97.12 151.05 20.16 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.071 1.348 . . . . 0.0 110.838 173.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 59.9 mt -117.21 159.97 21.8 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.263 1.825 . . . . 0.0 112.864 -172.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.7 t -58.8 -25.1 62.8 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.721 1.608 . . . . 0.0 113.368 177.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.8 p -67.33 -11.5 57.8 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.204 1.801 . . . . 0.0 115.236 172.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.78 -1.42 83.52 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 125.193 1.378 . . . . 0.0 114.664 -170.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -95.92 173.12 7.6 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.247 1.819 . . . . 0.0 112.835 -175.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.7 p -143.36 164.25 30.79 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 17.5 tp -139.09 137.07 35.87 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.331 1.452 . . . . 0.0 111.204 174.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.7 mtmt -113.69 117.72 32.33 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.023 1.329 . . . . 0.0 112.803 -176.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.2 m -143.48 153.93 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 125.868 1.667 . . . . 0.0 113.08 -163.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.6 p -70.16 149.76 96.09 Favored Pre-proline 0 N--CA 1.475 0.813 0 O-C-N 120.731 -1.231 . . . . 0.0 112.824 176.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -60.86 -22.76 75.01 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.692 2.928 . . . . 0.0 114.069 -174.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 58.9 p -88.81 -11.49 44.68 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.882 1.673 . . . . 0.0 115.02 177.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -65.74 121.78 77.27 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-N 119.332 0.969 . . . . 0.0 110.887 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -77.35 128.24 9.54 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.709 2.272 . . . . 0.0 112.789 177.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.0 t -100.0 137.55 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 C-N-CA 126.425 1.89 . . . . 0.0 109.692 176.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.33 108.35 13.86 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.6 mp -103.4 146.65 28.17 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.346 1.458 . . . . 0.0 111.904 -177.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -96.92 96.74 8.73 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.181 0.515 . . . . 0.0 111.518 170.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -124.73 73.73 1.29 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 122.808 1.289 . . . . 0.0 110.148 -178.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.4 t70 60.38 4.03 0.64 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 128.165 2.586 . . . . 0.0 114.79 -162.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -177.66 174.63 47.05 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 126.566 2.032 . . . . 0.0 111.28 -175.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.0 mt -76.5 123.36 25.92 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.748 1.219 . . . . 0.0 110.376 174.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -155.09 159.46 40.25 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.007 1.323 . . . . 0.0 112.492 176.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -107.16 131.76 53.79 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.901 0.88 . . . . 0.0 112.367 -175.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 97.1 t -132.72 129.39 21.26 Favored Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 124.099 0.96 . . . . 0.0 110.829 175.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -62.21 144.65 95.87 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.741 2.294 . . . . 0.0 111.944 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.68 -31.57 26.38 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.32 -25.61 67.24 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 172.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -108.37 -2.85 18.79 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.924 1.69 . . . . 0.0 112.945 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 89.6 t -70.0 139.2 20.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 O-C-N 121.542 -0.724 . . . . 0.0 109.563 162.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.18 154.96 74.38 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 126.187 1.795 . . . . 0.0 110.113 -177.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.69 121.14 8.03 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.194 1.93 . . . . 0.0 110.641 -175.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.37 4.95 34.89 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.377 0.989 . . . . 0.0 114.609 -174.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -65.87 175.79 1.84 Allowed 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 118.897 1.349 . . . . 0.0 113.08 168.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.5 p -125.16 123.26 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 125.069 1.348 . . . . 0.0 111.945 -176.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 26.0 t -115.9 131.9 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 125.652 1.581 . . . . 0.0 111.923 -167.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.0 t -88.18 140.88 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 122.063 0.935 . . . . 0.0 111.659 -178.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -170.07 -144.35 4.27 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.906 1.717 . . . . 0.0 111.845 -176.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.3 p -150.49 163.88 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 126.722 2.009 . . . . 0.0 109.131 173.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 . . . . . 0 N--CA 1.477 0.891 0 C-N-CA 123.635 0.774 . . . . 0.0 111.887 169.954 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 . . . . . 0 N--CA 1.475 0.817 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 97.0 mt -138.92 176.94 8.26 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 128.404 2.682 . . . . 0.0 112.321 -178.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -155.63 159.76 39.88 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.963 2.105 . . . . 0.0 111.535 169.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -107.44 151.2 25.87 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.63 1.172 . . . . 0.0 113.0 169.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -135.69 136.79 41.17 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.037 1.335 . . . . 0.0 110.704 -167.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -85.08 134.14 34.2 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.507 -0.745 . . . . 0.0 111.878 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 70.3 t -73.89 126.17 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.167 0.587 . . . . 0.0 110.279 171.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.6 t -81.35 -49.56 10.54 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.146 1.778 . . . . 0.0 112.461 175.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.4 m -156.09 161.34 40.4 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.709 1.204 . . . . 0.0 110.633 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.5 m -134.14 144.35 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.077 0.951 . . . . 0.0 110.337 167.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -152.24 155.79 38.43 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 173.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 85.9 mt -86.81 139.95 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 167.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 21.9 pt -130.52 148.82 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 125.958 1.703 . . . . 0.0 110.94 174.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -86.64 89.72 8.02 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.391 -0.818 . . . . 0.0 109.825 177.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -71.87 -44.0 64.51 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -172.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 51.61 26.8 3.53 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 126.544 1.938 . . . . 0.0 114.832 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 -139.65 175.56 9.47 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.694 1.198 . . . . 0.0 111.662 -173.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -74.19 140.81 45.37 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 124.006 0.922 . . . . 0.0 112.617 177.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 15.0 m -122.68 154.95 27.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 126.131 1.772 . . . . 0.0 109.079 172.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.458 ' CG ' HG12 ' A' ' 21' ' ' ILE . 3.2 p90 -110.34 159.32 17.54 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.558 0.743 . . . . 0.0 112.217 -177.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -137.9 143.84 41.04 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 122.639 0.376 . . . . 0.0 110.356 158.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 60.4 tp -111.39 103.59 11.97 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.526 1.13 . . . . 0.0 110.223 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.0 t -81.05 122.95 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -158.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 24.2 mm -112.42 96.33 35.4 Favored Pre-proline 0 N--CA 1.469 0.513 0 C-N-CA 125.464 1.506 . . . . 0.0 110.035 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.38 -14.77 37.83 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.022 1.815 . . . . 0.0 113.553 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -73.16 -65.34 0.82 Allowed 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 119.145 0.884 . . . . 0.0 111.735 177.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 67.7 p -114.88 -10.72 12.3 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.296 1.439 . . . . 0.0 114.04 -171.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 59.06 18.86 6.71 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.46 1.504 . . . . 0.0 114.243 -167.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -146.63 145.66 30.14 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -175.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -146.46 163.76 34.66 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.62 1.568 . . . . 0.0 112.596 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.0 mp -102.14 134.94 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 O-C-N 121.261 -0.9 . . . . 0.0 111.715 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.32 154.24 54.14 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 124.956 1.302 . . . . 0.0 112.307 170.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.09 -17.05 54.34 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.705 2.937 . . . . 0.0 114.736 -173.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -73.07 -6.01 42.74 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 169.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 111.66 -20.87 22.07 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 126.359 1.933 . . . . 0.0 115.221 172.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 54.4 mt -81.92 145.51 30.28 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 120.1 1.95 . . . . 0.0 113.842 -166.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.5 t -89.26 123.87 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.954 0.902 . . . . 0.0 110.603 176.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 20.8 mt -115.73 137.93 51.61 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.644 1.578 . . . . 0.0 111.184 -174.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -101.16 145.26 29.02 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.149 0.979 . . . . 0.0 111.016 168.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 21.8 m120 . . . . . 0 CA--C 1.547 0.842 0 C-N-CA 124.411 1.084 . . . . 0.0 112.06 170.146 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.58 159.9 41.19 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.867 1.667 . . . . 0.0 112.09 -168.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.27 146.48 39.21 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.177 1.391 . . . . 0.0 113.015 175.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.03 -22.72 64.83 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.098 1.359 . . . . 0.0 114.521 177.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -87.4 -2.54 58.69 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.7 m -65.02 134.87 54.82 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.902 0.881 . . . . 0.0 111.628 175.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -75.07 153.29 38.43 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.009 0.924 . . . . 0.0 112.882 172.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 p -145.56 158.96 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.287 1.035 . . . . 0.0 112.389 -174.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -127.82 133.52 49.41 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.018 1.727 . . . . 0.0 109.456 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -156.28 168.93 25.78 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 170.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -132.91 143.72 49.68 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.321 1.448 . . . . 0.0 111.52 -178.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -157.86 136.41 11.2 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.071 1.349 . . . . 0.0 109.566 175.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.5 t0 50.48 46.91 24.87 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.397 1.479 . . . . 0.0 113.972 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.7 m 61.86 42.4 10.47 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 176.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.1 p -155.05 140.51 12.46 Favored Pre-proline 0 CA--C 1.548 0.871 0 O-C-N 121.027 -1.046 . . . . 0.0 111.514 167.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -91.21 157.42 3.8 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 124.981 3.787 . . . . 0.0 114.802 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 33.1 m80 -136.74 138.17 40.68 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.63 1.972 . . . . 0.0 110.553 -173.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 41.6 ttm -144.64 107.82 4.55 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.666 0.787 . . . . 0.0 111.809 176.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -156.8 -179.97 8.71 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.287 1.435 . . . . 0.0 111.746 -174.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.3 m -67.34 136.81 55.39 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.376 -0.828 . . . . 0.0 110.023 171.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.43 HG12 ' CG ' ' A' ' 152' ' ' TYR . 7.8 tp -54.85 -36.53 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 121.173 -0.954 . . . . 0.0 112.924 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -62.36 -17.96 60.29 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -82.24 -54.44 5.25 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.3 1.44 . . . . 0.0 110.37 174.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -65.26 -32.63 74.39 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.63 -0.669 . . . . 0.0 112.013 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -60.4 -51.12 70.83 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.33 0.652 . . . . 0.0 111.454 169.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.0 t -61.23 -38.07 85.31 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.667 0.787 . . . . 0.0 111.001 -177.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -62.71 -52.72 62.16 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 125.328 1.451 . . . . 0.0 110.845 174.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -72.17 -32.68 67.07 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.199 -0.938 . . . . 0.0 113.2 -176.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.46 -31.22 68.28 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.971 0.908 . . . . 0.0 112.547 174.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.8 t -78.6 -20.65 50.0 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.969 1.308 . . . . 0.0 112.322 176.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 46.4 mtm -96.62 -58.61 2.01 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.913 1.685 . . . . 0.0 113.601 177.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -100.0 -15.14 18.38 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.427 1.491 . . . . 0.0 113.611 -170.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 87.49 162.89 38.37 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 124.433 1.016 . . . . 0.0 114.515 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -110.65 134.45 52.42 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.976 1.311 . . . . 0.0 110.017 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.7 mp -120.75 148.34 48.06 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 125.531 1.532 . . . . 0.0 111.522 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.05 150.6 60.64 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.841 3.028 . . . . 0.0 112.762 -177.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -134.05 168.0 19.61 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.422 1.489 . . . . 0.0 111.653 177.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.19 -50.58 37.41 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.066 1.347 . . . . 0.0 113.886 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -111.44 -2.51 15.54 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.802 1.641 . . . . 0.0 114.18 -175.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.04 -137.16 2.37 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 121.423 -0.798 . . . . 0.0 114.116 -173.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -136.0 161.12 36.55 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.311 1.845 . . . . 0.0 111.516 176.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.95 158.06 44.48 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.323 1.049 . . . . 0.0 112.168 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 84.6 t -126.64 117.01 22.71 Favored Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 125.919 1.688 . . . . 0.0 109.904 176.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.0 130.76 17.11 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 123.993 3.129 . . . . 0.0 112.617 -174.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 89.4 mt -102.05 162.2 13.09 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.179 0.992 . . . . 0.0 113.294 176.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -144.86 124.83 13.51 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.225 1.01 . . . . 0.0 112.235 173.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 47.82 52.56 12.64 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.652 1.581 . . . . 0.0 112.777 -174.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.9 t -113.46 132.87 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 125.059 1.344 . . . . 0.0 110.079 175.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -132.26 151.18 51.95 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.499 1.12 . . . . 0.0 112.899 -166.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.6 m -140.41 153.53 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 126.24 1.816 . . . . 0.0 111.912 177.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -68.13 132.05 46.51 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.134 0.974 . . . . 0.0 109.948 168.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.5 t -134.33 153.56 51.82 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.762 2.025 . . . . 0.0 111.175 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 49.0 tp -103.05 129.33 49.81 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.25 1.02 . . . . 0.0 109.637 175.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -77.23 97.56 4.85 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.678 0.791 . . . . 0.0 109.157 173.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 30.5 mm -59.25 -25.68 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 O-C-N 120.877 -1.14 . . . . 0.0 112.907 -170.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.49 -39.73 31.4 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -176.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.3 m -110.99 -6.36 14.68 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.23 1.012 . . . . 0.0 113.214 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.82 29.24 74.66 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.558 1.551 . . . . 0.0 113.649 177.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -96.37 139.28 32.72 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.772 1.629 . . . . 0.0 112.142 -178.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 mp -80.26 130.03 36.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 125.552 1.541 . . . . 0.0 108.974 173.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -151.6 169.11 22.92 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.976 1.71 . . . . 0.0 111.278 -177.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -100.06 147.67 25.39 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.536 1.134 . . . . 0.0 110.552 170.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.3 t -142.0 168.73 19.05 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.817 0.847 . . . . 0.0 112.085 173.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 -102.01 145.95 28.58 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.492 1.117 . . . . 0.0 113.535 -174.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -108.07 139.18 43.1 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.236 1.414 . . . . 0.0 111.228 178.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.86 -47.02 7.85 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.565 0.746 . . . . 0.0 112.733 -170.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -153.58 156.89 38.85 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.998 1.319 . . . . 0.0 110.834 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.7 mt -86.17 154.39 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 163.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -138.87 151.15 46.74 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.464 1.505 . . . . 0.0 112.264 -175.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -144.63 152.78 40.98 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.003 1.321 . . . . 0.0 113.301 170.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -155.25 160.25 40.67 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.014 1.326 . . . . 0.0 110.586 173.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp -87.78 143.71 27.0 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.278 1.431 . . . . 0.0 111.546 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.5 m -147.13 146.0 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 124.983 1.313 . . . . 0.0 111.556 176.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -95.31 -34.27 12.23 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.539 1.536 . . . . 0.0 111.596 170.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -113.16 119.24 37.12 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.377 1.471 . . . . 0.0 109.421 -169.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.0 tp -133.99 162.09 33.03 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.379 1.472 . . . . 0.0 109.524 -178.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.5 mt -120.5 129.3 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.351 1.061 . . . . 0.0 108.742 177.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -99.28 125.68 44.95 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.346 0.658 . . . . 0.0 110.798 168.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -109.81 127.56 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.821 1.248 . . . . 0.0 109.471 170.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -94.16 146.38 24.03 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.443 1.497 . . . . 0.0 110.92 171.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 49.2 mt -112.73 162.16 16.06 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.597 1.559 . . . . 0.0 111.95 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.0 t -63.74 -16.09 60.26 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.917 1.287 . . . . 0.0 113.3 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 77.9 p -77.89 -9.74 59.22 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.249 2.22 . . . . 0.0 115.167 170.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 83.65 0.69 89.98 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.957 1.265 . . . . 0.0 114.869 -171.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -77.42 148.47 35.44 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.773 1.229 . . . . 0.0 110.635 175.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 93.3 p -122.66 143.26 49.89 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.457 1.103 . . . . 0.0 112.689 173.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.5 tp -127.53 132.13 49.96 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.973 1.709 . . . . 0.0 110.528 178.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.0 mtpt -118.31 115.72 25.28 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.036 1.334 . . . . 0.0 111.751 -171.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.5 m -143.93 154.5 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.131 1.372 . . . . 0.0 113.665 -164.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 21.3 p -66.77 147.96 98.9 Favored Pre-proline 0 N--CA 1.471 0.615 0 O-C-N 121.163 -0.96 . . . . 0.0 112.397 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -57.82 -29.01 84.59 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.199 2.599 . . . . 0.0 113.086 -177.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.2 p -71.83 -20.96 61.75 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.457 2.303 . . . . 0.0 115.782 176.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -71.62 119.65 75.3 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.254 1.022 . . . . 0.0 112.052 -168.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -75.68 129.0 11.37 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.713 2.276 . . . . 0.0 112.341 175.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.0 t -108.95 144.44 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 126.112 1.765 . . . . 0.0 109.113 176.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.21 104.95 12.03 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.141 0.496 . . . . 0.0 109.992 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.7 mp -104.22 160.99 14.42 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.692 1.597 . . . . 0.0 111.541 -178.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -112.38 119.21 37.47 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 176.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.8 mtp-105 -136.89 81.78 1.9 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.098 0.959 . . . . 0.0 110.448 161.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 58.62 10.3 1.38 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.694 1.998 . . . . 0.0 115.515 -170.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 177.67 163.25 29.16 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.892 1.234 . . . . 0.0 113.22 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 46.0 mt -64.01 116.53 5.96 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.725 1.61 . . . . 0.0 111.612 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -144.62 144.46 31.28 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 178.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -95.27 129.82 42.26 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.139 0.976 . . . . 0.0 110.79 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.8 t -133.66 127.96 19.75 Favored Pre-proline 0 N--CA 1.476 0.848 0 C-N-CA 123.891 0.876 . . . . 0.0 110.438 -178.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -65.58 141.04 65.17 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.326 2.017 . . . . 0.0 111.084 177.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.99 -30.4 14.99 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 176.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.04 -17.89 63.81 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 174.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -108.5 -14.83 14.57 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.098 1.359 . . . . 0.0 112.793 175.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 87.2 t -63.47 140.78 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.823 1.249 . . . . 0.0 110.434 173.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.86 153.56 78.77 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 125.93 1.692 . . . . 0.0 110.866 -174.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -68.86 116.1 4.29 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.644 2.229 . . . . 0.0 111.543 -169.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 115.29 0.36 22.2 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 124.416 1.008 . . . . 0.0 115.1 -176.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -63.4 156.74 25.07 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 118.583 1.191 . . . . 0.0 111.351 169.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.6 t -97.56 132.32 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 124.539 1.135 . . . . 0.0 110.875 173.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.2 t -106.63 143.5 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 127.308 2.243 . . . . 0.0 110.285 176.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.5 t -95.44 140.85 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.274 1.029 . . . . 0.0 111.153 176.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -165.65 -150.87 6.43 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.551 1.072 . . . . 0.0 112.887 176.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.6 p -134.29 163.0 38.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 127.676 2.39 . . . . 0.0 108.258 173.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 38.9 mtt180 . . . . . 0 N--CA 1.47 0.553 0 C-N-CA 124.623 1.169 . . . . 0.0 109.894 172.364 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 80.3 mt -137.64 161.81 35.47 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.972 1.709 . . . . 0.0 111.161 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -144.08 130.32 19.72 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.726 1.21 . . . . 0.0 113.306 -177.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -79.66 144.38 33.79 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.226 1.41 . . . . 0.0 112.099 175.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -134.05 141.46 47.2 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.068 1.347 . . . . 0.0 110.631 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -102.65 139.25 38.48 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.126 -0.984 . . . . 0.0 112.855 -175.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 78.6 t -76.11 134.71 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.912 0.885 . . . . 0.0 111.491 175.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.9 t -99.06 -39.13 8.67 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.873 2.069 . . . . 0.0 113.525 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 26.2 t -157.41 160.32 38.27 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.58 1.152 . . . . 0.0 110.918 175.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.4 m -136.51 147.79 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.599 1.159 . . . . 0.0 110.028 164.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 31.7 ptt-85 -158.41 159.58 35.92 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 162.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 45.6 mt -85.03 134.29 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.065 0.946 . . . . 0.0 108.685 173.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 19.0 pt -126.99 156.27 38.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 125.396 1.478 . . . . 0.0 112.524 -177.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.94 96.79 10.84 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.749 1.22 . . . . 0.0 111.737 173.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -78.46 -53.12 7.59 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.232 -0.917 . . . . 0.0 112.316 176.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 46.53 47.94 14.19 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.513 1.525 . . . . 0.0 112.434 -172.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -151.97 178.52 9.35 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.702 0.801 . . . . 0.0 112.732 -176.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -80.01 139.27 37.04 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.708 1.203 . . . . 0.0 113.042 177.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.5 m -121.25 160.63 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.526 1.93 . . . . 0.0 110.084 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.43 ' CG ' HG12 ' A' ' 21' ' ' ILE . 0.7 OUTLIER -113.78 161.83 17.06 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.988 0.915 . . . . 0.0 112.87 -178.357 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -144.03 163.37 33.7 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.571 0.748 . . . . 0.0 111.156 154.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 46.4 tp -115.17 122.93 47.56 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.277 1.431 . . . . 0.0 109.927 172.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 58.6 t -87.52 121.88 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 O-C-N 121.276 -0.89 . . . . 0.0 111.919 -171.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 20.5 mm -119.56 89.95 41.92 Favored Pre-proline 0 N--CA 1.47 0.531 0 C-N-CA 125.836 1.655 . . . . 0.0 109.371 -177.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -66.21 -23.19 52.72 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.331 2.02 . . . . 0.0 112.524 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 -81.76 -29.57 32.75 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -171.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 69.1 p -140.5 -22.33 0.82 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -177.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 65.33 15.86 10.24 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 127.113 2.165 . . . . 0.0 115.507 -171.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.49 150.52 26.67 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 120.735 -1.228 . . . . 0.0 114.144 -177.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -150.92 170.38 19.45 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.102 1.361 . . . . 0.0 113.09 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.1 mp -106.98 137.42 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.648 1.179 . . . . 0.0 111.937 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.91 157.99 50.9 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.684 1.194 . . . . 0.0 113.097 173.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -66.06 -18.07 56.14 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.302 2.668 . . . . 0.0 113.989 -175.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -83.83 6.07 22.77 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 171.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 107.04 -23.69 26.83 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 126.106 1.813 . . . . 0.0 116.954 165.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 75.2 mt -83.3 151.42 25.6 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 120.252 2.026 . . . . 0.0 114.46 -169.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.0 t -93.83 129.0 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.657 1.183 . . . . 0.0 111.93 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 25.5 mt -119.69 141.74 49.11 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.77 2.028 . . . . 0.0 111.552 -170.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -102.36 134.83 45.02 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 119.206 0.912 . . . . 0.0 112.681 171.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 35.1 m120 . . . . . 0 C--O 1.24 0.569 0 C-N-CA 124.43 1.092 . . . . 0.0 111.733 -169.164 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -142.58 163.64 32.27 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.082 1.353 . . . . 0.0 112.389 -167.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.13 146.05 48.85 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.629 1.572 . . . . 0.0 112.821 175.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.6 ppt_? -63.48 -21.49 66.34 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 176.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -83.79 0.36 47.69 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 176.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.6 m -66.45 147.7 52.92 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.613 1.165 . . . . 0.0 113.112 174.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -88.62 156.28 19.13 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.844 1.657 . . . . 0.0 114.423 175.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 p -145.82 150.66 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.948 0.899 . . . . 0.0 113.217 -172.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -128.42 121.98 30.29 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.788 2.035 . . . . 0.0 107.679 175.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -139.74 174.44 10.51 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.209 1.004 . . . . 0.0 111.422 173.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.421 ' CD ' ' HZ1' ' A' ' 62' ' ' LYS . 23.5 mt-10 -131.23 134.46 46.46 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.053 -1.029 . . . . 0.0 111.393 170.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -159.33 166.53 30.97 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.483 1.913 . . . . 0.0 108.257 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.0 t70 55.5 22.42 5.09 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 120.083 1.311 . . . . 0.0 113.093 -167.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.2 m 56.84 36.17 27.34 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.646 1.978 . . . . 0.0 114.185 -170.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.2 p -152.82 143.77 15.89 Favored Pre-proline 0 CA--C 1.547 0.85 0 O-C-N 120.534 -1.354 . . . . 0.0 112.141 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -70.03 140.98 42.94 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.74 2.96 . . . . 0.0 113.622 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -129.16 137.05 50.94 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 127.519 2.328 . . . . 0.0 110.339 -178.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 45.4 mtp -143.76 119.2 10.3 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.266 1.426 . . . . 0.0 112.093 -174.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -164.43 -173.51 3.1 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.617 1.567 . . . . 0.0 112.709 -172.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 65.4 m -74.53 141.57 44.83 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.089 -1.007 . . . . 0.0 111.127 167.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.421 HG12 ' CG ' ' A' ' 152' ' ' TYR . 7.4 tp -57.53 -38.21 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 121.256 -0.903 . . . . 0.0 112.857 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -60.92 -28.41 68.91 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.733 0.697 . . . . 0.0 111.913 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -80.49 -43.91 20.04 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 124.135 0.974 . . . . 0.0 110.974 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 12.9 ptm -65.19 -35.14 80.16 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.322 0.964 . . . . 0.0 111.625 173.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -60.83 -48.48 81.62 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.356 0.662 . . . . 0.0 110.557 173.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.1 t -59.78 -39.55 85.27 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.815 1.246 . . . . 0.0 111.39 177.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.3 ttmm -61.31 -56.73 17.21 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.414 1.486 . . . . 0.0 110.793 174.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -74.6 -33.05 62.53 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.108 -0.995 . . . . 0.0 112.564 -172.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.63 -19.91 62.78 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.975 0.91 . . . . 0.0 112.522 172.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 51.0 m -90.02 -18.98 24.97 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.252 1.421 . . . . 0.0 113.678 171.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 72.0 mtm -98.27 -44.91 6.38 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.893 1.277 . . . . 0.0 113.334 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -112.11 -23.77 10.26 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.592 1.557 . . . . 0.0 112.962 -169.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.32 162.98 38.97 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.693 1.616 . . . . 0.0 114.172 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -107.53 133.78 51.5 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.256 1.022 . . . . 0.0 110.94 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.3 mp -118.51 150.83 48.78 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 126.921 2.088 . . . . 0.0 110.936 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -75.53 148.03 32.76 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.693 2.929 . . . . 0.0 112.429 177.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -131.21 169.3 16.13 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.518 1.927 . . . . 0.0 111.595 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.58 -56.34 7.36 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.569 1.548 . . . . 0.0 114.613 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -105.33 -6.57 19.51 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -168.37 -137.84 2.33 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 123.716 0.674 . . . . 0.0 113.918 -170.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -131.84 155.89 47.02 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.51 1.524 . . . . 0.0 111.498 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.31 148.77 41.88 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.041 0.936 . . . . 0.0 112.214 -177.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 84.2 t -118.38 111.14 38.49 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 125.593 1.557 . . . . 0.0 109.476 176.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.58 140.23 51.25 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 124.569 3.513 . . . . 0.0 111.231 -177.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.5 mt -107.5 163.42 13.08 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.153 0.981 . . . . 0.0 113.528 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -137.63 116.34 12.2 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 127.58 2.352 . . . . 0.0 110.238 176.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 52.69 38.66 26.76 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 126.83 2.052 . . . . 0.0 115.133 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.6 t -99.92 133.71 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.18 1.392 . . . . 0.0 110.857 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -127.95 159.88 33.6 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.275 1.83 . . . . 0.0 113.319 -175.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.8 m -138.32 161.2 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 127.257 2.223 . . . . 0.0 111.593 174.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -76.38 131.05 38.9 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 122.02 0.914 . . . . 0.0 108.933 163.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.8 t -132.32 151.25 51.93 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.116 1.766 . . . . 0.0 111.054 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.6 tp -109.51 136.29 49.15 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.574 1.15 . . . . 0.0 109.546 174.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -85.38 115.9 23.39 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 118.57 -0.729 . . . . 0.0 109.762 160.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.2 mm -66.36 -28.5 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 119.685 1.129 . . . . 0.0 112.331 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.43 -47.86 31.09 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -168.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 64.3 m -96.06 -17.77 20.68 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.247 -0.908 . . . . 0.0 112.075 169.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.84 32.37 33.11 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.552 1.072 . . . . 0.0 112.856 -176.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -88.35 119.79 29.1 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 118.246 1.023 . . . . 0.0 111.865 -172.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.2 mp -72.98 125.64 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 167.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -152.15 175.39 12.63 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.658 1.183 . . . . 0.0 112.178 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.421 ' HZ1' ' CD ' ' A' ' 11' ' ' GLU . 3.0 tppt? -99.1 148.76 23.72 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.363 1.465 . . . . 0.0 110.601 172.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.7 t -143.93 158.72 43.51 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 118.547 0.612 . . . . 0.0 111.554 165.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.7 ptt85 -67.21 156.04 37.29 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.862 0.865 . . . . 0.0 112.576 170.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -112.99 138.34 50.02 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.704 0.802 . . . . 0.0 110.198 160.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.9 t -88.71 -47.62 8.11 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.282 1.033 . . . . 0.0 112.697 -167.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -154.46 156.59 37.02 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.141 1.776 . . . . 0.0 111.549 173.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.4 mt -86.01 153.35 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 165.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -133.93 148.14 51.17 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.43 1.492 . . . . 0.0 112.113 -172.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -142.77 149.08 38.21 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 165.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -146.13 162.5 37.84 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.937 1.695 . . . . 0.0 110.23 171.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.51 147.26 23.14 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.75 0.82 . . . . 0.0 112.965 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.5 m -149.05 145.96 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.505 1.522 . . . . 0.0 111.653 177.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -93.54 -31.13 14.66 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.823 1.249 . . . . 0.0 112.395 173.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -128.0 137.11 52.09 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 122.147 0.975 . . . . 0.0 112.648 -176.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.4 tp -137.79 165.45 26.43 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.715 2.006 . . . . 0.0 110.333 -174.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.6 mt -119.15 127.82 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.555 1.142 . . . . 0.0 109.532 175.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -95.25 124.52 39.34 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.809 0.843 . . . . 0.0 111.293 163.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -106.62 127.77 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 125.574 1.55 . . . . 0.0 108.835 168.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -96.59 145.77 25.44 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.075 1.35 . . . . 0.0 111.075 173.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 81.8 mt -104.92 162.29 13.46 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.538 1.935 . . . . 0.0 111.59 -178.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.3 t -60.03 -28.86 68.1 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.346 1.458 . . . . 0.0 111.915 177.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 97.3 p -63.27 -12.81 31.9 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.707 1.603 . . . . 0.0 114.646 169.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.1 2.47 89.39 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.695 1.616 . . . . 0.0 114.06 -170.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -88.86 173.26 8.62 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.494 1.518 . . . . 0.0 111.891 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 86.8 p -143.0 148.82 37.41 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 -171.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 61.3 tp -120.7 131.65 54.66 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 127.577 2.351 . . . . 0.0 109.787 174.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -122.89 113.24 18.86 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.15 1.38 . . . . 0.0 111.697 -176.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.9 m -145.06 155.46 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 125.081 1.353 . . . . 0.0 113.286 -163.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.2 p -68.08 147.05 98.39 Favored Pre-proline 0 N--CA 1.473 0.709 0 O-C-N 121.404 -0.81 . . . . 0.0 112.417 176.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -60.79 -33.99 92.17 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.775 2.317 . . . . 0.0 113.265 -170.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.4 p -78.83 -7.48 57.91 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.829 1.651 . . . . 0.0 114.946 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -86.99 124.75 68.31 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.373 1.069 . . . . 0.0 113.353 -168.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -72.66 143.55 37.98 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.337 2.691 . . . . 0.0 115.479 -178.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.7 t -122.77 146.87 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 126.777 2.031 . . . . 0.0 109.693 174.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 31.0 tp -84.68 114.6 22.14 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.285 0.634 . . . . 0.0 111.358 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.7 mp -113.87 153.66 28.82 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.285 1.834 . . . . 0.0 112.686 -172.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -103.34 101.63 11.55 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.804 1.641 . . . . 0.0 110.733 171.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 76.5 mtt-85 -136.17 74.14 1.49 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.535 1.134 . . . . 0.0 110.722 173.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 61.7 2.4 0.71 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 126.486 1.914 . . . . 0.0 115.748 -167.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -176.3 167.89 39.73 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.456 1.503 . . . . 0.0 112.115 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 75.6 mt -81.96 108.58 15.58 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.132 1.373 . . . . 0.0 110.727 -178.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -140.71 144.02 35.36 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.527 0.731 . . . . 0.0 112.765 -168.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -96.57 120.59 37.17 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.673 1.189 . . . . 0.0 111.118 -176.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 62.1 t -130.08 131.99 23.81 Favored Pre-proline 0 N--CA 1.482 1.162 0 C-N-CA 124.777 1.231 . . . . 0.0 110.43 -176.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -67.42 146.99 76.62 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.344 2.696 . . . . 0.0 112.257 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.41 -31.71 23.74 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 176.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.8 -23.39 66.69 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 173.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -104.35 0.89 29.63 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.02 1.728 . . . . 0.0 112.053 174.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 84.0 t -74.88 141.37 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 O-C-N 120.796 -1.19 . . . . 0.0 109.773 167.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.52 154.39 81.63 Favored Pre-proline 0 N--CA 1.472 0.649 0 C-N-CA 127.334 2.254 . . . . 0.0 110.436 -176.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.27 115.03 3.27 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 121.664 1.576 . . . . 0.0 109.613 177.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.37 3.41 24.18 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.745 1.164 . . . . 0.0 115.542 -177.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -60.13 161.89 6.42 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 118.65 1.225 . . . . 0.0 111.85 161.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 24.5 t -118.22 128.7 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.5 1.52 . . . . 0.0 110.225 174.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.0 t -104.09 145.11 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 127.16 2.184 . . . . 0.0 110.606 -175.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 43.7 t -87.77 137.76 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.376 1.07 . . . . 0.0 111.112 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -167.32 -146.65 4.97 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 115.262 0.865 . . . . 0.0 115.262 179.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.8 p -155.75 165.04 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 126.658 1.983 . . . . 0.0 108.639 176.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 . . . . . 0 N--CA 1.473 0.698 0 C-N-CA 124.871 1.268 . . . . 0.0 111.773 176.884 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 . . . . . 0 N--CA 1.475 0.822 0 CA-C-O 119.566 -0.254 . . . . 0.0 111.529 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 85.8 mt -149.0 151.46 34.59 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.767 2.027 . . . . 0.0 112.561 -174.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -136.5 171.63 14.2 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.208 1.803 . . . . 0.0 111.386 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -131.01 157.06 44.03 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 120.631 -1.293 . . . . 0.0 112.724 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -138.34 123.83 19.56 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.576 1.15 . . . . 0.0 110.2 -167.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -84.67 145.63 27.88 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.952 -1.092 . . . . 0.0 112.307 -178.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.5 t -77.55 133.1 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.285 1.034 . . . . 0.0 111.699 175.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 26.9 t -87.16 -46.31 9.87 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.625 1.97 . . . . 0.0 112.405 171.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 29.6 t -157.26 160.72 38.91 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.42 0.688 . . . . 0.0 111.788 -173.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.0 m -135.36 145.73 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.285 1.034 . . . . 0.0 111.61 167.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -152.73 151.23 30.28 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.551 1.14 . . . . 0.0 113.344 172.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 75.4 mt -89.0 138.86 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.953 1.301 . . . . 0.0 109.051 169.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 44.9 pt -131.65 146.62 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.936 1.694 . . . . 0.0 111.62 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -80.07 104.92 10.96 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.668 -0.645 . . . . 0.0 109.549 165.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -81.62 -49.01 11.01 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.077 -1.015 . . . . 0.0 113.518 174.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 44.33 52.71 7.16 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.069 1.348 . . . . 0.0 111.989 -173.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -150.02 176.85 10.41 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.808 0.843 . . . . 0.0 111.97 -177.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -75.52 146.94 40.15 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.565 -0.709 . . . . 0.0 111.638 168.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 6.8 m -126.23 158.22 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.799 1.64 . . . . 0.0 109.47 172.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.421 ' CG ' HG12 ' A' ' 21' ' ' ILE . 0.6 OUTLIER -110.89 160.75 16.49 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.294 0.637 . . . . 0.0 112.577 -175.753 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -141.91 163.17 33.63 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.914 0.886 . . . . 0.0 110.22 157.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 54.8 tp -123.98 123.92 41.44 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.502 -1.374 . . . . 0.0 110.235 176.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 42.4 t -90.6 122.13 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -165.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 42.1 mm -124.1 84.31 55.39 Favored Pre-proline 0 N--CA 1.47 0.539 0 C-N-CA 126.196 1.798 . . . . 0.0 108.832 -172.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -66.83 -17.57 52.09 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.759 2.306 . . . . 0.0 113.752 -176.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -83.8 -32.78 25.16 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -174.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 80.9 p -140.74 -12.46 0.99 Allowed 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 -174.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 60.6 m80 56.23 26.23 10.15 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 -173.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.31 148.23 25.59 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 120.557 -1.34 . . . . 0.0 113.21 178.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -148.8 163.34 37.67 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.914 1.286 . . . . 0.0 112.211 -178.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.5 mp -112.67 137.73 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.864 0.866 . . . . 0.0 111.973 -176.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.89 157.34 51.77 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 125.38 1.472 . . . . 0.0 113.15 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.14 -17.87 50.78 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.549 2.833 . . . . 0.0 113.748 -176.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -74.58 -10.3 59.41 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 171.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 112.91 -24.66 12.6 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 125.743 1.64 . . . . 0.0 115.798 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.43 139.92 49.88 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.625 1.712 . . . . 0.0 113.799 -167.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 20.3 t -87.09 123.99 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.02 0.928 . . . . 0.0 110.958 173.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 33.5 mt -115.86 150.26 37.31 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.141 1.776 . . . . 0.0 111.709 -173.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -88.76 159.86 17.57 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.583 0.753 . . . . 0.0 110.79 170.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 . . . . . 0 CA--C 1.54 0.568 0 O-C-N 121.141 -0.974 . . . . 0.0 109.601 163.635 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -139.72 163.32 32.91 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.636 1.974 . . . . 0.0 111.082 -172.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.03 146.16 51.04 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.86 1.264 . . . . 0.0 113.383 -177.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -62.91 -19.88 64.63 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.929 1.292 . . . . 0.0 113.426 174.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -75.55 -10.44 59.45 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.248 1.819 . . . . 0.0 112.953 176.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.8 m -70.96 144.39 50.55 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 121.142 -0.974 . . . . 0.0 113.316 -175.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -91.72 150.88 20.9 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.055 1.742 . . . . 0.0 113.305 176.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.3 p -148.74 156.3 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 124.202 1.001 . . . . 0.0 113.484 -167.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -136.95 125.99 24.41 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.522 1.929 . . . . 0.0 109.042 -174.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -150.86 175.49 11.97 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 119.741 1.155 . . . . 0.0 113.154 -177.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -130.07 144.56 51.41 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.111 1.365 . . . . 0.0 112.933 171.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -161.97 162.43 29.0 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.749 2.02 . . . . 0.0 109.666 168.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.5 t0 53.77 28.74 8.61 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.372 1.469 . . . . 0.0 114.292 -177.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.8 m 59.33 38.0 23.23 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.431 1.892 . . . . 0.0 114.571 -172.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.6 p -151.98 140.63 13.66 Favored Pre-proline 0 CA--C 1.544 0.728 0 O-C-N 120.501 -1.375 . . . . 0.0 112.609 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -72.1 151.03 55.07 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 123.336 2.69 . . . . 0.0 113.106 175.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -134.44 140.63 46.39 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.281 2.232 . . . . 0.0 110.708 -176.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 36.7 ttm -141.75 121.9 13.83 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.396 1.078 . . . . 0.0 110.776 179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -163.83 -177.01 4.88 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.487 1.515 . . . . 0.0 112.983 -179.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.6 m -77.04 144.26 38.74 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.005 -1.06 . . . . 0.0 110.146 167.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.418 HG12 ' CG ' ' A' ' 152' ' ' TYR . 9.3 tp -57.31 -38.22 60.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -61.43 -24.18 66.36 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -76.5 -51.06 12.45 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.909 1.283 . . . . 0.0 110.862 175.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 19.9 ptm -68.86 -32.69 72.54 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.753 -0.592 . . . . 0.0 112.361 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -59.84 -51.04 71.44 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.216 0.606 . . . . 0.0 110.701 173.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.0 t -66.54 -34.86 78.85 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.412 0.551 . . . . 0.0 111.264 -176.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -61.12 -54.45 44.42 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.124 1.37 . . . . 0.0 110.305 174.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -70.68 -36.42 73.31 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.367 -0.833 . . . . 0.0 112.763 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.4 -33.01 74.75 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.971 0.908 . . . . 0.0 112.337 176.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.1 t -75.9 -32.27 59.57 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.923 0.889 . . . . 0.0 112.463 176.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 37.9 mtm -85.62 -47.21 10.05 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.308 1.443 . . . . 0.0 113.728 -177.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 48.3 m-20 -109.97 -20.39 12.75 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.49 1.516 . . . . 0.0 113.455 -171.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.13 163.97 39.52 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 122.247 0.915 . . . . 0.0 114.603 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -110.4 133.24 53.46 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.278 1.831 . . . . 0.0 110.175 -178.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.2 mp -116.05 146.92 38.16 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 126.79 2.036 . . . . 0.0 111.691 -176.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.65 141.55 19.73 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 124.589 3.526 . . . . 0.0 114.29 -173.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -133.97 166.18 23.31 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.669 1.988 . . . . 0.0 111.839 -177.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.45 -52.67 35.89 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.719 1.208 . . . . 0.0 114.036 -177.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -105.87 -4.78 20.33 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -173.25 -132.75 1.57 Allowed Glycine 0 CA--C 1.529 0.92 0 O-C-N 120.758 -1.214 . . . . 0.0 115.335 -174.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -141.04 153.58 45.57 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.266 1.427 . . . . 0.0 112.658 -173.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -132.59 153.84 50.63 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.389 1.476 . . . . 0.0 112.18 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.2 t -125.08 118.33 25.46 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 125.393 1.477 . . . . 0.0 110.86 177.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.57 136.88 24.32 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 124.521 3.481 . . . . 0.0 112.331 -175.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 70.6 mt -104.17 166.58 10.32 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.413 1.085 . . . . 0.0 112.514 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -141.45 118.68 11.38 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.519 1.928 . . . . 0.0 109.703 177.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 51.31 51.63 16.48 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 126.031 1.732 . . . . 0.0 114.095 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.1 t -113.54 133.06 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.761 1.224 . . . . 0.0 112.021 -177.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -127.94 157.29 40.97 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.882 1.273 . . . . 0.0 113.755 -175.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.2 m -144.11 164.12 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 127.46 2.304 . . . . 0.0 111.634 177.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -82.94 133.71 35.1 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.681 1.192 . . . . 0.0 110.102 171.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.2 t -131.8 153.62 49.94 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 127.395 2.278 . . . . 0.0 112.104 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 32.9 tp -106.09 133.61 50.53 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.177 0.991 . . . . 0.0 110.973 169.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -90.42 95.6 10.25 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.549 1.539 . . . . 0.0 111.501 175.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.4 mm -61.12 -18.75 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 124.8 1.24 . . . . 0.0 113.43 -174.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.56 -37.13 84.31 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.615 1.566 . . . . 0.0 114.334 172.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.6 p -127.56 -26.82 2.94 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.778 1.231 . . . . 0.0 113.545 -167.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.13 29.1 65.11 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.905 1.241 . . . . 0.0 113.38 -167.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -77.54 125.04 28.72 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.312 1.056 . . . . 0.0 110.615 167.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 mp -79.71 123.9 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 165.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -148.71 167.78 24.64 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -173.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -92.93 145.13 24.61 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.271 1.428 . . . . 0.0 110.005 174.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.5 t -144.49 155.43 43.7 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.522 1.129 . . . . 0.0 111.65 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.56 137.55 32.24 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.92 143.94 29.56 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.526 1.13 . . . . 0.0 110.666 171.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.6 t -99.2 -50.17 4.23 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.636 1.174 . . . . 0.0 112.885 -170.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -154.41 157.74 38.96 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.246 1.018 . . . . 0.0 112.286 176.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.7 mt -84.42 150.18 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 165.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -138.6 150.76 46.63 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.351 1.46 . . . . 0.0 111.731 -175.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -143.18 154.4 43.83 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 168.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -143.06 166.01 25.82 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.868 1.667 . . . . 0.0 109.789 172.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.7 tmtp? -100.68 136.57 40.34 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.209 0.603 . . . . 0.0 111.062 178.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.6 m -142.76 144.69 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 122.614 1.197 . . . . 0.0 111.021 178.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -93.5 -33.96 13.57 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 125.228 1.411 . . . . 0.0 111.148 173.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -121.17 137.35 54.71 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 124.418 1.087 . . . . 0.0 110.34 -173.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.4 tp -141.53 159.97 41.11 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 125.386 1.474 . . . . 0.0 109.191 -175.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.5 mt -109.36 124.25 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 175.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -93.5 125.92 38.36 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.891 0.877 . . . . 0.0 110.169 166.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.2 mp -110.84 124.84 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 124.512 1.125 . . . . 0.0 108.372 168.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -92.31 144.52 25.3 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.826 1.25 . . . . 0.0 110.202 173.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 59.9 mt -103.58 155.67 18.37 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 126.659 1.984 . . . . 0.0 110.263 178.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.8 t -66.37 -20.54 66.1 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.175 0.99 . . . . 0.0 112.949 -176.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 86.8 p -63.02 -18.48 63.38 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.111 1.765 . . . . 0.0 114.184 165.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 99.78 -7.35 59.19 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 126.254 1.883 . . . . 0.0 114.523 -174.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -86.18 171.12 11.55 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.475 1.51 . . . . 0.0 111.573 -178.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 95.2 p -142.81 157.6 44.46 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -177.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 14.3 tp -128.59 138.88 52.44 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.918 1.687 . . . . 0.0 109.969 171.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -120.78 116.97 26.26 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.242 1.417 . . . . 0.0 111.54 -176.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.4 m -140.21 153.29 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.058 1.343 . . . . 0.0 112.566 -164.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.9 p -67.79 146.68 98.48 Favored Pre-proline 0 N--CA 1.469 0.476 0 O-C-N 121.125 -0.985 . . . . 0.0 111.832 172.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -58.68 -18.69 41.97 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 124.279 3.319 . . . . 0.0 114.702 -175.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.7 p -88.81 -8.44 54.36 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.242 1.817 . . . . 0.0 114.987 177.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -71.61 120.96 82.97 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 119.526 1.057 . . . . 0.0 111.589 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -79.17 122.74 5.34 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.152 2.568 . . . . 0.0 112.537 176.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 40.1 t -93.72 141.17 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.927 1.691 . . . . 0.0 110.04 177.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 32.7 tp -80.01 104.65 10.73 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.518 0.599 . . . . 0.0 111.091 176.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -92.69 157.65 16.35 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.474 1.51 . . . . 0.0 112.323 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -121.17 71.1 0.94 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.684 0.754 . . . . 0.0 111.203 -177.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 73.0 mtp85 -119.65 74.08 0.99 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.651 1.18 . . . . 0.0 110.888 -169.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 58.22 6.07 0.49 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 127.337 2.255 . . . . 0.0 115.212 -166.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -178.35 157.9 22.16 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 125.693 1.616 . . . . 0.0 112.437 -177.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 48.4 mt -76.25 115.16 15.72 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.82 0.848 . . . . 0.0 109.871 177.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -146.0 141.74 27.96 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.946 0.898 . . . . 0.0 111.859 -173.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -101.32 111.82 24.16 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.777 0.831 . . . . 0.0 110.857 -175.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 54.1 t -117.85 127.78 26.41 Favored Pre-proline 0 N--CA 1.478 0.952 0 C-N-CA 123.953 0.901 . . . . 0.0 109.646 -173.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -64.44 143.79 83.41 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.192 1.928 . . . . 0.0 111.123 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.23 -31.63 21.4 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 175.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.17 -14.88 62.58 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 174.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -114.16 3.35 15.17 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.444 1.497 . . . . 0.0 112.22 175.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.2 t -78.2 149.06 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 125.185 1.394 . . . . 0.0 110.169 168.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.64 156.8 79.18 Favored Pre-proline 0 N--CA 1.47 0.527 0 C-N-CA 128.409 2.684 . . . . 0.0 108.857 178.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -67.81 138.9 46.15 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.098 1.865 . . . . 0.0 111.765 -177.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 102.5 -1.6 49.65 Favored Glycine 0 N--CA 1.47 0.923 0 C-N-CA 124.452 1.025 . . . . 0.0 115.418 175.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.67 177.68 8.71 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 118.526 1.163 . . . . 0.0 114.116 176.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.3 p -122.54 122.5 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -168.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.8 t -102.84 144.05 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 127.426 2.29 . . . . 0.0 110.877 -177.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.8 t -89.17 142.95 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.472 1.109 . . . . 0.0 111.563 175.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -160.87 -152.48 6.61 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.369 0.985 . . . . 0.0 113.879 177.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.9 p -141.39 157.66 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.938 1.695 . . . . 0.0 110.058 172.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 . . . . . 0 N--CA 1.47 0.563 0 C-N-CA 123.995 0.918 . . . . 0.0 111.052 176.407 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 . . . . . 0 N--CA 1.481 1.117 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 89.7 mt -143.61 163.71 32.46 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.83 1.652 . . . . 0.0 113.15 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -131.94 171.87 13.04 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 128.214 2.605 . . . . 0.0 110.742 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -135.24 158.43 44.39 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.836 -1.165 . . . . 0.0 113.496 169.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -134.92 136.14 42.08 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.544 1.538 . . . . 0.0 109.975 -174.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -99.41 138.79 36.0 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.282 1.033 . . . . 0.0 112.019 -177.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 93.8 t -77.18 126.95 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 O-C-N 121.062 -1.024 . . . . 0.0 111.614 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 12.3 t -83.24 -44.7 14.68 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.559 1.944 . . . . 0.0 113.022 175.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 31.0 t -158.57 161.24 37.25 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.941 1.296 . . . . 0.0 110.039 -177.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.4 m -133.92 147.86 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.117 0.967 . . . . 0.0 110.306 166.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -154.87 154.58 32.91 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.417 0.687 . . . . 0.0 112.247 169.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 66.8 mt -86.06 135.01 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 165.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 23.6 pt -123.64 166.79 18.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 125.773 1.629 . . . . 0.0 111.305 -177.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -103.74 98.7 8.53 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.011 1.325 . . . . 0.0 110.975 175.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -80.47 -57.22 3.69 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.463 -0.773 . . . . 0.0 112.016 177.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 45.7 51.59 10.1 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.326 1.05 . . . . 0.0 112.135 -172.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -150.21 173.91 13.4 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.921 1.289 . . . . 0.0 111.651 174.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -71.06 136.76 48.47 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.06 0.944 . . . . 0.0 112.502 173.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.3 m -117.23 155.47 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 125.673 1.589 . . . . 0.0 110.093 174.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.418 ' CG ' HG12 ' A' ' 21' ' ' ILE . 0.7 OUTLIER -112.1 160.68 17.29 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -172.834 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -143.17 160.31 40.68 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.527 0.731 . . . . 0.0 110.34 156.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 56.0 tp -124.3 109.59 13.55 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.874 1.269 . . . . 0.0 110.106 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 85.8 t -83.79 123.54 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -159.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 11.6 mm -116.86 88.88 27.35 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.197 1.399 . . . . 0.0 110.33 -176.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -65.5 -16.44 53.96 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.871 2.381 . . . . 0.0 113.25 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -78.11 -45.51 23.18 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.016 -1.052 . . . . 0.0 113.19 178.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 76.8 p -140.54 -2.9 1.35 Allowed 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -171.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 42.0 m-70 59.23 7.09 0.82 Allowed 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -149.2 145.52 27.18 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 120.886 -1.134 . . . . 0.0 112.235 -175.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -146.23 151.5 37.68 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.759 1.224 . . . . 0.0 112.476 -176.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.9 mp -99.97 140.01 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.053 0.941 . . . . 0.0 111.789 -176.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -91.04 157.99 42.26 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 126.482 1.913 . . . . 0.0 112.949 176.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.99 -19.24 57.92 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.785 2.99 . . . . 0.0 113.487 -176.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -80.86 3.77 21.5 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.036 1.334 . . . . 0.0 113.682 174.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.89 -17.94 58.36 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 126.233 1.873 . . . . 0.0 116.029 175.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 54.8 mt -77.78 148.29 34.88 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.387 1.594 . . . . 0.0 112.899 -175.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.8 p -96.41 136.92 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.284 1.034 . . . . 0.0 112.394 174.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 40.5 mt -115.54 145.91 42.21 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 127.236 2.215 . . . . 0.0 110.155 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -134.43 130.0 36.13 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.802 1.241 . . . . 0.0 111.12 -174.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 12.4 m120 . . . . . 0 N--CA 1.475 0.806 0 C-N-CA 123.707 0.803 . . . . 0.0 112.374 -178.671 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 110.854 -0.054 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.44 159.0 43.19 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.36 1.464 . . . . 0.0 111.446 -168.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.22 147.74 46.91 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.879 0.872 . . . . 0.0 113.02 177.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -58.01 -23.9 56.01 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 174.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -82.96 0.54 44.1 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.3 m -72.74 142.46 48.15 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.356 -0.84 . . . . 0.0 112.407 176.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -79.89 158.61 26.65 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.08 -1.013 . . . . 0.0 113.38 169.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.6 p -147.98 157.13 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.887 0.875 . . . . 0.0 111.842 -174.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -126.51 135.84 51.83 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.358 1.863 . . . . 0.0 108.853 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -155.23 179.99 8.62 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.946 0.898 . . . . 0.0 112.057 174.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -135.31 143.21 46.06 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.732 1.213 . . . . 0.0 109.618 171.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -156.66 152.68 27.43 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.385 1.474 . . . . 0.0 109.221 178.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.1 t0 53.94 35.06 20.96 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.669 1.122 . . . . 0.0 113.304 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.0 m 53.8 37.61 26.75 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.736 1.615 . . . . 0.0 114.241 -172.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.3 p -148.7 138.57 12.81 Favored Pre-proline 0 CA--C 1.549 0.924 0 O-C-N 120.033 -1.667 . . . . 0.0 112.131 177.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.42 153.88 69.87 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.756 2.971 . . . . 0.0 113.187 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 47.0 m80 -138.78 138.91 38.04 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.189 2.196 . . . . 0.0 110.464 -175.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 40.1 ttm -152.96 114.67 4.29 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.536 1.134 . . . . 0.0 110.987 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -160.26 -179.49 7.77 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.976 1.31 . . . . 0.0 111.661 -175.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 m -67.43 138.3 56.54 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.065 -1.022 . . . . 0.0 110.135 169.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.9 tp -58.03 -36.44 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 121.256 -0.903 . . . . 0.0 112.269 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -61.72 -23.02 65.87 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.521 0.729 . . . . 0.0 112.909 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -83.4 -49.39 9.38 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.657 0.783 . . . . 0.0 110.014 177.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -66.02 -34.66 78.6 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.586 -0.696 . . . . 0.0 112.336 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -59.75 -51.81 68.16 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.769 0.828 . . . . 0.0 111.346 169.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.6 t -61.3 -36.13 79.24 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.514 0.726 . . . . 0.0 111.266 -178.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -63.46 -55.74 21.73 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.494 1.517 . . . . 0.0 111.206 172.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -72.15 -32.47 66.91 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 121.147 -0.971 . . . . 0.0 112.68 -173.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.43 -28.93 68.99 Favored 'General case' 0 CA--C 1.551 1.014 0 O-C-N 121.498 -0.752 . . . . 0.0 112.347 171.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.4 t -83.01 -25.64 31.98 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.841 1.256 . . . . 0.0 112.993 175.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 50.7 mtm -88.85 -48.19 7.65 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.859 1.263 . . . . 0.0 113.446 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 -110.55 -20.73 12.46 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.325 1.45 . . . . 0.0 113.681 -170.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.99 159.54 35.45 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.626 1.108 . . . . 0.0 114.853 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -103.36 131.02 50.78 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.772 1.229 . . . . 0.0 110.479 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.3 mp -110.12 142.57 26.21 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 126.447 1.899 . . . . 0.0 110.271 175.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.12 159.0 44.94 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.687 2.925 . . . . 0.0 111.366 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -140.13 173.07 11.88 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.239 1.415 . . . . 0.0 111.505 -176.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -55.31 -57.16 12.96 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.413 1.085 . . . . 0.0 113.014 176.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -105.08 -0.01 27.11 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -172.41 -128.44 1.05 Allowed Glycine 0 CA--C 1.536 1.379 0 N-CA-C 115.982 1.153 . . . . 0.0 115.982 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -137.51 161.29 36.79 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 126.623 1.969 . . . . 0.0 110.772 175.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.87 159.45 42.16 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.323 1.449 . . . . 0.0 112.148 177.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 98.1 t -128.48 117.89 20.05 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 125.972 1.709 . . . . 0.0 109.498 174.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.24 142.14 54.33 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 124.065 3.177 . . . . 0.0 111.456 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 74.3 mt -118.13 152.67 35.17 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.398 1.079 . . . . 0.0 112.855 175.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -137.42 125.23 22.51 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.385 1.874 . . . . 0.0 110.167 178.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 51.63 54.85 10.28 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.145 0.978 . . . . 0.0 112.286 -174.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.4 t -123.22 119.23 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 124.603 1.161 . . . . 0.0 109.632 173.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -113.16 158.94 19.79 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.577 1.551 . . . . 0.0 112.642 -176.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.0 m -140.64 152.25 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 126.113 1.765 . . . . 0.0 111.609 170.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -65.58 130.47 43.43 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.495 0.718 . . . . 0.0 109.139 163.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.0 t -133.48 148.07 51.7 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.514 1.926 . . . . 0.0 110.786 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 45.3 tp -99.53 140.17 34.11 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.768 0.827 . . . . 0.0 111.542 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -85.81 117.79 24.9 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.133 -0.979 . . . . 0.0 110.488 158.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.0 mm -74.45 -22.53 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 CA-C-N 119.084 0.856 . . . . 0.0 112.19 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.64 -33.52 64.56 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -173.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.2 m -121.45 -10.95 8.8 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.931 1.292 . . . . 0.0 112.919 169.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.51 39.46 56.42 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 -173.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -97.53 138.02 35.59 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.153 1.781 . . . . 0.0 111.715 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.1 mp -91.62 130.9 40.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 124.549 1.14 . . . . 0.0 109.669 -177.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -152.6 171.34 18.3 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.612 1.165 . . . . 0.0 111.509 -177.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -106.08 150.45 25.76 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.479 1.112 . . . . 0.0 111.242 176.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.8 t -139.58 153.11 47.33 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.466 1.106 . . . . 0.0 110.977 170.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 72.4 mtt85 -87.01 133.5 33.58 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.914 0.885 . . . . 0.0 110.303 172.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -87.12 149.64 24.54 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.196 0.998 . . . . 0.0 111.733 176.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.7 t -88.76 -54.19 4.27 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.834 1.254 . . . . 0.0 112.508 -169.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -157.63 160.03 37.63 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.672 1.589 . . . . 0.0 111.028 178.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.0 mt -84.8 150.42 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 162.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -139.76 152.42 46.59 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.529 1.531 . . . . 0.0 111.099 -176.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.8 ptt-85 -139.74 152.44 46.63 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.058 0.943 . . . . 0.0 113.321 166.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -146.41 168.93 19.93 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.811 2.045 . . . . 0.0 110.115 175.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -112.11 136.92 50.88 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 120.661 -1.274 . . . . 0.0 112.859 -170.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.2 m -144.51 142.04 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 122.796 1.284 . . . . 0.0 113.327 -176.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -97.63 -28.61 13.85 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 127.196 2.199 . . . . 0.0 111.745 178.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -120.85 127.92 52.35 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.606 1.562 . . . . 0.0 110.646 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.4 tp -136.95 161.26 36.53 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.469 1.508 . . . . 0.0 110.115 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.4 mt -117.7 126.0 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.356 1.062 . . . . 0.0 109.455 177.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 68.7 tt0 -100.09 117.15 33.73 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.156 0.982 . . . . 0.0 111.876 169.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.7 mp -108.42 129.26 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.365 1.466 . . . . 0.0 109.415 175.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -96.88 148.68 22.69 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.937 1.695 . . . . 0.0 111.4 176.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 59.6 mt -116.67 165.32 13.41 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.933 1.693 . . . . 0.0 112.483 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.6 t -71.06 -13.28 61.92 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 77.8 p -70.76 -15.58 62.69 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 120.428 -1.42 . . . . 0.0 113.59 165.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.49 -1.93 84.43 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.085 1.326 . . . . 0.0 114.178 -170.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -72.33 153.7 41.35 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.702 1.251 . . . . 0.0 110.605 174.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 95.1 p -130.01 143.23 50.69 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 167.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.2 tp -113.06 135.86 53.33 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.414 1.486 . . . . 0.0 109.768 173.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -115.25 110.85 20.05 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.28 1.832 . . . . 0.0 110.176 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.3 m -137.23 158.84 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.37 1.068 . . . . 0.0 113.083 -168.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.0 p -68.99 146.76 97.55 Favored Pre-proline 0 N--CA 1.467 0.413 0 O-C-N 121.692 -0.63 . . . . 0.0 112.541 175.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.52 -30.69 86.76 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.776 2.317 . . . . 0.0 113.294 -171.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.0 p -77.3 -7.09 55.44 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.367 1.867 . . . . 0.0 114.649 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -73.31 116.95 56.15 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 119.936 1.244 . . . . 0.0 112.97 -174.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -76.07 135.45 17.18 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.899 2.399 . . . . 0.0 113.782 178.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.5 t -118.91 143.81 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 126.655 1.982 . . . . 0.0 108.953 176.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 17.3 tp -82.51 114.57 21.01 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.569 -0.707 . . . . 0.0 110.44 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.5 mp -115.86 159.78 21.06 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.675 1.99 . . . . 0.0 111.499 -176.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -112.72 101.84 9.92 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.875 0.87 . . . . 0.0 113.073 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 68.9 mtp85 -125.82 81.56 1.99 Allowed 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 122.426 1.108 . . . . 0.0 108.799 174.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 59.79 -4.39 0.1 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 128.388 2.675 . . . . 0.0 115.282 -167.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -168.06 170.73 42.13 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 128.701 3.048 . . . . 0.0 111.242 -175.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 62.8 mt -83.57 115.21 22.01 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.395 1.478 . . . . 0.0 111.83 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -128.84 137.15 51.32 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.837 1.255 . . . . 0.0 112.107 -171.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -87.9 110.34 20.47 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.504 0.322 . . . . 0.0 111.413 172.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 52.3 t -121.56 126.34 26.49 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 124.723 1.209 . . . . 0.0 109.892 -172.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -66.96 149.48 82.91 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.576 2.184 . . . . 0.0 111.837 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.79 -31.21 26.19 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.19 -21.47 66.77 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 172.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -99.7 -6.76 26.58 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.048 1.739 . . . . 0.0 112.575 172.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.1 t -73.39 142.42 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 O-C-N 121.041 -1.037 . . . . 0.0 110.125 171.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.32 155.75 67.63 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 127.549 2.34 . . . . 0.0 110.197 -175.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.9 123.37 10.31 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.992 1.794 . . . . 0.0 111.891 -170.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 103.91 1.68 45.67 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.636 1.113 . . . . 0.0 114.738 -175.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -58.65 155.41 12.62 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.468 1.134 . . . . 0.0 113.148 170.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.3 p -107.55 119.21 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 126.243 1.817 . . . . 0.0 111.055 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 38.7 t -113.04 134.33 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 125.92 1.688 . . . . 0.0 110.927 -167.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.7 t -88.44 134.92 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 O-C-N 121.267 -0.896 . . . . 0.0 111.376 -172.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -169.12 -147.16 5.31 Favored Glycine 0 CA--C 1.529 0.935 0 O-C-N 121.796 -0.565 . . . . 0.0 112.872 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.2 p -135.58 161.31 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 127.384 2.274 . . . . 0.0 108.475 171.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 68.8 mtp85 . . . . . 0 N--CA 1.469 0.521 0 O-C-N 121.73 -0.606 . . . . 0.0 110.775 173.65 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 . . . . . 0 CA--C 1.541 0.628 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 96.8 mt -138.07 166.49 23.97 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 127.013 2.125 . . . . 0.0 112.136 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -154.38 148.43 25.75 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.463 1.905 . . . . 0.0 111.084 167.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -94.62 143.42 26.45 Favored 'General case' 0 CA--C 1.548 0.87 0 O-C-N 120.889 -1.132 . . . . 0.0 112.423 172.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -122.63 160.27 26.13 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.495 1.918 . . . . 0.0 110.926 -170.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -111.33 130.11 55.78 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -168.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 84.4 t -73.01 136.67 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 121.599 0.714 . . . . 0.0 110.674 171.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 12.3 t -94.42 -49.54 5.64 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.966 2.106 . . . . 0.0 112.537 176.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.4 t -157.48 162.06 38.89 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.216 1.006 . . . . 0.0 111.433 -176.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.7 m -135.19 148.34 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 124.435 1.094 . . . . 0.0 112.066 172.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -152.47 155.18 36.99 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.659 1.183 . . . . 0.0 112.914 170.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 89.2 mt -91.79 133.39 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.359 1.064 . . . . 0.0 108.642 167.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 44.3 pt -126.78 154.28 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 126.09 1.756 . . . . 0.0 111.83 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -96.26 98.91 10.67 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.393 0.677 . . . . 0.0 109.71 178.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -78.62 -53.06 7.58 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 51.88 36.65 18.71 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.648 1.179 . . . . 0.0 113.26 -174.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -144.16 171.7 13.93 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 120.888 -1.132 . . . . 0.0 111.464 -173.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -77.39 134.49 38.42 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.566 1.146 . . . . 0.0 111.794 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 14.1 m -117.64 152.46 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 125.704 1.602 . . . . 0.0 109.993 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -106.56 160.48 15.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.686 0.755 . . . . 0.0 112.942 -173.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.35 140.24 27.57 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.482 1.113 . . . . 0.0 109.098 166.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 64.9 tp -109.33 115.93 30.91 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 120.456 -1.403 . . . . 0.0 110.129 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 57.3 t -86.24 123.07 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -158.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 42.6 mm -118.4 92.32 43.08 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 126.569 1.948 . . . . 0.0 109.451 -176.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.88 -18.99 41.04 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 123.071 2.514 . . . . 0.0 113.736 176.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -78.74 -50.83 10.7 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 120.207 1.367 . . . . 0.0 112.81 -174.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 76.9 p -128.6 -7.01 5.15 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.496 1.518 . . . . 0.0 114.417 -169.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 74.9 m-70 57.22 19.49 4.95 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -170.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -140.9 149.61 42.13 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 120.892 1.678 . . . . 0.0 114.136 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -141.52 154.63 45.61 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.232 1.013 . . . . 0.0 111.316 168.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.4 mp -102.46 132.45 48.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.118 0.967 . . . . 0.0 110.926 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.46 158.79 62.78 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.62 1.168 . . . . 0.0 112.518 175.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.44 -16.82 52.41 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.227 2.618 . . . . 0.0 113.274 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 33.0 p30 -70.07 -2.26 12.32 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 124.702 1.201 . . . . 0.0 113.565 169.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.33 -10.95 69.32 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 126.831 2.157 . . . . 0.0 115.893 176.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 52.4 mt -96.34 150.28 20.75 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 120.317 2.059 . . . . 0.0 113.663 -169.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.2 p -97.54 133.16 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.261 1.024 . . . . 0.0 113.023 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 31.7 mt -119.46 132.81 55.86 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.03 1.732 . . . . 0.0 111.112 -169.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -88.42 118.44 28.05 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.056 0.843 . . . . 0.0 111.937 175.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 . . . . . 0 CA--C 1.545 0.77 0 O-C-N 120.949 -1.095 . . . . 0.0 113.393 -172.039 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.687 0 CA-C-O 120.897 0.38 . . . . 0.0 111.572 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.61 161.56 38.18 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.657 1.583 . . . . 0.0 110.724 -169.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.81 141.03 50.31 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.511 1.124 . . . . 0.0 112.949 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.02 -22.48 49.93 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.511 1.524 . . . . 0.0 114.198 176.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -78.39 -17.31 56.62 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 177.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.6 m -58.6 136.75 57.69 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 119.347 0.976 . . . . 0.0 113.504 -169.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.33 150.65 47.1 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.12 0.968 . . . . 0.0 113.378 175.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.2 p -146.06 155.67 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.894 1.277 . . . . 0.0 112.141 -171.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -128.98 137.62 51.47 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.449 1.9 . . . . 0.0 108.744 176.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -153.83 168.39 26.49 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.214 0.916 . . . . 0.0 113.256 168.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -130.13 146.02 51.75 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.309 1.443 . . . . 0.0 111.026 177.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -163.0 145.03 10.17 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.217 1.407 . . . . 0.0 109.151 174.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.3 t70 53.76 39.02 29.78 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.349 1.059 . . . . 0.0 113.033 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.2 m 67.41 16.3 10.0 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.331 1.852 . . . . 0.0 114.979 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.0 p -133.67 133.47 22.48 Favored Pre-proline 0 CA--C 1.554 1.1 0 O-C-N 120.175 -1.578 . . . . 0.0 113.229 -177.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -85.72 153.06 10.14 Favored 'Trans proline' 0 CA--C 1.539 0.742 1 C-N-CA 125.593 4.195 . . . . 0.0 114.713 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -135.42 144.87 46.74 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.353 2.261 . . . . 0.0 111.156 -178.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 50.7 ttm -149.37 111.23 4.57 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.784 0.834 . . . . 0.0 110.904 -176.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -158.98 -168.8 2.47 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.81 1.244 . . . . 0.0 112.302 -169.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.4 m -85.71 143.99 28.05 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.098 -1.001 . . . . 0.0 111.36 166.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.401 HG12 ' CG ' ' A' ' 152' ' ' TYR . 8.4 tp -56.81 -38.23 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -177.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -61.75 -22.58 65.52 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.608 0.763 . . . . 0.0 112.848 179.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -80.41 -49.4 11.51 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.302 1.041 . . . . 0.0 111.235 176.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 19.3 ptm -65.77 -31.48 72.49 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 122.062 -0.399 . . . . 0.0 111.589 176.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -57.92 -51.63 68.81 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.603 0.638 . . . . 0.0 111.031 172.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.9 t -67.68 -29.98 69.39 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.148 0.579 . . . . 0.0 111.679 -177.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -66.71 -53.19 36.13 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.323 1.449 . . . . 0.0 111.04 172.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -71.72 -30.82 66.05 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.004 -1.06 . . . . 0.0 112.805 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.48 -31.36 71.46 Favored 'General case' 0 CA--C 1.552 1.054 0 O-C-N 121.51 -0.744 . . . . 0.0 111.992 171.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.0 t -80.07 -22.74 41.93 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 120.668 -1.27 . . . . 0.0 113.095 174.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 55.9 mtm -92.13 -49.7 6.06 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.543 1.137 . . . . 0.0 113.43 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -109.21 -24.09 11.29 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.356 1.462 . . . . 0.0 112.612 -169.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 87.26 164.5 40.2 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 125.556 1.551 . . . . 0.0 114.787 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -109.18 143.57 38.42 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.969 1.308 . . . . 0.0 111.392 -173.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.4 mp -117.33 140.72 27.64 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 126.146 1.778 . . . . 0.0 111.181 172.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.25 141.77 18.56 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 124.469 3.446 . . . . 0.0 111.784 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -126.36 156.16 40.92 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.632 1.573 . . . . 0.0 111.459 -177.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.87 -46.92 16.09 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.387 1.475 . . . . 0.0 114.056 178.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -97.73 -16.58 19.84 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 176.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.26 -126.83 0.95 Allowed Glycine 0 CA--C 1.538 1.504 0 N-CA-C 116.585 1.394 . . . . 0.0 116.585 -168.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -144.54 155.08 43.5 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.61 1.564 . . . . 0.0 112.538 -178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.48 154.73 50.67 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.759 1.224 . . . . 0.0 113.15 175.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.9 t -130.45 115.75 17.3 Favored Pre-proline 0 N--CA 1.481 1.097 0 C-N-CA 126.125 1.77 . . . . 0.0 110.606 177.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.52 138.64 27.24 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 125.057 3.838 . . . . 0.0 112.52 -176.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.8 mt -112.69 160.98 17.38 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.874 1.27 . . . . 0.0 113.125 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -146.34 128.29 15.48 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.606 1.162 . . . . 0.0 111.349 168.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 55.39 40.39 31.36 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.6 1.56 . . . . 0.0 113.839 -173.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.4 t -107.71 113.3 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 O-C-N 121.109 -0.994 . . . . 0.0 109.346 175.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -113.79 152.0 31.23 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.144 1.378 . . . . 0.0 113.59 -166.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.0 m -143.18 154.35 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 127.119 2.168 . . . . 0.0 111.119 175.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -72.08 135.67 46.36 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.744 0.818 . . . . 0.0 109.873 166.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.0 t -133.35 153.49 51.54 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.131 1.772 . . . . 0.0 112.842 -179.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 50.3 tp -100.13 133.89 43.86 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.512 1.125 . . . . 0.0 109.861 168.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -84.59 119.39 25.15 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.94 1.296 . . . . 0.0 110.407 164.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.8 mm -76.38 -19.48 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 119.569 1.077 . . . . 0.0 112.265 -179.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.44 -41.03 48.88 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -174.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.3 m -110.57 -11.76 14.42 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.695 1.198 . . . . 0.0 112.814 172.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.5 36.82 68.93 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-N 118.42 0.555 . . . . 0.0 112.037 -173.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -96.69 136.8 36.71 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.222 1.809 . . . . 0.0 111.769 -175.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 mp -85.84 130.6 36.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 124.504 1.121 . . . . 0.0 107.992 172.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.3 pttt -154.91 168.46 26.85 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.803 1.241 . . . . 0.0 112.913 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -89.56 146.7 24.4 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.574 0.749 . . . . 0.0 111.183 172.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.431 ' HG1' ' CD ' ' A' ' 158' ' ' GLU . 7.7 t -143.25 164.13 31.06 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.108 0.963 . . . . 0.0 111.645 172.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -99.88 142.85 30.81 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.241 1.016 . . . . 0.0 112.077 174.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.73 137.39 32.37 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.262 0.625 . . . . 0.0 110.109 167.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 22.8 t -86.97 -46.38 9.91 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.427 1.491 . . . . 0.0 112.334 -172.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -152.89 155.45 37.06 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.618 0.723 . . . . 0.0 112.356 174.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.9 mt -85.12 147.36 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 163.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -136.25 147.78 47.72 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 125.747 1.619 . . . . 0.0 110.839 -175.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 30.6 ptt-85 -143.92 153.95 42.82 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.052 0.941 . . . . 0.0 113.424 167.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -154.82 172.43 18.0 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.846 1.259 . . . . 0.0 110.728 169.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -95.39 147.27 23.7 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.646 0.778 . . . . 0.0 111.943 177.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.1 m -143.74 144.55 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 125.18 1.392 . . . . 0.0 110.481 171.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -94.18 -29.05 15.32 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 124.888 1.275 . . . . 0.0 111.469 175.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -121.01 134.27 55.29 Favored 'General case' 0 C--N 1.344 0.358 0 C-N-CA 125.17 1.388 . . . . 0.0 109.416 -176.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.5 tp -143.53 159.69 41.96 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.164 1.386 . . . . 0.0 109.966 -177.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.6 mt -111.21 128.49 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 O-C-N 121.246 -0.909 . . . . 0.0 109.632 177.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -102.67 112.98 26.0 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.363 1.465 . . . . 0.0 110.261 173.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.2 mp -106.92 131.13 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.608 1.163 . . . . 0.0 109.376 174.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.2 tttt -100.96 147.63 25.94 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.678 1.591 . . . . 0.0 111.51 175.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 61.5 mt -107.75 164.39 12.28 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 126.83 2.052 . . . . 0.0 111.195 -178.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.7 t -75.02 -1.53 23.18 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -178.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.8 p -79.06 -15.09 58.68 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.954 1.702 . . . . 0.0 113.766 160.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.78 -3.63 84.89 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 125.73 1.633 . . . . 0.0 114.199 -169.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -74.54 151.37 39.48 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.451 1.625 . . . . 0.0 111.45 177.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.7 p -128.68 138.63 52.26 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 178.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 14.7 tp -117.01 140.02 49.98 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.995 1.718 . . . . 0.0 110.538 177.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.6 mtmm -118.49 116.38 26.55 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.687 1.195 . . . . 0.0 112.402 -175.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.1 m -141.61 152.49 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 125.204 1.402 . . . . 0.0 113.031 -163.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.7 p -68.39 148.3 98.18 Favored Pre-proline 0 N--CA 1.474 0.73 0 O-C-N 121.031 -1.043 . . . . 0.0 112.433 174.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.79 -17.63 60.31 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.594 2.862 . . . . 0.0 113.728 -175.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 36.3 p -86.35 -10.94 53.4 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.949 2.1 . . . . 0.0 114.48 176.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -72.46 122.17 86.76 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-N 119.699 1.136 . . . . 0.0 111.736 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -80.35 125.06 5.57 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 123.711 2.941 . . . . 0.0 113.113 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.3 t -94.52 141.09 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.686 1.595 . . . . 0.0 109.848 175.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 17.4 tp -83.86 107.23 16.13 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.103 0.561 . . . . 0.0 110.664 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.9 mp -100.15 144.34 29.3 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.756 1.622 . . . . 0.0 111.755 -176.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -104.29 90.23 3.49 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.933 0.893 . . . . 0.0 112.244 -177.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 46.6 mtm180 -133.91 81.43 1.92 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.865 0.866 . . . . 0.0 110.841 -177.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.7 t70 66.3 -17.94 0.11 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 128.09 2.556 . . . . 0.0 115.888 -167.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.48 167.26 39.87 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 126.171 1.843 . . . . 0.0 113.258 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 77.3 mt -62.94 113.83 3.31 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.493 1.917 . . . . 0.0 111.392 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -141.94 142.83 33.03 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.646 0.778 . . . . 0.0 112.847 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -97.56 122.14 40.28 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.877 1.271 . . . . 0.0 110.768 -175.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 71.2 t -128.45 126.69 23.57 Favored Pre-proline 0 N--CA 1.477 0.914 0 C-N-CA 124.289 1.036 . . . . 0.0 110.007 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -64.71 148.65 90.3 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.301 2.001 . . . . 0.0 112.014 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.59 -31.98 17.42 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 173.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.93 -17.89 63.68 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 173.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -111.82 -0.61 15.84 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.568 1.547 . . . . 0.0 112.989 174.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 71.3 t -72.12 148.67 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 120.679 -1.263 . . . . 0.0 110.833 171.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.96 157.09 75.36 Favored Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 127.369 2.268 . . . . 0.0 111.129 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.59 113.42 3.16 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.715 2.277 . . . . 0.0 112.003 -175.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 111.91 6.09 24.87 Favored Glycine 0 CA--C 1.537 1.449 0 CA-C-O 118.691 -1.061 . . . . 0.0 115.264 -175.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -62.86 161.31 12.95 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 118.946 1.373 . . . . 0.0 112.403 163.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 5.8 p -109.45 129.52 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.384 1.474 . . . . 0.0 111.747 178.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.1 t -107.55 137.07 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 126.729 2.012 . . . . 0.0 110.2 -175.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 51.8 t -87.25 134.39 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.744 0.817 . . . . 0.0 110.31 172.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -157.82 -153.91 6.91 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.53 1.062 . . . . 0.0 112.49 176.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.1 p -145.22 176.86 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 126.415 1.886 . . . . 0.0 108.492 174.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 . . . . . 0 N--CA 1.468 0.464 0 O-C-N 121.071 -1.018 . . . . 0.0 113.067 175.685 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 . . . . . 0 CA--C 1.539 0.537 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 89.9 mt -131.04 165.21 23.71 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.858 2.063 . . . . 0.0 111.741 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -131.59 157.17 44.36 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.739 1.616 . . . . 0.0 110.912 173.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -113.28 142.89 45.3 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.608 1.163 . . . . 0.0 111.587 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -133.54 156.24 48.15 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.606 1.562 . . . . 0.0 110.544 -173.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 57.4 tt0 -114.68 137.79 51.48 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.128 -0.983 . . . . 0.0 112.288 -170.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 92.2 t -73.79 133.32 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 122.003 0.906 . . . . 0.0 110.622 173.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 27.5 t -87.11 -59.64 2.2 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.941 1.697 . . . . 0.0 111.748 173.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 59.2 m -149.61 158.88 44.58 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.259 1.424 . . . . 0.0 110.901 -170.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.2 m -136.37 152.86 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 124.126 0.97 . . . . 0.0 111.925 173.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 9.4 ptp85 -158.14 159.48 36.24 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.74 1.216 . . . . 0.0 112.684 168.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 76.3 mt -99.03 129.92 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.935 0.894 . . . . 0.0 109.211 170.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 13.2 pt -121.15 156.58 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.574 1.55 . . . . 0.0 111.908 -174.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -92.7 97.96 11.11 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.754 0.787 . . . . 0.0 110.957 170.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -76.63 -47.89 20.8 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 44.39 39.46 3.13 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.576 1.15 . . . . 0.0 113.826 -174.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 -144.31 174.71 10.67 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.17 0.988 . . . . 0.0 111.392 -174.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -77.27 137.88 39.06 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 124.588 1.155 . . . . 0.0 112.466 -177.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.2 m -119.8 152.74 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 125.084 1.353 . . . . 0.0 109.97 176.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.401 ' CG ' HG12 ' A' ' 21' ' ' ILE . 1.4 p90 -112.1 160.53 17.45 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.08 0.952 . . . . 0.0 112.278 -178.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -141.3 156.06 45.9 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.052 0.541 . . . . 0.0 110.069 156.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 65.2 tp -128.69 103.0 6.83 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.767 1.227 . . . . 0.0 110.051 -175.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 87.8 t -86.63 124.12 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -151.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 20.8 mm -110.71 98.27 36.78 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 125.27 1.428 . . . . 0.0 109.681 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.5 -16.73 38.81 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.512 2.142 . . . . 0.0 113.193 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.431 ' CD ' ' HG1' ' A' ' 63' ' ' THR . 37.7 mt-10 -74.51 -61.28 1.92 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.784 0.834 . . . . 0.0 112.363 178.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 54.9 p -122.82 -7.95 8.43 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -171.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 61.37 15.38 6.5 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.086 1.754 . . . . 0.0 115.657 -175.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.81 148.52 30.03 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.082 -1.011 . . . . 0.0 113.532 -178.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -145.9 158.93 43.84 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.746 1.218 . . . . 0.0 112.385 177.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.3 mp -102.39 137.22 31.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 123.975 0.91 . . . . 0.0 111.377 -177.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -88.56 160.24 45.1 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 125.938 1.695 . . . . 0.0 113.088 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.36 -19.46 61.62 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.299 2.666 . . . . 0.0 113.989 -176.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 50.6 p30 -86.18 -2.26 58.2 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.961 1.304 . . . . 0.0 113.551 175.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 102.12 -15.04 56.88 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 126.628 2.061 . . . . 0.0 116.756 173.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 66.7 mt -74.09 145.39 44.43 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.425 1.613 . . . . 0.0 111.965 -178.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.1 p -91.36 135.76 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.528 0.731 . . . . 0.0 111.304 171.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 39.6 mt -113.61 142.09 46.41 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.156 1.783 . . . . 0.0 109.792 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -127.54 127.01 43.22 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.279 1.432 . . . . 0.0 110.146 -177.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 21.2 m120 . . . . . 0 CA--C 1.543 0.686 0 C-N-CA 123.912 0.885 . . . . 0.0 112.696 -174.24 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.566 0 CA-C-O 120.62 0.248 . . . . 0.0 111.504 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.54 156.99 47.01 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.247 1.419 . . . . 0.0 111.063 -170.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.54 143.97 33.4 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.346 1.458 . . . . 0.0 113.901 -178.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -61.11 -26.09 67.43 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.494 1.117 . . . . 0.0 113.241 174.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -83.03 -1.46 52.73 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.312 1.045 . . . . 0.0 113.803 176.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.4 m -68.59 143.51 54.83 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 119.845 1.202 . . . . 0.0 111.77 174.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -74.68 159.22 32.34 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.205 -0.934 . . . . 0.0 112.817 167.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 p -149.0 156.26 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.049 0.94 . . . . 0.0 111.867 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -121.26 141.8 50.55 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.638 1.975 . . . . 0.0 108.134 176.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -156.44 -178.28 7.22 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.666 0.786 . . . . 0.0 111.128 164.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -136.6 143.13 43.41 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.564 1.545 . . . . 0.0 110.216 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -154.96 -45.68 0.08 Allowed 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 174.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -83.24 37.1 0.54 Allowed 'General case' 0 N--CA 1.481 1.097 0 O-C-N 120.65 -1.281 . . . . 0.0 112.857 -175.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.2 m 61.0 24.92 14.99 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 126.007 1.723 . . . . 0.0 112.915 -167.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.2 p -158.61 149.89 16.57 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 126.412 1.885 . . . . 0.0 109.276 -170.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.45 160.53 32.05 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.974 3.116 . . . . 0.0 114.306 176.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -140.48 151.16 44.6 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 128.029 2.532 . . . . 0.0 110.561 -173.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 34.8 ttm -149.48 126.14 11.03 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.485 -0.759 . . . . 0.0 112.148 177.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -160.89 -178.17 6.64 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.528 1.531 . . . . 0.0 111.75 178.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.52 143.12 51.76 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 121.017 -1.052 . . . . 0.0 109.433 171.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.438 HG12 ' CG ' ' A' ' 152' ' ' TYR . 8.1 tp -56.55 -38.54 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 O-C-N 121.24 -0.913 . . . . 0.0 112.002 179.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -60.56 -24.51 65.47 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.359 0.982 . . . . 0.0 112.566 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -81.6 -46.95 13.68 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.499 1.12 . . . . 0.0 111.402 179.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -70.71 -34.07 71.54 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.441 -0.787 . . . . 0.0 111.6 176.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -58.58 -52.6 64.99 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 124.196 0.998 . . . . 0.0 110.591 172.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.8 t -67.58 -30.4 70.01 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 122.661 0.384 . . . . 0.0 111.043 -174.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -64.69 -52.91 54.69 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.043 1.337 . . . . 0.0 110.969 172.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -71.57 -31.01 66.5 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.074 -1.016 . . . . 0.0 113.14 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.93 -30.44 67.84 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.99 0.916 . . . . 0.0 111.305 172.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.4 m -74.21 -35.21 63.89 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 120.398 -1.439 . . . . 0.0 112.081 172.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 42.5 mtm -86.79 -42.95 12.88 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.366 1.066 . . . . 0.0 113.664 -173.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -114.55 -21.16 10.43 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.803 1.241 . . . . 0.0 112.639 -171.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.95 155.64 21.69 Favored Glycine 0 C--N 1.341 0.816 0 C-N-CA 125.441 1.496 . . . . 0.0 114.38 176.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -98.15 139.15 34.38 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.404 1.081 . . . . 0.0 110.645 -177.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.4 mp -106.86 143.91 28.01 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 127.331 2.252 . . . . 0.0 110.89 175.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.52 145.97 34.15 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.905 3.07 . . . . 0.0 112.415 176.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -142.12 157.52 44.79 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.856 1.662 . . . . 0.0 111.322 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.14 -52.66 58.01 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 120.63 -1.294 . . . . 0.0 113.997 -177.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -84.53 -16.0 43.84 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 176.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -178.65 -131.82 1.63 Allowed Glycine 0 CA--C 1.53 1.002 0 N-CA-C 115.626 1.01 . . . . 0.0 115.626 -165.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -143.59 159.3 42.69 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.284 1.434 . . . . 0.0 111.803 -178.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.06 149.4 45.97 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.862 1.265 . . . . 0.0 112.853 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.4 t -125.63 113.37 25.14 Favored Pre-proline 0 N--CA 1.484 1.263 0 C-N-CA 125.472 1.509 . . . . 0.0 111.933 177.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -68.73 134.72 31.0 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 124.235 3.29 . . . . 0.0 111.02 178.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 96.9 mt -99.65 164.25 12.14 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.884 1.274 . . . . 0.0 112.665 -177.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -133.71 120.65 20.86 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.224 1.01 . . . . 0.0 110.514 172.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 48.15 42.47 17.31 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.342 1.457 . . . . 0.0 113.593 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 97.7 t -100.88 123.76 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 O-C-N 121.488 -0.757 . . . . 0.0 109.734 178.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -126.23 161.18 28.32 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.419 1.088 . . . . 0.0 112.99 -172.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.8 m -148.09 153.32 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.927 2.091 . . . . 0.0 111.321 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -60.29 132.24 53.31 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 122.144 0.974 . . . . 0.0 109.611 155.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.3 t -134.6 147.58 50.25 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.175 1.79 . . . . 0.0 110.901 176.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 61.9 tp -98.16 137.01 37.55 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.244 1.017 . . . . 0.0 109.725 175.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -80.9 106.98 13.33 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.549 0.739 . . . . 0.0 110.404 167.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 46.0 mm -66.13 -23.0 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 O-C-N 120.774 -1.204 . . . . 0.0 112.286 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.66 -43.13 76.87 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.455 1.102 . . . . 0.0 113.973 -175.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.1 m -128.82 -8.01 5.0 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.94 35.13 22.49 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.321 0.962 . . . . 0.0 114.024 178.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -90.68 135.95 33.38 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.062 1.345 . . . . 0.0 112.204 176.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 mp -85.46 127.14 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 124.876 1.27 . . . . 0.0 109.43 176.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -147.15 169.91 18.32 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.582 1.153 . . . . 0.0 111.838 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -99.13 147.4 25.12 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.14 0.976 . . . . 0.0 110.535 170.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.2 t -146.53 167.96 22.39 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.689 0.796 . . . . 0.0 112.441 174.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 50.5 ptt85 -94.07 150.83 19.98 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.639 1.576 . . . . 0.0 112.75 177.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -105.82 132.87 51.41 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.601 1.161 . . . . 0.0 110.921 168.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.2 t -85.96 -45.55 11.38 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.732 1.213 . . . . 0.0 112.379 -171.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -152.25 162.11 41.63 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.394 1.078 . . . . 0.0 112.828 173.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.9 mt -89.7 155.01 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 125.094 1.357 . . . . 0.0 108.407 162.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -137.6 148.85 46.18 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.986 1.715 . . . . 0.0 110.448 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -138.46 149.56 45.57 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.867 1.267 . . . . 0.0 113.174 171.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -148.79 164.26 34.95 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.736 1.614 . . . . 0.0 110.09 170.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.5 mmtp -93.18 148.79 21.72 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.508 1.123 . . . . 0.0 111.047 176.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.1 m -148.38 144.77 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.683 1.193 . . . . 0.0 111.074 172.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -94.05 -31.33 14.27 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.66 1.184 . . . . 0.0 112.069 173.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -121.76 129.57 52.79 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.68 1.192 . . . . 0.0 110.457 -174.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.3 tp -136.52 162.34 33.36 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.392 1.877 . . . . 0.0 109.676 -172.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.9 mt -115.02 125.52 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.707 1.203 . . . . 0.0 109.274 176.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -96.97 123.74 40.77 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.148 0.979 . . . . 0.0 110.198 168.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.9 mp -111.18 126.96 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.846 1.258 . . . . 0.0 109.488 172.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.6 tttt -93.9 146.42 23.91 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.355 1.862 . . . . 0.0 110.672 174.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 80.9 mt -116.56 158.49 23.59 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.773 1.629 . . . . 0.0 111.869 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 18.8 t -59.36 -30.82 68.68 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.677 1.191 . . . . 0.0 112.699 -178.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.0 p -62.66 -15.96 54.74 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 173.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.0 7.0 68.7 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 124.749 1.166 . . . . 0.0 113.825 -171.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -81.33 159.52 24.39 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.726 1.211 . . . . 0.0 111.722 171.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 77.2 p -142.03 143.15 33.0 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.988 0.915 . . . . 0.0 112.739 169.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.1 tp -121.7 142.21 50.39 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.767 1.627 . . . . 0.0 110.858 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -120.41 110.36 16.42 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.224 1.809 . . . . 0.0 111.093 -172.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.0 m -141.06 154.37 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.029 1.332 . . . . 0.0 112.927 -165.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.4 p -68.43 150.43 97.7 Favored Pre-proline 0 N--CA 1.47 0.552 0 O-C-N 120.65 -1.281 . . . . 0.0 113.19 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -61.73 -29.65 83.72 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.678 2.252 . . . . 0.0 112.395 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 38.8 p -83.37 10.17 9.31 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 128.054 2.542 . . . . 0.0 114.859 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.559 ' HD1' ' CD2' ' A' ' 171' ' ' HIS . 17.4 t60 -99.1 109.52 54.51 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 124.748 1.219 . . . . 0.0 112.237 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -63.57 124.16 13.25 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.258 2.639 . . . . 0.0 113.841 164.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.5 t -101.27 146.67 9.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 127.433 2.293 . . . . 0.0 109.0 176.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.29 107.57 11.0 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.998 -0.438 . . . . 0.0 110.052 177.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.1 mp -110.22 155.69 21.67 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.541 1.537 . . . . 0.0 111.992 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -96.72 117.45 31.05 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.17 0.588 . . . . 0.0 112.359 174.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 73.4 mtp85 -136.15 78.75 1.73 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.607 1.163 . . . . 0.0 109.791 168.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 56.57 0.42 0.07 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 128.175 2.59 . . . . 0.0 115.78 -164.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -172.68 173.62 45.5 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 126.44 1.971 . . . . 0.0 111.341 -178.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 63.4 mt -70.15 125.72 27.59 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.434 1.494 . . . . 0.0 110.171 177.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -157.13 155.81 31.65 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 173.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -103.73 120.82 41.73 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.217 1.007 . . . . 0.0 112.639 -172.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 49.0 t -129.59 127.01 22.93 Favored Pre-proline 0 N--CA 1.482 1.147 0 C-N-CA 124.905 1.282 . . . . 0.0 110.698 -175.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -64.32 140.41 70.24 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.077 2.518 . . . . 0.0 112.225 -179.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.08 -32.38 15.54 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 176.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.76 -20.95 66.16 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 173.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -106.84 -9.56 16.33 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.61 1.564 . . . . 0.0 113.17 177.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 78.1 t -68.45 145.48 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.696 1.598 . . . . 0.0 109.969 172.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.63 157.93 75.03 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 125.697 1.599 . . . . 0.0 111.62 -178.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -64.81 122.11 9.84 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 121.986 1.791 . . . . 0.0 111.32 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 108.11 0.16 33.54 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 124.565 1.078 . . . . 0.0 115.377 -178.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -63.34 162.25 12.61 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.872 1.269 . . . . 0.0 112.372 169.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -109.07 122.73 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 125.35 1.46 . . . . 0.0 111.332 177.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.45 135.86 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 126.324 1.85 . . . . 0.0 110.102 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.9 t -85.79 143.8 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 119.522 1.055 . . . . 0.0 111.733 -176.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -168.21 -149.4 6.11 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 124.794 1.188 . . . . 0.0 114.174 -177.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.1 p -156.97 165.55 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 127.287 2.235 . . . . 0.0 107.767 -174.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? . . . . . 0 N--CA 1.479 0.993 0 O-C-N 121.095 -1.003 . . . . 0.0 112.84 179.891 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 59.7 mt -149.56 156.48 42.02 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.222 1.409 . . . . 0.0 113.522 -176.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -142.62 167.21 22.62 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.657 1.983 . . . . 0.0 111.199 -179.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -128.15 156.93 42.09 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 120.348 -1.47 . . . . 0.0 113.945 158.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -116.15 136.31 53.14 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 128.116 2.566 . . . . 0.0 109.159 -173.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -89.11 131.78 35.1 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.965 0.802 . . . . 0.0 111.936 178.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 93.8 t -69.91 127.8 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 123.421 0.688 . . . . 0.0 110.734 171.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.3 t -88.27 -45.1 10.34 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.528 1.931 . . . . 0.0 112.091 175.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.2 t -157.67 163.54 38.1 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.443 1.097 . . . . 0.0 111.404 177.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.9 m -136.63 148.54 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 124.81 1.244 . . . . 0.0 111.193 171.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -158.18 155.98 30.02 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 172.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 74.3 mt -86.81 131.8 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.549 1.14 . . . . 0.0 109.061 168.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 25.1 pt -127.0 161.77 33.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 126.611 1.964 . . . . 0.0 112.257 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -95.91 99.06 10.89 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.777 1.631 . . . . 0.0 111.976 177.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -85.63 -51.95 6.13 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 177.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 48.37 41.18 16.1 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.325 1.05 . . . . 0.0 113.164 -175.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 33.9 t-20 -145.41 167.84 21.95 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.684 1.193 . . . . 0.0 110.38 -176.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -68.87 145.44 53.7 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.32 1.048 . . . . 0.0 112.149 177.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.1 m -128.77 152.8 37.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 126.069 1.748 . . . . 0.0 109.422 177.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.438 ' CG ' HG12 ' A' ' 21' ' ' ILE . 2.3 p90 -111.43 160.42 17.12 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -174.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -146.39 127.89 15.05 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.334 1.053 . . . . 0.0 109.299 170.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 32.7 tp -93.06 134.9 34.74 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 120.336 -1.478 . . . . 0.0 112.315 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 23.1 t -99.25 119.67 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 121.545 0.688 . . . . 0.0 112.822 -172.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 20.2 mm -125.96 96.57 37.12 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 126.914 2.085 . . . . 0.0 107.969 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.79 -18.14 22.27 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 122.623 2.216 . . . . 0.0 113.285 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -82.58 -34.48 27.71 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -172.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 44.5 p -139.02 -10.93 1.29 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.615 1.166 . . . . 0.0 113.474 -175.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . 0.306 51.7 m-70 55.37 26.08 8.33 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.09 1.756 . . . . 0.0 115.635 -173.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -154.19 158.96 41.11 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 120.795 -1.191 . . . . 0.0 113.68 173.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -147.06 166.18 27.67 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.544 1.538 . . . . 0.0 112.209 176.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.0 mp -107.96 139.28 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.085 0.954 . . . . 0.0 111.588 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.94 157.16 63.65 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.483 1.113 . . . . 0.0 112.52 174.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.01 -13.98 41.92 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.897 2.398 . . . . 0.0 113.165 177.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -85.94 7.87 22.59 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 124.438 1.095 . . . . 0.0 113.104 171.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 94.4 -23.92 29.81 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 126.24 1.876 . . . . 0.0 116.47 173.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 65.7 mt -70.17 146.27 50.9 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.906 1.353 . . . . 0.0 113.497 -174.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 4.1 t -90.46 128.51 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 123.748 0.819 . . . . 0.0 111.685 174.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 47.3 mt -117.79 160.6 21.09 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 127.598 2.359 . . . . 0.0 111.919 -176.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.559 ' CD2' ' HD1' ' A' ' 93' ' ' HIS . 0.0 OUTLIER -100.31 166.17 11.11 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 -175.282 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 37.4 t30 . . . . . 0 CA--C 1.551 0.986 0 C-N-CA 125.672 1.589 . . . . 0.0 109.972 148.491 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 111.365 0.135 . . . . 0.0 111.365 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -129.01 159.91 34.4 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.555 1.942 . . . . 0.0 111.151 -177.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.95 145.87 34.34 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.25 0.62 . . . . 0.0 111.268 173.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.92 -24.2 50.66 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 178.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -74.24 -15.4 60.99 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.721 1.608 . . . . 0.0 112.633 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.0 m -68.94 144.02 54.28 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.021 0.929 . . . . 0.0 112.46 -170.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -78.98 156.62 28.38 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 176.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 p -146.17 154.33 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.296 1.438 . . . . 0.0 111.878 -175.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -130.22 127.26 39.28 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 126.293 1.837 . . . . 0.0 108.493 177.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -153.85 171.91 18.21 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.588 0.755 . . . . 0.0 112.133 175.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -130.81 148.82 52.63 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.731 1.213 . . . . 0.0 111.27 171.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -152.59 140.16 19.75 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.528 1.131 . . . . 0.0 110.061 172.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.1 t0 49.13 49.17 20.0 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.01 1.324 . . . . 0.0 113.967 170.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.0 m 62.05 35.42 15.95 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.741 2.016 . . . . 0.0 114.636 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.5 p -152.39 138.42 11.74 Favored Pre-proline 0 CA--C 1.546 0.826 0 O-C-N 120.838 -1.164 . . . . 0.0 113.054 167.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.41 154.95 28.26 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 124.543 3.495 . . . . 0.0 113.814 174.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -133.21 142.51 48.62 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.856 2.062 . . . . 0.0 110.81 172.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 47.1 ttm -145.16 90.65 2.06 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.094 1.358 . . . . 0.0 109.404 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -139.21 -168.72 2.5 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.695 1.998 . . . . 0.0 111.094 -168.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 m -79.03 151.32 31.57 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 121.0 -1.062 . . . . 0.0 111.477 168.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.3 tp -57.64 -37.65 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 O-C-N 121.607 -0.683 . . . . 0.0 111.829 173.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -61.59 -29.68 70.19 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.484 1.038 . . . . 0.0 112.781 175.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -80.74 -35.87 32.8 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.592 0.757 . . . . 0.0 111.674 -175.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 21.6 ptm -71.11 -35.26 71.72 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.207 0.458 . . . . 0.0 111.115 169.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -60.27 -51.53 69.16 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.695 0.798 . . . . 0.0 111.559 176.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.9 t -61.68 -39.62 92.07 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.309 1.044 . . . . 0.0 110.956 -176.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -63.71 -52.97 58.18 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 124.872 1.269 . . . . 0.0 110.851 177.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -72.7 -32.1 65.52 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.297 -0.877 . . . . 0.0 113.179 -178.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.54 -32.17 72.77 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.186 0.995 . . . . 0.0 111.892 173.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.1 m -81.61 -27.05 34.38 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.27 1.028 . . . . 0.0 112.463 176.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 70.2 mtm -80.17 -55.09 5.17 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.314 1.046 . . . . 0.0 112.25 174.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -108.22 -20.58 13.1 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.073 1.349 . . . . 0.0 114.13 -167.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.27 157.6 33.6 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 124.779 1.18 . . . . 0.0 114.216 -176.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -102.02 128.51 48.44 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.455 1.102 . . . . 0.0 108.414 174.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.3 mp -104.39 143.09 25.98 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 125.684 1.594 . . . . 0.0 110.23 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.69 149.13 54.25 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 123.725 2.95 . . . . 0.0 111.884 -176.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -144.14 161.82 37.88 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.995 1.318 . . . . 0.0 111.563 -175.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -51.33 -55.3 19.15 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.461 1.505 . . . . 0.0 113.505 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -90.78 -7.04 53.5 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 177.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 174.73 -124.75 1.04 Allowed Glycine 0 CA--C 1.53 0.978 0 CA-C-N 119.856 1.207 . . . . 0.0 115.55 -174.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -141.57 158.97 43.17 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.7 1.6 . . . . 0.0 111.126 177.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.94 149.12 44.41 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.817 1.247 . . . . 0.0 112.121 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.0 t -119.12 117.8 33.19 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 125.249 1.42 . . . . 0.0 110.625 178.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -74.69 140.49 26.44 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 124.421 3.414 . . . . 0.0 112.315 -177.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 64.2 mt -107.34 170.51 7.92 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.575 1.15 . . . . 0.0 113.604 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -152.63 135.18 15.24 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 127.225 2.21 . . . . 0.0 109.295 166.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 51.43 47.01 25.64 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.278 1.431 . . . . 0.0 113.162 -178.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 56.8 t -115.3 129.37 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.874 0.869 . . . . 0.0 110.637 176.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -126.93 149.0 50.03 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.748 1.219 . . . . 0.0 111.828 -170.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.0 m -137.25 150.42 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.011 1.324 . . . . 0.0 110.793 175.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -77.58 144.45 37.52 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.956 0.884 . . . . 0.0 111.006 168.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.1 t -151.81 151.77 31.78 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.581 1.152 . . . . 0.0 111.055 -165.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.4 tp -98.11 129.01 44.94 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.322 0.649 . . . . 0.0 109.573 171.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -69.88 101.88 1.84 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 162.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.0 mm -64.15 -26.83 41.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 O-C-N 120.951 -1.093 . . . . 0.0 111.279 -174.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.42 -42.15 18.95 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.67 1.188 . . . . 0.0 113.938 -174.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.2 m -101.29 -16.78 16.83 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.075 0.95 . . . . 0.0 112.308 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.45 20.67 79.51 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.461 1.505 . . . . 0.0 114.288 -176.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -79.24 123.95 27.91 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.138 1.375 . . . . 0.0 110.524 177.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.9 mp -72.9 124.24 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 165.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -142.85 174.03 11.02 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.762 1.225 . . . . 0.0 112.707 -178.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -105.5 139.42 40.14 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.99 1.316 . . . . 0.0 110.517 172.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.7 t -135.44 166.59 22.81 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.642 1.177 . . . . 0.0 112.152 176.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -100.92 137.06 39.8 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.613 1.165 . . . . 0.0 113.78 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -94.11 149.28 21.38 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.139 1.376 . . . . 0.0 112.422 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 85.4 p -99.47 -54.1 3.03 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.144 0.978 . . . . 0.0 113.563 -173.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -150.73 156.36 41.14 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.033 1.124 . . . . 0.0 114.033 176.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.0 mt -89.59 152.52 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.264 1.425 . . . . 0.0 108.685 168.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -140.66 144.04 35.47 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.169 -0.957 . . . . 0.0 112.229 -172.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -131.77 142.75 49.84 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.072 1.349 . . . . 0.0 111.882 175.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -149.92 164.18 36.1 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.112 1.365 . . . . 0.0 109.746 175.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -97.55 143.35 28.33 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 123.989 0.916 . . . . 0.0 111.419 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.1 m -147.03 145.46 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.842 1.257 . . . . 0.0 111.427 173.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -94.53 -32.97 13.24 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.867 1.667 . . . . 0.0 112.184 175.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -122.68 134.38 54.48 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 124.093 0.957 . . . . 0.0 110.68 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.8 tp -132.49 160.99 34.89 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.66 1.584 . . . . 0.0 109.299 -176.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.2 mt -115.6 122.88 70.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 121.232 -0.917 . . . . 0.0 109.401 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -93.82 115.92 28.35 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.387 1.075 . . . . 0.0 111.294 169.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -103.75 124.98 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 124.471 1.108 . . . . 0.0 108.721 170.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -91.93 146.11 24.01 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.487 1.515 . . . . 0.0 110.336 172.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 60.4 mt -106.86 160.92 15.15 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.486 1.914 . . . . 0.0 110.939 -178.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.6 t -65.11 -18.74 65.56 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.168 -0.958 . . . . 0.0 113.06 -178.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.7 p -69.02 -17.08 63.86 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.46 1.504 . . . . 0.0 114.572 167.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 83.73 7.43 85.94 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 126.458 1.98 . . . . 0.0 114.907 -170.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -80.44 167.45 20.15 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 118.771 1.285 . . . . 0.0 109.811 168.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 91.9 p -144.79 158.46 43.78 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 120.953 -1.092 . . . . 0.0 113.582 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 61.1 tp -130.64 133.53 46.2 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.383 1.873 . . . . 0.0 110.007 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -113.61 113.66 25.36 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.782 1.233 . . . . 0.0 111.65 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.4 m -139.67 157.08 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 125.721 1.608 . . . . 0.0 112.598 -169.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.9 p -68.25 149.72 97.99 Favored Pre-proline 0 N--CA 1.468 0.442 0 O-C-N 121.262 -0.899 . . . . 0.0 112.514 177.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -57.11 -33.61 96.15 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.642 2.228 . . . . 0.0 112.015 -178.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.7 m -89.54 21.63 3.34 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.526 1.93 . . . . 0.0 114.551 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -102.82 115.95 63.38 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 125.139 1.375 . . . . 0.0 111.072 176.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -72.93 142.43 34.94 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.895 2.396 . . . . 0.0 114.213 177.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 39.9 t -121.54 143.27 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 126.954 2.101 . . . . 0.0 109.298 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 25.8 tp -79.0 113.73 17.36 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.403 0.547 . . . . 0.0 110.292 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.43 159.58 18.6 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.222 2.609 . . . . 0.0 110.27 -172.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -124.18 121.13 34.26 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 174.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -138.63 89.45 2.37 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.822 0.849 . . . . 0.0 110.595 165.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 56.5 -0.17 0.06 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.995 2.118 . . . . 0.0 115.206 -163.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -176.47 167.23 38.64 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 125.627 1.584 . . . . 0.0 112.344 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 38.0 mt -64.38 128.54 36.21 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 126.001 1.721 . . . . 0.0 110.909 178.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -152.59 144.57 23.74 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.54 1.136 . . . . 0.0 112.727 175.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -94.39 130.1 40.85 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.109 0.964 . . . . 0.0 110.643 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 47.9 t -133.72 127.4 19.44 Favored Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 124.047 0.939 . . . . 0.0 110.527 -177.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -65.81 143.79 74.96 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.698 2.265 . . . . 0.0 111.434 175.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.27 -31.7 22.07 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.44 -16.46 62.46 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 173.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -113.15 -7.94 13.59 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.485 1.514 . . . . 0.0 113.042 177.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.4 t -67.06 150.24 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.1 1.36 . . . . 0.0 110.522 168.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.36 157.78 71.88 Favored Pre-proline 0 N--CA 1.475 0.799 0 C-N-CA 126.71 2.004 . . . . 0.0 111.246 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -68.2 122.27 9.31 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.598 2.199 . . . . 0.0 111.806 -173.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 104.62 5.49 42.11 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.309 0.957 . . . . 0.0 114.647 -176.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -67.43 166.68 14.11 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.557 1.143 . . . . 0.0 112.166 168.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.2 p -117.11 118.46 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.133 0.973 . . . . 0.0 112.052 -176.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.0 t -89.75 139.03 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 125.474 1.51 . . . . 0.0 110.008 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.3 t -91.57 139.04 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 123.731 0.812 . . . . 0.0 110.243 174.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -160.65 -155.88 7.97 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.011 0.815 . . . . 0.0 113.284 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.4 p -137.22 161.76 34.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 128.279 2.632 . . . . 0.0 107.919 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 . . . . . 0 N--CA 1.476 0.847 0 C-N-CA 123.761 0.824 . . . . 0.0 112.301 -173.276 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 . . . . . 0 N--CA 1.477 0.896 0 CA-C-O 121.089 0.471 . . . . 0.0 111.477 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 96.4 mt -67.36 146.18 54.33 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.813 0.845 . . . . 0.0 112.514 -175.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -140.18 123.89 17.27 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.422 1.489 . . . . 0.0 110.459 176.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -87.2 146.09 26.14 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 122.991 0.516 . . . . 0.0 111.367 176.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 23.9 m80 -129.08 128.4 43.47 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.666 1.587 . . . . 0.0 108.545 -173.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -88.31 141.01 28.9 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 120.944 -1.098 . . . . 0.0 112.494 -178.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 76.6 t -67.78 136.39 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 124.755 1.222 . . . . 0.0 110.078 171.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 29.6 t -90.18 -53.11 4.61 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.81 1.644 . . . . 0.0 111.506 171.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.6 m -156.97 159.87 38.49 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 121.194 -0.941 . . . . 0.0 111.121 -174.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.8 m -134.96 152.5 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.158 0.983 . . . . 0.0 111.813 174.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -162.56 159.84 25.24 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.386 1.074 . . . . 0.0 112.481 168.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 83.4 mt -82.66 144.41 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 166.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 44.4 pt -133.82 155.02 39.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.981 1.713 . . . . 0.0 111.074 174.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -93.78 95.96 9.47 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.739 0.816 . . . . 0.0 111.108 -177.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -76.95 -56.72 4.34 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.193 0.997 . . . . 0.0 112.842 179.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 44.82 51.08 8.61 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.046 1.338 . . . . 0.0 112.783 -171.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -152.09 172.02 16.97 Favored 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 124.929 1.292 . . . . 0.0 112.451 -175.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -72.27 135.35 45.98 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 120.739 -1.226 . . . . 0.0 112.144 172.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 4.0 m -111.14 152.14 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.839 1.256 . . . . 0.0 109.645 172.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -115.77 156.17 26.5 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 122.129 0.966 . . . . 0.0 112.105 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -158.59 164.88 35.64 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.22 1.408 . . . . 0.0 109.206 -163.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 44.1 tp -143.02 141.97 31.47 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.712 1.205 . . . . 0.0 110.103 -170.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.9 t -112.4 128.58 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.097 0.959 . . . . 0.0 111.534 -172.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.9 mm -135.09 83.28 39.94 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 126.445 1.898 . . . . 0.0 108.743 -176.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -64.27 -16.77 56.88 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.825 2.35 . . . . 0.0 113.303 -178.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -74.88 -32.29 61.82 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.014 1.726 . . . . 0.0 113.348 -175.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 59.7 p -141.87 -25.82 0.67 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -173.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 56.6 31.27 18.82 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.945 1.698 . . . . 0.0 115.339 -161.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -159.15 152.91 23.06 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.026 1.285 . . . . 0.0 114.137 171.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -148.07 175.69 10.8 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.914 1.686 . . . . 0.0 112.278 175.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 91.2 mt -117.94 128.95 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.731 1.212 . . . . 0.0 110.69 -174.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -80.71 156.95 72.6 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 123.173 0.589 . . . . 0.0 111.636 173.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.9 -20.91 64.53 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.555 2.17 . . . . 0.0 112.673 178.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -74.86 8.12 2.68 Favored 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 124.457 1.103 . . . . 0.0 112.872 172.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 93.09 -25.21 21.19 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 127.319 2.39 . . . . 0.0 115.621 171.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 40.6 mt -75.07 146.02 41.83 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 118.715 1.257 . . . . 0.0 113.121 -170.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.8 t -88.61 125.89 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.514 0.726 . . . . 0.0 110.632 174.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 32.0 mt -113.31 148.83 34.9 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.973 1.709 . . . . 0.0 111.193 -177.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -91.05 153.24 20.27 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.844 0.857 . . . . 0.0 112.315 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 25.9 m120 . . . . . 0 CA--C 1.543 0.691 0 C-N-CA 123.875 0.87 . . . . 0.0 111.656 178.593 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.486 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.32 158.42 39.15 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.006 1.322 . . . . 0.0 111.282 -173.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -63.71 148.68 48.48 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.879 0.872 . . . . 0.0 113.079 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -61.46 -22.6 65.2 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.615 1.566 . . . . 0.0 113.805 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -76.17 -14.99 60.14 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.348 1.459 . . . . 0.0 112.406 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.5 m -64.23 136.99 57.71 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.426 1.091 . . . . 0.0 112.548 -175.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -77.94 147.96 34.72 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.357 1.063 . . . . 0.0 112.703 169.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.6 p -144.85 159.88 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.269 1.028 . . . . 0.0 112.373 -171.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -129.55 135.43 48.58 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.606 1.963 . . . . 0.0 108.883 -177.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -155.83 175.19 14.25 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.079 0.854 . . . . 0.0 112.155 168.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -136.13 139.26 42.8 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.452 1.101 . . . . 0.0 111.86 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -156.76 150.79 24.98 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.987 1.315 . . . . 0.0 110.633 173.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.8 t0 49.96 42.08 23.93 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.656 1.182 . . . . 0.0 112.66 -173.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.1 m 55.75 36.17 26.74 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 126.401 1.881 . . . . 0.0 114.609 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.3 p -149.0 139.88 13.81 Favored Pre-proline 0 CA--C 1.54 0.579 0 O-C-N 120.419 -1.426 . . . . 0.0 111.242 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.33 150.29 32.42 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.708 2.938 . . . . 0.0 113.309 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -126.78 140.22 52.53 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.775 2.03 . . . . 0.0 109.894 172.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -148.03 113.2 5.53 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.098 0.959 . . . . 0.0 110.039 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -164.33 -175.51 3.97 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.428 1.891 . . . . 0.0 110.249 -174.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 m -72.09 146.32 47.61 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 120.872 -1.142 . . . . 0.0 109.928 173.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.407 HG12 ' CG ' ' A' ' 152' ' ' TYR . 9.1 tp -56.84 -37.99 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 O-C-N 121.593 -0.692 . . . . 0.0 112.29 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -63.83 -26.27 68.54 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.104 0.866 . . . . 0.0 112.451 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -78.31 -40.64 36.13 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.841 1.257 . . . . 0.0 111.112 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -73.0 -32.58 65.24 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.422 -0.799 . . . . 0.0 111.725 173.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -59.62 -49.18 78.77 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.842 0.857 . . . . 0.0 111.026 169.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.2 t -65.95 -31.5 72.45 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.438 0.695 . . . . 0.0 111.968 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -67.85 -53.52 26.13 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.04 1.336 . . . . 0.0 110.983 173.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -70.4 -33.29 71.2 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.33 -31.88 72.94 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.684 0.794 . . . . 0.0 111.943 173.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.3 t -78.52 -29.98 46.82 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 121.199 -0.938 . . . . 0.0 112.011 174.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 65.5 mtm -81.08 -49.96 10.23 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.113 0.965 . . . . 0.0 113.454 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 -111.8 -20.28 12.12 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.639 1.576 . . . . 0.0 114.295 -168.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.55 158.31 33.56 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 124.553 1.073 . . . . 0.0 114.613 -178.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -104.68 126.42 51.75 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.279 1.032 . . . . 0.0 110.475 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 11.1 mp -99.82 148.51 34.89 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 126.406 1.882 . . . . 0.0 110.517 177.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -72.4 154.92 55.95 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.118 2.546 . . . . 0.0 111.668 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -134.37 167.81 20.05 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.566 1.146 . . . . 0.0 111.202 168.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -51.57 -58.08 7.33 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.036 1.335 . . . . 0.0 111.453 171.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -96.57 -8.79 30.93 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -171.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -175.16 -131.08 1.38 Allowed Glycine 0 CA--C 1.535 1.294 0 N-CA-C 114.871 0.708 . . . . 0.0 114.871 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -136.81 159.7 41.07 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.206 1.802 . . . . 0.0 111.211 176.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.44 149.03 42.07 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.209 1.404 . . . . 0.0 111.213 -177.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.2 t -123.5 116.97 27.94 Favored Pre-proline 0 N--CA 1.482 1.154 0 C-N-CA 125.432 1.493 . . . . 0.0 109.912 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.72 140.97 40.25 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 124.23 3.287 . . . . 0.0 111.78 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 87.5 mt -109.47 169.68 8.55 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.386 1.074 . . . . 0.0 113.309 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -148.29 123.01 9.89 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.723 1.609 . . . . 0.0 110.022 174.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 50.17 40.59 22.31 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.543 1.537 . . . . 0.0 114.022 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.9 t -102.12 122.74 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 121.243 -0.91 . . . . 0.0 110.048 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -121.25 150.9 40.67 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.281 1.032 . . . . 0.0 113.115 -171.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.4 m -138.19 155.49 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 126.862 2.065 . . . . 0.0 111.634 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -69.06 132.55 46.8 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.328 0.651 . . . . 0.0 109.682 167.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.2 t -132.28 148.48 52.44 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.585 1.954 . . . . 0.0 110.654 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 55.9 tp -104.98 134.35 48.23 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.457 1.103 . . . . 0.0 109.654 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -78.1 105.57 9.41 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.59 0.756 . . . . 0.0 109.071 167.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 29.5 mm -66.75 -23.51 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 119.656 1.116 . . . . 0.0 111.633 -176.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.57 -48.22 49.8 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.661 1.184 . . . . 0.0 114.093 -177.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.2 m -114.87 -3.12 12.76 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.214 1.006 . . . . 0.0 113.435 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.59 28.85 68.63 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.293 1.425 . . . . 0.0 113.479 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -95.04 141.58 28.52 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.508 1.123 . . . . 0.0 112.039 -173.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.9 mp -89.81 128.02 42.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 C-N-CA 125.106 1.362 . . . . 0.0 109.501 -176.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -151.53 170.39 19.75 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.331 1.052 . . . . 0.0 112.645 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -114.23 135.12 54.4 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.82 1.248 . . . . 0.0 111.23 -177.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.6 t -134.58 153.87 51.76 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.219 1.008 . . . . 0.0 112.769 -174.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -80.42 140.9 35.77 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 175.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -93.45 143.0 26.7 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.387 1.075 . . . . 0.0 110.92 167.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 96.0 p -85.56 -53.95 4.86 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.81 1.244 . . . . 0.0 112.269 -174.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -152.1 158.82 43.51 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.964 1.705 . . . . 0.0 112.669 177.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.2 mt -85.66 152.51 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 163.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -143.56 148.05 35.35 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.103 1.361 . . . . 0.0 111.466 -177.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.1 ptt-85 -144.11 150.8 38.69 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 168.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -148.62 172.16 15.0 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.293 1.837 . . . . 0.0 110.586 175.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp -101.32 143.87 30.85 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.131 0.973 . . . . 0.0 112.186 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.6 m -145.35 146.57 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.464 1.506 . . . . 0.0 110.815 173.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -92.81 -34.46 13.86 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.731 1.212 . . . . 0.0 111.729 173.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -114.86 124.4 51.63 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.876 1.67 . . . . 0.0 110.224 -170.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.5 tp -134.29 158.5 43.61 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.61 1.564 . . . . 0.0 109.746 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 14.4 mt -109.61 130.83 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.324 1.049 . . . . 0.0 108.762 173.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -100.12 123.83 44.8 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.188 1.395 . . . . 0.0 110.083 168.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -113.3 115.79 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.557 1.543 . . . . 0.0 108.269 173.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.2 tttt -87.82 148.52 24.64 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.444 1.098 . . . . 0.0 110.966 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 85.8 mt -115.06 158.41 22.16 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.17 1.388 . . . . 0.0 112.347 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.1 t -65.04 -23.02 67.07 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 121.881 -0.512 . . . . 0.0 112.077 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 96.1 p -63.35 -22.26 66.77 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.697 1.599 . . . . 0.0 115.031 170.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.83 1.22 61.78 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 125.275 1.417 . . . . 0.0 115.198 -171.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -85.7 161.67 19.1 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.633 1.217 . . . . 0.0 111.194 172.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.2 p -134.49 135.34 42.35 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.359 1.076 . . . . 0.0 112.79 172.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 63.4 tp -97.76 115.09 27.32 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.659 1.584 . . . . 0.0 108.797 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -111.09 109.48 19.58 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.637 1.575 . . . . 0.0 109.878 -177.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.2 m -149.81 154.18 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 126.157 1.783 . . . . 0.0 113.254 -161.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.9 p -66.7 149.75 98.03 Favored Pre-proline 0 N--CA 1.471 0.587 0 O-C-N 121.072 -1.017 . . . . 0.0 113.244 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -60.5 -21.62 68.92 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 124.316 3.344 . . . . 0.0 114.685 -175.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.6 p -76.95 -23.08 52.4 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 128.318 2.647 . . . . 0.0 114.704 175.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 44.0 t60 -75.19 121.19 84.7 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-O 118.349 -0.834 . . . . 0.0 112.671 -162.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -75.13 126.28 9.78 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.881 2.387 . . . . 0.0 112.866 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.8 t -106.08 145.01 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 126.011 1.725 . . . . 0.0 109.175 175.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 18.0 tp -79.46 109.86 14.22 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.4 0.545 . . . . 0.0 110.363 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.1 mp -107.35 161.05 15.16 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.252 1.821 . . . . 0.0 111.556 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -117.91 112.16 19.97 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 174.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.1 mtt-85 -139.62 91.1 2.45 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.76 1.224 . . . . 0.0 109.162 165.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 56.28 -2.68 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 128.25 2.62 . . . . 0.0 116.984 -167.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.76 164.66 37.39 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 125.515 1.531 . . . . 0.0 112.682 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 67.6 mt -71.5 114.86 10.02 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.884 1.674 . . . . 0.0 110.403 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -138.35 136.59 36.52 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -174.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -92.21 112.41 24.34 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.57 1.148 . . . . 0.0 110.85 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 60.5 t -124.32 127.4 25.3 Favored Pre-proline 0 N--CA 1.478 0.962 0 C-N-CA 123.95 0.9 . . . . 0.0 110.233 -172.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -64.22 143.35 83.4 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.487 2.125 . . . . 0.0 111.584 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.14 -30.52 26.91 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 177.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.61 -22.06 66.63 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 173.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -105.43 -6.52 19.43 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.334 1.454 . . . . 0.0 112.486 175.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 84.8 t -68.51 142.25 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 O-C-N 121.292 -0.88 . . . . 0.0 109.594 166.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.61 154.65 80.92 Favored Pre-proline 0 N--CA 1.469 0.505 0 C-N-CA 128.289 2.636 . . . . 0.0 109.496 -178.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.46 132.49 31.36 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.994 1.796 . . . . 0.0 111.05 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 104.04 -6.06 46.81 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.166 1.365 . . . . 0.0 114.221 175.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.33 162.28 28.85 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 118.734 1.267 . . . . 0.0 112.439 177.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 50.5 t -91.12 121.59 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.071 1.348 . . . . 0.0 110.661 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.1 t -94.87 137.69 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.853 1.261 . . . . 0.0 110.233 169.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 41.1 t -89.58 137.82 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.14 0.976 . . . . 0.0 110.473 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -164.99 -149.01 5.67 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.245 0.926 . . . . 0.0 113.002 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.9 p -148.44 166.15 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 127.404 2.281 . . . . 0.0 108.486 175.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -60.67 106.86 0.61 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.67 0.788 . . . . 0.0 111.909 174.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.73 -25.45 68.2 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -175.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -68.9 -42.01 77.49 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.024 -1.048 . . . . 0.0 112.042 170.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 49.1 t -65.39 -38.82 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.047 0.939 . . . . 0.0 110.455 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 30.7 tp -63.24 -13.46 38.16 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.615 1.566 . . . . 0.0 113.739 175.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -117.97 9.27 12.75 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.523 1.529 . . . . 0.0 114.655 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.86 168.9 16.92 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.099 1.359 . . . . 0.0 111.56 167.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -71.76 -43.43 65.77 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 121.019 -1.05 . . . . 0.0 111.89 174.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 mp -105.57 122.39 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 127.185 2.194 . . . . 0.0 107.649 169.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 65.6 mt -92.67 118.56 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 123.683 0.793 . . . . 0.0 108.957 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 10.0 t -72.68 84.39 1.17 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.071 0.949 . . . . 0.0 110.955 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -64.05 173.6 1.84 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 127.079 2.152 . . . . 0.0 115.393 -171.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 73.42 22.27 78.78 Favored Glycine 0 N--CA 1.471 1.01 0 N-CA-C 116.489 1.355 . . . . 0.0 116.489 169.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -134.66 163.85 28.83 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.939 1.295 . . . . 0.0 112.221 174.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 95.7 mt -137.13 164.83 27.5 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.674 1.99 . . . . 0.0 109.634 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -142.09 134.73 28.3 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.207 1.403 . . . . 0.0 111.83 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -90.59 143.54 26.64 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.557 1.543 . . . . 0.0 111.702 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -131.65 136.07 47.42 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.35 1.46 . . . . 0.0 110.917 -173.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -87.33 130.65 34.54 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 119.011 0.823 . . . . 0.0 112.394 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 82.8 t -68.35 122.15 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 121.77 0.795 . . . . 0.0 110.573 167.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 45.5 t -76.92 -50.29 13.63 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.823 1.649 . . . . 0.0 112.602 176.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.4 t -158.8 164.99 35.28 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.474 1.51 . . . . 0.0 110.552 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.8 m -132.61 149.5 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 124.486 1.114 . . . . 0.0 111.543 170.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -155.34 154.37 31.93 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.247 1.019 . . . . 0.0 113.565 171.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 71.2 mt -90.25 130.6 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.561 1.144 . . . . 0.0 109.26 169.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 16.1 pt -126.39 159.04 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.925 1.69 . . . . 0.0 112.496 -174.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -95.38 96.53 9.19 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 122.24 1.019 . . . . 0.0 111.534 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -76.01 -52.02 11.11 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.064 0.945 . . . . 0.0 113.2 176.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 50.89 33.12 8.18 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.954 1.301 . . . . 0.0 113.952 -176.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -141.04 172.97 11.95 Favored 'General case' 0 CA--C 1.549 0.928 0 O-C-N 120.775 -1.203 . . . . 0.0 112.471 -170.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -74.01 137.89 43.75 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.262 -0.899 . . . . 0.0 112.091 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 12.2 m -122.35 154.5 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.399 1.88 . . . . 0.0 110.141 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.407 ' CG ' HG12 ' A' ' 21' ' ' ILE . 1.5 p90 -113.06 159.73 18.88 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -174.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -137.68 145.29 42.43 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.256 1.422 . . . . 0.0 109.092 158.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 67.1 tp -120.89 103.99 9.49 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.829 1.252 . . . . 0.0 109.426 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 57.6 t -87.71 131.66 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -150.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.4 mm -124.62 85.78 56.21 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 124.536 1.134 . . . . 0.0 110.793 -176.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -65.48 -10.3 25.7 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.561 2.174 . . . . 0.0 114.216 177.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -72.15 -47.74 48.69 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 119.816 1.189 . . . . 0.0 113.0 172.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 71.1 p -135.32 -15.2 1.93 Allowed 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -171.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . 0.295 68.6 m80 56.78 25.9 10.83 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 128.079 2.552 . . . . 0.0 116.03 -170.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.92 146.85 26.55 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 120.796 -1.19 . . . . 0.0 113.548 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -147.56 166.05 28.49 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.299 1.439 . . . . 0.0 112.302 -176.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.9 mp -109.82 135.59 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.82 1.248 . . . . 0.0 111.663 177.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -85.81 159.05 55.67 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 124.315 1.046 . . . . 0.0 112.624 171.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.0 -23.19 74.06 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.69 2.926 . . . . 0.0 112.582 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.74 8.22 2.05 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.548 1.139 . . . . 0.0 113.176 171.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 90.68 -20.61 37.59 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 127.098 2.285 . . . . 0.0 116.048 169.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 47.2 mt -70.87 151.76 44.41 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.279 1.432 . . . . 0.0 112.889 -173.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.41 124.72 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 124.565 1.146 . . . . 0.0 111.926 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.96 144.07 43.68 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.738 2.015 . . . . 0.0 111.96 -173.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -100.27 146.52 26.81 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.563 0.745 . . . . 0.0 111.98 166.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -61.91 128.1 34.56 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.562 -0.711 . . . . 0.0 110.832 168.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -161.24 154.2 21.01 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.365 1.066 . . . . 0.0 110.643 173.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 117.847 -1.073 . . . . 0.0 109.392 166.164 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.667 0 CA-C-O 121.023 0.44 . . . . 0.0 112.031 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.414 ' HB2' ' CE1' ' A' ' 152' ' ' TYR . 0.0 OUTLIER -146.6 164.45 32.59 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.645 1.578 . . . . 0.0 111.058 -172.419 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.74 143.58 57.43 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.66 1.184 . . . . 0.0 113.725 -175.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? -58.71 -25.22 62.69 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.182 1.393 . . . . 0.0 114.238 177.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -87.02 1.03 54.19 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.924 1.29 . . . . 0.0 113.399 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.1 m -69.35 142.06 54.07 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.592 1.157 . . . . 0.0 113.099 175.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -79.32 148.06 32.23 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.436 1.494 . . . . 0.0 113.464 171.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.0 p -147.19 158.52 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.648 1.179 . . . . 0.0 111.904 -173.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -126.35 139.86 52.96 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.444 1.898 . . . . 0.0 108.807 178.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -155.28 177.21 11.61 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.608 0.718 . . . . 0.0 111.379 165.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -134.9 143.1 46.75 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.135 0.974 . . . . 0.0 110.181 173.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -159.53 143.12 14.56 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.483 1.113 . . . . 0.0 109.826 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.4 t70 48.49 50.28 17.07 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.927 1.291 . . . . 0.0 113.595 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.4 m 68.71 11.06 8.22 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 128.38 2.672 . . . . 0.0 116.145 174.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.6 p -134.71 136.87 26.22 Favored Pre-proline 0 CA--C 1.545 0.756 0 O-C-N 120.279 -1.513 . . . . 0.0 112.871 -176.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -73.0 154.39 52.82 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 123.793 2.996 . . . . 0.0 112.597 174.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -135.31 136.86 41.92 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.739 2.016 . . . . 0.0 109.147 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 50.6 ttm -152.95 104.01 2.8 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.749 0.82 . . . . 0.0 110.277 -176.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -162.29 -176.86 5.34 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.138 1.375 . . . . 0.0 111.067 -169.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.4 m -71.6 143.75 49.71 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 120.855 -1.153 . . . . 0.0 110.673 171.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.1 tp -55.02 -38.29 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -62.64 -24.04 67.39 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.365 -0.834 . . . . 0.0 113.02 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -80.55 -39.39 27.83 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.08 0.952 . . . . 0.0 111.313 176.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -73.18 -33.23 65.32 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.079 0.854 . . . . 0.0 111.72 174.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -56.96 -51.73 68.02 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.701 1.2 . . . . 0.0 111.908 169.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.1 t -62.17 -40.42 95.97 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.631 0.772 . . . . 0.0 111.423 -177.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -61.05 -53.01 62.49 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.756 1.223 . . . . 0.0 110.425 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -72.07 -33.28 67.8 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.0 -31.58 72.56 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.254 1.022 . . . . 0.0 112.513 175.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.7 t -79.81 -33.07 40.69 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 118.796 0.725 . . . . 0.0 111.878 174.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 69.8 mtm -75.99 -48.15 22.22 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.566 0.747 . . . . 0.0 112.665 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 35.7 m-20 -116.86 -19.88 9.67 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.437 1.495 . . . . 0.0 113.887 -166.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.75 159.17 34.89 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 125.087 1.327 . . . . 0.0 114.755 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -104.19 124.33 48.92 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.703 1.201 . . . . 0.0 109.435 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.3 mp -106.24 141.4 22.67 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 125.777 1.631 . . . . 0.0 110.613 -178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.12 146.23 57.35 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.505 2.803 . . . . 0.0 112.09 -173.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -134.25 154.73 51.1 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.42 1.088 . . . . 0.0 112.234 177.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -42.17 -47.45 4.65 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.897 1.679 . . . . 0.0 114.673 -176.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -116.3 7.65 14.04 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.13 -137.43 2.44 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 116.097 1.199 . . . . 0.0 116.097 -172.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -145.35 157.0 44.13 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 127.562 2.345 . . . . 0.0 111.062 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.09 151.98 47.15 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.376 1.071 . . . . 0.0 112.306 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.4 t -123.96 116.96 27.31 Favored Pre-proline 0 N--CA 1.48 1.046 0 C-N-CA 125.393 1.477 . . . . 0.0 110.284 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.43 141.63 31.96 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 124.529 3.486 . . . . 0.0 111.584 -176.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 77.2 mt -115.54 171.21 7.87 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.822 1.249 . . . . 0.0 112.682 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -148.92 135.02 19.16 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.843 1.657 . . . . 0.0 109.479 165.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 52.17 50.28 18.78 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.971 1.308 . . . . 0.0 113.562 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 67.0 t -113.05 107.67 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.075 0.95 . . . . 0.0 110.48 177.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -103.71 137.66 41.43 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.603 1.161 . . . . 0.0 113.335 -167.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.8 m -134.74 149.84 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.574 1.549 . . . . 0.0 112.599 175.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -65.44 141.95 58.34 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.648 0.779 . . . . 0.0 111.028 169.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.9 t -144.78 154.17 42.42 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.609 1.564 . . . . 0.0 111.259 -174.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 54.0 tp -114.05 138.88 49.8 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.06 1.344 . . . . 0.0 110.821 -175.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -86.6 120.69 28.19 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.17 1.388 . . . . 0.0 108.987 161.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 24.2 mm -78.87 -28.85 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 O-C-N 121.256 -0.903 . . . . 0.0 111.154 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.05 -36.19 80.86 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.437 1.095 . . . . 0.0 113.492 -171.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.9 m -121.54 -21.26 6.28 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.217 1.407 . . . . 0.0 112.998 171.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.49 31.01 20.19 Favored Glycine 0 N--CA 1.474 1.232 0 CA-C-N 118.878 0.763 . . . . 0.0 113.099 -173.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -91.92 143.68 26.24 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.819 1.248 . . . . 0.0 112.05 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.0 144.23 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.482 1.113 . . . . 0.0 110.6 -176.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.3 ptpt -154.0 176.91 11.65 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.901 1.68 . . . . 0.0 112.367 -177.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -121.45 147.82 45.24 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.792 1.637 . . . . 0.0 111.567 174.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.7 t -143.61 160.4 40.72 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.013 1.325 . . . . 0.0 111.187 175.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -97.88 132.36 43.54 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 170.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.33 142.2 39.51 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.056 0.943 . . . . 0.0 111.004 175.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.6 t -89.96 -46.14 8.72 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -169.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -153.53 160.55 42.52 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.684 1.193 . . . . 0.0 112.272 174.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.7 mt -88.79 152.81 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.481 1.112 . . . . 0.0 108.423 165.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -139.69 148.04 41.8 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.459 1.504 . . . . 0.0 110.537 -177.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.4 ptt85 -143.32 150.16 38.81 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.099 0.96 . . . . 0.0 113.155 169.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -151.66 166.08 32.36 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.988 1.715 . . . . 0.0 109.984 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -94.09 151.93 19.14 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.036 0.834 . . . . 0.0 111.459 172.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.7 m -148.74 143.12 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 124.879 1.272 . . . . 0.0 110.333 170.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -90.22 -30.14 17.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 117.632 -1.175 . . . . 0.0 112.019 175.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.7 mttt -131.95 130.43 41.51 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.274 0.943 . . . . 0.0 110.915 -174.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.8 tp -139.93 162.78 34.37 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.804 2.042 . . . . 0.0 110.158 -168.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.7 mt -116.46 127.58 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.604 1.162 . . . . 0.0 110.138 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -96.62 126.45 41.8 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.139 0.975 . . . . 0.0 110.625 166.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -111.0 129.03 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.436 1.094 . . . . 0.0 109.835 169.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -97.65 143.73 28.02 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.025 1.73 . . . . 0.0 111.301 173.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.3 mt -104.55 157.35 17.23 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 127.094 2.158 . . . . 0.0 110.317 -176.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.3 t -66.88 -23.6 66.02 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -173.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.7 t -66.84 -20.05 65.85 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.251 -0.905 . . . . 0.0 113.415 167.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 108.13 -5.52 34.08 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 127.575 2.512 . . . . 0.0 115.71 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -82.85 161.07 22.05 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.166 1.387 . . . . 0.0 110.831 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 65.2 p -141.46 159.83 41.41 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 24.3 tp -129.41 138.89 51.74 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.461 1.904 . . . . 0.0 110.324 177.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -111.22 121.63 45.79 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.876 1.27 . . . . 0.0 112.113 177.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.12 153.41 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.728 1.611 . . . . 0.0 112.85 -166.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.2 p -68.55 148.57 98.11 Favored Pre-proline 0 N--CA 1.472 0.64 0 O-C-N 120.944 -1.098 . . . . 0.0 112.573 173.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -60.84 -30.32 89.9 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 123.069 2.513 . . . . 0.0 114.366 -168.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 95.9 p -85.19 -6.56 59.27 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -61.5 119.21 44.75 Favored Pre-proline 0 CA--C 1.544 0.747 0 CA-C-N 119.635 1.107 . . . . 0.0 111.548 -177.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -73.47 127.38 11.75 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.415 2.077 . . . . 0.0 113.097 178.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.1 t -109.38 141.04 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.389 1.876 . . . . 0.0 109.374 174.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 20.2 tp -84.12 116.06 22.71 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.935 -0.478 . . . . 0.0 110.369 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.4 mp -115.67 148.28 39.88 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.961 1.704 . . . . 0.0 111.358 -173.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -107.0 81.54 1.56 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.877 0.846 . . . . 0.0 112.662 -173.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -119.0 78.81 1.32 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.691 1.196 . . . . 0.0 110.055 -169.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.6 t70 64.54 -14.79 0.09 Allowed 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 128.697 2.799 . . . . 0.0 115.602 -160.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.58 179.45 43.32 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 126.471 1.986 . . . . 0.0 111.506 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 73.0 mt -71.49 127.38 32.36 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.501 1.12 . . . . 0.0 109.981 178.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -153.33 144.93 23.34 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.902 0.881 . . . . 0.0 112.387 174.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -89.83 128.13 36.11 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.163 0.985 . . . . 0.0 110.879 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.0 t -131.65 128.94 21.93 Favored Pre-proline 0 N--CA 1.473 0.698 0 C-N-CA 124.584 1.154 . . . . 0.0 110.801 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -65.21 144.57 81.61 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.08 1.854 . . . . 0.0 110.974 175.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.44 -29.9 17.72 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 176.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.81 -23.0 67.19 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 173.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -108.83 0.76 20.49 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.302 1.841 . . . . 0.0 112.178 178.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.7 t -78.37 142.92 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.478 1.111 . . . . 0.0 110.014 166.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.74 154.94 73.24 Favored Pre-proline 0 N--CA 1.469 0.478 0 C-N-CA 126.202 1.801 . . . . 0.0 111.127 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -63.69 122.5 10.62 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.188 1.926 . . . . 0.0 109.978 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 102.08 5.27 50.23 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 124.355 0.979 . . . . 0.0 115.316 -176.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -64.38 165.08 10.23 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 118.956 1.378 . . . . 0.0 112.302 164.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.1 p -113.48 125.03 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.171 1.388 . . . . 0.0 111.744 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.3 t -101.64 142.92 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 127.938 2.495 . . . . 0.0 110.652 -173.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 43.8 t -99.99 143.35 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.842 1.257 . . . . 0.0 112.314 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -162.9 -152.12 6.67 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.826 1.679 . . . . 0.0 112.63 175.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.4 p -138.82 157.01 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 127.519 2.328 . . . . 0.0 108.873 -177.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -59.85 125.82 25.15 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.068 0.547 . . . . 0.0 110.815 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -54.3 -34.11 60.23 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.227 1.011 . . . . 0.0 112.663 -172.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -47.22 -48.16 24.2 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.897 1.279 . . . . 0.0 114.328 174.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.6 p -71.0 -22.14 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-N 120.9 1.682 . . . . 0.0 113.582 -174.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -85.03 -35.44 21.92 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.624 1.169 . . . . 0.0 111.547 172.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 52.1 ttt85 -100.64 -45.92 5.35 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 -164.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -169.68 102.28 0.32 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 127.108 2.163 . . . . 0.0 110.43 177.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 33.8 ttt-85 -155.29 165.27 37.18 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 125.99 1.716 . . . . 0.0 111.747 175.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.64 142.61 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.831 1.252 . . . . 0.0 109.76 155.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 44.9 pt -58.25 139.83 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -172.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 79.3 p -159.52 177.47 10.89 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.56 1.944 . . . . 0.0 111.363 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -135.05 168.88 18.32 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.206 1.402 . . . . 0.0 112.174 166.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.96 -3.18 85.91 Favored Glycine 0 CA--C 1.537 1.425 0 N-CA-C 119.438 2.535 . . . . 0.0 119.438 162.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -89.0 70.27 8.51 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.186 1.493 . . . . 0.0 113.637 -168.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 98.8 mt -66.03 138.98 58.16 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.003 1.721 . . . . 0.0 113.838 -177.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -131.11 149.88 52.4 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.439 1.496 . . . . 0.0 112.98 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -130.95 136.13 48.28 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.895 0.878 . . . . 0.0 113.142 -170.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -125.9 142.41 51.53 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.42 1.088 . . . . 0.0 111.297 -175.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -88.99 138.46 31.38 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.55 0.74 . . . . 0.0 110.894 174.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 71.9 t -72.41 126.26 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 O-C-N 120.705 -1.247 . . . . 0.0 110.115 172.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 28.2 t -77.71 -48.55 16.43 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.412 1.485 . . . . 0.0 111.629 172.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.72 170.54 20.57 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.412 -0.805 . . . . 0.0 111.588 176.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 11.1 m -132.81 155.24 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.772 1.229 . . . . 0.0 110.255 169.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -153.9 153.9 32.89 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.201 1.001 . . . . 0.0 112.391 168.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 96.3 mt -94.14 135.99 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.949 1.3 . . . . 0.0 108.091 168.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 28.2 pt -132.56 148.21 31.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 125.147 1.379 . . . . 0.0 111.029 -178.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -84.39 96.01 8.94 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 170.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -74.12 -45.95 45.68 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.096 -1.003 . . . . 0.0 112.105 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 47.12 40.51 9.97 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.559 1.143 . . . . 0.0 112.498 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -148.41 172.3 14.66 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.244 1.418 . . . . 0.0 110.763 -170.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -76.94 142.55 40.0 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 122.052 0.93 . . . . 0.0 112.638 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.36 157.53 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 126.557 1.943 . . . . 0.0 109.344 177.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.414 ' CE1' ' HB2' ' A' ' 2' ' ' PHE . 7.8 p90 -110.51 161.44 15.69 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.973 0.909 . . . . 0.0 112.016 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -137.38 154.03 50.08 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.865 0.866 . . . . 0.0 108.944 158.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.0 tt -129.05 108.99 10.82 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.738 -1.226 . . . . 0.0 108.823 -172.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.7 t -90.87 127.47 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -153.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 28.8 mm -124.18 85.84 54.7 Favored Pre-proline 0 N--CA 1.47 0.571 0 C-N-CA 125.627 1.571 . . . . 0.0 109.705 -172.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -64.65 -16.92 57.74 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.098 1.866 . . . . 0.0 113.816 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -78.45 -45.03 23.18 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.742 1.156 . . . . 0.0 113.089 -176.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 76.6 p -131.65 -8.52 3.62 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.338 1.455 . . . . 0.0 114.288 -172.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 54.73 15.68 1.17 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.555 1.542 . . . . 0.0 114.773 -165.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -143.45 142.48 31.22 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 121.248 1.84 . . . . 0.0 114.951 -175.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -141.74 162.91 34.31 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.383 1.473 . . . . 0.0 112.069 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 95.2 mt -112.29 130.62 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.281 1.032 . . . . 0.0 110.568 -173.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -77.74 160.1 75.18 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 124.151 0.981 . . . . 0.0 111.866 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -62.19 -20.12 68.91 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.577 2.185 . . . . 0.0 112.719 177.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -73.81 -12.21 60.62 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.039 1.336 . . . . 0.0 113.226 175.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 102.61 -22.43 37.38 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.851 1.691 . . . . 0.0 115.446 177.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 72.2 mt -72.14 148.12 45.98 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 119.479 1.639 . . . . 0.0 113.087 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.9 p -99.89 134.38 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.396 1.079 . . . . 0.0 112.48 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 41.4 mt -119.47 133.75 55.54 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.498 1.919 . . . . 0.0 110.913 -171.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 31.6 t-80 -86.23 126.56 34.36 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.606 -0.684 . . . . 0.0 110.379 165.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.436 ' ND2' ' H ' ' A' ' 174' ' ' GLN . 0.0 OUTLIER -73.53 144.75 46.0 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.069 0.948 . . . . 0.0 109.464 170.837 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -110.78 7.76 22.16 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.83 1.418 . . . . 0.0 114.83 -170.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . 0.436 ' H ' ' ND2' ' A' ' 172' ' ' ASN . 45.1 mm-40 . . . . . 0 C--O 1.253 1.255 0 C-N-CA 125.603 1.561 . . . . 0.0 113.194 -172.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.878 0 CA-C-O 121.085 0.469 . . . . 0.0 111.983 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -131.01 160.26 35.1 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 127.014 2.126 . . . . 0.0 111.196 -175.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -55.46 145.86 21.57 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.379 1.071 . . . . 0.0 112.615 175.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -26.26 67.89 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -79.21 -8.26 58.88 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 175.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.0 m -63.11 134.8 56.63 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 121.063 -1.023 . . . . 0.0 111.29 -175.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -76.78 149.32 36.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 122.268 1.033 . . . . 0.0 113.719 175.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.0 p -145.35 152.14 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 124.595 1.158 . . . . 0.0 111.675 -173.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -122.06 143.26 49.62 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.766 2.026 . . . . 0.0 107.284 176.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -150.86 -175.88 5.31 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.427 0.691 . . . . 0.0 111.132 164.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -136.15 142.24 44.18 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.258 1.423 . . . . 0.0 110.624 174.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -164.04 151.21 11.95 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.879 2.071 . . . . 0.0 108.109 176.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.2 t0 50.95 43.18 28.86 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.791 1.237 . . . . 0.0 113.698 -177.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.5 m 56.66 35.18 25.76 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.625 1.57 . . . . 0.0 114.523 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.1 p -154.66 140.8 12.85 Favored Pre-proline 0 CA--C 1.538 0.482 0 O-C-N 120.505 -1.372 . . . . 0.0 112.012 177.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.35 144.87 57.67 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.588 2.192 . . . . 0.0 112.194 173.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -123.34 142.21 51.19 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 128.819 2.848 . . . . 0.0 108.806 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 41.6 ttm -153.29 120.43 5.8 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.678 -0.639 . . . . 0.0 111.634 -175.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -160.44 -172.43 3.55 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.47 1.908 . . . . 0.0 110.56 -176.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.4 m -76.16 150.08 37.21 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 120.639 -1.288 . . . . 0.0 110.541 167.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.2 tp -59.22 -36.36 62.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 O-C-N 121.019 -1.051 . . . . 0.0 111.985 177.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -59.71 -27.64 66.62 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.202 0.91 . . . . 0.0 113.455 173.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -81.46 -47.51 13.08 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.542 0.737 . . . . 0.0 110.194 -176.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.9 ppp? -68.27 -33.26 74.04 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 176.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -58.46 -50.05 75.1 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.428 0.691 . . . . 0.0 111.6 170.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.4 t -66.18 -29.61 69.93 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 121.646 -0.659 . . . . 0.0 111.973 -173.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -69.53 -57.13 5.6 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 126.39 1.876 . . . . 0.0 110.731 173.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -69.7 -34.86 74.51 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.282 -0.886 . . . . 0.0 112.89 -176.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.57 -24.79 64.65 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.303 1.041 . . . . 0.0 113.616 174.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 30.9 t -82.38 -35.27 27.91 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.765 0.712 . . . . 0.0 111.975 172.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 63.8 mtm -77.55 -58.08 3.46 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.85 0.86 . . . . 0.0 111.793 -178.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 47.2 m-20 -98.53 -20.02 17.29 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.828 1.251 . . . . 0.0 112.555 -171.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.7 159.35 33.2 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-O 121.941 0.745 . . . . 0.0 114.008 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -105.01 124.2 49.12 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.223 1.009 . . . . 0.0 110.577 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.6 mp -98.46 151.31 37.41 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 125.225 1.41 . . . . 0.0 110.488 174.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -69.09 156.12 66.05 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.834 2.356 . . . . 0.0 111.624 176.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -140.6 169.54 17.45 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.988 1.715 . . . . 0.0 110.26 174.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -48.93 -49.48 39.99 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -176.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -107.4 -13.43 15.1 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 177.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -161.21 -134.96 1.73 Allowed Glycine 0 CA--C 1.528 0.847 0 O-C-N 121.507 -0.745 . . . . 0.0 113.935 -167.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -140.69 154.72 46.49 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.284 1.034 . . . . 0.0 111.891 -177.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -135.95 145.4 46.17 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.774 1.23 . . . . 0.0 112.454 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 52.1 t -118.53 116.78 34.85 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 125.642 1.577 . . . . 0.0 110.758 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -71.34 138.23 32.54 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 124.091 3.194 . . . . 0.0 111.603 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 82.2 mt -107.18 158.13 17.34 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.974 1.31 . . . . 0.0 112.507 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -139.12 124.37 19.11 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.316 1.446 . . . . 0.0 109.444 174.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 51.33 51.2 17.35 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.797 1.639 . . . . 0.0 113.98 -178.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.4 t -116.41 128.71 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.408 1.483 . . . . 0.0 109.981 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -129.25 158.28 39.5 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.603 1.161 . . . . 0.0 113.364 -170.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.1 m -146.12 152.48 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 126.784 2.034 . . . . 0.0 112.269 176.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -61.7 131.45 49.99 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.402 1.481 . . . . 0.0 110.45 161.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.6 t -134.84 153.09 52.18 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.201 2.2 . . . . 0.0 111.565 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 37.6 tp -106.63 136.2 46.84 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.032 0.933 . . . . 0.0 112.169 -176.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -82.61 93.56 7.35 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.733 1.613 . . . . 0.0 110.173 170.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 31.7 mm -59.92 -21.82 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 O-C-N 120.854 -1.154 . . . . 0.0 112.888 -175.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.26 -50.12 64.84 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.081 -1.012 . . . . 0.0 113.455 175.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -111.91 -15.28 13.37 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.917 0.887 . . . . 0.0 112.652 -168.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.86 36.27 91.93 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.395 0.998 . . . . 0.0 112.105 -172.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -103.67 150.0 24.43 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.529 1.932 . . . . 0.0 111.084 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 mp -95.41 135.47 29.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 124.774 1.23 . . . . 0.0 110.801 -173.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.05 163.5 38.0 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.679 1.592 . . . . 0.0 112.569 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.4 150.19 20.65 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.232 1.413 . . . . 0.0 111.695 172.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.8 t -143.25 165.1 28.39 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.616 1.167 . . . . 0.0 111.787 167.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -91.58 153.38 19.78 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.142 1.377 . . . . 0.0 112.639 172.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -107.39 144.06 34.83 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.397 1.079 . . . . 0.0 111.487 170.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.6 t -97.64 -44.19 6.89 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.699 0.999 . . . . 0.0 113.699 -170.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -153.83 159.13 41.72 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.402 1.081 . . . . 0.0 112.761 173.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.2 mt -90.21 153.02 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.268 1.427 . . . . 0.0 108.398 164.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -137.41 148.42 46.16 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.051 1.34 . . . . 0.0 112.614 -177.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 37.3 ptt85 -138.29 145.89 41.8 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.836 1.254 . . . . 0.0 114.105 174.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -152.63 168.35 25.89 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.942 2.097 . . . . 0.0 110.314 177.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -110.26 139.56 45.31 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.285 1.434 . . . . 0.0 112.602 -175.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.1 m -148.48 146.82 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 124.794 1.238 . . . . 0.0 112.133 -176.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -104.32 -25.32 12.91 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 126.188 1.795 . . . . 0.0 112.923 174.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -122.23 118.05 27.63 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.64 1.109 . . . . 0.0 111.021 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.9 tp -128.03 159.15 35.92 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.813 2.045 . . . . 0.0 108.388 -175.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.1 mt -113.37 129.58 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 119.727 1.149 . . . . 0.0 109.146 177.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -103.76 117.24 33.9 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.769 0.828 . . . . 0.0 110.978 170.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.2 mp -102.84 125.58 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 C-N-CA 125.399 1.479 . . . . 0.0 108.241 175.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.4 tttt -95.46 147.75 23.2 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.057 1.343 . . . . 0.0 110.67 171.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 54.3 mt -117.67 160.57 21.09 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.364 1.466 . . . . 0.0 112.149 -172.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.7 t -64.76 -16.86 63.58 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.571 1.148 . . . . 0.0 112.979 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.2 p -70.37 -11.16 60.72 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.974 1.71 . . . . 0.0 114.214 167.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.76 -4.17 84.95 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 126.193 1.854 . . . . 0.0 113.985 -174.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -88.72 165.76 14.52 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.236 1.814 . . . . 0.0 112.151 -175.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.9 p -131.2 152.78 50.14 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 174.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 61.8 tp -127.94 129.28 46.56 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.63 1.972 . . . . 0.0 109.394 178.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -114.09 113.31 24.56 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.262 1.425 . . . . 0.0 111.15 -177.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.9 m -141.72 155.39 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 125.634 1.574 . . . . 0.0 113.036 -170.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.4 p -64.25 147.18 97.22 Favored Pre-proline 0 N--CA 1.469 0.513 0 O-C-N 121.212 -0.93 . . . . 0.0 112.677 175.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -62.83 -29.81 77.01 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.864 2.376 . . . . 0.0 113.589 -170.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.8 p -72.04 -10.93 60.46 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.196 1.798 . . . . 0.0 114.768 174.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -78.38 119.19 76.41 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 119.524 1.056 . . . . 0.0 112.787 -164.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -68.74 137.85 39.66 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.847 2.365 . . . . 0.0 113.207 -177.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.9 t -120.25 140.81 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 126.388 1.875 . . . . 0.0 109.156 175.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 39.5 tp -81.83 110.43 17.13 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 122.848 0.459 . . . . 0.0 110.158 178.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.0 mp -105.12 150.53 24.96 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.972 1.709 . . . . 0.0 111.801 -175.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -108.74 102.06 11.14 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.641 0.776 . . . . 0.0 111.792 171.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 59.0 mtt-85 -139.61 80.52 1.78 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.312 1.045 . . . . 0.0 111.6 174.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.9 t0 64.5 1.05 1.21 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 127.728 2.411 . . . . 0.0 115.148 -167.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 179.32 165.63 33.83 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 124.764 1.173 . . . . 0.0 113.018 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 39.6 mt -72.43 117.58 14.27 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.174 0.99 . . . . 0.0 111.133 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -145.63 137.09 25.06 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.22 1.008 . . . . 0.0 112.609 -176.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -91.79 121.85 33.79 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.209 1.004 . . . . 0.0 110.902 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 71.3 t -134.0 130.27 20.4 Favored Pre-proline 0 N--CA 1.48 1.039 0 C-N-CA 125.472 1.509 . . . . 0.0 109.561 -175.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.05 151.53 77.43 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 122.815 2.343 . . . . 0.0 112.797 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.47 -31.91 16.57 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 174.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.09 -23.31 67.28 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 173.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -106.07 -5.01 19.77 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.027 1.731 . . . . 0.0 112.082 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 89.9 t -69.53 147.07 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.592 1.157 . . . . 0.0 110.26 166.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.53 154.13 80.64 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 127.78 2.432 . . . . 0.0 110.625 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.56 116.15 3.93 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.431 2.087 . . . . 0.0 111.043 -178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.65 0.37 24.6 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.677 1.132 . . . . 0.0 114.948 -177.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -60.21 157.04 14.08 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 119.682 1.741 . . . . 0.0 112.119 169.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.6 t -95.65 126.05 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.542 1.137 . . . . 0.0 110.574 168.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.1 t -101.08 142.51 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 126.92 2.088 . . . . 0.0 110.09 173.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.1 t -90.63 137.62 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.852 0.861 . . . . 0.0 111.111 175.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -166.48 -150.87 6.54 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.298 0.951 . . . . 0.0 113.533 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.0 p -152.81 172.86 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 127.25 2.22 . . . . 0.0 109.895 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -67.71 122.23 17.64 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.051 1.34 . . . . 0.0 112.7 174.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.29 -39.2 72.32 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.193 0.997 . . . . 0.0 112.948 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -62.24 -27.27 68.88 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 175.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 66.6 t -76.51 -30.69 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-N 119.026 0.83 . . . . 0.0 110.764 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -76.99 -31.41 56.47 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.768 1.227 . . . . 0.0 111.886 171.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 26.9 ttp-105 -82.42 -11.92 58.22 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.596 1.558 . . . . 0.0 114.226 177.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -53.26 150.47 6.16 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.06 1.744 . . . . 0.0 111.993 170.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 69.2 mtt85 -70.55 -32.81 70.4 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 118.657 0.662 . . . . 0.0 112.512 -178.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 10.5 tt -90.57 144.73 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.714 1.206 . . . . 0.0 112.465 176.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 46.6 pt -68.65 121.67 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 121.681 0.753 . . . . 0.0 110.444 172.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 58.2 m -120.07 151.07 39.57 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.903 1.281 . . . . 0.0 111.898 -166.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -136.24 169.64 17.32 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.399 1.48 . . . . 0.0 113.987 -167.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.71 13.31 83.14 Favored Glycine 0 CA--C 1.542 1.77 0 N-CA-C 117.492 1.757 . . . . 0.0 117.492 166.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -120.94 148.94 43.39 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 120.501 2.151 . . . . 0.0 113.011 -176.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 43.4 mt -147.31 154.42 40.92 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.584 1.554 . . . . 0.0 111.968 172.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -149.7 127.75 11.95 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.101 1.76 . . . . 0.0 110.836 177.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -88.14 148.6 24.35 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.309 -0.869 . . . . 0.0 111.54 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -130.2 133.39 46.53 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.925 1.29 . . . . 0.0 109.622 -170.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -90.82 140.77 29.49 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 119.812 1.187 . . . . 0.0 111.847 175.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 78.4 t -74.8 139.65 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.16 0.984 . . . . 0.0 111.271 175.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.1 t -94.58 -48.27 6.17 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.503 1.921 . . . . 0.0 112.29 175.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 13.1 t -156.61 161.63 39.91 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.352 1.061 . . . . 0.0 111.551 -177.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.6 m -139.52 149.38 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 125.365 1.466 . . . . 0.0 111.512 168.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -161.85 168.76 22.49 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 160.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 43.9 mt -93.09 128.06 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.006 1.322 . . . . 0.0 110.004 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 31.6 pt -120.78 154.8 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 127.159 2.184 . . . . 0.0 112.485 -174.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -100.48 75.51 1.78 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.182 1.393 . . . . 0.0 111.159 -168.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -66.97 -47.89 70.17 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.26 -0.9 . . . . 0.0 112.465 -169.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 49.5 41.5 21.23 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.09 1.756 . . . . 0.0 111.941 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -146.17 176.62 9.61 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.114 1.366 . . . . 0.0 111.34 -171.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -74.42 147.0 42.44 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.008 0.923 . . . . 0.0 112.067 170.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 6.8 m -127.98 150.17 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.087 1.755 . . . . 0.0 109.484 175.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -118.34 156.8 28.29 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.526 0.73 . . . . 0.0 112.74 -173.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -155.64 151.41 27.43 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.481 1.113 . . . . 0.0 109.485 -165.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 38.0 tp -128.68 128.34 43.91 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.067 0.947 . . . . 0.0 111.782 -173.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 59.6 t -98.99 118.95 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.537 0.684 . . . . 0.0 112.742 -166.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 16.2 mm -124.41 86.87 54.63 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 127.451 2.3 . . . . 0.0 108.754 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -64.3 -17.82 61.04 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.837 2.358 . . . . 0.0 114.192 175.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -72.18 -55.62 6.95 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.705 1.139 . . . . 0.0 112.6 -177.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 67.7 p -124.97 -10.18 7.16 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.238 1.415 . . . . 0.0 113.9 -172.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 53.43 29.25 8.57 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -171.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -156.94 147.47 21.41 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 120.024 -1.673 . . . . 0.0 113.562 175.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -150.38 161.15 43.05 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.403 1.081 . . . . 0.0 112.076 176.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.7 mp -101.03 136.56 32.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 123.911 0.885 . . . . 0.0 111.486 -176.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -82.55 159.21 64.56 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 125.745 1.618 . . . . 0.0 112.456 173.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.01 -16.65 40.88 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.91 2.407 . . . . 0.0 113.68 -177.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -79.68 -1.09 36.8 Favored 'General case' 0 CA--C 1.556 1.194 0 O-C-N 121.398 -0.814 . . . . 0.0 112.487 170.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 97.91 -14.52 62.72 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.999 1.761 . . . . 0.0 115.65 175.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 57.9 mt -74.19 145.47 44.16 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.831 1.252 . . . . 0.0 111.953 -177.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.4 p -91.09 137.5 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 118.796 0.725 . . . . 0.0 112.318 174.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 67.5 mt -116.45 155.63 28.24 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.177 2.191 . . . . 0.0 110.78 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -100.87 155.44 17.94 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.935 0.894 . . . . 0.0 111.075 177.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 25.6 t30 -80.51 86.72 5.77 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.051 -1.031 . . . . 0.0 109.336 161.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -152.41 104.7 2.95 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 117.323 -1.322 . . . . 0.0 111.92 153.398 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -132.29 163.9 27.61 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 127.557 2.343 . . . . 0.0 111.183 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.3 145.09 54.69 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.64 1.176 . . . . 0.0 113.587 177.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -61.26 -24.28 66.27 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.545 1.138 . . . . 0.0 113.292 173.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -86.33 4.68 38.12 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.697 1.599 . . . . 0.0 113.658 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.6 m -74.25 141.06 45.39 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.047 0.939 . . . . 0.0 111.915 171.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -81.34 155.75 25.83 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.03 0.932 . . . . 0.0 113.038 169.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.0 p -148.07 155.8 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.957 0.903 . . . . 0.0 111.724 -173.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.47 139.22 54.24 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.151 1.78 . . . . 0.0 108.016 175.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -152.03 -179.06 7.16 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.951 0.9 . . . . 0.0 111.236 167.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -135.23 142.14 45.93 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.211 1.404 . . . . 0.0 111.082 177.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -164.14 159.08 19.92 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 127.618 2.367 . . . . 0.0 107.359 174.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.7 t0 53.49 32.94 15.03 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 m 58.73 33.21 22.91 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.894 1.278 . . . . 0.0 113.399 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.6 p -154.39 140.57 12.77 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 125.133 1.373 . . . . 0.0 112.527 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -70.02 150.85 67.2 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 123.13 2.553 . . . . 0.0 113.489 176.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -130.31 133.12 46.23 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 127.903 2.481 . . . . 0.0 108.744 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 39.9 ttm -145.75 113.11 6.23 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.074 0.95 . . . . 0.0 112.298 -175.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -162.79 -177.07 5.3 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.515 1.526 . . . . 0.0 112.606 -174.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.9 m -69.96 137.81 51.78 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.289 -0.882 . . . . 0.0 110.531 170.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.6 tp -55.68 -36.5 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 121.378 -0.826 . . . . 0.0 113.1 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -60.8 -26.93 67.64 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.522 1.129 . . . . 0.0 112.596 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -81.49 -42.83 19.69 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.477 1.111 . . . . 0.0 111.191 178.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.6 ptm -68.65 -32.21 71.9 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.331 0.969 . . . . 0.0 111.591 174.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -57.67 -48.97 78.01 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.562 0.745 . . . . 0.0 110.632 171.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.6 t -62.79 -38.07 89.21 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.629 0.772 . . . . 0.0 111.829 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -64.32 -52.37 58.82 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.004 1.321 . . . . 0.0 110.585 177.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -71.08 -34.3 71.03 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.409 -0.807 . . . . 0.0 113.018 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.21 -35.32 80.7 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.788 0.835 . . . . 0.0 111.535 172.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 66.7 m -74.54 -29.34 61.33 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.115 0.966 . . . . 0.0 112.647 178.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 66.5 mtm -86.86 -47.31 9.14 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.068 1.347 . . . . 0.0 113.237 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -116.92 -13.76 10.66 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.835 1.254 . . . . 0.0 113.825 -165.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.46 163.72 39.56 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 124.4 1.0 . . . . 0.0 114.4 175.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -113.75 126.21 54.97 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.885 1.274 . . . . 0.0 110.452 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.6 mp -105.42 151.33 39.69 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 127.247 2.219 . . . . 0.0 110.54 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -76.91 155.91 34.44 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 123.558 2.839 . . . . 0.0 112.973 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.75 162.92 34.28 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.197 1.399 . . . . 0.0 110.519 163.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.36 -54.1 36.16 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 120.854 -1.154 . . . . 0.0 113.496 -176.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -96.96 -6.91 34.44 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 177.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -163.17 -140.5 2.89 Favored Glycine 0 CA--C 1.534 1.244 0 N-CA-C 116.602 1.401 . . . . 0.0 116.602 -172.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -149.0 157.13 43.18 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.752 1.621 . . . . 0.0 112.958 -171.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.83 148.75 41.07 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.434 1.094 . . . . 0.0 113.531 -176.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 51.4 t -129.18 121.72 20.75 Favored Pre-proline 0 N--CA 1.48 1.056 0 C-N-CA 126.085 1.754 . . . . 0.0 111.534 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -80.55 132.99 9.24 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 124.379 3.386 . . . . 0.0 113.227 -175.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 78.0 mt -97.77 165.76 11.8 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.042 1.337 . . . . 0.0 113.682 179.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -148.97 121.21 8.36 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.94 1.296 . . . . 0.0 111.079 176.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 46.14 52.77 9.97 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.782 1.633 . . . . 0.0 112.823 -173.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.7 t -112.46 128.43 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.44 1.096 . . . . 0.0 108.577 174.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -134.4 161.29 35.41 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -168.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.1 p -152.84 148.66 13.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 124.306 1.042 . . . . 0.0 112.18 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -64.41 133.45 52.58 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 122.348 1.07 . . . . 0.0 109.93 166.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.7 t -138.38 153.59 48.92 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.803 2.041 . . . . 0.0 110.49 -171.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.0 tp -113.95 145.02 42.11 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.322 -0.861 . . . . 0.0 111.537 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -96.8 118.02 32.34 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 124.485 1.114 . . . . 0.0 110.845 164.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mp -80.53 -20.65 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 124.135 0.974 . . . . 0.0 112.457 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.65 -36.93 85.12 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.206 1.003 . . . . 0.0 113.459 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.4 m -121.11 -16.97 7.89 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.565 1.146 . . . . 0.0 112.827 173.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.21 23.69 39.82 Favored Glycine 0 N--CA 1.475 1.293 0 C-N-CA 124.173 0.892 . . . . 0.0 113.667 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -100.02 137.75 38.04 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.862 1.665 . . . . 0.0 112.745 -169.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 mp -75.7 144.83 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 125.636 1.575 . . . . 0.0 111.866 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -155.6 176.19 12.92 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 127.093 2.157 . . . . 0.0 111.629 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -129.08 141.86 51.08 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 125.14 1.376 . . . . 0.0 111.151 175.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -139.83 168.98 18.57 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.398 1.079 . . . . 0.0 113.287 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -92.2 147.95 22.54 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.178 1.391 . . . . 0.0 112.563 173.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.88 138.31 37.13 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.245 1.018 . . . . 0.0 110.311 167.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.0 t -94.28 -48.69 6.06 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -167.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.17 156.03 40.11 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.657 1.183 . . . . 0.0 111.629 175.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.7 mt -89.94 145.05 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.43 1.092 . . . . 0.0 108.414 165.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -128.52 150.65 50.08 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.949 1.7 . . . . 0.0 111.004 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.3 ptt-85 -143.63 151.35 40.02 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.201 1.0 . . . . 0.0 113.578 168.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -147.45 167.89 23.26 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.928 1.691 . . . . 0.0 110.938 175.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.54 146.89 23.8 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.621 0.768 . . . . 0.0 112.131 173.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.8 m -149.15 147.97 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 125.784 1.634 . . . . 0.0 111.522 171.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -100.31 -29.06 12.64 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.788 1.635 . . . . 0.0 112.36 175.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -122.23 128.76 51.54 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.513 1.125 . . . . 0.0 110.582 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 12.2 tp -135.45 160.86 37.13 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.841 1.657 . . . . 0.0 109.503 -174.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.7 mt -109.04 126.65 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 119.836 1.198 . . . . 0.0 109.653 175.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -102.46 119.93 39.66 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.775 1.23 . . . . 0.0 110.792 169.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -105.65 125.01 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.063 1.345 . . . . 0.0 108.478 173.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.6 tttt -92.33 146.54 23.61 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.675 1.19 . . . . 0.0 110.623 172.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 78.5 mt -106.57 160.48 15.4 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.769 1.627 . . . . 0.0 111.475 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.5 t -67.78 -11.42 58.43 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.626 1.17 . . . . 0.0 112.591 -176.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.6 p -81.44 -8.78 59.78 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 128.63 2.772 . . . . 0.0 114.947 168.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.65 -7.9 80.65 Favored Glycine 0 CA--C 1.54 1.632 0 C-N-CA 125.752 1.644 . . . . 0.0 115.362 -173.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -74.04 162.67 28.78 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.544 1.538 . . . . 0.0 111.201 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 86.3 p -140.41 146.02 37.79 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 66.8 tp -121.96 132.51 54.57 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.485 1.914 . . . . 0.0 110.068 176.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -117.03 116.5 27.47 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.871 1.668 . . . . 0.0 111.522 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.5 m -141.61 153.08 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.327 1.451 . . . . 0.0 113.082 -169.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.7 p -68.08 148.97 98.33 Favored Pre-proline 0 N--CA 1.466 0.372 0 O-C-N 121.258 -0.901 . . . . 0.0 111.66 171.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.22 -28.32 83.74 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.409 2.739 . . . . 0.0 114.346 -166.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.8 m -85.21 -4.96 59.34 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.39 1.255 . . . . 0.0 114.39 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 63.8 t60 -65.92 118.53 52.93 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 119.909 1.231 . . . . 0.0 111.918 -176.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -76.36 132.63 13.83 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.758 2.305 . . . . 0.0 113.441 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.3 t -111.33 143.82 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 126.111 1.765 . . . . 0.0 109.798 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 25.6 tp -81.31 102.0 10.14 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.014 0.526 . . . . 0.0 110.78 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.1 mp -98.96 153.64 18.68 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.971 1.709 . . . . 0.0 111.434 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -108.7 107.94 18.59 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.413 0.625 . . . . 0.0 112.593 176.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.414 ' C ' ' H ' ' A' ' 101' ' ' GLY . 36.4 mtp-105 -136.24 80.05 1.8 Allowed 'General case' 0 N--CA 1.479 1.004 0 O-C-N 120.861 -1.149 . . . . 0.0 110.211 -178.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 53.43 -3.25 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 127.657 2.383 . . . . 0.0 115.584 -156.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 99' ' ' ARG . . . -171.81 171.27 44.02 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 125.591 1.567 . . . . 0.0 113.206 -178.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 82.1 mt -76.3 115.16 15.77 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.45 1.9 . . . . 0.0 111.007 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -146.83 147.93 31.36 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -99.4 117.06 32.97 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.183 1.393 . . . . 0.0 111.375 -173.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.4 t -124.49 128.45 24.97 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 123.862 0.865 . . . . 0.0 109.908 -176.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -64.56 147.34 90.22 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.575 2.184 . . . . 0.0 111.419 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.26 -30.78 18.8 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 175.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.54 -21.36 66.16 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 173.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -105.06 4.02 31.09 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.84 2.056 . . . . 0.0 112.436 175.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.6 t -84.12 143.84 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.166 1.386 . . . . 0.0 111.099 169.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.34 155.17 81.07 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 126.995 2.118 . . . . 0.0 111.33 -177.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.52 118.45 5.6 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.006 2.47 . . . . 0.0 111.681 -175.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.74 5.88 35.63 Favored Glycine 0 CA--C 1.538 1.516 0 CA-C-O 119.12 -0.822 . . . . 0.0 115.139 -176.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -61.43 166.11 4.24 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.251 1.421 . . . . 0.0 112.474 166.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.3 p -116.79 131.69 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 125.84 1.656 . . . . 0.0 111.546 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.5 t -117.22 140.67 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 126.147 1.779 . . . . 0.0 110.632 -172.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.1 t -89.03 134.42 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 123.818 0.847 . . . . 0.0 110.943 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -160.05 -151.52 6.2 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 121.674 -0.641 . . . . 0.0 113.66 174.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.3 p -139.52 159.87 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 127.051 2.14 . . . . 0.0 108.981 173.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -64.92 113.29 3.75 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.84 0.856 . . . . 0.0 109.833 173.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . 0.256 0.0 OUTLIER -66.56 -14.49 62.42 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -170.399 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -54.03 -35.24 61.74 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.037 -1.039 . . . . 0.0 112.442 165.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -75.22 -24.95 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 123.582 0.753 . . . . 0.0 112.201 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 59.7 mt -84.87 -21.3 29.82 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.441 1.496 . . . . 0.0 111.779 172.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -90.27 -1.56 57.94 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 126.484 1.914 . . . . 0.0 114.652 174.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 91.0 mtt-85 -67.47 160.01 28.4 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 126.013 1.725 . . . . 0.0 112.454 168.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 64.1 ttp85 -72.87 -36.71 67.44 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.623 0.769 . . . . 0.0 111.47 166.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 46.0 mm -101.98 94.68 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.175 1.39 . . . . 0.0 108.474 167.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.4 pt -71.32 95.07 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 122.275 1.036 . . . . 0.0 110.347 -173.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 55.2 m -86.61 62.46 7.42 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 120.814 -1.178 . . . . 0.0 112.406 -161.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.32 167.43 18.08 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.94 1.696 . . . . 0.0 114.514 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 117.38 4.18 16.03 Favored Glycine 0 CA--C 1.54 1.605 0 C-N-CA 125.336 1.446 . . . . 0.0 114.971 -174.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -129.89 165.56 21.81 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.387 2.275 . . . . 0.0 110.969 176.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 96.0 mt -139.32 163.14 33.28 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.923 1.289 . . . . 0.0 112.84 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -153.66 154.26 33.82 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.824 1.65 . . . . 0.0 112.658 172.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -78.15 153.39 32.11 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 120.961 -1.087 . . . . 0.0 113.848 178.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 43.9 m80 -131.27 158.21 41.21 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.992 1.717 . . . . 0.0 108.385 166.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -120.29 142.24 49.27 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 121.259 -0.901 . . . . 0.0 111.464 -173.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 99.3 t -76.36 132.96 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 121.767 -0.583 . . . . 0.0 110.885 172.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.6 t -91.3 -46.07 8.25 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.89 2.076 . . . . 0.0 111.725 172.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.4 t -158.36 169.54 24.24 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.04 -1.038 . . . . 0.0 111.284 175.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.5 m -133.68 148.95 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.086 1.354 . . . . 0.0 110.745 167.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -154.27 154.82 34.07 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.681 0.792 . . . . 0.0 112.686 167.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 96.9 mt -84.16 130.7 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 166.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 16.3 pt -123.95 158.6 30.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 126.362 1.865 . . . . 0.0 112.299 -174.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -94.46 94.5 8.27 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.127 1.371 . . . . 0.0 112.246 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -83.4 -56.29 3.83 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.459 -0.776 . . . . 0.0 112.771 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 51.82 36.83 18.97 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.081 0.953 . . . . 0.0 112.449 -177.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -150.98 172.97 14.87 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.142 1.377 . . . . 0.0 110.837 -172.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -75.04 138.83 42.44 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.997 0.903 . . . . 0.0 112.962 -176.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 15.5 m -120.25 153.97 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 126.046 1.738 . . . . 0.0 109.57 177.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -114.05 160.79 18.5 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.081 0.952 . . . . 0.0 112.568 -175.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -142.63 148.63 37.75 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.612 -0.68 . . . . 0.0 109.856 157.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 55.1 tp -108.5 119.58 39.92 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.684 1.193 . . . . 0.0 109.965 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 50.7 t -88.35 120.25 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -166.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 27.9 mm -118.66 86.93 30.76 Favored Pre-proline 0 N--CA 1.471 0.592 0 C-N-CA 125.833 1.653 . . . . 0.0 109.375 -177.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -70.9 -9.75 26.32 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.271 2.647 . . . . 0.0 113.995 -174.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -81.32 -60.57 2.23 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 118.898 0.772 . . . . 0.0 112.203 175.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 73.7 p -118.61 -10.67 10.0 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -171.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 66.6 m80 53.33 27.36 6.14 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.306 1.442 . . . . 0.0 114.692 -172.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.6 149.96 30.55 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 120.629 -1.294 . . . . 0.0 113.237 178.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -153.01 162.8 40.89 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.358 1.463 . . . . 0.0 111.415 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.8 mp -103.66 137.99 29.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 124.053 0.941 . . . . 0.0 110.945 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.76 156.82 64.51 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 123.944 0.898 . . . . 0.0 111.839 173.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -64.78 -23.76 62.41 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.553 2.169 . . . . 0.0 112.641 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -79.41 3.91 17.0 Favored 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 124.931 1.292 . . . . 0.0 112.711 174.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 105.96 -21.6 33.5 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.645 1.593 . . . . 0.0 116.612 164.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 64.4 mt -77.7 149.33 34.63 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.832 1.816 . . . . 0.0 113.818 -171.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 4.6 t -89.41 123.81 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.175 0.99 . . . . 0.0 110.646 174.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 54.6 mt -116.08 148.48 40.21 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.56 1.944 . . . . 0.0 111.629 -174.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -96.62 136.79 36.64 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.756 0.823 . . . . 0.0 110.873 170.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -71.15 106.67 3.85 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 162.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -79.56 -11.1 59.89 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -163.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 116.671 -1.633 . . . . 0.0 112.967 -163.453 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.686 0 CA-C-O 121.063 0.459 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -140.01 164.78 29.11 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.369 1.468 . . . . 0.0 112.303 -178.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.3 151.3 47.73 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -172.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.65 -22.03 43.36 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 177.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -73.9 -21.63 60.0 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.392 1.477 . . . . 0.0 113.639 177.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.4 m -64.68 126.41 27.81 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.091 0.957 . . . . 0.0 112.017 -166.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -74.14 150.48 40.44 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 174.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.2 p -148.33 153.19 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.114 0.966 . . . . 0.0 111.683 -170.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -126.49 120.77 30.53 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.85 1.66 . . . . 0.0 108.79 -173.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -150.2 168.12 24.92 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -176.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -134.17 144.21 48.37 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.807 1.243 . . . . 0.0 111.041 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -160.92 136.56 8.01 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.175 0.99 . . . . 0.0 111.172 176.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.7 t70 54.53 47.62 22.31 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.1 1.36 . . . . 0.0 113.541 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.9 m 60.47 38.88 18.92 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 127.538 2.335 . . . . 0.0 114.127 176.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.4 p -154.12 140.18 12.57 Favored Pre-proline 0 CA--C 1.547 0.858 0 O-C-N 121.098 -1.001 . . . . 0.0 112.025 173.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -83.31 151.69 13.71 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 124.818 3.679 . . . . 0.0 113.625 175.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -133.91 145.5 49.66 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.472 2.309 . . . . 0.0 111.514 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 43.4 ttm -147.67 95.95 2.59 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.823 0.849 . . . . 0.0 111.503 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -148.64 -178.71 6.49 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.647 1.579 . . . . 0.0 111.952 -171.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.3 m -71.23 148.48 47.19 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 120.74 -1.225 . . . . 0.0 110.238 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.4 tp -57.17 -35.48 48.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 O-C-N 121.368 -0.832 . . . . 0.0 112.418 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -65.68 -29.76 70.36 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.577 1.08 . . . . 0.0 112.792 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -74.86 -42.83 57.15 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.316 1.046 . . . . 0.0 110.037 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -71.93 -40.2 68.92 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.56 -0.713 . . . . 0.0 111.666 176.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -54.27 -48.57 71.05 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.745 0.818 . . . . 0.0 110.939 175.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.0 t -66.59 -32.04 73.12 Favored 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -174.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.2 ttpt -65.53 -50.73 64.16 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.192 0.997 . . . . 0.0 110.131 177.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -70.38 -33.98 72.05 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.607 -0.683 . . . . 0.0 112.287 177.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.52 -22.46 63.58 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.226 -0.921 . . . . 0.0 113.198 173.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.7 m -92.88 -14.96 26.96 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.332 1.453 . . . . 0.0 113.475 176.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 72.6 mtm -97.06 -57.91 2.15 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.068 1.747 . . . . 0.0 112.005 174.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -94.27 -27.49 16.11 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.638 1.575 . . . . 0.0 111.985 -170.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.95 158.85 13.37 Favored Glycine 0 C--N 1.341 0.837 0 C-N-CA 125.248 1.404 . . . . 0.0 114.07 -177.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -104.91 150.49 24.83 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.683 1.193 . . . . 0.0 111.851 -170.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.2 mp -121.97 145.02 42.57 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 127.026 2.13 . . . . 0.0 111.569 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.32 156.35 37.19 Favored 'Trans proline' 0 C--O 1.24 0.616 0 C-N-CA 124.718 3.612 . . . . 0.0 112.848 -176.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -145.85 165.85 27.69 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -177.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -47.56 -53.81 13.48 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.5 1.92 . . . . 0.0 114.054 177.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -106.55 0.71 24.78 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 115.051 1.501 . . . . 0.0 115.051 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 177.78 -122.49 0.83 Allowed Glycine 0 CA--C 1.53 1.019 0 N-CA-C 115.966 1.146 . . . . 0.0 115.966 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -145.36 159.84 42.44 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.025 1.73 . . . . 0.0 111.28 -177.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.68 154.27 48.6 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.076 1.351 . . . . 0.0 111.998 -178.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 67.9 t -127.87 118.12 20.94 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 125.133 1.373 . . . . 0.0 110.44 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.49 138.55 42.5 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.986 3.124 . . . . 0.0 111.34 177.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 87.4 mt -111.49 157.84 19.84 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.673 1.189 . . . . 0.0 112.559 175.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -142.0 129.57 21.44 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.993 1.317 . . . . 0.0 111.023 169.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 59.97 33.03 21.38 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 126.692 1.997 . . . . 0.0 114.673 -177.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.1 t -100.19 137.74 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 O-C-N 120.359 -1.463 . . . . 0.0 111.309 176.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -132.99 154.53 50.42 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.328 1.851 . . . . 0.0 112.851 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.8 m -141.06 162.6 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 126.714 2.006 . . . . 0.0 110.84 174.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -89.36 145.86 25.07 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.328 -0.858 . . . . 0.0 111.847 172.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.5 t -148.47 152.16 36.44 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.259 1.824 . . . . 0.0 111.311 -167.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 48.3 tp -102.22 138.63 38.91 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.773 1.229 . . . . 0.0 109.963 173.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -87.92 130.69 34.85 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.794 0.837 . . . . 0.0 111.347 161.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 43.8 mm -77.21 -25.46 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 120.941 -1.099 . . . . 0.0 112.546 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.99 -42.68 31.94 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -169.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.4 m -112.99 -9.5 13.59 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.928 1.291 . . . . 0.0 112.861 174.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.05 28.71 66.01 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 123.659 0.647 . . . . 0.0 113.987 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -89.51 136.52 32.98 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.999 1.319 . . . . 0.0 110.685 -177.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 mp -88.54 126.85 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 174.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -147.92 169.74 19.19 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.612 1.165 . . . . 0.0 112.661 -173.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.5 ttmt -92.7 149.35 21.37 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.42 1.488 . . . . 0.0 110.438 174.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.1 t -146.21 158.93 43.91 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.199 1.0 . . . . 0.0 111.171 171.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.73 159.91 22.46 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 121.27 -0.894 . . . . 0.0 112.83 177.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.28 135.56 54.96 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.285 0.634 . . . . 0.0 111.38 168.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.8 t -88.78 -46.28 9.1 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.565 1.146 . . . . 0.0 112.676 -167.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -155.25 157.31 37.09 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.494 1.518 . . . . 0.0 111.398 174.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.4 mt -88.81 151.41 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.772 1.229 . . . . 0.0 108.53 167.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -140.27 149.82 43.31 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.857 1.263 . . . . 0.0 112.426 -175.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.9 ptp85 -132.39 155.73 47.94 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.696 1.198 . . . . 0.0 112.714 171.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -150.29 163.26 38.77 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.803 1.241 . . . . 0.0 110.338 167.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -96.94 145.21 26.12 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.351 1.06 . . . . 0.0 110.973 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.4 m -150.13 141.08 16.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 124.862 1.265 . . . . 0.0 110.297 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -83.1 -34.41 26.13 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.955 1.302 . . . . 0.0 110.921 171.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -131.93 132.35 43.48 Favored 'General case' 0 C--N 1.345 0.393 0 C-N-CA 123.942 0.897 . . . . 0.0 112.33 -169.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.5 tp -131.88 164.95 24.95 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.311 1.844 . . . . 0.0 109.678 -173.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.1 mt -112.16 123.83 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 119.587 1.085 . . . . 0.0 109.167 175.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -96.08 123.32 39.65 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.416 0.686 . . . . 0.0 111.489 166.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -108.77 123.18 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.083 1.353 . . . . 0.0 108.621 170.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.1 tttt -92.86 147.87 22.49 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.664 1.586 . . . . 0.0 109.952 173.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 87.8 mt -118.91 158.32 25.93 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.615 1.566 . . . . 0.0 112.337 -175.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.7 t -66.93 -10.41 48.69 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.694 1.198 . . . . 0.0 113.264 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 88.6 p -77.62 0.59 22.6 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 127.625 2.37 . . . . 0.0 114.899 165.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.58 -3.1 56.28 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 125.126 1.346 . . . . 0.0 114.522 -173.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -76.81 163.95 26.3 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.041 1.736 . . . . 0.0 111.957 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 60.4 p -142.2 144.67 33.5 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 165.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.8 tp -118.29 131.55 56.34 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.449 1.899 . . . . 0.0 110.02 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -111.23 114.93 28.49 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.385 1.474 . . . . 0.0 111.515 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.2 m -138.01 153.83 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 126.337 1.855 . . . . 0.0 112.215 -171.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.2 p -67.27 150.48 97.87 Favored Pre-proline 0 N--CA 1.471 0.618 0 O-C-N 120.906 -1.121 . . . . 0.0 112.354 171.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -60.21 -31.38 93.0 Favored 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 123.103 2.535 . . . . 0.0 114.32 -168.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.2 m -84.07 -0.96 53.9 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 49.5 t60 -73.85 117.11 58.43 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.927 1.291 . . . . 0.0 111.177 -175.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -68.35 132.06 24.81 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.04 2.494 . . . . 0.0 112.892 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.0 t -110.74 137.0 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 126.078 1.751 . . . . 0.0 109.422 174.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.13 112.39 19.77 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.7 mp -105.58 149.68 26.06 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.802 1.641 . . . . 0.0 112.212 -175.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -101.99 112.01 24.5 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.033 0.933 . . . . 0.0 112.454 172.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -143.49 80.43 1.67 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.645 1.178 . . . . 0.0 111.024 170.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 59.74 -15.16 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 128.203 2.601 . . . . 0.0 116.759 -164.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -162.67 168.06 37.39 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 126.026 1.775 . . . . 0.0 113.89 177.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.5 mt -72.01 116.11 12.03 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.104 1.762 . . . . 0.0 110.98 -176.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -144.87 139.79 27.92 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.65 0.78 . . . . 0.0 112.786 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -96.53 123.64 40.26 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.251 1.02 . . . . 0.0 112.052 -177.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 57.3 t -128.2 129.84 23.62 Favored Pre-proline 0 N--CA 1.48 1.044 0 C-N-CA 124.928 1.291 . . . . 0.0 109.738 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -64.68 148.37 90.24 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.856 2.371 . . . . 0.0 112.057 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.67 -32.14 18.35 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.28 -25.48 67.88 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 173.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -107.85 -1.34 20.89 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.777 1.631 . . . . 0.0 113.158 178.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 74.9 t -70.1 144.17 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 124.368 1.067 . . . . 0.0 109.655 166.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.86 156.95 77.01 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 127.098 2.159 . . . . 0.0 110.324 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -65.48 125.3 14.18 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.74 1.627 . . . . 0.0 110.776 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 103.22 0.42 47.57 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.649 1.119 . . . . 0.0 114.931 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -57.95 153.73 13.75 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.176 0.991 . . . . 0.0 111.309 167.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.4 t -97.64 122.2 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.062 0.945 . . . . 0.0 109.957 172.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.2 t -94.12 141.48 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 126.68 1.992 . . . . 0.0 110.016 173.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 59.4 t -92.62 131.59 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.959 0.904 . . . . 0.0 110.399 172.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -155.08 -150.86 5.67 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.028 1.299 . . . . 0.0 111.644 176.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.8 p -143.8 169.28 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.227 1.411 . . . . 0.0 111.118 177.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 -69.48 122.6 19.33 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 127.332 2.253 . . . . 0.0 110.153 177.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -57.82 -37.16 73.31 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.712 0.687 . . . . 0.0 112.326 178.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -55.08 -47.26 75.13 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.066 0.848 . . . . 0.0 113.045 -175.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.6 p -75.8 -16.1 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.393 1.077 . . . . 0.0 112.821 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 17.0 tp -88.58 -32.65 18.01 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.55 1.14 . . . . 0.0 112.331 174.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 94.7 mtt-85 -98.57 -38.21 9.24 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -171.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.4 ttp85 -158.2 -33.35 0.07 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 116.882 2.178 . . . . 0.0 116.882 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 16.2 tpt85 -67.58 160.36 27.94 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 125.821 1.648 . . . . 0.0 112.711 -172.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 40.3 mm -39.26 121.19 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 126.067 1.747 . . . . 0.0 112.032 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.7 tp -63.88 131.18 29.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 122.263 1.03 . . . . 0.0 112.721 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 34.6 t -146.11 135.0 22.49 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.084 1.354 . . . . 0.0 109.784 170.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -96.78 159.96 14.63 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.645 1.978 . . . . 0.0 114.857 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 77.47 20.21 74.98 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 114.096 -1.411 . . . . 0.0 115.266 160.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -120.97 155.4 34.38 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.336 1.854 . . . . 0.0 111.796 174.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 97.0 mt -136.9 157.47 46.66 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.689 1.596 . . . . 0.0 112.062 -172.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -132.66 132.78 42.79 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.372 1.469 . . . . 0.0 112.007 174.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -87.49 143.61 27.13 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.593 1.157 . . . . 0.0 112.518 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -131.11 136.57 48.5 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.739 1.616 . . . . 0.0 110.115 -174.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -85.36 137.12 33.15 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.97 -1.081 . . . . 0.0 112.828 176.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 97.6 t -69.93 122.51 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.101 0.961 . . . . 0.0 111.372 163.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.4 t -81.77 -53.04 6.53 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.791 1.636 . . . . 0.0 112.329 176.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.5 m -154.92 156.3 35.84 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.346 1.058 . . . . 0.0 111.921 177.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.4 m -128.63 148.13 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.043 0.937 . . . . 0.0 111.33 176.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -157.93 156.13 30.76 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.849 0.86 . . . . 0.0 112.015 169.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 74.6 mt -80.58 145.43 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 160.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 44.8 pt -131.25 153.49 39.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 126.515 1.926 . . . . 0.0 110.076 177.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -88.29 108.02 19.11 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 122.581 1.182 . . . . 0.0 109.904 169.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -83.35 -50.48 8.31 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.363 1.865 . . . . 0.0 112.355 174.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 42.23 51.5 4.54 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.847 1.659 . . . . 0.0 111.76 -172.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -155.84 177.28 11.58 Favored 'General case' 0 CA--C 1.552 1.037 0 O-C-N 121.257 -0.902 . . . . 0.0 113.099 -175.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -77.65 134.95 38.06 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.182 1.393 . . . . 0.0 112.928 174.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 5.9 m -114.29 153.63 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.34 1.456 . . . . 0.0 109.664 175.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -119.81 159.62 24.21 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -171.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -155.04 157.59 37.81 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 113.614 -1.63 . . . . 0.0 110.289 -172.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 41.5 tp -134.82 119.07 17.69 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.92 0.888 . . . . 0.0 109.391 -175.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 51.9 t -86.93 118.03 32.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.154 0.502 . . . . 0.0 111.749 -165.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 29.7 mm -115.29 94.09 38.1 Favored Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 124.944 1.297 . . . . 0.0 109.194 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.4 -12.47 33.66 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.732 2.288 . . . . 0.0 113.339 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -79.45 -64.04 1.28 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 119.039 0.836 . . . . 0.0 112.586 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 76.0 p -114.48 -13.7 12.19 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.174 1.39 . . . . 0.0 114.459 -173.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 63.05 15.01 8.1 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -169.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -150.79 151.93 33.05 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 120.21 1.368 . . . . 0.0 113.257 -175.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -152.55 179.67 8.38 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.788 1.235 . . . . 0.0 112.241 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 85.1 mt -123.62 138.88 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.689 1.196 . . . . 0.0 111.473 -170.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -93.32 154.6 41.4 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.931 1.292 . . . . 0.0 112.302 173.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -66.76 -16.21 49.58 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.789 2.992 . . . . 0.0 114.054 -174.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -72.42 -3.55 24.86 Favored 'General case' 0 CA--C 1.556 1.179 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 170.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.9 -8.92 68.18 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.555 1.55 . . . . 0.0 114.919 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 66.9 mt -79.55 144.66 33.7 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.886 1.274 . . . . 0.0 111.99 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.2 p -89.86 139.07 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.135 0.974 . . . . 0.0 111.035 173.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 74.1 mt -118.19 152.21 36.11 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.855 2.062 . . . . 0.0 111.114 178.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -120.33 148.56 43.58 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.89 0.876 . . . . 0.0 112.93 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -120.24 -34.97 3.54 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.112 0.965 . . . . 0.0 113.47 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 54.98 22.79 4.59 Favored 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 -175.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . 0.253 45.2 tt0 . . . . . 0 C--O 1.253 1.257 0 C-N-CA 126.59 1.956 . . . . 0.0 113.393 -170.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.93 0 N-CA-C 110.763 -0.088 . . . . 0.0 110.763 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.03 162.57 33.78 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.775 1.23 . . . . 0.0 112.615 -173.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -55.91 145.3 25.37 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.946 1.699 . . . . 0.0 113.317 176.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.0 ppt_? -63.75 -22.71 67.04 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 172.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -83.19 3.66 30.03 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.6 m -69.75 150.97 46.35 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.797 1.239 . . . . 0.0 112.883 170.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -101.52 155.35 18.13 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.16 1.784 . . . . 0.0 113.169 174.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 p -148.15 158.35 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.511 0.724 . . . . 0.0 112.484 -168.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -127.34 126.36 42.4 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.387 1.875 . . . . 0.0 108.698 -174.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -153.32 173.41 15.64 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -128.15 144.43 51.12 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.588 1.155 . . . . 0.0 111.378 168.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -165.19 154.01 12.19 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.62 1.568 . . . . 0.0 110.052 174.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.9 t70 48.98 44.38 22.5 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.83 1.252 . . . . 0.0 114.181 -175.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.9 m 58.06 37.32 26.51 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.544 1.538 . . . . 0.0 114.023 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.2 p -157.7 142.47 11.96 Favored Pre-proline 0 CA--C 1.551 0.992 0 O-C-N 120.562 -1.336 . . . . 0.0 112.964 176.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.24 152.31 39.53 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 124.567 3.511 . . . . 0.0 113.516 174.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -136.62 142.63 43.28 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.742 2.017 . . . . 0.0 111.371 -175.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 52.2 ttm -147.35 86.39 1.62 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.208 1.003 . . . . 0.0 110.979 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -137.46 -179.2 5.59 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.532 1.533 . . . . 0.0 112.491 -174.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.9 m -73.17 140.91 47.33 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 120.759 -1.213 . . . . 0.0 110.637 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.405 HG12 ' CD2' ' A' ' 152' ' ' TYR . 9.3 tp -58.0 -36.12 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 O-C-N 121.303 -0.873 . . . . 0.0 112.958 -178.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.01 -24.77 68.07 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.758 -0.589 . . . . 0.0 112.455 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -79.09 -49.25 12.93 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.028 0.931 . . . . 0.0 109.916 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 20.7 ptm -65.85 -33.0 74.84 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.606 -0.684 . . . . 0.0 112.114 175.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -54.88 -49.87 70.12 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.295 0.952 . . . . 0.0 111.207 172.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 39.9 t -61.29 -39.48 90.59 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.348 1.059 . . . . 0.0 111.486 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -65.32 -53.46 43.43 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.319 1.447 . . . . 0.0 110.932 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -72.84 -31.5 64.81 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.249 -0.907 . . . . 0.0 112.473 -177.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.43 -32.26 73.52 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.129 -0.982 . . . . 0.0 111.907 170.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 60.4 m -79.2 -26.03 42.63 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.664 0.786 . . . . 0.0 112.864 178.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 61.2 mtm -91.53 -46.61 7.87 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.24 1.416 . . . . 0.0 113.264 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -112.22 -13.91 13.43 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.034 1.334 . . . . 0.0 113.572 -169.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.9 163.75 35.94 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.849 1.214 . . . . 0.0 114.573 178.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -111.38 134.85 52.67 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.189 1.395 . . . . 0.0 110.014 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.5 mp -116.75 148.46 42.07 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 126.14 1.776 . . . . 0.0 111.617 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -70.65 143.44 46.55 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.38 2.72 . . . . 0.0 111.349 175.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -130.07 169.53 15.18 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.876 1.67 . . . . 0.0 111.149 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.91 -52.8 62.83 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 120.975 -1.078 . . . . 0.0 113.538 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -99.86 -8.86 23.56 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.98 -134.25 1.76 Allowed Glycine 0 CA--C 1.53 0.994 0 CA-C-N 119.137 0.88 . . . . 0.0 114.235 -172.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -135.27 151.3 50.45 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.14 1.776 . . . . 0.0 112.066 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.25 142.59 39.89 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.4 1.08 . . . . 0.0 112.784 -174.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.9 t -116.38 111.62 41.99 Favored Pre-proline 0 N--CA 1.474 0.74 0 C-N-CA 126.653 1.981 . . . . 0.0 109.638 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -65.17 139.69 61.72 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.867 3.044 . . . . 0.0 110.931 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.0 mt -110.06 165.13 11.98 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.601 1.16 . . . . 0.0 111.941 176.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -144.16 127.0 16.28 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.75 1.62 . . . . 0.0 110.123 169.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 50.5 46.81 25.01 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.387 1.075 . . . . 0.0 113.306 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.8 t -111.4 116.92 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.18 0.992 . . . . 0.0 108.797 173.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -113.63 151.8 31.24 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -167.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.6 m -135.82 154.13 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.494 1.518 . . . . 0.0 111.565 174.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -66.74 133.25 49.78 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 161.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.0 t -135.52 145.28 46.9 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.737 1.615 . . . . 0.0 110.54 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.4 tp -99.87 136.51 39.68 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.792 0.837 . . . . 0.0 110.351 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -85.46 91.43 8.22 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.755 1.222 . . . . 0.0 109.422 171.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.7 mm -58.97 -25.22 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 119.372 0.987 . . . . 0.0 112.282 -171.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.69 -45.92 87.86 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.63 1.172 . . . . 0.0 114.108 175.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 m -107.67 -22.75 12.38 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.632 1.173 . . . . 0.0 112.61 -173.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.44 25.16 66.26 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.642 1.592 . . . . 0.0 113.281 -169.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -90.49 141.39 28.8 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.177 1.391 . . . . 0.0 112.061 -175.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.2 mp -90.83 122.41 42.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 125.042 1.337 . . . . 0.0 110.681 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -146.91 179.23 7.74 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.773 1.629 . . . . 0.0 112.093 -177.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -110.89 152.27 26.91 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.886 1.674 . . . . 0.0 111.358 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.3 t -147.65 162.08 39.87 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.61 -0.681 . . . . 0.0 110.852 165.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -94.41 142.78 27.03 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.091 0.957 . . . . 0.0 112.335 173.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.41 143.8 26.77 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.555 0.742 . . . . 0.0 111.311 174.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 84.4 p -84.5 -48.34 9.69 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.437 1.095 . . . . 0.0 112.454 -172.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -151.86 159.95 43.69 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.306 1.842 . . . . 0.0 112.191 173.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.5 mt -86.73 146.98 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 160.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -132.9 148.11 52.29 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 125.246 1.418 . . . . 0.0 110.927 -175.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -146.13 150.23 35.51 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 165.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -146.99 165.97 28.23 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.183 1.793 . . . . 0.0 110.878 173.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.45 146.78 23.84 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.194 -0.941 . . . . 0.0 112.8 -177.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.1 m -147.53 151.36 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.366 1.066 . . . . 0.0 112.299 173.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -113.36 -5.37 13.56 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.988 2.115 . . . . 0.0 113.184 177.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -138.43 119.21 14.14 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.792 1.637 . . . . 0.0 109.992 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.6 tp -133.24 159.35 40.46 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.812 1.645 . . . . 0.0 109.601 -175.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 13.5 mt -110.48 127.72 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 119.245 0.93 . . . . 0.0 109.492 176.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -98.68 127.63 44.67 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.406 1.082 . . . . 0.0 111.048 167.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.8 mp -112.9 126.07 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.152 1.381 . . . . 0.0 109.77 172.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -91.68 143.41 26.58 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.662 1.585 . . . . 0.0 110.48 171.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 83.9 mt -113.32 156.45 23.36 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.091 1.357 . . . . 0.0 112.113 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.1 t -59.55 -26.4 65.34 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.251 1.42 . . . . 0.0 112.005 174.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 94.2 p -64.57 -16.72 63.11 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.207 1.403 . . . . 0.0 114.477 171.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.33 4.04 74.55 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 125.919 1.723 . . . . 0.0 114.505 -174.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -85.22 158.73 20.27 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.889 1.675 . . . . 0.0 110.729 172.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 84.5 p -137.66 142.64 41.13 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 165.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.8 tp -121.48 140.62 51.94 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.73 2.012 . . . . 0.0 110.09 -172.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -121.16 116.56 25.19 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.189 1.396 . . . . 0.0 112.165 -174.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.1 m -139.81 154.78 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.286 1.434 . . . . 0.0 112.899 -167.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.1 p -65.79 148.1 98.41 Favored Pre-proline 0 N--CA 1.471 0.598 0 O-C-N 120.912 -1.117 . . . . 0.0 111.572 173.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.08 -29.47 87.16 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.166 2.578 . . . . 0.0 113.535 -173.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 32.9 p -84.62 0.2 51.03 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.178 2.191 . . . . 0.0 114.875 177.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -73.95 116.47 52.49 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 119.89 1.223 . . . . 0.0 112.023 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -77.9 127.13 8.41 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.681 2.254 . . . . 0.0 112.468 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 38.4 t -107.0 142.08 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 126.095 1.758 . . . . 0.0 109.43 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 22.4 tp -80.68 113.29 18.78 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 122.588 0.355 . . . . 0.0 110.693 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.8 mp -109.38 147.54 32.59 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.655 1.582 . . . . 0.0 112.701 -172.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -96.18 95.21 7.98 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.55 1.54 . . . . 0.0 109.569 170.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -130.35 71.88 1.47 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.288 1.435 . . . . 0.0 109.662 174.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.9 t70 63.37 -15.88 0.07 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 128.712 2.805 . . . . 0.0 115.866 -163.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -168.51 159.34 32.46 Favored Glycine 0 CA--C 1.522 0.524 0 O-C-N 121.189 -0.945 . . . . 0.0 114.09 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 59.6 mt -61.21 112.72 2.24 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.786 1.634 . . . . 0.0 110.95 -175.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -145.85 145.33 30.71 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -93.15 119.62 32.55 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.571 1.148 . . . . 0.0 110.895 -178.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 57.7 t -127.61 130.08 23.72 Favored Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 124.073 0.949 . . . . 0.0 110.081 -178.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -65.37 147.88 87.72 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.872 2.382 . . . . 0.0 111.82 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.1 -31.89 20.63 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 174.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.52 -18.42 65.36 Favored 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 173.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -108.57 2.09 21.86 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.237 1.815 . . . . 0.0 112.477 173.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.5 t -78.26 143.32 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 120.875 -1.141 . . . . 0.0 109.993 168.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.65 151.54 78.23 Favored Pre-proline 0 N--CA 1.471 0.596 0 C-N-CA 127.505 2.322 . . . . 0.0 110.682 -177.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -65.22 116.19 3.73 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.418 2.079 . . . . 0.0 110.798 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.7 2.22 34.69 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 124.571 1.082 . . . . 0.0 115.543 -173.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -56.59 159.94 3.54 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.804 1.302 . . . . 0.0 111.912 162.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.6 t -116.78 125.4 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 123.936 0.894 . . . . 0.0 110.042 175.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.6 t -100.78 145.19 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 126.774 2.03 . . . . 0.0 110.279 -178.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 44.1 t -86.05 135.99 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.818 1.247 . . . . 0.0 109.926 175.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -166.68 -149.56 6.02 Favored Glycine 0 CA--C 1.529 0.915 0 O-C-N 121.952 -0.468 . . . . 0.0 113.837 178.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.3 p -151.07 162.43 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 125.403 1.481 . . . . 0.0 110.579 175.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 42.4 mtm105 -67.33 121.0 14.77 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.696 1.198 . . . . 0.0 111.065 172.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -64.64 -24.78 67.7 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -175.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -52.72 -29.54 27.44 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 169.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 24.1 t -79.96 -45.31 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 118.612 0.642 . . . . 0.0 110.479 178.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -62.52 -23.31 66.89 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.699 1.199 . . . . 0.0 112.677 174.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 35.3 ttt180 -97.2 -4.18 39.51 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.346 1.458 . . . . 0.0 114.135 174.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . 0.282 3.5 mpt_? 55.05 41.19 32.0 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.829 1.651 . . . . 0.0 113.851 -176.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -81.07 -25.68 36.88 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.672 1.589 . . . . 0.0 111.098 157.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 52.0 mt -123.17 142.89 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.025 1.33 . . . . 0.0 107.66 153.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 4.1 mt -112.0 89.95 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 118.9 0.773 . . . . 0.0 109.953 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 79.9 p -139.21 158.82 43.49 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.903 2.081 . . . . 0.0 112.538 -176.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.21 160.5 38.83 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.858 1.263 . . . . 0.0 113.778 174.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.67 18.29 73.48 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 123.527 0.584 . . . . 0.0 113.411 -177.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -112.7 143.44 43.9 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.742 1.617 . . . . 0.0 111.898 -171.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 91.3 mt -140.46 163.49 32.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.219 1.807 . . . . 0.0 111.73 -177.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -146.35 161.8 39.55 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.443 1.897 . . . . 0.0 111.882 -176.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -107.12 149.17 27.94 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.924 0.89 . . . . 0.0 112.096 170.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -128.48 119.05 24.15 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.354 1.061 . . . . 0.0 108.497 173.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -85.22 144.19 28.29 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 120.94 -1.1 . . . . 0.0 111.786 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 97.1 t -76.36 142.87 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 125.418 1.487 . . . . 0.0 111.027 174.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 26.0 t -100.76 -50.03 3.98 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.438 1.895 . . . . 0.0 112.506 174.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 13.9 m -149.5 156.37 41.88 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.134 1.373 . . . . 0.0 111.035 -175.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.4 m -134.97 147.09 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.893 0.877 . . . . 0.0 111.97 169.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -154.99 156.87 36.76 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 176.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 90.9 mt -92.27 138.42 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.69 1.196 . . . . 0.0 108.499 168.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 16.0 pt -132.83 155.87 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 126.388 1.875 . . . . 0.0 111.587 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -96.07 94.54 7.61 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 122.122 0.963 . . . . 0.0 112.491 173.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -72.34 -43.47 64.03 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 8.0 m120 49.22 38.79 14.18 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.849 1.66 . . . . 0.0 113.583 -178.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -154.15 175.62 13.24 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.627 1.171 . . . . 0.0 111.109 -170.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -72.28 141.53 48.89 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.157 0.983 . . . . 0.0 113.218 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.8 m -122.53 153.96 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 126.465 1.906 . . . . 0.0 109.614 173.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.405 ' CD2' HG12 ' A' ' 21' ' ' ILE . 3.4 p90 -113.59 164.66 13.38 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -174.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -140.07 159.98 40.96 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.547 151.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.1 tt -127.06 98.86 5.47 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.182 0.993 . . . . 0.0 108.796 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 98.9 t -82.73 128.25 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -148.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 23.3 mm -116.59 100.61 53.54 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 124.767 1.227 . . . . 0.0 109.445 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -73.16 -13.33 25.87 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.356 2.037 . . . . 0.0 113.101 176.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 76.7 tt0 -74.0 -67.76 0.58 Allowed 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.815 1.188 . . . . 0.0 111.97 174.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 68.6 p -109.83 -7.97 14.95 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.928 1.291 . . . . 0.0 114.215 -169.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 56.42 21.23 5.36 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.929 1.291 . . . . 0.0 114.468 -169.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.37 145.56 26.18 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 -178.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -138.66 166.84 23.33 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.04 1.336 . . . . 0.0 112.416 176.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.8 mp -110.21 135.45 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.731 1.212 . . . . 0.0 111.634 177.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -86.5 156.62 56.32 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.091 0.956 . . . . 0.0 112.568 171.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -67.3 -11.99 34.22 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.826 3.017 . . . . 0.0 113.875 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -70.27 -17.82 63.11 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 121.767 -0.583 . . . . 0.0 112.443 168.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 115.23 -24.69 10.42 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 126.46 1.981 . . . . 0.0 115.069 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 50.0 mt -68.73 151.82 46.16 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.807 1.643 . . . . 0.0 113.63 -170.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 4.1 t -104.02 122.82 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 124.977 1.311 . . . . 0.0 111.96 176.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.8 144.27 43.77 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.355 1.862 . . . . 0.0 112.868 -170.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 62.7 t60 -96.61 150.48 20.61 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.136 0.975 . . . . 0.0 113.183 169.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -71.47 169.64 14.98 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 115.533 1.679 . . . . 0.0 115.533 177.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -89.2 -3.58 58.52 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.708 2.003 . . . . 0.0 113.079 170.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 . . . . . 0 C--O 1.25 1.111 0 C-N-CA 127.171 2.188 . . . . 0.0 111.476 -176.268 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.7 166.51 22.77 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.446 1.898 . . . . 0.0 111.772 -174.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.45 146.88 54.06 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.244 1.418 . . . . 0.0 114.608 -176.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -67.85 -21.22 65.19 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.748 1.219 . . . . 0.0 113.96 175.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -84.76 -3.66 58.7 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 174.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.2 m -65.16 141.65 58.61 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 119.363 0.983 . . . . 0.0 113.233 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -79.35 147.89 32.25 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.581 1.152 . . . . 0.0 112.917 170.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 p -146.39 156.77 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.498 1.119 . . . . 0.0 112.328 -172.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -126.28 135.19 51.24 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.844 2.058 . . . . 0.0 108.088 177.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -153.59 176.09 12.47 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.493 0.717 . . . . 0.0 112.249 169.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -131.85 140.98 49.29 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.148 1.379 . . . . 0.0 110.819 174.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -162.12 166.19 26.06 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.713 2.005 . . . . 0.0 108.328 174.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.4 t70 58.99 24.73 12.98 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 120.176 1.353 . . . . 0.0 113.2 170.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 63.55 29.81 15.22 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.158 1.783 . . . . 0.0 114.8 -171.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.8 p -152.78 141.75 14.31 Favored Pre-proline 0 CA--C 1.548 0.884 0 O-C-N 119.678 -1.889 . . . . 0.0 113.473 -176.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.33 152.96 50.38 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.713 2.942 . . . . 0.0 112.595 173.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -135.75 142.59 44.99 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.033 2.133 . . . . 0.0 109.96 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 35.9 ttm -153.24 106.21 2.96 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.035 0.534 . . . . 0.0 111.555 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -157.14 -179.54 8.3 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.444 1.898 . . . . 0.0 111.682 -172.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.7 m -67.73 138.49 56.29 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.219 -0.926 . . . . 0.0 110.013 170.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.6 tp -55.9 -37.33 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -176.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -69.53 -16.67 63.48 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.84 1.2 . . . . 0.0 112.755 -178.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -80.44 -46.55 15.75 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.416 1.086 . . . . 0.0 109.836 177.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -67.92 -34.62 76.96 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 122.015 -0.428 . . . . 0.0 112.079 173.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -58.59 -49.97 75.52 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.497 0.719 . . . . 0.0 110.835 172.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.5 t -68.99 -30.3 68.68 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.263 0.625 . . . . 0.0 111.513 -176.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -64.67 -54.04 37.89 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.43 1.492 . . . . 0.0 110.514 172.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -69.4 -33.85 73.63 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.203 -0.936 . . . . 0.0 112.347 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.33 -19.1 64.64 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 121.104 -0.997 . . . . 0.0 113.309 174.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.0 m -96.04 -7.64 35.69 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.874 1.669 . . . . 0.0 113.855 174.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 59.2 mtm -113.08 -49.51 2.92 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.756 1.623 . . . . 0.0 112.895 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -102.33 -19.59 14.94 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.175 1.79 . . . . 0.0 112.021 -174.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.96 166.59 42.33 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.589 1.09 . . . . 0.0 114.103 174.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -112.89 130.19 56.2 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.731 1.212 . . . . 0.0 110.465 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.2 mp -119.38 148.87 46.44 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 126.431 1.893 . . . . 0.0 110.808 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -72.06 162.31 42.18 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.452 2.768 . . . . 0.0 113.977 -173.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -145.45 170.07 17.1 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.047 1.739 . . . . 0.0 110.847 175.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -60.03 -58.23 9.42 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.546 1.138 . . . . 0.0 113.151 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -90.56 -3.87 57.28 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 176.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.93 -128.31 1.15 Allowed Glycine 0 CA--C 1.534 1.239 0 CA-C-N 120.322 1.419 . . . . 0.0 116.504 -177.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -139.56 161.07 38.39 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.092 1.757 . . . . 0.0 111.668 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.6 159.74 41.54 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.571 1.148 . . . . 0.0 112.691 177.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 81.6 t -127.17 113.47 21.63 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 125.782 1.633 . . . . 0.0 109.855 176.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -65.71 142.42 70.18 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 124.25 3.3 . . . . 0.0 111.263 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.2 mt -116.12 151.97 34.58 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 122.608 1.194 . . . . 0.0 112.853 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -133.84 129.74 36.9 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.824 1.249 . . . . 0.0 110.581 170.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 57.84 33.68 23.49 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.209 1.404 . . . . 0.0 114.157 176.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.3 t -101.68 133.7 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.492 1.517 . . . . 0.0 110.031 174.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -132.39 154.18 50.06 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.927 1.691 . . . . 0.0 112.912 -174.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.3 m -146.68 158.6 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 127.725 2.41 . . . . 0.0 110.542 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -79.32 149.06 31.87 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.013 -1.054 . . . . 0.0 112.232 170.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.0 t -148.24 157.17 43.34 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.904 1.682 . . . . 0.0 111.81 -169.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 38.6 tp -112.35 134.22 54.01 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.05 1.34 . . . . 0.0 110.226 176.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -83.46 104.12 13.36 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 163.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 mm -63.32 -29.94 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-N 120.935 1.698 . . . . 0.0 111.546 -177.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.77 -45.31 90.36 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.071 1.348 . . . . 0.0 113.241 -177.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.8 m -101.84 -20.24 14.98 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.918 0.887 . . . . 0.0 112.465 177.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.25 37.72 81.16 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.981 1.277 . . . . 0.0 112.42 -170.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -103.01 136.33 43.02 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.393 1.877 . . . . 0.0 110.644 -177.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 mp -93.7 127.69 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.7 pttt -144.86 169.65 17.64 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.987 1.315 . . . . 0.0 112.072 -177.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -103.5 143.46 32.69 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.959 0.904 . . . . 0.0 110.887 175.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.6 t -142.44 162.08 36.38 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.017 1.327 . . . . 0.0 112.62 -175.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -81.74 151.73 27.34 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 173.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -107.69 138.66 43.51 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.778 0.831 . . . . 0.0 110.942 164.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.9 t -91.86 -46.83 7.65 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.978 1.311 . . . . 0.0 113.255 -169.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -150.73 158.49 44.21 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.868 1.267 . . . . 0.0 111.559 172.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.1 mt -87.25 153.22 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 162.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -139.05 149.65 44.87 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.304 1.441 . . . . 0.0 111.715 -175.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 21.6 ptt-85 -139.12 150.5 45.74 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.769 1.228 . . . . 0.0 113.547 169.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -144.53 159.56 42.57 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.152 1.781 . . . . 0.0 109.445 172.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -102.91 136.43 42.74 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.133 0.879 . . . . 0.0 110.788 -176.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.9 m -144.87 145.48 20.97 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-O 122.324 1.059 . . . . 0.0 111.962 -176.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -97.48 -28.64 13.89 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 125.987 1.715 . . . . 0.0 111.867 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -120.28 128.69 53.54 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.544 1.138 . . . . 0.0 110.385 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.8 tp -131.89 160.69 34.97 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.342 1.457 . . . . 0.0 109.781 178.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.0 mt -113.4 126.21 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 119.858 1.208 . . . . 0.0 109.123 175.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -97.15 120.6 37.81 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.465 1.106 . . . . 0.0 111.119 169.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -109.55 122.22 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.496 1.518 . . . . 0.0 109.266 173.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -90.68 146.09 24.3 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.254 1.822 . . . . 0.0 110.601 175.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.6 mt -115.92 158.63 22.72 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.497 1.519 . . . . 0.0 111.74 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.5 t -61.71 -20.0 63.02 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.396 1.079 . . . . 0.0 113.561 -176.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 78.1 p -85.3 4.76 33.51 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.27 1.828 . . . . 0.0 115.619 172.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.78 10.04 86.49 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 124.306 0.955 . . . . 0.0 114.652 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -76.52 152.82 35.91 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.996 1.319 . . . . 0.0 109.829 166.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 80.5 p -135.68 135.62 40.26 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 165.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.9 tp -109.42 137.22 47.6 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.906 1.682 . . . . 0.0 109.755 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt -119.64 117.83 29.33 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.86 1.264 . . . . 0.0 111.105 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.5 m -139.15 153.49 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.994 1.318 . . . . 0.0 112.479 -168.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.8 p -64.87 145.66 98.9 Favored Pre-proline 0 N--CA 1.468 0.462 0 O-C-N 121.098 -1.001 . . . . 0.0 111.003 170.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -59.09 -24.81 75.4 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.381 2.721 . . . . 0.0 113.322 -173.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 61.7 p -76.3 -12.77 60.13 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 128.033 2.533 . . . . 0.0 115.539 175.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -70.96 116.68 48.92 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 124.344 1.058 . . . . 0.0 111.886 -174.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -78.52 120.81 4.93 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 123.253 2.636 . . . . 0.0 111.966 177.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.2 t -92.89 142.95 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 126.689 1.996 . . . . 0.0 110.124 178.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.74 101.08 6.5 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.534 0.683 . . . . 0.0 109.395 173.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.6 tp -98.76 152.77 19.32 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.015 1.726 . . . . 0.0 111.735 -173.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -111.85 113.2 25.4 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.056 0.542 . . . . 0.0 111.932 167.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -130.67 77.47 1.79 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.876 0.871 . . . . 0.0 109.274 165.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.2 t70 62.99 -7.92 0.14 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 128.634 2.774 . . . . 0.0 116.335 -166.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -165.32 163.36 36.5 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 125.628 1.585 . . . . 0.0 112.722 -177.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 78.2 mt -70.28 119.35 14.33 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.627 1.571 . . . . 0.0 110.594 -174.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -149.63 149.86 31.3 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -103.16 121.82 43.44 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.427 1.091 . . . . 0.0 111.028 -177.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 54.4 t -136.59 129.47 17.53 Favored Pre-proline 0 N--CA 1.481 1.104 0 C-N-CA 124.185 0.994 . . . . 0.0 110.87 -174.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -66.31 146.71 81.68 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.081 2.521 . . . . 0.0 112.811 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.11 -32.05 21.37 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 175.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.29 -19.43 65.41 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 173.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -107.8 -3.88 18.61 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.29 1.836 . . . . 0.0 112.824 177.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 92.6 t -73.47 146.23 10.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 C-N-CA 124.987 1.315 . . . . 0.0 110.479 168.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.78 159.26 72.03 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 127.762 2.425 . . . . 0.0 109.387 177.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -65.64 127.78 18.7 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 121.637 1.558 . . . . 0.0 110.724 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 99.14 7.81 54.41 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.238 0.923 . . . . 0.0 114.756 -178.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -67.15 165.65 15.55 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 118.301 1.05 . . . . 0.0 112.21 162.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.56 132.37 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 124.242 1.017 . . . . 0.0 111.211 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.0 t -107.26 134.1 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 126.367 1.867 . . . . 0.0 110.521 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 49.5 t -91.26 143.02 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.905 0.882 . . . . 0.0 111.355 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -169.1 -149.38 6.2 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.424 1.488 . . . . 0.0 111.846 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.6 p -136.88 162.99 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 125.388 1.475 . . . . 0.0 111.096 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -64.48 103.22 0.63 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.705 2.002 . . . . 0.0 110.427 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -62.65 -27.64 69.37 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -173.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -61.0 -28.16 68.84 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 173.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.7 t -85.96 -30.52 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.194 0.998 . . . . 0.0 110.394 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 47.7 tp -77.38 -26.51 51.92 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.667 1.587 . . . . 0.0 112.926 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -67.02 -18.25 65.29 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.582 1.553 . . . . 0.0 113.568 173.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -66.65 159.15 28.26 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.275 1.43 . . . . 0.0 112.844 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 55.4 mtt85 -71.86 -42.08 67.31 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.63 0.772 . . . . 0.0 112.438 174.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 42.1 mt -95.43 142.52 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.31 1.044 . . . . 0.0 110.13 168.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 42.0 mm -101.74 140.33 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.824 1.249 . . . . 0.0 111.305 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 40.1 t -116.02 134.77 54.61 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.017 1.727 . . . . 0.0 110.783 171.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -93.58 165.84 12.54 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -173.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 81.64 25.83 52.38 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 116.783 1.473 . . . . 0.0 116.783 165.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -117.7 155.21 30.35 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.619 1.568 . . . . 0.0 111.319 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.1 mt -146.83 153.36 40.08 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.221 1.009 . . . . 0.0 113.508 -177.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -135.8 151.47 50.11 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.156 1.782 . . . . 0.0 113.11 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -124.16 130.57 52.77 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.989 1.715 . . . . 0.0 110.701 -175.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -129.43 126.48 38.85 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.075 0.95 . . . . 0.0 110.411 -164.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -84.71 134.03 34.36 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.322 0.965 . . . . 0.0 112.152 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 75.0 t -67.41 129.41 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 124.142 0.977 . . . . 0.0 110.259 170.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.0 t -88.48 -42.94 11.8 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.412 1.485 . . . . 0.0 113.059 176.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.8 t -159.84 161.17 34.43 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.834 0.854 . . . . 0.0 111.426 -177.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 10.7 m -136.92 154.99 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.639 1.175 . . . . 0.0 112.555 170.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -162.36 162.11 27.73 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.428 1.091 . . . . 0.0 112.809 156.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 64.9 mt -76.05 141.34 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.953 0.901 . . . . 0.0 108.827 163.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 35.8 pt -130.67 156.67 42.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 126.988 2.115 . . . . 0.0 111.16 176.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -100.15 85.84 3.1 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 122.354 1.073 . . . . 0.0 111.382 -175.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -72.12 -46.45 56.57 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 121.308 -0.87 . . . . 0.0 112.862 -173.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 48.21 37.54 8.45 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.468 1.507 . . . . 0.0 113.097 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -145.47 174.52 11.08 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.503 1.121 . . . . 0.0 111.165 -170.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -74.64 132.81 42.03 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 123.553 0.741 . . . . 0.0 111.826 173.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 5.7 m -102.24 170.78 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.945 1.298 . . . . 0.0 109.474 169.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -123.0 161.47 24.2 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.973 0.909 . . . . 0.0 112.6 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -144.48 154.99 43.5 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.628 0.771 . . . . 0.0 110.184 158.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 40.8 tp -116.27 122.69 45.69 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.013 1.325 . . . . 0.0 110.232 175.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 99.7 t -91.83 121.25 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -165.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 25.1 mm -118.08 88.58 32.33 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 125.747 1.619 . . . . 0.0 110.227 -176.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -68.29 -13.69 38.43 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.47 2.113 . . . . 0.0 113.547 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -76.53 -46.39 26.73 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.326 0.966 . . . . 0.0 112.637 -177.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 81.3 p -138.78 -4.02 1.61 Allowed 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 126.077 1.751 . . . . 0.0 114.782 -169.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 31.0 m170 60.39 18.45 8.13 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 -177.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.15 148.51 25.02 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 120.095 -1.628 . . . . 0.0 113.582 177.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -132.66 170.9 14.56 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.939 1.696 . . . . 0.0 112.365 176.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 81.1 mt -121.54 132.99 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.471 1.108 . . . . 0.0 110.925 -175.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -80.36 161.74 63.76 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 125.102 1.361 . . . . 0.0 113.439 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.44 -18.35 62.71 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 122.869 2.379 . . . . 0.0 112.158 174.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.74 10.85 10.27 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.116 0.966 . . . . 0.0 113.181 172.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.21 -14.43 27.94 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.6 1.571 . . . . 0.0 116.559 176.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 78.6 mt -69.65 144.94 52.77 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 118.947 1.373 . . . . 0.0 112.833 -177.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 19.7 t -85.23 132.21 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.732 0.813 . . . . 0.0 110.629 171.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 77.1 mt -118.15 138.22 52.43 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.957 2.103 . . . . 0.0 110.061 177.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 42.3 t60 -137.76 141.85 40.93 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -168.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -159.73 151.5 20.29 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.977 1.311 . . . . 0.0 111.078 158.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -128.67 30.48 5.11 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.593 1.557 . . . . 0.0 114.59 -174.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 . . . . . 0 C--O 1.253 1.261 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -177.046 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.835 0 CA-C-O 119.474 -0.298 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.0 162.18 25.86 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.358 1.463 . . . . 0.0 112.238 -178.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.72 148.94 41.18 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.901 1.28 . . . . 0.0 113.697 177.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -12.54 31.98 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.047 1.339 . . . . 0.0 113.724 171.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.79 -24.19 64.38 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.187 2.195 . . . . 0.0 111.411 175.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.4 m -66.64 139.28 57.86 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.429 1.092 . . . . 0.0 113.62 -170.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -88.34 152.26 22.05 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.929 1.291 . . . . 0.0 113.427 171.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 p -148.17 153.3 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.122 0.969 . . . . 0.0 112.543 -169.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -132.88 127.22 33.92 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.175 1.79 . . . . 0.0 107.767 -173.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -153.0 177.7 10.49 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.111 0.964 . . . . 0.0 111.562 -175.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -134.48 141.79 46.87 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.036 -1.04 . . . . 0.0 111.275 173.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -154.51 162.38 41.17 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.774 1.63 . . . . 0.0 108.72 171.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.9 t70 51.28 29.74 5.28 Favored 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -174.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.1 m 57.34 39.74 28.14 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.703 1.601 . . . . 0.0 113.675 -171.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.0 p -153.58 141.13 13.53 Favored Pre-proline 0 CA--C 1.545 0.785 0 O-C-N 120.395 -1.441 . . . . 0.0 112.452 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.18 143.87 45.15 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.526 2.817 . . . . 0.0 113.871 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.5 m80 -128.45 141.67 51.33 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 128.294 2.637 . . . . 0.0 109.194 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 52.6 ttm -149.55 106.31 3.55 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.054 -1.029 . . . . 0.0 111.48 -174.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -153.95 179.39 8.95 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.115 0.966 . . . . 0.0 112.514 -171.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.9 m -74.86 141.08 44.25 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.028 -1.045 . . . . 0.0 109.479 168.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.4 tp -53.63 -36.28 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -176.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -63.44 -27.27 69.18 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.198 0.908 . . . . 0.0 112.564 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -74.85 -44.09 50.97 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.506 -0.746 . . . . 0.0 110.426 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 20.2 ptm -69.32 -37.44 77.74 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 119.371 -0.347 . . . . 0.0 111.3 172.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -59.78 -52.16 66.64 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.093 0.86 . . . . 0.0 110.874 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.7 t -65.51 -28.47 69.21 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.851 1.261 . . . . 0.0 111.773 -175.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -72.04 -56.78 5.03 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 127.373 2.269 . . . . 0.0 111.378 171.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -71.72 -33.77 69.02 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 120.919 -1.113 . . . . 0.0 112.791 -175.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.33 -23.07 65.59 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 121.288 -0.883 . . . . 0.0 112.663 172.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.2 t -89.67 -23.88 21.76 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.156 0.982 . . . . 0.0 113.316 174.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 70.5 mtm -86.44 -52.09 5.8 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.0 0.92 . . . . 0.0 112.013 176.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -106.65 -18.44 13.95 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.344 1.458 . . . . 0.0 112.724 -168.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.95 161.75 35.57 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.303 0.954 . . . . 0.0 114.05 176.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -109.42 126.89 53.94 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.954 0.902 . . . . 0.0 111.104 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.5 mp -98.6 144.94 29.04 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 125.32 1.448 . . . . 0.0 110.589 176.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -72.91 146.19 41.63 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 123.838 3.026 . . . . 0.0 112.199 -177.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.41 154.37 49.98 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.114 1.366 . . . . 0.0 111.941 178.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -52.55 -46.67 66.89 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.649 1.18 . . . . 0.0 113.745 -177.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -88.81 -9.98 49.77 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 172.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 173.81 -123.3 0.96 Allowed Glycine 0 CA--C 1.532 1.099 0 N-CA-C 116.958 1.543 . . . . 0.0 116.958 -168.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -142.7 159.25 42.59 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.007 1.723 . . . . 0.0 111.953 -177.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.25 150.66 46.91 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.522 1.529 . . . . 0.0 111.997 176.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.9 t -125.79 118.27 24.24 Favored Pre-proline 0 N--CA 1.486 1.34 0 C-N-CA 125.302 1.441 . . . . 0.0 111.29 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.62 140.89 40.41 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 124.186 3.257 . . . . 0.0 112.157 -178.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 73.3 mt -111.1 165.79 11.6 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.084 1.354 . . . . 0.0 112.568 176.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -145.59 124.09 12.43 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.881 1.272 . . . . 0.0 111.534 169.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 51.18 44.66 28.63 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.421 1.889 . . . . 0.0 113.856 -177.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.7 t -106.81 130.75 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.857 1.663 . . . . 0.0 109.884 173.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -130.15 159.19 37.57 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.948 1.299 . . . . 0.0 113.014 -169.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.5 m -144.78 150.63 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.951 1.7 . . . . 0.0 112.13 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -65.31 132.57 49.37 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.962 1.305 . . . . 0.0 108.027 164.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.4 t -141.37 154.9 45.9 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.335 1.054 . . . . 0.0 112.005 -169.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 56.8 tp -115.64 133.41 56.06 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.957 1.303 . . . . 0.0 110.785 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.426 ' HB2' ' HE3' ' A' ' 61' ' ' LYS . 8.2 t0 -79.51 117.02 20.08 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.223 0.609 . . . . 0.0 111.255 163.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.4 mm -70.15 -16.64 20.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 O-C-N 121.056 -1.028 . . . . 0.0 113.261 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.48 -46.87 24.92 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.545 -1.347 . . . . 0.0 113.92 -177.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.0 m -121.36 -8.73 9.14 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 179.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.4 29.06 54.27 Favored Glycine 0 CA--C 1.535 1.291 0 O-C-N 121.388 -0.82 . . . . 0.0 114.016 -176.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -77.83 131.59 37.63 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.142 0.971 . . . . 0.0 110.933 175.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 mp -81.74 139.57 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 170.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.426 ' HE3' ' HB2' ' A' ' 54' ' ' ASP . 5.9 mttt -141.12 173.13 11.78 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.567 1.547 . . . . 0.0 110.485 174.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -111.53 128.53 56.05 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.476 0.71 . . . . 0.0 110.433 162.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.9 t -131.41 164.54 25.48 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.202 1.001 . . . . 0.0 112.601 -174.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.8 ppt_? -86.09 139.59 30.99 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.231 1.013 . . . . 0.0 112.772 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -93.8 144.01 25.81 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.063 0.945 . . . . 0.0 109.587 166.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.7 t -101.01 -45.88 5.27 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -172.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -153.78 155.55 36.06 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.767 1.227 . . . . 0.0 112.551 175.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.9 mt -87.23 159.88 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.855 1.262 . . . . 0.0 108.85 167.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -142.54 151.03 41.19 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.178 1.791 . . . . 0.0 111.106 -176.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 42.9 ptt85 -145.5 159.41 43.14 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 167.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -152.09 159.42 43.67 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.333 1.853 . . . . 0.0 110.663 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -97.28 140.95 30.98 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.632 1.173 . . . . 0.0 112.526 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.1 m -148.12 141.62 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.073 0.949 . . . . 0.0 113.25 -176.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -99.66 -24.34 14.75 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.269 1.428 . . . . 0.0 113.226 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -127.86 126.83 42.33 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.451 1.101 . . . . 0.0 110.994 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.7 tp -136.84 167.11 22.08 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.947 2.099 . . . . 0.0 109.29 -173.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 20.2 mt -119.82 126.95 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.75 1.22 . . . . 0.0 108.816 176.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -99.31 116.63 31.93 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.917 0.887 . . . . 0.0 111.073 170.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.0 mp -101.4 122.33 53.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 125.175 1.39 . . . . 0.0 108.416 172.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -90.37 148.91 22.52 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.782 1.233 . . . . 0.0 110.791 174.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 65.2 mt -116.38 157.78 24.52 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.436 1.494 . . . . 0.0 111.831 178.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.1 t -64.65 -27.17 68.75 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.665 -0.647 . . . . 0.0 112.469 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 84.3 p -59.82 -22.43 62.22 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.374 1.469 . . . . 0.0 114.354 172.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 86.27 19.0 58.09 Favored Glycine 0 CA--C 1.537 1.452 0 O-C-N 121.284 -0.885 . . . . 0.0 113.806 -167.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -93.67 158.32 15.74 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.082 0.941 . . . . 0.0 111.062 161.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 83.8 p -138.21 137.53 37.66 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.52 1.528 . . . . 0.0 110.785 177.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.6 tp -115.97 130.65 56.91 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.93 1.292 . . . . 0.0 109.79 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -111.53 113.53 26.01 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.484 1.514 . . . . 0.0 109.929 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.8 m -137.41 153.82 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.16 1.384 . . . . 0.0 113.504 -169.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.6 p -66.71 143.25 98.0 Favored Pre-proline 0 N--CA 1.472 0.644 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 176.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -62.43 -22.26 73.83 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.713 2.942 . . . . 0.0 113.454 -178.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.6 p -88.55 -1.67 58.18 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.324 1.85 . . . . 0.0 114.215 176.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -87.74 124.28 67.69 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 119.158 0.89 . . . . 0.0 112.583 -175.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -70.97 129.75 16.79 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.607 2.872 . . . . 0.0 111.215 176.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.1 t -108.03 140.35 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 125.679 1.591 . . . . 0.0 110.337 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 51.9 tp -81.51 104.67 12.1 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.493 0.717 . . . . 0.0 110.812 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.1 mp -104.5 158.38 16.52 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.431 1.893 . . . . 0.0 112.119 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -106.14 127.02 52.91 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 169.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 72.4 mtp85 -138.23 74.87 1.49 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.981 0.912 . . . . 0.0 111.009 162.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 50.97 21.14 0.92 Allowed 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 125.44 1.496 . . . . 0.0 113.173 -164.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 179.27 149.02 8.06 Favored Glycine 0 CA--C 1.521 0.455 0 O-C-N 120.536 -1.352 . . . . 0.0 111.447 -170.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 60.6 mt -75.01 120.89 21.15 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.34 1.456 . . . . 0.0 109.523 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -150.34 151.68 33.27 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -177.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -105.76 121.12 43.37 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.458 1.103 . . . . 0.0 112.106 -172.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 78.5 t -139.07 132.56 15.92 Favored Pre-proline 0 N--CA 1.484 1.257 0 C-N-CA 124.916 1.286 . . . . 0.0 110.563 -178.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -66.82 145.29 74.38 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.827 2.352 . . . . 0.0 113.333 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.01 -34.03 19.89 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 175.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.84 -23.99 67.56 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 174.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -98.02 -15.49 20.03 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.552 1.141 . . . . 0.0 112.94 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.7 t -63.02 149.95 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.565 1.546 . . . . 0.0 111.416 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.427 ' HZ2' ' CG ' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -129.8 154.3 81.02 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 126.094 1.757 . . . . 0.0 111.389 178.168 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -65.98 130.3 24.09 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.311 2.007 . . . . 0.0 111.513 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.62 4.09 54.88 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.775 1.179 . . . . 0.0 114.073 -176.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.427 ' CG ' ' HZ2' ' A' ' 111' ' ' LYS . 70.5 m-20 -65.06 168.76 6.15 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.668 1.187 . . . . 0.0 112.291 165.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.3 t -115.54 124.23 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.949 1.3 . . . . 0.0 111.069 -173.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.0 t -95.71 143.38 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.74 1.616 . . . . 0.0 110.31 175.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.5 t -89.56 133.71 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.706 0.803 . . . . 0.0 110.507 177.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -158.28 -158.52 9.05 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.139 0.876 . . . . 0.0 113.053 178.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.439 ' CG2' ' H ' ' A' ' 120' ' ' ARG . 4.1 p -141.38 -179.71 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 126.589 1.955 . . . . 0.0 111.746 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.439 ' H ' ' CG2' ' A' ' 119' ' ' VAL . 64.8 mtt-85 -78.74 98.71 6.36 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.489 1.916 . . . . 0.0 111.459 -175.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -58.8 -30.11 67.36 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.175 0.99 . . . . 0.0 112.227 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -63.01 -37.84 88.81 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.065 -1.022 . . . . 0.0 113.605 174.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 22.0 t -75.42 -39.94 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 13.1 tp -63.49 -14.59 52.42 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.52 1.528 . . . . 0.0 113.522 176.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 83.1 mtm-85 -80.45 -21.29 42.24 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.838 1.655 . . . . 0.0 115.056 169.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 11.8 mpt_? -77.87 169.05 18.93 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 119.821 1.191 . . . . 0.0 111.063 171.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 60.1 ttt-85 -91.36 71.35 6.09 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.629 1.172 . . . . 0.0 109.891 174.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 20.7 tt -142.8 152.39 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.054 1.341 . . . . 0.0 112.525 -164.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 71.6 mt -81.33 102.81 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.111 0.964 . . . . 0.0 108.655 162.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.3 m -77.71 61.57 2.43 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.175 0.99 . . . . 0.0 111.883 -176.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.26 151.52 43.42 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -170.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 67.24 -1.99 5.92 Favored Glycine 0 CA--C 1.536 1.376 0 N-CA-C 119.838 2.695 . . . . 0.0 119.838 162.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -107.79 152.96 23.67 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 120.257 2.028 . . . . 0.0 114.335 -169.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 92.5 mt -138.41 159.74 41.3 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.71 2.004 . . . . 0.0 111.353 168.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -150.73 127.05 10.65 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.473 2.309 . . . . 0.0 110.452 174.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -84.67 146.37 27.49 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.401 1.08 . . . . 0.0 112.227 -177.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 52.0 m80 -129.63 137.89 50.92 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.297 1.039 . . . . 0.0 111.479 -174.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -89.48 136.61 32.93 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.293 1.037 . . . . 0.0 113.529 -174.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 77.5 t -74.27 120.0 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.407 1.083 . . . . 0.0 111.379 171.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.8 t -87.68 -29.62 21.0 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.034 1.733 . . . . 0.0 114.105 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.1 m -164.93 164.54 20.73 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.693 1.197 . . . . 0.0 111.291 172.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.9 m -132.79 145.69 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.235 1.014 . . . . 0.0 111.221 165.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -151.21 154.56 37.08 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.78 1.232 . . . . 0.0 112.281 170.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 97.0 mt -76.59 141.89 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 160.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 24.7 pt -131.05 159.37 43.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 125.288 1.435 . . . . 0.0 110.898 169.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -98.54 101.49 12.94 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.731 0.776 . . . . 0.0 111.942 169.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -80.21 -47.71 14.23 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.609 -0.682 . . . . 0.0 112.281 -177.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 55.66 32.51 19.43 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.346 1.058 . . . . 0.0 113.095 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -144.65 178.2 8.15 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.0 1.32 . . . . 0.0 111.814 -170.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -80.51 139.94 36.12 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.115 1.366 . . . . 0.0 112.753 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.8 m -125.88 154.7 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 125.841 1.656 . . . . 0.0 110.063 177.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -115.67 162.92 16.56 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -171.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -140.87 150.78 43.67 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 125.8 1.64 . . . . 0.0 108.633 160.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 56.5 tp -119.19 115.26 23.85 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.326 -1.484 . . . . 0.0 109.677 175.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 35.0 t -86.0 120.47 35.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -163.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 13.1 mm -119.6 84.64 30.71 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 125.384 1.474 . . . . 0.0 109.424 -177.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -65.77 -8.14 18.68 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.777 2.984 . . . . 0.0 114.371 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -84.56 -42.15 15.74 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.03 1.332 . . . . 0.0 113.212 177.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 68.9 p -142.26 -11.93 0.83 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -170.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . 0.25 92.0 m-70 57.36 24.13 9.72 Favored 'General case' 0 CA--C 1.553 1.079 0 N-CA-C 116.782 2.141 . . . . 0.0 116.782 -176.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -157.36 150.53 23.64 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 119.929 -1.732 . . . . 0.0 114.169 175.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -148.18 142.69 26.44 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.526 1.53 . . . . 0.0 112.43 -174.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.8 mp -92.7 137.04 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 O-C-N 120.477 -1.389 . . . . 0.0 112.162 -175.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -91.97 159.42 37.91 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 126.698 1.999 . . . . 0.0 113.386 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.25 -13.76 33.81 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.95 3.1 . . . . 0.0 113.885 -177.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -72.85 -7.69 52.0 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.28 0.632 . . . . 0.0 112.049 168.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 98.54 -20.17 51.49 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 126.749 2.119 . . . . 0.0 113.902 -177.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 74.7 mt -69.72 144.57 52.75 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.043 1.422 . . . . 0.0 112.844 -174.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 56.8 t -74.49 125.73 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 165.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 47.0 mt -106.53 166.27 10.67 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.081 1.752 . . . . 0.0 110.487 167.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -132.31 155.04 49.07 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.153 0.981 . . . . 0.0 112.446 -157.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -117.19 122.01 42.82 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.268 1.027 . . . . 0.0 111.499 172.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -154.45 51.11 0.64 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.061 1.344 . . . . 0.0 112.684 -178.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 . . . . . 0 C--O 1.248 0.994 0 C-N-CA 124.639 1.175 . . . . 0.0 113.724 171.66 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.948 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -140.02 156.58 46.55 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.044 1.737 . . . . 0.0 111.239 -171.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.88 146.33 55.06 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 120.491 -1.381 . . . . 0.0 114.21 -177.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.87 -14.49 15.55 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.226 1.411 . . . . 0.0 114.605 165.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -69.87 -14.9 62.96 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.167 0.987 . . . . 0.0 112.24 170.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.8 m -80.5 143.55 33.23 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -170.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -80.17 152.69 29.06 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.604 1.562 . . . . 0.0 112.741 168.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.6 p -146.99 158.35 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.505 1.122 . . . . 0.0 112.534 -172.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -124.92 137.59 54.27 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.621 1.968 . . . . 0.0 108.749 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -156.27 177.13 11.79 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 118.863 0.756 . . . . 0.0 111.96 168.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -135.78 144.71 45.93 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.037 1.335 . . . . 0.0 110.206 171.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -150.77 -63.31 0.19 Allowed 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 176.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -76.6 45.07 0.38 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.815 1.246 . . . . 0.0 112.722 -175.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.4 m 49.56 45.12 24.37 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.321 1.448 . . . . 0.0 110.706 -168.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.9 p -165.98 144.23 4.8 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 127.021 2.128 . . . . 0.0 110.126 -173.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.2 161.3 23.21 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 124.013 3.142 . . . . 0.0 113.855 175.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -142.23 143.93 33.11 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.57 2.348 . . . . 0.0 111.337 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 40.7 ttm -145.83 120.34 9.72 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.15 1.38 . . . . 0.0 110.02 172.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -165.77 -179.03 5.09 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.217 1.407 . . . . 0.0 110.628 -172.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.7 m -76.82 142.94 40.09 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 120.83 -1.168 . . . . 0.0 110.635 171.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.426 HG12 ' CG ' ' A' ' 152' ' ' TYR . 8.4 tp -56.0 -36.64 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -177.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -69.71 -18.0 63.5 Favored 'General case' 0 CA--C 1.549 0.909 0 O-C-N 121.673 -0.642 . . . . 0.0 112.529 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -75.3 -46.9 30.53 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.156 -0.965 . . . . 0.0 110.465 172.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.7 ptm -71.95 -35.83 69.7 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -57.93 -53.59 56.54 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 118.921 0.782 . . . . 0.0 110.709 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.2 t -64.68 -33.68 76.52 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.318 1.047 . . . . 0.0 111.509 -176.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -65.12 -52.66 53.99 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.209 1.404 . . . . 0.0 110.683 175.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -70.1 -32.38 70.4 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.321 -0.862 . . . . 0.0 112.671 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.01 -27.68 67.63 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.999 0.92 . . . . 0.0 113.176 172.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.7 t -79.86 -35.46 38.11 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.469 1.107 . . . . 0.0 112.073 173.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 46.0 mtm -85.13 -43.47 13.83 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.157 0.983 . . . . 0.0 113.395 -174.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -107.5 -31.86 7.95 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.289 1.435 . . . . 0.0 111.404 -172.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 102.05 165.36 26.82 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.016 1.293 . . . . 0.0 113.508 -177.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -114.44 135.65 53.87 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.675 1.59 . . . . 0.0 111.136 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.6 mp -100.43 148.29 34.74 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 125.878 1.671 . . . . 0.0 109.833 166.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -75.79 159.34 38.56 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.328 2.685 . . . . 0.0 111.615 175.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -135.59 161.36 35.75 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.461 1.505 . . . . 0.0 109.861 164.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -42.9 -48.55 5.84 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -117.14 3.94 12.69 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -160.89 -145.64 4.36 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 115.515 0.966 . . . . 0.0 115.515 -172.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -150.53 155.53 39.65 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.388 1.875 . . . . 0.0 112.378 -175.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.72 143.43 41.22 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.459 1.504 . . . . 0.0 112.095 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 86.7 t -125.71 111.65 25.16 Favored Pre-proline 0 N--CA 1.484 1.233 0 C-N-CA 125.16 1.384 . . . . 0.0 110.787 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.63 127.74 13.5 Favored 'Trans proline' 0 C--N 1.351 0.686 1 C-N-CA 125.348 4.032 . . . . 0.0 112.307 -174.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 68.6 mt -106.64 156.4 18.65 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.183 0.993 . . . . 0.0 113.152 -177.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -134.98 132.66 38.63 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.91 1.684 . . . . 0.0 111.046 168.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 50.13 45.84 25.23 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.347 1.859 . . . . 0.0 113.244 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 49.1 t -109.07 127.76 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.69 0.796 . . . . 0.0 109.604 175.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -127.99 155.34 44.44 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.268 1.027 . . . . 0.0 113.471 -168.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.5 m -141.94 151.88 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 126.543 1.937 . . . . 0.0 112.25 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -72.25 136.35 46.3 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.298 1.839 . . . . 0.0 108.137 169.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.2 t -151.33 154.65 37.12 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.186 -0.946 . . . . 0.0 113.323 -170.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 60.2 tp -107.09 129.04 54.88 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.758 1.623 . . . . 0.0 110.579 177.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -79.78 102.35 9.01 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.602 -0.686 . . . . 0.0 109.876 168.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.5 mm -59.31 -23.36 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.318 1.047 . . . . 0.0 112.586 -175.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.81 -39.77 69.6 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.428 1.891 . . . . 0.0 114.746 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.3 m -108.4 -24.65 11.35 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.971 1.309 . . . . 0.0 112.94 -173.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.13 29.4 68.8 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.234 1.397 . . . . 0.0 113.161 -169.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -103.38 137.23 41.76 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.69 1.596 . . . . 0.0 111.386 -176.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.3 mp -93.33 135.58 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.111 0.965 . . . . 0.0 109.088 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -153.27 172.2 17.37 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.796 1.638 . . . . 0.0 111.192 -176.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt -90.58 144.11 26.09 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.842 0.857 . . . . 0.0 111.146 165.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.8 t -136.48 166.38 23.64 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.056 1.342 . . . . 0.0 111.41 170.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.6 ptp85 -97.64 146.88 24.88 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.773 1.229 . . . . 0.0 112.939 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -103.13 146.21 28.74 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.468 1.107 . . . . 0.0 111.19 170.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.7 t -98.13 -43.35 7.05 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -174.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -153.9 159.01 41.58 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.062 0.945 . . . . 0.0 112.789 173.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.8 mt -89.42 151.48 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.08 0.952 . . . . 0.0 108.465 164.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -137.46 146.71 44.62 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.778 1.631 . . . . 0.0 110.31 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -144.07 151.55 39.78 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 119.833 1.197 . . . . 0.0 113.482 166.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -152.05 169.99 21.02 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.013 1.725 . . . . 0.0 110.597 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -103.35 140.13 37.84 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.689 1.195 . . . . 0.0 111.605 -175.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.1 m -146.88 142.22 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.649 1.18 . . . . 0.0 111.795 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -104.99 -11.15 16.78 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.639 1.575 . . . . 0.0 113.451 175.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -123.75 121.21 34.86 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.969 1.308 . . . . 0.0 109.908 173.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.0 tp -136.9 161.03 37.14 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.43 1.492 . . . . 0.0 109.419 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.4 mt -114.5 128.11 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 120.982 -1.074 . . . . 0.0 109.348 178.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -100.6 113.61 26.58 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.559 1.143 . . . . 0.0 110.518 171.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.2 mp -100.79 122.11 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.174 1.39 . . . . 0.0 108.526 172.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -91.6 148.75 22.05 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.548 1.139 . . . . 0.0 111.108 176.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 82.8 mt -115.34 158.74 21.98 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.876 1.27 . . . . 0.0 112.822 -176.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.8 t -66.31 -39.71 89.5 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.993 1.317 . . . . 0.0 112.205 -175.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.7 m -75.29 0.28 17.19 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 172.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 105.99 -2.53 38.28 Favored Glycine 0 CA--C 1.534 1.268 0 N-CA-C 117.089 1.596 . . . . 0.0 117.089 162.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -81.48 171.64 14.47 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.529 1.664 . . . . 0.0 111.654 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 85.2 p -139.73 135.55 33.24 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.993 0.917 . . . . 0.0 112.926 174.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 68.4 tp -105.41 126.0 51.62 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.126 1.77 . . . . 0.0 109.468 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -114.52 110.62 20.1 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.422 1.489 . . . . 0.0 110.54 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.6 m -140.69 154.09 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.586 1.554 . . . . 0.0 112.34 -167.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.49 150.36 97.32 Favored Pre-proline 0 N--CA 1.468 0.427 0 C-N-CA 123.761 0.824 . . . . 0.0 113.115 177.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -63.51 -35.58 59.31 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.598 2.198 . . . . 0.0 114.951 -167.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.7 m -89.5 3.06 53.63 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -67.65 119.36 65.49 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 124.539 1.135 . . . . 0.0 110.928 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -80.12 126.47 6.35 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.914 2.409 . . . . 0.0 112.347 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.6 t -106.32 146.23 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 125.938 1.695 . . . . 0.0 109.537 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 21.6 tp -78.8 105.17 9.92 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.081 0.467 . . . . 0.0 110.221 177.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.6 mp -104.19 158.94 16.1 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.475 1.51 . . . . 0.0 111.508 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -103.35 122.81 45.6 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.186 0.594 . . . . 0.0 112.202 168.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.402 ' C ' ' H ' ' A' ' 101' ' ' GLY . 44.9 mtp180 -143.36 85.42 1.85 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.528 1.531 . . . . 0.0 109.366 170.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 54.56 -3.72 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 127.464 2.305 . . . . 0.0 115.855 -160.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 99' ' ' ARG . . . -175.21 174.81 46.99 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 126.933 2.206 . . . . 0.0 113.059 -178.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 37.1 mt -64.58 122.33 16.56 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.965 1.706 . . . . 0.0 110.673 173.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -151.94 152.04 32.0 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.08 0.952 . . . . 0.0 113.4 170.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -97.96 118.48 34.64 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.297 1.439 . . . . 0.0 111.126 -173.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.3 t -130.09 130.59 23.11 Favored Pre-proline 0 N--CA 1.48 1.046 0 C-N-CA 124.001 0.921 . . . . 0.0 110.872 -172.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -65.71 140.36 61.59 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.67 2.246 . . . . 0.0 111.877 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.36 -31.52 14.88 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 176.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.25 -29.28 69.75 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 174.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -101.32 -2.71 30.38 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.241 1.416 . . . . 0.0 112.169 178.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 89.9 t -72.95 142.9 14.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 O-C-N 121.064 -1.022 . . . . 0.0 110.328 167.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.46 154.57 76.98 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 127.108 2.163 . . . . 0.0 109.804 -177.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.21 136.07 42.61 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.778 1.652 . . . . 0.0 111.147 -170.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 93.37 3.65 64.84 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.812 1.196 . . . . 0.0 114.222 -176.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -62.54 158.64 17.53 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.441 1.096 . . . . 0.0 111.096 164.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.0 t -106.05 119.24 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.997 1.319 . . . . 0.0 110.16 -177.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.6 t -91.88 140.47 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.158 1.383 . . . . 0.0 109.694 174.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 38.2 t -90.64 135.67 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 123.739 0.816 . . . . 0.0 110.644 177.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -164.44 -145.29 4.34 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 114.268 0.467 . . . . 0.0 114.268 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.9 p -156.07 169.77 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 126.263 1.825 . . . . 0.0 109.545 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 74.1 mtm-85 -62.88 109.31 1.41 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.18 1.392 . . . . 0.0 111.946 175.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -65.02 -25.89 68.04 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 178.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -64.54 -39.27 93.45 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.37 0.986 . . . . 0.0 113.038 176.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.0 p -80.57 -29.04 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 119.227 0.921 . . . . 0.0 111.582 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 17.6 tp -70.76 -17.67 62.79 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 121.381 -0.824 . . . . 0.0 112.613 171.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.8 mtt85 -95.75 9.51 40.16 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 127.226 2.21 . . . . 0.0 114.329 171.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -86.35 154.82 20.93 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.129 1.372 . . . . 0.0 110.182 158.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -75.85 -25.83 56.56 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 119.755 1.161 . . . . 0.0 112.401 172.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 59.1 mt -85.73 81.64 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 162.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.15 113.39 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.935 0.894 . . . . 0.0 111.019 177.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 38.4 t -78.16 129.69 35.45 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.422 0.689 . . . . 0.0 112.054 -175.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -97.22 165.76 11.89 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.018 0.927 . . . . 0.0 113.123 170.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 93.31 6.16 63.09 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 125.244 1.402 . . . . 0.0 116.194 171.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -129.2 152.38 48.84 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.969 1.708 . . . . 0.0 112.326 -177.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.3 mt -140.76 160.28 40.38 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.622 1.569 . . . . 0.0 112.103 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -144.05 165.15 28.61 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.409 1.484 . . . . 0.0 111.248 174.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -110.73 152.28 26.77 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.727 1.211 . . . . 0.0 111.91 174.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 64.1 m-70 -135.36 137.81 42.73 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.493 1.117 . . . . 0.0 109.635 -176.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -103.52 135.29 45.4 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.453 -0.78 . . . . 0.0 112.475 -169.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 91.4 t -73.86 125.64 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 121.631 0.729 . . . . 0.0 111.352 177.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 21.2 t -88.28 -37.77 15.75 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.734 1.614 . . . . 0.0 113.403 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.2 m -154.47 159.67 41.15 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.824 1.25 . . . . 0.0 111.327 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.5 m -138.2 148.94 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 123.434 0.693 . . . . 0.0 111.193 163.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -163.16 159.65 23.25 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.309 1.044 . . . . 0.0 113.41 165.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 89.9 mt -79.22 135.57 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 164.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 16.3 pt -124.54 163.49 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 127.589 2.355 . . . . 0.0 109.828 173.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . 0.328 1.6 p-10 -114.13 65.98 0.67 Allowed 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 -172.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -56.27 -39.93 73.42 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.794 1.637 . . . . 0.0 115.335 -160.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 47.9 36.02 5.57 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.81 2.044 . . . . 0.0 113.461 -175.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -146.48 175.52 10.5 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 120.841 -1.162 . . . . 0.0 112.458 -170.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -67.21 133.74 50.33 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 122.396 1.093 . . . . 0.0 113.433 -176.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.7 m -114.45 150.83 16.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.437 164.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.426 ' CG ' HG12 ' A' ' 21' ' ' ILE . 2.8 p90 -111.78 163.88 13.67 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.987 1.315 . . . . 0.0 111.656 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -143.84 147.99 34.87 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.348 0.659 . . . . 0.0 109.844 160.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 34.6 tp -107.15 122.18 45.99 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.687 1.195 . . . . 0.0 110.271 174.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 36.1 t -87.47 118.04 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 O-C-N 121.948 -0.47 . . . . 0.0 111.911 -168.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 12.7 mm -123.19 84.78 51.53 Favored Pre-proline 0 N--CA 1.472 0.66 0 C-N-CA 125.29 1.436 . . . . 0.0 110.416 -176.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -70.04 -12.08 31.68 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 122.646 2.231 . . . . 0.0 113.835 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -74.34 -40.5 62.12 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.066 1.346 . . . . 0.0 113.83 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 70.9 p -139.73 -13.9 1.09 Allowed 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -170.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 77.4 m80 56.11 20.69 4.58 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.984 1.713 . . . . 0.0 115.179 -164.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -150.13 151.0 32.45 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.618 -1.301 . . . . 0.0 114.476 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -145.87 173.84 11.77 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.307 1.843 . . . . 0.0 111.065 177.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 79.4 mt -122.26 138.29 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.01 0.924 . . . . 0.0 110.534 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -89.0 158.18 47.43 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 124.087 0.955 . . . . 0.0 112.438 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -65.7 -18.69 59.05 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.136 2.557 . . . . 0.0 112.751 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -74.57 7.92 2.66 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.868 1.267 . . . . 0.0 112.812 170.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 91.55 -25.11 16.78 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 126.968 2.223 . . . . 0.0 115.644 175.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 41.3 mt -75.19 144.37 42.72 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.553 1.176 . . . . 0.0 113.79 -166.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.9 t -86.1 127.66 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.012 0.925 . . . . 0.0 111.079 174.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 52.9 mt -117.29 150.35 38.94 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.113 2.165 . . . . 0.0 112.169 -174.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -109.24 145.52 35.76 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.632 1.173 . . . . 0.0 112.809 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -84.22 76.34 10.11 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 121.21 -0.931 . . . . 0.0 111.811 169.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -154.58 146.47 23.48 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.951 1.301 . . . . 0.0 111.865 172.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 . . . . . 0 C--O 1.256 1.44 0 C-N-CA 127.459 2.303 . . . . 0.0 113.515 -170.332 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.638 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -135.04 162.04 33.59 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.673 1.989 . . . . 0.0 111.098 -174.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.46 141.7 57.5 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.1 0.96 . . . . 0.0 111.673 172.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -11.58 38.66 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 176.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -81.43 -13.11 58.62 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.565 1.946 . . . . 0.0 113.306 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.3 m -64.47 136.92 57.55 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.153 0.981 . . . . 0.0 112.253 -177.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -81.32 151.64 27.93 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.662 0.744 . . . . 0.0 112.073 171.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 p -144.14 160.68 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 123.611 0.764 . . . . 0.0 111.038 -170.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -132.09 124.78 29.85 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.167 1.387 . . . . 0.0 108.929 -175.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -149.58 174.87 12.06 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 118.921 0.782 . . . . 0.0 112.73 176.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -131.03 142.43 50.32 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.117 1.367 . . . . 0.0 110.879 170.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -162.91 141.98 8.73 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.996 1.319 . . . . 0.0 110.533 174.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.2 t70 61.34 38.21 16.45 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.38 1.472 . . . . 0.0 113.448 -173.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.8 m 59.41 40.6 20.66 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.317 1.447 . . . . 0.0 112.651 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.2 p -158.85 140.51 9.8 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 124.866 1.266 . . . . 0.0 110.873 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -75.46 155.82 40.89 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 123.791 2.994 . . . . 0.0 113.806 176.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 39.1 m-70 -137.0 142.99 42.53 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 127.072 2.149 . . . . 0.0 110.767 176.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 43.1 ttm -154.29 82.64 1.12 Allowed 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.764 0.792 . . . . 0.0 112.432 -170.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -143.49 -176.34 4.91 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.238 1.415 . . . . 0.0 112.085 -173.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.9 m -69.37 138.47 53.7 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 120.955 -1.091 . . . . 0.0 110.755 174.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.5 tp -55.06 -36.34 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -66.73 -17.91 65.1 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.338 -0.851 . . . . 0.0 113.127 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -75.43 -51.76 12.31 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.354 1.061 . . . . 0.0 109.927 172.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 22.2 ptm -68.08 -36.21 79.46 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.43 -0.794 . . . . 0.0 112.034 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -56.17 -51.83 66.58 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.5 0.72 . . . . 0.0 111.299 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.1 m -57.27 -40.16 77.16 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 125.324 1.449 . . . . 0.0 111.727 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -69.51 -50.93 40.43 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.017 0.927 . . . . 0.0 111.173 178.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -68.19 -33.66 74.84 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 121.338 -0.851 . . . . 0.0 112.213 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.68 -23.46 65.31 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.59 0.756 . . . . 0.0 112.782 172.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.57 -11.94 38.54 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.957 1.303 . . . . 0.0 114.112 174.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 67.0 mtm -103.66 -52.2 3.03 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.103 1.361 . . . . 0.0 111.669 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -105.14 -16.53 14.76 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.972 1.309 . . . . 0.0 112.346 -171.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.36 161.97 32.21 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 124.234 0.921 . . . . 0.0 113.271 175.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -104.96 140.58 37.97 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.913 0.885 . . . . 0.0 109.845 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.3 mp -118.51 149.09 45.47 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 126.375 1.87 . . . . 0.0 110.611 176.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -81.44 151.24 17.43 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.074 3.183 . . . . 0.0 112.222 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -138.9 163.35 32.54 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.308 1.843 . . . . 0.0 111.097 -175.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -50.76 -55.88 14.66 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.844 1.258 . . . . 0.0 113.573 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -95.54 -7.45 37.91 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.47 -134.23 1.84 Allowed Glycine 0 CA--C 1.533 1.167 0 N-CA-C 115.507 0.963 . . . . 0.0 115.507 -170.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -138.98 160.23 40.26 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.623 1.969 . . . . 0.0 111.05 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.98 155.71 45.45 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.205 1.002 . . . . 0.0 113.311 176.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.8 t -126.46 115.97 23.13 Favored Pre-proline 0 N--CA 1.48 1.059 0 C-N-CA 126.09 1.756 . . . . 0.0 110.457 175.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.95 139.3 29.87 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 124.63 3.554 . . . . 0.0 112.296 -176.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 78.4 mt -107.76 163.98 12.63 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.65 1.18 . . . . 0.0 112.752 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -147.93 128.41 14.04 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.686 1.594 . . . . 0.0 109.345 168.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 55.04 41.31 31.9 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.865 1.666 . . . . 0.0 114.264 -176.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.4 t -108.32 118.43 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 O-C-N 121.308 -0.87 . . . . 0.0 109.618 175.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -114.52 148.33 38.07 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.458 1.103 . . . . 0.0 112.166 -171.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.9 m -139.44 153.97 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.091 1.357 . . . . 0.0 111.431 175.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -76.27 147.21 38.42 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.726 0.775 . . . . 0.0 111.557 172.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.6 t -154.96 167.08 31.53 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.69 1.596 . . . . 0.0 111.316 -165.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 36.9 tp -124.76 139.11 54.15 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.453 1.501 . . . . 0.0 110.326 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -87.14 112.96 22.46 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.363 1.065 . . . . 0.0 109.652 164.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.1 mm -71.62 -21.39 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 121.049 -1.032 . . . . 0.0 112.513 -175.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.47 -45.62 21.66 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -174.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.2 m -101.89 -15.63 16.81 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.266 1.027 . . . . 0.0 112.681 173.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.55 23.33 75.62 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.045 0.831 . . . . 0.0 113.524 -174.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -82.41 133.66 35.22 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.501 1.12 . . . . 0.0 111.519 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.3 mp -80.67 136.06 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 174.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -142.92 171.08 14.54 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.444 1.898 . . . . 0.0 111.528 -174.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -117.56 144.98 44.58 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.911 1.684 . . . . 0.0 110.118 167.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.7 t -143.68 153.29 42.32 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.221 1.008 . . . . 0.0 112.492 -174.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.3 137.07 37.88 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.362 1.065 . . . . 0.0 112.198 172.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.83 136.78 36.89 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.16 0.984 . . . . 0.0 110.984 172.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 91.4 p -89.02 -47.25 8.25 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.862 0.865 . . . . 0.0 113.267 -167.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -154.12 156.97 38.21 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.393 1.477 . . . . 0.0 112.356 173.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.7 mt -87.19 153.57 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 124.683 1.193 . . . . 0.0 107.941 164.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -138.6 152.61 48.29 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.858 1.663 . . . . 0.0 111.581 -173.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -146.52 152.88 39.69 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 164.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -150.39 167.22 27.72 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 127.453 2.301 . . . . 0.0 110.574 177.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -106.33 138.63 42.16 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.079 1.351 . . . . 0.0 113.779 -173.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.8 m -145.97 145.28 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 C-N-CA 124.764 1.226 . . . . 0.0 111.881 -176.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -96.22 -30.86 13.24 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 125.867 1.667 . . . . 0.0 112.26 175.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -129.41 133.25 47.25 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.144 0.978 . . . . 0.0 111.822 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.9 tp -136.39 158.45 44.4 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.15 2.18 . . . . 0.0 109.161 -170.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.2 mt -110.17 127.66 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 O-C-N 121.241 -0.912 . . . . 0.0 109.617 176.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -102.91 119.08 38.21 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.321 1.048 . . . . 0.0 111.648 168.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -104.86 123.65 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.694 1.598 . . . . 0.0 108.547 174.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -91.54 143.93 26.07 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.431 1.092 . . . . 0.0 111.142 173.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.4 mt -109.73 151.94 26.29 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.231 1.812 . . . . 0.0 110.706 175.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.9 t -66.53 -22.8 66.16 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -168.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.9 m -76.9 -10.29 59.27 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.863 1.265 . . . . 0.0 114.159 172.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 107.03 2.28 36.19 Favored Glycine 0 CA--C 1.54 1.634 0 N-CA-C 116.731 1.452 . . . . 0.0 116.731 175.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -80.86 153.81 27.43 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.41 1.484 . . . . 0.0 110.841 172.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 39.1 p -131.06 144.32 51.35 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 168.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 60.0 tp -111.72 126.35 54.95 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.168 2.187 . . . . 0.0 109.566 177.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -118.61 107.8 14.17 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.823 1.649 . . . . 0.0 110.556 -173.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.3 m -143.42 151.49 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.83 1.252 . . . . 0.0 113.174 -161.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.4 p -67.9 149.07 98.37 Favored Pre-proline 0 N--CA 1.467 0.402 0 O-C-N 121.43 -0.794 . . . . 0.0 111.93 174.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -59.5 -29.81 90.93 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 123.144 2.563 . . . . 0.0 114.09 -168.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.3 p -81.04 -9.42 59.83 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 55.6 t60 -69.38 120.81 79.39 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 119.717 1.144 . . . . 0.0 111.637 -178.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -79.31 129.49 8.65 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.019 2.479 . . . . 0.0 113.687 178.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.4 t -103.95 143.13 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 126.112 1.765 . . . . 0.0 109.544 175.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.05 109.32 15.51 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.181 0.515 . . . . 0.0 110.729 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.4 mp -106.23 153.84 21.57 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.417 1.887 . . . . 0.0 111.33 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -108.65 107.72 18.3 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.403 ' C ' ' H ' ' A' ' 101' ' ' GLY . 40.8 mtp180 -139.83 89.71 2.33 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 120.9 -1.125 . . . . 0.0 109.842 174.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 59.76 -13.84 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 128.154 2.581 . . . . 0.0 116.049 -163.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 99' ' ' ARG . . . -174.2 -176.36 42.53 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 126.163 1.839 . . . . 0.0 113.329 174.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 95.1 mt -72.37 117.51 14.11 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.796 2.038 . . . . 0.0 111.738 -174.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -146.59 141.84 27.35 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -95.96 120.92 37.09 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.428 1.491 . . . . 0.0 111.225 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 83.9 t -123.5 128.03 25.35 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 123.652 0.781 . . . . 0.0 109.945 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -62.87 142.93 90.42 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.283 1.989 . . . . 0.0 111.147 176.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.0 -31.89 19.46 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 176.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.42 -11.29 57.43 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 174.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -112.71 -4.62 14.03 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.144 1.378 . . . . 0.0 113.552 171.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.4 t -71.63 149.35 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.067 1.347 . . . . 0.0 111.712 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.14 152.04 79.47 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 126.26 1.824 . . . . 0.0 111.747 178.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -67.56 125.24 13.04 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.271 2.647 . . . . 0.0 111.093 -175.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 96.93 9.58 55.99 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-O 119.673 -0.515 . . . . 0.0 114.266 -173.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -65.52 161.37 20.28 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 118.183 0.991 . . . . 0.0 111.587 159.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.4 p -106.59 126.96 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.617 1.567 . . . . 0.0 111.604 178.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.9 t -106.2 136.41 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.791 1.636 . . . . 0.0 111.199 -177.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.3 t -89.78 134.74 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.081 0.952 . . . . 0.0 110.9 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -158.49 -153.11 6.64 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.533 1.064 . . . . 0.0 111.522 172.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.6 p -131.88 162.5 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.766 1.226 . . . . 0.0 110.294 167.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 40.3 mtt-85 -60.15 107.61 0.67 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.47 1.908 . . . . 0.0 112.556 -165.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -64.13 -31.04 72.09 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -176.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -62.09 -22.21 65.62 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 173.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 57.4 t -85.51 -53.74 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 173.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 16.2 tp -65.43 -15.66 62.85 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.99 1.716 . . . . 0.0 114.611 -172.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -95.3 -15.58 23.04 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 171.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.3 ttm180 -146.13 -8.66 0.53 Allowed 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 -162.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -137.93 176.0 9.09 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.924 1.29 . . . . 0.0 112.592 -174.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 16.0 tt -48.37 141.2 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 126.234 1.814 . . . . 0.0 111.178 159.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 10.9 pt -78.4 117.7 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 120.959 -1.088 . . . . 0.0 111.627 -174.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 59.9 p -81.44 72.95 8.49 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 120.978 -1.076 . . . . 0.0 111.698 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.45 148.45 48.54 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 121.366 -0.834 . . . . 0.0 111.748 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 89.87 11.34 63.67 Favored Glycine 0 CA--C 1.538 1.519 0 N-CA-C 116.0 1.16 . . . . 0.0 116.0 -177.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -127.9 158.81 36.79 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.257 1.423 . . . . 0.0 112.313 174.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.7 mt -137.94 158.56 44.09 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.276 1.83 . . . . 0.0 111.4 173.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -142.02 150.41 41.27 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.429 1.492 . . . . 0.0 112.339 177.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -91.52 148.87 21.98 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.944 1.697 . . . . 0.0 113.25 176.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -137.09 139.4 41.24 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.438 1.495 . . . . 0.0 109.911 -177.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -91.5 130.21 37.36 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.844 0.747 . . . . 0.0 111.843 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 71.1 t -67.94 125.47 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 O-C-N 121.498 -0.751 . . . . 0.0 109.758 168.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.4 t -85.62 -42.64 14.15 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.944 1.698 . . . . 0.0 112.635 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.5 t -159.93 165.41 32.16 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.602 1.161 . . . . 0.0 111.108 174.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.9 m -135.11 149.94 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.671 1.188 . . . . 0.0 110.936 168.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -156.02 160.31 39.91 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.964 0.906 . . . . 0.0 112.65 167.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 87.8 mt -81.67 143.44 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 161.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 43.2 pt -131.91 152.33 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.949 2.1 . . . . 0.0 111.383 173.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -87.12 97.21 10.62 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.004 -1.06 . . . . 0.0 110.769 174.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -76.94 -46.63 23.48 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.554 -1.341 . . . . 0.0 112.59 177.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 50.84 31.94 6.65 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.59 1.156 . . . . 0.0 114.077 -176.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -139.19 172.59 12.61 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.808 -1.183 . . . . 0.0 111.61 -176.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -71.18 141.35 50.7 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.34 1.056 . . . . 0.0 111.562 173.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.9 m -123.53 153.26 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 126.219 1.808 . . . . 0.0 109.551 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -109.72 161.92 14.94 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.169 0.587 . . . . 0.0 112.258 -173.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -143.19 157.59 44.37 Favored 'General case' 0 CA--C 1.55 0.949 0 O-C-N 121.722 -0.612 . . . . 0.0 111.366 158.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 44.1 tp -114.76 127.88 55.99 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.056 1.342 . . . . 0.0 110.555 174.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 37.8 t -98.26 132.73 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 121.689 0.757 . . . . 0.0 112.415 -169.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 20.8 mm -132.66 92.61 26.59 Favored Pre-proline 0 N--CA 1.47 0.535 0 C-N-CA 126.08 1.752 . . . . 0.0 108.599 -173.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -70.41 -13.25 32.86 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.404 2.069 . . . . 0.0 113.469 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -72.88 -45.66 57.03 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 118.725 0.693 . . . . 0.0 112.368 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 82.5 p -140.74 -10.21 1.04 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.807 1.643 . . . . 0.0 114.55 -171.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 45.8 m80 55.66 21.46 4.6 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 -169.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -143.7 148.57 35.93 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 120.74 -1.225 . . . . 0.0 113.955 177.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -143.3 167.62 21.72 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.346 1.458 . . . . 0.0 112.449 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 92.5 mt -115.18 131.12 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.416 1.486 . . . . 0.0 110.501 -172.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -81.31 160.23 65.69 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 123.914 0.886 . . . . 0.0 112.543 177.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.92 -12.34 32.4 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.741 2.294 . . . . 0.0 113.421 174.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -94.11 24.13 4.54 Favored 'General case' 0 CA--C 1.555 1.141 0 CA-C-N 118.785 0.72 . . . . 0.0 111.576 165.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 83.42 -23.31 6.45 Favored Glycine 0 CA--C 1.528 0.905 0 O-C-N 120.051 -1.655 . . . . 0.0 117.102 166.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 72.7 mt -61.84 142.03 57.59 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.897 1.348 . . . . 0.0 112.797 -175.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.2 t -98.02 124.95 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.96 0.904 . . . . 0.0 110.525 174.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 27.4 mt -119.37 139.69 51.58 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.856 1.662 . . . . 0.0 111.77 -168.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -97.87 139.75 33.26 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.007 0.923 . . . . 0.0 112.794 172.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -67.81 121.53 16.17 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.705 1.202 . . . . 0.0 111.883 176.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -134.06 85.26 2.18 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.977 0.911 . . . . 0.0 112.511 -176.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.253 1.288 0 C-N-CA 127.158 2.183 . . . . 0.0 112.462 173.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -137.42 155.78 48.95 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.422 1.889 . . . . 0.0 110.988 -172.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -55.28 141.46 35.53 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.203 1.001 . . . . 0.0 112.364 174.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -59.92 -21.09 60.65 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.012 0.925 . . . . 0.0 113.367 172.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -77.53 -3.68 41.84 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.493 1.517 . . . . 0.0 112.635 175.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.8 m -79.22 145.0 33.85 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 122.443 1.116 . . . . 0.0 112.689 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -73.64 158.74 34.19 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.726 1.61 . . . . 0.0 114.112 171.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.3 p -149.2 153.64 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 124.325 1.05 . . . . 0.0 111.599 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -122.91 130.71 53.18 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.69 1.996 . . . . 0.0 107.466 175.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -150.61 179.49 8.14 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.994 0.917 . . . . 0.0 111.287 169.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -140.77 143.69 35.05 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.447 1.499 . . . . 0.0 110.565 178.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -158.28 -39.95 0.06 Allowed 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -100.01 41.1 1.18 Allowed 'General case' 0 N--CA 1.479 1.023 0 O-C-N 120.999 -1.063 . . . . 0.0 112.936 -172.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.6 m 53.26 33.49 15.58 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.247 1.419 . . . . 0.0 112.434 -167.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.6 p -159.44 146.32 12.62 Favored Pre-proline 0 C--O 1.24 0.559 0 C-N-CA 126.8 2.04 . . . . 0.0 107.799 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -74.1 161.01 41.78 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.282 2.655 . . . . 0.0 111.596 171.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -137.75 125.33 22.18 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 126.416 1.886 . . . . 0.0 109.58 -175.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -127.75 112.78 15.17 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.458 1.503 . . . . 0.0 109.023 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -155.45 -175.64 5.54 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.293 1.437 . . . . 0.0 110.704 -177.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.5 m -78.07 148.05 34.44 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 120.9 -1.125 . . . . 0.0 110.045 168.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.466 HG12 ' CG ' ' A' ' 152' ' ' TYR . 7.3 tp -58.05 -38.71 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 O-C-N 121.508 -0.745 . . . . 0.0 111.831 177.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -61.09 -20.1 62.22 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 178.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -85.34 -46.07 11.32 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.87 1.268 . . . . 0.0 111.217 175.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -73.29 -33.59 65.3 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 121.202 -0.936 . . . . 0.0 112.158 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -59.95 -46.96 87.7 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.795 0.838 . . . . 0.0 111.1 176.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.9 t -63.04 -36.03 82.2 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.41 1.084 . . . . 0.0 111.551 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -65.23 -53.61 41.82 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.342 1.457 . . . . 0.0 110.395 175.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -72.29 -34.13 67.94 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.006 -1.059 . . . . 0.0 113.382 -178.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.16 -28.01 66.92 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.964 0.906 . . . . 0.0 112.748 176.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 51.3 m -75.89 -41.89 50.7 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.406 0.682 . . . . 0.0 111.479 172.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 45.5 mtm -78.71 -45.02 22.2 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.44 1.096 . . . . 0.0 113.006 -172.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 23.5 m-20 -111.44 -26.36 9.14 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.124 1.37 . . . . 0.0 112.238 -170.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.19 163.47 27.55 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.85 1.214 . . . . 0.0 114.424 176.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -110.79 126.6 54.79 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.575 1.15 . . . . 0.0 111.167 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.3 mp -95.69 147.68 33.39 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 127.077 2.151 . . . . 0.0 110.988 174.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -73.1 151.15 49.27 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.243 2.629 . . . . 0.0 111.125 174.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -133.73 160.67 36.88 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.318 1.447 . . . . 0.0 111.155 165.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -46.76 -49.03 20.38 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.058 1.343 . . . . 0.0 113.852 177.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -101.18 -5.93 24.94 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 177.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.49 -129.64 1.28 Allowed Glycine 0 CA--C 1.528 0.865 0 CA-C-N 119.75 1.159 . . . . 0.0 115.148 -173.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -144.64 156.32 44.05 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.684 1.194 . . . . 0.0 112.738 -174.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.34 150.45 47.74 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.547 1.139 . . . . 0.0 111.814 177.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.5 t -126.01 120.18 23.96 Favored Pre-proline 0 N--CA 1.48 1.065 0 C-N-CA 125.437 1.495 . . . . 0.0 110.027 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -76.05 139.19 21.42 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 124.13 3.22 . . . . 0.0 111.482 -176.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.3 mt -108.36 155.6 20.36 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.56 0.744 . . . . 0.0 112.516 178.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -138.11 132.5 32.11 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.098 1.359 . . . . 0.0 110.056 167.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 57.5 33.89 23.87 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.503 1.521 . . . . 0.0 113.896 -178.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.8 t -107.88 127.84 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 121.074 -1.016 . . . . 0.0 111.473 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -132.79 160.95 35.38 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.08 1.352 . . . . 0.0 113.905 -172.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.9 p -151.5 155.83 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 125.8 1.64 . . . . 0.0 112.467 -178.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -65.51 132.41 48.84 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.841 0.856 . . . . 0.0 110.153 168.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.8 t -132.81 140.17 47.85 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.711 1.605 . . . . 0.0 109.937 173.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.5 tp -91.15 134.1 34.81 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 171.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -79.73 105.32 10.94 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 164.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 23.2 mm -63.29 -24.74 36.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 O-C-N 121.647 -0.658 . . . . 0.0 111.566 -174.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -81.47 -37.21 28.31 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.307 1.843 . . . . 0.0 115.784 -178.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.0 m -106.13 -18.53 13.99 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.658 1.183 . . . . 0.0 112.483 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.4 25.73 73.67 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 125.324 1.44 . . . . 0.0 113.52 -168.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -79.52 131.28 35.99 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.899 1.68 . . . . 0.0 111.093 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.8 mp -92.37 113.47 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 173.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -138.38 172.81 12.35 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.079 1.352 . . . . 0.0 112.019 -174.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -103.9 148.05 26.61 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.66 1.184 . . . . 0.0 111.009 173.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.6 t -140.66 151.85 44.91 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.393 1.077 . . . . 0.0 111.178 173.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -72.89 157.58 37.17 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.252 1.021 . . . . 0.0 111.967 171.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -115.81 143.4 45.45 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.308 1.443 . . . . 0.0 110.942 168.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -88.67 -48.5 7.49 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.229 1.012 . . . . 0.0 112.933 -173.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -157.35 157.35 33.95 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.686 1.194 . . . . 0.0 112.043 177.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.5 mt -88.1 153.14 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 124.918 1.287 . . . . 0.0 108.265 166.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -135.22 151.31 50.5 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.025 1.73 . . . . 0.0 111.27 -178.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 26.8 ptt-85 -147.34 156.65 43.1 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 167.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -152.36 163.07 40.23 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.508 1.923 . . . . 0.0 108.945 176.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.17 143.44 26.37 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.36 -0.838 . . . . 0.0 110.577 176.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.0 m -143.28 143.81 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 122.417 1.103 . . . . 0.0 111.641 175.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -101.82 -15.23 16.98 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.657 1.183 . . . . 0.0 113.009 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -132.22 125.44 31.13 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.549 1.54 . . . . 0.0 110.903 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.1 tp -140.26 159.85 41.27 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.012 1.725 . . . . 0.0 109.538 -173.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.2 mt -112.53 128.52 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.372 1.069 . . . . 0.0 109.177 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -102.51 119.67 39.22 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.225 1.01 . . . . 0.0 110.696 169.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -104.16 127.9 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 124.821 1.249 . . . . 0.0 108.556 173.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -94.19 148.35 22.27 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.865 1.266 . . . . 0.0 110.719 172.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 70.6 mt -114.87 156.89 24.12 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.545 1.938 . . . . 0.0 111.367 -177.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 36.3 t -68.38 -20.1 64.67 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -163.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 37.2 m -93.86 4.76 53.45 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 173.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 102.08 11.57 36.52 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.129 1.347 . . . . 0.0 116.254 171.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -96.23 167.99 10.86 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.977 1.311 . . . . 0.0 111.706 177.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 97.1 p -142.46 157.76 44.41 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -176.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.1 tp -135.8 127.8 29.62 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.989 1.716 . . . . 0.0 110.337 177.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -108.7 115.81 30.79 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.491 1.516 . . . . 0.0 111.949 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.4 m -142.33 153.55 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.721 1.608 . . . . 0.0 113.142 -169.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.2 p -67.56 147.96 98.67 Favored Pre-proline 0 N--CA 1.465 0.314 0 O-C-N 121.308 -0.87 . . . . 0.0 112.305 174.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -55.5 -33.77 87.38 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.673 2.916 . . . . 0.0 114.102 -174.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.9 p -81.76 -6.96 59.52 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 30.1 t60 -76.27 120.18 80.54 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 124.737 1.215 . . . . 0.0 112.333 -174.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -75.65 129.78 12.06 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.869 2.379 . . . . 0.0 113.436 176.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.72 144.98 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 126.499 1.92 . . . . 0.0 109.256 174.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 21.2 tp -80.88 106.62 13.02 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.343 0.519 . . . . 0.0 110.561 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.5 mp -107.49 165.63 11.26 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.859 2.063 . . . . 0.0 112.272 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -119.86 119.43 33.52 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.447 1.099 . . . . 0.0 113.05 176.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 33.6 mtm180 -132.59 77.86 1.77 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.176 1.39 . . . . 0.0 108.486 164.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.2 t70 59.23 8.49 1.11 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 126.862 2.065 . . . . 0.0 115.501 -169.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.34 169.01 42.12 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.953 1.739 . . . . 0.0 111.228 -174.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 71.7 mt -76.58 119.23 20.12 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.512 1.125 . . . . 0.0 110.639 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -133.55 131.76 40.12 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.127 0.971 . . . . 0.0 110.915 -176.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -88.32 122.29 31.67 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 172.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 67.0 t -132.2 127.11 20.79 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 123.87 0.868 . . . . 0.0 110.301 -175.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -65.89 142.72 70.31 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.378 2.052 . . . . 0.0 111.239 176.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.97 -30.85 16.07 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 176.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.08 -18.44 65.31 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 173.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -111.74 -3.97 14.81 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.151 1.38 . . . . 0.0 112.248 175.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 89.3 t -71.16 144.49 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.833 1.253 . . . . 0.0 110.316 169.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.12 156.66 78.92 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 126.407 1.883 . . . . 0.0 110.895 -177.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.36 126.24 13.99 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.337 2.025 . . . . 0.0 112.404 -172.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 108.07 -2.85 33.4 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.03 1.3 . . . . 0.0 114.814 -178.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -59.81 160.38 7.66 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.938 1.295 . . . . 0.0 113.221 174.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.8 t -102.56 118.35 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.139 1.375 . . . . 0.0 109.975 177.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.4 t -93.79 141.55 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.698 1.599 . . . . 0.0 110.058 173.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.5 t -91.38 138.66 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.259 1.024 . . . . 0.0 110.555 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -164.7 -149.13 5.7 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 123.402 0.525 . . . . 0.0 114.339 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.7 p -150.33 159.44 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 127.008 2.123 . . . . 0.0 108.573 175.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -59.11 124.45 20.0 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.91 0.884 . . . . 0.0 112.249 176.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -59.38 -31.81 69.57 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -64.22 -21.8 66.71 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 175.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 86.9 t -80.13 -31.39 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 118.906 0.776 . . . . 0.0 111.075 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -85.2 -16.17 41.21 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.28 1.832 . . . . 0.0 113.154 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 70.2 mtt-85 -69.92 -14.14 62.58 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 166.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 10.4 mmp_? -80.16 145.4 32.35 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.55 1.14 . . . . 0.0 111.74 -176.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -72.66 -26.55 61.68 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 177.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 70.6 mt -98.7 127.94 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.836 1.255 . . . . 0.0 108.599 165.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 48.6 mm -102.64 116.33 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.81 1.244 . . . . 0.0 109.917 -176.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 9.5 t -87.86 149.36 24.16 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -101.32 169.66 8.75 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.044 1.738 . . . . 0.0 113.357 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.95 2.51 88.69 Favored Glycine 0 CA--C 1.54 1.619 0 N-CA-C 117.545 1.778 . . . . 0.0 117.545 167.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -125.11 148.37 48.58 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 119.62 1.71 . . . . 0.0 113.556 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 96.7 mt -139.58 174.25 10.7 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 127.864 2.465 . . . . 0.0 111.907 -177.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -142.25 170.85 14.94 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 127.437 2.295 . . . . 0.0 110.604 169.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -126.04 147.0 49.67 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.103 1.761 . . . . 0.0 110.805 172.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -135.76 134.79 39.37 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.257 1.023 . . . . 0.0 110.313 -168.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -95.13 138.95 32.15 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.523 -0.736 . . . . 0.0 112.916 -174.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 71.0 t -74.15 132.67 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.351 1.06 . . . . 0.0 111.012 174.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 36.1 t -91.64 -40.36 11.35 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.211 1.804 . . . . 0.0 113.082 176.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.5 t -162.08 165.97 26.45 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.18 0.992 . . . . 0.0 110.643 176.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.2 m -131.93 148.23 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.491 1.116 . . . . 0.0 109.986 166.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -152.0 154.46 36.05 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.377 1.071 . . . . 0.0 112.766 172.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 87.7 mt -94.32 129.21 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.414 1.086 . . . . 0.0 108.537 169.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 16.8 pt -123.02 165.4 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 126.393 1.877 . . . . 0.0 112.131 -177.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -108.24 68.21 0.69 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.463 1.905 . . . . 0.0 112.509 -173.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -62.21 -43.88 97.84 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 121.097 -1.002 . . . . 0.0 113.24 -164.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 50.97 33.27 8.59 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.338 1.455 . . . . 0.0 113.894 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -141.5 177.64 7.99 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.853 1.261 . . . . 0.0 111.962 -174.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -77.65 142.07 39.06 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.161 0.985 . . . . 0.0 113.055 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 14.8 m -126.76 151.04 33.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 125.666 1.586 . . . . 0.0 109.671 177.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.466 ' CG ' HG12 ' A' ' 21' ' ' ILE . 1.2 p90 -111.04 164.18 13.08 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.678 0.791 . . . . 0.0 112.463 -175.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -144.31 155.4 43.8 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 122.439 0.296 . . . . 0.0 110.761 154.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 46.6 tp -107.49 124.39 49.83 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.568 1.147 . . . . 0.0 110.329 175.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 23.1 t -91.98 117.44 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 121.768 0.794 . . . . 0.0 111.887 -171.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 13.7 mm -120.73 83.25 35.52 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 126.396 1.879 . . . . 0.0 109.063 -177.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -63.24 -19.31 68.21 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.123 1.882 . . . . 0.0 113.808 178.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -76.13 -30.38 58.16 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 120.533 -1.355 . . . . 0.0 113.944 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 69.7 p -141.43 -18.1 0.79 Allowed 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . 0.253 75.6 m80 56.82 21.89 6.47 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.077 2.151 . . . . 0.0 115.165 -168.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -147.32 145.66 29.42 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.618 1.099 . . . . 0.0 113.767 -179.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -148.66 164.79 33.27 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.085 1.354 . . . . 0.0 111.709 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.2 mp -111.39 136.3 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.296 1.038 . . . . 0.0 111.466 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -81.88 157.64 68.82 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 124.033 0.933 . . . . 0.0 112.374 175.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -64.92 -22.71 62.67 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.815 2.344 . . . . 0.0 112.76 178.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -77.27 -5.48 49.58 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.559 0.744 . . . . 0.0 112.856 173.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 112.55 -21.68 18.65 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 125.955 1.74 . . . . 0.0 116.566 165.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 58.3 mt -76.87 149.89 36.09 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.097 1.448 . . . . 0.0 113.88 -171.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.9 t -96.78 123.84 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.761 1.224 . . . . 0.0 111.818 -178.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 25.4 mt -117.47 142.88 46.63 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.323 1.849 . . . . 0.0 112.577 -169.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -102.72 140.42 37.02 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.266 1.026 . . . . 0.0 112.369 170.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -66.89 133.94 51.04 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.944 0.897 . . . . 0.0 111.649 174.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -142.85 113.89 7.68 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.08 0.952 . . . . 0.0 113.487 -176.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 . . . . . 0 C--O 1.253 1.273 0 C-N-CA 127.164 2.185 . . . . 0.0 111.774 -177.858 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.676 0 CA-C-O 120.832 0.349 . . . . 0.0 111.481 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.11 161.75 32.51 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.702 2.401 . . . . 0.0 110.684 -177.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.84 141.68 56.85 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.338 1.055 . . . . 0.0 112.59 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.2 ppt_? -56.54 -28.55 60.33 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.016 1.327 . . . . 0.0 113.166 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -81.74 -6.89 59.45 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.725 2.01 . . . . 0.0 114.599 -177.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.1 m -69.02 144.04 54.17 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.159 1.384 . . . . 0.0 112.856 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -82.06 152.02 26.8 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.438 1.495 . . . . 0.0 113.88 171.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.7 p -148.19 162.57 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.698 1.599 . . . . 0.0 111.685 -173.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -134.89 130.02 35.28 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.685 1.594 . . . . 0.0 109.823 -173.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -157.3 -178.53 7.42 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 118.924 0.784 . . . . 0.0 112.793 175.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -135.3 138.86 43.87 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.399 1.479 . . . . 0.0 111.43 172.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -169.0 146.92 3.8 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.139 1.376 . . . . 0.0 111.374 174.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.5 t0 62.92 36.93 12.38 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 115.321 1.601 . . . . 0.0 115.321 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 m 62.59 37.51 13.0 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.579 1.552 . . . . 0.0 113.504 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.8 p -157.29 137.08 8.58 Favored Pre-proline 0 CA--C 1.543 0.703 0 O-C-N 121.329 -0.857 . . . . 0.0 111.499 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.26 147.4 32.94 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.962 3.108 . . . . 0.0 111.111 171.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -127.35 135.97 51.26 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.812 1.245 . . . . 0.0 112.02 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 52.1 ttm -143.79 88.29 1.97 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.736 1.215 . . . . 0.0 109.789 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -146.31 -176.42 5.16 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.729 2.012 . . . . 0.0 111.645 -168.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -73.64 150.98 40.96 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.472 -1.392 . . . . 0.0 111.893 176.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.8 tp -58.34 -37.25 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 O-C-N 121.527 -0.733 . . . . 0.0 111.927 173.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -64.5 -30.44 71.47 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.215 0.916 . . . . 0.0 113.003 174.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -73.76 -41.39 62.51 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.587 -0.696 . . . . 0.0 110.301 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 20.0 ptm -69.47 -39.51 77.67 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.654 171.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -57.41 -52.41 65.49 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.975 0.807 . . . . 0.0 111.756 -178.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.8 t -71.55 -29.13 64.4 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 122.718 0.407 . . . . 0.0 111.503 -173.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -65.19 -53.01 51.17 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.363 1.465 . . . . 0.0 110.634 173.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -68.26 -32.77 73.18 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.376 -0.827 . . . . 0.0 112.015 177.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.74 -28.54 66.9 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.495 1.118 . . . . 0.0 113.658 174.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.4 t -83.83 -31.49 25.79 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.416 -0.802 . . . . 0.0 111.736 174.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 67.1 mtm -81.33 -42.75 20.09 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -114.27 -23.11 9.59 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.193 1.397 . . . . 0.0 113.875 -171.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.98 161.74 37.01 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.836 1.208 . . . . 0.0 114.647 -178.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -112.83 128.43 56.44 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.566 1.547 . . . . 0.0 110.406 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.8 mp -105.54 142.56 25.01 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 125.393 1.477 . . . . 0.0 111.789 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.24 146.27 40.25 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 124.04 3.16 . . . . 0.0 112.349 -177.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -141.12 159.55 41.98 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.083 1.753 . . . . 0.0 111.346 -178.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -61.42 -52.07 66.12 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 120.203 -1.56 . . . . 0.0 114.578 -178.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -79.84 -15.34 57.59 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 172.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -179.05 -125.99 0.98 Allowed Glycine 0 CA--C 1.539 1.549 0 N-CA-C 117.177 1.631 . . . . 0.0 117.177 -175.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -143.6 161.89 37.32 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.897 1.679 . . . . 0.0 111.003 178.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.19 148.52 41.7 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.952 1.301 . . . . 0.0 112.486 -176.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 54.5 t -124.11 120.99 26.28 Favored Pre-proline 0 N--CA 1.481 1.113 0 C-N-CA 125.756 1.623 . . . . 0.0 110.861 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -75.9 141.91 24.65 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 124.245 3.297 . . . . 0.0 112.317 -178.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.3 mt -106.45 164.58 11.93 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.52 1.128 . . . . 0.0 113.692 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -146.65 125.71 12.87 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.297 1.439 . . . . 0.0 111.009 173.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 54.46 32.96 17.74 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 125.758 1.623 . . . . 0.0 114.251 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.2 t -96.31 122.38 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 120.849 -1.157 . . . . 0.0 110.179 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -124.12 155.04 39.14 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.488 1.115 . . . . 0.0 113.508 -174.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.5 p -150.49 152.19 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.663 1.185 . . . . 0.0 111.976 -176.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -63.31 129.83 41.95 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 122.026 0.917 . . . . 0.0 110.228 167.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.2 t -131.22 152.17 50.76 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.624 1.97 . . . . 0.0 111.248 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.6 tp -105.0 135.0 47.15 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.428 1.091 . . . . 0.0 110.211 175.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -80.8 116.04 20.59 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.769 0.828 . . . . 0.0 110.404 164.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 39.4 mm -71.9 -21.43 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.634 0.774 . . . . 0.0 112.473 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.8 -43.11 31.61 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.91 0.884 . . . . 0.0 113.305 -176.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -107.28 -23.67 12.16 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.405 1.082 . . . . 0.0 111.882 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.9 34.25 38.95 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.519 1.056 . . . . 0.0 113.272 -170.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -99.27 147.18 25.43 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.747 1.274 . . . . 0.0 113.502 -175.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.4 mp -91.95 130.88 40.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 C-N-CA 125.999 1.72 . . . . 0.0 110.025 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -157.5 171.43 20.37 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.367 1.467 . . . . 0.0 112.374 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -102.86 141.65 35.32 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.075 1.35 . . . . 0.0 111.047 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.1 t -141.5 166.44 24.74 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.094 0.958 . . . . 0.0 112.373 176.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -93.61 150.79 20.13 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.941 1.296 . . . . 0.0 112.809 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.56 139.16 46.07 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.563 1.145 . . . . 0.0 111.556 173.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 93.1 p -91.0 -51.93 5.1 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -165.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -155.07 159.56 40.35 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.494 1.517 . . . . 0.0 112.95 177.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.3 mt -96.66 151.59 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 125.803 1.641 . . . . 0.0 109.117 170.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -137.6 148.5 45.9 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.347 1.459 . . . . 0.0 111.569 -174.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.51 149.12 52.38 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.399 1.48 . . . . 0.0 112.423 176.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -155.6 162.41 40.64 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.945 1.298 . . . . 0.0 110.386 176.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -101.74 140.92 35.38 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.08 0.952 . . . . 0.0 110.983 -176.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.8 m -149.05 144.47 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 124.527 1.131 . . . . 0.0 111.522 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -93.01 -36.16 12.88 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 126.278 1.831 . . . . 0.0 111.384 170.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -118.38 130.61 56.09 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.355 1.062 . . . . 0.0 110.981 -171.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.3 tp -139.02 159.14 42.86 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.648 1.979 . . . . 0.0 109.403 -173.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.4 mt -113.07 126.05 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.884 0.874 . . . . 0.0 109.209 176.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -97.03 127.82 43.38 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.08 0.952 . . . . 0.0 111.268 167.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -113.79 133.02 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.467 1.507 . . . . 0.0 109.474 173.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -103.78 146.47 28.58 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 126.753 2.021 . . . . 0.0 111.957 -179.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 68.2 mt -119.48 156.72 29.7 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.785 1.634 . . . . 0.0 113.08 -173.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.9 t -57.45 -29.39 64.16 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.312 1.445 . . . . 0.0 113.913 -178.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 55.7 m -75.44 1.38 14.17 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 173.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.63 43.26 19.4 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-N 119.608 1.095 . . . . 0.0 112.596 -178.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -130.48 152.78 49.5 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.15 1.78 . . . . 0.0 109.667 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 54.3 p -132.37 149.68 52.3 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 174.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 67.3 tp -122.19 134.18 54.72 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 126.501 1.92 . . . . 0.0 110.791 176.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -113.26 117.29 31.44 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.286 1.435 . . . . 0.0 111.962 -178.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.0 m -140.59 158.33 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.275 1.43 . . . . 0.0 112.913 -174.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.6 p -65.61 147.56 98.63 Favored Pre-proline 0 N--CA 1.471 0.61 0 O-C-N 120.975 -1.078 . . . . 0.0 112.766 174.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -59.5 -32.7 96.69 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.385 2.723 . . . . 0.0 113.763 -172.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 64.6 p -75.66 -1.64 25.66 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.774 2.03 . . . . 0.0 114.9 177.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 53.6 t60 -91.07 122.11 66.98 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 124.497 1.119 . . . . 0.0 113.022 -165.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -73.22 142.28 33.67 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.929 2.419 . . . . 0.0 114.425 -177.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.2 t -125.89 143.14 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 126.73 2.012 . . . . 0.0 109.479 174.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.1 tt -81.21 105.52 12.48 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.703 0.763 . . . . 0.0 110.087 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.8 mp -99.73 159.58 14.95 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.335 1.854 . . . . 0.0 111.381 177.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -113.54 133.31 55.32 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.675 -0.641 . . . . 0.0 111.89 174.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -153.46 96.86 2.08 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.942 1.697 . . . . 0.0 110.224 155.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 56.27 -3.33 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 127.328 2.251 . . . . 0.0 116.898 -167.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.83 163.43 34.52 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.372 1.463 . . . . 0.0 113.333 177.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 67.5 mt -67.93 115.16 7.14 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.066 2.146 . . . . 0.0 110.943 -177.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -141.73 139.81 32.97 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -178.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -98.37 124.53 43.09 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.919 0.887 . . . . 0.0 112.157 -175.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 62.1 t -131.58 131.28 22.74 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 125.196 1.398 . . . . 0.0 110.258 -172.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.43 145.62 77.67 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.583 2.188 . . . . 0.0 111.878 177.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.57 -30.95 14.4 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 176.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.27 -25.93 68.27 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 173.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -102.59 -4.95 24.45 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.032 1.733 . . . . 0.0 112.737 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 98.5 t -69.69 148.76 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.024 0.929 . . . . 0.0 109.647 166.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.92 155.22 71.09 Favored Pre-proline 0 N--CA 1.471 0.585 0 C-N-CA 127.252 2.221 . . . . 0.0 109.987 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.89 119.48 6.51 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.041 1.827 . . . . 0.0 111.577 -177.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.24 6.87 33.45 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.158 1.361 . . . . 0.0 114.705 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -61.15 155.62 20.22 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.275 1.037 . . . . 0.0 111.654 163.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.6 t -93.04 128.46 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.421 1.088 . . . . 0.0 110.071 169.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 28.0 t -103.03 139.03 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 126.381 1.872 . . . . 0.0 109.695 171.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.6 t -91.68 141.34 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.531 0.732 . . . . 0.0 110.772 176.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -168.38 -150.52 6.66 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 121.728 -0.607 . . . . 0.0 114.188 -177.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.4 p -140.33 168.36 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 126.253 1.821 . . . . 0.0 109.979 175.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 35.9 mtp180 -62.02 112.62 2.41 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.584 1.554 . . . . 0.0 112.607 -175.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -63.58 -21.38 66.32 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.083 1.353 . . . . 0.0 113.085 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -83.09 -31.12 27.46 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 173.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 46.6 t -86.29 -40.88 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.488 0.715 . . . . 0.0 110.972 -174.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 42.2 tp -65.9 -28.64 69.09 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.535 0.734 . . . . 0.0 112.2 178.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 36.5 mtp-105 -95.07 28.59 2.73 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.698 1.599 . . . . 0.0 113.082 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 71.1 mtt85 -138.09 157.98 45.23 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 127.699 2.4 . . . . 0.0 109.64 170.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -70.19 147.68 49.54 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.027 0.931 . . . . 0.0 112.04 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 91.4 mt 60.09 114.0 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 127.07 2.148 . . . . 0.0 112.486 -162.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.5 mp -86.13 134.34 27.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 123.975 0.91 . . . . 0.0 108.973 167.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 41.3 t -79.89 130.38 35.26 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.381 0.673 . . . . 0.0 109.7 167.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.3 ptpt -91.39 144.0 26.03 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.505 1.122 . . . . 0.0 111.866 -172.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 74.32 24.49 73.07 Favored Glycine 0 CA--C 1.54 1.597 0 N-CA-C 114.985 0.754 . . . . 0.0 114.985 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -121.97 136.72 54.94 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.293 1.437 . . . . 0.0 112.658 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 60.9 mt -128.93 174.18 9.74 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.652 1.981 . . . . 0.0 112.297 178.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -140.05 169.53 17.53 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.885 2.474 . . . . 0.0 109.279 171.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -135.5 156.18 49.32 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 119.992 -1.693 . . . . 0.0 111.627 164.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.29 140.09 52.07 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.589 1.156 . . . . 0.0 110.862 -172.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -89.28 133.69 34.36 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.51 0.724 . . . . 0.0 110.985 170.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 79.4 t -72.15 122.58 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 123.433 0.693 . . . . 0.0 110.229 174.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 47.9 t -77.76 -41.98 35.68 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.652 1.181 . . . . 0.0 112.478 174.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.7 t -160.8 164.67 31.26 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.458 -0.777 . . . . 0.0 112.376 -177.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.7 m -135.72 150.71 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.485 1.114 . . . . 0.0 110.999 167.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -152.68 155.94 38.24 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.397 1.079 . . . . 0.0 112.943 173.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 80.5 mt -93.01 130.82 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 168.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 36.3 pt -122.33 149.37 25.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 124.63 1.172 . . . . 0.0 112.371 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.53 102.47 12.88 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.421 1.088 . . . . 0.0 110.069 168.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -84.34 -50.38 7.87 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.211 0.604 . . . . 0.0 111.715 172.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 44.57 57.17 4.62 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.978 1.311 . . . . 0.0 112.504 -173.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -151.63 175.71 12.08 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.712 0.805 . . . . 0.0 112.176 -177.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -67.67 144.42 55.5 Favored 'General case' 0 N--CA 1.463 0.189 0 O-C-N 121.727 -0.608 . . . . 0.0 110.79 162.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.1 m -122.5 152.16 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.521 1.128 . . . . 0.0 109.466 169.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -114.47 157.2 23.25 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 121.781 0.801 . . . . 0.0 112.09 -178.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -155.59 153.94 30.89 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.777 0.831 . . . . 0.0 109.784 -165.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 32.3 tp -136.51 139.44 42.27 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.174 -0.954 . . . . 0.0 111.788 -170.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 28.9 t -113.17 130.04 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.763 0.825 . . . . 0.0 112.608 -168.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 11.0 mm -134.08 85.55 39.51 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 125.728 1.611 . . . . 0.0 109.535 -175.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.98 -13.71 39.08 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.006 2.471 . . . . 0.0 113.766 -177.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -79.43 -40.18 30.58 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.383 0.882 . . . . 0.0 113.383 -177.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 59.1 p -140.14 -6.41 1.24 Allowed 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -171.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 58.01 13.35 2.15 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.203 1.801 . . . . 0.0 115.851 -174.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.03 147.55 24.15 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 120.96 1.709 . . . . 0.0 114.983 -176.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -146.85 159.24 43.76 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.369 1.068 . . . . 0.0 113.539 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.7 mp -99.7 137.96 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.466 1.106 . . . . 0.0 112.643 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -91.0 156.26 44.32 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 126.664 1.986 . . . . 0.0 112.428 172.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -67.75 -19.83 46.85 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.763 2.976 . . . . 0.0 113.74 -174.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 47.6 p30 -73.18 -0.94 15.67 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.063 1.345 . . . . 0.0 113.418 171.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.2 -5.63 68.28 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 126.391 1.948 . . . . 0.0 115.385 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 66.8 mt -84.94 153.54 22.76 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.231 1.516 . . . . 0.0 111.846 -175.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.7 p -110.55 133.04 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.785 0.834 . . . . 0.0 111.798 175.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 24.4 mt -116.2 154.33 30.26 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.831 2.052 . . . . 0.0 110.844 -172.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 8.3 t-80 -111.64 149.75 31.09 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.081 0.952 . . . . 0.0 112.86 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -60.47 137.07 58.21 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.474 0.709 . . . . 0.0 111.161 162.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -91.71 -3.57 56.1 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 -171.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 . . . . . 0 C--O 1.247 0.957 0 C-N-CA 125.101 1.36 . . . . 0.0 112.042 -168.622 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.608 0 CA-C-O 120.819 0.343 . . . . 0.0 111.6 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.12 156.32 45.37 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.704 1.602 . . . . 0.0 110.748 -169.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.08 145.3 31.3 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.825 1.25 . . . . 0.0 114.203 -177.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -60.64 -23.39 64.73 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.474 1.509 . . . . 0.0 114.216 177.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -92.79 4.37 53.93 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.792 0.837 . . . . 0.0 112.973 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.8 m -71.47 140.14 49.89 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.027 -1.045 . . . . 0.0 111.603 174.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -65.67 155.61 35.44 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.241 1.417 . . . . 0.0 113.648 167.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.7 p -148.11 151.93 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.331 1.052 . . . . 0.0 111.341 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -128.08 126.22 40.78 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.544 1.538 . . . . 0.0 108.254 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -156.92 176.98 12.03 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.396 0.678 . . . . 0.0 111.616 -177.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -134.83 138.36 44.15 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.683 1.193 . . . . 0.0 110.08 178.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -161.66 158.79 26.61 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.425 1.09 . . . . 0.0 110.213 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.3 t0 50.27 37.87 16.14 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.063 0.945 . . . . 0.0 113.26 -175.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.7 m 53.39 41.85 32.07 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.398 1.079 . . . . 0.0 113.372 -176.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.0 p -157.92 142.19 11.61 Favored Pre-proline 0 CA--C 1.545 0.753 0 O-C-N 120.968 -1.083 . . . . 0.0 111.216 174.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.14 149.26 64.21 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 123.003 2.468 . . . . 0.0 112.604 174.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -137.11 139.82 41.5 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 127.209 2.203 . . . . 0.0 109.629 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 42.6 ttm -153.08 106.1 2.98 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.361 -0.837 . . . . 0.0 110.775 -174.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -159.55 -179.3 7.78 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.006 1.322 . . . . 0.0 111.963 -165.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.4 m -71.03 138.02 49.51 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.099 -1.0 . . . . 0.0 110.565 169.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.458 HG12 ' CG ' ' A' ' 152' ' ' TYR . 6.6 tp -55.13 -38.75 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 O-C-N 121.251 -0.906 . . . . 0.0 112.606 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -66.29 -16.78 64.31 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.389 0.995 . . . . 0.0 113.104 -177.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -87.2 -41.13 13.97 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.846 1.258 . . . . 0.0 111.178 173.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 2.1 ppp? -73.4 -36.93 66.09 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 120.914 -1.116 . . . . 0.0 112.062 176.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -55.42 -45.7 76.73 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.447 1.099 . . . . 0.0 110.673 175.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.2 t -60.98 -34.67 75.14 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.1 0.96 . . . . 0.0 111.156 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -65.47 -53.08 47.78 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.457 1.103 . . . . 0.0 110.513 174.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -73.28 -35.36 66.15 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 121.495 -0.753 . . . . 0.0 112.739 -173.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.01 -35.67 80.45 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.262 0.625 . . . . 0.0 110.686 172.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 54.5 m -76.9 -24.08 52.51 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 121.049 -1.032 . . . . 0.0 113.538 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 33.1 mtm -90.54 -52.98 4.63 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.844 1.258 . . . . 0.0 112.062 177.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -100.31 -21.33 15.49 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.34 1.456 . . . . 0.0 112.049 -167.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.84 161.09 31.58 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.632 1.111 . . . . 0.0 113.049 -177.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -102.76 138.38 39.73 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.663 1.185 . . . . 0.0 111.155 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.6 mp -107.4 148.21 36.73 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 128.925 2.89 . . . . 0.0 110.212 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.85 155.68 43.68 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 123.516 2.811 . . . . 0.0 112.53 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -142.46 175.95 9.38 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.857 1.263 . . . . 0.0 112.524 169.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.61 -55.96 25.95 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.555 1.142 . . . . 0.0 112.119 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -105.94 -4.19 20.91 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -175.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -169.7 -135.69 1.95 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 114.61 0.604 . . . . 0.0 114.61 -172.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -144.65 165.37 28.23 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.086 1.754 . . . . 0.0 111.334 -175.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.29 159.33 42.33 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.687 1.595 . . . . 0.0 111.617 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 54.2 t -131.52 117.18 16.47 Favored Pre-proline 0 N--CA 1.48 1.061 0 C-N-CA 125.747 1.619 . . . . 0.0 111.102 178.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -82.46 123.3 3.81 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 124.233 3.289 . . . . 0.0 112.664 -172.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 90.5 mt -97.74 157.48 16.04 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -171.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -134.49 127.04 30.62 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.731 1.613 . . . . 0.0 112.588 171.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 52.32 40.95 30.23 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.246 1.418 . . . . 0.0 113.578 178.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.7 t -104.26 126.62 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.974 1.31 . . . . 0.0 109.543 172.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -126.46 158.74 35.26 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.927 1.291 . . . . 0.0 112.305 -175.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.8 m -143.09 150.18 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 126.334 1.853 . . . . 0.0 111.457 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -69.56 133.07 47.21 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 122.925 1.345 . . . . 0.0 109.666 164.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.3 t -137.13 164.68 27.87 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.7 2.4 . . . . 0.0 110.345 -173.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.3 tp -119.22 135.37 54.72 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.389 1.076 . . . . 0.0 109.194 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -79.1 105.99 10.83 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 163.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.2 mm -70.62 -24.63 25.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.685 0.794 . . . . 0.0 111.579 -175.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.97 -47.56 71.2 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.439 1.496 . . . . 0.0 113.391 -177.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.1 m -107.98 -19.27 13.56 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.599 1.16 . . . . 0.0 112.745 178.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.62 36.87 15.14 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.018 0.818 . . . . 0.0 112.318 -176.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -101.63 134.5 44.67 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.875 1.67 . . . . 0.0 112.591 -177.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 mp -76.64 136.53 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 O-C-N 121.798 -0.564 . . . . 0.0 109.934 178.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.1 ptpt -146.94 168.09 22.36 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.559 1.544 . . . . 0.0 111.781 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -116.05 147.71 40.98 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.414 1.486 . . . . 0.0 109.349 170.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.3 t -147.12 161.3 41.15 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.714 0.806 . . . . 0.0 111.866 -178.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -83.75 137.92 33.51 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.727 1.211 . . . . 0.0 112.027 175.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.34 132.18 44.03 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.229 1.011 . . . . 0.0 109.707 169.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.3 t -94.63 -41.09 9.48 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -163.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -150.51 156.23 41.03 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.923 1.289 . . . . 0.0 110.842 173.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.4 mt -88.49 149.4 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 162.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -126.95 149.2 49.96 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 126.324 1.85 . . . . 0.0 109.742 175.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.52 142.67 47.09 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.661 1.184 . . . . 0.0 111.71 167.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -141.98 153.22 44.13 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.595 1.158 . . . . 0.0 109.868 171.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.5 mmtt -84.06 144.36 29.12 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.813 -0.555 . . . . 0.0 110.661 171.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 20.5 m -143.09 140.51 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 122.457 1.122 . . . . 0.0 111.883 173.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -102.05 -9.11 20.87 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.594 1.558 . . . . 0.0 112.453 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -139.46 131.3 27.6 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.076 1.35 . . . . 0.0 109.952 175.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 13.0 tp -139.52 160.28 40.22 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.996 1.318 . . . . 0.0 109.513 -176.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.9 mt -111.63 127.5 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.851 0.861 . . . . 0.0 109.451 179.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -98.51 120.02 38.21 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.091 0.956 . . . . 0.0 110.786 167.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.4 mp -102.16 127.47 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.316 1.046 . . . . 0.0 108.473 168.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -97.12 151.05 20.16 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.071 1.348 . . . . 0.0 110.838 173.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 59.9 mt -117.21 159.97 21.8 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.263 1.825 . . . . 0.0 112.864 -172.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.7 t -58.8 -25.1 62.8 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.721 1.608 . . . . 0.0 113.368 177.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.8 p -67.33 -11.5 57.8 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.204 1.801 . . . . 0.0 115.236 172.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.78 -1.42 83.52 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 125.193 1.378 . . . . 0.0 114.664 -170.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -95.92 173.12 7.6 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.247 1.819 . . . . 0.0 112.835 -175.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.7 p -143.36 164.25 30.79 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 17.5 tp -139.09 137.07 35.87 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.331 1.452 . . . . 0.0 111.204 174.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.7 mtmt -113.69 117.72 32.33 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.023 1.329 . . . . 0.0 112.803 -176.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.2 m -143.48 153.93 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 125.868 1.667 . . . . 0.0 113.08 -163.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.6 p -70.16 149.76 96.09 Favored Pre-proline 0 N--CA 1.475 0.813 0 O-C-N 120.731 -1.231 . . . . 0.0 112.824 176.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -60.86 -22.76 75.01 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.692 2.928 . . . . 0.0 114.069 -174.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 58.9 p -88.81 -11.49 44.68 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.882 1.673 . . . . 0.0 115.02 177.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -65.74 121.78 77.27 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-N 119.332 0.969 . . . . 0.0 110.887 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -77.35 128.24 9.54 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.709 2.272 . . . . 0.0 112.789 177.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.0 t -100.0 137.55 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 C-N-CA 126.425 1.89 . . . . 0.0 109.692 176.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.33 108.35 13.86 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.6 mp -103.4 146.65 28.17 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.346 1.458 . . . . 0.0 111.904 -177.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -96.92 96.74 8.73 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.181 0.515 . . . . 0.0 111.518 170.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -124.73 73.73 1.29 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 122.808 1.289 . . . . 0.0 110.148 -178.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.4 t70 60.38 4.03 0.64 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 128.165 2.586 . . . . 0.0 114.79 -162.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -177.66 174.63 47.05 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 126.566 2.032 . . . . 0.0 111.28 -175.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.0 mt -76.5 123.36 25.92 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.748 1.219 . . . . 0.0 110.376 174.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -155.09 159.46 40.25 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.007 1.323 . . . . 0.0 112.492 176.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -107.16 131.76 53.79 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.901 0.88 . . . . 0.0 112.367 -175.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 97.1 t -132.72 129.39 21.26 Favored Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 124.099 0.96 . . . . 0.0 110.829 175.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -62.21 144.65 95.87 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.741 2.294 . . . . 0.0 111.944 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.68 -31.57 26.38 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.32 -25.61 67.24 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 172.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -108.37 -2.85 18.79 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.924 1.69 . . . . 0.0 112.945 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 89.6 t -70.0 139.2 20.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 O-C-N 121.542 -0.724 . . . . 0.0 109.563 162.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.18 154.96 74.38 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 126.187 1.795 . . . . 0.0 110.113 -177.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.69 121.14 8.03 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.194 1.93 . . . . 0.0 110.641 -175.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.37 4.95 34.89 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.377 0.989 . . . . 0.0 114.609 -174.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -65.87 175.79 1.84 Allowed 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 118.897 1.349 . . . . 0.0 113.08 168.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.5 p -125.16 123.26 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 125.069 1.348 . . . . 0.0 111.945 -176.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 26.0 t -115.9 131.9 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 125.652 1.581 . . . . 0.0 111.923 -167.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.0 t -88.18 140.88 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 122.063 0.935 . . . . 0.0 111.659 -178.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -170.07 -144.35 4.27 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.906 1.717 . . . . 0.0 111.845 -176.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.3 p -150.49 163.88 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 126.722 2.009 . . . . 0.0 109.131 173.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -62.66 121.19 12.76 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.635 0.774 . . . . 0.0 111.887 169.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -67.9 -29.25 68.3 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -169.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -56.31 -33.97 66.08 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 172.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 23.8 t -75.03 -40.01 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.812 0.815 . . . . 0.0 110.202 176.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 23.1 tp -72.8 -29.85 63.6 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.086 0.954 . . . . 0.0 112.922 -177.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 90.7 mtt-85 -84.79 15.84 3.67 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.995 1.718 . . . . 0.0 112.394 172.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 19.6 mmm-85 60.1 9.73 1.96 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 128.595 2.758 . . . . 0.0 116.324 176.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -66.85 -22.22 66.0 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 119.626 1.103 . . . . 0.0 113.208 -178.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 14.3 tt -141.0 153.99 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 125.621 1.568 . . . . 0.0 110.099 170.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 30.5 pt -93.91 126.79 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.171 0.989 . . . . 0.0 111.822 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 2.0 t -167.06 122.74 1.11 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.769 1.627 . . . . 0.0 109.177 172.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -99.91 143.7 29.82 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.484 1.114 . . . . 0.0 113.474 -174.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 63.65 26.44 69.82 Favored Glycine 0 CA--C 1.535 1.328 0 N-CA-C 117.535 1.774 . . . . 0.0 117.535 168.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -109.62 165.31 11.77 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 119.891 1.845 . . . . 0.0 114.478 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 97.0 mt -138.92 176.94 8.26 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 128.404 2.682 . . . . 0.0 112.321 -178.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -155.63 159.76 39.88 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.963 2.105 . . . . 0.0 111.535 169.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -107.44 151.2 25.87 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.63 1.172 . . . . 0.0 113.0 169.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -135.69 136.79 41.17 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.037 1.335 . . . . 0.0 110.704 -167.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -85.08 134.14 34.2 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.507 -0.745 . . . . 0.0 111.878 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 70.3 t -73.89 126.17 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.167 0.587 . . . . 0.0 110.279 171.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.6 t -81.35 -49.56 10.54 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.146 1.778 . . . . 0.0 112.461 175.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.4 m -156.09 161.34 40.4 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.709 1.204 . . . . 0.0 110.633 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.5 m -134.14 144.35 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.077 0.951 . . . . 0.0 110.337 167.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -152.24 155.79 38.43 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 173.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 85.9 mt -86.81 139.95 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 167.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 21.9 pt -130.52 148.82 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 125.958 1.703 . . . . 0.0 110.94 174.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -86.64 89.72 8.02 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.391 -0.818 . . . . 0.0 109.825 177.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -71.87 -44.0 64.51 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -172.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 51.61 26.8 3.53 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 126.544 1.938 . . . . 0.0 114.832 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 -139.65 175.56 9.47 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.694 1.198 . . . . 0.0 111.662 -173.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -74.19 140.81 45.37 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 124.006 0.922 . . . . 0.0 112.617 177.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 15.0 m -122.68 154.95 27.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 126.131 1.772 . . . . 0.0 109.079 172.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.458 ' CG ' HG12 ' A' ' 21' ' ' ILE . 3.2 p90 -110.34 159.32 17.54 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.558 0.743 . . . . 0.0 112.217 -177.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -137.9 143.84 41.04 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 122.639 0.376 . . . . 0.0 110.356 158.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 60.4 tp -111.39 103.59 11.97 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.526 1.13 . . . . 0.0 110.223 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.0 t -81.05 122.95 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -158.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 24.2 mm -112.42 96.33 35.4 Favored Pre-proline 0 N--CA 1.469 0.513 0 C-N-CA 125.464 1.506 . . . . 0.0 110.035 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.38 -14.77 37.83 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.022 1.815 . . . . 0.0 113.553 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -73.16 -65.34 0.82 Allowed 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 119.145 0.884 . . . . 0.0 111.735 177.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 67.7 p -114.88 -10.72 12.3 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.296 1.439 . . . . 0.0 114.04 -171.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 59.06 18.86 6.71 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.46 1.504 . . . . 0.0 114.243 -167.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -146.63 145.66 30.14 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -175.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -146.46 163.76 34.66 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.62 1.568 . . . . 0.0 112.596 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.0 mp -102.14 134.94 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 O-C-N 121.261 -0.9 . . . . 0.0 111.715 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.32 154.24 54.14 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 124.956 1.302 . . . . 0.0 112.307 170.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.09 -17.05 54.34 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.705 2.937 . . . . 0.0 114.736 -173.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -73.07 -6.01 42.74 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 169.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 111.66 -20.87 22.07 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 126.359 1.933 . . . . 0.0 115.221 172.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 54.4 mt -81.92 145.51 30.28 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 120.1 1.95 . . . . 0.0 113.842 -166.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.5 t -89.26 123.87 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.954 0.902 . . . . 0.0 110.603 176.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 20.8 mt -115.73 137.93 51.61 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.644 1.578 . . . . 0.0 111.184 -174.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -101.16 145.26 29.02 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.149 0.979 . . . . 0.0 111.016 168.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -59.62 164.94 3.23 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.411 1.084 . . . . 0.0 112.06 170.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -127.26 14.18 7.2 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 116.678 2.103 . . . . 0.0 116.678 -175.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 . . . . . 0 N--CA 1.484 1.228 0 CA-C-N 121.108 1.776 . . . . 0.0 114.979 -176.758 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.58 159.9 41.19 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.867 1.667 . . . . 0.0 112.09 -168.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.27 146.48 39.21 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.177 1.391 . . . . 0.0 113.015 175.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.03 -22.72 64.83 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.098 1.359 . . . . 0.0 114.521 177.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -87.4 -2.54 58.69 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.7 m -65.02 134.87 54.82 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.902 0.881 . . . . 0.0 111.628 175.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -75.07 153.29 38.43 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.009 0.924 . . . . 0.0 112.882 172.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 p -145.56 158.96 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.287 1.035 . . . . 0.0 112.389 -174.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -127.82 133.52 49.41 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.018 1.727 . . . . 0.0 109.456 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -156.28 168.93 25.78 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 170.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -132.91 143.72 49.68 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.321 1.448 . . . . 0.0 111.52 -178.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -157.86 136.41 11.2 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.071 1.349 . . . . 0.0 109.566 175.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.5 t0 50.48 46.91 24.87 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.397 1.479 . . . . 0.0 113.972 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.7 m 61.86 42.4 10.47 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 176.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.1 p -155.05 140.51 12.46 Favored Pre-proline 0 CA--C 1.548 0.871 0 O-C-N 121.027 -1.046 . . . . 0.0 111.514 167.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -91.21 157.42 3.8 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 124.981 3.787 . . . . 0.0 114.802 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 33.1 m80 -136.74 138.17 40.68 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.63 1.972 . . . . 0.0 110.553 -173.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 41.6 ttm -144.64 107.82 4.55 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.666 0.787 . . . . 0.0 111.809 176.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -156.8 -179.97 8.71 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.287 1.435 . . . . 0.0 111.746 -174.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.3 m -67.34 136.81 55.39 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.376 -0.828 . . . . 0.0 110.023 171.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.43 HG12 ' CG ' ' A' ' 152' ' ' TYR . 7.8 tp -54.85 -36.53 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 121.173 -0.954 . . . . 0.0 112.924 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -62.36 -17.96 60.29 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -82.24 -54.44 5.25 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.3 1.44 . . . . 0.0 110.37 174.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -65.26 -32.63 74.39 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.63 -0.669 . . . . 0.0 112.013 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -60.4 -51.12 70.83 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.33 0.652 . . . . 0.0 111.454 169.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.0 t -61.23 -38.07 85.31 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.667 0.787 . . . . 0.0 111.001 -177.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -62.71 -52.72 62.16 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 125.328 1.451 . . . . 0.0 110.845 174.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -72.17 -32.68 67.07 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.199 -0.938 . . . . 0.0 113.2 -176.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.46 -31.22 68.28 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.971 0.908 . . . . 0.0 112.547 174.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.8 t -78.6 -20.65 50.0 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.969 1.308 . . . . 0.0 112.322 176.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 46.4 mtm -96.62 -58.61 2.01 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.913 1.685 . . . . 0.0 113.601 177.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -100.0 -15.14 18.38 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.427 1.491 . . . . 0.0 113.611 -170.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 87.49 162.89 38.37 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 124.433 1.016 . . . . 0.0 114.515 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -110.65 134.45 52.42 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.976 1.311 . . . . 0.0 110.017 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.7 mp -120.75 148.34 48.06 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 125.531 1.532 . . . . 0.0 111.522 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.05 150.6 60.64 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.841 3.028 . . . . 0.0 112.762 -177.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -134.05 168.0 19.61 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.422 1.489 . . . . 0.0 111.653 177.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.19 -50.58 37.41 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.066 1.347 . . . . 0.0 113.886 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -111.44 -2.51 15.54 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.802 1.641 . . . . 0.0 114.18 -175.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.04 -137.16 2.37 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 121.423 -0.798 . . . . 0.0 114.116 -173.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -136.0 161.12 36.55 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.311 1.845 . . . . 0.0 111.516 176.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.95 158.06 44.48 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.323 1.049 . . . . 0.0 112.168 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 84.6 t -126.64 117.01 22.71 Favored Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 125.919 1.688 . . . . 0.0 109.904 176.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.0 130.76 17.11 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 123.993 3.129 . . . . 0.0 112.617 -174.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 89.4 mt -102.05 162.2 13.09 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.179 0.992 . . . . 0.0 113.294 176.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -144.86 124.83 13.51 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.225 1.01 . . . . 0.0 112.235 173.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 47.82 52.56 12.64 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.652 1.581 . . . . 0.0 112.777 -174.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.9 t -113.46 132.87 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 125.059 1.344 . . . . 0.0 110.079 175.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -132.26 151.18 51.95 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.499 1.12 . . . . 0.0 112.899 -166.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.6 m -140.41 153.53 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 126.24 1.816 . . . . 0.0 111.912 177.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -68.13 132.05 46.51 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.134 0.974 . . . . 0.0 109.948 168.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.5 t -134.33 153.56 51.82 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.762 2.025 . . . . 0.0 111.175 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 49.0 tp -103.05 129.33 49.81 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.25 1.02 . . . . 0.0 109.637 175.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -77.23 97.56 4.85 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.678 0.791 . . . . 0.0 109.157 173.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 30.5 mm -59.25 -25.68 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 O-C-N 120.877 -1.14 . . . . 0.0 112.907 -170.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.49 -39.73 31.4 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -176.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.3 m -110.99 -6.36 14.68 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.23 1.012 . . . . 0.0 113.214 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.82 29.24 74.66 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.558 1.551 . . . . 0.0 113.649 177.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -96.37 139.28 32.72 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.772 1.629 . . . . 0.0 112.142 -178.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 mp -80.26 130.03 36.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 125.552 1.541 . . . . 0.0 108.974 173.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -151.6 169.11 22.92 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.976 1.71 . . . . 0.0 111.278 -177.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -100.06 147.67 25.39 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.536 1.134 . . . . 0.0 110.552 170.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.3 t -142.0 168.73 19.05 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.817 0.847 . . . . 0.0 112.085 173.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 -102.01 145.95 28.58 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.492 1.117 . . . . 0.0 113.535 -174.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -108.07 139.18 43.1 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.236 1.414 . . . . 0.0 111.228 178.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.86 -47.02 7.85 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.565 0.746 . . . . 0.0 112.733 -170.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -153.58 156.89 38.85 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.998 1.319 . . . . 0.0 110.834 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.7 mt -86.17 154.39 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 163.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -138.87 151.15 46.74 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.464 1.505 . . . . 0.0 112.264 -175.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -144.63 152.78 40.98 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.003 1.321 . . . . 0.0 113.301 170.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -155.25 160.25 40.67 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.014 1.326 . . . . 0.0 110.586 173.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp -87.78 143.71 27.0 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.278 1.431 . . . . 0.0 111.546 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.5 m -147.13 146.0 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 124.983 1.313 . . . . 0.0 111.556 176.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -95.31 -34.27 12.23 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.539 1.536 . . . . 0.0 111.596 170.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -113.16 119.24 37.12 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.377 1.471 . . . . 0.0 109.421 -169.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.0 tp -133.99 162.09 33.03 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.379 1.472 . . . . 0.0 109.524 -178.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.5 mt -120.5 129.3 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.351 1.061 . . . . 0.0 108.742 177.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -99.28 125.68 44.95 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.346 0.658 . . . . 0.0 110.798 168.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -109.81 127.56 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.821 1.248 . . . . 0.0 109.471 170.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -94.16 146.38 24.03 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.443 1.497 . . . . 0.0 110.92 171.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 49.2 mt -112.73 162.16 16.06 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.597 1.559 . . . . 0.0 111.95 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.0 t -63.74 -16.09 60.26 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.917 1.287 . . . . 0.0 113.3 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 77.9 p -77.89 -9.74 59.22 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.249 2.22 . . . . 0.0 115.167 170.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 83.65 0.69 89.98 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.957 1.265 . . . . 0.0 114.869 -171.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -77.42 148.47 35.44 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.773 1.229 . . . . 0.0 110.635 175.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 93.3 p -122.66 143.26 49.89 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.457 1.103 . . . . 0.0 112.689 173.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.5 tp -127.53 132.13 49.96 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.973 1.709 . . . . 0.0 110.528 178.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.0 mtpt -118.31 115.72 25.28 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.036 1.334 . . . . 0.0 111.751 -171.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.5 m -143.93 154.5 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.131 1.372 . . . . 0.0 113.665 -164.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 21.3 p -66.77 147.96 98.9 Favored Pre-proline 0 N--CA 1.471 0.615 0 O-C-N 121.163 -0.96 . . . . 0.0 112.397 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -57.82 -29.01 84.59 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.199 2.599 . . . . 0.0 113.086 -177.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.2 p -71.83 -20.96 61.75 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.457 2.303 . . . . 0.0 115.782 176.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -71.62 119.65 75.3 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.254 1.022 . . . . 0.0 112.052 -168.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -75.68 129.0 11.37 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.713 2.276 . . . . 0.0 112.341 175.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.0 t -108.95 144.44 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 126.112 1.765 . . . . 0.0 109.113 176.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.21 104.95 12.03 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.141 0.496 . . . . 0.0 109.992 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.7 mp -104.22 160.99 14.42 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.692 1.597 . . . . 0.0 111.541 -178.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -112.38 119.21 37.47 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 176.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.8 mtp-105 -136.89 81.78 1.9 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.098 0.959 . . . . 0.0 110.448 161.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 58.62 10.3 1.38 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.694 1.998 . . . . 0.0 115.515 -170.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 177.67 163.25 29.16 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.892 1.234 . . . . 0.0 113.22 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 46.0 mt -64.01 116.53 5.96 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.725 1.61 . . . . 0.0 111.612 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -144.62 144.46 31.28 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 178.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -95.27 129.82 42.26 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.139 0.976 . . . . 0.0 110.79 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.8 t -133.66 127.96 19.75 Favored Pre-proline 0 N--CA 1.476 0.848 0 C-N-CA 123.891 0.876 . . . . 0.0 110.438 -178.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -65.58 141.04 65.17 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.326 2.017 . . . . 0.0 111.084 177.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.99 -30.4 14.99 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 176.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.04 -17.89 63.81 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 174.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -108.5 -14.83 14.57 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.098 1.359 . . . . 0.0 112.793 175.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 87.2 t -63.47 140.78 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.823 1.249 . . . . 0.0 110.434 173.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.86 153.56 78.77 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 125.93 1.692 . . . . 0.0 110.866 -174.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -68.86 116.1 4.29 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.644 2.229 . . . . 0.0 111.543 -169.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 115.29 0.36 22.2 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 124.416 1.008 . . . . 0.0 115.1 -176.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -63.4 156.74 25.07 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 118.583 1.191 . . . . 0.0 111.351 169.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.6 t -97.56 132.32 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 124.539 1.135 . . . . 0.0 110.875 173.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.2 t -106.63 143.5 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 127.308 2.243 . . . . 0.0 110.285 176.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.5 t -95.44 140.85 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.274 1.029 . . . . 0.0 111.153 176.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -165.65 -150.87 6.43 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.551 1.072 . . . . 0.0 112.887 176.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.6 p -134.29 163.0 38.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 127.676 2.39 . . . . 0.0 108.258 173.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 38.9 mtt180 -50.99 119.14 3.67 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.623 1.169 . . . . 0.0 109.894 172.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -60.3 -26.27 66.39 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 118.664 0.665 . . . . 0.0 112.415 -176.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -68.79 -27.21 65.67 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 172.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.11 -27.55 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-N 120.941 1.7 . . . . 0.0 111.828 -176.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 70.5 mt -84.85 -18.48 34.71 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.316 1.446 . . . . 0.0 112.933 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 44.5 ttt180 -116.97 -25.47 7.21 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 -170.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -87.88 155.99 19.59 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.666 1.186 . . . . 0.0 111.77 176.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 58.9 ttt-85 -63.31 -28.96 70.36 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.184 1.393 . . . . 0.0 113.138 174.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 70.8 mt -78.7 120.63 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.371 1.069 . . . . 0.0 109.077 169.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 21.3 tt -124.39 152.76 30.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 125.698 1.599 . . . . 0.0 111.457 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 33.8 t -140.81 161.58 37.47 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.075 1.75 . . . . 0.0 111.282 -178.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.8 ptpt -125.02 149.44 47.76 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.416 1.886 . . . . 0.0 113.221 -176.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 73.25 20.02 79.8 Favored Glycine 0 CA--C 1.537 1.41 0 N-CA-C 115.304 0.882 . . . . 0.0 115.304 175.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -116.22 147.42 41.47 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.481 1.513 . . . . 0.0 111.608 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 80.3 mt -137.64 161.81 35.47 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.972 1.709 . . . . 0.0 111.161 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -144.08 130.32 19.72 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.726 1.21 . . . . 0.0 113.306 -177.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -79.66 144.38 33.79 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.226 1.41 . . . . 0.0 112.099 175.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -134.05 141.46 47.2 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.068 1.347 . . . . 0.0 110.631 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -102.65 139.25 38.48 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.126 -0.984 . . . . 0.0 112.855 -175.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 78.6 t -76.11 134.71 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.912 0.885 . . . . 0.0 111.491 175.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.9 t -99.06 -39.13 8.67 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.873 2.069 . . . . 0.0 113.525 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 26.2 t -157.41 160.32 38.27 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.58 1.152 . . . . 0.0 110.918 175.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.4 m -136.51 147.79 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.599 1.159 . . . . 0.0 110.028 164.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 31.7 ptt-85 -158.41 159.58 35.92 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 162.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 45.6 mt -85.03 134.29 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.065 0.946 . . . . 0.0 108.685 173.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 19.0 pt -126.99 156.27 38.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 125.396 1.478 . . . . 0.0 112.524 -177.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.94 96.79 10.84 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.749 1.22 . . . . 0.0 111.737 173.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -78.46 -53.12 7.59 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.232 -0.917 . . . . 0.0 112.316 176.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 46.53 47.94 14.19 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.513 1.525 . . . . 0.0 112.434 -172.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -151.97 178.52 9.35 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.702 0.801 . . . . 0.0 112.732 -176.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -80.01 139.27 37.04 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.708 1.203 . . . . 0.0 113.042 177.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.5 m -121.25 160.63 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.526 1.93 . . . . 0.0 110.084 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.43 ' CG ' HG12 ' A' ' 21' ' ' ILE . 0.7 OUTLIER -113.78 161.83 17.06 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.988 0.915 . . . . 0.0 112.87 -178.357 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -144.03 163.37 33.7 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.571 0.748 . . . . 0.0 111.156 154.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 46.4 tp -115.17 122.93 47.56 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.277 1.431 . . . . 0.0 109.927 172.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 58.6 t -87.52 121.88 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 O-C-N 121.276 -0.89 . . . . 0.0 111.919 -171.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 20.5 mm -119.56 89.95 41.92 Favored Pre-proline 0 N--CA 1.47 0.531 0 C-N-CA 125.836 1.655 . . . . 0.0 109.371 -177.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -66.21 -23.19 52.72 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.331 2.02 . . . . 0.0 112.524 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 -81.76 -29.57 32.75 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -171.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 69.1 p -140.5 -22.33 0.82 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -177.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 65.33 15.86 10.24 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 127.113 2.165 . . . . 0.0 115.507 -171.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.49 150.52 26.67 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 120.735 -1.228 . . . . 0.0 114.144 -177.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -150.92 170.38 19.45 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.102 1.361 . . . . 0.0 113.09 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.1 mp -106.98 137.42 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.648 1.179 . . . . 0.0 111.937 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.91 157.99 50.9 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.684 1.194 . . . . 0.0 113.097 173.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -66.06 -18.07 56.14 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.302 2.668 . . . . 0.0 113.989 -175.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -83.83 6.07 22.77 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 171.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 107.04 -23.69 26.83 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 126.106 1.813 . . . . 0.0 116.954 165.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 75.2 mt -83.3 151.42 25.6 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 120.252 2.026 . . . . 0.0 114.46 -169.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.0 t -93.83 129.0 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.657 1.183 . . . . 0.0 111.93 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 25.5 mt -119.69 141.74 49.11 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.77 2.028 . . . . 0.0 111.552 -170.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -102.36 134.83 45.02 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 119.206 0.912 . . . . 0.0 112.681 171.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -92.16 81.06 5.02 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.43 1.092 . . . . 0.0 111.733 -169.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -145.21 152.82 40.59 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.854 1.662 . . . . 0.0 112.869 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 8.5 mp0 . . . . . 0 C--O 1.252 1.212 0 C-N-CA 125.887 1.675 . . . . 0.0 113.287 -177.798 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -142.58 163.64 32.27 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.082 1.353 . . . . 0.0 112.389 -167.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.13 146.05 48.85 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.629 1.572 . . . . 0.0 112.821 175.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.6 ppt_? -63.48 -21.49 66.34 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 176.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -83.79 0.36 47.69 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 176.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.6 m -66.45 147.7 52.92 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.613 1.165 . . . . 0.0 113.112 174.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -88.62 156.28 19.13 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.844 1.657 . . . . 0.0 114.423 175.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 p -145.82 150.66 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.948 0.899 . . . . 0.0 113.217 -172.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -128.42 121.98 30.29 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.788 2.035 . . . . 0.0 107.679 175.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -139.74 174.44 10.51 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.209 1.004 . . . . 0.0 111.422 173.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.421 ' CD ' ' HZ1' ' A' ' 62' ' ' LYS . 23.5 mt-10 -131.23 134.46 46.46 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.053 -1.029 . . . . 0.0 111.393 170.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -159.33 166.53 30.97 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.483 1.913 . . . . 0.0 108.257 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.0 t70 55.5 22.42 5.09 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 120.083 1.311 . . . . 0.0 113.093 -167.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.2 m 56.84 36.17 27.34 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.646 1.978 . . . . 0.0 114.185 -170.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.2 p -152.82 143.77 15.89 Favored Pre-proline 0 CA--C 1.547 0.85 0 O-C-N 120.534 -1.354 . . . . 0.0 112.141 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -70.03 140.98 42.94 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.74 2.96 . . . . 0.0 113.622 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -129.16 137.05 50.94 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 127.519 2.328 . . . . 0.0 110.339 -178.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 45.4 mtp -143.76 119.2 10.3 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.266 1.426 . . . . 0.0 112.093 -174.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -164.43 -173.51 3.1 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.617 1.567 . . . . 0.0 112.709 -172.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 65.4 m -74.53 141.57 44.83 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.089 -1.007 . . . . 0.0 111.127 167.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.421 HG12 ' CG ' ' A' ' 152' ' ' TYR . 7.4 tp -57.53 -38.21 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 121.256 -0.903 . . . . 0.0 112.857 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -60.92 -28.41 68.91 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.733 0.697 . . . . 0.0 111.913 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -80.49 -43.91 20.04 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 124.135 0.974 . . . . 0.0 110.974 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 12.9 ptm -65.19 -35.14 80.16 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.322 0.964 . . . . 0.0 111.625 173.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -60.83 -48.48 81.62 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.356 0.662 . . . . 0.0 110.557 173.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.1 t -59.78 -39.55 85.27 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.815 1.246 . . . . 0.0 111.39 177.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.3 ttmm -61.31 -56.73 17.21 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.414 1.486 . . . . 0.0 110.793 174.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -74.6 -33.05 62.53 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.108 -0.995 . . . . 0.0 112.564 -172.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.63 -19.91 62.78 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.975 0.91 . . . . 0.0 112.522 172.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 51.0 m -90.02 -18.98 24.97 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.252 1.421 . . . . 0.0 113.678 171.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 72.0 mtm -98.27 -44.91 6.38 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.893 1.277 . . . . 0.0 113.334 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -112.11 -23.77 10.26 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.592 1.557 . . . . 0.0 112.962 -169.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.32 162.98 38.97 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.693 1.616 . . . . 0.0 114.172 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -107.53 133.78 51.5 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.256 1.022 . . . . 0.0 110.94 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.3 mp -118.51 150.83 48.78 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 126.921 2.088 . . . . 0.0 110.936 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -75.53 148.03 32.76 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.693 2.929 . . . . 0.0 112.429 177.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -131.21 169.3 16.13 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.518 1.927 . . . . 0.0 111.595 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.58 -56.34 7.36 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.569 1.548 . . . . 0.0 114.613 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -105.33 -6.57 19.51 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -168.37 -137.84 2.33 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 123.716 0.674 . . . . 0.0 113.918 -170.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -131.84 155.89 47.02 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.51 1.524 . . . . 0.0 111.498 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.31 148.77 41.88 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.041 0.936 . . . . 0.0 112.214 -177.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 84.2 t -118.38 111.14 38.49 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 125.593 1.557 . . . . 0.0 109.476 176.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.58 140.23 51.25 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 124.569 3.513 . . . . 0.0 111.231 -177.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.5 mt -107.5 163.42 13.08 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.153 0.981 . . . . 0.0 113.528 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -137.63 116.34 12.2 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 127.58 2.352 . . . . 0.0 110.238 176.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 52.69 38.66 26.76 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 126.83 2.052 . . . . 0.0 115.133 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.6 t -99.92 133.71 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.18 1.392 . . . . 0.0 110.857 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -127.95 159.88 33.6 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.275 1.83 . . . . 0.0 113.319 -175.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.8 m -138.32 161.2 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 127.257 2.223 . . . . 0.0 111.593 174.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -76.38 131.05 38.9 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 122.02 0.914 . . . . 0.0 108.933 163.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.8 t -132.32 151.25 51.93 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.116 1.766 . . . . 0.0 111.054 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.6 tp -109.51 136.29 49.15 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.574 1.15 . . . . 0.0 109.546 174.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -85.38 115.9 23.39 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 118.57 -0.729 . . . . 0.0 109.762 160.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.2 mm -66.36 -28.5 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 119.685 1.129 . . . . 0.0 112.331 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.43 -47.86 31.09 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -168.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 64.3 m -96.06 -17.77 20.68 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.247 -0.908 . . . . 0.0 112.075 169.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.84 32.37 33.11 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.552 1.072 . . . . 0.0 112.856 -176.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -88.35 119.79 29.1 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 118.246 1.023 . . . . 0.0 111.865 -172.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.2 mp -72.98 125.64 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 167.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -152.15 175.39 12.63 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.658 1.183 . . . . 0.0 112.178 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.421 ' HZ1' ' CD ' ' A' ' 11' ' ' GLU . 3.0 tppt? -99.1 148.76 23.72 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.363 1.465 . . . . 0.0 110.601 172.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.7 t -143.93 158.72 43.51 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 118.547 0.612 . . . . 0.0 111.554 165.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.7 ptt85 -67.21 156.04 37.29 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.862 0.865 . . . . 0.0 112.576 170.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -112.99 138.34 50.02 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.704 0.802 . . . . 0.0 110.198 160.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.9 t -88.71 -47.62 8.11 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.282 1.033 . . . . 0.0 112.697 -167.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -154.46 156.59 37.02 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.141 1.776 . . . . 0.0 111.549 173.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.4 mt -86.01 153.35 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 165.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -133.93 148.14 51.17 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.43 1.492 . . . . 0.0 112.113 -172.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -142.77 149.08 38.21 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 165.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -146.13 162.5 37.84 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.937 1.695 . . . . 0.0 110.23 171.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.51 147.26 23.14 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.75 0.82 . . . . 0.0 112.965 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.5 m -149.05 145.96 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.505 1.522 . . . . 0.0 111.653 177.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -93.54 -31.13 14.66 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.823 1.249 . . . . 0.0 112.395 173.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -128.0 137.11 52.09 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 122.147 0.975 . . . . 0.0 112.648 -176.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.4 tp -137.79 165.45 26.43 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.715 2.006 . . . . 0.0 110.333 -174.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.6 mt -119.15 127.82 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.555 1.142 . . . . 0.0 109.532 175.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -95.25 124.52 39.34 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.809 0.843 . . . . 0.0 111.293 163.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -106.62 127.77 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 125.574 1.55 . . . . 0.0 108.835 168.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -96.59 145.77 25.44 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.075 1.35 . . . . 0.0 111.075 173.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 81.8 mt -104.92 162.29 13.46 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.538 1.935 . . . . 0.0 111.59 -178.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.3 t -60.03 -28.86 68.1 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.346 1.458 . . . . 0.0 111.915 177.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 97.3 p -63.27 -12.81 31.9 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.707 1.603 . . . . 0.0 114.646 169.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.1 2.47 89.39 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.695 1.616 . . . . 0.0 114.06 -170.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -88.86 173.26 8.62 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.494 1.518 . . . . 0.0 111.891 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 86.8 p -143.0 148.82 37.41 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 -171.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 61.3 tp -120.7 131.65 54.66 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 127.577 2.351 . . . . 0.0 109.787 174.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -122.89 113.24 18.86 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.15 1.38 . . . . 0.0 111.697 -176.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.9 m -145.06 155.46 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 125.081 1.353 . . . . 0.0 113.286 -163.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.2 p -68.08 147.05 98.39 Favored Pre-proline 0 N--CA 1.473 0.709 0 O-C-N 121.404 -0.81 . . . . 0.0 112.417 176.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -60.79 -33.99 92.17 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.775 2.317 . . . . 0.0 113.265 -170.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.4 p -78.83 -7.48 57.91 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.829 1.651 . . . . 0.0 114.946 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -86.99 124.75 68.31 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.373 1.069 . . . . 0.0 113.353 -168.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -72.66 143.55 37.98 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.337 2.691 . . . . 0.0 115.479 -178.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.7 t -122.77 146.87 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 126.777 2.031 . . . . 0.0 109.693 174.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 31.0 tp -84.68 114.6 22.14 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.285 0.634 . . . . 0.0 111.358 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.7 mp -113.87 153.66 28.82 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.285 1.834 . . . . 0.0 112.686 -172.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -103.34 101.63 11.55 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.804 1.641 . . . . 0.0 110.733 171.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 76.5 mtt-85 -136.17 74.14 1.49 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.535 1.134 . . . . 0.0 110.722 173.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 61.7 2.4 0.71 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 126.486 1.914 . . . . 0.0 115.748 -167.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -176.3 167.89 39.73 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.456 1.503 . . . . 0.0 112.115 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 75.6 mt -81.96 108.58 15.58 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.132 1.373 . . . . 0.0 110.727 -178.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -140.71 144.02 35.36 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.527 0.731 . . . . 0.0 112.765 -168.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -96.57 120.59 37.17 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.673 1.189 . . . . 0.0 111.118 -176.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 62.1 t -130.08 131.99 23.81 Favored Pre-proline 0 N--CA 1.482 1.162 0 C-N-CA 124.777 1.231 . . . . 0.0 110.43 -176.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -67.42 146.99 76.62 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.344 2.696 . . . . 0.0 112.257 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.41 -31.71 23.74 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 176.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.8 -23.39 66.69 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 173.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -104.35 0.89 29.63 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.02 1.728 . . . . 0.0 112.053 174.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 84.0 t -74.88 141.37 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 O-C-N 120.796 -1.19 . . . . 0.0 109.773 167.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.52 154.39 81.63 Favored Pre-proline 0 N--CA 1.472 0.649 0 C-N-CA 127.334 2.254 . . . . 0.0 110.436 -176.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.27 115.03 3.27 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 121.664 1.576 . . . . 0.0 109.613 177.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.37 3.41 24.18 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.745 1.164 . . . . 0.0 115.542 -177.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -60.13 161.89 6.42 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 118.65 1.225 . . . . 0.0 111.85 161.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 24.5 t -118.22 128.7 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.5 1.52 . . . . 0.0 110.225 174.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.0 t -104.09 145.11 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 127.16 2.184 . . . . 0.0 110.606 -175.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 43.7 t -87.77 137.76 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.376 1.07 . . . . 0.0 111.112 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -167.32 -146.65 4.97 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 115.262 0.865 . . . . 0.0 115.262 179.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.8 p -155.75 165.04 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 126.658 1.983 . . . . 0.0 108.639 176.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -56.77 126.66 27.89 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.871 1.268 . . . . 0.0 111.773 176.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -60.83 -38.07 84.19 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.966 0.906 . . . . 0.0 111.361 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -67.04 -28.67 68.41 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 28.3 t -71.93 -31.03 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 O-C-N 121.329 -0.857 . . . . 0.0 110.552 177.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 25.6 mt -78.18 -16.53 57.81 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.519 1.128 . . . . 0.0 113.304 169.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.87 -24.65 35.62 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 172.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 57.7 ttt85 -61.78 136.77 58.12 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.971 0.908 . . . . 0.0 109.388 170.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 84.0 mtt85 -69.72 -25.66 63.96 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -175.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 96.6 mt -88.61 126.35 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.311 1.445 . . . . 0.0 108.737 157.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 96.3 mt -102.91 112.1 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.877 0.871 . . . . 0.0 109.568 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 31.2 t -66.28 134.87 53.53 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -173.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -96.76 139.58 32.6 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.168 1.387 . . . . 0.0 112.419 175.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.26 19.22 55.85 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 125.154 1.359 . . . . 0.0 114.8 177.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -123.8 136.36 54.35 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.983 1.713 . . . . 0.0 111.529 176.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 85.8 mt -149.0 151.46 34.59 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.767 2.027 . . . . 0.0 112.561 -174.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -136.5 171.63 14.2 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.208 1.803 . . . . 0.0 111.386 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -131.01 157.06 44.03 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 120.631 -1.293 . . . . 0.0 112.724 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -138.34 123.83 19.56 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.576 1.15 . . . . 0.0 110.2 -167.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -84.67 145.63 27.88 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.952 -1.092 . . . . 0.0 112.307 -178.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.5 t -77.55 133.1 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.285 1.034 . . . . 0.0 111.699 175.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 26.9 t -87.16 -46.31 9.87 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.625 1.97 . . . . 0.0 112.405 171.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 29.6 t -157.26 160.72 38.91 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.42 0.688 . . . . 0.0 111.788 -173.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.0 m -135.36 145.73 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.285 1.034 . . . . 0.0 111.61 167.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -152.73 151.23 30.28 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.551 1.14 . . . . 0.0 113.344 172.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 75.4 mt -89.0 138.86 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.953 1.301 . . . . 0.0 109.051 169.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 44.9 pt -131.65 146.62 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.936 1.694 . . . . 0.0 111.62 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -80.07 104.92 10.96 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.668 -0.645 . . . . 0.0 109.549 165.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -81.62 -49.01 11.01 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.077 -1.015 . . . . 0.0 113.518 174.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 44.33 52.71 7.16 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.069 1.348 . . . . 0.0 111.989 -173.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -150.02 176.85 10.41 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.808 0.843 . . . . 0.0 111.97 -177.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -75.52 146.94 40.15 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.565 -0.709 . . . . 0.0 111.638 168.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 6.8 m -126.23 158.22 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.799 1.64 . . . . 0.0 109.47 172.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.421 ' CG ' HG12 ' A' ' 21' ' ' ILE . 0.6 OUTLIER -110.89 160.75 16.49 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.294 0.637 . . . . 0.0 112.577 -175.753 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -141.91 163.17 33.63 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.914 0.886 . . . . 0.0 110.22 157.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 54.8 tp -123.98 123.92 41.44 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.502 -1.374 . . . . 0.0 110.235 176.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 42.4 t -90.6 122.13 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -165.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 42.1 mm -124.1 84.31 55.39 Favored Pre-proline 0 N--CA 1.47 0.539 0 C-N-CA 126.196 1.798 . . . . 0.0 108.832 -172.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -66.83 -17.57 52.09 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.759 2.306 . . . . 0.0 113.752 -176.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -83.8 -32.78 25.16 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -174.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 80.9 p -140.74 -12.46 0.99 Allowed 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 -174.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 60.6 m80 56.23 26.23 10.15 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 -173.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.31 148.23 25.59 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 120.557 -1.34 . . . . 0.0 113.21 178.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -148.8 163.34 37.67 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.914 1.286 . . . . 0.0 112.211 -178.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.5 mp -112.67 137.73 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.864 0.866 . . . . 0.0 111.973 -176.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.89 157.34 51.77 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 125.38 1.472 . . . . 0.0 113.15 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.14 -17.87 50.78 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.549 2.833 . . . . 0.0 113.748 -176.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -74.58 -10.3 59.41 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 171.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 112.91 -24.66 12.6 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 125.743 1.64 . . . . 0.0 115.798 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.43 139.92 49.88 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.625 1.712 . . . . 0.0 113.799 -167.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 20.3 t -87.09 123.99 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.02 0.928 . . . . 0.0 110.958 173.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 33.5 mt -115.86 150.26 37.31 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.141 1.776 . . . . 0.0 111.709 -173.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -88.76 159.86 17.57 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.583 0.753 . . . . 0.0 110.79 170.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -98.26 118.47 34.97 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.141 -0.974 . . . . 0.0 109.601 163.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 52.36 -127.4 2.43 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.376 1.471 . . . . 0.0 112.857 -177.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 15.0 tm0? . . . . . 0 C--O 1.255 1.356 0 C-N-CA 126.1 1.76 . . . . 0.0 110.891 177.958 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -139.72 163.32 32.91 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.636 1.974 . . . . 0.0 111.082 -172.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.03 146.16 51.04 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.86 1.264 . . . . 0.0 113.383 -177.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -62.91 -19.88 64.63 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.929 1.292 . . . . 0.0 113.426 174.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -75.55 -10.44 59.45 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.248 1.819 . . . . 0.0 112.953 176.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.8 m -70.96 144.39 50.55 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 121.142 -0.974 . . . . 0.0 113.316 -175.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -91.72 150.88 20.9 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.055 1.742 . . . . 0.0 113.305 176.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.3 p -148.74 156.3 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 124.202 1.001 . . . . 0.0 113.484 -167.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -136.95 125.99 24.41 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.522 1.929 . . . . 0.0 109.042 -174.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -150.86 175.49 11.97 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 119.741 1.155 . . . . 0.0 113.154 -177.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -130.07 144.56 51.41 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.111 1.365 . . . . 0.0 112.933 171.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -161.97 162.43 29.0 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.749 2.02 . . . . 0.0 109.666 168.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.5 t0 53.77 28.74 8.61 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.372 1.469 . . . . 0.0 114.292 -177.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.8 m 59.33 38.0 23.23 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.431 1.892 . . . . 0.0 114.571 -172.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.6 p -151.98 140.63 13.66 Favored Pre-proline 0 CA--C 1.544 0.728 0 O-C-N 120.501 -1.375 . . . . 0.0 112.609 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -72.1 151.03 55.07 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 123.336 2.69 . . . . 0.0 113.106 175.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -134.44 140.63 46.39 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.281 2.232 . . . . 0.0 110.708 -176.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 36.7 ttm -141.75 121.9 13.83 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.396 1.078 . . . . 0.0 110.776 179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -163.83 -177.01 4.88 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.487 1.515 . . . . 0.0 112.983 -179.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.6 m -77.04 144.26 38.74 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.005 -1.06 . . . . 0.0 110.146 167.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.418 HG12 ' CG ' ' A' ' 152' ' ' TYR . 9.3 tp -57.31 -38.22 60.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -61.43 -24.18 66.36 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -76.5 -51.06 12.45 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.909 1.283 . . . . 0.0 110.862 175.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 19.9 ptm -68.86 -32.69 72.54 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.753 -0.592 . . . . 0.0 112.361 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -59.84 -51.04 71.44 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.216 0.606 . . . . 0.0 110.701 173.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.0 t -66.54 -34.86 78.85 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.412 0.551 . . . . 0.0 111.264 -176.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -61.12 -54.45 44.42 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.124 1.37 . . . . 0.0 110.305 174.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -70.68 -36.42 73.31 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.367 -0.833 . . . . 0.0 112.763 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.4 -33.01 74.75 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.971 0.908 . . . . 0.0 112.337 176.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.1 t -75.9 -32.27 59.57 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.923 0.889 . . . . 0.0 112.463 176.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 37.9 mtm -85.62 -47.21 10.05 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.308 1.443 . . . . 0.0 113.728 -177.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 48.3 m-20 -109.97 -20.39 12.75 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.49 1.516 . . . . 0.0 113.455 -171.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.13 163.97 39.52 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 122.247 0.915 . . . . 0.0 114.603 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -110.4 133.24 53.46 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.278 1.831 . . . . 0.0 110.175 -178.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.2 mp -116.05 146.92 38.16 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 126.79 2.036 . . . . 0.0 111.691 -176.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.65 141.55 19.73 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 124.589 3.526 . . . . 0.0 114.29 -173.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -133.97 166.18 23.31 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.669 1.988 . . . . 0.0 111.839 -177.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.45 -52.67 35.89 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.719 1.208 . . . . 0.0 114.036 -177.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -105.87 -4.78 20.33 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -173.25 -132.75 1.57 Allowed Glycine 0 CA--C 1.529 0.92 0 O-C-N 120.758 -1.214 . . . . 0.0 115.335 -174.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -141.04 153.58 45.57 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.266 1.427 . . . . 0.0 112.658 -173.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -132.59 153.84 50.63 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.389 1.476 . . . . 0.0 112.18 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.2 t -125.08 118.33 25.46 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 125.393 1.477 . . . . 0.0 110.86 177.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.57 136.88 24.32 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 124.521 3.481 . . . . 0.0 112.331 -175.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 70.6 mt -104.17 166.58 10.32 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.413 1.085 . . . . 0.0 112.514 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -141.45 118.68 11.38 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.519 1.928 . . . . 0.0 109.703 177.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 51.31 51.63 16.48 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 126.031 1.732 . . . . 0.0 114.095 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.1 t -113.54 133.06 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.761 1.224 . . . . 0.0 112.021 -177.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -127.94 157.29 40.97 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.882 1.273 . . . . 0.0 113.755 -175.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.2 m -144.11 164.12 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 127.46 2.304 . . . . 0.0 111.634 177.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -82.94 133.71 35.1 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.681 1.192 . . . . 0.0 110.102 171.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.2 t -131.8 153.62 49.94 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 127.395 2.278 . . . . 0.0 112.104 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 32.9 tp -106.09 133.61 50.53 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.177 0.991 . . . . 0.0 110.973 169.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -90.42 95.6 10.25 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.549 1.539 . . . . 0.0 111.501 175.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.4 mm -61.12 -18.75 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 124.8 1.24 . . . . 0.0 113.43 -174.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.56 -37.13 84.31 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.615 1.566 . . . . 0.0 114.334 172.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.6 p -127.56 -26.82 2.94 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.778 1.231 . . . . 0.0 113.545 -167.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.13 29.1 65.11 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.905 1.241 . . . . 0.0 113.38 -167.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -77.54 125.04 28.72 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.312 1.056 . . . . 0.0 110.615 167.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 mp -79.71 123.9 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 165.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -148.71 167.78 24.64 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -173.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -92.93 145.13 24.61 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.271 1.428 . . . . 0.0 110.005 174.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.5 t -144.49 155.43 43.7 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.522 1.129 . . . . 0.0 111.65 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.56 137.55 32.24 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.92 143.94 29.56 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.526 1.13 . . . . 0.0 110.666 171.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.6 t -99.2 -50.17 4.23 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.636 1.174 . . . . 0.0 112.885 -170.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -154.41 157.74 38.96 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.246 1.018 . . . . 0.0 112.286 176.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.7 mt -84.42 150.18 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 165.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -138.6 150.76 46.63 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.351 1.46 . . . . 0.0 111.731 -175.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -143.18 154.4 43.83 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 168.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -143.06 166.01 25.82 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.868 1.667 . . . . 0.0 109.789 172.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.7 tmtp? -100.68 136.57 40.34 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.209 0.603 . . . . 0.0 111.062 178.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.6 m -142.76 144.69 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 122.614 1.197 . . . . 0.0 111.021 178.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -93.5 -33.96 13.57 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 125.228 1.411 . . . . 0.0 111.148 173.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -121.17 137.35 54.71 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 124.418 1.087 . . . . 0.0 110.34 -173.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.4 tp -141.53 159.97 41.11 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 125.386 1.474 . . . . 0.0 109.191 -175.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.5 mt -109.36 124.25 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 175.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -93.5 125.92 38.36 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.891 0.877 . . . . 0.0 110.169 166.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.2 mp -110.84 124.84 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 124.512 1.125 . . . . 0.0 108.372 168.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -92.31 144.52 25.3 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.826 1.25 . . . . 0.0 110.202 173.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 59.9 mt -103.58 155.67 18.37 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 126.659 1.984 . . . . 0.0 110.263 178.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.8 t -66.37 -20.54 66.1 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.175 0.99 . . . . 0.0 112.949 -176.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 86.8 p -63.02 -18.48 63.38 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.111 1.765 . . . . 0.0 114.184 165.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 99.78 -7.35 59.19 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 126.254 1.883 . . . . 0.0 114.523 -174.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -86.18 171.12 11.55 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.475 1.51 . . . . 0.0 111.573 -178.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 95.2 p -142.81 157.6 44.46 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -177.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 14.3 tp -128.59 138.88 52.44 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.918 1.687 . . . . 0.0 109.969 171.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -120.78 116.97 26.26 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.242 1.417 . . . . 0.0 111.54 -176.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.4 m -140.21 153.29 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.058 1.343 . . . . 0.0 112.566 -164.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.9 p -67.79 146.68 98.48 Favored Pre-proline 0 N--CA 1.469 0.476 0 O-C-N 121.125 -0.985 . . . . 0.0 111.832 172.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -58.68 -18.69 41.97 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 124.279 3.319 . . . . 0.0 114.702 -175.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.7 p -88.81 -8.44 54.36 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.242 1.817 . . . . 0.0 114.987 177.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -71.61 120.96 82.97 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 119.526 1.057 . . . . 0.0 111.589 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -79.17 122.74 5.34 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.152 2.568 . . . . 0.0 112.537 176.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 40.1 t -93.72 141.17 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.927 1.691 . . . . 0.0 110.04 177.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 32.7 tp -80.01 104.65 10.73 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.518 0.599 . . . . 0.0 111.091 176.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -92.69 157.65 16.35 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.474 1.51 . . . . 0.0 112.323 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -121.17 71.1 0.94 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.684 0.754 . . . . 0.0 111.203 -177.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 73.0 mtp85 -119.65 74.08 0.99 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.651 1.18 . . . . 0.0 110.888 -169.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 58.22 6.07 0.49 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 127.337 2.255 . . . . 0.0 115.212 -166.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -178.35 157.9 22.16 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 125.693 1.616 . . . . 0.0 112.437 -177.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 48.4 mt -76.25 115.16 15.72 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.82 0.848 . . . . 0.0 109.871 177.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -146.0 141.74 27.96 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.946 0.898 . . . . 0.0 111.859 -173.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -101.32 111.82 24.16 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.777 0.831 . . . . 0.0 110.857 -175.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 54.1 t -117.85 127.78 26.41 Favored Pre-proline 0 N--CA 1.478 0.952 0 C-N-CA 123.953 0.901 . . . . 0.0 109.646 -173.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -64.44 143.79 83.41 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.192 1.928 . . . . 0.0 111.123 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.23 -31.63 21.4 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 175.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.17 -14.88 62.58 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 174.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -114.16 3.35 15.17 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.444 1.497 . . . . 0.0 112.22 175.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.2 t -78.2 149.06 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 125.185 1.394 . . . . 0.0 110.169 168.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.64 156.8 79.18 Favored Pre-proline 0 N--CA 1.47 0.527 0 C-N-CA 128.409 2.684 . . . . 0.0 108.857 178.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -67.81 138.9 46.15 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.098 1.865 . . . . 0.0 111.765 -177.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 102.5 -1.6 49.65 Favored Glycine 0 N--CA 1.47 0.923 0 C-N-CA 124.452 1.025 . . . . 0.0 115.418 175.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.67 177.68 8.71 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 118.526 1.163 . . . . 0.0 114.116 176.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.3 p -122.54 122.5 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -168.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.8 t -102.84 144.05 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 127.426 2.29 . . . . 0.0 110.877 -177.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.8 t -89.17 142.95 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.472 1.109 . . . . 0.0 111.563 175.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -160.87 -152.48 6.61 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.369 0.985 . . . . 0.0 113.879 177.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.9 p -141.39 157.66 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.938 1.695 . . . . 0.0 110.058 172.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -60.64 117.6 5.54 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.995 0.918 . . . . 0.0 111.052 176.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -66.46 -14.71 62.6 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -173.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -65.84 -40.26 91.57 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.86 0.864 . . . . 0.0 112.643 166.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 83.0 t -64.78 -34.31 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 121.042 -1.037 . . . . 0.0 111.005 -177.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 58.5 mt -75.13 -5.07 42.33 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -119.41 -15.01 9.13 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 115.807 1.781 . . . . 0.0 115.807 169.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 74.9 mtt180 -63.58 155.45 29.54 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.816 1.246 . . . . 0.0 112.454 175.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -79.59 -12.37 59.84 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 125.295 1.438 . . . . 0.0 114.355 -177.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.2 tt -115.94 148.22 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 125.133 1.373 . . . . 0.0 109.95 165.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 18.7 tt -140.22 129.55 27.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.095 0.958 . . . . 0.0 111.51 175.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.4 t -124.76 115.56 20.91 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.744 1.218 . . . . 0.0 111.094 -177.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -62.08 157.48 18.89 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.886 1.275 . . . . 0.0 112.895 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 91.58 21.34 34.63 Favored Glycine 0 CA--C 1.541 1.712 0 N-CA-C 116.276 1.27 . . . . 0.0 116.276 173.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -120.67 150.76 40.43 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.226 1.411 . . . . 0.0 112.579 169.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 89.7 mt -143.61 163.71 32.46 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.83 1.652 . . . . 0.0 113.15 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -131.94 171.87 13.04 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 128.214 2.605 . . . . 0.0 110.742 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -135.24 158.43 44.39 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.836 -1.165 . . . . 0.0 113.496 169.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -134.92 136.14 42.08 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.544 1.538 . . . . 0.0 109.975 -174.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -99.41 138.79 36.0 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.282 1.033 . . . . 0.0 112.019 -177.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 93.8 t -77.18 126.95 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 O-C-N 121.062 -1.024 . . . . 0.0 111.614 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 12.3 t -83.24 -44.7 14.68 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.559 1.944 . . . . 0.0 113.022 175.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 31.0 t -158.57 161.24 37.25 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.941 1.296 . . . . 0.0 110.039 -177.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.4 m -133.92 147.86 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.117 0.967 . . . . 0.0 110.306 166.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -154.87 154.58 32.91 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.417 0.687 . . . . 0.0 112.247 169.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 66.8 mt -86.06 135.01 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 165.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 23.6 pt -123.64 166.79 18.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 125.773 1.629 . . . . 0.0 111.305 -177.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -103.74 98.7 8.53 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.011 1.325 . . . . 0.0 110.975 175.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -80.47 -57.22 3.69 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.463 -0.773 . . . . 0.0 112.016 177.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 45.7 51.59 10.1 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.326 1.05 . . . . 0.0 112.135 -172.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -150.21 173.91 13.4 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.921 1.289 . . . . 0.0 111.651 174.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -71.06 136.76 48.47 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.06 0.944 . . . . 0.0 112.502 173.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.3 m -117.23 155.47 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 125.673 1.589 . . . . 0.0 110.093 174.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.418 ' CG ' HG12 ' A' ' 21' ' ' ILE . 0.7 OUTLIER -112.1 160.68 17.29 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -172.834 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -143.17 160.31 40.68 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.527 0.731 . . . . 0.0 110.34 156.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 56.0 tp -124.3 109.59 13.55 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.874 1.269 . . . . 0.0 110.106 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 85.8 t -83.79 123.54 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -159.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 11.6 mm -116.86 88.88 27.35 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.197 1.399 . . . . 0.0 110.33 -176.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -65.5 -16.44 53.96 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.871 2.381 . . . . 0.0 113.25 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -78.11 -45.51 23.18 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.016 -1.052 . . . . 0.0 113.19 178.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 76.8 p -140.54 -2.9 1.35 Allowed 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -171.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 42.0 m-70 59.23 7.09 0.82 Allowed 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -149.2 145.52 27.18 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 120.886 -1.134 . . . . 0.0 112.235 -175.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -146.23 151.5 37.68 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.759 1.224 . . . . 0.0 112.476 -176.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.9 mp -99.97 140.01 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.053 0.941 . . . . 0.0 111.789 -176.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -91.04 157.99 42.26 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 126.482 1.913 . . . . 0.0 112.949 176.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.99 -19.24 57.92 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.785 2.99 . . . . 0.0 113.487 -176.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -80.86 3.77 21.5 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.036 1.334 . . . . 0.0 113.682 174.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.89 -17.94 58.36 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 126.233 1.873 . . . . 0.0 116.029 175.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 54.8 mt -77.78 148.29 34.88 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.387 1.594 . . . . 0.0 112.899 -175.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.8 p -96.41 136.92 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.284 1.034 . . . . 0.0 112.394 174.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 40.5 mt -115.54 145.91 42.21 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 127.236 2.215 . . . . 0.0 110.155 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -134.43 130.0 36.13 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.802 1.241 . . . . 0.0 111.12 -174.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -58.41 122.54 13.56 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.707 0.803 . . . . 0.0 112.374 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -103.89 5.77 35.96 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 -174.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 . . . . . 0 C--O 1.253 1.267 0 C-N-CA 125.724 1.61 . . . . 0.0 111.439 -177.949 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 110.854 -0.054 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.44 159.0 43.19 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.36 1.464 . . . . 0.0 111.446 -168.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.22 147.74 46.91 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.879 0.872 . . . . 0.0 113.02 177.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -58.01 -23.9 56.01 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 174.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -82.96 0.54 44.1 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.3 m -72.74 142.46 48.15 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.356 -0.84 . . . . 0.0 112.407 176.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -79.89 158.61 26.65 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.08 -1.013 . . . . 0.0 113.38 169.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.6 p -147.98 157.13 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.887 0.875 . . . . 0.0 111.842 -174.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -126.51 135.84 51.83 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.358 1.863 . . . . 0.0 108.853 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -155.23 179.99 8.62 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.946 0.898 . . . . 0.0 112.057 174.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -135.31 143.21 46.06 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.732 1.213 . . . . 0.0 109.618 171.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -156.66 152.68 27.43 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.385 1.474 . . . . 0.0 109.221 178.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.1 t0 53.94 35.06 20.96 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.669 1.122 . . . . 0.0 113.304 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.0 m 53.8 37.61 26.75 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.736 1.615 . . . . 0.0 114.241 -172.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.3 p -148.7 138.57 12.81 Favored Pre-proline 0 CA--C 1.549 0.924 0 O-C-N 120.033 -1.667 . . . . 0.0 112.131 177.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.42 153.88 69.87 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.756 2.971 . . . . 0.0 113.187 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 47.0 m80 -138.78 138.91 38.04 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.189 2.196 . . . . 0.0 110.464 -175.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 40.1 ttm -152.96 114.67 4.29 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.536 1.134 . . . . 0.0 110.987 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -160.26 -179.49 7.77 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.976 1.31 . . . . 0.0 111.661 -175.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 m -67.43 138.3 56.54 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.065 -1.022 . . . . 0.0 110.135 169.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.9 tp -58.03 -36.44 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 121.256 -0.903 . . . . 0.0 112.269 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -61.72 -23.02 65.87 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.521 0.729 . . . . 0.0 112.909 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -83.4 -49.39 9.38 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.657 0.783 . . . . 0.0 110.014 177.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -66.02 -34.66 78.6 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.586 -0.696 . . . . 0.0 112.336 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -59.75 -51.81 68.16 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.769 0.828 . . . . 0.0 111.346 169.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.6 t -61.3 -36.13 79.24 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.514 0.726 . . . . 0.0 111.266 -178.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -63.46 -55.74 21.73 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.494 1.517 . . . . 0.0 111.206 172.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -72.15 -32.47 66.91 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 121.147 -0.971 . . . . 0.0 112.68 -173.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.43 -28.93 68.99 Favored 'General case' 0 CA--C 1.551 1.014 0 O-C-N 121.498 -0.752 . . . . 0.0 112.347 171.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.4 t -83.01 -25.64 31.98 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.841 1.256 . . . . 0.0 112.993 175.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 50.7 mtm -88.85 -48.19 7.65 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.859 1.263 . . . . 0.0 113.446 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 -110.55 -20.73 12.46 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.325 1.45 . . . . 0.0 113.681 -170.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.99 159.54 35.45 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.626 1.108 . . . . 0.0 114.853 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -103.36 131.02 50.78 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.772 1.229 . . . . 0.0 110.479 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.3 mp -110.12 142.57 26.21 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 126.447 1.899 . . . . 0.0 110.271 175.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.12 159.0 44.94 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.687 2.925 . . . . 0.0 111.366 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -140.13 173.07 11.88 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.239 1.415 . . . . 0.0 111.505 -176.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -55.31 -57.16 12.96 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.413 1.085 . . . . 0.0 113.014 176.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -105.08 -0.01 27.11 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -172.41 -128.44 1.05 Allowed Glycine 0 CA--C 1.536 1.379 0 N-CA-C 115.982 1.153 . . . . 0.0 115.982 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -137.51 161.29 36.79 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 126.623 1.969 . . . . 0.0 110.772 175.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.87 159.45 42.16 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.323 1.449 . . . . 0.0 112.148 177.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 98.1 t -128.48 117.89 20.05 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 125.972 1.709 . . . . 0.0 109.498 174.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.24 142.14 54.33 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 124.065 3.177 . . . . 0.0 111.456 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 74.3 mt -118.13 152.67 35.17 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.398 1.079 . . . . 0.0 112.855 175.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -137.42 125.23 22.51 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.385 1.874 . . . . 0.0 110.167 178.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 51.63 54.85 10.28 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.145 0.978 . . . . 0.0 112.286 -174.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.4 t -123.22 119.23 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 124.603 1.161 . . . . 0.0 109.632 173.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -113.16 158.94 19.79 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.577 1.551 . . . . 0.0 112.642 -176.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.0 m -140.64 152.25 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 126.113 1.765 . . . . 0.0 111.609 170.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -65.58 130.47 43.43 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.495 0.718 . . . . 0.0 109.139 163.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.0 t -133.48 148.07 51.7 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.514 1.926 . . . . 0.0 110.786 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 45.3 tp -99.53 140.17 34.11 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.768 0.827 . . . . 0.0 111.542 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -85.81 117.79 24.9 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.133 -0.979 . . . . 0.0 110.488 158.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.0 mm -74.45 -22.53 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 CA-C-N 119.084 0.856 . . . . 0.0 112.19 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.64 -33.52 64.56 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -173.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.2 m -121.45 -10.95 8.8 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.931 1.292 . . . . 0.0 112.919 169.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.51 39.46 56.42 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 -173.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -97.53 138.02 35.59 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.153 1.781 . . . . 0.0 111.715 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.1 mp -91.62 130.9 40.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 124.549 1.14 . . . . 0.0 109.669 -177.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -152.6 171.34 18.3 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.612 1.165 . . . . 0.0 111.509 -177.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -106.08 150.45 25.76 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.479 1.112 . . . . 0.0 111.242 176.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.8 t -139.58 153.11 47.33 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.466 1.106 . . . . 0.0 110.977 170.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 72.4 mtt85 -87.01 133.5 33.58 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.914 0.885 . . . . 0.0 110.303 172.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -87.12 149.64 24.54 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.196 0.998 . . . . 0.0 111.733 176.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.7 t -88.76 -54.19 4.27 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.834 1.254 . . . . 0.0 112.508 -169.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -157.63 160.03 37.63 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.672 1.589 . . . . 0.0 111.028 178.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.0 mt -84.8 150.42 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 162.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -139.76 152.42 46.59 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.529 1.531 . . . . 0.0 111.099 -176.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.8 ptt-85 -139.74 152.44 46.63 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.058 0.943 . . . . 0.0 113.321 166.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -146.41 168.93 19.93 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.811 2.045 . . . . 0.0 110.115 175.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -112.11 136.92 50.88 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 120.661 -1.274 . . . . 0.0 112.859 -170.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.2 m -144.51 142.04 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 122.796 1.284 . . . . 0.0 113.327 -176.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -97.63 -28.61 13.85 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 127.196 2.199 . . . . 0.0 111.745 178.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -120.85 127.92 52.35 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.606 1.562 . . . . 0.0 110.646 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.4 tp -136.95 161.26 36.53 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.469 1.508 . . . . 0.0 110.115 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.4 mt -117.7 126.0 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.356 1.062 . . . . 0.0 109.455 177.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 68.7 tt0 -100.09 117.15 33.73 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.156 0.982 . . . . 0.0 111.876 169.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.7 mp -108.42 129.26 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.365 1.466 . . . . 0.0 109.415 175.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -96.88 148.68 22.69 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.937 1.695 . . . . 0.0 111.4 176.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 59.6 mt -116.67 165.32 13.41 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.933 1.693 . . . . 0.0 112.483 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.6 t -71.06 -13.28 61.92 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 77.8 p -70.76 -15.58 62.69 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 120.428 -1.42 . . . . 0.0 113.59 165.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.49 -1.93 84.43 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.085 1.326 . . . . 0.0 114.178 -170.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -72.33 153.7 41.35 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.702 1.251 . . . . 0.0 110.605 174.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 95.1 p -130.01 143.23 50.69 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 167.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.2 tp -113.06 135.86 53.33 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.414 1.486 . . . . 0.0 109.768 173.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -115.25 110.85 20.05 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.28 1.832 . . . . 0.0 110.176 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.3 m -137.23 158.84 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.37 1.068 . . . . 0.0 113.083 -168.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.0 p -68.99 146.76 97.55 Favored Pre-proline 0 N--CA 1.467 0.413 0 O-C-N 121.692 -0.63 . . . . 0.0 112.541 175.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.52 -30.69 86.76 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.776 2.317 . . . . 0.0 113.294 -171.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.0 p -77.3 -7.09 55.44 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.367 1.867 . . . . 0.0 114.649 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -73.31 116.95 56.15 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 119.936 1.244 . . . . 0.0 112.97 -174.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -76.07 135.45 17.18 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.899 2.399 . . . . 0.0 113.782 178.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.5 t -118.91 143.81 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 126.655 1.982 . . . . 0.0 108.953 176.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 17.3 tp -82.51 114.57 21.01 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.569 -0.707 . . . . 0.0 110.44 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.5 mp -115.86 159.78 21.06 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.675 1.99 . . . . 0.0 111.499 -176.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -112.72 101.84 9.92 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.875 0.87 . . . . 0.0 113.073 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 68.9 mtp85 -125.82 81.56 1.99 Allowed 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 122.426 1.108 . . . . 0.0 108.799 174.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 59.79 -4.39 0.1 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 128.388 2.675 . . . . 0.0 115.282 -167.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -168.06 170.73 42.13 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 128.701 3.048 . . . . 0.0 111.242 -175.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 62.8 mt -83.57 115.21 22.01 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.395 1.478 . . . . 0.0 111.83 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -128.84 137.15 51.32 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.837 1.255 . . . . 0.0 112.107 -171.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -87.9 110.34 20.47 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.504 0.322 . . . . 0.0 111.413 172.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 52.3 t -121.56 126.34 26.49 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 124.723 1.209 . . . . 0.0 109.892 -172.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -66.96 149.48 82.91 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.576 2.184 . . . . 0.0 111.837 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.79 -31.21 26.19 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.19 -21.47 66.77 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 172.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -99.7 -6.76 26.58 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.048 1.739 . . . . 0.0 112.575 172.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.1 t -73.39 142.42 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 O-C-N 121.041 -1.037 . . . . 0.0 110.125 171.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.32 155.75 67.63 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 127.549 2.34 . . . . 0.0 110.197 -175.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.9 123.37 10.31 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.992 1.794 . . . . 0.0 111.891 -170.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 103.91 1.68 45.67 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.636 1.113 . . . . 0.0 114.738 -175.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -58.65 155.41 12.62 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.468 1.134 . . . . 0.0 113.148 170.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.3 p -107.55 119.21 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 126.243 1.817 . . . . 0.0 111.055 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 38.7 t -113.04 134.33 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 125.92 1.688 . . . . 0.0 110.927 -167.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.7 t -88.44 134.92 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 O-C-N 121.267 -0.896 . . . . 0.0 111.376 -172.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -169.12 -147.16 5.31 Favored Glycine 0 CA--C 1.529 0.935 0 O-C-N 121.796 -0.565 . . . . 0.0 112.872 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.2 p -135.58 161.31 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 127.384 2.274 . . . . 0.0 108.475 171.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 68.8 mtp85 -64.99 117.6 7.87 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.73 -0.606 . . . . 0.0 110.775 173.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -61.84 -26.79 68.34 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -176.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -58.39 -25.64 62.32 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 174.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.4 t -85.78 -37.76 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 123.911 0.884 . . . . 0.0 110.511 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 21.2 tp -68.96 -27.96 66.2 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.346 1.459 . . . . 0.0 111.883 175.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -94.98 17.17 14.4 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 127.201 2.201 . . . . 0.0 112.955 174.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -95.7 159.56 14.93 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.944 2.098 . . . . 0.0 110.589 168.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -73.06 -45.23 58.59 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.24 1.016 . . . . 0.0 113.001 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 39.5 mm -97.22 102.78 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.936 1.294 . . . . 0.0 108.704 166.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 58.2 mt -82.19 90.24 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 49.4 m -69.71 78.11 0.44 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.94 1.696 . . . . 0.0 111.489 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -82.69 164.41 20.73 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 126.969 2.108 . . . . 0.0 113.915 -165.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 101.91 20.42 12.86 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 115.389 -0.823 . . . . 0.0 113.176 -172.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -127.48 160.27 32.01 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.519 1.527 . . . . 0.0 113.21 173.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 96.8 mt -138.07 166.49 23.97 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 127.013 2.125 . . . . 0.0 112.136 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -154.38 148.43 25.75 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.463 1.905 . . . . 0.0 111.084 167.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -94.62 143.42 26.45 Favored 'General case' 0 CA--C 1.548 0.87 0 O-C-N 120.889 -1.132 . . . . 0.0 112.423 172.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -122.63 160.27 26.13 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.495 1.918 . . . . 0.0 110.926 -170.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -111.33 130.11 55.78 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -168.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 84.4 t -73.01 136.67 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 121.599 0.714 . . . . 0.0 110.674 171.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 12.3 t -94.42 -49.54 5.64 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.966 2.106 . . . . 0.0 112.537 176.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.4 t -157.48 162.06 38.89 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.216 1.006 . . . . 0.0 111.433 -176.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.7 m -135.19 148.34 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 124.435 1.094 . . . . 0.0 112.066 172.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -152.47 155.18 36.99 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.659 1.183 . . . . 0.0 112.914 170.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 89.2 mt -91.79 133.39 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.359 1.064 . . . . 0.0 108.642 167.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 44.3 pt -126.78 154.28 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 126.09 1.756 . . . . 0.0 111.83 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -96.26 98.91 10.67 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.393 0.677 . . . . 0.0 109.71 178.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -78.62 -53.06 7.58 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 51.88 36.65 18.71 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.648 1.179 . . . . 0.0 113.26 -174.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -144.16 171.7 13.93 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 120.888 -1.132 . . . . 0.0 111.464 -173.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -77.39 134.49 38.42 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.566 1.146 . . . . 0.0 111.794 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 14.1 m -117.64 152.46 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 125.704 1.602 . . . . 0.0 109.993 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -106.56 160.48 15.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.686 0.755 . . . . 0.0 112.942 -173.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.35 140.24 27.57 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.482 1.113 . . . . 0.0 109.098 166.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 64.9 tp -109.33 115.93 30.91 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 120.456 -1.403 . . . . 0.0 110.129 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 57.3 t -86.24 123.07 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -158.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 42.6 mm -118.4 92.32 43.08 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 126.569 1.948 . . . . 0.0 109.451 -176.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.88 -18.99 41.04 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 123.071 2.514 . . . . 0.0 113.736 176.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -78.74 -50.83 10.7 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 120.207 1.367 . . . . 0.0 112.81 -174.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 76.9 p -128.6 -7.01 5.15 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.496 1.518 . . . . 0.0 114.417 -169.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 74.9 m-70 57.22 19.49 4.95 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -170.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -140.9 149.61 42.13 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 120.892 1.678 . . . . 0.0 114.136 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -141.52 154.63 45.61 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.232 1.013 . . . . 0.0 111.316 168.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.4 mp -102.46 132.45 48.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.118 0.967 . . . . 0.0 110.926 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.46 158.79 62.78 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.62 1.168 . . . . 0.0 112.518 175.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.44 -16.82 52.41 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.227 2.618 . . . . 0.0 113.274 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 33.0 p30 -70.07 -2.26 12.32 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 124.702 1.201 . . . . 0.0 113.565 169.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.33 -10.95 69.32 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 126.831 2.157 . . . . 0.0 115.893 176.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 52.4 mt -96.34 150.28 20.75 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 120.317 2.059 . . . . 0.0 113.663 -169.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.2 p -97.54 133.16 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.261 1.024 . . . . 0.0 113.023 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 31.7 mt -119.46 132.81 55.86 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.03 1.732 . . . . 0.0 111.112 -169.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -88.42 118.44 28.05 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.056 0.843 . . . . 0.0 111.937 175.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -81.65 140.09 34.59 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 120.949 -1.095 . . . . 0.0 113.393 -172.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 59.7 14.43 4.06 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.458 2.303 . . . . 0.0 116.995 167.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 . . . . . 0 C--O 1.253 1.246 0 C-N-CA 125.992 1.717 . . . . 0.0 113.422 167.429 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.687 0 CA-C-O 120.897 0.38 . . . . 0.0 111.572 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.61 161.56 38.18 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.657 1.583 . . . . 0.0 110.724 -169.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.81 141.03 50.31 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.511 1.124 . . . . 0.0 112.949 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.02 -22.48 49.93 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.511 1.524 . . . . 0.0 114.198 176.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -78.39 -17.31 56.62 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 177.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.6 m -58.6 136.75 57.69 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 119.347 0.976 . . . . 0.0 113.504 -169.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.33 150.65 47.1 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.12 0.968 . . . . 0.0 113.378 175.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.2 p -146.06 155.67 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.894 1.277 . . . . 0.0 112.141 -171.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -128.98 137.62 51.47 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.449 1.9 . . . . 0.0 108.744 176.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -153.83 168.39 26.49 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.214 0.916 . . . . 0.0 113.256 168.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -130.13 146.02 51.75 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.309 1.443 . . . . 0.0 111.026 177.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -163.0 145.03 10.17 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.217 1.407 . . . . 0.0 109.151 174.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.3 t70 53.76 39.02 29.78 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.349 1.059 . . . . 0.0 113.033 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.2 m 67.41 16.3 10.0 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.331 1.852 . . . . 0.0 114.979 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.0 p -133.67 133.47 22.48 Favored Pre-proline 0 CA--C 1.554 1.1 0 O-C-N 120.175 -1.578 . . . . 0.0 113.229 -177.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -85.72 153.06 10.14 Favored 'Trans proline' 0 CA--C 1.539 0.742 1 C-N-CA 125.593 4.195 . . . . 0.0 114.713 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -135.42 144.87 46.74 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.353 2.261 . . . . 0.0 111.156 -178.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 50.7 ttm -149.37 111.23 4.57 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.784 0.834 . . . . 0.0 110.904 -176.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -158.98 -168.8 2.47 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.81 1.244 . . . . 0.0 112.302 -169.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.4 m -85.71 143.99 28.05 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.098 -1.001 . . . . 0.0 111.36 166.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.401 HG12 ' CG ' ' A' ' 152' ' ' TYR . 8.4 tp -56.81 -38.23 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -177.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -61.75 -22.58 65.52 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.608 0.763 . . . . 0.0 112.848 179.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -80.41 -49.4 11.51 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.302 1.041 . . . . 0.0 111.235 176.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 19.3 ptm -65.77 -31.48 72.49 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 122.062 -0.399 . . . . 0.0 111.589 176.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -57.92 -51.63 68.81 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.603 0.638 . . . . 0.0 111.031 172.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.9 t -67.68 -29.98 69.39 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.148 0.579 . . . . 0.0 111.679 -177.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -66.71 -53.19 36.13 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.323 1.449 . . . . 0.0 111.04 172.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -71.72 -30.82 66.05 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.004 -1.06 . . . . 0.0 112.805 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.48 -31.36 71.46 Favored 'General case' 0 CA--C 1.552 1.054 0 O-C-N 121.51 -0.744 . . . . 0.0 111.992 171.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.0 t -80.07 -22.74 41.93 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 120.668 -1.27 . . . . 0.0 113.095 174.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 55.9 mtm -92.13 -49.7 6.06 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.543 1.137 . . . . 0.0 113.43 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -109.21 -24.09 11.29 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.356 1.462 . . . . 0.0 112.612 -169.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 87.26 164.5 40.2 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 125.556 1.551 . . . . 0.0 114.787 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -109.18 143.57 38.42 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.969 1.308 . . . . 0.0 111.392 -173.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.4 mp -117.33 140.72 27.64 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 126.146 1.778 . . . . 0.0 111.181 172.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.25 141.77 18.56 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 124.469 3.446 . . . . 0.0 111.784 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -126.36 156.16 40.92 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.632 1.573 . . . . 0.0 111.459 -177.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.87 -46.92 16.09 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.387 1.475 . . . . 0.0 114.056 178.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -97.73 -16.58 19.84 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 176.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.26 -126.83 0.95 Allowed Glycine 0 CA--C 1.538 1.504 0 N-CA-C 116.585 1.394 . . . . 0.0 116.585 -168.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -144.54 155.08 43.5 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.61 1.564 . . . . 0.0 112.538 -178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.48 154.73 50.67 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.759 1.224 . . . . 0.0 113.15 175.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.9 t -130.45 115.75 17.3 Favored Pre-proline 0 N--CA 1.481 1.097 0 C-N-CA 126.125 1.77 . . . . 0.0 110.606 177.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.52 138.64 27.24 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 125.057 3.838 . . . . 0.0 112.52 -176.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.8 mt -112.69 160.98 17.38 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.874 1.27 . . . . 0.0 113.125 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -146.34 128.29 15.48 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.606 1.162 . . . . 0.0 111.349 168.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 55.39 40.39 31.36 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.6 1.56 . . . . 0.0 113.839 -173.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.4 t -107.71 113.3 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 O-C-N 121.109 -0.994 . . . . 0.0 109.346 175.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -113.79 152.0 31.23 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.144 1.378 . . . . 0.0 113.59 -166.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.0 m -143.18 154.35 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 127.119 2.168 . . . . 0.0 111.119 175.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -72.08 135.67 46.36 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.744 0.818 . . . . 0.0 109.873 166.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.0 t -133.35 153.49 51.54 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.131 1.772 . . . . 0.0 112.842 -179.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 50.3 tp -100.13 133.89 43.86 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.512 1.125 . . . . 0.0 109.861 168.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -84.59 119.39 25.15 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.94 1.296 . . . . 0.0 110.407 164.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.8 mm -76.38 -19.48 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 119.569 1.077 . . . . 0.0 112.265 -179.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.44 -41.03 48.88 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -174.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.3 m -110.57 -11.76 14.42 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.695 1.198 . . . . 0.0 112.814 172.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.5 36.82 68.93 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-N 118.42 0.555 . . . . 0.0 112.037 -173.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -96.69 136.8 36.71 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.222 1.809 . . . . 0.0 111.769 -175.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 mp -85.84 130.6 36.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 124.504 1.121 . . . . 0.0 107.992 172.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.3 pttt -154.91 168.46 26.85 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.803 1.241 . . . . 0.0 112.913 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -89.56 146.7 24.4 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.574 0.749 . . . . 0.0 111.183 172.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.431 ' HG1' ' CD ' ' A' ' 158' ' ' GLU . 7.7 t -143.25 164.13 31.06 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.108 0.963 . . . . 0.0 111.645 172.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -99.88 142.85 30.81 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.241 1.016 . . . . 0.0 112.077 174.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.73 137.39 32.37 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.262 0.625 . . . . 0.0 110.109 167.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 22.8 t -86.97 -46.38 9.91 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.427 1.491 . . . . 0.0 112.334 -172.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -152.89 155.45 37.06 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.618 0.723 . . . . 0.0 112.356 174.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.9 mt -85.12 147.36 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 163.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -136.25 147.78 47.72 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 125.747 1.619 . . . . 0.0 110.839 -175.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 30.6 ptt-85 -143.92 153.95 42.82 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.052 0.941 . . . . 0.0 113.424 167.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -154.82 172.43 18.0 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.846 1.259 . . . . 0.0 110.728 169.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -95.39 147.27 23.7 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.646 0.778 . . . . 0.0 111.943 177.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.1 m -143.74 144.55 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 125.18 1.392 . . . . 0.0 110.481 171.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -94.18 -29.05 15.32 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 124.888 1.275 . . . . 0.0 111.469 175.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -121.01 134.27 55.29 Favored 'General case' 0 C--N 1.344 0.358 0 C-N-CA 125.17 1.388 . . . . 0.0 109.416 -176.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.5 tp -143.53 159.69 41.96 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.164 1.386 . . . . 0.0 109.966 -177.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.6 mt -111.21 128.49 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 O-C-N 121.246 -0.909 . . . . 0.0 109.632 177.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -102.67 112.98 26.0 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.363 1.465 . . . . 0.0 110.261 173.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.2 mp -106.92 131.13 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.608 1.163 . . . . 0.0 109.376 174.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.2 tttt -100.96 147.63 25.94 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.678 1.591 . . . . 0.0 111.51 175.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 61.5 mt -107.75 164.39 12.28 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 126.83 2.052 . . . . 0.0 111.195 -178.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.7 t -75.02 -1.53 23.18 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -178.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.8 p -79.06 -15.09 58.68 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.954 1.702 . . . . 0.0 113.766 160.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.78 -3.63 84.89 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 125.73 1.633 . . . . 0.0 114.199 -169.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -74.54 151.37 39.48 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.451 1.625 . . . . 0.0 111.45 177.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.7 p -128.68 138.63 52.26 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 178.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 14.7 tp -117.01 140.02 49.98 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.995 1.718 . . . . 0.0 110.538 177.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.6 mtmm -118.49 116.38 26.55 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.687 1.195 . . . . 0.0 112.402 -175.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.1 m -141.61 152.49 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 125.204 1.402 . . . . 0.0 113.031 -163.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.7 p -68.39 148.3 98.18 Favored Pre-proline 0 N--CA 1.474 0.73 0 O-C-N 121.031 -1.043 . . . . 0.0 112.433 174.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.79 -17.63 60.31 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.594 2.862 . . . . 0.0 113.728 -175.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 36.3 p -86.35 -10.94 53.4 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.949 2.1 . . . . 0.0 114.48 176.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -72.46 122.17 86.76 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-N 119.699 1.136 . . . . 0.0 111.736 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -80.35 125.06 5.57 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 123.711 2.941 . . . . 0.0 113.113 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.3 t -94.52 141.09 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.686 1.595 . . . . 0.0 109.848 175.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 17.4 tp -83.86 107.23 16.13 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.103 0.561 . . . . 0.0 110.664 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.9 mp -100.15 144.34 29.3 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.756 1.622 . . . . 0.0 111.755 -176.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -104.29 90.23 3.49 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.933 0.893 . . . . 0.0 112.244 -177.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 46.6 mtm180 -133.91 81.43 1.92 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.865 0.866 . . . . 0.0 110.841 -177.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.7 t70 66.3 -17.94 0.11 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 128.09 2.556 . . . . 0.0 115.888 -167.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.48 167.26 39.87 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 126.171 1.843 . . . . 0.0 113.258 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 77.3 mt -62.94 113.83 3.31 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.493 1.917 . . . . 0.0 111.392 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -141.94 142.83 33.03 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.646 0.778 . . . . 0.0 112.847 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -97.56 122.14 40.28 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.877 1.271 . . . . 0.0 110.768 -175.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 71.2 t -128.45 126.69 23.57 Favored Pre-proline 0 N--CA 1.477 0.914 0 C-N-CA 124.289 1.036 . . . . 0.0 110.007 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -64.71 148.65 90.3 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.301 2.001 . . . . 0.0 112.014 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.59 -31.98 17.42 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 173.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.93 -17.89 63.68 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 173.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -111.82 -0.61 15.84 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.568 1.547 . . . . 0.0 112.989 174.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 71.3 t -72.12 148.67 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 120.679 -1.263 . . . . 0.0 110.833 171.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.96 157.09 75.36 Favored Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 127.369 2.268 . . . . 0.0 111.129 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.59 113.42 3.16 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.715 2.277 . . . . 0.0 112.003 -175.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 111.91 6.09 24.87 Favored Glycine 0 CA--C 1.537 1.449 0 CA-C-O 118.691 -1.061 . . . . 0.0 115.264 -175.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -62.86 161.31 12.95 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 118.946 1.373 . . . . 0.0 112.403 163.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 5.8 p -109.45 129.52 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.384 1.474 . . . . 0.0 111.747 178.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.1 t -107.55 137.07 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 126.729 2.012 . . . . 0.0 110.2 -175.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 51.8 t -87.25 134.39 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.744 0.817 . . . . 0.0 110.31 172.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -157.82 -153.91 6.91 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.53 1.062 . . . . 0.0 112.49 176.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.1 p -145.22 176.86 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 126.415 1.886 . . . . 0.0 108.492 174.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -80.91 139.42 35.9 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.071 -1.018 . . . . 0.0 113.067 175.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.58 -39.37 80.13 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.792 0.837 . . . . 0.0 112.859 173.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -61.44 -26.72 68.06 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 178.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 55.8 t -78.74 -41.49 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.069 0.948 . . . . 0.0 110.335 178.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -65.37 -33.47 76.05 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.909 1.283 . . . . 0.0 111.922 173.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -88.11 9.65 21.94 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.709 1.603 . . . . 0.0 113.443 170.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.4 mtt-85 49.89 22.64 0.89 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 127.375 2.27 . . . . 0.0 116.411 175.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -56.25 -39.28 72.33 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.052 -1.03 . . . . 0.0 110.485 175.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.4 tp -133.84 144.0 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 128.845 2.858 . . . . 0.0 107.393 168.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 7.0 tp -81.64 134.48 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.228 1.011 . . . . 0.0 111.162 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.3 t -154.43 132.16 11.46 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.829 -0.544 . . . . 0.0 111.926 165.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -132.75 140.81 48.23 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.929 1.292 . . . . 0.0 111.736 169.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.94 -2.31 59.94 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 124.801 1.191 . . . . 0.0 115.646 177.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -123.92 153.03 41.76 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.15 1.38 . . . . 0.0 112.563 -169.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 89.9 mt -131.04 165.21 23.71 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.858 2.063 . . . . 0.0 111.741 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -131.59 157.17 44.36 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.739 1.616 . . . . 0.0 110.912 173.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -113.28 142.89 45.3 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.608 1.163 . . . . 0.0 111.587 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -133.54 156.24 48.15 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.606 1.562 . . . . 0.0 110.544 -173.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 57.4 tt0 -114.68 137.79 51.48 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.128 -0.983 . . . . 0.0 112.288 -170.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 92.2 t -73.79 133.32 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 122.003 0.906 . . . . 0.0 110.622 173.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 27.5 t -87.11 -59.64 2.2 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.941 1.697 . . . . 0.0 111.748 173.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 59.2 m -149.61 158.88 44.58 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.259 1.424 . . . . 0.0 110.901 -170.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.2 m -136.37 152.86 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 124.126 0.97 . . . . 0.0 111.925 173.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 9.4 ptp85 -158.14 159.48 36.24 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.74 1.216 . . . . 0.0 112.684 168.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 76.3 mt -99.03 129.92 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.935 0.894 . . . . 0.0 109.211 170.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 13.2 pt -121.15 156.58 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.574 1.55 . . . . 0.0 111.908 -174.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -92.7 97.96 11.11 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.754 0.787 . . . . 0.0 110.957 170.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -76.63 -47.89 20.8 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 44.39 39.46 3.13 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.576 1.15 . . . . 0.0 113.826 -174.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 -144.31 174.71 10.67 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.17 0.988 . . . . 0.0 111.392 -174.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -77.27 137.88 39.06 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 124.588 1.155 . . . . 0.0 112.466 -177.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.2 m -119.8 152.74 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 125.084 1.353 . . . . 0.0 109.97 176.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.401 ' CG ' HG12 ' A' ' 21' ' ' ILE . 1.4 p90 -112.1 160.53 17.45 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.08 0.952 . . . . 0.0 112.278 -178.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -141.3 156.06 45.9 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.052 0.541 . . . . 0.0 110.069 156.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 65.2 tp -128.69 103.0 6.83 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.767 1.227 . . . . 0.0 110.051 -175.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 87.8 t -86.63 124.12 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -151.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 20.8 mm -110.71 98.27 36.78 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 125.27 1.428 . . . . 0.0 109.681 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.5 -16.73 38.81 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.512 2.142 . . . . 0.0 113.193 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.431 ' CD ' ' HG1' ' A' ' 63' ' ' THR . 37.7 mt-10 -74.51 -61.28 1.92 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.784 0.834 . . . . 0.0 112.363 178.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 54.9 p -122.82 -7.95 8.43 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -171.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 61.37 15.38 6.5 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.086 1.754 . . . . 0.0 115.657 -175.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.81 148.52 30.03 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.082 -1.011 . . . . 0.0 113.532 -178.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -145.9 158.93 43.84 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.746 1.218 . . . . 0.0 112.385 177.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.3 mp -102.39 137.22 31.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 123.975 0.91 . . . . 0.0 111.377 -177.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -88.56 160.24 45.1 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 125.938 1.695 . . . . 0.0 113.088 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.36 -19.46 61.62 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.299 2.666 . . . . 0.0 113.989 -176.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 50.6 p30 -86.18 -2.26 58.2 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.961 1.304 . . . . 0.0 113.551 175.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 102.12 -15.04 56.88 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 126.628 2.061 . . . . 0.0 116.756 173.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 66.7 mt -74.09 145.39 44.43 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.425 1.613 . . . . 0.0 111.965 -178.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.1 p -91.36 135.76 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.528 0.731 . . . . 0.0 111.304 171.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 39.6 mt -113.61 142.09 46.41 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.156 1.783 . . . . 0.0 109.792 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -127.54 127.01 43.22 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.279 1.432 . . . . 0.0 110.146 -177.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -60.46 129.7 42.9 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.912 0.885 . . . . 0.0 112.696 -174.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -154.96 124.94 6.63 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.453 0.701 . . . . 0.0 112.593 175.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 . . . . . 0 C--O 1.252 1.186 0 C-N-CA 124.846 1.259 . . . . 0.0 114.198 -179.29 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.566 0 CA-C-O 120.62 0.248 . . . . 0.0 111.504 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.54 156.99 47.01 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.247 1.419 . . . . 0.0 111.063 -170.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.54 143.97 33.4 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.346 1.458 . . . . 0.0 113.901 -178.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -61.11 -26.09 67.43 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.494 1.117 . . . . 0.0 113.241 174.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -83.03 -1.46 52.73 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.312 1.045 . . . . 0.0 113.803 176.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.4 m -68.59 143.51 54.83 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 119.845 1.202 . . . . 0.0 111.77 174.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -74.68 159.22 32.34 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.205 -0.934 . . . . 0.0 112.817 167.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 p -149.0 156.26 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.049 0.94 . . . . 0.0 111.867 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -121.26 141.8 50.55 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.638 1.975 . . . . 0.0 108.134 176.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -156.44 -178.28 7.22 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.666 0.786 . . . . 0.0 111.128 164.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -136.6 143.13 43.41 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.564 1.545 . . . . 0.0 110.216 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -154.96 -45.68 0.08 Allowed 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 174.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -83.24 37.1 0.54 Allowed 'General case' 0 N--CA 1.481 1.097 0 O-C-N 120.65 -1.281 . . . . 0.0 112.857 -175.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.2 m 61.0 24.92 14.99 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 126.007 1.723 . . . . 0.0 112.915 -167.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.2 p -158.61 149.89 16.57 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 126.412 1.885 . . . . 0.0 109.276 -170.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.45 160.53 32.05 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.974 3.116 . . . . 0.0 114.306 176.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -140.48 151.16 44.6 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 128.029 2.532 . . . . 0.0 110.561 -173.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 34.8 ttm -149.48 126.14 11.03 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.485 -0.759 . . . . 0.0 112.148 177.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -160.89 -178.17 6.64 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.528 1.531 . . . . 0.0 111.75 178.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.52 143.12 51.76 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 121.017 -1.052 . . . . 0.0 109.433 171.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.438 HG12 ' CG ' ' A' ' 152' ' ' TYR . 8.1 tp -56.55 -38.54 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 O-C-N 121.24 -0.913 . . . . 0.0 112.002 179.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -60.56 -24.51 65.47 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.359 0.982 . . . . 0.0 112.566 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -81.6 -46.95 13.68 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.499 1.12 . . . . 0.0 111.402 179.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -70.71 -34.07 71.54 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.441 -0.787 . . . . 0.0 111.6 176.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -58.58 -52.6 64.99 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 124.196 0.998 . . . . 0.0 110.591 172.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.8 t -67.58 -30.4 70.01 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 122.661 0.384 . . . . 0.0 111.043 -174.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -64.69 -52.91 54.69 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.043 1.337 . . . . 0.0 110.969 172.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -71.57 -31.01 66.5 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.074 -1.016 . . . . 0.0 113.14 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.93 -30.44 67.84 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.99 0.916 . . . . 0.0 111.305 172.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.4 m -74.21 -35.21 63.89 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 120.398 -1.439 . . . . 0.0 112.081 172.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 42.5 mtm -86.79 -42.95 12.88 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.366 1.066 . . . . 0.0 113.664 -173.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -114.55 -21.16 10.43 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.803 1.241 . . . . 0.0 112.639 -171.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.95 155.64 21.69 Favored Glycine 0 C--N 1.341 0.816 0 C-N-CA 125.441 1.496 . . . . 0.0 114.38 176.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -98.15 139.15 34.38 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.404 1.081 . . . . 0.0 110.645 -177.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.4 mp -106.86 143.91 28.01 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 127.331 2.252 . . . . 0.0 110.89 175.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.52 145.97 34.15 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.905 3.07 . . . . 0.0 112.415 176.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -142.12 157.52 44.79 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.856 1.662 . . . . 0.0 111.322 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.14 -52.66 58.01 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 120.63 -1.294 . . . . 0.0 113.997 -177.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -84.53 -16.0 43.84 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 176.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -178.65 -131.82 1.63 Allowed Glycine 0 CA--C 1.53 1.002 0 N-CA-C 115.626 1.01 . . . . 0.0 115.626 -165.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -143.59 159.3 42.69 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.284 1.434 . . . . 0.0 111.803 -178.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.06 149.4 45.97 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.862 1.265 . . . . 0.0 112.853 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.4 t -125.63 113.37 25.14 Favored Pre-proline 0 N--CA 1.484 1.263 0 C-N-CA 125.472 1.509 . . . . 0.0 111.933 177.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -68.73 134.72 31.0 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 124.235 3.29 . . . . 0.0 111.02 178.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 96.9 mt -99.65 164.25 12.14 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.884 1.274 . . . . 0.0 112.665 -177.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -133.71 120.65 20.86 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.224 1.01 . . . . 0.0 110.514 172.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 48.15 42.47 17.31 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.342 1.457 . . . . 0.0 113.593 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 97.7 t -100.88 123.76 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 O-C-N 121.488 -0.757 . . . . 0.0 109.734 178.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -126.23 161.18 28.32 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.419 1.088 . . . . 0.0 112.99 -172.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.8 m -148.09 153.32 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.927 2.091 . . . . 0.0 111.321 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -60.29 132.24 53.31 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 122.144 0.974 . . . . 0.0 109.611 155.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.3 t -134.6 147.58 50.25 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.175 1.79 . . . . 0.0 110.901 176.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 61.9 tp -98.16 137.01 37.55 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.244 1.017 . . . . 0.0 109.725 175.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -80.9 106.98 13.33 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.549 0.739 . . . . 0.0 110.404 167.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 46.0 mm -66.13 -23.0 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 O-C-N 120.774 -1.204 . . . . 0.0 112.286 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.66 -43.13 76.87 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.455 1.102 . . . . 0.0 113.973 -175.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.1 m -128.82 -8.01 5.0 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.94 35.13 22.49 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.321 0.962 . . . . 0.0 114.024 178.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -90.68 135.95 33.38 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.062 1.345 . . . . 0.0 112.204 176.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 mp -85.46 127.14 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 124.876 1.27 . . . . 0.0 109.43 176.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -147.15 169.91 18.32 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.582 1.153 . . . . 0.0 111.838 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -99.13 147.4 25.12 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.14 0.976 . . . . 0.0 110.535 170.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.2 t -146.53 167.96 22.39 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.689 0.796 . . . . 0.0 112.441 174.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 50.5 ptt85 -94.07 150.83 19.98 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.639 1.576 . . . . 0.0 112.75 177.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -105.82 132.87 51.41 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.601 1.161 . . . . 0.0 110.921 168.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.2 t -85.96 -45.55 11.38 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.732 1.213 . . . . 0.0 112.379 -171.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -152.25 162.11 41.63 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.394 1.078 . . . . 0.0 112.828 173.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.9 mt -89.7 155.01 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 125.094 1.357 . . . . 0.0 108.407 162.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -137.6 148.85 46.18 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.986 1.715 . . . . 0.0 110.448 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -138.46 149.56 45.57 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.867 1.267 . . . . 0.0 113.174 171.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -148.79 164.26 34.95 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.736 1.614 . . . . 0.0 110.09 170.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.5 mmtp -93.18 148.79 21.72 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.508 1.123 . . . . 0.0 111.047 176.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.1 m -148.38 144.77 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.683 1.193 . . . . 0.0 111.074 172.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -94.05 -31.33 14.27 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.66 1.184 . . . . 0.0 112.069 173.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -121.76 129.57 52.79 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.68 1.192 . . . . 0.0 110.457 -174.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.3 tp -136.52 162.34 33.36 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.392 1.877 . . . . 0.0 109.676 -172.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.9 mt -115.02 125.52 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.707 1.203 . . . . 0.0 109.274 176.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -96.97 123.74 40.77 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.148 0.979 . . . . 0.0 110.198 168.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.9 mp -111.18 126.96 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.846 1.258 . . . . 0.0 109.488 172.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.6 tttt -93.9 146.42 23.91 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.355 1.862 . . . . 0.0 110.672 174.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 80.9 mt -116.56 158.49 23.59 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.773 1.629 . . . . 0.0 111.869 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 18.8 t -59.36 -30.82 68.68 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.677 1.191 . . . . 0.0 112.699 -178.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.0 p -62.66 -15.96 54.74 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 173.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.0 7.0 68.7 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 124.749 1.166 . . . . 0.0 113.825 -171.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -81.33 159.52 24.39 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.726 1.211 . . . . 0.0 111.722 171.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 77.2 p -142.03 143.15 33.0 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.988 0.915 . . . . 0.0 112.739 169.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.1 tp -121.7 142.21 50.39 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.767 1.627 . . . . 0.0 110.858 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -120.41 110.36 16.42 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.224 1.809 . . . . 0.0 111.093 -172.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.0 m -141.06 154.37 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.029 1.332 . . . . 0.0 112.927 -165.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.4 p -68.43 150.43 97.7 Favored Pre-proline 0 N--CA 1.47 0.552 0 O-C-N 120.65 -1.281 . . . . 0.0 113.19 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -61.73 -29.65 83.72 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.678 2.252 . . . . 0.0 112.395 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 38.8 p -83.37 10.17 9.31 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 128.054 2.542 . . . . 0.0 114.859 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.559 ' HD1' ' CD2' ' A' ' 171' ' ' HIS . 17.4 t60 -99.1 109.52 54.51 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 124.748 1.219 . . . . 0.0 112.237 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -63.57 124.16 13.25 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.258 2.639 . . . . 0.0 113.841 164.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.5 t -101.27 146.67 9.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 127.433 2.293 . . . . 0.0 109.0 176.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.29 107.57 11.0 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.998 -0.438 . . . . 0.0 110.052 177.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.1 mp -110.22 155.69 21.67 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.541 1.537 . . . . 0.0 111.992 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -96.72 117.45 31.05 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.17 0.588 . . . . 0.0 112.359 174.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 73.4 mtp85 -136.15 78.75 1.73 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.607 1.163 . . . . 0.0 109.791 168.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 56.57 0.42 0.07 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 128.175 2.59 . . . . 0.0 115.78 -164.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -172.68 173.62 45.5 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 126.44 1.971 . . . . 0.0 111.341 -178.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 63.4 mt -70.15 125.72 27.59 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.434 1.494 . . . . 0.0 110.171 177.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -157.13 155.81 31.65 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 173.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -103.73 120.82 41.73 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.217 1.007 . . . . 0.0 112.639 -172.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 49.0 t -129.59 127.01 22.93 Favored Pre-proline 0 N--CA 1.482 1.147 0 C-N-CA 124.905 1.282 . . . . 0.0 110.698 -175.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -64.32 140.41 70.24 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.077 2.518 . . . . 0.0 112.225 -179.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.08 -32.38 15.54 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 176.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.76 -20.95 66.16 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 173.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -106.84 -9.56 16.33 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.61 1.564 . . . . 0.0 113.17 177.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 78.1 t -68.45 145.48 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.696 1.598 . . . . 0.0 109.969 172.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.63 157.93 75.03 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 125.697 1.599 . . . . 0.0 111.62 -178.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -64.81 122.11 9.84 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 121.986 1.791 . . . . 0.0 111.32 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 108.11 0.16 33.54 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 124.565 1.078 . . . . 0.0 115.377 -178.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -63.34 162.25 12.61 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.872 1.269 . . . . 0.0 112.372 169.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -109.07 122.73 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 125.35 1.46 . . . . 0.0 111.332 177.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.45 135.86 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 126.324 1.85 . . . . 0.0 110.102 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.9 t -85.79 143.8 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 119.522 1.055 . . . . 0.0 111.733 -176.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -168.21 -149.4 6.11 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 124.794 1.188 . . . . 0.0 114.174 -177.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.1 p -156.97 165.55 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 127.287 2.235 . . . . 0.0 107.767 -174.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -58.62 109.29 0.77 Allowed 'General case' 0 N--CA 1.479 0.993 0 O-C-N 121.095 -1.003 . . . . 0.0 112.84 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -59.53 -30.38 68.55 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.539 0.736 . . . . 0.0 112.865 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -65.61 -29.74 70.37 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 178.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -84.64 -36.36 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-N 119.362 0.983 . . . . 0.0 111.08 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -62.48 -24.07 67.26 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.007 1.323 . . . . 0.0 113.057 173.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 20.3 mtt85 -87.44 5.44 38.89 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.739 1.615 . . . . 0.0 114.91 172.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -132.41 -169.14 2.17 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 125.915 1.686 . . . . 0.0 112.763 -175.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 51.5 ttp85 -56.73 -34.41 67.47 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 127.611 2.364 . . . . 0.0 116.209 -166.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 63.5 mt -124.15 142.67 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 CA-C-N 119.665 1.12 . . . . 0.0 111.587 -171.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 48.6 mt -95.73 115.0 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 160.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 64.1 m -74.86 128.39 35.45 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.333 0.653 . . . . 0.0 112.756 -172.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -79.64 145.08 33.23 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.022 0.929 . . . . 0.0 111.791 176.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 68.11 24.52 74.63 Favored Glycine 0 CA--C 1.539 1.538 0 N-CA-C 116.644 1.418 . . . . 0.0 116.644 174.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -127.79 139.75 52.46 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.081 1.441 . . . . 0.0 112.681 -177.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 59.7 mt -149.56 156.48 42.02 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.222 1.409 . . . . 0.0 113.522 -176.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -142.62 167.21 22.62 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.657 1.983 . . . . 0.0 111.199 -179.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -128.15 156.93 42.09 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 120.348 -1.47 . . . . 0.0 113.945 158.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -116.15 136.31 53.14 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 128.116 2.566 . . . . 0.0 109.159 -173.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -89.11 131.78 35.1 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.965 0.802 . . . . 0.0 111.936 178.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 93.8 t -69.91 127.8 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 123.421 0.688 . . . . 0.0 110.734 171.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.3 t -88.27 -45.1 10.34 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.528 1.931 . . . . 0.0 112.091 175.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.2 t -157.67 163.54 38.1 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.443 1.097 . . . . 0.0 111.404 177.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.9 m -136.63 148.54 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 124.81 1.244 . . . . 0.0 111.193 171.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -158.18 155.98 30.02 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 172.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 74.3 mt -86.81 131.8 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.549 1.14 . . . . 0.0 109.061 168.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 25.1 pt -127.0 161.77 33.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 126.611 1.964 . . . . 0.0 112.257 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -95.91 99.06 10.89 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.777 1.631 . . . . 0.0 111.976 177.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -85.63 -51.95 6.13 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 177.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 48.37 41.18 16.1 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.325 1.05 . . . . 0.0 113.164 -175.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 33.9 t-20 -145.41 167.84 21.95 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.684 1.193 . . . . 0.0 110.38 -176.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -68.87 145.44 53.7 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.32 1.048 . . . . 0.0 112.149 177.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.1 m -128.77 152.8 37.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 126.069 1.748 . . . . 0.0 109.422 177.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.438 ' CG ' HG12 ' A' ' 21' ' ' ILE . 2.3 p90 -111.43 160.42 17.12 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -174.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -146.39 127.89 15.05 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.334 1.053 . . . . 0.0 109.299 170.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 32.7 tp -93.06 134.9 34.74 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 120.336 -1.478 . . . . 0.0 112.315 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 23.1 t -99.25 119.67 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 121.545 0.688 . . . . 0.0 112.822 -172.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 20.2 mm -125.96 96.57 37.12 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 126.914 2.085 . . . . 0.0 107.969 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.79 -18.14 22.27 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 122.623 2.216 . . . . 0.0 113.285 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -82.58 -34.48 27.71 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -172.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 44.5 p -139.02 -10.93 1.29 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.615 1.166 . . . . 0.0 113.474 -175.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . 0.306 51.7 m-70 55.37 26.08 8.33 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.09 1.756 . . . . 0.0 115.635 -173.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -154.19 158.96 41.11 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 120.795 -1.191 . . . . 0.0 113.68 173.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -147.06 166.18 27.67 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.544 1.538 . . . . 0.0 112.209 176.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.0 mp -107.96 139.28 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.085 0.954 . . . . 0.0 111.588 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.94 157.16 63.65 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.483 1.113 . . . . 0.0 112.52 174.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.01 -13.98 41.92 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.897 2.398 . . . . 0.0 113.165 177.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -85.94 7.87 22.59 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 124.438 1.095 . . . . 0.0 113.104 171.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 94.4 -23.92 29.81 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 126.24 1.876 . . . . 0.0 116.47 173.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 65.7 mt -70.17 146.27 50.9 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.906 1.353 . . . . 0.0 113.497 -174.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 4.1 t -90.46 128.51 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 123.748 0.819 . . . . 0.0 111.685 174.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 47.3 mt -117.79 160.6 21.09 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 127.598 2.359 . . . . 0.0 111.919 -176.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.559 ' CD2' ' HD1' ' A' ' 93' ' ' HIS . 0.0 OUTLIER -100.31 166.17 11.11 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 -175.282 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -99.15 144.97 27.68 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.672 1.589 . . . . 0.0 109.972 148.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -138.26 26.78 2.62 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.625 1.17 . . . . 0.0 113.84 172.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 . . . . . 0 C--O 1.251 1.156 0 C-N-CA 126.345 1.858 . . . . 0.0 111.784 178.757 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 111.365 0.135 . . . . 0.0 111.365 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -129.01 159.91 34.4 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.555 1.942 . . . . 0.0 111.151 -177.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.95 145.87 34.34 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.25 0.62 . . . . 0.0 111.268 173.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.92 -24.2 50.66 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 178.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -74.24 -15.4 60.99 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.721 1.608 . . . . 0.0 112.633 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.0 m -68.94 144.02 54.28 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.021 0.929 . . . . 0.0 112.46 -170.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -78.98 156.62 28.38 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 176.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 p -146.17 154.33 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.296 1.438 . . . . 0.0 111.878 -175.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -130.22 127.26 39.28 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 126.293 1.837 . . . . 0.0 108.493 177.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -153.85 171.91 18.21 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.588 0.755 . . . . 0.0 112.133 175.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -130.81 148.82 52.63 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.731 1.213 . . . . 0.0 111.27 171.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -152.59 140.16 19.75 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.528 1.131 . . . . 0.0 110.061 172.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.1 t0 49.13 49.17 20.0 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.01 1.324 . . . . 0.0 113.967 170.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.0 m 62.05 35.42 15.95 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.741 2.016 . . . . 0.0 114.636 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.5 p -152.39 138.42 11.74 Favored Pre-proline 0 CA--C 1.546 0.826 0 O-C-N 120.838 -1.164 . . . . 0.0 113.054 167.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.41 154.95 28.26 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 124.543 3.495 . . . . 0.0 113.814 174.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -133.21 142.51 48.62 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.856 2.062 . . . . 0.0 110.81 172.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 47.1 ttm -145.16 90.65 2.06 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.094 1.358 . . . . 0.0 109.404 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -139.21 -168.72 2.5 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.695 1.998 . . . . 0.0 111.094 -168.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 m -79.03 151.32 31.57 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 121.0 -1.062 . . . . 0.0 111.477 168.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.3 tp -57.64 -37.65 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 O-C-N 121.607 -0.683 . . . . 0.0 111.829 173.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -61.59 -29.68 70.19 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.484 1.038 . . . . 0.0 112.781 175.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -80.74 -35.87 32.8 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.592 0.757 . . . . 0.0 111.674 -175.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 21.6 ptm -71.11 -35.26 71.72 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.207 0.458 . . . . 0.0 111.115 169.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -60.27 -51.53 69.16 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.695 0.798 . . . . 0.0 111.559 176.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.9 t -61.68 -39.62 92.07 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.309 1.044 . . . . 0.0 110.956 -176.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -63.71 -52.97 58.18 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 124.872 1.269 . . . . 0.0 110.851 177.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -72.7 -32.1 65.52 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.297 -0.877 . . . . 0.0 113.179 -178.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.54 -32.17 72.77 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.186 0.995 . . . . 0.0 111.892 173.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.1 m -81.61 -27.05 34.38 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.27 1.028 . . . . 0.0 112.463 176.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 70.2 mtm -80.17 -55.09 5.17 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.314 1.046 . . . . 0.0 112.25 174.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -108.22 -20.58 13.1 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.073 1.349 . . . . 0.0 114.13 -167.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.27 157.6 33.6 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 124.779 1.18 . . . . 0.0 114.216 -176.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -102.02 128.51 48.44 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.455 1.102 . . . . 0.0 108.414 174.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.3 mp -104.39 143.09 25.98 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 125.684 1.594 . . . . 0.0 110.23 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.69 149.13 54.25 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 123.725 2.95 . . . . 0.0 111.884 -176.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -144.14 161.82 37.88 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.995 1.318 . . . . 0.0 111.563 -175.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -51.33 -55.3 19.15 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.461 1.505 . . . . 0.0 113.505 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -90.78 -7.04 53.5 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 177.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 174.73 -124.75 1.04 Allowed Glycine 0 CA--C 1.53 0.978 0 CA-C-N 119.856 1.207 . . . . 0.0 115.55 -174.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -141.57 158.97 43.17 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.7 1.6 . . . . 0.0 111.126 177.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.94 149.12 44.41 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.817 1.247 . . . . 0.0 112.121 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.0 t -119.12 117.8 33.19 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 125.249 1.42 . . . . 0.0 110.625 178.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -74.69 140.49 26.44 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 124.421 3.414 . . . . 0.0 112.315 -177.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 64.2 mt -107.34 170.51 7.92 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.575 1.15 . . . . 0.0 113.604 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -152.63 135.18 15.24 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 127.225 2.21 . . . . 0.0 109.295 166.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 51.43 47.01 25.64 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.278 1.431 . . . . 0.0 113.162 -178.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 56.8 t -115.3 129.37 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.874 0.869 . . . . 0.0 110.637 176.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -126.93 149.0 50.03 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.748 1.219 . . . . 0.0 111.828 -170.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.0 m -137.25 150.42 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.011 1.324 . . . . 0.0 110.793 175.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -77.58 144.45 37.52 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.956 0.884 . . . . 0.0 111.006 168.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.1 t -151.81 151.77 31.78 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.581 1.152 . . . . 0.0 111.055 -165.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.4 tp -98.11 129.01 44.94 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.322 0.649 . . . . 0.0 109.573 171.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -69.88 101.88 1.84 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 162.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.0 mm -64.15 -26.83 41.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 O-C-N 120.951 -1.093 . . . . 0.0 111.279 -174.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.42 -42.15 18.95 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.67 1.188 . . . . 0.0 113.938 -174.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.2 m -101.29 -16.78 16.83 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.075 0.95 . . . . 0.0 112.308 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.45 20.67 79.51 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.461 1.505 . . . . 0.0 114.288 -176.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -79.24 123.95 27.91 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.138 1.375 . . . . 0.0 110.524 177.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.9 mp -72.9 124.24 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 165.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -142.85 174.03 11.02 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.762 1.225 . . . . 0.0 112.707 -178.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -105.5 139.42 40.14 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.99 1.316 . . . . 0.0 110.517 172.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.7 t -135.44 166.59 22.81 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.642 1.177 . . . . 0.0 112.152 176.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -100.92 137.06 39.8 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.613 1.165 . . . . 0.0 113.78 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -94.11 149.28 21.38 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.139 1.376 . . . . 0.0 112.422 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 85.4 p -99.47 -54.1 3.03 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.144 0.978 . . . . 0.0 113.563 -173.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -150.73 156.36 41.14 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.033 1.124 . . . . 0.0 114.033 176.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.0 mt -89.59 152.52 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.264 1.425 . . . . 0.0 108.685 168.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -140.66 144.04 35.47 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.169 -0.957 . . . . 0.0 112.229 -172.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -131.77 142.75 49.84 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.072 1.349 . . . . 0.0 111.882 175.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -149.92 164.18 36.1 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.112 1.365 . . . . 0.0 109.746 175.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -97.55 143.35 28.33 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 123.989 0.916 . . . . 0.0 111.419 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.1 m -147.03 145.46 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.842 1.257 . . . . 0.0 111.427 173.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -94.53 -32.97 13.24 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.867 1.667 . . . . 0.0 112.184 175.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -122.68 134.38 54.48 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 124.093 0.957 . . . . 0.0 110.68 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.8 tp -132.49 160.99 34.89 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.66 1.584 . . . . 0.0 109.299 -176.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.2 mt -115.6 122.88 70.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 121.232 -0.917 . . . . 0.0 109.401 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -93.82 115.92 28.35 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.387 1.075 . . . . 0.0 111.294 169.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -103.75 124.98 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 124.471 1.108 . . . . 0.0 108.721 170.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -91.93 146.11 24.01 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.487 1.515 . . . . 0.0 110.336 172.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 60.4 mt -106.86 160.92 15.15 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.486 1.914 . . . . 0.0 110.939 -178.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.6 t -65.11 -18.74 65.56 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.168 -0.958 . . . . 0.0 113.06 -178.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.7 p -69.02 -17.08 63.86 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.46 1.504 . . . . 0.0 114.572 167.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 83.73 7.43 85.94 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 126.458 1.98 . . . . 0.0 114.907 -170.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -80.44 167.45 20.15 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 118.771 1.285 . . . . 0.0 109.811 168.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 91.9 p -144.79 158.46 43.78 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 120.953 -1.092 . . . . 0.0 113.582 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 61.1 tp -130.64 133.53 46.2 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.383 1.873 . . . . 0.0 110.007 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -113.61 113.66 25.36 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.782 1.233 . . . . 0.0 111.65 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.4 m -139.67 157.08 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 125.721 1.608 . . . . 0.0 112.598 -169.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.9 p -68.25 149.72 97.99 Favored Pre-proline 0 N--CA 1.468 0.442 0 O-C-N 121.262 -0.899 . . . . 0.0 112.514 177.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -57.11 -33.61 96.15 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.642 2.228 . . . . 0.0 112.015 -178.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.7 m -89.54 21.63 3.34 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.526 1.93 . . . . 0.0 114.551 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -102.82 115.95 63.38 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 125.139 1.375 . . . . 0.0 111.072 176.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -72.93 142.43 34.94 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.895 2.396 . . . . 0.0 114.213 177.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 39.9 t -121.54 143.27 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 126.954 2.101 . . . . 0.0 109.298 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 25.8 tp -79.0 113.73 17.36 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.403 0.547 . . . . 0.0 110.292 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.43 159.58 18.6 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.222 2.609 . . . . 0.0 110.27 -172.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -124.18 121.13 34.26 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 174.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -138.63 89.45 2.37 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.822 0.849 . . . . 0.0 110.595 165.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 56.5 -0.17 0.06 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.995 2.118 . . . . 0.0 115.206 -163.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -176.47 167.23 38.64 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 125.627 1.584 . . . . 0.0 112.344 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 38.0 mt -64.38 128.54 36.21 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 126.001 1.721 . . . . 0.0 110.909 178.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -152.59 144.57 23.74 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.54 1.136 . . . . 0.0 112.727 175.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -94.39 130.1 40.85 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.109 0.964 . . . . 0.0 110.643 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 47.9 t -133.72 127.4 19.44 Favored Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 124.047 0.939 . . . . 0.0 110.527 -177.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -65.81 143.79 74.96 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.698 2.265 . . . . 0.0 111.434 175.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.27 -31.7 22.07 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.44 -16.46 62.46 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 173.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -113.15 -7.94 13.59 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.485 1.514 . . . . 0.0 113.042 177.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.4 t -67.06 150.24 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.1 1.36 . . . . 0.0 110.522 168.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.36 157.78 71.88 Favored Pre-proline 0 N--CA 1.475 0.799 0 C-N-CA 126.71 2.004 . . . . 0.0 111.246 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -68.2 122.27 9.31 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.598 2.199 . . . . 0.0 111.806 -173.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 104.62 5.49 42.11 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.309 0.957 . . . . 0.0 114.647 -176.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -67.43 166.68 14.11 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.557 1.143 . . . . 0.0 112.166 168.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.2 p -117.11 118.46 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.133 0.973 . . . . 0.0 112.052 -176.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.0 t -89.75 139.03 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 125.474 1.51 . . . . 0.0 110.008 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.3 t -91.57 139.04 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 123.731 0.812 . . . . 0.0 110.243 174.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -160.65 -155.88 7.97 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.011 0.815 . . . . 0.0 113.284 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.4 p -137.22 161.76 34.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 128.279 2.632 . . . . 0.0 107.919 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -62.08 103.42 0.37 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.761 0.824 . . . . 0.0 112.301 -173.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.18 -29.31 70.12 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.817 0.847 . . . . 0.0 113.018 -175.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -66.2 -29.64 69.95 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.289 1.036 . . . . 0.0 113.792 172.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 76.2 t -85.89 -40.97 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 123.682 0.793 . . . . 0.0 109.825 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.5 tp -60.98 -21.35 63.44 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.753 1.221 . . . . 0.0 112.765 176.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 42.9 ttm105 -76.61 -15.38 59.85 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 127.072 2.149 . . . . 0.0 114.738 174.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -81.13 153.15 27.43 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.7 1.2 . . . . 0.0 110.925 -178.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -66.38 -36.64 83.36 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 118.362 0.528 . . . . 0.0 110.931 177.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 92.6 mt -88.49 108.96 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.37 1.468 . . . . 0.0 109.767 164.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 62.9 mt -91.72 90.57 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.493 1.117 . . . . 0.0 109.907 -176.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 44.9 m -77.88 70.51 4.26 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.735 1.214 . . . . 0.0 111.803 178.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.19 -176.05 0.51 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 127.267 2.227 . . . . 0.0 114.639 -173.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.04 -2.97 61.89 Favored Glycine 0 CA--C 1.535 1.33 0 N-CA-C 116.512 1.365 . . . . 0.0 116.512 172.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -120.49 99.9 6.83 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 118.803 1.302 . . . . 0.0 111.477 -168.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 96.4 mt -67.36 146.18 54.33 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.813 0.845 . . . . 0.0 112.514 -175.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -140.18 123.89 17.27 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.422 1.489 . . . . 0.0 110.459 176.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -87.2 146.09 26.14 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 122.991 0.516 . . . . 0.0 111.367 176.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 23.9 m80 -129.08 128.4 43.47 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.666 1.587 . . . . 0.0 108.545 -173.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -88.31 141.01 28.9 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 120.944 -1.098 . . . . 0.0 112.494 -178.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 76.6 t -67.78 136.39 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 124.755 1.222 . . . . 0.0 110.078 171.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 29.6 t -90.18 -53.11 4.61 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.81 1.644 . . . . 0.0 111.506 171.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.6 m -156.97 159.87 38.49 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 121.194 -0.941 . . . . 0.0 111.121 -174.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.8 m -134.96 152.5 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.158 0.983 . . . . 0.0 111.813 174.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -162.56 159.84 25.24 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.386 1.074 . . . . 0.0 112.481 168.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 83.4 mt -82.66 144.41 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 166.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 44.4 pt -133.82 155.02 39.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.981 1.713 . . . . 0.0 111.074 174.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -93.78 95.96 9.47 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.739 0.816 . . . . 0.0 111.108 -177.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -76.95 -56.72 4.34 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.193 0.997 . . . . 0.0 112.842 179.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 44.82 51.08 8.61 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.046 1.338 . . . . 0.0 112.783 -171.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -152.09 172.02 16.97 Favored 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 124.929 1.292 . . . . 0.0 112.451 -175.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -72.27 135.35 45.98 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 120.739 -1.226 . . . . 0.0 112.144 172.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 4.0 m -111.14 152.14 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.839 1.256 . . . . 0.0 109.645 172.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -115.77 156.17 26.5 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 122.129 0.966 . . . . 0.0 112.105 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -158.59 164.88 35.64 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.22 1.408 . . . . 0.0 109.206 -163.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 44.1 tp -143.02 141.97 31.47 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.712 1.205 . . . . 0.0 110.103 -170.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.9 t -112.4 128.58 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.097 0.959 . . . . 0.0 111.534 -172.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.9 mm -135.09 83.28 39.94 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 126.445 1.898 . . . . 0.0 108.743 -176.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -64.27 -16.77 56.88 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.825 2.35 . . . . 0.0 113.303 -178.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -74.88 -32.29 61.82 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.014 1.726 . . . . 0.0 113.348 -175.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 59.7 p -141.87 -25.82 0.67 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -173.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 56.6 31.27 18.82 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.945 1.698 . . . . 0.0 115.339 -161.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -159.15 152.91 23.06 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.026 1.285 . . . . 0.0 114.137 171.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -148.07 175.69 10.8 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.914 1.686 . . . . 0.0 112.278 175.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 91.2 mt -117.94 128.95 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.731 1.212 . . . . 0.0 110.69 -174.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -80.71 156.95 72.6 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 123.173 0.589 . . . . 0.0 111.636 173.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.9 -20.91 64.53 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.555 2.17 . . . . 0.0 112.673 178.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -74.86 8.12 2.68 Favored 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 124.457 1.103 . . . . 0.0 112.872 172.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 93.09 -25.21 21.19 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 127.319 2.39 . . . . 0.0 115.621 171.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 40.6 mt -75.07 146.02 41.83 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 118.715 1.257 . . . . 0.0 113.121 -170.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.8 t -88.61 125.89 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.514 0.726 . . . . 0.0 110.632 174.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 32.0 mt -113.31 148.83 34.9 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.973 1.709 . . . . 0.0 111.193 -177.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -91.05 153.24 20.27 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.844 0.857 . . . . 0.0 112.315 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -118.81 81.1 1.64 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.875 0.87 . . . . 0.0 111.656 178.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -148.52 144.14 27.13 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.904 1.281 . . . . 0.0 111.962 170.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.28 0 C-N-CA 126.514 1.926 . . . . 0.0 111.766 173.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.486 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.32 158.42 39.15 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.006 1.322 . . . . 0.0 111.282 -173.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -63.71 148.68 48.48 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.879 0.872 . . . . 0.0 113.079 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -61.46 -22.6 65.2 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.615 1.566 . . . . 0.0 113.805 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -76.17 -14.99 60.14 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.348 1.459 . . . . 0.0 112.406 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.5 m -64.23 136.99 57.71 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.426 1.091 . . . . 0.0 112.548 -175.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -77.94 147.96 34.72 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.357 1.063 . . . . 0.0 112.703 169.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.6 p -144.85 159.88 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.269 1.028 . . . . 0.0 112.373 -171.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -129.55 135.43 48.58 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.606 1.963 . . . . 0.0 108.883 -177.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -155.83 175.19 14.25 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.079 0.854 . . . . 0.0 112.155 168.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -136.13 139.26 42.8 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.452 1.101 . . . . 0.0 111.86 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -156.76 150.79 24.98 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.987 1.315 . . . . 0.0 110.633 173.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.8 t0 49.96 42.08 23.93 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.656 1.182 . . . . 0.0 112.66 -173.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.1 m 55.75 36.17 26.74 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 126.401 1.881 . . . . 0.0 114.609 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.3 p -149.0 139.88 13.81 Favored Pre-proline 0 CA--C 1.54 0.579 0 O-C-N 120.419 -1.426 . . . . 0.0 111.242 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.33 150.29 32.42 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.708 2.938 . . . . 0.0 113.309 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -126.78 140.22 52.53 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.775 2.03 . . . . 0.0 109.894 172.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -148.03 113.2 5.53 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.098 0.959 . . . . 0.0 110.039 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -164.33 -175.51 3.97 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.428 1.891 . . . . 0.0 110.249 -174.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 m -72.09 146.32 47.61 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 120.872 -1.142 . . . . 0.0 109.928 173.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.426 HG12 ' CG ' ' A' ' 152' ' ' TYR . 9.1 tp -56.84 -37.99 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 O-C-N 121.593 -0.692 . . . . 0.0 112.29 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -63.83 -26.27 68.54 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.104 0.866 . . . . 0.0 112.451 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -78.31 -40.64 36.13 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.841 1.257 . . . . 0.0 111.112 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -73.0 -32.58 65.24 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.422 -0.799 . . . . 0.0 111.725 173.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -59.62 -49.18 78.77 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.842 0.857 . . . . 0.0 111.026 169.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.2 t -65.95 -31.5 72.45 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.438 0.695 . . . . 0.0 111.968 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -67.85 -53.52 26.13 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.04 1.336 . . . . 0.0 110.983 173.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -70.4 -33.29 71.2 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.33 -31.88 72.94 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.684 0.794 . . . . 0.0 111.943 173.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.3 t -78.52 -29.98 46.82 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 121.199 -0.938 . . . . 0.0 112.011 174.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 65.5 mtm -81.08 -49.96 10.23 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.113 0.965 . . . . 0.0 113.454 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 -111.8 -20.28 12.12 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.639 1.576 . . . . 0.0 114.295 -168.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.55 158.31 33.56 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 124.553 1.073 . . . . 0.0 114.613 -178.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -104.68 126.42 51.75 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.279 1.032 . . . . 0.0 110.475 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 11.1 mp -99.82 148.51 34.89 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 126.406 1.882 . . . . 0.0 110.517 177.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -72.4 154.92 55.95 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.118 2.546 . . . . 0.0 111.668 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -134.37 167.81 20.05 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.566 1.146 . . . . 0.0 111.202 168.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -51.57 -58.08 7.33 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.036 1.335 . . . . 0.0 111.453 171.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -96.57 -8.79 30.93 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -171.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -175.16 -131.08 1.38 Allowed Glycine 0 CA--C 1.535 1.294 0 N-CA-C 114.871 0.708 . . . . 0.0 114.871 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -136.81 159.7 41.07 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.206 1.802 . . . . 0.0 111.211 176.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.44 149.03 42.07 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.209 1.404 . . . . 0.0 111.213 -177.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.2 t -123.5 116.97 27.94 Favored Pre-proline 0 N--CA 1.482 1.154 0 C-N-CA 125.432 1.493 . . . . 0.0 109.912 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.72 140.97 40.25 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 124.23 3.287 . . . . 0.0 111.78 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 87.5 mt -109.47 169.68 8.55 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.386 1.074 . . . . 0.0 113.309 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -148.29 123.01 9.89 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.723 1.609 . . . . 0.0 110.022 174.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 50.17 40.59 22.31 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.543 1.537 . . . . 0.0 114.022 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.9 t -102.12 122.74 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 121.243 -0.91 . . . . 0.0 110.048 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -121.25 150.9 40.67 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.281 1.032 . . . . 0.0 113.115 -171.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.4 m -138.19 155.49 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 126.862 2.065 . . . . 0.0 111.634 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -69.06 132.55 46.8 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.328 0.651 . . . . 0.0 109.682 167.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.2 t -132.28 148.48 52.44 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.585 1.954 . . . . 0.0 110.654 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 55.9 tp -104.98 134.35 48.23 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.457 1.103 . . . . 0.0 109.654 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -78.1 105.57 9.41 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.59 0.756 . . . . 0.0 109.071 167.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 29.5 mm -66.75 -23.51 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 119.656 1.116 . . . . 0.0 111.633 -176.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.57 -48.22 49.8 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.661 1.184 . . . . 0.0 114.093 -177.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.2 m -114.87 -3.12 12.76 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.214 1.006 . . . . 0.0 113.435 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.59 28.85 68.63 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.293 1.425 . . . . 0.0 113.479 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -95.04 141.58 28.52 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.508 1.123 . . . . 0.0 112.039 -173.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.9 mp -89.81 128.02 42.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 C-N-CA 125.106 1.362 . . . . 0.0 109.501 -176.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -151.53 170.39 19.75 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.331 1.052 . . . . 0.0 112.645 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -114.23 135.12 54.4 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.82 1.248 . . . . 0.0 111.23 -177.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.6 t -134.58 153.87 51.76 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.219 1.008 . . . . 0.0 112.769 -174.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -80.42 140.9 35.77 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 175.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -93.45 143.0 26.7 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.387 1.075 . . . . 0.0 110.92 167.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 96.0 p -85.56 -53.95 4.86 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.81 1.244 . . . . 0.0 112.269 -174.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -152.1 158.82 43.51 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.964 1.705 . . . . 0.0 112.669 177.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.2 mt -85.66 152.51 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 163.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -143.56 148.05 35.35 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.103 1.361 . . . . 0.0 111.466 -177.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.1 ptt-85 -144.11 150.8 38.69 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 168.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -148.62 172.16 15.0 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.293 1.837 . . . . 0.0 110.586 175.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp -101.32 143.87 30.85 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.131 0.973 . . . . 0.0 112.186 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.6 m -145.35 146.57 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.464 1.506 . . . . 0.0 110.815 173.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -92.81 -34.46 13.86 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.731 1.212 . . . . 0.0 111.729 173.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -114.86 124.4 51.63 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.876 1.67 . . . . 0.0 110.224 -170.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.5 tp -134.29 158.5 43.61 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.61 1.564 . . . . 0.0 109.746 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 14.4 mt -109.61 130.83 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.324 1.049 . . . . 0.0 108.762 173.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -100.12 123.83 44.8 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.188 1.395 . . . . 0.0 110.083 168.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -113.3 115.79 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.557 1.543 . . . . 0.0 108.269 173.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.2 tttt -87.82 148.52 24.64 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.444 1.098 . . . . 0.0 110.966 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 85.8 mt -115.06 158.41 22.16 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.17 1.388 . . . . 0.0 112.347 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.1 t -65.04 -23.02 67.07 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 121.881 -0.512 . . . . 0.0 112.077 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 96.1 p -63.35 -22.26 66.77 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.697 1.599 . . . . 0.0 115.031 170.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.83 1.22 61.78 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 125.275 1.417 . . . . 0.0 115.198 -171.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -85.7 161.67 19.1 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.633 1.217 . . . . 0.0 111.194 172.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.2 p -134.49 135.34 42.35 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.359 1.076 . . . . 0.0 112.79 172.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 63.4 tp -97.76 115.09 27.32 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.659 1.584 . . . . 0.0 108.797 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -111.09 109.48 19.58 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.637 1.575 . . . . 0.0 109.878 -177.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.2 m -149.81 154.18 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 126.157 1.783 . . . . 0.0 113.254 -161.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.9 p -66.7 149.75 98.03 Favored Pre-proline 0 N--CA 1.471 0.587 0 O-C-N 121.072 -1.017 . . . . 0.0 113.244 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -60.5 -21.62 68.92 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 124.316 3.344 . . . . 0.0 114.685 -175.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.6 p -76.95 -23.08 52.4 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 128.318 2.647 . . . . 0.0 114.704 175.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 44.0 t60 -75.19 121.19 84.7 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-O 118.349 -0.834 . . . . 0.0 112.671 -162.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -75.13 126.28 9.78 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.881 2.387 . . . . 0.0 112.866 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.8 t -106.08 145.01 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 126.011 1.725 . . . . 0.0 109.175 175.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 18.0 tp -79.46 109.86 14.22 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.4 0.545 . . . . 0.0 110.363 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.1 mp -107.35 161.05 15.16 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.252 1.821 . . . . 0.0 111.556 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -117.91 112.16 19.97 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 174.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.1 mtt-85 -139.62 91.1 2.45 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.76 1.224 . . . . 0.0 109.162 165.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 56.28 -2.68 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 128.25 2.62 . . . . 0.0 116.984 -167.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.76 164.66 37.39 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 125.515 1.531 . . . . 0.0 112.682 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 67.6 mt -71.5 114.86 10.02 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.884 1.674 . . . . 0.0 110.403 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -138.35 136.59 36.52 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -174.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -92.21 112.41 24.34 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.57 1.148 . . . . 0.0 110.85 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 60.5 t -124.32 127.4 25.3 Favored Pre-proline 0 N--CA 1.478 0.962 0 C-N-CA 123.95 0.9 . . . . 0.0 110.233 -172.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -64.22 143.35 83.4 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.487 2.125 . . . . 0.0 111.584 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.14 -30.52 26.91 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 177.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.61 -22.06 66.63 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 173.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -105.43 -6.52 19.43 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.334 1.454 . . . . 0.0 112.486 175.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 84.8 t -68.51 142.25 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 O-C-N 121.292 -0.88 . . . . 0.0 109.594 166.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.61 154.65 80.92 Favored Pre-proline 0 N--CA 1.469 0.505 0 C-N-CA 128.289 2.636 . . . . 0.0 109.496 -178.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.46 132.49 31.36 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.994 1.796 . . . . 0.0 111.05 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 104.04 -6.06 46.81 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.166 1.365 . . . . 0.0 114.221 175.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.33 162.28 28.85 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 118.734 1.267 . . . . 0.0 112.439 177.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 50.5 t -91.12 121.59 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.071 1.348 . . . . 0.0 110.661 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.1 t -94.87 137.69 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.853 1.261 . . . . 0.0 110.233 169.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 41.1 t -89.58 137.82 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.14 0.976 . . . . 0.0 110.473 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -164.99 -149.01 5.67 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.245 0.926 . . . . 0.0 113.002 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.9 p -148.44 166.15 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 127.404 2.281 . . . . 0.0 108.486 175.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 . . . . . 0 N--CA 1.472 0.664 0 C-N-CA 123.67 0.788 . . . . 0.0 111.909 174.649 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 0 CA--C 1.536 0.415 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 95.7 mt -137.13 164.83 27.5 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.674 1.99 . . . . 0.0 109.634 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -142.09 134.73 28.3 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.207 1.403 . . . . 0.0 111.83 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -90.59 143.54 26.64 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.557 1.543 . . . . 0.0 111.702 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -131.65 136.07 47.42 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.35 1.46 . . . . 0.0 110.917 -173.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -87.33 130.65 34.54 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 119.011 0.823 . . . . 0.0 112.394 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 82.8 t -68.35 122.15 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 121.77 0.795 . . . . 0.0 110.573 167.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 45.5 t -76.92 -50.29 13.63 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.823 1.649 . . . . 0.0 112.602 176.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.4 t -158.8 164.99 35.28 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.474 1.51 . . . . 0.0 110.552 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.8 m -132.61 149.5 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 124.486 1.114 . . . . 0.0 111.543 170.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -155.34 154.37 31.93 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.247 1.019 . . . . 0.0 113.565 171.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 71.2 mt -90.25 130.6 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.561 1.144 . . . . 0.0 109.26 169.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 16.1 pt -126.39 159.04 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.925 1.69 . . . . 0.0 112.496 -174.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -95.38 96.53 9.19 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 122.24 1.019 . . . . 0.0 111.534 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -76.01 -52.02 11.11 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.064 0.945 . . . . 0.0 113.2 176.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 50.89 33.12 8.18 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.954 1.301 . . . . 0.0 113.952 -176.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -141.04 172.97 11.95 Favored 'General case' 0 CA--C 1.549 0.928 0 O-C-N 120.775 -1.203 . . . . 0.0 112.471 -170.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -74.01 137.89 43.75 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.262 -0.899 . . . . 0.0 112.091 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 12.2 m -122.35 154.5 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.399 1.88 . . . . 0.0 110.141 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.426 ' CG ' HG12 ' A' ' 21' ' ' ILE . 1.5 p90 -113.06 159.73 18.88 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -174.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -137.68 145.29 42.43 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.256 1.422 . . . . 0.0 109.092 158.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 67.1 tp -120.89 103.99 9.49 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.829 1.252 . . . . 0.0 109.426 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 57.6 t -87.71 131.66 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -150.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.4 mm -124.62 85.78 56.21 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 124.536 1.134 . . . . 0.0 110.793 -176.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -65.48 -10.3 25.7 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.561 2.174 . . . . 0.0 114.216 177.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -72.15 -47.74 48.69 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 119.816 1.189 . . . . 0.0 113.0 172.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 71.1 p -135.32 -15.2 1.93 Allowed 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -171.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . 0.295 94.4 m-70 56.78 25.9 10.83 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 128.079 2.552 . . . . 0.0 116.03 -170.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.92 146.85 26.55 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 120.796 -1.19 . . . . 0.0 113.548 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -147.56 166.05 28.49 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.299 1.439 . . . . 0.0 112.302 -176.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.9 mp -109.82 135.59 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.82 1.248 . . . . 0.0 111.663 177.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -85.81 159.05 55.67 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 124.315 1.046 . . . . 0.0 112.624 171.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.0 -23.19 74.06 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.69 2.926 . . . . 0.0 112.582 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.74 8.22 2.05 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.548 1.139 . . . . 0.0 113.176 171.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 90.68 -20.61 37.59 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 127.098 2.285 . . . . 0.0 116.048 169.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 47.2 mt -70.87 151.76 44.41 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.279 1.432 . . . . 0.0 112.889 -173.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.41 124.72 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 124.565 1.146 . . . . 0.0 111.926 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.96 144.07 43.68 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.738 2.015 . . . . 0.0 111.96 -173.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -100.27 146.52 26.81 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.563 0.745 . . . . 0.0 111.98 166.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 22.8 m120 . . . . . 0 CA--C 1.538 0.483 0 O-C-N 121.562 -0.711 . . . . 0.0 110.832 168.388 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.667 0 CA-C-O 121.023 0.44 . . . . 0.0 112.031 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.422 ' HB2' ' CE1' ' A' ' 152' ' ' TYR . 0.0 OUTLIER -146.6 164.45 32.59 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.645 1.578 . . . . 0.0 111.058 -172.419 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.74 143.58 57.43 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.66 1.184 . . . . 0.0 113.725 -175.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? -58.71 -25.22 62.69 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.182 1.393 . . . . 0.0 114.238 177.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -87.02 1.03 54.19 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.924 1.29 . . . . 0.0 113.399 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.1 m -69.35 142.06 54.07 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.592 1.157 . . . . 0.0 113.099 175.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -79.32 148.06 32.23 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.436 1.494 . . . . 0.0 113.464 171.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.0 p -147.19 158.52 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.648 1.179 . . . . 0.0 111.904 -173.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -126.35 139.86 52.96 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.444 1.898 . . . . 0.0 108.807 178.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -155.28 177.21 11.61 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.608 0.718 . . . . 0.0 111.379 165.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -134.9 143.1 46.75 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.135 0.974 . . . . 0.0 110.181 173.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -159.53 143.12 14.56 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.483 1.113 . . . . 0.0 109.826 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.4 t70 48.49 50.28 17.07 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.927 1.291 . . . . 0.0 113.595 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.4 m 68.71 11.06 8.22 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 128.38 2.672 . . . . 0.0 116.145 174.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.6 p -134.71 136.87 26.22 Favored Pre-proline 0 CA--C 1.545 0.756 0 O-C-N 120.279 -1.513 . . . . 0.0 112.871 -176.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -73.0 154.39 52.82 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 123.793 2.996 . . . . 0.0 112.597 174.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -135.31 136.86 41.92 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.739 2.016 . . . . 0.0 109.147 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 50.6 ttm -152.95 104.01 2.8 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.749 0.82 . . . . 0.0 110.277 -176.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -162.29 -176.86 5.34 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.138 1.375 . . . . 0.0 111.067 -169.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.4 m -71.6 143.75 49.71 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 120.855 -1.153 . . . . 0.0 110.673 171.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.414 HG21 ' CD1' ' A' ' 152' ' ' TYR . 9.1 tp -55.02 -38.29 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -62.64 -24.04 67.39 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.365 -0.834 . . . . 0.0 113.02 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -80.55 -39.39 27.83 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.08 0.952 . . . . 0.0 111.313 176.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -73.18 -33.23 65.32 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.079 0.854 . . . . 0.0 111.72 174.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -56.96 -51.73 68.02 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.701 1.2 . . . . 0.0 111.908 169.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.1 t -62.17 -40.42 95.97 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.631 0.772 . . . . 0.0 111.423 -177.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -61.05 -53.01 62.49 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.756 1.223 . . . . 0.0 110.425 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -72.07 -33.28 67.8 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.0 -31.58 72.56 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.254 1.022 . . . . 0.0 112.513 175.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.7 t -79.81 -33.07 40.69 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 118.796 0.725 . . . . 0.0 111.878 174.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 69.8 mtm -75.99 -48.15 22.22 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.566 0.747 . . . . 0.0 112.665 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 35.7 m-20 -116.86 -19.88 9.67 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.437 1.495 . . . . 0.0 113.887 -166.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.75 159.17 34.89 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 125.087 1.327 . . . . 0.0 114.755 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -104.19 124.33 48.92 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.703 1.201 . . . . 0.0 109.435 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.3 mp -106.24 141.4 22.67 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 125.777 1.631 . . . . 0.0 110.613 -178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.12 146.23 57.35 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.505 2.803 . . . . 0.0 112.09 -173.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -134.25 154.73 51.1 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.42 1.088 . . . . 0.0 112.234 177.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -42.17 -47.45 4.65 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.897 1.679 . . . . 0.0 114.673 -176.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -116.3 7.65 14.04 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.13 -137.43 2.44 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 116.097 1.199 . . . . 0.0 116.097 -172.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -145.35 157.0 44.13 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 127.562 2.345 . . . . 0.0 111.062 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.09 151.98 47.15 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.376 1.071 . . . . 0.0 112.306 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.4 t -123.96 116.96 27.31 Favored Pre-proline 0 N--CA 1.48 1.046 0 C-N-CA 125.393 1.477 . . . . 0.0 110.284 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.43 141.63 31.96 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 124.529 3.486 . . . . 0.0 111.584 -176.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 77.2 mt -115.54 171.21 7.87 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.822 1.249 . . . . 0.0 112.682 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -148.92 135.02 19.16 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.843 1.657 . . . . 0.0 109.479 165.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 52.17 50.28 18.78 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.971 1.308 . . . . 0.0 113.562 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 67.0 t -113.05 107.67 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.075 0.95 . . . . 0.0 110.48 177.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -103.71 137.66 41.43 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.603 1.161 . . . . 0.0 113.335 -167.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.8 m -134.74 149.84 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.574 1.549 . . . . 0.0 112.599 175.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -65.44 141.95 58.34 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.648 0.779 . . . . 0.0 111.028 169.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.9 t -144.78 154.17 42.42 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.609 1.564 . . . . 0.0 111.259 -174.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 54.0 tp -114.05 138.88 49.8 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.06 1.344 . . . . 0.0 110.821 -175.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -86.6 120.69 28.19 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.17 1.388 . . . . 0.0 108.987 161.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 24.2 mm -78.87 -28.85 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 O-C-N 121.256 -0.903 . . . . 0.0 111.154 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.05 -36.19 80.86 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.437 1.095 . . . . 0.0 113.492 -171.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.9 m -121.54 -21.26 6.28 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.217 1.407 . . . . 0.0 112.998 171.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.49 31.01 20.19 Favored Glycine 0 N--CA 1.474 1.232 0 CA-C-N 118.878 0.763 . . . . 0.0 113.099 -173.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -91.92 143.68 26.24 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.819 1.248 . . . . 0.0 112.05 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.0 144.23 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.482 1.113 . . . . 0.0 110.6 -176.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.3 ptpt -154.0 176.91 11.65 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.901 1.68 . . . . 0.0 112.367 -177.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -121.45 147.82 45.24 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.792 1.637 . . . . 0.0 111.567 174.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.7 t -143.61 160.4 40.72 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.013 1.325 . . . . 0.0 111.187 175.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -97.88 132.36 43.54 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 170.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.33 142.2 39.51 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.056 0.943 . . . . 0.0 111.004 175.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.6 t -89.96 -46.14 8.72 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -169.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -153.53 160.55 42.52 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.684 1.193 . . . . 0.0 112.272 174.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.7 mt -88.79 152.81 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.481 1.112 . . . . 0.0 108.423 165.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -139.69 148.04 41.8 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.459 1.504 . . . . 0.0 110.537 -177.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.4 ptt85 -143.32 150.16 38.81 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.099 0.96 . . . . 0.0 113.155 169.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -151.66 166.08 32.36 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.988 1.715 . . . . 0.0 109.984 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -94.09 151.93 19.14 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.036 0.834 . . . . 0.0 111.459 172.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.7 m -148.74 143.12 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 124.879 1.272 . . . . 0.0 110.333 170.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -90.22 -30.14 17.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 117.632 -1.175 . . . . 0.0 112.019 175.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.7 mttt -131.95 130.43 41.51 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.274 0.943 . . . . 0.0 110.915 -174.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.8 tp -139.93 162.78 34.37 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.804 2.042 . . . . 0.0 110.158 -168.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.7 mt -116.46 127.58 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.604 1.162 . . . . 0.0 110.138 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -96.62 126.45 41.8 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.139 0.975 . . . . 0.0 110.625 166.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -111.0 129.03 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.436 1.094 . . . . 0.0 109.835 169.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -97.65 143.73 28.02 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.025 1.73 . . . . 0.0 111.301 173.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.3 mt -104.55 157.35 17.23 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 127.094 2.158 . . . . 0.0 110.317 -176.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.3 t -66.88 -23.6 66.02 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -173.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.7 t -66.84 -20.05 65.85 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.251 -0.905 . . . . 0.0 113.415 167.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 108.13 -5.52 34.08 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 127.575 2.512 . . . . 0.0 115.71 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -82.85 161.07 22.05 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.166 1.387 . . . . 0.0 110.831 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 65.2 p -141.46 159.83 41.41 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 24.3 tp -129.41 138.89 51.74 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.461 1.904 . . . . 0.0 110.324 177.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -111.22 121.63 45.79 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.876 1.27 . . . . 0.0 112.113 177.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.12 153.41 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.728 1.611 . . . . 0.0 112.85 -166.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.2 p -68.55 148.57 98.11 Favored Pre-proline 0 N--CA 1.472 0.64 0 O-C-N 120.944 -1.098 . . . . 0.0 112.573 173.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -60.84 -30.32 89.9 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 123.069 2.513 . . . . 0.0 114.366 -168.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 95.9 p -85.19 -6.56 59.27 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -61.5 119.21 44.75 Favored Pre-proline 0 CA--C 1.544 0.747 0 CA-C-N 119.635 1.107 . . . . 0.0 111.548 -177.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -73.47 127.38 11.75 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.415 2.077 . . . . 0.0 113.097 178.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.1 t -109.38 141.04 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.389 1.876 . . . . 0.0 109.374 174.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 20.2 tp -84.12 116.06 22.71 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.935 -0.478 . . . . 0.0 110.369 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.4 mp -115.67 148.28 39.88 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.961 1.704 . . . . 0.0 111.358 -173.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -107.0 81.54 1.56 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.877 0.846 . . . . 0.0 112.662 -173.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -119.0 78.81 1.32 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.691 1.196 . . . . 0.0 110.055 -169.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.6 t70 64.54 -14.79 0.09 Allowed 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 128.697 2.799 . . . . 0.0 115.602 -160.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.58 179.45 43.32 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 126.471 1.986 . . . . 0.0 111.506 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 73.0 mt -71.49 127.38 32.36 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.501 1.12 . . . . 0.0 109.981 178.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -153.33 144.93 23.34 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.902 0.881 . . . . 0.0 112.387 174.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -89.83 128.13 36.11 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.163 0.985 . . . . 0.0 110.879 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.0 t -131.65 128.94 21.93 Favored Pre-proline 0 N--CA 1.473 0.698 0 C-N-CA 124.584 1.154 . . . . 0.0 110.801 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -65.21 144.57 81.61 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.08 1.854 . . . . 0.0 110.974 175.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.44 -29.9 17.72 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 176.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.81 -23.0 67.19 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 173.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -108.83 0.76 20.49 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.302 1.841 . . . . 0.0 112.178 178.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.7 t -78.37 142.92 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.478 1.111 . . . . 0.0 110.014 166.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.74 154.94 73.24 Favored Pre-proline 0 N--CA 1.469 0.478 0 C-N-CA 126.202 1.801 . . . . 0.0 111.127 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.412 ' HD3' HG22 ' A' ' 142' ' ' VAL . 64.2 Cg_endo -63.69 122.5 10.62 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.188 1.926 . . . . 0.0 109.978 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 102.08 5.27 50.23 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 124.355 0.979 . . . . 0.0 115.316 -176.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -64.38 165.08 10.23 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 118.956 1.378 . . . . 0.0 112.302 164.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.1 p -113.48 125.03 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.171 1.388 . . . . 0.0 111.744 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.3 t -101.64 142.92 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 127.938 2.495 . . . . 0.0 110.652 -173.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 43.8 t -99.99 143.35 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.842 1.257 . . . . 0.0 112.314 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -162.9 -152.12 6.67 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.826 1.679 . . . . 0.0 112.63 175.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.4 p -138.82 157.01 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 127.519 2.328 . . . . 0.0 108.873 -177.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 . . . . . 0 N--CA 1.476 0.834 0 C-N-CA 123.068 0.547 . . . . 0.0 110.815 179.029 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 N--CA 1.477 0.893 0 CA-C-O 122.4 1.095 . . . . 0.0 113.637 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 98.8 mt -66.03 138.98 58.16 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.003 1.721 . . . . 0.0 113.838 -177.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -131.11 149.88 52.4 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.439 1.496 . . . . 0.0 112.98 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -130.95 136.13 48.28 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.895 0.878 . . . . 0.0 113.142 -170.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -125.9 142.41 51.53 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.42 1.088 . . . . 0.0 111.297 -175.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -88.99 138.46 31.38 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.55 0.74 . . . . 0.0 110.894 174.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 71.9 t -72.41 126.26 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 O-C-N 120.705 -1.247 . . . . 0.0 110.115 172.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 28.2 t -77.71 -48.55 16.43 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.412 1.485 . . . . 0.0 111.629 172.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.72 170.54 20.57 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.412 -0.805 . . . . 0.0 111.588 176.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.412 HG22 ' HD3' ' A' ' 112' ' ' PRO . 11.1 m -132.81 155.24 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.772 1.229 . . . . 0.0 110.255 169.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -153.9 153.9 32.89 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.201 1.001 . . . . 0.0 112.391 168.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 96.3 mt -94.14 135.99 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.949 1.3 . . . . 0.0 108.091 168.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 28.2 pt -132.56 148.21 31.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 125.147 1.379 . . . . 0.0 111.029 -178.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -84.39 96.01 8.94 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 170.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -74.12 -45.95 45.68 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.096 -1.003 . . . . 0.0 112.105 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 47.12 40.51 9.97 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.559 1.143 . . . . 0.0 112.498 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -148.41 172.3 14.66 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.244 1.418 . . . . 0.0 110.763 -170.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -76.94 142.55 40.0 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 122.052 0.93 . . . . 0.0 112.638 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.36 157.53 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 126.557 1.943 . . . . 0.0 109.344 177.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.422 ' CE1' ' HB2' ' A' ' 2' ' ' PHE . 7.8 p90 -110.51 161.44 15.69 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.973 0.909 . . . . 0.0 112.016 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -137.38 154.03 50.08 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.865 0.866 . . . . 0.0 108.944 158.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.0 tt -129.05 108.99 10.82 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.738 -1.226 . . . . 0.0 108.823 -172.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.7 t -90.87 127.47 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -153.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 28.8 mm -124.18 85.84 54.7 Favored Pre-proline 0 N--CA 1.47 0.571 0 C-N-CA 125.627 1.571 . . . . 0.0 109.705 -172.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -64.65 -16.92 57.74 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.098 1.866 . . . . 0.0 113.816 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -78.45 -45.03 23.18 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.742 1.156 . . . . 0.0 113.089 -176.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 76.6 p -131.65 -8.52 3.62 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.338 1.455 . . . . 0.0 114.288 -172.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 54.73 15.68 1.17 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.555 1.542 . . . . 0.0 114.773 -165.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -143.45 142.48 31.22 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 121.248 1.84 . . . . 0.0 114.951 -175.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -141.74 162.91 34.31 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.383 1.473 . . . . 0.0 112.069 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 95.2 mt -112.29 130.62 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.281 1.032 . . . . 0.0 110.568 -173.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -77.74 160.1 75.18 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 124.151 0.981 . . . . 0.0 111.866 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -62.19 -20.12 68.91 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.577 2.185 . . . . 0.0 112.719 177.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -73.81 -12.21 60.62 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.039 1.336 . . . . 0.0 113.226 175.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 102.61 -22.43 37.38 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.851 1.691 . . . . 0.0 115.446 177.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 72.2 mt -72.14 148.12 45.98 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 119.479 1.639 . . . . 0.0 113.087 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.9 p -99.89 134.38 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.396 1.079 . . . . 0.0 112.48 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 41.4 mt -119.47 133.75 55.54 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.498 1.919 . . . . 0.0 110.913 -171.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 31.6 t-80 -86.23 126.56 34.36 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.606 -0.684 . . . . 0.0 110.379 165.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.542 0.655 0 C-N-CA 124.069 0.948 . . . . 0.0 109.464 170.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.878 0 CA-C-O 121.085 0.469 . . . . 0.0 111.983 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -131.01 160.26 35.1 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 127.014 2.126 . . . . 0.0 111.196 -175.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -55.46 145.86 21.57 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.379 1.071 . . . . 0.0 112.615 175.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -26.26 67.89 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -79.21 -8.26 58.88 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 175.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.0 m -63.11 134.8 56.63 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 121.063 -1.023 . . . . 0.0 111.29 -175.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -76.78 149.32 36.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 122.268 1.033 . . . . 0.0 113.719 175.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.0 p -145.35 152.14 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 124.595 1.158 . . . . 0.0 111.675 -173.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -122.06 143.26 49.62 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.766 2.026 . . . . 0.0 107.284 176.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -150.86 -175.88 5.31 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.427 0.691 . . . . 0.0 111.132 164.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -136.15 142.24 44.18 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.258 1.423 . . . . 0.0 110.624 174.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -164.04 151.21 11.95 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.879 2.071 . . . . 0.0 108.109 176.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.2 t0 50.95 43.18 28.86 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.791 1.237 . . . . 0.0 113.698 -177.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.5 m 56.66 35.18 25.76 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.625 1.57 . . . . 0.0 114.523 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.1 p -154.66 140.8 12.85 Favored Pre-proline 0 CA--C 1.538 0.482 0 O-C-N 120.505 -1.372 . . . . 0.0 112.012 177.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.35 144.87 57.67 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.588 2.192 . . . . 0.0 112.194 173.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -123.34 142.21 51.19 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 128.819 2.848 . . . . 0.0 108.806 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 41.6 ttm -153.29 120.43 5.8 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.678 -0.639 . . . . 0.0 111.634 -175.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -160.44 -172.43 3.55 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.47 1.908 . . . . 0.0 110.56 -176.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.4 m -76.16 150.08 37.21 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 120.639 -1.288 . . . . 0.0 110.541 167.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.2 tp -59.22 -36.36 62.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 O-C-N 121.019 -1.051 . . . . 0.0 111.985 177.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -59.71 -27.64 66.62 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.202 0.91 . . . . 0.0 113.455 173.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -81.46 -47.51 13.08 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.542 0.737 . . . . 0.0 110.194 -176.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.9 ppp? -68.27 -33.26 74.04 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 176.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -58.46 -50.05 75.1 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.428 0.691 . . . . 0.0 111.6 170.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.4 t -66.18 -29.61 69.93 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 121.646 -0.659 . . . . 0.0 111.973 -173.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -69.53 -57.13 5.6 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 126.39 1.876 . . . . 0.0 110.731 173.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -69.7 -34.86 74.51 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.282 -0.886 . . . . 0.0 112.89 -176.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.57 -24.79 64.65 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.303 1.041 . . . . 0.0 113.616 174.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 30.9 t -82.38 -35.27 27.91 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.765 0.712 . . . . 0.0 111.975 172.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 63.8 mtm -77.55 -58.08 3.46 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.85 0.86 . . . . 0.0 111.793 -178.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 47.2 m-20 -98.53 -20.02 17.29 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.828 1.251 . . . . 0.0 112.555 -171.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.7 159.35 33.2 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-O 121.941 0.745 . . . . 0.0 114.008 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -105.01 124.2 49.12 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.223 1.009 . . . . 0.0 110.577 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.6 mp -98.46 151.31 37.41 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 125.225 1.41 . . . . 0.0 110.488 174.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -69.09 156.12 66.05 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.834 2.356 . . . . 0.0 111.624 176.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -140.6 169.54 17.45 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.988 1.715 . . . . 0.0 110.26 174.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -48.93 -49.48 39.99 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -176.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -107.4 -13.43 15.1 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 177.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -161.21 -134.96 1.73 Allowed Glycine 0 CA--C 1.528 0.847 0 O-C-N 121.507 -0.745 . . . . 0.0 113.935 -167.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -140.69 154.72 46.49 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.284 1.034 . . . . 0.0 111.891 -177.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -135.95 145.4 46.17 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.774 1.23 . . . . 0.0 112.454 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 52.1 t -118.53 116.78 34.85 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 125.642 1.577 . . . . 0.0 110.758 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -71.34 138.23 32.54 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 124.091 3.194 . . . . 0.0 111.603 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 82.2 mt -107.18 158.13 17.34 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.974 1.31 . . . . 0.0 112.507 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -139.12 124.37 19.11 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.316 1.446 . . . . 0.0 109.444 174.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 51.33 51.2 17.35 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.797 1.639 . . . . 0.0 113.98 -178.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.4 t -116.41 128.71 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.408 1.483 . . . . 0.0 109.981 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -129.25 158.28 39.5 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.603 1.161 . . . . 0.0 113.364 -170.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.1 m -146.12 152.48 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 126.784 2.034 . . . . 0.0 112.269 176.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -61.7 131.45 49.99 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.402 1.481 . . . . 0.0 110.45 161.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.6 t -134.84 153.09 52.18 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.201 2.2 . . . . 0.0 111.565 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 37.6 tp -106.63 136.2 46.84 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.032 0.933 . . . . 0.0 112.169 -176.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -82.61 93.56 7.35 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.733 1.613 . . . . 0.0 110.173 170.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 31.7 mm -59.92 -21.82 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 O-C-N 120.854 -1.154 . . . . 0.0 112.888 -175.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.26 -50.12 64.84 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.081 -1.012 . . . . 0.0 113.455 175.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -111.91 -15.28 13.37 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.917 0.887 . . . . 0.0 112.652 -168.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.86 36.27 91.93 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.395 0.998 . . . . 0.0 112.105 -172.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -103.67 150.0 24.43 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.529 1.932 . . . . 0.0 111.084 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 mp -95.41 135.47 29.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 124.774 1.23 . . . . 0.0 110.801 -173.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.05 163.5 38.0 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.679 1.592 . . . . 0.0 112.569 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.4 150.19 20.65 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.232 1.413 . . . . 0.0 111.695 172.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.8 t -143.25 165.1 28.39 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.616 1.167 . . . . 0.0 111.787 167.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -91.58 153.38 19.78 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.142 1.377 . . . . 0.0 112.639 172.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -107.39 144.06 34.83 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.397 1.079 . . . . 0.0 111.487 170.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.6 t -97.64 -44.19 6.89 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.699 0.999 . . . . 0.0 113.699 -170.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -153.83 159.13 41.72 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.402 1.081 . . . . 0.0 112.761 173.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.2 mt -90.21 153.02 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.268 1.427 . . . . 0.0 108.398 164.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -137.41 148.42 46.16 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.051 1.34 . . . . 0.0 112.614 -177.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 37.3 ptt85 -138.29 145.89 41.8 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.836 1.254 . . . . 0.0 114.105 174.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -152.63 168.35 25.89 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.942 2.097 . . . . 0.0 110.314 177.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.423 ' HE2' ' HA ' ' A' ' 149' ' ' ASN . 1.0 OUTLIER -110.26 139.56 45.31 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.285 1.434 . . . . 0.0 112.602 -175.252 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.1 m -148.48 146.82 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 124.794 1.238 . . . . 0.0 112.133 -176.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.439 ' HA ' ' H ' ' A' ' 148' ' ' ASN . 6.4 pt-20 -104.32 -25.32 12.91 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 126.188 1.795 . . . . 0.0 112.923 174.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -122.23 118.05 27.63 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.64 1.109 . . . . 0.0 111.021 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.9 tp -128.03 159.15 35.92 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.813 2.045 . . . . 0.0 108.388 -175.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.1 mt -113.37 129.58 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 119.727 1.149 . . . . 0.0 109.146 177.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -103.76 117.24 33.9 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.769 0.828 . . . . 0.0 110.978 170.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.2 mp -102.84 125.58 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 C-N-CA 125.399 1.479 . . . . 0.0 108.241 175.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.4 tttt -95.46 147.75 23.2 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.057 1.343 . . . . 0.0 110.67 171.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 54.3 mt -117.67 160.57 21.09 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.364 1.466 . . . . 0.0 112.149 -172.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.7 t -64.76 -16.86 63.58 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.571 1.148 . . . . 0.0 112.979 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.2 p -70.37 -11.16 60.72 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.974 1.71 . . . . 0.0 114.214 167.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.76 -4.17 84.95 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 126.193 1.854 . . . . 0.0 113.985 -174.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -88.72 165.76 14.52 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.236 1.814 . . . . 0.0 112.151 -175.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.9 p -131.2 152.78 50.14 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 174.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 61.8 tp -127.94 129.28 46.56 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.63 1.972 . . . . 0.0 109.394 178.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -114.09 113.31 24.56 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.262 1.425 . . . . 0.0 111.15 -177.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.9 m -141.72 155.39 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 125.634 1.574 . . . . 0.0 113.036 -170.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.4 p -64.25 147.18 97.22 Favored Pre-proline 0 N--CA 1.469 0.513 0 O-C-N 121.212 -0.93 . . . . 0.0 112.677 175.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -62.83 -29.81 77.01 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.864 2.376 . . . . 0.0 113.589 -170.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.8 p -72.04 -10.93 60.46 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.196 1.798 . . . . 0.0 114.768 174.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -78.38 119.19 76.41 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 119.524 1.056 . . . . 0.0 112.787 -164.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -68.74 137.85 39.66 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.847 2.365 . . . . 0.0 113.207 -177.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.9 t -120.25 140.81 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 126.388 1.875 . . . . 0.0 109.156 175.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 39.5 tp -81.83 110.43 17.13 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 122.848 0.459 . . . . 0.0 110.158 178.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.0 mp -105.12 150.53 24.96 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.972 1.709 . . . . 0.0 111.801 -175.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -108.74 102.06 11.14 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.641 0.776 . . . . 0.0 111.792 171.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 59.0 mtt-85 -139.61 80.52 1.78 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.312 1.045 . . . . 0.0 111.6 174.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.9 t0 64.5 1.05 1.21 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 127.728 2.411 . . . . 0.0 115.148 -167.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 179.32 165.63 33.83 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 124.764 1.173 . . . . 0.0 113.018 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 39.6 mt -72.43 117.58 14.27 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.174 0.99 . . . . 0.0 111.133 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -145.63 137.09 25.06 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.22 1.008 . . . . 0.0 112.609 -176.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -91.79 121.85 33.79 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.209 1.004 . . . . 0.0 110.902 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 71.3 t -134.0 130.27 20.4 Favored Pre-proline 0 N--CA 1.48 1.039 0 C-N-CA 125.472 1.509 . . . . 0.0 109.561 -175.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.05 151.53 77.43 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 122.815 2.343 . . . . 0.0 112.797 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.47 -31.91 16.57 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 174.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.09 -23.31 67.28 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 173.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -106.07 -5.01 19.77 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.027 1.731 . . . . 0.0 112.082 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 89.9 t -69.53 147.07 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.592 1.157 . . . . 0.0 110.26 166.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.53 154.13 80.64 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 127.78 2.432 . . . . 0.0 110.625 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.401 ' HD3' HG22 ' A' ' 142' ' ' VAL . 58.0 Cg_endo -66.56 116.15 3.93 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.431 2.087 . . . . 0.0 111.043 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.414 ' H ' ' HB ' ' A' ' 139' ' ' VAL . . . 113.65 0.37 24.6 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.677 1.132 . . . . 0.0 114.948 -177.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -60.21 157.04 14.08 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 119.682 1.741 . . . . 0.0 112.119 169.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.6 t -95.65 126.05 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.542 1.137 . . . . 0.0 110.574 168.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.1 t -101.08 142.51 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 126.92 2.088 . . . . 0.0 110.09 173.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.1 t -90.63 137.62 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.852 0.861 . . . . 0.0 111.111 175.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -166.48 -150.87 6.54 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.298 0.951 . . . . 0.0 113.533 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.0 p -152.81 172.86 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 127.25 2.22 . . . . 0.0 109.895 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 . . . . . 0 N--CA 1.473 0.714 0 C-N-CA 125.051 1.34 . . . . 0.0 112.7 174.583 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 . . . . . 0 N--CA 1.481 1.076 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 43.4 mt -147.31 154.42 40.92 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.584 1.554 . . . . 0.0 111.968 172.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -149.7 127.75 11.95 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.101 1.76 . . . . 0.0 110.836 177.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -88.14 148.6 24.35 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.309 -0.869 . . . . 0.0 111.54 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -130.2 133.39 46.53 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.925 1.29 . . . . 0.0 109.622 -170.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -90.82 140.77 29.49 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 119.812 1.187 . . . . 0.0 111.847 175.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.414 ' HB ' ' H ' ' A' ' 113' ' ' GLY . 78.4 t -74.8 139.65 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.16 0.984 . . . . 0.0 111.271 175.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.1 t -94.58 -48.27 6.17 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.503 1.921 . . . . 0.0 112.29 175.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 13.1 t -156.61 161.63 39.91 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.352 1.061 . . . . 0.0 111.551 -177.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.401 HG22 ' HD3' ' A' ' 112' ' ' PRO . 5.6 m -139.52 149.38 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 125.365 1.466 . . . . 0.0 111.512 168.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -161.85 168.76 22.49 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 160.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 43.9 mt -93.09 128.06 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.006 1.322 . . . . 0.0 110.004 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 31.6 pt -120.78 154.8 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 127.159 2.184 . . . . 0.0 112.485 -174.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -100.48 75.51 1.78 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.182 1.393 . . . . 0.0 111.159 -168.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -66.97 -47.89 70.17 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.26 -0.9 . . . . 0.0 112.465 -169.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.439 ' H ' ' HA ' ' A' ' 74' ' ' GLU . 3.9 m120 49.5 41.5 21.23 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.09 1.756 . . . . 0.0 111.941 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.423 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 22.3 t-20 -146.17 176.62 9.61 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.114 1.366 . . . . 0.0 111.34 -171.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -74.42 147.0 42.44 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.008 0.923 . . . . 0.0 112.067 170.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 6.8 m -127.98 150.17 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.087 1.755 . . . . 0.0 109.484 175.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -118.34 156.8 28.29 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.526 0.73 . . . . 0.0 112.74 -173.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -155.64 151.41 27.43 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.481 1.113 . . . . 0.0 109.485 -165.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 38.0 tp -128.68 128.34 43.91 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.067 0.947 . . . . 0.0 111.782 -173.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 59.6 t -98.99 118.95 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.537 0.684 . . . . 0.0 112.742 -166.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 16.2 mm -124.41 86.87 54.63 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 127.451 2.3 . . . . 0.0 108.754 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -64.3 -17.82 61.04 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.837 2.358 . . . . 0.0 114.192 175.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -72.18 -55.62 6.95 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.705 1.139 . . . . 0.0 112.6 -177.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 67.7 p -124.97 -10.18 7.16 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.238 1.415 . . . . 0.0 113.9 -172.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 53.43 29.25 8.57 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -171.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -156.94 147.47 21.41 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 120.024 -1.673 . . . . 0.0 113.562 175.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -150.38 161.15 43.05 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.403 1.081 . . . . 0.0 112.076 176.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.7 mp -101.03 136.56 32.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 123.911 0.885 . . . . 0.0 111.486 -176.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -82.55 159.21 64.56 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 125.745 1.618 . . . . 0.0 112.456 173.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.01 -16.65 40.88 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.91 2.407 . . . . 0.0 113.68 -177.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -79.68 -1.09 36.8 Favored 'General case' 0 CA--C 1.556 1.194 0 O-C-N 121.398 -0.814 . . . . 0.0 112.487 170.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 97.91 -14.52 62.72 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.999 1.761 . . . . 0.0 115.65 175.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 57.9 mt -74.19 145.47 44.16 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.831 1.252 . . . . 0.0 111.953 -177.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.4 p -91.09 137.5 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 118.796 0.725 . . . . 0.0 112.318 174.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 67.5 mt -116.45 155.63 28.24 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.177 2.191 . . . . 0.0 110.78 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -100.87 155.44 17.94 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.935 0.894 . . . . 0.0 111.075 177.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 25.6 t30 . . . . . 0 CA--C 1.543 0.674 0 O-C-N 121.051 -1.031 . . . . 0.0 109.336 161.97 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -132.29 163.9 27.61 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 127.557 2.343 . . . . 0.0 111.183 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.3 145.09 54.69 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.64 1.176 . . . . 0.0 113.587 177.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -61.26 -24.28 66.27 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.545 1.138 . . . . 0.0 113.292 173.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -86.33 4.68 38.12 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.697 1.599 . . . . 0.0 113.658 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.6 m -74.25 141.06 45.39 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.047 0.939 . . . . 0.0 111.915 171.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -81.34 155.75 25.83 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.03 0.932 . . . . 0.0 113.038 169.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.0 p -148.07 155.8 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.957 0.903 . . . . 0.0 111.724 -173.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.47 139.22 54.24 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.151 1.78 . . . . 0.0 108.016 175.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -152.03 -179.06 7.16 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.951 0.9 . . . . 0.0 111.236 167.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -135.23 142.14 45.93 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.211 1.404 . . . . 0.0 111.082 177.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -164.14 159.08 19.92 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 127.618 2.367 . . . . 0.0 107.359 174.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.7 t0 53.49 32.94 15.03 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 m 58.73 33.21 22.91 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.894 1.278 . . . . 0.0 113.399 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.6 p -154.39 140.57 12.77 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 125.133 1.373 . . . . 0.0 112.527 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -70.02 150.85 67.2 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 123.13 2.553 . . . . 0.0 113.489 176.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -130.31 133.12 46.23 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 127.903 2.481 . . . . 0.0 108.744 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 39.9 ttm -145.75 113.11 6.23 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.074 0.95 . . . . 0.0 112.298 -175.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -162.79 -177.07 5.3 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.515 1.526 . . . . 0.0 112.606 -174.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.9 m -69.96 137.81 51.78 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.289 -0.882 . . . . 0.0 110.531 170.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.413 HG12 ' CG ' ' A' ' 152' ' ' TYR . 7.6 tp -55.68 -36.5 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 121.378 -0.826 . . . . 0.0 113.1 -178.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -60.8 -26.93 67.64 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.522 1.129 . . . . 0.0 112.596 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -81.49 -42.83 19.69 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.477 1.111 . . . . 0.0 111.191 178.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.6 ptm -68.65 -32.21 71.9 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.331 0.969 . . . . 0.0 111.591 174.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -57.67 -48.97 78.01 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.562 0.745 . . . . 0.0 110.632 171.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.6 t -62.79 -38.07 89.21 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.629 0.772 . . . . 0.0 111.829 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -64.32 -52.37 58.82 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.004 1.321 . . . . 0.0 110.585 177.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -71.08 -34.3 71.03 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.409 -0.807 . . . . 0.0 113.018 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.21 -35.32 80.7 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.788 0.835 . . . . 0.0 111.535 172.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 66.7 m -74.54 -29.34 61.33 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.115 0.966 . . . . 0.0 112.647 178.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 66.5 mtm -86.86 -47.31 9.14 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.068 1.347 . . . . 0.0 113.237 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -116.92 -13.76 10.66 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.835 1.254 . . . . 0.0 113.825 -165.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.46 163.72 39.56 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 124.4 1.0 . . . . 0.0 114.4 175.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -113.75 126.21 54.97 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.885 1.274 . . . . 0.0 110.452 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.6 mp -105.42 151.33 39.69 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 127.247 2.219 . . . . 0.0 110.54 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -76.91 155.91 34.44 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 123.558 2.839 . . . . 0.0 112.973 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.75 162.92 34.28 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.197 1.399 . . . . 0.0 110.519 163.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.36 -54.1 36.16 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 120.854 -1.154 . . . . 0.0 113.496 -176.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -96.96 -6.91 34.44 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 177.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -163.17 -140.5 2.89 Favored Glycine 0 CA--C 1.534 1.244 0 N-CA-C 116.602 1.401 . . . . 0.0 116.602 -172.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -149.0 157.13 43.18 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.752 1.621 . . . . 0.0 112.958 -171.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.83 148.75 41.07 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.434 1.094 . . . . 0.0 113.531 -176.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 51.4 t -129.18 121.72 20.75 Favored Pre-proline 0 N--CA 1.48 1.056 0 C-N-CA 126.085 1.754 . . . . 0.0 111.534 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -80.55 132.99 9.24 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 124.379 3.386 . . . . 0.0 113.227 -175.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 78.0 mt -97.77 165.76 11.8 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.042 1.337 . . . . 0.0 113.682 179.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -148.97 121.21 8.36 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.94 1.296 . . . . 0.0 111.079 176.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 46.14 52.77 9.97 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.782 1.633 . . . . 0.0 112.823 -173.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.7 t -112.46 128.43 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.44 1.096 . . . . 0.0 108.577 174.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -134.4 161.29 35.41 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -168.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.1 p -152.84 148.66 13.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 124.306 1.042 . . . . 0.0 112.18 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -64.41 133.45 52.58 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 122.348 1.07 . . . . 0.0 109.93 166.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.452 HG23 ' HG3' ' A' ' 61' ' ' LYS . 6.7 t -138.38 153.59 48.92 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.803 2.041 . . . . 0.0 110.49 -171.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.0 tp -113.95 145.02 42.11 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.322 -0.861 . . . . 0.0 111.537 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -96.8 118.02 32.34 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 124.485 1.114 . . . . 0.0 110.845 164.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mp -80.53 -20.65 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 124.135 0.974 . . . . 0.0 112.457 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.65 -36.93 85.12 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.206 1.003 . . . . 0.0 113.459 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.4 m -121.11 -16.97 7.89 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.565 1.146 . . . . 0.0 112.827 173.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.21 23.69 39.82 Favored Glycine 0 N--CA 1.475 1.293 0 C-N-CA 124.173 0.892 . . . . 0.0 113.667 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -100.02 137.75 38.04 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.862 1.665 . . . . 0.0 112.745 -169.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 mp -75.7 144.83 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 125.636 1.575 . . . . 0.0 111.866 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.452 ' HG3' HG23 ' A' ' 52' ' ' THR . 13.7 ptpt -155.6 176.19 12.92 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 127.093 2.157 . . . . 0.0 111.629 -178.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -129.08 141.86 51.08 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 125.14 1.376 . . . . 0.0 111.151 175.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -139.83 168.98 18.57 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.398 1.079 . . . . 0.0 113.287 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -92.2 147.95 22.54 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.178 1.391 . . . . 0.0 112.563 173.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.88 138.31 37.13 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.245 1.018 . . . . 0.0 110.311 167.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.0 t -94.28 -48.69 6.06 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -167.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.17 156.03 40.11 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.657 1.183 . . . . 0.0 111.629 175.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.7 mt -89.94 145.05 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.43 1.092 . . . . 0.0 108.414 165.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -128.52 150.65 50.08 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.949 1.7 . . . . 0.0 111.004 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.3 ptt-85 -143.63 151.35 40.02 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.201 1.0 . . . . 0.0 113.578 168.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -147.45 167.89 23.26 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.928 1.691 . . . . 0.0 110.938 175.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.54 146.89 23.8 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.621 0.768 . . . . 0.0 112.131 173.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.8 m -149.15 147.97 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 125.784 1.634 . . . . 0.0 111.522 171.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -100.31 -29.06 12.64 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.788 1.635 . . . . 0.0 112.36 175.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -122.23 128.76 51.54 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.513 1.125 . . . . 0.0 110.582 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 12.2 tp -135.45 160.86 37.13 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.841 1.657 . . . . 0.0 109.503 -174.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.7 mt -109.04 126.65 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 119.836 1.198 . . . . 0.0 109.653 175.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -102.46 119.93 39.66 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.775 1.23 . . . . 0.0 110.792 169.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -105.65 125.01 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.063 1.345 . . . . 0.0 108.478 173.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.6 tttt -92.33 146.54 23.61 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.675 1.19 . . . . 0.0 110.623 172.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 78.5 mt -106.57 160.48 15.4 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.769 1.627 . . . . 0.0 111.475 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.5 t -67.78 -11.42 58.43 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.626 1.17 . . . . 0.0 112.591 -176.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.6 p -81.44 -8.78 59.78 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 128.63 2.772 . . . . 0.0 114.947 168.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.65 -7.9 80.65 Favored Glycine 0 CA--C 1.54 1.632 0 C-N-CA 125.752 1.644 . . . . 0.0 115.362 -173.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -74.04 162.67 28.78 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.544 1.538 . . . . 0.0 111.201 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 86.3 p -140.41 146.02 37.79 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 66.8 tp -121.96 132.51 54.57 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.485 1.914 . . . . 0.0 110.068 176.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -117.03 116.5 27.47 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.871 1.668 . . . . 0.0 111.522 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.5 m -141.61 153.08 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.327 1.451 . . . . 0.0 113.082 -169.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.7 p -68.08 148.97 98.33 Favored Pre-proline 0 N--CA 1.466 0.372 0 O-C-N 121.258 -0.901 . . . . 0.0 111.66 171.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.22 -28.32 83.74 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.409 2.739 . . . . 0.0 114.346 -166.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.8 m -85.21 -4.96 59.34 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.39 1.255 . . . . 0.0 114.39 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -65.92 118.53 52.93 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 119.909 1.231 . . . . 0.0 111.918 -176.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -76.36 132.63 13.83 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.758 2.305 . . . . 0.0 113.441 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.3 t -111.33 143.82 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 126.111 1.765 . . . . 0.0 109.798 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 25.6 tp -81.31 102.0 10.14 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.014 0.526 . . . . 0.0 110.78 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.1 mp -98.96 153.64 18.68 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.971 1.709 . . . . 0.0 111.434 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -108.7 107.94 18.59 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.413 0.625 . . . . 0.0 112.593 176.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 36.4 mtp-105 -136.24 80.05 1.8 Allowed 'General case' 0 N--CA 1.479 1.004 0 O-C-N 120.861 -1.149 . . . . 0.0 110.211 -178.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 53.43 -3.25 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 127.657 2.383 . . . . 0.0 115.584 -156.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.81 171.27 44.02 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 125.591 1.567 . . . . 0.0 113.206 -178.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 82.1 mt -76.3 115.16 15.77 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.45 1.9 . . . . 0.0 111.007 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -146.83 147.93 31.36 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -99.4 117.06 32.97 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.183 1.393 . . . . 0.0 111.375 -173.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.4 t -124.49 128.45 24.97 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 123.862 0.865 . . . . 0.0 109.908 -176.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -64.56 147.34 90.22 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.575 2.184 . . . . 0.0 111.419 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.26 -30.78 18.8 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 175.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.54 -21.36 66.16 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 173.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -105.06 4.02 31.09 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.84 2.056 . . . . 0.0 112.436 175.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.6 t -84.12 143.84 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.166 1.386 . . . . 0.0 111.099 169.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.34 155.17 81.07 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 126.995 2.118 . . . . 0.0 111.33 -177.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.52 118.45 5.6 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.006 2.47 . . . . 0.0 111.681 -175.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.74 5.88 35.63 Favored Glycine 0 CA--C 1.538 1.516 0 CA-C-O 119.12 -0.822 . . . . 0.0 115.139 -176.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -61.43 166.11 4.24 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.251 1.421 . . . . 0.0 112.474 166.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.3 p -116.79 131.69 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 125.84 1.656 . . . . 0.0 111.546 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.5 t -117.22 140.67 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 126.147 1.779 . . . . 0.0 110.632 -172.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.1 t -89.03 134.42 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 123.818 0.847 . . . . 0.0 110.943 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -160.05 -151.52 6.2 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 121.674 -0.641 . . . . 0.0 113.66 174.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.3 p -139.52 159.87 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 127.051 2.14 . . . . 0.0 108.981 173.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 . . . . . 0 N--CA 1.473 0.687 0 C-N-CA 123.84 0.856 . . . . 0.0 109.833 173.229 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 . . . . . 0 CA--C 1.541 0.632 0 CA-C-O 119.423 -0.323 . . . . 0.0 110.969 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 96.0 mt -139.32 163.14 33.28 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.923 1.289 . . . . 0.0 112.84 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -153.66 154.26 33.82 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.824 1.65 . . . . 0.0 112.658 172.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -78.15 153.39 32.11 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 120.961 -1.087 . . . . 0.0 113.848 178.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 43.9 m80 -131.27 158.21 41.21 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.992 1.717 . . . . 0.0 108.385 166.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -120.29 142.24 49.27 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 121.259 -0.901 . . . . 0.0 111.464 -173.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 99.3 t -76.36 132.96 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 121.767 -0.583 . . . . 0.0 110.885 172.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.6 t -91.3 -46.07 8.25 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.89 2.076 . . . . 0.0 111.725 172.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.4 t -158.36 169.54 24.24 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.04 -1.038 . . . . 0.0 111.284 175.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.5 m -133.68 148.95 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.086 1.354 . . . . 0.0 110.745 167.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -154.27 154.82 34.07 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.681 0.792 . . . . 0.0 112.686 167.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 96.9 mt -84.16 130.7 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 166.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 16.3 pt -123.95 158.6 30.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 126.362 1.865 . . . . 0.0 112.299 -174.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -94.46 94.5 8.27 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.127 1.371 . . . . 0.0 112.246 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -83.4 -56.29 3.83 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.459 -0.776 . . . . 0.0 112.771 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 51.82 36.83 18.97 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.081 0.953 . . . . 0.0 112.449 -177.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -150.98 172.97 14.87 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.142 1.377 . . . . 0.0 110.837 -172.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -75.04 138.83 42.44 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.997 0.903 . . . . 0.0 112.962 -176.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 15.5 m -120.25 153.97 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 126.046 1.738 . . . . 0.0 109.57 177.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.413 ' CG ' HG12 ' A' ' 21' ' ' ILE . 1.5 p90 -114.05 160.79 18.5 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.081 0.952 . . . . 0.0 112.568 -175.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -142.63 148.63 37.75 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.612 -0.68 . . . . 0.0 109.856 157.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 55.1 tp -108.5 119.58 39.92 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.684 1.193 . . . . 0.0 109.965 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 50.7 t -88.35 120.25 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -166.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 27.9 mm -118.66 86.93 30.76 Favored Pre-proline 0 N--CA 1.471 0.592 0 C-N-CA 125.833 1.653 . . . . 0.0 109.375 -177.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -70.9 -9.75 26.32 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.271 2.647 . . . . 0.0 113.995 -174.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -81.32 -60.57 2.23 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 118.898 0.772 . . . . 0.0 112.203 175.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 73.7 p -118.61 -10.67 10.0 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -171.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 66.6 m80 53.33 27.36 6.14 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.306 1.442 . . . . 0.0 114.692 -172.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.6 149.96 30.55 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 120.629 -1.294 . . . . 0.0 113.237 178.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -153.01 162.8 40.89 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.358 1.463 . . . . 0.0 111.415 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.8 mp -103.66 137.99 29.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 124.053 0.941 . . . . 0.0 110.945 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.76 156.82 64.51 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 123.944 0.898 . . . . 0.0 111.839 173.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -64.78 -23.76 62.41 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.553 2.169 . . . . 0.0 112.641 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -79.41 3.91 17.0 Favored 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 124.931 1.292 . . . . 0.0 112.711 174.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 105.96 -21.6 33.5 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.645 1.593 . . . . 0.0 116.612 164.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 64.4 mt -77.7 149.33 34.63 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.832 1.816 . . . . 0.0 113.818 -171.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 4.6 t -89.41 123.81 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.175 0.99 . . . . 0.0 110.646 174.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 54.6 mt -116.08 148.48 40.21 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.56 1.944 . . . . 0.0 111.629 -174.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -96.62 136.79 36.64 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.756 0.823 . . . . 0.0 110.873 170.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 . . . . . 0 CA--C 1.535 0.372 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 162.544 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.686 0 CA-C-O 121.063 0.459 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -140.01 164.78 29.11 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.369 1.468 . . . . 0.0 112.303 -178.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.3 151.3 47.73 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -172.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.65 -22.03 43.36 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 177.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -73.9 -21.63 60.0 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.392 1.477 . . . . 0.0 113.639 177.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.4 m -64.68 126.41 27.81 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.091 0.957 . . . . 0.0 112.017 -166.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -74.14 150.48 40.44 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 174.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.2 p -148.33 153.19 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.114 0.966 . . . . 0.0 111.683 -170.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -126.49 120.77 30.53 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.85 1.66 . . . . 0.0 108.79 -173.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -150.2 168.12 24.92 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -176.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -134.17 144.21 48.37 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.807 1.243 . . . . 0.0 111.041 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -160.92 136.56 8.01 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.175 0.99 . . . . 0.0 111.172 176.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.7 t70 54.53 47.62 22.31 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.1 1.36 . . . . 0.0 113.541 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.9 m 60.47 38.88 18.92 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 127.538 2.335 . . . . 0.0 114.127 176.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.4 p -154.12 140.18 12.57 Favored Pre-proline 0 CA--C 1.547 0.858 0 O-C-N 121.098 -1.001 . . . . 0.0 112.025 173.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -83.31 151.69 13.71 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 124.818 3.679 . . . . 0.0 113.625 175.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -133.91 145.5 49.66 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.472 2.309 . . . . 0.0 111.514 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 43.4 ttm -147.67 95.95 2.59 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.823 0.849 . . . . 0.0 111.503 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -148.64 -178.71 6.49 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.647 1.579 . . . . 0.0 111.952 -171.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.3 m -71.23 148.48 47.19 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 120.74 -1.225 . . . . 0.0 110.238 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.4 tp -57.17 -35.48 48.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 O-C-N 121.368 -0.832 . . . . 0.0 112.418 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -65.68 -29.76 70.36 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.577 1.08 . . . . 0.0 112.792 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -74.86 -42.83 57.15 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.316 1.046 . . . . 0.0 110.037 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -71.93 -40.2 68.92 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.56 -0.713 . . . . 0.0 111.666 176.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -54.27 -48.57 71.05 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.745 0.818 . . . . 0.0 110.939 175.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.0 t -66.59 -32.04 73.12 Favored 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -174.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.2 ttpt -65.53 -50.73 64.16 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.192 0.997 . . . . 0.0 110.131 177.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -70.38 -33.98 72.05 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.607 -0.683 . . . . 0.0 112.287 177.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.52 -22.46 63.58 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.226 -0.921 . . . . 0.0 113.198 173.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.7 m -92.88 -14.96 26.96 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.332 1.453 . . . . 0.0 113.475 176.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 72.6 mtm -97.06 -57.91 2.15 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.068 1.747 . . . . 0.0 112.005 174.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -94.27 -27.49 16.11 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.638 1.575 . . . . 0.0 111.985 -170.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.95 158.85 13.37 Favored Glycine 0 C--N 1.341 0.837 0 C-N-CA 125.248 1.404 . . . . 0.0 114.07 -177.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -104.91 150.49 24.83 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.683 1.193 . . . . 0.0 111.851 -170.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.2 mp -121.97 145.02 42.57 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 127.026 2.13 . . . . 0.0 111.569 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.32 156.35 37.19 Favored 'Trans proline' 0 C--O 1.24 0.616 0 C-N-CA 124.718 3.612 . . . . 0.0 112.848 -176.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -145.85 165.85 27.69 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -177.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -47.56 -53.81 13.48 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.5 1.92 . . . . 0.0 114.054 177.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -106.55 0.71 24.78 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 115.051 1.501 . . . . 0.0 115.051 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 177.78 -122.49 0.83 Allowed Glycine 0 CA--C 1.53 1.019 0 N-CA-C 115.966 1.146 . . . . 0.0 115.966 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -145.36 159.84 42.44 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.025 1.73 . . . . 0.0 111.28 -177.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.68 154.27 48.6 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.076 1.351 . . . . 0.0 111.998 -178.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 67.9 t -127.87 118.12 20.94 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 125.133 1.373 . . . . 0.0 110.44 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.49 138.55 42.5 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.986 3.124 . . . . 0.0 111.34 177.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 87.4 mt -111.49 157.84 19.84 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.673 1.189 . . . . 0.0 112.559 175.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -142.0 129.57 21.44 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.993 1.317 . . . . 0.0 111.023 169.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 59.97 33.03 21.38 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 126.692 1.997 . . . . 0.0 114.673 -177.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.1 t -100.19 137.74 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 O-C-N 120.359 -1.463 . . . . 0.0 111.309 176.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -132.99 154.53 50.42 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.328 1.851 . . . . 0.0 112.851 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.8 m -141.06 162.6 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 126.714 2.006 . . . . 0.0 110.84 174.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -89.36 145.86 25.07 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.328 -0.858 . . . . 0.0 111.847 172.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.5 t -148.47 152.16 36.44 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.259 1.824 . . . . 0.0 111.311 -167.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 48.3 tp -102.22 138.63 38.91 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.773 1.229 . . . . 0.0 109.963 173.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -87.92 130.69 34.85 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.794 0.837 . . . . 0.0 111.347 161.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 43.8 mm -77.21 -25.46 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 120.941 -1.099 . . . . 0.0 112.546 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.99 -42.68 31.94 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -169.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.4 m -112.99 -9.5 13.59 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.928 1.291 . . . . 0.0 112.861 174.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.05 28.71 66.01 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 123.659 0.647 . . . . 0.0 113.987 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -89.51 136.52 32.98 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.999 1.319 . . . . 0.0 110.685 -177.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 mp -88.54 126.85 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 174.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -147.92 169.74 19.19 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.612 1.165 . . . . 0.0 112.661 -173.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.5 ttmt -92.7 149.35 21.37 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.42 1.488 . . . . 0.0 110.438 174.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.1 t -146.21 158.93 43.91 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.199 1.0 . . . . 0.0 111.171 171.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.73 159.91 22.46 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 121.27 -0.894 . . . . 0.0 112.83 177.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.28 135.56 54.96 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.285 0.634 . . . . 0.0 111.38 168.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.8 t -88.78 -46.28 9.1 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.565 1.146 . . . . 0.0 112.676 -167.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -155.25 157.31 37.09 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.494 1.518 . . . . 0.0 111.398 174.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.4 mt -88.81 151.41 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.772 1.229 . . . . 0.0 108.53 167.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -140.27 149.82 43.31 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.857 1.263 . . . . 0.0 112.426 -175.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.9 ptp85 -132.39 155.73 47.94 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.696 1.198 . . . . 0.0 112.714 171.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -150.29 163.26 38.77 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.803 1.241 . . . . 0.0 110.338 167.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -96.94 145.21 26.12 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.351 1.06 . . . . 0.0 110.973 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.4 m -150.13 141.08 16.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 124.862 1.265 . . . . 0.0 110.297 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -83.1 -34.41 26.13 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.955 1.302 . . . . 0.0 110.921 171.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -131.93 132.35 43.48 Favored 'General case' 0 C--N 1.345 0.393 0 C-N-CA 123.942 0.897 . . . . 0.0 112.33 -169.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.5 tp -131.88 164.95 24.95 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.311 1.844 . . . . 0.0 109.678 -173.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.1 mt -112.16 123.83 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 119.587 1.085 . . . . 0.0 109.167 175.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -96.08 123.32 39.65 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.416 0.686 . . . . 0.0 111.489 166.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -108.77 123.18 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.083 1.353 . . . . 0.0 108.621 170.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.1 tttt -92.86 147.87 22.49 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.664 1.586 . . . . 0.0 109.952 173.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 87.8 mt -118.91 158.32 25.93 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.615 1.566 . . . . 0.0 112.337 -175.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.7 t -66.93 -10.41 48.69 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.694 1.198 . . . . 0.0 113.264 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 88.6 p -77.62 0.59 22.6 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 127.625 2.37 . . . . 0.0 114.899 165.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.58 -3.1 56.28 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 125.126 1.346 . . . . 0.0 114.522 -173.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -76.81 163.95 26.3 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.041 1.736 . . . . 0.0 111.957 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 60.4 p -142.2 144.67 33.5 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 165.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.8 tp -118.29 131.55 56.34 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.449 1.899 . . . . 0.0 110.02 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -111.23 114.93 28.49 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.385 1.474 . . . . 0.0 111.515 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.2 m -138.01 153.83 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 126.337 1.855 . . . . 0.0 112.215 -171.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.2 p -67.27 150.48 97.87 Favored Pre-proline 0 N--CA 1.471 0.618 0 O-C-N 120.906 -1.121 . . . . 0.0 112.354 171.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -60.21 -31.38 93.0 Favored 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 123.103 2.535 . . . . 0.0 114.32 -168.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.2 m -84.07 -0.96 53.9 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -73.85 117.11 58.43 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.927 1.291 . . . . 0.0 111.177 -175.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -68.35 132.06 24.81 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.04 2.494 . . . . 0.0 112.892 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.0 t -110.74 137.0 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 126.078 1.751 . . . . 0.0 109.422 174.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.13 112.39 19.77 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.7 mp -105.58 149.68 26.06 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.802 1.641 . . . . 0.0 112.212 -175.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -101.99 112.01 24.5 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.033 0.933 . . . . 0.0 112.454 172.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -143.49 80.43 1.67 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.645 1.178 . . . . 0.0 111.024 170.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 59.74 -15.16 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 128.203 2.601 . . . . 0.0 116.759 -164.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -162.67 168.06 37.39 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 126.026 1.775 . . . . 0.0 113.89 177.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.5 mt -72.01 116.11 12.03 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.104 1.762 . . . . 0.0 110.98 -176.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -144.87 139.79 27.92 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.65 0.78 . . . . 0.0 112.786 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -96.53 123.64 40.26 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.251 1.02 . . . . 0.0 112.052 -177.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 57.3 t -128.2 129.84 23.62 Favored Pre-proline 0 N--CA 1.48 1.044 0 C-N-CA 124.928 1.291 . . . . 0.0 109.738 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -64.68 148.37 90.24 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.856 2.371 . . . . 0.0 112.057 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.67 -32.14 18.35 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.28 -25.48 67.88 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 173.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -107.85 -1.34 20.89 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.777 1.631 . . . . 0.0 113.158 178.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 74.9 t -70.1 144.17 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 124.368 1.067 . . . . 0.0 109.655 166.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.86 156.95 77.01 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 127.098 2.159 . . . . 0.0 110.324 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -65.48 125.3 14.18 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.74 1.627 . . . . 0.0 110.776 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 103.22 0.42 47.57 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.649 1.119 . . . . 0.0 114.931 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -57.95 153.73 13.75 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.176 0.991 . . . . 0.0 111.309 167.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.4 t -97.64 122.2 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.062 0.945 . . . . 0.0 109.957 172.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.2 t -94.12 141.48 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 126.68 1.992 . . . . 0.0 110.016 173.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 59.4 t -92.62 131.59 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.959 0.904 . . . . 0.0 110.399 172.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -155.08 -150.86 5.67 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.028 1.299 . . . . 0.0 111.644 176.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.8 p -143.8 169.28 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.227 1.411 . . . . 0.0 111.118 177.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 . . . . . 0 N--CA 1.472 0.673 0 C-N-CA 127.332 2.253 . . . . 0.0 110.153 177.492 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 . . . . . 0 N--CA 1.472 0.645 0 CA-C-O 120.763 0.316 . . . . 0.0 111.796 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 97.0 mt -136.9 157.47 46.66 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.689 1.596 . . . . 0.0 112.062 -172.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -132.66 132.78 42.79 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.372 1.469 . . . . 0.0 112.007 174.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -87.49 143.61 27.13 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.593 1.157 . . . . 0.0 112.518 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -131.11 136.57 48.5 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.739 1.616 . . . . 0.0 110.115 -174.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -85.36 137.12 33.15 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.97 -1.081 . . . . 0.0 112.828 176.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 97.6 t -69.93 122.51 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.101 0.961 . . . . 0.0 111.372 163.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.4 t -81.77 -53.04 6.53 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.791 1.636 . . . . 0.0 112.329 176.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.5 m -154.92 156.3 35.84 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.346 1.058 . . . . 0.0 111.921 177.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.4 m -128.63 148.13 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.043 0.937 . . . . 0.0 111.33 176.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -157.93 156.13 30.76 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.849 0.86 . . . . 0.0 112.015 169.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 74.6 mt -80.58 145.43 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 160.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 44.8 pt -131.25 153.49 39.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 126.515 1.926 . . . . 0.0 110.076 177.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -88.29 108.02 19.11 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 122.581 1.182 . . . . 0.0 109.904 169.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -83.35 -50.48 8.31 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.363 1.865 . . . . 0.0 112.355 174.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 42.23 51.5 4.54 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.847 1.659 . . . . 0.0 111.76 -172.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -155.84 177.28 11.58 Favored 'General case' 0 CA--C 1.552 1.037 0 O-C-N 121.257 -0.902 . . . . 0.0 113.099 -175.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -77.65 134.95 38.06 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.182 1.393 . . . . 0.0 112.928 174.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 5.9 m -114.29 153.63 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.34 1.456 . . . . 0.0 109.664 175.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -119.81 159.62 24.21 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -171.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -155.04 157.59 37.81 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 113.614 -1.63 . . . . 0.0 110.289 -172.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 41.5 tp -134.82 119.07 17.69 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.92 0.888 . . . . 0.0 109.391 -175.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 51.9 t -86.93 118.03 32.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.154 0.502 . . . . 0.0 111.749 -165.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 29.7 mm -115.29 94.09 38.1 Favored Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 124.944 1.297 . . . . 0.0 109.194 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.4 -12.47 33.66 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.732 2.288 . . . . 0.0 113.339 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -79.45 -64.04 1.28 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 119.039 0.836 . . . . 0.0 112.586 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 76.0 p -114.48 -13.7 12.19 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.174 1.39 . . . . 0.0 114.459 -173.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 63.05 15.01 8.1 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -169.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -150.79 151.93 33.05 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 120.21 1.368 . . . . 0.0 113.257 -175.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -152.55 179.67 8.38 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.788 1.235 . . . . 0.0 112.241 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 85.1 mt -123.62 138.88 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.689 1.196 . . . . 0.0 111.473 -170.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -93.32 154.6 41.4 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.931 1.292 . . . . 0.0 112.302 173.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -66.76 -16.21 49.58 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.789 2.992 . . . . 0.0 114.054 -174.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -72.42 -3.55 24.86 Favored 'General case' 0 CA--C 1.556 1.179 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 170.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.9 -8.92 68.18 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.555 1.55 . . . . 0.0 114.919 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 66.9 mt -79.55 144.66 33.7 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.886 1.274 . . . . 0.0 111.99 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.2 p -89.86 139.07 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.135 0.974 . . . . 0.0 111.035 173.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 74.1 mt -118.19 152.21 36.11 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.855 2.062 . . . . 0.0 111.114 178.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -120.33 148.56 43.58 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.89 0.876 . . . . 0.0 112.93 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.545 0.773 0 C-N-CA 124.112 0.965 . . . . 0.0 113.47 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.93 0 N-CA-C 110.763 -0.088 . . . . 0.0 110.763 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.03 162.57 33.78 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.775 1.23 . . . . 0.0 112.615 -173.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -55.91 145.3 25.37 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.946 1.699 . . . . 0.0 113.317 176.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.0 ppt_? -63.75 -22.71 67.04 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 172.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -83.19 3.66 30.03 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.6 m -69.75 150.97 46.35 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.797 1.239 . . . . 0.0 112.883 170.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -101.52 155.35 18.13 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.16 1.784 . . . . 0.0 113.169 174.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 p -148.15 158.35 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.511 0.724 . . . . 0.0 112.484 -168.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -127.34 126.36 42.4 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.387 1.875 . . . . 0.0 108.698 -174.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -153.32 173.41 15.64 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -128.15 144.43 51.12 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.588 1.155 . . . . 0.0 111.378 168.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -165.19 154.01 12.19 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.62 1.568 . . . . 0.0 110.052 174.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.9 t70 48.98 44.38 22.5 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.83 1.252 . . . . 0.0 114.181 -175.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.9 m 58.06 37.32 26.51 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.544 1.538 . . . . 0.0 114.023 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.2 p -157.7 142.47 11.96 Favored Pre-proline 0 CA--C 1.551 0.992 0 O-C-N 120.562 -1.336 . . . . 0.0 112.964 176.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.24 152.31 39.53 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 124.567 3.511 . . . . 0.0 113.516 174.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -136.62 142.63 43.28 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.742 2.017 . . . . 0.0 111.371 -175.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 52.2 ttm -147.35 86.39 1.62 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.208 1.003 . . . . 0.0 110.979 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -137.46 -179.2 5.59 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.532 1.533 . . . . 0.0 112.491 -174.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.9 m -73.17 140.91 47.33 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 120.759 -1.213 . . . . 0.0 110.637 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.42 HG12 ' CD2' ' A' ' 152' ' ' TYR . 9.3 tp -58.0 -36.12 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 O-C-N 121.303 -0.873 . . . . 0.0 112.958 -178.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.01 -24.77 68.07 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.758 -0.589 . . . . 0.0 112.455 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -79.09 -49.25 12.93 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.028 0.931 . . . . 0.0 109.916 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 20.7 ptm -65.85 -33.0 74.84 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.606 -0.684 . . . . 0.0 112.114 175.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -54.88 -49.87 70.12 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.295 0.952 . . . . 0.0 111.207 172.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 39.9 t -61.29 -39.48 90.59 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.348 1.059 . . . . 0.0 111.486 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -65.32 -53.46 43.43 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.319 1.447 . . . . 0.0 110.932 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -72.84 -31.5 64.81 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.249 -0.907 . . . . 0.0 112.473 -177.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.43 -32.26 73.52 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.129 -0.982 . . . . 0.0 111.907 170.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 60.4 m -79.2 -26.03 42.63 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.664 0.786 . . . . 0.0 112.864 178.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 61.2 mtm -91.53 -46.61 7.87 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.24 1.416 . . . . 0.0 113.264 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -112.22 -13.91 13.43 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.034 1.334 . . . . 0.0 113.572 -169.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.9 163.75 35.94 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.849 1.214 . . . . 0.0 114.573 178.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -111.38 134.85 52.67 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.189 1.395 . . . . 0.0 110.014 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.5 mp -116.75 148.46 42.07 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 126.14 1.776 . . . . 0.0 111.617 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -70.65 143.44 46.55 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.38 2.72 . . . . 0.0 111.349 175.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -130.07 169.53 15.18 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.876 1.67 . . . . 0.0 111.149 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.91 -52.8 62.83 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 120.975 -1.078 . . . . 0.0 113.538 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -99.86 -8.86 23.56 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.98 -134.25 1.76 Allowed Glycine 0 CA--C 1.53 0.994 0 CA-C-N 119.137 0.88 . . . . 0.0 114.235 -172.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -135.27 151.3 50.45 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.14 1.776 . . . . 0.0 112.066 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.25 142.59 39.89 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.4 1.08 . . . . 0.0 112.784 -174.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.9 t -116.38 111.62 41.99 Favored Pre-proline 0 N--CA 1.474 0.74 0 C-N-CA 126.653 1.981 . . . . 0.0 109.638 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -65.17 139.69 61.72 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.867 3.044 . . . . 0.0 110.931 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.0 mt -110.06 165.13 11.98 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.601 1.16 . . . . 0.0 111.941 176.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -144.16 127.0 16.28 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.75 1.62 . . . . 0.0 110.123 169.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 50.5 46.81 25.01 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.387 1.075 . . . . 0.0 113.306 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.8 t -111.4 116.92 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.18 0.992 . . . . 0.0 108.797 173.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -113.63 151.8 31.24 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -167.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.6 m -135.82 154.13 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.494 1.518 . . . . 0.0 111.565 174.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -66.74 133.25 49.78 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 161.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.0 t -135.52 145.28 46.9 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.737 1.615 . . . . 0.0 110.54 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.4 tp -99.87 136.51 39.68 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.792 0.837 . . . . 0.0 110.351 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -85.46 91.43 8.22 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.755 1.222 . . . . 0.0 109.422 171.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.7 mm -58.97 -25.22 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 119.372 0.987 . . . . 0.0 112.282 -171.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.69 -45.92 87.86 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.63 1.172 . . . . 0.0 114.108 175.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 m -107.67 -22.75 12.38 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.632 1.173 . . . . 0.0 112.61 -173.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.44 25.16 66.26 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.642 1.592 . . . . 0.0 113.281 -169.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -90.49 141.39 28.8 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.177 1.391 . . . . 0.0 112.061 -175.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.2 mp -90.83 122.41 42.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 125.042 1.337 . . . . 0.0 110.681 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -146.91 179.23 7.74 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.773 1.629 . . . . 0.0 112.093 -177.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -110.89 152.27 26.91 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.886 1.674 . . . . 0.0 111.358 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.3 t -147.65 162.08 39.87 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.61 -0.681 . . . . 0.0 110.852 165.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -94.41 142.78 27.03 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.091 0.957 . . . . 0.0 112.335 173.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.41 143.8 26.77 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.555 0.742 . . . . 0.0 111.311 174.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 84.4 p -84.5 -48.34 9.69 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.437 1.095 . . . . 0.0 112.454 -172.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -151.86 159.95 43.69 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.306 1.842 . . . . 0.0 112.191 173.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.5 mt -86.73 146.98 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 160.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -132.9 148.11 52.29 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 125.246 1.418 . . . . 0.0 110.927 -175.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -146.13 150.23 35.51 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 165.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -146.99 165.97 28.23 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.183 1.793 . . . . 0.0 110.878 173.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.45 146.78 23.84 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.194 -0.941 . . . . 0.0 112.8 -177.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.1 m -147.53 151.36 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.366 1.066 . . . . 0.0 112.299 173.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -113.36 -5.37 13.56 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.988 2.115 . . . . 0.0 113.184 177.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -138.43 119.21 14.14 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.792 1.637 . . . . 0.0 109.992 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.6 tp -133.24 159.35 40.46 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.812 1.645 . . . . 0.0 109.601 -175.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 13.5 mt -110.48 127.72 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 119.245 0.93 . . . . 0.0 109.492 176.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -98.68 127.63 44.67 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.406 1.082 . . . . 0.0 111.048 167.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.8 mp -112.9 126.07 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.152 1.381 . . . . 0.0 109.77 172.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -91.68 143.41 26.58 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.662 1.585 . . . . 0.0 110.48 171.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 83.9 mt -113.32 156.45 23.36 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.091 1.357 . . . . 0.0 112.113 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.1 t -59.55 -26.4 65.34 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.251 1.42 . . . . 0.0 112.005 174.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 94.2 p -64.57 -16.72 63.11 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.207 1.403 . . . . 0.0 114.477 171.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.33 4.04 74.55 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 125.919 1.723 . . . . 0.0 114.505 -174.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -85.22 158.73 20.27 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.889 1.675 . . . . 0.0 110.729 172.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 84.5 p -137.66 142.64 41.13 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 165.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.8 tp -121.48 140.62 51.94 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.73 2.012 . . . . 0.0 110.09 -172.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -121.16 116.56 25.19 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.189 1.396 . . . . 0.0 112.165 -174.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.1 m -139.81 154.78 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.286 1.434 . . . . 0.0 112.899 -167.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.1 p -65.79 148.1 98.41 Favored Pre-proline 0 N--CA 1.471 0.598 0 O-C-N 120.912 -1.117 . . . . 0.0 111.572 173.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.08 -29.47 87.16 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.166 2.578 . . . . 0.0 113.535 -173.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 32.9 p -84.62 0.2 51.03 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.178 2.191 . . . . 0.0 114.875 177.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -73.95 116.47 52.49 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 119.89 1.223 . . . . 0.0 112.023 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -77.9 127.13 8.41 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.681 2.254 . . . . 0.0 112.468 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 38.4 t -107.0 142.08 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 126.095 1.758 . . . . 0.0 109.43 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 22.4 tp -80.68 113.29 18.78 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 122.588 0.355 . . . . 0.0 110.693 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.8 mp -109.38 147.54 32.59 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.655 1.582 . . . . 0.0 112.701 -172.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -96.18 95.21 7.98 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.55 1.54 . . . . 0.0 109.569 170.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -130.35 71.88 1.47 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.288 1.435 . . . . 0.0 109.662 174.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.9 t70 63.37 -15.88 0.07 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 128.712 2.805 . . . . 0.0 115.866 -163.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -168.51 159.34 32.46 Favored Glycine 0 CA--C 1.522 0.524 0 O-C-N 121.189 -0.945 . . . . 0.0 114.09 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 59.6 mt -61.21 112.72 2.24 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.786 1.634 . . . . 0.0 110.95 -175.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -145.85 145.33 30.71 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -93.15 119.62 32.55 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.571 1.148 . . . . 0.0 110.895 -178.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 57.7 t -127.61 130.08 23.72 Favored Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 124.073 0.949 . . . . 0.0 110.081 -178.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -65.37 147.88 87.72 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.872 2.382 . . . . 0.0 111.82 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.1 -31.89 20.63 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 174.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.52 -18.42 65.36 Favored 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 173.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -108.57 2.09 21.86 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.237 1.815 . . . . 0.0 112.477 173.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.5 t -78.26 143.32 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 120.875 -1.141 . . . . 0.0 109.993 168.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.65 151.54 78.23 Favored Pre-proline 0 N--CA 1.471 0.596 0 C-N-CA 127.505 2.322 . . . . 0.0 110.682 -177.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -65.22 116.19 3.73 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.418 2.079 . . . . 0.0 110.798 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.7 2.22 34.69 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 124.571 1.082 . . . . 0.0 115.543 -173.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -56.59 159.94 3.54 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.804 1.302 . . . . 0.0 111.912 162.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.6 t -116.78 125.4 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 123.936 0.894 . . . . 0.0 110.042 175.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.6 t -100.78 145.19 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 126.774 2.03 . . . . 0.0 110.279 -178.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 44.1 t -86.05 135.99 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.818 1.247 . . . . 0.0 109.926 175.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -166.68 -149.56 6.02 Favored Glycine 0 CA--C 1.529 0.915 0 O-C-N 121.952 -0.468 . . . . 0.0 113.837 178.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.3 p -151.07 162.43 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 125.403 1.481 . . . . 0.0 110.579 175.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 42.4 mtm105 . . . . . 0 N--CA 1.465 0.302 0 C-N-CA 124.696 1.198 . . . . 0.0 111.065 172.479 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 91.3 mt -140.46 163.49 32.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.219 1.807 . . . . 0.0 111.73 -177.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -146.35 161.8 39.55 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.443 1.897 . . . . 0.0 111.882 -176.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -107.12 149.17 27.94 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.924 0.89 . . . . 0.0 112.096 170.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -128.48 119.05 24.15 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.354 1.061 . . . . 0.0 108.497 173.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -85.22 144.19 28.29 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 120.94 -1.1 . . . . 0.0 111.786 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 97.1 t -76.36 142.87 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 125.418 1.487 . . . . 0.0 111.027 174.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 26.0 t -100.76 -50.03 3.98 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.438 1.895 . . . . 0.0 112.506 174.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 13.9 m -149.5 156.37 41.88 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.134 1.373 . . . . 0.0 111.035 -175.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.4 m -134.97 147.09 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.893 0.877 . . . . 0.0 111.97 169.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -154.99 156.87 36.76 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 176.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 90.9 mt -92.27 138.42 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.69 1.196 . . . . 0.0 108.499 168.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 16.0 pt -132.83 155.87 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 126.388 1.875 . . . . 0.0 111.587 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -96.07 94.54 7.61 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 122.122 0.963 . . . . 0.0 112.491 173.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -72.34 -43.47 64.03 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 49.22 38.79 14.18 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.849 1.66 . . . . 0.0 113.583 -178.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -154.15 175.62 13.24 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.627 1.171 . . . . 0.0 111.109 -170.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -72.28 141.53 48.89 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.157 0.983 . . . . 0.0 113.218 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.8 m -122.53 153.96 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 126.465 1.906 . . . . 0.0 109.614 173.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.42 ' CD2' HG12 ' A' ' 21' ' ' ILE . 3.4 p90 -113.59 164.66 13.38 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -174.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -140.07 159.98 40.96 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.547 151.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.1 tt -127.06 98.86 5.47 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.182 0.993 . . . . 0.0 108.796 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 98.9 t -82.73 128.25 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -148.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 23.3 mm -116.59 100.61 53.54 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 124.767 1.227 . . . . 0.0 109.445 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -73.16 -13.33 25.87 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.356 2.037 . . . . 0.0 113.101 176.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 76.7 tt0 -74.0 -67.76 0.58 Allowed 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.815 1.188 . . . . 0.0 111.97 174.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 68.6 p -109.83 -7.97 14.95 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.928 1.291 . . . . 0.0 114.215 -169.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 56.42 21.23 5.36 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.929 1.291 . . . . 0.0 114.468 -169.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.37 145.56 26.18 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 -178.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -138.66 166.84 23.33 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.04 1.336 . . . . 0.0 112.416 176.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.8 mp -110.21 135.45 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.731 1.212 . . . . 0.0 111.634 177.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -86.5 156.62 56.32 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.091 0.956 . . . . 0.0 112.568 171.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -67.3 -11.99 34.22 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.826 3.017 . . . . 0.0 113.875 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -70.27 -17.82 63.11 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 121.767 -0.583 . . . . 0.0 112.443 168.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 115.23 -24.69 10.42 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 126.46 1.981 . . . . 0.0 115.069 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 50.0 mt -68.73 151.82 46.16 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.807 1.643 . . . . 0.0 113.63 -170.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 4.1 t -104.02 122.82 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 124.977 1.311 . . . . 0.0 111.96 176.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.8 144.27 43.77 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.355 1.862 . . . . 0.0 112.868 -170.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 62.7 t60 -96.61 150.48 20.61 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.136 0.975 . . . . 0.0 113.183 169.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 16.9 m120 . . . . . 0 CA--C 1.546 0.795 0 N-CA-C 115.533 1.679 . . . . 0.0 115.533 177.628 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.7 166.51 22.77 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.446 1.898 . . . . 0.0 111.772 -174.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.45 146.88 54.06 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.244 1.418 . . . . 0.0 114.608 -176.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -67.85 -21.22 65.19 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.748 1.219 . . . . 0.0 113.96 175.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -84.76 -3.66 58.7 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 174.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.2 m -65.16 141.65 58.61 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 119.363 0.983 . . . . 0.0 113.233 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -79.35 147.89 32.25 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.581 1.152 . . . . 0.0 112.917 170.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 p -146.39 156.77 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.498 1.119 . . . . 0.0 112.328 -172.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -126.28 135.19 51.24 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.844 2.058 . . . . 0.0 108.088 177.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -153.59 176.09 12.47 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.493 0.717 . . . . 0.0 112.249 169.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -131.85 140.98 49.29 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.148 1.379 . . . . 0.0 110.819 174.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -162.12 166.19 26.06 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.713 2.005 . . . . 0.0 108.328 174.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.4 t70 58.99 24.73 12.98 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 120.176 1.353 . . . . 0.0 113.2 170.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 63.55 29.81 15.22 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.158 1.783 . . . . 0.0 114.8 -171.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.8 p -152.78 141.75 14.31 Favored Pre-proline 0 CA--C 1.548 0.884 0 O-C-N 119.678 -1.889 . . . . 0.0 113.473 -176.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.33 152.96 50.38 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.713 2.942 . . . . 0.0 112.595 173.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -135.75 142.59 44.99 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.033 2.133 . . . . 0.0 109.96 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 35.9 ttm -153.24 106.21 2.96 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.035 0.534 . . . . 0.0 111.555 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -157.14 -179.54 8.3 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.444 1.898 . . . . 0.0 111.682 -172.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.7 m -67.73 138.49 56.29 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.219 -0.926 . . . . 0.0 110.013 170.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.6 tp -55.9 -37.33 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -176.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -69.53 -16.67 63.48 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.84 1.2 . . . . 0.0 112.755 -178.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -80.44 -46.55 15.75 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.416 1.086 . . . . 0.0 109.836 177.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -67.92 -34.62 76.96 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 122.015 -0.428 . . . . 0.0 112.079 173.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -58.59 -49.97 75.52 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.497 0.719 . . . . 0.0 110.835 172.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.5 t -68.99 -30.3 68.68 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.263 0.625 . . . . 0.0 111.513 -176.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -64.67 -54.04 37.89 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.43 1.492 . . . . 0.0 110.514 172.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -69.4 -33.85 73.63 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.203 -0.936 . . . . 0.0 112.347 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.33 -19.1 64.64 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 121.104 -0.997 . . . . 0.0 113.309 174.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.0 m -96.04 -7.64 35.69 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.874 1.669 . . . . 0.0 113.855 174.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 59.2 mtm -113.08 -49.51 2.92 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.756 1.623 . . . . 0.0 112.895 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -102.33 -19.59 14.94 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.175 1.79 . . . . 0.0 112.021 -174.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.96 166.59 42.33 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.589 1.09 . . . . 0.0 114.103 174.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -112.89 130.19 56.2 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.731 1.212 . . . . 0.0 110.465 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.2 mp -119.38 148.87 46.44 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 126.431 1.893 . . . . 0.0 110.808 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -72.06 162.31 42.18 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.452 2.768 . . . . 0.0 113.977 -173.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -145.45 170.07 17.1 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.047 1.739 . . . . 0.0 110.847 175.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -60.03 -58.23 9.42 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.546 1.138 . . . . 0.0 113.151 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -90.56 -3.87 57.28 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 176.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.93 -128.31 1.15 Allowed Glycine 0 CA--C 1.534 1.239 0 CA-C-N 120.322 1.419 . . . . 0.0 116.504 -177.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -139.56 161.07 38.39 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.092 1.757 . . . . 0.0 111.668 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.6 159.74 41.54 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.571 1.148 . . . . 0.0 112.691 177.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 81.6 t -127.17 113.47 21.63 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 125.782 1.633 . . . . 0.0 109.855 176.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -65.71 142.42 70.18 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 124.25 3.3 . . . . 0.0 111.263 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.2 mt -116.12 151.97 34.58 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 122.608 1.194 . . . . 0.0 112.853 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -133.84 129.74 36.9 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.824 1.249 . . . . 0.0 110.581 170.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 57.84 33.68 23.49 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.209 1.404 . . . . 0.0 114.157 176.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.3 t -101.68 133.7 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.492 1.517 . . . . 0.0 110.031 174.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -132.39 154.18 50.06 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.927 1.691 . . . . 0.0 112.912 -174.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.3 m -146.68 158.6 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 127.725 2.41 . . . . 0.0 110.542 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -79.32 149.06 31.87 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.013 -1.054 . . . . 0.0 112.232 170.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.0 t -148.24 157.17 43.34 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.904 1.682 . . . . 0.0 111.81 -169.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 38.6 tp -112.35 134.22 54.01 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.05 1.34 . . . . 0.0 110.226 176.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -83.46 104.12 13.36 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 163.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 mm -63.32 -29.94 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-N 120.935 1.698 . . . . 0.0 111.546 -177.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.77 -45.31 90.36 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.071 1.348 . . . . 0.0 113.241 -177.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.8 m -101.84 -20.24 14.98 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.918 0.887 . . . . 0.0 112.465 177.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.25 37.72 81.16 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.981 1.277 . . . . 0.0 112.42 -170.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -103.01 136.33 43.02 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.393 1.877 . . . . 0.0 110.644 -177.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 mp -93.7 127.69 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.7 pttt -144.86 169.65 17.64 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.987 1.315 . . . . 0.0 112.072 -177.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -103.5 143.46 32.69 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.959 0.904 . . . . 0.0 110.887 175.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.6 t -142.44 162.08 36.38 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.017 1.327 . . . . 0.0 112.62 -175.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -81.74 151.73 27.34 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 173.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -107.69 138.66 43.51 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.778 0.831 . . . . 0.0 110.942 164.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.9 t -91.86 -46.83 7.65 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.978 1.311 . . . . 0.0 113.255 -169.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -150.73 158.49 44.21 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.868 1.267 . . . . 0.0 111.559 172.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.1 mt -87.25 153.22 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 162.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -139.05 149.65 44.87 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.304 1.441 . . . . 0.0 111.715 -175.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 21.6 ptt-85 -139.12 150.5 45.74 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.769 1.228 . . . . 0.0 113.547 169.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -144.53 159.56 42.57 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.152 1.781 . . . . 0.0 109.445 172.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -102.91 136.43 42.74 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.133 0.879 . . . . 0.0 110.788 -176.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.9 m -144.87 145.48 20.97 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-O 122.324 1.059 . . . . 0.0 111.962 -176.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -97.48 -28.64 13.89 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 125.987 1.715 . . . . 0.0 111.867 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -120.28 128.69 53.54 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.544 1.138 . . . . 0.0 110.385 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.8 tp -131.89 160.69 34.97 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.342 1.457 . . . . 0.0 109.781 178.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.0 mt -113.4 126.21 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 119.858 1.208 . . . . 0.0 109.123 175.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -97.15 120.6 37.81 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.465 1.106 . . . . 0.0 111.119 169.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -109.55 122.22 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.496 1.518 . . . . 0.0 109.266 173.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -90.68 146.09 24.3 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.254 1.822 . . . . 0.0 110.601 175.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.6 mt -115.92 158.63 22.72 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.497 1.519 . . . . 0.0 111.74 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.5 t -61.71 -20.0 63.02 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.396 1.079 . . . . 0.0 113.561 -176.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 78.1 p -85.3 4.76 33.51 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.27 1.828 . . . . 0.0 115.619 172.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.78 10.04 86.49 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 124.306 0.955 . . . . 0.0 114.652 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -76.52 152.82 35.91 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.996 1.319 . . . . 0.0 109.829 166.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 80.5 p -135.68 135.62 40.26 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 165.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.9 tp -109.42 137.22 47.6 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.906 1.682 . . . . 0.0 109.755 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt -119.64 117.83 29.33 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.86 1.264 . . . . 0.0 111.105 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.5 m -139.15 153.49 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.994 1.318 . . . . 0.0 112.479 -168.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.8 p -64.87 145.66 98.9 Favored Pre-proline 0 N--CA 1.468 0.462 0 O-C-N 121.098 -1.001 . . . . 0.0 111.003 170.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -59.09 -24.81 75.4 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.381 2.721 . . . . 0.0 113.322 -173.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 61.7 p -76.3 -12.77 60.13 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 128.033 2.533 . . . . 0.0 115.539 175.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -70.96 116.68 48.92 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 124.344 1.058 . . . . 0.0 111.886 -174.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -78.52 120.81 4.93 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 123.253 2.636 . . . . 0.0 111.966 177.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.2 t -92.89 142.95 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 126.689 1.996 . . . . 0.0 110.124 178.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.74 101.08 6.5 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.534 0.683 . . . . 0.0 109.395 173.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.6 tp -98.76 152.77 19.32 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.015 1.726 . . . . 0.0 111.735 -173.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -111.85 113.2 25.4 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.056 0.542 . . . . 0.0 111.932 167.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -130.67 77.47 1.79 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.876 0.871 . . . . 0.0 109.274 165.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.2 t70 62.99 -7.92 0.14 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 128.634 2.774 . . . . 0.0 116.335 -166.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -165.32 163.36 36.5 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 125.628 1.585 . . . . 0.0 112.722 -177.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 78.2 mt -70.28 119.35 14.33 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.627 1.571 . . . . 0.0 110.594 -174.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -149.63 149.86 31.3 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -103.16 121.82 43.44 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.427 1.091 . . . . 0.0 111.028 -177.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 54.4 t -136.59 129.47 17.53 Favored Pre-proline 0 N--CA 1.481 1.104 0 C-N-CA 124.185 0.994 . . . . 0.0 110.87 -174.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -66.31 146.71 81.68 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.081 2.521 . . . . 0.0 112.811 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.11 -32.05 21.37 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 175.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.29 -19.43 65.41 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 173.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -107.8 -3.88 18.61 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.29 1.836 . . . . 0.0 112.824 177.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 92.6 t -73.47 146.23 10.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 C-N-CA 124.987 1.315 . . . . 0.0 110.479 168.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.78 159.26 72.03 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 127.762 2.425 . . . . 0.0 109.387 177.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -65.64 127.78 18.7 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 121.637 1.558 . . . . 0.0 110.724 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 99.14 7.81 54.41 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.238 0.923 . . . . 0.0 114.756 -178.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -67.15 165.65 15.55 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 118.301 1.05 . . . . 0.0 112.21 162.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.56 132.37 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 124.242 1.017 . . . . 0.0 111.211 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.0 t -107.26 134.1 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 126.367 1.867 . . . . 0.0 110.521 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 49.5 t -91.26 143.02 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.905 0.882 . . . . 0.0 111.355 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -169.1 -149.38 6.2 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.424 1.488 . . . . 0.0 111.846 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.6 p -136.88 162.99 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 125.388 1.475 . . . . 0.0 111.096 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 . . . . . 0 N--CA 1.469 0.478 0 C-N-CA 126.705 2.002 . . . . 0.0 110.427 179.356 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 . . . . . 0 N--CA 1.471 0.606 0 CA-C-O 119.107 -0.473 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.1 mt -146.83 153.36 40.08 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.221 1.009 . . . . 0.0 113.508 -177.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -135.8 151.47 50.11 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.156 1.782 . . . . 0.0 113.11 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -124.16 130.57 52.77 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.989 1.715 . . . . 0.0 110.701 -175.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -129.43 126.48 38.85 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.075 0.95 . . . . 0.0 110.411 -164.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -84.71 134.03 34.36 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.322 0.965 . . . . 0.0 112.152 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 75.0 t -67.41 129.41 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 124.142 0.977 . . . . 0.0 110.259 170.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.0 t -88.48 -42.94 11.8 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.412 1.485 . . . . 0.0 113.059 176.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.8 t -159.84 161.17 34.43 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.834 0.854 . . . . 0.0 111.426 -177.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 10.7 m -136.92 154.99 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.639 1.175 . . . . 0.0 112.555 170.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -162.36 162.11 27.73 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.428 1.091 . . . . 0.0 112.809 156.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 64.9 mt -76.05 141.34 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.953 0.901 . . . . 0.0 108.827 163.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 35.8 pt -130.67 156.67 42.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 126.988 2.115 . . . . 0.0 111.16 176.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -100.15 85.84 3.1 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 122.354 1.073 . . . . 0.0 111.382 -175.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -72.12 -46.45 56.57 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 121.308 -0.87 . . . . 0.0 112.862 -173.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 48.21 37.54 8.45 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.468 1.507 . . . . 0.0 113.097 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -145.47 174.52 11.08 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.503 1.121 . . . . 0.0 111.165 -170.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -74.64 132.81 42.03 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 123.553 0.741 . . . . 0.0 111.826 173.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 5.7 m -102.24 170.78 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.945 1.298 . . . . 0.0 109.474 169.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -123.0 161.47 24.2 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.973 0.909 . . . . 0.0 112.6 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -144.48 154.99 43.5 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.628 0.771 . . . . 0.0 110.184 158.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 40.8 tp -116.27 122.69 45.69 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.013 1.325 . . . . 0.0 110.232 175.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 99.7 t -91.83 121.25 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -165.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 25.1 mm -118.08 88.58 32.33 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 125.747 1.619 . . . . 0.0 110.227 -176.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -68.29 -13.69 38.43 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.47 2.113 . . . . 0.0 113.547 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -76.53 -46.39 26.73 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.326 0.966 . . . . 0.0 112.637 -177.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 81.3 p -138.78 -4.02 1.61 Allowed 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 126.077 1.751 . . . . 0.0 114.782 -169.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 31.0 m170 60.39 18.45 8.13 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 -177.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.15 148.51 25.02 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 120.095 -1.628 . . . . 0.0 113.582 177.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -132.66 170.9 14.56 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.939 1.696 . . . . 0.0 112.365 176.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 81.1 mt -121.54 132.99 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.471 1.108 . . . . 0.0 110.925 -175.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -80.36 161.74 63.76 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 125.102 1.361 . . . . 0.0 113.439 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.44 -18.35 62.71 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 122.869 2.379 . . . . 0.0 112.158 174.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.74 10.85 10.27 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.116 0.966 . . . . 0.0 113.181 172.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.21 -14.43 27.94 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.6 1.571 . . . . 0.0 116.559 176.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 78.6 mt -69.65 144.94 52.77 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 118.947 1.373 . . . . 0.0 112.833 -177.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 19.7 t -85.23 132.21 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.732 0.813 . . . . 0.0 110.629 171.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 77.1 mt -118.15 138.22 52.43 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.957 2.103 . . . . 0.0 110.061 177.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 42.3 t60 -137.76 141.85 40.93 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -168.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 . . . . . 0 CA--C 1.548 0.884 0 C-N-CA 124.977 1.311 . . . . 0.0 111.078 158.232 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.835 0 CA-C-O 119.474 -0.298 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.0 162.18 25.86 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.358 1.463 . . . . 0.0 112.238 -178.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.72 148.94 41.18 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.901 1.28 . . . . 0.0 113.697 177.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -12.54 31.98 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.047 1.339 . . . . 0.0 113.724 171.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.79 -24.19 64.38 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.187 2.195 . . . . 0.0 111.411 175.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.4 m -66.64 139.28 57.86 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.429 1.092 . . . . 0.0 113.62 -170.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -88.34 152.26 22.05 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.929 1.291 . . . . 0.0 113.427 171.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 p -148.17 153.3 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.122 0.969 . . . . 0.0 112.543 -169.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -132.88 127.22 33.92 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.175 1.79 . . . . 0.0 107.767 -173.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -153.0 177.7 10.49 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.111 0.964 . . . . 0.0 111.562 -175.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -134.48 141.79 46.87 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.036 -1.04 . . . . 0.0 111.275 173.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -154.51 162.38 41.17 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.774 1.63 . . . . 0.0 108.72 171.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.9 t70 51.28 29.74 5.28 Favored 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -174.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.1 m 57.34 39.74 28.14 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.703 1.601 . . . . 0.0 113.675 -171.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.0 p -153.58 141.13 13.53 Favored Pre-proline 0 CA--C 1.545 0.785 0 O-C-N 120.395 -1.441 . . . . 0.0 112.452 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.18 143.87 45.15 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.526 2.817 . . . . 0.0 113.871 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.5 m80 -128.45 141.67 51.33 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 128.294 2.637 . . . . 0.0 109.194 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 52.6 ttm -149.55 106.31 3.55 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.054 -1.029 . . . . 0.0 111.48 -174.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -153.95 179.39 8.95 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.115 0.966 . . . . 0.0 112.514 -171.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.9 m -74.86 141.08 44.25 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.028 -1.045 . . . . 0.0 109.479 168.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.425 HG12 ' CG ' ' A' ' 152' ' ' TYR . 8.4 tp -53.63 -36.28 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -176.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -63.44 -27.27 69.18 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.198 0.908 . . . . 0.0 112.564 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -74.85 -44.09 50.97 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.506 -0.746 . . . . 0.0 110.426 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 20.2 ptm -69.32 -37.44 77.74 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 119.371 -0.347 . . . . 0.0 111.3 172.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -59.78 -52.16 66.64 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.093 0.86 . . . . 0.0 110.874 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.7 t -65.51 -28.47 69.21 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.851 1.261 . . . . 0.0 111.773 -175.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -72.04 -56.78 5.03 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 127.373 2.269 . . . . 0.0 111.378 171.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -71.72 -33.77 69.02 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 120.919 -1.113 . . . . 0.0 112.791 -175.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.33 -23.07 65.59 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 121.288 -0.883 . . . . 0.0 112.663 172.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.2 t -89.67 -23.88 21.76 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.156 0.982 . . . . 0.0 113.316 174.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 70.5 mtm -86.44 -52.09 5.8 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.0 0.92 . . . . 0.0 112.013 176.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -106.65 -18.44 13.95 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.344 1.458 . . . . 0.0 112.724 -168.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.95 161.75 35.57 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.303 0.954 . . . . 0.0 114.05 176.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -109.42 126.89 53.94 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.954 0.902 . . . . 0.0 111.104 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.5 mp -98.6 144.94 29.04 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 125.32 1.448 . . . . 0.0 110.589 176.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -72.91 146.19 41.63 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 123.838 3.026 . . . . 0.0 112.199 -177.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.41 154.37 49.98 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.114 1.366 . . . . 0.0 111.941 178.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -52.55 -46.67 66.89 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.649 1.18 . . . . 0.0 113.745 -177.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -88.81 -9.98 49.77 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 172.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 173.81 -123.3 0.96 Allowed Glycine 0 CA--C 1.532 1.099 0 N-CA-C 116.958 1.543 . . . . 0.0 116.958 -168.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -142.7 159.25 42.59 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.007 1.723 . . . . 0.0 111.953 -177.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.25 150.66 46.91 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.522 1.529 . . . . 0.0 111.997 176.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.9 t -125.79 118.27 24.24 Favored Pre-proline 0 N--CA 1.486 1.34 0 C-N-CA 125.302 1.441 . . . . 0.0 111.29 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.62 140.89 40.41 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 124.186 3.257 . . . . 0.0 112.157 -178.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 73.3 mt -111.1 165.79 11.6 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.084 1.354 . . . . 0.0 112.568 176.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -145.59 124.09 12.43 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.881 1.272 . . . . 0.0 111.534 169.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 51.18 44.66 28.63 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.421 1.889 . . . . 0.0 113.856 -177.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.7 t -106.81 130.75 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.857 1.663 . . . . 0.0 109.884 173.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -130.15 159.19 37.57 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.948 1.299 . . . . 0.0 113.014 -169.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.5 m -144.78 150.63 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.951 1.7 . . . . 0.0 112.13 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -65.31 132.57 49.37 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.962 1.305 . . . . 0.0 108.027 164.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.461 HG21 ' HB ' ' A' ' 63' ' ' THR . 6.4 t -141.37 154.9 45.9 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.335 1.054 . . . . 0.0 112.005 -169.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 56.8 tp -115.64 133.41 56.06 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.957 1.303 . . . . 0.0 110.785 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.462 ' HB2' ' HE3' ' A' ' 61' ' ' LYS . 8.2 t0 -79.51 117.02 20.08 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.223 0.609 . . . . 0.0 111.255 163.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.4 mm -70.15 -16.64 20.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 O-C-N 121.056 -1.028 . . . . 0.0 113.261 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.48 -46.87 24.92 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.545 -1.347 . . . . 0.0 113.92 -177.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.0 m -121.36 -8.73 9.14 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 179.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.4 29.06 54.27 Favored Glycine 0 CA--C 1.535 1.291 0 O-C-N 121.388 -0.82 . . . . 0.0 114.016 -176.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -77.83 131.59 37.63 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.142 0.971 . . . . 0.0 110.933 175.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 mp -81.74 139.57 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 170.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.462 ' HE3' ' HB2' ' A' ' 54' ' ' ASP . 5.9 mttt -141.12 173.13 11.78 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.567 1.547 . . . . 0.0 110.485 174.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -111.53 128.53 56.05 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.476 0.71 . . . . 0.0 110.433 162.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.461 ' HB ' HG21 ' A' ' 52' ' ' THR . 2.9 t -131.41 164.54 25.48 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.202 1.001 . . . . 0.0 112.601 -174.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.8 ppt_? -86.09 139.59 30.99 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.231 1.013 . . . . 0.0 112.772 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -93.8 144.01 25.81 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.063 0.945 . . . . 0.0 109.587 166.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.7 t -101.01 -45.88 5.27 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -172.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -153.78 155.55 36.06 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.767 1.227 . . . . 0.0 112.551 175.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.9 mt -87.23 159.88 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.855 1.262 . . . . 0.0 108.85 167.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -142.54 151.03 41.19 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.178 1.791 . . . . 0.0 111.106 -176.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 42.9 ptt85 -145.5 159.41 43.14 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 167.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -152.09 159.42 43.67 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.333 1.853 . . . . 0.0 110.663 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -97.28 140.95 30.98 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.632 1.173 . . . . 0.0 112.526 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.1 m -148.12 141.62 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.073 0.949 . . . . 0.0 113.25 -176.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -99.66 -24.34 14.75 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.269 1.428 . . . . 0.0 113.226 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -127.86 126.83 42.33 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.451 1.101 . . . . 0.0 110.994 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.7 tp -136.84 167.11 22.08 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.947 2.099 . . . . 0.0 109.29 -173.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 20.2 mt -119.82 126.95 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.75 1.22 . . . . 0.0 108.816 176.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -99.31 116.63 31.93 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.917 0.887 . . . . 0.0 111.073 170.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.0 mp -101.4 122.33 53.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 125.175 1.39 . . . . 0.0 108.416 172.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -90.37 148.91 22.52 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.782 1.233 . . . . 0.0 110.791 174.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 65.2 mt -116.38 157.78 24.52 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.436 1.494 . . . . 0.0 111.831 178.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.1 t -64.65 -27.17 68.75 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.665 -0.647 . . . . 0.0 112.469 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 84.3 p -59.82 -22.43 62.22 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.374 1.469 . . . . 0.0 114.354 172.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 86.27 19.0 58.09 Favored Glycine 0 CA--C 1.537 1.452 0 O-C-N 121.284 -0.885 . . . . 0.0 113.806 -167.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -93.67 158.32 15.74 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.082 0.941 . . . . 0.0 111.062 161.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 83.8 p -138.21 137.53 37.66 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.52 1.528 . . . . 0.0 110.785 177.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.6 tp -115.97 130.65 56.91 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.93 1.292 . . . . 0.0 109.79 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -111.53 113.53 26.01 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.484 1.514 . . . . 0.0 109.929 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.8 m -137.41 153.82 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.16 1.384 . . . . 0.0 113.504 -169.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.6 p -66.71 143.25 98.0 Favored Pre-proline 0 N--CA 1.472 0.644 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 176.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -62.43 -22.26 73.83 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.713 2.942 . . . . 0.0 113.454 -178.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.6 p -88.55 -1.67 58.18 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.324 1.85 . . . . 0.0 114.215 176.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -87.74 124.28 67.69 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 119.158 0.89 . . . . 0.0 112.583 -175.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -70.97 129.75 16.79 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.607 2.872 . . . . 0.0 111.215 176.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.1 t -108.03 140.35 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 125.679 1.591 . . . . 0.0 110.337 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 51.9 tp -81.51 104.67 12.1 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.493 0.717 . . . . 0.0 110.812 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.1 mp -104.5 158.38 16.52 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.431 1.893 . . . . 0.0 112.119 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -106.14 127.02 52.91 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 169.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 72.4 mtp85 -138.23 74.87 1.49 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.981 0.912 . . . . 0.0 111.009 162.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 50.97 21.14 0.92 Allowed 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 125.44 1.496 . . . . 0.0 113.173 -164.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 179.27 149.02 8.06 Favored Glycine 0 CA--C 1.521 0.455 0 O-C-N 120.536 -1.352 . . . . 0.0 111.447 -170.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 60.6 mt -75.01 120.89 21.15 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.34 1.456 . . . . 0.0 109.523 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -150.34 151.68 33.27 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -177.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -105.76 121.12 43.37 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.458 1.103 . . . . 0.0 112.106 -172.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 78.5 t -139.07 132.56 15.92 Favored Pre-proline 0 N--CA 1.484 1.257 0 C-N-CA 124.916 1.286 . . . . 0.0 110.563 -178.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -66.82 145.29 74.38 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.827 2.352 . . . . 0.0 113.333 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.01 -34.03 19.89 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 175.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.84 -23.99 67.56 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 174.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -98.02 -15.49 20.03 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.552 1.141 . . . . 0.0 112.94 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.7 t -63.02 149.95 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.565 1.546 . . . . 0.0 111.416 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.8 154.3 81.02 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 126.094 1.757 . . . . 0.0 111.389 178.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -65.98 130.3 24.09 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.311 2.007 . . . . 0.0 111.513 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.62 4.09 54.88 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.775 1.179 . . . . 0.0 114.073 -176.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -65.06 168.76 6.15 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.668 1.187 . . . . 0.0 112.291 165.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.3 t -115.54 124.23 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.949 1.3 . . . . 0.0 111.069 -173.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.0 t -95.71 143.38 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.74 1.616 . . . . 0.0 110.31 175.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.5 t -89.56 133.71 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.706 0.803 . . . . 0.0 110.507 177.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -158.28 -158.52 9.05 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.139 0.876 . . . . 0.0 113.053 178.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.732 HG22 ' H ' ' A' ' 120' ' ' ARG . 4.1 p -141.38 -179.71 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 126.589 1.955 . . . . 0.0 111.746 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.732 ' H ' HG22 ' A' ' 119' ' ' VAL . 64.8 mtt-85 . . . . . 0 N--CA 1.468 0.449 0 C-N-CA 126.489 1.916 . . . . 0.0 111.459 -175.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 92.5 mt -138.41 159.74 41.3 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.71 2.004 . . . . 0.0 111.353 168.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -150.73 127.05 10.65 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.473 2.309 . . . . 0.0 110.452 174.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -84.67 146.37 27.49 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.401 1.08 . . . . 0.0 112.227 -177.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 52.0 m80 -129.63 137.89 50.92 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.297 1.039 . . . . 0.0 111.479 -174.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -89.48 136.61 32.93 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.293 1.037 . . . . 0.0 113.529 -174.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 77.5 t -74.27 120.0 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.407 1.083 . . . . 0.0 111.379 171.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.8 t -87.68 -29.62 21.0 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.034 1.733 . . . . 0.0 114.105 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.1 m -164.93 164.54 20.73 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.693 1.197 . . . . 0.0 111.291 172.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.9 m -132.79 145.69 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.235 1.014 . . . . 0.0 111.221 165.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -151.21 154.56 37.08 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.78 1.232 . . . . 0.0 112.281 170.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 97.0 mt -76.59 141.89 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 160.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 24.7 pt -131.05 159.37 43.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 125.288 1.435 . . . . 0.0 110.898 169.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -98.54 101.49 12.94 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.731 0.776 . . . . 0.0 111.942 169.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -80.21 -47.71 14.23 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.609 -0.682 . . . . 0.0 112.281 -177.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 55.66 32.51 19.43 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.346 1.058 . . . . 0.0 113.095 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -144.65 178.2 8.15 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.0 1.32 . . . . 0.0 111.814 -170.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -80.51 139.94 36.12 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.115 1.366 . . . . 0.0 112.753 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.8 m -125.88 154.7 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 125.841 1.656 . . . . 0.0 110.063 177.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.425 ' CG ' HG12 ' A' ' 21' ' ' ILE . 1.6 p90 -115.67 162.92 16.56 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -171.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -140.87 150.78 43.67 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 125.8 1.64 . . . . 0.0 108.633 160.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 56.5 tp -119.19 115.26 23.85 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.326 -1.484 . . . . 0.0 109.677 175.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 35.0 t -86.0 120.47 35.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -163.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 13.1 mm -119.6 84.64 30.71 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 125.384 1.474 . . . . 0.0 109.424 -177.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -65.77 -8.14 18.68 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.777 2.984 . . . . 0.0 114.371 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -84.56 -42.15 15.74 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.03 1.332 . . . . 0.0 113.212 177.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 68.9 p -142.26 -11.93 0.83 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -170.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . 0.25 92.0 m-70 57.36 24.13 9.72 Favored 'General case' 0 CA--C 1.553 1.079 0 N-CA-C 116.782 2.141 . . . . 0.0 116.782 -176.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -157.36 150.53 23.64 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 119.929 -1.732 . . . . 0.0 114.169 175.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -148.18 142.69 26.44 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.526 1.53 . . . . 0.0 112.43 -174.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.8 mp -92.7 137.04 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 O-C-N 120.477 -1.389 . . . . 0.0 112.162 -175.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -91.97 159.42 37.91 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 126.698 1.999 . . . . 0.0 113.386 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.25 -13.76 33.81 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.95 3.1 . . . . 0.0 113.885 -177.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -72.85 -7.69 52.0 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.28 0.632 . . . . 0.0 112.049 168.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 98.54 -20.17 51.49 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 126.749 2.119 . . . . 0.0 113.902 -177.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 74.7 mt -69.72 144.57 52.75 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.043 1.422 . . . . 0.0 112.844 -174.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 56.8 t -74.49 125.73 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 165.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 47.0 mt -106.53 166.27 10.67 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.081 1.752 . . . . 0.0 110.487 167.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -132.31 155.04 49.07 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.153 0.981 . . . . 0.0 112.446 -157.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 . . . . . 0 CA--C 1.541 0.634 0 C-N-CA 124.268 1.027 . . . . 0.0 111.499 172.191 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.948 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -140.02 156.58 46.55 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.044 1.737 . . . . 0.0 111.239 -171.077 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.88 146.33 55.06 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 120.491 -1.381 . . . . 0.0 114.21 -177.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.87 -14.49 15.55 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.226 1.411 . . . . 0.0 114.605 165.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -69.87 -14.9 62.96 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.167 0.987 . . . . 0.0 112.24 170.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.8 m -80.5 143.55 33.23 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -170.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -80.17 152.69 29.06 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.604 1.562 . . . . 0.0 112.741 168.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.6 p -146.99 158.35 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.505 1.122 . . . . 0.0 112.534 -172.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -124.92 137.59 54.27 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.621 1.968 . . . . 0.0 108.749 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -156.27 177.13 11.79 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 118.863 0.756 . . . . 0.0 111.96 168.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -135.78 144.71 45.93 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.037 1.335 . . . . 0.0 110.206 171.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -150.77 -63.31 0.19 Allowed 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 176.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -76.6 45.07 0.38 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.815 1.246 . . . . 0.0 112.722 -175.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.4 m 49.56 45.12 24.37 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.321 1.448 . . . . 0.0 110.706 -168.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.9 p -165.98 144.23 4.8 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 127.021 2.128 . . . . 0.0 110.126 -173.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.2 161.3 23.21 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 124.013 3.142 . . . . 0.0 113.855 175.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -142.23 143.93 33.11 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.57 2.348 . . . . 0.0 111.337 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 40.7 ttm -145.83 120.34 9.72 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.15 1.38 . . . . 0.0 110.02 172.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -165.77 -179.03 5.09 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.217 1.407 . . . . 0.0 110.628 -172.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.7 m -76.82 142.94 40.09 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 120.83 -1.168 . . . . 0.0 110.635 171.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.436 HG12 ' CG ' ' A' ' 152' ' ' TYR . 8.4 tp -56.0 -36.64 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -177.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -69.71 -18.0 63.5 Favored 'General case' 0 CA--C 1.549 0.909 0 O-C-N 121.673 -0.642 . . . . 0.0 112.529 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -75.3 -46.9 30.53 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.156 -0.965 . . . . 0.0 110.465 172.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.7 ptm -71.95 -35.83 69.7 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -57.93 -53.59 56.54 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 118.921 0.782 . . . . 0.0 110.709 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.2 t -64.68 -33.68 76.52 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.318 1.047 . . . . 0.0 111.509 -176.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -65.12 -52.66 53.99 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.209 1.404 . . . . 0.0 110.683 175.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -70.1 -32.38 70.4 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.321 -0.862 . . . . 0.0 112.671 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.01 -27.68 67.63 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.999 0.92 . . . . 0.0 113.176 172.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.7 t -79.86 -35.46 38.11 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.469 1.107 . . . . 0.0 112.073 173.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 46.0 mtm -85.13 -43.47 13.83 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.157 0.983 . . . . 0.0 113.395 -174.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -107.5 -31.86 7.95 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.289 1.435 . . . . 0.0 111.404 -172.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 102.05 165.36 26.82 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.016 1.293 . . . . 0.0 113.508 -177.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -114.44 135.65 53.87 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.675 1.59 . . . . 0.0 111.136 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.6 mp -100.43 148.29 34.74 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 125.878 1.671 . . . . 0.0 109.833 166.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -75.79 159.34 38.56 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.328 2.685 . . . . 0.0 111.615 175.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -135.59 161.36 35.75 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.461 1.505 . . . . 0.0 109.861 164.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -42.9 -48.55 5.84 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -117.14 3.94 12.69 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -160.89 -145.64 4.36 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 115.515 0.966 . . . . 0.0 115.515 -172.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -150.53 155.53 39.65 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.388 1.875 . . . . 0.0 112.378 -175.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.72 143.43 41.22 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.459 1.504 . . . . 0.0 112.095 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 86.7 t -125.71 111.65 25.16 Favored Pre-proline 0 N--CA 1.484 1.233 0 C-N-CA 125.16 1.384 . . . . 0.0 110.787 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.63 127.74 13.5 Favored 'Trans proline' 0 C--N 1.351 0.686 1 C-N-CA 125.348 4.032 . . . . 0.0 112.307 -174.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 68.6 mt -106.64 156.4 18.65 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.183 0.993 . . . . 0.0 113.152 -177.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -134.98 132.66 38.63 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.91 1.684 . . . . 0.0 111.046 168.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 50.13 45.84 25.23 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.347 1.859 . . . . 0.0 113.244 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 49.1 t -109.07 127.76 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.69 0.796 . . . . 0.0 109.604 175.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -127.99 155.34 44.44 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.268 1.027 . . . . 0.0 113.471 -168.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.5 m -141.94 151.88 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 126.543 1.937 . . . . 0.0 112.25 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -72.25 136.35 46.3 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.298 1.839 . . . . 0.0 108.137 169.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.2 t -151.33 154.65 37.12 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.186 -0.946 . . . . 0.0 113.323 -170.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 60.2 tp -107.09 129.04 54.88 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.758 1.623 . . . . 0.0 110.579 177.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -79.78 102.35 9.01 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.602 -0.686 . . . . 0.0 109.876 168.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.5 mm -59.31 -23.36 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.318 1.047 . . . . 0.0 112.586 -175.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.81 -39.77 69.6 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.428 1.891 . . . . 0.0 114.746 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.3 m -108.4 -24.65 11.35 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.971 1.309 . . . . 0.0 112.94 -173.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.13 29.4 68.8 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.234 1.397 . . . . 0.0 113.161 -169.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -103.38 137.23 41.76 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.69 1.596 . . . . 0.0 111.386 -176.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.464 HD12 ' N ' ' A' ' 60' ' ' ILE . 1.3 mp -93.33 135.58 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.111 0.965 . . . . 0.0 109.088 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -153.27 172.2 17.37 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.796 1.638 . . . . 0.0 111.192 -176.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt -90.58 144.11 26.09 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.842 0.857 . . . . 0.0 111.146 165.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.8 t -136.48 166.38 23.64 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.056 1.342 . . . . 0.0 111.41 170.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.6 ptp85 -97.64 146.88 24.88 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.773 1.229 . . . . 0.0 112.939 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -103.13 146.21 28.74 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.468 1.107 . . . . 0.0 111.19 170.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.7 t -98.13 -43.35 7.05 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -174.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -153.9 159.01 41.58 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.062 0.945 . . . . 0.0 112.789 173.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.8 mt -89.42 151.48 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.08 0.952 . . . . 0.0 108.465 164.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -137.46 146.71 44.62 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.778 1.631 . . . . 0.0 110.31 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -144.07 151.55 39.78 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 119.833 1.197 . . . . 0.0 113.482 166.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -152.05 169.99 21.02 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.013 1.725 . . . . 0.0 110.597 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -103.35 140.13 37.84 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.689 1.195 . . . . 0.0 111.605 -175.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.1 m -146.88 142.22 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.649 1.18 . . . . 0.0 111.795 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.453 ' HA ' ' H ' ' A' ' 148' ' ' ASN . 11.6 pt-20 -104.99 -11.15 16.78 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.639 1.575 . . . . 0.0 113.451 175.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -123.75 121.21 34.86 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.969 1.308 . . . . 0.0 109.908 173.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.0 tp -136.9 161.03 37.14 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.43 1.492 . . . . 0.0 109.419 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.4 mt -114.5 128.11 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 120.982 -1.074 . . . . 0.0 109.348 178.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -100.6 113.61 26.58 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.559 1.143 . . . . 0.0 110.518 171.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.2 mp -100.79 122.11 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.174 1.39 . . . . 0.0 108.526 172.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -91.6 148.75 22.05 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.548 1.139 . . . . 0.0 111.108 176.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 82.8 mt -115.34 158.74 21.98 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.876 1.27 . . . . 0.0 112.822 -176.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.8 t -66.31 -39.71 89.5 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.993 1.317 . . . . 0.0 112.205 -175.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.7 m -75.29 0.28 17.19 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 172.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 105.99 -2.53 38.28 Favored Glycine 0 CA--C 1.534 1.268 0 N-CA-C 117.089 1.596 . . . . 0.0 117.089 162.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -81.48 171.64 14.47 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.529 1.664 . . . . 0.0 111.654 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 85.2 p -139.73 135.55 33.24 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.993 0.917 . . . . 0.0 112.926 174.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 68.4 tp -105.41 126.0 51.62 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.126 1.77 . . . . 0.0 109.468 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -114.52 110.62 20.1 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.422 1.489 . . . . 0.0 110.54 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.6 m -140.69 154.09 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.586 1.554 . . . . 0.0 112.34 -167.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.49 150.36 97.32 Favored Pre-proline 0 N--CA 1.468 0.427 0 C-N-CA 123.761 0.824 . . . . 0.0 113.115 177.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -63.51 -35.58 59.31 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.598 2.198 . . . . 0.0 114.951 -167.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.7 m -89.5 3.06 53.63 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -67.65 119.36 65.49 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 124.539 1.135 . . . . 0.0 110.928 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -80.12 126.47 6.35 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.914 2.409 . . . . 0.0 112.347 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.6 t -106.32 146.23 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 125.938 1.695 . . . . 0.0 109.537 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 21.6 tp -78.8 105.17 9.92 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.081 0.467 . . . . 0.0 110.221 177.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.6 mp -104.19 158.94 16.1 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.475 1.51 . . . . 0.0 111.508 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -103.35 122.81 45.6 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.186 0.594 . . . . 0.0 112.202 168.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 44.9 mtp180 -143.36 85.42 1.85 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.528 1.531 . . . . 0.0 109.366 170.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 54.56 -3.72 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 127.464 2.305 . . . . 0.0 115.855 -160.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -175.21 174.81 46.99 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 126.933 2.206 . . . . 0.0 113.059 -178.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 37.1 mt -64.58 122.33 16.56 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.965 1.706 . . . . 0.0 110.673 173.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -151.94 152.04 32.0 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.08 0.952 . . . . 0.0 113.4 170.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -97.96 118.48 34.64 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.297 1.439 . . . . 0.0 111.126 -173.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.3 t -130.09 130.59 23.11 Favored Pre-proline 0 N--CA 1.48 1.046 0 C-N-CA 124.001 0.921 . . . . 0.0 110.872 -172.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -65.71 140.36 61.59 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.67 2.246 . . . . 0.0 111.877 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.36 -31.52 14.88 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 176.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.25 -29.28 69.75 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 174.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -101.32 -2.71 30.38 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.241 1.416 . . . . 0.0 112.169 178.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 89.9 t -72.95 142.9 14.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 O-C-N 121.064 -1.022 . . . . 0.0 110.328 167.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.46 154.57 76.98 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 127.108 2.163 . . . . 0.0 109.804 -177.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.432 ' HD3' HG22 ' A' ' 142' ' ' VAL . 60.7 Cg_endo -66.21 136.07 42.61 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.778 1.652 . . . . 0.0 111.147 -170.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 93.37 3.65 64.84 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.812 1.196 . . . . 0.0 114.222 -176.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -62.54 158.64 17.53 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.441 1.096 . . . . 0.0 111.096 164.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.0 t -106.05 119.24 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.997 1.319 . . . . 0.0 110.16 -177.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.6 t -91.88 140.47 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.158 1.383 . . . . 0.0 109.694 174.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 38.2 t -90.64 135.67 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 123.739 0.816 . . . . 0.0 110.644 177.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -164.44 -145.29 4.34 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 114.268 0.467 . . . . 0.0 114.268 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.9 p -156.07 169.77 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 126.263 1.825 . . . . 0.0 109.545 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 74.1 mtm-85 . . . . . 0 N--CA 1.469 0.508 0 C-N-CA 125.18 1.392 . . . . 0.0 111.946 175.967 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.3 mt -140.76 160.28 40.38 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.622 1.569 . . . . 0.0 112.103 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -144.05 165.15 28.61 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.409 1.484 . . . . 0.0 111.248 174.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -110.73 152.28 26.77 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.727 1.211 . . . . 0.0 111.91 174.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 64.1 m-70 -135.36 137.81 42.73 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.493 1.117 . . . . 0.0 109.635 -176.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -103.52 135.29 45.4 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.453 -0.78 . . . . 0.0 112.475 -169.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 91.4 t -73.86 125.64 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 121.631 0.729 . . . . 0.0 111.352 177.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 21.2 t -88.28 -37.77 15.75 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.734 1.614 . . . . 0.0 113.403 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.2 m -154.47 159.67 41.15 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.824 1.25 . . . . 0.0 111.327 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.432 HG22 ' HD3' ' A' ' 112' ' ' PRO . 4.5 m -138.2 148.94 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 123.434 0.693 . . . . 0.0 111.193 163.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -163.16 159.65 23.25 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.309 1.044 . . . . 0.0 113.41 165.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 89.9 mt -79.22 135.57 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 164.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 16.3 pt -124.54 163.49 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 127.589 2.355 . . . . 0.0 109.828 173.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . 0.328 1.6 p-10 -114.13 65.98 0.67 Allowed 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 -172.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -56.27 -39.93 73.42 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.794 1.637 . . . . 0.0 115.335 -160.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.453 ' H ' ' HA ' ' A' ' 74' ' ' GLU . 6.1 m-80 47.9 36.02 5.57 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.81 2.044 . . . . 0.0 113.461 -175.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -146.48 175.52 10.5 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 120.841 -1.162 . . . . 0.0 112.458 -170.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -67.21 133.74 50.33 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 122.396 1.093 . . . . 0.0 113.433 -176.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.7 m -114.45 150.83 16.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.437 164.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.436 ' CG ' HG12 ' A' ' 21' ' ' ILE . 2.8 p90 -111.78 163.88 13.67 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.987 1.315 . . . . 0.0 111.656 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -143.84 147.99 34.87 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.348 0.659 . . . . 0.0 109.844 160.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 34.6 tp -107.15 122.18 45.99 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.687 1.195 . . . . 0.0 110.271 174.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 36.1 t -87.47 118.04 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 O-C-N 121.948 -0.47 . . . . 0.0 111.911 -168.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 12.7 mm -123.19 84.78 51.53 Favored Pre-proline 0 N--CA 1.472 0.66 0 C-N-CA 125.29 1.436 . . . . 0.0 110.416 -176.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -70.04 -12.08 31.68 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 122.646 2.231 . . . . 0.0 113.835 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -74.34 -40.5 62.12 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.066 1.346 . . . . 0.0 113.83 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 70.9 p -139.73 -13.9 1.09 Allowed 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -170.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 77.4 m80 56.11 20.69 4.58 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.984 1.713 . . . . 0.0 115.179 -164.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -150.13 151.0 32.45 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.618 -1.301 . . . . 0.0 114.476 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -145.87 173.84 11.77 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.307 1.843 . . . . 0.0 111.065 177.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 79.4 mt -122.26 138.29 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.01 0.924 . . . . 0.0 110.534 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -89.0 158.18 47.43 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 124.087 0.955 . . . . 0.0 112.438 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -65.7 -18.69 59.05 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.136 2.557 . . . . 0.0 112.751 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -74.57 7.92 2.66 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.868 1.267 . . . . 0.0 112.812 170.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 91.55 -25.11 16.78 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 126.968 2.223 . . . . 0.0 115.644 175.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 41.3 mt -75.19 144.37 42.72 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.553 1.176 . . . . 0.0 113.79 -166.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.9 t -86.1 127.66 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.012 0.925 . . . . 0.0 111.079 174.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 52.9 mt -117.29 150.35 38.94 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.113 2.165 . . . . 0.0 112.169 -174.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -109.24 145.52 35.76 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.632 1.173 . . . . 0.0 112.809 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 . . . . . 0 CA--C 1.547 0.858 0 O-C-N 121.21 -0.931 . . . . 0.0 111.811 169.793 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.638 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -135.04 162.04 33.59 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.673 1.989 . . . . 0.0 111.098 -174.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.46 141.7 57.5 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.1 0.96 . . . . 0.0 111.673 172.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -11.58 38.66 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 176.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -81.43 -13.11 58.62 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.565 1.946 . . . . 0.0 113.306 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.3 m -64.47 136.92 57.55 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.153 0.981 . . . . 0.0 112.253 -177.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -81.32 151.64 27.93 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.662 0.744 . . . . 0.0 112.073 171.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 p -144.14 160.68 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 123.611 0.764 . . . . 0.0 111.038 -170.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -132.09 124.78 29.85 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.167 1.387 . . . . 0.0 108.929 -175.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -149.58 174.87 12.06 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 118.921 0.782 . . . . 0.0 112.73 176.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -131.03 142.43 50.32 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.117 1.367 . . . . 0.0 110.879 170.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -162.91 141.98 8.73 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.996 1.319 . . . . 0.0 110.533 174.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.2 t70 61.34 38.21 16.45 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.38 1.472 . . . . 0.0 113.448 -173.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.8 m 59.41 40.6 20.66 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.317 1.447 . . . . 0.0 112.651 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.2 p -158.85 140.51 9.8 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 124.866 1.266 . . . . 0.0 110.873 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -75.46 155.82 40.89 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 123.791 2.994 . . . . 0.0 113.806 176.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 39.1 m-70 -137.0 142.99 42.53 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 127.072 2.149 . . . . 0.0 110.767 176.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 43.1 ttm -154.29 82.64 1.12 Allowed 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.764 0.792 . . . . 0.0 112.432 -170.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -143.49 -176.34 4.91 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.238 1.415 . . . . 0.0 112.085 -173.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.9 m -69.37 138.47 53.7 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 120.955 -1.091 . . . . 0.0 110.755 174.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.5 tp -55.06 -36.34 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -66.73 -17.91 65.1 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.338 -0.851 . . . . 0.0 113.127 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -75.43 -51.76 12.31 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.354 1.061 . . . . 0.0 109.927 172.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 22.2 ptm -68.08 -36.21 79.46 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.43 -0.794 . . . . 0.0 112.034 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -56.17 -51.83 66.58 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.5 0.72 . . . . 0.0 111.299 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.1 m -57.27 -40.16 77.16 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 125.324 1.449 . . . . 0.0 111.727 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -69.51 -50.93 40.43 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.017 0.927 . . . . 0.0 111.173 178.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -68.19 -33.66 74.84 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 121.338 -0.851 . . . . 0.0 112.213 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.68 -23.46 65.31 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.59 0.756 . . . . 0.0 112.782 172.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.57 -11.94 38.54 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.957 1.303 . . . . 0.0 114.112 174.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 67.0 mtm -103.66 -52.2 3.03 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.103 1.361 . . . . 0.0 111.669 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -105.14 -16.53 14.76 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.972 1.309 . . . . 0.0 112.346 -171.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.36 161.97 32.21 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 124.234 0.921 . . . . 0.0 113.271 175.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -104.96 140.58 37.97 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.913 0.885 . . . . 0.0 109.845 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.3 mp -118.51 149.09 45.47 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 126.375 1.87 . . . . 0.0 110.611 176.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -81.44 151.24 17.43 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.074 3.183 . . . . 0.0 112.222 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -138.9 163.35 32.54 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.308 1.843 . . . . 0.0 111.097 -175.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -50.76 -55.88 14.66 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.844 1.258 . . . . 0.0 113.573 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -95.54 -7.45 37.91 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.47 -134.23 1.84 Allowed Glycine 0 CA--C 1.533 1.167 0 N-CA-C 115.507 0.963 . . . . 0.0 115.507 -170.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -138.98 160.23 40.26 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.623 1.969 . . . . 0.0 111.05 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.98 155.71 45.45 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.205 1.002 . . . . 0.0 113.311 176.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.8 t -126.46 115.97 23.13 Favored Pre-proline 0 N--CA 1.48 1.059 0 C-N-CA 126.09 1.756 . . . . 0.0 110.457 175.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.95 139.3 29.87 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 124.63 3.554 . . . . 0.0 112.296 -176.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 78.4 mt -107.76 163.98 12.63 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.65 1.18 . . . . 0.0 112.752 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -147.93 128.41 14.04 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.686 1.594 . . . . 0.0 109.345 168.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 55.04 41.31 31.9 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.865 1.666 . . . . 0.0 114.264 -176.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.4 t -108.32 118.43 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 O-C-N 121.308 -0.87 . . . . 0.0 109.618 175.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -114.52 148.33 38.07 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.458 1.103 . . . . 0.0 112.166 -171.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.9 m -139.44 153.97 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.091 1.357 . . . . 0.0 111.431 175.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -76.27 147.21 38.42 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.726 0.775 . . . . 0.0 111.557 172.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.6 t -154.96 167.08 31.53 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.69 1.596 . . . . 0.0 111.316 -165.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 36.9 tp -124.76 139.11 54.15 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.453 1.501 . . . . 0.0 110.326 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -87.14 112.96 22.46 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.363 1.065 . . . . 0.0 109.652 164.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.1 mm -71.62 -21.39 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 121.049 -1.032 . . . . 0.0 112.513 -175.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.47 -45.62 21.66 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -174.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.2 m -101.89 -15.63 16.81 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.266 1.027 . . . . 0.0 112.681 173.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.55 23.33 75.62 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.045 0.831 . . . . 0.0 113.524 -174.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -82.41 133.66 35.22 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.501 1.12 . . . . 0.0 111.519 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.3 mp -80.67 136.06 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 174.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -142.92 171.08 14.54 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.444 1.898 . . . . 0.0 111.528 -174.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -117.56 144.98 44.58 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.911 1.684 . . . . 0.0 110.118 167.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.7 t -143.68 153.29 42.32 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.221 1.008 . . . . 0.0 112.492 -174.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.3 137.07 37.88 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.362 1.065 . . . . 0.0 112.198 172.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.83 136.78 36.89 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.16 0.984 . . . . 0.0 110.984 172.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 91.4 p -89.02 -47.25 8.25 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.862 0.865 . . . . 0.0 113.267 -167.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -154.12 156.97 38.21 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.393 1.477 . . . . 0.0 112.356 173.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.7 mt -87.19 153.57 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 124.683 1.193 . . . . 0.0 107.941 164.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -138.6 152.61 48.29 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.858 1.663 . . . . 0.0 111.581 -173.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -146.52 152.88 39.69 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 164.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -150.39 167.22 27.72 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 127.453 2.301 . . . . 0.0 110.574 177.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -106.33 138.63 42.16 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.079 1.351 . . . . 0.0 113.779 -173.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.8 m -145.97 145.28 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 C-N-CA 124.764 1.226 . . . . 0.0 111.881 -176.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -96.22 -30.86 13.24 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 125.867 1.667 . . . . 0.0 112.26 175.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -129.41 133.25 47.25 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.144 0.978 . . . . 0.0 111.822 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.9 tp -136.39 158.45 44.4 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.15 2.18 . . . . 0.0 109.161 -170.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.2 mt -110.17 127.66 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 O-C-N 121.241 -0.912 . . . . 0.0 109.617 176.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -102.91 119.08 38.21 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.321 1.048 . . . . 0.0 111.648 168.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -104.86 123.65 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.694 1.598 . . . . 0.0 108.547 174.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -91.54 143.93 26.07 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.431 1.092 . . . . 0.0 111.142 173.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.4 mt -109.73 151.94 26.29 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.231 1.812 . . . . 0.0 110.706 175.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.9 t -66.53 -22.8 66.16 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -168.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.9 m -76.9 -10.29 59.27 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.863 1.265 . . . . 0.0 114.159 172.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 107.03 2.28 36.19 Favored Glycine 0 CA--C 1.54 1.634 0 N-CA-C 116.731 1.452 . . . . 0.0 116.731 175.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -80.86 153.81 27.43 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.41 1.484 . . . . 0.0 110.841 172.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 39.1 p -131.06 144.32 51.35 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 168.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 60.0 tp -111.72 126.35 54.95 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.168 2.187 . . . . 0.0 109.566 177.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -118.61 107.8 14.17 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.823 1.649 . . . . 0.0 110.556 -173.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.3 m -143.42 151.49 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.83 1.252 . . . . 0.0 113.174 -161.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.4 p -67.9 149.07 98.37 Favored Pre-proline 0 N--CA 1.467 0.402 0 O-C-N 121.43 -0.794 . . . . 0.0 111.93 174.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -59.5 -29.81 90.93 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 123.144 2.563 . . . . 0.0 114.09 -168.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.3 p -81.04 -9.42 59.83 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 55.6 t60 -69.38 120.81 79.39 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 119.717 1.144 . . . . 0.0 111.637 -178.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -79.31 129.49 8.65 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.019 2.479 . . . . 0.0 113.687 178.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.4 t -103.95 143.13 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 126.112 1.765 . . . . 0.0 109.544 175.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.05 109.32 15.51 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.181 0.515 . . . . 0.0 110.729 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.4 mp -106.23 153.84 21.57 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.417 1.887 . . . . 0.0 111.33 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -108.65 107.72 18.3 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 40.8 mtp180 -139.83 89.71 2.33 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 120.9 -1.125 . . . . 0.0 109.842 174.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 59.76 -13.84 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 128.154 2.581 . . . . 0.0 116.049 -163.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -174.2 -176.36 42.53 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 126.163 1.839 . . . . 0.0 113.329 174.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 95.1 mt -72.37 117.51 14.11 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.796 2.038 . . . . 0.0 111.738 -174.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -146.59 141.84 27.35 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -95.96 120.92 37.09 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.428 1.491 . . . . 0.0 111.225 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 83.9 t -123.5 128.03 25.35 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 123.652 0.781 . . . . 0.0 109.945 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -62.87 142.93 90.42 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.283 1.989 . . . . 0.0 111.147 176.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.0 -31.89 19.46 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 176.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.42 -11.29 57.43 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 174.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -112.71 -4.62 14.03 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.144 1.378 . . . . 0.0 113.552 171.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.4 t -71.63 149.35 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.067 1.347 . . . . 0.0 111.712 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.14 152.04 79.47 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 126.26 1.824 . . . . 0.0 111.747 178.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -67.56 125.24 13.04 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.271 2.647 . . . . 0.0 111.093 -175.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 96.93 9.58 55.99 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-O 119.673 -0.515 . . . . 0.0 114.266 -173.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -65.52 161.37 20.28 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 118.183 0.991 . . . . 0.0 111.587 159.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.4 p -106.59 126.96 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.617 1.567 . . . . 0.0 111.604 178.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.9 t -106.2 136.41 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.791 1.636 . . . . 0.0 111.199 -177.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.3 t -89.78 134.74 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.081 0.952 . . . . 0.0 110.9 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -158.49 -153.11 6.64 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.533 1.064 . . . . 0.0 111.522 172.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.408 HG22 ' H ' ' A' ' 120' ' ' ARG . 3.6 p -131.88 162.5 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.766 1.226 . . . . 0.0 110.294 167.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.408 ' H ' HG22 ' A' ' 119' ' ' VAL . 40.3 mtt-85 . . . . . 0 N--CA 1.472 0.639 0 C-N-CA 126.47 1.908 . . . . 0.0 112.556 -165.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 . . . . . 0 N--CA 1.475 0.816 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.7 mt -137.94 158.56 44.09 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.276 1.83 . . . . 0.0 111.4 173.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -142.02 150.41 41.27 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.429 1.492 . . . . 0.0 112.339 177.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -91.52 148.87 21.98 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.944 1.697 . . . . 0.0 113.25 176.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -137.09 139.4 41.24 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.438 1.495 . . . . 0.0 109.911 -177.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -91.5 130.21 37.36 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.844 0.747 . . . . 0.0 111.843 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 71.1 t -67.94 125.47 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 O-C-N 121.498 -0.751 . . . . 0.0 109.758 168.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.4 t -85.62 -42.64 14.15 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.944 1.698 . . . . 0.0 112.635 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.5 t -159.93 165.41 32.16 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.602 1.161 . . . . 0.0 111.108 174.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.9 m -135.11 149.94 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.671 1.188 . . . . 0.0 110.936 168.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -156.02 160.31 39.91 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.964 0.906 . . . . 0.0 112.65 167.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 87.8 mt -81.67 143.44 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 161.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 43.2 pt -131.91 152.33 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.949 2.1 . . . . 0.0 111.383 173.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -87.12 97.21 10.62 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.004 -1.06 . . . . 0.0 110.769 174.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -76.94 -46.63 23.48 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.554 -1.341 . . . . 0.0 112.59 177.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 50.84 31.94 6.65 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.59 1.156 . . . . 0.0 114.077 -176.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -139.19 172.59 12.61 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.808 -1.183 . . . . 0.0 111.61 -176.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -71.18 141.35 50.7 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.34 1.056 . . . . 0.0 111.562 173.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.9 m -123.53 153.26 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 126.219 1.808 . . . . 0.0 109.551 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -109.72 161.92 14.94 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.169 0.587 . . . . 0.0 112.258 -173.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -143.19 157.59 44.37 Favored 'General case' 0 CA--C 1.55 0.949 0 O-C-N 121.722 -0.612 . . . . 0.0 111.366 158.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 44.1 tp -114.76 127.88 55.99 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.056 1.342 . . . . 0.0 110.555 174.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 37.8 t -98.26 132.73 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 121.689 0.757 . . . . 0.0 112.415 -169.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 20.8 mm -132.66 92.61 26.59 Favored Pre-proline 0 N--CA 1.47 0.535 0 C-N-CA 126.08 1.752 . . . . 0.0 108.599 -173.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -70.41 -13.25 32.86 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.404 2.069 . . . . 0.0 113.469 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -72.88 -45.66 57.03 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 118.725 0.693 . . . . 0.0 112.368 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 82.5 p -140.74 -10.21 1.04 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.807 1.643 . . . . 0.0 114.55 -171.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 45.8 m80 55.66 21.46 4.6 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 -169.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -143.7 148.57 35.93 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 120.74 -1.225 . . . . 0.0 113.955 177.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -143.3 167.62 21.72 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.346 1.458 . . . . 0.0 112.449 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 92.5 mt -115.18 131.12 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.416 1.486 . . . . 0.0 110.501 -172.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -81.31 160.23 65.69 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 123.914 0.886 . . . . 0.0 112.543 177.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.92 -12.34 32.4 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.741 2.294 . . . . 0.0 113.421 174.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -94.11 24.13 4.54 Favored 'General case' 0 CA--C 1.555 1.141 0 CA-C-N 118.785 0.72 . . . . 0.0 111.576 165.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 83.42 -23.31 6.45 Favored Glycine 0 CA--C 1.528 0.905 0 O-C-N 120.051 -1.655 . . . . 0.0 117.102 166.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 72.7 mt -61.84 142.03 57.59 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.897 1.348 . . . . 0.0 112.797 -175.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.2 t -98.02 124.95 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.96 0.904 . . . . 0.0 110.525 174.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 27.4 mt -119.37 139.69 51.58 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.856 1.662 . . . . 0.0 111.77 -168.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -97.87 139.75 33.26 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.007 0.923 . . . . 0.0 112.794 172.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 . . . . . 0 CA--C 1.544 0.723 0 C-N-CA 124.705 1.202 . . . . 0.0 111.883 176.367 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -137.42 155.78 48.95 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.422 1.889 . . . . 0.0 110.988 -172.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -55.28 141.46 35.53 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.203 1.001 . . . . 0.0 112.364 174.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -59.92 -21.09 60.65 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.012 0.925 . . . . 0.0 113.367 172.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -77.53 -3.68 41.84 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.493 1.517 . . . . 0.0 112.635 175.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.8 m -79.22 145.0 33.85 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 122.443 1.116 . . . . 0.0 112.689 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -73.64 158.74 34.19 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.726 1.61 . . . . 0.0 114.112 171.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.3 p -149.2 153.64 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 124.325 1.05 . . . . 0.0 111.599 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -122.91 130.71 53.18 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.69 1.996 . . . . 0.0 107.466 175.246 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -150.61 179.49 8.14 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.994 0.917 . . . . 0.0 111.287 169.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -140.77 143.69 35.05 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.447 1.499 . . . . 0.0 110.565 178.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -158.28 -39.95 0.06 Allowed 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -100.01 41.1 1.18 Allowed 'General case' 0 N--CA 1.479 1.023 0 O-C-N 120.999 -1.063 . . . . 0.0 112.936 -172.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.6 m 53.26 33.49 15.58 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.247 1.419 . . . . 0.0 112.434 -167.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.6 p -159.44 146.32 12.62 Favored Pre-proline 0 C--O 1.24 0.559 0 C-N-CA 126.8 2.04 . . . . 0.0 107.799 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -74.1 161.01 41.78 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.282 2.655 . . . . 0.0 111.596 171.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -137.75 125.33 22.18 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 126.416 1.886 . . . . 0.0 109.58 -175.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -127.75 112.78 15.17 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.458 1.503 . . . . 0.0 109.023 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -155.45 -175.64 5.54 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.293 1.437 . . . . 0.0 110.704 -177.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.5 m -78.07 148.05 34.44 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 120.9 -1.125 . . . . 0.0 110.045 168.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.472 HG12 ' CG ' ' A' ' 152' ' ' TYR . 7.3 tp -58.05 -38.71 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 O-C-N 121.508 -0.745 . . . . 0.0 111.831 177.454 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -61.09 -20.1 62.22 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 178.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -85.34 -46.07 11.32 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.87 1.268 . . . . 0.0 111.217 175.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -73.29 -33.59 65.3 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 121.202 -0.936 . . . . 0.0 112.158 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -59.95 -46.96 87.7 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.795 0.838 . . . . 0.0 111.1 176.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.9 t -63.04 -36.03 82.2 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.41 1.084 . . . . 0.0 111.551 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -65.23 -53.61 41.82 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.342 1.457 . . . . 0.0 110.395 175.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -72.29 -34.13 67.94 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.006 -1.059 . . . . 0.0 113.382 -178.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.16 -28.01 66.92 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.964 0.906 . . . . 0.0 112.748 176.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 51.3 m -75.89 -41.89 50.7 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.406 0.682 . . . . 0.0 111.479 172.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 45.5 mtm -78.71 -45.02 22.2 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.44 1.096 . . . . 0.0 113.006 -172.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 23.5 m-20 -111.44 -26.36 9.14 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.124 1.37 . . . . 0.0 112.238 -170.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.19 163.47 27.55 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.85 1.214 . . . . 0.0 114.424 176.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -110.79 126.6 54.79 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.575 1.15 . . . . 0.0 111.167 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.3 mp -95.69 147.68 33.39 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 127.077 2.151 . . . . 0.0 110.988 174.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -73.1 151.15 49.27 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.243 2.629 . . . . 0.0 111.125 174.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -133.73 160.67 36.88 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.318 1.447 . . . . 0.0 111.155 165.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -46.76 -49.03 20.38 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.058 1.343 . . . . 0.0 113.852 177.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -101.18 -5.93 24.94 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 177.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.49 -129.64 1.28 Allowed Glycine 0 CA--C 1.528 0.865 0 CA-C-N 119.75 1.159 . . . . 0.0 115.148 -173.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -144.64 156.32 44.05 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.684 1.194 . . . . 0.0 112.738 -174.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.34 150.45 47.74 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.547 1.139 . . . . 0.0 111.814 177.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.5 t -126.01 120.18 23.96 Favored Pre-proline 0 N--CA 1.48 1.065 0 C-N-CA 125.437 1.495 . . . . 0.0 110.027 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -76.05 139.19 21.42 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 124.13 3.22 . . . . 0.0 111.482 -176.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.3 mt -108.36 155.6 20.36 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.56 0.744 . . . . 0.0 112.516 178.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -138.11 132.5 32.11 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.098 1.359 . . . . 0.0 110.056 167.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 57.5 33.89 23.87 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.503 1.521 . . . . 0.0 113.896 -178.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.8 t -107.88 127.84 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 121.074 -1.016 . . . . 0.0 111.473 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -132.79 160.95 35.38 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.08 1.352 . . . . 0.0 113.905 -172.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.9 p -151.5 155.83 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 125.8 1.64 . . . . 0.0 112.467 -178.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.515 ' CE1' HG23 ' A' ' 60' ' ' ILE . 1.1 t80 -65.51 132.41 48.84 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.841 0.856 . . . . 0.0 110.153 168.021 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.8 t -132.81 140.17 47.85 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.711 1.605 . . . . 0.0 109.937 173.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.5 tp -91.15 134.1 34.81 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 171.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -79.73 105.32 10.94 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 164.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 23.2 mm -63.29 -24.74 36.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 O-C-N 121.647 -0.658 . . . . 0.0 111.566 -174.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -81.47 -37.21 28.31 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.307 1.843 . . . . 0.0 115.784 -178.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.0 m -106.13 -18.53 13.99 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.658 1.183 . . . . 0.0 112.483 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.4 25.73 73.67 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 125.324 1.44 . . . . 0.0 113.52 -168.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -79.52 131.28 35.99 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.899 1.68 . . . . 0.0 111.093 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.515 HG23 ' CE1' ' A' ' 51' ' ' TYR . 2.8 mp -92.37 113.47 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 173.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -138.38 172.81 12.35 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.079 1.352 . . . . 0.0 112.019 -174.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -103.9 148.05 26.61 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.66 1.184 . . . . 0.0 111.009 173.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.6 t -140.66 151.85 44.91 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.393 1.077 . . . . 0.0 111.178 173.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -72.89 157.58 37.17 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.252 1.021 . . . . 0.0 111.967 171.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -115.81 143.4 45.45 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.308 1.443 . . . . 0.0 110.942 168.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -88.67 -48.5 7.49 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.229 1.012 . . . . 0.0 112.933 -173.174 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -157.35 157.35 33.95 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.686 1.194 . . . . 0.0 112.043 177.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.5 mt -88.1 153.14 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 124.918 1.287 . . . . 0.0 108.265 166.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -135.22 151.31 50.5 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.025 1.73 . . . . 0.0 111.27 -178.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 26.8 ptt-85 -147.34 156.65 43.1 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 167.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -152.36 163.07 40.23 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.508 1.923 . . . . 0.0 108.945 176.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.17 143.44 26.37 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.36 -0.838 . . . . 0.0 110.577 176.073 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.0 m -143.28 143.81 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 122.417 1.103 . . . . 0.0 111.641 175.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -101.82 -15.23 16.98 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.657 1.183 . . . . 0.0 113.009 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -132.22 125.44 31.13 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.549 1.54 . . . . 0.0 110.903 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.1 tp -140.26 159.85 41.27 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.012 1.725 . . . . 0.0 109.538 -173.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.2 mt -112.53 128.52 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.372 1.069 . . . . 0.0 109.177 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -102.51 119.67 39.22 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.225 1.01 . . . . 0.0 110.696 169.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -104.16 127.9 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 124.821 1.249 . . . . 0.0 108.556 173.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -94.19 148.35 22.27 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.865 1.266 . . . . 0.0 110.719 172.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 70.6 mt -114.87 156.89 24.12 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.545 1.938 . . . . 0.0 111.367 -177.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 36.3 t -68.38 -20.1 64.67 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -163.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 37.2 m -93.86 4.76 53.45 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 173.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 102.08 11.57 36.52 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.129 1.347 . . . . 0.0 116.254 171.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -96.23 167.99 10.86 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.977 1.311 . . . . 0.0 111.706 177.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 97.1 p -142.46 157.76 44.41 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -176.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.1 tp -135.8 127.8 29.62 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.989 1.716 . . . . 0.0 110.337 177.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -108.7 115.81 30.79 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.491 1.516 . . . . 0.0 111.949 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.4 m -142.33 153.55 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.721 1.608 . . . . 0.0 113.142 -169.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.2 p -67.56 147.96 98.67 Favored Pre-proline 0 N--CA 1.465 0.314 0 O-C-N 121.308 -0.87 . . . . 0.0 112.305 174.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -55.5 -33.77 87.38 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.673 2.916 . . . . 0.0 114.102 -174.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.9 p -81.76 -6.96 59.52 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 30.1 t60 -76.27 120.18 80.54 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 124.737 1.215 . . . . 0.0 112.333 -174.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -75.65 129.78 12.06 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.869 2.379 . . . . 0.0 113.436 176.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.72 144.98 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 126.499 1.92 . . . . 0.0 109.256 174.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 21.2 tp -80.88 106.62 13.02 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.343 0.519 . . . . 0.0 110.561 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.5 mp -107.49 165.63 11.26 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.859 2.063 . . . . 0.0 112.272 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -119.86 119.43 33.52 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.447 1.099 . . . . 0.0 113.05 176.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 33.6 mtm180 -132.59 77.86 1.77 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.176 1.39 . . . . 0.0 108.486 164.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.2 t70 59.23 8.49 1.11 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 126.862 2.065 . . . . 0.0 115.501 -169.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.34 169.01 42.12 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.953 1.739 . . . . 0.0 111.228 -174.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 71.7 mt -76.58 119.23 20.12 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.512 1.125 . . . . 0.0 110.639 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -133.55 131.76 40.12 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.127 0.971 . . . . 0.0 110.915 -176.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -88.32 122.29 31.67 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 172.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 67.0 t -132.2 127.11 20.79 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 123.87 0.868 . . . . 0.0 110.301 -175.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -65.89 142.72 70.31 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.378 2.052 . . . . 0.0 111.239 176.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.97 -30.85 16.07 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 176.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.08 -18.44 65.31 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 173.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -111.74 -3.97 14.81 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.151 1.38 . . . . 0.0 112.248 175.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 89.3 t -71.16 144.49 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.833 1.253 . . . . 0.0 110.316 169.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.12 156.66 78.92 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 126.407 1.883 . . . . 0.0 110.895 -177.016 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.36 126.24 13.99 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.337 2.025 . . . . 0.0 112.404 -172.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 108.07 -2.85 33.4 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.03 1.3 . . . . 0.0 114.814 -178.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -59.81 160.38 7.66 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.938 1.295 . . . . 0.0 113.221 174.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.8 t -102.56 118.35 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.139 1.375 . . . . 0.0 109.975 177.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.4 t -93.79 141.55 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.698 1.599 . . . . 0.0 110.058 173.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.5 t -91.38 138.66 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.259 1.024 . . . . 0.0 110.555 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -164.7 -149.13 5.7 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 123.402 0.525 . . . . 0.0 114.339 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.7 p -150.33 159.44 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 127.008 2.123 . . . . 0.0 108.573 175.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 N--CA 1.472 0.671 0 C-N-CA 123.91 0.884 . . . . 0.0 112.249 176.724 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 . . . . . 0 N--CA 1.477 0.896 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 96.7 mt -139.58 174.25 10.7 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 127.864 2.465 . . . . 0.0 111.907 -177.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -142.25 170.85 14.94 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 127.437 2.295 . . . . 0.0 110.604 169.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -126.04 147.0 49.67 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.103 1.761 . . . . 0.0 110.805 172.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -135.76 134.79 39.37 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.257 1.023 . . . . 0.0 110.313 -168.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -95.13 138.95 32.15 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.523 -0.736 . . . . 0.0 112.916 -174.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 71.0 t -74.15 132.67 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.351 1.06 . . . . 0.0 111.012 174.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 36.1 t -91.64 -40.36 11.35 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.211 1.804 . . . . 0.0 113.082 176.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.5 t -162.08 165.97 26.45 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.18 0.992 . . . . 0.0 110.643 176.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.2 m -131.93 148.23 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.491 1.116 . . . . 0.0 109.986 166.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -152.0 154.46 36.05 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.377 1.071 . . . . 0.0 112.766 172.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 87.7 mt -94.32 129.21 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.414 1.086 . . . . 0.0 108.537 169.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 16.8 pt -123.02 165.4 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 126.393 1.877 . . . . 0.0 112.131 -177.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -108.24 68.21 0.69 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.463 1.905 . . . . 0.0 112.509 -173.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -62.21 -43.88 97.84 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 121.097 -1.002 . . . . 0.0 113.24 -164.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 50.97 33.27 8.59 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.338 1.455 . . . . 0.0 113.894 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -141.5 177.64 7.99 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.853 1.261 . . . . 0.0 111.962 -174.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -77.65 142.07 39.06 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.161 0.985 . . . . 0.0 113.055 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 14.8 m -126.76 151.04 33.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 125.666 1.586 . . . . 0.0 109.671 177.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.472 ' CG ' HG12 ' A' ' 21' ' ' ILE . 1.2 p90 -111.04 164.18 13.08 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.678 0.791 . . . . 0.0 112.463 -175.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -144.31 155.4 43.8 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 122.439 0.296 . . . . 0.0 110.761 154.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 46.6 tp -107.49 124.39 49.83 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.568 1.147 . . . . 0.0 110.329 175.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 23.1 t -91.98 117.44 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 121.768 0.794 . . . . 0.0 111.887 -171.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 13.7 mm -120.73 83.25 35.52 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 126.396 1.879 . . . . 0.0 109.063 -177.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -63.24 -19.31 68.21 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.123 1.882 . . . . 0.0 113.808 178.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -76.13 -30.38 58.16 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 120.533 -1.355 . . . . 0.0 113.944 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 69.7 p -141.43 -18.1 0.79 Allowed 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . 0.253 75.6 m80 56.82 21.89 6.47 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.077 2.151 . . . . 0.0 115.165 -168.046 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -147.32 145.66 29.42 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.618 1.099 . . . . 0.0 113.767 -179.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -148.66 164.79 33.27 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.085 1.354 . . . . 0.0 111.709 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.2 mp -111.39 136.3 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.296 1.038 . . . . 0.0 111.466 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -81.88 157.64 68.82 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 124.033 0.933 . . . . 0.0 112.374 175.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -64.92 -22.71 62.67 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.815 2.344 . . . . 0.0 112.76 178.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -77.27 -5.48 49.58 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.559 0.744 . . . . 0.0 112.856 173.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 112.55 -21.68 18.65 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 125.955 1.74 . . . . 0.0 116.566 165.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 58.3 mt -76.87 149.89 36.09 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.097 1.448 . . . . 0.0 113.88 -171.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.9 t -96.78 123.84 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.761 1.224 . . . . 0.0 111.818 -178.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 25.4 mt -117.47 142.88 46.63 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.323 1.849 . . . . 0.0 112.577 -169.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -102.72 140.42 37.02 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.266 1.026 . . . . 0.0 112.369 170.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 . . . . . 0 CA--C 1.545 0.783 0 C-N-CA 123.944 0.897 . . . . 0.0 111.649 174.057 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.676 0 CA-C-O 120.832 0.349 . . . . 0.0 111.481 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.11 161.75 32.51 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.702 2.401 . . . . 0.0 110.684 -177.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.84 141.68 56.85 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.338 1.055 . . . . 0.0 112.59 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.2 ppt_? -56.54 -28.55 60.33 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.016 1.327 . . . . 0.0 113.166 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -81.74 -6.89 59.45 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.725 2.01 . . . . 0.0 114.599 -177.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.1 m -69.02 144.04 54.17 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.159 1.384 . . . . 0.0 112.856 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -82.06 152.02 26.8 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.438 1.495 . . . . 0.0 113.88 171.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.7 p -148.19 162.57 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.698 1.599 . . . . 0.0 111.685 -173.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -134.89 130.02 35.28 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.685 1.594 . . . . 0.0 109.823 -173.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -157.3 -178.53 7.42 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 118.924 0.784 . . . . 0.0 112.793 175.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -135.3 138.86 43.87 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.399 1.479 . . . . 0.0 111.43 172.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -169.0 146.92 3.8 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.139 1.376 . . . . 0.0 111.374 174.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.5 t0 62.92 36.93 12.38 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 115.321 1.601 . . . . 0.0 115.321 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 m 62.59 37.51 13.0 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.579 1.552 . . . . 0.0 113.504 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.8 p -157.29 137.08 8.58 Favored Pre-proline 0 CA--C 1.543 0.703 0 O-C-N 121.329 -0.857 . . . . 0.0 111.499 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.26 147.4 32.94 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.962 3.108 . . . . 0.0 111.111 171.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -127.35 135.97 51.26 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.812 1.245 . . . . 0.0 112.02 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 52.1 ttm -143.79 88.29 1.97 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.736 1.215 . . . . 0.0 109.789 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -146.31 -176.42 5.16 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.729 2.012 . . . . 0.0 111.645 -168.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -73.64 150.98 40.96 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.472 -1.392 . . . . 0.0 111.893 176.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.8 tp -58.34 -37.25 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 O-C-N 121.527 -0.733 . . . . 0.0 111.927 173.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -64.5 -30.44 71.47 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.215 0.916 . . . . 0.0 113.003 174.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -73.76 -41.39 62.51 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.587 -0.696 . . . . 0.0 110.301 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 20.0 ptm -69.47 -39.51 77.67 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.654 171.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -57.41 -52.41 65.49 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.975 0.807 . . . . 0.0 111.756 -178.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.8 t -71.55 -29.13 64.4 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 122.718 0.407 . . . . 0.0 111.503 -173.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -65.19 -53.01 51.17 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.363 1.465 . . . . 0.0 110.634 173.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -68.26 -32.77 73.18 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.376 -0.827 . . . . 0.0 112.015 177.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.74 -28.54 66.9 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.495 1.118 . . . . 0.0 113.658 174.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.4 t -83.83 -31.49 25.79 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.416 -0.802 . . . . 0.0 111.736 174.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 67.1 mtm -81.33 -42.75 20.09 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -114.27 -23.11 9.59 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.193 1.397 . . . . 0.0 113.875 -171.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.98 161.74 37.01 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.836 1.208 . . . . 0.0 114.647 -178.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -112.83 128.43 56.44 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.566 1.547 . . . . 0.0 110.406 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.8 mp -105.54 142.56 25.01 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 125.393 1.477 . . . . 0.0 111.789 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.24 146.27 40.25 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 124.04 3.16 . . . . 0.0 112.349 -177.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -141.12 159.55 41.98 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.083 1.753 . . . . 0.0 111.346 -178.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -61.42 -52.07 66.12 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 120.203 -1.56 . . . . 0.0 114.578 -178.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -79.84 -15.34 57.59 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 172.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -179.05 -125.99 0.98 Allowed Glycine 0 CA--C 1.539 1.549 0 N-CA-C 117.177 1.631 . . . . 0.0 117.177 -175.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -143.6 161.89 37.32 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.897 1.679 . . . . 0.0 111.003 178.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.19 148.52 41.7 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.952 1.301 . . . . 0.0 112.486 -176.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 54.5 t -124.11 120.99 26.28 Favored Pre-proline 0 N--CA 1.481 1.113 0 C-N-CA 125.756 1.623 . . . . 0.0 110.861 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -75.9 141.91 24.65 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 124.245 3.297 . . . . 0.0 112.317 -178.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.3 mt -106.45 164.58 11.93 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.52 1.128 . . . . 0.0 113.692 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -146.65 125.71 12.87 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.297 1.439 . . . . 0.0 111.009 173.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 54.46 32.96 17.74 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 125.758 1.623 . . . . 0.0 114.251 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.2 t -96.31 122.38 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 120.849 -1.157 . . . . 0.0 110.179 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -124.12 155.04 39.14 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.488 1.115 . . . . 0.0 113.508 -174.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.5 p -150.49 152.19 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.663 1.185 . . . . 0.0 111.976 -176.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.412 ' CE1' HG23 ' A' ' 60' ' ' ILE . 1.2 t80 -63.31 129.83 41.95 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 122.026 0.917 . . . . 0.0 110.228 167.184 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.405 HG21 ' HB ' ' A' ' 63' ' ' THR . 5.2 t -131.22 152.17 50.76 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.624 1.97 . . . . 0.0 111.248 178.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.6 tp -105.0 135.0 47.15 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.428 1.091 . . . . 0.0 110.211 175.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -80.8 116.04 20.59 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.769 0.828 . . . . 0.0 110.404 164.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 39.4 mm -71.9 -21.43 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.634 0.774 . . . . 0.0 112.473 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.8 -43.11 31.61 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.91 0.884 . . . . 0.0 113.305 -176.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -107.28 -23.67 12.16 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.405 1.082 . . . . 0.0 111.882 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.9 34.25 38.95 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.519 1.056 . . . . 0.0 113.272 -170.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -99.27 147.18 25.43 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.747 1.274 . . . . 0.0 113.502 -175.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.412 HG23 ' CE1' ' A' ' 51' ' ' TYR . 3.4 mp -91.95 130.88 40.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 C-N-CA 125.999 1.72 . . . . 0.0 110.025 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -157.5 171.43 20.37 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.367 1.467 . . . . 0.0 112.374 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -102.86 141.65 35.32 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.075 1.35 . . . . 0.0 111.047 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.405 ' HB ' HG21 ' A' ' 52' ' ' THR . 1.1 t -141.5 166.44 24.74 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.094 0.958 . . . . 0.0 112.373 176.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -93.61 150.79 20.13 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.941 1.296 . . . . 0.0 112.809 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.56 139.16 46.07 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.563 1.145 . . . . 0.0 111.556 173.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 93.1 p -91.0 -51.93 5.1 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -165.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -155.07 159.56 40.35 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.494 1.517 . . . . 0.0 112.95 177.053 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.3 mt -96.66 151.59 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 125.803 1.641 . . . . 0.0 109.117 170.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -137.6 148.5 45.9 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.347 1.459 . . . . 0.0 111.569 -174.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.51 149.12 52.38 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.399 1.48 . . . . 0.0 112.423 176.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -155.6 162.41 40.64 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.945 1.298 . . . . 0.0 110.386 176.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -101.74 140.92 35.38 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.08 0.952 . . . . 0.0 110.983 -176.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.8 m -149.05 144.47 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 124.527 1.131 . . . . 0.0 111.522 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -93.01 -36.16 12.88 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 126.278 1.831 . . . . 0.0 111.384 170.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -118.38 130.61 56.09 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.355 1.062 . . . . 0.0 110.981 -171.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.3 tp -139.02 159.14 42.86 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.648 1.979 . . . . 0.0 109.403 -173.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.4 mt -113.07 126.05 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.884 0.874 . . . . 0.0 109.209 176.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -97.03 127.82 43.38 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.08 0.952 . . . . 0.0 111.268 167.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -113.79 133.02 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.467 1.507 . . . . 0.0 109.474 173.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -103.78 146.47 28.58 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 126.753 2.021 . . . . 0.0 111.957 -179.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 68.2 mt -119.48 156.72 29.7 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.785 1.634 . . . . 0.0 113.08 -173.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.9 t -57.45 -29.39 64.16 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.312 1.445 . . . . 0.0 113.913 -178.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 55.7 m -75.44 1.38 14.17 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 173.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.63 43.26 19.4 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-N 119.608 1.095 . . . . 0.0 112.596 -178.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -130.48 152.78 49.5 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.15 1.78 . . . . 0.0 109.667 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 54.3 p -132.37 149.68 52.3 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 174.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 67.3 tp -122.19 134.18 54.72 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 126.501 1.92 . . . . 0.0 110.791 176.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -113.26 117.29 31.44 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.286 1.435 . . . . 0.0 111.962 -178.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.0 m -140.59 158.33 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.275 1.43 . . . . 0.0 112.913 -174.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.6 p -65.61 147.56 98.63 Favored Pre-proline 0 N--CA 1.471 0.61 0 O-C-N 120.975 -1.078 . . . . 0.0 112.766 174.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -59.5 -32.7 96.69 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.385 2.723 . . . . 0.0 113.763 -172.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 64.6 p -75.66 -1.64 25.66 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.774 2.03 . . . . 0.0 114.9 177.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 53.6 t60 -91.07 122.11 66.98 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 124.497 1.119 . . . . 0.0 113.022 -165.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 93' ' ' HIS . 17.3 Cg_exo -73.22 142.28 33.67 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.929 2.419 . . . . 0.0 114.425 -177.027 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.2 t -125.89 143.14 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 126.73 2.012 . . . . 0.0 109.479 174.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.1 tt -81.21 105.52 12.48 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.703 0.763 . . . . 0.0 110.087 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.8 mp -99.73 159.58 14.95 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.335 1.854 . . . . 0.0 111.381 177.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -113.54 133.31 55.32 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.675 -0.641 . . . . 0.0 111.89 174.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -153.46 96.86 2.08 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.942 1.697 . . . . 0.0 110.224 155.056 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 56.27 -3.33 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 127.328 2.251 . . . . 0.0 116.898 -167.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.83 163.43 34.52 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.372 1.463 . . . . 0.0 113.333 177.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 67.5 mt -67.93 115.16 7.14 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.066 2.146 . . . . 0.0 110.943 -177.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -141.73 139.81 32.97 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -178.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -98.37 124.53 43.09 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.919 0.887 . . . . 0.0 112.157 -175.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 62.1 t -131.58 131.28 22.74 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 125.196 1.398 . . . . 0.0 110.258 -172.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.43 145.62 77.67 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.583 2.188 . . . . 0.0 111.878 177.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.57 -30.95 14.4 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 176.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.27 -25.93 68.27 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 173.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -102.59 -4.95 24.45 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.032 1.733 . . . . 0.0 112.737 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 98.5 t -69.69 148.76 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.024 0.929 . . . . 0.0 109.647 166.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.92 155.22 71.09 Favored Pre-proline 0 N--CA 1.471 0.585 0 C-N-CA 127.252 2.221 . . . . 0.0 109.987 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.403 ' HD3' HG22 ' A' ' 142' ' ' VAL . 55.6 Cg_endo -65.89 119.48 6.51 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.041 1.827 . . . . 0.0 111.577 -177.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.42 ' H ' ' HB ' ' A' ' 139' ' ' VAL . . . 107.24 6.87 33.45 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.158 1.361 . . . . 0.0 114.705 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -61.15 155.62 20.22 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.275 1.037 . . . . 0.0 111.654 163.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.6 t -93.04 128.46 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.421 1.088 . . . . 0.0 110.071 169.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 28.0 t -103.03 139.03 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 126.381 1.872 . . . . 0.0 109.695 171.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.6 t -91.68 141.34 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.531 0.732 . . . . 0.0 110.772 176.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -168.38 -150.52 6.66 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 121.728 -0.607 . . . . 0.0 114.188 -177.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 120' ' ' ARG . 9.4 p -140.33 168.36 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 126.253 1.821 . . . . 0.0 109.979 175.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.41 ' H ' HG22 ' A' ' 119' ' ' VAL . 35.9 mtp180 . . . . . 0 N--CA 1.467 0.383 0 C-N-CA 125.584 1.554 . . . . 0.0 112.607 -175.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 . . . . . 0 N--CA 1.472 0.663 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 60.9 mt -128.93 174.18 9.74 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.652 1.981 . . . . 0.0 112.297 178.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -140.05 169.53 17.53 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.885 2.474 . . . . 0.0 109.279 171.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -135.5 156.18 49.32 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 119.992 -1.693 . . . . 0.0 111.627 164.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.29 140.09 52.07 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.589 1.156 . . . . 0.0 110.862 -172.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -89.28 133.69 34.36 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.51 0.724 . . . . 0.0 110.985 170.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.42 ' HB ' ' H ' ' A' ' 113' ' ' GLY . 79.4 t -72.15 122.58 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 123.433 0.693 . . . . 0.0 110.229 174.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 47.9 t -77.76 -41.98 35.68 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.652 1.181 . . . . 0.0 112.478 174.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.7 t -160.8 164.67 31.26 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.458 -0.777 . . . . 0.0 112.376 -177.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.403 HG22 ' HD3' ' A' ' 112' ' ' PRO . 5.7 m -135.72 150.71 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.485 1.114 . . . . 0.0 110.999 167.21 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -152.68 155.94 38.24 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.397 1.079 . . . . 0.0 112.943 173.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 80.5 mt -93.01 130.82 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 168.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 36.3 pt -122.33 149.37 25.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 124.63 1.172 . . . . 0.0 112.371 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.53 102.47 12.88 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.421 1.088 . . . . 0.0 110.069 168.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -84.34 -50.38 7.87 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.211 0.604 . . . . 0.0 111.715 172.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 44.57 57.17 4.62 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.978 1.311 . . . . 0.0 112.504 -173.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -151.63 175.71 12.08 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.712 0.805 . . . . 0.0 112.176 -177.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -67.67 144.42 55.5 Favored 'General case' 0 N--CA 1.463 0.189 0 O-C-N 121.727 -0.608 . . . . 0.0 110.79 162.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.1 m -122.5 152.16 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.521 1.128 . . . . 0.0 109.466 169.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -114.47 157.2 23.25 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 121.781 0.801 . . . . 0.0 112.09 -178.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -155.59 153.94 30.89 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.777 0.831 . . . . 0.0 109.784 -165.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 32.3 tp -136.51 139.44 42.27 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.174 -0.954 . . . . 0.0 111.788 -170.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 28.9 t -113.17 130.04 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.763 0.825 . . . . 0.0 112.608 -168.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 11.0 mm -134.08 85.55 39.51 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 125.728 1.611 . . . . 0.0 109.535 -175.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.98 -13.71 39.08 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.006 2.471 . . . . 0.0 113.766 -177.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -79.43 -40.18 30.58 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.383 0.882 . . . . 0.0 113.383 -177.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 59.1 p -140.14 -6.41 1.24 Allowed 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -171.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 58.01 13.35 2.15 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.203 1.801 . . . . 0.0 115.851 -174.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.03 147.55 24.15 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 120.96 1.709 . . . . 0.0 114.983 -176.157 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -146.85 159.24 43.76 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.369 1.068 . . . . 0.0 113.539 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.7 mp -99.7 137.96 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.466 1.106 . . . . 0.0 112.643 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -91.0 156.26 44.32 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 126.664 1.986 . . . . 0.0 112.428 172.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -67.75 -19.83 46.85 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.763 2.976 . . . . 0.0 113.74 -174.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 47.6 p30 -73.18 -0.94 15.67 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.063 1.345 . . . . 0.0 113.418 171.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.2 -5.63 68.28 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 126.391 1.948 . . . . 0.0 115.385 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 66.8 mt -84.94 153.54 22.76 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.231 1.516 . . . . 0.0 111.846 -175.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.7 p -110.55 133.04 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.785 0.834 . . . . 0.0 111.798 175.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 24.4 mt -116.2 154.33 30.26 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.831 2.052 . . . . 0.0 110.844 -172.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 8.3 t-80 -111.64 149.75 31.09 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.081 0.952 . . . . 0.0 112.86 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 3.4 t30 . . . . . 0 CA--C 1.55 0.976 0 C-N-CA 123.474 0.709 . . . . 0.0 111.161 162.351 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.608 0 CA-C-O 120.819 0.343 . . . . 0.0 111.6 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.12 156.32 45.37 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.704 1.602 . . . . 0.0 110.748 -169.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.08 145.3 31.3 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.825 1.25 . . . . 0.0 114.203 -177.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -60.64 -23.39 64.73 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.474 1.509 . . . . 0.0 114.216 177.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -92.79 4.37 53.93 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.792 0.837 . . . . 0.0 112.973 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.8 m -71.47 140.14 49.89 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.027 -1.045 . . . . 0.0 111.603 174.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -65.67 155.61 35.44 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.241 1.417 . . . . 0.0 113.648 167.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.7 p -148.11 151.93 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.331 1.052 . . . . 0.0 111.341 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -128.08 126.22 40.78 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.544 1.538 . . . . 0.0 108.254 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -156.92 176.98 12.03 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.396 0.678 . . . . 0.0 111.616 -177.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -134.83 138.36 44.15 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.683 1.193 . . . . 0.0 110.08 178.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -161.66 158.79 26.61 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.425 1.09 . . . . 0.0 110.213 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.3 t0 50.27 37.87 16.14 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.063 0.945 . . . . 0.0 113.26 -175.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.7 m 53.39 41.85 32.07 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.398 1.079 . . . . 0.0 113.372 -176.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.0 p -157.92 142.19 11.61 Favored Pre-proline 0 CA--C 1.545 0.753 0 O-C-N 120.968 -1.083 . . . . 0.0 111.216 174.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.14 149.26 64.21 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 123.003 2.468 . . . . 0.0 112.604 174.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -137.11 139.82 41.5 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 127.209 2.203 . . . . 0.0 109.629 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 42.6 ttm -153.08 106.1 2.98 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.361 -0.837 . . . . 0.0 110.775 -174.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -159.55 -179.3 7.78 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.006 1.322 . . . . 0.0 111.963 -165.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.4 m -71.03 138.02 49.51 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.099 -1.0 . . . . 0.0 110.565 169.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.466 HG12 ' CG ' ' A' ' 152' ' ' TYR . 6.6 tp -55.13 -38.75 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 O-C-N 121.251 -0.906 . . . . 0.0 112.606 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -66.29 -16.78 64.31 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.389 0.995 . . . . 0.0 113.104 -177.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -87.2 -41.13 13.97 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.846 1.258 . . . . 0.0 111.178 173.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 2.1 ppp? -73.4 -36.93 66.09 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 120.914 -1.116 . . . . 0.0 112.062 176.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -55.42 -45.7 76.73 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.447 1.099 . . . . 0.0 110.673 175.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.2 t -60.98 -34.67 75.14 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.1 0.96 . . . . 0.0 111.156 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -65.47 -53.08 47.78 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.457 1.103 . . . . 0.0 110.513 174.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -73.28 -35.36 66.15 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 121.495 -0.753 . . . . 0.0 112.739 -173.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.01 -35.67 80.45 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.262 0.625 . . . . 0.0 110.686 172.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 54.5 m -76.9 -24.08 52.51 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 121.049 -1.032 . . . . 0.0 113.538 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 33.1 mtm -90.54 -52.98 4.63 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.844 1.258 . . . . 0.0 112.062 177.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -100.31 -21.33 15.49 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.34 1.456 . . . . 0.0 112.049 -167.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.84 161.09 31.58 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.632 1.111 . . . . 0.0 113.049 -177.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -102.76 138.38 39.73 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.663 1.185 . . . . 0.0 111.155 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.6 mp -107.4 148.21 36.73 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 128.925 2.89 . . . . 0.0 110.212 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.85 155.68 43.68 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 123.516 2.811 . . . . 0.0 112.53 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -142.46 175.95 9.38 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.857 1.263 . . . . 0.0 112.524 169.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.61 -55.96 25.95 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.555 1.142 . . . . 0.0 112.119 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -105.94 -4.19 20.91 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -175.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -169.7 -135.69 1.95 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 114.61 0.604 . . . . 0.0 114.61 -172.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -144.65 165.37 28.23 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.086 1.754 . . . . 0.0 111.334 -175.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.29 159.33 42.33 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.687 1.595 . . . . 0.0 111.617 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 54.2 t -131.52 117.18 16.47 Favored Pre-proline 0 N--CA 1.48 1.061 0 C-N-CA 125.747 1.619 . . . . 0.0 111.102 178.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -82.46 123.3 3.81 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 124.233 3.289 . . . . 0.0 112.664 -172.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 90.5 mt -97.74 157.48 16.04 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -171.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -134.49 127.04 30.62 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.731 1.613 . . . . 0.0 112.588 171.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 52.32 40.95 30.23 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.246 1.418 . . . . 0.0 113.578 178.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.7 t -104.26 126.62 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.974 1.31 . . . . 0.0 109.543 172.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -126.46 158.74 35.26 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.927 1.291 . . . . 0.0 112.305 -175.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.8 m -143.09 150.18 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 126.334 1.853 . . . . 0.0 111.457 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -69.56 133.07 47.21 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 122.925 1.345 . . . . 0.0 109.666 164.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.3 t -137.13 164.68 27.87 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.7 2.4 . . . . 0.0 110.345 -173.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.3 tp -119.22 135.37 54.72 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.389 1.076 . . . . 0.0 109.194 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -79.1 105.99 10.83 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 163.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.2 mm -70.62 -24.63 25.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.685 0.794 . . . . 0.0 111.579 -175.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.97 -47.56 71.2 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.439 1.496 . . . . 0.0 113.391 -177.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.1 m -107.98 -19.27 13.56 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.599 1.16 . . . . 0.0 112.745 178.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.62 36.87 15.14 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.018 0.818 . . . . 0.0 112.318 -176.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -101.63 134.5 44.67 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.875 1.67 . . . . 0.0 112.591 -177.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 mp -76.64 136.53 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 O-C-N 121.798 -0.564 . . . . 0.0 109.934 178.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.1 ptpt -146.94 168.09 22.36 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.559 1.544 . . . . 0.0 111.781 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -116.05 147.71 40.98 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.414 1.486 . . . . 0.0 109.349 170.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.3 t -147.12 161.3 41.15 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.714 0.806 . . . . 0.0 111.866 -178.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -83.75 137.92 33.51 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.727 1.211 . . . . 0.0 112.027 175.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.34 132.18 44.03 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.229 1.011 . . . . 0.0 109.707 169.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.3 t -94.63 -41.09 9.48 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -163.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -150.51 156.23 41.03 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.923 1.289 . . . . 0.0 110.842 173.08 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.4 mt -88.49 149.4 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 162.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -126.95 149.2 49.96 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 126.324 1.85 . . . . 0.0 109.742 175.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.52 142.67 47.09 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.661 1.184 . . . . 0.0 111.71 167.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -141.98 153.22 44.13 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.595 1.158 . . . . 0.0 109.868 171.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.5 mmtt -84.06 144.36 29.12 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.813 -0.555 . . . . 0.0 110.661 171.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 20.5 m -143.09 140.51 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 122.457 1.122 . . . . 0.0 111.883 173.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -102.05 -9.11 20.87 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.594 1.558 . . . . 0.0 112.453 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -139.46 131.3 27.6 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.076 1.35 . . . . 0.0 109.952 175.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 13.0 tp -139.52 160.28 40.22 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.996 1.318 . . . . 0.0 109.513 -176.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.9 mt -111.63 127.5 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.851 0.861 . . . . 0.0 109.451 179.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -98.51 120.02 38.21 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.091 0.956 . . . . 0.0 110.786 167.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.4 mp -102.16 127.47 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.316 1.046 . . . . 0.0 108.473 168.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -97.12 151.05 20.16 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.071 1.348 . . . . 0.0 110.838 173.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 59.9 mt -117.21 159.97 21.8 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.263 1.825 . . . . 0.0 112.864 -172.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.7 t -58.8 -25.1 62.8 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.721 1.608 . . . . 0.0 113.368 177.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.8 p -67.33 -11.5 57.8 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.204 1.801 . . . . 0.0 115.236 172.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.78 -1.42 83.52 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 125.193 1.378 . . . . 0.0 114.664 -170.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -95.92 173.12 7.6 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.247 1.819 . . . . 0.0 112.835 -175.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.7 p -143.36 164.25 30.79 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 17.5 tp -139.09 137.07 35.87 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.331 1.452 . . . . 0.0 111.204 174.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.7 mtmt -113.69 117.72 32.33 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.023 1.329 . . . . 0.0 112.803 -176.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.2 m -143.48 153.93 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 125.868 1.667 . . . . 0.0 113.08 -163.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.6 p -70.16 149.76 96.09 Favored Pre-proline 0 N--CA 1.475 0.813 0 O-C-N 120.731 -1.231 . . . . 0.0 112.824 176.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -60.86 -22.76 75.01 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.692 2.928 . . . . 0.0 114.069 -174.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 58.9 p -88.81 -11.49 44.68 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.882 1.673 . . . . 0.0 115.02 177.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -65.74 121.78 77.27 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-N 119.332 0.969 . . . . 0.0 110.887 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -77.35 128.24 9.54 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.709 2.272 . . . . 0.0 112.789 177.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.0 t -100.0 137.55 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 C-N-CA 126.425 1.89 . . . . 0.0 109.692 176.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.33 108.35 13.86 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.6 mp -103.4 146.65 28.17 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.346 1.458 . . . . 0.0 111.904 -177.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -96.92 96.74 8.73 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.181 0.515 . . . . 0.0 111.518 170.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -124.73 73.73 1.29 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 122.808 1.289 . . . . 0.0 110.148 -178.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.4 t70 60.38 4.03 0.64 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 128.165 2.586 . . . . 0.0 114.79 -162.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -177.66 174.63 47.05 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 126.566 2.032 . . . . 0.0 111.28 -175.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.0 mt -76.5 123.36 25.92 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.748 1.219 . . . . 0.0 110.376 174.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -155.09 159.46 40.25 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.007 1.323 . . . . 0.0 112.492 176.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -107.16 131.76 53.79 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.901 0.88 . . . . 0.0 112.367 -175.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 97.1 t -132.72 129.39 21.26 Favored Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 124.099 0.96 . . . . 0.0 110.829 175.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -62.21 144.65 95.87 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.741 2.294 . . . . 0.0 111.944 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.68 -31.57 26.38 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.32 -25.61 67.24 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 172.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -108.37 -2.85 18.79 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.924 1.69 . . . . 0.0 112.945 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 89.6 t -70.0 139.2 20.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 O-C-N 121.542 -0.724 . . . . 0.0 109.563 162.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.18 154.96 74.38 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 126.187 1.795 . . . . 0.0 110.113 -177.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.69 121.14 8.03 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.194 1.93 . . . . 0.0 110.641 -175.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.37 4.95 34.89 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.377 0.989 . . . . 0.0 114.609 -174.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -65.87 175.79 1.84 Allowed 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 118.897 1.349 . . . . 0.0 113.08 168.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.5 p -125.16 123.26 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 125.069 1.348 . . . . 0.0 111.945 -176.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 26.0 t -115.9 131.9 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 125.652 1.581 . . . . 0.0 111.923 -167.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.0 t -88.18 140.88 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 122.063 0.935 . . . . 0.0 111.659 -178.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -170.07 -144.35 4.27 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.906 1.717 . . . . 0.0 111.845 -176.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.3 p -150.49 163.88 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 126.722 2.009 . . . . 0.0 109.131 173.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 . . . . . 0 N--CA 1.477 0.891 0 C-N-CA 123.635 0.774 . . . . 0.0 111.887 169.954 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 . . . . . 0 N--CA 1.475 0.817 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 97.0 mt -138.92 176.94 8.26 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 128.404 2.682 . . . . 0.0 112.321 -178.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -155.63 159.76 39.88 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.963 2.105 . . . . 0.0 111.535 169.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -107.44 151.2 25.87 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.63 1.172 . . . . 0.0 113.0 169.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -135.69 136.79 41.17 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.037 1.335 . . . . 0.0 110.704 -167.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -85.08 134.14 34.2 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.507 -0.745 . . . . 0.0 111.878 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 70.3 t -73.89 126.17 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.167 0.587 . . . . 0.0 110.279 171.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.6 t -81.35 -49.56 10.54 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.146 1.778 . . . . 0.0 112.461 175.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.4 m -156.09 161.34 40.4 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.709 1.204 . . . . 0.0 110.633 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.5 m -134.14 144.35 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.077 0.951 . . . . 0.0 110.337 167.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -152.24 155.79 38.43 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 173.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 85.9 mt -86.81 139.95 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 167.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 21.9 pt -130.52 148.82 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 125.958 1.703 . . . . 0.0 110.94 174.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -86.64 89.72 8.02 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.391 -0.818 . . . . 0.0 109.825 177.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -71.87 -44.0 64.51 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -172.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 51.61 26.8 3.53 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 126.544 1.938 . . . . 0.0 114.832 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 -139.65 175.56 9.47 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.694 1.198 . . . . 0.0 111.662 -173.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -74.19 140.81 45.37 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 124.006 0.922 . . . . 0.0 112.617 177.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 15.0 m -122.68 154.95 27.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 126.131 1.772 . . . . 0.0 109.079 172.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.466 ' CG ' HG12 ' A' ' 21' ' ' ILE . 3.2 p90 -110.34 159.32 17.54 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.558 0.743 . . . . 0.0 112.217 -177.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -137.9 143.84 41.04 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 122.639 0.376 . . . . 0.0 110.356 158.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 60.4 tp -111.39 103.59 11.97 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.526 1.13 . . . . 0.0 110.223 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.0 t -81.05 122.95 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -158.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 24.2 mm -112.42 96.33 35.4 Favored Pre-proline 0 N--CA 1.469 0.513 0 C-N-CA 125.464 1.506 . . . . 0.0 110.035 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.38 -14.77 37.83 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.022 1.815 . . . . 0.0 113.553 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -73.16 -65.34 0.82 Allowed 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 119.145 0.884 . . . . 0.0 111.735 177.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 67.7 p -114.88 -10.72 12.3 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.296 1.439 . . . . 0.0 114.04 -171.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 59.06 18.86 6.71 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.46 1.504 . . . . 0.0 114.243 -167.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -146.63 145.66 30.14 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -175.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -146.46 163.76 34.66 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.62 1.568 . . . . 0.0 112.596 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.0 mp -102.14 134.94 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 O-C-N 121.261 -0.9 . . . . 0.0 111.715 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.32 154.24 54.14 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 124.956 1.302 . . . . 0.0 112.307 170.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.09 -17.05 54.34 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.705 2.937 . . . . 0.0 114.736 -173.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -73.07 -6.01 42.74 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 169.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 111.66 -20.87 22.07 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 126.359 1.933 . . . . 0.0 115.221 172.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 54.4 mt -81.92 145.51 30.28 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 120.1 1.95 . . . . 0.0 113.842 -166.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.5 t -89.26 123.87 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.954 0.902 . . . . 0.0 110.603 176.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 20.8 mt -115.73 137.93 51.61 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.644 1.578 . . . . 0.0 111.184 -174.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -101.16 145.26 29.02 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.149 0.979 . . . . 0.0 111.016 168.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 21.8 m120 . . . . . 0 CA--C 1.547 0.842 0 C-N-CA 124.411 1.084 . . . . 0.0 112.06 170.146 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.58 159.9 41.19 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.867 1.667 . . . . 0.0 112.09 -168.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.27 146.48 39.21 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.177 1.391 . . . . 0.0 113.015 175.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.03 -22.72 64.83 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.098 1.359 . . . . 0.0 114.521 177.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -87.4 -2.54 58.69 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.7 m -65.02 134.87 54.82 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.902 0.881 . . . . 0.0 111.628 175.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -75.07 153.29 38.43 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.009 0.924 . . . . 0.0 112.882 172.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 p -145.56 158.96 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.287 1.035 . . . . 0.0 112.389 -174.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -127.82 133.52 49.41 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.018 1.727 . . . . 0.0 109.456 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -156.28 168.93 25.78 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 170.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -132.91 143.72 49.68 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.321 1.448 . . . . 0.0 111.52 -178.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -157.86 136.41 11.2 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.071 1.349 . . . . 0.0 109.566 175.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.5 t0 50.48 46.91 24.87 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.397 1.479 . . . . 0.0 113.972 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.7 m 61.86 42.4 10.47 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 176.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.1 p -155.05 140.51 12.46 Favored Pre-proline 0 CA--C 1.548 0.871 0 O-C-N 121.027 -1.046 . . . . 0.0 111.514 167.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -91.21 157.42 3.8 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 124.981 3.787 . . . . 0.0 114.802 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 33.1 m80 -136.74 138.17 40.68 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.63 1.972 . . . . 0.0 110.553 -173.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 41.6 ttm -144.64 107.82 4.55 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.666 0.787 . . . . 0.0 111.809 176.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -156.8 -179.97 8.71 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.287 1.435 . . . . 0.0 111.746 -174.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.3 m -67.34 136.81 55.39 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.376 -0.828 . . . . 0.0 110.023 171.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.451 HG12 ' CG ' ' A' ' 152' ' ' TYR . 7.8 tp -54.85 -36.53 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 121.173 -0.954 . . . . 0.0 112.924 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -62.36 -17.96 60.29 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -82.24 -54.44 5.25 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.3 1.44 . . . . 0.0 110.37 174.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -65.26 -32.63 74.39 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.63 -0.669 . . . . 0.0 112.013 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -60.4 -51.12 70.83 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.33 0.652 . . . . 0.0 111.454 169.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.0 t -61.23 -38.07 85.31 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.667 0.787 . . . . 0.0 111.001 -177.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -62.71 -52.72 62.16 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 125.328 1.451 . . . . 0.0 110.845 174.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -72.17 -32.68 67.07 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.199 -0.938 . . . . 0.0 113.2 -176.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.46 -31.22 68.28 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.971 0.908 . . . . 0.0 112.547 174.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.8 t -78.6 -20.65 50.0 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.969 1.308 . . . . 0.0 112.322 176.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 46.4 mtm -96.62 -58.61 2.01 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.913 1.685 . . . . 0.0 113.601 177.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -100.0 -15.14 18.38 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.427 1.491 . . . . 0.0 113.611 -170.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 87.49 162.89 38.37 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 124.433 1.016 . . . . 0.0 114.515 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -110.65 134.45 52.42 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.976 1.311 . . . . 0.0 110.017 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.7 mp -120.75 148.34 48.06 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 125.531 1.532 . . . . 0.0 111.522 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.05 150.6 60.64 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.841 3.028 . . . . 0.0 112.762 -177.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -134.05 168.0 19.61 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.422 1.489 . . . . 0.0 111.653 177.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.19 -50.58 37.41 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.066 1.347 . . . . 0.0 113.886 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -111.44 -2.51 15.54 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.802 1.641 . . . . 0.0 114.18 -175.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.04 -137.16 2.37 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 121.423 -0.798 . . . . 0.0 114.116 -173.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -136.0 161.12 36.55 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.311 1.845 . . . . 0.0 111.516 176.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.95 158.06 44.48 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.323 1.049 . . . . 0.0 112.168 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 84.6 t -126.64 117.01 22.71 Favored Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 125.919 1.688 . . . . 0.0 109.904 176.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.0 130.76 17.11 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 123.993 3.129 . . . . 0.0 112.617 -174.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 89.4 mt -102.05 162.2 13.09 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.179 0.992 . . . . 0.0 113.294 176.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -144.86 124.83 13.51 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.225 1.01 . . . . 0.0 112.235 173.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 47.82 52.56 12.64 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.652 1.581 . . . . 0.0 112.777 -174.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.9 t -113.46 132.87 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 125.059 1.344 . . . . 0.0 110.079 175.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -132.26 151.18 51.95 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.499 1.12 . . . . 0.0 112.899 -166.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.6 m -140.41 153.53 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 126.24 1.816 . . . . 0.0 111.912 177.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -68.13 132.05 46.51 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.134 0.974 . . . . 0.0 109.948 168.133 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.5 t -134.33 153.56 51.82 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.762 2.025 . . . . 0.0 111.175 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 49.0 tp -103.05 129.33 49.81 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.25 1.02 . . . . 0.0 109.637 175.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -77.23 97.56 4.85 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.678 0.791 . . . . 0.0 109.157 173.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 30.5 mm -59.25 -25.68 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 O-C-N 120.877 -1.14 . . . . 0.0 112.907 -170.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.49 -39.73 31.4 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -176.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.3 m -110.99 -6.36 14.68 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.23 1.012 . . . . 0.0 113.214 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.82 29.24 74.66 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.558 1.551 . . . . 0.0 113.649 177.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -96.37 139.28 32.72 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.772 1.629 . . . . 0.0 112.142 -178.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 mp -80.26 130.03 36.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 125.552 1.541 . . . . 0.0 108.974 173.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -151.6 169.11 22.92 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.976 1.71 . . . . 0.0 111.278 -177.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -100.06 147.67 25.39 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.536 1.134 . . . . 0.0 110.552 170.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.3 t -142.0 168.73 19.05 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.817 0.847 . . . . 0.0 112.085 173.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 -102.01 145.95 28.58 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.492 1.117 . . . . 0.0 113.535 -174.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -108.07 139.18 43.1 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.236 1.414 . . . . 0.0 111.228 178.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.86 -47.02 7.85 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.565 0.746 . . . . 0.0 112.733 -170.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -153.58 156.89 38.85 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.998 1.319 . . . . 0.0 110.834 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.7 mt -86.17 154.39 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 163.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -138.87 151.15 46.74 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.464 1.505 . . . . 0.0 112.264 -175.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -144.63 152.78 40.98 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.003 1.321 . . . . 0.0 113.301 170.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -155.25 160.25 40.67 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.014 1.326 . . . . 0.0 110.586 173.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp -87.78 143.71 27.0 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.278 1.431 . . . . 0.0 111.546 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.5 m -147.13 146.0 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 124.983 1.313 . . . . 0.0 111.556 176.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -95.31 -34.27 12.23 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.539 1.536 . . . . 0.0 111.596 170.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -113.16 119.24 37.12 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.377 1.471 . . . . 0.0 109.421 -169.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.0 tp -133.99 162.09 33.03 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.379 1.472 . . . . 0.0 109.524 -178.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.5 mt -120.5 129.3 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.351 1.061 . . . . 0.0 108.742 177.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -99.28 125.68 44.95 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.346 0.658 . . . . 0.0 110.798 168.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -109.81 127.56 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.821 1.248 . . . . 0.0 109.471 170.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -94.16 146.38 24.03 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.443 1.497 . . . . 0.0 110.92 171.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 49.2 mt -112.73 162.16 16.06 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.597 1.559 . . . . 0.0 111.95 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.0 t -63.74 -16.09 60.26 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.917 1.287 . . . . 0.0 113.3 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 77.9 p -77.89 -9.74 59.22 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.249 2.22 . . . . 0.0 115.167 170.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 83.65 0.69 89.98 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.957 1.265 . . . . 0.0 114.869 -171.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -77.42 148.47 35.44 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.773 1.229 . . . . 0.0 110.635 175.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 93.3 p -122.66 143.26 49.89 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.457 1.103 . . . . 0.0 112.689 173.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.5 tp -127.53 132.13 49.96 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.973 1.709 . . . . 0.0 110.528 178.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.0 mtpt -118.31 115.72 25.28 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.036 1.334 . . . . 0.0 111.751 -171.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.5 m -143.93 154.5 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.131 1.372 . . . . 0.0 113.665 -164.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 21.3 p -66.77 147.96 98.9 Favored Pre-proline 0 N--CA 1.471 0.615 0 O-C-N 121.163 -0.96 . . . . 0.0 112.397 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -57.82 -29.01 84.59 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.199 2.599 . . . . 0.0 113.086 -177.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.2 p -71.83 -20.96 61.75 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.457 2.303 . . . . 0.0 115.782 176.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -71.62 119.65 75.3 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.254 1.022 . . . . 0.0 112.052 -168.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -75.68 129.0 11.37 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.713 2.276 . . . . 0.0 112.341 175.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.0 t -108.95 144.44 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 126.112 1.765 . . . . 0.0 109.113 176.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.21 104.95 12.03 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.141 0.496 . . . . 0.0 109.992 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.7 mp -104.22 160.99 14.42 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.692 1.597 . . . . 0.0 111.541 -178.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -112.38 119.21 37.47 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 176.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.8 mtp-105 -136.89 81.78 1.9 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.098 0.959 . . . . 0.0 110.448 161.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 58.62 10.3 1.38 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.694 1.998 . . . . 0.0 115.515 -170.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 177.67 163.25 29.16 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.892 1.234 . . . . 0.0 113.22 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 46.0 mt -64.01 116.53 5.96 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.725 1.61 . . . . 0.0 111.612 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -144.62 144.46 31.28 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 178.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -95.27 129.82 42.26 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.139 0.976 . . . . 0.0 110.79 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.8 t -133.66 127.96 19.75 Favored Pre-proline 0 N--CA 1.476 0.848 0 C-N-CA 123.891 0.876 . . . . 0.0 110.438 -178.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -65.58 141.04 65.17 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.326 2.017 . . . . 0.0 111.084 177.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.99 -30.4 14.99 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 176.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.04 -17.89 63.81 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 174.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -108.5 -14.83 14.57 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.098 1.359 . . . . 0.0 112.793 175.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 87.2 t -63.47 140.78 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.823 1.249 . . . . 0.0 110.434 173.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.86 153.56 78.77 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 125.93 1.692 . . . . 0.0 110.866 -174.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.435 ' HD3' HG22 ' A' ' 142' ' ' VAL . 50.8 Cg_endo -68.86 116.1 4.29 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.644 2.229 . . . . 0.0 111.543 -169.055 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 115.29 0.36 22.2 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 124.416 1.008 . . . . 0.0 115.1 -176.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -63.4 156.74 25.07 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 118.583 1.191 . . . . 0.0 111.351 169.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.6 t -97.56 132.32 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 124.539 1.135 . . . . 0.0 110.875 173.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.2 t -106.63 143.5 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 127.308 2.243 . . . . 0.0 110.285 176.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.5 t -95.44 140.85 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.274 1.029 . . . . 0.0 111.153 176.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -165.65 -150.87 6.43 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.551 1.072 . . . . 0.0 112.887 176.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.6 p -134.29 163.0 38.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 127.676 2.39 . . . . 0.0 108.258 173.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 38.9 mtt180 . . . . . 0 N--CA 1.47 0.553 0 C-N-CA 124.623 1.169 . . . . 0.0 109.894 172.364 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 80.3 mt -137.64 161.81 35.47 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.972 1.709 . . . . 0.0 111.161 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -144.08 130.32 19.72 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.726 1.21 . . . . 0.0 113.306 -177.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -79.66 144.38 33.79 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.226 1.41 . . . . 0.0 112.099 175.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -134.05 141.46 47.2 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.068 1.347 . . . . 0.0 110.631 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -102.65 139.25 38.48 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.126 -0.984 . . . . 0.0 112.855 -175.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 78.6 t -76.11 134.71 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.912 0.885 . . . . 0.0 111.491 175.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.9 t -99.06 -39.13 8.67 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.873 2.069 . . . . 0.0 113.525 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 26.2 t -157.41 160.32 38.27 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.58 1.152 . . . . 0.0 110.918 175.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.435 HG22 ' HD3' ' A' ' 112' ' ' PRO . 3.4 m -136.51 147.79 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.599 1.159 . . . . 0.0 110.028 164.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 31.7 ptt-85 -158.41 159.58 35.92 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 162.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 45.6 mt -85.03 134.29 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.065 0.946 . . . . 0.0 108.685 173.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 19.0 pt -126.99 156.27 38.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 125.396 1.478 . . . . 0.0 112.524 -177.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.94 96.79 10.84 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.749 1.22 . . . . 0.0 111.737 173.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -78.46 -53.12 7.59 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.232 -0.917 . . . . 0.0 112.316 176.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 46.53 47.94 14.19 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.513 1.525 . . . . 0.0 112.434 -172.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -151.97 178.52 9.35 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.702 0.801 . . . . 0.0 112.732 -176.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -80.01 139.27 37.04 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.708 1.203 . . . . 0.0 113.042 177.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.5 m -121.25 160.63 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.526 1.93 . . . . 0.0 110.084 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.451 ' CG ' HG12 ' A' ' 21' ' ' ILE . 0.7 OUTLIER -113.78 161.83 17.06 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.988 0.915 . . . . 0.0 112.87 -178.357 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -144.03 163.37 33.7 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.571 0.748 . . . . 0.0 111.156 154.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 46.4 tp -115.17 122.93 47.56 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.277 1.431 . . . . 0.0 109.927 172.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 58.6 t -87.52 121.88 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 O-C-N 121.276 -0.89 . . . . 0.0 111.919 -171.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 20.5 mm -119.56 89.95 41.92 Favored Pre-proline 0 N--CA 1.47 0.531 0 C-N-CA 125.836 1.655 . . . . 0.0 109.371 -177.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -66.21 -23.19 52.72 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.331 2.02 . . . . 0.0 112.524 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 -81.76 -29.57 32.75 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -171.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 69.1 p -140.5 -22.33 0.82 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -177.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 65.33 15.86 10.24 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 127.113 2.165 . . . . 0.0 115.507 -171.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.49 150.52 26.67 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 120.735 -1.228 . . . . 0.0 114.144 -177.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -150.92 170.38 19.45 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.102 1.361 . . . . 0.0 113.09 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.1 mp -106.98 137.42 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.648 1.179 . . . . 0.0 111.937 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.91 157.99 50.9 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.684 1.194 . . . . 0.0 113.097 173.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -66.06 -18.07 56.14 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.302 2.668 . . . . 0.0 113.989 -175.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -83.83 6.07 22.77 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 171.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 107.04 -23.69 26.83 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 126.106 1.813 . . . . 0.0 116.954 165.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 75.2 mt -83.3 151.42 25.6 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 120.252 2.026 . . . . 0.0 114.46 -169.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.0 t -93.83 129.0 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.657 1.183 . . . . 0.0 111.93 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 25.5 mt -119.69 141.74 49.11 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.77 2.028 . . . . 0.0 111.552 -170.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -102.36 134.83 45.02 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 119.206 0.912 . . . . 0.0 112.681 171.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 35.1 m120 . . . . . 0 C--O 1.24 0.569 0 C-N-CA 124.43 1.092 . . . . 0.0 111.733 -169.164 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -142.58 163.64 32.27 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.082 1.353 . . . . 0.0 112.389 -167.123 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.13 146.05 48.85 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.629 1.572 . . . . 0.0 112.821 175.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.6 ppt_? -63.48 -21.49 66.34 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 176.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -83.79 0.36 47.69 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 176.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.6 m -66.45 147.7 52.92 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.613 1.165 . . . . 0.0 113.112 174.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -88.62 156.28 19.13 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.844 1.657 . . . . 0.0 114.423 175.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.425 HG11 ' SD ' ' A' ' 24' ' ' MET . 3.5 p -145.82 150.66 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.948 0.899 . . . . 0.0 113.217 -172.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -128.42 121.98 30.29 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.788 2.035 . . . . 0.0 107.679 175.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -139.74 174.44 10.51 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.209 1.004 . . . . 0.0 111.422 173.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -131.23 134.46 46.46 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.053 -1.029 . . . . 0.0 111.393 170.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -159.33 166.53 30.97 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.483 1.913 . . . . 0.0 108.257 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.0 t70 55.5 22.42 5.09 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 120.083 1.311 . . . . 0.0 113.093 -167.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.2 m 56.84 36.17 27.34 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.646 1.978 . . . . 0.0 114.185 -170.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.2 p -152.82 143.77 15.89 Favored Pre-proline 0 CA--C 1.547 0.85 0 O-C-N 120.534 -1.354 . . . . 0.0 112.141 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -70.03 140.98 42.94 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.74 2.96 . . . . 0.0 113.622 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -129.16 137.05 50.94 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 127.519 2.328 . . . . 0.0 110.339 -178.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 45.4 mtp -143.76 119.2 10.3 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.266 1.426 . . . . 0.0 112.093 -174.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -164.43 -173.51 3.1 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.617 1.567 . . . . 0.0 112.709 -172.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 65.4 m -74.53 141.57 44.83 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.089 -1.007 . . . . 0.0 111.127 167.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.451 HG12 ' CG ' ' A' ' 152' ' ' TYR . 7.4 tp -57.53 -38.21 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 121.256 -0.903 . . . . 0.0 112.857 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -60.92 -28.41 68.91 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.733 0.697 . . . . 0.0 111.913 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -80.49 -43.91 20.04 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 124.135 0.974 . . . . 0.0 110.974 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.425 ' SD ' HG11 ' A' ' 8' ' ' VAL . 12.9 ptm -65.19 -35.14 80.16 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.322 0.964 . . . . 0.0 111.625 173.335 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -60.83 -48.48 81.62 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.356 0.662 . . . . 0.0 110.557 173.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.1 t -59.78 -39.55 85.27 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.815 1.246 . . . . 0.0 111.39 177.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.3 ttmm -61.31 -56.73 17.21 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.414 1.486 . . . . 0.0 110.793 174.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -74.6 -33.05 62.53 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.108 -0.995 . . . . 0.0 112.564 -172.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.63 -19.91 62.78 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.975 0.91 . . . . 0.0 112.522 172.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 51.0 m -90.02 -18.98 24.97 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.252 1.421 . . . . 0.0 113.678 171.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 72.0 mtm -98.27 -44.91 6.38 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.893 1.277 . . . . 0.0 113.334 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -112.11 -23.77 10.26 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.592 1.557 . . . . 0.0 112.962 -169.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.32 162.98 38.97 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.693 1.616 . . . . 0.0 114.172 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -107.53 133.78 51.5 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.256 1.022 . . . . 0.0 110.94 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.3 mp -118.51 150.83 48.78 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 126.921 2.088 . . . . 0.0 110.936 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -75.53 148.03 32.76 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.693 2.929 . . . . 0.0 112.429 177.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -131.21 169.3 16.13 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.518 1.927 . . . . 0.0 111.595 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.58 -56.34 7.36 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.569 1.548 . . . . 0.0 114.613 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -105.33 -6.57 19.51 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -168.37 -137.84 2.33 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 123.716 0.674 . . . . 0.0 113.918 -170.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -131.84 155.89 47.02 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.51 1.524 . . . . 0.0 111.498 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.31 148.77 41.88 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.041 0.936 . . . . 0.0 112.214 -177.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 84.2 t -118.38 111.14 38.49 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 125.593 1.557 . . . . 0.0 109.476 176.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.58 140.23 51.25 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 124.569 3.513 . . . . 0.0 111.231 -177.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.5 mt -107.5 163.42 13.08 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.153 0.981 . . . . 0.0 113.528 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -137.63 116.34 12.2 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 127.58 2.352 . . . . 0.0 110.238 176.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 52.69 38.66 26.76 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 126.83 2.052 . . . . 0.0 115.133 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.6 t -99.92 133.71 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.18 1.392 . . . . 0.0 110.857 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -127.95 159.88 33.6 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.275 1.83 . . . . 0.0 113.319 -175.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.8 m -138.32 161.2 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 127.257 2.223 . . . . 0.0 111.593 174.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.464 ' CE1' HG23 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -76.38 131.05 38.9 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 122.02 0.914 . . . . 0.0 108.933 163.115 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.8 t -132.32 151.25 51.93 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.116 1.766 . . . . 0.0 111.054 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.6 tp -109.51 136.29 49.15 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.574 1.15 . . . . 0.0 109.546 174.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -85.38 115.9 23.39 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 118.57 -0.729 . . . . 0.0 109.762 160.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.2 mm -66.36 -28.5 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 119.685 1.129 . . . . 0.0 112.331 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.43 -47.86 31.09 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -168.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 64.3 m -96.06 -17.77 20.68 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.247 -0.908 . . . . 0.0 112.075 169.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.84 32.37 33.11 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.552 1.072 . . . . 0.0 112.856 -176.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -88.35 119.79 29.1 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 118.246 1.023 . . . . 0.0 111.865 -172.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.464 HG23 ' CE1' ' A' ' 51' ' ' TYR . 3.2 mp -72.98 125.64 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 167.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -152.15 175.39 12.63 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.658 1.183 . . . . 0.0 112.178 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -99.1 148.76 23.72 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.363 1.465 . . . . 0.0 110.601 172.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.7 t -143.93 158.72 43.51 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 118.547 0.612 . . . . 0.0 111.554 165.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.7 ptt85 -67.21 156.04 37.29 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.862 0.865 . . . . 0.0 112.576 170.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -112.99 138.34 50.02 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.704 0.802 . . . . 0.0 110.198 160.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.9 t -88.71 -47.62 8.11 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.282 1.033 . . . . 0.0 112.697 -167.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -154.46 156.59 37.02 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.141 1.776 . . . . 0.0 111.549 173.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.4 mt -86.01 153.35 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 165.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -133.93 148.14 51.17 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.43 1.492 . . . . 0.0 112.113 -172.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -142.77 149.08 38.21 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 165.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -146.13 162.5 37.84 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.937 1.695 . . . . 0.0 110.23 171.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.51 147.26 23.14 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.75 0.82 . . . . 0.0 112.965 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.5 m -149.05 145.96 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.505 1.522 . . . . 0.0 111.653 177.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -93.54 -31.13 14.66 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.823 1.249 . . . . 0.0 112.395 173.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -128.0 137.11 52.09 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 122.147 0.975 . . . . 0.0 112.648 -176.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.4 tp -137.79 165.45 26.43 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.715 2.006 . . . . 0.0 110.333 -174.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.6 mt -119.15 127.82 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.555 1.142 . . . . 0.0 109.532 175.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -95.25 124.52 39.34 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.809 0.843 . . . . 0.0 111.293 163.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -106.62 127.77 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 125.574 1.55 . . . . 0.0 108.835 168.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -96.59 145.77 25.44 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.075 1.35 . . . . 0.0 111.075 173.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 81.8 mt -104.92 162.29 13.46 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.538 1.935 . . . . 0.0 111.59 -178.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.3 t -60.03 -28.86 68.1 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.346 1.458 . . . . 0.0 111.915 177.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 97.3 p -63.27 -12.81 31.9 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.707 1.603 . . . . 0.0 114.646 169.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.1 2.47 89.39 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.695 1.616 . . . . 0.0 114.06 -170.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -88.86 173.26 8.62 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.494 1.518 . . . . 0.0 111.891 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 86.8 p -143.0 148.82 37.41 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 -171.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 61.3 tp -120.7 131.65 54.66 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 127.577 2.351 . . . . 0.0 109.787 174.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -122.89 113.24 18.86 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.15 1.38 . . . . 0.0 111.697 -176.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.9 m -145.06 155.46 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 125.081 1.353 . . . . 0.0 113.286 -163.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.2 p -68.08 147.05 98.39 Favored Pre-proline 0 N--CA 1.473 0.709 0 O-C-N 121.404 -0.81 . . . . 0.0 112.417 176.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -60.79 -33.99 92.17 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.775 2.317 . . . . 0.0 113.265 -170.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.4 p -78.83 -7.48 57.91 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.829 1.651 . . . . 0.0 114.946 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -86.99 124.75 68.31 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.373 1.069 . . . . 0.0 113.353 -168.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -72.66 143.55 37.98 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.337 2.691 . . . . 0.0 115.479 -178.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.7 t -122.77 146.87 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 126.777 2.031 . . . . 0.0 109.693 174.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 31.0 tp -84.68 114.6 22.14 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.285 0.634 . . . . 0.0 111.358 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.7 mp -113.87 153.66 28.82 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.285 1.834 . . . . 0.0 112.686 -172.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -103.34 101.63 11.55 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.804 1.641 . . . . 0.0 110.733 171.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 76.5 mtt-85 -136.17 74.14 1.49 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.535 1.134 . . . . 0.0 110.722 173.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 61.7 2.4 0.71 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 126.486 1.914 . . . . 0.0 115.748 -167.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -176.3 167.89 39.73 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.456 1.503 . . . . 0.0 112.115 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 75.6 mt -81.96 108.58 15.58 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.132 1.373 . . . . 0.0 110.727 -178.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -140.71 144.02 35.36 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.527 0.731 . . . . 0.0 112.765 -168.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -96.57 120.59 37.17 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.673 1.189 . . . . 0.0 111.118 -176.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 62.1 t -130.08 131.99 23.81 Favored Pre-proline 0 N--CA 1.482 1.162 0 C-N-CA 124.777 1.231 . . . . 0.0 110.43 -176.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -67.42 146.99 76.62 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.344 2.696 . . . . 0.0 112.257 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.41 -31.71 23.74 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 176.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.8 -23.39 66.69 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 173.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -104.35 0.89 29.63 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.02 1.728 . . . . 0.0 112.053 174.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 84.0 t -74.88 141.37 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 O-C-N 120.796 -1.19 . . . . 0.0 109.773 167.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.52 154.39 81.63 Favored Pre-proline 0 N--CA 1.472 0.649 0 C-N-CA 127.334 2.254 . . . . 0.0 110.436 -176.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.417 ' HD3' HG22 ' A' ' 142' ' ' VAL . 59.6 Cg_endo -66.27 115.03 3.27 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 121.664 1.576 . . . . 0.0 109.613 177.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.37 3.41 24.18 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.745 1.164 . . . . 0.0 115.542 -177.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -60.13 161.89 6.42 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 118.65 1.225 . . . . 0.0 111.85 161.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 24.5 t -118.22 128.7 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.5 1.52 . . . . 0.0 110.225 174.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.0 t -104.09 145.11 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 127.16 2.184 . . . . 0.0 110.606 -175.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 43.7 t -87.77 137.76 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.376 1.07 . . . . 0.0 111.112 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -167.32 -146.65 4.97 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 115.262 0.865 . . . . 0.0 115.262 179.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.8 p -155.75 165.04 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 126.658 1.983 . . . . 0.0 108.639 176.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 . . . . . 0 N--CA 1.473 0.698 0 C-N-CA 124.871 1.268 . . . . 0.0 111.773 176.884 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 . . . . . 0 N--CA 1.475 0.822 0 CA-C-O 119.566 -0.254 . . . . 0.0 111.529 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 85.8 mt -149.0 151.46 34.59 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.767 2.027 . . . . 0.0 112.561 -174.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -136.5 171.63 14.2 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.208 1.803 . . . . 0.0 111.386 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -131.01 157.06 44.03 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 120.631 -1.293 . . . . 0.0 112.724 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -138.34 123.83 19.56 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.576 1.15 . . . . 0.0 110.2 -167.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -84.67 145.63 27.88 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.952 -1.092 . . . . 0.0 112.307 -178.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.5 t -77.55 133.1 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.285 1.034 . . . . 0.0 111.699 175.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 26.9 t -87.16 -46.31 9.87 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.625 1.97 . . . . 0.0 112.405 171.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 29.6 t -157.26 160.72 38.91 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.42 0.688 . . . . 0.0 111.788 -173.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.417 HG22 ' HD3' ' A' ' 112' ' ' PRO . 4.0 m -135.36 145.73 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.285 1.034 . . . . 0.0 111.61 167.391 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -152.73 151.23 30.28 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.551 1.14 . . . . 0.0 113.344 172.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 75.4 mt -89.0 138.86 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.953 1.301 . . . . 0.0 109.051 169.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 44.9 pt -131.65 146.62 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.936 1.694 . . . . 0.0 111.62 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -80.07 104.92 10.96 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.668 -0.645 . . . . 0.0 109.549 165.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -81.62 -49.01 11.01 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.077 -1.015 . . . . 0.0 113.518 174.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 44.33 52.71 7.16 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.069 1.348 . . . . 0.0 111.989 -173.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -150.02 176.85 10.41 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.808 0.843 . . . . 0.0 111.97 -177.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -75.52 146.94 40.15 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.565 -0.709 . . . . 0.0 111.638 168.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 6.8 m -126.23 158.22 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.799 1.64 . . . . 0.0 109.47 172.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.451 ' CG ' HG12 ' A' ' 21' ' ' ILE . 0.6 OUTLIER -110.89 160.75 16.49 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.294 0.637 . . . . 0.0 112.577 -175.753 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -141.91 163.17 33.63 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.914 0.886 . . . . 0.0 110.22 157.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 54.8 tp -123.98 123.92 41.44 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.502 -1.374 . . . . 0.0 110.235 176.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 42.4 t -90.6 122.13 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -165.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 42.1 mm -124.1 84.31 55.39 Favored Pre-proline 0 N--CA 1.47 0.539 0 C-N-CA 126.196 1.798 . . . . 0.0 108.832 -172.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -66.83 -17.57 52.09 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.759 2.306 . . . . 0.0 113.752 -176.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -83.8 -32.78 25.16 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -174.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 80.9 p -140.74 -12.46 0.99 Allowed 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 -174.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 60.6 m80 56.23 26.23 10.15 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 -173.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.31 148.23 25.59 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 120.557 -1.34 . . . . 0.0 113.21 178.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -148.8 163.34 37.67 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.914 1.286 . . . . 0.0 112.211 -178.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.5 mp -112.67 137.73 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.864 0.866 . . . . 0.0 111.973 -176.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.89 157.34 51.77 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 125.38 1.472 . . . . 0.0 113.15 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.14 -17.87 50.78 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.549 2.833 . . . . 0.0 113.748 -176.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -74.58 -10.3 59.41 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 171.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 112.91 -24.66 12.6 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 125.743 1.64 . . . . 0.0 115.798 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.43 139.92 49.88 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.625 1.712 . . . . 0.0 113.799 -167.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 20.3 t -87.09 123.99 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.02 0.928 . . . . 0.0 110.958 173.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 33.5 mt -115.86 150.26 37.31 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.141 1.776 . . . . 0.0 111.709 -173.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -88.76 159.86 17.57 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.583 0.753 . . . . 0.0 110.79 170.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 . . . . . 0 CA--C 1.54 0.568 0 O-C-N 121.141 -0.974 . . . . 0.0 109.601 163.635 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -139.72 163.32 32.91 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.636 1.974 . . . . 0.0 111.082 -172.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.03 146.16 51.04 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.86 1.264 . . . . 0.0 113.383 -177.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -62.91 -19.88 64.63 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.929 1.292 . . . . 0.0 113.426 174.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -75.55 -10.44 59.45 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.248 1.819 . . . . 0.0 112.953 176.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.8 m -70.96 144.39 50.55 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 121.142 -0.974 . . . . 0.0 113.316 -175.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -91.72 150.88 20.9 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.055 1.742 . . . . 0.0 113.305 176.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.3 p -148.74 156.3 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 124.202 1.001 . . . . 0.0 113.484 -167.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -136.95 125.99 24.41 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.522 1.929 . . . . 0.0 109.042 -174.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -150.86 175.49 11.97 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 119.741 1.155 . . . . 0.0 113.154 -177.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -130.07 144.56 51.41 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.111 1.365 . . . . 0.0 112.933 171.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -161.97 162.43 29.0 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.749 2.02 . . . . 0.0 109.666 168.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.5 t0 53.77 28.74 8.61 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.372 1.469 . . . . 0.0 114.292 -177.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.8 m 59.33 38.0 23.23 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.431 1.892 . . . . 0.0 114.571 -172.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.6 p -151.98 140.63 13.66 Favored Pre-proline 0 CA--C 1.544 0.728 0 O-C-N 120.501 -1.375 . . . . 0.0 112.609 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -72.1 151.03 55.07 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 123.336 2.69 . . . . 0.0 113.106 175.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -134.44 140.63 46.39 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.281 2.232 . . . . 0.0 110.708 -176.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 36.7 ttm -141.75 121.9 13.83 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.396 1.078 . . . . 0.0 110.776 179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -163.83 -177.01 4.88 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.487 1.515 . . . . 0.0 112.983 -179.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.6 m -77.04 144.26 38.74 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.005 -1.06 . . . . 0.0 110.146 167.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.447 HG12 ' CG ' ' A' ' 152' ' ' TYR . 9.3 tp -57.31 -38.22 60.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -61.43 -24.18 66.36 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -76.5 -51.06 12.45 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.909 1.283 . . . . 0.0 110.862 175.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 19.9 ptm -68.86 -32.69 72.54 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.753 -0.592 . . . . 0.0 112.361 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -59.84 -51.04 71.44 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.216 0.606 . . . . 0.0 110.701 173.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.0 t -66.54 -34.86 78.85 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.412 0.551 . . . . 0.0 111.264 -176.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -61.12 -54.45 44.42 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.124 1.37 . . . . 0.0 110.305 174.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -70.68 -36.42 73.31 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.367 -0.833 . . . . 0.0 112.763 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.4 -33.01 74.75 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.971 0.908 . . . . 0.0 112.337 176.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.1 t -75.9 -32.27 59.57 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.923 0.889 . . . . 0.0 112.463 176.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 37.9 mtm -85.62 -47.21 10.05 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.308 1.443 . . . . 0.0 113.728 -177.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 48.3 m-20 -109.97 -20.39 12.75 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.49 1.516 . . . . 0.0 113.455 -171.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.13 163.97 39.52 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 122.247 0.915 . . . . 0.0 114.603 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -110.4 133.24 53.46 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.278 1.831 . . . . 0.0 110.175 -178.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.2 mp -116.05 146.92 38.16 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 126.79 2.036 . . . . 0.0 111.691 -176.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.65 141.55 19.73 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 124.589 3.526 . . . . 0.0 114.29 -173.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -133.97 166.18 23.31 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.669 1.988 . . . . 0.0 111.839 -177.101 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.45 -52.67 35.89 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.719 1.208 . . . . 0.0 114.036 -177.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -105.87 -4.78 20.33 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -173.25 -132.75 1.57 Allowed Glycine 0 CA--C 1.529 0.92 0 O-C-N 120.758 -1.214 . . . . 0.0 115.335 -174.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -141.04 153.58 45.57 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.266 1.427 . . . . 0.0 112.658 -173.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -132.59 153.84 50.63 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.389 1.476 . . . . 0.0 112.18 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.2 t -125.08 118.33 25.46 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 125.393 1.477 . . . . 0.0 110.86 177.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.57 136.88 24.32 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 124.521 3.481 . . . . 0.0 112.331 -175.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 70.6 mt -104.17 166.58 10.32 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.413 1.085 . . . . 0.0 112.514 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -141.45 118.68 11.38 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.519 1.928 . . . . 0.0 109.703 177.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 51.31 51.63 16.48 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 126.031 1.732 . . . . 0.0 114.095 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.1 t -113.54 133.06 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.761 1.224 . . . . 0.0 112.021 -177.113 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -127.94 157.29 40.97 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.882 1.273 . . . . 0.0 113.755 -175.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.2 m -144.11 164.12 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 127.46 2.304 . . . . 0.0 111.634 177.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.486 ' CE1' HG23 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -82.94 133.71 35.1 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.681 1.192 . . . . 0.0 110.102 171.461 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.2 t -131.8 153.62 49.94 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 127.395 2.278 . . . . 0.0 112.104 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 32.9 tp -106.09 133.61 50.53 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.177 0.991 . . . . 0.0 110.973 169.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -90.42 95.6 10.25 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.549 1.539 . . . . 0.0 111.501 175.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.4 mm -61.12 -18.75 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 124.8 1.24 . . . . 0.0 113.43 -174.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.56 -37.13 84.31 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.615 1.566 . . . . 0.0 114.334 172.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.6 p -127.56 -26.82 2.94 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.778 1.231 . . . . 0.0 113.545 -167.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.13 29.1 65.11 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.905 1.241 . . . . 0.0 113.38 -167.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -77.54 125.04 28.72 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.312 1.056 . . . . 0.0 110.615 167.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.486 HG23 ' CE1' ' A' ' 51' ' ' TYR . 1.9 mp -79.71 123.9 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 165.111 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -148.71 167.78 24.64 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -173.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -92.93 145.13 24.61 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.271 1.428 . . . . 0.0 110.005 174.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.5 t -144.49 155.43 43.7 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.522 1.129 . . . . 0.0 111.65 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.56 137.55 32.24 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.92 143.94 29.56 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.526 1.13 . . . . 0.0 110.666 171.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.6 t -99.2 -50.17 4.23 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.636 1.174 . . . . 0.0 112.885 -170.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -154.41 157.74 38.96 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.246 1.018 . . . . 0.0 112.286 176.012 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.7 mt -84.42 150.18 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 165.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -138.6 150.76 46.63 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.351 1.46 . . . . 0.0 111.731 -175.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -143.18 154.4 43.83 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 168.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -143.06 166.01 25.82 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.868 1.667 . . . . 0.0 109.789 172.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.7 tmtp? -100.68 136.57 40.34 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.209 0.603 . . . . 0.0 111.062 178.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.6 m -142.76 144.69 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 122.614 1.197 . . . . 0.0 111.021 178.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -93.5 -33.96 13.57 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 125.228 1.411 . . . . 0.0 111.148 173.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -121.17 137.35 54.71 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 124.418 1.087 . . . . 0.0 110.34 -173.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.4 tp -141.53 159.97 41.11 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 125.386 1.474 . . . . 0.0 109.191 -175.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.5 mt -109.36 124.25 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 175.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -93.5 125.92 38.36 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.891 0.877 . . . . 0.0 110.169 166.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.2 mp -110.84 124.84 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 124.512 1.125 . . . . 0.0 108.372 168.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -92.31 144.52 25.3 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.826 1.25 . . . . 0.0 110.202 173.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 59.9 mt -103.58 155.67 18.37 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 126.659 1.984 . . . . 0.0 110.263 178.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.8 t -66.37 -20.54 66.1 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.175 0.99 . . . . 0.0 112.949 -176.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 86.8 p -63.02 -18.48 63.38 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.111 1.765 . . . . 0.0 114.184 165.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 99.78 -7.35 59.19 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 126.254 1.883 . . . . 0.0 114.523 -174.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -86.18 171.12 11.55 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.475 1.51 . . . . 0.0 111.573 -178.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 95.2 p -142.81 157.6 44.46 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -177.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 14.3 tp -128.59 138.88 52.44 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.918 1.687 . . . . 0.0 109.969 171.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -120.78 116.97 26.26 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.242 1.417 . . . . 0.0 111.54 -176.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.4 m -140.21 153.29 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.058 1.343 . . . . 0.0 112.566 -164.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.9 p -67.79 146.68 98.48 Favored Pre-proline 0 N--CA 1.469 0.476 0 O-C-N 121.125 -0.985 . . . . 0.0 111.832 172.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -58.68 -18.69 41.97 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 124.279 3.319 . . . . 0.0 114.702 -175.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.7 p -88.81 -8.44 54.36 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.242 1.817 . . . . 0.0 114.987 177.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -71.61 120.96 82.97 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 119.526 1.057 . . . . 0.0 111.589 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -79.17 122.74 5.34 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.152 2.568 . . . . 0.0 112.537 176.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 40.1 t -93.72 141.17 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.927 1.691 . . . . 0.0 110.04 177.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 32.7 tp -80.01 104.65 10.73 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.518 0.599 . . . . 0.0 111.091 176.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -92.69 157.65 16.35 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.474 1.51 . . . . 0.0 112.323 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -121.17 71.1 0.94 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.684 0.754 . . . . 0.0 111.203 -177.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 73.0 mtp85 -119.65 74.08 0.99 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.651 1.18 . . . . 0.0 110.888 -169.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 58.22 6.07 0.49 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 127.337 2.255 . . . . 0.0 115.212 -166.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -178.35 157.9 22.16 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 125.693 1.616 . . . . 0.0 112.437 -177.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 48.4 mt -76.25 115.16 15.72 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.82 0.848 . . . . 0.0 109.871 177.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -146.0 141.74 27.96 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.946 0.898 . . . . 0.0 111.859 -173.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -101.32 111.82 24.16 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.777 0.831 . . . . 0.0 110.857 -175.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 54.1 t -117.85 127.78 26.41 Favored Pre-proline 0 N--CA 1.478 0.952 0 C-N-CA 123.953 0.901 . . . . 0.0 109.646 -173.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -64.44 143.79 83.41 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.192 1.928 . . . . 0.0 111.123 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.23 -31.63 21.4 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 175.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.17 -14.88 62.58 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 174.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -114.16 3.35 15.17 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.444 1.497 . . . . 0.0 112.22 175.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.2 t -78.2 149.06 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 125.185 1.394 . . . . 0.0 110.169 168.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.64 156.8 79.18 Favored Pre-proline 0 N--CA 1.47 0.527 0 C-N-CA 128.409 2.684 . . . . 0.0 108.857 178.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.401 ' HD3' HG22 ' A' ' 142' ' ' VAL . 60.5 Cg_endo -67.81 138.9 46.15 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.098 1.865 . . . . 0.0 111.765 -177.162 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 102.5 -1.6 49.65 Favored Glycine 0 N--CA 1.47 0.923 0 C-N-CA 124.452 1.025 . . . . 0.0 115.418 175.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.67 177.68 8.71 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 118.526 1.163 . . . . 0.0 114.116 176.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.3 p -122.54 122.5 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -168.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.8 t -102.84 144.05 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 127.426 2.29 . . . . 0.0 110.877 -177.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.8 t -89.17 142.95 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.472 1.109 . . . . 0.0 111.563 175.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -160.87 -152.48 6.61 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.369 0.985 . . . . 0.0 113.879 177.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.9 p -141.39 157.66 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.938 1.695 . . . . 0.0 110.058 172.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 . . . . . 0 N--CA 1.47 0.563 0 C-N-CA 123.995 0.918 . . . . 0.0 111.052 176.407 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 . . . . . 0 N--CA 1.481 1.117 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 89.7 mt -143.61 163.71 32.46 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.83 1.652 . . . . 0.0 113.15 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -131.94 171.87 13.04 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 128.214 2.605 . . . . 0.0 110.742 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -135.24 158.43 44.39 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.836 -1.165 . . . . 0.0 113.496 169.002 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -134.92 136.14 42.08 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.544 1.538 . . . . 0.0 109.975 -174.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -99.41 138.79 36.0 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.282 1.033 . . . . 0.0 112.019 -177.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 93.8 t -77.18 126.95 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 O-C-N 121.062 -1.024 . . . . 0.0 111.614 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 12.3 t -83.24 -44.7 14.68 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.559 1.944 . . . . 0.0 113.022 175.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 31.0 t -158.57 161.24 37.25 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.941 1.296 . . . . 0.0 110.039 -177.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.401 HG22 ' HD3' ' A' ' 112' ' ' PRO . 5.4 m -133.92 147.86 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.117 0.967 . . . . 0.0 110.306 166.129 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -154.87 154.58 32.91 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.417 0.687 . . . . 0.0 112.247 169.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 66.8 mt -86.06 135.01 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 165.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 23.6 pt -123.64 166.79 18.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 125.773 1.629 . . . . 0.0 111.305 -177.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -103.74 98.7 8.53 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.011 1.325 . . . . 0.0 110.975 175.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -80.47 -57.22 3.69 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.463 -0.773 . . . . 0.0 112.016 177.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 45.7 51.59 10.1 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.326 1.05 . . . . 0.0 112.135 -172.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -150.21 173.91 13.4 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.921 1.289 . . . . 0.0 111.651 174.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -71.06 136.76 48.47 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.06 0.944 . . . . 0.0 112.502 173.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.3 m -117.23 155.47 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 125.673 1.589 . . . . 0.0 110.093 174.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.447 ' CG ' HG12 ' A' ' 21' ' ' ILE . 0.7 OUTLIER -112.1 160.68 17.29 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -172.834 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -143.17 160.31 40.68 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.527 0.731 . . . . 0.0 110.34 156.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 56.0 tp -124.3 109.59 13.55 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.874 1.269 . . . . 0.0 110.106 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 85.8 t -83.79 123.54 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -159.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 11.6 mm -116.86 88.88 27.35 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.197 1.399 . . . . 0.0 110.33 -176.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -65.5 -16.44 53.96 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.871 2.381 . . . . 0.0 113.25 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -78.11 -45.51 23.18 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.016 -1.052 . . . . 0.0 113.19 178.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 76.8 p -140.54 -2.9 1.35 Allowed 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -171.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 42.0 m-70 59.23 7.09 0.82 Allowed 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -149.2 145.52 27.18 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 120.886 -1.134 . . . . 0.0 112.235 -175.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -146.23 151.5 37.68 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.759 1.224 . . . . 0.0 112.476 -176.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.9 mp -99.97 140.01 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.053 0.941 . . . . 0.0 111.789 -176.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -91.04 157.99 42.26 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 126.482 1.913 . . . . 0.0 112.949 176.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.99 -19.24 57.92 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.785 2.99 . . . . 0.0 113.487 -176.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -80.86 3.77 21.5 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.036 1.334 . . . . 0.0 113.682 174.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.89 -17.94 58.36 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 126.233 1.873 . . . . 0.0 116.029 175.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 54.8 mt -77.78 148.29 34.88 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.387 1.594 . . . . 0.0 112.899 -175.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.8 p -96.41 136.92 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.284 1.034 . . . . 0.0 112.394 174.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 40.5 mt -115.54 145.91 42.21 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 127.236 2.215 . . . . 0.0 110.155 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -134.43 130.0 36.13 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.802 1.241 . . . . 0.0 111.12 -174.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 12.4 m120 . . . . . 0 N--CA 1.475 0.806 0 C-N-CA 123.707 0.803 . . . . 0.0 112.374 -178.671 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 110.854 -0.054 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.44 159.0 43.19 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.36 1.464 . . . . 0.0 111.446 -168.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.22 147.74 46.91 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.879 0.872 . . . . 0.0 113.02 177.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -58.01 -23.9 56.01 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 174.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -82.96 0.54 44.1 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.3 m -72.74 142.46 48.15 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.356 -0.84 . . . . 0.0 112.407 176.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -79.89 158.61 26.65 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.08 -1.013 . . . . 0.0 113.38 169.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.6 p -147.98 157.13 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.887 0.875 . . . . 0.0 111.842 -174.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -126.51 135.84 51.83 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.358 1.863 . . . . 0.0 108.853 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -155.23 179.99 8.62 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.946 0.898 . . . . 0.0 112.057 174.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -135.31 143.21 46.06 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.732 1.213 . . . . 0.0 109.618 171.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -156.66 152.68 27.43 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.385 1.474 . . . . 0.0 109.221 178.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.1 t0 53.94 35.06 20.96 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.669 1.122 . . . . 0.0 113.304 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.0 m 53.8 37.61 26.75 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.736 1.615 . . . . 0.0 114.241 -172.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.3 p -148.7 138.57 12.81 Favored Pre-proline 0 CA--C 1.549 0.924 0 O-C-N 120.033 -1.667 . . . . 0.0 112.131 177.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.42 153.88 69.87 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.756 2.971 . . . . 0.0 113.187 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 47.0 m80 -138.78 138.91 38.04 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.189 2.196 . . . . 0.0 110.464 -175.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 40.1 ttm -152.96 114.67 4.29 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.536 1.134 . . . . 0.0 110.987 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -160.26 -179.49 7.77 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.976 1.31 . . . . 0.0 111.661 -175.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 m -67.43 138.3 56.54 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.065 -1.022 . . . . 0.0 110.135 169.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.9 tp -58.03 -36.44 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 121.256 -0.903 . . . . 0.0 112.269 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -61.72 -23.02 65.87 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.521 0.729 . . . . 0.0 112.909 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -83.4 -49.39 9.38 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.657 0.783 . . . . 0.0 110.014 177.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -66.02 -34.66 78.6 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.586 -0.696 . . . . 0.0 112.336 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -59.75 -51.81 68.16 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.769 0.828 . . . . 0.0 111.346 169.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.6 t -61.3 -36.13 79.24 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.514 0.726 . . . . 0.0 111.266 -178.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -63.46 -55.74 21.73 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.494 1.517 . . . . 0.0 111.206 172.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -72.15 -32.47 66.91 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 121.147 -0.971 . . . . 0.0 112.68 -173.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.43 -28.93 68.99 Favored 'General case' 0 CA--C 1.551 1.014 0 O-C-N 121.498 -0.752 . . . . 0.0 112.347 171.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.4 t -83.01 -25.64 31.98 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.841 1.256 . . . . 0.0 112.993 175.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 50.7 mtm -88.85 -48.19 7.65 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.859 1.263 . . . . 0.0 113.446 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 -110.55 -20.73 12.46 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.325 1.45 . . . . 0.0 113.681 -170.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.99 159.54 35.45 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.626 1.108 . . . . 0.0 114.853 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -103.36 131.02 50.78 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.772 1.229 . . . . 0.0 110.479 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.3 mp -110.12 142.57 26.21 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 126.447 1.899 . . . . 0.0 110.271 175.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.12 159.0 44.94 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.687 2.925 . . . . 0.0 111.366 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -140.13 173.07 11.88 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.239 1.415 . . . . 0.0 111.505 -176.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -55.31 -57.16 12.96 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.413 1.085 . . . . 0.0 113.014 176.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -105.08 -0.01 27.11 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -172.41 -128.44 1.05 Allowed Glycine 0 CA--C 1.536 1.379 0 N-CA-C 115.982 1.153 . . . . 0.0 115.982 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -137.51 161.29 36.79 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 126.623 1.969 . . . . 0.0 110.772 175.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.87 159.45 42.16 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.323 1.449 . . . . 0.0 112.148 177.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 98.1 t -128.48 117.89 20.05 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 125.972 1.709 . . . . 0.0 109.498 174.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.24 142.14 54.33 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 124.065 3.177 . . . . 0.0 111.456 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 74.3 mt -118.13 152.67 35.17 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.398 1.079 . . . . 0.0 112.855 175.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -137.42 125.23 22.51 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.385 1.874 . . . . 0.0 110.167 178.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 51.63 54.85 10.28 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.145 0.978 . . . . 0.0 112.286 -174.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.4 t -123.22 119.23 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 124.603 1.161 . . . . 0.0 109.632 173.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -113.16 158.94 19.79 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.577 1.551 . . . . 0.0 112.642 -176.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.0 m -140.64 152.25 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 126.113 1.765 . . . . 0.0 111.609 170.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -65.58 130.47 43.43 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.495 0.718 . . . . 0.0 109.139 163.245 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.0 t -133.48 148.07 51.7 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.514 1.926 . . . . 0.0 110.786 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 45.3 tp -99.53 140.17 34.11 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.768 0.827 . . . . 0.0 111.542 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -85.81 117.79 24.9 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.133 -0.979 . . . . 0.0 110.488 158.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.0 mm -74.45 -22.53 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 CA-C-N 119.084 0.856 . . . . 0.0 112.19 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.64 -33.52 64.56 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -173.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.2 m -121.45 -10.95 8.8 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.931 1.292 . . . . 0.0 112.919 169.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.51 39.46 56.42 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 -173.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -97.53 138.02 35.59 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.153 1.781 . . . . 0.0 111.715 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.1 mp -91.62 130.9 40.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 124.549 1.14 . . . . 0.0 109.669 -177.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -152.6 171.34 18.3 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.612 1.165 . . . . 0.0 111.509 -177.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -106.08 150.45 25.76 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.479 1.112 . . . . 0.0 111.242 176.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.8 t -139.58 153.11 47.33 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.466 1.106 . . . . 0.0 110.977 170.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 72.4 mtt85 -87.01 133.5 33.58 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.914 0.885 . . . . 0.0 110.303 172.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -87.12 149.64 24.54 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.196 0.998 . . . . 0.0 111.733 176.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.7 t -88.76 -54.19 4.27 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.834 1.254 . . . . 0.0 112.508 -169.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -157.63 160.03 37.63 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.672 1.589 . . . . 0.0 111.028 178.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.0 mt -84.8 150.42 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 162.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -139.76 152.42 46.59 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.529 1.531 . . . . 0.0 111.099 -176.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.8 ptt-85 -139.74 152.44 46.63 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.058 0.943 . . . . 0.0 113.321 166.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -146.41 168.93 19.93 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.811 2.045 . . . . 0.0 110.115 175.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -112.11 136.92 50.88 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 120.661 -1.274 . . . . 0.0 112.859 -170.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.2 m -144.51 142.04 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 122.796 1.284 . . . . 0.0 113.327 -176.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -97.63 -28.61 13.85 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 127.196 2.199 . . . . 0.0 111.745 178.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -120.85 127.92 52.35 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.606 1.562 . . . . 0.0 110.646 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.4 tp -136.95 161.26 36.53 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.469 1.508 . . . . 0.0 110.115 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.4 mt -117.7 126.0 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.356 1.062 . . . . 0.0 109.455 177.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 68.7 tt0 -100.09 117.15 33.73 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.156 0.982 . . . . 0.0 111.876 169.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.7 mp -108.42 129.26 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.365 1.466 . . . . 0.0 109.415 175.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -96.88 148.68 22.69 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.937 1.695 . . . . 0.0 111.4 176.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 59.6 mt -116.67 165.32 13.41 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.933 1.693 . . . . 0.0 112.483 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.6 t -71.06 -13.28 61.92 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 77.8 p -70.76 -15.58 62.69 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 120.428 -1.42 . . . . 0.0 113.59 165.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.49 -1.93 84.43 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.085 1.326 . . . . 0.0 114.178 -170.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -72.33 153.7 41.35 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.702 1.251 . . . . 0.0 110.605 174.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 95.1 p -130.01 143.23 50.69 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 167.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.2 tp -113.06 135.86 53.33 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.414 1.486 . . . . 0.0 109.768 173.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -115.25 110.85 20.05 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.28 1.832 . . . . 0.0 110.176 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.3 m -137.23 158.84 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.37 1.068 . . . . 0.0 113.083 -168.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.0 p -68.99 146.76 97.55 Favored Pre-proline 0 N--CA 1.467 0.413 0 O-C-N 121.692 -0.63 . . . . 0.0 112.541 175.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.52 -30.69 86.76 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.776 2.317 . . . . 0.0 113.294 -171.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.0 p -77.3 -7.09 55.44 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.367 1.867 . . . . 0.0 114.649 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -73.31 116.95 56.15 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 119.936 1.244 . . . . 0.0 112.97 -174.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -76.07 135.45 17.18 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.899 2.399 . . . . 0.0 113.782 178.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.5 t -118.91 143.81 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 126.655 1.982 . . . . 0.0 108.953 176.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 17.3 tp -82.51 114.57 21.01 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.569 -0.707 . . . . 0.0 110.44 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.5 mp -115.86 159.78 21.06 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.675 1.99 . . . . 0.0 111.499 -176.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -112.72 101.84 9.92 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.875 0.87 . . . . 0.0 113.073 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 68.9 mtp85 -125.82 81.56 1.99 Allowed 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 122.426 1.108 . . . . 0.0 108.799 174.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 59.79 -4.39 0.1 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 128.388 2.675 . . . . 0.0 115.282 -167.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -168.06 170.73 42.13 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 128.701 3.048 . . . . 0.0 111.242 -175.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 62.8 mt -83.57 115.21 22.01 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.395 1.478 . . . . 0.0 111.83 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -128.84 137.15 51.32 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.837 1.255 . . . . 0.0 112.107 -171.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -87.9 110.34 20.47 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.504 0.322 . . . . 0.0 111.413 172.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 52.3 t -121.56 126.34 26.49 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 124.723 1.209 . . . . 0.0 109.892 -172.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -66.96 149.48 82.91 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.576 2.184 . . . . 0.0 111.837 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.79 -31.21 26.19 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.19 -21.47 66.77 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 172.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -99.7 -6.76 26.58 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.048 1.739 . . . . 0.0 112.575 172.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.1 t -73.39 142.42 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 O-C-N 121.041 -1.037 . . . . 0.0 110.125 171.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.32 155.75 67.63 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 127.549 2.34 . . . . 0.0 110.197 -175.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.9 123.37 10.31 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.992 1.794 . . . . 0.0 111.891 -170.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 103.91 1.68 45.67 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.636 1.113 . . . . 0.0 114.738 -175.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -58.65 155.41 12.62 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.468 1.134 . . . . 0.0 113.148 170.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.3 p -107.55 119.21 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 126.243 1.817 . . . . 0.0 111.055 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 38.7 t -113.04 134.33 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 125.92 1.688 . . . . 0.0 110.927 -167.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.7 t -88.44 134.92 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 O-C-N 121.267 -0.896 . . . . 0.0 111.376 -172.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -169.12 -147.16 5.31 Favored Glycine 0 CA--C 1.529 0.935 0 O-C-N 121.796 -0.565 . . . . 0.0 112.872 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.2 p -135.58 161.31 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 127.384 2.274 . . . . 0.0 108.475 171.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 68.8 mtp85 . . . . . 0 N--CA 1.469 0.521 0 O-C-N 121.73 -0.606 . . . . 0.0 110.775 173.65 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 . . . . . 0 CA--C 1.541 0.628 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 96.8 mt -138.07 166.49 23.97 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 127.013 2.125 . . . . 0.0 112.136 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -154.38 148.43 25.75 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.463 1.905 . . . . 0.0 111.084 167.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -94.62 143.42 26.45 Favored 'General case' 0 CA--C 1.548 0.87 0 O-C-N 120.889 -1.132 . . . . 0.0 112.423 172.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -122.63 160.27 26.13 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.495 1.918 . . . . 0.0 110.926 -170.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -111.33 130.11 55.78 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -168.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 84.4 t -73.01 136.67 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 121.599 0.714 . . . . 0.0 110.674 171.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 12.3 t -94.42 -49.54 5.64 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.966 2.106 . . . . 0.0 112.537 176.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.4 t -157.48 162.06 38.89 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.216 1.006 . . . . 0.0 111.433 -176.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.7 m -135.19 148.34 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 124.435 1.094 . . . . 0.0 112.066 172.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -152.47 155.18 36.99 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.659 1.183 . . . . 0.0 112.914 170.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 89.2 mt -91.79 133.39 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.359 1.064 . . . . 0.0 108.642 167.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 44.3 pt -126.78 154.28 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 126.09 1.756 . . . . 0.0 111.83 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -96.26 98.91 10.67 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.393 0.677 . . . . 0.0 109.71 178.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -78.62 -53.06 7.58 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 51.88 36.65 18.71 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.648 1.179 . . . . 0.0 113.26 -174.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -144.16 171.7 13.93 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 120.888 -1.132 . . . . 0.0 111.464 -173.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -77.39 134.49 38.42 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.566 1.146 . . . . 0.0 111.794 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 14.1 m -117.64 152.46 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 125.704 1.602 . . . . 0.0 109.993 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -106.56 160.48 15.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.686 0.755 . . . . 0.0 112.942 -173.255 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.35 140.24 27.57 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.482 1.113 . . . . 0.0 109.098 166.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 64.9 tp -109.33 115.93 30.91 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 120.456 -1.403 . . . . 0.0 110.129 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 57.3 t -86.24 123.07 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -158.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 42.6 mm -118.4 92.32 43.08 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 126.569 1.948 . . . . 0.0 109.451 -176.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.88 -18.99 41.04 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 123.071 2.514 . . . . 0.0 113.736 176.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -78.74 -50.83 10.7 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 120.207 1.367 . . . . 0.0 112.81 -174.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 76.9 p -128.6 -7.01 5.15 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.496 1.518 . . . . 0.0 114.417 -169.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 74.9 m-70 57.22 19.49 4.95 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -170.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -140.9 149.61 42.13 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 120.892 1.678 . . . . 0.0 114.136 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -141.52 154.63 45.61 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.232 1.013 . . . . 0.0 111.316 168.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.4 mp -102.46 132.45 48.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.118 0.967 . . . . 0.0 110.926 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.46 158.79 62.78 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.62 1.168 . . . . 0.0 112.518 175.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.44 -16.82 52.41 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.227 2.618 . . . . 0.0 113.274 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 33.0 p30 -70.07 -2.26 12.32 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 124.702 1.201 . . . . 0.0 113.565 169.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.33 -10.95 69.32 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 126.831 2.157 . . . . 0.0 115.893 176.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 52.4 mt -96.34 150.28 20.75 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 120.317 2.059 . . . . 0.0 113.663 -169.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.2 p -97.54 133.16 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.261 1.024 . . . . 0.0 113.023 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 31.7 mt -119.46 132.81 55.86 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.03 1.732 . . . . 0.0 111.112 -169.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -88.42 118.44 28.05 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.056 0.843 . . . . 0.0 111.937 175.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 . . . . . 0 CA--C 1.545 0.77 0 O-C-N 120.949 -1.095 . . . . 0.0 113.393 -172.039 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.687 0 CA-C-O 120.897 0.38 . . . . 0.0 111.572 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.61 161.56 38.18 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.657 1.583 . . . . 0.0 110.724 -169.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.81 141.03 50.31 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.511 1.124 . . . . 0.0 112.949 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.02 -22.48 49.93 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.511 1.524 . . . . 0.0 114.198 176.096 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -78.39 -17.31 56.62 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 177.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.6 m -58.6 136.75 57.69 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 119.347 0.976 . . . . 0.0 113.504 -169.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.33 150.65 47.1 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.12 0.968 . . . . 0.0 113.378 175.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.2 p -146.06 155.67 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.894 1.277 . . . . 0.0 112.141 -171.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -128.98 137.62 51.47 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.449 1.9 . . . . 0.0 108.744 176.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -153.83 168.39 26.49 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.214 0.916 . . . . 0.0 113.256 168.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -130.13 146.02 51.75 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.309 1.443 . . . . 0.0 111.026 177.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -163.0 145.03 10.17 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.217 1.407 . . . . 0.0 109.151 174.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.3 t70 53.76 39.02 29.78 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.349 1.059 . . . . 0.0 113.033 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.2 m 67.41 16.3 10.0 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.331 1.852 . . . . 0.0 114.979 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.0 p -133.67 133.47 22.48 Favored Pre-proline 0 CA--C 1.554 1.1 0 O-C-N 120.175 -1.578 . . . . 0.0 113.229 -177.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -85.72 153.06 10.14 Favored 'Trans proline' 0 CA--C 1.539 0.742 1 C-N-CA 125.593 4.195 . . . . 0.0 114.713 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -135.42 144.87 46.74 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.353 2.261 . . . . 0.0 111.156 -178.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 50.7 ttm -149.37 111.23 4.57 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.784 0.834 . . . . 0.0 110.904 -176.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -158.98 -168.8 2.47 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.81 1.244 . . . . 0.0 112.302 -169.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.4 m -85.71 143.99 28.05 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.098 -1.001 . . . . 0.0 111.36 166.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.43 HG12 ' CG ' ' A' ' 152' ' ' TYR . 8.4 tp -56.81 -38.23 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -177.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -61.75 -22.58 65.52 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.608 0.763 . . . . 0.0 112.848 179.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -80.41 -49.4 11.51 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.302 1.041 . . . . 0.0 111.235 176.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 19.3 ptm -65.77 -31.48 72.49 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 122.062 -0.399 . . . . 0.0 111.589 176.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -57.92 -51.63 68.81 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.603 0.638 . . . . 0.0 111.031 172.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.9 t -67.68 -29.98 69.39 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.148 0.579 . . . . 0.0 111.679 -177.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -66.71 -53.19 36.13 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.323 1.449 . . . . 0.0 111.04 172.194 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -71.72 -30.82 66.05 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.004 -1.06 . . . . 0.0 112.805 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.48 -31.36 71.46 Favored 'General case' 0 CA--C 1.552 1.054 0 O-C-N 121.51 -0.744 . . . . 0.0 111.992 171.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.0 t -80.07 -22.74 41.93 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 120.668 -1.27 . . . . 0.0 113.095 174.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 55.9 mtm -92.13 -49.7 6.06 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.543 1.137 . . . . 0.0 113.43 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -109.21 -24.09 11.29 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.356 1.462 . . . . 0.0 112.612 -169.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 87.26 164.5 40.2 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 125.556 1.551 . . . . 0.0 114.787 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -109.18 143.57 38.42 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.969 1.308 . . . . 0.0 111.392 -173.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.4 mp -117.33 140.72 27.64 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 126.146 1.778 . . . . 0.0 111.181 172.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.25 141.77 18.56 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 124.469 3.446 . . . . 0.0 111.784 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -126.36 156.16 40.92 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.632 1.573 . . . . 0.0 111.459 -177.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.87 -46.92 16.09 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.387 1.475 . . . . 0.0 114.056 178.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -97.73 -16.58 19.84 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 176.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.26 -126.83 0.95 Allowed Glycine 0 CA--C 1.538 1.504 0 N-CA-C 116.585 1.394 . . . . 0.0 116.585 -168.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -144.54 155.08 43.5 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.61 1.564 . . . . 0.0 112.538 -178.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.48 154.73 50.67 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.759 1.224 . . . . 0.0 113.15 175.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.9 t -130.45 115.75 17.3 Favored Pre-proline 0 N--CA 1.481 1.097 0 C-N-CA 126.125 1.77 . . . . 0.0 110.606 177.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.52 138.64 27.24 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 125.057 3.838 . . . . 0.0 112.52 -176.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.8 mt -112.69 160.98 17.38 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.874 1.27 . . . . 0.0 113.125 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -146.34 128.29 15.48 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.606 1.162 . . . . 0.0 111.349 168.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 55.39 40.39 31.36 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.6 1.56 . . . . 0.0 113.839 -173.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.4 t -107.71 113.3 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 O-C-N 121.109 -0.994 . . . . 0.0 109.346 175.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -113.79 152.0 31.23 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.144 1.378 . . . . 0.0 113.59 -166.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.0 m -143.18 154.35 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 127.119 2.168 . . . . 0.0 111.119 175.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.487 ' CE1' HG23 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -72.08 135.67 46.36 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.744 0.818 . . . . 0.0 109.873 166.541 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.0 t -133.35 153.49 51.54 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.131 1.772 . . . . 0.0 112.842 -179.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 50.3 tp -100.13 133.89 43.86 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.512 1.125 . . . . 0.0 109.861 168.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -84.59 119.39 25.15 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.94 1.296 . . . . 0.0 110.407 164.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.8 mm -76.38 -19.48 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 119.569 1.077 . . . . 0.0 112.265 -179.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.44 -41.03 48.88 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -174.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.3 m -110.57 -11.76 14.42 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.695 1.198 . . . . 0.0 112.814 172.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.5 36.82 68.93 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-N 118.42 0.555 . . . . 0.0 112.037 -173.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -96.69 136.8 36.71 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.222 1.809 . . . . 0.0 111.769 -175.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.487 HG23 ' CE1' ' A' ' 51' ' ' TYR . 1.9 mp -85.84 130.6 36.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 124.504 1.121 . . . . 0.0 107.992 172.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.3 pttt -154.91 168.46 26.85 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.803 1.241 . . . . 0.0 112.913 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -89.56 146.7 24.4 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.574 0.749 . . . . 0.0 111.183 172.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.7 t -143.25 164.13 31.06 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.108 0.963 . . . . 0.0 111.645 172.204 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -99.88 142.85 30.81 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.241 1.016 . . . . 0.0 112.077 174.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.73 137.39 32.37 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.262 0.625 . . . . 0.0 110.109 167.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 22.8 t -86.97 -46.38 9.91 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.427 1.491 . . . . 0.0 112.334 -172.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -152.89 155.45 37.06 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.618 0.723 . . . . 0.0 112.356 174.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.9 mt -85.12 147.36 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 163.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -136.25 147.78 47.72 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 125.747 1.619 . . . . 0.0 110.839 -175.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 30.6 ptt-85 -143.92 153.95 42.82 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.052 0.941 . . . . 0.0 113.424 167.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -154.82 172.43 18.0 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.846 1.259 . . . . 0.0 110.728 169.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -95.39 147.27 23.7 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.646 0.778 . . . . 0.0 111.943 177.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.1 m -143.74 144.55 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 125.18 1.392 . . . . 0.0 110.481 171.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -94.18 -29.05 15.32 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 124.888 1.275 . . . . 0.0 111.469 175.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -121.01 134.27 55.29 Favored 'General case' 0 C--N 1.344 0.358 0 C-N-CA 125.17 1.388 . . . . 0.0 109.416 -176.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.5 tp -143.53 159.69 41.96 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.164 1.386 . . . . 0.0 109.966 -177.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.6 mt -111.21 128.49 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 O-C-N 121.246 -0.909 . . . . 0.0 109.632 177.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -102.67 112.98 26.0 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.363 1.465 . . . . 0.0 110.261 173.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.2 mp -106.92 131.13 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.608 1.163 . . . . 0.0 109.376 174.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.2 tttt -100.96 147.63 25.94 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.678 1.591 . . . . 0.0 111.51 175.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 61.5 mt -107.75 164.39 12.28 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 126.83 2.052 . . . . 0.0 111.195 -178.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.7 t -75.02 -1.53 23.18 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -178.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.8 p -79.06 -15.09 58.68 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.954 1.702 . . . . 0.0 113.766 160.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.78 -3.63 84.89 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 125.73 1.633 . . . . 0.0 114.199 -169.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -74.54 151.37 39.48 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.451 1.625 . . . . 0.0 111.45 177.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.7 p -128.68 138.63 52.26 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 178.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 14.7 tp -117.01 140.02 49.98 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.995 1.718 . . . . 0.0 110.538 177.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.6 mtmm -118.49 116.38 26.55 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.687 1.195 . . . . 0.0 112.402 -175.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.1 m -141.61 152.49 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 125.204 1.402 . . . . 0.0 113.031 -163.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.7 p -68.39 148.3 98.18 Favored Pre-proline 0 N--CA 1.474 0.73 0 O-C-N 121.031 -1.043 . . . . 0.0 112.433 174.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.79 -17.63 60.31 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.594 2.862 . . . . 0.0 113.728 -175.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 36.3 p -86.35 -10.94 53.4 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.949 2.1 . . . . 0.0 114.48 176.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -72.46 122.17 86.76 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-N 119.699 1.136 . . . . 0.0 111.736 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -80.35 125.06 5.57 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 123.711 2.941 . . . . 0.0 113.113 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.3 t -94.52 141.09 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.686 1.595 . . . . 0.0 109.848 175.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 17.4 tp -83.86 107.23 16.13 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.103 0.561 . . . . 0.0 110.664 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.9 mp -100.15 144.34 29.3 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.756 1.622 . . . . 0.0 111.755 -176.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -104.29 90.23 3.49 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.933 0.893 . . . . 0.0 112.244 -177.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 46.6 mtm180 -133.91 81.43 1.92 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.865 0.866 . . . . 0.0 110.841 -177.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.7 t70 66.3 -17.94 0.11 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 128.09 2.556 . . . . 0.0 115.888 -167.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.48 167.26 39.87 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 126.171 1.843 . . . . 0.0 113.258 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 77.3 mt -62.94 113.83 3.31 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.493 1.917 . . . . 0.0 111.392 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -141.94 142.83 33.03 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.646 0.778 . . . . 0.0 112.847 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -97.56 122.14 40.28 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.877 1.271 . . . . 0.0 110.768 -175.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 71.2 t -128.45 126.69 23.57 Favored Pre-proline 0 N--CA 1.477 0.914 0 C-N-CA 124.289 1.036 . . . . 0.0 110.007 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -64.71 148.65 90.3 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.301 2.001 . . . . 0.0 112.014 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.59 -31.98 17.42 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 173.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.93 -17.89 63.68 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 173.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -111.82 -0.61 15.84 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.568 1.547 . . . . 0.0 112.989 174.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 71.3 t -72.12 148.67 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 120.679 -1.263 . . . . 0.0 110.833 171.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.96 157.09 75.36 Favored Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 127.369 2.268 . . . . 0.0 111.129 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.59 113.42 3.16 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.715 2.277 . . . . 0.0 112.003 -175.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 111.91 6.09 24.87 Favored Glycine 0 CA--C 1.537 1.449 0 CA-C-O 118.691 -1.061 . . . . 0.0 115.264 -175.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -62.86 161.31 12.95 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 118.946 1.373 . . . . 0.0 112.403 163.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 5.8 p -109.45 129.52 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.384 1.474 . . . . 0.0 111.747 178.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.1 t -107.55 137.07 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 126.729 2.012 . . . . 0.0 110.2 -175.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 51.8 t -87.25 134.39 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.744 0.817 . . . . 0.0 110.31 172.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -157.82 -153.91 6.91 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.53 1.062 . . . . 0.0 112.49 176.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.1 p -145.22 176.86 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 126.415 1.886 . . . . 0.0 108.492 174.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 . . . . . 0 N--CA 1.468 0.464 0 O-C-N 121.071 -1.018 . . . . 0.0 113.067 175.685 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 . . . . . 0 CA--C 1.539 0.537 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 89.9 mt -131.04 165.21 23.71 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.858 2.063 . . . . 0.0 111.741 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -131.59 157.17 44.36 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.739 1.616 . . . . 0.0 110.912 173.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -113.28 142.89 45.3 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.608 1.163 . . . . 0.0 111.587 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -133.54 156.24 48.15 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.606 1.562 . . . . 0.0 110.544 -173.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 57.4 tt0 -114.68 137.79 51.48 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.128 -0.983 . . . . 0.0 112.288 -170.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 92.2 t -73.79 133.32 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 122.003 0.906 . . . . 0.0 110.622 173.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 27.5 t -87.11 -59.64 2.2 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.941 1.697 . . . . 0.0 111.748 173.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 59.2 m -149.61 158.88 44.58 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.259 1.424 . . . . 0.0 110.901 -170.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.2 m -136.37 152.86 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 124.126 0.97 . . . . 0.0 111.925 173.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 9.4 ptp85 -158.14 159.48 36.24 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.74 1.216 . . . . 0.0 112.684 168.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 76.3 mt -99.03 129.92 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.935 0.894 . . . . 0.0 109.211 170.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 13.2 pt -121.15 156.58 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.574 1.55 . . . . 0.0 111.908 -174.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -92.7 97.96 11.11 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.754 0.787 . . . . 0.0 110.957 170.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -76.63 -47.89 20.8 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 44.39 39.46 3.13 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.576 1.15 . . . . 0.0 113.826 -174.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 -144.31 174.71 10.67 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.17 0.988 . . . . 0.0 111.392 -174.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -77.27 137.88 39.06 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 124.588 1.155 . . . . 0.0 112.466 -177.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.2 m -119.8 152.74 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 125.084 1.353 . . . . 0.0 109.97 176.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.43 ' CG ' HG12 ' A' ' 21' ' ' ILE . 1.4 p90 -112.1 160.53 17.45 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.08 0.952 . . . . 0.0 112.278 -178.194 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -141.3 156.06 45.9 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.052 0.541 . . . . 0.0 110.069 156.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 65.2 tp -128.69 103.0 6.83 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.767 1.227 . . . . 0.0 110.051 -175.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 87.8 t -86.63 124.12 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -151.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 20.8 mm -110.71 98.27 36.78 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 125.27 1.428 . . . . 0.0 109.681 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.5 -16.73 38.81 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.512 2.142 . . . . 0.0 113.193 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -74.51 -61.28 1.92 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.784 0.834 . . . . 0.0 112.363 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 54.9 p -122.82 -7.95 8.43 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -171.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 61.37 15.38 6.5 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.086 1.754 . . . . 0.0 115.657 -175.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.81 148.52 30.03 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.082 -1.011 . . . . 0.0 113.532 -178.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -145.9 158.93 43.84 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.746 1.218 . . . . 0.0 112.385 177.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.3 mp -102.39 137.22 31.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 123.975 0.91 . . . . 0.0 111.377 -177.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -88.56 160.24 45.1 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 125.938 1.695 . . . . 0.0 113.088 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.36 -19.46 61.62 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.299 2.666 . . . . 0.0 113.989 -176.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 50.6 p30 -86.18 -2.26 58.2 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.961 1.304 . . . . 0.0 113.551 175.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 102.12 -15.04 56.88 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 126.628 2.061 . . . . 0.0 116.756 173.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 66.7 mt -74.09 145.39 44.43 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.425 1.613 . . . . 0.0 111.965 -178.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.1 p -91.36 135.76 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.528 0.731 . . . . 0.0 111.304 171.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 39.6 mt -113.61 142.09 46.41 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.156 1.783 . . . . 0.0 109.792 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -127.54 127.01 43.22 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.279 1.432 . . . . 0.0 110.146 -177.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 21.2 m120 . . . . . 0 CA--C 1.543 0.686 0 C-N-CA 123.912 0.885 . . . . 0.0 112.696 -174.24 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.566 0 CA-C-O 120.62 0.248 . . . . 0.0 111.504 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.54 156.99 47.01 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.247 1.419 . . . . 0.0 111.063 -170.155 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.54 143.97 33.4 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.346 1.458 . . . . 0.0 113.901 -178.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -61.11 -26.09 67.43 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.494 1.117 . . . . 0.0 113.241 174.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -83.03 -1.46 52.73 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.312 1.045 . . . . 0.0 113.803 176.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.4 m -68.59 143.51 54.83 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 119.845 1.202 . . . . 0.0 111.77 174.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -74.68 159.22 32.34 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.205 -0.934 . . . . 0.0 112.817 167.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 p -149.0 156.26 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.049 0.94 . . . . 0.0 111.867 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -121.26 141.8 50.55 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.638 1.975 . . . . 0.0 108.134 176.155 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -156.44 -178.28 7.22 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.666 0.786 . . . . 0.0 111.128 164.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -136.6 143.13 43.41 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.564 1.545 . . . . 0.0 110.216 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -154.96 -45.68 0.08 Allowed 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 174.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -83.24 37.1 0.54 Allowed 'General case' 0 N--CA 1.481 1.097 0 O-C-N 120.65 -1.281 . . . . 0.0 112.857 -175.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.2 m 61.0 24.92 14.99 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 126.007 1.723 . . . . 0.0 112.915 -167.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.2 p -158.61 149.89 16.57 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 126.412 1.885 . . . . 0.0 109.276 -170.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.45 160.53 32.05 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.974 3.116 . . . . 0.0 114.306 176.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -140.48 151.16 44.6 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 128.029 2.532 . . . . 0.0 110.561 -173.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 34.8 ttm -149.48 126.14 11.03 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.485 -0.759 . . . . 0.0 112.148 177.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -160.89 -178.17 6.64 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.528 1.531 . . . . 0.0 111.75 178.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.52 143.12 51.76 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 121.017 -1.052 . . . . 0.0 109.433 171.373 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.45 HG12 ' CG ' ' A' ' 152' ' ' TYR . 8.1 tp -56.55 -38.54 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 O-C-N 121.24 -0.913 . . . . 0.0 112.002 179.019 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -60.56 -24.51 65.47 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.359 0.982 . . . . 0.0 112.566 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -81.6 -46.95 13.68 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.499 1.12 . . . . 0.0 111.402 179.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -70.71 -34.07 71.54 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.441 -0.787 . . . . 0.0 111.6 176.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -58.58 -52.6 64.99 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 124.196 0.998 . . . . 0.0 110.591 172.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.8 t -67.58 -30.4 70.01 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 122.661 0.384 . . . . 0.0 111.043 -174.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -64.69 -52.91 54.69 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.043 1.337 . . . . 0.0 110.969 172.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -71.57 -31.01 66.5 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.074 -1.016 . . . . 0.0 113.14 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.93 -30.44 67.84 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.99 0.916 . . . . 0.0 111.305 172.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.4 m -74.21 -35.21 63.89 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 120.398 -1.439 . . . . 0.0 112.081 172.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 42.5 mtm -86.79 -42.95 12.88 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.366 1.066 . . . . 0.0 113.664 -173.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -114.55 -21.16 10.43 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.803 1.241 . . . . 0.0 112.639 -171.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.95 155.64 21.69 Favored Glycine 0 C--N 1.341 0.816 0 C-N-CA 125.441 1.496 . . . . 0.0 114.38 176.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -98.15 139.15 34.38 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.404 1.081 . . . . 0.0 110.645 -177.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.4 mp -106.86 143.91 28.01 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 127.331 2.252 . . . . 0.0 110.89 175.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.52 145.97 34.15 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.905 3.07 . . . . 0.0 112.415 176.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -142.12 157.52 44.79 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.856 1.662 . . . . 0.0 111.322 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.14 -52.66 58.01 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 120.63 -1.294 . . . . 0.0 113.997 -177.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -84.53 -16.0 43.84 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 176.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -178.65 -131.82 1.63 Allowed Glycine 0 CA--C 1.53 1.002 0 N-CA-C 115.626 1.01 . . . . 0.0 115.626 -165.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -143.59 159.3 42.69 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.284 1.434 . . . . 0.0 111.803 -178.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.06 149.4 45.97 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.862 1.265 . . . . 0.0 112.853 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.4 t -125.63 113.37 25.14 Favored Pre-proline 0 N--CA 1.484 1.263 0 C-N-CA 125.472 1.509 . . . . 0.0 111.933 177.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -68.73 134.72 31.0 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 124.235 3.29 . . . . 0.0 111.02 178.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 96.9 mt -99.65 164.25 12.14 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.884 1.274 . . . . 0.0 112.665 -177.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -133.71 120.65 20.86 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.224 1.01 . . . . 0.0 110.514 172.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 48.15 42.47 17.31 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.342 1.457 . . . . 0.0 113.593 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 97.7 t -100.88 123.76 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 O-C-N 121.488 -0.757 . . . . 0.0 109.734 178.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -126.23 161.18 28.32 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.419 1.088 . . . . 0.0 112.99 -172.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.8 m -148.09 153.32 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.927 2.091 . . . . 0.0 111.321 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -60.29 132.24 53.31 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 122.144 0.974 . . . . 0.0 109.611 155.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.3 t -134.6 147.58 50.25 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.175 1.79 . . . . 0.0 110.901 176.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 61.9 tp -98.16 137.01 37.55 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.244 1.017 . . . . 0.0 109.725 175.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -80.9 106.98 13.33 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.549 0.739 . . . . 0.0 110.404 167.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 46.0 mm -66.13 -23.0 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 O-C-N 120.774 -1.204 . . . . 0.0 112.286 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.66 -43.13 76.87 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.455 1.102 . . . . 0.0 113.973 -175.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.1 m -128.82 -8.01 5.0 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.94 35.13 22.49 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.321 0.962 . . . . 0.0 114.024 178.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -90.68 135.95 33.38 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.062 1.345 . . . . 0.0 112.204 176.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 mp -85.46 127.14 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 124.876 1.27 . . . . 0.0 109.43 176.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -147.15 169.91 18.32 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.582 1.153 . . . . 0.0 111.838 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -99.13 147.4 25.12 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.14 0.976 . . . . 0.0 110.535 170.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.2 t -146.53 167.96 22.39 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.689 0.796 . . . . 0.0 112.441 174.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 50.5 ptt85 -94.07 150.83 19.98 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.639 1.576 . . . . 0.0 112.75 177.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -105.82 132.87 51.41 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.601 1.161 . . . . 0.0 110.921 168.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.2 t -85.96 -45.55 11.38 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.732 1.213 . . . . 0.0 112.379 -171.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -152.25 162.11 41.63 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.394 1.078 . . . . 0.0 112.828 173.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.9 mt -89.7 155.01 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 125.094 1.357 . . . . 0.0 108.407 162.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -137.6 148.85 46.18 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.986 1.715 . . . . 0.0 110.448 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -138.46 149.56 45.57 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.867 1.267 . . . . 0.0 113.174 171.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -148.79 164.26 34.95 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.736 1.614 . . . . 0.0 110.09 170.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.5 mmtp -93.18 148.79 21.72 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.508 1.123 . . . . 0.0 111.047 176.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.1 m -148.38 144.77 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.683 1.193 . . . . 0.0 111.074 172.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -94.05 -31.33 14.27 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.66 1.184 . . . . 0.0 112.069 173.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -121.76 129.57 52.79 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.68 1.192 . . . . 0.0 110.457 -174.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.3 tp -136.52 162.34 33.36 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.392 1.877 . . . . 0.0 109.676 -172.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.9 mt -115.02 125.52 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.707 1.203 . . . . 0.0 109.274 176.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -96.97 123.74 40.77 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.148 0.979 . . . . 0.0 110.198 168.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.9 mp -111.18 126.96 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.846 1.258 . . . . 0.0 109.488 172.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.6 tttt -93.9 146.42 23.91 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.355 1.862 . . . . 0.0 110.672 174.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 80.9 mt -116.56 158.49 23.59 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.773 1.629 . . . . 0.0 111.869 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 18.8 t -59.36 -30.82 68.68 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.677 1.191 . . . . 0.0 112.699 -178.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.0 p -62.66 -15.96 54.74 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 173.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.0 7.0 68.7 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 124.749 1.166 . . . . 0.0 113.825 -171.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -81.33 159.52 24.39 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.726 1.211 . . . . 0.0 111.722 171.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 77.2 p -142.03 143.15 33.0 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.988 0.915 . . . . 0.0 112.739 169.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.1 tp -121.7 142.21 50.39 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.767 1.627 . . . . 0.0 110.858 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -120.41 110.36 16.42 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.224 1.809 . . . . 0.0 111.093 -172.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.0 m -141.06 154.37 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.029 1.332 . . . . 0.0 112.927 -165.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.4 p -68.43 150.43 97.7 Favored Pre-proline 0 N--CA 1.47 0.552 0 O-C-N 120.65 -1.281 . . . . 0.0 113.19 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -61.73 -29.65 83.72 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.678 2.252 . . . . 0.0 112.395 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 38.8 p -83.37 10.17 9.31 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 128.054 2.542 . . . . 0.0 114.859 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -99.1 109.52 54.51 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 124.748 1.219 . . . . 0.0 112.237 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -63.57 124.16 13.25 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.258 2.639 . . . . 0.0 113.841 164.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.5 t -101.27 146.67 9.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 127.433 2.293 . . . . 0.0 109.0 176.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.29 107.57 11.0 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.998 -0.438 . . . . 0.0 110.052 177.328 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.1 mp -110.22 155.69 21.67 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.541 1.537 . . . . 0.0 111.992 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -96.72 117.45 31.05 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.17 0.588 . . . . 0.0 112.359 174.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 73.4 mtp85 -136.15 78.75 1.73 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.607 1.163 . . . . 0.0 109.791 168.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 56.57 0.42 0.07 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 128.175 2.59 . . . . 0.0 115.78 -164.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -172.68 173.62 45.5 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 126.44 1.971 . . . . 0.0 111.341 -178.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 63.4 mt -70.15 125.72 27.59 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.434 1.494 . . . . 0.0 110.171 177.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -157.13 155.81 31.65 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 173.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -103.73 120.82 41.73 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.217 1.007 . . . . 0.0 112.639 -172.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 49.0 t -129.59 127.01 22.93 Favored Pre-proline 0 N--CA 1.482 1.147 0 C-N-CA 124.905 1.282 . . . . 0.0 110.698 -175.244 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -64.32 140.41 70.24 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.077 2.518 . . . . 0.0 112.225 -179.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.08 -32.38 15.54 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 176.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.76 -20.95 66.16 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 173.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -106.84 -9.56 16.33 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.61 1.564 . . . . 0.0 113.17 177.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 78.1 t -68.45 145.48 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.696 1.598 . . . . 0.0 109.969 172.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.63 157.93 75.03 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 125.697 1.599 . . . . 0.0 111.62 -178.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.416 ' HD3' HG22 ' A' ' 142' ' ' VAL . 42.9 Cg_endo -64.81 122.11 9.84 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 121.986 1.791 . . . . 0.0 111.32 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 108.11 0.16 33.54 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 124.565 1.078 . . . . 0.0 115.377 -178.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -63.34 162.25 12.61 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.872 1.269 . . . . 0.0 112.372 169.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -109.07 122.73 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 125.35 1.46 . . . . 0.0 111.332 177.049 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.45 135.86 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 126.324 1.85 . . . . 0.0 110.102 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.9 t -85.79 143.8 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 119.522 1.055 . . . . 0.0 111.733 -176.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -168.21 -149.4 6.11 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 124.794 1.188 . . . . 0.0 114.174 -177.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.1 p -156.97 165.55 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 127.287 2.235 . . . . 0.0 107.767 -174.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? . . . . . 0 N--CA 1.479 0.993 0 O-C-N 121.095 -1.003 . . . . 0.0 112.84 179.891 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 59.7 mt -149.56 156.48 42.02 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.222 1.409 . . . . 0.0 113.522 -176.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -142.62 167.21 22.62 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.657 1.983 . . . . 0.0 111.199 -179.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -128.15 156.93 42.09 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 120.348 -1.47 . . . . 0.0 113.945 158.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -116.15 136.31 53.14 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 128.116 2.566 . . . . 0.0 109.159 -173.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -89.11 131.78 35.1 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.965 0.802 . . . . 0.0 111.936 178.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 93.8 t -69.91 127.8 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 123.421 0.688 . . . . 0.0 110.734 171.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.3 t -88.27 -45.1 10.34 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.528 1.931 . . . . 0.0 112.091 175.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.2 t -157.67 163.54 38.1 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.443 1.097 . . . . 0.0 111.404 177.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.416 HG22 ' HD3' ' A' ' 112' ' ' PRO . 4.9 m -136.63 148.54 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 124.81 1.244 . . . . 0.0 111.193 171.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -158.18 155.98 30.02 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 172.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 74.3 mt -86.81 131.8 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.549 1.14 . . . . 0.0 109.061 168.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 25.1 pt -127.0 161.77 33.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 126.611 1.964 . . . . 0.0 112.257 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -95.91 99.06 10.89 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.777 1.631 . . . . 0.0 111.976 177.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -85.63 -51.95 6.13 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 177.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 48.37 41.18 16.1 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.325 1.05 . . . . 0.0 113.164 -175.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 33.9 t-20 -145.41 167.84 21.95 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.684 1.193 . . . . 0.0 110.38 -176.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -68.87 145.44 53.7 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.32 1.048 . . . . 0.0 112.149 177.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.1 m -128.77 152.8 37.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 126.069 1.748 . . . . 0.0 109.422 177.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.45 ' CG ' HG12 ' A' ' 21' ' ' ILE . 2.3 p90 -111.43 160.42 17.12 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -174.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -146.39 127.89 15.05 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.334 1.053 . . . . 0.0 109.299 170.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 32.7 tp -93.06 134.9 34.74 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 120.336 -1.478 . . . . 0.0 112.315 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 23.1 t -99.25 119.67 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 121.545 0.688 . . . . 0.0 112.822 -172.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 20.2 mm -125.96 96.57 37.12 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 126.914 2.085 . . . . 0.0 107.969 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.79 -18.14 22.27 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 122.623 2.216 . . . . 0.0 113.285 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -82.58 -34.48 27.71 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -172.155 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 44.5 p -139.02 -10.93 1.29 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.615 1.166 . . . . 0.0 113.474 -175.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . 0.306 51.7 m-70 55.37 26.08 8.33 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.09 1.756 . . . . 0.0 115.635 -173.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -154.19 158.96 41.11 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 120.795 -1.191 . . . . 0.0 113.68 173.173 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -147.06 166.18 27.67 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.544 1.538 . . . . 0.0 112.209 176.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.0 mp -107.96 139.28 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.085 0.954 . . . . 0.0 111.588 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.94 157.16 63.65 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.483 1.113 . . . . 0.0 112.52 174.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.01 -13.98 41.92 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.897 2.398 . . . . 0.0 113.165 177.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -85.94 7.87 22.59 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 124.438 1.095 . . . . 0.0 113.104 171.046 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 94.4 -23.92 29.81 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 126.24 1.876 . . . . 0.0 116.47 173.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 65.7 mt -70.17 146.27 50.9 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.906 1.353 . . . . 0.0 113.497 -174.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 4.1 t -90.46 128.51 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 123.748 0.819 . . . . 0.0 111.685 174.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 47.3 mt -117.79 160.6 21.09 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 127.598 2.359 . . . . 0.0 111.919 -176.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.31 166.17 11.11 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 -175.282 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 37.4 t30 . . . . . 0 CA--C 1.551 0.986 0 C-N-CA 125.672 1.589 . . . . 0.0 109.972 148.491 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 111.365 0.135 . . . . 0.0 111.365 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -129.01 159.91 34.4 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.555 1.942 . . . . 0.0 111.151 -177.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.95 145.87 34.34 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.25 0.62 . . . . 0.0 111.268 173.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.92 -24.2 50.66 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 178.184 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -74.24 -15.4 60.99 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.721 1.608 . . . . 0.0 112.633 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.0 m -68.94 144.02 54.28 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.021 0.929 . . . . 0.0 112.46 -170.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -78.98 156.62 28.38 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 176.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 p -146.17 154.33 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.296 1.438 . . . . 0.0 111.878 -175.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -130.22 127.26 39.28 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 126.293 1.837 . . . . 0.0 108.493 177.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -153.85 171.91 18.21 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.588 0.755 . . . . 0.0 112.133 175.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -130.81 148.82 52.63 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.731 1.213 . . . . 0.0 111.27 171.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -152.59 140.16 19.75 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.528 1.131 . . . . 0.0 110.061 172.085 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.1 t0 49.13 49.17 20.0 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.01 1.324 . . . . 0.0 113.967 170.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.0 m 62.05 35.42 15.95 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.741 2.016 . . . . 0.0 114.636 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.5 p -152.39 138.42 11.74 Favored Pre-proline 0 CA--C 1.546 0.826 0 O-C-N 120.838 -1.164 . . . . 0.0 113.054 167.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.41 154.95 28.26 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 124.543 3.495 . . . . 0.0 113.814 174.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -133.21 142.51 48.62 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.856 2.062 . . . . 0.0 110.81 172.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 47.1 ttm -145.16 90.65 2.06 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.094 1.358 . . . . 0.0 109.404 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -139.21 -168.72 2.5 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.695 1.998 . . . . 0.0 111.094 -168.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 m -79.03 151.32 31.57 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 121.0 -1.062 . . . . 0.0 111.477 168.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.3 tp -57.64 -37.65 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 O-C-N 121.607 -0.683 . . . . 0.0 111.829 173.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -61.59 -29.68 70.19 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.484 1.038 . . . . 0.0 112.781 175.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -80.74 -35.87 32.8 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.592 0.757 . . . . 0.0 111.674 -175.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 21.6 ptm -71.11 -35.26 71.72 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.207 0.458 . . . . 0.0 111.115 169.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -60.27 -51.53 69.16 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.695 0.798 . . . . 0.0 111.559 176.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.9 t -61.68 -39.62 92.07 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.309 1.044 . . . . 0.0 110.956 -176.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -63.71 -52.97 58.18 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 124.872 1.269 . . . . 0.0 110.851 177.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -72.7 -32.1 65.52 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.297 -0.877 . . . . 0.0 113.179 -178.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.54 -32.17 72.77 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.186 0.995 . . . . 0.0 111.892 173.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.1 m -81.61 -27.05 34.38 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.27 1.028 . . . . 0.0 112.463 176.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 70.2 mtm -80.17 -55.09 5.17 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.314 1.046 . . . . 0.0 112.25 174.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -108.22 -20.58 13.1 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.073 1.349 . . . . 0.0 114.13 -167.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.27 157.6 33.6 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 124.779 1.18 . . . . 0.0 114.216 -176.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -102.02 128.51 48.44 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.455 1.102 . . . . 0.0 108.414 174.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.3 mp -104.39 143.09 25.98 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 125.684 1.594 . . . . 0.0 110.23 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.69 149.13 54.25 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 123.725 2.95 . . . . 0.0 111.884 -176.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -144.14 161.82 37.88 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.995 1.318 . . . . 0.0 111.563 -175.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -51.33 -55.3 19.15 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.461 1.505 . . . . 0.0 113.505 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -90.78 -7.04 53.5 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 177.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 174.73 -124.75 1.04 Allowed Glycine 0 CA--C 1.53 0.978 0 CA-C-N 119.856 1.207 . . . . 0.0 115.55 -174.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -141.57 158.97 43.17 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.7 1.6 . . . . 0.0 111.126 177.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.94 149.12 44.41 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.817 1.247 . . . . 0.0 112.121 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.0 t -119.12 117.8 33.19 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 125.249 1.42 . . . . 0.0 110.625 178.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -74.69 140.49 26.44 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 124.421 3.414 . . . . 0.0 112.315 -177.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 64.2 mt -107.34 170.51 7.92 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.575 1.15 . . . . 0.0 113.604 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -152.63 135.18 15.24 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 127.225 2.21 . . . . 0.0 109.295 166.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 51.43 47.01 25.64 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.278 1.431 . . . . 0.0 113.162 -178.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 56.8 t -115.3 129.37 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.874 0.869 . . . . 0.0 110.637 176.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -126.93 149.0 50.03 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.748 1.219 . . . . 0.0 111.828 -170.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.0 m -137.25 150.42 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.011 1.324 . . . . 0.0 110.793 175.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -77.58 144.45 37.52 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.956 0.884 . . . . 0.0 111.006 168.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.1 t -151.81 151.77 31.78 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.581 1.152 . . . . 0.0 111.055 -165.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.4 tp -98.11 129.01 44.94 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.322 0.649 . . . . 0.0 109.573 171.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -69.88 101.88 1.84 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 162.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.0 mm -64.15 -26.83 41.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 O-C-N 120.951 -1.093 . . . . 0.0 111.279 -174.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.42 -42.15 18.95 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.67 1.188 . . . . 0.0 113.938 -174.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.2 m -101.29 -16.78 16.83 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.075 0.95 . . . . 0.0 112.308 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.45 20.67 79.51 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.461 1.505 . . . . 0.0 114.288 -176.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -79.24 123.95 27.91 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.138 1.375 . . . . 0.0 110.524 177.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.9 mp -72.9 124.24 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 165.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -142.85 174.03 11.02 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.762 1.225 . . . . 0.0 112.707 -178.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -105.5 139.42 40.14 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.99 1.316 . . . . 0.0 110.517 172.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.7 t -135.44 166.59 22.81 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.642 1.177 . . . . 0.0 112.152 176.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -100.92 137.06 39.8 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.613 1.165 . . . . 0.0 113.78 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -94.11 149.28 21.38 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.139 1.376 . . . . 0.0 112.422 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 85.4 p -99.47 -54.1 3.03 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.144 0.978 . . . . 0.0 113.563 -173.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -150.73 156.36 41.14 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.033 1.124 . . . . 0.0 114.033 176.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.0 mt -89.59 152.52 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.264 1.425 . . . . 0.0 108.685 168.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -140.66 144.04 35.47 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.169 -0.957 . . . . 0.0 112.229 -172.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -131.77 142.75 49.84 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.072 1.349 . . . . 0.0 111.882 175.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -149.92 164.18 36.1 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.112 1.365 . . . . 0.0 109.746 175.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -97.55 143.35 28.33 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 123.989 0.916 . . . . 0.0 111.419 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.1 m -147.03 145.46 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.842 1.257 . . . . 0.0 111.427 173.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -94.53 -32.97 13.24 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.867 1.667 . . . . 0.0 112.184 175.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -122.68 134.38 54.48 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 124.093 0.957 . . . . 0.0 110.68 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.8 tp -132.49 160.99 34.89 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.66 1.584 . . . . 0.0 109.299 -176.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.2 mt -115.6 122.88 70.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 121.232 -0.917 . . . . 0.0 109.401 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -93.82 115.92 28.35 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.387 1.075 . . . . 0.0 111.294 169.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -103.75 124.98 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 124.471 1.108 . . . . 0.0 108.721 170.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -91.93 146.11 24.01 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.487 1.515 . . . . 0.0 110.336 172.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 60.4 mt -106.86 160.92 15.15 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.486 1.914 . . . . 0.0 110.939 -178.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.6 t -65.11 -18.74 65.56 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.168 -0.958 . . . . 0.0 113.06 -178.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.7 p -69.02 -17.08 63.86 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.46 1.504 . . . . 0.0 114.572 167.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 83.73 7.43 85.94 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 126.458 1.98 . . . . 0.0 114.907 -170.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -80.44 167.45 20.15 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 118.771 1.285 . . . . 0.0 109.811 168.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 91.9 p -144.79 158.46 43.78 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 120.953 -1.092 . . . . 0.0 113.582 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 61.1 tp -130.64 133.53 46.2 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.383 1.873 . . . . 0.0 110.007 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -113.61 113.66 25.36 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.782 1.233 . . . . 0.0 111.65 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.4 m -139.67 157.08 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 125.721 1.608 . . . . 0.0 112.598 -169.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.9 p -68.25 149.72 97.99 Favored Pre-proline 0 N--CA 1.468 0.442 0 O-C-N 121.262 -0.899 . . . . 0.0 112.514 177.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -57.11 -33.61 96.15 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.642 2.228 . . . . 0.0 112.015 -178.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.7 m -89.54 21.63 3.34 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.526 1.93 . . . . 0.0 114.551 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -102.82 115.95 63.38 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 125.139 1.375 . . . . 0.0 111.072 176.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -72.93 142.43 34.94 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.895 2.396 . . . . 0.0 114.213 177.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 39.9 t -121.54 143.27 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 126.954 2.101 . . . . 0.0 109.298 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 25.8 tp -79.0 113.73 17.36 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.403 0.547 . . . . 0.0 110.292 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.43 159.58 18.6 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.222 2.609 . . . . 0.0 110.27 -172.025 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -124.18 121.13 34.26 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 174.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -138.63 89.45 2.37 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.822 0.849 . . . . 0.0 110.595 165.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 56.5 -0.17 0.06 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.995 2.118 . . . . 0.0 115.206 -163.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -176.47 167.23 38.64 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 125.627 1.584 . . . . 0.0 112.344 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 38.0 mt -64.38 128.54 36.21 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 126.001 1.721 . . . . 0.0 110.909 178.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -152.59 144.57 23.74 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.54 1.136 . . . . 0.0 112.727 175.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -94.39 130.1 40.85 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.109 0.964 . . . . 0.0 110.643 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 47.9 t -133.72 127.4 19.44 Favored Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 124.047 0.939 . . . . 0.0 110.527 -177.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -65.81 143.79 74.96 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.698 2.265 . . . . 0.0 111.434 175.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.27 -31.7 22.07 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.44 -16.46 62.46 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 173.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -113.15 -7.94 13.59 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.485 1.514 . . . . 0.0 113.042 177.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.4 t -67.06 150.24 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.1 1.36 . . . . 0.0 110.522 168.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.36 157.78 71.88 Favored Pre-proline 0 N--CA 1.475 0.799 0 C-N-CA 126.71 2.004 . . . . 0.0 111.246 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -68.2 122.27 9.31 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.598 2.199 . . . . 0.0 111.806 -173.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 104.62 5.49 42.11 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.309 0.957 . . . . 0.0 114.647 -176.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -67.43 166.68 14.11 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.557 1.143 . . . . 0.0 112.166 168.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.2 p -117.11 118.46 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.133 0.973 . . . . 0.0 112.052 -176.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.0 t -89.75 139.03 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 125.474 1.51 . . . . 0.0 110.008 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.3 t -91.57 139.04 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 123.731 0.812 . . . . 0.0 110.243 174.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -160.65 -155.88 7.97 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.011 0.815 . . . . 0.0 113.284 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.4 p -137.22 161.76 34.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 128.279 2.632 . . . . 0.0 107.919 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 . . . . . 0 N--CA 1.476 0.847 0 C-N-CA 123.761 0.824 . . . . 0.0 112.301 -173.276 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 . . . . . 0 N--CA 1.477 0.896 0 CA-C-O 121.089 0.471 . . . . 0.0 111.477 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 96.4 mt -67.36 146.18 54.33 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.813 0.845 . . . . 0.0 112.514 -175.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -140.18 123.89 17.27 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.422 1.489 . . . . 0.0 110.459 176.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -87.2 146.09 26.14 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 122.991 0.516 . . . . 0.0 111.367 176.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 23.9 m80 -129.08 128.4 43.47 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.666 1.587 . . . . 0.0 108.545 -173.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -88.31 141.01 28.9 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 120.944 -1.098 . . . . 0.0 112.494 -178.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 76.6 t -67.78 136.39 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 124.755 1.222 . . . . 0.0 110.078 171.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 29.6 t -90.18 -53.11 4.61 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.81 1.644 . . . . 0.0 111.506 171.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.6 m -156.97 159.87 38.49 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 121.194 -0.941 . . . . 0.0 111.121 -174.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.8 m -134.96 152.5 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.158 0.983 . . . . 0.0 111.813 174.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -162.56 159.84 25.24 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.386 1.074 . . . . 0.0 112.481 168.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 83.4 mt -82.66 144.41 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 166.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 44.4 pt -133.82 155.02 39.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.981 1.713 . . . . 0.0 111.074 174.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -93.78 95.96 9.47 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.739 0.816 . . . . 0.0 111.108 -177.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -76.95 -56.72 4.34 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.193 0.997 . . . . 0.0 112.842 179.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 44.82 51.08 8.61 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.046 1.338 . . . . 0.0 112.783 -171.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -152.09 172.02 16.97 Favored 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 124.929 1.292 . . . . 0.0 112.451 -175.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -72.27 135.35 45.98 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 120.739 -1.226 . . . . 0.0 112.144 172.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 4.0 m -111.14 152.14 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.839 1.256 . . . . 0.0 109.645 172.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -115.77 156.17 26.5 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 122.129 0.966 . . . . 0.0 112.105 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -158.59 164.88 35.64 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.22 1.408 . . . . 0.0 109.206 -163.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 44.1 tp -143.02 141.97 31.47 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.712 1.205 . . . . 0.0 110.103 -170.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.9 t -112.4 128.58 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.097 0.959 . . . . 0.0 111.534 -172.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.9 mm -135.09 83.28 39.94 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 126.445 1.898 . . . . 0.0 108.743 -176.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -64.27 -16.77 56.88 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.825 2.35 . . . . 0.0 113.303 -178.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -74.88 -32.29 61.82 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.014 1.726 . . . . 0.0 113.348 -175.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 59.7 p -141.87 -25.82 0.67 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -173.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 56.6 31.27 18.82 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.945 1.698 . . . . 0.0 115.339 -161.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -159.15 152.91 23.06 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.026 1.285 . . . . 0.0 114.137 171.148 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -148.07 175.69 10.8 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.914 1.686 . . . . 0.0 112.278 175.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 91.2 mt -117.94 128.95 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.731 1.212 . . . . 0.0 110.69 -174.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -80.71 156.95 72.6 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 123.173 0.589 . . . . 0.0 111.636 173.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.9 -20.91 64.53 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.555 2.17 . . . . 0.0 112.673 178.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -74.86 8.12 2.68 Favored 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 124.457 1.103 . . . . 0.0 112.872 172.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 93.09 -25.21 21.19 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 127.319 2.39 . . . . 0.0 115.621 171.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 40.6 mt -75.07 146.02 41.83 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 118.715 1.257 . . . . 0.0 113.121 -170.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.8 t -88.61 125.89 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.514 0.726 . . . . 0.0 110.632 174.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 32.0 mt -113.31 148.83 34.9 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.973 1.709 . . . . 0.0 111.193 -177.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -91.05 153.24 20.27 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.844 0.857 . . . . 0.0 112.315 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 25.9 m120 . . . . . 0 CA--C 1.543 0.691 0 C-N-CA 123.875 0.87 . . . . 0.0 111.656 178.593 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.486 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.32 158.42 39.15 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.006 1.322 . . . . 0.0 111.282 -173.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -63.71 148.68 48.48 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.879 0.872 . . . . 0.0 113.079 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -61.46 -22.6 65.2 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.615 1.566 . . . . 0.0 113.805 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -76.17 -14.99 60.14 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.348 1.459 . . . . 0.0 112.406 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.5 m -64.23 136.99 57.71 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.426 1.091 . . . . 0.0 112.548 -175.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -77.94 147.96 34.72 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.357 1.063 . . . . 0.0 112.703 169.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.6 p -144.85 159.88 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.269 1.028 . . . . 0.0 112.373 -171.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -129.55 135.43 48.58 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.606 1.963 . . . . 0.0 108.883 -177.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -155.83 175.19 14.25 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.079 0.854 . . . . 0.0 112.155 168.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -136.13 139.26 42.8 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.452 1.101 . . . . 0.0 111.86 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -156.76 150.79 24.98 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.987 1.315 . . . . 0.0 110.633 173.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.8 t0 49.96 42.08 23.93 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.656 1.182 . . . . 0.0 112.66 -173.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.1 m 55.75 36.17 26.74 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 126.401 1.881 . . . . 0.0 114.609 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.3 p -149.0 139.88 13.81 Favored Pre-proline 0 CA--C 1.54 0.579 0 O-C-N 120.419 -1.426 . . . . 0.0 111.242 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.33 150.29 32.42 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.708 2.938 . . . . 0.0 113.309 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -126.78 140.22 52.53 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.775 2.03 . . . . 0.0 109.894 172.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -148.03 113.2 5.53 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.098 0.959 . . . . 0.0 110.039 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -164.33 -175.51 3.97 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.428 1.891 . . . . 0.0 110.249 -174.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 m -72.09 146.32 47.61 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 120.872 -1.142 . . . . 0.0 109.928 173.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.426 HG12 ' CG ' ' A' ' 152' ' ' TYR . 9.1 tp -56.84 -37.99 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 O-C-N 121.593 -0.692 . . . . 0.0 112.29 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -63.83 -26.27 68.54 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.104 0.866 . . . . 0.0 112.451 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -78.31 -40.64 36.13 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.841 1.257 . . . . 0.0 111.112 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -73.0 -32.58 65.24 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.422 -0.799 . . . . 0.0 111.725 173.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -59.62 -49.18 78.77 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.842 0.857 . . . . 0.0 111.026 169.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.2 t -65.95 -31.5 72.45 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.438 0.695 . . . . 0.0 111.968 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -67.85 -53.52 26.13 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.04 1.336 . . . . 0.0 110.983 173.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -70.4 -33.29 71.2 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.33 -31.88 72.94 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.684 0.794 . . . . 0.0 111.943 173.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.3 t -78.52 -29.98 46.82 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 121.199 -0.938 . . . . 0.0 112.011 174.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 65.5 mtm -81.08 -49.96 10.23 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.113 0.965 . . . . 0.0 113.454 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 -111.8 -20.28 12.12 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.639 1.576 . . . . 0.0 114.295 -168.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.55 158.31 33.56 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 124.553 1.073 . . . . 0.0 114.613 -178.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -104.68 126.42 51.75 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.279 1.032 . . . . 0.0 110.475 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 11.1 mp -99.82 148.51 34.89 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 126.406 1.882 . . . . 0.0 110.517 177.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -72.4 154.92 55.95 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.118 2.546 . . . . 0.0 111.668 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -134.37 167.81 20.05 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.566 1.146 . . . . 0.0 111.202 168.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -51.57 -58.08 7.33 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.036 1.335 . . . . 0.0 111.453 171.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -96.57 -8.79 30.93 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -171.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -175.16 -131.08 1.38 Allowed Glycine 0 CA--C 1.535 1.294 0 N-CA-C 114.871 0.708 . . . . 0.0 114.871 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -136.81 159.7 41.07 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.206 1.802 . . . . 0.0 111.211 176.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.44 149.03 42.07 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.209 1.404 . . . . 0.0 111.213 -177.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.2 t -123.5 116.97 27.94 Favored Pre-proline 0 N--CA 1.482 1.154 0 C-N-CA 125.432 1.493 . . . . 0.0 109.912 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.72 140.97 40.25 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 124.23 3.287 . . . . 0.0 111.78 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 87.5 mt -109.47 169.68 8.55 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.386 1.074 . . . . 0.0 113.309 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -148.29 123.01 9.89 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.723 1.609 . . . . 0.0 110.022 174.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 50.17 40.59 22.31 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.543 1.537 . . . . 0.0 114.022 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.9 t -102.12 122.74 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 121.243 -0.91 . . . . 0.0 110.048 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -121.25 150.9 40.67 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.281 1.032 . . . . 0.0 113.115 -171.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.4 m -138.19 155.49 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 126.862 2.065 . . . . 0.0 111.634 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -69.06 132.55 46.8 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.328 0.651 . . . . 0.0 109.682 167.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.2 t -132.28 148.48 52.44 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.585 1.954 . . . . 0.0 110.654 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 55.9 tp -104.98 134.35 48.23 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.457 1.103 . . . . 0.0 109.654 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -78.1 105.57 9.41 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.59 0.756 . . . . 0.0 109.071 167.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 29.5 mm -66.75 -23.51 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 119.656 1.116 . . . . 0.0 111.633 -176.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.57 -48.22 49.8 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.661 1.184 . . . . 0.0 114.093 -177.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.2 m -114.87 -3.12 12.76 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.214 1.006 . . . . 0.0 113.435 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.59 28.85 68.63 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.293 1.425 . . . . 0.0 113.479 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -95.04 141.58 28.52 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.508 1.123 . . . . 0.0 112.039 -173.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.9 mp -89.81 128.02 42.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 C-N-CA 125.106 1.362 . . . . 0.0 109.501 -176.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -151.53 170.39 19.75 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.331 1.052 . . . . 0.0 112.645 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -114.23 135.12 54.4 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.82 1.248 . . . . 0.0 111.23 -177.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.6 t -134.58 153.87 51.76 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.219 1.008 . . . . 0.0 112.769 -174.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -80.42 140.9 35.77 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 175.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -93.45 143.0 26.7 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.387 1.075 . . . . 0.0 110.92 167.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 96.0 p -85.56 -53.95 4.86 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.81 1.244 . . . . 0.0 112.269 -174.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -152.1 158.82 43.51 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.964 1.705 . . . . 0.0 112.669 177.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.2 mt -85.66 152.51 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 163.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -143.56 148.05 35.35 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.103 1.361 . . . . 0.0 111.466 -177.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.1 ptt-85 -144.11 150.8 38.69 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 168.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -148.62 172.16 15.0 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.293 1.837 . . . . 0.0 110.586 175.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp -101.32 143.87 30.85 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.131 0.973 . . . . 0.0 112.186 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.6 m -145.35 146.57 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.464 1.506 . . . . 0.0 110.815 173.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -92.81 -34.46 13.86 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.731 1.212 . . . . 0.0 111.729 173.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -114.86 124.4 51.63 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.876 1.67 . . . . 0.0 110.224 -170.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.5 tp -134.29 158.5 43.61 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.61 1.564 . . . . 0.0 109.746 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 14.4 mt -109.61 130.83 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.324 1.049 . . . . 0.0 108.762 173.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -100.12 123.83 44.8 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.188 1.395 . . . . 0.0 110.083 168.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -113.3 115.79 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.557 1.543 . . . . 0.0 108.269 173.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.2 tttt -87.82 148.52 24.64 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.444 1.098 . . . . 0.0 110.966 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 85.8 mt -115.06 158.41 22.16 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.17 1.388 . . . . 0.0 112.347 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.1 t -65.04 -23.02 67.07 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 121.881 -0.512 . . . . 0.0 112.077 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 96.1 p -63.35 -22.26 66.77 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.697 1.599 . . . . 0.0 115.031 170.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.83 1.22 61.78 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 125.275 1.417 . . . . 0.0 115.198 -171.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -85.7 161.67 19.1 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.633 1.217 . . . . 0.0 111.194 172.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.2 p -134.49 135.34 42.35 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.359 1.076 . . . . 0.0 112.79 172.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 63.4 tp -97.76 115.09 27.32 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.659 1.584 . . . . 0.0 108.797 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -111.09 109.48 19.58 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.637 1.575 . . . . 0.0 109.878 -177.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.2 m -149.81 154.18 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 126.157 1.783 . . . . 0.0 113.254 -161.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.9 p -66.7 149.75 98.03 Favored Pre-proline 0 N--CA 1.471 0.587 0 O-C-N 121.072 -1.017 . . . . 0.0 113.244 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -60.5 -21.62 68.92 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 124.316 3.344 . . . . 0.0 114.685 -175.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.6 p -76.95 -23.08 52.4 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 128.318 2.647 . . . . 0.0 114.704 175.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 44.0 t60 -75.19 121.19 84.7 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-O 118.349 -0.834 . . . . 0.0 112.671 -162.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -75.13 126.28 9.78 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.881 2.387 . . . . 0.0 112.866 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.8 t -106.08 145.01 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 126.011 1.725 . . . . 0.0 109.175 175.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 18.0 tp -79.46 109.86 14.22 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.4 0.545 . . . . 0.0 110.363 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.1 mp -107.35 161.05 15.16 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.252 1.821 . . . . 0.0 111.556 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -117.91 112.16 19.97 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 174.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.1 mtt-85 -139.62 91.1 2.45 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.76 1.224 . . . . 0.0 109.162 165.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 56.28 -2.68 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 128.25 2.62 . . . . 0.0 116.984 -167.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.76 164.66 37.39 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 125.515 1.531 . . . . 0.0 112.682 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 67.6 mt -71.5 114.86 10.02 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.884 1.674 . . . . 0.0 110.403 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -138.35 136.59 36.52 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -174.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -92.21 112.41 24.34 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.57 1.148 . . . . 0.0 110.85 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 60.5 t -124.32 127.4 25.3 Favored Pre-proline 0 N--CA 1.478 0.962 0 C-N-CA 123.95 0.9 . . . . 0.0 110.233 -172.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -64.22 143.35 83.4 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.487 2.125 . . . . 0.0 111.584 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.14 -30.52 26.91 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 177.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.61 -22.06 66.63 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 173.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -105.43 -6.52 19.43 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.334 1.454 . . . . 0.0 112.486 175.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 84.8 t -68.51 142.25 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 O-C-N 121.292 -0.88 . . . . 0.0 109.594 166.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.61 154.65 80.92 Favored Pre-proline 0 N--CA 1.469 0.505 0 C-N-CA 128.289 2.636 . . . . 0.0 109.496 -178.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.46 132.49 31.36 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.994 1.796 . . . . 0.0 111.05 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 104.04 -6.06 46.81 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.166 1.365 . . . . 0.0 114.221 175.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.33 162.28 28.85 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 118.734 1.267 . . . . 0.0 112.439 177.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 50.5 t -91.12 121.59 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.071 1.348 . . . . 0.0 110.661 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.1 t -94.87 137.69 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.853 1.261 . . . . 0.0 110.233 169.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 41.1 t -89.58 137.82 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.14 0.976 . . . . 0.0 110.473 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -164.99 -149.01 5.67 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.245 0.926 . . . . 0.0 113.002 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.9 p -148.44 166.15 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 127.404 2.281 . . . . 0.0 108.486 175.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -60.67 106.86 0.61 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.67 0.788 . . . . 0.0 111.909 174.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.73 -25.45 68.2 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -175.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -68.9 -42.01 77.49 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.024 -1.048 . . . . 0.0 112.042 170.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 49.1 t -65.39 -38.82 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.047 0.939 . . . . 0.0 110.455 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 30.7 tp -63.24 -13.46 38.16 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.615 1.566 . . . . 0.0 113.739 175.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -117.97 9.27 12.75 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.523 1.529 . . . . 0.0 114.655 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.86 168.9 16.92 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.099 1.359 . . . . 0.0 111.56 167.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -71.76 -43.43 65.77 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 121.019 -1.05 . . . . 0.0 111.89 174.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 mp -105.57 122.39 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 127.185 2.194 . . . . 0.0 107.649 169.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 65.6 mt -92.67 118.56 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 123.683 0.793 . . . . 0.0 108.957 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 10.0 t -72.68 84.39 1.17 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.071 0.949 . . . . 0.0 110.955 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -64.05 173.6 1.84 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 127.079 2.152 . . . . 0.0 115.393 -171.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 73.42 22.27 78.78 Favored Glycine 0 N--CA 1.471 1.01 0 N-CA-C 116.489 1.355 . . . . 0.0 116.489 169.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -134.66 163.85 28.83 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.939 1.295 . . . . 0.0 112.221 174.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 95.7 mt -137.13 164.83 27.5 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.674 1.99 . . . . 0.0 109.634 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -142.09 134.73 28.3 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.207 1.403 . . . . 0.0 111.83 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -90.59 143.54 26.64 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.557 1.543 . . . . 0.0 111.702 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -131.65 136.07 47.42 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.35 1.46 . . . . 0.0 110.917 -173.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -87.33 130.65 34.54 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 119.011 0.823 . . . . 0.0 112.394 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 82.8 t -68.35 122.15 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 121.77 0.795 . . . . 0.0 110.573 167.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 45.5 t -76.92 -50.29 13.63 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.823 1.649 . . . . 0.0 112.602 176.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.4 t -158.8 164.99 35.28 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.474 1.51 . . . . 0.0 110.552 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.8 m -132.61 149.5 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 124.486 1.114 . . . . 0.0 111.543 170.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -155.34 154.37 31.93 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.247 1.019 . . . . 0.0 113.565 171.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 71.2 mt -90.25 130.6 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.561 1.144 . . . . 0.0 109.26 169.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 16.1 pt -126.39 159.04 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.925 1.69 . . . . 0.0 112.496 -174.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -95.38 96.53 9.19 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 122.24 1.019 . . . . 0.0 111.534 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -76.01 -52.02 11.11 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.064 0.945 . . . . 0.0 113.2 176.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 50.89 33.12 8.18 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.954 1.301 . . . . 0.0 113.952 -176.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -141.04 172.97 11.95 Favored 'General case' 0 CA--C 1.549 0.928 0 O-C-N 120.775 -1.203 . . . . 0.0 112.471 -170.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -74.01 137.89 43.75 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.262 -0.899 . . . . 0.0 112.091 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 12.2 m -122.35 154.5 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.399 1.88 . . . . 0.0 110.141 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.426 ' CG ' HG12 ' A' ' 21' ' ' ILE . 1.5 p90 -113.06 159.73 18.88 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -174.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -137.68 145.29 42.43 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.256 1.422 . . . . 0.0 109.092 158.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 67.1 tp -120.89 103.99 9.49 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.829 1.252 . . . . 0.0 109.426 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 57.6 t -87.71 131.66 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -150.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.4 mm -124.62 85.78 56.21 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 124.536 1.134 . . . . 0.0 110.793 -176.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -65.48 -10.3 25.7 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.561 2.174 . . . . 0.0 114.216 177.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -72.15 -47.74 48.69 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 119.816 1.189 . . . . 0.0 113.0 172.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 71.1 p -135.32 -15.2 1.93 Allowed 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -171.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . 0.295 94.4 m-70 56.78 25.9 10.83 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 128.079 2.552 . . . . 0.0 116.03 -170.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.92 146.85 26.55 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 120.796 -1.19 . . . . 0.0 113.548 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -147.56 166.05 28.49 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.299 1.439 . . . . 0.0 112.302 -176.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.9 mp -109.82 135.59 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.82 1.248 . . . . 0.0 111.663 177.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -85.81 159.05 55.67 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 124.315 1.046 . . . . 0.0 112.624 171.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.0 -23.19 74.06 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.69 2.926 . . . . 0.0 112.582 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.74 8.22 2.05 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.548 1.139 . . . . 0.0 113.176 171.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 90.68 -20.61 37.59 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 127.098 2.285 . . . . 0.0 116.048 169.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 47.2 mt -70.87 151.76 44.41 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.279 1.432 . . . . 0.0 112.889 -173.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.41 124.72 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 124.565 1.146 . . . . 0.0 111.926 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.96 144.07 43.68 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.738 2.015 . . . . 0.0 111.96 -173.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -100.27 146.52 26.81 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.563 0.745 . . . . 0.0 111.98 166.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -61.91 128.1 34.56 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.562 -0.711 . . . . 0.0 110.832 168.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -161.24 154.2 21.01 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.365 1.066 . . . . 0.0 110.643 173.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 117.847 -1.073 . . . . 0.0 109.392 166.164 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.667 0 CA-C-O 121.023 0.44 . . . . 0.0 112.031 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.422 ' HB2' ' CE1' ' A' ' 152' ' ' TYR . 0.0 OUTLIER -146.6 164.45 32.59 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.645 1.578 . . . . 0.0 111.058 -172.419 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.74 143.58 57.43 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.66 1.184 . . . . 0.0 113.725 -175.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? -58.71 -25.22 62.69 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.182 1.393 . . . . 0.0 114.238 177.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -87.02 1.03 54.19 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.924 1.29 . . . . 0.0 113.399 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.1 m -69.35 142.06 54.07 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.592 1.157 . . . . 0.0 113.099 175.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -79.32 148.06 32.23 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.436 1.494 . . . . 0.0 113.464 171.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.0 p -147.19 158.52 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.648 1.179 . . . . 0.0 111.904 -173.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -126.35 139.86 52.96 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.444 1.898 . . . . 0.0 108.807 178.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -155.28 177.21 11.61 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.608 0.718 . . . . 0.0 111.379 165.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -134.9 143.1 46.75 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.135 0.974 . . . . 0.0 110.181 173.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -159.53 143.12 14.56 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.483 1.113 . . . . 0.0 109.826 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.4 t70 48.49 50.28 17.07 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.927 1.291 . . . . 0.0 113.595 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.4 m 68.71 11.06 8.22 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 128.38 2.672 . . . . 0.0 116.145 174.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.6 p -134.71 136.87 26.22 Favored Pre-proline 0 CA--C 1.545 0.756 0 O-C-N 120.279 -1.513 . . . . 0.0 112.871 -176.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -73.0 154.39 52.82 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 123.793 2.996 . . . . 0.0 112.597 174.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -135.31 136.86 41.92 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.739 2.016 . . . . 0.0 109.147 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 50.6 ttm -152.95 104.01 2.8 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.749 0.82 . . . . 0.0 110.277 -176.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -162.29 -176.86 5.34 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.138 1.375 . . . . 0.0 111.067 -169.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.4 m -71.6 143.75 49.71 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 120.855 -1.153 . . . . 0.0 110.673 171.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.414 HG21 ' CD1' ' A' ' 152' ' ' TYR . 9.1 tp -55.02 -38.29 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -62.64 -24.04 67.39 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.365 -0.834 . . . . 0.0 113.02 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -80.55 -39.39 27.83 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.08 0.952 . . . . 0.0 111.313 176.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -73.18 -33.23 65.32 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.079 0.854 . . . . 0.0 111.72 174.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -56.96 -51.73 68.02 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.701 1.2 . . . . 0.0 111.908 169.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.1 t -62.17 -40.42 95.97 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.631 0.772 . . . . 0.0 111.423 -177.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -61.05 -53.01 62.49 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.756 1.223 . . . . 0.0 110.425 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -72.07 -33.28 67.8 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.0 -31.58 72.56 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.254 1.022 . . . . 0.0 112.513 175.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.7 t -79.81 -33.07 40.69 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 118.796 0.725 . . . . 0.0 111.878 174.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 69.8 mtm -75.99 -48.15 22.22 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.566 0.747 . . . . 0.0 112.665 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 35.7 m-20 -116.86 -19.88 9.67 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.437 1.495 . . . . 0.0 113.887 -166.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.75 159.17 34.89 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 125.087 1.327 . . . . 0.0 114.755 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -104.19 124.33 48.92 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.703 1.201 . . . . 0.0 109.435 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.3 mp -106.24 141.4 22.67 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 125.777 1.631 . . . . 0.0 110.613 -178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.12 146.23 57.35 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.505 2.803 . . . . 0.0 112.09 -173.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -134.25 154.73 51.1 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.42 1.088 . . . . 0.0 112.234 177.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -42.17 -47.45 4.65 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.897 1.679 . . . . 0.0 114.673 -176.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -116.3 7.65 14.04 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.13 -137.43 2.44 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 116.097 1.199 . . . . 0.0 116.097 -172.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -145.35 157.0 44.13 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 127.562 2.345 . . . . 0.0 111.062 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.09 151.98 47.15 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.376 1.071 . . . . 0.0 112.306 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.4 t -123.96 116.96 27.31 Favored Pre-proline 0 N--CA 1.48 1.046 0 C-N-CA 125.393 1.477 . . . . 0.0 110.284 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.43 141.63 31.96 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 124.529 3.486 . . . . 0.0 111.584 -176.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 77.2 mt -115.54 171.21 7.87 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.822 1.249 . . . . 0.0 112.682 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -148.92 135.02 19.16 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.843 1.657 . . . . 0.0 109.479 165.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 52.17 50.28 18.78 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.971 1.308 . . . . 0.0 113.562 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 67.0 t -113.05 107.67 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.075 0.95 . . . . 0.0 110.48 177.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -103.71 137.66 41.43 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.603 1.161 . . . . 0.0 113.335 -167.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.8 m -134.74 149.84 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.574 1.549 . . . . 0.0 112.599 175.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -65.44 141.95 58.34 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.648 0.779 . . . . 0.0 111.028 169.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.9 t -144.78 154.17 42.42 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.609 1.564 . . . . 0.0 111.259 -174.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 54.0 tp -114.05 138.88 49.8 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.06 1.344 . . . . 0.0 110.821 -175.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -86.6 120.69 28.19 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.17 1.388 . . . . 0.0 108.987 161.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 24.2 mm -78.87 -28.85 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 O-C-N 121.256 -0.903 . . . . 0.0 111.154 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.05 -36.19 80.86 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.437 1.095 . . . . 0.0 113.492 -171.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.9 m -121.54 -21.26 6.28 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.217 1.407 . . . . 0.0 112.998 171.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.49 31.01 20.19 Favored Glycine 0 N--CA 1.474 1.232 0 CA-C-N 118.878 0.763 . . . . 0.0 113.099 -173.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -91.92 143.68 26.24 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.819 1.248 . . . . 0.0 112.05 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.0 144.23 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.482 1.113 . . . . 0.0 110.6 -176.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.3 ptpt -154.0 176.91 11.65 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.901 1.68 . . . . 0.0 112.367 -177.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -121.45 147.82 45.24 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.792 1.637 . . . . 0.0 111.567 174.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.7 t -143.61 160.4 40.72 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.013 1.325 . . . . 0.0 111.187 175.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -97.88 132.36 43.54 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 170.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.33 142.2 39.51 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.056 0.943 . . . . 0.0 111.004 175.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.6 t -89.96 -46.14 8.72 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -169.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -153.53 160.55 42.52 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.684 1.193 . . . . 0.0 112.272 174.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.7 mt -88.79 152.81 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.481 1.112 . . . . 0.0 108.423 165.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -139.69 148.04 41.8 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.459 1.504 . . . . 0.0 110.537 -177.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.4 ptt85 -143.32 150.16 38.81 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.099 0.96 . . . . 0.0 113.155 169.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -151.66 166.08 32.36 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.988 1.715 . . . . 0.0 109.984 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -94.09 151.93 19.14 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.036 0.834 . . . . 0.0 111.459 172.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.7 m -148.74 143.12 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 124.879 1.272 . . . . 0.0 110.333 170.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -90.22 -30.14 17.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 117.632 -1.175 . . . . 0.0 112.019 175.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.7 mttt -131.95 130.43 41.51 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.274 0.943 . . . . 0.0 110.915 -174.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.8 tp -139.93 162.78 34.37 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.804 2.042 . . . . 0.0 110.158 -168.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.7 mt -116.46 127.58 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.604 1.162 . . . . 0.0 110.138 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -96.62 126.45 41.8 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.139 0.975 . . . . 0.0 110.625 166.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -111.0 129.03 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.436 1.094 . . . . 0.0 109.835 169.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -97.65 143.73 28.02 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.025 1.73 . . . . 0.0 111.301 173.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.3 mt -104.55 157.35 17.23 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 127.094 2.158 . . . . 0.0 110.317 -176.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.3 t -66.88 -23.6 66.02 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -173.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.7 t -66.84 -20.05 65.85 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.251 -0.905 . . . . 0.0 113.415 167.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 108.13 -5.52 34.08 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 127.575 2.512 . . . . 0.0 115.71 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -82.85 161.07 22.05 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.166 1.387 . . . . 0.0 110.831 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 65.2 p -141.46 159.83 41.41 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 24.3 tp -129.41 138.89 51.74 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.461 1.904 . . . . 0.0 110.324 177.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -111.22 121.63 45.79 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.876 1.27 . . . . 0.0 112.113 177.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.12 153.41 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.728 1.611 . . . . 0.0 112.85 -166.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.2 p -68.55 148.57 98.11 Favored Pre-proline 0 N--CA 1.472 0.64 0 O-C-N 120.944 -1.098 . . . . 0.0 112.573 173.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -60.84 -30.32 89.9 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 123.069 2.513 . . . . 0.0 114.366 -168.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 95.9 p -85.19 -6.56 59.27 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -61.5 119.21 44.75 Favored Pre-proline 0 CA--C 1.544 0.747 0 CA-C-N 119.635 1.107 . . . . 0.0 111.548 -177.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -73.47 127.38 11.75 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.415 2.077 . . . . 0.0 113.097 178.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.1 t -109.38 141.04 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.389 1.876 . . . . 0.0 109.374 174.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 20.2 tp -84.12 116.06 22.71 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.935 -0.478 . . . . 0.0 110.369 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.4 mp -115.67 148.28 39.88 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.961 1.704 . . . . 0.0 111.358 -173.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -107.0 81.54 1.56 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.877 0.846 . . . . 0.0 112.662 -173.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -119.0 78.81 1.32 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.691 1.196 . . . . 0.0 110.055 -169.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.6 t70 64.54 -14.79 0.09 Allowed 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 128.697 2.799 . . . . 0.0 115.602 -160.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.58 179.45 43.32 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 126.471 1.986 . . . . 0.0 111.506 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 73.0 mt -71.49 127.38 32.36 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.501 1.12 . . . . 0.0 109.981 178.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -153.33 144.93 23.34 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.902 0.881 . . . . 0.0 112.387 174.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -89.83 128.13 36.11 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.163 0.985 . . . . 0.0 110.879 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.0 t -131.65 128.94 21.93 Favored Pre-proline 0 N--CA 1.473 0.698 0 C-N-CA 124.584 1.154 . . . . 0.0 110.801 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -65.21 144.57 81.61 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.08 1.854 . . . . 0.0 110.974 175.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.44 -29.9 17.72 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 176.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.81 -23.0 67.19 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 173.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -108.83 0.76 20.49 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.302 1.841 . . . . 0.0 112.178 178.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.7 t -78.37 142.92 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.478 1.111 . . . . 0.0 110.014 166.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.74 154.94 73.24 Favored Pre-proline 0 N--CA 1.469 0.478 0 C-N-CA 126.202 1.801 . . . . 0.0 111.127 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.412 ' HD3' HG22 ' A' ' 142' ' ' VAL . 64.2 Cg_endo -63.69 122.5 10.62 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.188 1.926 . . . . 0.0 109.978 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 102.08 5.27 50.23 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 124.355 0.979 . . . . 0.0 115.316 -176.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -64.38 165.08 10.23 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 118.956 1.378 . . . . 0.0 112.302 164.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.1 p -113.48 125.03 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.171 1.388 . . . . 0.0 111.744 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.3 t -101.64 142.92 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 127.938 2.495 . . . . 0.0 110.652 -173.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 43.8 t -99.99 143.35 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.842 1.257 . . . . 0.0 112.314 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -162.9 -152.12 6.67 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.826 1.679 . . . . 0.0 112.63 175.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.4 p -138.82 157.01 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 127.519 2.328 . . . . 0.0 108.873 -177.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -59.85 125.82 25.15 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.068 0.547 . . . . 0.0 110.815 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -54.3 -34.11 60.23 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.227 1.011 . . . . 0.0 112.663 -172.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -47.22 -48.16 24.2 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.897 1.279 . . . . 0.0 114.328 174.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.6 p -71.0 -22.14 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-N 120.9 1.682 . . . . 0.0 113.582 -174.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -85.03 -35.44 21.92 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.624 1.169 . . . . 0.0 111.547 172.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 52.1 ttt85 -100.64 -45.92 5.35 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 -164.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -169.68 102.28 0.32 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 127.108 2.163 . . . . 0.0 110.43 177.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 33.8 ttt-85 -155.29 165.27 37.18 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 125.99 1.716 . . . . 0.0 111.747 175.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.64 142.61 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.831 1.252 . . . . 0.0 109.76 155.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 44.9 pt -58.25 139.83 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -172.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 79.3 p -159.52 177.47 10.89 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.56 1.944 . . . . 0.0 111.363 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -135.05 168.88 18.32 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.206 1.402 . . . . 0.0 112.174 166.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.96 -3.18 85.91 Favored Glycine 0 CA--C 1.537 1.425 0 N-CA-C 119.438 2.535 . . . . 0.0 119.438 162.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -89.0 70.27 8.51 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.186 1.493 . . . . 0.0 113.637 -168.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 98.8 mt -66.03 138.98 58.16 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.003 1.721 . . . . 0.0 113.838 -177.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -131.11 149.88 52.4 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.439 1.496 . . . . 0.0 112.98 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -130.95 136.13 48.28 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.895 0.878 . . . . 0.0 113.142 -170.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -125.9 142.41 51.53 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.42 1.088 . . . . 0.0 111.297 -175.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -88.99 138.46 31.38 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.55 0.74 . . . . 0.0 110.894 174.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 71.9 t -72.41 126.26 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 O-C-N 120.705 -1.247 . . . . 0.0 110.115 172.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 28.2 t -77.71 -48.55 16.43 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.412 1.485 . . . . 0.0 111.629 172.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.72 170.54 20.57 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.412 -0.805 . . . . 0.0 111.588 176.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.412 HG22 ' HD3' ' A' ' 112' ' ' PRO . 11.1 m -132.81 155.24 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.772 1.229 . . . . 0.0 110.255 169.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -153.9 153.9 32.89 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.201 1.001 . . . . 0.0 112.391 168.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 96.3 mt -94.14 135.99 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.949 1.3 . . . . 0.0 108.091 168.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 28.2 pt -132.56 148.21 31.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 125.147 1.379 . . . . 0.0 111.029 -178.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -84.39 96.01 8.94 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 170.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -74.12 -45.95 45.68 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.096 -1.003 . . . . 0.0 112.105 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 47.12 40.51 9.97 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.559 1.143 . . . . 0.0 112.498 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -148.41 172.3 14.66 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.244 1.418 . . . . 0.0 110.763 -170.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -76.94 142.55 40.0 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 122.052 0.93 . . . . 0.0 112.638 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.36 157.53 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 126.557 1.943 . . . . 0.0 109.344 177.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.422 ' CE1' ' HB2' ' A' ' 2' ' ' PHE . 7.8 p90 -110.51 161.44 15.69 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.973 0.909 . . . . 0.0 112.016 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -137.38 154.03 50.08 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.865 0.866 . . . . 0.0 108.944 158.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.0 tt -129.05 108.99 10.82 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.738 -1.226 . . . . 0.0 108.823 -172.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.7 t -90.87 127.47 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -153.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 28.8 mm -124.18 85.84 54.7 Favored Pre-proline 0 N--CA 1.47 0.571 0 C-N-CA 125.627 1.571 . . . . 0.0 109.705 -172.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -64.65 -16.92 57.74 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.098 1.866 . . . . 0.0 113.816 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -78.45 -45.03 23.18 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.742 1.156 . . . . 0.0 113.089 -176.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 76.6 p -131.65 -8.52 3.62 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.338 1.455 . . . . 0.0 114.288 -172.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 54.73 15.68 1.17 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.555 1.542 . . . . 0.0 114.773 -165.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -143.45 142.48 31.22 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 121.248 1.84 . . . . 0.0 114.951 -175.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -141.74 162.91 34.31 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.383 1.473 . . . . 0.0 112.069 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 95.2 mt -112.29 130.62 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.281 1.032 . . . . 0.0 110.568 -173.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -77.74 160.1 75.18 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 124.151 0.981 . . . . 0.0 111.866 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -62.19 -20.12 68.91 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.577 2.185 . . . . 0.0 112.719 177.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -73.81 -12.21 60.62 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.039 1.336 . . . . 0.0 113.226 175.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 102.61 -22.43 37.38 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.851 1.691 . . . . 0.0 115.446 177.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 72.2 mt -72.14 148.12 45.98 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 119.479 1.639 . . . . 0.0 113.087 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.9 p -99.89 134.38 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.396 1.079 . . . . 0.0 112.48 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 41.4 mt -119.47 133.75 55.54 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.498 1.919 . . . . 0.0 110.913 -171.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 31.6 t-80 -86.23 126.56 34.36 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.606 -0.684 . . . . 0.0 110.379 165.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.471 ' ND2' ' H ' ' A' ' 174' ' ' GLN . 0.0 OUTLIER -73.53 144.75 46.0 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.069 0.948 . . . . 0.0 109.464 170.837 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -110.78 7.76 22.16 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.83 1.418 . . . . 0.0 114.83 -170.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLN . . . . . 0.471 ' H ' ' ND2' ' A' ' 172' ' ' ASN . 45.1 mm-40 . . . . . 0 C--O 1.253 1.255 0 C-N-CA 125.603 1.561 . . . . 0.0 113.194 -172.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.878 0 CA-C-O 121.085 0.469 . . . . 0.0 111.983 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -131.01 160.26 35.1 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 127.014 2.126 . . . . 0.0 111.196 -175.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -55.46 145.86 21.57 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.379 1.071 . . . . 0.0 112.615 175.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -26.26 67.89 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -79.21 -8.26 58.88 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 175.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.0 m -63.11 134.8 56.63 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 121.063 -1.023 . . . . 0.0 111.29 -175.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -76.78 149.32 36.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 122.268 1.033 . . . . 0.0 113.719 175.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.0 p -145.35 152.14 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 124.595 1.158 . . . . 0.0 111.675 -173.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -122.06 143.26 49.62 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.766 2.026 . . . . 0.0 107.284 176.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -150.86 -175.88 5.31 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.427 0.691 . . . . 0.0 111.132 164.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -136.15 142.24 44.18 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.258 1.423 . . . . 0.0 110.624 174.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -164.04 151.21 11.95 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.879 2.071 . . . . 0.0 108.109 176.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.2 t0 50.95 43.18 28.86 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.791 1.237 . . . . 0.0 113.698 -177.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.5 m 56.66 35.18 25.76 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.625 1.57 . . . . 0.0 114.523 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.1 p -154.66 140.8 12.85 Favored Pre-proline 0 CA--C 1.538 0.482 0 O-C-N 120.505 -1.372 . . . . 0.0 112.012 177.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.35 144.87 57.67 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.588 2.192 . . . . 0.0 112.194 173.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -123.34 142.21 51.19 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 128.819 2.848 . . . . 0.0 108.806 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 41.6 ttm -153.29 120.43 5.8 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.678 -0.639 . . . . 0.0 111.634 -175.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -160.44 -172.43 3.55 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.47 1.908 . . . . 0.0 110.56 -176.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.4 m -76.16 150.08 37.21 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 120.639 -1.288 . . . . 0.0 110.541 167.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.2 tp -59.22 -36.36 62.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 O-C-N 121.019 -1.051 . . . . 0.0 111.985 177.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -59.71 -27.64 66.62 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.202 0.91 . . . . 0.0 113.455 173.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -81.46 -47.51 13.08 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.542 0.737 . . . . 0.0 110.194 -176.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.9 ppp? -68.27 -33.26 74.04 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 176.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -58.46 -50.05 75.1 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.428 0.691 . . . . 0.0 111.6 170.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.4 t -66.18 -29.61 69.93 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 121.646 -0.659 . . . . 0.0 111.973 -173.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -69.53 -57.13 5.6 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 126.39 1.876 . . . . 0.0 110.731 173.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -69.7 -34.86 74.51 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.282 -0.886 . . . . 0.0 112.89 -176.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.57 -24.79 64.65 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.303 1.041 . . . . 0.0 113.616 174.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 30.9 t -82.38 -35.27 27.91 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.765 0.712 . . . . 0.0 111.975 172.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 63.8 mtm -77.55 -58.08 3.46 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.85 0.86 . . . . 0.0 111.793 -178.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 47.2 m-20 -98.53 -20.02 17.29 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.828 1.251 . . . . 0.0 112.555 -171.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.7 159.35 33.2 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-O 121.941 0.745 . . . . 0.0 114.008 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -105.01 124.2 49.12 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.223 1.009 . . . . 0.0 110.577 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.6 mp -98.46 151.31 37.41 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 125.225 1.41 . . . . 0.0 110.488 174.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -69.09 156.12 66.05 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.834 2.356 . . . . 0.0 111.624 176.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -140.6 169.54 17.45 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.988 1.715 . . . . 0.0 110.26 174.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -48.93 -49.48 39.99 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -176.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -107.4 -13.43 15.1 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 177.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -161.21 -134.96 1.73 Allowed Glycine 0 CA--C 1.528 0.847 0 O-C-N 121.507 -0.745 . . . . 0.0 113.935 -167.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -140.69 154.72 46.49 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.284 1.034 . . . . 0.0 111.891 -177.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -135.95 145.4 46.17 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.774 1.23 . . . . 0.0 112.454 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 52.1 t -118.53 116.78 34.85 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 125.642 1.577 . . . . 0.0 110.758 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -71.34 138.23 32.54 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 124.091 3.194 . . . . 0.0 111.603 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 82.2 mt -107.18 158.13 17.34 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.974 1.31 . . . . 0.0 112.507 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -139.12 124.37 19.11 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.316 1.446 . . . . 0.0 109.444 174.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 51.33 51.2 17.35 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.797 1.639 . . . . 0.0 113.98 -178.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.4 t -116.41 128.71 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.408 1.483 . . . . 0.0 109.981 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -129.25 158.28 39.5 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.603 1.161 . . . . 0.0 113.364 -170.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.1 m -146.12 152.48 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 126.784 2.034 . . . . 0.0 112.269 176.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -61.7 131.45 49.99 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.402 1.481 . . . . 0.0 110.45 161.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.6 t -134.84 153.09 52.18 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.201 2.2 . . . . 0.0 111.565 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 37.6 tp -106.63 136.2 46.84 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.032 0.933 . . . . 0.0 112.169 -176.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -82.61 93.56 7.35 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.733 1.613 . . . . 0.0 110.173 170.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 31.7 mm -59.92 -21.82 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 O-C-N 120.854 -1.154 . . . . 0.0 112.888 -175.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.26 -50.12 64.84 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.081 -1.012 . . . . 0.0 113.455 175.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -111.91 -15.28 13.37 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.917 0.887 . . . . 0.0 112.652 -168.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.86 36.27 91.93 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.395 0.998 . . . . 0.0 112.105 -172.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -103.67 150.0 24.43 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.529 1.932 . . . . 0.0 111.084 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 mp -95.41 135.47 29.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 124.774 1.23 . . . . 0.0 110.801 -173.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.05 163.5 38.0 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.679 1.592 . . . . 0.0 112.569 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.4 150.19 20.65 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.232 1.413 . . . . 0.0 111.695 172.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.8 t -143.25 165.1 28.39 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.616 1.167 . . . . 0.0 111.787 167.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -91.58 153.38 19.78 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.142 1.377 . . . . 0.0 112.639 172.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -107.39 144.06 34.83 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.397 1.079 . . . . 0.0 111.487 170.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.6 t -97.64 -44.19 6.89 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.699 0.999 . . . . 0.0 113.699 -170.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -153.83 159.13 41.72 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.402 1.081 . . . . 0.0 112.761 173.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.2 mt -90.21 153.02 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.268 1.427 . . . . 0.0 108.398 164.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -137.41 148.42 46.16 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.051 1.34 . . . . 0.0 112.614 -177.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 37.3 ptt85 -138.29 145.89 41.8 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.836 1.254 . . . . 0.0 114.105 174.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -152.63 168.35 25.89 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.942 2.097 . . . . 0.0 110.314 177.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.423 ' HE2' ' HA ' ' A' ' 149' ' ' ASN . 1.0 OUTLIER -110.26 139.56 45.31 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.285 1.434 . . . . 0.0 112.602 -175.252 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.1 m -148.48 146.82 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 124.794 1.238 . . . . 0.0 112.133 -176.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.439 ' HA ' ' H ' ' A' ' 148' ' ' ASN . 6.4 pt-20 -104.32 -25.32 12.91 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 126.188 1.795 . . . . 0.0 112.923 174.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -122.23 118.05 27.63 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.64 1.109 . . . . 0.0 111.021 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.9 tp -128.03 159.15 35.92 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.813 2.045 . . . . 0.0 108.388 -175.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.1 mt -113.37 129.58 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 119.727 1.149 . . . . 0.0 109.146 177.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -103.76 117.24 33.9 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.769 0.828 . . . . 0.0 110.978 170.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.2 mp -102.84 125.58 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 C-N-CA 125.399 1.479 . . . . 0.0 108.241 175.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.4 tttt -95.46 147.75 23.2 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.057 1.343 . . . . 0.0 110.67 171.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 54.3 mt -117.67 160.57 21.09 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.364 1.466 . . . . 0.0 112.149 -172.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.7 t -64.76 -16.86 63.58 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.571 1.148 . . . . 0.0 112.979 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.2 p -70.37 -11.16 60.72 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.974 1.71 . . . . 0.0 114.214 167.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.76 -4.17 84.95 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 126.193 1.854 . . . . 0.0 113.985 -174.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -88.72 165.76 14.52 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.236 1.814 . . . . 0.0 112.151 -175.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.9 p -131.2 152.78 50.14 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 174.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 61.8 tp -127.94 129.28 46.56 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.63 1.972 . . . . 0.0 109.394 178.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -114.09 113.31 24.56 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.262 1.425 . . . . 0.0 111.15 -177.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.9 m -141.72 155.39 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 125.634 1.574 . . . . 0.0 113.036 -170.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.4 p -64.25 147.18 97.22 Favored Pre-proline 0 N--CA 1.469 0.513 0 O-C-N 121.212 -0.93 . . . . 0.0 112.677 175.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -62.83 -29.81 77.01 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.864 2.376 . . . . 0.0 113.589 -170.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.8 p -72.04 -10.93 60.46 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.196 1.798 . . . . 0.0 114.768 174.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -78.38 119.19 76.41 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 119.524 1.056 . . . . 0.0 112.787 -164.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -68.74 137.85 39.66 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.847 2.365 . . . . 0.0 113.207 -177.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.9 t -120.25 140.81 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 126.388 1.875 . . . . 0.0 109.156 175.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 39.5 tp -81.83 110.43 17.13 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 122.848 0.459 . . . . 0.0 110.158 178.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.0 mp -105.12 150.53 24.96 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.972 1.709 . . . . 0.0 111.801 -175.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -108.74 102.06 11.14 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.641 0.776 . . . . 0.0 111.792 171.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 59.0 mtt-85 -139.61 80.52 1.78 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.312 1.045 . . . . 0.0 111.6 174.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.9 t0 64.5 1.05 1.21 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 127.728 2.411 . . . . 0.0 115.148 -167.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 179.32 165.63 33.83 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 124.764 1.173 . . . . 0.0 113.018 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 39.6 mt -72.43 117.58 14.27 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.174 0.99 . . . . 0.0 111.133 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -145.63 137.09 25.06 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.22 1.008 . . . . 0.0 112.609 -176.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -91.79 121.85 33.79 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.209 1.004 . . . . 0.0 110.902 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 71.3 t -134.0 130.27 20.4 Favored Pre-proline 0 N--CA 1.48 1.039 0 C-N-CA 125.472 1.509 . . . . 0.0 109.561 -175.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.05 151.53 77.43 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 122.815 2.343 . . . . 0.0 112.797 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.47 -31.91 16.57 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 174.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.09 -23.31 67.28 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 173.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -106.07 -5.01 19.77 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.027 1.731 . . . . 0.0 112.082 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 89.9 t -69.53 147.07 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.592 1.157 . . . . 0.0 110.26 166.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.53 154.13 80.64 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 127.78 2.432 . . . . 0.0 110.625 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.401 ' HD3' HG22 ' A' ' 142' ' ' VAL . 58.0 Cg_endo -66.56 116.15 3.93 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.431 2.087 . . . . 0.0 111.043 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.414 ' H ' ' HB ' ' A' ' 139' ' ' VAL . . . 113.65 0.37 24.6 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.677 1.132 . . . . 0.0 114.948 -177.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -60.21 157.04 14.08 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 119.682 1.741 . . . . 0.0 112.119 169.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.6 t -95.65 126.05 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.542 1.137 . . . . 0.0 110.574 168.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.1 t -101.08 142.51 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 126.92 2.088 . . . . 0.0 110.09 173.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.1 t -90.63 137.62 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.852 0.861 . . . . 0.0 111.111 175.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -166.48 -150.87 6.54 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.298 0.951 . . . . 0.0 113.533 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.0 p -152.81 172.86 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 127.25 2.22 . . . . 0.0 109.895 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -67.71 122.23 17.64 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.051 1.34 . . . . 0.0 112.7 174.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.29 -39.2 72.32 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.193 0.997 . . . . 0.0 112.948 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -62.24 -27.27 68.88 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 175.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 66.6 t -76.51 -30.69 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-N 119.026 0.83 . . . . 0.0 110.764 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -76.99 -31.41 56.47 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.768 1.227 . . . . 0.0 111.886 171.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 26.9 ttp-105 -82.42 -11.92 58.22 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.596 1.558 . . . . 0.0 114.226 177.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -53.26 150.47 6.16 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.06 1.744 . . . . 0.0 111.993 170.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 69.2 mtt85 -70.55 -32.81 70.4 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 118.657 0.662 . . . . 0.0 112.512 -178.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 10.5 tt -90.57 144.73 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.714 1.206 . . . . 0.0 112.465 176.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 46.6 pt -68.65 121.67 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 121.681 0.753 . . . . 0.0 110.444 172.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 58.2 m -120.07 151.07 39.57 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.903 1.281 . . . . 0.0 111.898 -166.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -136.24 169.64 17.32 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.399 1.48 . . . . 0.0 113.987 -167.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.71 13.31 83.14 Favored Glycine 0 CA--C 1.542 1.77 0 N-CA-C 117.492 1.757 . . . . 0.0 117.492 166.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -120.94 148.94 43.39 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 120.501 2.151 . . . . 0.0 113.011 -176.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 43.4 mt -147.31 154.42 40.92 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.584 1.554 . . . . 0.0 111.968 172.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -149.7 127.75 11.95 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.101 1.76 . . . . 0.0 110.836 177.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -88.14 148.6 24.35 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.309 -0.869 . . . . 0.0 111.54 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -130.2 133.39 46.53 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.925 1.29 . . . . 0.0 109.622 -170.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -90.82 140.77 29.49 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 119.812 1.187 . . . . 0.0 111.847 175.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.414 ' HB ' ' H ' ' A' ' 113' ' ' GLY . 78.4 t -74.8 139.65 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.16 0.984 . . . . 0.0 111.271 175.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.1 t -94.58 -48.27 6.17 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.503 1.921 . . . . 0.0 112.29 175.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 13.1 t -156.61 161.63 39.91 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.352 1.061 . . . . 0.0 111.551 -177.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.401 HG22 ' HD3' ' A' ' 112' ' ' PRO . 5.6 m -139.52 149.38 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 125.365 1.466 . . . . 0.0 111.512 168.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -161.85 168.76 22.49 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 160.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 43.9 mt -93.09 128.06 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.006 1.322 . . . . 0.0 110.004 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 31.6 pt -120.78 154.8 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 127.159 2.184 . . . . 0.0 112.485 -174.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -100.48 75.51 1.78 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.182 1.393 . . . . 0.0 111.159 -168.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -66.97 -47.89 70.17 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.26 -0.9 . . . . 0.0 112.465 -169.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.439 ' H ' ' HA ' ' A' ' 74' ' ' GLU . 3.9 m120 49.5 41.5 21.23 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.09 1.756 . . . . 0.0 111.941 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.423 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 22.3 t-20 -146.17 176.62 9.61 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.114 1.366 . . . . 0.0 111.34 -171.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -74.42 147.0 42.44 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.008 0.923 . . . . 0.0 112.067 170.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 6.8 m -127.98 150.17 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.087 1.755 . . . . 0.0 109.484 175.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -118.34 156.8 28.29 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.526 0.73 . . . . 0.0 112.74 -173.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -155.64 151.41 27.43 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.481 1.113 . . . . 0.0 109.485 -165.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 38.0 tp -128.68 128.34 43.91 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.067 0.947 . . . . 0.0 111.782 -173.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 59.6 t -98.99 118.95 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.537 0.684 . . . . 0.0 112.742 -166.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 16.2 mm -124.41 86.87 54.63 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 127.451 2.3 . . . . 0.0 108.754 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -64.3 -17.82 61.04 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.837 2.358 . . . . 0.0 114.192 175.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -72.18 -55.62 6.95 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.705 1.139 . . . . 0.0 112.6 -177.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 67.7 p -124.97 -10.18 7.16 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.238 1.415 . . . . 0.0 113.9 -172.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 53.43 29.25 8.57 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -171.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -156.94 147.47 21.41 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 120.024 -1.673 . . . . 0.0 113.562 175.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -150.38 161.15 43.05 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.403 1.081 . . . . 0.0 112.076 176.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.7 mp -101.03 136.56 32.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 123.911 0.885 . . . . 0.0 111.486 -176.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -82.55 159.21 64.56 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 125.745 1.618 . . . . 0.0 112.456 173.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.01 -16.65 40.88 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.91 2.407 . . . . 0.0 113.68 -177.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -79.68 -1.09 36.8 Favored 'General case' 0 CA--C 1.556 1.194 0 O-C-N 121.398 -0.814 . . . . 0.0 112.487 170.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 97.91 -14.52 62.72 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.999 1.761 . . . . 0.0 115.65 175.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 57.9 mt -74.19 145.47 44.16 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.831 1.252 . . . . 0.0 111.953 -177.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.4 p -91.09 137.5 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 118.796 0.725 . . . . 0.0 112.318 174.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 67.5 mt -116.45 155.63 28.24 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.177 2.191 . . . . 0.0 110.78 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -100.87 155.44 17.94 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.935 0.894 . . . . 0.0 111.075 177.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 25.6 t30 -80.51 86.72 5.77 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.051 -1.031 . . . . 0.0 109.336 161.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -152.41 104.7 2.95 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 117.323 -1.322 . . . . 0.0 111.92 153.398 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -132.29 163.9 27.61 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 127.557 2.343 . . . . 0.0 111.183 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.3 145.09 54.69 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.64 1.176 . . . . 0.0 113.587 177.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -61.26 -24.28 66.27 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.545 1.138 . . . . 0.0 113.292 173.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -86.33 4.68 38.12 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.697 1.599 . . . . 0.0 113.658 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.6 m -74.25 141.06 45.39 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.047 0.939 . . . . 0.0 111.915 171.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -81.34 155.75 25.83 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.03 0.932 . . . . 0.0 113.038 169.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.0 p -148.07 155.8 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.957 0.903 . . . . 0.0 111.724 -173.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.47 139.22 54.24 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.151 1.78 . . . . 0.0 108.016 175.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -152.03 -179.06 7.16 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.951 0.9 . . . . 0.0 111.236 167.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -135.23 142.14 45.93 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.211 1.404 . . . . 0.0 111.082 177.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -164.14 159.08 19.92 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 127.618 2.367 . . . . 0.0 107.359 174.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.7 t0 53.49 32.94 15.03 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 m 58.73 33.21 22.91 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.894 1.278 . . . . 0.0 113.399 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.6 p -154.39 140.57 12.77 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 125.133 1.373 . . . . 0.0 112.527 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -70.02 150.85 67.2 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 123.13 2.553 . . . . 0.0 113.489 176.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -130.31 133.12 46.23 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 127.903 2.481 . . . . 0.0 108.744 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 39.9 ttm -145.75 113.11 6.23 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.074 0.95 . . . . 0.0 112.298 -175.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -162.79 -177.07 5.3 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.515 1.526 . . . . 0.0 112.606 -174.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.9 m -69.96 137.81 51.78 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.289 -0.882 . . . . 0.0 110.531 170.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.413 HG12 ' CG ' ' A' ' 152' ' ' TYR . 7.6 tp -55.68 -36.5 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 121.378 -0.826 . . . . 0.0 113.1 -178.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -60.8 -26.93 67.64 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.522 1.129 . . . . 0.0 112.596 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -81.49 -42.83 19.69 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.477 1.111 . . . . 0.0 111.191 178.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.6 ptm -68.65 -32.21 71.9 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.331 0.969 . . . . 0.0 111.591 174.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -57.67 -48.97 78.01 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.562 0.745 . . . . 0.0 110.632 171.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.6 t -62.79 -38.07 89.21 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.629 0.772 . . . . 0.0 111.829 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -64.32 -52.37 58.82 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.004 1.321 . . . . 0.0 110.585 177.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -71.08 -34.3 71.03 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.409 -0.807 . . . . 0.0 113.018 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.21 -35.32 80.7 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.788 0.835 . . . . 0.0 111.535 172.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 66.7 m -74.54 -29.34 61.33 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.115 0.966 . . . . 0.0 112.647 178.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 66.5 mtm -86.86 -47.31 9.14 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.068 1.347 . . . . 0.0 113.237 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -116.92 -13.76 10.66 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.835 1.254 . . . . 0.0 113.825 -165.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.46 163.72 39.56 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 124.4 1.0 . . . . 0.0 114.4 175.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -113.75 126.21 54.97 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.885 1.274 . . . . 0.0 110.452 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.6 mp -105.42 151.33 39.69 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 127.247 2.219 . . . . 0.0 110.54 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -76.91 155.91 34.44 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 123.558 2.839 . . . . 0.0 112.973 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.75 162.92 34.28 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.197 1.399 . . . . 0.0 110.519 163.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.36 -54.1 36.16 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 120.854 -1.154 . . . . 0.0 113.496 -176.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -96.96 -6.91 34.44 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 177.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -163.17 -140.5 2.89 Favored Glycine 0 CA--C 1.534 1.244 0 N-CA-C 116.602 1.401 . . . . 0.0 116.602 -172.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -149.0 157.13 43.18 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.752 1.621 . . . . 0.0 112.958 -171.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.83 148.75 41.07 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.434 1.094 . . . . 0.0 113.531 -176.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 51.4 t -129.18 121.72 20.75 Favored Pre-proline 0 N--CA 1.48 1.056 0 C-N-CA 126.085 1.754 . . . . 0.0 111.534 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -80.55 132.99 9.24 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 124.379 3.386 . . . . 0.0 113.227 -175.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 78.0 mt -97.77 165.76 11.8 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.042 1.337 . . . . 0.0 113.682 179.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -148.97 121.21 8.36 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.94 1.296 . . . . 0.0 111.079 176.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 46.14 52.77 9.97 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.782 1.633 . . . . 0.0 112.823 -173.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.7 t -112.46 128.43 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.44 1.096 . . . . 0.0 108.577 174.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -134.4 161.29 35.41 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -168.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.1 p -152.84 148.66 13.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 124.306 1.042 . . . . 0.0 112.18 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -64.41 133.45 52.58 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 122.348 1.07 . . . . 0.0 109.93 166.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.452 HG23 ' HG3' ' A' ' 61' ' ' LYS . 6.7 t -138.38 153.59 48.92 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.803 2.041 . . . . 0.0 110.49 -171.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.0 tp -113.95 145.02 42.11 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.322 -0.861 . . . . 0.0 111.537 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -96.8 118.02 32.34 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 124.485 1.114 . . . . 0.0 110.845 164.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mp -80.53 -20.65 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 124.135 0.974 . . . . 0.0 112.457 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.65 -36.93 85.12 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.206 1.003 . . . . 0.0 113.459 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.4 m -121.11 -16.97 7.89 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.565 1.146 . . . . 0.0 112.827 173.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.21 23.69 39.82 Favored Glycine 0 N--CA 1.475 1.293 0 C-N-CA 124.173 0.892 . . . . 0.0 113.667 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -100.02 137.75 38.04 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.862 1.665 . . . . 0.0 112.745 -169.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 mp -75.7 144.83 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 125.636 1.575 . . . . 0.0 111.866 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.452 ' HG3' HG23 ' A' ' 52' ' ' THR . 13.7 ptpt -155.6 176.19 12.92 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 127.093 2.157 . . . . 0.0 111.629 -178.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -129.08 141.86 51.08 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 125.14 1.376 . . . . 0.0 111.151 175.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -139.83 168.98 18.57 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.398 1.079 . . . . 0.0 113.287 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -92.2 147.95 22.54 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.178 1.391 . . . . 0.0 112.563 173.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.88 138.31 37.13 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.245 1.018 . . . . 0.0 110.311 167.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.0 t -94.28 -48.69 6.06 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -167.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.17 156.03 40.11 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.657 1.183 . . . . 0.0 111.629 175.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.7 mt -89.94 145.05 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.43 1.092 . . . . 0.0 108.414 165.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -128.52 150.65 50.08 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.949 1.7 . . . . 0.0 111.004 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.3 ptt-85 -143.63 151.35 40.02 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.201 1.0 . . . . 0.0 113.578 168.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -147.45 167.89 23.26 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.928 1.691 . . . . 0.0 110.938 175.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.54 146.89 23.8 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.621 0.768 . . . . 0.0 112.131 173.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.8 m -149.15 147.97 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 125.784 1.634 . . . . 0.0 111.522 171.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -100.31 -29.06 12.64 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.788 1.635 . . . . 0.0 112.36 175.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -122.23 128.76 51.54 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.513 1.125 . . . . 0.0 110.582 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 12.2 tp -135.45 160.86 37.13 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.841 1.657 . . . . 0.0 109.503 -174.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.7 mt -109.04 126.65 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 119.836 1.198 . . . . 0.0 109.653 175.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -102.46 119.93 39.66 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.775 1.23 . . . . 0.0 110.792 169.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -105.65 125.01 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.063 1.345 . . . . 0.0 108.478 173.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.6 tttt -92.33 146.54 23.61 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.675 1.19 . . . . 0.0 110.623 172.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 78.5 mt -106.57 160.48 15.4 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.769 1.627 . . . . 0.0 111.475 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.5 t -67.78 -11.42 58.43 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.626 1.17 . . . . 0.0 112.591 -176.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.6 p -81.44 -8.78 59.78 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 128.63 2.772 . . . . 0.0 114.947 168.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.65 -7.9 80.65 Favored Glycine 0 CA--C 1.54 1.632 0 C-N-CA 125.752 1.644 . . . . 0.0 115.362 -173.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -74.04 162.67 28.78 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.544 1.538 . . . . 0.0 111.201 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 86.3 p -140.41 146.02 37.79 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 66.8 tp -121.96 132.51 54.57 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.485 1.914 . . . . 0.0 110.068 176.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -117.03 116.5 27.47 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.871 1.668 . . . . 0.0 111.522 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.5 m -141.61 153.08 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.327 1.451 . . . . 0.0 113.082 -169.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.7 p -68.08 148.97 98.33 Favored Pre-proline 0 N--CA 1.466 0.372 0 O-C-N 121.258 -0.901 . . . . 0.0 111.66 171.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.22 -28.32 83.74 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.409 2.739 . . . . 0.0 114.346 -166.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.8 m -85.21 -4.96 59.34 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.39 1.255 . . . . 0.0 114.39 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -65.92 118.53 52.93 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 119.909 1.231 . . . . 0.0 111.918 -176.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -76.36 132.63 13.83 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.758 2.305 . . . . 0.0 113.441 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.3 t -111.33 143.82 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 126.111 1.765 . . . . 0.0 109.798 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 25.6 tp -81.31 102.0 10.14 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.014 0.526 . . . . 0.0 110.78 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.1 mp -98.96 153.64 18.68 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.971 1.709 . . . . 0.0 111.434 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -108.7 107.94 18.59 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.413 0.625 . . . . 0.0 112.593 176.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 36.4 mtp-105 -136.24 80.05 1.8 Allowed 'General case' 0 N--CA 1.479 1.004 0 O-C-N 120.861 -1.149 . . . . 0.0 110.211 -178.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 53.43 -3.25 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 127.657 2.383 . . . . 0.0 115.584 -156.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.81 171.27 44.02 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 125.591 1.567 . . . . 0.0 113.206 -178.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 82.1 mt -76.3 115.16 15.77 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.45 1.9 . . . . 0.0 111.007 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -146.83 147.93 31.36 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -99.4 117.06 32.97 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.183 1.393 . . . . 0.0 111.375 -173.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.4 t -124.49 128.45 24.97 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 123.862 0.865 . . . . 0.0 109.908 -176.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -64.56 147.34 90.22 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.575 2.184 . . . . 0.0 111.419 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.26 -30.78 18.8 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 175.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.54 -21.36 66.16 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 173.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -105.06 4.02 31.09 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.84 2.056 . . . . 0.0 112.436 175.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.6 t -84.12 143.84 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.166 1.386 . . . . 0.0 111.099 169.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.34 155.17 81.07 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 126.995 2.118 . . . . 0.0 111.33 -177.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.52 118.45 5.6 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.006 2.47 . . . . 0.0 111.681 -175.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.74 5.88 35.63 Favored Glycine 0 CA--C 1.538 1.516 0 CA-C-O 119.12 -0.822 . . . . 0.0 115.139 -176.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -61.43 166.11 4.24 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.251 1.421 . . . . 0.0 112.474 166.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.3 p -116.79 131.69 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 125.84 1.656 . . . . 0.0 111.546 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.5 t -117.22 140.67 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 126.147 1.779 . . . . 0.0 110.632 -172.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.1 t -89.03 134.42 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 123.818 0.847 . . . . 0.0 110.943 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -160.05 -151.52 6.2 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 121.674 -0.641 . . . . 0.0 113.66 174.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.3 p -139.52 159.87 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 127.051 2.14 . . . . 0.0 108.981 173.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -64.92 113.29 3.75 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.84 0.856 . . . . 0.0 109.833 173.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . 0.256 0.0 OUTLIER -66.56 -14.49 62.42 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -170.399 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -54.03 -35.24 61.74 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.037 -1.039 . . . . 0.0 112.442 165.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -75.22 -24.95 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 123.582 0.753 . . . . 0.0 112.201 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 59.7 mt -84.87 -21.3 29.82 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.441 1.496 . . . . 0.0 111.779 172.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -90.27 -1.56 57.94 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 126.484 1.914 . . . . 0.0 114.652 174.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 91.0 mtt-85 -67.47 160.01 28.4 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 126.013 1.725 . . . . 0.0 112.454 168.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 64.1 ttp85 -72.87 -36.71 67.44 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.623 0.769 . . . . 0.0 111.47 166.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 46.0 mm -101.98 94.68 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.175 1.39 . . . . 0.0 108.474 167.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.4 pt -71.32 95.07 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 122.275 1.036 . . . . 0.0 110.347 -173.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 55.2 m -86.61 62.46 7.42 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 120.814 -1.178 . . . . 0.0 112.406 -161.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.32 167.43 18.08 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.94 1.696 . . . . 0.0 114.514 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 117.38 4.18 16.03 Favored Glycine 0 CA--C 1.54 1.605 0 C-N-CA 125.336 1.446 . . . . 0.0 114.971 -174.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -129.89 165.56 21.81 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.387 2.275 . . . . 0.0 110.969 176.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 96.0 mt -139.32 163.14 33.28 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.923 1.289 . . . . 0.0 112.84 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -153.66 154.26 33.82 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.824 1.65 . . . . 0.0 112.658 172.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -78.15 153.39 32.11 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 120.961 -1.087 . . . . 0.0 113.848 178.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 43.9 m80 -131.27 158.21 41.21 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.992 1.717 . . . . 0.0 108.385 166.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -120.29 142.24 49.27 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 121.259 -0.901 . . . . 0.0 111.464 -173.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 99.3 t -76.36 132.96 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 121.767 -0.583 . . . . 0.0 110.885 172.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.6 t -91.3 -46.07 8.25 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.89 2.076 . . . . 0.0 111.725 172.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.4 t -158.36 169.54 24.24 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.04 -1.038 . . . . 0.0 111.284 175.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.5 m -133.68 148.95 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.086 1.354 . . . . 0.0 110.745 167.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -154.27 154.82 34.07 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.681 0.792 . . . . 0.0 112.686 167.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 96.9 mt -84.16 130.7 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 166.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 16.3 pt -123.95 158.6 30.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 126.362 1.865 . . . . 0.0 112.299 -174.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -94.46 94.5 8.27 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.127 1.371 . . . . 0.0 112.246 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -83.4 -56.29 3.83 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.459 -0.776 . . . . 0.0 112.771 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 51.82 36.83 18.97 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.081 0.953 . . . . 0.0 112.449 -177.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -150.98 172.97 14.87 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.142 1.377 . . . . 0.0 110.837 -172.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -75.04 138.83 42.44 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.997 0.903 . . . . 0.0 112.962 -176.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 15.5 m -120.25 153.97 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 126.046 1.738 . . . . 0.0 109.57 177.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.413 ' CG ' HG12 ' A' ' 21' ' ' ILE . 1.5 p90 -114.05 160.79 18.5 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.081 0.952 . . . . 0.0 112.568 -175.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -142.63 148.63 37.75 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.612 -0.68 . . . . 0.0 109.856 157.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 55.1 tp -108.5 119.58 39.92 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.684 1.193 . . . . 0.0 109.965 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 50.7 t -88.35 120.25 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -166.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 27.9 mm -118.66 86.93 30.76 Favored Pre-proline 0 N--CA 1.471 0.592 0 C-N-CA 125.833 1.653 . . . . 0.0 109.375 -177.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -70.9 -9.75 26.32 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.271 2.647 . . . . 0.0 113.995 -174.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -81.32 -60.57 2.23 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 118.898 0.772 . . . . 0.0 112.203 175.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 73.7 p -118.61 -10.67 10.0 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -171.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 66.6 m80 53.33 27.36 6.14 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.306 1.442 . . . . 0.0 114.692 -172.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.6 149.96 30.55 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 120.629 -1.294 . . . . 0.0 113.237 178.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -153.01 162.8 40.89 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.358 1.463 . . . . 0.0 111.415 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.8 mp -103.66 137.99 29.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 124.053 0.941 . . . . 0.0 110.945 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.76 156.82 64.51 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 123.944 0.898 . . . . 0.0 111.839 173.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -64.78 -23.76 62.41 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.553 2.169 . . . . 0.0 112.641 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -79.41 3.91 17.0 Favored 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 124.931 1.292 . . . . 0.0 112.711 174.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 105.96 -21.6 33.5 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.645 1.593 . . . . 0.0 116.612 164.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 64.4 mt -77.7 149.33 34.63 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.832 1.816 . . . . 0.0 113.818 -171.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 4.6 t -89.41 123.81 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.175 0.99 . . . . 0.0 110.646 174.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 54.6 mt -116.08 148.48 40.21 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.56 1.944 . . . . 0.0 111.629 -174.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -96.62 136.79 36.64 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.756 0.823 . . . . 0.0 110.873 170.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -71.15 106.67 3.85 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 162.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -79.56 -11.1 59.89 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -163.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 116.671 -1.633 . . . . 0.0 112.967 -163.453 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.686 0 CA-C-O 121.063 0.459 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -140.01 164.78 29.11 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.369 1.468 . . . . 0.0 112.303 -178.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.3 151.3 47.73 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -172.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.65 -22.03 43.36 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 177.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -73.9 -21.63 60.0 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.392 1.477 . . . . 0.0 113.639 177.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.4 m -64.68 126.41 27.81 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.091 0.957 . . . . 0.0 112.017 -166.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -74.14 150.48 40.44 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 174.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.2 p -148.33 153.19 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.114 0.966 . . . . 0.0 111.683 -170.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -126.49 120.77 30.53 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.85 1.66 . . . . 0.0 108.79 -173.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -150.2 168.12 24.92 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -176.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -134.17 144.21 48.37 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.807 1.243 . . . . 0.0 111.041 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -160.92 136.56 8.01 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.175 0.99 . . . . 0.0 111.172 176.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.7 t70 54.53 47.62 22.31 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.1 1.36 . . . . 0.0 113.541 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.9 m 60.47 38.88 18.92 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 127.538 2.335 . . . . 0.0 114.127 176.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.4 p -154.12 140.18 12.57 Favored Pre-proline 0 CA--C 1.547 0.858 0 O-C-N 121.098 -1.001 . . . . 0.0 112.025 173.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -83.31 151.69 13.71 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 124.818 3.679 . . . . 0.0 113.625 175.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -133.91 145.5 49.66 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.472 2.309 . . . . 0.0 111.514 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 43.4 ttm -147.67 95.95 2.59 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.823 0.849 . . . . 0.0 111.503 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -148.64 -178.71 6.49 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.647 1.579 . . . . 0.0 111.952 -171.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.3 m -71.23 148.48 47.19 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 120.74 -1.225 . . . . 0.0 110.238 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.4 tp -57.17 -35.48 48.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 O-C-N 121.368 -0.832 . . . . 0.0 112.418 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -65.68 -29.76 70.36 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.577 1.08 . . . . 0.0 112.792 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -74.86 -42.83 57.15 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.316 1.046 . . . . 0.0 110.037 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -71.93 -40.2 68.92 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.56 -0.713 . . . . 0.0 111.666 176.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -54.27 -48.57 71.05 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.745 0.818 . . . . 0.0 110.939 175.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.0 t -66.59 -32.04 73.12 Favored 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -174.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.2 ttpt -65.53 -50.73 64.16 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.192 0.997 . . . . 0.0 110.131 177.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -70.38 -33.98 72.05 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.607 -0.683 . . . . 0.0 112.287 177.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.52 -22.46 63.58 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.226 -0.921 . . . . 0.0 113.198 173.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.7 m -92.88 -14.96 26.96 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.332 1.453 . . . . 0.0 113.475 176.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 72.6 mtm -97.06 -57.91 2.15 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.068 1.747 . . . . 0.0 112.005 174.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -94.27 -27.49 16.11 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.638 1.575 . . . . 0.0 111.985 -170.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.95 158.85 13.37 Favored Glycine 0 C--N 1.341 0.837 0 C-N-CA 125.248 1.404 . . . . 0.0 114.07 -177.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -104.91 150.49 24.83 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.683 1.193 . . . . 0.0 111.851 -170.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.2 mp -121.97 145.02 42.57 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 127.026 2.13 . . . . 0.0 111.569 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.32 156.35 37.19 Favored 'Trans proline' 0 C--O 1.24 0.616 0 C-N-CA 124.718 3.612 . . . . 0.0 112.848 -176.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -145.85 165.85 27.69 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -177.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -47.56 -53.81 13.48 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.5 1.92 . . . . 0.0 114.054 177.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -106.55 0.71 24.78 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 115.051 1.501 . . . . 0.0 115.051 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 177.78 -122.49 0.83 Allowed Glycine 0 CA--C 1.53 1.019 0 N-CA-C 115.966 1.146 . . . . 0.0 115.966 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -145.36 159.84 42.44 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.025 1.73 . . . . 0.0 111.28 -177.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.68 154.27 48.6 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.076 1.351 . . . . 0.0 111.998 -178.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 67.9 t -127.87 118.12 20.94 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 125.133 1.373 . . . . 0.0 110.44 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.49 138.55 42.5 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.986 3.124 . . . . 0.0 111.34 177.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 87.4 mt -111.49 157.84 19.84 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.673 1.189 . . . . 0.0 112.559 175.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -142.0 129.57 21.44 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.993 1.317 . . . . 0.0 111.023 169.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 59.97 33.03 21.38 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 126.692 1.997 . . . . 0.0 114.673 -177.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.1 t -100.19 137.74 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 O-C-N 120.359 -1.463 . . . . 0.0 111.309 176.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -132.99 154.53 50.42 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.328 1.851 . . . . 0.0 112.851 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.8 m -141.06 162.6 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 126.714 2.006 . . . . 0.0 110.84 174.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -89.36 145.86 25.07 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.328 -0.858 . . . . 0.0 111.847 172.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.5 t -148.47 152.16 36.44 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.259 1.824 . . . . 0.0 111.311 -167.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 48.3 tp -102.22 138.63 38.91 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.773 1.229 . . . . 0.0 109.963 173.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -87.92 130.69 34.85 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.794 0.837 . . . . 0.0 111.347 161.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 43.8 mm -77.21 -25.46 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 120.941 -1.099 . . . . 0.0 112.546 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.99 -42.68 31.94 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -169.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.4 m -112.99 -9.5 13.59 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.928 1.291 . . . . 0.0 112.861 174.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.05 28.71 66.01 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 123.659 0.647 . . . . 0.0 113.987 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -89.51 136.52 32.98 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.999 1.319 . . . . 0.0 110.685 -177.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 mp -88.54 126.85 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 174.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -147.92 169.74 19.19 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.612 1.165 . . . . 0.0 112.661 -173.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.5 ttmt -92.7 149.35 21.37 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.42 1.488 . . . . 0.0 110.438 174.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.1 t -146.21 158.93 43.91 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.199 1.0 . . . . 0.0 111.171 171.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.73 159.91 22.46 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 121.27 -0.894 . . . . 0.0 112.83 177.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.28 135.56 54.96 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.285 0.634 . . . . 0.0 111.38 168.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.8 t -88.78 -46.28 9.1 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.565 1.146 . . . . 0.0 112.676 -167.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -155.25 157.31 37.09 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.494 1.518 . . . . 0.0 111.398 174.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.4 mt -88.81 151.41 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.772 1.229 . . . . 0.0 108.53 167.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -140.27 149.82 43.31 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.857 1.263 . . . . 0.0 112.426 -175.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.9 ptp85 -132.39 155.73 47.94 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.696 1.198 . . . . 0.0 112.714 171.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -150.29 163.26 38.77 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.803 1.241 . . . . 0.0 110.338 167.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -96.94 145.21 26.12 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.351 1.06 . . . . 0.0 110.973 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.4 m -150.13 141.08 16.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 124.862 1.265 . . . . 0.0 110.297 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -83.1 -34.41 26.13 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.955 1.302 . . . . 0.0 110.921 171.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -131.93 132.35 43.48 Favored 'General case' 0 C--N 1.345 0.393 0 C-N-CA 123.942 0.897 . . . . 0.0 112.33 -169.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.5 tp -131.88 164.95 24.95 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.311 1.844 . . . . 0.0 109.678 -173.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.1 mt -112.16 123.83 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 119.587 1.085 . . . . 0.0 109.167 175.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -96.08 123.32 39.65 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.416 0.686 . . . . 0.0 111.489 166.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -108.77 123.18 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.083 1.353 . . . . 0.0 108.621 170.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.1 tttt -92.86 147.87 22.49 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.664 1.586 . . . . 0.0 109.952 173.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 87.8 mt -118.91 158.32 25.93 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.615 1.566 . . . . 0.0 112.337 -175.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.7 t -66.93 -10.41 48.69 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.694 1.198 . . . . 0.0 113.264 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 88.6 p -77.62 0.59 22.6 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 127.625 2.37 . . . . 0.0 114.899 165.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.58 -3.1 56.28 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 125.126 1.346 . . . . 0.0 114.522 -173.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -76.81 163.95 26.3 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.041 1.736 . . . . 0.0 111.957 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 60.4 p -142.2 144.67 33.5 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 165.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.8 tp -118.29 131.55 56.34 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.449 1.899 . . . . 0.0 110.02 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -111.23 114.93 28.49 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.385 1.474 . . . . 0.0 111.515 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.2 m -138.01 153.83 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 126.337 1.855 . . . . 0.0 112.215 -171.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.2 p -67.27 150.48 97.87 Favored Pre-proline 0 N--CA 1.471 0.618 0 O-C-N 120.906 -1.121 . . . . 0.0 112.354 171.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -60.21 -31.38 93.0 Favored 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 123.103 2.535 . . . . 0.0 114.32 -168.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.2 m -84.07 -0.96 53.9 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -73.85 117.11 58.43 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.927 1.291 . . . . 0.0 111.177 -175.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -68.35 132.06 24.81 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.04 2.494 . . . . 0.0 112.892 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.0 t -110.74 137.0 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 126.078 1.751 . . . . 0.0 109.422 174.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.13 112.39 19.77 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.7 mp -105.58 149.68 26.06 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.802 1.641 . . . . 0.0 112.212 -175.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -101.99 112.01 24.5 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.033 0.933 . . . . 0.0 112.454 172.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -143.49 80.43 1.67 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.645 1.178 . . . . 0.0 111.024 170.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 59.74 -15.16 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 128.203 2.601 . . . . 0.0 116.759 -164.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -162.67 168.06 37.39 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 126.026 1.775 . . . . 0.0 113.89 177.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.5 mt -72.01 116.11 12.03 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.104 1.762 . . . . 0.0 110.98 -176.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -144.87 139.79 27.92 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.65 0.78 . . . . 0.0 112.786 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -96.53 123.64 40.26 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.251 1.02 . . . . 0.0 112.052 -177.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 57.3 t -128.2 129.84 23.62 Favored Pre-proline 0 N--CA 1.48 1.044 0 C-N-CA 124.928 1.291 . . . . 0.0 109.738 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -64.68 148.37 90.24 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.856 2.371 . . . . 0.0 112.057 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.67 -32.14 18.35 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.28 -25.48 67.88 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 173.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -107.85 -1.34 20.89 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.777 1.631 . . . . 0.0 113.158 178.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 74.9 t -70.1 144.17 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 124.368 1.067 . . . . 0.0 109.655 166.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.86 156.95 77.01 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 127.098 2.159 . . . . 0.0 110.324 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -65.48 125.3 14.18 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.74 1.627 . . . . 0.0 110.776 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 103.22 0.42 47.57 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.649 1.119 . . . . 0.0 114.931 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -57.95 153.73 13.75 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.176 0.991 . . . . 0.0 111.309 167.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.4 t -97.64 122.2 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.062 0.945 . . . . 0.0 109.957 172.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.2 t -94.12 141.48 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 126.68 1.992 . . . . 0.0 110.016 173.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 59.4 t -92.62 131.59 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.959 0.904 . . . . 0.0 110.399 172.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -155.08 -150.86 5.67 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.028 1.299 . . . . 0.0 111.644 176.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.8 p -143.8 169.28 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.227 1.411 . . . . 0.0 111.118 177.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 -69.48 122.6 19.33 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 127.332 2.253 . . . . 0.0 110.153 177.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -57.82 -37.16 73.31 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.712 0.687 . . . . 0.0 112.326 178.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -55.08 -47.26 75.13 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.066 0.848 . . . . 0.0 113.045 -175.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.6 p -75.8 -16.1 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.393 1.077 . . . . 0.0 112.821 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 17.0 tp -88.58 -32.65 18.01 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.55 1.14 . . . . 0.0 112.331 174.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 94.7 mtt-85 -98.57 -38.21 9.24 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -171.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.4 ttp85 -158.2 -33.35 0.07 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 116.882 2.178 . . . . 0.0 116.882 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 16.2 tpt85 -67.58 160.36 27.94 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 125.821 1.648 . . . . 0.0 112.711 -172.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 40.3 mm -39.26 121.19 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 126.067 1.747 . . . . 0.0 112.032 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.7 tp -63.88 131.18 29.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 122.263 1.03 . . . . 0.0 112.721 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 34.6 t -146.11 135.0 22.49 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.084 1.354 . . . . 0.0 109.784 170.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -96.78 159.96 14.63 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.645 1.978 . . . . 0.0 114.857 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 77.47 20.21 74.98 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 114.096 -1.411 . . . . 0.0 115.266 160.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -120.97 155.4 34.38 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.336 1.854 . . . . 0.0 111.796 174.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 97.0 mt -136.9 157.47 46.66 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.689 1.596 . . . . 0.0 112.062 -172.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -132.66 132.78 42.79 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.372 1.469 . . . . 0.0 112.007 174.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -87.49 143.61 27.13 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.593 1.157 . . . . 0.0 112.518 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -131.11 136.57 48.5 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.739 1.616 . . . . 0.0 110.115 -174.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -85.36 137.12 33.15 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.97 -1.081 . . . . 0.0 112.828 176.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 97.6 t -69.93 122.51 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.101 0.961 . . . . 0.0 111.372 163.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.4 t -81.77 -53.04 6.53 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.791 1.636 . . . . 0.0 112.329 176.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.5 m -154.92 156.3 35.84 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.346 1.058 . . . . 0.0 111.921 177.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.4 m -128.63 148.13 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.043 0.937 . . . . 0.0 111.33 176.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -157.93 156.13 30.76 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.849 0.86 . . . . 0.0 112.015 169.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 74.6 mt -80.58 145.43 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 160.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 44.8 pt -131.25 153.49 39.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 126.515 1.926 . . . . 0.0 110.076 177.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -88.29 108.02 19.11 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 122.581 1.182 . . . . 0.0 109.904 169.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -83.35 -50.48 8.31 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.363 1.865 . . . . 0.0 112.355 174.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 42.23 51.5 4.54 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.847 1.659 . . . . 0.0 111.76 -172.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -155.84 177.28 11.58 Favored 'General case' 0 CA--C 1.552 1.037 0 O-C-N 121.257 -0.902 . . . . 0.0 113.099 -175.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -77.65 134.95 38.06 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.182 1.393 . . . . 0.0 112.928 174.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 5.9 m -114.29 153.63 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.34 1.456 . . . . 0.0 109.664 175.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -119.81 159.62 24.21 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -171.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -155.04 157.59 37.81 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 113.614 -1.63 . . . . 0.0 110.289 -172.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 41.5 tp -134.82 119.07 17.69 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.92 0.888 . . . . 0.0 109.391 -175.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 51.9 t -86.93 118.03 32.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.154 0.502 . . . . 0.0 111.749 -165.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 29.7 mm -115.29 94.09 38.1 Favored Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 124.944 1.297 . . . . 0.0 109.194 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.4 -12.47 33.66 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.732 2.288 . . . . 0.0 113.339 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -79.45 -64.04 1.28 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 119.039 0.836 . . . . 0.0 112.586 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 76.0 p -114.48 -13.7 12.19 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.174 1.39 . . . . 0.0 114.459 -173.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 63.05 15.01 8.1 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -169.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -150.79 151.93 33.05 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 120.21 1.368 . . . . 0.0 113.257 -175.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -152.55 179.67 8.38 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.788 1.235 . . . . 0.0 112.241 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 85.1 mt -123.62 138.88 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.689 1.196 . . . . 0.0 111.473 -170.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -93.32 154.6 41.4 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.931 1.292 . . . . 0.0 112.302 173.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -66.76 -16.21 49.58 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.789 2.992 . . . . 0.0 114.054 -174.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -72.42 -3.55 24.86 Favored 'General case' 0 CA--C 1.556 1.179 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 170.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.9 -8.92 68.18 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.555 1.55 . . . . 0.0 114.919 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 66.9 mt -79.55 144.66 33.7 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.886 1.274 . . . . 0.0 111.99 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.2 p -89.86 139.07 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.135 0.974 . . . . 0.0 111.035 173.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 74.1 mt -118.19 152.21 36.11 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.855 2.062 . . . . 0.0 111.114 178.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -120.33 148.56 43.58 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.89 0.876 . . . . 0.0 112.93 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -120.24 -34.97 3.54 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.112 0.965 . . . . 0.0 113.47 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 54.98 22.79 4.59 Favored 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 -175.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . 0.253 45.2 tt0 . . . . . 0 C--O 1.253 1.257 0 C-N-CA 126.59 1.956 . . . . 0.0 113.393 -170.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.93 0 N-CA-C 110.763 -0.088 . . . . 0.0 110.763 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.03 162.57 33.78 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.775 1.23 . . . . 0.0 112.615 -173.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -55.91 145.3 25.37 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.946 1.699 . . . . 0.0 113.317 176.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.0 ppt_? -63.75 -22.71 67.04 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 172.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -83.19 3.66 30.03 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.6 m -69.75 150.97 46.35 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.797 1.239 . . . . 0.0 112.883 170.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -101.52 155.35 18.13 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.16 1.784 . . . . 0.0 113.169 174.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 p -148.15 158.35 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.511 0.724 . . . . 0.0 112.484 -168.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -127.34 126.36 42.4 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.387 1.875 . . . . 0.0 108.698 -174.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -153.32 173.41 15.64 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -128.15 144.43 51.12 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.588 1.155 . . . . 0.0 111.378 168.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -165.19 154.01 12.19 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.62 1.568 . . . . 0.0 110.052 174.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.9 t70 48.98 44.38 22.5 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.83 1.252 . . . . 0.0 114.181 -175.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.9 m 58.06 37.32 26.51 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.544 1.538 . . . . 0.0 114.023 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.2 p -157.7 142.47 11.96 Favored Pre-proline 0 CA--C 1.551 0.992 0 O-C-N 120.562 -1.336 . . . . 0.0 112.964 176.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.24 152.31 39.53 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 124.567 3.511 . . . . 0.0 113.516 174.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -136.62 142.63 43.28 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.742 2.017 . . . . 0.0 111.371 -175.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 52.2 ttm -147.35 86.39 1.62 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.208 1.003 . . . . 0.0 110.979 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -137.46 -179.2 5.59 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.532 1.533 . . . . 0.0 112.491 -174.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.9 m -73.17 140.91 47.33 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 120.759 -1.213 . . . . 0.0 110.637 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.42 HG12 ' CD2' ' A' ' 152' ' ' TYR . 9.3 tp -58.0 -36.12 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 O-C-N 121.303 -0.873 . . . . 0.0 112.958 -178.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.01 -24.77 68.07 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.758 -0.589 . . . . 0.0 112.455 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -79.09 -49.25 12.93 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.028 0.931 . . . . 0.0 109.916 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 20.7 ptm -65.85 -33.0 74.84 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.606 -0.684 . . . . 0.0 112.114 175.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -54.88 -49.87 70.12 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.295 0.952 . . . . 0.0 111.207 172.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 39.9 t -61.29 -39.48 90.59 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.348 1.059 . . . . 0.0 111.486 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -65.32 -53.46 43.43 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.319 1.447 . . . . 0.0 110.932 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -72.84 -31.5 64.81 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.249 -0.907 . . . . 0.0 112.473 -177.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.43 -32.26 73.52 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.129 -0.982 . . . . 0.0 111.907 170.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 60.4 m -79.2 -26.03 42.63 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.664 0.786 . . . . 0.0 112.864 178.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 61.2 mtm -91.53 -46.61 7.87 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.24 1.416 . . . . 0.0 113.264 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -112.22 -13.91 13.43 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.034 1.334 . . . . 0.0 113.572 -169.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.9 163.75 35.94 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.849 1.214 . . . . 0.0 114.573 178.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -111.38 134.85 52.67 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.189 1.395 . . . . 0.0 110.014 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.5 mp -116.75 148.46 42.07 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 126.14 1.776 . . . . 0.0 111.617 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -70.65 143.44 46.55 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.38 2.72 . . . . 0.0 111.349 175.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -130.07 169.53 15.18 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.876 1.67 . . . . 0.0 111.149 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.91 -52.8 62.83 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 120.975 -1.078 . . . . 0.0 113.538 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -99.86 -8.86 23.56 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.98 -134.25 1.76 Allowed Glycine 0 CA--C 1.53 0.994 0 CA-C-N 119.137 0.88 . . . . 0.0 114.235 -172.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -135.27 151.3 50.45 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.14 1.776 . . . . 0.0 112.066 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.25 142.59 39.89 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.4 1.08 . . . . 0.0 112.784 -174.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.9 t -116.38 111.62 41.99 Favored Pre-proline 0 N--CA 1.474 0.74 0 C-N-CA 126.653 1.981 . . . . 0.0 109.638 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -65.17 139.69 61.72 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.867 3.044 . . . . 0.0 110.931 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.0 mt -110.06 165.13 11.98 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.601 1.16 . . . . 0.0 111.941 176.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -144.16 127.0 16.28 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.75 1.62 . . . . 0.0 110.123 169.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 50.5 46.81 25.01 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.387 1.075 . . . . 0.0 113.306 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.8 t -111.4 116.92 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.18 0.992 . . . . 0.0 108.797 173.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -113.63 151.8 31.24 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -167.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.6 m -135.82 154.13 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.494 1.518 . . . . 0.0 111.565 174.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -66.74 133.25 49.78 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 161.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.0 t -135.52 145.28 46.9 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.737 1.615 . . . . 0.0 110.54 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.4 tp -99.87 136.51 39.68 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.792 0.837 . . . . 0.0 110.351 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -85.46 91.43 8.22 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.755 1.222 . . . . 0.0 109.422 171.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.7 mm -58.97 -25.22 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 119.372 0.987 . . . . 0.0 112.282 -171.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.69 -45.92 87.86 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.63 1.172 . . . . 0.0 114.108 175.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 m -107.67 -22.75 12.38 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.632 1.173 . . . . 0.0 112.61 -173.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.44 25.16 66.26 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.642 1.592 . . . . 0.0 113.281 -169.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -90.49 141.39 28.8 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.177 1.391 . . . . 0.0 112.061 -175.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.2 mp -90.83 122.41 42.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 125.042 1.337 . . . . 0.0 110.681 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -146.91 179.23 7.74 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.773 1.629 . . . . 0.0 112.093 -177.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -110.89 152.27 26.91 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.886 1.674 . . . . 0.0 111.358 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.3 t -147.65 162.08 39.87 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.61 -0.681 . . . . 0.0 110.852 165.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -94.41 142.78 27.03 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.091 0.957 . . . . 0.0 112.335 173.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.41 143.8 26.77 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.555 0.742 . . . . 0.0 111.311 174.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 84.4 p -84.5 -48.34 9.69 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.437 1.095 . . . . 0.0 112.454 -172.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -151.86 159.95 43.69 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.306 1.842 . . . . 0.0 112.191 173.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.5 mt -86.73 146.98 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 160.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -132.9 148.11 52.29 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 125.246 1.418 . . . . 0.0 110.927 -175.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -146.13 150.23 35.51 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 165.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -146.99 165.97 28.23 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.183 1.793 . . . . 0.0 110.878 173.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.45 146.78 23.84 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.194 -0.941 . . . . 0.0 112.8 -177.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.1 m -147.53 151.36 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.366 1.066 . . . . 0.0 112.299 173.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -113.36 -5.37 13.56 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.988 2.115 . . . . 0.0 113.184 177.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -138.43 119.21 14.14 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.792 1.637 . . . . 0.0 109.992 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.6 tp -133.24 159.35 40.46 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.812 1.645 . . . . 0.0 109.601 -175.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 13.5 mt -110.48 127.72 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 119.245 0.93 . . . . 0.0 109.492 176.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -98.68 127.63 44.67 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.406 1.082 . . . . 0.0 111.048 167.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.8 mp -112.9 126.07 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.152 1.381 . . . . 0.0 109.77 172.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -91.68 143.41 26.58 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.662 1.585 . . . . 0.0 110.48 171.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 83.9 mt -113.32 156.45 23.36 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.091 1.357 . . . . 0.0 112.113 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.1 t -59.55 -26.4 65.34 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.251 1.42 . . . . 0.0 112.005 174.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 94.2 p -64.57 -16.72 63.11 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.207 1.403 . . . . 0.0 114.477 171.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.33 4.04 74.55 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 125.919 1.723 . . . . 0.0 114.505 -174.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -85.22 158.73 20.27 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.889 1.675 . . . . 0.0 110.729 172.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 84.5 p -137.66 142.64 41.13 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 165.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.8 tp -121.48 140.62 51.94 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.73 2.012 . . . . 0.0 110.09 -172.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -121.16 116.56 25.19 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.189 1.396 . . . . 0.0 112.165 -174.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.1 m -139.81 154.78 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.286 1.434 . . . . 0.0 112.899 -167.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.1 p -65.79 148.1 98.41 Favored Pre-proline 0 N--CA 1.471 0.598 0 O-C-N 120.912 -1.117 . . . . 0.0 111.572 173.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.08 -29.47 87.16 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.166 2.578 . . . . 0.0 113.535 -173.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 32.9 p -84.62 0.2 51.03 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.178 2.191 . . . . 0.0 114.875 177.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -73.95 116.47 52.49 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 119.89 1.223 . . . . 0.0 112.023 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -77.9 127.13 8.41 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.681 2.254 . . . . 0.0 112.468 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 38.4 t -107.0 142.08 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 126.095 1.758 . . . . 0.0 109.43 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 22.4 tp -80.68 113.29 18.78 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 122.588 0.355 . . . . 0.0 110.693 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.8 mp -109.38 147.54 32.59 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.655 1.582 . . . . 0.0 112.701 -172.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -96.18 95.21 7.98 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.55 1.54 . . . . 0.0 109.569 170.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -130.35 71.88 1.47 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.288 1.435 . . . . 0.0 109.662 174.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.9 t70 63.37 -15.88 0.07 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 128.712 2.805 . . . . 0.0 115.866 -163.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -168.51 159.34 32.46 Favored Glycine 0 CA--C 1.522 0.524 0 O-C-N 121.189 -0.945 . . . . 0.0 114.09 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 59.6 mt -61.21 112.72 2.24 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.786 1.634 . . . . 0.0 110.95 -175.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -145.85 145.33 30.71 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -93.15 119.62 32.55 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.571 1.148 . . . . 0.0 110.895 -178.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 57.7 t -127.61 130.08 23.72 Favored Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 124.073 0.949 . . . . 0.0 110.081 -178.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -65.37 147.88 87.72 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.872 2.382 . . . . 0.0 111.82 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.1 -31.89 20.63 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 174.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.52 -18.42 65.36 Favored 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 173.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -108.57 2.09 21.86 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.237 1.815 . . . . 0.0 112.477 173.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.5 t -78.26 143.32 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 120.875 -1.141 . . . . 0.0 109.993 168.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.65 151.54 78.23 Favored Pre-proline 0 N--CA 1.471 0.596 0 C-N-CA 127.505 2.322 . . . . 0.0 110.682 -177.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -65.22 116.19 3.73 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.418 2.079 . . . . 0.0 110.798 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.7 2.22 34.69 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 124.571 1.082 . . . . 0.0 115.543 -173.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -56.59 159.94 3.54 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.804 1.302 . . . . 0.0 111.912 162.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.6 t -116.78 125.4 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 123.936 0.894 . . . . 0.0 110.042 175.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.6 t -100.78 145.19 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 126.774 2.03 . . . . 0.0 110.279 -178.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 44.1 t -86.05 135.99 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.818 1.247 . . . . 0.0 109.926 175.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -166.68 -149.56 6.02 Favored Glycine 0 CA--C 1.529 0.915 0 O-C-N 121.952 -0.468 . . . . 0.0 113.837 178.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.3 p -151.07 162.43 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 125.403 1.481 . . . . 0.0 110.579 175.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 42.4 mtm105 -67.33 121.0 14.77 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.696 1.198 . . . . 0.0 111.065 172.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -64.64 -24.78 67.7 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -175.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -52.72 -29.54 27.44 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 169.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 24.1 t -79.96 -45.31 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 118.612 0.642 . . . . 0.0 110.479 178.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -62.52 -23.31 66.89 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.699 1.199 . . . . 0.0 112.677 174.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 35.3 ttt180 -97.2 -4.18 39.51 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.346 1.458 . . . . 0.0 114.135 174.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . 0.282 3.5 mpt_? 55.05 41.19 32.0 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.829 1.651 . . . . 0.0 113.851 -176.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -81.07 -25.68 36.88 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.672 1.589 . . . . 0.0 111.098 157.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 52.0 mt -123.17 142.89 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.025 1.33 . . . . 0.0 107.66 153.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 4.1 mt -112.0 89.95 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 118.9 0.773 . . . . 0.0 109.953 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 79.9 p -139.21 158.82 43.49 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.903 2.081 . . . . 0.0 112.538 -176.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.21 160.5 38.83 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.858 1.263 . . . . 0.0 113.778 174.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.67 18.29 73.48 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 123.527 0.584 . . . . 0.0 113.411 -177.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -112.7 143.44 43.9 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.742 1.617 . . . . 0.0 111.898 -171.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 91.3 mt -140.46 163.49 32.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.219 1.807 . . . . 0.0 111.73 -177.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -146.35 161.8 39.55 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.443 1.897 . . . . 0.0 111.882 -176.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -107.12 149.17 27.94 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.924 0.89 . . . . 0.0 112.096 170.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -128.48 119.05 24.15 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.354 1.061 . . . . 0.0 108.497 173.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -85.22 144.19 28.29 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 120.94 -1.1 . . . . 0.0 111.786 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 97.1 t -76.36 142.87 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 125.418 1.487 . . . . 0.0 111.027 174.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 26.0 t -100.76 -50.03 3.98 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.438 1.895 . . . . 0.0 112.506 174.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 13.9 m -149.5 156.37 41.88 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.134 1.373 . . . . 0.0 111.035 -175.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.4 m -134.97 147.09 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.893 0.877 . . . . 0.0 111.97 169.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -154.99 156.87 36.76 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 176.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 90.9 mt -92.27 138.42 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.69 1.196 . . . . 0.0 108.499 168.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 16.0 pt -132.83 155.87 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 126.388 1.875 . . . . 0.0 111.587 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -96.07 94.54 7.61 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 122.122 0.963 . . . . 0.0 112.491 173.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -72.34 -43.47 64.03 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 49.22 38.79 14.18 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.849 1.66 . . . . 0.0 113.583 -178.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -154.15 175.62 13.24 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.627 1.171 . . . . 0.0 111.109 -170.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -72.28 141.53 48.89 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.157 0.983 . . . . 0.0 113.218 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.8 m -122.53 153.96 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 126.465 1.906 . . . . 0.0 109.614 173.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.42 ' CD2' HG12 ' A' ' 21' ' ' ILE . 3.4 p90 -113.59 164.66 13.38 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -174.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -140.07 159.98 40.96 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.547 151.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.1 tt -127.06 98.86 5.47 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.182 0.993 . . . . 0.0 108.796 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 98.9 t -82.73 128.25 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -148.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 23.3 mm -116.59 100.61 53.54 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 124.767 1.227 . . . . 0.0 109.445 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -73.16 -13.33 25.87 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.356 2.037 . . . . 0.0 113.101 176.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 76.7 tt0 -74.0 -67.76 0.58 Allowed 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.815 1.188 . . . . 0.0 111.97 174.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 68.6 p -109.83 -7.97 14.95 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.928 1.291 . . . . 0.0 114.215 -169.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 56.42 21.23 5.36 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.929 1.291 . . . . 0.0 114.468 -169.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.37 145.56 26.18 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 -178.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -138.66 166.84 23.33 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.04 1.336 . . . . 0.0 112.416 176.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.8 mp -110.21 135.45 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.731 1.212 . . . . 0.0 111.634 177.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -86.5 156.62 56.32 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.091 0.956 . . . . 0.0 112.568 171.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -67.3 -11.99 34.22 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.826 3.017 . . . . 0.0 113.875 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -70.27 -17.82 63.11 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 121.767 -0.583 . . . . 0.0 112.443 168.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 115.23 -24.69 10.42 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 126.46 1.981 . . . . 0.0 115.069 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 50.0 mt -68.73 151.82 46.16 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.807 1.643 . . . . 0.0 113.63 -170.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 4.1 t -104.02 122.82 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 124.977 1.311 . . . . 0.0 111.96 176.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.8 144.27 43.77 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.355 1.862 . . . . 0.0 112.868 -170.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 62.7 t60 -96.61 150.48 20.61 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.136 0.975 . . . . 0.0 113.183 169.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -71.47 169.64 14.98 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 115.533 1.679 . . . . 0.0 115.533 177.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -89.2 -3.58 58.52 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.708 2.003 . . . . 0.0 113.079 170.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 . . . . . 0 C--O 1.25 1.111 0 C-N-CA 127.171 2.188 . . . . 0.0 111.476 -176.268 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.7 166.51 22.77 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.446 1.898 . . . . 0.0 111.772 -174.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.45 146.88 54.06 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.244 1.418 . . . . 0.0 114.608 -176.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -67.85 -21.22 65.19 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.748 1.219 . . . . 0.0 113.96 175.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -84.76 -3.66 58.7 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 174.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.2 m -65.16 141.65 58.61 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 119.363 0.983 . . . . 0.0 113.233 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -79.35 147.89 32.25 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.581 1.152 . . . . 0.0 112.917 170.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 p -146.39 156.77 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.498 1.119 . . . . 0.0 112.328 -172.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -126.28 135.19 51.24 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.844 2.058 . . . . 0.0 108.088 177.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -153.59 176.09 12.47 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.493 0.717 . . . . 0.0 112.249 169.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -131.85 140.98 49.29 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.148 1.379 . . . . 0.0 110.819 174.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -162.12 166.19 26.06 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.713 2.005 . . . . 0.0 108.328 174.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.4 t70 58.99 24.73 12.98 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 120.176 1.353 . . . . 0.0 113.2 170.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 63.55 29.81 15.22 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.158 1.783 . . . . 0.0 114.8 -171.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.8 p -152.78 141.75 14.31 Favored Pre-proline 0 CA--C 1.548 0.884 0 O-C-N 119.678 -1.889 . . . . 0.0 113.473 -176.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.33 152.96 50.38 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.713 2.942 . . . . 0.0 112.595 173.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -135.75 142.59 44.99 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.033 2.133 . . . . 0.0 109.96 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 35.9 ttm -153.24 106.21 2.96 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.035 0.534 . . . . 0.0 111.555 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -157.14 -179.54 8.3 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.444 1.898 . . . . 0.0 111.682 -172.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.7 m -67.73 138.49 56.29 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.219 -0.926 . . . . 0.0 110.013 170.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.6 tp -55.9 -37.33 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -176.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -69.53 -16.67 63.48 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.84 1.2 . . . . 0.0 112.755 -178.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -80.44 -46.55 15.75 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.416 1.086 . . . . 0.0 109.836 177.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -67.92 -34.62 76.96 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 122.015 -0.428 . . . . 0.0 112.079 173.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -58.59 -49.97 75.52 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.497 0.719 . . . . 0.0 110.835 172.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.5 t -68.99 -30.3 68.68 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.263 0.625 . . . . 0.0 111.513 -176.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -64.67 -54.04 37.89 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.43 1.492 . . . . 0.0 110.514 172.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -69.4 -33.85 73.63 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.203 -0.936 . . . . 0.0 112.347 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.33 -19.1 64.64 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 121.104 -0.997 . . . . 0.0 113.309 174.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.0 m -96.04 -7.64 35.69 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.874 1.669 . . . . 0.0 113.855 174.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 59.2 mtm -113.08 -49.51 2.92 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.756 1.623 . . . . 0.0 112.895 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -102.33 -19.59 14.94 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.175 1.79 . . . . 0.0 112.021 -174.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.96 166.59 42.33 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.589 1.09 . . . . 0.0 114.103 174.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -112.89 130.19 56.2 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.731 1.212 . . . . 0.0 110.465 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.2 mp -119.38 148.87 46.44 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 126.431 1.893 . . . . 0.0 110.808 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -72.06 162.31 42.18 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.452 2.768 . . . . 0.0 113.977 -173.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -145.45 170.07 17.1 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.047 1.739 . . . . 0.0 110.847 175.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -60.03 -58.23 9.42 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.546 1.138 . . . . 0.0 113.151 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -90.56 -3.87 57.28 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 176.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.93 -128.31 1.15 Allowed Glycine 0 CA--C 1.534 1.239 0 CA-C-N 120.322 1.419 . . . . 0.0 116.504 -177.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -139.56 161.07 38.39 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.092 1.757 . . . . 0.0 111.668 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.6 159.74 41.54 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.571 1.148 . . . . 0.0 112.691 177.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 81.6 t -127.17 113.47 21.63 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 125.782 1.633 . . . . 0.0 109.855 176.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -65.71 142.42 70.18 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 124.25 3.3 . . . . 0.0 111.263 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.2 mt -116.12 151.97 34.58 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 122.608 1.194 . . . . 0.0 112.853 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -133.84 129.74 36.9 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.824 1.249 . . . . 0.0 110.581 170.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 57.84 33.68 23.49 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.209 1.404 . . . . 0.0 114.157 176.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.3 t -101.68 133.7 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.492 1.517 . . . . 0.0 110.031 174.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -132.39 154.18 50.06 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.927 1.691 . . . . 0.0 112.912 -174.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.3 m -146.68 158.6 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 127.725 2.41 . . . . 0.0 110.542 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -79.32 149.06 31.87 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.013 -1.054 . . . . 0.0 112.232 170.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.0 t -148.24 157.17 43.34 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.904 1.682 . . . . 0.0 111.81 -169.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 38.6 tp -112.35 134.22 54.01 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.05 1.34 . . . . 0.0 110.226 176.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -83.46 104.12 13.36 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 163.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 mm -63.32 -29.94 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-N 120.935 1.698 . . . . 0.0 111.546 -177.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.77 -45.31 90.36 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.071 1.348 . . . . 0.0 113.241 -177.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.8 m -101.84 -20.24 14.98 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.918 0.887 . . . . 0.0 112.465 177.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.25 37.72 81.16 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.981 1.277 . . . . 0.0 112.42 -170.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -103.01 136.33 43.02 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.393 1.877 . . . . 0.0 110.644 -177.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 mp -93.7 127.69 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.7 pttt -144.86 169.65 17.64 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.987 1.315 . . . . 0.0 112.072 -177.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -103.5 143.46 32.69 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.959 0.904 . . . . 0.0 110.887 175.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.6 t -142.44 162.08 36.38 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.017 1.327 . . . . 0.0 112.62 -175.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -81.74 151.73 27.34 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 173.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -107.69 138.66 43.51 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.778 0.831 . . . . 0.0 110.942 164.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.9 t -91.86 -46.83 7.65 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.978 1.311 . . . . 0.0 113.255 -169.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -150.73 158.49 44.21 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.868 1.267 . . . . 0.0 111.559 172.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.1 mt -87.25 153.22 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 162.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -139.05 149.65 44.87 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.304 1.441 . . . . 0.0 111.715 -175.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 21.6 ptt-85 -139.12 150.5 45.74 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.769 1.228 . . . . 0.0 113.547 169.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -144.53 159.56 42.57 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.152 1.781 . . . . 0.0 109.445 172.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -102.91 136.43 42.74 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.133 0.879 . . . . 0.0 110.788 -176.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.9 m -144.87 145.48 20.97 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-O 122.324 1.059 . . . . 0.0 111.962 -176.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -97.48 -28.64 13.89 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 125.987 1.715 . . . . 0.0 111.867 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -120.28 128.69 53.54 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.544 1.138 . . . . 0.0 110.385 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.8 tp -131.89 160.69 34.97 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.342 1.457 . . . . 0.0 109.781 178.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.0 mt -113.4 126.21 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 119.858 1.208 . . . . 0.0 109.123 175.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -97.15 120.6 37.81 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.465 1.106 . . . . 0.0 111.119 169.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -109.55 122.22 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.496 1.518 . . . . 0.0 109.266 173.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -90.68 146.09 24.3 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.254 1.822 . . . . 0.0 110.601 175.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.6 mt -115.92 158.63 22.72 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.497 1.519 . . . . 0.0 111.74 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.5 t -61.71 -20.0 63.02 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.396 1.079 . . . . 0.0 113.561 -176.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 78.1 p -85.3 4.76 33.51 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.27 1.828 . . . . 0.0 115.619 172.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.78 10.04 86.49 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 124.306 0.955 . . . . 0.0 114.652 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -76.52 152.82 35.91 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.996 1.319 . . . . 0.0 109.829 166.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 80.5 p -135.68 135.62 40.26 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 165.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.9 tp -109.42 137.22 47.6 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.906 1.682 . . . . 0.0 109.755 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt -119.64 117.83 29.33 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.86 1.264 . . . . 0.0 111.105 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.5 m -139.15 153.49 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.994 1.318 . . . . 0.0 112.479 -168.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.8 p -64.87 145.66 98.9 Favored Pre-proline 0 N--CA 1.468 0.462 0 O-C-N 121.098 -1.001 . . . . 0.0 111.003 170.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -59.09 -24.81 75.4 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.381 2.721 . . . . 0.0 113.322 -173.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 61.7 p -76.3 -12.77 60.13 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 128.033 2.533 . . . . 0.0 115.539 175.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -70.96 116.68 48.92 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 124.344 1.058 . . . . 0.0 111.886 -174.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -78.52 120.81 4.93 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 123.253 2.636 . . . . 0.0 111.966 177.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.2 t -92.89 142.95 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 126.689 1.996 . . . . 0.0 110.124 178.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.74 101.08 6.5 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.534 0.683 . . . . 0.0 109.395 173.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.6 tp -98.76 152.77 19.32 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.015 1.726 . . . . 0.0 111.735 -173.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -111.85 113.2 25.4 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.056 0.542 . . . . 0.0 111.932 167.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -130.67 77.47 1.79 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.876 0.871 . . . . 0.0 109.274 165.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.2 t70 62.99 -7.92 0.14 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 128.634 2.774 . . . . 0.0 116.335 -166.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -165.32 163.36 36.5 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 125.628 1.585 . . . . 0.0 112.722 -177.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 78.2 mt -70.28 119.35 14.33 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.627 1.571 . . . . 0.0 110.594 -174.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -149.63 149.86 31.3 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -103.16 121.82 43.44 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.427 1.091 . . . . 0.0 111.028 -177.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 54.4 t -136.59 129.47 17.53 Favored Pre-proline 0 N--CA 1.481 1.104 0 C-N-CA 124.185 0.994 . . . . 0.0 110.87 -174.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -66.31 146.71 81.68 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.081 2.521 . . . . 0.0 112.811 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.11 -32.05 21.37 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 175.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.29 -19.43 65.41 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 173.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -107.8 -3.88 18.61 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.29 1.836 . . . . 0.0 112.824 177.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 92.6 t -73.47 146.23 10.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 C-N-CA 124.987 1.315 . . . . 0.0 110.479 168.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.78 159.26 72.03 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 127.762 2.425 . . . . 0.0 109.387 177.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -65.64 127.78 18.7 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 121.637 1.558 . . . . 0.0 110.724 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 99.14 7.81 54.41 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.238 0.923 . . . . 0.0 114.756 -178.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -67.15 165.65 15.55 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 118.301 1.05 . . . . 0.0 112.21 162.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.56 132.37 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 124.242 1.017 . . . . 0.0 111.211 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.0 t -107.26 134.1 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 126.367 1.867 . . . . 0.0 110.521 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 49.5 t -91.26 143.02 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.905 0.882 . . . . 0.0 111.355 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -169.1 -149.38 6.2 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.424 1.488 . . . . 0.0 111.846 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.6 p -136.88 162.99 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 125.388 1.475 . . . . 0.0 111.096 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -64.48 103.22 0.63 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.705 2.002 . . . . 0.0 110.427 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -62.65 -27.64 69.37 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -173.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -61.0 -28.16 68.84 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 173.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.7 t -85.96 -30.52 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.194 0.998 . . . . 0.0 110.394 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 47.7 tp -77.38 -26.51 51.92 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.667 1.587 . . . . 0.0 112.926 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -67.02 -18.25 65.29 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.582 1.553 . . . . 0.0 113.568 173.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -66.65 159.15 28.26 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.275 1.43 . . . . 0.0 112.844 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 55.4 mtt85 -71.86 -42.08 67.31 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.63 0.772 . . . . 0.0 112.438 174.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 42.1 mt -95.43 142.52 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.31 1.044 . . . . 0.0 110.13 168.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 42.0 mm -101.74 140.33 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.824 1.249 . . . . 0.0 111.305 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 40.1 t -116.02 134.77 54.61 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.017 1.727 . . . . 0.0 110.783 171.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -93.58 165.84 12.54 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -173.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 81.64 25.83 52.38 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 116.783 1.473 . . . . 0.0 116.783 165.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -117.7 155.21 30.35 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.619 1.568 . . . . 0.0 111.319 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.1 mt -146.83 153.36 40.08 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.221 1.009 . . . . 0.0 113.508 -177.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -135.8 151.47 50.11 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.156 1.782 . . . . 0.0 113.11 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -124.16 130.57 52.77 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.989 1.715 . . . . 0.0 110.701 -175.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -129.43 126.48 38.85 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.075 0.95 . . . . 0.0 110.411 -164.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -84.71 134.03 34.36 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.322 0.965 . . . . 0.0 112.152 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 75.0 t -67.41 129.41 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 124.142 0.977 . . . . 0.0 110.259 170.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.0 t -88.48 -42.94 11.8 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.412 1.485 . . . . 0.0 113.059 176.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.8 t -159.84 161.17 34.43 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.834 0.854 . . . . 0.0 111.426 -177.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 10.7 m -136.92 154.99 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.639 1.175 . . . . 0.0 112.555 170.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -162.36 162.11 27.73 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.428 1.091 . . . . 0.0 112.809 156.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 64.9 mt -76.05 141.34 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.953 0.901 . . . . 0.0 108.827 163.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 35.8 pt -130.67 156.67 42.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 126.988 2.115 . . . . 0.0 111.16 176.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -100.15 85.84 3.1 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 122.354 1.073 . . . . 0.0 111.382 -175.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -72.12 -46.45 56.57 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 121.308 -0.87 . . . . 0.0 112.862 -173.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 48.21 37.54 8.45 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.468 1.507 . . . . 0.0 113.097 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -145.47 174.52 11.08 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.503 1.121 . . . . 0.0 111.165 -170.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -74.64 132.81 42.03 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 123.553 0.741 . . . . 0.0 111.826 173.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 5.7 m -102.24 170.78 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.945 1.298 . . . . 0.0 109.474 169.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -123.0 161.47 24.2 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.973 0.909 . . . . 0.0 112.6 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -144.48 154.99 43.5 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.628 0.771 . . . . 0.0 110.184 158.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 40.8 tp -116.27 122.69 45.69 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.013 1.325 . . . . 0.0 110.232 175.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 99.7 t -91.83 121.25 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -165.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 25.1 mm -118.08 88.58 32.33 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 125.747 1.619 . . . . 0.0 110.227 -176.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -68.29 -13.69 38.43 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.47 2.113 . . . . 0.0 113.547 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -76.53 -46.39 26.73 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.326 0.966 . . . . 0.0 112.637 -177.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 81.3 p -138.78 -4.02 1.61 Allowed 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 126.077 1.751 . . . . 0.0 114.782 -169.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 31.0 m170 60.39 18.45 8.13 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 -177.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.15 148.51 25.02 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 120.095 -1.628 . . . . 0.0 113.582 177.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -132.66 170.9 14.56 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.939 1.696 . . . . 0.0 112.365 176.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 81.1 mt -121.54 132.99 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.471 1.108 . . . . 0.0 110.925 -175.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -80.36 161.74 63.76 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 125.102 1.361 . . . . 0.0 113.439 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.44 -18.35 62.71 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 122.869 2.379 . . . . 0.0 112.158 174.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.74 10.85 10.27 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.116 0.966 . . . . 0.0 113.181 172.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.21 -14.43 27.94 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.6 1.571 . . . . 0.0 116.559 176.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 78.6 mt -69.65 144.94 52.77 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 118.947 1.373 . . . . 0.0 112.833 -177.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 19.7 t -85.23 132.21 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.732 0.813 . . . . 0.0 110.629 171.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 77.1 mt -118.15 138.22 52.43 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.957 2.103 . . . . 0.0 110.061 177.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 42.3 t60 -137.76 141.85 40.93 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -168.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -159.73 151.5 20.29 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.977 1.311 . . . . 0.0 111.078 158.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -128.67 30.48 5.11 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.593 1.557 . . . . 0.0 114.59 -174.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 . . . . . 0 C--O 1.253 1.261 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -177.046 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.835 0 CA-C-O 119.474 -0.298 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.0 162.18 25.86 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.358 1.463 . . . . 0.0 112.238 -178.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.72 148.94 41.18 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.901 1.28 . . . . 0.0 113.697 177.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -12.54 31.98 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.047 1.339 . . . . 0.0 113.724 171.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.79 -24.19 64.38 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.187 2.195 . . . . 0.0 111.411 175.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.4 m -66.64 139.28 57.86 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.429 1.092 . . . . 0.0 113.62 -170.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -88.34 152.26 22.05 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.929 1.291 . . . . 0.0 113.427 171.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 p -148.17 153.3 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.122 0.969 . . . . 0.0 112.543 -169.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -132.88 127.22 33.92 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.175 1.79 . . . . 0.0 107.767 -173.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -153.0 177.7 10.49 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.111 0.964 . . . . 0.0 111.562 -175.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -134.48 141.79 46.87 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.036 -1.04 . . . . 0.0 111.275 173.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -154.51 162.38 41.17 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.774 1.63 . . . . 0.0 108.72 171.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.9 t70 51.28 29.74 5.28 Favored 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -174.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.1 m 57.34 39.74 28.14 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.703 1.601 . . . . 0.0 113.675 -171.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.0 p -153.58 141.13 13.53 Favored Pre-proline 0 CA--C 1.545 0.785 0 O-C-N 120.395 -1.441 . . . . 0.0 112.452 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.18 143.87 45.15 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.526 2.817 . . . . 0.0 113.871 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.5 m80 -128.45 141.67 51.33 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 128.294 2.637 . . . . 0.0 109.194 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 52.6 ttm -149.55 106.31 3.55 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.054 -1.029 . . . . 0.0 111.48 -174.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -153.95 179.39 8.95 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.115 0.966 . . . . 0.0 112.514 -171.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.9 m -74.86 141.08 44.25 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.028 -1.045 . . . . 0.0 109.479 168.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.425 HG12 ' CG ' ' A' ' 152' ' ' TYR . 8.4 tp -53.63 -36.28 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -176.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -63.44 -27.27 69.18 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.198 0.908 . . . . 0.0 112.564 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -74.85 -44.09 50.97 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.506 -0.746 . . . . 0.0 110.426 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 20.2 ptm -69.32 -37.44 77.74 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 119.371 -0.347 . . . . 0.0 111.3 172.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -59.78 -52.16 66.64 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.093 0.86 . . . . 0.0 110.874 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.7 t -65.51 -28.47 69.21 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.851 1.261 . . . . 0.0 111.773 -175.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -72.04 -56.78 5.03 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 127.373 2.269 . . . . 0.0 111.378 171.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -71.72 -33.77 69.02 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 120.919 -1.113 . . . . 0.0 112.791 -175.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.33 -23.07 65.59 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 121.288 -0.883 . . . . 0.0 112.663 172.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.2 t -89.67 -23.88 21.76 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.156 0.982 . . . . 0.0 113.316 174.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 70.5 mtm -86.44 -52.09 5.8 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.0 0.92 . . . . 0.0 112.013 176.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -106.65 -18.44 13.95 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.344 1.458 . . . . 0.0 112.724 -168.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.95 161.75 35.57 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.303 0.954 . . . . 0.0 114.05 176.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -109.42 126.89 53.94 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.954 0.902 . . . . 0.0 111.104 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.5 mp -98.6 144.94 29.04 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 125.32 1.448 . . . . 0.0 110.589 176.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -72.91 146.19 41.63 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 123.838 3.026 . . . . 0.0 112.199 -177.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.41 154.37 49.98 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.114 1.366 . . . . 0.0 111.941 178.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -52.55 -46.67 66.89 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.649 1.18 . . . . 0.0 113.745 -177.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -88.81 -9.98 49.77 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 172.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 173.81 -123.3 0.96 Allowed Glycine 0 CA--C 1.532 1.099 0 N-CA-C 116.958 1.543 . . . . 0.0 116.958 -168.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -142.7 159.25 42.59 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.007 1.723 . . . . 0.0 111.953 -177.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.25 150.66 46.91 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.522 1.529 . . . . 0.0 111.997 176.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.9 t -125.79 118.27 24.24 Favored Pre-proline 0 N--CA 1.486 1.34 0 C-N-CA 125.302 1.441 . . . . 0.0 111.29 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.62 140.89 40.41 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 124.186 3.257 . . . . 0.0 112.157 -178.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 73.3 mt -111.1 165.79 11.6 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.084 1.354 . . . . 0.0 112.568 176.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -145.59 124.09 12.43 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.881 1.272 . . . . 0.0 111.534 169.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 51.18 44.66 28.63 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.421 1.889 . . . . 0.0 113.856 -177.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.7 t -106.81 130.75 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.857 1.663 . . . . 0.0 109.884 173.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -130.15 159.19 37.57 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.948 1.299 . . . . 0.0 113.014 -169.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.5 m -144.78 150.63 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.951 1.7 . . . . 0.0 112.13 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -65.31 132.57 49.37 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.962 1.305 . . . . 0.0 108.027 164.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.461 HG21 ' HB ' ' A' ' 63' ' ' THR . 6.4 t -141.37 154.9 45.9 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.335 1.054 . . . . 0.0 112.005 -169.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 56.8 tp -115.64 133.41 56.06 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.957 1.303 . . . . 0.0 110.785 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.462 ' HB2' ' HE3' ' A' ' 61' ' ' LYS . 8.2 t0 -79.51 117.02 20.08 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.223 0.609 . . . . 0.0 111.255 163.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.4 mm -70.15 -16.64 20.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 O-C-N 121.056 -1.028 . . . . 0.0 113.261 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.48 -46.87 24.92 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.545 -1.347 . . . . 0.0 113.92 -177.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.0 m -121.36 -8.73 9.14 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 179.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.4 29.06 54.27 Favored Glycine 0 CA--C 1.535 1.291 0 O-C-N 121.388 -0.82 . . . . 0.0 114.016 -176.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -77.83 131.59 37.63 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.142 0.971 . . . . 0.0 110.933 175.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 mp -81.74 139.57 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 170.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.462 ' HE3' ' HB2' ' A' ' 54' ' ' ASP . 5.9 mttt -141.12 173.13 11.78 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.567 1.547 . . . . 0.0 110.485 174.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -111.53 128.53 56.05 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.476 0.71 . . . . 0.0 110.433 162.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.461 ' HB ' HG21 ' A' ' 52' ' ' THR . 2.9 t -131.41 164.54 25.48 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.202 1.001 . . . . 0.0 112.601 -174.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.8 ppt_? -86.09 139.59 30.99 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.231 1.013 . . . . 0.0 112.772 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -93.8 144.01 25.81 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.063 0.945 . . . . 0.0 109.587 166.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.7 t -101.01 -45.88 5.27 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -172.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -153.78 155.55 36.06 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.767 1.227 . . . . 0.0 112.551 175.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.9 mt -87.23 159.88 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.855 1.262 . . . . 0.0 108.85 167.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -142.54 151.03 41.19 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.178 1.791 . . . . 0.0 111.106 -176.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 42.9 ptt85 -145.5 159.41 43.14 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 167.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -152.09 159.42 43.67 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.333 1.853 . . . . 0.0 110.663 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -97.28 140.95 30.98 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.632 1.173 . . . . 0.0 112.526 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.1 m -148.12 141.62 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.073 0.949 . . . . 0.0 113.25 -176.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -99.66 -24.34 14.75 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.269 1.428 . . . . 0.0 113.226 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -127.86 126.83 42.33 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.451 1.101 . . . . 0.0 110.994 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.7 tp -136.84 167.11 22.08 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.947 2.099 . . . . 0.0 109.29 -173.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 20.2 mt -119.82 126.95 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.75 1.22 . . . . 0.0 108.816 176.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -99.31 116.63 31.93 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.917 0.887 . . . . 0.0 111.073 170.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.0 mp -101.4 122.33 53.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 125.175 1.39 . . . . 0.0 108.416 172.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -90.37 148.91 22.52 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.782 1.233 . . . . 0.0 110.791 174.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 65.2 mt -116.38 157.78 24.52 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.436 1.494 . . . . 0.0 111.831 178.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.1 t -64.65 -27.17 68.75 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.665 -0.647 . . . . 0.0 112.469 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 84.3 p -59.82 -22.43 62.22 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.374 1.469 . . . . 0.0 114.354 172.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 86.27 19.0 58.09 Favored Glycine 0 CA--C 1.537 1.452 0 O-C-N 121.284 -0.885 . . . . 0.0 113.806 -167.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -93.67 158.32 15.74 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.082 0.941 . . . . 0.0 111.062 161.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 83.8 p -138.21 137.53 37.66 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.52 1.528 . . . . 0.0 110.785 177.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.6 tp -115.97 130.65 56.91 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.93 1.292 . . . . 0.0 109.79 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -111.53 113.53 26.01 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.484 1.514 . . . . 0.0 109.929 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.8 m -137.41 153.82 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.16 1.384 . . . . 0.0 113.504 -169.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.6 p -66.71 143.25 98.0 Favored Pre-proline 0 N--CA 1.472 0.644 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 176.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -62.43 -22.26 73.83 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.713 2.942 . . . . 0.0 113.454 -178.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.6 p -88.55 -1.67 58.18 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.324 1.85 . . . . 0.0 114.215 176.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -87.74 124.28 67.69 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 119.158 0.89 . . . . 0.0 112.583 -175.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -70.97 129.75 16.79 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.607 2.872 . . . . 0.0 111.215 176.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.1 t -108.03 140.35 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 125.679 1.591 . . . . 0.0 110.337 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 51.9 tp -81.51 104.67 12.1 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.493 0.717 . . . . 0.0 110.812 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.1 mp -104.5 158.38 16.52 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.431 1.893 . . . . 0.0 112.119 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -106.14 127.02 52.91 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 169.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 72.4 mtp85 -138.23 74.87 1.49 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.981 0.912 . . . . 0.0 111.009 162.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 50.97 21.14 0.92 Allowed 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 125.44 1.496 . . . . 0.0 113.173 -164.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 179.27 149.02 8.06 Favored Glycine 0 CA--C 1.521 0.455 0 O-C-N 120.536 -1.352 . . . . 0.0 111.447 -170.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 60.6 mt -75.01 120.89 21.15 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.34 1.456 . . . . 0.0 109.523 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -150.34 151.68 33.27 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -177.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -105.76 121.12 43.37 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.458 1.103 . . . . 0.0 112.106 -172.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 78.5 t -139.07 132.56 15.92 Favored Pre-proline 0 N--CA 1.484 1.257 0 C-N-CA 124.916 1.286 . . . . 0.0 110.563 -178.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -66.82 145.29 74.38 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.827 2.352 . . . . 0.0 113.333 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.01 -34.03 19.89 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 175.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.84 -23.99 67.56 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 174.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -98.02 -15.49 20.03 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.552 1.141 . . . . 0.0 112.94 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.7 t -63.02 149.95 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.565 1.546 . . . . 0.0 111.416 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.8 154.3 81.02 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 126.094 1.757 . . . . 0.0 111.389 178.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -65.98 130.3 24.09 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.311 2.007 . . . . 0.0 111.513 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.62 4.09 54.88 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.775 1.179 . . . . 0.0 114.073 -176.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -65.06 168.76 6.15 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.668 1.187 . . . . 0.0 112.291 165.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.3 t -115.54 124.23 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.949 1.3 . . . . 0.0 111.069 -173.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.0 t -95.71 143.38 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.74 1.616 . . . . 0.0 110.31 175.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.5 t -89.56 133.71 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.706 0.803 . . . . 0.0 110.507 177.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -158.28 -158.52 9.05 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.139 0.876 . . . . 0.0 113.053 178.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.732 HG22 ' H ' ' A' ' 120' ' ' ARG . 4.1 p -141.38 -179.71 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 126.589 1.955 . . . . 0.0 111.746 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.732 ' H ' HG22 ' A' ' 119' ' ' VAL . 64.8 mtt-85 -78.74 98.71 6.36 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.489 1.916 . . . . 0.0 111.459 -175.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -58.8 -30.11 67.36 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.175 0.99 . . . . 0.0 112.227 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -63.01 -37.84 88.81 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.065 -1.022 . . . . 0.0 113.605 174.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 22.0 t -75.42 -39.94 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 13.1 tp -63.49 -14.59 52.42 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.52 1.528 . . . . 0.0 113.522 176.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 83.1 mtm-85 -80.45 -21.29 42.24 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.838 1.655 . . . . 0.0 115.056 169.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 11.8 mpt_? -77.87 169.05 18.93 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 119.821 1.191 . . . . 0.0 111.063 171.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 60.1 ttt-85 -91.36 71.35 6.09 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.629 1.172 . . . . 0.0 109.891 174.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 20.7 tt -142.8 152.39 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.054 1.341 . . . . 0.0 112.525 -164.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 71.6 mt -81.33 102.81 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.111 0.964 . . . . 0.0 108.655 162.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.3 m -77.71 61.57 2.43 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.175 0.99 . . . . 0.0 111.883 -176.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.26 151.52 43.42 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -170.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 67.24 -1.99 5.92 Favored Glycine 0 CA--C 1.536 1.376 0 N-CA-C 119.838 2.695 . . . . 0.0 119.838 162.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -107.79 152.96 23.67 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 120.257 2.028 . . . . 0.0 114.335 -169.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 92.5 mt -138.41 159.74 41.3 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.71 2.004 . . . . 0.0 111.353 168.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -150.73 127.05 10.65 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.473 2.309 . . . . 0.0 110.452 174.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -84.67 146.37 27.49 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.401 1.08 . . . . 0.0 112.227 -177.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 52.0 m80 -129.63 137.89 50.92 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.297 1.039 . . . . 0.0 111.479 -174.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -89.48 136.61 32.93 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.293 1.037 . . . . 0.0 113.529 -174.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 77.5 t -74.27 120.0 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.407 1.083 . . . . 0.0 111.379 171.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.8 t -87.68 -29.62 21.0 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.034 1.733 . . . . 0.0 114.105 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.1 m -164.93 164.54 20.73 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.693 1.197 . . . . 0.0 111.291 172.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.9 m -132.79 145.69 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.235 1.014 . . . . 0.0 111.221 165.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -151.21 154.56 37.08 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.78 1.232 . . . . 0.0 112.281 170.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 97.0 mt -76.59 141.89 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 160.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 24.7 pt -131.05 159.37 43.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 125.288 1.435 . . . . 0.0 110.898 169.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -98.54 101.49 12.94 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.731 0.776 . . . . 0.0 111.942 169.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -80.21 -47.71 14.23 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.609 -0.682 . . . . 0.0 112.281 -177.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 55.66 32.51 19.43 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.346 1.058 . . . . 0.0 113.095 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -144.65 178.2 8.15 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.0 1.32 . . . . 0.0 111.814 -170.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -80.51 139.94 36.12 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.115 1.366 . . . . 0.0 112.753 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.8 m -125.88 154.7 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 125.841 1.656 . . . . 0.0 110.063 177.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.425 ' CG ' HG12 ' A' ' 21' ' ' ILE . 1.6 p90 -115.67 162.92 16.56 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -171.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -140.87 150.78 43.67 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 125.8 1.64 . . . . 0.0 108.633 160.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 56.5 tp -119.19 115.26 23.85 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.326 -1.484 . . . . 0.0 109.677 175.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 35.0 t -86.0 120.47 35.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -163.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 13.1 mm -119.6 84.64 30.71 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 125.384 1.474 . . . . 0.0 109.424 -177.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -65.77 -8.14 18.68 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.777 2.984 . . . . 0.0 114.371 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -84.56 -42.15 15.74 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.03 1.332 . . . . 0.0 113.212 177.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 68.9 p -142.26 -11.93 0.83 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -170.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . 0.25 92.0 m-70 57.36 24.13 9.72 Favored 'General case' 0 CA--C 1.553 1.079 0 N-CA-C 116.782 2.141 . . . . 0.0 116.782 -176.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -157.36 150.53 23.64 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 119.929 -1.732 . . . . 0.0 114.169 175.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -148.18 142.69 26.44 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.526 1.53 . . . . 0.0 112.43 -174.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.8 mp -92.7 137.04 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 O-C-N 120.477 -1.389 . . . . 0.0 112.162 -175.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -91.97 159.42 37.91 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 126.698 1.999 . . . . 0.0 113.386 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.25 -13.76 33.81 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.95 3.1 . . . . 0.0 113.885 -177.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -72.85 -7.69 52.0 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.28 0.632 . . . . 0.0 112.049 168.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 98.54 -20.17 51.49 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 126.749 2.119 . . . . 0.0 113.902 -177.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 74.7 mt -69.72 144.57 52.75 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.043 1.422 . . . . 0.0 112.844 -174.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 56.8 t -74.49 125.73 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 165.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 47.0 mt -106.53 166.27 10.67 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.081 1.752 . . . . 0.0 110.487 167.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -132.31 155.04 49.07 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.153 0.981 . . . . 0.0 112.446 -157.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -117.19 122.01 42.82 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.268 1.027 . . . . 0.0 111.499 172.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -154.45 51.11 0.64 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.061 1.344 . . . . 0.0 112.684 -178.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 . . . . . 0 C--O 1.248 0.994 0 C-N-CA 124.639 1.175 . . . . 0.0 113.724 171.66 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.948 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -140.02 156.58 46.55 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.044 1.737 . . . . 0.0 111.239 -171.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.88 146.33 55.06 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 120.491 -1.381 . . . . 0.0 114.21 -177.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.87 -14.49 15.55 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.226 1.411 . . . . 0.0 114.605 165.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -69.87 -14.9 62.96 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.167 0.987 . . . . 0.0 112.24 170.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.8 m -80.5 143.55 33.23 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -170.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -80.17 152.69 29.06 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.604 1.562 . . . . 0.0 112.741 168.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.6 p -146.99 158.35 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.505 1.122 . . . . 0.0 112.534 -172.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -124.92 137.59 54.27 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.621 1.968 . . . . 0.0 108.749 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -156.27 177.13 11.79 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 118.863 0.756 . . . . 0.0 111.96 168.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -135.78 144.71 45.93 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.037 1.335 . . . . 0.0 110.206 171.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -150.77 -63.31 0.19 Allowed 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 176.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -76.6 45.07 0.38 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.815 1.246 . . . . 0.0 112.722 -175.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.4 m 49.56 45.12 24.37 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.321 1.448 . . . . 0.0 110.706 -168.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.9 p -165.98 144.23 4.8 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 127.021 2.128 . . . . 0.0 110.126 -173.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.2 161.3 23.21 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 124.013 3.142 . . . . 0.0 113.855 175.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -142.23 143.93 33.11 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.57 2.348 . . . . 0.0 111.337 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 40.7 ttm -145.83 120.34 9.72 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.15 1.38 . . . . 0.0 110.02 172.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -165.77 -179.03 5.09 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.217 1.407 . . . . 0.0 110.628 -172.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.7 m -76.82 142.94 40.09 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 120.83 -1.168 . . . . 0.0 110.635 171.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.436 HG12 ' CG ' ' A' ' 152' ' ' TYR . 8.4 tp -56.0 -36.64 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -177.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -69.71 -18.0 63.5 Favored 'General case' 0 CA--C 1.549 0.909 0 O-C-N 121.673 -0.642 . . . . 0.0 112.529 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -75.3 -46.9 30.53 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.156 -0.965 . . . . 0.0 110.465 172.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.7 ptm -71.95 -35.83 69.7 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -57.93 -53.59 56.54 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 118.921 0.782 . . . . 0.0 110.709 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.2 t -64.68 -33.68 76.52 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.318 1.047 . . . . 0.0 111.509 -176.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -65.12 -52.66 53.99 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.209 1.404 . . . . 0.0 110.683 175.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -70.1 -32.38 70.4 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.321 -0.862 . . . . 0.0 112.671 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.01 -27.68 67.63 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.999 0.92 . . . . 0.0 113.176 172.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.7 t -79.86 -35.46 38.11 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.469 1.107 . . . . 0.0 112.073 173.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 46.0 mtm -85.13 -43.47 13.83 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.157 0.983 . . . . 0.0 113.395 -174.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -107.5 -31.86 7.95 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.289 1.435 . . . . 0.0 111.404 -172.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 102.05 165.36 26.82 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.016 1.293 . . . . 0.0 113.508 -177.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -114.44 135.65 53.87 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.675 1.59 . . . . 0.0 111.136 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.6 mp -100.43 148.29 34.74 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 125.878 1.671 . . . . 0.0 109.833 166.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -75.79 159.34 38.56 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.328 2.685 . . . . 0.0 111.615 175.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -135.59 161.36 35.75 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.461 1.505 . . . . 0.0 109.861 164.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -42.9 -48.55 5.84 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -117.14 3.94 12.69 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -160.89 -145.64 4.36 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 115.515 0.966 . . . . 0.0 115.515 -172.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -150.53 155.53 39.65 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.388 1.875 . . . . 0.0 112.378 -175.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.72 143.43 41.22 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.459 1.504 . . . . 0.0 112.095 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 86.7 t -125.71 111.65 25.16 Favored Pre-proline 0 N--CA 1.484 1.233 0 C-N-CA 125.16 1.384 . . . . 0.0 110.787 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.63 127.74 13.5 Favored 'Trans proline' 0 C--N 1.351 0.686 1 C-N-CA 125.348 4.032 . . . . 0.0 112.307 -174.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 68.6 mt -106.64 156.4 18.65 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.183 0.993 . . . . 0.0 113.152 -177.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -134.98 132.66 38.63 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.91 1.684 . . . . 0.0 111.046 168.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 50.13 45.84 25.23 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.347 1.859 . . . . 0.0 113.244 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 49.1 t -109.07 127.76 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.69 0.796 . . . . 0.0 109.604 175.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -127.99 155.34 44.44 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.268 1.027 . . . . 0.0 113.471 -168.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.5 m -141.94 151.88 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 126.543 1.937 . . . . 0.0 112.25 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -72.25 136.35 46.3 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.298 1.839 . . . . 0.0 108.137 169.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.2 t -151.33 154.65 37.12 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.186 -0.946 . . . . 0.0 113.323 -170.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 60.2 tp -107.09 129.04 54.88 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.758 1.623 . . . . 0.0 110.579 177.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -79.78 102.35 9.01 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.602 -0.686 . . . . 0.0 109.876 168.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.5 mm -59.31 -23.36 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.318 1.047 . . . . 0.0 112.586 -175.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.81 -39.77 69.6 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.428 1.891 . . . . 0.0 114.746 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.3 m -108.4 -24.65 11.35 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.971 1.309 . . . . 0.0 112.94 -173.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.13 29.4 68.8 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.234 1.397 . . . . 0.0 113.161 -169.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -103.38 137.23 41.76 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.69 1.596 . . . . 0.0 111.386 -176.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.464 HD12 ' N ' ' A' ' 60' ' ' ILE . 1.3 mp -93.33 135.58 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.111 0.965 . . . . 0.0 109.088 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -153.27 172.2 17.37 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.796 1.638 . . . . 0.0 111.192 -176.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt -90.58 144.11 26.09 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.842 0.857 . . . . 0.0 111.146 165.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.8 t -136.48 166.38 23.64 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.056 1.342 . . . . 0.0 111.41 170.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.6 ptp85 -97.64 146.88 24.88 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.773 1.229 . . . . 0.0 112.939 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -103.13 146.21 28.74 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.468 1.107 . . . . 0.0 111.19 170.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.7 t -98.13 -43.35 7.05 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -174.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -153.9 159.01 41.58 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.062 0.945 . . . . 0.0 112.789 173.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.8 mt -89.42 151.48 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.08 0.952 . . . . 0.0 108.465 164.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -137.46 146.71 44.62 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.778 1.631 . . . . 0.0 110.31 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -144.07 151.55 39.78 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 119.833 1.197 . . . . 0.0 113.482 166.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -152.05 169.99 21.02 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.013 1.725 . . . . 0.0 110.597 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -103.35 140.13 37.84 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.689 1.195 . . . . 0.0 111.605 -175.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.1 m -146.88 142.22 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.649 1.18 . . . . 0.0 111.795 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.453 ' HA ' ' H ' ' A' ' 148' ' ' ASN . 11.6 pt-20 -104.99 -11.15 16.78 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.639 1.575 . . . . 0.0 113.451 175.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -123.75 121.21 34.86 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.969 1.308 . . . . 0.0 109.908 173.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.0 tp -136.9 161.03 37.14 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.43 1.492 . . . . 0.0 109.419 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.4 mt -114.5 128.11 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 120.982 -1.074 . . . . 0.0 109.348 178.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -100.6 113.61 26.58 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.559 1.143 . . . . 0.0 110.518 171.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.2 mp -100.79 122.11 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.174 1.39 . . . . 0.0 108.526 172.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -91.6 148.75 22.05 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.548 1.139 . . . . 0.0 111.108 176.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 82.8 mt -115.34 158.74 21.98 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.876 1.27 . . . . 0.0 112.822 -176.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.8 t -66.31 -39.71 89.5 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.993 1.317 . . . . 0.0 112.205 -175.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.7 m -75.29 0.28 17.19 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 172.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 105.99 -2.53 38.28 Favored Glycine 0 CA--C 1.534 1.268 0 N-CA-C 117.089 1.596 . . . . 0.0 117.089 162.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -81.48 171.64 14.47 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.529 1.664 . . . . 0.0 111.654 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 85.2 p -139.73 135.55 33.24 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.993 0.917 . . . . 0.0 112.926 174.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 68.4 tp -105.41 126.0 51.62 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.126 1.77 . . . . 0.0 109.468 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -114.52 110.62 20.1 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.422 1.489 . . . . 0.0 110.54 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.6 m -140.69 154.09 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.586 1.554 . . . . 0.0 112.34 -167.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.49 150.36 97.32 Favored Pre-proline 0 N--CA 1.468 0.427 0 C-N-CA 123.761 0.824 . . . . 0.0 113.115 177.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -63.51 -35.58 59.31 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.598 2.198 . . . . 0.0 114.951 -167.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.7 m -89.5 3.06 53.63 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -67.65 119.36 65.49 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 124.539 1.135 . . . . 0.0 110.928 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -80.12 126.47 6.35 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.914 2.409 . . . . 0.0 112.347 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.6 t -106.32 146.23 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 125.938 1.695 . . . . 0.0 109.537 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 21.6 tp -78.8 105.17 9.92 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.081 0.467 . . . . 0.0 110.221 177.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.6 mp -104.19 158.94 16.1 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.475 1.51 . . . . 0.0 111.508 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -103.35 122.81 45.6 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.186 0.594 . . . . 0.0 112.202 168.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 44.9 mtp180 -143.36 85.42 1.85 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.528 1.531 . . . . 0.0 109.366 170.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 54.56 -3.72 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 127.464 2.305 . . . . 0.0 115.855 -160.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -175.21 174.81 46.99 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 126.933 2.206 . . . . 0.0 113.059 -178.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 37.1 mt -64.58 122.33 16.56 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.965 1.706 . . . . 0.0 110.673 173.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -151.94 152.04 32.0 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.08 0.952 . . . . 0.0 113.4 170.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -97.96 118.48 34.64 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.297 1.439 . . . . 0.0 111.126 -173.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.3 t -130.09 130.59 23.11 Favored Pre-proline 0 N--CA 1.48 1.046 0 C-N-CA 124.001 0.921 . . . . 0.0 110.872 -172.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -65.71 140.36 61.59 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.67 2.246 . . . . 0.0 111.877 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.36 -31.52 14.88 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 176.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.25 -29.28 69.75 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 174.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -101.32 -2.71 30.38 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.241 1.416 . . . . 0.0 112.169 178.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 89.9 t -72.95 142.9 14.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 O-C-N 121.064 -1.022 . . . . 0.0 110.328 167.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.46 154.57 76.98 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 127.108 2.163 . . . . 0.0 109.804 -177.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.432 ' HD3' HG22 ' A' ' 142' ' ' VAL . 60.7 Cg_endo -66.21 136.07 42.61 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.778 1.652 . . . . 0.0 111.147 -170.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 93.37 3.65 64.84 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.812 1.196 . . . . 0.0 114.222 -176.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -62.54 158.64 17.53 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.441 1.096 . . . . 0.0 111.096 164.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.0 t -106.05 119.24 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.997 1.319 . . . . 0.0 110.16 -177.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.6 t -91.88 140.47 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.158 1.383 . . . . 0.0 109.694 174.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 38.2 t -90.64 135.67 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 123.739 0.816 . . . . 0.0 110.644 177.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -164.44 -145.29 4.34 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 114.268 0.467 . . . . 0.0 114.268 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.9 p -156.07 169.77 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 126.263 1.825 . . . . 0.0 109.545 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 74.1 mtm-85 -62.88 109.31 1.41 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.18 1.392 . . . . 0.0 111.946 175.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -65.02 -25.89 68.04 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 178.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -64.54 -39.27 93.45 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.37 0.986 . . . . 0.0 113.038 176.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.0 p -80.57 -29.04 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 119.227 0.921 . . . . 0.0 111.582 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 17.6 tp -70.76 -17.67 62.79 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 121.381 -0.824 . . . . 0.0 112.613 171.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.8 mtt85 -95.75 9.51 40.16 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 127.226 2.21 . . . . 0.0 114.329 171.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -86.35 154.82 20.93 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.129 1.372 . . . . 0.0 110.182 158.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -75.85 -25.83 56.56 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 119.755 1.161 . . . . 0.0 112.401 172.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 59.1 mt -85.73 81.64 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 162.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.542 HD13 ' H ' ' A' ' 129' ' ' ILE . 0.2 OUTLIER -71.15 113.39 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.935 0.894 . . . . 0.0 111.019 177.256 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 38.4 t -78.16 129.69 35.45 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.422 0.689 . . . . 0.0 112.054 -175.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -97.22 165.76 11.89 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.018 0.927 . . . . 0.0 113.123 170.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 93.31 6.16 63.09 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 125.244 1.402 . . . . 0.0 116.194 171.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -129.2 152.38 48.84 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.969 1.708 . . . . 0.0 112.326 -177.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.3 mt -140.76 160.28 40.38 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.622 1.569 . . . . 0.0 112.103 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -144.05 165.15 28.61 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.409 1.484 . . . . 0.0 111.248 174.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -110.73 152.28 26.77 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.727 1.211 . . . . 0.0 111.91 174.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 64.1 m-70 -135.36 137.81 42.73 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.493 1.117 . . . . 0.0 109.635 -176.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -103.52 135.29 45.4 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.453 -0.78 . . . . 0.0 112.475 -169.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 91.4 t -73.86 125.64 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 121.631 0.729 . . . . 0.0 111.352 177.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 21.2 t -88.28 -37.77 15.75 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.734 1.614 . . . . 0.0 113.403 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.2 m -154.47 159.67 41.15 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.824 1.25 . . . . 0.0 111.327 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.432 HG22 ' HD3' ' A' ' 112' ' ' PRO . 4.5 m -138.2 148.94 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 123.434 0.693 . . . . 0.0 111.193 163.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -163.16 159.65 23.25 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.309 1.044 . . . . 0.0 113.41 165.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 89.9 mt -79.22 135.57 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 164.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 16.3 pt -124.54 163.49 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 127.589 2.355 . . . . 0.0 109.828 173.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . 0.328 1.6 p-10 -114.13 65.98 0.67 Allowed 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 -172.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -56.27 -39.93 73.42 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.794 1.637 . . . . 0.0 115.335 -160.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.453 ' H ' ' HA ' ' A' ' 74' ' ' GLU . 6.1 m-80 47.9 36.02 5.57 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.81 2.044 . . . . 0.0 113.461 -175.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -146.48 175.52 10.5 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 120.841 -1.162 . . . . 0.0 112.458 -170.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -67.21 133.74 50.33 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 122.396 1.093 . . . . 0.0 113.433 -176.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.7 m -114.45 150.83 16.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.437 164.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.436 ' CG ' HG12 ' A' ' 21' ' ' ILE . 2.8 p90 -111.78 163.88 13.67 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.987 1.315 . . . . 0.0 111.656 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -143.84 147.99 34.87 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.348 0.659 . . . . 0.0 109.844 160.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 34.6 tp -107.15 122.18 45.99 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.687 1.195 . . . . 0.0 110.271 174.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 36.1 t -87.47 118.04 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 O-C-N 121.948 -0.47 . . . . 0.0 111.911 -168.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 12.7 mm -123.19 84.78 51.53 Favored Pre-proline 0 N--CA 1.472 0.66 0 C-N-CA 125.29 1.436 . . . . 0.0 110.416 -176.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -70.04 -12.08 31.68 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 122.646 2.231 . . . . 0.0 113.835 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -74.34 -40.5 62.12 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.066 1.346 . . . . 0.0 113.83 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 70.9 p -139.73 -13.9 1.09 Allowed 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -170.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 77.4 m80 56.11 20.69 4.58 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.984 1.713 . . . . 0.0 115.179 -164.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -150.13 151.0 32.45 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.618 -1.301 . . . . 0.0 114.476 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -145.87 173.84 11.77 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.307 1.843 . . . . 0.0 111.065 177.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 79.4 mt -122.26 138.29 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.01 0.924 . . . . 0.0 110.534 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -89.0 158.18 47.43 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 124.087 0.955 . . . . 0.0 112.438 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -65.7 -18.69 59.05 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.136 2.557 . . . . 0.0 112.751 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -74.57 7.92 2.66 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.868 1.267 . . . . 0.0 112.812 170.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 91.55 -25.11 16.78 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 126.968 2.223 . . . . 0.0 115.644 175.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 41.3 mt -75.19 144.37 42.72 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.553 1.176 . . . . 0.0 113.79 -166.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.9 t -86.1 127.66 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.012 0.925 . . . . 0.0 111.079 174.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 52.9 mt -117.29 150.35 38.94 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.113 2.165 . . . . 0.0 112.169 -174.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -109.24 145.52 35.76 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.632 1.173 . . . . 0.0 112.809 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -84.22 76.34 10.11 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 121.21 -0.931 . . . . 0.0 111.811 169.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -154.58 146.47 23.48 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.951 1.301 . . . . 0.0 111.865 172.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 . . . . . 0 C--O 1.256 1.44 0 C-N-CA 127.459 2.303 . . . . 0.0 113.515 -170.332 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.638 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -135.04 162.04 33.59 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.673 1.989 . . . . 0.0 111.098 -174.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.46 141.7 57.5 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.1 0.96 . . . . 0.0 111.673 172.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -11.58 38.66 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 176.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -81.43 -13.11 58.62 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.565 1.946 . . . . 0.0 113.306 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.3 m -64.47 136.92 57.55 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.153 0.981 . . . . 0.0 112.253 -177.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -81.32 151.64 27.93 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.662 0.744 . . . . 0.0 112.073 171.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 p -144.14 160.68 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 123.611 0.764 . . . . 0.0 111.038 -170.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -132.09 124.78 29.85 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.167 1.387 . . . . 0.0 108.929 -175.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -149.58 174.87 12.06 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 118.921 0.782 . . . . 0.0 112.73 176.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -131.03 142.43 50.32 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.117 1.367 . . . . 0.0 110.879 170.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -162.91 141.98 8.73 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.996 1.319 . . . . 0.0 110.533 174.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.2 t70 61.34 38.21 16.45 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.38 1.472 . . . . 0.0 113.448 -173.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.8 m 59.41 40.6 20.66 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.317 1.447 . . . . 0.0 112.651 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.2 p -158.85 140.51 9.8 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 124.866 1.266 . . . . 0.0 110.873 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -75.46 155.82 40.89 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 123.791 2.994 . . . . 0.0 113.806 176.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 39.1 m-70 -137.0 142.99 42.53 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 127.072 2.149 . . . . 0.0 110.767 176.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 43.1 ttm -154.29 82.64 1.12 Allowed 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.764 0.792 . . . . 0.0 112.432 -170.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -143.49 -176.34 4.91 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.238 1.415 . . . . 0.0 112.085 -173.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.9 m -69.37 138.47 53.7 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 120.955 -1.091 . . . . 0.0 110.755 174.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.5 tp -55.06 -36.34 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -66.73 -17.91 65.1 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.338 -0.851 . . . . 0.0 113.127 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -75.43 -51.76 12.31 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.354 1.061 . . . . 0.0 109.927 172.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 22.2 ptm -68.08 -36.21 79.46 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.43 -0.794 . . . . 0.0 112.034 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -56.17 -51.83 66.58 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.5 0.72 . . . . 0.0 111.299 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.1 m -57.27 -40.16 77.16 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 125.324 1.449 . . . . 0.0 111.727 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -69.51 -50.93 40.43 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.017 0.927 . . . . 0.0 111.173 178.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -68.19 -33.66 74.84 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 121.338 -0.851 . . . . 0.0 112.213 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.68 -23.46 65.31 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.59 0.756 . . . . 0.0 112.782 172.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.57 -11.94 38.54 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.957 1.303 . . . . 0.0 114.112 174.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 67.0 mtm -103.66 -52.2 3.03 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.103 1.361 . . . . 0.0 111.669 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -105.14 -16.53 14.76 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.972 1.309 . . . . 0.0 112.346 -171.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.36 161.97 32.21 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 124.234 0.921 . . . . 0.0 113.271 175.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -104.96 140.58 37.97 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.913 0.885 . . . . 0.0 109.845 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.3 mp -118.51 149.09 45.47 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 126.375 1.87 . . . . 0.0 110.611 176.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -81.44 151.24 17.43 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.074 3.183 . . . . 0.0 112.222 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -138.9 163.35 32.54 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.308 1.843 . . . . 0.0 111.097 -175.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -50.76 -55.88 14.66 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.844 1.258 . . . . 0.0 113.573 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -95.54 -7.45 37.91 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.47 -134.23 1.84 Allowed Glycine 0 CA--C 1.533 1.167 0 N-CA-C 115.507 0.963 . . . . 0.0 115.507 -170.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -138.98 160.23 40.26 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.623 1.969 . . . . 0.0 111.05 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.98 155.71 45.45 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.205 1.002 . . . . 0.0 113.311 176.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.8 t -126.46 115.97 23.13 Favored Pre-proline 0 N--CA 1.48 1.059 0 C-N-CA 126.09 1.756 . . . . 0.0 110.457 175.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.95 139.3 29.87 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 124.63 3.554 . . . . 0.0 112.296 -176.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 78.4 mt -107.76 163.98 12.63 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.65 1.18 . . . . 0.0 112.752 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -147.93 128.41 14.04 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.686 1.594 . . . . 0.0 109.345 168.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 55.04 41.31 31.9 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.865 1.666 . . . . 0.0 114.264 -176.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.4 t -108.32 118.43 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 O-C-N 121.308 -0.87 . . . . 0.0 109.618 175.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -114.52 148.33 38.07 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.458 1.103 . . . . 0.0 112.166 -171.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.9 m -139.44 153.97 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.091 1.357 . . . . 0.0 111.431 175.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -76.27 147.21 38.42 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.726 0.775 . . . . 0.0 111.557 172.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.6 t -154.96 167.08 31.53 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.69 1.596 . . . . 0.0 111.316 -165.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 36.9 tp -124.76 139.11 54.15 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.453 1.501 . . . . 0.0 110.326 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -87.14 112.96 22.46 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.363 1.065 . . . . 0.0 109.652 164.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.1 mm -71.62 -21.39 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 121.049 -1.032 . . . . 0.0 112.513 -175.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.47 -45.62 21.66 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -174.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.2 m -101.89 -15.63 16.81 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.266 1.027 . . . . 0.0 112.681 173.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.55 23.33 75.62 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.045 0.831 . . . . 0.0 113.524 -174.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -82.41 133.66 35.22 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.501 1.12 . . . . 0.0 111.519 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.3 mp -80.67 136.06 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 174.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -142.92 171.08 14.54 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.444 1.898 . . . . 0.0 111.528 -174.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -117.56 144.98 44.58 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.911 1.684 . . . . 0.0 110.118 167.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.7 t -143.68 153.29 42.32 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.221 1.008 . . . . 0.0 112.492 -174.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.3 137.07 37.88 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.362 1.065 . . . . 0.0 112.198 172.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.83 136.78 36.89 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.16 0.984 . . . . 0.0 110.984 172.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 91.4 p -89.02 -47.25 8.25 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.862 0.865 . . . . 0.0 113.267 -167.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -154.12 156.97 38.21 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.393 1.477 . . . . 0.0 112.356 173.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.7 mt -87.19 153.57 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 124.683 1.193 . . . . 0.0 107.941 164.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -138.6 152.61 48.29 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.858 1.663 . . . . 0.0 111.581 -173.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -146.52 152.88 39.69 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 164.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -150.39 167.22 27.72 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 127.453 2.301 . . . . 0.0 110.574 177.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -106.33 138.63 42.16 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.079 1.351 . . . . 0.0 113.779 -173.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.8 m -145.97 145.28 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 C-N-CA 124.764 1.226 . . . . 0.0 111.881 -176.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -96.22 -30.86 13.24 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 125.867 1.667 . . . . 0.0 112.26 175.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -129.41 133.25 47.25 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.144 0.978 . . . . 0.0 111.822 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.9 tp -136.39 158.45 44.4 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.15 2.18 . . . . 0.0 109.161 -170.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.2 mt -110.17 127.66 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 O-C-N 121.241 -0.912 . . . . 0.0 109.617 176.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -102.91 119.08 38.21 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.321 1.048 . . . . 0.0 111.648 168.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -104.86 123.65 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.694 1.598 . . . . 0.0 108.547 174.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -91.54 143.93 26.07 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.431 1.092 . . . . 0.0 111.142 173.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.4 mt -109.73 151.94 26.29 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.231 1.812 . . . . 0.0 110.706 175.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.9 t -66.53 -22.8 66.16 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -168.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.9 m -76.9 -10.29 59.27 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.863 1.265 . . . . 0.0 114.159 172.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 107.03 2.28 36.19 Favored Glycine 0 CA--C 1.54 1.634 0 N-CA-C 116.731 1.452 . . . . 0.0 116.731 175.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -80.86 153.81 27.43 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.41 1.484 . . . . 0.0 110.841 172.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 39.1 p -131.06 144.32 51.35 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 168.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 60.0 tp -111.72 126.35 54.95 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.168 2.187 . . . . 0.0 109.566 177.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -118.61 107.8 14.17 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.823 1.649 . . . . 0.0 110.556 -173.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.3 m -143.42 151.49 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.83 1.252 . . . . 0.0 113.174 -161.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.4 p -67.9 149.07 98.37 Favored Pre-proline 0 N--CA 1.467 0.402 0 O-C-N 121.43 -0.794 . . . . 0.0 111.93 174.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -59.5 -29.81 90.93 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 123.144 2.563 . . . . 0.0 114.09 -168.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.3 p -81.04 -9.42 59.83 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 55.6 t60 -69.38 120.81 79.39 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 119.717 1.144 . . . . 0.0 111.637 -178.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -79.31 129.49 8.65 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.019 2.479 . . . . 0.0 113.687 178.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.4 t -103.95 143.13 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 126.112 1.765 . . . . 0.0 109.544 175.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.05 109.32 15.51 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.181 0.515 . . . . 0.0 110.729 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.4 mp -106.23 153.84 21.57 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.417 1.887 . . . . 0.0 111.33 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -108.65 107.72 18.3 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 40.8 mtp180 -139.83 89.71 2.33 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 120.9 -1.125 . . . . 0.0 109.842 174.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 59.76 -13.84 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 128.154 2.581 . . . . 0.0 116.049 -163.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -174.2 -176.36 42.53 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 126.163 1.839 . . . . 0.0 113.329 174.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 95.1 mt -72.37 117.51 14.11 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.796 2.038 . . . . 0.0 111.738 -174.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -146.59 141.84 27.35 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -95.96 120.92 37.09 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.428 1.491 . . . . 0.0 111.225 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 83.9 t -123.5 128.03 25.35 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 123.652 0.781 . . . . 0.0 109.945 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -62.87 142.93 90.42 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.283 1.989 . . . . 0.0 111.147 176.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.0 -31.89 19.46 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 176.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.42 -11.29 57.43 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 174.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -112.71 -4.62 14.03 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.144 1.378 . . . . 0.0 113.552 171.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.4 t -71.63 149.35 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.067 1.347 . . . . 0.0 111.712 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.14 152.04 79.47 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 126.26 1.824 . . . . 0.0 111.747 178.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -67.56 125.24 13.04 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.271 2.647 . . . . 0.0 111.093 -175.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 96.93 9.58 55.99 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-O 119.673 -0.515 . . . . 0.0 114.266 -173.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -65.52 161.37 20.28 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 118.183 0.991 . . . . 0.0 111.587 159.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.4 p -106.59 126.96 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.617 1.567 . . . . 0.0 111.604 178.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.9 t -106.2 136.41 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.791 1.636 . . . . 0.0 111.199 -177.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.3 t -89.78 134.74 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.081 0.952 . . . . 0.0 110.9 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -158.49 -153.11 6.64 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.533 1.064 . . . . 0.0 111.522 172.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.408 HG22 ' H ' ' A' ' 120' ' ' ARG . 3.6 p -131.88 162.5 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.766 1.226 . . . . 0.0 110.294 167.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.408 ' H ' HG22 ' A' ' 119' ' ' VAL . 40.3 mtt-85 -60.15 107.61 0.67 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.47 1.908 . . . . 0.0 112.556 -165.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -64.13 -31.04 72.09 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -176.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -62.09 -22.21 65.62 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 173.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 57.4 t -85.51 -53.74 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 173.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 16.2 tp -65.43 -15.66 62.85 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.99 1.716 . . . . 0.0 114.611 -172.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -95.3 -15.58 23.04 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 171.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.3 ttm180 -146.13 -8.66 0.53 Allowed 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 -162.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -137.93 176.0 9.09 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.924 1.29 . . . . 0.0 112.592 -174.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 16.0 tt -48.37 141.2 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 126.234 1.814 . . . . 0.0 111.178 159.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 10.9 pt -78.4 117.7 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 120.959 -1.088 . . . . 0.0 111.627 -174.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 59.9 p -81.44 72.95 8.49 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 120.978 -1.076 . . . . 0.0 111.698 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.45 148.45 48.54 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 121.366 -0.834 . . . . 0.0 111.748 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 89.87 11.34 63.67 Favored Glycine 0 CA--C 1.538 1.519 0 N-CA-C 116.0 1.16 . . . . 0.0 116.0 -177.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -127.9 158.81 36.79 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.257 1.423 . . . . 0.0 112.313 174.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.7 mt -137.94 158.56 44.09 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.276 1.83 . . . . 0.0 111.4 173.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -142.02 150.41 41.27 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.429 1.492 . . . . 0.0 112.339 177.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -91.52 148.87 21.98 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.944 1.697 . . . . 0.0 113.25 176.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -137.09 139.4 41.24 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.438 1.495 . . . . 0.0 109.911 -177.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -91.5 130.21 37.36 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.844 0.747 . . . . 0.0 111.843 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 71.1 t -67.94 125.47 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 O-C-N 121.498 -0.751 . . . . 0.0 109.758 168.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.4 t -85.62 -42.64 14.15 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.944 1.698 . . . . 0.0 112.635 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.5 t -159.93 165.41 32.16 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.602 1.161 . . . . 0.0 111.108 174.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.9 m -135.11 149.94 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.671 1.188 . . . . 0.0 110.936 168.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -156.02 160.31 39.91 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.964 0.906 . . . . 0.0 112.65 167.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 87.8 mt -81.67 143.44 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 161.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 43.2 pt -131.91 152.33 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.949 2.1 . . . . 0.0 111.383 173.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -87.12 97.21 10.62 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.004 -1.06 . . . . 0.0 110.769 174.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -76.94 -46.63 23.48 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.554 -1.341 . . . . 0.0 112.59 177.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 50.84 31.94 6.65 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.59 1.156 . . . . 0.0 114.077 -176.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -139.19 172.59 12.61 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.808 -1.183 . . . . 0.0 111.61 -176.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -71.18 141.35 50.7 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.34 1.056 . . . . 0.0 111.562 173.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.9 m -123.53 153.26 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 126.219 1.808 . . . . 0.0 109.551 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -109.72 161.92 14.94 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.169 0.587 . . . . 0.0 112.258 -173.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -143.19 157.59 44.37 Favored 'General case' 0 CA--C 1.55 0.949 0 O-C-N 121.722 -0.612 . . . . 0.0 111.366 158.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 44.1 tp -114.76 127.88 55.99 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.056 1.342 . . . . 0.0 110.555 174.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 37.8 t -98.26 132.73 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 121.689 0.757 . . . . 0.0 112.415 -169.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 20.8 mm -132.66 92.61 26.59 Favored Pre-proline 0 N--CA 1.47 0.535 0 C-N-CA 126.08 1.752 . . . . 0.0 108.599 -173.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -70.41 -13.25 32.86 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.404 2.069 . . . . 0.0 113.469 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -72.88 -45.66 57.03 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 118.725 0.693 . . . . 0.0 112.368 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 82.5 p -140.74 -10.21 1.04 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.807 1.643 . . . . 0.0 114.55 -171.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 45.8 m80 55.66 21.46 4.6 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 -169.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -143.7 148.57 35.93 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 120.74 -1.225 . . . . 0.0 113.955 177.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -143.3 167.62 21.72 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.346 1.458 . . . . 0.0 112.449 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 92.5 mt -115.18 131.12 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.416 1.486 . . . . 0.0 110.501 -172.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -81.31 160.23 65.69 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 123.914 0.886 . . . . 0.0 112.543 177.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.92 -12.34 32.4 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.741 2.294 . . . . 0.0 113.421 174.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -94.11 24.13 4.54 Favored 'General case' 0 CA--C 1.555 1.141 0 CA-C-N 118.785 0.72 . . . . 0.0 111.576 165.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 83.42 -23.31 6.45 Favored Glycine 0 CA--C 1.528 0.905 0 O-C-N 120.051 -1.655 . . . . 0.0 117.102 166.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 72.7 mt -61.84 142.03 57.59 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.897 1.348 . . . . 0.0 112.797 -175.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.2 t -98.02 124.95 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.96 0.904 . . . . 0.0 110.525 174.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 27.4 mt -119.37 139.69 51.58 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.856 1.662 . . . . 0.0 111.77 -168.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -97.87 139.75 33.26 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.007 0.923 . . . . 0.0 112.794 172.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -67.81 121.53 16.17 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.705 1.202 . . . . 0.0 111.883 176.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -134.06 85.26 2.18 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.977 0.911 . . . . 0.0 112.511 -176.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.253 1.288 0 C-N-CA 127.158 2.183 . . . . 0.0 112.462 173.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -137.42 155.78 48.95 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.422 1.889 . . . . 0.0 110.988 -172.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -55.28 141.46 35.53 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.203 1.001 . . . . 0.0 112.364 174.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -59.92 -21.09 60.65 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.012 0.925 . . . . 0.0 113.367 172.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -77.53 -3.68 41.84 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.493 1.517 . . . . 0.0 112.635 175.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.8 m -79.22 145.0 33.85 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 122.443 1.116 . . . . 0.0 112.689 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -73.64 158.74 34.19 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.726 1.61 . . . . 0.0 114.112 171.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.3 p -149.2 153.64 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 124.325 1.05 . . . . 0.0 111.599 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -122.91 130.71 53.18 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.69 1.996 . . . . 0.0 107.466 175.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -150.61 179.49 8.14 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.994 0.917 . . . . 0.0 111.287 169.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -140.77 143.69 35.05 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.447 1.499 . . . . 0.0 110.565 178.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -158.28 -39.95 0.06 Allowed 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -100.01 41.1 1.18 Allowed 'General case' 0 N--CA 1.479 1.023 0 O-C-N 120.999 -1.063 . . . . 0.0 112.936 -172.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.6 m 53.26 33.49 15.58 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.247 1.419 . . . . 0.0 112.434 -167.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.6 p -159.44 146.32 12.62 Favored Pre-proline 0 C--O 1.24 0.559 0 C-N-CA 126.8 2.04 . . . . 0.0 107.799 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -74.1 161.01 41.78 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.282 2.655 . . . . 0.0 111.596 171.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -137.75 125.33 22.18 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 126.416 1.886 . . . . 0.0 109.58 -175.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -127.75 112.78 15.17 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.458 1.503 . . . . 0.0 109.023 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -155.45 -175.64 5.54 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.293 1.437 . . . . 0.0 110.704 -177.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.5 m -78.07 148.05 34.44 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 120.9 -1.125 . . . . 0.0 110.045 168.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.472 HG12 ' CG ' ' A' ' 152' ' ' TYR . 7.3 tp -58.05 -38.71 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 O-C-N 121.508 -0.745 . . . . 0.0 111.831 177.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -61.09 -20.1 62.22 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 178.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -85.34 -46.07 11.32 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.87 1.268 . . . . 0.0 111.217 175.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -73.29 -33.59 65.3 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 121.202 -0.936 . . . . 0.0 112.158 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -59.95 -46.96 87.7 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.795 0.838 . . . . 0.0 111.1 176.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.9 t -63.04 -36.03 82.2 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.41 1.084 . . . . 0.0 111.551 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -65.23 -53.61 41.82 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.342 1.457 . . . . 0.0 110.395 175.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -72.29 -34.13 67.94 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.006 -1.059 . . . . 0.0 113.382 -178.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.16 -28.01 66.92 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.964 0.906 . . . . 0.0 112.748 176.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 51.3 m -75.89 -41.89 50.7 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.406 0.682 . . . . 0.0 111.479 172.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 45.5 mtm -78.71 -45.02 22.2 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.44 1.096 . . . . 0.0 113.006 -172.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 23.5 m-20 -111.44 -26.36 9.14 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.124 1.37 . . . . 0.0 112.238 -170.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.19 163.47 27.55 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.85 1.214 . . . . 0.0 114.424 176.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -110.79 126.6 54.79 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.575 1.15 . . . . 0.0 111.167 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.3 mp -95.69 147.68 33.39 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 127.077 2.151 . . . . 0.0 110.988 174.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -73.1 151.15 49.27 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.243 2.629 . . . . 0.0 111.125 174.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -133.73 160.67 36.88 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.318 1.447 . . . . 0.0 111.155 165.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -46.76 -49.03 20.38 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.058 1.343 . . . . 0.0 113.852 177.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -101.18 -5.93 24.94 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 177.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.49 -129.64 1.28 Allowed Glycine 0 CA--C 1.528 0.865 0 CA-C-N 119.75 1.159 . . . . 0.0 115.148 -173.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -144.64 156.32 44.05 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.684 1.194 . . . . 0.0 112.738 -174.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.34 150.45 47.74 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.547 1.139 . . . . 0.0 111.814 177.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.5 t -126.01 120.18 23.96 Favored Pre-proline 0 N--CA 1.48 1.065 0 C-N-CA 125.437 1.495 . . . . 0.0 110.027 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -76.05 139.19 21.42 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 124.13 3.22 . . . . 0.0 111.482 -176.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.3 mt -108.36 155.6 20.36 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.56 0.744 . . . . 0.0 112.516 178.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -138.11 132.5 32.11 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.098 1.359 . . . . 0.0 110.056 167.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 57.5 33.89 23.87 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.503 1.521 . . . . 0.0 113.896 -178.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.8 t -107.88 127.84 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 121.074 -1.016 . . . . 0.0 111.473 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -132.79 160.95 35.38 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.08 1.352 . . . . 0.0 113.905 -172.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.9 p -151.5 155.83 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 125.8 1.64 . . . . 0.0 112.467 -178.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.515 ' CE1' HG23 ' A' ' 60' ' ' ILE . 1.1 t80 -65.51 132.41 48.84 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.841 0.856 . . . . 0.0 110.153 168.021 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.8 t -132.81 140.17 47.85 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.711 1.605 . . . . 0.0 109.937 173.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.5 tp -91.15 134.1 34.81 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 171.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -79.73 105.32 10.94 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 164.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 23.2 mm -63.29 -24.74 36.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 O-C-N 121.647 -0.658 . . . . 0.0 111.566 -174.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -81.47 -37.21 28.31 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.307 1.843 . . . . 0.0 115.784 -178.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.0 m -106.13 -18.53 13.99 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.658 1.183 . . . . 0.0 112.483 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.4 25.73 73.67 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 125.324 1.44 . . . . 0.0 113.52 -168.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -79.52 131.28 35.99 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.899 1.68 . . . . 0.0 111.093 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.515 HG23 ' CE1' ' A' ' 51' ' ' TYR . 2.8 mp -92.37 113.47 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 173.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -138.38 172.81 12.35 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.079 1.352 . . . . 0.0 112.019 -174.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -103.9 148.05 26.61 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.66 1.184 . . . . 0.0 111.009 173.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.6 t -140.66 151.85 44.91 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.393 1.077 . . . . 0.0 111.178 173.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -72.89 157.58 37.17 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.252 1.021 . . . . 0.0 111.967 171.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -115.81 143.4 45.45 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.308 1.443 . . . . 0.0 110.942 168.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -88.67 -48.5 7.49 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.229 1.012 . . . . 0.0 112.933 -173.174 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -157.35 157.35 33.95 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.686 1.194 . . . . 0.0 112.043 177.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.5 mt -88.1 153.14 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 124.918 1.287 . . . . 0.0 108.265 166.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -135.22 151.31 50.5 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.025 1.73 . . . . 0.0 111.27 -178.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 26.8 ptt-85 -147.34 156.65 43.1 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 167.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -152.36 163.07 40.23 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.508 1.923 . . . . 0.0 108.945 176.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.17 143.44 26.37 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.36 -0.838 . . . . 0.0 110.577 176.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.0 m -143.28 143.81 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 122.417 1.103 . . . . 0.0 111.641 175.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -101.82 -15.23 16.98 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.657 1.183 . . . . 0.0 113.009 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -132.22 125.44 31.13 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.549 1.54 . . . . 0.0 110.903 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.1 tp -140.26 159.85 41.27 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.012 1.725 . . . . 0.0 109.538 -173.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.2 mt -112.53 128.52 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.372 1.069 . . . . 0.0 109.177 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -102.51 119.67 39.22 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.225 1.01 . . . . 0.0 110.696 169.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -104.16 127.9 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 124.821 1.249 . . . . 0.0 108.556 173.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -94.19 148.35 22.27 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.865 1.266 . . . . 0.0 110.719 172.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 70.6 mt -114.87 156.89 24.12 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.545 1.938 . . . . 0.0 111.367 -177.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 36.3 t -68.38 -20.1 64.67 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -163.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 37.2 m -93.86 4.76 53.45 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 173.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 102.08 11.57 36.52 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.129 1.347 . . . . 0.0 116.254 171.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -96.23 167.99 10.86 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.977 1.311 . . . . 0.0 111.706 177.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 97.1 p -142.46 157.76 44.41 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -176.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.1 tp -135.8 127.8 29.62 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.989 1.716 . . . . 0.0 110.337 177.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -108.7 115.81 30.79 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.491 1.516 . . . . 0.0 111.949 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.4 m -142.33 153.55 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.721 1.608 . . . . 0.0 113.142 -169.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.2 p -67.56 147.96 98.67 Favored Pre-proline 0 N--CA 1.465 0.314 0 O-C-N 121.308 -0.87 . . . . 0.0 112.305 174.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -55.5 -33.77 87.38 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.673 2.916 . . . . 0.0 114.102 -174.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.9 p -81.76 -6.96 59.52 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 30.1 t60 -76.27 120.18 80.54 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 124.737 1.215 . . . . 0.0 112.333 -174.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -75.65 129.78 12.06 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.869 2.379 . . . . 0.0 113.436 176.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.72 144.98 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 126.499 1.92 . . . . 0.0 109.256 174.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 21.2 tp -80.88 106.62 13.02 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.343 0.519 . . . . 0.0 110.561 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.5 mp -107.49 165.63 11.26 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.859 2.063 . . . . 0.0 112.272 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -119.86 119.43 33.52 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.447 1.099 . . . . 0.0 113.05 176.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 33.6 mtm180 -132.59 77.86 1.77 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.176 1.39 . . . . 0.0 108.486 164.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.2 t70 59.23 8.49 1.11 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 126.862 2.065 . . . . 0.0 115.501 -169.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.34 169.01 42.12 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.953 1.739 . . . . 0.0 111.228 -174.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 71.7 mt -76.58 119.23 20.12 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.512 1.125 . . . . 0.0 110.639 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -133.55 131.76 40.12 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.127 0.971 . . . . 0.0 110.915 -176.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -88.32 122.29 31.67 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 172.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 67.0 t -132.2 127.11 20.79 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 123.87 0.868 . . . . 0.0 110.301 -175.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -65.89 142.72 70.31 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.378 2.052 . . . . 0.0 111.239 176.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.97 -30.85 16.07 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 176.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.08 -18.44 65.31 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 173.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -111.74 -3.97 14.81 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.151 1.38 . . . . 0.0 112.248 175.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 89.3 t -71.16 144.49 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.833 1.253 . . . . 0.0 110.316 169.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.12 156.66 78.92 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 126.407 1.883 . . . . 0.0 110.895 -177.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.36 126.24 13.99 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.337 2.025 . . . . 0.0 112.404 -172.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 108.07 -2.85 33.4 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.03 1.3 . . . . 0.0 114.814 -178.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -59.81 160.38 7.66 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.938 1.295 . . . . 0.0 113.221 174.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.8 t -102.56 118.35 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.139 1.375 . . . . 0.0 109.975 177.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.4 t -93.79 141.55 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.698 1.599 . . . . 0.0 110.058 173.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.5 t -91.38 138.66 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.259 1.024 . . . . 0.0 110.555 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -164.7 -149.13 5.7 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 123.402 0.525 . . . . 0.0 114.339 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.7 p -150.33 159.44 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 127.008 2.123 . . . . 0.0 108.573 175.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -59.11 124.45 20.0 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.91 0.884 . . . . 0.0 112.249 176.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -59.38 -31.81 69.57 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -64.22 -21.8 66.71 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 175.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 86.9 t -80.13 -31.39 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 118.906 0.776 . . . . 0.0 111.075 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -85.2 -16.17 41.21 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.28 1.832 . . . . 0.0 113.154 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 70.2 mtt-85 -69.92 -14.14 62.58 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 166.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 10.4 mmp_? -80.16 145.4 32.35 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.55 1.14 . . . . 0.0 111.74 -176.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -72.66 -26.55 61.68 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 177.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 70.6 mt -98.7 127.94 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.836 1.255 . . . . 0.0 108.599 165.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 48.6 mm -102.64 116.33 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.81 1.244 . . . . 0.0 109.917 -176.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 9.5 t -87.86 149.36 24.16 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -101.32 169.66 8.75 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.044 1.738 . . . . 0.0 113.357 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.95 2.51 88.69 Favored Glycine 0 CA--C 1.54 1.619 0 N-CA-C 117.545 1.778 . . . . 0.0 117.545 167.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -125.11 148.37 48.58 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 119.62 1.71 . . . . 0.0 113.556 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 96.7 mt -139.58 174.25 10.7 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 127.864 2.465 . . . . 0.0 111.907 -177.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -142.25 170.85 14.94 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 127.437 2.295 . . . . 0.0 110.604 169.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -126.04 147.0 49.67 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.103 1.761 . . . . 0.0 110.805 172.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -135.76 134.79 39.37 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.257 1.023 . . . . 0.0 110.313 -168.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -95.13 138.95 32.15 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.523 -0.736 . . . . 0.0 112.916 -174.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 71.0 t -74.15 132.67 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.351 1.06 . . . . 0.0 111.012 174.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 36.1 t -91.64 -40.36 11.35 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.211 1.804 . . . . 0.0 113.082 176.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.5 t -162.08 165.97 26.45 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.18 0.992 . . . . 0.0 110.643 176.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.2 m -131.93 148.23 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.491 1.116 . . . . 0.0 109.986 166.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -152.0 154.46 36.05 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.377 1.071 . . . . 0.0 112.766 172.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 87.7 mt -94.32 129.21 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.414 1.086 . . . . 0.0 108.537 169.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 16.8 pt -123.02 165.4 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 126.393 1.877 . . . . 0.0 112.131 -177.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -108.24 68.21 0.69 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.463 1.905 . . . . 0.0 112.509 -173.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -62.21 -43.88 97.84 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 121.097 -1.002 . . . . 0.0 113.24 -164.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 50.97 33.27 8.59 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.338 1.455 . . . . 0.0 113.894 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -141.5 177.64 7.99 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.853 1.261 . . . . 0.0 111.962 -174.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -77.65 142.07 39.06 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.161 0.985 . . . . 0.0 113.055 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 14.8 m -126.76 151.04 33.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 125.666 1.586 . . . . 0.0 109.671 177.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.472 ' CG ' HG12 ' A' ' 21' ' ' ILE . 1.2 p90 -111.04 164.18 13.08 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.678 0.791 . . . . 0.0 112.463 -175.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -144.31 155.4 43.8 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 122.439 0.296 . . . . 0.0 110.761 154.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 46.6 tp -107.49 124.39 49.83 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.568 1.147 . . . . 0.0 110.329 175.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 23.1 t -91.98 117.44 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 121.768 0.794 . . . . 0.0 111.887 -171.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 13.7 mm -120.73 83.25 35.52 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 126.396 1.879 . . . . 0.0 109.063 -177.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -63.24 -19.31 68.21 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.123 1.882 . . . . 0.0 113.808 178.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -76.13 -30.38 58.16 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 120.533 -1.355 . . . . 0.0 113.944 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 69.7 p -141.43 -18.1 0.79 Allowed 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . 0.253 75.6 m80 56.82 21.89 6.47 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.077 2.151 . . . . 0.0 115.165 -168.046 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -147.32 145.66 29.42 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.618 1.099 . . . . 0.0 113.767 -179.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -148.66 164.79 33.27 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.085 1.354 . . . . 0.0 111.709 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.2 mp -111.39 136.3 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.296 1.038 . . . . 0.0 111.466 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -81.88 157.64 68.82 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 124.033 0.933 . . . . 0.0 112.374 175.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -64.92 -22.71 62.67 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.815 2.344 . . . . 0.0 112.76 178.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -77.27 -5.48 49.58 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.559 0.744 . . . . 0.0 112.856 173.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 112.55 -21.68 18.65 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 125.955 1.74 . . . . 0.0 116.566 165.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 58.3 mt -76.87 149.89 36.09 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.097 1.448 . . . . 0.0 113.88 -171.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.9 t -96.78 123.84 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.761 1.224 . . . . 0.0 111.818 -178.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 25.4 mt -117.47 142.88 46.63 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.323 1.849 . . . . 0.0 112.577 -169.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -102.72 140.42 37.02 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.266 1.026 . . . . 0.0 112.369 170.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -66.89 133.94 51.04 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.944 0.897 . . . . 0.0 111.649 174.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -142.85 113.89 7.68 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.08 0.952 . . . . 0.0 113.487 -176.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 . . . . . 0 C--O 1.253 1.273 0 C-N-CA 127.164 2.185 . . . . 0.0 111.774 -177.858 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.676 0 CA-C-O 120.832 0.349 . . . . 0.0 111.481 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.11 161.75 32.51 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.702 2.401 . . . . 0.0 110.684 -177.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.84 141.68 56.85 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.338 1.055 . . . . 0.0 112.59 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.2 ppt_? -56.54 -28.55 60.33 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.016 1.327 . . . . 0.0 113.166 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -81.74 -6.89 59.45 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.725 2.01 . . . . 0.0 114.599 -177.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.1 m -69.02 144.04 54.17 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.159 1.384 . . . . 0.0 112.856 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -82.06 152.02 26.8 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.438 1.495 . . . . 0.0 113.88 171.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.7 p -148.19 162.57 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.698 1.599 . . . . 0.0 111.685 -173.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -134.89 130.02 35.28 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.685 1.594 . . . . 0.0 109.823 -173.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -157.3 -178.53 7.42 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 118.924 0.784 . . . . 0.0 112.793 175.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -135.3 138.86 43.87 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.399 1.479 . . . . 0.0 111.43 172.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -169.0 146.92 3.8 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.139 1.376 . . . . 0.0 111.374 174.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.5 t0 62.92 36.93 12.38 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 115.321 1.601 . . . . 0.0 115.321 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 m 62.59 37.51 13.0 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.579 1.552 . . . . 0.0 113.504 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.8 p -157.29 137.08 8.58 Favored Pre-proline 0 CA--C 1.543 0.703 0 O-C-N 121.329 -0.857 . . . . 0.0 111.499 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.26 147.4 32.94 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.962 3.108 . . . . 0.0 111.111 171.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -127.35 135.97 51.26 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.812 1.245 . . . . 0.0 112.02 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 52.1 ttm -143.79 88.29 1.97 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.736 1.215 . . . . 0.0 109.789 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -146.31 -176.42 5.16 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.729 2.012 . . . . 0.0 111.645 -168.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -73.64 150.98 40.96 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.472 -1.392 . . . . 0.0 111.893 176.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.8 tp -58.34 -37.25 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 O-C-N 121.527 -0.733 . . . . 0.0 111.927 173.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -64.5 -30.44 71.47 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.215 0.916 . . . . 0.0 113.003 174.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -73.76 -41.39 62.51 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.587 -0.696 . . . . 0.0 110.301 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 20.0 ptm -69.47 -39.51 77.67 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.654 171.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -57.41 -52.41 65.49 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.975 0.807 . . . . 0.0 111.756 -178.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.8 t -71.55 -29.13 64.4 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 122.718 0.407 . . . . 0.0 111.503 -173.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -65.19 -53.01 51.17 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.363 1.465 . . . . 0.0 110.634 173.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -68.26 -32.77 73.18 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.376 -0.827 . . . . 0.0 112.015 177.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.74 -28.54 66.9 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.495 1.118 . . . . 0.0 113.658 174.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.4 t -83.83 -31.49 25.79 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.416 -0.802 . . . . 0.0 111.736 174.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 67.1 mtm -81.33 -42.75 20.09 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -114.27 -23.11 9.59 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.193 1.397 . . . . 0.0 113.875 -171.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.98 161.74 37.01 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.836 1.208 . . . . 0.0 114.647 -178.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -112.83 128.43 56.44 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.566 1.547 . . . . 0.0 110.406 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.8 mp -105.54 142.56 25.01 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 125.393 1.477 . . . . 0.0 111.789 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.24 146.27 40.25 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 124.04 3.16 . . . . 0.0 112.349 -177.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -141.12 159.55 41.98 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.083 1.753 . . . . 0.0 111.346 -178.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -61.42 -52.07 66.12 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 120.203 -1.56 . . . . 0.0 114.578 -178.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -79.84 -15.34 57.59 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 172.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -179.05 -125.99 0.98 Allowed Glycine 0 CA--C 1.539 1.549 0 N-CA-C 117.177 1.631 . . . . 0.0 117.177 -175.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -143.6 161.89 37.32 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.897 1.679 . . . . 0.0 111.003 178.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.19 148.52 41.7 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.952 1.301 . . . . 0.0 112.486 -176.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 54.5 t -124.11 120.99 26.28 Favored Pre-proline 0 N--CA 1.481 1.113 0 C-N-CA 125.756 1.623 . . . . 0.0 110.861 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -75.9 141.91 24.65 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 124.245 3.297 . . . . 0.0 112.317 -178.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.3 mt -106.45 164.58 11.93 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.52 1.128 . . . . 0.0 113.692 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -146.65 125.71 12.87 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.297 1.439 . . . . 0.0 111.009 173.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 54.46 32.96 17.74 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 125.758 1.623 . . . . 0.0 114.251 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.2 t -96.31 122.38 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 120.849 -1.157 . . . . 0.0 110.179 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -124.12 155.04 39.14 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.488 1.115 . . . . 0.0 113.508 -174.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.5 p -150.49 152.19 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.663 1.185 . . . . 0.0 111.976 -176.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.412 ' CE1' HG23 ' A' ' 60' ' ' ILE . 1.2 t80 -63.31 129.83 41.95 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 122.026 0.917 . . . . 0.0 110.228 167.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.405 HG21 ' HB ' ' A' ' 63' ' ' THR . 5.2 t -131.22 152.17 50.76 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.624 1.97 . . . . 0.0 111.248 178.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.6 tp -105.0 135.0 47.15 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.428 1.091 . . . . 0.0 110.211 175.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -80.8 116.04 20.59 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.769 0.828 . . . . 0.0 110.404 164.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 39.4 mm -71.9 -21.43 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.634 0.774 . . . . 0.0 112.473 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.8 -43.11 31.61 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.91 0.884 . . . . 0.0 113.305 -176.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -107.28 -23.67 12.16 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.405 1.082 . . . . 0.0 111.882 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.9 34.25 38.95 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.519 1.056 . . . . 0.0 113.272 -170.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -99.27 147.18 25.43 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.747 1.274 . . . . 0.0 113.502 -175.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.412 HG23 ' CE1' ' A' ' 51' ' ' TYR . 3.4 mp -91.95 130.88 40.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 C-N-CA 125.999 1.72 . . . . 0.0 110.025 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -157.5 171.43 20.37 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.367 1.467 . . . . 0.0 112.374 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -102.86 141.65 35.32 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.075 1.35 . . . . 0.0 111.047 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.405 ' HB ' HG21 ' A' ' 52' ' ' THR . 1.1 t -141.5 166.44 24.74 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.094 0.958 . . . . 0.0 112.373 176.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -93.61 150.79 20.13 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.941 1.296 . . . . 0.0 112.809 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.56 139.16 46.07 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.563 1.145 . . . . 0.0 111.556 173.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 93.1 p -91.0 -51.93 5.1 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -165.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -155.07 159.56 40.35 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.494 1.517 . . . . 0.0 112.95 177.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.3 mt -96.66 151.59 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 125.803 1.641 . . . . 0.0 109.117 170.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -137.6 148.5 45.9 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.347 1.459 . . . . 0.0 111.569 -174.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.51 149.12 52.38 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.399 1.48 . . . . 0.0 112.423 176.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -155.6 162.41 40.64 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.945 1.298 . . . . 0.0 110.386 176.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -101.74 140.92 35.38 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.08 0.952 . . . . 0.0 110.983 -176.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.8 m -149.05 144.47 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 124.527 1.131 . . . . 0.0 111.522 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -93.01 -36.16 12.88 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 126.278 1.831 . . . . 0.0 111.384 170.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -118.38 130.61 56.09 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.355 1.062 . . . . 0.0 110.981 -171.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.3 tp -139.02 159.14 42.86 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.648 1.979 . . . . 0.0 109.403 -173.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.4 mt -113.07 126.05 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.884 0.874 . . . . 0.0 109.209 176.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -97.03 127.82 43.38 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.08 0.952 . . . . 0.0 111.268 167.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -113.79 133.02 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.467 1.507 . . . . 0.0 109.474 173.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -103.78 146.47 28.58 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 126.753 2.021 . . . . 0.0 111.957 -179.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 68.2 mt -119.48 156.72 29.7 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.785 1.634 . . . . 0.0 113.08 -173.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.9 t -57.45 -29.39 64.16 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.312 1.445 . . . . 0.0 113.913 -178.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 55.7 m -75.44 1.38 14.17 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 173.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.63 43.26 19.4 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-N 119.608 1.095 . . . . 0.0 112.596 -178.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -130.48 152.78 49.5 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.15 1.78 . . . . 0.0 109.667 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 54.3 p -132.37 149.68 52.3 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 174.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 67.3 tp -122.19 134.18 54.72 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 126.501 1.92 . . . . 0.0 110.791 176.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -113.26 117.29 31.44 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.286 1.435 . . . . 0.0 111.962 -178.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.0 m -140.59 158.33 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.275 1.43 . . . . 0.0 112.913 -174.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.6 p -65.61 147.56 98.63 Favored Pre-proline 0 N--CA 1.471 0.61 0 O-C-N 120.975 -1.078 . . . . 0.0 112.766 174.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -59.5 -32.7 96.69 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.385 2.723 . . . . 0.0 113.763 -172.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 64.6 p -75.66 -1.64 25.66 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.774 2.03 . . . . 0.0 114.9 177.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 53.6 t60 -91.07 122.11 66.98 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 124.497 1.119 . . . . 0.0 113.022 -165.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 93' ' ' HIS . 17.3 Cg_exo -73.22 142.28 33.67 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.929 2.419 . . . . 0.0 114.425 -177.027 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.2 t -125.89 143.14 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 126.73 2.012 . . . . 0.0 109.479 174.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.1 tt -81.21 105.52 12.48 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.703 0.763 . . . . 0.0 110.087 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.8 mp -99.73 159.58 14.95 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.335 1.854 . . . . 0.0 111.381 177.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -113.54 133.31 55.32 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.675 -0.641 . . . . 0.0 111.89 174.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -153.46 96.86 2.08 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.942 1.697 . . . . 0.0 110.224 155.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 56.27 -3.33 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 127.328 2.251 . . . . 0.0 116.898 -167.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.83 163.43 34.52 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.372 1.463 . . . . 0.0 113.333 177.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 67.5 mt -67.93 115.16 7.14 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.066 2.146 . . . . 0.0 110.943 -177.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -141.73 139.81 32.97 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -178.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -98.37 124.53 43.09 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.919 0.887 . . . . 0.0 112.157 -175.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 62.1 t -131.58 131.28 22.74 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 125.196 1.398 . . . . 0.0 110.258 -172.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.43 145.62 77.67 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.583 2.188 . . . . 0.0 111.878 177.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.57 -30.95 14.4 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 176.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.27 -25.93 68.27 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 173.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -102.59 -4.95 24.45 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.032 1.733 . . . . 0.0 112.737 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 98.5 t -69.69 148.76 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.024 0.929 . . . . 0.0 109.647 166.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.92 155.22 71.09 Favored Pre-proline 0 N--CA 1.471 0.585 0 C-N-CA 127.252 2.221 . . . . 0.0 109.987 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.403 ' HD3' HG22 ' A' ' 142' ' ' VAL . 55.6 Cg_endo -65.89 119.48 6.51 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.041 1.827 . . . . 0.0 111.577 -177.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.42 ' H ' ' HB ' ' A' ' 139' ' ' VAL . . . 107.24 6.87 33.45 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.158 1.361 . . . . 0.0 114.705 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -61.15 155.62 20.22 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.275 1.037 . . . . 0.0 111.654 163.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.6 t -93.04 128.46 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.421 1.088 . . . . 0.0 110.071 169.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 28.0 t -103.03 139.03 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 126.381 1.872 . . . . 0.0 109.695 171.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.6 t -91.68 141.34 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.531 0.732 . . . . 0.0 110.772 176.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -168.38 -150.52 6.66 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 121.728 -0.607 . . . . 0.0 114.188 -177.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 120' ' ' ARG . 9.4 p -140.33 168.36 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 126.253 1.821 . . . . 0.0 109.979 175.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.41 ' H ' HG22 ' A' ' 119' ' ' VAL . 35.9 mtp180 -62.02 112.62 2.41 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.584 1.554 . . . . 0.0 112.607 -175.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -63.58 -21.38 66.32 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.083 1.353 . . . . 0.0 113.085 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -83.09 -31.12 27.46 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 173.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 46.6 t -86.29 -40.88 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.488 0.715 . . . . 0.0 110.972 -174.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 42.2 tp -65.9 -28.64 69.09 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.535 0.734 . . . . 0.0 112.2 178.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 36.5 mtp-105 -95.07 28.59 2.73 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.698 1.599 . . . . 0.0 113.082 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 71.1 mtt85 -138.09 157.98 45.23 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 127.699 2.4 . . . . 0.0 109.64 170.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -70.19 147.68 49.54 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.027 0.931 . . . . 0.0 112.04 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 91.4 mt 60.09 114.0 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 127.07 2.148 . . . . 0.0 112.486 -162.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.5 mp -86.13 134.34 27.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 123.975 0.91 . . . . 0.0 108.973 167.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 41.3 t -79.89 130.38 35.26 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.381 0.673 . . . . 0.0 109.7 167.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.3 ptpt -91.39 144.0 26.03 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.505 1.122 . . . . 0.0 111.866 -172.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 74.32 24.49 73.07 Favored Glycine 0 CA--C 1.54 1.597 0 N-CA-C 114.985 0.754 . . . . 0.0 114.985 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -121.97 136.72 54.94 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.293 1.437 . . . . 0.0 112.658 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 60.9 mt -128.93 174.18 9.74 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.652 1.981 . . . . 0.0 112.297 178.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -140.05 169.53 17.53 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.885 2.474 . . . . 0.0 109.279 171.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -135.5 156.18 49.32 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 119.992 -1.693 . . . . 0.0 111.627 164.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.29 140.09 52.07 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.589 1.156 . . . . 0.0 110.862 -172.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -89.28 133.69 34.36 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.51 0.724 . . . . 0.0 110.985 170.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.42 ' HB ' ' H ' ' A' ' 113' ' ' GLY . 79.4 t -72.15 122.58 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 123.433 0.693 . . . . 0.0 110.229 174.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 47.9 t -77.76 -41.98 35.68 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.652 1.181 . . . . 0.0 112.478 174.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.7 t -160.8 164.67 31.26 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.458 -0.777 . . . . 0.0 112.376 -177.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.403 HG22 ' HD3' ' A' ' 112' ' ' PRO . 5.7 m -135.72 150.71 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.485 1.114 . . . . 0.0 110.999 167.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -152.68 155.94 38.24 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.397 1.079 . . . . 0.0 112.943 173.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 80.5 mt -93.01 130.82 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 168.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 36.3 pt -122.33 149.37 25.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 124.63 1.172 . . . . 0.0 112.371 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.53 102.47 12.88 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.421 1.088 . . . . 0.0 110.069 168.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -84.34 -50.38 7.87 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.211 0.604 . . . . 0.0 111.715 172.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 44.57 57.17 4.62 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.978 1.311 . . . . 0.0 112.504 -173.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -151.63 175.71 12.08 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.712 0.805 . . . . 0.0 112.176 -177.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -67.67 144.42 55.5 Favored 'General case' 0 N--CA 1.463 0.189 0 O-C-N 121.727 -0.608 . . . . 0.0 110.79 162.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.1 m -122.5 152.16 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.521 1.128 . . . . 0.0 109.466 169.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -114.47 157.2 23.25 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 121.781 0.801 . . . . 0.0 112.09 -178.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -155.59 153.94 30.89 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.777 0.831 . . . . 0.0 109.784 -165.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 32.3 tp -136.51 139.44 42.27 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.174 -0.954 . . . . 0.0 111.788 -170.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 28.9 t -113.17 130.04 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.763 0.825 . . . . 0.0 112.608 -168.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 11.0 mm -134.08 85.55 39.51 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 125.728 1.611 . . . . 0.0 109.535 -175.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.98 -13.71 39.08 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.006 2.471 . . . . 0.0 113.766 -177.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -79.43 -40.18 30.58 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.383 0.882 . . . . 0.0 113.383 -177.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 59.1 p -140.14 -6.41 1.24 Allowed 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -171.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 58.01 13.35 2.15 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.203 1.801 . . . . 0.0 115.851 -174.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.03 147.55 24.15 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 120.96 1.709 . . . . 0.0 114.983 -176.157 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -146.85 159.24 43.76 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.369 1.068 . . . . 0.0 113.539 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.7 mp -99.7 137.96 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.466 1.106 . . . . 0.0 112.643 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -91.0 156.26 44.32 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 126.664 1.986 . . . . 0.0 112.428 172.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -67.75 -19.83 46.85 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.763 2.976 . . . . 0.0 113.74 -174.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 47.6 p30 -73.18 -0.94 15.67 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.063 1.345 . . . . 0.0 113.418 171.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.2 -5.63 68.28 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 126.391 1.948 . . . . 0.0 115.385 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 66.8 mt -84.94 153.54 22.76 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.231 1.516 . . . . 0.0 111.846 -175.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.7 p -110.55 133.04 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.785 0.834 . . . . 0.0 111.798 175.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 24.4 mt -116.2 154.33 30.26 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.831 2.052 . . . . 0.0 110.844 -172.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 8.3 t-80 -111.64 149.75 31.09 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.081 0.952 . . . . 0.0 112.86 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -60.47 137.07 58.21 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.474 0.709 . . . . 0.0 111.161 162.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -91.71 -3.57 56.1 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 -171.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 . . . . . 0 C--O 1.247 0.957 0 C-N-CA 125.101 1.36 . . . . 0.0 112.042 -168.622 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.608 0 CA-C-O 120.819 0.343 . . . . 0.0 111.6 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.12 156.32 45.37 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.704 1.602 . . . . 0.0 110.748 -169.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.08 145.3 31.3 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.825 1.25 . . . . 0.0 114.203 -177.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -60.64 -23.39 64.73 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.474 1.509 . . . . 0.0 114.216 177.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -92.79 4.37 53.93 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.792 0.837 . . . . 0.0 112.973 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.8 m -71.47 140.14 49.89 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.027 -1.045 . . . . 0.0 111.603 174.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -65.67 155.61 35.44 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.241 1.417 . . . . 0.0 113.648 167.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.7 p -148.11 151.93 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.331 1.052 . . . . 0.0 111.341 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -128.08 126.22 40.78 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.544 1.538 . . . . 0.0 108.254 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -156.92 176.98 12.03 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.396 0.678 . . . . 0.0 111.616 -177.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -134.83 138.36 44.15 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.683 1.193 . . . . 0.0 110.08 178.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -161.66 158.79 26.61 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.425 1.09 . . . . 0.0 110.213 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.3 t0 50.27 37.87 16.14 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.063 0.945 . . . . 0.0 113.26 -175.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.7 m 53.39 41.85 32.07 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.398 1.079 . . . . 0.0 113.372 -176.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.0 p -157.92 142.19 11.61 Favored Pre-proline 0 CA--C 1.545 0.753 0 O-C-N 120.968 -1.083 . . . . 0.0 111.216 174.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.14 149.26 64.21 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 123.003 2.468 . . . . 0.0 112.604 174.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -137.11 139.82 41.5 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 127.209 2.203 . . . . 0.0 109.629 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 42.6 ttm -153.08 106.1 2.98 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.361 -0.837 . . . . 0.0 110.775 -174.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -159.55 -179.3 7.78 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.006 1.322 . . . . 0.0 111.963 -165.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.4 m -71.03 138.02 49.51 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.099 -1.0 . . . . 0.0 110.565 169.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.466 HG12 ' CG ' ' A' ' 152' ' ' TYR . 6.6 tp -55.13 -38.75 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 O-C-N 121.251 -0.906 . . . . 0.0 112.606 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -66.29 -16.78 64.31 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.389 0.995 . . . . 0.0 113.104 -177.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -87.2 -41.13 13.97 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.846 1.258 . . . . 0.0 111.178 173.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 2.1 ppp? -73.4 -36.93 66.09 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 120.914 -1.116 . . . . 0.0 112.062 176.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -55.42 -45.7 76.73 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.447 1.099 . . . . 0.0 110.673 175.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.2 t -60.98 -34.67 75.14 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.1 0.96 . . . . 0.0 111.156 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -65.47 -53.08 47.78 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.457 1.103 . . . . 0.0 110.513 174.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -73.28 -35.36 66.15 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 121.495 -0.753 . . . . 0.0 112.739 -173.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.01 -35.67 80.45 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.262 0.625 . . . . 0.0 110.686 172.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 54.5 m -76.9 -24.08 52.51 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 121.049 -1.032 . . . . 0.0 113.538 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 33.1 mtm -90.54 -52.98 4.63 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.844 1.258 . . . . 0.0 112.062 177.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -100.31 -21.33 15.49 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.34 1.456 . . . . 0.0 112.049 -167.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.84 161.09 31.58 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.632 1.111 . . . . 0.0 113.049 -177.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -102.76 138.38 39.73 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.663 1.185 . . . . 0.0 111.155 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.6 mp -107.4 148.21 36.73 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 128.925 2.89 . . . . 0.0 110.212 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.85 155.68 43.68 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 123.516 2.811 . . . . 0.0 112.53 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -142.46 175.95 9.38 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.857 1.263 . . . . 0.0 112.524 169.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.61 -55.96 25.95 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.555 1.142 . . . . 0.0 112.119 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -105.94 -4.19 20.91 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -175.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -169.7 -135.69 1.95 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 114.61 0.604 . . . . 0.0 114.61 -172.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -144.65 165.37 28.23 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.086 1.754 . . . . 0.0 111.334 -175.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.29 159.33 42.33 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.687 1.595 . . . . 0.0 111.617 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 54.2 t -131.52 117.18 16.47 Favored Pre-proline 0 N--CA 1.48 1.061 0 C-N-CA 125.747 1.619 . . . . 0.0 111.102 178.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -82.46 123.3 3.81 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 124.233 3.289 . . . . 0.0 112.664 -172.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 90.5 mt -97.74 157.48 16.04 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -171.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -134.49 127.04 30.62 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.731 1.613 . . . . 0.0 112.588 171.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 52.32 40.95 30.23 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.246 1.418 . . . . 0.0 113.578 178.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.7 t -104.26 126.62 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.974 1.31 . . . . 0.0 109.543 172.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -126.46 158.74 35.26 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.927 1.291 . . . . 0.0 112.305 -175.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.8 m -143.09 150.18 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 126.334 1.853 . . . . 0.0 111.457 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -69.56 133.07 47.21 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 122.925 1.345 . . . . 0.0 109.666 164.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.3 t -137.13 164.68 27.87 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.7 2.4 . . . . 0.0 110.345 -173.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.3 tp -119.22 135.37 54.72 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.389 1.076 . . . . 0.0 109.194 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -79.1 105.99 10.83 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 163.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.2 mm -70.62 -24.63 25.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.685 0.794 . . . . 0.0 111.579 -175.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.97 -47.56 71.2 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.439 1.496 . . . . 0.0 113.391 -177.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.1 m -107.98 -19.27 13.56 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.599 1.16 . . . . 0.0 112.745 178.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.62 36.87 15.14 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.018 0.818 . . . . 0.0 112.318 -176.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -101.63 134.5 44.67 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.875 1.67 . . . . 0.0 112.591 -177.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 mp -76.64 136.53 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 O-C-N 121.798 -0.564 . . . . 0.0 109.934 178.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.1 ptpt -146.94 168.09 22.36 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.559 1.544 . . . . 0.0 111.781 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -116.05 147.71 40.98 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.414 1.486 . . . . 0.0 109.349 170.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.3 t -147.12 161.3 41.15 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.714 0.806 . . . . 0.0 111.866 -178.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -83.75 137.92 33.51 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.727 1.211 . . . . 0.0 112.027 175.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.34 132.18 44.03 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.229 1.011 . . . . 0.0 109.707 169.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.3 t -94.63 -41.09 9.48 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -163.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -150.51 156.23 41.03 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.923 1.289 . . . . 0.0 110.842 173.08 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.4 mt -88.49 149.4 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 162.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -126.95 149.2 49.96 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 126.324 1.85 . . . . 0.0 109.742 175.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.52 142.67 47.09 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.661 1.184 . . . . 0.0 111.71 167.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -141.98 153.22 44.13 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.595 1.158 . . . . 0.0 109.868 171.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.5 mmtt -84.06 144.36 29.12 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.813 -0.555 . . . . 0.0 110.661 171.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 20.5 m -143.09 140.51 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 122.457 1.122 . . . . 0.0 111.883 173.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -102.05 -9.11 20.87 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.594 1.558 . . . . 0.0 112.453 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -139.46 131.3 27.6 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.076 1.35 . . . . 0.0 109.952 175.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 13.0 tp -139.52 160.28 40.22 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.996 1.318 . . . . 0.0 109.513 -176.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.9 mt -111.63 127.5 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.851 0.861 . . . . 0.0 109.451 179.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -98.51 120.02 38.21 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.091 0.956 . . . . 0.0 110.786 167.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.4 mp -102.16 127.47 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.316 1.046 . . . . 0.0 108.473 168.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -97.12 151.05 20.16 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.071 1.348 . . . . 0.0 110.838 173.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 59.9 mt -117.21 159.97 21.8 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.263 1.825 . . . . 0.0 112.864 -172.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.7 t -58.8 -25.1 62.8 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.721 1.608 . . . . 0.0 113.368 177.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.8 p -67.33 -11.5 57.8 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.204 1.801 . . . . 0.0 115.236 172.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.78 -1.42 83.52 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 125.193 1.378 . . . . 0.0 114.664 -170.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -95.92 173.12 7.6 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.247 1.819 . . . . 0.0 112.835 -175.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.7 p -143.36 164.25 30.79 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 17.5 tp -139.09 137.07 35.87 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.331 1.452 . . . . 0.0 111.204 174.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.7 mtmt -113.69 117.72 32.33 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.023 1.329 . . . . 0.0 112.803 -176.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.2 m -143.48 153.93 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 125.868 1.667 . . . . 0.0 113.08 -163.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.6 p -70.16 149.76 96.09 Favored Pre-proline 0 N--CA 1.475 0.813 0 O-C-N 120.731 -1.231 . . . . 0.0 112.824 176.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -60.86 -22.76 75.01 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.692 2.928 . . . . 0.0 114.069 -174.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 58.9 p -88.81 -11.49 44.68 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.882 1.673 . . . . 0.0 115.02 177.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -65.74 121.78 77.27 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-N 119.332 0.969 . . . . 0.0 110.887 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -77.35 128.24 9.54 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.709 2.272 . . . . 0.0 112.789 177.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.0 t -100.0 137.55 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 C-N-CA 126.425 1.89 . . . . 0.0 109.692 176.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.33 108.35 13.86 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.6 mp -103.4 146.65 28.17 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.346 1.458 . . . . 0.0 111.904 -177.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -96.92 96.74 8.73 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.181 0.515 . . . . 0.0 111.518 170.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -124.73 73.73 1.29 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 122.808 1.289 . . . . 0.0 110.148 -178.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.4 t70 60.38 4.03 0.64 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 128.165 2.586 . . . . 0.0 114.79 -162.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -177.66 174.63 47.05 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 126.566 2.032 . . . . 0.0 111.28 -175.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.0 mt -76.5 123.36 25.92 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.748 1.219 . . . . 0.0 110.376 174.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -155.09 159.46 40.25 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.007 1.323 . . . . 0.0 112.492 176.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -107.16 131.76 53.79 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.901 0.88 . . . . 0.0 112.367 -175.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 97.1 t -132.72 129.39 21.26 Favored Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 124.099 0.96 . . . . 0.0 110.829 175.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -62.21 144.65 95.87 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.741 2.294 . . . . 0.0 111.944 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.68 -31.57 26.38 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.32 -25.61 67.24 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 172.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -108.37 -2.85 18.79 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.924 1.69 . . . . 0.0 112.945 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 89.6 t -70.0 139.2 20.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 O-C-N 121.542 -0.724 . . . . 0.0 109.563 162.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.18 154.96 74.38 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 126.187 1.795 . . . . 0.0 110.113 -177.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.69 121.14 8.03 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.194 1.93 . . . . 0.0 110.641 -175.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.37 4.95 34.89 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.377 0.989 . . . . 0.0 114.609 -174.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -65.87 175.79 1.84 Allowed 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 118.897 1.349 . . . . 0.0 113.08 168.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.5 p -125.16 123.26 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 125.069 1.348 . . . . 0.0 111.945 -176.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 26.0 t -115.9 131.9 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 125.652 1.581 . . . . 0.0 111.923 -167.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.0 t -88.18 140.88 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 122.063 0.935 . . . . 0.0 111.659 -178.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -170.07 -144.35 4.27 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.906 1.717 . . . . 0.0 111.845 -176.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.3 p -150.49 163.88 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 126.722 2.009 . . . . 0.0 109.131 173.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -62.66 121.19 12.76 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.635 0.774 . . . . 0.0 111.887 169.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -67.9 -29.25 68.3 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -169.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -56.31 -33.97 66.08 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 172.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 23.8 t -75.03 -40.01 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.812 0.815 . . . . 0.0 110.202 176.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 23.1 tp -72.8 -29.85 63.6 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.086 0.954 . . . . 0.0 112.922 -177.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 90.7 mtt-85 -84.79 15.84 3.67 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.995 1.718 . . . . 0.0 112.394 172.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 19.6 mmm-85 60.1 9.73 1.96 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 128.595 2.758 . . . . 0.0 116.324 176.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -66.85 -22.22 66.0 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 119.626 1.103 . . . . 0.0 113.208 -178.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 14.3 tt -141.0 153.99 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 125.621 1.568 . . . . 0.0 110.099 170.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 30.5 pt -93.91 126.79 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.171 0.989 . . . . 0.0 111.822 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 2.0 t -167.06 122.74 1.11 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.769 1.627 . . . . 0.0 109.177 172.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -99.91 143.7 29.82 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.484 1.114 . . . . 0.0 113.474 -174.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 63.65 26.44 69.82 Favored Glycine 0 CA--C 1.535 1.328 0 N-CA-C 117.535 1.774 . . . . 0.0 117.535 168.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -109.62 165.31 11.77 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 119.891 1.845 . . . . 0.0 114.478 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 97.0 mt -138.92 176.94 8.26 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 128.404 2.682 . . . . 0.0 112.321 -178.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -155.63 159.76 39.88 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.963 2.105 . . . . 0.0 111.535 169.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -107.44 151.2 25.87 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.63 1.172 . . . . 0.0 113.0 169.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -135.69 136.79 41.17 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.037 1.335 . . . . 0.0 110.704 -167.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -85.08 134.14 34.2 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.507 -0.745 . . . . 0.0 111.878 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 70.3 t -73.89 126.17 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.167 0.587 . . . . 0.0 110.279 171.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.6 t -81.35 -49.56 10.54 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.146 1.778 . . . . 0.0 112.461 175.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.4 m -156.09 161.34 40.4 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.709 1.204 . . . . 0.0 110.633 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.5 m -134.14 144.35 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.077 0.951 . . . . 0.0 110.337 167.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -152.24 155.79 38.43 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 173.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 85.9 mt -86.81 139.95 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 167.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 21.9 pt -130.52 148.82 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 125.958 1.703 . . . . 0.0 110.94 174.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -86.64 89.72 8.02 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.391 -0.818 . . . . 0.0 109.825 177.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -71.87 -44.0 64.51 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -172.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 51.61 26.8 3.53 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 126.544 1.938 . . . . 0.0 114.832 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 -139.65 175.56 9.47 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.694 1.198 . . . . 0.0 111.662 -173.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -74.19 140.81 45.37 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 124.006 0.922 . . . . 0.0 112.617 177.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 15.0 m -122.68 154.95 27.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 126.131 1.772 . . . . 0.0 109.079 172.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.466 ' CG ' HG12 ' A' ' 21' ' ' ILE . 3.2 p90 -110.34 159.32 17.54 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.558 0.743 . . . . 0.0 112.217 -177.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -137.9 143.84 41.04 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 122.639 0.376 . . . . 0.0 110.356 158.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 60.4 tp -111.39 103.59 11.97 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.526 1.13 . . . . 0.0 110.223 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.0 t -81.05 122.95 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -158.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 24.2 mm -112.42 96.33 35.4 Favored Pre-proline 0 N--CA 1.469 0.513 0 C-N-CA 125.464 1.506 . . . . 0.0 110.035 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.38 -14.77 37.83 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.022 1.815 . . . . 0.0 113.553 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -73.16 -65.34 0.82 Allowed 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 119.145 0.884 . . . . 0.0 111.735 177.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 67.7 p -114.88 -10.72 12.3 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.296 1.439 . . . . 0.0 114.04 -171.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 59.06 18.86 6.71 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.46 1.504 . . . . 0.0 114.243 -167.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -146.63 145.66 30.14 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -175.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -146.46 163.76 34.66 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.62 1.568 . . . . 0.0 112.596 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.0 mp -102.14 134.94 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 O-C-N 121.261 -0.9 . . . . 0.0 111.715 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.32 154.24 54.14 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 124.956 1.302 . . . . 0.0 112.307 170.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.09 -17.05 54.34 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.705 2.937 . . . . 0.0 114.736 -173.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -73.07 -6.01 42.74 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 169.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 111.66 -20.87 22.07 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 126.359 1.933 . . . . 0.0 115.221 172.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 54.4 mt -81.92 145.51 30.28 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 120.1 1.95 . . . . 0.0 113.842 -166.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.5 t -89.26 123.87 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.954 0.902 . . . . 0.0 110.603 176.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 20.8 mt -115.73 137.93 51.61 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.644 1.578 . . . . 0.0 111.184 -174.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -101.16 145.26 29.02 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.149 0.979 . . . . 0.0 111.016 168.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -59.62 164.94 3.23 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.411 1.084 . . . . 0.0 112.06 170.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -127.26 14.18 7.2 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 116.678 2.103 . . . . 0.0 116.678 -175.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 . . . . . 0 N--CA 1.484 1.228 0 CA-C-N 121.108 1.776 . . . . 0.0 114.979 -176.758 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.58 159.9 41.19 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.867 1.667 . . . . 0.0 112.09 -168.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.27 146.48 39.21 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.177 1.391 . . . . 0.0 113.015 175.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.03 -22.72 64.83 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.098 1.359 . . . . 0.0 114.521 177.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -87.4 -2.54 58.69 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.7 m -65.02 134.87 54.82 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.902 0.881 . . . . 0.0 111.628 175.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -75.07 153.29 38.43 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.009 0.924 . . . . 0.0 112.882 172.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 p -145.56 158.96 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.287 1.035 . . . . 0.0 112.389 -174.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -127.82 133.52 49.41 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.018 1.727 . . . . 0.0 109.456 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -156.28 168.93 25.78 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 170.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -132.91 143.72 49.68 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.321 1.448 . . . . 0.0 111.52 -178.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -157.86 136.41 11.2 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.071 1.349 . . . . 0.0 109.566 175.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.5 t0 50.48 46.91 24.87 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.397 1.479 . . . . 0.0 113.972 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.7 m 61.86 42.4 10.47 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 176.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.1 p -155.05 140.51 12.46 Favored Pre-proline 0 CA--C 1.548 0.871 0 O-C-N 121.027 -1.046 . . . . 0.0 111.514 167.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -91.21 157.42 3.8 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 124.981 3.787 . . . . 0.0 114.802 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 33.1 m80 -136.74 138.17 40.68 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.63 1.972 . . . . 0.0 110.553 -173.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 41.6 ttm -144.64 107.82 4.55 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.666 0.787 . . . . 0.0 111.809 176.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -156.8 -179.97 8.71 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.287 1.435 . . . . 0.0 111.746 -174.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.3 m -67.34 136.81 55.39 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.376 -0.828 . . . . 0.0 110.023 171.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.451 HG12 ' CG ' ' A' ' 152' ' ' TYR . 7.8 tp -54.85 -36.53 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 121.173 -0.954 . . . . 0.0 112.924 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -62.36 -17.96 60.29 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -82.24 -54.44 5.25 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.3 1.44 . . . . 0.0 110.37 174.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -65.26 -32.63 74.39 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.63 -0.669 . . . . 0.0 112.013 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -60.4 -51.12 70.83 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.33 0.652 . . . . 0.0 111.454 169.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.0 t -61.23 -38.07 85.31 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.667 0.787 . . . . 0.0 111.001 -177.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -62.71 -52.72 62.16 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 125.328 1.451 . . . . 0.0 110.845 174.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -72.17 -32.68 67.07 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.199 -0.938 . . . . 0.0 113.2 -176.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.46 -31.22 68.28 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.971 0.908 . . . . 0.0 112.547 174.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.8 t -78.6 -20.65 50.0 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.969 1.308 . . . . 0.0 112.322 176.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 46.4 mtm -96.62 -58.61 2.01 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.913 1.685 . . . . 0.0 113.601 177.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -100.0 -15.14 18.38 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.427 1.491 . . . . 0.0 113.611 -170.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 87.49 162.89 38.37 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 124.433 1.016 . . . . 0.0 114.515 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -110.65 134.45 52.42 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.976 1.311 . . . . 0.0 110.017 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.7 mp -120.75 148.34 48.06 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 125.531 1.532 . . . . 0.0 111.522 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.05 150.6 60.64 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.841 3.028 . . . . 0.0 112.762 -177.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -134.05 168.0 19.61 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.422 1.489 . . . . 0.0 111.653 177.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.19 -50.58 37.41 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.066 1.347 . . . . 0.0 113.886 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -111.44 -2.51 15.54 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.802 1.641 . . . . 0.0 114.18 -175.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.04 -137.16 2.37 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 121.423 -0.798 . . . . 0.0 114.116 -173.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -136.0 161.12 36.55 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.311 1.845 . . . . 0.0 111.516 176.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.95 158.06 44.48 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.323 1.049 . . . . 0.0 112.168 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 84.6 t -126.64 117.01 22.71 Favored Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 125.919 1.688 . . . . 0.0 109.904 176.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.0 130.76 17.11 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 123.993 3.129 . . . . 0.0 112.617 -174.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 89.4 mt -102.05 162.2 13.09 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.179 0.992 . . . . 0.0 113.294 176.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -144.86 124.83 13.51 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.225 1.01 . . . . 0.0 112.235 173.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 47.82 52.56 12.64 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.652 1.581 . . . . 0.0 112.777 -174.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.9 t -113.46 132.87 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 125.059 1.344 . . . . 0.0 110.079 175.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -132.26 151.18 51.95 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.499 1.12 . . . . 0.0 112.899 -166.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.6 m -140.41 153.53 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 126.24 1.816 . . . . 0.0 111.912 177.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -68.13 132.05 46.51 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.134 0.974 . . . . 0.0 109.948 168.133 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.5 t -134.33 153.56 51.82 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.762 2.025 . . . . 0.0 111.175 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 49.0 tp -103.05 129.33 49.81 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.25 1.02 . . . . 0.0 109.637 175.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -77.23 97.56 4.85 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.678 0.791 . . . . 0.0 109.157 173.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 30.5 mm -59.25 -25.68 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 O-C-N 120.877 -1.14 . . . . 0.0 112.907 -170.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.49 -39.73 31.4 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -176.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.3 m -110.99 -6.36 14.68 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.23 1.012 . . . . 0.0 113.214 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.82 29.24 74.66 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.558 1.551 . . . . 0.0 113.649 177.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -96.37 139.28 32.72 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.772 1.629 . . . . 0.0 112.142 -178.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 mp -80.26 130.03 36.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 125.552 1.541 . . . . 0.0 108.974 173.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -151.6 169.11 22.92 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.976 1.71 . . . . 0.0 111.278 -177.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -100.06 147.67 25.39 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.536 1.134 . . . . 0.0 110.552 170.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.3 t -142.0 168.73 19.05 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.817 0.847 . . . . 0.0 112.085 173.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 -102.01 145.95 28.58 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.492 1.117 . . . . 0.0 113.535 -174.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -108.07 139.18 43.1 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.236 1.414 . . . . 0.0 111.228 178.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.86 -47.02 7.85 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.565 0.746 . . . . 0.0 112.733 -170.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -153.58 156.89 38.85 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.998 1.319 . . . . 0.0 110.834 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.7 mt -86.17 154.39 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 163.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -138.87 151.15 46.74 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.464 1.505 . . . . 0.0 112.264 -175.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -144.63 152.78 40.98 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.003 1.321 . . . . 0.0 113.301 170.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -155.25 160.25 40.67 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.014 1.326 . . . . 0.0 110.586 173.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp -87.78 143.71 27.0 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.278 1.431 . . . . 0.0 111.546 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.5 m -147.13 146.0 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 124.983 1.313 . . . . 0.0 111.556 176.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -95.31 -34.27 12.23 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.539 1.536 . . . . 0.0 111.596 170.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -113.16 119.24 37.12 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.377 1.471 . . . . 0.0 109.421 -169.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.0 tp -133.99 162.09 33.03 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.379 1.472 . . . . 0.0 109.524 -178.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.5 mt -120.5 129.3 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.351 1.061 . . . . 0.0 108.742 177.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -99.28 125.68 44.95 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.346 0.658 . . . . 0.0 110.798 168.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -109.81 127.56 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.821 1.248 . . . . 0.0 109.471 170.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -94.16 146.38 24.03 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.443 1.497 . . . . 0.0 110.92 171.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 49.2 mt -112.73 162.16 16.06 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.597 1.559 . . . . 0.0 111.95 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.0 t -63.74 -16.09 60.26 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.917 1.287 . . . . 0.0 113.3 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 77.9 p -77.89 -9.74 59.22 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.249 2.22 . . . . 0.0 115.167 170.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 83.65 0.69 89.98 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.957 1.265 . . . . 0.0 114.869 -171.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -77.42 148.47 35.44 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.773 1.229 . . . . 0.0 110.635 175.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 93.3 p -122.66 143.26 49.89 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.457 1.103 . . . . 0.0 112.689 173.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.5 tp -127.53 132.13 49.96 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.973 1.709 . . . . 0.0 110.528 178.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.0 mtpt -118.31 115.72 25.28 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.036 1.334 . . . . 0.0 111.751 -171.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.5 m -143.93 154.5 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.131 1.372 . . . . 0.0 113.665 -164.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 21.3 p -66.77 147.96 98.9 Favored Pre-proline 0 N--CA 1.471 0.615 0 O-C-N 121.163 -0.96 . . . . 0.0 112.397 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -57.82 -29.01 84.59 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.199 2.599 . . . . 0.0 113.086 -177.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.2 p -71.83 -20.96 61.75 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.457 2.303 . . . . 0.0 115.782 176.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -71.62 119.65 75.3 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.254 1.022 . . . . 0.0 112.052 -168.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -75.68 129.0 11.37 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.713 2.276 . . . . 0.0 112.341 175.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.0 t -108.95 144.44 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 126.112 1.765 . . . . 0.0 109.113 176.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.21 104.95 12.03 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.141 0.496 . . . . 0.0 109.992 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.7 mp -104.22 160.99 14.42 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.692 1.597 . . . . 0.0 111.541 -178.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -112.38 119.21 37.47 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 176.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.8 mtp-105 -136.89 81.78 1.9 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.098 0.959 . . . . 0.0 110.448 161.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 58.62 10.3 1.38 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.694 1.998 . . . . 0.0 115.515 -170.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 177.67 163.25 29.16 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.892 1.234 . . . . 0.0 113.22 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 46.0 mt -64.01 116.53 5.96 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.725 1.61 . . . . 0.0 111.612 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -144.62 144.46 31.28 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 178.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -95.27 129.82 42.26 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.139 0.976 . . . . 0.0 110.79 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.8 t -133.66 127.96 19.75 Favored Pre-proline 0 N--CA 1.476 0.848 0 C-N-CA 123.891 0.876 . . . . 0.0 110.438 -178.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -65.58 141.04 65.17 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.326 2.017 . . . . 0.0 111.084 177.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.99 -30.4 14.99 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 176.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.04 -17.89 63.81 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 174.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -108.5 -14.83 14.57 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.098 1.359 . . . . 0.0 112.793 175.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 87.2 t -63.47 140.78 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.823 1.249 . . . . 0.0 110.434 173.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.86 153.56 78.77 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 125.93 1.692 . . . . 0.0 110.866 -174.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.435 ' HD3' HG22 ' A' ' 142' ' ' VAL . 50.8 Cg_endo -68.86 116.1 4.29 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.644 2.229 . . . . 0.0 111.543 -169.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 115.29 0.36 22.2 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 124.416 1.008 . . . . 0.0 115.1 -176.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -63.4 156.74 25.07 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 118.583 1.191 . . . . 0.0 111.351 169.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.6 t -97.56 132.32 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 124.539 1.135 . . . . 0.0 110.875 173.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.2 t -106.63 143.5 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 127.308 2.243 . . . . 0.0 110.285 176.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.5 t -95.44 140.85 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.274 1.029 . . . . 0.0 111.153 176.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -165.65 -150.87 6.43 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.551 1.072 . . . . 0.0 112.887 176.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.6 p -134.29 163.0 38.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 127.676 2.39 . . . . 0.0 108.258 173.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 38.9 mtt180 -50.99 119.14 3.67 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.623 1.169 . . . . 0.0 109.894 172.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -60.3 -26.27 66.39 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 118.664 0.665 . . . . 0.0 112.415 -176.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -68.79 -27.21 65.67 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 172.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.11 -27.55 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-N 120.941 1.7 . . . . 0.0 111.828 -176.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 70.5 mt -84.85 -18.48 34.71 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.316 1.446 . . . . 0.0 112.933 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 44.5 ttt180 -116.97 -25.47 7.21 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 -170.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -87.88 155.99 19.59 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.666 1.186 . . . . 0.0 111.77 176.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 58.9 ttt-85 -63.31 -28.96 70.36 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.184 1.393 . . . . 0.0 113.138 174.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 70.8 mt -78.7 120.63 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.371 1.069 . . . . 0.0 109.077 169.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 21.3 tt -124.39 152.76 30.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 125.698 1.599 . . . . 0.0 111.457 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 33.8 t -140.81 161.58 37.47 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.075 1.75 . . . . 0.0 111.282 -178.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.8 ptpt -125.02 149.44 47.76 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.416 1.886 . . . . 0.0 113.221 -176.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 73.25 20.02 79.8 Favored Glycine 0 CA--C 1.537 1.41 0 N-CA-C 115.304 0.882 . . . . 0.0 115.304 175.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -116.22 147.42 41.47 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.481 1.513 . . . . 0.0 111.608 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 80.3 mt -137.64 161.81 35.47 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.972 1.709 . . . . 0.0 111.161 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -144.08 130.32 19.72 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.726 1.21 . . . . 0.0 113.306 -177.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -79.66 144.38 33.79 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.226 1.41 . . . . 0.0 112.099 175.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -134.05 141.46 47.2 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.068 1.347 . . . . 0.0 110.631 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -102.65 139.25 38.48 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.126 -0.984 . . . . 0.0 112.855 -175.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 78.6 t -76.11 134.71 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.912 0.885 . . . . 0.0 111.491 175.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.9 t -99.06 -39.13 8.67 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.873 2.069 . . . . 0.0 113.525 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 26.2 t -157.41 160.32 38.27 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.58 1.152 . . . . 0.0 110.918 175.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.435 HG22 ' HD3' ' A' ' 112' ' ' PRO . 3.4 m -136.51 147.79 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.599 1.159 . . . . 0.0 110.028 164.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 31.7 ptt-85 -158.41 159.58 35.92 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 162.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 45.6 mt -85.03 134.29 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.065 0.946 . . . . 0.0 108.685 173.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 19.0 pt -126.99 156.27 38.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 125.396 1.478 . . . . 0.0 112.524 -177.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.94 96.79 10.84 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.749 1.22 . . . . 0.0 111.737 173.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -78.46 -53.12 7.59 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.232 -0.917 . . . . 0.0 112.316 176.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 46.53 47.94 14.19 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.513 1.525 . . . . 0.0 112.434 -172.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -151.97 178.52 9.35 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.702 0.801 . . . . 0.0 112.732 -176.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -80.01 139.27 37.04 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.708 1.203 . . . . 0.0 113.042 177.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.5 m -121.25 160.63 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.526 1.93 . . . . 0.0 110.084 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.451 ' CG ' HG12 ' A' ' 21' ' ' ILE . 0.7 OUTLIER -113.78 161.83 17.06 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.988 0.915 . . . . 0.0 112.87 -178.357 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -144.03 163.37 33.7 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.571 0.748 . . . . 0.0 111.156 154.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 46.4 tp -115.17 122.93 47.56 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.277 1.431 . . . . 0.0 109.927 172.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 58.6 t -87.52 121.88 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 O-C-N 121.276 -0.89 . . . . 0.0 111.919 -171.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 20.5 mm -119.56 89.95 41.92 Favored Pre-proline 0 N--CA 1.47 0.531 0 C-N-CA 125.836 1.655 . . . . 0.0 109.371 -177.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -66.21 -23.19 52.72 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.331 2.02 . . . . 0.0 112.524 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 -81.76 -29.57 32.75 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -171.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 69.1 p -140.5 -22.33 0.82 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -177.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 65.33 15.86 10.24 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 127.113 2.165 . . . . 0.0 115.507 -171.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.49 150.52 26.67 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 120.735 -1.228 . . . . 0.0 114.144 -177.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -150.92 170.38 19.45 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.102 1.361 . . . . 0.0 113.09 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.1 mp -106.98 137.42 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.648 1.179 . . . . 0.0 111.937 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.91 157.99 50.9 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.684 1.194 . . . . 0.0 113.097 173.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -66.06 -18.07 56.14 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.302 2.668 . . . . 0.0 113.989 -175.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -83.83 6.07 22.77 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 171.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 107.04 -23.69 26.83 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 126.106 1.813 . . . . 0.0 116.954 165.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 75.2 mt -83.3 151.42 25.6 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 120.252 2.026 . . . . 0.0 114.46 -169.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.0 t -93.83 129.0 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.657 1.183 . . . . 0.0 111.93 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 25.5 mt -119.69 141.74 49.11 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.77 2.028 . . . . 0.0 111.552 -170.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -102.36 134.83 45.02 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 119.206 0.912 . . . . 0.0 112.681 171.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -92.16 81.06 5.02 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.43 1.092 . . . . 0.0 111.733 -169.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -145.21 152.82 40.59 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.854 1.662 . . . . 0.0 112.869 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 8.5 mp0 . . . . . 0 C--O 1.252 1.212 0 C-N-CA 125.887 1.675 . . . . 0.0 113.287 -177.798 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -142.58 163.64 32.27 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.082 1.353 . . . . 0.0 112.389 -167.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.13 146.05 48.85 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.629 1.572 . . . . 0.0 112.821 175.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.6 ppt_? -63.48 -21.49 66.34 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 176.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -83.79 0.36 47.69 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 176.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.6 m -66.45 147.7 52.92 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.613 1.165 . . . . 0.0 113.112 174.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -88.62 156.28 19.13 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.844 1.657 . . . . 0.0 114.423 175.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.425 HG11 ' SD ' ' A' ' 24' ' ' MET . 3.5 p -145.82 150.66 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.948 0.899 . . . . 0.0 113.217 -172.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -128.42 121.98 30.29 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.788 2.035 . . . . 0.0 107.679 175.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -139.74 174.44 10.51 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.209 1.004 . . . . 0.0 111.422 173.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -131.23 134.46 46.46 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.053 -1.029 . . . . 0.0 111.393 170.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -159.33 166.53 30.97 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.483 1.913 . . . . 0.0 108.257 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.0 t70 55.5 22.42 5.09 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 120.083 1.311 . . . . 0.0 113.093 -167.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.2 m 56.84 36.17 27.34 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.646 1.978 . . . . 0.0 114.185 -170.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.2 p -152.82 143.77 15.89 Favored Pre-proline 0 CA--C 1.547 0.85 0 O-C-N 120.534 -1.354 . . . . 0.0 112.141 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -70.03 140.98 42.94 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.74 2.96 . . . . 0.0 113.622 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -129.16 137.05 50.94 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 127.519 2.328 . . . . 0.0 110.339 -178.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 45.4 mtp -143.76 119.2 10.3 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.266 1.426 . . . . 0.0 112.093 -174.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -164.43 -173.51 3.1 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.617 1.567 . . . . 0.0 112.709 -172.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 65.4 m -74.53 141.57 44.83 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.089 -1.007 . . . . 0.0 111.127 167.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.451 HG12 ' CG ' ' A' ' 152' ' ' TYR . 7.4 tp -57.53 -38.21 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 121.256 -0.903 . . . . 0.0 112.857 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -60.92 -28.41 68.91 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.733 0.697 . . . . 0.0 111.913 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -80.49 -43.91 20.04 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 124.135 0.974 . . . . 0.0 110.974 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.425 ' SD ' HG11 ' A' ' 8' ' ' VAL . 12.9 ptm -65.19 -35.14 80.16 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.322 0.964 . . . . 0.0 111.625 173.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -60.83 -48.48 81.62 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.356 0.662 . . . . 0.0 110.557 173.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.1 t -59.78 -39.55 85.27 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.815 1.246 . . . . 0.0 111.39 177.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.3 ttmm -61.31 -56.73 17.21 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.414 1.486 . . . . 0.0 110.793 174.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -74.6 -33.05 62.53 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.108 -0.995 . . . . 0.0 112.564 -172.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.63 -19.91 62.78 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.975 0.91 . . . . 0.0 112.522 172.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 51.0 m -90.02 -18.98 24.97 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.252 1.421 . . . . 0.0 113.678 171.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 72.0 mtm -98.27 -44.91 6.38 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.893 1.277 . . . . 0.0 113.334 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -112.11 -23.77 10.26 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.592 1.557 . . . . 0.0 112.962 -169.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.32 162.98 38.97 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.693 1.616 . . . . 0.0 114.172 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -107.53 133.78 51.5 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.256 1.022 . . . . 0.0 110.94 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.3 mp -118.51 150.83 48.78 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 126.921 2.088 . . . . 0.0 110.936 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -75.53 148.03 32.76 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.693 2.929 . . . . 0.0 112.429 177.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -131.21 169.3 16.13 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.518 1.927 . . . . 0.0 111.595 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.58 -56.34 7.36 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.569 1.548 . . . . 0.0 114.613 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -105.33 -6.57 19.51 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -168.37 -137.84 2.33 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 123.716 0.674 . . . . 0.0 113.918 -170.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -131.84 155.89 47.02 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.51 1.524 . . . . 0.0 111.498 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.31 148.77 41.88 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.041 0.936 . . . . 0.0 112.214 -177.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 84.2 t -118.38 111.14 38.49 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 125.593 1.557 . . . . 0.0 109.476 176.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.58 140.23 51.25 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 124.569 3.513 . . . . 0.0 111.231 -177.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.5 mt -107.5 163.42 13.08 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.153 0.981 . . . . 0.0 113.528 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -137.63 116.34 12.2 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 127.58 2.352 . . . . 0.0 110.238 176.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 52.69 38.66 26.76 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 126.83 2.052 . . . . 0.0 115.133 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.6 t -99.92 133.71 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.18 1.392 . . . . 0.0 110.857 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -127.95 159.88 33.6 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.275 1.83 . . . . 0.0 113.319 -175.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.8 m -138.32 161.2 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 127.257 2.223 . . . . 0.0 111.593 174.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.464 ' CE1' HG23 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -76.38 131.05 38.9 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 122.02 0.914 . . . . 0.0 108.933 163.115 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.8 t -132.32 151.25 51.93 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.116 1.766 . . . . 0.0 111.054 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.6 tp -109.51 136.29 49.15 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.574 1.15 . . . . 0.0 109.546 174.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -85.38 115.9 23.39 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 118.57 -0.729 . . . . 0.0 109.762 160.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.2 mm -66.36 -28.5 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 119.685 1.129 . . . . 0.0 112.331 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.43 -47.86 31.09 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -168.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 64.3 m -96.06 -17.77 20.68 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.247 -0.908 . . . . 0.0 112.075 169.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.84 32.37 33.11 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.552 1.072 . . . . 0.0 112.856 -176.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -88.35 119.79 29.1 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 118.246 1.023 . . . . 0.0 111.865 -172.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.464 HG23 ' CE1' ' A' ' 51' ' ' TYR . 3.2 mp -72.98 125.64 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 167.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -152.15 175.39 12.63 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.658 1.183 . . . . 0.0 112.178 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -99.1 148.76 23.72 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.363 1.465 . . . . 0.0 110.601 172.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.7 t -143.93 158.72 43.51 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 118.547 0.612 . . . . 0.0 111.554 165.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.7 ptt85 -67.21 156.04 37.29 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.862 0.865 . . . . 0.0 112.576 170.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -112.99 138.34 50.02 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.704 0.802 . . . . 0.0 110.198 160.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.9 t -88.71 -47.62 8.11 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.282 1.033 . . . . 0.0 112.697 -167.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -154.46 156.59 37.02 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.141 1.776 . . . . 0.0 111.549 173.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.4 mt -86.01 153.35 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 165.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -133.93 148.14 51.17 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.43 1.492 . . . . 0.0 112.113 -172.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -142.77 149.08 38.21 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 165.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -146.13 162.5 37.84 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.937 1.695 . . . . 0.0 110.23 171.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.51 147.26 23.14 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.75 0.82 . . . . 0.0 112.965 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.5 m -149.05 145.96 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.505 1.522 . . . . 0.0 111.653 177.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -93.54 -31.13 14.66 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.823 1.249 . . . . 0.0 112.395 173.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -128.0 137.11 52.09 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 122.147 0.975 . . . . 0.0 112.648 -176.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.4 tp -137.79 165.45 26.43 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.715 2.006 . . . . 0.0 110.333 -174.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.6 mt -119.15 127.82 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.555 1.142 . . . . 0.0 109.532 175.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -95.25 124.52 39.34 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.809 0.843 . . . . 0.0 111.293 163.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -106.62 127.77 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 125.574 1.55 . . . . 0.0 108.835 168.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -96.59 145.77 25.44 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.075 1.35 . . . . 0.0 111.075 173.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 81.8 mt -104.92 162.29 13.46 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.538 1.935 . . . . 0.0 111.59 -178.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.3 t -60.03 -28.86 68.1 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.346 1.458 . . . . 0.0 111.915 177.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 97.3 p -63.27 -12.81 31.9 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.707 1.603 . . . . 0.0 114.646 169.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.1 2.47 89.39 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.695 1.616 . . . . 0.0 114.06 -170.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -88.86 173.26 8.62 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.494 1.518 . . . . 0.0 111.891 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 86.8 p -143.0 148.82 37.41 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 -171.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 61.3 tp -120.7 131.65 54.66 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 127.577 2.351 . . . . 0.0 109.787 174.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -122.89 113.24 18.86 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.15 1.38 . . . . 0.0 111.697 -176.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.9 m -145.06 155.46 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 125.081 1.353 . . . . 0.0 113.286 -163.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.2 p -68.08 147.05 98.39 Favored Pre-proline 0 N--CA 1.473 0.709 0 O-C-N 121.404 -0.81 . . . . 0.0 112.417 176.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -60.79 -33.99 92.17 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.775 2.317 . . . . 0.0 113.265 -170.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.4 p -78.83 -7.48 57.91 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.829 1.651 . . . . 0.0 114.946 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -86.99 124.75 68.31 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.373 1.069 . . . . 0.0 113.353 -168.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -72.66 143.55 37.98 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.337 2.691 . . . . 0.0 115.479 -178.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.7 t -122.77 146.87 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 126.777 2.031 . . . . 0.0 109.693 174.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 31.0 tp -84.68 114.6 22.14 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.285 0.634 . . . . 0.0 111.358 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.7 mp -113.87 153.66 28.82 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.285 1.834 . . . . 0.0 112.686 -172.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -103.34 101.63 11.55 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.804 1.641 . . . . 0.0 110.733 171.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 76.5 mtt-85 -136.17 74.14 1.49 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.535 1.134 . . . . 0.0 110.722 173.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 61.7 2.4 0.71 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 126.486 1.914 . . . . 0.0 115.748 -167.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -176.3 167.89 39.73 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.456 1.503 . . . . 0.0 112.115 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 75.6 mt -81.96 108.58 15.58 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.132 1.373 . . . . 0.0 110.727 -178.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -140.71 144.02 35.36 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.527 0.731 . . . . 0.0 112.765 -168.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -96.57 120.59 37.17 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.673 1.189 . . . . 0.0 111.118 -176.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 62.1 t -130.08 131.99 23.81 Favored Pre-proline 0 N--CA 1.482 1.162 0 C-N-CA 124.777 1.231 . . . . 0.0 110.43 -176.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -67.42 146.99 76.62 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.344 2.696 . . . . 0.0 112.257 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.41 -31.71 23.74 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 176.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.8 -23.39 66.69 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 173.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -104.35 0.89 29.63 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.02 1.728 . . . . 0.0 112.053 174.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 84.0 t -74.88 141.37 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 O-C-N 120.796 -1.19 . . . . 0.0 109.773 167.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.52 154.39 81.63 Favored Pre-proline 0 N--CA 1.472 0.649 0 C-N-CA 127.334 2.254 . . . . 0.0 110.436 -176.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.417 ' HD3' HG22 ' A' ' 142' ' ' VAL . 59.6 Cg_endo -66.27 115.03 3.27 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 121.664 1.576 . . . . 0.0 109.613 177.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.37 3.41 24.18 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.745 1.164 . . . . 0.0 115.542 -177.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -60.13 161.89 6.42 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 118.65 1.225 . . . . 0.0 111.85 161.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 24.5 t -118.22 128.7 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.5 1.52 . . . . 0.0 110.225 174.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.0 t -104.09 145.11 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 127.16 2.184 . . . . 0.0 110.606 -175.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 43.7 t -87.77 137.76 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.376 1.07 . . . . 0.0 111.112 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -167.32 -146.65 4.97 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 115.262 0.865 . . . . 0.0 115.262 179.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.8 p -155.75 165.04 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 126.658 1.983 . . . . 0.0 108.639 176.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -56.77 126.66 27.89 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.871 1.268 . . . . 0.0 111.773 176.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -60.83 -38.07 84.19 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.966 0.906 . . . . 0.0 111.361 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -67.04 -28.67 68.41 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 28.3 t -71.93 -31.03 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 O-C-N 121.329 -0.857 . . . . 0.0 110.552 177.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 25.6 mt -78.18 -16.53 57.81 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.519 1.128 . . . . 0.0 113.304 169.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.87 -24.65 35.62 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 172.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 57.7 ttt85 -61.78 136.77 58.12 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.971 0.908 . . . . 0.0 109.388 170.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 84.0 mtt85 -69.72 -25.66 63.96 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -175.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 96.6 mt -88.61 126.35 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.311 1.445 . . . . 0.0 108.737 157.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 96.3 mt -102.91 112.1 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.877 0.871 . . . . 0.0 109.568 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 31.2 t -66.28 134.87 53.53 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -173.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -96.76 139.58 32.6 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.168 1.387 . . . . 0.0 112.419 175.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.26 19.22 55.85 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 125.154 1.359 . . . . 0.0 114.8 177.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -123.8 136.36 54.35 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.983 1.713 . . . . 0.0 111.529 176.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 85.8 mt -149.0 151.46 34.59 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.767 2.027 . . . . 0.0 112.561 -174.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -136.5 171.63 14.2 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.208 1.803 . . . . 0.0 111.386 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -131.01 157.06 44.03 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 120.631 -1.293 . . . . 0.0 112.724 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -138.34 123.83 19.56 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.576 1.15 . . . . 0.0 110.2 -167.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -84.67 145.63 27.88 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.952 -1.092 . . . . 0.0 112.307 -178.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.5 t -77.55 133.1 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.285 1.034 . . . . 0.0 111.699 175.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 26.9 t -87.16 -46.31 9.87 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.625 1.97 . . . . 0.0 112.405 171.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 29.6 t -157.26 160.72 38.91 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.42 0.688 . . . . 0.0 111.788 -173.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.417 HG22 ' HD3' ' A' ' 112' ' ' PRO . 4.0 m -135.36 145.73 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.285 1.034 . . . . 0.0 111.61 167.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -152.73 151.23 30.28 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.551 1.14 . . . . 0.0 113.344 172.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 75.4 mt -89.0 138.86 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.953 1.301 . . . . 0.0 109.051 169.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 44.9 pt -131.65 146.62 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.936 1.694 . . . . 0.0 111.62 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -80.07 104.92 10.96 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.668 -0.645 . . . . 0.0 109.549 165.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -81.62 -49.01 11.01 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.077 -1.015 . . . . 0.0 113.518 174.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 44.33 52.71 7.16 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.069 1.348 . . . . 0.0 111.989 -173.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -150.02 176.85 10.41 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.808 0.843 . . . . 0.0 111.97 -177.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -75.52 146.94 40.15 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.565 -0.709 . . . . 0.0 111.638 168.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 6.8 m -126.23 158.22 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.799 1.64 . . . . 0.0 109.47 172.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.451 ' CG ' HG12 ' A' ' 21' ' ' ILE . 0.6 OUTLIER -110.89 160.75 16.49 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.294 0.637 . . . . 0.0 112.577 -175.753 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -141.91 163.17 33.63 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.914 0.886 . . . . 0.0 110.22 157.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 54.8 tp -123.98 123.92 41.44 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.502 -1.374 . . . . 0.0 110.235 176.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 42.4 t -90.6 122.13 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -165.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 42.1 mm -124.1 84.31 55.39 Favored Pre-proline 0 N--CA 1.47 0.539 0 C-N-CA 126.196 1.798 . . . . 0.0 108.832 -172.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -66.83 -17.57 52.09 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.759 2.306 . . . . 0.0 113.752 -176.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -83.8 -32.78 25.16 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -174.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 80.9 p -140.74 -12.46 0.99 Allowed 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 -174.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 60.6 m80 56.23 26.23 10.15 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 -173.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.31 148.23 25.59 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 120.557 -1.34 . . . . 0.0 113.21 178.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -148.8 163.34 37.67 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.914 1.286 . . . . 0.0 112.211 -178.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.5 mp -112.67 137.73 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.864 0.866 . . . . 0.0 111.973 -176.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.89 157.34 51.77 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 125.38 1.472 . . . . 0.0 113.15 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.14 -17.87 50.78 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.549 2.833 . . . . 0.0 113.748 -176.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -74.58 -10.3 59.41 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 171.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 112.91 -24.66 12.6 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 125.743 1.64 . . . . 0.0 115.798 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.43 139.92 49.88 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.625 1.712 . . . . 0.0 113.799 -167.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 20.3 t -87.09 123.99 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.02 0.928 . . . . 0.0 110.958 173.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 33.5 mt -115.86 150.26 37.31 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.141 1.776 . . . . 0.0 111.709 -173.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -88.76 159.86 17.57 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.583 0.753 . . . . 0.0 110.79 170.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -98.26 118.47 34.97 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.141 -0.974 . . . . 0.0 109.601 163.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 52.36 -127.4 2.43 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.376 1.471 . . . . 0.0 112.857 -177.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 15.0 tm0? . . . . . 0 C--O 1.255 1.356 0 C-N-CA 126.1 1.76 . . . . 0.0 110.891 177.958 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -139.72 163.32 32.91 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.636 1.974 . . . . 0.0 111.082 -172.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.03 146.16 51.04 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.86 1.264 . . . . 0.0 113.383 -177.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -62.91 -19.88 64.63 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.929 1.292 . . . . 0.0 113.426 174.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -75.55 -10.44 59.45 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.248 1.819 . . . . 0.0 112.953 176.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.8 m -70.96 144.39 50.55 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 121.142 -0.974 . . . . 0.0 113.316 -175.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -91.72 150.88 20.9 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.055 1.742 . . . . 0.0 113.305 176.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.3 p -148.74 156.3 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 124.202 1.001 . . . . 0.0 113.484 -167.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -136.95 125.99 24.41 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.522 1.929 . . . . 0.0 109.042 -174.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -150.86 175.49 11.97 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 119.741 1.155 . . . . 0.0 113.154 -177.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -130.07 144.56 51.41 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.111 1.365 . . . . 0.0 112.933 171.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -161.97 162.43 29.0 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.749 2.02 . . . . 0.0 109.666 168.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.5 t0 53.77 28.74 8.61 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.372 1.469 . . . . 0.0 114.292 -177.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.8 m 59.33 38.0 23.23 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.431 1.892 . . . . 0.0 114.571 -172.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.6 p -151.98 140.63 13.66 Favored Pre-proline 0 CA--C 1.544 0.728 0 O-C-N 120.501 -1.375 . . . . 0.0 112.609 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -72.1 151.03 55.07 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 123.336 2.69 . . . . 0.0 113.106 175.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -134.44 140.63 46.39 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.281 2.232 . . . . 0.0 110.708 -176.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 36.7 ttm -141.75 121.9 13.83 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.396 1.078 . . . . 0.0 110.776 179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -163.83 -177.01 4.88 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.487 1.515 . . . . 0.0 112.983 -179.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.6 m -77.04 144.26 38.74 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.005 -1.06 . . . . 0.0 110.146 167.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.447 HG12 ' CG ' ' A' ' 152' ' ' TYR . 9.3 tp -57.31 -38.22 60.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -61.43 -24.18 66.36 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -76.5 -51.06 12.45 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.909 1.283 . . . . 0.0 110.862 175.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 19.9 ptm -68.86 -32.69 72.54 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.753 -0.592 . . . . 0.0 112.361 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -59.84 -51.04 71.44 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.216 0.606 . . . . 0.0 110.701 173.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.0 t -66.54 -34.86 78.85 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.412 0.551 . . . . 0.0 111.264 -176.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -61.12 -54.45 44.42 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.124 1.37 . . . . 0.0 110.305 174.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -70.68 -36.42 73.31 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.367 -0.833 . . . . 0.0 112.763 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.4 -33.01 74.75 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.971 0.908 . . . . 0.0 112.337 176.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.1 t -75.9 -32.27 59.57 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.923 0.889 . . . . 0.0 112.463 176.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 37.9 mtm -85.62 -47.21 10.05 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.308 1.443 . . . . 0.0 113.728 -177.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 48.3 m-20 -109.97 -20.39 12.75 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.49 1.516 . . . . 0.0 113.455 -171.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.13 163.97 39.52 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 122.247 0.915 . . . . 0.0 114.603 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -110.4 133.24 53.46 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.278 1.831 . . . . 0.0 110.175 -178.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.2 mp -116.05 146.92 38.16 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 126.79 2.036 . . . . 0.0 111.691 -176.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.65 141.55 19.73 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 124.589 3.526 . . . . 0.0 114.29 -173.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -133.97 166.18 23.31 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.669 1.988 . . . . 0.0 111.839 -177.101 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.45 -52.67 35.89 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.719 1.208 . . . . 0.0 114.036 -177.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -105.87 -4.78 20.33 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -173.25 -132.75 1.57 Allowed Glycine 0 CA--C 1.529 0.92 0 O-C-N 120.758 -1.214 . . . . 0.0 115.335 -174.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -141.04 153.58 45.57 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.266 1.427 . . . . 0.0 112.658 -173.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -132.59 153.84 50.63 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.389 1.476 . . . . 0.0 112.18 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.2 t -125.08 118.33 25.46 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 125.393 1.477 . . . . 0.0 110.86 177.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.57 136.88 24.32 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 124.521 3.481 . . . . 0.0 112.331 -175.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 70.6 mt -104.17 166.58 10.32 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.413 1.085 . . . . 0.0 112.514 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -141.45 118.68 11.38 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.519 1.928 . . . . 0.0 109.703 177.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 51.31 51.63 16.48 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 126.031 1.732 . . . . 0.0 114.095 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.1 t -113.54 133.06 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.761 1.224 . . . . 0.0 112.021 -177.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -127.94 157.29 40.97 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.882 1.273 . . . . 0.0 113.755 -175.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.2 m -144.11 164.12 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 127.46 2.304 . . . . 0.0 111.634 177.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.486 ' CE1' HG23 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -82.94 133.71 35.1 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.681 1.192 . . . . 0.0 110.102 171.461 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.2 t -131.8 153.62 49.94 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 127.395 2.278 . . . . 0.0 112.104 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 32.9 tp -106.09 133.61 50.53 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.177 0.991 . . . . 0.0 110.973 169.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -90.42 95.6 10.25 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.549 1.539 . . . . 0.0 111.501 175.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.4 mm -61.12 -18.75 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 124.8 1.24 . . . . 0.0 113.43 -174.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.56 -37.13 84.31 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.615 1.566 . . . . 0.0 114.334 172.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.6 p -127.56 -26.82 2.94 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.778 1.231 . . . . 0.0 113.545 -167.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.13 29.1 65.11 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.905 1.241 . . . . 0.0 113.38 -167.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -77.54 125.04 28.72 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.312 1.056 . . . . 0.0 110.615 167.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.486 HG23 ' CE1' ' A' ' 51' ' ' TYR . 1.9 mp -79.71 123.9 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 165.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -148.71 167.78 24.64 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -173.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -92.93 145.13 24.61 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.271 1.428 . . . . 0.0 110.005 174.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.5 t -144.49 155.43 43.7 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.522 1.129 . . . . 0.0 111.65 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.56 137.55 32.24 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.92 143.94 29.56 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.526 1.13 . . . . 0.0 110.666 171.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.6 t -99.2 -50.17 4.23 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.636 1.174 . . . . 0.0 112.885 -170.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -154.41 157.74 38.96 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.246 1.018 . . . . 0.0 112.286 176.012 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.7 mt -84.42 150.18 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 165.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -138.6 150.76 46.63 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.351 1.46 . . . . 0.0 111.731 -175.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -143.18 154.4 43.83 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 168.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -143.06 166.01 25.82 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.868 1.667 . . . . 0.0 109.789 172.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.7 tmtp? -100.68 136.57 40.34 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.209 0.603 . . . . 0.0 111.062 178.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.6 m -142.76 144.69 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 122.614 1.197 . . . . 0.0 111.021 178.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -93.5 -33.96 13.57 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 125.228 1.411 . . . . 0.0 111.148 173.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -121.17 137.35 54.71 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 124.418 1.087 . . . . 0.0 110.34 -173.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.4 tp -141.53 159.97 41.11 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 125.386 1.474 . . . . 0.0 109.191 -175.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.5 mt -109.36 124.25 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 175.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -93.5 125.92 38.36 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.891 0.877 . . . . 0.0 110.169 166.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.2 mp -110.84 124.84 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 124.512 1.125 . . . . 0.0 108.372 168.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -92.31 144.52 25.3 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.826 1.25 . . . . 0.0 110.202 173.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 59.9 mt -103.58 155.67 18.37 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 126.659 1.984 . . . . 0.0 110.263 178.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.8 t -66.37 -20.54 66.1 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.175 0.99 . . . . 0.0 112.949 -176.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 86.8 p -63.02 -18.48 63.38 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.111 1.765 . . . . 0.0 114.184 165.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 99.78 -7.35 59.19 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 126.254 1.883 . . . . 0.0 114.523 -174.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -86.18 171.12 11.55 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.475 1.51 . . . . 0.0 111.573 -178.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 95.2 p -142.81 157.6 44.46 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -177.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 14.3 tp -128.59 138.88 52.44 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.918 1.687 . . . . 0.0 109.969 171.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -120.78 116.97 26.26 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.242 1.417 . . . . 0.0 111.54 -176.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.4 m -140.21 153.29 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.058 1.343 . . . . 0.0 112.566 -164.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.9 p -67.79 146.68 98.48 Favored Pre-proline 0 N--CA 1.469 0.476 0 O-C-N 121.125 -0.985 . . . . 0.0 111.832 172.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -58.68 -18.69 41.97 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 124.279 3.319 . . . . 0.0 114.702 -175.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.7 p -88.81 -8.44 54.36 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.242 1.817 . . . . 0.0 114.987 177.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -71.61 120.96 82.97 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 119.526 1.057 . . . . 0.0 111.589 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -79.17 122.74 5.34 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.152 2.568 . . . . 0.0 112.537 176.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 40.1 t -93.72 141.17 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.927 1.691 . . . . 0.0 110.04 177.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 32.7 tp -80.01 104.65 10.73 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.518 0.599 . . . . 0.0 111.091 176.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -92.69 157.65 16.35 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.474 1.51 . . . . 0.0 112.323 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -121.17 71.1 0.94 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.684 0.754 . . . . 0.0 111.203 -177.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 73.0 mtp85 -119.65 74.08 0.99 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.651 1.18 . . . . 0.0 110.888 -169.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 58.22 6.07 0.49 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 127.337 2.255 . . . . 0.0 115.212 -166.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -178.35 157.9 22.16 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 125.693 1.616 . . . . 0.0 112.437 -177.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 48.4 mt -76.25 115.16 15.72 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.82 0.848 . . . . 0.0 109.871 177.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -146.0 141.74 27.96 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.946 0.898 . . . . 0.0 111.859 -173.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -101.32 111.82 24.16 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.777 0.831 . . . . 0.0 110.857 -175.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 54.1 t -117.85 127.78 26.41 Favored Pre-proline 0 N--CA 1.478 0.952 0 C-N-CA 123.953 0.901 . . . . 0.0 109.646 -173.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -64.44 143.79 83.41 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.192 1.928 . . . . 0.0 111.123 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.23 -31.63 21.4 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 175.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.17 -14.88 62.58 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 174.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -114.16 3.35 15.17 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.444 1.497 . . . . 0.0 112.22 175.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.2 t -78.2 149.06 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 125.185 1.394 . . . . 0.0 110.169 168.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.64 156.8 79.18 Favored Pre-proline 0 N--CA 1.47 0.527 0 C-N-CA 128.409 2.684 . . . . 0.0 108.857 178.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.401 ' HD3' HG22 ' A' ' 142' ' ' VAL . 60.5 Cg_endo -67.81 138.9 46.15 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.098 1.865 . . . . 0.0 111.765 -177.162 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 102.5 -1.6 49.65 Favored Glycine 0 N--CA 1.47 0.923 0 C-N-CA 124.452 1.025 . . . . 0.0 115.418 175.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.67 177.68 8.71 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 118.526 1.163 . . . . 0.0 114.116 176.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.3 p -122.54 122.5 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -168.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.8 t -102.84 144.05 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 127.426 2.29 . . . . 0.0 110.877 -177.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.8 t -89.17 142.95 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.472 1.109 . . . . 0.0 111.563 175.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -160.87 -152.48 6.61 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.369 0.985 . . . . 0.0 113.879 177.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.9 p -141.39 157.66 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.938 1.695 . . . . 0.0 110.058 172.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -60.64 117.6 5.54 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.995 0.918 . . . . 0.0 111.052 176.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -66.46 -14.71 62.6 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -173.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -65.84 -40.26 91.57 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.86 0.864 . . . . 0.0 112.643 166.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 83.0 t -64.78 -34.31 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 121.042 -1.037 . . . . 0.0 111.005 -177.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 58.5 mt -75.13 -5.07 42.33 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -119.41 -15.01 9.13 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 115.807 1.781 . . . . 0.0 115.807 169.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 74.9 mtt180 -63.58 155.45 29.54 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.816 1.246 . . . . 0.0 112.454 175.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -79.59 -12.37 59.84 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 125.295 1.438 . . . . 0.0 114.355 -177.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.2 tt -115.94 148.22 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 125.133 1.373 . . . . 0.0 109.95 165.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 18.7 tt -140.22 129.55 27.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.095 0.958 . . . . 0.0 111.51 175.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.4 t -124.76 115.56 20.91 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.744 1.218 . . . . 0.0 111.094 -177.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -62.08 157.48 18.89 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.886 1.275 . . . . 0.0 112.895 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 91.58 21.34 34.63 Favored Glycine 0 CA--C 1.541 1.712 0 N-CA-C 116.276 1.27 . . . . 0.0 116.276 173.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -120.67 150.76 40.43 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.226 1.411 . . . . 0.0 112.579 169.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 89.7 mt -143.61 163.71 32.46 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.83 1.652 . . . . 0.0 113.15 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -131.94 171.87 13.04 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 128.214 2.605 . . . . 0.0 110.742 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -135.24 158.43 44.39 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.836 -1.165 . . . . 0.0 113.496 169.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -134.92 136.14 42.08 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.544 1.538 . . . . 0.0 109.975 -174.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -99.41 138.79 36.0 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.282 1.033 . . . . 0.0 112.019 -177.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 93.8 t -77.18 126.95 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 O-C-N 121.062 -1.024 . . . . 0.0 111.614 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 12.3 t -83.24 -44.7 14.68 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.559 1.944 . . . . 0.0 113.022 175.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 31.0 t -158.57 161.24 37.25 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.941 1.296 . . . . 0.0 110.039 -177.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.401 HG22 ' HD3' ' A' ' 112' ' ' PRO . 5.4 m -133.92 147.86 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.117 0.967 . . . . 0.0 110.306 166.129 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -154.87 154.58 32.91 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.417 0.687 . . . . 0.0 112.247 169.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 66.8 mt -86.06 135.01 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 165.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 23.6 pt -123.64 166.79 18.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 125.773 1.629 . . . . 0.0 111.305 -177.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -103.74 98.7 8.53 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.011 1.325 . . . . 0.0 110.975 175.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -80.47 -57.22 3.69 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.463 -0.773 . . . . 0.0 112.016 177.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 45.7 51.59 10.1 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.326 1.05 . . . . 0.0 112.135 -172.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -150.21 173.91 13.4 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.921 1.289 . . . . 0.0 111.651 174.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -71.06 136.76 48.47 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.06 0.944 . . . . 0.0 112.502 173.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.3 m -117.23 155.47 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 125.673 1.589 . . . . 0.0 110.093 174.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.447 ' CG ' HG12 ' A' ' 21' ' ' ILE . 0.7 OUTLIER -112.1 160.68 17.29 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -172.834 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -143.17 160.31 40.68 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.527 0.731 . . . . 0.0 110.34 156.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 56.0 tp -124.3 109.59 13.55 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.874 1.269 . . . . 0.0 110.106 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 85.8 t -83.79 123.54 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -159.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 11.6 mm -116.86 88.88 27.35 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.197 1.399 . . . . 0.0 110.33 -176.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -65.5 -16.44 53.96 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.871 2.381 . . . . 0.0 113.25 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -78.11 -45.51 23.18 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.016 -1.052 . . . . 0.0 113.19 178.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 76.8 p -140.54 -2.9 1.35 Allowed 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -171.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 42.0 m-70 59.23 7.09 0.82 Allowed 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -149.2 145.52 27.18 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 120.886 -1.134 . . . . 0.0 112.235 -175.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -146.23 151.5 37.68 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.759 1.224 . . . . 0.0 112.476 -176.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.9 mp -99.97 140.01 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.053 0.941 . . . . 0.0 111.789 -176.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -91.04 157.99 42.26 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 126.482 1.913 . . . . 0.0 112.949 176.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.99 -19.24 57.92 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.785 2.99 . . . . 0.0 113.487 -176.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -80.86 3.77 21.5 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.036 1.334 . . . . 0.0 113.682 174.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.89 -17.94 58.36 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 126.233 1.873 . . . . 0.0 116.029 175.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 54.8 mt -77.78 148.29 34.88 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.387 1.594 . . . . 0.0 112.899 -175.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.8 p -96.41 136.92 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.284 1.034 . . . . 0.0 112.394 174.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 40.5 mt -115.54 145.91 42.21 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 127.236 2.215 . . . . 0.0 110.155 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -134.43 130.0 36.13 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.802 1.241 . . . . 0.0 111.12 -174.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -58.41 122.54 13.56 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.707 0.803 . . . . 0.0 112.374 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -103.89 5.77 35.96 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 -174.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 . . . . . 0 C--O 1.253 1.267 0 C-N-CA 125.724 1.61 . . . . 0.0 111.439 -177.949 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 110.854 -0.054 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.44 159.0 43.19 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.36 1.464 . . . . 0.0 111.446 -168.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.22 147.74 46.91 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.879 0.872 . . . . 0.0 113.02 177.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -58.01 -23.9 56.01 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 174.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -82.96 0.54 44.1 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.3 m -72.74 142.46 48.15 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.356 -0.84 . . . . 0.0 112.407 176.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -79.89 158.61 26.65 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.08 -1.013 . . . . 0.0 113.38 169.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.6 p -147.98 157.13 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.887 0.875 . . . . 0.0 111.842 -174.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -126.51 135.84 51.83 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.358 1.863 . . . . 0.0 108.853 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -155.23 179.99 8.62 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.946 0.898 . . . . 0.0 112.057 174.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -135.31 143.21 46.06 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.732 1.213 . . . . 0.0 109.618 171.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -156.66 152.68 27.43 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.385 1.474 . . . . 0.0 109.221 178.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.1 t0 53.94 35.06 20.96 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.669 1.122 . . . . 0.0 113.304 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.0 m 53.8 37.61 26.75 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.736 1.615 . . . . 0.0 114.241 -172.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.3 p -148.7 138.57 12.81 Favored Pre-proline 0 CA--C 1.549 0.924 0 O-C-N 120.033 -1.667 . . . . 0.0 112.131 177.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.42 153.88 69.87 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.756 2.971 . . . . 0.0 113.187 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 47.0 m80 -138.78 138.91 38.04 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.189 2.196 . . . . 0.0 110.464 -175.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 40.1 ttm -152.96 114.67 4.29 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.536 1.134 . . . . 0.0 110.987 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -160.26 -179.49 7.77 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.976 1.31 . . . . 0.0 111.661 -175.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 m -67.43 138.3 56.54 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.065 -1.022 . . . . 0.0 110.135 169.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.9 tp -58.03 -36.44 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 121.256 -0.903 . . . . 0.0 112.269 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -61.72 -23.02 65.87 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.521 0.729 . . . . 0.0 112.909 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -83.4 -49.39 9.38 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.657 0.783 . . . . 0.0 110.014 177.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -66.02 -34.66 78.6 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.586 -0.696 . . . . 0.0 112.336 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -59.75 -51.81 68.16 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.769 0.828 . . . . 0.0 111.346 169.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.6 t -61.3 -36.13 79.24 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.514 0.726 . . . . 0.0 111.266 -178.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -63.46 -55.74 21.73 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.494 1.517 . . . . 0.0 111.206 172.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -72.15 -32.47 66.91 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 121.147 -0.971 . . . . 0.0 112.68 -173.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.43 -28.93 68.99 Favored 'General case' 0 CA--C 1.551 1.014 0 O-C-N 121.498 -0.752 . . . . 0.0 112.347 171.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.4 t -83.01 -25.64 31.98 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.841 1.256 . . . . 0.0 112.993 175.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 50.7 mtm -88.85 -48.19 7.65 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.859 1.263 . . . . 0.0 113.446 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 -110.55 -20.73 12.46 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.325 1.45 . . . . 0.0 113.681 -170.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.99 159.54 35.45 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.626 1.108 . . . . 0.0 114.853 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -103.36 131.02 50.78 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.772 1.229 . . . . 0.0 110.479 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.3 mp -110.12 142.57 26.21 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 126.447 1.899 . . . . 0.0 110.271 175.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.12 159.0 44.94 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.687 2.925 . . . . 0.0 111.366 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -140.13 173.07 11.88 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.239 1.415 . . . . 0.0 111.505 -176.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -55.31 -57.16 12.96 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.413 1.085 . . . . 0.0 113.014 176.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -105.08 -0.01 27.11 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -172.41 -128.44 1.05 Allowed Glycine 0 CA--C 1.536 1.379 0 N-CA-C 115.982 1.153 . . . . 0.0 115.982 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -137.51 161.29 36.79 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 126.623 1.969 . . . . 0.0 110.772 175.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.87 159.45 42.16 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.323 1.449 . . . . 0.0 112.148 177.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 98.1 t -128.48 117.89 20.05 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 125.972 1.709 . . . . 0.0 109.498 174.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.24 142.14 54.33 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 124.065 3.177 . . . . 0.0 111.456 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 74.3 mt -118.13 152.67 35.17 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.398 1.079 . . . . 0.0 112.855 175.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -137.42 125.23 22.51 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.385 1.874 . . . . 0.0 110.167 178.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 51.63 54.85 10.28 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.145 0.978 . . . . 0.0 112.286 -174.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.4 t -123.22 119.23 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 124.603 1.161 . . . . 0.0 109.632 173.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -113.16 158.94 19.79 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.577 1.551 . . . . 0.0 112.642 -176.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.0 m -140.64 152.25 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 126.113 1.765 . . . . 0.0 111.609 170.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -65.58 130.47 43.43 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.495 0.718 . . . . 0.0 109.139 163.245 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.0 t -133.48 148.07 51.7 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.514 1.926 . . . . 0.0 110.786 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 45.3 tp -99.53 140.17 34.11 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.768 0.827 . . . . 0.0 111.542 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -85.81 117.79 24.9 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.133 -0.979 . . . . 0.0 110.488 158.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.0 mm -74.45 -22.53 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 CA-C-N 119.084 0.856 . . . . 0.0 112.19 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.64 -33.52 64.56 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -173.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.2 m -121.45 -10.95 8.8 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.931 1.292 . . . . 0.0 112.919 169.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.51 39.46 56.42 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 -173.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -97.53 138.02 35.59 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.153 1.781 . . . . 0.0 111.715 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.1 mp -91.62 130.9 40.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 124.549 1.14 . . . . 0.0 109.669 -177.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -152.6 171.34 18.3 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.612 1.165 . . . . 0.0 111.509 -177.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -106.08 150.45 25.76 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.479 1.112 . . . . 0.0 111.242 176.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.8 t -139.58 153.11 47.33 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.466 1.106 . . . . 0.0 110.977 170.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 72.4 mtt85 -87.01 133.5 33.58 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.914 0.885 . . . . 0.0 110.303 172.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -87.12 149.64 24.54 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.196 0.998 . . . . 0.0 111.733 176.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.7 t -88.76 -54.19 4.27 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.834 1.254 . . . . 0.0 112.508 -169.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -157.63 160.03 37.63 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.672 1.589 . . . . 0.0 111.028 178.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.0 mt -84.8 150.42 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 162.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -139.76 152.42 46.59 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.529 1.531 . . . . 0.0 111.099 -176.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.8 ptt-85 -139.74 152.44 46.63 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.058 0.943 . . . . 0.0 113.321 166.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -146.41 168.93 19.93 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.811 2.045 . . . . 0.0 110.115 175.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -112.11 136.92 50.88 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 120.661 -1.274 . . . . 0.0 112.859 -170.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.2 m -144.51 142.04 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 122.796 1.284 . . . . 0.0 113.327 -176.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -97.63 -28.61 13.85 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 127.196 2.199 . . . . 0.0 111.745 178.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -120.85 127.92 52.35 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.606 1.562 . . . . 0.0 110.646 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.4 tp -136.95 161.26 36.53 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.469 1.508 . . . . 0.0 110.115 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.4 mt -117.7 126.0 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.356 1.062 . . . . 0.0 109.455 177.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 68.7 tt0 -100.09 117.15 33.73 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.156 0.982 . . . . 0.0 111.876 169.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.7 mp -108.42 129.26 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.365 1.466 . . . . 0.0 109.415 175.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -96.88 148.68 22.69 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.937 1.695 . . . . 0.0 111.4 176.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 59.6 mt -116.67 165.32 13.41 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.933 1.693 . . . . 0.0 112.483 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.6 t -71.06 -13.28 61.92 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 77.8 p -70.76 -15.58 62.69 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 120.428 -1.42 . . . . 0.0 113.59 165.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.49 -1.93 84.43 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.085 1.326 . . . . 0.0 114.178 -170.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -72.33 153.7 41.35 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.702 1.251 . . . . 0.0 110.605 174.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 95.1 p -130.01 143.23 50.69 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 167.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.2 tp -113.06 135.86 53.33 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.414 1.486 . . . . 0.0 109.768 173.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -115.25 110.85 20.05 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.28 1.832 . . . . 0.0 110.176 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.3 m -137.23 158.84 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.37 1.068 . . . . 0.0 113.083 -168.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.0 p -68.99 146.76 97.55 Favored Pre-proline 0 N--CA 1.467 0.413 0 O-C-N 121.692 -0.63 . . . . 0.0 112.541 175.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.52 -30.69 86.76 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.776 2.317 . . . . 0.0 113.294 -171.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.0 p -77.3 -7.09 55.44 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.367 1.867 . . . . 0.0 114.649 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -73.31 116.95 56.15 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 119.936 1.244 . . . . 0.0 112.97 -174.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -76.07 135.45 17.18 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.899 2.399 . . . . 0.0 113.782 178.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.5 t -118.91 143.81 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 126.655 1.982 . . . . 0.0 108.953 176.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 17.3 tp -82.51 114.57 21.01 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.569 -0.707 . . . . 0.0 110.44 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.5 mp -115.86 159.78 21.06 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.675 1.99 . . . . 0.0 111.499 -176.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -112.72 101.84 9.92 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.875 0.87 . . . . 0.0 113.073 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 68.9 mtp85 -125.82 81.56 1.99 Allowed 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 122.426 1.108 . . . . 0.0 108.799 174.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 59.79 -4.39 0.1 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 128.388 2.675 . . . . 0.0 115.282 -167.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -168.06 170.73 42.13 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 128.701 3.048 . . . . 0.0 111.242 -175.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 62.8 mt -83.57 115.21 22.01 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.395 1.478 . . . . 0.0 111.83 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -128.84 137.15 51.32 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.837 1.255 . . . . 0.0 112.107 -171.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -87.9 110.34 20.47 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.504 0.322 . . . . 0.0 111.413 172.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 52.3 t -121.56 126.34 26.49 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 124.723 1.209 . . . . 0.0 109.892 -172.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -66.96 149.48 82.91 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.576 2.184 . . . . 0.0 111.837 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.79 -31.21 26.19 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.19 -21.47 66.77 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 172.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -99.7 -6.76 26.58 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.048 1.739 . . . . 0.0 112.575 172.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.1 t -73.39 142.42 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 O-C-N 121.041 -1.037 . . . . 0.0 110.125 171.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.32 155.75 67.63 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 127.549 2.34 . . . . 0.0 110.197 -175.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.9 123.37 10.31 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.992 1.794 . . . . 0.0 111.891 -170.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 103.91 1.68 45.67 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.636 1.113 . . . . 0.0 114.738 -175.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -58.65 155.41 12.62 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.468 1.134 . . . . 0.0 113.148 170.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.3 p -107.55 119.21 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 126.243 1.817 . . . . 0.0 111.055 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 38.7 t -113.04 134.33 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 125.92 1.688 . . . . 0.0 110.927 -167.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.7 t -88.44 134.92 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 O-C-N 121.267 -0.896 . . . . 0.0 111.376 -172.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -169.12 -147.16 5.31 Favored Glycine 0 CA--C 1.529 0.935 0 O-C-N 121.796 -0.565 . . . . 0.0 112.872 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.2 p -135.58 161.31 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 127.384 2.274 . . . . 0.0 108.475 171.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 68.8 mtp85 -64.99 117.6 7.87 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.73 -0.606 . . . . 0.0 110.775 173.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -61.84 -26.79 68.34 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -176.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -58.39 -25.64 62.32 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 174.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.4 t -85.78 -37.76 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 123.911 0.884 . . . . 0.0 110.511 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 21.2 tp -68.96 -27.96 66.2 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.346 1.459 . . . . 0.0 111.883 175.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -94.98 17.17 14.4 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 127.201 2.201 . . . . 0.0 112.955 174.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -95.7 159.56 14.93 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.944 2.098 . . . . 0.0 110.589 168.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -73.06 -45.23 58.59 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.24 1.016 . . . . 0.0 113.001 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 39.5 mm -97.22 102.78 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.936 1.294 . . . . 0.0 108.704 166.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 58.2 mt -82.19 90.24 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 49.4 m -69.71 78.11 0.44 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.94 1.696 . . . . 0.0 111.489 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -82.69 164.41 20.73 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 126.969 2.108 . . . . 0.0 113.915 -165.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 101.91 20.42 12.86 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 115.389 -0.823 . . . . 0.0 113.176 -172.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -127.48 160.27 32.01 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.519 1.527 . . . . 0.0 113.21 173.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 96.8 mt -138.07 166.49 23.97 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 127.013 2.125 . . . . 0.0 112.136 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -154.38 148.43 25.75 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.463 1.905 . . . . 0.0 111.084 167.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -94.62 143.42 26.45 Favored 'General case' 0 CA--C 1.548 0.87 0 O-C-N 120.889 -1.132 . . . . 0.0 112.423 172.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -122.63 160.27 26.13 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.495 1.918 . . . . 0.0 110.926 -170.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -111.33 130.11 55.78 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -168.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 84.4 t -73.01 136.67 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 121.599 0.714 . . . . 0.0 110.674 171.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 12.3 t -94.42 -49.54 5.64 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.966 2.106 . . . . 0.0 112.537 176.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.4 t -157.48 162.06 38.89 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.216 1.006 . . . . 0.0 111.433 -176.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.7 m -135.19 148.34 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 124.435 1.094 . . . . 0.0 112.066 172.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -152.47 155.18 36.99 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.659 1.183 . . . . 0.0 112.914 170.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 89.2 mt -91.79 133.39 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.359 1.064 . . . . 0.0 108.642 167.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 44.3 pt -126.78 154.28 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 126.09 1.756 . . . . 0.0 111.83 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -96.26 98.91 10.67 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.393 0.677 . . . . 0.0 109.71 178.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -78.62 -53.06 7.58 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 51.88 36.65 18.71 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.648 1.179 . . . . 0.0 113.26 -174.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -144.16 171.7 13.93 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 120.888 -1.132 . . . . 0.0 111.464 -173.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -77.39 134.49 38.42 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.566 1.146 . . . . 0.0 111.794 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 14.1 m -117.64 152.46 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 125.704 1.602 . . . . 0.0 109.993 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -106.56 160.48 15.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.686 0.755 . . . . 0.0 112.942 -173.255 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.35 140.24 27.57 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.482 1.113 . . . . 0.0 109.098 166.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 64.9 tp -109.33 115.93 30.91 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 120.456 -1.403 . . . . 0.0 110.129 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 57.3 t -86.24 123.07 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -158.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 42.6 mm -118.4 92.32 43.08 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 126.569 1.948 . . . . 0.0 109.451 -176.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.88 -18.99 41.04 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 123.071 2.514 . . . . 0.0 113.736 176.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -78.74 -50.83 10.7 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 120.207 1.367 . . . . 0.0 112.81 -174.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 76.9 p -128.6 -7.01 5.15 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.496 1.518 . . . . 0.0 114.417 -169.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 74.9 m-70 57.22 19.49 4.95 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -170.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -140.9 149.61 42.13 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 120.892 1.678 . . . . 0.0 114.136 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -141.52 154.63 45.61 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.232 1.013 . . . . 0.0 111.316 168.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.4 mp -102.46 132.45 48.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.118 0.967 . . . . 0.0 110.926 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.46 158.79 62.78 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.62 1.168 . . . . 0.0 112.518 175.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.44 -16.82 52.41 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.227 2.618 . . . . 0.0 113.274 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 33.0 p30 -70.07 -2.26 12.32 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 124.702 1.201 . . . . 0.0 113.565 169.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.33 -10.95 69.32 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 126.831 2.157 . . . . 0.0 115.893 176.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 52.4 mt -96.34 150.28 20.75 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 120.317 2.059 . . . . 0.0 113.663 -169.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.2 p -97.54 133.16 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.261 1.024 . . . . 0.0 113.023 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 31.7 mt -119.46 132.81 55.86 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.03 1.732 . . . . 0.0 111.112 -169.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -88.42 118.44 28.05 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.056 0.843 . . . . 0.0 111.937 175.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -81.65 140.09 34.59 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 120.949 -1.095 . . . . 0.0 113.393 -172.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 59.7 14.43 4.06 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.458 2.303 . . . . 0.0 116.995 167.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 . . . . . 0 C--O 1.253 1.246 0 C-N-CA 125.992 1.717 . . . . 0.0 113.422 167.429 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.687 0 CA-C-O 120.897 0.38 . . . . 0.0 111.572 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.61 161.56 38.18 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.657 1.583 . . . . 0.0 110.724 -169.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.81 141.03 50.31 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.511 1.124 . . . . 0.0 112.949 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.02 -22.48 49.93 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.511 1.524 . . . . 0.0 114.198 176.096 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -78.39 -17.31 56.62 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 177.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.6 m -58.6 136.75 57.69 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 119.347 0.976 . . . . 0.0 113.504 -169.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.33 150.65 47.1 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.12 0.968 . . . . 0.0 113.378 175.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.2 p -146.06 155.67 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.894 1.277 . . . . 0.0 112.141 -171.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -128.98 137.62 51.47 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.449 1.9 . . . . 0.0 108.744 176.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -153.83 168.39 26.49 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.214 0.916 . . . . 0.0 113.256 168.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -130.13 146.02 51.75 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.309 1.443 . . . . 0.0 111.026 177.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -163.0 145.03 10.17 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.217 1.407 . . . . 0.0 109.151 174.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.3 t70 53.76 39.02 29.78 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.349 1.059 . . . . 0.0 113.033 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.2 m 67.41 16.3 10.0 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.331 1.852 . . . . 0.0 114.979 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.0 p -133.67 133.47 22.48 Favored Pre-proline 0 CA--C 1.554 1.1 0 O-C-N 120.175 -1.578 . . . . 0.0 113.229 -177.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -85.72 153.06 10.14 Favored 'Trans proline' 0 CA--C 1.539 0.742 1 C-N-CA 125.593 4.195 . . . . 0.0 114.713 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -135.42 144.87 46.74 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.353 2.261 . . . . 0.0 111.156 -178.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 50.7 ttm -149.37 111.23 4.57 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.784 0.834 . . . . 0.0 110.904 -176.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -158.98 -168.8 2.47 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.81 1.244 . . . . 0.0 112.302 -169.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.4 m -85.71 143.99 28.05 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.098 -1.001 . . . . 0.0 111.36 166.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.43 HG12 ' CG ' ' A' ' 152' ' ' TYR . 8.4 tp -56.81 -38.23 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -177.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -61.75 -22.58 65.52 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.608 0.763 . . . . 0.0 112.848 179.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -80.41 -49.4 11.51 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.302 1.041 . . . . 0.0 111.235 176.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 19.3 ptm -65.77 -31.48 72.49 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 122.062 -0.399 . . . . 0.0 111.589 176.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -57.92 -51.63 68.81 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.603 0.638 . . . . 0.0 111.031 172.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.9 t -67.68 -29.98 69.39 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.148 0.579 . . . . 0.0 111.679 -177.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -66.71 -53.19 36.13 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.323 1.449 . . . . 0.0 111.04 172.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -71.72 -30.82 66.05 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.004 -1.06 . . . . 0.0 112.805 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.48 -31.36 71.46 Favored 'General case' 0 CA--C 1.552 1.054 0 O-C-N 121.51 -0.744 . . . . 0.0 111.992 171.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.0 t -80.07 -22.74 41.93 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 120.668 -1.27 . . . . 0.0 113.095 174.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 55.9 mtm -92.13 -49.7 6.06 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.543 1.137 . . . . 0.0 113.43 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -109.21 -24.09 11.29 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.356 1.462 . . . . 0.0 112.612 -169.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 87.26 164.5 40.2 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 125.556 1.551 . . . . 0.0 114.787 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -109.18 143.57 38.42 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.969 1.308 . . . . 0.0 111.392 -173.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.4 mp -117.33 140.72 27.64 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 126.146 1.778 . . . . 0.0 111.181 172.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.25 141.77 18.56 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 124.469 3.446 . . . . 0.0 111.784 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -126.36 156.16 40.92 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.632 1.573 . . . . 0.0 111.459 -177.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.87 -46.92 16.09 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.387 1.475 . . . . 0.0 114.056 178.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -97.73 -16.58 19.84 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 176.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.26 -126.83 0.95 Allowed Glycine 0 CA--C 1.538 1.504 0 N-CA-C 116.585 1.394 . . . . 0.0 116.585 -168.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -144.54 155.08 43.5 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.61 1.564 . . . . 0.0 112.538 -178.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.48 154.73 50.67 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.759 1.224 . . . . 0.0 113.15 175.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.9 t -130.45 115.75 17.3 Favored Pre-proline 0 N--CA 1.481 1.097 0 C-N-CA 126.125 1.77 . . . . 0.0 110.606 177.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.52 138.64 27.24 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 125.057 3.838 . . . . 0.0 112.52 -176.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.8 mt -112.69 160.98 17.38 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.874 1.27 . . . . 0.0 113.125 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -146.34 128.29 15.48 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.606 1.162 . . . . 0.0 111.349 168.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 55.39 40.39 31.36 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.6 1.56 . . . . 0.0 113.839 -173.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.4 t -107.71 113.3 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 O-C-N 121.109 -0.994 . . . . 0.0 109.346 175.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -113.79 152.0 31.23 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.144 1.378 . . . . 0.0 113.59 -166.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.0 m -143.18 154.35 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 127.119 2.168 . . . . 0.0 111.119 175.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.487 ' CE1' HG23 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -72.08 135.67 46.36 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.744 0.818 . . . . 0.0 109.873 166.541 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.0 t -133.35 153.49 51.54 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.131 1.772 . . . . 0.0 112.842 -179.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 50.3 tp -100.13 133.89 43.86 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.512 1.125 . . . . 0.0 109.861 168.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -84.59 119.39 25.15 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.94 1.296 . . . . 0.0 110.407 164.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.8 mm -76.38 -19.48 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 119.569 1.077 . . . . 0.0 112.265 -179.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.44 -41.03 48.88 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -174.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.3 m -110.57 -11.76 14.42 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.695 1.198 . . . . 0.0 112.814 172.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.5 36.82 68.93 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-N 118.42 0.555 . . . . 0.0 112.037 -173.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -96.69 136.8 36.71 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.222 1.809 . . . . 0.0 111.769 -175.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.487 HG23 ' CE1' ' A' ' 51' ' ' TYR . 1.9 mp -85.84 130.6 36.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 124.504 1.121 . . . . 0.0 107.992 172.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.3 pttt -154.91 168.46 26.85 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.803 1.241 . . . . 0.0 112.913 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -89.56 146.7 24.4 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.574 0.749 . . . . 0.0 111.183 172.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.7 t -143.25 164.13 31.06 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.108 0.963 . . . . 0.0 111.645 172.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -99.88 142.85 30.81 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.241 1.016 . . . . 0.0 112.077 174.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.73 137.39 32.37 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.262 0.625 . . . . 0.0 110.109 167.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 22.8 t -86.97 -46.38 9.91 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.427 1.491 . . . . 0.0 112.334 -172.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -152.89 155.45 37.06 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.618 0.723 . . . . 0.0 112.356 174.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.9 mt -85.12 147.36 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 163.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -136.25 147.78 47.72 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 125.747 1.619 . . . . 0.0 110.839 -175.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 30.6 ptt-85 -143.92 153.95 42.82 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.052 0.941 . . . . 0.0 113.424 167.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -154.82 172.43 18.0 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.846 1.259 . . . . 0.0 110.728 169.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -95.39 147.27 23.7 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.646 0.778 . . . . 0.0 111.943 177.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.1 m -143.74 144.55 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 125.18 1.392 . . . . 0.0 110.481 171.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -94.18 -29.05 15.32 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 124.888 1.275 . . . . 0.0 111.469 175.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -121.01 134.27 55.29 Favored 'General case' 0 C--N 1.344 0.358 0 C-N-CA 125.17 1.388 . . . . 0.0 109.416 -176.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.5 tp -143.53 159.69 41.96 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.164 1.386 . . . . 0.0 109.966 -177.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.6 mt -111.21 128.49 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 O-C-N 121.246 -0.909 . . . . 0.0 109.632 177.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -102.67 112.98 26.0 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.363 1.465 . . . . 0.0 110.261 173.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.2 mp -106.92 131.13 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.608 1.163 . . . . 0.0 109.376 174.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.2 tttt -100.96 147.63 25.94 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.678 1.591 . . . . 0.0 111.51 175.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 61.5 mt -107.75 164.39 12.28 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 126.83 2.052 . . . . 0.0 111.195 -178.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.7 t -75.02 -1.53 23.18 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -178.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.8 p -79.06 -15.09 58.68 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.954 1.702 . . . . 0.0 113.766 160.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.78 -3.63 84.89 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 125.73 1.633 . . . . 0.0 114.199 -169.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -74.54 151.37 39.48 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.451 1.625 . . . . 0.0 111.45 177.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.7 p -128.68 138.63 52.26 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 178.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 14.7 tp -117.01 140.02 49.98 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.995 1.718 . . . . 0.0 110.538 177.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.6 mtmm -118.49 116.38 26.55 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.687 1.195 . . . . 0.0 112.402 -175.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.1 m -141.61 152.49 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 125.204 1.402 . . . . 0.0 113.031 -163.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.7 p -68.39 148.3 98.18 Favored Pre-proline 0 N--CA 1.474 0.73 0 O-C-N 121.031 -1.043 . . . . 0.0 112.433 174.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.79 -17.63 60.31 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.594 2.862 . . . . 0.0 113.728 -175.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 36.3 p -86.35 -10.94 53.4 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.949 2.1 . . . . 0.0 114.48 176.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -72.46 122.17 86.76 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-N 119.699 1.136 . . . . 0.0 111.736 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -80.35 125.06 5.57 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 123.711 2.941 . . . . 0.0 113.113 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.3 t -94.52 141.09 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.686 1.595 . . . . 0.0 109.848 175.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 17.4 tp -83.86 107.23 16.13 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.103 0.561 . . . . 0.0 110.664 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.9 mp -100.15 144.34 29.3 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.756 1.622 . . . . 0.0 111.755 -176.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -104.29 90.23 3.49 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.933 0.893 . . . . 0.0 112.244 -177.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 46.6 mtm180 -133.91 81.43 1.92 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.865 0.866 . . . . 0.0 110.841 -177.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.7 t70 66.3 -17.94 0.11 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 128.09 2.556 . . . . 0.0 115.888 -167.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.48 167.26 39.87 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 126.171 1.843 . . . . 0.0 113.258 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 77.3 mt -62.94 113.83 3.31 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.493 1.917 . . . . 0.0 111.392 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -141.94 142.83 33.03 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.646 0.778 . . . . 0.0 112.847 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -97.56 122.14 40.28 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.877 1.271 . . . . 0.0 110.768 -175.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 71.2 t -128.45 126.69 23.57 Favored Pre-proline 0 N--CA 1.477 0.914 0 C-N-CA 124.289 1.036 . . . . 0.0 110.007 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -64.71 148.65 90.3 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.301 2.001 . . . . 0.0 112.014 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.59 -31.98 17.42 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 173.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.93 -17.89 63.68 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 173.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -111.82 -0.61 15.84 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.568 1.547 . . . . 0.0 112.989 174.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 71.3 t -72.12 148.67 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 120.679 -1.263 . . . . 0.0 110.833 171.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.96 157.09 75.36 Favored Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 127.369 2.268 . . . . 0.0 111.129 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.59 113.42 3.16 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.715 2.277 . . . . 0.0 112.003 -175.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 111.91 6.09 24.87 Favored Glycine 0 CA--C 1.537 1.449 0 CA-C-O 118.691 -1.061 . . . . 0.0 115.264 -175.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -62.86 161.31 12.95 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 118.946 1.373 . . . . 0.0 112.403 163.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 5.8 p -109.45 129.52 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.384 1.474 . . . . 0.0 111.747 178.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.1 t -107.55 137.07 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 126.729 2.012 . . . . 0.0 110.2 -175.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 51.8 t -87.25 134.39 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.744 0.817 . . . . 0.0 110.31 172.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -157.82 -153.91 6.91 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.53 1.062 . . . . 0.0 112.49 176.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.1 p -145.22 176.86 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 126.415 1.886 . . . . 0.0 108.492 174.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -80.91 139.42 35.9 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.071 -1.018 . . . . 0.0 113.067 175.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.58 -39.37 80.13 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.792 0.837 . . . . 0.0 112.859 173.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -61.44 -26.72 68.06 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 178.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 55.8 t -78.74 -41.49 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.069 0.948 . . . . 0.0 110.335 178.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -65.37 -33.47 76.05 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.909 1.283 . . . . 0.0 111.922 173.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -88.11 9.65 21.94 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.709 1.603 . . . . 0.0 113.443 170.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.4 mtt-85 49.89 22.64 0.89 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 127.375 2.27 . . . . 0.0 116.411 175.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -56.25 -39.28 72.33 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.052 -1.03 . . . . 0.0 110.485 175.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.4 tp -133.84 144.0 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 128.845 2.858 . . . . 0.0 107.393 168.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 7.0 tp -81.64 134.48 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.228 1.011 . . . . 0.0 111.162 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.3 t -154.43 132.16 11.46 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.829 -0.544 . . . . 0.0 111.926 165.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -132.75 140.81 48.23 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.929 1.292 . . . . 0.0 111.736 169.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.94 -2.31 59.94 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 124.801 1.191 . . . . 0.0 115.646 177.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -123.92 153.03 41.76 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.15 1.38 . . . . 0.0 112.563 -169.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 89.9 mt -131.04 165.21 23.71 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.858 2.063 . . . . 0.0 111.741 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -131.59 157.17 44.36 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.739 1.616 . . . . 0.0 110.912 173.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -113.28 142.89 45.3 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.608 1.163 . . . . 0.0 111.587 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -133.54 156.24 48.15 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.606 1.562 . . . . 0.0 110.544 -173.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 57.4 tt0 -114.68 137.79 51.48 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.128 -0.983 . . . . 0.0 112.288 -170.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 92.2 t -73.79 133.32 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 122.003 0.906 . . . . 0.0 110.622 173.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 27.5 t -87.11 -59.64 2.2 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.941 1.697 . . . . 0.0 111.748 173.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 59.2 m -149.61 158.88 44.58 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.259 1.424 . . . . 0.0 110.901 -170.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.2 m -136.37 152.86 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 124.126 0.97 . . . . 0.0 111.925 173.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 9.4 ptp85 -158.14 159.48 36.24 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.74 1.216 . . . . 0.0 112.684 168.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 76.3 mt -99.03 129.92 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.935 0.894 . . . . 0.0 109.211 170.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 13.2 pt -121.15 156.58 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.574 1.55 . . . . 0.0 111.908 -174.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -92.7 97.96 11.11 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.754 0.787 . . . . 0.0 110.957 170.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -76.63 -47.89 20.8 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 44.39 39.46 3.13 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.576 1.15 . . . . 0.0 113.826 -174.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 -144.31 174.71 10.67 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.17 0.988 . . . . 0.0 111.392 -174.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -77.27 137.88 39.06 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 124.588 1.155 . . . . 0.0 112.466 -177.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.2 m -119.8 152.74 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 125.084 1.353 . . . . 0.0 109.97 176.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.43 ' CG ' HG12 ' A' ' 21' ' ' ILE . 1.4 p90 -112.1 160.53 17.45 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.08 0.952 . . . . 0.0 112.278 -178.194 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -141.3 156.06 45.9 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.052 0.541 . . . . 0.0 110.069 156.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 65.2 tp -128.69 103.0 6.83 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.767 1.227 . . . . 0.0 110.051 -175.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 87.8 t -86.63 124.12 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -151.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 20.8 mm -110.71 98.27 36.78 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 125.27 1.428 . . . . 0.0 109.681 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.5 -16.73 38.81 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.512 2.142 . . . . 0.0 113.193 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -74.51 -61.28 1.92 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.784 0.834 . . . . 0.0 112.363 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 54.9 p -122.82 -7.95 8.43 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -171.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 61.37 15.38 6.5 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.086 1.754 . . . . 0.0 115.657 -175.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.81 148.52 30.03 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.082 -1.011 . . . . 0.0 113.532 -178.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -145.9 158.93 43.84 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.746 1.218 . . . . 0.0 112.385 177.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.3 mp -102.39 137.22 31.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 123.975 0.91 . . . . 0.0 111.377 -177.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -88.56 160.24 45.1 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 125.938 1.695 . . . . 0.0 113.088 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.36 -19.46 61.62 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.299 2.666 . . . . 0.0 113.989 -176.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 50.6 p30 -86.18 -2.26 58.2 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.961 1.304 . . . . 0.0 113.551 175.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 102.12 -15.04 56.88 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 126.628 2.061 . . . . 0.0 116.756 173.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 66.7 mt -74.09 145.39 44.43 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.425 1.613 . . . . 0.0 111.965 -178.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.1 p -91.36 135.76 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.528 0.731 . . . . 0.0 111.304 171.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 39.6 mt -113.61 142.09 46.41 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.156 1.783 . . . . 0.0 109.792 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -127.54 127.01 43.22 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.279 1.432 . . . . 0.0 110.146 -177.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -60.46 129.7 42.9 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.912 0.885 . . . . 0.0 112.696 -174.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -154.96 124.94 6.63 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.453 0.701 . . . . 0.0 112.593 175.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 . . . . . 0 C--O 1.252 1.186 0 C-N-CA 124.846 1.259 . . . . 0.0 114.198 -179.29 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.566 0 CA-C-O 120.62 0.248 . . . . 0.0 111.504 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.54 156.99 47.01 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.247 1.419 . . . . 0.0 111.063 -170.155 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.54 143.97 33.4 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.346 1.458 . . . . 0.0 113.901 -178.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -61.11 -26.09 67.43 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.494 1.117 . . . . 0.0 113.241 174.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -83.03 -1.46 52.73 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.312 1.045 . . . . 0.0 113.803 176.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.4 m -68.59 143.51 54.83 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 119.845 1.202 . . . . 0.0 111.77 174.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -74.68 159.22 32.34 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.205 -0.934 . . . . 0.0 112.817 167.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 p -149.0 156.26 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.049 0.94 . . . . 0.0 111.867 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -121.26 141.8 50.55 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.638 1.975 . . . . 0.0 108.134 176.155 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -156.44 -178.28 7.22 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.666 0.786 . . . . 0.0 111.128 164.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -136.6 143.13 43.41 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.564 1.545 . . . . 0.0 110.216 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -154.96 -45.68 0.08 Allowed 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 174.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -83.24 37.1 0.54 Allowed 'General case' 0 N--CA 1.481 1.097 0 O-C-N 120.65 -1.281 . . . . 0.0 112.857 -175.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.2 m 61.0 24.92 14.99 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 126.007 1.723 . . . . 0.0 112.915 -167.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.2 p -158.61 149.89 16.57 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 126.412 1.885 . . . . 0.0 109.276 -170.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.45 160.53 32.05 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.974 3.116 . . . . 0.0 114.306 176.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -140.48 151.16 44.6 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 128.029 2.532 . . . . 0.0 110.561 -173.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 34.8 ttm -149.48 126.14 11.03 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.485 -0.759 . . . . 0.0 112.148 177.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -160.89 -178.17 6.64 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.528 1.531 . . . . 0.0 111.75 178.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.52 143.12 51.76 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 121.017 -1.052 . . . . 0.0 109.433 171.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.45 HG12 ' CG ' ' A' ' 152' ' ' TYR . 8.1 tp -56.55 -38.54 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 O-C-N 121.24 -0.913 . . . . 0.0 112.002 179.019 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -60.56 -24.51 65.47 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.359 0.982 . . . . 0.0 112.566 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -81.6 -46.95 13.68 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.499 1.12 . . . . 0.0 111.402 179.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -70.71 -34.07 71.54 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.441 -0.787 . . . . 0.0 111.6 176.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -58.58 -52.6 64.99 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 124.196 0.998 . . . . 0.0 110.591 172.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.8 t -67.58 -30.4 70.01 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 122.661 0.384 . . . . 0.0 111.043 -174.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -64.69 -52.91 54.69 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.043 1.337 . . . . 0.0 110.969 172.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -71.57 -31.01 66.5 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.074 -1.016 . . . . 0.0 113.14 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.93 -30.44 67.84 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.99 0.916 . . . . 0.0 111.305 172.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.4 m -74.21 -35.21 63.89 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 120.398 -1.439 . . . . 0.0 112.081 172.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 42.5 mtm -86.79 -42.95 12.88 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.366 1.066 . . . . 0.0 113.664 -173.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -114.55 -21.16 10.43 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.803 1.241 . . . . 0.0 112.639 -171.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.95 155.64 21.69 Favored Glycine 0 C--N 1.341 0.816 0 C-N-CA 125.441 1.496 . . . . 0.0 114.38 176.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -98.15 139.15 34.38 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.404 1.081 . . . . 0.0 110.645 -177.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.4 mp -106.86 143.91 28.01 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 127.331 2.252 . . . . 0.0 110.89 175.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.52 145.97 34.15 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.905 3.07 . . . . 0.0 112.415 176.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -142.12 157.52 44.79 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.856 1.662 . . . . 0.0 111.322 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.14 -52.66 58.01 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 120.63 -1.294 . . . . 0.0 113.997 -177.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -84.53 -16.0 43.84 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 176.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -178.65 -131.82 1.63 Allowed Glycine 0 CA--C 1.53 1.002 0 N-CA-C 115.626 1.01 . . . . 0.0 115.626 -165.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -143.59 159.3 42.69 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.284 1.434 . . . . 0.0 111.803 -178.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.06 149.4 45.97 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.862 1.265 . . . . 0.0 112.853 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.4 t -125.63 113.37 25.14 Favored Pre-proline 0 N--CA 1.484 1.263 0 C-N-CA 125.472 1.509 . . . . 0.0 111.933 177.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -68.73 134.72 31.0 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 124.235 3.29 . . . . 0.0 111.02 178.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 96.9 mt -99.65 164.25 12.14 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.884 1.274 . . . . 0.0 112.665 -177.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -133.71 120.65 20.86 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.224 1.01 . . . . 0.0 110.514 172.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 48.15 42.47 17.31 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.342 1.457 . . . . 0.0 113.593 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 97.7 t -100.88 123.76 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 O-C-N 121.488 -0.757 . . . . 0.0 109.734 178.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -126.23 161.18 28.32 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.419 1.088 . . . . 0.0 112.99 -172.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.8 m -148.09 153.32 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.927 2.091 . . . . 0.0 111.321 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -60.29 132.24 53.31 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 122.144 0.974 . . . . 0.0 109.611 155.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.3 t -134.6 147.58 50.25 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.175 1.79 . . . . 0.0 110.901 176.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 61.9 tp -98.16 137.01 37.55 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.244 1.017 . . . . 0.0 109.725 175.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -80.9 106.98 13.33 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.549 0.739 . . . . 0.0 110.404 167.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 46.0 mm -66.13 -23.0 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 O-C-N 120.774 -1.204 . . . . 0.0 112.286 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.66 -43.13 76.87 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.455 1.102 . . . . 0.0 113.973 -175.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.1 m -128.82 -8.01 5.0 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.94 35.13 22.49 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.321 0.962 . . . . 0.0 114.024 178.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -90.68 135.95 33.38 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.062 1.345 . . . . 0.0 112.204 176.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 mp -85.46 127.14 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 124.876 1.27 . . . . 0.0 109.43 176.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -147.15 169.91 18.32 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.582 1.153 . . . . 0.0 111.838 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -99.13 147.4 25.12 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.14 0.976 . . . . 0.0 110.535 170.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.2 t -146.53 167.96 22.39 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.689 0.796 . . . . 0.0 112.441 174.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 50.5 ptt85 -94.07 150.83 19.98 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.639 1.576 . . . . 0.0 112.75 177.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -105.82 132.87 51.41 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.601 1.161 . . . . 0.0 110.921 168.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.2 t -85.96 -45.55 11.38 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.732 1.213 . . . . 0.0 112.379 -171.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -152.25 162.11 41.63 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.394 1.078 . . . . 0.0 112.828 173.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.9 mt -89.7 155.01 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 125.094 1.357 . . . . 0.0 108.407 162.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -137.6 148.85 46.18 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.986 1.715 . . . . 0.0 110.448 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -138.46 149.56 45.57 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.867 1.267 . . . . 0.0 113.174 171.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -148.79 164.26 34.95 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.736 1.614 . . . . 0.0 110.09 170.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.5 mmtp -93.18 148.79 21.72 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.508 1.123 . . . . 0.0 111.047 176.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.1 m -148.38 144.77 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.683 1.193 . . . . 0.0 111.074 172.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -94.05 -31.33 14.27 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.66 1.184 . . . . 0.0 112.069 173.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -121.76 129.57 52.79 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.68 1.192 . . . . 0.0 110.457 -174.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.3 tp -136.52 162.34 33.36 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.392 1.877 . . . . 0.0 109.676 -172.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.9 mt -115.02 125.52 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.707 1.203 . . . . 0.0 109.274 176.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -96.97 123.74 40.77 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.148 0.979 . . . . 0.0 110.198 168.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.9 mp -111.18 126.96 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.846 1.258 . . . . 0.0 109.488 172.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.6 tttt -93.9 146.42 23.91 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.355 1.862 . . . . 0.0 110.672 174.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 80.9 mt -116.56 158.49 23.59 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.773 1.629 . . . . 0.0 111.869 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 18.8 t -59.36 -30.82 68.68 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.677 1.191 . . . . 0.0 112.699 -178.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.0 p -62.66 -15.96 54.74 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 173.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.0 7.0 68.7 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 124.749 1.166 . . . . 0.0 113.825 -171.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -81.33 159.52 24.39 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.726 1.211 . . . . 0.0 111.722 171.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 77.2 p -142.03 143.15 33.0 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.988 0.915 . . . . 0.0 112.739 169.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.1 tp -121.7 142.21 50.39 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.767 1.627 . . . . 0.0 110.858 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -120.41 110.36 16.42 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.224 1.809 . . . . 0.0 111.093 -172.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.0 m -141.06 154.37 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.029 1.332 . . . . 0.0 112.927 -165.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.4 p -68.43 150.43 97.7 Favored Pre-proline 0 N--CA 1.47 0.552 0 O-C-N 120.65 -1.281 . . . . 0.0 113.19 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -61.73 -29.65 83.72 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.678 2.252 . . . . 0.0 112.395 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 38.8 p -83.37 10.17 9.31 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 128.054 2.542 . . . . 0.0 114.859 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -99.1 109.52 54.51 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 124.748 1.219 . . . . 0.0 112.237 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -63.57 124.16 13.25 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.258 2.639 . . . . 0.0 113.841 164.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.5 t -101.27 146.67 9.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 127.433 2.293 . . . . 0.0 109.0 176.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.29 107.57 11.0 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.998 -0.438 . . . . 0.0 110.052 177.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.1 mp -110.22 155.69 21.67 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.541 1.537 . . . . 0.0 111.992 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -96.72 117.45 31.05 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.17 0.588 . . . . 0.0 112.359 174.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 73.4 mtp85 -136.15 78.75 1.73 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.607 1.163 . . . . 0.0 109.791 168.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 56.57 0.42 0.07 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 128.175 2.59 . . . . 0.0 115.78 -164.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -172.68 173.62 45.5 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 126.44 1.971 . . . . 0.0 111.341 -178.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 63.4 mt -70.15 125.72 27.59 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.434 1.494 . . . . 0.0 110.171 177.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -157.13 155.81 31.65 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 173.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -103.73 120.82 41.73 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.217 1.007 . . . . 0.0 112.639 -172.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 49.0 t -129.59 127.01 22.93 Favored Pre-proline 0 N--CA 1.482 1.147 0 C-N-CA 124.905 1.282 . . . . 0.0 110.698 -175.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -64.32 140.41 70.24 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.077 2.518 . . . . 0.0 112.225 -179.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.08 -32.38 15.54 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 176.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.76 -20.95 66.16 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 173.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -106.84 -9.56 16.33 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.61 1.564 . . . . 0.0 113.17 177.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 78.1 t -68.45 145.48 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.696 1.598 . . . . 0.0 109.969 172.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.63 157.93 75.03 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 125.697 1.599 . . . . 0.0 111.62 -178.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.416 ' HD3' HG22 ' A' ' 142' ' ' VAL . 42.9 Cg_endo -64.81 122.11 9.84 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 121.986 1.791 . . . . 0.0 111.32 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 108.11 0.16 33.54 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 124.565 1.078 . . . . 0.0 115.377 -178.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -63.34 162.25 12.61 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.872 1.269 . . . . 0.0 112.372 169.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -109.07 122.73 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 125.35 1.46 . . . . 0.0 111.332 177.049 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.45 135.86 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 126.324 1.85 . . . . 0.0 110.102 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.9 t -85.79 143.8 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 119.522 1.055 . . . . 0.0 111.733 -176.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -168.21 -149.4 6.11 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 124.794 1.188 . . . . 0.0 114.174 -177.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.1 p -156.97 165.55 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 127.287 2.235 . . . . 0.0 107.767 -174.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -58.62 109.29 0.77 Allowed 'General case' 0 N--CA 1.479 0.993 0 O-C-N 121.095 -1.003 . . . . 0.0 112.84 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -59.53 -30.38 68.55 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.539 0.736 . . . . 0.0 112.865 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -65.61 -29.74 70.37 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 178.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -84.64 -36.36 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-N 119.362 0.983 . . . . 0.0 111.08 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -62.48 -24.07 67.26 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.007 1.323 . . . . 0.0 113.057 173.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 20.3 mtt85 -87.44 5.44 38.89 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.739 1.615 . . . . 0.0 114.91 172.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -132.41 -169.14 2.17 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 125.915 1.686 . . . . 0.0 112.763 -175.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 51.5 ttp85 -56.73 -34.41 67.47 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 127.611 2.364 . . . . 0.0 116.209 -166.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 63.5 mt -124.15 142.67 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 CA-C-N 119.665 1.12 . . . . 0.0 111.587 -171.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 48.6 mt -95.73 115.0 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 160.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 64.1 m -74.86 128.39 35.45 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.333 0.653 . . . . 0.0 112.756 -172.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -79.64 145.08 33.23 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.022 0.929 . . . . 0.0 111.791 176.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 68.11 24.52 74.63 Favored Glycine 0 CA--C 1.539 1.538 0 N-CA-C 116.644 1.418 . . . . 0.0 116.644 174.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -127.79 139.75 52.46 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.081 1.441 . . . . 0.0 112.681 -177.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 59.7 mt -149.56 156.48 42.02 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.222 1.409 . . . . 0.0 113.522 -176.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -142.62 167.21 22.62 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.657 1.983 . . . . 0.0 111.199 -179.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -128.15 156.93 42.09 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 120.348 -1.47 . . . . 0.0 113.945 158.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -116.15 136.31 53.14 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 128.116 2.566 . . . . 0.0 109.159 -173.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -89.11 131.78 35.1 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.965 0.802 . . . . 0.0 111.936 178.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 93.8 t -69.91 127.8 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 123.421 0.688 . . . . 0.0 110.734 171.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.3 t -88.27 -45.1 10.34 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.528 1.931 . . . . 0.0 112.091 175.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.2 t -157.67 163.54 38.1 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.443 1.097 . . . . 0.0 111.404 177.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.416 HG22 ' HD3' ' A' ' 112' ' ' PRO . 4.9 m -136.63 148.54 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 124.81 1.244 . . . . 0.0 111.193 171.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -158.18 155.98 30.02 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 172.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 74.3 mt -86.81 131.8 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.549 1.14 . . . . 0.0 109.061 168.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 25.1 pt -127.0 161.77 33.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 126.611 1.964 . . . . 0.0 112.257 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -95.91 99.06 10.89 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.777 1.631 . . . . 0.0 111.976 177.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -85.63 -51.95 6.13 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 177.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 48.37 41.18 16.1 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.325 1.05 . . . . 0.0 113.164 -175.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 33.9 t-20 -145.41 167.84 21.95 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.684 1.193 . . . . 0.0 110.38 -176.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -68.87 145.44 53.7 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.32 1.048 . . . . 0.0 112.149 177.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.1 m -128.77 152.8 37.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 126.069 1.748 . . . . 0.0 109.422 177.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.45 ' CG ' HG12 ' A' ' 21' ' ' ILE . 2.3 p90 -111.43 160.42 17.12 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -174.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -146.39 127.89 15.05 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.334 1.053 . . . . 0.0 109.299 170.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 32.7 tp -93.06 134.9 34.74 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 120.336 -1.478 . . . . 0.0 112.315 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 23.1 t -99.25 119.67 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 121.545 0.688 . . . . 0.0 112.822 -172.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 20.2 mm -125.96 96.57 37.12 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 126.914 2.085 . . . . 0.0 107.969 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.79 -18.14 22.27 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 122.623 2.216 . . . . 0.0 113.285 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -82.58 -34.48 27.71 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -172.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 44.5 p -139.02 -10.93 1.29 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.615 1.166 . . . . 0.0 113.474 -175.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . 0.306 51.7 m-70 55.37 26.08 8.33 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.09 1.756 . . . . 0.0 115.635 -173.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -154.19 158.96 41.11 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 120.795 -1.191 . . . . 0.0 113.68 173.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -147.06 166.18 27.67 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.544 1.538 . . . . 0.0 112.209 176.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.0 mp -107.96 139.28 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.085 0.954 . . . . 0.0 111.588 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.94 157.16 63.65 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.483 1.113 . . . . 0.0 112.52 174.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.01 -13.98 41.92 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.897 2.398 . . . . 0.0 113.165 177.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -85.94 7.87 22.59 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 124.438 1.095 . . . . 0.0 113.104 171.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 94.4 -23.92 29.81 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 126.24 1.876 . . . . 0.0 116.47 173.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 65.7 mt -70.17 146.27 50.9 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.906 1.353 . . . . 0.0 113.497 -174.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 4.1 t -90.46 128.51 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 123.748 0.819 . . . . 0.0 111.685 174.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 47.3 mt -117.79 160.6 21.09 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 127.598 2.359 . . . . 0.0 111.919 -176.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.31 166.17 11.11 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 -175.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -99.15 144.97 27.68 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.672 1.589 . . . . 0.0 109.972 148.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -138.26 26.78 2.62 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.625 1.17 . . . . 0.0 113.84 172.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 . . . . . 0 C--O 1.251 1.156 0 C-N-CA 126.345 1.858 . . . . 0.0 111.784 178.757 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 111.365 0.135 . . . . 0.0 111.365 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -129.01 159.91 34.4 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.555 1.942 . . . . 0.0 111.151 -177.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.95 145.87 34.34 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.25 0.62 . . . . 0.0 111.268 173.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.92 -24.2 50.66 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 178.184 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -74.24 -15.4 60.99 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.721 1.608 . . . . 0.0 112.633 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.0 m -68.94 144.02 54.28 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.021 0.929 . . . . 0.0 112.46 -170.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -78.98 156.62 28.38 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 176.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 p -146.17 154.33 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.296 1.438 . . . . 0.0 111.878 -175.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -130.22 127.26 39.28 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 126.293 1.837 . . . . 0.0 108.493 177.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -153.85 171.91 18.21 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.588 0.755 . . . . 0.0 112.133 175.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -130.81 148.82 52.63 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.731 1.213 . . . . 0.0 111.27 171.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -152.59 140.16 19.75 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.528 1.131 . . . . 0.0 110.061 172.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.1 t0 49.13 49.17 20.0 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.01 1.324 . . . . 0.0 113.967 170.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.0 m 62.05 35.42 15.95 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.741 2.016 . . . . 0.0 114.636 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.5 p -152.39 138.42 11.74 Favored Pre-proline 0 CA--C 1.546 0.826 0 O-C-N 120.838 -1.164 . . . . 0.0 113.054 167.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.41 154.95 28.26 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 124.543 3.495 . . . . 0.0 113.814 174.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -133.21 142.51 48.62 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.856 2.062 . . . . 0.0 110.81 172.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 47.1 ttm -145.16 90.65 2.06 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.094 1.358 . . . . 0.0 109.404 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -139.21 -168.72 2.5 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.695 1.998 . . . . 0.0 111.094 -168.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 m -79.03 151.32 31.57 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 121.0 -1.062 . . . . 0.0 111.477 168.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.3 tp -57.64 -37.65 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 O-C-N 121.607 -0.683 . . . . 0.0 111.829 173.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -61.59 -29.68 70.19 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.484 1.038 . . . . 0.0 112.781 175.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -80.74 -35.87 32.8 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.592 0.757 . . . . 0.0 111.674 -175.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 21.6 ptm -71.11 -35.26 71.72 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.207 0.458 . . . . 0.0 111.115 169.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -60.27 -51.53 69.16 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.695 0.798 . . . . 0.0 111.559 176.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.9 t -61.68 -39.62 92.07 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.309 1.044 . . . . 0.0 110.956 -176.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -63.71 -52.97 58.18 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 124.872 1.269 . . . . 0.0 110.851 177.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -72.7 -32.1 65.52 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.297 -0.877 . . . . 0.0 113.179 -178.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.54 -32.17 72.77 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.186 0.995 . . . . 0.0 111.892 173.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.1 m -81.61 -27.05 34.38 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.27 1.028 . . . . 0.0 112.463 176.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 70.2 mtm -80.17 -55.09 5.17 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.314 1.046 . . . . 0.0 112.25 174.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -108.22 -20.58 13.1 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.073 1.349 . . . . 0.0 114.13 -167.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.27 157.6 33.6 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 124.779 1.18 . . . . 0.0 114.216 -176.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -102.02 128.51 48.44 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.455 1.102 . . . . 0.0 108.414 174.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.3 mp -104.39 143.09 25.98 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 125.684 1.594 . . . . 0.0 110.23 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.69 149.13 54.25 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 123.725 2.95 . . . . 0.0 111.884 -176.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -144.14 161.82 37.88 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.995 1.318 . . . . 0.0 111.563 -175.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -51.33 -55.3 19.15 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.461 1.505 . . . . 0.0 113.505 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -90.78 -7.04 53.5 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 177.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 174.73 -124.75 1.04 Allowed Glycine 0 CA--C 1.53 0.978 0 CA-C-N 119.856 1.207 . . . . 0.0 115.55 -174.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -141.57 158.97 43.17 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.7 1.6 . . . . 0.0 111.126 177.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.94 149.12 44.41 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.817 1.247 . . . . 0.0 112.121 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.0 t -119.12 117.8 33.19 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 125.249 1.42 . . . . 0.0 110.625 178.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -74.69 140.49 26.44 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 124.421 3.414 . . . . 0.0 112.315 -177.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 64.2 mt -107.34 170.51 7.92 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.575 1.15 . . . . 0.0 113.604 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -152.63 135.18 15.24 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 127.225 2.21 . . . . 0.0 109.295 166.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 51.43 47.01 25.64 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.278 1.431 . . . . 0.0 113.162 -178.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 56.8 t -115.3 129.37 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.874 0.869 . . . . 0.0 110.637 176.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -126.93 149.0 50.03 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.748 1.219 . . . . 0.0 111.828 -170.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.0 m -137.25 150.42 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.011 1.324 . . . . 0.0 110.793 175.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -77.58 144.45 37.52 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.956 0.884 . . . . 0.0 111.006 168.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.1 t -151.81 151.77 31.78 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.581 1.152 . . . . 0.0 111.055 -165.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.4 tp -98.11 129.01 44.94 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.322 0.649 . . . . 0.0 109.573 171.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -69.88 101.88 1.84 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 162.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.0 mm -64.15 -26.83 41.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 O-C-N 120.951 -1.093 . . . . 0.0 111.279 -174.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.42 -42.15 18.95 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.67 1.188 . . . . 0.0 113.938 -174.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.2 m -101.29 -16.78 16.83 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.075 0.95 . . . . 0.0 112.308 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.45 20.67 79.51 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.461 1.505 . . . . 0.0 114.288 -176.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -79.24 123.95 27.91 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.138 1.375 . . . . 0.0 110.524 177.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.9 mp -72.9 124.24 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 165.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -142.85 174.03 11.02 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.762 1.225 . . . . 0.0 112.707 -178.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -105.5 139.42 40.14 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.99 1.316 . . . . 0.0 110.517 172.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.7 t -135.44 166.59 22.81 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.642 1.177 . . . . 0.0 112.152 176.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -100.92 137.06 39.8 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.613 1.165 . . . . 0.0 113.78 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -94.11 149.28 21.38 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.139 1.376 . . . . 0.0 112.422 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 85.4 p -99.47 -54.1 3.03 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.144 0.978 . . . . 0.0 113.563 -173.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -150.73 156.36 41.14 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.033 1.124 . . . . 0.0 114.033 176.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.0 mt -89.59 152.52 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.264 1.425 . . . . 0.0 108.685 168.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -140.66 144.04 35.47 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.169 -0.957 . . . . 0.0 112.229 -172.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -131.77 142.75 49.84 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.072 1.349 . . . . 0.0 111.882 175.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -149.92 164.18 36.1 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.112 1.365 . . . . 0.0 109.746 175.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -97.55 143.35 28.33 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 123.989 0.916 . . . . 0.0 111.419 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.1 m -147.03 145.46 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.842 1.257 . . . . 0.0 111.427 173.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -94.53 -32.97 13.24 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.867 1.667 . . . . 0.0 112.184 175.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -122.68 134.38 54.48 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 124.093 0.957 . . . . 0.0 110.68 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.8 tp -132.49 160.99 34.89 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.66 1.584 . . . . 0.0 109.299 -176.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.2 mt -115.6 122.88 70.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 121.232 -0.917 . . . . 0.0 109.401 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -93.82 115.92 28.35 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.387 1.075 . . . . 0.0 111.294 169.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -103.75 124.98 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 124.471 1.108 . . . . 0.0 108.721 170.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -91.93 146.11 24.01 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.487 1.515 . . . . 0.0 110.336 172.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 60.4 mt -106.86 160.92 15.15 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.486 1.914 . . . . 0.0 110.939 -178.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.6 t -65.11 -18.74 65.56 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.168 -0.958 . . . . 0.0 113.06 -178.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.7 p -69.02 -17.08 63.86 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.46 1.504 . . . . 0.0 114.572 167.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 83.73 7.43 85.94 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 126.458 1.98 . . . . 0.0 114.907 -170.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -80.44 167.45 20.15 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 118.771 1.285 . . . . 0.0 109.811 168.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 91.9 p -144.79 158.46 43.78 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 120.953 -1.092 . . . . 0.0 113.582 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 61.1 tp -130.64 133.53 46.2 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.383 1.873 . . . . 0.0 110.007 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -113.61 113.66 25.36 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.782 1.233 . . . . 0.0 111.65 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.4 m -139.67 157.08 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 125.721 1.608 . . . . 0.0 112.598 -169.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.9 p -68.25 149.72 97.99 Favored Pre-proline 0 N--CA 1.468 0.442 0 O-C-N 121.262 -0.899 . . . . 0.0 112.514 177.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -57.11 -33.61 96.15 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.642 2.228 . . . . 0.0 112.015 -178.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.7 m -89.54 21.63 3.34 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.526 1.93 . . . . 0.0 114.551 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -102.82 115.95 63.38 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 125.139 1.375 . . . . 0.0 111.072 176.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -72.93 142.43 34.94 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.895 2.396 . . . . 0.0 114.213 177.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 39.9 t -121.54 143.27 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 126.954 2.101 . . . . 0.0 109.298 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 25.8 tp -79.0 113.73 17.36 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.403 0.547 . . . . 0.0 110.292 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.43 159.58 18.6 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.222 2.609 . . . . 0.0 110.27 -172.025 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -124.18 121.13 34.26 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 174.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -138.63 89.45 2.37 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.822 0.849 . . . . 0.0 110.595 165.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 56.5 -0.17 0.06 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.995 2.118 . . . . 0.0 115.206 -163.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -176.47 167.23 38.64 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 125.627 1.584 . . . . 0.0 112.344 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 38.0 mt -64.38 128.54 36.21 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 126.001 1.721 . . . . 0.0 110.909 178.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -152.59 144.57 23.74 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.54 1.136 . . . . 0.0 112.727 175.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -94.39 130.1 40.85 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.109 0.964 . . . . 0.0 110.643 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 47.9 t -133.72 127.4 19.44 Favored Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 124.047 0.939 . . . . 0.0 110.527 -177.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -65.81 143.79 74.96 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.698 2.265 . . . . 0.0 111.434 175.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.27 -31.7 22.07 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.44 -16.46 62.46 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 173.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -113.15 -7.94 13.59 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.485 1.514 . . . . 0.0 113.042 177.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.4 t -67.06 150.24 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.1 1.36 . . . . 0.0 110.522 168.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.36 157.78 71.88 Favored Pre-proline 0 N--CA 1.475 0.799 0 C-N-CA 126.71 2.004 . . . . 0.0 111.246 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -68.2 122.27 9.31 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.598 2.199 . . . . 0.0 111.806 -173.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 104.62 5.49 42.11 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.309 0.957 . . . . 0.0 114.647 -176.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -67.43 166.68 14.11 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.557 1.143 . . . . 0.0 112.166 168.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.2 p -117.11 118.46 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.133 0.973 . . . . 0.0 112.052 -176.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.0 t -89.75 139.03 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 125.474 1.51 . . . . 0.0 110.008 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.3 t -91.57 139.04 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 123.731 0.812 . . . . 0.0 110.243 174.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -160.65 -155.88 7.97 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.011 0.815 . . . . 0.0 113.284 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.4 p -137.22 161.76 34.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 128.279 2.632 . . . . 0.0 107.919 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -62.08 103.42 0.37 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.761 0.824 . . . . 0.0 112.301 -173.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.18 -29.31 70.12 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.817 0.847 . . . . 0.0 113.018 -175.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -66.2 -29.64 69.95 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.289 1.036 . . . . 0.0 113.792 172.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 76.2 t -85.89 -40.97 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 123.682 0.793 . . . . 0.0 109.825 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.5 tp -60.98 -21.35 63.44 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.753 1.221 . . . . 0.0 112.765 176.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 42.9 ttm105 -76.61 -15.38 59.85 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 127.072 2.149 . . . . 0.0 114.738 174.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -81.13 153.15 27.43 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.7 1.2 . . . . 0.0 110.925 -178.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -66.38 -36.64 83.36 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 118.362 0.528 . . . . 0.0 110.931 177.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 92.6 mt -88.49 108.96 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.37 1.468 . . . . 0.0 109.767 164.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 62.9 mt -91.72 90.57 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.493 1.117 . . . . 0.0 109.907 -176.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 44.9 m -77.88 70.51 4.26 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.735 1.214 . . . . 0.0 111.803 178.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.19 -176.05 0.51 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 127.267 2.227 . . . . 0.0 114.639 -173.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.04 -2.97 61.89 Favored Glycine 0 CA--C 1.535 1.33 0 N-CA-C 116.512 1.365 . . . . 0.0 116.512 172.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -120.49 99.9 6.83 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 118.803 1.302 . . . . 0.0 111.477 -168.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 96.4 mt -67.36 146.18 54.33 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.813 0.845 . . . . 0.0 112.514 -175.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -140.18 123.89 17.27 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.422 1.489 . . . . 0.0 110.459 176.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -87.2 146.09 26.14 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 122.991 0.516 . . . . 0.0 111.367 176.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 23.9 m80 -129.08 128.4 43.47 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.666 1.587 . . . . 0.0 108.545 -173.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -88.31 141.01 28.9 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 120.944 -1.098 . . . . 0.0 112.494 -178.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 76.6 t -67.78 136.39 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 124.755 1.222 . . . . 0.0 110.078 171.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 29.6 t -90.18 -53.11 4.61 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.81 1.644 . . . . 0.0 111.506 171.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.6 m -156.97 159.87 38.49 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 121.194 -0.941 . . . . 0.0 111.121 -174.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.8 m -134.96 152.5 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.158 0.983 . . . . 0.0 111.813 174.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -162.56 159.84 25.24 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.386 1.074 . . . . 0.0 112.481 168.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 83.4 mt -82.66 144.41 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 166.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 44.4 pt -133.82 155.02 39.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.981 1.713 . . . . 0.0 111.074 174.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -93.78 95.96 9.47 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.739 0.816 . . . . 0.0 111.108 -177.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -76.95 -56.72 4.34 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.193 0.997 . . . . 0.0 112.842 179.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 44.82 51.08 8.61 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.046 1.338 . . . . 0.0 112.783 -171.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -152.09 172.02 16.97 Favored 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 124.929 1.292 . . . . 0.0 112.451 -175.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -72.27 135.35 45.98 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 120.739 -1.226 . . . . 0.0 112.144 172.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 4.0 m -111.14 152.14 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.839 1.256 . . . . 0.0 109.645 172.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -115.77 156.17 26.5 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 122.129 0.966 . . . . 0.0 112.105 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -158.59 164.88 35.64 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.22 1.408 . . . . 0.0 109.206 -163.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 44.1 tp -143.02 141.97 31.47 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.712 1.205 . . . . 0.0 110.103 -170.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.9 t -112.4 128.58 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.097 0.959 . . . . 0.0 111.534 -172.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.9 mm -135.09 83.28 39.94 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 126.445 1.898 . . . . 0.0 108.743 -176.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -64.27 -16.77 56.88 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.825 2.35 . . . . 0.0 113.303 -178.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -74.88 -32.29 61.82 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.014 1.726 . . . . 0.0 113.348 -175.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 59.7 p -141.87 -25.82 0.67 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -173.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 56.6 31.27 18.82 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.945 1.698 . . . . 0.0 115.339 -161.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -159.15 152.91 23.06 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.026 1.285 . . . . 0.0 114.137 171.148 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -148.07 175.69 10.8 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.914 1.686 . . . . 0.0 112.278 175.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 91.2 mt -117.94 128.95 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.731 1.212 . . . . 0.0 110.69 -174.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -80.71 156.95 72.6 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 123.173 0.589 . . . . 0.0 111.636 173.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.9 -20.91 64.53 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.555 2.17 . . . . 0.0 112.673 178.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -74.86 8.12 2.68 Favored 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 124.457 1.103 . . . . 0.0 112.872 172.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 93.09 -25.21 21.19 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 127.319 2.39 . . . . 0.0 115.621 171.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 40.6 mt -75.07 146.02 41.83 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 118.715 1.257 . . . . 0.0 113.121 -170.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.8 t -88.61 125.89 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.514 0.726 . . . . 0.0 110.632 174.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 32.0 mt -113.31 148.83 34.9 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.973 1.709 . . . . 0.0 111.193 -177.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -91.05 153.24 20.27 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.844 0.857 . . . . 0.0 112.315 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -118.81 81.1 1.64 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.875 0.87 . . . . 0.0 111.656 178.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -148.52 144.14 27.13 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.904 1.281 . . . . 0.0 111.962 170.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.28 0 C-N-CA 126.514 1.926 . . . . 0.0 111.766 173.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.486 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.32 158.42 39.15 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.006 1.322 . . . . 0.0 111.282 -173.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -63.71 148.68 48.48 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.879 0.872 . . . . 0.0 113.079 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -61.46 -22.6 65.2 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.615 1.566 . . . . 0.0 113.805 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -76.17 -14.99 60.14 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.348 1.459 . . . . 0.0 112.406 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.5 m -64.23 136.99 57.71 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.426 1.091 . . . . 0.0 112.548 -175.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -77.94 147.96 34.72 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.357 1.063 . . . . 0.0 112.703 169.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.6 p -144.85 159.88 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.269 1.028 . . . . 0.0 112.373 -171.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -129.55 135.43 48.58 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.606 1.963 . . . . 0.0 108.883 -177.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -155.83 175.19 14.25 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.079 0.854 . . . . 0.0 112.155 168.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -136.13 139.26 42.8 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.452 1.101 . . . . 0.0 111.86 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -156.76 150.79 24.98 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.987 1.315 . . . . 0.0 110.633 173.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.8 t0 49.96 42.08 23.93 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.656 1.182 . . . . 0.0 112.66 -173.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.1 m 55.75 36.17 26.74 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 126.401 1.881 . . . . 0.0 114.609 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.3 p -149.0 139.88 13.81 Favored Pre-proline 0 CA--C 1.54 0.579 0 O-C-N 120.419 -1.426 . . . . 0.0 111.242 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.33 150.29 32.42 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.708 2.938 . . . . 0.0 113.309 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -126.78 140.22 52.53 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.775 2.03 . . . . 0.0 109.894 172.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -148.03 113.2 5.53 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.098 0.959 . . . . 0.0 110.039 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -164.33 -175.51 3.97 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.428 1.891 . . . . 0.0 110.249 -174.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 m -72.09 146.32 47.61 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 120.872 -1.142 . . . . 0.0 109.928 173.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.426 HG12 ' CG ' ' A' ' 152' ' ' TYR . 9.1 tp -56.84 -37.99 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 O-C-N 121.593 -0.692 . . . . 0.0 112.29 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -63.83 -26.27 68.54 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.104 0.866 . . . . 0.0 112.451 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -78.31 -40.64 36.13 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.841 1.257 . . . . 0.0 111.112 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -73.0 -32.58 65.24 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.422 -0.799 . . . . 0.0 111.725 173.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -59.62 -49.18 78.77 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.842 0.857 . . . . 0.0 111.026 169.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.2 t -65.95 -31.5 72.45 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.438 0.695 . . . . 0.0 111.968 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -67.85 -53.52 26.13 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.04 1.336 . . . . 0.0 110.983 173.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -70.4 -33.29 71.2 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.33 -31.88 72.94 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.684 0.794 . . . . 0.0 111.943 173.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.3 t -78.52 -29.98 46.82 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 121.199 -0.938 . . . . 0.0 112.011 174.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 65.5 mtm -81.08 -49.96 10.23 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.113 0.965 . . . . 0.0 113.454 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 -111.8 -20.28 12.12 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.639 1.576 . . . . 0.0 114.295 -168.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.55 158.31 33.56 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 124.553 1.073 . . . . 0.0 114.613 -178.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -104.68 126.42 51.75 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.279 1.032 . . . . 0.0 110.475 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 11.1 mp -99.82 148.51 34.89 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 126.406 1.882 . . . . 0.0 110.517 177.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -72.4 154.92 55.95 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.118 2.546 . . . . 0.0 111.668 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -134.37 167.81 20.05 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.566 1.146 . . . . 0.0 111.202 168.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -51.57 -58.08 7.33 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.036 1.335 . . . . 0.0 111.453 171.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -96.57 -8.79 30.93 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -171.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -175.16 -131.08 1.38 Allowed Glycine 0 CA--C 1.535 1.294 0 N-CA-C 114.871 0.708 . . . . 0.0 114.871 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -136.81 159.7 41.07 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.206 1.802 . . . . 0.0 111.211 176.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.44 149.03 42.07 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.209 1.404 . . . . 0.0 111.213 -177.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.2 t -123.5 116.97 27.94 Favored Pre-proline 0 N--CA 1.482 1.154 0 C-N-CA 125.432 1.493 . . . . 0.0 109.912 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.72 140.97 40.25 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 124.23 3.287 . . . . 0.0 111.78 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 87.5 mt -109.47 169.68 8.55 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.386 1.074 . . . . 0.0 113.309 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -148.29 123.01 9.89 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.723 1.609 . . . . 0.0 110.022 174.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 50.17 40.59 22.31 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.543 1.537 . . . . 0.0 114.022 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.9 t -102.12 122.74 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 121.243 -0.91 . . . . 0.0 110.048 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -121.25 150.9 40.67 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.281 1.032 . . . . 0.0 113.115 -171.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.4 m -138.19 155.49 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 126.862 2.065 . . . . 0.0 111.634 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -69.06 132.55 46.8 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.328 0.651 . . . . 0.0 109.682 167.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.2 t -132.28 148.48 52.44 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.585 1.954 . . . . 0.0 110.654 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 55.9 tp -104.98 134.35 48.23 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.457 1.103 . . . . 0.0 109.654 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -78.1 105.57 9.41 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.59 0.756 . . . . 0.0 109.071 167.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 29.5 mm -66.75 -23.51 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 119.656 1.116 . . . . 0.0 111.633 -176.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.57 -48.22 49.8 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.661 1.184 . . . . 0.0 114.093 -177.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.2 m -114.87 -3.12 12.76 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.214 1.006 . . . . 0.0 113.435 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.59 28.85 68.63 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.293 1.425 . . . . 0.0 113.479 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -95.04 141.58 28.52 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.508 1.123 . . . . 0.0 112.039 -173.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.9 mp -89.81 128.02 42.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 C-N-CA 125.106 1.362 . . . . 0.0 109.501 -176.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -151.53 170.39 19.75 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.331 1.052 . . . . 0.0 112.645 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -114.23 135.12 54.4 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.82 1.248 . . . . 0.0 111.23 -177.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.6 t -134.58 153.87 51.76 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.219 1.008 . . . . 0.0 112.769 -174.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -80.42 140.9 35.77 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 175.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -93.45 143.0 26.7 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.387 1.075 . . . . 0.0 110.92 167.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 96.0 p -85.56 -53.95 4.86 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.81 1.244 . . . . 0.0 112.269 -174.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -152.1 158.82 43.51 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.964 1.705 . . . . 0.0 112.669 177.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.2 mt -85.66 152.51 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 163.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -143.56 148.05 35.35 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.103 1.361 . . . . 0.0 111.466 -177.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.1 ptt-85 -144.11 150.8 38.69 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 168.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -148.62 172.16 15.0 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.293 1.837 . . . . 0.0 110.586 175.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp -101.32 143.87 30.85 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.131 0.973 . . . . 0.0 112.186 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.6 m -145.35 146.57 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.464 1.506 . . . . 0.0 110.815 173.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -92.81 -34.46 13.86 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.731 1.212 . . . . 0.0 111.729 173.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -114.86 124.4 51.63 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.876 1.67 . . . . 0.0 110.224 -170.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.5 tp -134.29 158.5 43.61 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.61 1.564 . . . . 0.0 109.746 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 14.4 mt -109.61 130.83 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.324 1.049 . . . . 0.0 108.762 173.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -100.12 123.83 44.8 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.188 1.395 . . . . 0.0 110.083 168.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -113.3 115.79 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.557 1.543 . . . . 0.0 108.269 173.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.2 tttt -87.82 148.52 24.64 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.444 1.098 . . . . 0.0 110.966 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 85.8 mt -115.06 158.41 22.16 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.17 1.388 . . . . 0.0 112.347 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.1 t -65.04 -23.02 67.07 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 121.881 -0.512 . . . . 0.0 112.077 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 96.1 p -63.35 -22.26 66.77 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.697 1.599 . . . . 0.0 115.031 170.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.83 1.22 61.78 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 125.275 1.417 . . . . 0.0 115.198 -171.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -85.7 161.67 19.1 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.633 1.217 . . . . 0.0 111.194 172.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.2 p -134.49 135.34 42.35 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.359 1.076 . . . . 0.0 112.79 172.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 63.4 tp -97.76 115.09 27.32 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.659 1.584 . . . . 0.0 108.797 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -111.09 109.48 19.58 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.637 1.575 . . . . 0.0 109.878 -177.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.2 m -149.81 154.18 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 126.157 1.783 . . . . 0.0 113.254 -161.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.9 p -66.7 149.75 98.03 Favored Pre-proline 0 N--CA 1.471 0.587 0 O-C-N 121.072 -1.017 . . . . 0.0 113.244 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -60.5 -21.62 68.92 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 124.316 3.344 . . . . 0.0 114.685 -175.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.6 p -76.95 -23.08 52.4 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 128.318 2.647 . . . . 0.0 114.704 175.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 44.0 t60 -75.19 121.19 84.7 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-O 118.349 -0.834 . . . . 0.0 112.671 -162.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -75.13 126.28 9.78 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.881 2.387 . . . . 0.0 112.866 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.8 t -106.08 145.01 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 126.011 1.725 . . . . 0.0 109.175 175.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 18.0 tp -79.46 109.86 14.22 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.4 0.545 . . . . 0.0 110.363 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.1 mp -107.35 161.05 15.16 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.252 1.821 . . . . 0.0 111.556 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -117.91 112.16 19.97 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 174.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.1 mtt-85 -139.62 91.1 2.45 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.76 1.224 . . . . 0.0 109.162 165.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 56.28 -2.68 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 128.25 2.62 . . . . 0.0 116.984 -167.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.76 164.66 37.39 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 125.515 1.531 . . . . 0.0 112.682 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 67.6 mt -71.5 114.86 10.02 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.884 1.674 . . . . 0.0 110.403 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -138.35 136.59 36.52 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -174.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -92.21 112.41 24.34 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.57 1.148 . . . . 0.0 110.85 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 60.5 t -124.32 127.4 25.3 Favored Pre-proline 0 N--CA 1.478 0.962 0 C-N-CA 123.95 0.9 . . . . 0.0 110.233 -172.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -64.22 143.35 83.4 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.487 2.125 . . . . 0.0 111.584 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.14 -30.52 26.91 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 177.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.61 -22.06 66.63 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 173.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -105.43 -6.52 19.43 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.334 1.454 . . . . 0.0 112.486 175.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 84.8 t -68.51 142.25 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 O-C-N 121.292 -0.88 . . . . 0.0 109.594 166.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.61 154.65 80.92 Favored Pre-proline 0 N--CA 1.469 0.505 0 C-N-CA 128.289 2.636 . . . . 0.0 109.496 -178.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.46 132.49 31.36 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.994 1.796 . . . . 0.0 111.05 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 104.04 -6.06 46.81 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.166 1.365 . . . . 0.0 114.221 175.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.33 162.28 28.85 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 118.734 1.267 . . . . 0.0 112.439 177.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 50.5 t -91.12 121.59 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.071 1.348 . . . . 0.0 110.661 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.1 t -94.87 137.69 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.853 1.261 . . . . 0.0 110.233 169.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 41.1 t -89.58 137.82 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.14 0.976 . . . . 0.0 110.473 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -164.99 -149.01 5.67 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.245 0.926 . . . . 0.0 113.002 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.9 p -148.44 166.15 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 127.404 2.281 . . . . 0.0 108.486 175.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 . . . . . 0 N--CA 1.472 0.664 0 C-N-CA 123.67 0.788 . . . . 0.0 111.909 174.649 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 0 CA--C 1.536 0.415 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 95.7 mt -137.13 164.83 27.5 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.674 1.99 . . . . 0.0 109.634 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -142.09 134.73 28.3 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.207 1.403 . . . . 0.0 111.83 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -90.59 143.54 26.64 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.557 1.543 . . . . 0.0 111.702 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -131.65 136.07 47.42 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.35 1.46 . . . . 0.0 110.917 -173.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -87.33 130.65 34.54 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 119.011 0.823 . . . . 0.0 112.394 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 82.8 t -68.35 122.15 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 121.77 0.795 . . . . 0.0 110.573 167.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 45.5 t -76.92 -50.29 13.63 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.823 1.649 . . . . 0.0 112.602 176.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.4 t -158.8 164.99 35.28 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.474 1.51 . . . . 0.0 110.552 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.8 m -132.61 149.5 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 124.486 1.114 . . . . 0.0 111.543 170.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -155.34 154.37 31.93 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.247 1.019 . . . . 0.0 113.565 171.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 71.2 mt -90.25 130.6 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.561 1.144 . . . . 0.0 109.26 169.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 16.1 pt -126.39 159.04 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.925 1.69 . . . . 0.0 112.496 -174.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -95.38 96.53 9.19 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 122.24 1.019 . . . . 0.0 111.534 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -76.01 -52.02 11.11 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.064 0.945 . . . . 0.0 113.2 176.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 50.89 33.12 8.18 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.954 1.301 . . . . 0.0 113.952 -176.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -141.04 172.97 11.95 Favored 'General case' 0 CA--C 1.549 0.928 0 O-C-N 120.775 -1.203 . . . . 0.0 112.471 -170.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -74.01 137.89 43.75 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.262 -0.899 . . . . 0.0 112.091 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 12.2 m -122.35 154.5 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.399 1.88 . . . . 0.0 110.141 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.426 ' CG ' HG12 ' A' ' 21' ' ' ILE . 1.5 p90 -113.06 159.73 18.88 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -174.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -137.68 145.29 42.43 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.256 1.422 . . . . 0.0 109.092 158.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 67.1 tp -120.89 103.99 9.49 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.829 1.252 . . . . 0.0 109.426 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 57.6 t -87.71 131.66 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -150.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.4 mm -124.62 85.78 56.21 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 124.536 1.134 . . . . 0.0 110.793 -176.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -65.48 -10.3 25.7 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.561 2.174 . . . . 0.0 114.216 177.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -72.15 -47.74 48.69 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 119.816 1.189 . . . . 0.0 113.0 172.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 71.1 p -135.32 -15.2 1.93 Allowed 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -171.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . 0.295 68.6 m80 56.78 25.9 10.83 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 128.079 2.552 . . . . 0.0 116.03 -170.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.92 146.85 26.55 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 120.796 -1.19 . . . . 0.0 113.548 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -147.56 166.05 28.49 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.299 1.439 . . . . 0.0 112.302 -176.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.9 mp -109.82 135.59 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.82 1.248 . . . . 0.0 111.663 177.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -85.81 159.05 55.67 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 124.315 1.046 . . . . 0.0 112.624 171.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.0 -23.19 74.06 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.69 2.926 . . . . 0.0 112.582 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.74 8.22 2.05 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.548 1.139 . . . . 0.0 113.176 171.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 90.68 -20.61 37.59 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 127.098 2.285 . . . . 0.0 116.048 169.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 47.2 mt -70.87 151.76 44.41 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.279 1.432 . . . . 0.0 112.889 -173.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.41 124.72 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 124.565 1.146 . . . . 0.0 111.926 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.96 144.07 43.68 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.738 2.015 . . . . 0.0 111.96 -173.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -100.27 146.52 26.81 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.563 0.745 . . . . 0.0 111.98 166.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 22.8 m120 . . . . . 0 CA--C 1.538 0.483 0 O-C-N 121.562 -0.711 . . . . 0.0 110.832 168.388 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.667 0 CA-C-O 121.023 0.44 . . . . 0.0 112.031 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.422 ' HB2' ' CE1' ' A' ' 152' ' ' TYR . 0.0 OUTLIER -146.6 164.45 32.59 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.645 1.578 . . . . 0.0 111.058 -172.419 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.74 143.58 57.43 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.66 1.184 . . . . 0.0 113.725 -175.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? -58.71 -25.22 62.69 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.182 1.393 . . . . 0.0 114.238 177.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -87.02 1.03 54.19 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.924 1.29 . . . . 0.0 113.399 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.1 m -69.35 142.06 54.07 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.592 1.157 . . . . 0.0 113.099 175.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -79.32 148.06 32.23 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.436 1.494 . . . . 0.0 113.464 171.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.0 p -147.19 158.52 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.648 1.179 . . . . 0.0 111.904 -173.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -126.35 139.86 52.96 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.444 1.898 . . . . 0.0 108.807 178.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -155.28 177.21 11.61 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.608 0.718 . . . . 0.0 111.379 165.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -134.9 143.1 46.75 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.135 0.974 . . . . 0.0 110.181 173.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -159.53 143.12 14.56 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.483 1.113 . . . . 0.0 109.826 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.4 t70 48.49 50.28 17.07 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.927 1.291 . . . . 0.0 113.595 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.4 m 68.71 11.06 8.22 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 128.38 2.672 . . . . 0.0 116.145 174.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.6 p -134.71 136.87 26.22 Favored Pre-proline 0 CA--C 1.545 0.756 0 O-C-N 120.279 -1.513 . . . . 0.0 112.871 -176.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -73.0 154.39 52.82 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 123.793 2.996 . . . . 0.0 112.597 174.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -135.31 136.86 41.92 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.739 2.016 . . . . 0.0 109.147 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 50.6 ttm -152.95 104.01 2.8 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.749 0.82 . . . . 0.0 110.277 -176.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -162.29 -176.86 5.34 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.138 1.375 . . . . 0.0 111.067 -169.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.4 m -71.6 143.75 49.71 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 120.855 -1.153 . . . . 0.0 110.673 171.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.414 HG21 ' CD1' ' A' ' 152' ' ' TYR . 9.1 tp -55.02 -38.29 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -62.64 -24.04 67.39 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.365 -0.834 . . . . 0.0 113.02 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -80.55 -39.39 27.83 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.08 0.952 . . . . 0.0 111.313 176.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -73.18 -33.23 65.32 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.079 0.854 . . . . 0.0 111.72 174.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -56.96 -51.73 68.02 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.701 1.2 . . . . 0.0 111.908 169.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.1 t -62.17 -40.42 95.97 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.631 0.772 . . . . 0.0 111.423 -177.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -61.05 -53.01 62.49 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.756 1.223 . . . . 0.0 110.425 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -72.07 -33.28 67.8 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.0 -31.58 72.56 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.254 1.022 . . . . 0.0 112.513 175.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.7 t -79.81 -33.07 40.69 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 118.796 0.725 . . . . 0.0 111.878 174.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 69.8 mtm -75.99 -48.15 22.22 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.566 0.747 . . . . 0.0 112.665 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 35.7 m-20 -116.86 -19.88 9.67 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.437 1.495 . . . . 0.0 113.887 -166.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.75 159.17 34.89 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 125.087 1.327 . . . . 0.0 114.755 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -104.19 124.33 48.92 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.703 1.201 . . . . 0.0 109.435 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.3 mp -106.24 141.4 22.67 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 125.777 1.631 . . . . 0.0 110.613 -178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.12 146.23 57.35 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.505 2.803 . . . . 0.0 112.09 -173.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -134.25 154.73 51.1 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.42 1.088 . . . . 0.0 112.234 177.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -42.17 -47.45 4.65 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.897 1.679 . . . . 0.0 114.673 -176.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -116.3 7.65 14.04 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.13 -137.43 2.44 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 116.097 1.199 . . . . 0.0 116.097 -172.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -145.35 157.0 44.13 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 127.562 2.345 . . . . 0.0 111.062 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.09 151.98 47.15 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.376 1.071 . . . . 0.0 112.306 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.4 t -123.96 116.96 27.31 Favored Pre-proline 0 N--CA 1.48 1.046 0 C-N-CA 125.393 1.477 . . . . 0.0 110.284 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.43 141.63 31.96 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 124.529 3.486 . . . . 0.0 111.584 -176.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 77.2 mt -115.54 171.21 7.87 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.822 1.249 . . . . 0.0 112.682 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -148.92 135.02 19.16 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.843 1.657 . . . . 0.0 109.479 165.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 52.17 50.28 18.78 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.971 1.308 . . . . 0.0 113.562 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 67.0 t -113.05 107.67 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.075 0.95 . . . . 0.0 110.48 177.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -103.71 137.66 41.43 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.603 1.161 . . . . 0.0 113.335 -167.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.8 m -134.74 149.84 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.574 1.549 . . . . 0.0 112.599 175.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -65.44 141.95 58.34 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.648 0.779 . . . . 0.0 111.028 169.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.9 t -144.78 154.17 42.42 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.609 1.564 . . . . 0.0 111.259 -174.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 54.0 tp -114.05 138.88 49.8 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.06 1.344 . . . . 0.0 110.821 -175.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -86.6 120.69 28.19 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.17 1.388 . . . . 0.0 108.987 161.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 24.2 mm -78.87 -28.85 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 O-C-N 121.256 -0.903 . . . . 0.0 111.154 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.05 -36.19 80.86 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.437 1.095 . . . . 0.0 113.492 -171.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.9 m -121.54 -21.26 6.28 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.217 1.407 . . . . 0.0 112.998 171.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.49 31.01 20.19 Favored Glycine 0 N--CA 1.474 1.232 0 CA-C-N 118.878 0.763 . . . . 0.0 113.099 -173.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -91.92 143.68 26.24 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.819 1.248 . . . . 0.0 112.05 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.0 144.23 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.482 1.113 . . . . 0.0 110.6 -176.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.3 ptpt -154.0 176.91 11.65 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.901 1.68 . . . . 0.0 112.367 -177.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -121.45 147.82 45.24 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.792 1.637 . . . . 0.0 111.567 174.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.7 t -143.61 160.4 40.72 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.013 1.325 . . . . 0.0 111.187 175.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -97.88 132.36 43.54 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 170.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.33 142.2 39.51 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.056 0.943 . . . . 0.0 111.004 175.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.6 t -89.96 -46.14 8.72 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -169.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -153.53 160.55 42.52 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.684 1.193 . . . . 0.0 112.272 174.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.7 mt -88.79 152.81 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.481 1.112 . . . . 0.0 108.423 165.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -139.69 148.04 41.8 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.459 1.504 . . . . 0.0 110.537 -177.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.4 ptt85 -143.32 150.16 38.81 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.099 0.96 . . . . 0.0 113.155 169.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -151.66 166.08 32.36 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.988 1.715 . . . . 0.0 109.984 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -94.09 151.93 19.14 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.036 0.834 . . . . 0.0 111.459 172.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.7 m -148.74 143.12 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 124.879 1.272 . . . . 0.0 110.333 170.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -90.22 -30.14 17.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 117.632 -1.175 . . . . 0.0 112.019 175.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.7 mttt -131.95 130.43 41.51 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.274 0.943 . . . . 0.0 110.915 -174.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.8 tp -139.93 162.78 34.37 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.804 2.042 . . . . 0.0 110.158 -168.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.7 mt -116.46 127.58 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.604 1.162 . . . . 0.0 110.138 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -96.62 126.45 41.8 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.139 0.975 . . . . 0.0 110.625 166.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -111.0 129.03 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.436 1.094 . . . . 0.0 109.835 169.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -97.65 143.73 28.02 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.025 1.73 . . . . 0.0 111.301 173.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.3 mt -104.55 157.35 17.23 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 127.094 2.158 . . . . 0.0 110.317 -176.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.3 t -66.88 -23.6 66.02 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -173.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.7 t -66.84 -20.05 65.85 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.251 -0.905 . . . . 0.0 113.415 167.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 108.13 -5.52 34.08 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 127.575 2.512 . . . . 0.0 115.71 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -82.85 161.07 22.05 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.166 1.387 . . . . 0.0 110.831 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 65.2 p -141.46 159.83 41.41 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 24.3 tp -129.41 138.89 51.74 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.461 1.904 . . . . 0.0 110.324 177.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -111.22 121.63 45.79 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.876 1.27 . . . . 0.0 112.113 177.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.12 153.41 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.728 1.611 . . . . 0.0 112.85 -166.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.2 p -68.55 148.57 98.11 Favored Pre-proline 0 N--CA 1.472 0.64 0 O-C-N 120.944 -1.098 . . . . 0.0 112.573 173.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -60.84 -30.32 89.9 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 123.069 2.513 . . . . 0.0 114.366 -168.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 95.9 p -85.19 -6.56 59.27 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -61.5 119.21 44.75 Favored Pre-proline 0 CA--C 1.544 0.747 0 CA-C-N 119.635 1.107 . . . . 0.0 111.548 -177.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -73.47 127.38 11.75 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.415 2.077 . . . . 0.0 113.097 178.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.1 t -109.38 141.04 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.389 1.876 . . . . 0.0 109.374 174.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 20.2 tp -84.12 116.06 22.71 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.935 -0.478 . . . . 0.0 110.369 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.4 mp -115.67 148.28 39.88 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.961 1.704 . . . . 0.0 111.358 -173.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -107.0 81.54 1.56 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.877 0.846 . . . . 0.0 112.662 -173.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -119.0 78.81 1.32 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.691 1.196 . . . . 0.0 110.055 -169.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.6 t70 64.54 -14.79 0.09 Allowed 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 128.697 2.799 . . . . 0.0 115.602 -160.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.58 179.45 43.32 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 126.471 1.986 . . . . 0.0 111.506 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 73.0 mt -71.49 127.38 32.36 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.501 1.12 . . . . 0.0 109.981 178.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -153.33 144.93 23.34 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.902 0.881 . . . . 0.0 112.387 174.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -89.83 128.13 36.11 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.163 0.985 . . . . 0.0 110.879 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.0 t -131.65 128.94 21.93 Favored Pre-proline 0 N--CA 1.473 0.698 0 C-N-CA 124.584 1.154 . . . . 0.0 110.801 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -65.21 144.57 81.61 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.08 1.854 . . . . 0.0 110.974 175.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.44 -29.9 17.72 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 176.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.81 -23.0 67.19 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 173.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -108.83 0.76 20.49 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.302 1.841 . . . . 0.0 112.178 178.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.7 t -78.37 142.92 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.478 1.111 . . . . 0.0 110.014 166.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.74 154.94 73.24 Favored Pre-proline 0 N--CA 1.469 0.478 0 C-N-CA 126.202 1.801 . . . . 0.0 111.127 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.412 ' HD3' HG22 ' A' ' 142' ' ' VAL . 64.2 Cg_endo -63.69 122.5 10.62 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.188 1.926 . . . . 0.0 109.978 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 102.08 5.27 50.23 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 124.355 0.979 . . . . 0.0 115.316 -176.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -64.38 165.08 10.23 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 118.956 1.378 . . . . 0.0 112.302 164.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.1 p -113.48 125.03 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.171 1.388 . . . . 0.0 111.744 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.3 t -101.64 142.92 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 127.938 2.495 . . . . 0.0 110.652 -173.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 43.8 t -99.99 143.35 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.842 1.257 . . . . 0.0 112.314 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -162.9 -152.12 6.67 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.826 1.679 . . . . 0.0 112.63 175.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.4 p -138.82 157.01 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 127.519 2.328 . . . . 0.0 108.873 -177.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 . . . . . 0 N--CA 1.476 0.834 0 C-N-CA 123.068 0.547 . . . . 0.0 110.815 179.029 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 N--CA 1.477 0.893 0 CA-C-O 122.4 1.095 . . . . 0.0 113.637 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 98.8 mt -66.03 138.98 58.16 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.003 1.721 . . . . 0.0 113.838 -177.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -131.11 149.88 52.4 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.439 1.496 . . . . 0.0 112.98 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -130.95 136.13 48.28 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.895 0.878 . . . . 0.0 113.142 -170.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -125.9 142.41 51.53 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.42 1.088 . . . . 0.0 111.297 -175.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -88.99 138.46 31.38 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.55 0.74 . . . . 0.0 110.894 174.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 71.9 t -72.41 126.26 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 O-C-N 120.705 -1.247 . . . . 0.0 110.115 172.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 28.2 t -77.71 -48.55 16.43 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.412 1.485 . . . . 0.0 111.629 172.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.72 170.54 20.57 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.412 -0.805 . . . . 0.0 111.588 176.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.412 HG22 ' HD3' ' A' ' 112' ' ' PRO . 11.1 m -132.81 155.24 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.772 1.229 . . . . 0.0 110.255 169.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -153.9 153.9 32.89 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.201 1.001 . . . . 0.0 112.391 168.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 96.3 mt -94.14 135.99 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.949 1.3 . . . . 0.0 108.091 168.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 28.2 pt -132.56 148.21 31.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 125.147 1.379 . . . . 0.0 111.029 -178.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -84.39 96.01 8.94 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 170.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -74.12 -45.95 45.68 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.096 -1.003 . . . . 0.0 112.105 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 47.12 40.51 9.97 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.559 1.143 . . . . 0.0 112.498 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -148.41 172.3 14.66 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.244 1.418 . . . . 0.0 110.763 -170.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -76.94 142.55 40.0 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 122.052 0.93 . . . . 0.0 112.638 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.36 157.53 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 126.557 1.943 . . . . 0.0 109.344 177.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.422 ' CE1' ' HB2' ' A' ' 2' ' ' PHE . 7.8 p90 -110.51 161.44 15.69 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.973 0.909 . . . . 0.0 112.016 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -137.38 154.03 50.08 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.865 0.866 . . . . 0.0 108.944 158.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.0 tt -129.05 108.99 10.82 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.738 -1.226 . . . . 0.0 108.823 -172.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.7 t -90.87 127.47 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -153.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 28.8 mm -124.18 85.84 54.7 Favored Pre-proline 0 N--CA 1.47 0.571 0 C-N-CA 125.627 1.571 . . . . 0.0 109.705 -172.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -64.65 -16.92 57.74 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.098 1.866 . . . . 0.0 113.816 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -78.45 -45.03 23.18 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.742 1.156 . . . . 0.0 113.089 -176.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 76.6 p -131.65 -8.52 3.62 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.338 1.455 . . . . 0.0 114.288 -172.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 54.73 15.68 1.17 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.555 1.542 . . . . 0.0 114.773 -165.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -143.45 142.48 31.22 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 121.248 1.84 . . . . 0.0 114.951 -175.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -141.74 162.91 34.31 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.383 1.473 . . . . 0.0 112.069 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 95.2 mt -112.29 130.62 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.281 1.032 . . . . 0.0 110.568 -173.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -77.74 160.1 75.18 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 124.151 0.981 . . . . 0.0 111.866 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -62.19 -20.12 68.91 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.577 2.185 . . . . 0.0 112.719 177.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -73.81 -12.21 60.62 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.039 1.336 . . . . 0.0 113.226 175.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 102.61 -22.43 37.38 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.851 1.691 . . . . 0.0 115.446 177.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 72.2 mt -72.14 148.12 45.98 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 119.479 1.639 . . . . 0.0 113.087 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.9 p -99.89 134.38 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.396 1.079 . . . . 0.0 112.48 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 41.4 mt -119.47 133.75 55.54 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.498 1.919 . . . . 0.0 110.913 -171.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 31.6 t-80 -86.23 126.56 34.36 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.606 -0.684 . . . . 0.0 110.379 165.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.542 0.655 0 C-N-CA 124.069 0.948 . . . . 0.0 109.464 170.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.878 0 CA-C-O 121.085 0.469 . . . . 0.0 111.983 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -131.01 160.26 35.1 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 127.014 2.126 . . . . 0.0 111.196 -175.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -55.46 145.86 21.57 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.379 1.071 . . . . 0.0 112.615 175.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -26.26 67.89 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -79.21 -8.26 58.88 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 175.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.0 m -63.11 134.8 56.63 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 121.063 -1.023 . . . . 0.0 111.29 -175.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -76.78 149.32 36.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 122.268 1.033 . . . . 0.0 113.719 175.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.0 p -145.35 152.14 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 124.595 1.158 . . . . 0.0 111.675 -173.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -122.06 143.26 49.62 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.766 2.026 . . . . 0.0 107.284 176.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -150.86 -175.88 5.31 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.427 0.691 . . . . 0.0 111.132 164.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -136.15 142.24 44.18 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.258 1.423 . . . . 0.0 110.624 174.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -164.04 151.21 11.95 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.879 2.071 . . . . 0.0 108.109 176.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.2 t0 50.95 43.18 28.86 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.791 1.237 . . . . 0.0 113.698 -177.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.5 m 56.66 35.18 25.76 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.625 1.57 . . . . 0.0 114.523 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.1 p -154.66 140.8 12.85 Favored Pre-proline 0 CA--C 1.538 0.482 0 O-C-N 120.505 -1.372 . . . . 0.0 112.012 177.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.35 144.87 57.67 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.588 2.192 . . . . 0.0 112.194 173.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -123.34 142.21 51.19 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 128.819 2.848 . . . . 0.0 108.806 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 41.6 ttm -153.29 120.43 5.8 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.678 -0.639 . . . . 0.0 111.634 -175.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -160.44 -172.43 3.55 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.47 1.908 . . . . 0.0 110.56 -176.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.4 m -76.16 150.08 37.21 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 120.639 -1.288 . . . . 0.0 110.541 167.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.2 tp -59.22 -36.36 62.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 O-C-N 121.019 -1.051 . . . . 0.0 111.985 177.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -59.71 -27.64 66.62 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.202 0.91 . . . . 0.0 113.455 173.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -81.46 -47.51 13.08 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.542 0.737 . . . . 0.0 110.194 -176.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.9 ppp? -68.27 -33.26 74.04 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 176.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -58.46 -50.05 75.1 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.428 0.691 . . . . 0.0 111.6 170.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.4 t -66.18 -29.61 69.93 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 121.646 -0.659 . . . . 0.0 111.973 -173.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -69.53 -57.13 5.6 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 126.39 1.876 . . . . 0.0 110.731 173.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -69.7 -34.86 74.51 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.282 -0.886 . . . . 0.0 112.89 -176.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.57 -24.79 64.65 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.303 1.041 . . . . 0.0 113.616 174.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 30.9 t -82.38 -35.27 27.91 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.765 0.712 . . . . 0.0 111.975 172.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 63.8 mtm -77.55 -58.08 3.46 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.85 0.86 . . . . 0.0 111.793 -178.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 47.2 m-20 -98.53 -20.02 17.29 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.828 1.251 . . . . 0.0 112.555 -171.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.7 159.35 33.2 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-O 121.941 0.745 . . . . 0.0 114.008 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -105.01 124.2 49.12 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.223 1.009 . . . . 0.0 110.577 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.6 mp -98.46 151.31 37.41 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 125.225 1.41 . . . . 0.0 110.488 174.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -69.09 156.12 66.05 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.834 2.356 . . . . 0.0 111.624 176.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -140.6 169.54 17.45 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.988 1.715 . . . . 0.0 110.26 174.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -48.93 -49.48 39.99 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -176.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -107.4 -13.43 15.1 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 177.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -161.21 -134.96 1.73 Allowed Glycine 0 CA--C 1.528 0.847 0 O-C-N 121.507 -0.745 . . . . 0.0 113.935 -167.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -140.69 154.72 46.49 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.284 1.034 . . . . 0.0 111.891 -177.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -135.95 145.4 46.17 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.774 1.23 . . . . 0.0 112.454 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 52.1 t -118.53 116.78 34.85 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 125.642 1.577 . . . . 0.0 110.758 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -71.34 138.23 32.54 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 124.091 3.194 . . . . 0.0 111.603 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 82.2 mt -107.18 158.13 17.34 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.974 1.31 . . . . 0.0 112.507 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -139.12 124.37 19.11 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.316 1.446 . . . . 0.0 109.444 174.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 51.33 51.2 17.35 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.797 1.639 . . . . 0.0 113.98 -178.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.4 t -116.41 128.71 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.408 1.483 . . . . 0.0 109.981 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -129.25 158.28 39.5 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.603 1.161 . . . . 0.0 113.364 -170.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.1 m -146.12 152.48 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 126.784 2.034 . . . . 0.0 112.269 176.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -61.7 131.45 49.99 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.402 1.481 . . . . 0.0 110.45 161.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.6 t -134.84 153.09 52.18 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.201 2.2 . . . . 0.0 111.565 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 37.6 tp -106.63 136.2 46.84 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.032 0.933 . . . . 0.0 112.169 -176.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -82.61 93.56 7.35 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.733 1.613 . . . . 0.0 110.173 170.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 31.7 mm -59.92 -21.82 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 O-C-N 120.854 -1.154 . . . . 0.0 112.888 -175.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.26 -50.12 64.84 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.081 -1.012 . . . . 0.0 113.455 175.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -111.91 -15.28 13.37 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.917 0.887 . . . . 0.0 112.652 -168.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.86 36.27 91.93 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.395 0.998 . . . . 0.0 112.105 -172.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -103.67 150.0 24.43 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.529 1.932 . . . . 0.0 111.084 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 mp -95.41 135.47 29.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 124.774 1.23 . . . . 0.0 110.801 -173.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.05 163.5 38.0 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.679 1.592 . . . . 0.0 112.569 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.4 150.19 20.65 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.232 1.413 . . . . 0.0 111.695 172.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.8 t -143.25 165.1 28.39 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.616 1.167 . . . . 0.0 111.787 167.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -91.58 153.38 19.78 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.142 1.377 . . . . 0.0 112.639 172.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -107.39 144.06 34.83 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.397 1.079 . . . . 0.0 111.487 170.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.6 t -97.64 -44.19 6.89 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.699 0.999 . . . . 0.0 113.699 -170.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -153.83 159.13 41.72 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.402 1.081 . . . . 0.0 112.761 173.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.2 mt -90.21 153.02 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.268 1.427 . . . . 0.0 108.398 164.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -137.41 148.42 46.16 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.051 1.34 . . . . 0.0 112.614 -177.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 37.3 ptt85 -138.29 145.89 41.8 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.836 1.254 . . . . 0.0 114.105 174.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -152.63 168.35 25.89 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.942 2.097 . . . . 0.0 110.314 177.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.423 ' HE2' ' HA ' ' A' ' 149' ' ' ASN . 1.0 OUTLIER -110.26 139.56 45.31 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.285 1.434 . . . . 0.0 112.602 -175.252 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.1 m -148.48 146.82 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 124.794 1.238 . . . . 0.0 112.133 -176.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.439 ' HA ' ' H ' ' A' ' 148' ' ' ASN . 6.4 pt-20 -104.32 -25.32 12.91 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 126.188 1.795 . . . . 0.0 112.923 174.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -122.23 118.05 27.63 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.64 1.109 . . . . 0.0 111.021 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.9 tp -128.03 159.15 35.92 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.813 2.045 . . . . 0.0 108.388 -175.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.1 mt -113.37 129.58 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 119.727 1.149 . . . . 0.0 109.146 177.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -103.76 117.24 33.9 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.769 0.828 . . . . 0.0 110.978 170.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.2 mp -102.84 125.58 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 C-N-CA 125.399 1.479 . . . . 0.0 108.241 175.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.4 tttt -95.46 147.75 23.2 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.057 1.343 . . . . 0.0 110.67 171.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 54.3 mt -117.67 160.57 21.09 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.364 1.466 . . . . 0.0 112.149 -172.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.7 t -64.76 -16.86 63.58 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.571 1.148 . . . . 0.0 112.979 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.2 p -70.37 -11.16 60.72 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.974 1.71 . . . . 0.0 114.214 167.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.76 -4.17 84.95 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 126.193 1.854 . . . . 0.0 113.985 -174.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -88.72 165.76 14.52 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.236 1.814 . . . . 0.0 112.151 -175.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.9 p -131.2 152.78 50.14 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 174.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 61.8 tp -127.94 129.28 46.56 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.63 1.972 . . . . 0.0 109.394 178.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -114.09 113.31 24.56 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.262 1.425 . . . . 0.0 111.15 -177.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.9 m -141.72 155.39 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 125.634 1.574 . . . . 0.0 113.036 -170.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.4 p -64.25 147.18 97.22 Favored Pre-proline 0 N--CA 1.469 0.513 0 O-C-N 121.212 -0.93 . . . . 0.0 112.677 175.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -62.83 -29.81 77.01 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.864 2.376 . . . . 0.0 113.589 -170.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.8 p -72.04 -10.93 60.46 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.196 1.798 . . . . 0.0 114.768 174.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -78.38 119.19 76.41 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 119.524 1.056 . . . . 0.0 112.787 -164.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -68.74 137.85 39.66 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.847 2.365 . . . . 0.0 113.207 -177.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.9 t -120.25 140.81 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 126.388 1.875 . . . . 0.0 109.156 175.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 39.5 tp -81.83 110.43 17.13 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 122.848 0.459 . . . . 0.0 110.158 178.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.0 mp -105.12 150.53 24.96 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.972 1.709 . . . . 0.0 111.801 -175.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -108.74 102.06 11.14 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.641 0.776 . . . . 0.0 111.792 171.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 59.0 mtt-85 -139.61 80.52 1.78 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.312 1.045 . . . . 0.0 111.6 174.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.9 t0 64.5 1.05 1.21 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 127.728 2.411 . . . . 0.0 115.148 -167.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 179.32 165.63 33.83 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 124.764 1.173 . . . . 0.0 113.018 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 39.6 mt -72.43 117.58 14.27 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.174 0.99 . . . . 0.0 111.133 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -145.63 137.09 25.06 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.22 1.008 . . . . 0.0 112.609 -176.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -91.79 121.85 33.79 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.209 1.004 . . . . 0.0 110.902 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 71.3 t -134.0 130.27 20.4 Favored Pre-proline 0 N--CA 1.48 1.039 0 C-N-CA 125.472 1.509 . . . . 0.0 109.561 -175.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.05 151.53 77.43 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 122.815 2.343 . . . . 0.0 112.797 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.47 -31.91 16.57 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 174.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.09 -23.31 67.28 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 173.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -106.07 -5.01 19.77 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.027 1.731 . . . . 0.0 112.082 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 89.9 t -69.53 147.07 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.592 1.157 . . . . 0.0 110.26 166.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.53 154.13 80.64 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 127.78 2.432 . . . . 0.0 110.625 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.401 ' HD3' HG22 ' A' ' 142' ' ' VAL . 58.0 Cg_endo -66.56 116.15 3.93 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.431 2.087 . . . . 0.0 111.043 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.414 ' H ' ' HB ' ' A' ' 139' ' ' VAL . . . 113.65 0.37 24.6 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.677 1.132 . . . . 0.0 114.948 -177.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -60.21 157.04 14.08 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 119.682 1.741 . . . . 0.0 112.119 169.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.6 t -95.65 126.05 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.542 1.137 . . . . 0.0 110.574 168.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.1 t -101.08 142.51 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 126.92 2.088 . . . . 0.0 110.09 173.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.1 t -90.63 137.62 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.852 0.861 . . . . 0.0 111.111 175.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -166.48 -150.87 6.54 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.298 0.951 . . . . 0.0 113.533 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.0 p -152.81 172.86 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 127.25 2.22 . . . . 0.0 109.895 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 . . . . . 0 N--CA 1.473 0.714 0 C-N-CA 125.051 1.34 . . . . 0.0 112.7 174.583 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 . . . . . 0 N--CA 1.481 1.076 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 43.4 mt -147.31 154.42 40.92 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.584 1.554 . . . . 0.0 111.968 172.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -149.7 127.75 11.95 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.101 1.76 . . . . 0.0 110.836 177.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -88.14 148.6 24.35 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.309 -0.869 . . . . 0.0 111.54 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -130.2 133.39 46.53 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.925 1.29 . . . . 0.0 109.622 -170.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -90.82 140.77 29.49 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 119.812 1.187 . . . . 0.0 111.847 175.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.414 ' HB ' ' H ' ' A' ' 113' ' ' GLY . 78.4 t -74.8 139.65 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.16 0.984 . . . . 0.0 111.271 175.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.1 t -94.58 -48.27 6.17 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.503 1.921 . . . . 0.0 112.29 175.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 13.1 t -156.61 161.63 39.91 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.352 1.061 . . . . 0.0 111.551 -177.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.401 HG22 ' HD3' ' A' ' 112' ' ' PRO . 5.6 m -139.52 149.38 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 125.365 1.466 . . . . 0.0 111.512 168.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -161.85 168.76 22.49 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 160.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 43.9 mt -93.09 128.06 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.006 1.322 . . . . 0.0 110.004 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 31.6 pt -120.78 154.8 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 127.159 2.184 . . . . 0.0 112.485 -174.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -100.48 75.51 1.78 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.182 1.393 . . . . 0.0 111.159 -168.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -66.97 -47.89 70.17 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.26 -0.9 . . . . 0.0 112.465 -169.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.439 ' H ' ' HA ' ' A' ' 74' ' ' GLU . 1.5 m-80 49.5 41.5 21.23 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.09 1.756 . . . . 0.0 111.941 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.423 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 22.3 t-20 -146.17 176.62 9.61 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.114 1.366 . . . . 0.0 111.34 -171.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -74.42 147.0 42.44 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.008 0.923 . . . . 0.0 112.067 170.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 6.8 m -127.98 150.17 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.087 1.755 . . . . 0.0 109.484 175.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -118.34 156.8 28.29 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.526 0.73 . . . . 0.0 112.74 -173.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -155.64 151.41 27.43 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.481 1.113 . . . . 0.0 109.485 -165.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 38.0 tp -128.68 128.34 43.91 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.067 0.947 . . . . 0.0 111.782 -173.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 59.6 t -98.99 118.95 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.537 0.684 . . . . 0.0 112.742 -166.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 16.2 mm -124.41 86.87 54.63 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 127.451 2.3 . . . . 0.0 108.754 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -64.3 -17.82 61.04 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.837 2.358 . . . . 0.0 114.192 175.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -72.18 -55.62 6.95 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.705 1.139 . . . . 0.0 112.6 -177.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 67.7 p -124.97 -10.18 7.16 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.238 1.415 . . . . 0.0 113.9 -172.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 53.43 29.25 8.57 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -171.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -156.94 147.47 21.41 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 120.024 -1.673 . . . . 0.0 113.562 175.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -150.38 161.15 43.05 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.403 1.081 . . . . 0.0 112.076 176.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.7 mp -101.03 136.56 32.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 123.911 0.885 . . . . 0.0 111.486 -176.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -82.55 159.21 64.56 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 125.745 1.618 . . . . 0.0 112.456 173.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.01 -16.65 40.88 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.91 2.407 . . . . 0.0 113.68 -177.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -79.68 -1.09 36.8 Favored 'General case' 0 CA--C 1.556 1.194 0 O-C-N 121.398 -0.814 . . . . 0.0 112.487 170.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 97.91 -14.52 62.72 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.999 1.761 . . . . 0.0 115.65 175.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 57.9 mt -74.19 145.47 44.16 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.831 1.252 . . . . 0.0 111.953 -177.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.4 p -91.09 137.5 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 118.796 0.725 . . . . 0.0 112.318 174.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 67.5 mt -116.45 155.63 28.24 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.177 2.191 . . . . 0.0 110.78 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -100.87 155.44 17.94 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.935 0.894 . . . . 0.0 111.075 177.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 25.6 t30 . . . . . 0 CA--C 1.543 0.674 0 O-C-N 121.051 -1.031 . . . . 0.0 109.336 161.97 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -132.29 163.9 27.61 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 127.557 2.343 . . . . 0.0 111.183 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.3 145.09 54.69 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.64 1.176 . . . . 0.0 113.587 177.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -61.26 -24.28 66.27 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.545 1.138 . . . . 0.0 113.292 173.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -86.33 4.68 38.12 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.697 1.599 . . . . 0.0 113.658 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.6 m -74.25 141.06 45.39 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.047 0.939 . . . . 0.0 111.915 171.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -81.34 155.75 25.83 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.03 0.932 . . . . 0.0 113.038 169.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.0 p -148.07 155.8 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.957 0.903 . . . . 0.0 111.724 -173.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.47 139.22 54.24 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.151 1.78 . . . . 0.0 108.016 175.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -152.03 -179.06 7.16 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.951 0.9 . . . . 0.0 111.236 167.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -135.23 142.14 45.93 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.211 1.404 . . . . 0.0 111.082 177.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -164.14 159.08 19.92 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 127.618 2.367 . . . . 0.0 107.359 174.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.7 t0 53.49 32.94 15.03 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 m 58.73 33.21 22.91 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.894 1.278 . . . . 0.0 113.399 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.6 p -154.39 140.57 12.77 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 125.133 1.373 . . . . 0.0 112.527 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -70.02 150.85 67.2 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 123.13 2.553 . . . . 0.0 113.489 176.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -130.31 133.12 46.23 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 127.903 2.481 . . . . 0.0 108.744 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 39.9 ttm -145.75 113.11 6.23 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.074 0.95 . . . . 0.0 112.298 -175.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -162.79 -177.07 5.3 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.515 1.526 . . . . 0.0 112.606 -174.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.9 m -69.96 137.81 51.78 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.289 -0.882 . . . . 0.0 110.531 170.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.413 HG12 ' CG ' ' A' ' 152' ' ' TYR . 7.6 tp -55.68 -36.5 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 121.378 -0.826 . . . . 0.0 113.1 -178.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -60.8 -26.93 67.64 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.522 1.129 . . . . 0.0 112.596 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -81.49 -42.83 19.69 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.477 1.111 . . . . 0.0 111.191 178.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.6 ptm -68.65 -32.21 71.9 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.331 0.969 . . . . 0.0 111.591 174.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -57.67 -48.97 78.01 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.562 0.745 . . . . 0.0 110.632 171.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.6 t -62.79 -38.07 89.21 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.629 0.772 . . . . 0.0 111.829 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -64.32 -52.37 58.82 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.004 1.321 . . . . 0.0 110.585 177.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -71.08 -34.3 71.03 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.409 -0.807 . . . . 0.0 113.018 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.21 -35.32 80.7 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.788 0.835 . . . . 0.0 111.535 172.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 66.7 m -74.54 -29.34 61.33 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.115 0.966 . . . . 0.0 112.647 178.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 66.5 mtm -86.86 -47.31 9.14 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.068 1.347 . . . . 0.0 113.237 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -116.92 -13.76 10.66 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.835 1.254 . . . . 0.0 113.825 -165.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.46 163.72 39.56 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 124.4 1.0 . . . . 0.0 114.4 175.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -113.75 126.21 54.97 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.885 1.274 . . . . 0.0 110.452 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.6 mp -105.42 151.33 39.69 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 127.247 2.219 . . . . 0.0 110.54 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -76.91 155.91 34.44 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 123.558 2.839 . . . . 0.0 112.973 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.75 162.92 34.28 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.197 1.399 . . . . 0.0 110.519 163.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.36 -54.1 36.16 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 120.854 -1.154 . . . . 0.0 113.496 -176.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -96.96 -6.91 34.44 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 177.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -163.17 -140.5 2.89 Favored Glycine 0 CA--C 1.534 1.244 0 N-CA-C 116.602 1.401 . . . . 0.0 116.602 -172.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -149.0 157.13 43.18 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.752 1.621 . . . . 0.0 112.958 -171.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.83 148.75 41.07 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.434 1.094 . . . . 0.0 113.531 -176.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 51.4 t -129.18 121.72 20.75 Favored Pre-proline 0 N--CA 1.48 1.056 0 C-N-CA 126.085 1.754 . . . . 0.0 111.534 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -80.55 132.99 9.24 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 124.379 3.386 . . . . 0.0 113.227 -175.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 78.0 mt -97.77 165.76 11.8 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.042 1.337 . . . . 0.0 113.682 179.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -148.97 121.21 8.36 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.94 1.296 . . . . 0.0 111.079 176.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 46.14 52.77 9.97 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.782 1.633 . . . . 0.0 112.823 -173.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.7 t -112.46 128.43 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.44 1.096 . . . . 0.0 108.577 174.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -134.4 161.29 35.41 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -168.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.1 p -152.84 148.66 13.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 124.306 1.042 . . . . 0.0 112.18 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -64.41 133.45 52.58 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 122.348 1.07 . . . . 0.0 109.93 166.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.452 HG23 ' HG3' ' A' ' 61' ' ' LYS . 6.7 t -138.38 153.59 48.92 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.803 2.041 . . . . 0.0 110.49 -171.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.0 tp -113.95 145.02 42.11 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.322 -0.861 . . . . 0.0 111.537 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -96.8 118.02 32.34 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 124.485 1.114 . . . . 0.0 110.845 164.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mp -80.53 -20.65 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 124.135 0.974 . . . . 0.0 112.457 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.65 -36.93 85.12 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.206 1.003 . . . . 0.0 113.459 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.4 m -121.11 -16.97 7.89 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.565 1.146 . . . . 0.0 112.827 173.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.21 23.69 39.82 Favored Glycine 0 N--CA 1.475 1.293 0 C-N-CA 124.173 0.892 . . . . 0.0 113.667 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -100.02 137.75 38.04 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.862 1.665 . . . . 0.0 112.745 -169.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 mp -75.7 144.83 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 125.636 1.575 . . . . 0.0 111.866 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.452 ' HG3' HG23 ' A' ' 52' ' ' THR . 13.7 ptpt -155.6 176.19 12.92 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 127.093 2.157 . . . . 0.0 111.629 -178.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -129.08 141.86 51.08 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 125.14 1.376 . . . . 0.0 111.151 175.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -139.83 168.98 18.57 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.398 1.079 . . . . 0.0 113.287 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -92.2 147.95 22.54 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.178 1.391 . . . . 0.0 112.563 173.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.88 138.31 37.13 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.245 1.018 . . . . 0.0 110.311 167.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.0 t -94.28 -48.69 6.06 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -167.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.17 156.03 40.11 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.657 1.183 . . . . 0.0 111.629 175.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.7 mt -89.94 145.05 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.43 1.092 . . . . 0.0 108.414 165.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -128.52 150.65 50.08 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.949 1.7 . . . . 0.0 111.004 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.3 ptt-85 -143.63 151.35 40.02 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.201 1.0 . . . . 0.0 113.578 168.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -147.45 167.89 23.26 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.928 1.691 . . . . 0.0 110.938 175.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.54 146.89 23.8 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.621 0.768 . . . . 0.0 112.131 173.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.8 m -149.15 147.97 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 125.784 1.634 . . . . 0.0 111.522 171.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -100.31 -29.06 12.64 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.788 1.635 . . . . 0.0 112.36 175.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -122.23 128.76 51.54 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.513 1.125 . . . . 0.0 110.582 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 12.2 tp -135.45 160.86 37.13 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.841 1.657 . . . . 0.0 109.503 -174.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.7 mt -109.04 126.65 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 119.836 1.198 . . . . 0.0 109.653 175.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -102.46 119.93 39.66 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.775 1.23 . . . . 0.0 110.792 169.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -105.65 125.01 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.063 1.345 . . . . 0.0 108.478 173.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.6 tttt -92.33 146.54 23.61 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.675 1.19 . . . . 0.0 110.623 172.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 78.5 mt -106.57 160.48 15.4 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.769 1.627 . . . . 0.0 111.475 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.5 t -67.78 -11.42 58.43 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.626 1.17 . . . . 0.0 112.591 -176.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.6 p -81.44 -8.78 59.78 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 128.63 2.772 . . . . 0.0 114.947 168.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.65 -7.9 80.65 Favored Glycine 0 CA--C 1.54 1.632 0 C-N-CA 125.752 1.644 . . . . 0.0 115.362 -173.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -74.04 162.67 28.78 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.544 1.538 . . . . 0.0 111.201 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 86.3 p -140.41 146.02 37.79 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 66.8 tp -121.96 132.51 54.57 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.485 1.914 . . . . 0.0 110.068 176.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -117.03 116.5 27.47 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.871 1.668 . . . . 0.0 111.522 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.5 m -141.61 153.08 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.327 1.451 . . . . 0.0 113.082 -169.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.7 p -68.08 148.97 98.33 Favored Pre-proline 0 N--CA 1.466 0.372 0 O-C-N 121.258 -0.901 . . . . 0.0 111.66 171.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.22 -28.32 83.74 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.409 2.739 . . . . 0.0 114.346 -166.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.8 m -85.21 -4.96 59.34 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.39 1.255 . . . . 0.0 114.39 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 63.8 t60 -65.92 118.53 52.93 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 119.909 1.231 . . . . 0.0 111.918 -176.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -76.36 132.63 13.83 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.758 2.305 . . . . 0.0 113.441 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.3 t -111.33 143.82 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 126.111 1.765 . . . . 0.0 109.798 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 25.6 tp -81.31 102.0 10.14 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.014 0.526 . . . . 0.0 110.78 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.1 mp -98.96 153.64 18.68 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.971 1.709 . . . . 0.0 111.434 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -108.7 107.94 18.59 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.413 0.625 . . . . 0.0 112.593 176.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 36.4 mtp-105 -136.24 80.05 1.8 Allowed 'General case' 0 N--CA 1.479 1.004 0 O-C-N 120.861 -1.149 . . . . 0.0 110.211 -178.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 53.43 -3.25 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 127.657 2.383 . . . . 0.0 115.584 -156.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.81 171.27 44.02 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 125.591 1.567 . . . . 0.0 113.206 -178.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 82.1 mt -76.3 115.16 15.77 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.45 1.9 . . . . 0.0 111.007 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -146.83 147.93 31.36 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -99.4 117.06 32.97 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.183 1.393 . . . . 0.0 111.375 -173.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.4 t -124.49 128.45 24.97 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 123.862 0.865 . . . . 0.0 109.908 -176.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -64.56 147.34 90.22 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.575 2.184 . . . . 0.0 111.419 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.26 -30.78 18.8 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 175.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.54 -21.36 66.16 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 173.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -105.06 4.02 31.09 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.84 2.056 . . . . 0.0 112.436 175.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.6 t -84.12 143.84 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.166 1.386 . . . . 0.0 111.099 169.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.34 155.17 81.07 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 126.995 2.118 . . . . 0.0 111.33 -177.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.52 118.45 5.6 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.006 2.47 . . . . 0.0 111.681 -175.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.74 5.88 35.63 Favored Glycine 0 CA--C 1.538 1.516 0 CA-C-O 119.12 -0.822 . . . . 0.0 115.139 -176.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -61.43 166.11 4.24 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.251 1.421 . . . . 0.0 112.474 166.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.3 p -116.79 131.69 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 125.84 1.656 . . . . 0.0 111.546 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.5 t -117.22 140.67 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 126.147 1.779 . . . . 0.0 110.632 -172.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.1 t -89.03 134.42 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 123.818 0.847 . . . . 0.0 110.943 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -160.05 -151.52 6.2 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 121.674 -0.641 . . . . 0.0 113.66 174.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.3 p -139.52 159.87 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 127.051 2.14 . . . . 0.0 108.981 173.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 . . . . . 0 N--CA 1.473 0.687 0 C-N-CA 123.84 0.856 . . . . 0.0 109.833 173.229 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 . . . . . 0 CA--C 1.541 0.632 0 CA-C-O 119.423 -0.323 . . . . 0.0 110.969 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 96.0 mt -139.32 163.14 33.28 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.923 1.289 . . . . 0.0 112.84 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -153.66 154.26 33.82 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.824 1.65 . . . . 0.0 112.658 172.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -78.15 153.39 32.11 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 120.961 -1.087 . . . . 0.0 113.848 178.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 43.9 m80 -131.27 158.21 41.21 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.992 1.717 . . . . 0.0 108.385 166.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -120.29 142.24 49.27 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 121.259 -0.901 . . . . 0.0 111.464 -173.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 99.3 t -76.36 132.96 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 121.767 -0.583 . . . . 0.0 110.885 172.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.6 t -91.3 -46.07 8.25 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.89 2.076 . . . . 0.0 111.725 172.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.4 t -158.36 169.54 24.24 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.04 -1.038 . . . . 0.0 111.284 175.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.5 m -133.68 148.95 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.086 1.354 . . . . 0.0 110.745 167.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -154.27 154.82 34.07 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.681 0.792 . . . . 0.0 112.686 167.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 96.9 mt -84.16 130.7 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 166.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 16.3 pt -123.95 158.6 30.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 126.362 1.865 . . . . 0.0 112.299 -174.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -94.46 94.5 8.27 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.127 1.371 . . . . 0.0 112.246 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -83.4 -56.29 3.83 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.459 -0.776 . . . . 0.0 112.771 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 51.82 36.83 18.97 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.081 0.953 . . . . 0.0 112.449 -177.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -150.98 172.97 14.87 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.142 1.377 . . . . 0.0 110.837 -172.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -75.04 138.83 42.44 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.997 0.903 . . . . 0.0 112.962 -176.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 15.5 m -120.25 153.97 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 126.046 1.738 . . . . 0.0 109.57 177.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.413 ' CG ' HG12 ' A' ' 21' ' ' ILE . 1.5 p90 -114.05 160.79 18.5 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.081 0.952 . . . . 0.0 112.568 -175.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -142.63 148.63 37.75 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.612 -0.68 . . . . 0.0 109.856 157.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 55.1 tp -108.5 119.58 39.92 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.684 1.193 . . . . 0.0 109.965 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 50.7 t -88.35 120.25 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -166.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 27.9 mm -118.66 86.93 30.76 Favored Pre-proline 0 N--CA 1.471 0.592 0 C-N-CA 125.833 1.653 . . . . 0.0 109.375 -177.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -70.9 -9.75 26.32 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.271 2.647 . . . . 0.0 113.995 -174.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -81.32 -60.57 2.23 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 118.898 0.772 . . . . 0.0 112.203 175.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 73.7 p -118.61 -10.67 10.0 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -171.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 66.6 m80 53.33 27.36 6.14 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.306 1.442 . . . . 0.0 114.692 -172.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.6 149.96 30.55 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 120.629 -1.294 . . . . 0.0 113.237 178.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -153.01 162.8 40.89 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.358 1.463 . . . . 0.0 111.415 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.8 mp -103.66 137.99 29.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 124.053 0.941 . . . . 0.0 110.945 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.76 156.82 64.51 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 123.944 0.898 . . . . 0.0 111.839 173.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -64.78 -23.76 62.41 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.553 2.169 . . . . 0.0 112.641 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -79.41 3.91 17.0 Favored 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 124.931 1.292 . . . . 0.0 112.711 174.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 105.96 -21.6 33.5 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.645 1.593 . . . . 0.0 116.612 164.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 64.4 mt -77.7 149.33 34.63 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.832 1.816 . . . . 0.0 113.818 -171.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 4.6 t -89.41 123.81 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.175 0.99 . . . . 0.0 110.646 174.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 54.6 mt -116.08 148.48 40.21 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.56 1.944 . . . . 0.0 111.629 -174.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -96.62 136.79 36.64 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.756 0.823 . . . . 0.0 110.873 170.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 . . . . . 0 CA--C 1.535 0.372 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 162.544 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.686 0 CA-C-O 121.063 0.459 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -140.01 164.78 29.11 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.369 1.468 . . . . 0.0 112.303 -178.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.3 151.3 47.73 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -172.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.65 -22.03 43.36 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 177.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -73.9 -21.63 60.0 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.392 1.477 . . . . 0.0 113.639 177.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.4 m -64.68 126.41 27.81 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.091 0.957 . . . . 0.0 112.017 -166.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -74.14 150.48 40.44 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 174.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.2 p -148.33 153.19 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.114 0.966 . . . . 0.0 111.683 -170.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -126.49 120.77 30.53 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.85 1.66 . . . . 0.0 108.79 -173.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -150.2 168.12 24.92 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -176.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -134.17 144.21 48.37 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.807 1.243 . . . . 0.0 111.041 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -160.92 136.56 8.01 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.175 0.99 . . . . 0.0 111.172 176.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.7 t70 54.53 47.62 22.31 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.1 1.36 . . . . 0.0 113.541 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.9 m 60.47 38.88 18.92 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 127.538 2.335 . . . . 0.0 114.127 176.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.4 p -154.12 140.18 12.57 Favored Pre-proline 0 CA--C 1.547 0.858 0 O-C-N 121.098 -1.001 . . . . 0.0 112.025 173.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -83.31 151.69 13.71 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 124.818 3.679 . . . . 0.0 113.625 175.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -133.91 145.5 49.66 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.472 2.309 . . . . 0.0 111.514 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 43.4 ttm -147.67 95.95 2.59 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.823 0.849 . . . . 0.0 111.503 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -148.64 -178.71 6.49 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.647 1.579 . . . . 0.0 111.952 -171.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.3 m -71.23 148.48 47.19 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 120.74 -1.225 . . . . 0.0 110.238 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.4 tp -57.17 -35.48 48.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 O-C-N 121.368 -0.832 . . . . 0.0 112.418 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -65.68 -29.76 70.36 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.577 1.08 . . . . 0.0 112.792 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -74.86 -42.83 57.15 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.316 1.046 . . . . 0.0 110.037 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -71.93 -40.2 68.92 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.56 -0.713 . . . . 0.0 111.666 176.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -54.27 -48.57 71.05 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.745 0.818 . . . . 0.0 110.939 175.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.0 t -66.59 -32.04 73.12 Favored 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -174.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.2 ttpt -65.53 -50.73 64.16 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.192 0.997 . . . . 0.0 110.131 177.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -70.38 -33.98 72.05 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.607 -0.683 . . . . 0.0 112.287 177.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.52 -22.46 63.58 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.226 -0.921 . . . . 0.0 113.198 173.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.7 m -92.88 -14.96 26.96 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.332 1.453 . . . . 0.0 113.475 176.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 72.6 mtm -97.06 -57.91 2.15 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.068 1.747 . . . . 0.0 112.005 174.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -94.27 -27.49 16.11 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.638 1.575 . . . . 0.0 111.985 -170.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.95 158.85 13.37 Favored Glycine 0 C--N 1.341 0.837 0 C-N-CA 125.248 1.404 . . . . 0.0 114.07 -177.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -104.91 150.49 24.83 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.683 1.193 . . . . 0.0 111.851 -170.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.2 mp -121.97 145.02 42.57 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 127.026 2.13 . . . . 0.0 111.569 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.32 156.35 37.19 Favored 'Trans proline' 0 C--O 1.24 0.616 0 C-N-CA 124.718 3.612 . . . . 0.0 112.848 -176.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -145.85 165.85 27.69 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -177.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -47.56 -53.81 13.48 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.5 1.92 . . . . 0.0 114.054 177.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -106.55 0.71 24.78 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 115.051 1.501 . . . . 0.0 115.051 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 177.78 -122.49 0.83 Allowed Glycine 0 CA--C 1.53 1.019 0 N-CA-C 115.966 1.146 . . . . 0.0 115.966 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -145.36 159.84 42.44 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.025 1.73 . . . . 0.0 111.28 -177.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.68 154.27 48.6 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.076 1.351 . . . . 0.0 111.998 -178.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 67.9 t -127.87 118.12 20.94 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 125.133 1.373 . . . . 0.0 110.44 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.49 138.55 42.5 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.986 3.124 . . . . 0.0 111.34 177.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 87.4 mt -111.49 157.84 19.84 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.673 1.189 . . . . 0.0 112.559 175.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -142.0 129.57 21.44 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.993 1.317 . . . . 0.0 111.023 169.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 59.97 33.03 21.38 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 126.692 1.997 . . . . 0.0 114.673 -177.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.1 t -100.19 137.74 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 O-C-N 120.359 -1.463 . . . . 0.0 111.309 176.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -132.99 154.53 50.42 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.328 1.851 . . . . 0.0 112.851 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.8 m -141.06 162.6 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 126.714 2.006 . . . . 0.0 110.84 174.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -89.36 145.86 25.07 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.328 -0.858 . . . . 0.0 111.847 172.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.5 t -148.47 152.16 36.44 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.259 1.824 . . . . 0.0 111.311 -167.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 48.3 tp -102.22 138.63 38.91 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.773 1.229 . . . . 0.0 109.963 173.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -87.92 130.69 34.85 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.794 0.837 . . . . 0.0 111.347 161.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 43.8 mm -77.21 -25.46 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 120.941 -1.099 . . . . 0.0 112.546 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.99 -42.68 31.94 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -169.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.4 m -112.99 -9.5 13.59 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.928 1.291 . . . . 0.0 112.861 174.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.05 28.71 66.01 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 123.659 0.647 . . . . 0.0 113.987 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -89.51 136.52 32.98 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.999 1.319 . . . . 0.0 110.685 -177.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 mp -88.54 126.85 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 174.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -147.92 169.74 19.19 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.612 1.165 . . . . 0.0 112.661 -173.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.5 ttmt -92.7 149.35 21.37 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.42 1.488 . . . . 0.0 110.438 174.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.1 t -146.21 158.93 43.91 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.199 1.0 . . . . 0.0 111.171 171.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.73 159.91 22.46 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 121.27 -0.894 . . . . 0.0 112.83 177.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.28 135.56 54.96 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.285 0.634 . . . . 0.0 111.38 168.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.8 t -88.78 -46.28 9.1 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.565 1.146 . . . . 0.0 112.676 -167.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -155.25 157.31 37.09 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.494 1.518 . . . . 0.0 111.398 174.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.4 mt -88.81 151.41 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.772 1.229 . . . . 0.0 108.53 167.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -140.27 149.82 43.31 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.857 1.263 . . . . 0.0 112.426 -175.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.9 ptp85 -132.39 155.73 47.94 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.696 1.198 . . . . 0.0 112.714 171.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -150.29 163.26 38.77 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.803 1.241 . . . . 0.0 110.338 167.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -96.94 145.21 26.12 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.351 1.06 . . . . 0.0 110.973 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.4 m -150.13 141.08 16.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 124.862 1.265 . . . . 0.0 110.297 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -83.1 -34.41 26.13 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.955 1.302 . . . . 0.0 110.921 171.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -131.93 132.35 43.48 Favored 'General case' 0 C--N 1.345 0.393 0 C-N-CA 123.942 0.897 . . . . 0.0 112.33 -169.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.5 tp -131.88 164.95 24.95 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.311 1.844 . . . . 0.0 109.678 -173.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.1 mt -112.16 123.83 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 119.587 1.085 . . . . 0.0 109.167 175.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -96.08 123.32 39.65 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.416 0.686 . . . . 0.0 111.489 166.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -108.77 123.18 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.083 1.353 . . . . 0.0 108.621 170.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.1 tttt -92.86 147.87 22.49 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.664 1.586 . . . . 0.0 109.952 173.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 87.8 mt -118.91 158.32 25.93 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.615 1.566 . . . . 0.0 112.337 -175.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.7 t -66.93 -10.41 48.69 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.694 1.198 . . . . 0.0 113.264 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 88.6 p -77.62 0.59 22.6 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 127.625 2.37 . . . . 0.0 114.899 165.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.58 -3.1 56.28 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 125.126 1.346 . . . . 0.0 114.522 -173.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -76.81 163.95 26.3 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.041 1.736 . . . . 0.0 111.957 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 60.4 p -142.2 144.67 33.5 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 165.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.8 tp -118.29 131.55 56.34 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.449 1.899 . . . . 0.0 110.02 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -111.23 114.93 28.49 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.385 1.474 . . . . 0.0 111.515 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.2 m -138.01 153.83 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 126.337 1.855 . . . . 0.0 112.215 -171.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.2 p -67.27 150.48 97.87 Favored Pre-proline 0 N--CA 1.471 0.618 0 O-C-N 120.906 -1.121 . . . . 0.0 112.354 171.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -60.21 -31.38 93.0 Favored 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 123.103 2.535 . . . . 0.0 114.32 -168.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.2 m -84.07 -0.96 53.9 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 49.5 t60 -73.85 117.11 58.43 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.927 1.291 . . . . 0.0 111.177 -175.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -68.35 132.06 24.81 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.04 2.494 . . . . 0.0 112.892 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.0 t -110.74 137.0 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 126.078 1.751 . . . . 0.0 109.422 174.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.13 112.39 19.77 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.7 mp -105.58 149.68 26.06 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.802 1.641 . . . . 0.0 112.212 -175.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -101.99 112.01 24.5 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.033 0.933 . . . . 0.0 112.454 172.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -143.49 80.43 1.67 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.645 1.178 . . . . 0.0 111.024 170.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 59.74 -15.16 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 128.203 2.601 . . . . 0.0 116.759 -164.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -162.67 168.06 37.39 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 126.026 1.775 . . . . 0.0 113.89 177.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.5 mt -72.01 116.11 12.03 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.104 1.762 . . . . 0.0 110.98 -176.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -144.87 139.79 27.92 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.65 0.78 . . . . 0.0 112.786 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -96.53 123.64 40.26 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.251 1.02 . . . . 0.0 112.052 -177.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 57.3 t -128.2 129.84 23.62 Favored Pre-proline 0 N--CA 1.48 1.044 0 C-N-CA 124.928 1.291 . . . . 0.0 109.738 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -64.68 148.37 90.24 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.856 2.371 . . . . 0.0 112.057 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.67 -32.14 18.35 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.28 -25.48 67.88 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 173.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -107.85 -1.34 20.89 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.777 1.631 . . . . 0.0 113.158 178.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 74.9 t -70.1 144.17 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 124.368 1.067 . . . . 0.0 109.655 166.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.86 156.95 77.01 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 127.098 2.159 . . . . 0.0 110.324 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -65.48 125.3 14.18 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.74 1.627 . . . . 0.0 110.776 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 103.22 0.42 47.57 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.649 1.119 . . . . 0.0 114.931 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -57.95 153.73 13.75 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.176 0.991 . . . . 0.0 111.309 167.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.4 t -97.64 122.2 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.062 0.945 . . . . 0.0 109.957 172.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.2 t -94.12 141.48 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 126.68 1.992 . . . . 0.0 110.016 173.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 59.4 t -92.62 131.59 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.959 0.904 . . . . 0.0 110.399 172.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -155.08 -150.86 5.67 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.028 1.299 . . . . 0.0 111.644 176.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.8 p -143.8 169.28 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.227 1.411 . . . . 0.0 111.118 177.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 . . . . . 0 N--CA 1.472 0.673 0 C-N-CA 127.332 2.253 . . . . 0.0 110.153 177.492 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 . . . . . 0 N--CA 1.472 0.645 0 CA-C-O 120.763 0.316 . . . . 0.0 111.796 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 97.0 mt -136.9 157.47 46.66 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.689 1.596 . . . . 0.0 112.062 -172.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -132.66 132.78 42.79 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.372 1.469 . . . . 0.0 112.007 174.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -87.49 143.61 27.13 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.593 1.157 . . . . 0.0 112.518 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -131.11 136.57 48.5 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.739 1.616 . . . . 0.0 110.115 -174.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -85.36 137.12 33.15 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.97 -1.081 . . . . 0.0 112.828 176.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 97.6 t -69.93 122.51 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.101 0.961 . . . . 0.0 111.372 163.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.4 t -81.77 -53.04 6.53 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.791 1.636 . . . . 0.0 112.329 176.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.5 m -154.92 156.3 35.84 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.346 1.058 . . . . 0.0 111.921 177.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.4 m -128.63 148.13 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.043 0.937 . . . . 0.0 111.33 176.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -157.93 156.13 30.76 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.849 0.86 . . . . 0.0 112.015 169.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 74.6 mt -80.58 145.43 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 160.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 44.8 pt -131.25 153.49 39.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 126.515 1.926 . . . . 0.0 110.076 177.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -88.29 108.02 19.11 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 122.581 1.182 . . . . 0.0 109.904 169.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -83.35 -50.48 8.31 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.363 1.865 . . . . 0.0 112.355 174.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 42.23 51.5 4.54 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.847 1.659 . . . . 0.0 111.76 -172.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -155.84 177.28 11.58 Favored 'General case' 0 CA--C 1.552 1.037 0 O-C-N 121.257 -0.902 . . . . 0.0 113.099 -175.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -77.65 134.95 38.06 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.182 1.393 . . . . 0.0 112.928 174.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 5.9 m -114.29 153.63 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.34 1.456 . . . . 0.0 109.664 175.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -119.81 159.62 24.21 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -171.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -155.04 157.59 37.81 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 113.614 -1.63 . . . . 0.0 110.289 -172.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 41.5 tp -134.82 119.07 17.69 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.92 0.888 . . . . 0.0 109.391 -175.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 51.9 t -86.93 118.03 32.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.154 0.502 . . . . 0.0 111.749 -165.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 29.7 mm -115.29 94.09 38.1 Favored Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 124.944 1.297 . . . . 0.0 109.194 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.4 -12.47 33.66 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.732 2.288 . . . . 0.0 113.339 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -79.45 -64.04 1.28 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 119.039 0.836 . . . . 0.0 112.586 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 76.0 p -114.48 -13.7 12.19 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.174 1.39 . . . . 0.0 114.459 -173.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 63.05 15.01 8.1 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -169.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -150.79 151.93 33.05 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 120.21 1.368 . . . . 0.0 113.257 -175.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -152.55 179.67 8.38 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.788 1.235 . . . . 0.0 112.241 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 85.1 mt -123.62 138.88 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.689 1.196 . . . . 0.0 111.473 -170.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -93.32 154.6 41.4 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.931 1.292 . . . . 0.0 112.302 173.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -66.76 -16.21 49.58 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.789 2.992 . . . . 0.0 114.054 -174.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -72.42 -3.55 24.86 Favored 'General case' 0 CA--C 1.556 1.179 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 170.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.9 -8.92 68.18 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.555 1.55 . . . . 0.0 114.919 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 66.9 mt -79.55 144.66 33.7 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.886 1.274 . . . . 0.0 111.99 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.2 p -89.86 139.07 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.135 0.974 . . . . 0.0 111.035 173.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 74.1 mt -118.19 152.21 36.11 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.855 2.062 . . . . 0.0 111.114 178.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -120.33 148.56 43.58 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.89 0.876 . . . . 0.0 112.93 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.545 0.773 0 C-N-CA 124.112 0.965 . . . . 0.0 113.47 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.93 0 N-CA-C 110.763 -0.088 . . . . 0.0 110.763 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.03 162.57 33.78 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.775 1.23 . . . . 0.0 112.615 -173.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -55.91 145.3 25.37 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.946 1.699 . . . . 0.0 113.317 176.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.0 ppt_? -63.75 -22.71 67.04 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 172.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -83.19 3.66 30.03 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.6 m -69.75 150.97 46.35 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.797 1.239 . . . . 0.0 112.883 170.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -101.52 155.35 18.13 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.16 1.784 . . . . 0.0 113.169 174.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 p -148.15 158.35 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.511 0.724 . . . . 0.0 112.484 -168.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -127.34 126.36 42.4 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.387 1.875 . . . . 0.0 108.698 -174.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -153.32 173.41 15.64 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -128.15 144.43 51.12 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.588 1.155 . . . . 0.0 111.378 168.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -165.19 154.01 12.19 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.62 1.568 . . . . 0.0 110.052 174.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.9 t70 48.98 44.38 22.5 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.83 1.252 . . . . 0.0 114.181 -175.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.9 m 58.06 37.32 26.51 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.544 1.538 . . . . 0.0 114.023 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.2 p -157.7 142.47 11.96 Favored Pre-proline 0 CA--C 1.551 0.992 0 O-C-N 120.562 -1.336 . . . . 0.0 112.964 176.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.24 152.31 39.53 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 124.567 3.511 . . . . 0.0 113.516 174.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -136.62 142.63 43.28 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.742 2.017 . . . . 0.0 111.371 -175.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 52.2 ttm -147.35 86.39 1.62 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.208 1.003 . . . . 0.0 110.979 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -137.46 -179.2 5.59 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.532 1.533 . . . . 0.0 112.491 -174.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.9 m -73.17 140.91 47.33 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 120.759 -1.213 . . . . 0.0 110.637 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.42 HG12 ' CD2' ' A' ' 152' ' ' TYR . 9.3 tp -58.0 -36.12 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 O-C-N 121.303 -0.873 . . . . 0.0 112.958 -178.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.01 -24.77 68.07 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.758 -0.589 . . . . 0.0 112.455 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -79.09 -49.25 12.93 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.028 0.931 . . . . 0.0 109.916 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 20.7 ptm -65.85 -33.0 74.84 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.606 -0.684 . . . . 0.0 112.114 175.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -54.88 -49.87 70.12 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.295 0.952 . . . . 0.0 111.207 172.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 39.9 t -61.29 -39.48 90.59 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.348 1.059 . . . . 0.0 111.486 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -65.32 -53.46 43.43 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.319 1.447 . . . . 0.0 110.932 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -72.84 -31.5 64.81 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.249 -0.907 . . . . 0.0 112.473 -177.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.43 -32.26 73.52 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.129 -0.982 . . . . 0.0 111.907 170.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 60.4 m -79.2 -26.03 42.63 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.664 0.786 . . . . 0.0 112.864 178.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 61.2 mtm -91.53 -46.61 7.87 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.24 1.416 . . . . 0.0 113.264 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -112.22 -13.91 13.43 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.034 1.334 . . . . 0.0 113.572 -169.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.9 163.75 35.94 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.849 1.214 . . . . 0.0 114.573 178.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -111.38 134.85 52.67 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.189 1.395 . . . . 0.0 110.014 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.5 mp -116.75 148.46 42.07 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 126.14 1.776 . . . . 0.0 111.617 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -70.65 143.44 46.55 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.38 2.72 . . . . 0.0 111.349 175.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -130.07 169.53 15.18 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.876 1.67 . . . . 0.0 111.149 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.91 -52.8 62.83 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 120.975 -1.078 . . . . 0.0 113.538 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -99.86 -8.86 23.56 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.98 -134.25 1.76 Allowed Glycine 0 CA--C 1.53 0.994 0 CA-C-N 119.137 0.88 . . . . 0.0 114.235 -172.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -135.27 151.3 50.45 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.14 1.776 . . . . 0.0 112.066 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.25 142.59 39.89 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.4 1.08 . . . . 0.0 112.784 -174.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.9 t -116.38 111.62 41.99 Favored Pre-proline 0 N--CA 1.474 0.74 0 C-N-CA 126.653 1.981 . . . . 0.0 109.638 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -65.17 139.69 61.72 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.867 3.044 . . . . 0.0 110.931 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.0 mt -110.06 165.13 11.98 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.601 1.16 . . . . 0.0 111.941 176.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -144.16 127.0 16.28 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.75 1.62 . . . . 0.0 110.123 169.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 50.5 46.81 25.01 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.387 1.075 . . . . 0.0 113.306 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.8 t -111.4 116.92 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.18 0.992 . . . . 0.0 108.797 173.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -113.63 151.8 31.24 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -167.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.6 m -135.82 154.13 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.494 1.518 . . . . 0.0 111.565 174.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -66.74 133.25 49.78 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 161.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.0 t -135.52 145.28 46.9 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.737 1.615 . . . . 0.0 110.54 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.4 tp -99.87 136.51 39.68 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.792 0.837 . . . . 0.0 110.351 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -85.46 91.43 8.22 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.755 1.222 . . . . 0.0 109.422 171.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.7 mm -58.97 -25.22 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 119.372 0.987 . . . . 0.0 112.282 -171.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.69 -45.92 87.86 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.63 1.172 . . . . 0.0 114.108 175.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 m -107.67 -22.75 12.38 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.632 1.173 . . . . 0.0 112.61 -173.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.44 25.16 66.26 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.642 1.592 . . . . 0.0 113.281 -169.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -90.49 141.39 28.8 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.177 1.391 . . . . 0.0 112.061 -175.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.2 mp -90.83 122.41 42.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 125.042 1.337 . . . . 0.0 110.681 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -146.91 179.23 7.74 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.773 1.629 . . . . 0.0 112.093 -177.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -110.89 152.27 26.91 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.886 1.674 . . . . 0.0 111.358 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.3 t -147.65 162.08 39.87 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.61 -0.681 . . . . 0.0 110.852 165.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -94.41 142.78 27.03 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.091 0.957 . . . . 0.0 112.335 173.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.41 143.8 26.77 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.555 0.742 . . . . 0.0 111.311 174.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 84.4 p -84.5 -48.34 9.69 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.437 1.095 . . . . 0.0 112.454 -172.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -151.86 159.95 43.69 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.306 1.842 . . . . 0.0 112.191 173.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.5 mt -86.73 146.98 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 160.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -132.9 148.11 52.29 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 125.246 1.418 . . . . 0.0 110.927 -175.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -146.13 150.23 35.51 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 165.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -146.99 165.97 28.23 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.183 1.793 . . . . 0.0 110.878 173.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.45 146.78 23.84 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.194 -0.941 . . . . 0.0 112.8 -177.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.1 m -147.53 151.36 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.366 1.066 . . . . 0.0 112.299 173.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -113.36 -5.37 13.56 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.988 2.115 . . . . 0.0 113.184 177.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -138.43 119.21 14.14 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.792 1.637 . . . . 0.0 109.992 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.6 tp -133.24 159.35 40.46 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.812 1.645 . . . . 0.0 109.601 -175.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 13.5 mt -110.48 127.72 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 119.245 0.93 . . . . 0.0 109.492 176.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -98.68 127.63 44.67 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.406 1.082 . . . . 0.0 111.048 167.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.8 mp -112.9 126.07 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.152 1.381 . . . . 0.0 109.77 172.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -91.68 143.41 26.58 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.662 1.585 . . . . 0.0 110.48 171.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 83.9 mt -113.32 156.45 23.36 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.091 1.357 . . . . 0.0 112.113 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.1 t -59.55 -26.4 65.34 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.251 1.42 . . . . 0.0 112.005 174.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 94.2 p -64.57 -16.72 63.11 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.207 1.403 . . . . 0.0 114.477 171.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.33 4.04 74.55 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 125.919 1.723 . . . . 0.0 114.505 -174.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -85.22 158.73 20.27 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.889 1.675 . . . . 0.0 110.729 172.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 84.5 p -137.66 142.64 41.13 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 165.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.8 tp -121.48 140.62 51.94 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.73 2.012 . . . . 0.0 110.09 -172.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -121.16 116.56 25.19 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.189 1.396 . . . . 0.0 112.165 -174.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.1 m -139.81 154.78 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.286 1.434 . . . . 0.0 112.899 -167.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.1 p -65.79 148.1 98.41 Favored Pre-proline 0 N--CA 1.471 0.598 0 O-C-N 120.912 -1.117 . . . . 0.0 111.572 173.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.08 -29.47 87.16 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.166 2.578 . . . . 0.0 113.535 -173.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 32.9 p -84.62 0.2 51.03 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.178 2.191 . . . . 0.0 114.875 177.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -73.95 116.47 52.49 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 119.89 1.223 . . . . 0.0 112.023 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -77.9 127.13 8.41 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.681 2.254 . . . . 0.0 112.468 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 38.4 t -107.0 142.08 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 126.095 1.758 . . . . 0.0 109.43 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 22.4 tp -80.68 113.29 18.78 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 122.588 0.355 . . . . 0.0 110.693 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.8 mp -109.38 147.54 32.59 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.655 1.582 . . . . 0.0 112.701 -172.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -96.18 95.21 7.98 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.55 1.54 . . . . 0.0 109.569 170.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -130.35 71.88 1.47 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.288 1.435 . . . . 0.0 109.662 174.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.9 t70 63.37 -15.88 0.07 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 128.712 2.805 . . . . 0.0 115.866 -163.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -168.51 159.34 32.46 Favored Glycine 0 CA--C 1.522 0.524 0 O-C-N 121.189 -0.945 . . . . 0.0 114.09 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 59.6 mt -61.21 112.72 2.24 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.786 1.634 . . . . 0.0 110.95 -175.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -145.85 145.33 30.71 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -93.15 119.62 32.55 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.571 1.148 . . . . 0.0 110.895 -178.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 57.7 t -127.61 130.08 23.72 Favored Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 124.073 0.949 . . . . 0.0 110.081 -178.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -65.37 147.88 87.72 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.872 2.382 . . . . 0.0 111.82 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.1 -31.89 20.63 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 174.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.52 -18.42 65.36 Favored 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 173.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -108.57 2.09 21.86 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.237 1.815 . . . . 0.0 112.477 173.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.5 t -78.26 143.32 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 120.875 -1.141 . . . . 0.0 109.993 168.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.65 151.54 78.23 Favored Pre-proline 0 N--CA 1.471 0.596 0 C-N-CA 127.505 2.322 . . . . 0.0 110.682 -177.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -65.22 116.19 3.73 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.418 2.079 . . . . 0.0 110.798 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.7 2.22 34.69 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 124.571 1.082 . . . . 0.0 115.543 -173.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -56.59 159.94 3.54 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.804 1.302 . . . . 0.0 111.912 162.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.6 t -116.78 125.4 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 123.936 0.894 . . . . 0.0 110.042 175.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.6 t -100.78 145.19 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 126.774 2.03 . . . . 0.0 110.279 -178.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 44.1 t -86.05 135.99 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.818 1.247 . . . . 0.0 109.926 175.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -166.68 -149.56 6.02 Favored Glycine 0 CA--C 1.529 0.915 0 O-C-N 121.952 -0.468 . . . . 0.0 113.837 178.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.3 p -151.07 162.43 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 125.403 1.481 . . . . 0.0 110.579 175.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 42.4 mtm105 . . . . . 0 N--CA 1.465 0.302 0 C-N-CA 124.696 1.198 . . . . 0.0 111.065 172.479 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 91.3 mt -140.46 163.49 32.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.219 1.807 . . . . 0.0 111.73 -177.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -146.35 161.8 39.55 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.443 1.897 . . . . 0.0 111.882 -176.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -107.12 149.17 27.94 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.924 0.89 . . . . 0.0 112.096 170.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -128.48 119.05 24.15 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.354 1.061 . . . . 0.0 108.497 173.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -85.22 144.19 28.29 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 120.94 -1.1 . . . . 0.0 111.786 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 97.1 t -76.36 142.87 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 125.418 1.487 . . . . 0.0 111.027 174.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 26.0 t -100.76 -50.03 3.98 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.438 1.895 . . . . 0.0 112.506 174.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 13.9 m -149.5 156.37 41.88 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.134 1.373 . . . . 0.0 111.035 -175.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.4 m -134.97 147.09 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.893 0.877 . . . . 0.0 111.97 169.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -154.99 156.87 36.76 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 176.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 90.9 mt -92.27 138.42 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.69 1.196 . . . . 0.0 108.499 168.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 16.0 pt -132.83 155.87 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 126.388 1.875 . . . . 0.0 111.587 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -96.07 94.54 7.61 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 122.122 0.963 . . . . 0.0 112.491 173.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -72.34 -43.47 64.03 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 8.0 m120 49.22 38.79 14.18 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.849 1.66 . . . . 0.0 113.583 -178.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -154.15 175.62 13.24 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.627 1.171 . . . . 0.0 111.109 -170.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -72.28 141.53 48.89 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.157 0.983 . . . . 0.0 113.218 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.8 m -122.53 153.96 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 126.465 1.906 . . . . 0.0 109.614 173.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.42 ' CD2' HG12 ' A' ' 21' ' ' ILE . 3.4 p90 -113.59 164.66 13.38 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -174.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -140.07 159.98 40.96 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.547 151.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.1 tt -127.06 98.86 5.47 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.182 0.993 . . . . 0.0 108.796 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 98.9 t -82.73 128.25 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -148.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 23.3 mm -116.59 100.61 53.54 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 124.767 1.227 . . . . 0.0 109.445 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -73.16 -13.33 25.87 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.356 2.037 . . . . 0.0 113.101 176.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 76.7 tt0 -74.0 -67.76 0.58 Allowed 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.815 1.188 . . . . 0.0 111.97 174.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 68.6 p -109.83 -7.97 14.95 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.928 1.291 . . . . 0.0 114.215 -169.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 56.42 21.23 5.36 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.929 1.291 . . . . 0.0 114.468 -169.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.37 145.56 26.18 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 -178.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -138.66 166.84 23.33 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.04 1.336 . . . . 0.0 112.416 176.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.8 mp -110.21 135.45 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.731 1.212 . . . . 0.0 111.634 177.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -86.5 156.62 56.32 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.091 0.956 . . . . 0.0 112.568 171.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -67.3 -11.99 34.22 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.826 3.017 . . . . 0.0 113.875 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -70.27 -17.82 63.11 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 121.767 -0.583 . . . . 0.0 112.443 168.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 115.23 -24.69 10.42 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 126.46 1.981 . . . . 0.0 115.069 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 50.0 mt -68.73 151.82 46.16 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.807 1.643 . . . . 0.0 113.63 -170.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 4.1 t -104.02 122.82 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 124.977 1.311 . . . . 0.0 111.96 176.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.8 144.27 43.77 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.355 1.862 . . . . 0.0 112.868 -170.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 62.7 t60 -96.61 150.48 20.61 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.136 0.975 . . . . 0.0 113.183 169.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 16.9 m120 . . . . . 0 CA--C 1.546 0.795 0 N-CA-C 115.533 1.679 . . . . 0.0 115.533 177.628 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.7 166.51 22.77 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.446 1.898 . . . . 0.0 111.772 -174.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.45 146.88 54.06 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.244 1.418 . . . . 0.0 114.608 -176.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -67.85 -21.22 65.19 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.748 1.219 . . . . 0.0 113.96 175.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -84.76 -3.66 58.7 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 174.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.2 m -65.16 141.65 58.61 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 119.363 0.983 . . . . 0.0 113.233 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -79.35 147.89 32.25 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.581 1.152 . . . . 0.0 112.917 170.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 p -146.39 156.77 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.498 1.119 . . . . 0.0 112.328 -172.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -126.28 135.19 51.24 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.844 2.058 . . . . 0.0 108.088 177.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -153.59 176.09 12.47 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.493 0.717 . . . . 0.0 112.249 169.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -131.85 140.98 49.29 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.148 1.379 . . . . 0.0 110.819 174.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -162.12 166.19 26.06 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.713 2.005 . . . . 0.0 108.328 174.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.4 t70 58.99 24.73 12.98 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 120.176 1.353 . . . . 0.0 113.2 170.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 63.55 29.81 15.22 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.158 1.783 . . . . 0.0 114.8 -171.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.8 p -152.78 141.75 14.31 Favored Pre-proline 0 CA--C 1.548 0.884 0 O-C-N 119.678 -1.889 . . . . 0.0 113.473 -176.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.33 152.96 50.38 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.713 2.942 . . . . 0.0 112.595 173.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -135.75 142.59 44.99 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.033 2.133 . . . . 0.0 109.96 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 35.9 ttm -153.24 106.21 2.96 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.035 0.534 . . . . 0.0 111.555 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -157.14 -179.54 8.3 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.444 1.898 . . . . 0.0 111.682 -172.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.7 m -67.73 138.49 56.29 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.219 -0.926 . . . . 0.0 110.013 170.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.6 tp -55.9 -37.33 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -176.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -69.53 -16.67 63.48 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.84 1.2 . . . . 0.0 112.755 -178.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -80.44 -46.55 15.75 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.416 1.086 . . . . 0.0 109.836 177.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -67.92 -34.62 76.96 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 122.015 -0.428 . . . . 0.0 112.079 173.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -58.59 -49.97 75.52 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.497 0.719 . . . . 0.0 110.835 172.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.5 t -68.99 -30.3 68.68 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.263 0.625 . . . . 0.0 111.513 -176.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -64.67 -54.04 37.89 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.43 1.492 . . . . 0.0 110.514 172.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -69.4 -33.85 73.63 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.203 -0.936 . . . . 0.0 112.347 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.33 -19.1 64.64 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 121.104 -0.997 . . . . 0.0 113.309 174.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.0 m -96.04 -7.64 35.69 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.874 1.669 . . . . 0.0 113.855 174.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 59.2 mtm -113.08 -49.51 2.92 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.756 1.623 . . . . 0.0 112.895 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -102.33 -19.59 14.94 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.175 1.79 . . . . 0.0 112.021 -174.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.96 166.59 42.33 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.589 1.09 . . . . 0.0 114.103 174.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -112.89 130.19 56.2 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.731 1.212 . . . . 0.0 110.465 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.2 mp -119.38 148.87 46.44 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 126.431 1.893 . . . . 0.0 110.808 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -72.06 162.31 42.18 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.452 2.768 . . . . 0.0 113.977 -173.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -145.45 170.07 17.1 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.047 1.739 . . . . 0.0 110.847 175.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -60.03 -58.23 9.42 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.546 1.138 . . . . 0.0 113.151 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -90.56 -3.87 57.28 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 176.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.93 -128.31 1.15 Allowed Glycine 0 CA--C 1.534 1.239 0 CA-C-N 120.322 1.419 . . . . 0.0 116.504 -177.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -139.56 161.07 38.39 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.092 1.757 . . . . 0.0 111.668 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.6 159.74 41.54 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.571 1.148 . . . . 0.0 112.691 177.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 81.6 t -127.17 113.47 21.63 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 125.782 1.633 . . . . 0.0 109.855 176.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -65.71 142.42 70.18 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 124.25 3.3 . . . . 0.0 111.263 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.2 mt -116.12 151.97 34.58 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 122.608 1.194 . . . . 0.0 112.853 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -133.84 129.74 36.9 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.824 1.249 . . . . 0.0 110.581 170.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 57.84 33.68 23.49 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.209 1.404 . . . . 0.0 114.157 176.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.3 t -101.68 133.7 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.492 1.517 . . . . 0.0 110.031 174.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -132.39 154.18 50.06 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.927 1.691 . . . . 0.0 112.912 -174.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.3 m -146.68 158.6 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 127.725 2.41 . . . . 0.0 110.542 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -79.32 149.06 31.87 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.013 -1.054 . . . . 0.0 112.232 170.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.0 t -148.24 157.17 43.34 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.904 1.682 . . . . 0.0 111.81 -169.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 38.6 tp -112.35 134.22 54.01 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.05 1.34 . . . . 0.0 110.226 176.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -83.46 104.12 13.36 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 163.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 mm -63.32 -29.94 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-N 120.935 1.698 . . . . 0.0 111.546 -177.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.77 -45.31 90.36 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.071 1.348 . . . . 0.0 113.241 -177.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.8 m -101.84 -20.24 14.98 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.918 0.887 . . . . 0.0 112.465 177.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.25 37.72 81.16 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.981 1.277 . . . . 0.0 112.42 -170.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -103.01 136.33 43.02 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.393 1.877 . . . . 0.0 110.644 -177.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 mp -93.7 127.69 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.7 pttt -144.86 169.65 17.64 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.987 1.315 . . . . 0.0 112.072 -177.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -103.5 143.46 32.69 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.959 0.904 . . . . 0.0 110.887 175.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.6 t -142.44 162.08 36.38 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.017 1.327 . . . . 0.0 112.62 -175.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -81.74 151.73 27.34 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 173.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -107.69 138.66 43.51 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.778 0.831 . . . . 0.0 110.942 164.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.9 t -91.86 -46.83 7.65 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.978 1.311 . . . . 0.0 113.255 -169.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -150.73 158.49 44.21 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.868 1.267 . . . . 0.0 111.559 172.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.1 mt -87.25 153.22 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 162.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -139.05 149.65 44.87 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.304 1.441 . . . . 0.0 111.715 -175.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 21.6 ptt-85 -139.12 150.5 45.74 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.769 1.228 . . . . 0.0 113.547 169.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -144.53 159.56 42.57 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.152 1.781 . . . . 0.0 109.445 172.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -102.91 136.43 42.74 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.133 0.879 . . . . 0.0 110.788 -176.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.9 m -144.87 145.48 20.97 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-O 122.324 1.059 . . . . 0.0 111.962 -176.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -97.48 -28.64 13.89 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 125.987 1.715 . . . . 0.0 111.867 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -120.28 128.69 53.54 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.544 1.138 . . . . 0.0 110.385 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.8 tp -131.89 160.69 34.97 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.342 1.457 . . . . 0.0 109.781 178.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.0 mt -113.4 126.21 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 119.858 1.208 . . . . 0.0 109.123 175.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -97.15 120.6 37.81 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.465 1.106 . . . . 0.0 111.119 169.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -109.55 122.22 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.496 1.518 . . . . 0.0 109.266 173.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -90.68 146.09 24.3 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.254 1.822 . . . . 0.0 110.601 175.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.6 mt -115.92 158.63 22.72 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.497 1.519 . . . . 0.0 111.74 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.5 t -61.71 -20.0 63.02 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.396 1.079 . . . . 0.0 113.561 -176.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 78.1 p -85.3 4.76 33.51 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.27 1.828 . . . . 0.0 115.619 172.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.78 10.04 86.49 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 124.306 0.955 . . . . 0.0 114.652 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -76.52 152.82 35.91 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.996 1.319 . . . . 0.0 109.829 166.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 80.5 p -135.68 135.62 40.26 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 165.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.9 tp -109.42 137.22 47.6 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.906 1.682 . . . . 0.0 109.755 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt -119.64 117.83 29.33 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.86 1.264 . . . . 0.0 111.105 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.5 m -139.15 153.49 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.994 1.318 . . . . 0.0 112.479 -168.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.8 p -64.87 145.66 98.9 Favored Pre-proline 0 N--CA 1.468 0.462 0 O-C-N 121.098 -1.001 . . . . 0.0 111.003 170.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -59.09 -24.81 75.4 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.381 2.721 . . . . 0.0 113.322 -173.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 61.7 p -76.3 -12.77 60.13 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 128.033 2.533 . . . . 0.0 115.539 175.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -70.96 116.68 48.92 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 124.344 1.058 . . . . 0.0 111.886 -174.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -78.52 120.81 4.93 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 123.253 2.636 . . . . 0.0 111.966 177.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.2 t -92.89 142.95 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 126.689 1.996 . . . . 0.0 110.124 178.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.74 101.08 6.5 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.534 0.683 . . . . 0.0 109.395 173.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.6 tp -98.76 152.77 19.32 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.015 1.726 . . . . 0.0 111.735 -173.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -111.85 113.2 25.4 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.056 0.542 . . . . 0.0 111.932 167.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -130.67 77.47 1.79 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.876 0.871 . . . . 0.0 109.274 165.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.2 t70 62.99 -7.92 0.14 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 128.634 2.774 . . . . 0.0 116.335 -166.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -165.32 163.36 36.5 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 125.628 1.585 . . . . 0.0 112.722 -177.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 78.2 mt -70.28 119.35 14.33 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.627 1.571 . . . . 0.0 110.594 -174.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -149.63 149.86 31.3 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -103.16 121.82 43.44 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.427 1.091 . . . . 0.0 111.028 -177.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 54.4 t -136.59 129.47 17.53 Favored Pre-proline 0 N--CA 1.481 1.104 0 C-N-CA 124.185 0.994 . . . . 0.0 110.87 -174.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -66.31 146.71 81.68 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.081 2.521 . . . . 0.0 112.811 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.11 -32.05 21.37 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 175.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.29 -19.43 65.41 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 173.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -107.8 -3.88 18.61 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.29 1.836 . . . . 0.0 112.824 177.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 92.6 t -73.47 146.23 10.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 C-N-CA 124.987 1.315 . . . . 0.0 110.479 168.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.78 159.26 72.03 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 127.762 2.425 . . . . 0.0 109.387 177.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -65.64 127.78 18.7 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 121.637 1.558 . . . . 0.0 110.724 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 99.14 7.81 54.41 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.238 0.923 . . . . 0.0 114.756 -178.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -67.15 165.65 15.55 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 118.301 1.05 . . . . 0.0 112.21 162.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.56 132.37 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 124.242 1.017 . . . . 0.0 111.211 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.0 t -107.26 134.1 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 126.367 1.867 . . . . 0.0 110.521 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 49.5 t -91.26 143.02 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.905 0.882 . . . . 0.0 111.355 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -169.1 -149.38 6.2 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.424 1.488 . . . . 0.0 111.846 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.6 p -136.88 162.99 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 125.388 1.475 . . . . 0.0 111.096 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 . . . . . 0 N--CA 1.469 0.478 0 C-N-CA 126.705 2.002 . . . . 0.0 110.427 179.356 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 . . . . . 0 N--CA 1.471 0.606 0 CA-C-O 119.107 -0.473 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.1 mt -146.83 153.36 40.08 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.221 1.009 . . . . 0.0 113.508 -177.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -135.8 151.47 50.11 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.156 1.782 . . . . 0.0 113.11 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -124.16 130.57 52.77 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.989 1.715 . . . . 0.0 110.701 -175.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -129.43 126.48 38.85 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.075 0.95 . . . . 0.0 110.411 -164.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -84.71 134.03 34.36 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.322 0.965 . . . . 0.0 112.152 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 75.0 t -67.41 129.41 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 124.142 0.977 . . . . 0.0 110.259 170.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.0 t -88.48 -42.94 11.8 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.412 1.485 . . . . 0.0 113.059 176.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.8 t -159.84 161.17 34.43 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.834 0.854 . . . . 0.0 111.426 -177.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 10.7 m -136.92 154.99 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.639 1.175 . . . . 0.0 112.555 170.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -162.36 162.11 27.73 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.428 1.091 . . . . 0.0 112.809 156.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 64.9 mt -76.05 141.34 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.953 0.901 . . . . 0.0 108.827 163.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 35.8 pt -130.67 156.67 42.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 126.988 2.115 . . . . 0.0 111.16 176.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -100.15 85.84 3.1 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 122.354 1.073 . . . . 0.0 111.382 -175.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -72.12 -46.45 56.57 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 121.308 -0.87 . . . . 0.0 112.862 -173.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 48.21 37.54 8.45 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.468 1.507 . . . . 0.0 113.097 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -145.47 174.52 11.08 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.503 1.121 . . . . 0.0 111.165 -170.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -74.64 132.81 42.03 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 123.553 0.741 . . . . 0.0 111.826 173.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 5.7 m -102.24 170.78 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.945 1.298 . . . . 0.0 109.474 169.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -123.0 161.47 24.2 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.973 0.909 . . . . 0.0 112.6 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -144.48 154.99 43.5 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.628 0.771 . . . . 0.0 110.184 158.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 40.8 tp -116.27 122.69 45.69 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.013 1.325 . . . . 0.0 110.232 175.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 99.7 t -91.83 121.25 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -165.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 25.1 mm -118.08 88.58 32.33 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 125.747 1.619 . . . . 0.0 110.227 -176.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -68.29 -13.69 38.43 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.47 2.113 . . . . 0.0 113.547 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -76.53 -46.39 26.73 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.326 0.966 . . . . 0.0 112.637 -177.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 81.3 p -138.78 -4.02 1.61 Allowed 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 126.077 1.751 . . . . 0.0 114.782 -169.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 31.0 m170 60.39 18.45 8.13 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 -177.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.15 148.51 25.02 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 120.095 -1.628 . . . . 0.0 113.582 177.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -132.66 170.9 14.56 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.939 1.696 . . . . 0.0 112.365 176.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 81.1 mt -121.54 132.99 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.471 1.108 . . . . 0.0 110.925 -175.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -80.36 161.74 63.76 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 125.102 1.361 . . . . 0.0 113.439 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.44 -18.35 62.71 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 122.869 2.379 . . . . 0.0 112.158 174.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.74 10.85 10.27 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.116 0.966 . . . . 0.0 113.181 172.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.21 -14.43 27.94 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.6 1.571 . . . . 0.0 116.559 176.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 78.6 mt -69.65 144.94 52.77 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 118.947 1.373 . . . . 0.0 112.833 -177.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 19.7 t -85.23 132.21 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.732 0.813 . . . . 0.0 110.629 171.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 77.1 mt -118.15 138.22 52.43 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.957 2.103 . . . . 0.0 110.061 177.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 42.3 t60 -137.76 141.85 40.93 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -168.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 . . . . . 0 CA--C 1.548 0.884 0 C-N-CA 124.977 1.311 . . . . 0.0 111.078 158.232 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.835 0 CA-C-O 119.474 -0.298 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.0 162.18 25.86 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.358 1.463 . . . . 0.0 112.238 -178.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.72 148.94 41.18 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.901 1.28 . . . . 0.0 113.697 177.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -12.54 31.98 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.047 1.339 . . . . 0.0 113.724 171.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.79 -24.19 64.38 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.187 2.195 . . . . 0.0 111.411 175.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.4 m -66.64 139.28 57.86 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.429 1.092 . . . . 0.0 113.62 -170.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -88.34 152.26 22.05 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.929 1.291 . . . . 0.0 113.427 171.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 p -148.17 153.3 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.122 0.969 . . . . 0.0 112.543 -169.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -132.88 127.22 33.92 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.175 1.79 . . . . 0.0 107.767 -173.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -153.0 177.7 10.49 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.111 0.964 . . . . 0.0 111.562 -175.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -134.48 141.79 46.87 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.036 -1.04 . . . . 0.0 111.275 173.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -154.51 162.38 41.17 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.774 1.63 . . . . 0.0 108.72 171.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.9 t70 51.28 29.74 5.28 Favored 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -174.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.1 m 57.34 39.74 28.14 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.703 1.601 . . . . 0.0 113.675 -171.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.0 p -153.58 141.13 13.53 Favored Pre-proline 0 CA--C 1.545 0.785 0 O-C-N 120.395 -1.441 . . . . 0.0 112.452 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.18 143.87 45.15 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.526 2.817 . . . . 0.0 113.871 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.5 m80 -128.45 141.67 51.33 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 128.294 2.637 . . . . 0.0 109.194 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 52.6 ttm -149.55 106.31 3.55 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.054 -1.029 . . . . 0.0 111.48 -174.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -153.95 179.39 8.95 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.115 0.966 . . . . 0.0 112.514 -171.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.9 m -74.86 141.08 44.25 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.028 -1.045 . . . . 0.0 109.479 168.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.425 HG12 ' CG ' ' A' ' 152' ' ' TYR . 8.4 tp -53.63 -36.28 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -176.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -63.44 -27.27 69.18 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.198 0.908 . . . . 0.0 112.564 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -74.85 -44.09 50.97 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.506 -0.746 . . . . 0.0 110.426 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 20.2 ptm -69.32 -37.44 77.74 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 119.371 -0.347 . . . . 0.0 111.3 172.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -59.78 -52.16 66.64 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.093 0.86 . . . . 0.0 110.874 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.7 t -65.51 -28.47 69.21 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.851 1.261 . . . . 0.0 111.773 -175.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -72.04 -56.78 5.03 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 127.373 2.269 . . . . 0.0 111.378 171.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -71.72 -33.77 69.02 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 120.919 -1.113 . . . . 0.0 112.791 -175.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.33 -23.07 65.59 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 121.288 -0.883 . . . . 0.0 112.663 172.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.2 t -89.67 -23.88 21.76 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.156 0.982 . . . . 0.0 113.316 174.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 70.5 mtm -86.44 -52.09 5.8 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.0 0.92 . . . . 0.0 112.013 176.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -106.65 -18.44 13.95 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.344 1.458 . . . . 0.0 112.724 -168.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.95 161.75 35.57 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.303 0.954 . . . . 0.0 114.05 176.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -109.42 126.89 53.94 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.954 0.902 . . . . 0.0 111.104 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.5 mp -98.6 144.94 29.04 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 125.32 1.448 . . . . 0.0 110.589 176.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -72.91 146.19 41.63 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 123.838 3.026 . . . . 0.0 112.199 -177.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.41 154.37 49.98 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.114 1.366 . . . . 0.0 111.941 178.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -52.55 -46.67 66.89 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.649 1.18 . . . . 0.0 113.745 -177.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -88.81 -9.98 49.77 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 172.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 173.81 -123.3 0.96 Allowed Glycine 0 CA--C 1.532 1.099 0 N-CA-C 116.958 1.543 . . . . 0.0 116.958 -168.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -142.7 159.25 42.59 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.007 1.723 . . . . 0.0 111.953 -177.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.25 150.66 46.91 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.522 1.529 . . . . 0.0 111.997 176.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.9 t -125.79 118.27 24.24 Favored Pre-proline 0 N--CA 1.486 1.34 0 C-N-CA 125.302 1.441 . . . . 0.0 111.29 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.62 140.89 40.41 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 124.186 3.257 . . . . 0.0 112.157 -178.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 73.3 mt -111.1 165.79 11.6 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.084 1.354 . . . . 0.0 112.568 176.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -145.59 124.09 12.43 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.881 1.272 . . . . 0.0 111.534 169.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 51.18 44.66 28.63 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.421 1.889 . . . . 0.0 113.856 -177.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.7 t -106.81 130.75 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.857 1.663 . . . . 0.0 109.884 173.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -130.15 159.19 37.57 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.948 1.299 . . . . 0.0 113.014 -169.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.5 m -144.78 150.63 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.951 1.7 . . . . 0.0 112.13 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -65.31 132.57 49.37 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.962 1.305 . . . . 0.0 108.027 164.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.461 HG21 ' HB ' ' A' ' 63' ' ' THR . 6.4 t -141.37 154.9 45.9 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.335 1.054 . . . . 0.0 112.005 -169.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 56.8 tp -115.64 133.41 56.06 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.957 1.303 . . . . 0.0 110.785 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.462 ' HB2' ' HE3' ' A' ' 61' ' ' LYS . 8.2 t0 -79.51 117.02 20.08 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.223 0.609 . . . . 0.0 111.255 163.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.4 mm -70.15 -16.64 20.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 O-C-N 121.056 -1.028 . . . . 0.0 113.261 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.48 -46.87 24.92 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.545 -1.347 . . . . 0.0 113.92 -177.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.0 m -121.36 -8.73 9.14 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 179.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.4 29.06 54.27 Favored Glycine 0 CA--C 1.535 1.291 0 O-C-N 121.388 -0.82 . . . . 0.0 114.016 -176.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -77.83 131.59 37.63 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.142 0.971 . . . . 0.0 110.933 175.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 mp -81.74 139.57 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 170.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.462 ' HE3' ' HB2' ' A' ' 54' ' ' ASP . 5.9 mttt -141.12 173.13 11.78 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.567 1.547 . . . . 0.0 110.485 174.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -111.53 128.53 56.05 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.476 0.71 . . . . 0.0 110.433 162.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.461 ' HB ' HG21 ' A' ' 52' ' ' THR . 2.9 t -131.41 164.54 25.48 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.202 1.001 . . . . 0.0 112.601 -174.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.8 ppt_? -86.09 139.59 30.99 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.231 1.013 . . . . 0.0 112.772 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -93.8 144.01 25.81 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.063 0.945 . . . . 0.0 109.587 166.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.7 t -101.01 -45.88 5.27 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -172.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -153.78 155.55 36.06 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.767 1.227 . . . . 0.0 112.551 175.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.9 mt -87.23 159.88 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.855 1.262 . . . . 0.0 108.85 167.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -142.54 151.03 41.19 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.178 1.791 . . . . 0.0 111.106 -176.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 42.9 ptt85 -145.5 159.41 43.14 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 167.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -152.09 159.42 43.67 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.333 1.853 . . . . 0.0 110.663 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -97.28 140.95 30.98 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.632 1.173 . . . . 0.0 112.526 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.1 m -148.12 141.62 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.073 0.949 . . . . 0.0 113.25 -176.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -99.66 -24.34 14.75 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.269 1.428 . . . . 0.0 113.226 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -127.86 126.83 42.33 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.451 1.101 . . . . 0.0 110.994 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.7 tp -136.84 167.11 22.08 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.947 2.099 . . . . 0.0 109.29 -173.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 20.2 mt -119.82 126.95 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.75 1.22 . . . . 0.0 108.816 176.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -99.31 116.63 31.93 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.917 0.887 . . . . 0.0 111.073 170.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.0 mp -101.4 122.33 53.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 125.175 1.39 . . . . 0.0 108.416 172.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -90.37 148.91 22.52 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.782 1.233 . . . . 0.0 110.791 174.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 65.2 mt -116.38 157.78 24.52 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.436 1.494 . . . . 0.0 111.831 178.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.1 t -64.65 -27.17 68.75 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.665 -0.647 . . . . 0.0 112.469 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 84.3 p -59.82 -22.43 62.22 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.374 1.469 . . . . 0.0 114.354 172.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 86.27 19.0 58.09 Favored Glycine 0 CA--C 1.537 1.452 0 O-C-N 121.284 -0.885 . . . . 0.0 113.806 -167.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -93.67 158.32 15.74 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.082 0.941 . . . . 0.0 111.062 161.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 83.8 p -138.21 137.53 37.66 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.52 1.528 . . . . 0.0 110.785 177.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.6 tp -115.97 130.65 56.91 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.93 1.292 . . . . 0.0 109.79 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -111.53 113.53 26.01 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.484 1.514 . . . . 0.0 109.929 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.8 m -137.41 153.82 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.16 1.384 . . . . 0.0 113.504 -169.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.6 p -66.71 143.25 98.0 Favored Pre-proline 0 N--CA 1.472 0.644 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 176.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -62.43 -22.26 73.83 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.713 2.942 . . . . 0.0 113.454 -178.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.6 p -88.55 -1.67 58.18 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.324 1.85 . . . . 0.0 114.215 176.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -87.74 124.28 67.69 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 119.158 0.89 . . . . 0.0 112.583 -175.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -70.97 129.75 16.79 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.607 2.872 . . . . 0.0 111.215 176.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.1 t -108.03 140.35 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 125.679 1.591 . . . . 0.0 110.337 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 51.9 tp -81.51 104.67 12.1 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.493 0.717 . . . . 0.0 110.812 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.1 mp -104.5 158.38 16.52 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.431 1.893 . . . . 0.0 112.119 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -106.14 127.02 52.91 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 169.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 72.4 mtp85 -138.23 74.87 1.49 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.981 0.912 . . . . 0.0 111.009 162.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 50.97 21.14 0.92 Allowed 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 125.44 1.496 . . . . 0.0 113.173 -164.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 179.27 149.02 8.06 Favored Glycine 0 CA--C 1.521 0.455 0 O-C-N 120.536 -1.352 . . . . 0.0 111.447 -170.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 60.6 mt -75.01 120.89 21.15 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.34 1.456 . . . . 0.0 109.523 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -150.34 151.68 33.27 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -177.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -105.76 121.12 43.37 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.458 1.103 . . . . 0.0 112.106 -172.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 78.5 t -139.07 132.56 15.92 Favored Pre-proline 0 N--CA 1.484 1.257 0 C-N-CA 124.916 1.286 . . . . 0.0 110.563 -178.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -66.82 145.29 74.38 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.827 2.352 . . . . 0.0 113.333 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.01 -34.03 19.89 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 175.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.84 -23.99 67.56 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 174.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -98.02 -15.49 20.03 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.552 1.141 . . . . 0.0 112.94 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.7 t -63.02 149.95 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.565 1.546 . . . . 0.0 111.416 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.8 154.3 81.02 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 126.094 1.757 . . . . 0.0 111.389 178.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -65.98 130.3 24.09 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.311 2.007 . . . . 0.0 111.513 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.62 4.09 54.88 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.775 1.179 . . . . 0.0 114.073 -176.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -65.06 168.76 6.15 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.668 1.187 . . . . 0.0 112.291 165.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.3 t -115.54 124.23 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.949 1.3 . . . . 0.0 111.069 -173.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.0 t -95.71 143.38 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.74 1.616 . . . . 0.0 110.31 175.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.5 t -89.56 133.71 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.706 0.803 . . . . 0.0 110.507 177.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -158.28 -158.52 9.05 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.139 0.876 . . . . 0.0 113.053 178.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.732 HG22 ' H ' ' A' ' 120' ' ' ARG . 4.1 p -141.38 -179.71 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 126.589 1.955 . . . . 0.0 111.746 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.732 ' H ' HG22 ' A' ' 119' ' ' VAL . 64.8 mtt-85 . . . . . 0 N--CA 1.468 0.449 0 C-N-CA 126.489 1.916 . . . . 0.0 111.459 -175.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 92.5 mt -138.41 159.74 41.3 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.71 2.004 . . . . 0.0 111.353 168.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -150.73 127.05 10.65 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.473 2.309 . . . . 0.0 110.452 174.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -84.67 146.37 27.49 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.401 1.08 . . . . 0.0 112.227 -177.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 52.0 m80 -129.63 137.89 50.92 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.297 1.039 . . . . 0.0 111.479 -174.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -89.48 136.61 32.93 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.293 1.037 . . . . 0.0 113.529 -174.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 77.5 t -74.27 120.0 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.407 1.083 . . . . 0.0 111.379 171.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.8 t -87.68 -29.62 21.0 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.034 1.733 . . . . 0.0 114.105 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.1 m -164.93 164.54 20.73 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.693 1.197 . . . . 0.0 111.291 172.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.9 m -132.79 145.69 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.235 1.014 . . . . 0.0 111.221 165.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -151.21 154.56 37.08 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.78 1.232 . . . . 0.0 112.281 170.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 97.0 mt -76.59 141.89 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 160.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 24.7 pt -131.05 159.37 43.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 125.288 1.435 . . . . 0.0 110.898 169.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -98.54 101.49 12.94 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.731 0.776 . . . . 0.0 111.942 169.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -80.21 -47.71 14.23 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.609 -0.682 . . . . 0.0 112.281 -177.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 55.66 32.51 19.43 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.346 1.058 . . . . 0.0 113.095 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -144.65 178.2 8.15 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.0 1.32 . . . . 0.0 111.814 -170.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -80.51 139.94 36.12 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.115 1.366 . . . . 0.0 112.753 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.8 m -125.88 154.7 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 125.841 1.656 . . . . 0.0 110.063 177.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.425 ' CG ' HG12 ' A' ' 21' ' ' ILE . 1.6 p90 -115.67 162.92 16.56 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -171.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -140.87 150.78 43.67 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 125.8 1.64 . . . . 0.0 108.633 160.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 56.5 tp -119.19 115.26 23.85 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.326 -1.484 . . . . 0.0 109.677 175.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 35.0 t -86.0 120.47 35.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -163.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 13.1 mm -119.6 84.64 30.71 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 125.384 1.474 . . . . 0.0 109.424 -177.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -65.77 -8.14 18.68 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.777 2.984 . . . . 0.0 114.371 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -84.56 -42.15 15.74 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.03 1.332 . . . . 0.0 113.212 177.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 68.9 p -142.26 -11.93 0.83 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -170.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . 0.25 92.0 m-70 57.36 24.13 9.72 Favored 'General case' 0 CA--C 1.553 1.079 0 N-CA-C 116.782 2.141 . . . . 0.0 116.782 -176.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -157.36 150.53 23.64 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 119.929 -1.732 . . . . 0.0 114.169 175.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -148.18 142.69 26.44 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.526 1.53 . . . . 0.0 112.43 -174.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.8 mp -92.7 137.04 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 O-C-N 120.477 -1.389 . . . . 0.0 112.162 -175.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -91.97 159.42 37.91 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 126.698 1.999 . . . . 0.0 113.386 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.25 -13.76 33.81 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.95 3.1 . . . . 0.0 113.885 -177.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -72.85 -7.69 52.0 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.28 0.632 . . . . 0.0 112.049 168.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 98.54 -20.17 51.49 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 126.749 2.119 . . . . 0.0 113.902 -177.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 74.7 mt -69.72 144.57 52.75 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.043 1.422 . . . . 0.0 112.844 -174.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 56.8 t -74.49 125.73 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 165.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 47.0 mt -106.53 166.27 10.67 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.081 1.752 . . . . 0.0 110.487 167.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -132.31 155.04 49.07 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.153 0.981 . . . . 0.0 112.446 -157.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 . . . . . 0 CA--C 1.541 0.634 0 C-N-CA 124.268 1.027 . . . . 0.0 111.499 172.191 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.948 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -140.02 156.58 46.55 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.044 1.737 . . . . 0.0 111.239 -171.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.88 146.33 55.06 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 120.491 -1.381 . . . . 0.0 114.21 -177.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.87 -14.49 15.55 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.226 1.411 . . . . 0.0 114.605 165.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -69.87 -14.9 62.96 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.167 0.987 . . . . 0.0 112.24 170.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.8 m -80.5 143.55 33.23 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -170.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -80.17 152.69 29.06 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.604 1.562 . . . . 0.0 112.741 168.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.6 p -146.99 158.35 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.505 1.122 . . . . 0.0 112.534 -172.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -124.92 137.59 54.27 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.621 1.968 . . . . 0.0 108.749 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -156.27 177.13 11.79 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 118.863 0.756 . . . . 0.0 111.96 168.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -135.78 144.71 45.93 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.037 1.335 . . . . 0.0 110.206 171.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -150.77 -63.31 0.19 Allowed 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 176.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -76.6 45.07 0.38 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.815 1.246 . . . . 0.0 112.722 -175.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.4 m 49.56 45.12 24.37 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.321 1.448 . . . . 0.0 110.706 -168.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.9 p -165.98 144.23 4.8 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 127.021 2.128 . . . . 0.0 110.126 -173.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.2 161.3 23.21 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 124.013 3.142 . . . . 0.0 113.855 175.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -142.23 143.93 33.11 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.57 2.348 . . . . 0.0 111.337 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 40.7 ttm -145.83 120.34 9.72 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.15 1.38 . . . . 0.0 110.02 172.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -165.77 -179.03 5.09 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.217 1.407 . . . . 0.0 110.628 -172.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.7 m -76.82 142.94 40.09 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 120.83 -1.168 . . . . 0.0 110.635 171.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.436 HG12 ' CG ' ' A' ' 152' ' ' TYR . 8.4 tp -56.0 -36.64 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -177.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -69.71 -18.0 63.5 Favored 'General case' 0 CA--C 1.549 0.909 0 O-C-N 121.673 -0.642 . . . . 0.0 112.529 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -75.3 -46.9 30.53 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.156 -0.965 . . . . 0.0 110.465 172.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.7 ptm -71.95 -35.83 69.7 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -57.93 -53.59 56.54 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 118.921 0.782 . . . . 0.0 110.709 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.2 t -64.68 -33.68 76.52 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.318 1.047 . . . . 0.0 111.509 -176.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -65.12 -52.66 53.99 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.209 1.404 . . . . 0.0 110.683 175.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -70.1 -32.38 70.4 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.321 -0.862 . . . . 0.0 112.671 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.01 -27.68 67.63 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.999 0.92 . . . . 0.0 113.176 172.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.7 t -79.86 -35.46 38.11 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.469 1.107 . . . . 0.0 112.073 173.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 46.0 mtm -85.13 -43.47 13.83 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.157 0.983 . . . . 0.0 113.395 -174.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -107.5 -31.86 7.95 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.289 1.435 . . . . 0.0 111.404 -172.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 102.05 165.36 26.82 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.016 1.293 . . . . 0.0 113.508 -177.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -114.44 135.65 53.87 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.675 1.59 . . . . 0.0 111.136 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.6 mp -100.43 148.29 34.74 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 125.878 1.671 . . . . 0.0 109.833 166.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -75.79 159.34 38.56 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.328 2.685 . . . . 0.0 111.615 175.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -135.59 161.36 35.75 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.461 1.505 . . . . 0.0 109.861 164.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -42.9 -48.55 5.84 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -117.14 3.94 12.69 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -160.89 -145.64 4.36 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 115.515 0.966 . . . . 0.0 115.515 -172.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -150.53 155.53 39.65 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.388 1.875 . . . . 0.0 112.378 -175.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.72 143.43 41.22 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.459 1.504 . . . . 0.0 112.095 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 86.7 t -125.71 111.65 25.16 Favored Pre-proline 0 N--CA 1.484 1.233 0 C-N-CA 125.16 1.384 . . . . 0.0 110.787 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.63 127.74 13.5 Favored 'Trans proline' 0 C--N 1.351 0.686 1 C-N-CA 125.348 4.032 . . . . 0.0 112.307 -174.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 68.6 mt -106.64 156.4 18.65 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.183 0.993 . . . . 0.0 113.152 -177.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -134.98 132.66 38.63 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.91 1.684 . . . . 0.0 111.046 168.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 50.13 45.84 25.23 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.347 1.859 . . . . 0.0 113.244 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 49.1 t -109.07 127.76 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.69 0.796 . . . . 0.0 109.604 175.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -127.99 155.34 44.44 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.268 1.027 . . . . 0.0 113.471 -168.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.5 m -141.94 151.88 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 126.543 1.937 . . . . 0.0 112.25 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -72.25 136.35 46.3 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.298 1.839 . . . . 0.0 108.137 169.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.2 t -151.33 154.65 37.12 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.186 -0.946 . . . . 0.0 113.323 -170.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 60.2 tp -107.09 129.04 54.88 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.758 1.623 . . . . 0.0 110.579 177.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -79.78 102.35 9.01 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.602 -0.686 . . . . 0.0 109.876 168.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.5 mm -59.31 -23.36 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.318 1.047 . . . . 0.0 112.586 -175.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.81 -39.77 69.6 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.428 1.891 . . . . 0.0 114.746 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.3 m -108.4 -24.65 11.35 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.971 1.309 . . . . 0.0 112.94 -173.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.13 29.4 68.8 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.234 1.397 . . . . 0.0 113.161 -169.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -103.38 137.23 41.76 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.69 1.596 . . . . 0.0 111.386 -176.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.464 HD12 ' N ' ' A' ' 60' ' ' ILE . 1.3 mp -93.33 135.58 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.111 0.965 . . . . 0.0 109.088 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -153.27 172.2 17.37 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.796 1.638 . . . . 0.0 111.192 -176.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt -90.58 144.11 26.09 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.842 0.857 . . . . 0.0 111.146 165.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.8 t -136.48 166.38 23.64 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.056 1.342 . . . . 0.0 111.41 170.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.6 ptp85 -97.64 146.88 24.88 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.773 1.229 . . . . 0.0 112.939 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -103.13 146.21 28.74 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.468 1.107 . . . . 0.0 111.19 170.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.7 t -98.13 -43.35 7.05 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -174.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -153.9 159.01 41.58 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.062 0.945 . . . . 0.0 112.789 173.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.8 mt -89.42 151.48 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.08 0.952 . . . . 0.0 108.465 164.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -137.46 146.71 44.62 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.778 1.631 . . . . 0.0 110.31 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -144.07 151.55 39.78 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 119.833 1.197 . . . . 0.0 113.482 166.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -152.05 169.99 21.02 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.013 1.725 . . . . 0.0 110.597 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -103.35 140.13 37.84 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.689 1.195 . . . . 0.0 111.605 -175.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.1 m -146.88 142.22 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.649 1.18 . . . . 0.0 111.795 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.453 ' HA ' ' H ' ' A' ' 148' ' ' ASN . 11.6 pt-20 -104.99 -11.15 16.78 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.639 1.575 . . . . 0.0 113.451 175.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -123.75 121.21 34.86 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.969 1.308 . . . . 0.0 109.908 173.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.0 tp -136.9 161.03 37.14 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.43 1.492 . . . . 0.0 109.419 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.4 mt -114.5 128.11 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 120.982 -1.074 . . . . 0.0 109.348 178.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -100.6 113.61 26.58 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.559 1.143 . . . . 0.0 110.518 171.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.2 mp -100.79 122.11 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.174 1.39 . . . . 0.0 108.526 172.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -91.6 148.75 22.05 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.548 1.139 . . . . 0.0 111.108 176.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 82.8 mt -115.34 158.74 21.98 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.876 1.27 . . . . 0.0 112.822 -176.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.8 t -66.31 -39.71 89.5 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.993 1.317 . . . . 0.0 112.205 -175.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.7 m -75.29 0.28 17.19 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 172.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 105.99 -2.53 38.28 Favored Glycine 0 CA--C 1.534 1.268 0 N-CA-C 117.089 1.596 . . . . 0.0 117.089 162.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -81.48 171.64 14.47 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.529 1.664 . . . . 0.0 111.654 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 85.2 p -139.73 135.55 33.24 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.993 0.917 . . . . 0.0 112.926 174.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 68.4 tp -105.41 126.0 51.62 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.126 1.77 . . . . 0.0 109.468 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -114.52 110.62 20.1 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.422 1.489 . . . . 0.0 110.54 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.6 m -140.69 154.09 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.586 1.554 . . . . 0.0 112.34 -167.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.49 150.36 97.32 Favored Pre-proline 0 N--CA 1.468 0.427 0 C-N-CA 123.761 0.824 . . . . 0.0 113.115 177.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -63.51 -35.58 59.31 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.598 2.198 . . . . 0.0 114.951 -167.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.7 m -89.5 3.06 53.63 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -67.65 119.36 65.49 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 124.539 1.135 . . . . 0.0 110.928 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -80.12 126.47 6.35 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.914 2.409 . . . . 0.0 112.347 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.6 t -106.32 146.23 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 125.938 1.695 . . . . 0.0 109.537 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 21.6 tp -78.8 105.17 9.92 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.081 0.467 . . . . 0.0 110.221 177.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.6 mp -104.19 158.94 16.1 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.475 1.51 . . . . 0.0 111.508 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -103.35 122.81 45.6 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.186 0.594 . . . . 0.0 112.202 168.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 44.9 mtp180 -143.36 85.42 1.85 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.528 1.531 . . . . 0.0 109.366 170.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 54.56 -3.72 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 127.464 2.305 . . . . 0.0 115.855 -160.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -175.21 174.81 46.99 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 126.933 2.206 . . . . 0.0 113.059 -178.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 37.1 mt -64.58 122.33 16.56 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.965 1.706 . . . . 0.0 110.673 173.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -151.94 152.04 32.0 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.08 0.952 . . . . 0.0 113.4 170.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -97.96 118.48 34.64 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.297 1.439 . . . . 0.0 111.126 -173.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.3 t -130.09 130.59 23.11 Favored Pre-proline 0 N--CA 1.48 1.046 0 C-N-CA 124.001 0.921 . . . . 0.0 110.872 -172.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -65.71 140.36 61.59 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.67 2.246 . . . . 0.0 111.877 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.36 -31.52 14.88 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 176.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.25 -29.28 69.75 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 174.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -101.32 -2.71 30.38 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.241 1.416 . . . . 0.0 112.169 178.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 89.9 t -72.95 142.9 14.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 O-C-N 121.064 -1.022 . . . . 0.0 110.328 167.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.46 154.57 76.98 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 127.108 2.163 . . . . 0.0 109.804 -177.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.432 ' HD3' HG22 ' A' ' 142' ' ' VAL . 60.7 Cg_endo -66.21 136.07 42.61 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.778 1.652 . . . . 0.0 111.147 -170.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 93.37 3.65 64.84 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.812 1.196 . . . . 0.0 114.222 -176.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -62.54 158.64 17.53 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.441 1.096 . . . . 0.0 111.096 164.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.0 t -106.05 119.24 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.997 1.319 . . . . 0.0 110.16 -177.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.6 t -91.88 140.47 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.158 1.383 . . . . 0.0 109.694 174.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 38.2 t -90.64 135.67 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 123.739 0.816 . . . . 0.0 110.644 177.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -164.44 -145.29 4.34 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 114.268 0.467 . . . . 0.0 114.268 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.9 p -156.07 169.77 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 126.263 1.825 . . . . 0.0 109.545 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 74.1 mtm-85 . . . . . 0 N--CA 1.469 0.508 0 C-N-CA 125.18 1.392 . . . . 0.0 111.946 175.967 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.3 mt -140.76 160.28 40.38 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.622 1.569 . . . . 0.0 112.103 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -144.05 165.15 28.61 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.409 1.484 . . . . 0.0 111.248 174.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -110.73 152.28 26.77 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.727 1.211 . . . . 0.0 111.91 174.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 64.1 m-70 -135.36 137.81 42.73 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.493 1.117 . . . . 0.0 109.635 -176.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -103.52 135.29 45.4 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.453 -0.78 . . . . 0.0 112.475 -169.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 91.4 t -73.86 125.64 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 121.631 0.729 . . . . 0.0 111.352 177.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 21.2 t -88.28 -37.77 15.75 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.734 1.614 . . . . 0.0 113.403 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.2 m -154.47 159.67 41.15 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.824 1.25 . . . . 0.0 111.327 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.432 HG22 ' HD3' ' A' ' 112' ' ' PRO . 4.5 m -138.2 148.94 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 123.434 0.693 . . . . 0.0 111.193 163.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -163.16 159.65 23.25 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.309 1.044 . . . . 0.0 113.41 165.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 89.9 mt -79.22 135.57 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 164.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 16.3 pt -124.54 163.49 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 127.589 2.355 . . . . 0.0 109.828 173.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . 0.328 1.6 p-10 -114.13 65.98 0.67 Allowed 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 -172.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -56.27 -39.93 73.42 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.794 1.637 . . . . 0.0 115.335 -160.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.453 ' H ' ' HA ' ' A' ' 74' ' ' GLU . 6.1 m-80 47.9 36.02 5.57 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.81 2.044 . . . . 0.0 113.461 -175.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -146.48 175.52 10.5 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 120.841 -1.162 . . . . 0.0 112.458 -170.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -67.21 133.74 50.33 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 122.396 1.093 . . . . 0.0 113.433 -176.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.7 m -114.45 150.83 16.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.437 164.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.436 ' CG ' HG12 ' A' ' 21' ' ' ILE . 2.8 p90 -111.78 163.88 13.67 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.987 1.315 . . . . 0.0 111.656 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -143.84 147.99 34.87 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.348 0.659 . . . . 0.0 109.844 160.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 34.6 tp -107.15 122.18 45.99 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.687 1.195 . . . . 0.0 110.271 174.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 36.1 t -87.47 118.04 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 O-C-N 121.948 -0.47 . . . . 0.0 111.911 -168.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 12.7 mm -123.19 84.78 51.53 Favored Pre-proline 0 N--CA 1.472 0.66 0 C-N-CA 125.29 1.436 . . . . 0.0 110.416 -176.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -70.04 -12.08 31.68 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 122.646 2.231 . . . . 0.0 113.835 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -74.34 -40.5 62.12 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.066 1.346 . . . . 0.0 113.83 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 70.9 p -139.73 -13.9 1.09 Allowed 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -170.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 77.4 m80 56.11 20.69 4.58 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.984 1.713 . . . . 0.0 115.179 -164.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -150.13 151.0 32.45 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.618 -1.301 . . . . 0.0 114.476 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -145.87 173.84 11.77 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.307 1.843 . . . . 0.0 111.065 177.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 79.4 mt -122.26 138.29 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.01 0.924 . . . . 0.0 110.534 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -89.0 158.18 47.43 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 124.087 0.955 . . . . 0.0 112.438 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -65.7 -18.69 59.05 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.136 2.557 . . . . 0.0 112.751 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -74.57 7.92 2.66 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.868 1.267 . . . . 0.0 112.812 170.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 91.55 -25.11 16.78 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 126.968 2.223 . . . . 0.0 115.644 175.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 41.3 mt -75.19 144.37 42.72 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.553 1.176 . . . . 0.0 113.79 -166.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.9 t -86.1 127.66 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.012 0.925 . . . . 0.0 111.079 174.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 52.9 mt -117.29 150.35 38.94 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.113 2.165 . . . . 0.0 112.169 -174.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -109.24 145.52 35.76 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.632 1.173 . . . . 0.0 112.809 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 . . . . . 0 CA--C 1.547 0.858 0 O-C-N 121.21 -0.931 . . . . 0.0 111.811 169.793 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.638 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -135.04 162.04 33.59 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.673 1.989 . . . . 0.0 111.098 -174.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.46 141.7 57.5 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.1 0.96 . . . . 0.0 111.673 172.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -11.58 38.66 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 176.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -81.43 -13.11 58.62 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.565 1.946 . . . . 0.0 113.306 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.3 m -64.47 136.92 57.55 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.153 0.981 . . . . 0.0 112.253 -177.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -81.32 151.64 27.93 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.662 0.744 . . . . 0.0 112.073 171.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 p -144.14 160.68 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 123.611 0.764 . . . . 0.0 111.038 -170.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -132.09 124.78 29.85 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.167 1.387 . . . . 0.0 108.929 -175.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -149.58 174.87 12.06 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 118.921 0.782 . . . . 0.0 112.73 176.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -131.03 142.43 50.32 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.117 1.367 . . . . 0.0 110.879 170.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -162.91 141.98 8.73 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.996 1.319 . . . . 0.0 110.533 174.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.2 t70 61.34 38.21 16.45 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.38 1.472 . . . . 0.0 113.448 -173.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.8 m 59.41 40.6 20.66 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.317 1.447 . . . . 0.0 112.651 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.2 p -158.85 140.51 9.8 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 124.866 1.266 . . . . 0.0 110.873 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -75.46 155.82 40.89 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 123.791 2.994 . . . . 0.0 113.806 176.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 39.1 m-70 -137.0 142.99 42.53 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 127.072 2.149 . . . . 0.0 110.767 176.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 43.1 ttm -154.29 82.64 1.12 Allowed 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.764 0.792 . . . . 0.0 112.432 -170.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -143.49 -176.34 4.91 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.238 1.415 . . . . 0.0 112.085 -173.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.9 m -69.37 138.47 53.7 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 120.955 -1.091 . . . . 0.0 110.755 174.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.5 tp -55.06 -36.34 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -66.73 -17.91 65.1 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.338 -0.851 . . . . 0.0 113.127 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -75.43 -51.76 12.31 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.354 1.061 . . . . 0.0 109.927 172.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 22.2 ptm -68.08 -36.21 79.46 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.43 -0.794 . . . . 0.0 112.034 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -56.17 -51.83 66.58 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.5 0.72 . . . . 0.0 111.299 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.1 m -57.27 -40.16 77.16 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 125.324 1.449 . . . . 0.0 111.727 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -69.51 -50.93 40.43 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.017 0.927 . . . . 0.0 111.173 178.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -68.19 -33.66 74.84 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 121.338 -0.851 . . . . 0.0 112.213 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.68 -23.46 65.31 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.59 0.756 . . . . 0.0 112.782 172.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.57 -11.94 38.54 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.957 1.303 . . . . 0.0 114.112 174.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 67.0 mtm -103.66 -52.2 3.03 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.103 1.361 . . . . 0.0 111.669 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -105.14 -16.53 14.76 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.972 1.309 . . . . 0.0 112.346 -171.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.36 161.97 32.21 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 124.234 0.921 . . . . 0.0 113.271 175.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -104.96 140.58 37.97 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.913 0.885 . . . . 0.0 109.845 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.3 mp -118.51 149.09 45.47 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 126.375 1.87 . . . . 0.0 110.611 176.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -81.44 151.24 17.43 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.074 3.183 . . . . 0.0 112.222 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -138.9 163.35 32.54 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.308 1.843 . . . . 0.0 111.097 -175.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -50.76 -55.88 14.66 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.844 1.258 . . . . 0.0 113.573 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -95.54 -7.45 37.91 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.47 -134.23 1.84 Allowed Glycine 0 CA--C 1.533 1.167 0 N-CA-C 115.507 0.963 . . . . 0.0 115.507 -170.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -138.98 160.23 40.26 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.623 1.969 . . . . 0.0 111.05 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.98 155.71 45.45 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.205 1.002 . . . . 0.0 113.311 176.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.8 t -126.46 115.97 23.13 Favored Pre-proline 0 N--CA 1.48 1.059 0 C-N-CA 126.09 1.756 . . . . 0.0 110.457 175.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.95 139.3 29.87 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 124.63 3.554 . . . . 0.0 112.296 -176.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 78.4 mt -107.76 163.98 12.63 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.65 1.18 . . . . 0.0 112.752 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -147.93 128.41 14.04 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.686 1.594 . . . . 0.0 109.345 168.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 55.04 41.31 31.9 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.865 1.666 . . . . 0.0 114.264 -176.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.4 t -108.32 118.43 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 O-C-N 121.308 -0.87 . . . . 0.0 109.618 175.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -114.52 148.33 38.07 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.458 1.103 . . . . 0.0 112.166 -171.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.9 m -139.44 153.97 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.091 1.357 . . . . 0.0 111.431 175.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -76.27 147.21 38.42 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.726 0.775 . . . . 0.0 111.557 172.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.6 t -154.96 167.08 31.53 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.69 1.596 . . . . 0.0 111.316 -165.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 36.9 tp -124.76 139.11 54.15 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.453 1.501 . . . . 0.0 110.326 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -87.14 112.96 22.46 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.363 1.065 . . . . 0.0 109.652 164.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.1 mm -71.62 -21.39 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 121.049 -1.032 . . . . 0.0 112.513 -175.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.47 -45.62 21.66 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -174.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.2 m -101.89 -15.63 16.81 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.266 1.027 . . . . 0.0 112.681 173.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.55 23.33 75.62 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.045 0.831 . . . . 0.0 113.524 -174.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -82.41 133.66 35.22 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.501 1.12 . . . . 0.0 111.519 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.3 mp -80.67 136.06 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 174.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -142.92 171.08 14.54 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.444 1.898 . . . . 0.0 111.528 -174.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -117.56 144.98 44.58 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.911 1.684 . . . . 0.0 110.118 167.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.7 t -143.68 153.29 42.32 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.221 1.008 . . . . 0.0 112.492 -174.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.3 137.07 37.88 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.362 1.065 . . . . 0.0 112.198 172.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.83 136.78 36.89 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.16 0.984 . . . . 0.0 110.984 172.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 91.4 p -89.02 -47.25 8.25 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.862 0.865 . . . . 0.0 113.267 -167.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -154.12 156.97 38.21 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.393 1.477 . . . . 0.0 112.356 173.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.7 mt -87.19 153.57 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 124.683 1.193 . . . . 0.0 107.941 164.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -138.6 152.61 48.29 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.858 1.663 . . . . 0.0 111.581 -173.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -146.52 152.88 39.69 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 164.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -150.39 167.22 27.72 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 127.453 2.301 . . . . 0.0 110.574 177.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -106.33 138.63 42.16 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.079 1.351 . . . . 0.0 113.779 -173.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.8 m -145.97 145.28 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 C-N-CA 124.764 1.226 . . . . 0.0 111.881 -176.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -96.22 -30.86 13.24 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 125.867 1.667 . . . . 0.0 112.26 175.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -129.41 133.25 47.25 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.144 0.978 . . . . 0.0 111.822 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.9 tp -136.39 158.45 44.4 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.15 2.18 . . . . 0.0 109.161 -170.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.2 mt -110.17 127.66 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 O-C-N 121.241 -0.912 . . . . 0.0 109.617 176.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -102.91 119.08 38.21 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.321 1.048 . . . . 0.0 111.648 168.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -104.86 123.65 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.694 1.598 . . . . 0.0 108.547 174.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -91.54 143.93 26.07 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.431 1.092 . . . . 0.0 111.142 173.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.4 mt -109.73 151.94 26.29 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.231 1.812 . . . . 0.0 110.706 175.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.9 t -66.53 -22.8 66.16 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -168.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.9 m -76.9 -10.29 59.27 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.863 1.265 . . . . 0.0 114.159 172.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 107.03 2.28 36.19 Favored Glycine 0 CA--C 1.54 1.634 0 N-CA-C 116.731 1.452 . . . . 0.0 116.731 175.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -80.86 153.81 27.43 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.41 1.484 . . . . 0.0 110.841 172.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 39.1 p -131.06 144.32 51.35 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 168.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 60.0 tp -111.72 126.35 54.95 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.168 2.187 . . . . 0.0 109.566 177.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -118.61 107.8 14.17 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.823 1.649 . . . . 0.0 110.556 -173.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.3 m -143.42 151.49 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.83 1.252 . . . . 0.0 113.174 -161.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.4 p -67.9 149.07 98.37 Favored Pre-proline 0 N--CA 1.467 0.402 0 O-C-N 121.43 -0.794 . . . . 0.0 111.93 174.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -59.5 -29.81 90.93 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 123.144 2.563 . . . . 0.0 114.09 -168.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.3 p -81.04 -9.42 59.83 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 55.6 t60 -69.38 120.81 79.39 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 119.717 1.144 . . . . 0.0 111.637 -178.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -79.31 129.49 8.65 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.019 2.479 . . . . 0.0 113.687 178.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.4 t -103.95 143.13 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 126.112 1.765 . . . . 0.0 109.544 175.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.05 109.32 15.51 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.181 0.515 . . . . 0.0 110.729 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.4 mp -106.23 153.84 21.57 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.417 1.887 . . . . 0.0 111.33 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -108.65 107.72 18.3 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 40.8 mtp180 -139.83 89.71 2.33 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 120.9 -1.125 . . . . 0.0 109.842 174.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 59.76 -13.84 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 128.154 2.581 . . . . 0.0 116.049 -163.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -174.2 -176.36 42.53 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 126.163 1.839 . . . . 0.0 113.329 174.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 95.1 mt -72.37 117.51 14.11 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.796 2.038 . . . . 0.0 111.738 -174.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -146.59 141.84 27.35 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -95.96 120.92 37.09 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.428 1.491 . . . . 0.0 111.225 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 83.9 t -123.5 128.03 25.35 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 123.652 0.781 . . . . 0.0 109.945 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -62.87 142.93 90.42 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.283 1.989 . . . . 0.0 111.147 176.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.0 -31.89 19.46 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 176.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.42 -11.29 57.43 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 174.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -112.71 -4.62 14.03 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.144 1.378 . . . . 0.0 113.552 171.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.4 t -71.63 149.35 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.067 1.347 . . . . 0.0 111.712 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.14 152.04 79.47 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 126.26 1.824 . . . . 0.0 111.747 178.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -67.56 125.24 13.04 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.271 2.647 . . . . 0.0 111.093 -175.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 96.93 9.58 55.99 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-O 119.673 -0.515 . . . . 0.0 114.266 -173.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -65.52 161.37 20.28 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 118.183 0.991 . . . . 0.0 111.587 159.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.4 p -106.59 126.96 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.617 1.567 . . . . 0.0 111.604 178.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.9 t -106.2 136.41 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.791 1.636 . . . . 0.0 111.199 -177.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.3 t -89.78 134.74 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.081 0.952 . . . . 0.0 110.9 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -158.49 -153.11 6.64 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.533 1.064 . . . . 0.0 111.522 172.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.408 HG22 ' H ' ' A' ' 120' ' ' ARG . 3.6 p -131.88 162.5 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.766 1.226 . . . . 0.0 110.294 167.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.408 ' H ' HG22 ' A' ' 119' ' ' VAL . 40.3 mtt-85 . . . . . 0 N--CA 1.472 0.639 0 C-N-CA 126.47 1.908 . . . . 0.0 112.556 -165.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 . . . . . 0 N--CA 1.475 0.816 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.7 mt -137.94 158.56 44.09 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.276 1.83 . . . . 0.0 111.4 173.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -142.02 150.41 41.27 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.429 1.492 . . . . 0.0 112.339 177.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -91.52 148.87 21.98 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.944 1.697 . . . . 0.0 113.25 176.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -137.09 139.4 41.24 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.438 1.495 . . . . 0.0 109.911 -177.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -91.5 130.21 37.36 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.844 0.747 . . . . 0.0 111.843 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 71.1 t -67.94 125.47 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 O-C-N 121.498 -0.751 . . . . 0.0 109.758 168.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.4 t -85.62 -42.64 14.15 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.944 1.698 . . . . 0.0 112.635 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.5 t -159.93 165.41 32.16 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.602 1.161 . . . . 0.0 111.108 174.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.9 m -135.11 149.94 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.671 1.188 . . . . 0.0 110.936 168.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -156.02 160.31 39.91 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.964 0.906 . . . . 0.0 112.65 167.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 87.8 mt -81.67 143.44 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 161.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 43.2 pt -131.91 152.33 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.949 2.1 . . . . 0.0 111.383 173.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -87.12 97.21 10.62 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.004 -1.06 . . . . 0.0 110.769 174.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -76.94 -46.63 23.48 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.554 -1.341 . . . . 0.0 112.59 177.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 50.84 31.94 6.65 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.59 1.156 . . . . 0.0 114.077 -176.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -139.19 172.59 12.61 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.808 -1.183 . . . . 0.0 111.61 -176.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -71.18 141.35 50.7 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.34 1.056 . . . . 0.0 111.562 173.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.9 m -123.53 153.26 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 126.219 1.808 . . . . 0.0 109.551 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -109.72 161.92 14.94 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.169 0.587 . . . . 0.0 112.258 -173.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -143.19 157.59 44.37 Favored 'General case' 0 CA--C 1.55 0.949 0 O-C-N 121.722 -0.612 . . . . 0.0 111.366 158.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 44.1 tp -114.76 127.88 55.99 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.056 1.342 . . . . 0.0 110.555 174.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 37.8 t -98.26 132.73 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 121.689 0.757 . . . . 0.0 112.415 -169.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 20.8 mm -132.66 92.61 26.59 Favored Pre-proline 0 N--CA 1.47 0.535 0 C-N-CA 126.08 1.752 . . . . 0.0 108.599 -173.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -70.41 -13.25 32.86 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.404 2.069 . . . . 0.0 113.469 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -72.88 -45.66 57.03 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 118.725 0.693 . . . . 0.0 112.368 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 82.5 p -140.74 -10.21 1.04 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.807 1.643 . . . . 0.0 114.55 -171.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 45.8 m80 55.66 21.46 4.6 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 -169.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -143.7 148.57 35.93 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 120.74 -1.225 . . . . 0.0 113.955 177.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -143.3 167.62 21.72 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.346 1.458 . . . . 0.0 112.449 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 92.5 mt -115.18 131.12 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.416 1.486 . . . . 0.0 110.501 -172.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -81.31 160.23 65.69 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 123.914 0.886 . . . . 0.0 112.543 177.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.92 -12.34 32.4 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.741 2.294 . . . . 0.0 113.421 174.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -94.11 24.13 4.54 Favored 'General case' 0 CA--C 1.555 1.141 0 CA-C-N 118.785 0.72 . . . . 0.0 111.576 165.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 83.42 -23.31 6.45 Favored Glycine 0 CA--C 1.528 0.905 0 O-C-N 120.051 -1.655 . . . . 0.0 117.102 166.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 72.7 mt -61.84 142.03 57.59 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.897 1.348 . . . . 0.0 112.797 -175.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.2 t -98.02 124.95 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.96 0.904 . . . . 0.0 110.525 174.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 27.4 mt -119.37 139.69 51.58 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.856 1.662 . . . . 0.0 111.77 -168.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -97.87 139.75 33.26 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.007 0.923 . . . . 0.0 112.794 172.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 . . . . . 0 CA--C 1.544 0.723 0 C-N-CA 124.705 1.202 . . . . 0.0 111.883 176.367 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -137.42 155.78 48.95 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.422 1.889 . . . . 0.0 110.988 -172.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -55.28 141.46 35.53 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.203 1.001 . . . . 0.0 112.364 174.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -59.92 -21.09 60.65 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.012 0.925 . . . . 0.0 113.367 172.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -77.53 -3.68 41.84 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.493 1.517 . . . . 0.0 112.635 175.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.8 m -79.22 145.0 33.85 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 122.443 1.116 . . . . 0.0 112.689 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -73.64 158.74 34.19 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.726 1.61 . . . . 0.0 114.112 171.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.3 p -149.2 153.64 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 124.325 1.05 . . . . 0.0 111.599 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -122.91 130.71 53.18 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.69 1.996 . . . . 0.0 107.466 175.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -150.61 179.49 8.14 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.994 0.917 . . . . 0.0 111.287 169.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -140.77 143.69 35.05 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.447 1.499 . . . . 0.0 110.565 178.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -158.28 -39.95 0.06 Allowed 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -100.01 41.1 1.18 Allowed 'General case' 0 N--CA 1.479 1.023 0 O-C-N 120.999 -1.063 . . . . 0.0 112.936 -172.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.6 m 53.26 33.49 15.58 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.247 1.419 . . . . 0.0 112.434 -167.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.6 p -159.44 146.32 12.62 Favored Pre-proline 0 C--O 1.24 0.559 0 C-N-CA 126.8 2.04 . . . . 0.0 107.799 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -74.1 161.01 41.78 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.282 2.655 . . . . 0.0 111.596 171.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -137.75 125.33 22.18 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 126.416 1.886 . . . . 0.0 109.58 -175.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -127.75 112.78 15.17 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.458 1.503 . . . . 0.0 109.023 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -155.45 -175.64 5.54 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.293 1.437 . . . . 0.0 110.704 -177.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.5 m -78.07 148.05 34.44 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 120.9 -1.125 . . . . 0.0 110.045 168.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.472 HG12 ' CG ' ' A' ' 152' ' ' TYR . 7.3 tp -58.05 -38.71 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 O-C-N 121.508 -0.745 . . . . 0.0 111.831 177.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -61.09 -20.1 62.22 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 178.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -85.34 -46.07 11.32 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.87 1.268 . . . . 0.0 111.217 175.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -73.29 -33.59 65.3 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 121.202 -0.936 . . . . 0.0 112.158 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -59.95 -46.96 87.7 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.795 0.838 . . . . 0.0 111.1 176.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.9 t -63.04 -36.03 82.2 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.41 1.084 . . . . 0.0 111.551 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -65.23 -53.61 41.82 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.342 1.457 . . . . 0.0 110.395 175.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -72.29 -34.13 67.94 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.006 -1.059 . . . . 0.0 113.382 -178.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.16 -28.01 66.92 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.964 0.906 . . . . 0.0 112.748 176.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 51.3 m -75.89 -41.89 50.7 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.406 0.682 . . . . 0.0 111.479 172.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 45.5 mtm -78.71 -45.02 22.2 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.44 1.096 . . . . 0.0 113.006 -172.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 23.5 m-20 -111.44 -26.36 9.14 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.124 1.37 . . . . 0.0 112.238 -170.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.19 163.47 27.55 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.85 1.214 . . . . 0.0 114.424 176.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -110.79 126.6 54.79 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.575 1.15 . . . . 0.0 111.167 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.3 mp -95.69 147.68 33.39 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 127.077 2.151 . . . . 0.0 110.988 174.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -73.1 151.15 49.27 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.243 2.629 . . . . 0.0 111.125 174.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -133.73 160.67 36.88 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.318 1.447 . . . . 0.0 111.155 165.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -46.76 -49.03 20.38 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.058 1.343 . . . . 0.0 113.852 177.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -101.18 -5.93 24.94 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 177.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.49 -129.64 1.28 Allowed Glycine 0 CA--C 1.528 0.865 0 CA-C-N 119.75 1.159 . . . . 0.0 115.148 -173.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -144.64 156.32 44.05 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.684 1.194 . . . . 0.0 112.738 -174.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.34 150.45 47.74 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.547 1.139 . . . . 0.0 111.814 177.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.5 t -126.01 120.18 23.96 Favored Pre-proline 0 N--CA 1.48 1.065 0 C-N-CA 125.437 1.495 . . . . 0.0 110.027 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -76.05 139.19 21.42 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 124.13 3.22 . . . . 0.0 111.482 -176.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.3 mt -108.36 155.6 20.36 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.56 0.744 . . . . 0.0 112.516 178.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -138.11 132.5 32.11 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.098 1.359 . . . . 0.0 110.056 167.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 57.5 33.89 23.87 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.503 1.521 . . . . 0.0 113.896 -178.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.8 t -107.88 127.84 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 121.074 -1.016 . . . . 0.0 111.473 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -132.79 160.95 35.38 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.08 1.352 . . . . 0.0 113.905 -172.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.9 p -151.5 155.83 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 125.8 1.64 . . . . 0.0 112.467 -178.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.515 ' CE1' HG23 ' A' ' 60' ' ' ILE . 1.1 t80 -65.51 132.41 48.84 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.841 0.856 . . . . 0.0 110.153 168.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.8 t -132.81 140.17 47.85 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.711 1.605 . . . . 0.0 109.937 173.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.5 tp -91.15 134.1 34.81 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 171.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -79.73 105.32 10.94 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 164.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 23.2 mm -63.29 -24.74 36.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 O-C-N 121.647 -0.658 . . . . 0.0 111.566 -174.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -81.47 -37.21 28.31 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.307 1.843 . . . . 0.0 115.784 -178.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.0 m -106.13 -18.53 13.99 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.658 1.183 . . . . 0.0 112.483 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.4 25.73 73.67 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 125.324 1.44 . . . . 0.0 113.52 -168.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -79.52 131.28 35.99 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.899 1.68 . . . . 0.0 111.093 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.515 HG23 ' CE1' ' A' ' 51' ' ' TYR . 2.8 mp -92.37 113.47 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 173.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -138.38 172.81 12.35 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.079 1.352 . . . . 0.0 112.019 -174.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -103.9 148.05 26.61 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.66 1.184 . . . . 0.0 111.009 173.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.6 t -140.66 151.85 44.91 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.393 1.077 . . . . 0.0 111.178 173.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -72.89 157.58 37.17 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.252 1.021 . . . . 0.0 111.967 171.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -115.81 143.4 45.45 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.308 1.443 . . . . 0.0 110.942 168.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -88.67 -48.5 7.49 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.229 1.012 . . . . 0.0 112.933 -173.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -157.35 157.35 33.95 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.686 1.194 . . . . 0.0 112.043 177.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.5 mt -88.1 153.14 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 124.918 1.287 . . . . 0.0 108.265 166.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -135.22 151.31 50.5 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.025 1.73 . . . . 0.0 111.27 -178.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 26.8 ptt-85 -147.34 156.65 43.1 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 167.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -152.36 163.07 40.23 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.508 1.923 . . . . 0.0 108.945 176.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.17 143.44 26.37 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.36 -0.838 . . . . 0.0 110.577 176.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.0 m -143.28 143.81 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 122.417 1.103 . . . . 0.0 111.641 175.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -101.82 -15.23 16.98 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.657 1.183 . . . . 0.0 113.009 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -132.22 125.44 31.13 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.549 1.54 . . . . 0.0 110.903 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.1 tp -140.26 159.85 41.27 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.012 1.725 . . . . 0.0 109.538 -173.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.2 mt -112.53 128.52 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.372 1.069 . . . . 0.0 109.177 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -102.51 119.67 39.22 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.225 1.01 . . . . 0.0 110.696 169.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -104.16 127.9 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 124.821 1.249 . . . . 0.0 108.556 173.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -94.19 148.35 22.27 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.865 1.266 . . . . 0.0 110.719 172.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 70.6 mt -114.87 156.89 24.12 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.545 1.938 . . . . 0.0 111.367 -177.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 36.3 t -68.38 -20.1 64.67 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -163.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 37.2 m -93.86 4.76 53.45 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 173.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 102.08 11.57 36.52 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.129 1.347 . . . . 0.0 116.254 171.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -96.23 167.99 10.86 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.977 1.311 . . . . 0.0 111.706 177.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 97.1 p -142.46 157.76 44.41 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -176.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.1 tp -135.8 127.8 29.62 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.989 1.716 . . . . 0.0 110.337 177.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -108.7 115.81 30.79 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.491 1.516 . . . . 0.0 111.949 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.4 m -142.33 153.55 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.721 1.608 . . . . 0.0 113.142 -169.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.2 p -67.56 147.96 98.67 Favored Pre-proline 0 N--CA 1.465 0.314 0 O-C-N 121.308 -0.87 . . . . 0.0 112.305 174.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -55.5 -33.77 87.38 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.673 2.916 . . . . 0.0 114.102 -174.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.9 p -81.76 -6.96 59.52 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 30.1 t60 -76.27 120.18 80.54 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 124.737 1.215 . . . . 0.0 112.333 -174.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -75.65 129.78 12.06 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.869 2.379 . . . . 0.0 113.436 176.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.72 144.98 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 126.499 1.92 . . . . 0.0 109.256 174.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 21.2 tp -80.88 106.62 13.02 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.343 0.519 . . . . 0.0 110.561 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.5 mp -107.49 165.63 11.26 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.859 2.063 . . . . 0.0 112.272 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -119.86 119.43 33.52 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.447 1.099 . . . . 0.0 113.05 176.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 33.6 mtm180 -132.59 77.86 1.77 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.176 1.39 . . . . 0.0 108.486 164.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.2 t70 59.23 8.49 1.11 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 126.862 2.065 . . . . 0.0 115.501 -169.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.34 169.01 42.12 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.953 1.739 . . . . 0.0 111.228 -174.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 71.7 mt -76.58 119.23 20.12 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.512 1.125 . . . . 0.0 110.639 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -133.55 131.76 40.12 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.127 0.971 . . . . 0.0 110.915 -176.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -88.32 122.29 31.67 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 172.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 67.0 t -132.2 127.11 20.79 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 123.87 0.868 . . . . 0.0 110.301 -175.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -65.89 142.72 70.31 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.378 2.052 . . . . 0.0 111.239 176.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.97 -30.85 16.07 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 176.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.08 -18.44 65.31 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 173.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -111.74 -3.97 14.81 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.151 1.38 . . . . 0.0 112.248 175.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 89.3 t -71.16 144.49 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.833 1.253 . . . . 0.0 110.316 169.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.12 156.66 78.92 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 126.407 1.883 . . . . 0.0 110.895 -177.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.36 126.24 13.99 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.337 2.025 . . . . 0.0 112.404 -172.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 108.07 -2.85 33.4 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.03 1.3 . . . . 0.0 114.814 -178.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -59.81 160.38 7.66 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.938 1.295 . . . . 0.0 113.221 174.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.8 t -102.56 118.35 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.139 1.375 . . . . 0.0 109.975 177.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.4 t -93.79 141.55 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.698 1.599 . . . . 0.0 110.058 173.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.5 t -91.38 138.66 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.259 1.024 . . . . 0.0 110.555 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -164.7 -149.13 5.7 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 123.402 0.525 . . . . 0.0 114.339 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.7 p -150.33 159.44 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 127.008 2.123 . . . . 0.0 108.573 175.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 N--CA 1.472 0.671 0 C-N-CA 123.91 0.884 . . . . 0.0 112.249 176.724 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 . . . . . 0 N--CA 1.477 0.896 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 96.7 mt -139.58 174.25 10.7 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 127.864 2.465 . . . . 0.0 111.907 -177.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -142.25 170.85 14.94 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 127.437 2.295 . . . . 0.0 110.604 169.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -126.04 147.0 49.67 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.103 1.761 . . . . 0.0 110.805 172.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -135.76 134.79 39.37 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.257 1.023 . . . . 0.0 110.313 -168.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -95.13 138.95 32.15 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.523 -0.736 . . . . 0.0 112.916 -174.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 71.0 t -74.15 132.67 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.351 1.06 . . . . 0.0 111.012 174.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 36.1 t -91.64 -40.36 11.35 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.211 1.804 . . . . 0.0 113.082 176.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.5 t -162.08 165.97 26.45 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.18 0.992 . . . . 0.0 110.643 176.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.2 m -131.93 148.23 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.491 1.116 . . . . 0.0 109.986 166.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -152.0 154.46 36.05 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.377 1.071 . . . . 0.0 112.766 172.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 87.7 mt -94.32 129.21 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.414 1.086 . . . . 0.0 108.537 169.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 16.8 pt -123.02 165.4 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 126.393 1.877 . . . . 0.0 112.131 -177.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -108.24 68.21 0.69 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.463 1.905 . . . . 0.0 112.509 -173.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -62.21 -43.88 97.84 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 121.097 -1.002 . . . . 0.0 113.24 -164.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 50.97 33.27 8.59 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.338 1.455 . . . . 0.0 113.894 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -141.5 177.64 7.99 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.853 1.261 . . . . 0.0 111.962 -174.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -77.65 142.07 39.06 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.161 0.985 . . . . 0.0 113.055 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 14.8 m -126.76 151.04 33.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 125.666 1.586 . . . . 0.0 109.671 177.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.472 ' CG ' HG12 ' A' ' 21' ' ' ILE . 1.2 p90 -111.04 164.18 13.08 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.678 0.791 . . . . 0.0 112.463 -175.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -144.31 155.4 43.8 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 122.439 0.296 . . . . 0.0 110.761 154.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 46.6 tp -107.49 124.39 49.83 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.568 1.147 . . . . 0.0 110.329 175.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 23.1 t -91.98 117.44 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 121.768 0.794 . . . . 0.0 111.887 -171.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 13.7 mm -120.73 83.25 35.52 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 126.396 1.879 . . . . 0.0 109.063 -177.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -63.24 -19.31 68.21 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.123 1.882 . . . . 0.0 113.808 178.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -76.13 -30.38 58.16 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 120.533 -1.355 . . . . 0.0 113.944 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 69.7 p -141.43 -18.1 0.79 Allowed 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . 0.253 75.6 m80 56.82 21.89 6.47 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.077 2.151 . . . . 0.0 115.165 -168.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -147.32 145.66 29.42 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.618 1.099 . . . . 0.0 113.767 -179.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -148.66 164.79 33.27 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.085 1.354 . . . . 0.0 111.709 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.2 mp -111.39 136.3 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.296 1.038 . . . . 0.0 111.466 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -81.88 157.64 68.82 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 124.033 0.933 . . . . 0.0 112.374 175.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -64.92 -22.71 62.67 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.815 2.344 . . . . 0.0 112.76 178.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -77.27 -5.48 49.58 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.559 0.744 . . . . 0.0 112.856 173.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 112.55 -21.68 18.65 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 125.955 1.74 . . . . 0.0 116.566 165.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 58.3 mt -76.87 149.89 36.09 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.097 1.448 . . . . 0.0 113.88 -171.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.9 t -96.78 123.84 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.761 1.224 . . . . 0.0 111.818 -178.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 25.4 mt -117.47 142.88 46.63 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.323 1.849 . . . . 0.0 112.577 -169.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -102.72 140.42 37.02 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.266 1.026 . . . . 0.0 112.369 170.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 . . . . . 0 CA--C 1.545 0.783 0 C-N-CA 123.944 0.897 . . . . 0.0 111.649 174.057 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.676 0 CA-C-O 120.832 0.349 . . . . 0.0 111.481 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.11 161.75 32.51 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.702 2.401 . . . . 0.0 110.684 -177.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.84 141.68 56.85 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.338 1.055 . . . . 0.0 112.59 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.2 ppt_? -56.54 -28.55 60.33 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.016 1.327 . . . . 0.0 113.166 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -81.74 -6.89 59.45 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.725 2.01 . . . . 0.0 114.599 -177.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.1 m -69.02 144.04 54.17 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.159 1.384 . . . . 0.0 112.856 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -82.06 152.02 26.8 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.438 1.495 . . . . 0.0 113.88 171.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.7 p -148.19 162.57 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.698 1.599 . . . . 0.0 111.685 -173.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -134.89 130.02 35.28 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.685 1.594 . . . . 0.0 109.823 -173.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -157.3 -178.53 7.42 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 118.924 0.784 . . . . 0.0 112.793 175.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -135.3 138.86 43.87 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.399 1.479 . . . . 0.0 111.43 172.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -169.0 146.92 3.8 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.139 1.376 . . . . 0.0 111.374 174.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.5 t0 62.92 36.93 12.38 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 115.321 1.601 . . . . 0.0 115.321 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 m 62.59 37.51 13.0 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.579 1.552 . . . . 0.0 113.504 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.8 p -157.29 137.08 8.58 Favored Pre-proline 0 CA--C 1.543 0.703 0 O-C-N 121.329 -0.857 . . . . 0.0 111.499 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.26 147.4 32.94 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.962 3.108 . . . . 0.0 111.111 171.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -127.35 135.97 51.26 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.812 1.245 . . . . 0.0 112.02 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 52.1 ttm -143.79 88.29 1.97 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.736 1.215 . . . . 0.0 109.789 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -146.31 -176.42 5.16 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.729 2.012 . . . . 0.0 111.645 -168.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -73.64 150.98 40.96 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.472 -1.392 . . . . 0.0 111.893 176.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.8 tp -58.34 -37.25 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 O-C-N 121.527 -0.733 . . . . 0.0 111.927 173.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -64.5 -30.44 71.47 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.215 0.916 . . . . 0.0 113.003 174.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -73.76 -41.39 62.51 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.587 -0.696 . . . . 0.0 110.301 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 20.0 ptm -69.47 -39.51 77.67 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.654 171.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -57.41 -52.41 65.49 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.975 0.807 . . . . 0.0 111.756 -178.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.8 t -71.55 -29.13 64.4 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 122.718 0.407 . . . . 0.0 111.503 -173.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -65.19 -53.01 51.17 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.363 1.465 . . . . 0.0 110.634 173.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -68.26 -32.77 73.18 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.376 -0.827 . . . . 0.0 112.015 177.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.74 -28.54 66.9 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.495 1.118 . . . . 0.0 113.658 174.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.4 t -83.83 -31.49 25.79 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.416 -0.802 . . . . 0.0 111.736 174.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 67.1 mtm -81.33 -42.75 20.09 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -114.27 -23.11 9.59 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.193 1.397 . . . . 0.0 113.875 -171.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.98 161.74 37.01 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.836 1.208 . . . . 0.0 114.647 -178.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -112.83 128.43 56.44 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.566 1.547 . . . . 0.0 110.406 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.8 mp -105.54 142.56 25.01 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 125.393 1.477 . . . . 0.0 111.789 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.24 146.27 40.25 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 124.04 3.16 . . . . 0.0 112.349 -177.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -141.12 159.55 41.98 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.083 1.753 . . . . 0.0 111.346 -178.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -61.42 -52.07 66.12 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 120.203 -1.56 . . . . 0.0 114.578 -178.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -79.84 -15.34 57.59 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 172.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -179.05 -125.99 0.98 Allowed Glycine 0 CA--C 1.539 1.549 0 N-CA-C 117.177 1.631 . . . . 0.0 117.177 -175.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -143.6 161.89 37.32 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.897 1.679 . . . . 0.0 111.003 178.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.19 148.52 41.7 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.952 1.301 . . . . 0.0 112.486 -176.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 54.5 t -124.11 120.99 26.28 Favored Pre-proline 0 N--CA 1.481 1.113 0 C-N-CA 125.756 1.623 . . . . 0.0 110.861 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -75.9 141.91 24.65 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 124.245 3.297 . . . . 0.0 112.317 -178.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.3 mt -106.45 164.58 11.93 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.52 1.128 . . . . 0.0 113.692 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -146.65 125.71 12.87 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.297 1.439 . . . . 0.0 111.009 173.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 54.46 32.96 17.74 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 125.758 1.623 . . . . 0.0 114.251 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.2 t -96.31 122.38 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 120.849 -1.157 . . . . 0.0 110.179 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -124.12 155.04 39.14 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.488 1.115 . . . . 0.0 113.508 -174.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.5 p -150.49 152.19 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.663 1.185 . . . . 0.0 111.976 -176.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.412 ' CE1' HG23 ' A' ' 60' ' ' ILE . 1.2 t80 -63.31 129.83 41.95 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 122.026 0.917 . . . . 0.0 110.228 167.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.405 HG21 ' HB ' ' A' ' 63' ' ' THR . 5.2 t -131.22 152.17 50.76 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.624 1.97 . . . . 0.0 111.248 178.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.6 tp -105.0 135.0 47.15 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.428 1.091 . . . . 0.0 110.211 175.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -80.8 116.04 20.59 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.769 0.828 . . . . 0.0 110.404 164.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 39.4 mm -71.9 -21.43 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.634 0.774 . . . . 0.0 112.473 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.8 -43.11 31.61 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.91 0.884 . . . . 0.0 113.305 -176.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -107.28 -23.67 12.16 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.405 1.082 . . . . 0.0 111.882 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.9 34.25 38.95 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.519 1.056 . . . . 0.0 113.272 -170.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -99.27 147.18 25.43 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.747 1.274 . . . . 0.0 113.502 -175.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.412 HG23 ' CE1' ' A' ' 51' ' ' TYR . 3.4 mp -91.95 130.88 40.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 C-N-CA 125.999 1.72 . . . . 0.0 110.025 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -157.5 171.43 20.37 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.367 1.467 . . . . 0.0 112.374 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -102.86 141.65 35.32 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.075 1.35 . . . . 0.0 111.047 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.405 ' HB ' HG21 ' A' ' 52' ' ' THR . 1.1 t -141.5 166.44 24.74 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.094 0.958 . . . . 0.0 112.373 176.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -93.61 150.79 20.13 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.941 1.296 . . . . 0.0 112.809 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.56 139.16 46.07 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.563 1.145 . . . . 0.0 111.556 173.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 93.1 p -91.0 -51.93 5.1 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -165.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -155.07 159.56 40.35 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.494 1.517 . . . . 0.0 112.95 177.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.3 mt -96.66 151.59 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 125.803 1.641 . . . . 0.0 109.117 170.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -137.6 148.5 45.9 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.347 1.459 . . . . 0.0 111.569 -174.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.51 149.12 52.38 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.399 1.48 . . . . 0.0 112.423 176.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -155.6 162.41 40.64 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.945 1.298 . . . . 0.0 110.386 176.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -101.74 140.92 35.38 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.08 0.952 . . . . 0.0 110.983 -176.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.8 m -149.05 144.47 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 124.527 1.131 . . . . 0.0 111.522 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -93.01 -36.16 12.88 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 126.278 1.831 . . . . 0.0 111.384 170.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -118.38 130.61 56.09 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.355 1.062 . . . . 0.0 110.981 -171.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.3 tp -139.02 159.14 42.86 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.648 1.979 . . . . 0.0 109.403 -173.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.4 mt -113.07 126.05 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.884 0.874 . . . . 0.0 109.209 176.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -97.03 127.82 43.38 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.08 0.952 . . . . 0.0 111.268 167.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -113.79 133.02 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.467 1.507 . . . . 0.0 109.474 173.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -103.78 146.47 28.58 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 126.753 2.021 . . . . 0.0 111.957 -179.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 68.2 mt -119.48 156.72 29.7 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.785 1.634 . . . . 0.0 113.08 -173.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.9 t -57.45 -29.39 64.16 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.312 1.445 . . . . 0.0 113.913 -178.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 55.7 m -75.44 1.38 14.17 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 173.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.63 43.26 19.4 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-N 119.608 1.095 . . . . 0.0 112.596 -178.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -130.48 152.78 49.5 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.15 1.78 . . . . 0.0 109.667 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 54.3 p -132.37 149.68 52.3 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 174.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 67.3 tp -122.19 134.18 54.72 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 126.501 1.92 . . . . 0.0 110.791 176.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -113.26 117.29 31.44 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.286 1.435 . . . . 0.0 111.962 -178.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.0 m -140.59 158.33 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.275 1.43 . . . . 0.0 112.913 -174.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.6 p -65.61 147.56 98.63 Favored Pre-proline 0 N--CA 1.471 0.61 0 O-C-N 120.975 -1.078 . . . . 0.0 112.766 174.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -59.5 -32.7 96.69 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.385 2.723 . . . . 0.0 113.763 -172.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 64.6 p -75.66 -1.64 25.66 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.774 2.03 . . . . 0.0 114.9 177.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 53.6 t60 -91.07 122.11 66.98 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 124.497 1.119 . . . . 0.0 113.022 -165.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 93' ' ' HIS . 17.3 Cg_exo -73.22 142.28 33.67 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.929 2.419 . . . . 0.0 114.425 -177.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.2 t -125.89 143.14 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 126.73 2.012 . . . . 0.0 109.479 174.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.1 tt -81.21 105.52 12.48 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.703 0.763 . . . . 0.0 110.087 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.8 mp -99.73 159.58 14.95 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.335 1.854 . . . . 0.0 111.381 177.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -113.54 133.31 55.32 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.675 -0.641 . . . . 0.0 111.89 174.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -153.46 96.86 2.08 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.942 1.697 . . . . 0.0 110.224 155.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 56.27 -3.33 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 127.328 2.251 . . . . 0.0 116.898 -167.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.83 163.43 34.52 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.372 1.463 . . . . 0.0 113.333 177.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 67.5 mt -67.93 115.16 7.14 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.066 2.146 . . . . 0.0 110.943 -177.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -141.73 139.81 32.97 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -178.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -98.37 124.53 43.09 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.919 0.887 . . . . 0.0 112.157 -175.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 62.1 t -131.58 131.28 22.74 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 125.196 1.398 . . . . 0.0 110.258 -172.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.43 145.62 77.67 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.583 2.188 . . . . 0.0 111.878 177.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.57 -30.95 14.4 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 176.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.27 -25.93 68.27 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 173.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -102.59 -4.95 24.45 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.032 1.733 . . . . 0.0 112.737 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 98.5 t -69.69 148.76 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.024 0.929 . . . . 0.0 109.647 166.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.92 155.22 71.09 Favored Pre-proline 0 N--CA 1.471 0.585 0 C-N-CA 127.252 2.221 . . . . 0.0 109.987 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.403 ' HD3' HG22 ' A' ' 142' ' ' VAL . 55.6 Cg_endo -65.89 119.48 6.51 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.041 1.827 . . . . 0.0 111.577 -177.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.42 ' H ' ' HB ' ' A' ' 139' ' ' VAL . . . 107.24 6.87 33.45 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.158 1.361 . . . . 0.0 114.705 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -61.15 155.62 20.22 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.275 1.037 . . . . 0.0 111.654 163.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.6 t -93.04 128.46 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.421 1.088 . . . . 0.0 110.071 169.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 28.0 t -103.03 139.03 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 126.381 1.872 . . . . 0.0 109.695 171.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.6 t -91.68 141.34 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.531 0.732 . . . . 0.0 110.772 176.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -168.38 -150.52 6.66 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 121.728 -0.607 . . . . 0.0 114.188 -177.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 120' ' ' ARG . 9.4 p -140.33 168.36 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 126.253 1.821 . . . . 0.0 109.979 175.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.41 ' H ' HG22 ' A' ' 119' ' ' VAL . 35.9 mtp180 . . . . . 0 N--CA 1.467 0.383 0 C-N-CA 125.584 1.554 . . . . 0.0 112.607 -175.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 . . . . . 0 N--CA 1.472 0.663 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 60.9 mt -128.93 174.18 9.74 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.652 1.981 . . . . 0.0 112.297 178.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -140.05 169.53 17.53 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.885 2.474 . . . . 0.0 109.279 171.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -135.5 156.18 49.32 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 119.992 -1.693 . . . . 0.0 111.627 164.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.29 140.09 52.07 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.589 1.156 . . . . 0.0 110.862 -172.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -89.28 133.69 34.36 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.51 0.724 . . . . 0.0 110.985 170.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.42 ' HB ' ' H ' ' A' ' 113' ' ' GLY . 79.4 t -72.15 122.58 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 123.433 0.693 . . . . 0.0 110.229 174.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 47.9 t -77.76 -41.98 35.68 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.652 1.181 . . . . 0.0 112.478 174.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.7 t -160.8 164.67 31.26 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.458 -0.777 . . . . 0.0 112.376 -177.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.403 HG22 ' HD3' ' A' ' 112' ' ' PRO . 5.7 m -135.72 150.71 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.485 1.114 . . . . 0.0 110.999 167.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -152.68 155.94 38.24 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.397 1.079 . . . . 0.0 112.943 173.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 80.5 mt -93.01 130.82 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 168.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 36.3 pt -122.33 149.37 25.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 124.63 1.172 . . . . 0.0 112.371 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.53 102.47 12.88 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.421 1.088 . . . . 0.0 110.069 168.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -84.34 -50.38 7.87 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.211 0.604 . . . . 0.0 111.715 172.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 44.57 57.17 4.62 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.978 1.311 . . . . 0.0 112.504 -173.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -151.63 175.71 12.08 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.712 0.805 . . . . 0.0 112.176 -177.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -67.67 144.42 55.5 Favored 'General case' 0 N--CA 1.463 0.189 0 O-C-N 121.727 -0.608 . . . . 0.0 110.79 162.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.1 m -122.5 152.16 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.521 1.128 . . . . 0.0 109.466 169.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -114.47 157.2 23.25 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 121.781 0.801 . . . . 0.0 112.09 -178.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -155.59 153.94 30.89 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.777 0.831 . . . . 0.0 109.784 -165.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 32.3 tp -136.51 139.44 42.27 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.174 -0.954 . . . . 0.0 111.788 -170.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 28.9 t -113.17 130.04 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.763 0.825 . . . . 0.0 112.608 -168.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 11.0 mm -134.08 85.55 39.51 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 125.728 1.611 . . . . 0.0 109.535 -175.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.98 -13.71 39.08 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.006 2.471 . . . . 0.0 113.766 -177.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -79.43 -40.18 30.58 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.383 0.882 . . . . 0.0 113.383 -177.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 59.1 p -140.14 -6.41 1.24 Allowed 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -171.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 58.01 13.35 2.15 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.203 1.801 . . . . 0.0 115.851 -174.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.03 147.55 24.15 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 120.96 1.709 . . . . 0.0 114.983 -176.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -146.85 159.24 43.76 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.369 1.068 . . . . 0.0 113.539 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.7 mp -99.7 137.96 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.466 1.106 . . . . 0.0 112.643 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -91.0 156.26 44.32 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 126.664 1.986 . . . . 0.0 112.428 172.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -67.75 -19.83 46.85 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.763 2.976 . . . . 0.0 113.74 -174.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 47.6 p30 -73.18 -0.94 15.67 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.063 1.345 . . . . 0.0 113.418 171.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.2 -5.63 68.28 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 126.391 1.948 . . . . 0.0 115.385 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 66.8 mt -84.94 153.54 22.76 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.231 1.516 . . . . 0.0 111.846 -175.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.7 p -110.55 133.04 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.785 0.834 . . . . 0.0 111.798 175.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 24.4 mt -116.2 154.33 30.26 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.831 2.052 . . . . 0.0 110.844 -172.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 8.3 t-80 -111.64 149.75 31.09 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.081 0.952 . . . . 0.0 112.86 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 3.4 t30 . . . . . 0 CA--C 1.55 0.976 0 C-N-CA 123.474 0.709 . . . . 0.0 111.161 162.351 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.608 0 CA-C-O 120.819 0.343 . . . . 0.0 111.6 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.12 156.32 45.37 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.704 1.602 . . . . 0.0 110.748 -169.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.08 145.3 31.3 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.825 1.25 . . . . 0.0 114.203 -177.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -60.64 -23.39 64.73 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.474 1.509 . . . . 0.0 114.216 177.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -92.79 4.37 53.93 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.792 0.837 . . . . 0.0 112.973 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.8 m -71.47 140.14 49.89 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.027 -1.045 . . . . 0.0 111.603 174.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -65.67 155.61 35.44 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.241 1.417 . . . . 0.0 113.648 167.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.7 p -148.11 151.93 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.331 1.052 . . . . 0.0 111.341 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -128.08 126.22 40.78 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.544 1.538 . . . . 0.0 108.254 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -156.92 176.98 12.03 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.396 0.678 . . . . 0.0 111.616 -177.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -134.83 138.36 44.15 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.683 1.193 . . . . 0.0 110.08 178.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -161.66 158.79 26.61 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.425 1.09 . . . . 0.0 110.213 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.3 t0 50.27 37.87 16.14 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.063 0.945 . . . . 0.0 113.26 -175.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.7 m 53.39 41.85 32.07 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.398 1.079 . . . . 0.0 113.372 -176.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.0 p -157.92 142.19 11.61 Favored Pre-proline 0 CA--C 1.545 0.753 0 O-C-N 120.968 -1.083 . . . . 0.0 111.216 174.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.14 149.26 64.21 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 123.003 2.468 . . . . 0.0 112.604 174.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -137.11 139.82 41.5 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 127.209 2.203 . . . . 0.0 109.629 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 42.6 ttm -153.08 106.1 2.98 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.361 -0.837 . . . . 0.0 110.775 -174.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -159.55 -179.3 7.78 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.006 1.322 . . . . 0.0 111.963 -165.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.4 m -71.03 138.02 49.51 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.099 -1.0 . . . . 0.0 110.565 169.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.466 HG12 ' CG ' ' A' ' 152' ' ' TYR . 6.6 tp -55.13 -38.75 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 O-C-N 121.251 -0.906 . . . . 0.0 112.606 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -66.29 -16.78 64.31 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.389 0.995 . . . . 0.0 113.104 -177.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -87.2 -41.13 13.97 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.846 1.258 . . . . 0.0 111.178 173.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 2.1 ppp? -73.4 -36.93 66.09 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 120.914 -1.116 . . . . 0.0 112.062 176.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -55.42 -45.7 76.73 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.447 1.099 . . . . 0.0 110.673 175.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.2 t -60.98 -34.67 75.14 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.1 0.96 . . . . 0.0 111.156 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -65.47 -53.08 47.78 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.457 1.103 . . . . 0.0 110.513 174.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -73.28 -35.36 66.15 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 121.495 -0.753 . . . . 0.0 112.739 -173.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.01 -35.67 80.45 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.262 0.625 . . . . 0.0 110.686 172.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 54.5 m -76.9 -24.08 52.51 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 121.049 -1.032 . . . . 0.0 113.538 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 33.1 mtm -90.54 -52.98 4.63 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.844 1.258 . . . . 0.0 112.062 177.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -100.31 -21.33 15.49 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.34 1.456 . . . . 0.0 112.049 -167.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.84 161.09 31.58 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.632 1.111 . . . . 0.0 113.049 -177.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -102.76 138.38 39.73 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.663 1.185 . . . . 0.0 111.155 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.6 mp -107.4 148.21 36.73 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 128.925 2.89 . . . . 0.0 110.212 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.85 155.68 43.68 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 123.516 2.811 . . . . 0.0 112.53 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -142.46 175.95 9.38 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.857 1.263 . . . . 0.0 112.524 169.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.61 -55.96 25.95 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.555 1.142 . . . . 0.0 112.119 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -105.94 -4.19 20.91 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -175.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -169.7 -135.69 1.95 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 114.61 0.604 . . . . 0.0 114.61 -172.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -144.65 165.37 28.23 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.086 1.754 . . . . 0.0 111.334 -175.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.29 159.33 42.33 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.687 1.595 . . . . 0.0 111.617 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 54.2 t -131.52 117.18 16.47 Favored Pre-proline 0 N--CA 1.48 1.061 0 C-N-CA 125.747 1.619 . . . . 0.0 111.102 178.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -82.46 123.3 3.81 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 124.233 3.289 . . . . 0.0 112.664 -172.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 90.5 mt -97.74 157.48 16.04 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -171.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -134.49 127.04 30.62 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.731 1.613 . . . . 0.0 112.588 171.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 52.32 40.95 30.23 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.246 1.418 . . . . 0.0 113.578 178.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.7 t -104.26 126.62 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.974 1.31 . . . . 0.0 109.543 172.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -126.46 158.74 35.26 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.927 1.291 . . . . 0.0 112.305 -175.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.8 m -143.09 150.18 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 126.334 1.853 . . . . 0.0 111.457 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -69.56 133.07 47.21 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 122.925 1.345 . . . . 0.0 109.666 164.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.3 t -137.13 164.68 27.87 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.7 2.4 . . . . 0.0 110.345 -173.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.3 tp -119.22 135.37 54.72 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.389 1.076 . . . . 0.0 109.194 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -79.1 105.99 10.83 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 163.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.2 mm -70.62 -24.63 25.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.685 0.794 . . . . 0.0 111.579 -175.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.97 -47.56 71.2 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.439 1.496 . . . . 0.0 113.391 -177.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.1 m -107.98 -19.27 13.56 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.599 1.16 . . . . 0.0 112.745 178.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.62 36.87 15.14 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.018 0.818 . . . . 0.0 112.318 -176.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -101.63 134.5 44.67 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.875 1.67 . . . . 0.0 112.591 -177.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 mp -76.64 136.53 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 O-C-N 121.798 -0.564 . . . . 0.0 109.934 178.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.1 ptpt -146.94 168.09 22.36 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.559 1.544 . . . . 0.0 111.781 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -116.05 147.71 40.98 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.414 1.486 . . . . 0.0 109.349 170.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.3 t -147.12 161.3 41.15 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.714 0.806 . . . . 0.0 111.866 -178.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -83.75 137.92 33.51 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.727 1.211 . . . . 0.0 112.027 175.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.34 132.18 44.03 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.229 1.011 . . . . 0.0 109.707 169.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.3 t -94.63 -41.09 9.48 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -163.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -150.51 156.23 41.03 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.923 1.289 . . . . 0.0 110.842 173.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.4 mt -88.49 149.4 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 162.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -126.95 149.2 49.96 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 126.324 1.85 . . . . 0.0 109.742 175.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.52 142.67 47.09 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.661 1.184 . . . . 0.0 111.71 167.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -141.98 153.22 44.13 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.595 1.158 . . . . 0.0 109.868 171.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.5 mmtt -84.06 144.36 29.12 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.813 -0.555 . . . . 0.0 110.661 171.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 20.5 m -143.09 140.51 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 122.457 1.122 . . . . 0.0 111.883 173.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -102.05 -9.11 20.87 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.594 1.558 . . . . 0.0 112.453 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -139.46 131.3 27.6 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.076 1.35 . . . . 0.0 109.952 175.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 13.0 tp -139.52 160.28 40.22 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.996 1.318 . . . . 0.0 109.513 -176.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.9 mt -111.63 127.5 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.851 0.861 . . . . 0.0 109.451 179.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -98.51 120.02 38.21 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.091 0.956 . . . . 0.0 110.786 167.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.4 mp -102.16 127.47 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.316 1.046 . . . . 0.0 108.473 168.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -97.12 151.05 20.16 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.071 1.348 . . . . 0.0 110.838 173.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 59.9 mt -117.21 159.97 21.8 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.263 1.825 . . . . 0.0 112.864 -172.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.7 t -58.8 -25.1 62.8 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.721 1.608 . . . . 0.0 113.368 177.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.8 p -67.33 -11.5 57.8 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.204 1.801 . . . . 0.0 115.236 172.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.78 -1.42 83.52 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 125.193 1.378 . . . . 0.0 114.664 -170.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -95.92 173.12 7.6 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.247 1.819 . . . . 0.0 112.835 -175.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.7 p -143.36 164.25 30.79 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 17.5 tp -139.09 137.07 35.87 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.331 1.452 . . . . 0.0 111.204 174.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.7 mtmt -113.69 117.72 32.33 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.023 1.329 . . . . 0.0 112.803 -176.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.2 m -143.48 153.93 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 125.868 1.667 . . . . 0.0 113.08 -163.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.6 p -70.16 149.76 96.09 Favored Pre-proline 0 N--CA 1.475 0.813 0 O-C-N 120.731 -1.231 . . . . 0.0 112.824 176.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -60.86 -22.76 75.01 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.692 2.928 . . . . 0.0 114.069 -174.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 58.9 p -88.81 -11.49 44.68 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.882 1.673 . . . . 0.0 115.02 177.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -65.74 121.78 77.27 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-N 119.332 0.969 . . . . 0.0 110.887 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -77.35 128.24 9.54 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.709 2.272 . . . . 0.0 112.789 177.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.0 t -100.0 137.55 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 C-N-CA 126.425 1.89 . . . . 0.0 109.692 176.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.33 108.35 13.86 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.6 mp -103.4 146.65 28.17 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.346 1.458 . . . . 0.0 111.904 -177.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -96.92 96.74 8.73 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.181 0.515 . . . . 0.0 111.518 170.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -124.73 73.73 1.29 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 122.808 1.289 . . . . 0.0 110.148 -178.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.4 t70 60.38 4.03 0.64 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 128.165 2.586 . . . . 0.0 114.79 -162.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -177.66 174.63 47.05 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 126.566 2.032 . . . . 0.0 111.28 -175.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.0 mt -76.5 123.36 25.92 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.748 1.219 . . . . 0.0 110.376 174.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -155.09 159.46 40.25 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.007 1.323 . . . . 0.0 112.492 176.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -107.16 131.76 53.79 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.901 0.88 . . . . 0.0 112.367 -175.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 97.1 t -132.72 129.39 21.26 Favored Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 124.099 0.96 . . . . 0.0 110.829 175.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -62.21 144.65 95.87 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.741 2.294 . . . . 0.0 111.944 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.68 -31.57 26.38 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.32 -25.61 67.24 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 172.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -108.37 -2.85 18.79 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.924 1.69 . . . . 0.0 112.945 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 89.6 t -70.0 139.2 20.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 O-C-N 121.542 -0.724 . . . . 0.0 109.563 162.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.18 154.96 74.38 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 126.187 1.795 . . . . 0.0 110.113 -177.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.69 121.14 8.03 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.194 1.93 . . . . 0.0 110.641 -175.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.37 4.95 34.89 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.377 0.989 . . . . 0.0 114.609 -174.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -65.87 175.79 1.84 Allowed 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 118.897 1.349 . . . . 0.0 113.08 168.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.5 p -125.16 123.26 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 125.069 1.348 . . . . 0.0 111.945 -176.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 26.0 t -115.9 131.9 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 125.652 1.581 . . . . 0.0 111.923 -167.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.0 t -88.18 140.88 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 122.063 0.935 . . . . 0.0 111.659 -178.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -170.07 -144.35 4.27 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.906 1.717 . . . . 0.0 111.845 -176.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.3 p -150.49 163.88 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 126.722 2.009 . . . . 0.0 109.131 173.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 . . . . . 0 N--CA 1.477 0.891 0 C-N-CA 123.635 0.774 . . . . 0.0 111.887 169.954 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 . . . . . 0 N--CA 1.475 0.817 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 97.0 mt -138.92 176.94 8.26 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 128.404 2.682 . . . . 0.0 112.321 -178.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -155.63 159.76 39.88 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.963 2.105 . . . . 0.0 111.535 169.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -107.44 151.2 25.87 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.63 1.172 . . . . 0.0 113.0 169.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -135.69 136.79 41.17 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.037 1.335 . . . . 0.0 110.704 -167.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -85.08 134.14 34.2 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.507 -0.745 . . . . 0.0 111.878 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 70.3 t -73.89 126.17 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.167 0.587 . . . . 0.0 110.279 171.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.6 t -81.35 -49.56 10.54 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.146 1.778 . . . . 0.0 112.461 175.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.4 m -156.09 161.34 40.4 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.709 1.204 . . . . 0.0 110.633 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.5 m -134.14 144.35 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.077 0.951 . . . . 0.0 110.337 167.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -152.24 155.79 38.43 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 173.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 85.9 mt -86.81 139.95 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 167.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 21.9 pt -130.52 148.82 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 125.958 1.703 . . . . 0.0 110.94 174.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -86.64 89.72 8.02 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.391 -0.818 . . . . 0.0 109.825 177.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -71.87 -44.0 64.51 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -172.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 51.61 26.8 3.53 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 126.544 1.938 . . . . 0.0 114.832 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 -139.65 175.56 9.47 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.694 1.198 . . . . 0.0 111.662 -173.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -74.19 140.81 45.37 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 124.006 0.922 . . . . 0.0 112.617 177.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 15.0 m -122.68 154.95 27.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 126.131 1.772 . . . . 0.0 109.079 172.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.466 ' CG ' HG12 ' A' ' 21' ' ' ILE . 3.2 p90 -110.34 159.32 17.54 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.558 0.743 . . . . 0.0 112.217 -177.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -137.9 143.84 41.04 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 122.639 0.376 . . . . 0.0 110.356 158.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 60.4 tp -111.39 103.59 11.97 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.526 1.13 . . . . 0.0 110.223 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.0 t -81.05 122.95 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -158.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 24.2 mm -112.42 96.33 35.4 Favored Pre-proline 0 N--CA 1.469 0.513 0 C-N-CA 125.464 1.506 . . . . 0.0 110.035 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.38 -14.77 37.83 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.022 1.815 . . . . 0.0 113.553 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -73.16 -65.34 0.82 Allowed 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 119.145 0.884 . . . . 0.0 111.735 177.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 67.7 p -114.88 -10.72 12.3 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.296 1.439 . . . . 0.0 114.04 -171.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 59.06 18.86 6.71 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.46 1.504 . . . . 0.0 114.243 -167.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -146.63 145.66 30.14 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -175.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -146.46 163.76 34.66 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.62 1.568 . . . . 0.0 112.596 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.0 mp -102.14 134.94 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 O-C-N 121.261 -0.9 . . . . 0.0 111.715 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.32 154.24 54.14 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 124.956 1.302 . . . . 0.0 112.307 170.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.09 -17.05 54.34 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.705 2.937 . . . . 0.0 114.736 -173.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -73.07 -6.01 42.74 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 169.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 111.66 -20.87 22.07 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 126.359 1.933 . . . . 0.0 115.221 172.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 54.4 mt -81.92 145.51 30.28 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 120.1 1.95 . . . . 0.0 113.842 -166.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.5 t -89.26 123.87 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.954 0.902 . . . . 0.0 110.603 176.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 20.8 mt -115.73 137.93 51.61 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.644 1.578 . . . . 0.0 111.184 -174.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -101.16 145.26 29.02 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.149 0.979 . . . . 0.0 111.016 168.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 21.8 m120 . . . . . 0 CA--C 1.547 0.842 0 C-N-CA 124.411 1.084 . . . . 0.0 112.06 170.146 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.58 159.9 41.19 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.867 1.667 . . . . 0.0 112.09 -168.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.27 146.48 39.21 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.177 1.391 . . . . 0.0 113.015 175.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.03 -22.72 64.83 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.098 1.359 . . . . 0.0 114.521 177.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -87.4 -2.54 58.69 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.7 m -65.02 134.87 54.82 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.902 0.881 . . . . 0.0 111.628 175.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -75.07 153.29 38.43 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.009 0.924 . . . . 0.0 112.882 172.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 p -145.56 158.96 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.287 1.035 . . . . 0.0 112.389 -174.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -127.82 133.52 49.41 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.018 1.727 . . . . 0.0 109.456 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -156.28 168.93 25.78 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 170.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -132.91 143.72 49.68 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.321 1.448 . . . . 0.0 111.52 -178.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -157.86 136.41 11.2 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.071 1.349 . . . . 0.0 109.566 175.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.5 t0 50.48 46.91 24.87 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.397 1.479 . . . . 0.0 113.972 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.7 m 61.86 42.4 10.47 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 176.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.1 p -155.05 140.51 12.46 Favored Pre-proline 0 CA--C 1.548 0.871 0 O-C-N 121.027 -1.046 . . . . 0.0 111.514 167.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -91.21 157.42 3.8 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 124.981 3.787 . . . . 0.0 114.802 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 33.1 m80 -136.74 138.17 40.68 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.63 1.972 . . . . 0.0 110.553 -173.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 41.6 ttm -144.64 107.82 4.55 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.666 0.787 . . . . 0.0 111.809 176.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -156.8 -179.97 8.71 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.287 1.435 . . . . 0.0 111.746 -174.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.3 m -67.34 136.81 55.39 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.376 -0.828 . . . . 0.0 110.023 171.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.451 HG12 ' CG ' ' A' ' 152' ' ' TYR . 7.8 tp -54.85 -36.53 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 121.173 -0.954 . . . . 0.0 112.924 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -62.36 -17.96 60.29 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -82.24 -54.44 5.25 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.3 1.44 . . . . 0.0 110.37 174.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -65.26 -32.63 74.39 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.63 -0.669 . . . . 0.0 112.013 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -60.4 -51.12 70.83 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.33 0.652 . . . . 0.0 111.454 169.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.0 t -61.23 -38.07 85.31 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.667 0.787 . . . . 0.0 111.001 -177.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -62.71 -52.72 62.16 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 125.328 1.451 . . . . 0.0 110.845 174.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -72.17 -32.68 67.07 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.199 -0.938 . . . . 0.0 113.2 -176.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.46 -31.22 68.28 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.971 0.908 . . . . 0.0 112.547 174.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.8 t -78.6 -20.65 50.0 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.969 1.308 . . . . 0.0 112.322 176.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 46.4 mtm -96.62 -58.61 2.01 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.913 1.685 . . . . 0.0 113.601 177.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -100.0 -15.14 18.38 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.427 1.491 . . . . 0.0 113.611 -170.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 87.49 162.89 38.37 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 124.433 1.016 . . . . 0.0 114.515 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -110.65 134.45 52.42 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.976 1.311 . . . . 0.0 110.017 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.7 mp -120.75 148.34 48.06 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 125.531 1.532 . . . . 0.0 111.522 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.05 150.6 60.64 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.841 3.028 . . . . 0.0 112.762 -177.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -134.05 168.0 19.61 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.422 1.489 . . . . 0.0 111.653 177.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.19 -50.58 37.41 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.066 1.347 . . . . 0.0 113.886 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -111.44 -2.51 15.54 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.802 1.641 . . . . 0.0 114.18 -175.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.04 -137.16 2.37 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 121.423 -0.798 . . . . 0.0 114.116 -173.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -136.0 161.12 36.55 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.311 1.845 . . . . 0.0 111.516 176.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.95 158.06 44.48 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.323 1.049 . . . . 0.0 112.168 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 84.6 t -126.64 117.01 22.71 Favored Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 125.919 1.688 . . . . 0.0 109.904 176.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.0 130.76 17.11 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 123.993 3.129 . . . . 0.0 112.617 -174.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 89.4 mt -102.05 162.2 13.09 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.179 0.992 . . . . 0.0 113.294 176.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -144.86 124.83 13.51 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.225 1.01 . . . . 0.0 112.235 173.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 47.82 52.56 12.64 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.652 1.581 . . . . 0.0 112.777 -174.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.9 t -113.46 132.87 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 125.059 1.344 . . . . 0.0 110.079 175.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -132.26 151.18 51.95 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.499 1.12 . . . . 0.0 112.899 -166.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.6 m -140.41 153.53 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 126.24 1.816 . . . . 0.0 111.912 177.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -68.13 132.05 46.51 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.134 0.974 . . . . 0.0 109.948 168.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.5 t -134.33 153.56 51.82 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.762 2.025 . . . . 0.0 111.175 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 49.0 tp -103.05 129.33 49.81 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.25 1.02 . . . . 0.0 109.637 175.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -77.23 97.56 4.85 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.678 0.791 . . . . 0.0 109.157 173.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 30.5 mm -59.25 -25.68 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 O-C-N 120.877 -1.14 . . . . 0.0 112.907 -170.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.49 -39.73 31.4 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -176.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.3 m -110.99 -6.36 14.68 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.23 1.012 . . . . 0.0 113.214 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.82 29.24 74.66 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.558 1.551 . . . . 0.0 113.649 177.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -96.37 139.28 32.72 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.772 1.629 . . . . 0.0 112.142 -178.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 mp -80.26 130.03 36.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 125.552 1.541 . . . . 0.0 108.974 173.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -151.6 169.11 22.92 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.976 1.71 . . . . 0.0 111.278 -177.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -100.06 147.67 25.39 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.536 1.134 . . . . 0.0 110.552 170.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.3 t -142.0 168.73 19.05 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.817 0.847 . . . . 0.0 112.085 173.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 -102.01 145.95 28.58 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.492 1.117 . . . . 0.0 113.535 -174.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -108.07 139.18 43.1 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.236 1.414 . . . . 0.0 111.228 178.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.86 -47.02 7.85 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.565 0.746 . . . . 0.0 112.733 -170.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -153.58 156.89 38.85 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.998 1.319 . . . . 0.0 110.834 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.7 mt -86.17 154.39 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 163.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -138.87 151.15 46.74 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.464 1.505 . . . . 0.0 112.264 -175.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -144.63 152.78 40.98 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.003 1.321 . . . . 0.0 113.301 170.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -155.25 160.25 40.67 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.014 1.326 . . . . 0.0 110.586 173.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp -87.78 143.71 27.0 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.278 1.431 . . . . 0.0 111.546 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.5 m -147.13 146.0 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 124.983 1.313 . . . . 0.0 111.556 176.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -95.31 -34.27 12.23 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.539 1.536 . . . . 0.0 111.596 170.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -113.16 119.24 37.12 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.377 1.471 . . . . 0.0 109.421 -169.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.0 tp -133.99 162.09 33.03 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.379 1.472 . . . . 0.0 109.524 -178.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.5 mt -120.5 129.3 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.351 1.061 . . . . 0.0 108.742 177.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -99.28 125.68 44.95 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.346 0.658 . . . . 0.0 110.798 168.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -109.81 127.56 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.821 1.248 . . . . 0.0 109.471 170.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -94.16 146.38 24.03 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.443 1.497 . . . . 0.0 110.92 171.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 49.2 mt -112.73 162.16 16.06 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.597 1.559 . . . . 0.0 111.95 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.0 t -63.74 -16.09 60.26 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.917 1.287 . . . . 0.0 113.3 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 77.9 p -77.89 -9.74 59.22 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.249 2.22 . . . . 0.0 115.167 170.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 83.65 0.69 89.98 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.957 1.265 . . . . 0.0 114.869 -171.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -77.42 148.47 35.44 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.773 1.229 . . . . 0.0 110.635 175.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 93.3 p -122.66 143.26 49.89 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.457 1.103 . . . . 0.0 112.689 173.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.5 tp -127.53 132.13 49.96 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.973 1.709 . . . . 0.0 110.528 178.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.0 mtpt -118.31 115.72 25.28 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.036 1.334 . . . . 0.0 111.751 -171.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.5 m -143.93 154.5 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.131 1.372 . . . . 0.0 113.665 -164.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 21.3 p -66.77 147.96 98.9 Favored Pre-proline 0 N--CA 1.471 0.615 0 O-C-N 121.163 -0.96 . . . . 0.0 112.397 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -57.82 -29.01 84.59 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.199 2.599 . . . . 0.0 113.086 -177.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.2 p -71.83 -20.96 61.75 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.457 2.303 . . . . 0.0 115.782 176.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -71.62 119.65 75.3 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.254 1.022 . . . . 0.0 112.052 -168.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -75.68 129.0 11.37 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.713 2.276 . . . . 0.0 112.341 175.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.0 t -108.95 144.44 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 126.112 1.765 . . . . 0.0 109.113 176.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.21 104.95 12.03 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.141 0.496 . . . . 0.0 109.992 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.7 mp -104.22 160.99 14.42 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.692 1.597 . . . . 0.0 111.541 -178.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -112.38 119.21 37.47 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 176.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.8 mtp-105 -136.89 81.78 1.9 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.098 0.959 . . . . 0.0 110.448 161.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 58.62 10.3 1.38 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.694 1.998 . . . . 0.0 115.515 -170.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 177.67 163.25 29.16 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.892 1.234 . . . . 0.0 113.22 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 46.0 mt -64.01 116.53 5.96 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.725 1.61 . . . . 0.0 111.612 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -144.62 144.46 31.28 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 178.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -95.27 129.82 42.26 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.139 0.976 . . . . 0.0 110.79 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.8 t -133.66 127.96 19.75 Favored Pre-proline 0 N--CA 1.476 0.848 0 C-N-CA 123.891 0.876 . . . . 0.0 110.438 -178.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -65.58 141.04 65.17 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.326 2.017 . . . . 0.0 111.084 177.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.99 -30.4 14.99 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 176.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.04 -17.89 63.81 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 174.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -108.5 -14.83 14.57 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.098 1.359 . . . . 0.0 112.793 175.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 87.2 t -63.47 140.78 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.823 1.249 . . . . 0.0 110.434 173.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.86 153.56 78.77 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 125.93 1.692 . . . . 0.0 110.866 -174.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.435 ' HD3' HG22 ' A' ' 142' ' ' VAL . 50.8 Cg_endo -68.86 116.1 4.29 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.644 2.229 . . . . 0.0 111.543 -169.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 115.29 0.36 22.2 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 124.416 1.008 . . . . 0.0 115.1 -176.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -63.4 156.74 25.07 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 118.583 1.191 . . . . 0.0 111.351 169.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.6 t -97.56 132.32 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 124.539 1.135 . . . . 0.0 110.875 173.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.2 t -106.63 143.5 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 127.308 2.243 . . . . 0.0 110.285 176.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.5 t -95.44 140.85 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.274 1.029 . . . . 0.0 111.153 176.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -165.65 -150.87 6.43 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.551 1.072 . . . . 0.0 112.887 176.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.6 p -134.29 163.0 38.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 127.676 2.39 . . . . 0.0 108.258 173.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 38.9 mtt180 . . . . . 0 N--CA 1.47 0.553 0 C-N-CA 124.623 1.169 . . . . 0.0 109.894 172.364 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 80.3 mt -137.64 161.81 35.47 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.972 1.709 . . . . 0.0 111.161 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -144.08 130.32 19.72 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.726 1.21 . . . . 0.0 113.306 -177.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -79.66 144.38 33.79 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.226 1.41 . . . . 0.0 112.099 175.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -134.05 141.46 47.2 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.068 1.347 . . . . 0.0 110.631 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -102.65 139.25 38.48 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.126 -0.984 . . . . 0.0 112.855 -175.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 78.6 t -76.11 134.71 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.912 0.885 . . . . 0.0 111.491 175.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.9 t -99.06 -39.13 8.67 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.873 2.069 . . . . 0.0 113.525 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 26.2 t -157.41 160.32 38.27 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.58 1.152 . . . . 0.0 110.918 175.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.435 HG22 ' HD3' ' A' ' 112' ' ' PRO . 3.4 m -136.51 147.79 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.599 1.159 . . . . 0.0 110.028 164.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 31.7 ptt-85 -158.41 159.58 35.92 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 162.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 45.6 mt -85.03 134.29 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.065 0.946 . . . . 0.0 108.685 173.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 19.0 pt -126.99 156.27 38.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 125.396 1.478 . . . . 0.0 112.524 -177.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.94 96.79 10.84 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.749 1.22 . . . . 0.0 111.737 173.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -78.46 -53.12 7.59 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.232 -0.917 . . . . 0.0 112.316 176.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 46.53 47.94 14.19 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.513 1.525 . . . . 0.0 112.434 -172.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -151.97 178.52 9.35 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.702 0.801 . . . . 0.0 112.732 -176.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -80.01 139.27 37.04 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.708 1.203 . . . . 0.0 113.042 177.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.5 m -121.25 160.63 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.526 1.93 . . . . 0.0 110.084 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.451 ' CG ' HG12 ' A' ' 21' ' ' ILE . 0.7 OUTLIER -113.78 161.83 17.06 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.988 0.915 . . . . 0.0 112.87 -178.357 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -144.03 163.37 33.7 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.571 0.748 . . . . 0.0 111.156 154.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 46.4 tp -115.17 122.93 47.56 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.277 1.431 . . . . 0.0 109.927 172.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 58.6 t -87.52 121.88 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 O-C-N 121.276 -0.89 . . . . 0.0 111.919 -171.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 20.5 mm -119.56 89.95 41.92 Favored Pre-proline 0 N--CA 1.47 0.531 0 C-N-CA 125.836 1.655 . . . . 0.0 109.371 -177.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -66.21 -23.19 52.72 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.331 2.02 . . . . 0.0 112.524 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 -81.76 -29.57 32.75 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -171.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 69.1 p -140.5 -22.33 0.82 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -177.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 65.33 15.86 10.24 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 127.113 2.165 . . . . 0.0 115.507 -171.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.49 150.52 26.67 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 120.735 -1.228 . . . . 0.0 114.144 -177.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -150.92 170.38 19.45 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.102 1.361 . . . . 0.0 113.09 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.1 mp -106.98 137.42 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.648 1.179 . . . . 0.0 111.937 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.91 157.99 50.9 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.684 1.194 . . . . 0.0 113.097 173.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -66.06 -18.07 56.14 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.302 2.668 . . . . 0.0 113.989 -175.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -83.83 6.07 22.77 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 171.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 107.04 -23.69 26.83 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 126.106 1.813 . . . . 0.0 116.954 165.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 75.2 mt -83.3 151.42 25.6 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 120.252 2.026 . . . . 0.0 114.46 -169.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.0 t -93.83 129.0 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.657 1.183 . . . . 0.0 111.93 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 25.5 mt -119.69 141.74 49.11 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.77 2.028 . . . . 0.0 111.552 -170.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -102.36 134.83 45.02 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 119.206 0.912 . . . . 0.0 112.681 171.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 35.1 m120 . . . . . 0 C--O 1.24 0.569 0 C-N-CA 124.43 1.092 . . . . 0.0 111.733 -169.164 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -142.58 163.64 32.27 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.082 1.353 . . . . 0.0 112.389 -167.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.13 146.05 48.85 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.629 1.572 . . . . 0.0 112.821 175.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.6 ppt_? -63.48 -21.49 66.34 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 176.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -83.79 0.36 47.69 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 176.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.6 m -66.45 147.7 52.92 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.613 1.165 . . . . 0.0 113.112 174.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -88.62 156.28 19.13 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.844 1.657 . . . . 0.0 114.423 175.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.425 HG11 ' SD ' ' A' ' 24' ' ' MET . 3.5 p -145.82 150.66 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.948 0.899 . . . . 0.0 113.217 -172.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -128.42 121.98 30.29 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.788 2.035 . . . . 0.0 107.679 175.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -139.74 174.44 10.51 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.209 1.004 . . . . 0.0 111.422 173.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -131.23 134.46 46.46 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.053 -1.029 . . . . 0.0 111.393 170.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -159.33 166.53 30.97 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.483 1.913 . . . . 0.0 108.257 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.0 t70 55.5 22.42 5.09 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 120.083 1.311 . . . . 0.0 113.093 -167.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.2 m 56.84 36.17 27.34 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.646 1.978 . . . . 0.0 114.185 -170.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.2 p -152.82 143.77 15.89 Favored Pre-proline 0 CA--C 1.547 0.85 0 O-C-N 120.534 -1.354 . . . . 0.0 112.141 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -70.03 140.98 42.94 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.74 2.96 . . . . 0.0 113.622 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -129.16 137.05 50.94 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 127.519 2.328 . . . . 0.0 110.339 -178.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 45.4 mtp -143.76 119.2 10.3 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.266 1.426 . . . . 0.0 112.093 -174.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -164.43 -173.51 3.1 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.617 1.567 . . . . 0.0 112.709 -172.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 65.4 m -74.53 141.57 44.83 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.089 -1.007 . . . . 0.0 111.127 167.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.451 HG12 ' CG ' ' A' ' 152' ' ' TYR . 7.4 tp -57.53 -38.21 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 121.256 -0.903 . . . . 0.0 112.857 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -60.92 -28.41 68.91 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.733 0.697 . . . . 0.0 111.913 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -80.49 -43.91 20.04 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 124.135 0.974 . . . . 0.0 110.974 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.425 ' SD ' HG11 ' A' ' 8' ' ' VAL . 12.9 ptm -65.19 -35.14 80.16 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.322 0.964 . . . . 0.0 111.625 173.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -60.83 -48.48 81.62 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.356 0.662 . . . . 0.0 110.557 173.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.1 t -59.78 -39.55 85.27 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.815 1.246 . . . . 0.0 111.39 177.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.3 ttmm -61.31 -56.73 17.21 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.414 1.486 . . . . 0.0 110.793 174.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -74.6 -33.05 62.53 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.108 -0.995 . . . . 0.0 112.564 -172.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.63 -19.91 62.78 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.975 0.91 . . . . 0.0 112.522 172.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 51.0 m -90.02 -18.98 24.97 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.252 1.421 . . . . 0.0 113.678 171.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 72.0 mtm -98.27 -44.91 6.38 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.893 1.277 . . . . 0.0 113.334 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -112.11 -23.77 10.26 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.592 1.557 . . . . 0.0 112.962 -169.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.32 162.98 38.97 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.693 1.616 . . . . 0.0 114.172 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -107.53 133.78 51.5 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.256 1.022 . . . . 0.0 110.94 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.3 mp -118.51 150.83 48.78 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 126.921 2.088 . . . . 0.0 110.936 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -75.53 148.03 32.76 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.693 2.929 . . . . 0.0 112.429 177.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -131.21 169.3 16.13 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.518 1.927 . . . . 0.0 111.595 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.58 -56.34 7.36 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.569 1.548 . . . . 0.0 114.613 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -105.33 -6.57 19.51 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -168.37 -137.84 2.33 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 123.716 0.674 . . . . 0.0 113.918 -170.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -131.84 155.89 47.02 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.51 1.524 . . . . 0.0 111.498 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.31 148.77 41.88 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.041 0.936 . . . . 0.0 112.214 -177.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 84.2 t -118.38 111.14 38.49 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 125.593 1.557 . . . . 0.0 109.476 176.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.58 140.23 51.25 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 124.569 3.513 . . . . 0.0 111.231 -177.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.5 mt -107.5 163.42 13.08 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.153 0.981 . . . . 0.0 113.528 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -137.63 116.34 12.2 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 127.58 2.352 . . . . 0.0 110.238 176.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 52.69 38.66 26.76 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 126.83 2.052 . . . . 0.0 115.133 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.6 t -99.92 133.71 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.18 1.392 . . . . 0.0 110.857 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -127.95 159.88 33.6 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.275 1.83 . . . . 0.0 113.319 -175.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.8 m -138.32 161.2 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 127.257 2.223 . . . . 0.0 111.593 174.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.464 ' CE1' HG23 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -76.38 131.05 38.9 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 122.02 0.914 . . . . 0.0 108.933 163.115 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.8 t -132.32 151.25 51.93 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.116 1.766 . . . . 0.0 111.054 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.6 tp -109.51 136.29 49.15 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.574 1.15 . . . . 0.0 109.546 174.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -85.38 115.9 23.39 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 118.57 -0.729 . . . . 0.0 109.762 160.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.2 mm -66.36 -28.5 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 119.685 1.129 . . . . 0.0 112.331 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.43 -47.86 31.09 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -168.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 64.3 m -96.06 -17.77 20.68 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.247 -0.908 . . . . 0.0 112.075 169.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.84 32.37 33.11 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.552 1.072 . . . . 0.0 112.856 -176.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -88.35 119.79 29.1 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 118.246 1.023 . . . . 0.0 111.865 -172.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.464 HG23 ' CE1' ' A' ' 51' ' ' TYR . 3.2 mp -72.98 125.64 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 167.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -152.15 175.39 12.63 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.658 1.183 . . . . 0.0 112.178 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -99.1 148.76 23.72 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.363 1.465 . . . . 0.0 110.601 172.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.7 t -143.93 158.72 43.51 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 118.547 0.612 . . . . 0.0 111.554 165.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.7 ptt85 -67.21 156.04 37.29 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.862 0.865 . . . . 0.0 112.576 170.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -112.99 138.34 50.02 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.704 0.802 . . . . 0.0 110.198 160.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.9 t -88.71 -47.62 8.11 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.282 1.033 . . . . 0.0 112.697 -167.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -154.46 156.59 37.02 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.141 1.776 . . . . 0.0 111.549 173.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.4 mt -86.01 153.35 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 165.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -133.93 148.14 51.17 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.43 1.492 . . . . 0.0 112.113 -172.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -142.77 149.08 38.21 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 165.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -146.13 162.5 37.84 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.937 1.695 . . . . 0.0 110.23 171.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.51 147.26 23.14 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.75 0.82 . . . . 0.0 112.965 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.5 m -149.05 145.96 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.505 1.522 . . . . 0.0 111.653 177.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -93.54 -31.13 14.66 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.823 1.249 . . . . 0.0 112.395 173.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -128.0 137.11 52.09 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 122.147 0.975 . . . . 0.0 112.648 -176.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.4 tp -137.79 165.45 26.43 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.715 2.006 . . . . 0.0 110.333 -174.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.6 mt -119.15 127.82 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.555 1.142 . . . . 0.0 109.532 175.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -95.25 124.52 39.34 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.809 0.843 . . . . 0.0 111.293 163.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -106.62 127.77 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 125.574 1.55 . . . . 0.0 108.835 168.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -96.59 145.77 25.44 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.075 1.35 . . . . 0.0 111.075 173.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 81.8 mt -104.92 162.29 13.46 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.538 1.935 . . . . 0.0 111.59 -178.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.3 t -60.03 -28.86 68.1 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.346 1.458 . . . . 0.0 111.915 177.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 97.3 p -63.27 -12.81 31.9 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.707 1.603 . . . . 0.0 114.646 169.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.1 2.47 89.39 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.695 1.616 . . . . 0.0 114.06 -170.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -88.86 173.26 8.62 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.494 1.518 . . . . 0.0 111.891 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 86.8 p -143.0 148.82 37.41 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 -171.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 61.3 tp -120.7 131.65 54.66 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 127.577 2.351 . . . . 0.0 109.787 174.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -122.89 113.24 18.86 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.15 1.38 . . . . 0.0 111.697 -176.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.9 m -145.06 155.46 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 125.081 1.353 . . . . 0.0 113.286 -163.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.2 p -68.08 147.05 98.39 Favored Pre-proline 0 N--CA 1.473 0.709 0 O-C-N 121.404 -0.81 . . . . 0.0 112.417 176.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -60.79 -33.99 92.17 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.775 2.317 . . . . 0.0 113.265 -170.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.4 p -78.83 -7.48 57.91 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.829 1.651 . . . . 0.0 114.946 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -86.99 124.75 68.31 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.373 1.069 . . . . 0.0 113.353 -168.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -72.66 143.55 37.98 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.337 2.691 . . . . 0.0 115.479 -178.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.7 t -122.77 146.87 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 126.777 2.031 . . . . 0.0 109.693 174.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 31.0 tp -84.68 114.6 22.14 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.285 0.634 . . . . 0.0 111.358 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.7 mp -113.87 153.66 28.82 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.285 1.834 . . . . 0.0 112.686 -172.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -103.34 101.63 11.55 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.804 1.641 . . . . 0.0 110.733 171.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 76.5 mtt-85 -136.17 74.14 1.49 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.535 1.134 . . . . 0.0 110.722 173.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 61.7 2.4 0.71 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 126.486 1.914 . . . . 0.0 115.748 -167.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -176.3 167.89 39.73 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.456 1.503 . . . . 0.0 112.115 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 75.6 mt -81.96 108.58 15.58 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.132 1.373 . . . . 0.0 110.727 -178.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -140.71 144.02 35.36 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.527 0.731 . . . . 0.0 112.765 -168.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -96.57 120.59 37.17 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.673 1.189 . . . . 0.0 111.118 -176.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 62.1 t -130.08 131.99 23.81 Favored Pre-proline 0 N--CA 1.482 1.162 0 C-N-CA 124.777 1.231 . . . . 0.0 110.43 -176.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -67.42 146.99 76.62 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.344 2.696 . . . . 0.0 112.257 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.41 -31.71 23.74 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 176.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.8 -23.39 66.69 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 173.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -104.35 0.89 29.63 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.02 1.728 . . . . 0.0 112.053 174.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 84.0 t -74.88 141.37 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 O-C-N 120.796 -1.19 . . . . 0.0 109.773 167.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.52 154.39 81.63 Favored Pre-proline 0 N--CA 1.472 0.649 0 C-N-CA 127.334 2.254 . . . . 0.0 110.436 -176.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.417 ' HD3' HG22 ' A' ' 142' ' ' VAL . 59.6 Cg_endo -66.27 115.03 3.27 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 121.664 1.576 . . . . 0.0 109.613 177.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.37 3.41 24.18 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.745 1.164 . . . . 0.0 115.542 -177.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -60.13 161.89 6.42 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 118.65 1.225 . . . . 0.0 111.85 161.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 24.5 t -118.22 128.7 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.5 1.52 . . . . 0.0 110.225 174.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.0 t -104.09 145.11 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 127.16 2.184 . . . . 0.0 110.606 -175.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 43.7 t -87.77 137.76 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.376 1.07 . . . . 0.0 111.112 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -167.32 -146.65 4.97 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 115.262 0.865 . . . . 0.0 115.262 179.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.8 p -155.75 165.04 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 126.658 1.983 . . . . 0.0 108.639 176.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 . . . . . 0 N--CA 1.473 0.698 0 C-N-CA 124.871 1.268 . . . . 0.0 111.773 176.884 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 . . . . . 0 N--CA 1.475 0.822 0 CA-C-O 119.566 -0.254 . . . . 0.0 111.529 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 85.8 mt -149.0 151.46 34.59 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.767 2.027 . . . . 0.0 112.561 -174.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -136.5 171.63 14.2 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.208 1.803 . . . . 0.0 111.386 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -131.01 157.06 44.03 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 120.631 -1.293 . . . . 0.0 112.724 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -138.34 123.83 19.56 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.576 1.15 . . . . 0.0 110.2 -167.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -84.67 145.63 27.88 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.952 -1.092 . . . . 0.0 112.307 -178.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.5 t -77.55 133.1 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.285 1.034 . . . . 0.0 111.699 175.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 26.9 t -87.16 -46.31 9.87 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.625 1.97 . . . . 0.0 112.405 171.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 29.6 t -157.26 160.72 38.91 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.42 0.688 . . . . 0.0 111.788 -173.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.417 HG22 ' HD3' ' A' ' 112' ' ' PRO . 4.0 m -135.36 145.73 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.285 1.034 . . . . 0.0 111.61 167.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -152.73 151.23 30.28 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.551 1.14 . . . . 0.0 113.344 172.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 75.4 mt -89.0 138.86 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.953 1.301 . . . . 0.0 109.051 169.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 44.9 pt -131.65 146.62 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.936 1.694 . . . . 0.0 111.62 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -80.07 104.92 10.96 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.668 -0.645 . . . . 0.0 109.549 165.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -81.62 -49.01 11.01 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.077 -1.015 . . . . 0.0 113.518 174.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 44.33 52.71 7.16 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.069 1.348 . . . . 0.0 111.989 -173.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -150.02 176.85 10.41 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.808 0.843 . . . . 0.0 111.97 -177.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -75.52 146.94 40.15 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.565 -0.709 . . . . 0.0 111.638 168.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 6.8 m -126.23 158.22 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.799 1.64 . . . . 0.0 109.47 172.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.451 ' CG ' HG12 ' A' ' 21' ' ' ILE . 0.6 OUTLIER -110.89 160.75 16.49 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.294 0.637 . . . . 0.0 112.577 -175.753 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -141.91 163.17 33.63 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.914 0.886 . . . . 0.0 110.22 157.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 54.8 tp -123.98 123.92 41.44 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.502 -1.374 . . . . 0.0 110.235 176.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 42.4 t -90.6 122.13 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -165.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 42.1 mm -124.1 84.31 55.39 Favored Pre-proline 0 N--CA 1.47 0.539 0 C-N-CA 126.196 1.798 . . . . 0.0 108.832 -172.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -66.83 -17.57 52.09 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.759 2.306 . . . . 0.0 113.752 -176.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -83.8 -32.78 25.16 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -174.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 80.9 p -140.74 -12.46 0.99 Allowed 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 -174.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 60.6 m80 56.23 26.23 10.15 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 -173.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.31 148.23 25.59 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 120.557 -1.34 . . . . 0.0 113.21 178.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -148.8 163.34 37.67 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.914 1.286 . . . . 0.0 112.211 -178.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.5 mp -112.67 137.73 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.864 0.866 . . . . 0.0 111.973 -176.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.89 157.34 51.77 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 125.38 1.472 . . . . 0.0 113.15 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.14 -17.87 50.78 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.549 2.833 . . . . 0.0 113.748 -176.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -74.58 -10.3 59.41 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 171.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 112.91 -24.66 12.6 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 125.743 1.64 . . . . 0.0 115.798 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.43 139.92 49.88 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.625 1.712 . . . . 0.0 113.799 -167.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 20.3 t -87.09 123.99 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.02 0.928 . . . . 0.0 110.958 173.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 33.5 mt -115.86 150.26 37.31 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.141 1.776 . . . . 0.0 111.709 -173.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -88.76 159.86 17.57 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.583 0.753 . . . . 0.0 110.79 170.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 . . . . . 0 CA--C 1.54 0.568 0 O-C-N 121.141 -0.974 . . . . 0.0 109.601 163.635 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -139.72 163.32 32.91 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.636 1.974 . . . . 0.0 111.082 -172.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.03 146.16 51.04 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.86 1.264 . . . . 0.0 113.383 -177.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -62.91 -19.88 64.63 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.929 1.292 . . . . 0.0 113.426 174.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -75.55 -10.44 59.45 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.248 1.819 . . . . 0.0 112.953 176.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.8 m -70.96 144.39 50.55 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 121.142 -0.974 . . . . 0.0 113.316 -175.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -91.72 150.88 20.9 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.055 1.742 . . . . 0.0 113.305 176.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.3 p -148.74 156.3 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 124.202 1.001 . . . . 0.0 113.484 -167.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -136.95 125.99 24.41 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.522 1.929 . . . . 0.0 109.042 -174.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -150.86 175.49 11.97 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 119.741 1.155 . . . . 0.0 113.154 -177.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -130.07 144.56 51.41 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.111 1.365 . . . . 0.0 112.933 171.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -161.97 162.43 29.0 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.749 2.02 . . . . 0.0 109.666 168.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.5 t0 53.77 28.74 8.61 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.372 1.469 . . . . 0.0 114.292 -177.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.8 m 59.33 38.0 23.23 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.431 1.892 . . . . 0.0 114.571 -172.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.6 p -151.98 140.63 13.66 Favored Pre-proline 0 CA--C 1.544 0.728 0 O-C-N 120.501 -1.375 . . . . 0.0 112.609 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -72.1 151.03 55.07 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 123.336 2.69 . . . . 0.0 113.106 175.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -134.44 140.63 46.39 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.281 2.232 . . . . 0.0 110.708 -176.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 36.7 ttm -141.75 121.9 13.83 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.396 1.078 . . . . 0.0 110.776 179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -163.83 -177.01 4.88 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.487 1.515 . . . . 0.0 112.983 -179.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.6 m -77.04 144.26 38.74 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.005 -1.06 . . . . 0.0 110.146 167.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.447 HG12 ' CG ' ' A' ' 152' ' ' TYR . 9.3 tp -57.31 -38.22 60.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -61.43 -24.18 66.36 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -76.5 -51.06 12.45 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.909 1.283 . . . . 0.0 110.862 175.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 19.9 ptm -68.86 -32.69 72.54 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.753 -0.592 . . . . 0.0 112.361 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -59.84 -51.04 71.44 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.216 0.606 . . . . 0.0 110.701 173.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.0 t -66.54 -34.86 78.85 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.412 0.551 . . . . 0.0 111.264 -176.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -61.12 -54.45 44.42 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.124 1.37 . . . . 0.0 110.305 174.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -70.68 -36.42 73.31 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.367 -0.833 . . . . 0.0 112.763 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.4 -33.01 74.75 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.971 0.908 . . . . 0.0 112.337 176.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.1 t -75.9 -32.27 59.57 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.923 0.889 . . . . 0.0 112.463 176.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 37.9 mtm -85.62 -47.21 10.05 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.308 1.443 . . . . 0.0 113.728 -177.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 48.3 m-20 -109.97 -20.39 12.75 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.49 1.516 . . . . 0.0 113.455 -171.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.13 163.97 39.52 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 122.247 0.915 . . . . 0.0 114.603 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -110.4 133.24 53.46 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.278 1.831 . . . . 0.0 110.175 -178.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.2 mp -116.05 146.92 38.16 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 126.79 2.036 . . . . 0.0 111.691 -176.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.65 141.55 19.73 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 124.589 3.526 . . . . 0.0 114.29 -173.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -133.97 166.18 23.31 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.669 1.988 . . . . 0.0 111.839 -177.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.45 -52.67 35.89 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.719 1.208 . . . . 0.0 114.036 -177.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -105.87 -4.78 20.33 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -173.25 -132.75 1.57 Allowed Glycine 0 CA--C 1.529 0.92 0 O-C-N 120.758 -1.214 . . . . 0.0 115.335 -174.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -141.04 153.58 45.57 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.266 1.427 . . . . 0.0 112.658 -173.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -132.59 153.84 50.63 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.389 1.476 . . . . 0.0 112.18 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.2 t -125.08 118.33 25.46 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 125.393 1.477 . . . . 0.0 110.86 177.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.57 136.88 24.32 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 124.521 3.481 . . . . 0.0 112.331 -175.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 70.6 mt -104.17 166.58 10.32 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.413 1.085 . . . . 0.0 112.514 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -141.45 118.68 11.38 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.519 1.928 . . . . 0.0 109.703 177.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 51.31 51.63 16.48 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 126.031 1.732 . . . . 0.0 114.095 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.1 t -113.54 133.06 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.761 1.224 . . . . 0.0 112.021 -177.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -127.94 157.29 40.97 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.882 1.273 . . . . 0.0 113.755 -175.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.2 m -144.11 164.12 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 127.46 2.304 . . . . 0.0 111.634 177.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.486 ' CE1' HG23 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -82.94 133.71 35.1 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.681 1.192 . . . . 0.0 110.102 171.461 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.2 t -131.8 153.62 49.94 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 127.395 2.278 . . . . 0.0 112.104 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 32.9 tp -106.09 133.61 50.53 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.177 0.991 . . . . 0.0 110.973 169.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -90.42 95.6 10.25 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.549 1.539 . . . . 0.0 111.501 175.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.4 mm -61.12 -18.75 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 124.8 1.24 . . . . 0.0 113.43 -174.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.56 -37.13 84.31 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.615 1.566 . . . . 0.0 114.334 172.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.6 p -127.56 -26.82 2.94 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.778 1.231 . . . . 0.0 113.545 -167.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.13 29.1 65.11 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.905 1.241 . . . . 0.0 113.38 -167.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -77.54 125.04 28.72 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.312 1.056 . . . . 0.0 110.615 167.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.486 HG23 ' CE1' ' A' ' 51' ' ' TYR . 1.9 mp -79.71 123.9 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 165.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -148.71 167.78 24.64 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -173.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -92.93 145.13 24.61 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.271 1.428 . . . . 0.0 110.005 174.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.5 t -144.49 155.43 43.7 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.522 1.129 . . . . 0.0 111.65 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.56 137.55 32.24 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.92 143.94 29.56 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.526 1.13 . . . . 0.0 110.666 171.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.6 t -99.2 -50.17 4.23 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.636 1.174 . . . . 0.0 112.885 -170.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -154.41 157.74 38.96 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.246 1.018 . . . . 0.0 112.286 176.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.7 mt -84.42 150.18 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 165.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -138.6 150.76 46.63 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.351 1.46 . . . . 0.0 111.731 -175.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -143.18 154.4 43.83 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 168.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -143.06 166.01 25.82 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.868 1.667 . . . . 0.0 109.789 172.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.7 tmtp? -100.68 136.57 40.34 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.209 0.603 . . . . 0.0 111.062 178.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.6 m -142.76 144.69 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 122.614 1.197 . . . . 0.0 111.021 178.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -93.5 -33.96 13.57 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 125.228 1.411 . . . . 0.0 111.148 173.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -121.17 137.35 54.71 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 124.418 1.087 . . . . 0.0 110.34 -173.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.4 tp -141.53 159.97 41.11 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 125.386 1.474 . . . . 0.0 109.191 -175.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.5 mt -109.36 124.25 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 175.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -93.5 125.92 38.36 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.891 0.877 . . . . 0.0 110.169 166.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.2 mp -110.84 124.84 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 124.512 1.125 . . . . 0.0 108.372 168.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -92.31 144.52 25.3 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.826 1.25 . . . . 0.0 110.202 173.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 59.9 mt -103.58 155.67 18.37 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 126.659 1.984 . . . . 0.0 110.263 178.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.8 t -66.37 -20.54 66.1 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.175 0.99 . . . . 0.0 112.949 -176.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 86.8 p -63.02 -18.48 63.38 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.111 1.765 . . . . 0.0 114.184 165.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 99.78 -7.35 59.19 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 126.254 1.883 . . . . 0.0 114.523 -174.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -86.18 171.12 11.55 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.475 1.51 . . . . 0.0 111.573 -178.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 95.2 p -142.81 157.6 44.46 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -177.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 14.3 tp -128.59 138.88 52.44 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.918 1.687 . . . . 0.0 109.969 171.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -120.78 116.97 26.26 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.242 1.417 . . . . 0.0 111.54 -176.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.4 m -140.21 153.29 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.058 1.343 . . . . 0.0 112.566 -164.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.9 p -67.79 146.68 98.48 Favored Pre-proline 0 N--CA 1.469 0.476 0 O-C-N 121.125 -0.985 . . . . 0.0 111.832 172.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -58.68 -18.69 41.97 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 124.279 3.319 . . . . 0.0 114.702 -175.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.7 p -88.81 -8.44 54.36 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.242 1.817 . . . . 0.0 114.987 177.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -71.61 120.96 82.97 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 119.526 1.057 . . . . 0.0 111.589 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -79.17 122.74 5.34 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.152 2.568 . . . . 0.0 112.537 176.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 40.1 t -93.72 141.17 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.927 1.691 . . . . 0.0 110.04 177.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 32.7 tp -80.01 104.65 10.73 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.518 0.599 . . . . 0.0 111.091 176.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -92.69 157.65 16.35 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.474 1.51 . . . . 0.0 112.323 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -121.17 71.1 0.94 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.684 0.754 . . . . 0.0 111.203 -177.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 73.0 mtp85 -119.65 74.08 0.99 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.651 1.18 . . . . 0.0 110.888 -169.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 58.22 6.07 0.49 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 127.337 2.255 . . . . 0.0 115.212 -166.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -178.35 157.9 22.16 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 125.693 1.616 . . . . 0.0 112.437 -177.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 48.4 mt -76.25 115.16 15.72 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.82 0.848 . . . . 0.0 109.871 177.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -146.0 141.74 27.96 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.946 0.898 . . . . 0.0 111.859 -173.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -101.32 111.82 24.16 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.777 0.831 . . . . 0.0 110.857 -175.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 54.1 t -117.85 127.78 26.41 Favored Pre-proline 0 N--CA 1.478 0.952 0 C-N-CA 123.953 0.901 . . . . 0.0 109.646 -173.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -64.44 143.79 83.41 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.192 1.928 . . . . 0.0 111.123 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.23 -31.63 21.4 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 175.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.17 -14.88 62.58 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 174.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -114.16 3.35 15.17 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.444 1.497 . . . . 0.0 112.22 175.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.2 t -78.2 149.06 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 125.185 1.394 . . . . 0.0 110.169 168.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.64 156.8 79.18 Favored Pre-proline 0 N--CA 1.47 0.527 0 C-N-CA 128.409 2.684 . . . . 0.0 108.857 178.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.401 ' HD3' HG22 ' A' ' 142' ' ' VAL . 60.5 Cg_endo -67.81 138.9 46.15 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.098 1.865 . . . . 0.0 111.765 -177.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 102.5 -1.6 49.65 Favored Glycine 0 N--CA 1.47 0.923 0 C-N-CA 124.452 1.025 . . . . 0.0 115.418 175.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.67 177.68 8.71 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 118.526 1.163 . . . . 0.0 114.116 176.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.3 p -122.54 122.5 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -168.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.8 t -102.84 144.05 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 127.426 2.29 . . . . 0.0 110.877 -177.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.8 t -89.17 142.95 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.472 1.109 . . . . 0.0 111.563 175.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -160.87 -152.48 6.61 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.369 0.985 . . . . 0.0 113.879 177.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.9 p -141.39 157.66 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.938 1.695 . . . . 0.0 110.058 172.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 . . . . . 0 N--CA 1.47 0.563 0 C-N-CA 123.995 0.918 . . . . 0.0 111.052 176.407 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 . . . . . 0 N--CA 1.481 1.117 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 89.7 mt -143.61 163.71 32.46 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.83 1.652 . . . . 0.0 113.15 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -131.94 171.87 13.04 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 128.214 2.605 . . . . 0.0 110.742 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -135.24 158.43 44.39 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.836 -1.165 . . . . 0.0 113.496 169.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -134.92 136.14 42.08 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.544 1.538 . . . . 0.0 109.975 -174.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -99.41 138.79 36.0 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.282 1.033 . . . . 0.0 112.019 -177.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 93.8 t -77.18 126.95 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 O-C-N 121.062 -1.024 . . . . 0.0 111.614 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 12.3 t -83.24 -44.7 14.68 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.559 1.944 . . . . 0.0 113.022 175.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 31.0 t -158.57 161.24 37.25 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.941 1.296 . . . . 0.0 110.039 -177.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.401 HG22 ' HD3' ' A' ' 112' ' ' PRO . 5.4 m -133.92 147.86 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.117 0.967 . . . . 0.0 110.306 166.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -154.87 154.58 32.91 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.417 0.687 . . . . 0.0 112.247 169.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 66.8 mt -86.06 135.01 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 165.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 23.6 pt -123.64 166.79 18.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 125.773 1.629 . . . . 0.0 111.305 -177.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -103.74 98.7 8.53 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.011 1.325 . . . . 0.0 110.975 175.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -80.47 -57.22 3.69 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.463 -0.773 . . . . 0.0 112.016 177.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 45.7 51.59 10.1 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.326 1.05 . . . . 0.0 112.135 -172.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -150.21 173.91 13.4 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.921 1.289 . . . . 0.0 111.651 174.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -71.06 136.76 48.47 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.06 0.944 . . . . 0.0 112.502 173.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.3 m -117.23 155.47 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 125.673 1.589 . . . . 0.0 110.093 174.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.447 ' CG ' HG12 ' A' ' 21' ' ' ILE . 0.7 OUTLIER -112.1 160.68 17.29 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -172.834 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -143.17 160.31 40.68 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.527 0.731 . . . . 0.0 110.34 156.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 56.0 tp -124.3 109.59 13.55 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.874 1.269 . . . . 0.0 110.106 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 85.8 t -83.79 123.54 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -159.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 11.6 mm -116.86 88.88 27.35 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.197 1.399 . . . . 0.0 110.33 -176.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -65.5 -16.44 53.96 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.871 2.381 . . . . 0.0 113.25 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -78.11 -45.51 23.18 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.016 -1.052 . . . . 0.0 113.19 178.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 76.8 p -140.54 -2.9 1.35 Allowed 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -171.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 42.0 m-70 59.23 7.09 0.82 Allowed 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -149.2 145.52 27.18 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 120.886 -1.134 . . . . 0.0 112.235 -175.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -146.23 151.5 37.68 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.759 1.224 . . . . 0.0 112.476 -176.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.9 mp -99.97 140.01 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.053 0.941 . . . . 0.0 111.789 -176.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -91.04 157.99 42.26 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 126.482 1.913 . . . . 0.0 112.949 176.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.99 -19.24 57.92 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.785 2.99 . . . . 0.0 113.487 -176.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -80.86 3.77 21.5 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.036 1.334 . . . . 0.0 113.682 174.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.89 -17.94 58.36 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 126.233 1.873 . . . . 0.0 116.029 175.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 54.8 mt -77.78 148.29 34.88 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.387 1.594 . . . . 0.0 112.899 -175.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.8 p -96.41 136.92 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.284 1.034 . . . . 0.0 112.394 174.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 40.5 mt -115.54 145.91 42.21 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 127.236 2.215 . . . . 0.0 110.155 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -134.43 130.0 36.13 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.802 1.241 . . . . 0.0 111.12 -174.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 12.4 m120 . . . . . 0 N--CA 1.475 0.806 0 C-N-CA 123.707 0.803 . . . . 0.0 112.374 -178.671 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 110.854 -0.054 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.44 159.0 43.19 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.36 1.464 . . . . 0.0 111.446 -168.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.22 147.74 46.91 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.879 0.872 . . . . 0.0 113.02 177.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -58.01 -23.9 56.01 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 174.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -82.96 0.54 44.1 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.3 m -72.74 142.46 48.15 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.356 -0.84 . . . . 0.0 112.407 176.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -79.89 158.61 26.65 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.08 -1.013 . . . . 0.0 113.38 169.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.6 p -147.98 157.13 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.887 0.875 . . . . 0.0 111.842 -174.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -126.51 135.84 51.83 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.358 1.863 . . . . 0.0 108.853 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -155.23 179.99 8.62 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.946 0.898 . . . . 0.0 112.057 174.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -135.31 143.21 46.06 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.732 1.213 . . . . 0.0 109.618 171.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -156.66 152.68 27.43 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.385 1.474 . . . . 0.0 109.221 178.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.1 t0 53.94 35.06 20.96 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.669 1.122 . . . . 0.0 113.304 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.0 m 53.8 37.61 26.75 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.736 1.615 . . . . 0.0 114.241 -172.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.3 p -148.7 138.57 12.81 Favored Pre-proline 0 CA--C 1.549 0.924 0 O-C-N 120.033 -1.667 . . . . 0.0 112.131 177.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.42 153.88 69.87 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.756 2.971 . . . . 0.0 113.187 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 47.0 m80 -138.78 138.91 38.04 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.189 2.196 . . . . 0.0 110.464 -175.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 40.1 ttm -152.96 114.67 4.29 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.536 1.134 . . . . 0.0 110.987 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -160.26 -179.49 7.77 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.976 1.31 . . . . 0.0 111.661 -175.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 m -67.43 138.3 56.54 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.065 -1.022 . . . . 0.0 110.135 169.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.9 tp -58.03 -36.44 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 121.256 -0.903 . . . . 0.0 112.269 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -61.72 -23.02 65.87 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.521 0.729 . . . . 0.0 112.909 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -83.4 -49.39 9.38 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.657 0.783 . . . . 0.0 110.014 177.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -66.02 -34.66 78.6 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.586 -0.696 . . . . 0.0 112.336 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -59.75 -51.81 68.16 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.769 0.828 . . . . 0.0 111.346 169.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.6 t -61.3 -36.13 79.24 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.514 0.726 . . . . 0.0 111.266 -178.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -63.46 -55.74 21.73 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.494 1.517 . . . . 0.0 111.206 172.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -72.15 -32.47 66.91 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 121.147 -0.971 . . . . 0.0 112.68 -173.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.43 -28.93 68.99 Favored 'General case' 0 CA--C 1.551 1.014 0 O-C-N 121.498 -0.752 . . . . 0.0 112.347 171.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.4 t -83.01 -25.64 31.98 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.841 1.256 . . . . 0.0 112.993 175.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 50.7 mtm -88.85 -48.19 7.65 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.859 1.263 . . . . 0.0 113.446 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 -110.55 -20.73 12.46 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.325 1.45 . . . . 0.0 113.681 -170.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.99 159.54 35.45 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.626 1.108 . . . . 0.0 114.853 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -103.36 131.02 50.78 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.772 1.229 . . . . 0.0 110.479 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.3 mp -110.12 142.57 26.21 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 126.447 1.899 . . . . 0.0 110.271 175.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.12 159.0 44.94 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.687 2.925 . . . . 0.0 111.366 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -140.13 173.07 11.88 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.239 1.415 . . . . 0.0 111.505 -176.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -55.31 -57.16 12.96 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.413 1.085 . . . . 0.0 113.014 176.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -105.08 -0.01 27.11 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -172.41 -128.44 1.05 Allowed Glycine 0 CA--C 1.536 1.379 0 N-CA-C 115.982 1.153 . . . . 0.0 115.982 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -137.51 161.29 36.79 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 126.623 1.969 . . . . 0.0 110.772 175.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.87 159.45 42.16 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.323 1.449 . . . . 0.0 112.148 177.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 98.1 t -128.48 117.89 20.05 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 125.972 1.709 . . . . 0.0 109.498 174.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.24 142.14 54.33 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 124.065 3.177 . . . . 0.0 111.456 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 74.3 mt -118.13 152.67 35.17 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.398 1.079 . . . . 0.0 112.855 175.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -137.42 125.23 22.51 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.385 1.874 . . . . 0.0 110.167 178.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 51.63 54.85 10.28 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.145 0.978 . . . . 0.0 112.286 -174.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.4 t -123.22 119.23 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 124.603 1.161 . . . . 0.0 109.632 173.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -113.16 158.94 19.79 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.577 1.551 . . . . 0.0 112.642 -176.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.0 m -140.64 152.25 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 126.113 1.765 . . . . 0.0 111.609 170.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -65.58 130.47 43.43 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.495 0.718 . . . . 0.0 109.139 163.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.0 t -133.48 148.07 51.7 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.514 1.926 . . . . 0.0 110.786 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 45.3 tp -99.53 140.17 34.11 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.768 0.827 . . . . 0.0 111.542 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -85.81 117.79 24.9 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.133 -0.979 . . . . 0.0 110.488 158.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.0 mm -74.45 -22.53 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 CA-C-N 119.084 0.856 . . . . 0.0 112.19 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.64 -33.52 64.56 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -173.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.2 m -121.45 -10.95 8.8 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.931 1.292 . . . . 0.0 112.919 169.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.51 39.46 56.42 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 -173.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -97.53 138.02 35.59 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.153 1.781 . . . . 0.0 111.715 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.1 mp -91.62 130.9 40.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 124.549 1.14 . . . . 0.0 109.669 -177.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -152.6 171.34 18.3 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.612 1.165 . . . . 0.0 111.509 -177.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -106.08 150.45 25.76 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.479 1.112 . . . . 0.0 111.242 176.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.8 t -139.58 153.11 47.33 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.466 1.106 . . . . 0.0 110.977 170.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 72.4 mtt85 -87.01 133.5 33.58 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.914 0.885 . . . . 0.0 110.303 172.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -87.12 149.64 24.54 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.196 0.998 . . . . 0.0 111.733 176.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.7 t -88.76 -54.19 4.27 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.834 1.254 . . . . 0.0 112.508 -169.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -157.63 160.03 37.63 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.672 1.589 . . . . 0.0 111.028 178.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.0 mt -84.8 150.42 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 162.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -139.76 152.42 46.59 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.529 1.531 . . . . 0.0 111.099 -176.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.8 ptt-85 -139.74 152.44 46.63 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.058 0.943 . . . . 0.0 113.321 166.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -146.41 168.93 19.93 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.811 2.045 . . . . 0.0 110.115 175.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -112.11 136.92 50.88 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 120.661 -1.274 . . . . 0.0 112.859 -170.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.2 m -144.51 142.04 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 122.796 1.284 . . . . 0.0 113.327 -176.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -97.63 -28.61 13.85 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 127.196 2.199 . . . . 0.0 111.745 178.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -120.85 127.92 52.35 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.606 1.562 . . . . 0.0 110.646 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.4 tp -136.95 161.26 36.53 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.469 1.508 . . . . 0.0 110.115 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.4 mt -117.7 126.0 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.356 1.062 . . . . 0.0 109.455 177.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 68.7 tt0 -100.09 117.15 33.73 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.156 0.982 . . . . 0.0 111.876 169.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.7 mp -108.42 129.26 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.365 1.466 . . . . 0.0 109.415 175.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -96.88 148.68 22.69 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.937 1.695 . . . . 0.0 111.4 176.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 59.6 mt -116.67 165.32 13.41 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.933 1.693 . . . . 0.0 112.483 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.6 t -71.06 -13.28 61.92 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 77.8 p -70.76 -15.58 62.69 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 120.428 -1.42 . . . . 0.0 113.59 165.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.49 -1.93 84.43 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.085 1.326 . . . . 0.0 114.178 -170.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -72.33 153.7 41.35 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.702 1.251 . . . . 0.0 110.605 174.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 95.1 p -130.01 143.23 50.69 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 167.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.2 tp -113.06 135.86 53.33 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.414 1.486 . . . . 0.0 109.768 173.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -115.25 110.85 20.05 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.28 1.832 . . . . 0.0 110.176 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.3 m -137.23 158.84 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.37 1.068 . . . . 0.0 113.083 -168.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.0 p -68.99 146.76 97.55 Favored Pre-proline 0 N--CA 1.467 0.413 0 O-C-N 121.692 -0.63 . . . . 0.0 112.541 175.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.52 -30.69 86.76 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.776 2.317 . . . . 0.0 113.294 -171.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.0 p -77.3 -7.09 55.44 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.367 1.867 . . . . 0.0 114.649 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -73.31 116.95 56.15 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 119.936 1.244 . . . . 0.0 112.97 -174.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -76.07 135.45 17.18 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.899 2.399 . . . . 0.0 113.782 178.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.5 t -118.91 143.81 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 126.655 1.982 . . . . 0.0 108.953 176.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 17.3 tp -82.51 114.57 21.01 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.569 -0.707 . . . . 0.0 110.44 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.5 mp -115.86 159.78 21.06 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.675 1.99 . . . . 0.0 111.499 -176.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -112.72 101.84 9.92 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.875 0.87 . . . . 0.0 113.073 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 68.9 mtp85 -125.82 81.56 1.99 Allowed 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 122.426 1.108 . . . . 0.0 108.799 174.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 59.79 -4.39 0.1 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 128.388 2.675 . . . . 0.0 115.282 -167.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -168.06 170.73 42.13 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 128.701 3.048 . . . . 0.0 111.242 -175.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 62.8 mt -83.57 115.21 22.01 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.395 1.478 . . . . 0.0 111.83 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -128.84 137.15 51.32 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.837 1.255 . . . . 0.0 112.107 -171.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -87.9 110.34 20.47 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.504 0.322 . . . . 0.0 111.413 172.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 52.3 t -121.56 126.34 26.49 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 124.723 1.209 . . . . 0.0 109.892 -172.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -66.96 149.48 82.91 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.576 2.184 . . . . 0.0 111.837 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.79 -31.21 26.19 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.19 -21.47 66.77 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 172.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -99.7 -6.76 26.58 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.048 1.739 . . . . 0.0 112.575 172.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.1 t -73.39 142.42 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 O-C-N 121.041 -1.037 . . . . 0.0 110.125 171.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.32 155.75 67.63 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 127.549 2.34 . . . . 0.0 110.197 -175.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.9 123.37 10.31 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.992 1.794 . . . . 0.0 111.891 -170.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 103.91 1.68 45.67 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.636 1.113 . . . . 0.0 114.738 -175.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -58.65 155.41 12.62 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.468 1.134 . . . . 0.0 113.148 170.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.3 p -107.55 119.21 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 126.243 1.817 . . . . 0.0 111.055 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 38.7 t -113.04 134.33 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 125.92 1.688 . . . . 0.0 110.927 -167.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.7 t -88.44 134.92 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 O-C-N 121.267 -0.896 . . . . 0.0 111.376 -172.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -169.12 -147.16 5.31 Favored Glycine 0 CA--C 1.529 0.935 0 O-C-N 121.796 -0.565 . . . . 0.0 112.872 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.2 p -135.58 161.31 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 127.384 2.274 . . . . 0.0 108.475 171.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 68.8 mtp85 . . . . . 0 N--CA 1.469 0.521 0 O-C-N 121.73 -0.606 . . . . 0.0 110.775 173.65 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 . . . . . 0 CA--C 1.541 0.628 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 96.8 mt -138.07 166.49 23.97 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 127.013 2.125 . . . . 0.0 112.136 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -154.38 148.43 25.75 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.463 1.905 . . . . 0.0 111.084 167.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -94.62 143.42 26.45 Favored 'General case' 0 CA--C 1.548 0.87 0 O-C-N 120.889 -1.132 . . . . 0.0 112.423 172.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -122.63 160.27 26.13 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.495 1.918 . . . . 0.0 110.926 -170.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -111.33 130.11 55.78 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -168.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 84.4 t -73.01 136.67 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 121.599 0.714 . . . . 0.0 110.674 171.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 12.3 t -94.42 -49.54 5.64 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.966 2.106 . . . . 0.0 112.537 176.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.4 t -157.48 162.06 38.89 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.216 1.006 . . . . 0.0 111.433 -176.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.7 m -135.19 148.34 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 124.435 1.094 . . . . 0.0 112.066 172.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -152.47 155.18 36.99 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.659 1.183 . . . . 0.0 112.914 170.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 89.2 mt -91.79 133.39 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.359 1.064 . . . . 0.0 108.642 167.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 44.3 pt -126.78 154.28 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 126.09 1.756 . . . . 0.0 111.83 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -96.26 98.91 10.67 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.393 0.677 . . . . 0.0 109.71 178.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -78.62 -53.06 7.58 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 51.88 36.65 18.71 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.648 1.179 . . . . 0.0 113.26 -174.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -144.16 171.7 13.93 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 120.888 -1.132 . . . . 0.0 111.464 -173.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -77.39 134.49 38.42 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.566 1.146 . . . . 0.0 111.794 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 14.1 m -117.64 152.46 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 125.704 1.602 . . . . 0.0 109.993 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -106.56 160.48 15.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.686 0.755 . . . . 0.0 112.942 -173.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.35 140.24 27.57 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.482 1.113 . . . . 0.0 109.098 166.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 64.9 tp -109.33 115.93 30.91 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 120.456 -1.403 . . . . 0.0 110.129 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 57.3 t -86.24 123.07 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -158.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 42.6 mm -118.4 92.32 43.08 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 126.569 1.948 . . . . 0.0 109.451 -176.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.88 -18.99 41.04 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 123.071 2.514 . . . . 0.0 113.736 176.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -78.74 -50.83 10.7 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 120.207 1.367 . . . . 0.0 112.81 -174.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 76.9 p -128.6 -7.01 5.15 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.496 1.518 . . . . 0.0 114.417 -169.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 74.9 m-70 57.22 19.49 4.95 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -170.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -140.9 149.61 42.13 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 120.892 1.678 . . . . 0.0 114.136 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -141.52 154.63 45.61 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.232 1.013 . . . . 0.0 111.316 168.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.4 mp -102.46 132.45 48.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.118 0.967 . . . . 0.0 110.926 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.46 158.79 62.78 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.62 1.168 . . . . 0.0 112.518 175.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.44 -16.82 52.41 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.227 2.618 . . . . 0.0 113.274 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 33.0 p30 -70.07 -2.26 12.32 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 124.702 1.201 . . . . 0.0 113.565 169.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.33 -10.95 69.32 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 126.831 2.157 . . . . 0.0 115.893 176.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 52.4 mt -96.34 150.28 20.75 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 120.317 2.059 . . . . 0.0 113.663 -169.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.2 p -97.54 133.16 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.261 1.024 . . . . 0.0 113.023 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 31.7 mt -119.46 132.81 55.86 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.03 1.732 . . . . 0.0 111.112 -169.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -88.42 118.44 28.05 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.056 0.843 . . . . 0.0 111.937 175.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 . . . . . 0 CA--C 1.545 0.77 0 O-C-N 120.949 -1.095 . . . . 0.0 113.393 -172.039 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.687 0 CA-C-O 120.897 0.38 . . . . 0.0 111.572 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.61 161.56 38.18 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.657 1.583 . . . . 0.0 110.724 -169.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.81 141.03 50.31 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.511 1.124 . . . . 0.0 112.949 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.02 -22.48 49.93 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.511 1.524 . . . . 0.0 114.198 176.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -78.39 -17.31 56.62 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 177.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.6 m -58.6 136.75 57.69 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 119.347 0.976 . . . . 0.0 113.504 -169.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.33 150.65 47.1 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.12 0.968 . . . . 0.0 113.378 175.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.2 p -146.06 155.67 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.894 1.277 . . . . 0.0 112.141 -171.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -128.98 137.62 51.47 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.449 1.9 . . . . 0.0 108.744 176.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -153.83 168.39 26.49 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.214 0.916 . . . . 0.0 113.256 168.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -130.13 146.02 51.75 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.309 1.443 . . . . 0.0 111.026 177.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -163.0 145.03 10.17 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.217 1.407 . . . . 0.0 109.151 174.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.3 t70 53.76 39.02 29.78 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.349 1.059 . . . . 0.0 113.033 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.2 m 67.41 16.3 10.0 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.331 1.852 . . . . 0.0 114.979 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.0 p -133.67 133.47 22.48 Favored Pre-proline 0 CA--C 1.554 1.1 0 O-C-N 120.175 -1.578 . . . . 0.0 113.229 -177.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -85.72 153.06 10.14 Favored 'Trans proline' 0 CA--C 1.539 0.742 1 C-N-CA 125.593 4.195 . . . . 0.0 114.713 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -135.42 144.87 46.74 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.353 2.261 . . . . 0.0 111.156 -178.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 50.7 ttm -149.37 111.23 4.57 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.784 0.834 . . . . 0.0 110.904 -176.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -158.98 -168.8 2.47 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.81 1.244 . . . . 0.0 112.302 -169.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.4 m -85.71 143.99 28.05 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.098 -1.001 . . . . 0.0 111.36 166.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.43 HG12 ' CG ' ' A' ' 152' ' ' TYR . 8.4 tp -56.81 -38.23 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -177.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -61.75 -22.58 65.52 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.608 0.763 . . . . 0.0 112.848 179.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -80.41 -49.4 11.51 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.302 1.041 . . . . 0.0 111.235 176.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 19.3 ptm -65.77 -31.48 72.49 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 122.062 -0.399 . . . . 0.0 111.589 176.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -57.92 -51.63 68.81 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.603 0.638 . . . . 0.0 111.031 172.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.9 t -67.68 -29.98 69.39 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.148 0.579 . . . . 0.0 111.679 -177.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -66.71 -53.19 36.13 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.323 1.449 . . . . 0.0 111.04 172.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -71.72 -30.82 66.05 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.004 -1.06 . . . . 0.0 112.805 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.48 -31.36 71.46 Favored 'General case' 0 CA--C 1.552 1.054 0 O-C-N 121.51 -0.744 . . . . 0.0 111.992 171.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.0 t -80.07 -22.74 41.93 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 120.668 -1.27 . . . . 0.0 113.095 174.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 55.9 mtm -92.13 -49.7 6.06 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.543 1.137 . . . . 0.0 113.43 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -109.21 -24.09 11.29 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.356 1.462 . . . . 0.0 112.612 -169.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 87.26 164.5 40.2 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 125.556 1.551 . . . . 0.0 114.787 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -109.18 143.57 38.42 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.969 1.308 . . . . 0.0 111.392 -173.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.4 mp -117.33 140.72 27.64 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 126.146 1.778 . . . . 0.0 111.181 172.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.25 141.77 18.56 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 124.469 3.446 . . . . 0.0 111.784 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -126.36 156.16 40.92 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.632 1.573 . . . . 0.0 111.459 -177.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.87 -46.92 16.09 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.387 1.475 . . . . 0.0 114.056 178.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -97.73 -16.58 19.84 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 176.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.26 -126.83 0.95 Allowed Glycine 0 CA--C 1.538 1.504 0 N-CA-C 116.585 1.394 . . . . 0.0 116.585 -168.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -144.54 155.08 43.5 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.61 1.564 . . . . 0.0 112.538 -178.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.48 154.73 50.67 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.759 1.224 . . . . 0.0 113.15 175.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.9 t -130.45 115.75 17.3 Favored Pre-proline 0 N--CA 1.481 1.097 0 C-N-CA 126.125 1.77 . . . . 0.0 110.606 177.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.52 138.64 27.24 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 125.057 3.838 . . . . 0.0 112.52 -176.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.8 mt -112.69 160.98 17.38 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.874 1.27 . . . . 0.0 113.125 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -146.34 128.29 15.48 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.606 1.162 . . . . 0.0 111.349 168.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 55.39 40.39 31.36 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.6 1.56 . . . . 0.0 113.839 -173.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.4 t -107.71 113.3 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 O-C-N 121.109 -0.994 . . . . 0.0 109.346 175.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -113.79 152.0 31.23 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.144 1.378 . . . . 0.0 113.59 -166.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.0 m -143.18 154.35 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 127.119 2.168 . . . . 0.0 111.119 175.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.487 ' CE1' HG23 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -72.08 135.67 46.36 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.744 0.818 . . . . 0.0 109.873 166.541 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.0 t -133.35 153.49 51.54 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.131 1.772 . . . . 0.0 112.842 -179.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 50.3 tp -100.13 133.89 43.86 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.512 1.125 . . . . 0.0 109.861 168.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -84.59 119.39 25.15 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.94 1.296 . . . . 0.0 110.407 164.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.8 mm -76.38 -19.48 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 119.569 1.077 . . . . 0.0 112.265 -179.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.44 -41.03 48.88 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -174.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.3 m -110.57 -11.76 14.42 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.695 1.198 . . . . 0.0 112.814 172.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.5 36.82 68.93 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-N 118.42 0.555 . . . . 0.0 112.037 -173.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -96.69 136.8 36.71 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.222 1.809 . . . . 0.0 111.769 -175.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.487 HG23 ' CE1' ' A' ' 51' ' ' TYR . 1.9 mp -85.84 130.6 36.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 124.504 1.121 . . . . 0.0 107.992 172.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.3 pttt -154.91 168.46 26.85 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.803 1.241 . . . . 0.0 112.913 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -89.56 146.7 24.4 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.574 0.749 . . . . 0.0 111.183 172.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.7 t -143.25 164.13 31.06 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.108 0.963 . . . . 0.0 111.645 172.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -99.88 142.85 30.81 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.241 1.016 . . . . 0.0 112.077 174.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.73 137.39 32.37 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.262 0.625 . . . . 0.0 110.109 167.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 22.8 t -86.97 -46.38 9.91 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.427 1.491 . . . . 0.0 112.334 -172.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -152.89 155.45 37.06 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.618 0.723 . . . . 0.0 112.356 174.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.9 mt -85.12 147.36 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 163.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -136.25 147.78 47.72 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 125.747 1.619 . . . . 0.0 110.839 -175.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 30.6 ptt-85 -143.92 153.95 42.82 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.052 0.941 . . . . 0.0 113.424 167.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -154.82 172.43 18.0 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.846 1.259 . . . . 0.0 110.728 169.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -95.39 147.27 23.7 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.646 0.778 . . . . 0.0 111.943 177.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.1 m -143.74 144.55 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 125.18 1.392 . . . . 0.0 110.481 171.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -94.18 -29.05 15.32 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 124.888 1.275 . . . . 0.0 111.469 175.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -121.01 134.27 55.29 Favored 'General case' 0 C--N 1.344 0.358 0 C-N-CA 125.17 1.388 . . . . 0.0 109.416 -176.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.5 tp -143.53 159.69 41.96 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.164 1.386 . . . . 0.0 109.966 -177.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.6 mt -111.21 128.49 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 O-C-N 121.246 -0.909 . . . . 0.0 109.632 177.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -102.67 112.98 26.0 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.363 1.465 . . . . 0.0 110.261 173.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.2 mp -106.92 131.13 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.608 1.163 . . . . 0.0 109.376 174.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.2 tttt -100.96 147.63 25.94 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.678 1.591 . . . . 0.0 111.51 175.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 61.5 mt -107.75 164.39 12.28 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 126.83 2.052 . . . . 0.0 111.195 -178.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.7 t -75.02 -1.53 23.18 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -178.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.8 p -79.06 -15.09 58.68 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.954 1.702 . . . . 0.0 113.766 160.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.78 -3.63 84.89 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 125.73 1.633 . . . . 0.0 114.199 -169.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -74.54 151.37 39.48 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.451 1.625 . . . . 0.0 111.45 177.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.7 p -128.68 138.63 52.26 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 178.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 14.7 tp -117.01 140.02 49.98 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.995 1.718 . . . . 0.0 110.538 177.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.6 mtmm -118.49 116.38 26.55 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.687 1.195 . . . . 0.0 112.402 -175.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.1 m -141.61 152.49 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 125.204 1.402 . . . . 0.0 113.031 -163.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.7 p -68.39 148.3 98.18 Favored Pre-proline 0 N--CA 1.474 0.73 0 O-C-N 121.031 -1.043 . . . . 0.0 112.433 174.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.79 -17.63 60.31 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.594 2.862 . . . . 0.0 113.728 -175.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 36.3 p -86.35 -10.94 53.4 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.949 2.1 . . . . 0.0 114.48 176.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -72.46 122.17 86.76 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-N 119.699 1.136 . . . . 0.0 111.736 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -80.35 125.06 5.57 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 123.711 2.941 . . . . 0.0 113.113 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.3 t -94.52 141.09 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.686 1.595 . . . . 0.0 109.848 175.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 17.4 tp -83.86 107.23 16.13 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.103 0.561 . . . . 0.0 110.664 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.9 mp -100.15 144.34 29.3 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.756 1.622 . . . . 0.0 111.755 -176.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -104.29 90.23 3.49 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.933 0.893 . . . . 0.0 112.244 -177.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 46.6 mtm180 -133.91 81.43 1.92 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.865 0.866 . . . . 0.0 110.841 -177.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.7 t70 66.3 -17.94 0.11 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 128.09 2.556 . . . . 0.0 115.888 -167.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.48 167.26 39.87 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 126.171 1.843 . . . . 0.0 113.258 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 77.3 mt -62.94 113.83 3.31 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.493 1.917 . . . . 0.0 111.392 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -141.94 142.83 33.03 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.646 0.778 . . . . 0.0 112.847 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -97.56 122.14 40.28 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.877 1.271 . . . . 0.0 110.768 -175.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 71.2 t -128.45 126.69 23.57 Favored Pre-proline 0 N--CA 1.477 0.914 0 C-N-CA 124.289 1.036 . . . . 0.0 110.007 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -64.71 148.65 90.3 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.301 2.001 . . . . 0.0 112.014 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.59 -31.98 17.42 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 173.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.93 -17.89 63.68 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 173.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -111.82 -0.61 15.84 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.568 1.547 . . . . 0.0 112.989 174.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 71.3 t -72.12 148.67 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 120.679 -1.263 . . . . 0.0 110.833 171.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.96 157.09 75.36 Favored Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 127.369 2.268 . . . . 0.0 111.129 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.59 113.42 3.16 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.715 2.277 . . . . 0.0 112.003 -175.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 111.91 6.09 24.87 Favored Glycine 0 CA--C 1.537 1.449 0 CA-C-O 118.691 -1.061 . . . . 0.0 115.264 -175.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -62.86 161.31 12.95 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 118.946 1.373 . . . . 0.0 112.403 163.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 5.8 p -109.45 129.52 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.384 1.474 . . . . 0.0 111.747 178.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.1 t -107.55 137.07 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 126.729 2.012 . . . . 0.0 110.2 -175.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 51.8 t -87.25 134.39 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.744 0.817 . . . . 0.0 110.31 172.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -157.82 -153.91 6.91 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.53 1.062 . . . . 0.0 112.49 176.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.1 p -145.22 176.86 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 126.415 1.886 . . . . 0.0 108.492 174.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 . . . . . 0 N--CA 1.468 0.464 0 O-C-N 121.071 -1.018 . . . . 0.0 113.067 175.685 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 . . . . . 0 CA--C 1.539 0.537 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 89.9 mt -131.04 165.21 23.71 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.858 2.063 . . . . 0.0 111.741 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -131.59 157.17 44.36 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.739 1.616 . . . . 0.0 110.912 173.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -113.28 142.89 45.3 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.608 1.163 . . . . 0.0 111.587 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -133.54 156.24 48.15 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.606 1.562 . . . . 0.0 110.544 -173.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 57.4 tt0 -114.68 137.79 51.48 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.128 -0.983 . . . . 0.0 112.288 -170.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 92.2 t -73.79 133.32 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 122.003 0.906 . . . . 0.0 110.622 173.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 27.5 t -87.11 -59.64 2.2 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.941 1.697 . . . . 0.0 111.748 173.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 59.2 m -149.61 158.88 44.58 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.259 1.424 . . . . 0.0 110.901 -170.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.2 m -136.37 152.86 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 124.126 0.97 . . . . 0.0 111.925 173.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 9.4 ptp85 -158.14 159.48 36.24 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.74 1.216 . . . . 0.0 112.684 168.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 76.3 mt -99.03 129.92 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.935 0.894 . . . . 0.0 109.211 170.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 13.2 pt -121.15 156.58 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.574 1.55 . . . . 0.0 111.908 -174.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -92.7 97.96 11.11 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.754 0.787 . . . . 0.0 110.957 170.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -76.63 -47.89 20.8 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 44.39 39.46 3.13 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.576 1.15 . . . . 0.0 113.826 -174.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 -144.31 174.71 10.67 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.17 0.988 . . . . 0.0 111.392 -174.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -77.27 137.88 39.06 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 124.588 1.155 . . . . 0.0 112.466 -177.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.2 m -119.8 152.74 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 125.084 1.353 . . . . 0.0 109.97 176.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.43 ' CG ' HG12 ' A' ' 21' ' ' ILE . 1.4 p90 -112.1 160.53 17.45 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.08 0.952 . . . . 0.0 112.278 -178.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -141.3 156.06 45.9 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.052 0.541 . . . . 0.0 110.069 156.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 65.2 tp -128.69 103.0 6.83 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.767 1.227 . . . . 0.0 110.051 -175.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 87.8 t -86.63 124.12 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -151.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 20.8 mm -110.71 98.27 36.78 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 125.27 1.428 . . . . 0.0 109.681 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.5 -16.73 38.81 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.512 2.142 . . . . 0.0 113.193 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -74.51 -61.28 1.92 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.784 0.834 . . . . 0.0 112.363 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 54.9 p -122.82 -7.95 8.43 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -171.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 61.37 15.38 6.5 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.086 1.754 . . . . 0.0 115.657 -175.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.81 148.52 30.03 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.082 -1.011 . . . . 0.0 113.532 -178.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -145.9 158.93 43.84 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.746 1.218 . . . . 0.0 112.385 177.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.3 mp -102.39 137.22 31.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 123.975 0.91 . . . . 0.0 111.377 -177.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -88.56 160.24 45.1 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 125.938 1.695 . . . . 0.0 113.088 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.36 -19.46 61.62 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.299 2.666 . . . . 0.0 113.989 -176.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 50.6 p30 -86.18 -2.26 58.2 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.961 1.304 . . . . 0.0 113.551 175.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 102.12 -15.04 56.88 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 126.628 2.061 . . . . 0.0 116.756 173.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 66.7 mt -74.09 145.39 44.43 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.425 1.613 . . . . 0.0 111.965 -178.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.1 p -91.36 135.76 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.528 0.731 . . . . 0.0 111.304 171.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 39.6 mt -113.61 142.09 46.41 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.156 1.783 . . . . 0.0 109.792 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -127.54 127.01 43.22 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.279 1.432 . . . . 0.0 110.146 -177.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 21.2 m120 . . . . . 0 CA--C 1.543 0.686 0 C-N-CA 123.912 0.885 . . . . 0.0 112.696 -174.24 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.566 0 CA-C-O 120.62 0.248 . . . . 0.0 111.504 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.54 156.99 47.01 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.247 1.419 . . . . 0.0 111.063 -170.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.54 143.97 33.4 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.346 1.458 . . . . 0.0 113.901 -178.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -61.11 -26.09 67.43 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.494 1.117 . . . . 0.0 113.241 174.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -83.03 -1.46 52.73 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.312 1.045 . . . . 0.0 113.803 176.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.4 m -68.59 143.51 54.83 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 119.845 1.202 . . . . 0.0 111.77 174.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -74.68 159.22 32.34 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.205 -0.934 . . . . 0.0 112.817 167.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 p -149.0 156.26 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.049 0.94 . . . . 0.0 111.867 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -121.26 141.8 50.55 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.638 1.975 . . . . 0.0 108.134 176.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -156.44 -178.28 7.22 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.666 0.786 . . . . 0.0 111.128 164.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -136.6 143.13 43.41 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.564 1.545 . . . . 0.0 110.216 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -154.96 -45.68 0.08 Allowed 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 174.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -83.24 37.1 0.54 Allowed 'General case' 0 N--CA 1.481 1.097 0 O-C-N 120.65 -1.281 . . . . 0.0 112.857 -175.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.2 m 61.0 24.92 14.99 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 126.007 1.723 . . . . 0.0 112.915 -167.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.2 p -158.61 149.89 16.57 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 126.412 1.885 . . . . 0.0 109.276 -170.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.45 160.53 32.05 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.974 3.116 . . . . 0.0 114.306 176.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -140.48 151.16 44.6 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 128.029 2.532 . . . . 0.0 110.561 -173.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 34.8 ttm -149.48 126.14 11.03 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.485 -0.759 . . . . 0.0 112.148 177.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -160.89 -178.17 6.64 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.528 1.531 . . . . 0.0 111.75 178.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.52 143.12 51.76 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 121.017 -1.052 . . . . 0.0 109.433 171.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.45 HG12 ' CG ' ' A' ' 152' ' ' TYR . 8.1 tp -56.55 -38.54 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 O-C-N 121.24 -0.913 . . . . 0.0 112.002 179.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -60.56 -24.51 65.47 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.359 0.982 . . . . 0.0 112.566 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -81.6 -46.95 13.68 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.499 1.12 . . . . 0.0 111.402 179.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -70.71 -34.07 71.54 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.441 -0.787 . . . . 0.0 111.6 176.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -58.58 -52.6 64.99 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 124.196 0.998 . . . . 0.0 110.591 172.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.8 t -67.58 -30.4 70.01 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 122.661 0.384 . . . . 0.0 111.043 -174.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -64.69 -52.91 54.69 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.043 1.337 . . . . 0.0 110.969 172.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -71.57 -31.01 66.5 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.074 -1.016 . . . . 0.0 113.14 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.93 -30.44 67.84 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.99 0.916 . . . . 0.0 111.305 172.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.4 m -74.21 -35.21 63.89 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 120.398 -1.439 . . . . 0.0 112.081 172.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 42.5 mtm -86.79 -42.95 12.88 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.366 1.066 . . . . 0.0 113.664 -173.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -114.55 -21.16 10.43 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.803 1.241 . . . . 0.0 112.639 -171.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.95 155.64 21.69 Favored Glycine 0 C--N 1.341 0.816 0 C-N-CA 125.441 1.496 . . . . 0.0 114.38 176.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -98.15 139.15 34.38 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.404 1.081 . . . . 0.0 110.645 -177.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.4 mp -106.86 143.91 28.01 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 127.331 2.252 . . . . 0.0 110.89 175.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.52 145.97 34.15 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.905 3.07 . . . . 0.0 112.415 176.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -142.12 157.52 44.79 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.856 1.662 . . . . 0.0 111.322 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.14 -52.66 58.01 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 120.63 -1.294 . . . . 0.0 113.997 -177.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -84.53 -16.0 43.84 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 176.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -178.65 -131.82 1.63 Allowed Glycine 0 CA--C 1.53 1.002 0 N-CA-C 115.626 1.01 . . . . 0.0 115.626 -165.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -143.59 159.3 42.69 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.284 1.434 . . . . 0.0 111.803 -178.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.06 149.4 45.97 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.862 1.265 . . . . 0.0 112.853 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.4 t -125.63 113.37 25.14 Favored Pre-proline 0 N--CA 1.484 1.263 0 C-N-CA 125.472 1.509 . . . . 0.0 111.933 177.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -68.73 134.72 31.0 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 124.235 3.29 . . . . 0.0 111.02 178.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 96.9 mt -99.65 164.25 12.14 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.884 1.274 . . . . 0.0 112.665 -177.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -133.71 120.65 20.86 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.224 1.01 . . . . 0.0 110.514 172.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 48.15 42.47 17.31 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.342 1.457 . . . . 0.0 113.593 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 97.7 t -100.88 123.76 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 O-C-N 121.488 -0.757 . . . . 0.0 109.734 178.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -126.23 161.18 28.32 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.419 1.088 . . . . 0.0 112.99 -172.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.8 m -148.09 153.32 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.927 2.091 . . . . 0.0 111.321 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -60.29 132.24 53.31 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 122.144 0.974 . . . . 0.0 109.611 155.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.3 t -134.6 147.58 50.25 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.175 1.79 . . . . 0.0 110.901 176.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 61.9 tp -98.16 137.01 37.55 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.244 1.017 . . . . 0.0 109.725 175.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -80.9 106.98 13.33 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.549 0.739 . . . . 0.0 110.404 167.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 46.0 mm -66.13 -23.0 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 O-C-N 120.774 -1.204 . . . . 0.0 112.286 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.66 -43.13 76.87 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.455 1.102 . . . . 0.0 113.973 -175.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.1 m -128.82 -8.01 5.0 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.94 35.13 22.49 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.321 0.962 . . . . 0.0 114.024 178.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -90.68 135.95 33.38 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.062 1.345 . . . . 0.0 112.204 176.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 mp -85.46 127.14 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 124.876 1.27 . . . . 0.0 109.43 176.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -147.15 169.91 18.32 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.582 1.153 . . . . 0.0 111.838 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -99.13 147.4 25.12 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.14 0.976 . . . . 0.0 110.535 170.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.2 t -146.53 167.96 22.39 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.689 0.796 . . . . 0.0 112.441 174.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 50.5 ptt85 -94.07 150.83 19.98 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.639 1.576 . . . . 0.0 112.75 177.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -105.82 132.87 51.41 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.601 1.161 . . . . 0.0 110.921 168.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.2 t -85.96 -45.55 11.38 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.732 1.213 . . . . 0.0 112.379 -171.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -152.25 162.11 41.63 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.394 1.078 . . . . 0.0 112.828 173.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.9 mt -89.7 155.01 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 125.094 1.357 . . . . 0.0 108.407 162.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -137.6 148.85 46.18 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.986 1.715 . . . . 0.0 110.448 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -138.46 149.56 45.57 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.867 1.267 . . . . 0.0 113.174 171.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -148.79 164.26 34.95 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.736 1.614 . . . . 0.0 110.09 170.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.5 mmtp -93.18 148.79 21.72 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.508 1.123 . . . . 0.0 111.047 176.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.1 m -148.38 144.77 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.683 1.193 . . . . 0.0 111.074 172.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -94.05 -31.33 14.27 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.66 1.184 . . . . 0.0 112.069 173.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -121.76 129.57 52.79 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.68 1.192 . . . . 0.0 110.457 -174.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.3 tp -136.52 162.34 33.36 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.392 1.877 . . . . 0.0 109.676 -172.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.9 mt -115.02 125.52 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.707 1.203 . . . . 0.0 109.274 176.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -96.97 123.74 40.77 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.148 0.979 . . . . 0.0 110.198 168.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.9 mp -111.18 126.96 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.846 1.258 . . . . 0.0 109.488 172.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.6 tttt -93.9 146.42 23.91 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.355 1.862 . . . . 0.0 110.672 174.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 80.9 mt -116.56 158.49 23.59 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.773 1.629 . . . . 0.0 111.869 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 18.8 t -59.36 -30.82 68.68 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.677 1.191 . . . . 0.0 112.699 -178.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.0 p -62.66 -15.96 54.74 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 173.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.0 7.0 68.7 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 124.749 1.166 . . . . 0.0 113.825 -171.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -81.33 159.52 24.39 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.726 1.211 . . . . 0.0 111.722 171.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 77.2 p -142.03 143.15 33.0 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.988 0.915 . . . . 0.0 112.739 169.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.1 tp -121.7 142.21 50.39 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.767 1.627 . . . . 0.0 110.858 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -120.41 110.36 16.42 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.224 1.809 . . . . 0.0 111.093 -172.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.0 m -141.06 154.37 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.029 1.332 . . . . 0.0 112.927 -165.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.4 p -68.43 150.43 97.7 Favored Pre-proline 0 N--CA 1.47 0.552 0 O-C-N 120.65 -1.281 . . . . 0.0 113.19 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -61.73 -29.65 83.72 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.678 2.252 . . . . 0.0 112.395 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 38.8 p -83.37 10.17 9.31 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 128.054 2.542 . . . . 0.0 114.859 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -99.1 109.52 54.51 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 124.748 1.219 . . . . 0.0 112.237 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -63.57 124.16 13.25 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.258 2.639 . . . . 0.0 113.841 164.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.5 t -101.27 146.67 9.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 127.433 2.293 . . . . 0.0 109.0 176.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.29 107.57 11.0 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.998 -0.438 . . . . 0.0 110.052 177.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.1 mp -110.22 155.69 21.67 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.541 1.537 . . . . 0.0 111.992 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -96.72 117.45 31.05 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.17 0.588 . . . . 0.0 112.359 174.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 73.4 mtp85 -136.15 78.75 1.73 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.607 1.163 . . . . 0.0 109.791 168.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 56.57 0.42 0.07 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 128.175 2.59 . . . . 0.0 115.78 -164.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -172.68 173.62 45.5 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 126.44 1.971 . . . . 0.0 111.341 -178.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 63.4 mt -70.15 125.72 27.59 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.434 1.494 . . . . 0.0 110.171 177.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -157.13 155.81 31.65 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 173.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -103.73 120.82 41.73 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.217 1.007 . . . . 0.0 112.639 -172.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 49.0 t -129.59 127.01 22.93 Favored Pre-proline 0 N--CA 1.482 1.147 0 C-N-CA 124.905 1.282 . . . . 0.0 110.698 -175.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -64.32 140.41 70.24 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.077 2.518 . . . . 0.0 112.225 -179.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.08 -32.38 15.54 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 176.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.76 -20.95 66.16 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 173.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -106.84 -9.56 16.33 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.61 1.564 . . . . 0.0 113.17 177.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 78.1 t -68.45 145.48 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.696 1.598 . . . . 0.0 109.969 172.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.63 157.93 75.03 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 125.697 1.599 . . . . 0.0 111.62 -178.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.416 ' HD3' HG22 ' A' ' 142' ' ' VAL . 42.9 Cg_endo -64.81 122.11 9.84 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 121.986 1.791 . . . . 0.0 111.32 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 108.11 0.16 33.54 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 124.565 1.078 . . . . 0.0 115.377 -178.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -63.34 162.25 12.61 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.872 1.269 . . . . 0.0 112.372 169.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -109.07 122.73 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 125.35 1.46 . . . . 0.0 111.332 177.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.45 135.86 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 126.324 1.85 . . . . 0.0 110.102 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.9 t -85.79 143.8 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 119.522 1.055 . . . . 0.0 111.733 -176.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -168.21 -149.4 6.11 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 124.794 1.188 . . . . 0.0 114.174 -177.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.1 p -156.97 165.55 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 127.287 2.235 . . . . 0.0 107.767 -174.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? . . . . . 0 N--CA 1.479 0.993 0 O-C-N 121.095 -1.003 . . . . 0.0 112.84 179.891 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 59.7 mt -149.56 156.48 42.02 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.222 1.409 . . . . 0.0 113.522 -176.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -142.62 167.21 22.62 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.657 1.983 . . . . 0.0 111.199 -179.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -128.15 156.93 42.09 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 120.348 -1.47 . . . . 0.0 113.945 158.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -116.15 136.31 53.14 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 128.116 2.566 . . . . 0.0 109.159 -173.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -89.11 131.78 35.1 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.965 0.802 . . . . 0.0 111.936 178.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 93.8 t -69.91 127.8 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 123.421 0.688 . . . . 0.0 110.734 171.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.3 t -88.27 -45.1 10.34 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.528 1.931 . . . . 0.0 112.091 175.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.2 t -157.67 163.54 38.1 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.443 1.097 . . . . 0.0 111.404 177.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.416 HG22 ' HD3' ' A' ' 112' ' ' PRO . 4.9 m -136.63 148.54 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 124.81 1.244 . . . . 0.0 111.193 171.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -158.18 155.98 30.02 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 172.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 74.3 mt -86.81 131.8 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.549 1.14 . . . . 0.0 109.061 168.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 25.1 pt -127.0 161.77 33.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 126.611 1.964 . . . . 0.0 112.257 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -95.91 99.06 10.89 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.777 1.631 . . . . 0.0 111.976 177.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -85.63 -51.95 6.13 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 177.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 48.37 41.18 16.1 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.325 1.05 . . . . 0.0 113.164 -175.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 33.9 t-20 -145.41 167.84 21.95 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.684 1.193 . . . . 0.0 110.38 -176.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -68.87 145.44 53.7 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.32 1.048 . . . . 0.0 112.149 177.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.1 m -128.77 152.8 37.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 126.069 1.748 . . . . 0.0 109.422 177.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.45 ' CG ' HG12 ' A' ' 21' ' ' ILE . 2.3 p90 -111.43 160.42 17.12 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -174.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -146.39 127.89 15.05 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.334 1.053 . . . . 0.0 109.299 170.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 32.7 tp -93.06 134.9 34.74 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 120.336 -1.478 . . . . 0.0 112.315 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 23.1 t -99.25 119.67 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 121.545 0.688 . . . . 0.0 112.822 -172.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 20.2 mm -125.96 96.57 37.12 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 126.914 2.085 . . . . 0.0 107.969 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.79 -18.14 22.27 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 122.623 2.216 . . . . 0.0 113.285 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -82.58 -34.48 27.71 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -172.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 44.5 p -139.02 -10.93 1.29 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.615 1.166 . . . . 0.0 113.474 -175.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . 0.306 51.7 m-70 55.37 26.08 8.33 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.09 1.756 . . . . 0.0 115.635 -173.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -154.19 158.96 41.11 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 120.795 -1.191 . . . . 0.0 113.68 173.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -147.06 166.18 27.67 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.544 1.538 . . . . 0.0 112.209 176.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.0 mp -107.96 139.28 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.085 0.954 . . . . 0.0 111.588 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.94 157.16 63.65 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.483 1.113 . . . . 0.0 112.52 174.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.01 -13.98 41.92 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.897 2.398 . . . . 0.0 113.165 177.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -85.94 7.87 22.59 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 124.438 1.095 . . . . 0.0 113.104 171.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 94.4 -23.92 29.81 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 126.24 1.876 . . . . 0.0 116.47 173.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 65.7 mt -70.17 146.27 50.9 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.906 1.353 . . . . 0.0 113.497 -174.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 4.1 t -90.46 128.51 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 123.748 0.819 . . . . 0.0 111.685 174.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 47.3 mt -117.79 160.6 21.09 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 127.598 2.359 . . . . 0.0 111.919 -176.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.31 166.17 11.11 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 -175.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 37.4 t30 . . . . . 0 CA--C 1.551 0.986 0 C-N-CA 125.672 1.589 . . . . 0.0 109.972 148.491 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 111.365 0.135 . . . . 0.0 111.365 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -129.01 159.91 34.4 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.555 1.942 . . . . 0.0 111.151 -177.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.95 145.87 34.34 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.25 0.62 . . . . 0.0 111.268 173.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.92 -24.2 50.66 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 178.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -74.24 -15.4 60.99 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.721 1.608 . . . . 0.0 112.633 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.0 m -68.94 144.02 54.28 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.021 0.929 . . . . 0.0 112.46 -170.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -78.98 156.62 28.38 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 176.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 p -146.17 154.33 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.296 1.438 . . . . 0.0 111.878 -175.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -130.22 127.26 39.28 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 126.293 1.837 . . . . 0.0 108.493 177.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -153.85 171.91 18.21 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.588 0.755 . . . . 0.0 112.133 175.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -130.81 148.82 52.63 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.731 1.213 . . . . 0.0 111.27 171.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -152.59 140.16 19.75 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.528 1.131 . . . . 0.0 110.061 172.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.1 t0 49.13 49.17 20.0 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.01 1.324 . . . . 0.0 113.967 170.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.0 m 62.05 35.42 15.95 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.741 2.016 . . . . 0.0 114.636 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.5 p -152.39 138.42 11.74 Favored Pre-proline 0 CA--C 1.546 0.826 0 O-C-N 120.838 -1.164 . . . . 0.0 113.054 167.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.41 154.95 28.26 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 124.543 3.495 . . . . 0.0 113.814 174.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -133.21 142.51 48.62 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.856 2.062 . . . . 0.0 110.81 172.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 47.1 ttm -145.16 90.65 2.06 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.094 1.358 . . . . 0.0 109.404 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -139.21 -168.72 2.5 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.695 1.998 . . . . 0.0 111.094 -168.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 m -79.03 151.32 31.57 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 121.0 -1.062 . . . . 0.0 111.477 168.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.3 tp -57.64 -37.65 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 O-C-N 121.607 -0.683 . . . . 0.0 111.829 173.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -61.59 -29.68 70.19 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.484 1.038 . . . . 0.0 112.781 175.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -80.74 -35.87 32.8 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.592 0.757 . . . . 0.0 111.674 -175.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 21.6 ptm -71.11 -35.26 71.72 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.207 0.458 . . . . 0.0 111.115 169.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -60.27 -51.53 69.16 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.695 0.798 . . . . 0.0 111.559 176.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.9 t -61.68 -39.62 92.07 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.309 1.044 . . . . 0.0 110.956 -176.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -63.71 -52.97 58.18 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 124.872 1.269 . . . . 0.0 110.851 177.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -72.7 -32.1 65.52 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.297 -0.877 . . . . 0.0 113.179 -178.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.54 -32.17 72.77 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.186 0.995 . . . . 0.0 111.892 173.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.1 m -81.61 -27.05 34.38 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.27 1.028 . . . . 0.0 112.463 176.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 70.2 mtm -80.17 -55.09 5.17 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.314 1.046 . . . . 0.0 112.25 174.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -108.22 -20.58 13.1 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.073 1.349 . . . . 0.0 114.13 -167.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.27 157.6 33.6 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 124.779 1.18 . . . . 0.0 114.216 -176.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -102.02 128.51 48.44 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.455 1.102 . . . . 0.0 108.414 174.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.3 mp -104.39 143.09 25.98 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 125.684 1.594 . . . . 0.0 110.23 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.69 149.13 54.25 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 123.725 2.95 . . . . 0.0 111.884 -176.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -144.14 161.82 37.88 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.995 1.318 . . . . 0.0 111.563 -175.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -51.33 -55.3 19.15 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.461 1.505 . . . . 0.0 113.505 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -90.78 -7.04 53.5 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 177.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 174.73 -124.75 1.04 Allowed Glycine 0 CA--C 1.53 0.978 0 CA-C-N 119.856 1.207 . . . . 0.0 115.55 -174.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -141.57 158.97 43.17 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.7 1.6 . . . . 0.0 111.126 177.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.94 149.12 44.41 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.817 1.247 . . . . 0.0 112.121 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.0 t -119.12 117.8 33.19 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 125.249 1.42 . . . . 0.0 110.625 178.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -74.69 140.49 26.44 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 124.421 3.414 . . . . 0.0 112.315 -177.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 64.2 mt -107.34 170.51 7.92 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.575 1.15 . . . . 0.0 113.604 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -152.63 135.18 15.24 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 127.225 2.21 . . . . 0.0 109.295 166.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 51.43 47.01 25.64 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.278 1.431 . . . . 0.0 113.162 -178.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 56.8 t -115.3 129.37 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.874 0.869 . . . . 0.0 110.637 176.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -126.93 149.0 50.03 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.748 1.219 . . . . 0.0 111.828 -170.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.0 m -137.25 150.42 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.011 1.324 . . . . 0.0 110.793 175.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -77.58 144.45 37.52 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.956 0.884 . . . . 0.0 111.006 168.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.1 t -151.81 151.77 31.78 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.581 1.152 . . . . 0.0 111.055 -165.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.4 tp -98.11 129.01 44.94 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.322 0.649 . . . . 0.0 109.573 171.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -69.88 101.88 1.84 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 162.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.0 mm -64.15 -26.83 41.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 O-C-N 120.951 -1.093 . . . . 0.0 111.279 -174.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.42 -42.15 18.95 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.67 1.188 . . . . 0.0 113.938 -174.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.2 m -101.29 -16.78 16.83 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.075 0.95 . . . . 0.0 112.308 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.45 20.67 79.51 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.461 1.505 . . . . 0.0 114.288 -176.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -79.24 123.95 27.91 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.138 1.375 . . . . 0.0 110.524 177.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.9 mp -72.9 124.24 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 165.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -142.85 174.03 11.02 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.762 1.225 . . . . 0.0 112.707 -178.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -105.5 139.42 40.14 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.99 1.316 . . . . 0.0 110.517 172.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.7 t -135.44 166.59 22.81 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.642 1.177 . . . . 0.0 112.152 176.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -100.92 137.06 39.8 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.613 1.165 . . . . 0.0 113.78 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -94.11 149.28 21.38 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.139 1.376 . . . . 0.0 112.422 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 85.4 p -99.47 -54.1 3.03 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.144 0.978 . . . . 0.0 113.563 -173.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -150.73 156.36 41.14 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.033 1.124 . . . . 0.0 114.033 176.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.0 mt -89.59 152.52 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.264 1.425 . . . . 0.0 108.685 168.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -140.66 144.04 35.47 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.169 -0.957 . . . . 0.0 112.229 -172.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -131.77 142.75 49.84 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.072 1.349 . . . . 0.0 111.882 175.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -149.92 164.18 36.1 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.112 1.365 . . . . 0.0 109.746 175.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -97.55 143.35 28.33 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 123.989 0.916 . . . . 0.0 111.419 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.1 m -147.03 145.46 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.842 1.257 . . . . 0.0 111.427 173.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -94.53 -32.97 13.24 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.867 1.667 . . . . 0.0 112.184 175.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -122.68 134.38 54.48 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 124.093 0.957 . . . . 0.0 110.68 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.8 tp -132.49 160.99 34.89 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.66 1.584 . . . . 0.0 109.299 -176.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.2 mt -115.6 122.88 70.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 121.232 -0.917 . . . . 0.0 109.401 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -93.82 115.92 28.35 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.387 1.075 . . . . 0.0 111.294 169.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -103.75 124.98 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 124.471 1.108 . . . . 0.0 108.721 170.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -91.93 146.11 24.01 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.487 1.515 . . . . 0.0 110.336 172.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 60.4 mt -106.86 160.92 15.15 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.486 1.914 . . . . 0.0 110.939 -178.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.6 t -65.11 -18.74 65.56 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.168 -0.958 . . . . 0.0 113.06 -178.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.7 p -69.02 -17.08 63.86 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.46 1.504 . . . . 0.0 114.572 167.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 83.73 7.43 85.94 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 126.458 1.98 . . . . 0.0 114.907 -170.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -80.44 167.45 20.15 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 118.771 1.285 . . . . 0.0 109.811 168.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 91.9 p -144.79 158.46 43.78 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 120.953 -1.092 . . . . 0.0 113.582 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 61.1 tp -130.64 133.53 46.2 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.383 1.873 . . . . 0.0 110.007 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -113.61 113.66 25.36 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.782 1.233 . . . . 0.0 111.65 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.4 m -139.67 157.08 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 125.721 1.608 . . . . 0.0 112.598 -169.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.9 p -68.25 149.72 97.99 Favored Pre-proline 0 N--CA 1.468 0.442 0 O-C-N 121.262 -0.899 . . . . 0.0 112.514 177.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -57.11 -33.61 96.15 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.642 2.228 . . . . 0.0 112.015 -178.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.7 m -89.54 21.63 3.34 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.526 1.93 . . . . 0.0 114.551 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -102.82 115.95 63.38 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 125.139 1.375 . . . . 0.0 111.072 176.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -72.93 142.43 34.94 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.895 2.396 . . . . 0.0 114.213 177.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 39.9 t -121.54 143.27 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 126.954 2.101 . . . . 0.0 109.298 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 25.8 tp -79.0 113.73 17.36 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.403 0.547 . . . . 0.0 110.292 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.43 159.58 18.6 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.222 2.609 . . . . 0.0 110.27 -172.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -124.18 121.13 34.26 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 174.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -138.63 89.45 2.37 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.822 0.849 . . . . 0.0 110.595 165.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 56.5 -0.17 0.06 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.995 2.118 . . . . 0.0 115.206 -163.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -176.47 167.23 38.64 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 125.627 1.584 . . . . 0.0 112.344 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 38.0 mt -64.38 128.54 36.21 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 126.001 1.721 . . . . 0.0 110.909 178.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -152.59 144.57 23.74 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.54 1.136 . . . . 0.0 112.727 175.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -94.39 130.1 40.85 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.109 0.964 . . . . 0.0 110.643 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 47.9 t -133.72 127.4 19.44 Favored Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 124.047 0.939 . . . . 0.0 110.527 -177.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -65.81 143.79 74.96 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.698 2.265 . . . . 0.0 111.434 175.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.27 -31.7 22.07 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.44 -16.46 62.46 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 173.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -113.15 -7.94 13.59 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.485 1.514 . . . . 0.0 113.042 177.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.4 t -67.06 150.24 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.1 1.36 . . . . 0.0 110.522 168.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.36 157.78 71.88 Favored Pre-proline 0 N--CA 1.475 0.799 0 C-N-CA 126.71 2.004 . . . . 0.0 111.246 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -68.2 122.27 9.31 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.598 2.199 . . . . 0.0 111.806 -173.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 104.62 5.49 42.11 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.309 0.957 . . . . 0.0 114.647 -176.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -67.43 166.68 14.11 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.557 1.143 . . . . 0.0 112.166 168.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.2 p -117.11 118.46 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.133 0.973 . . . . 0.0 112.052 -176.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.0 t -89.75 139.03 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 125.474 1.51 . . . . 0.0 110.008 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.3 t -91.57 139.04 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 123.731 0.812 . . . . 0.0 110.243 174.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -160.65 -155.88 7.97 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.011 0.815 . . . . 0.0 113.284 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.4 p -137.22 161.76 34.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 128.279 2.632 . . . . 0.0 107.919 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 . . . . . 0 N--CA 1.476 0.847 0 C-N-CA 123.761 0.824 . . . . 0.0 112.301 -173.276 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 . . . . . 0 N--CA 1.477 0.896 0 CA-C-O 121.089 0.471 . . . . 0.0 111.477 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 96.4 mt -67.36 146.18 54.33 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.813 0.845 . . . . 0.0 112.514 -175.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -140.18 123.89 17.27 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.422 1.489 . . . . 0.0 110.459 176.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -87.2 146.09 26.14 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 122.991 0.516 . . . . 0.0 111.367 176.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 23.9 m80 -129.08 128.4 43.47 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.666 1.587 . . . . 0.0 108.545 -173.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -88.31 141.01 28.9 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 120.944 -1.098 . . . . 0.0 112.494 -178.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 76.6 t -67.78 136.39 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 124.755 1.222 . . . . 0.0 110.078 171.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 29.6 t -90.18 -53.11 4.61 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.81 1.644 . . . . 0.0 111.506 171.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.6 m -156.97 159.87 38.49 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 121.194 -0.941 . . . . 0.0 111.121 -174.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.8 m -134.96 152.5 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.158 0.983 . . . . 0.0 111.813 174.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -162.56 159.84 25.24 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.386 1.074 . . . . 0.0 112.481 168.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 83.4 mt -82.66 144.41 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 166.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 44.4 pt -133.82 155.02 39.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.981 1.713 . . . . 0.0 111.074 174.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -93.78 95.96 9.47 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.739 0.816 . . . . 0.0 111.108 -177.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -76.95 -56.72 4.34 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.193 0.997 . . . . 0.0 112.842 179.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 44.82 51.08 8.61 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.046 1.338 . . . . 0.0 112.783 -171.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -152.09 172.02 16.97 Favored 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 124.929 1.292 . . . . 0.0 112.451 -175.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -72.27 135.35 45.98 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 120.739 -1.226 . . . . 0.0 112.144 172.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 4.0 m -111.14 152.14 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.839 1.256 . . . . 0.0 109.645 172.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -115.77 156.17 26.5 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 122.129 0.966 . . . . 0.0 112.105 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -158.59 164.88 35.64 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.22 1.408 . . . . 0.0 109.206 -163.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 44.1 tp -143.02 141.97 31.47 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.712 1.205 . . . . 0.0 110.103 -170.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.9 t -112.4 128.58 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.097 0.959 . . . . 0.0 111.534 -172.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.9 mm -135.09 83.28 39.94 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 126.445 1.898 . . . . 0.0 108.743 -176.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -64.27 -16.77 56.88 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.825 2.35 . . . . 0.0 113.303 -178.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -74.88 -32.29 61.82 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.014 1.726 . . . . 0.0 113.348 -175.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 59.7 p -141.87 -25.82 0.67 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -173.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 56.6 31.27 18.82 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.945 1.698 . . . . 0.0 115.339 -161.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -159.15 152.91 23.06 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.026 1.285 . . . . 0.0 114.137 171.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -148.07 175.69 10.8 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.914 1.686 . . . . 0.0 112.278 175.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 91.2 mt -117.94 128.95 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.731 1.212 . . . . 0.0 110.69 -174.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -80.71 156.95 72.6 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 123.173 0.589 . . . . 0.0 111.636 173.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.9 -20.91 64.53 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.555 2.17 . . . . 0.0 112.673 178.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -74.86 8.12 2.68 Favored 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 124.457 1.103 . . . . 0.0 112.872 172.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 93.09 -25.21 21.19 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 127.319 2.39 . . . . 0.0 115.621 171.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 40.6 mt -75.07 146.02 41.83 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 118.715 1.257 . . . . 0.0 113.121 -170.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.8 t -88.61 125.89 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.514 0.726 . . . . 0.0 110.632 174.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 32.0 mt -113.31 148.83 34.9 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.973 1.709 . . . . 0.0 111.193 -177.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -91.05 153.24 20.27 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.844 0.857 . . . . 0.0 112.315 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 25.9 m120 . . . . . 0 CA--C 1.543 0.691 0 C-N-CA 123.875 0.87 . . . . 0.0 111.656 178.593 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.486 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.32 158.42 39.15 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.006 1.322 . . . . 0.0 111.282 -173.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -63.71 148.68 48.48 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.879 0.872 . . . . 0.0 113.079 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -61.46 -22.6 65.2 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.615 1.566 . . . . 0.0 113.805 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -76.17 -14.99 60.14 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.348 1.459 . . . . 0.0 112.406 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.5 m -64.23 136.99 57.71 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.426 1.091 . . . . 0.0 112.548 -175.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -77.94 147.96 34.72 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.357 1.063 . . . . 0.0 112.703 169.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.6 p -144.85 159.88 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.269 1.028 . . . . 0.0 112.373 -171.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -129.55 135.43 48.58 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.606 1.963 . . . . 0.0 108.883 -177.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -155.83 175.19 14.25 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.079 0.854 . . . . 0.0 112.155 168.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -136.13 139.26 42.8 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.452 1.101 . . . . 0.0 111.86 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -156.76 150.79 24.98 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.987 1.315 . . . . 0.0 110.633 173.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.8 t0 49.96 42.08 23.93 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.656 1.182 . . . . 0.0 112.66 -173.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.1 m 55.75 36.17 26.74 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 126.401 1.881 . . . . 0.0 114.609 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.3 p -149.0 139.88 13.81 Favored Pre-proline 0 CA--C 1.54 0.579 0 O-C-N 120.419 -1.426 . . . . 0.0 111.242 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.33 150.29 32.42 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.708 2.938 . . . . 0.0 113.309 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -126.78 140.22 52.53 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.775 2.03 . . . . 0.0 109.894 172.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -148.03 113.2 5.53 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.098 0.959 . . . . 0.0 110.039 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -164.33 -175.51 3.97 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.428 1.891 . . . . 0.0 110.249 -174.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 m -72.09 146.32 47.61 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 120.872 -1.142 . . . . 0.0 109.928 173.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.426 HG12 ' CG ' ' A' ' 152' ' ' TYR . 9.1 tp -56.84 -37.99 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 O-C-N 121.593 -0.692 . . . . 0.0 112.29 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -63.83 -26.27 68.54 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.104 0.866 . . . . 0.0 112.451 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -78.31 -40.64 36.13 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.841 1.257 . . . . 0.0 111.112 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -73.0 -32.58 65.24 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.422 -0.799 . . . . 0.0 111.725 173.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -59.62 -49.18 78.77 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.842 0.857 . . . . 0.0 111.026 169.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.2 t -65.95 -31.5 72.45 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.438 0.695 . . . . 0.0 111.968 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -67.85 -53.52 26.13 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.04 1.336 . . . . 0.0 110.983 173.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -70.4 -33.29 71.2 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.33 -31.88 72.94 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.684 0.794 . . . . 0.0 111.943 173.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.3 t -78.52 -29.98 46.82 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 121.199 -0.938 . . . . 0.0 112.011 174.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 65.5 mtm -81.08 -49.96 10.23 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.113 0.965 . . . . 0.0 113.454 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 -111.8 -20.28 12.12 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.639 1.576 . . . . 0.0 114.295 -168.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.55 158.31 33.56 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 124.553 1.073 . . . . 0.0 114.613 -178.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -104.68 126.42 51.75 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.279 1.032 . . . . 0.0 110.475 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 11.1 mp -99.82 148.51 34.89 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 126.406 1.882 . . . . 0.0 110.517 177.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -72.4 154.92 55.95 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.118 2.546 . . . . 0.0 111.668 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -134.37 167.81 20.05 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.566 1.146 . . . . 0.0 111.202 168.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -51.57 -58.08 7.33 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.036 1.335 . . . . 0.0 111.453 171.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -96.57 -8.79 30.93 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -171.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -175.16 -131.08 1.38 Allowed Glycine 0 CA--C 1.535 1.294 0 N-CA-C 114.871 0.708 . . . . 0.0 114.871 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -136.81 159.7 41.07 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.206 1.802 . . . . 0.0 111.211 176.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.44 149.03 42.07 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.209 1.404 . . . . 0.0 111.213 -177.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.2 t -123.5 116.97 27.94 Favored Pre-proline 0 N--CA 1.482 1.154 0 C-N-CA 125.432 1.493 . . . . 0.0 109.912 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.72 140.97 40.25 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 124.23 3.287 . . . . 0.0 111.78 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 87.5 mt -109.47 169.68 8.55 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.386 1.074 . . . . 0.0 113.309 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -148.29 123.01 9.89 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.723 1.609 . . . . 0.0 110.022 174.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 50.17 40.59 22.31 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.543 1.537 . . . . 0.0 114.022 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.9 t -102.12 122.74 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 121.243 -0.91 . . . . 0.0 110.048 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -121.25 150.9 40.67 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.281 1.032 . . . . 0.0 113.115 -171.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.4 m -138.19 155.49 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 126.862 2.065 . . . . 0.0 111.634 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -69.06 132.55 46.8 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.328 0.651 . . . . 0.0 109.682 167.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.2 t -132.28 148.48 52.44 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.585 1.954 . . . . 0.0 110.654 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 55.9 tp -104.98 134.35 48.23 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.457 1.103 . . . . 0.0 109.654 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -78.1 105.57 9.41 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.59 0.756 . . . . 0.0 109.071 167.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 29.5 mm -66.75 -23.51 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 119.656 1.116 . . . . 0.0 111.633 -176.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.57 -48.22 49.8 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.661 1.184 . . . . 0.0 114.093 -177.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.2 m -114.87 -3.12 12.76 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.214 1.006 . . . . 0.0 113.435 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.59 28.85 68.63 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.293 1.425 . . . . 0.0 113.479 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -95.04 141.58 28.52 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.508 1.123 . . . . 0.0 112.039 -173.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.9 mp -89.81 128.02 42.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 C-N-CA 125.106 1.362 . . . . 0.0 109.501 -176.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -151.53 170.39 19.75 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.331 1.052 . . . . 0.0 112.645 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -114.23 135.12 54.4 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.82 1.248 . . . . 0.0 111.23 -177.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.6 t -134.58 153.87 51.76 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.219 1.008 . . . . 0.0 112.769 -174.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -80.42 140.9 35.77 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 175.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -93.45 143.0 26.7 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.387 1.075 . . . . 0.0 110.92 167.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 96.0 p -85.56 -53.95 4.86 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.81 1.244 . . . . 0.0 112.269 -174.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -152.1 158.82 43.51 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.964 1.705 . . . . 0.0 112.669 177.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.2 mt -85.66 152.51 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 163.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -143.56 148.05 35.35 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.103 1.361 . . . . 0.0 111.466 -177.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.1 ptt-85 -144.11 150.8 38.69 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 168.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -148.62 172.16 15.0 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.293 1.837 . . . . 0.0 110.586 175.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp -101.32 143.87 30.85 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.131 0.973 . . . . 0.0 112.186 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.6 m -145.35 146.57 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.464 1.506 . . . . 0.0 110.815 173.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -92.81 -34.46 13.86 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.731 1.212 . . . . 0.0 111.729 173.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -114.86 124.4 51.63 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.876 1.67 . . . . 0.0 110.224 -170.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.5 tp -134.29 158.5 43.61 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.61 1.564 . . . . 0.0 109.746 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 14.4 mt -109.61 130.83 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.324 1.049 . . . . 0.0 108.762 173.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -100.12 123.83 44.8 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.188 1.395 . . . . 0.0 110.083 168.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -113.3 115.79 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.557 1.543 . . . . 0.0 108.269 173.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.2 tttt -87.82 148.52 24.64 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.444 1.098 . . . . 0.0 110.966 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 85.8 mt -115.06 158.41 22.16 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.17 1.388 . . . . 0.0 112.347 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.1 t -65.04 -23.02 67.07 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 121.881 -0.512 . . . . 0.0 112.077 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 96.1 p -63.35 -22.26 66.77 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.697 1.599 . . . . 0.0 115.031 170.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.83 1.22 61.78 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 125.275 1.417 . . . . 0.0 115.198 -171.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -85.7 161.67 19.1 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.633 1.217 . . . . 0.0 111.194 172.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.2 p -134.49 135.34 42.35 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.359 1.076 . . . . 0.0 112.79 172.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 63.4 tp -97.76 115.09 27.32 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.659 1.584 . . . . 0.0 108.797 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -111.09 109.48 19.58 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.637 1.575 . . . . 0.0 109.878 -177.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.2 m -149.81 154.18 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 126.157 1.783 . . . . 0.0 113.254 -161.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.9 p -66.7 149.75 98.03 Favored Pre-proline 0 N--CA 1.471 0.587 0 O-C-N 121.072 -1.017 . . . . 0.0 113.244 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -60.5 -21.62 68.92 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 124.316 3.344 . . . . 0.0 114.685 -175.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.6 p -76.95 -23.08 52.4 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 128.318 2.647 . . . . 0.0 114.704 175.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 44.0 t60 -75.19 121.19 84.7 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-O 118.349 -0.834 . . . . 0.0 112.671 -162.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -75.13 126.28 9.78 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.881 2.387 . . . . 0.0 112.866 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.8 t -106.08 145.01 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 126.011 1.725 . . . . 0.0 109.175 175.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 18.0 tp -79.46 109.86 14.22 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.4 0.545 . . . . 0.0 110.363 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.1 mp -107.35 161.05 15.16 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.252 1.821 . . . . 0.0 111.556 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -117.91 112.16 19.97 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 174.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.1 mtt-85 -139.62 91.1 2.45 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.76 1.224 . . . . 0.0 109.162 165.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 56.28 -2.68 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 128.25 2.62 . . . . 0.0 116.984 -167.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.76 164.66 37.39 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 125.515 1.531 . . . . 0.0 112.682 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 67.6 mt -71.5 114.86 10.02 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.884 1.674 . . . . 0.0 110.403 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -138.35 136.59 36.52 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -174.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -92.21 112.41 24.34 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.57 1.148 . . . . 0.0 110.85 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 60.5 t -124.32 127.4 25.3 Favored Pre-proline 0 N--CA 1.478 0.962 0 C-N-CA 123.95 0.9 . . . . 0.0 110.233 -172.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -64.22 143.35 83.4 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.487 2.125 . . . . 0.0 111.584 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.14 -30.52 26.91 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 177.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.61 -22.06 66.63 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 173.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -105.43 -6.52 19.43 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.334 1.454 . . . . 0.0 112.486 175.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 84.8 t -68.51 142.25 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 O-C-N 121.292 -0.88 . . . . 0.0 109.594 166.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.61 154.65 80.92 Favored Pre-proline 0 N--CA 1.469 0.505 0 C-N-CA 128.289 2.636 . . . . 0.0 109.496 -178.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.46 132.49 31.36 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.994 1.796 . . . . 0.0 111.05 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 104.04 -6.06 46.81 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.166 1.365 . . . . 0.0 114.221 175.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.33 162.28 28.85 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 118.734 1.267 . . . . 0.0 112.439 177.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 50.5 t -91.12 121.59 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.071 1.348 . . . . 0.0 110.661 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.1 t -94.87 137.69 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.853 1.261 . . . . 0.0 110.233 169.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 41.1 t -89.58 137.82 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.14 0.976 . . . . 0.0 110.473 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -164.99 -149.01 5.67 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.245 0.926 . . . . 0.0 113.002 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.9 p -148.44 166.15 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 127.404 2.281 . . . . 0.0 108.486 175.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -60.67 106.86 0.61 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.67 0.788 . . . . 0.0 111.909 174.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.73 -25.45 68.2 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -175.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -68.9 -42.01 77.49 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.024 -1.048 . . . . 0.0 112.042 170.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 49.1 t -65.39 -38.82 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.047 0.939 . . . . 0.0 110.455 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 30.7 tp -63.24 -13.46 38.16 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.615 1.566 . . . . 0.0 113.739 175.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -117.97 9.27 12.75 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.523 1.529 . . . . 0.0 114.655 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.86 168.9 16.92 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.099 1.359 . . . . 0.0 111.56 167.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -71.76 -43.43 65.77 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 121.019 -1.05 . . . . 0.0 111.89 174.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 mp -105.57 122.39 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 127.185 2.194 . . . . 0.0 107.649 169.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 65.6 mt -92.67 118.56 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 123.683 0.793 . . . . 0.0 108.957 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 10.0 t -72.68 84.39 1.17 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.071 0.949 . . . . 0.0 110.955 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -64.05 173.6 1.84 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 127.079 2.152 . . . . 0.0 115.393 -171.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 73.42 22.27 78.78 Favored Glycine 0 N--CA 1.471 1.01 0 N-CA-C 116.489 1.355 . . . . 0.0 116.489 169.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -134.66 163.85 28.83 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.939 1.295 . . . . 0.0 112.221 174.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 95.7 mt -137.13 164.83 27.5 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.674 1.99 . . . . 0.0 109.634 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -142.09 134.73 28.3 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.207 1.403 . . . . 0.0 111.83 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -90.59 143.54 26.64 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.557 1.543 . . . . 0.0 111.702 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -131.65 136.07 47.42 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.35 1.46 . . . . 0.0 110.917 -173.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -87.33 130.65 34.54 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 119.011 0.823 . . . . 0.0 112.394 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 82.8 t -68.35 122.15 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 121.77 0.795 . . . . 0.0 110.573 167.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 45.5 t -76.92 -50.29 13.63 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.823 1.649 . . . . 0.0 112.602 176.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.4 t -158.8 164.99 35.28 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.474 1.51 . . . . 0.0 110.552 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.8 m -132.61 149.5 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 124.486 1.114 . . . . 0.0 111.543 170.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -155.34 154.37 31.93 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.247 1.019 . . . . 0.0 113.565 171.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 71.2 mt -90.25 130.6 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.561 1.144 . . . . 0.0 109.26 169.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 16.1 pt -126.39 159.04 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.925 1.69 . . . . 0.0 112.496 -174.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -95.38 96.53 9.19 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 122.24 1.019 . . . . 0.0 111.534 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -76.01 -52.02 11.11 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.064 0.945 . . . . 0.0 113.2 176.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 50.89 33.12 8.18 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.954 1.301 . . . . 0.0 113.952 -176.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -141.04 172.97 11.95 Favored 'General case' 0 CA--C 1.549 0.928 0 O-C-N 120.775 -1.203 . . . . 0.0 112.471 -170.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -74.01 137.89 43.75 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.262 -0.899 . . . . 0.0 112.091 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 12.2 m -122.35 154.5 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.399 1.88 . . . . 0.0 110.141 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.426 ' CG ' HG12 ' A' ' 21' ' ' ILE . 1.5 p90 -113.06 159.73 18.88 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -174.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -137.68 145.29 42.43 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.256 1.422 . . . . 0.0 109.092 158.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 67.1 tp -120.89 103.99 9.49 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.829 1.252 . . . . 0.0 109.426 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 57.6 t -87.71 131.66 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -150.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.4 mm -124.62 85.78 56.21 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 124.536 1.134 . . . . 0.0 110.793 -176.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -65.48 -10.3 25.7 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.561 2.174 . . . . 0.0 114.216 177.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -72.15 -47.74 48.69 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 119.816 1.189 . . . . 0.0 113.0 172.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 71.1 p -135.32 -15.2 1.93 Allowed 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -171.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . 0.295 68.6 m80 56.78 25.9 10.83 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 128.079 2.552 . . . . 0.0 116.03 -170.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.92 146.85 26.55 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 120.796 -1.19 . . . . 0.0 113.548 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -147.56 166.05 28.49 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.299 1.439 . . . . 0.0 112.302 -176.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.9 mp -109.82 135.59 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.82 1.248 . . . . 0.0 111.663 177.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -85.81 159.05 55.67 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 124.315 1.046 . . . . 0.0 112.624 171.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.0 -23.19 74.06 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.69 2.926 . . . . 0.0 112.582 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.74 8.22 2.05 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.548 1.139 . . . . 0.0 113.176 171.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 90.68 -20.61 37.59 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 127.098 2.285 . . . . 0.0 116.048 169.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 47.2 mt -70.87 151.76 44.41 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.279 1.432 . . . . 0.0 112.889 -173.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.41 124.72 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 124.565 1.146 . . . . 0.0 111.926 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.96 144.07 43.68 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.738 2.015 . . . . 0.0 111.96 -173.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -100.27 146.52 26.81 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.563 0.745 . . . . 0.0 111.98 166.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -61.91 128.1 34.56 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.562 -0.711 . . . . 0.0 110.832 168.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -161.24 154.2 21.01 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.365 1.066 . . . . 0.0 110.643 173.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 117.847 -1.073 . . . . 0.0 109.392 166.164 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.667 0 CA-C-O 121.023 0.44 . . . . 0.0 112.031 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.422 ' HB2' ' CE1' ' A' ' 152' ' ' TYR . 0.0 OUTLIER -146.6 164.45 32.59 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.645 1.578 . . . . 0.0 111.058 -172.419 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.74 143.58 57.43 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.66 1.184 . . . . 0.0 113.725 -175.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? -58.71 -25.22 62.69 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.182 1.393 . . . . 0.0 114.238 177.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -87.02 1.03 54.19 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.924 1.29 . . . . 0.0 113.399 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.1 m -69.35 142.06 54.07 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.592 1.157 . . . . 0.0 113.099 175.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -79.32 148.06 32.23 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.436 1.494 . . . . 0.0 113.464 171.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.0 p -147.19 158.52 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.648 1.179 . . . . 0.0 111.904 -173.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -126.35 139.86 52.96 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.444 1.898 . . . . 0.0 108.807 178.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -155.28 177.21 11.61 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.608 0.718 . . . . 0.0 111.379 165.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -134.9 143.1 46.75 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.135 0.974 . . . . 0.0 110.181 173.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -159.53 143.12 14.56 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.483 1.113 . . . . 0.0 109.826 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.4 t70 48.49 50.28 17.07 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.927 1.291 . . . . 0.0 113.595 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.4 m 68.71 11.06 8.22 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 128.38 2.672 . . . . 0.0 116.145 174.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.6 p -134.71 136.87 26.22 Favored Pre-proline 0 CA--C 1.545 0.756 0 O-C-N 120.279 -1.513 . . . . 0.0 112.871 -176.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -73.0 154.39 52.82 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 123.793 2.996 . . . . 0.0 112.597 174.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -135.31 136.86 41.92 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.739 2.016 . . . . 0.0 109.147 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 50.6 ttm -152.95 104.01 2.8 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.749 0.82 . . . . 0.0 110.277 -176.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -162.29 -176.86 5.34 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.138 1.375 . . . . 0.0 111.067 -169.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.4 m -71.6 143.75 49.71 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 120.855 -1.153 . . . . 0.0 110.673 171.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.414 HG21 ' CD1' ' A' ' 152' ' ' TYR . 9.1 tp -55.02 -38.29 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -62.64 -24.04 67.39 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.365 -0.834 . . . . 0.0 113.02 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -80.55 -39.39 27.83 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.08 0.952 . . . . 0.0 111.313 176.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -73.18 -33.23 65.32 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.079 0.854 . . . . 0.0 111.72 174.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -56.96 -51.73 68.02 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.701 1.2 . . . . 0.0 111.908 169.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.1 t -62.17 -40.42 95.97 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.631 0.772 . . . . 0.0 111.423 -177.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -61.05 -53.01 62.49 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.756 1.223 . . . . 0.0 110.425 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -72.07 -33.28 67.8 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.0 -31.58 72.56 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.254 1.022 . . . . 0.0 112.513 175.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.7 t -79.81 -33.07 40.69 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 118.796 0.725 . . . . 0.0 111.878 174.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 69.8 mtm -75.99 -48.15 22.22 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.566 0.747 . . . . 0.0 112.665 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 35.7 m-20 -116.86 -19.88 9.67 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.437 1.495 . . . . 0.0 113.887 -166.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.75 159.17 34.89 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 125.087 1.327 . . . . 0.0 114.755 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -104.19 124.33 48.92 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.703 1.201 . . . . 0.0 109.435 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.3 mp -106.24 141.4 22.67 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 125.777 1.631 . . . . 0.0 110.613 -178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.12 146.23 57.35 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.505 2.803 . . . . 0.0 112.09 -173.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -134.25 154.73 51.1 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.42 1.088 . . . . 0.0 112.234 177.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -42.17 -47.45 4.65 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.897 1.679 . . . . 0.0 114.673 -176.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -116.3 7.65 14.04 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.13 -137.43 2.44 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 116.097 1.199 . . . . 0.0 116.097 -172.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -145.35 157.0 44.13 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 127.562 2.345 . . . . 0.0 111.062 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.09 151.98 47.15 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.376 1.071 . . . . 0.0 112.306 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.4 t -123.96 116.96 27.31 Favored Pre-proline 0 N--CA 1.48 1.046 0 C-N-CA 125.393 1.477 . . . . 0.0 110.284 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.43 141.63 31.96 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 124.529 3.486 . . . . 0.0 111.584 -176.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 77.2 mt -115.54 171.21 7.87 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.822 1.249 . . . . 0.0 112.682 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -148.92 135.02 19.16 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.843 1.657 . . . . 0.0 109.479 165.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 52.17 50.28 18.78 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.971 1.308 . . . . 0.0 113.562 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 67.0 t -113.05 107.67 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.075 0.95 . . . . 0.0 110.48 177.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -103.71 137.66 41.43 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.603 1.161 . . . . 0.0 113.335 -167.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.8 m -134.74 149.84 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.574 1.549 . . . . 0.0 112.599 175.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -65.44 141.95 58.34 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.648 0.779 . . . . 0.0 111.028 169.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.9 t -144.78 154.17 42.42 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.609 1.564 . . . . 0.0 111.259 -174.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 54.0 tp -114.05 138.88 49.8 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.06 1.344 . . . . 0.0 110.821 -175.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -86.6 120.69 28.19 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.17 1.388 . . . . 0.0 108.987 161.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 24.2 mm -78.87 -28.85 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 O-C-N 121.256 -0.903 . . . . 0.0 111.154 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.05 -36.19 80.86 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.437 1.095 . . . . 0.0 113.492 -171.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.9 m -121.54 -21.26 6.28 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.217 1.407 . . . . 0.0 112.998 171.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.49 31.01 20.19 Favored Glycine 0 N--CA 1.474 1.232 0 CA-C-N 118.878 0.763 . . . . 0.0 113.099 -173.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -91.92 143.68 26.24 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.819 1.248 . . . . 0.0 112.05 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.0 144.23 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.482 1.113 . . . . 0.0 110.6 -176.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.3 ptpt -154.0 176.91 11.65 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.901 1.68 . . . . 0.0 112.367 -177.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -121.45 147.82 45.24 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.792 1.637 . . . . 0.0 111.567 174.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.7 t -143.61 160.4 40.72 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.013 1.325 . . . . 0.0 111.187 175.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -97.88 132.36 43.54 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 170.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.33 142.2 39.51 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.056 0.943 . . . . 0.0 111.004 175.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.6 t -89.96 -46.14 8.72 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -169.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -153.53 160.55 42.52 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.684 1.193 . . . . 0.0 112.272 174.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.7 mt -88.79 152.81 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.481 1.112 . . . . 0.0 108.423 165.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -139.69 148.04 41.8 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.459 1.504 . . . . 0.0 110.537 -177.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.4 ptt85 -143.32 150.16 38.81 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.099 0.96 . . . . 0.0 113.155 169.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -151.66 166.08 32.36 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.988 1.715 . . . . 0.0 109.984 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -94.09 151.93 19.14 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.036 0.834 . . . . 0.0 111.459 172.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.7 m -148.74 143.12 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 124.879 1.272 . . . . 0.0 110.333 170.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -90.22 -30.14 17.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 117.632 -1.175 . . . . 0.0 112.019 175.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.7 mttt -131.95 130.43 41.51 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.274 0.943 . . . . 0.0 110.915 -174.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.8 tp -139.93 162.78 34.37 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.804 2.042 . . . . 0.0 110.158 -168.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.7 mt -116.46 127.58 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.604 1.162 . . . . 0.0 110.138 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -96.62 126.45 41.8 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.139 0.975 . . . . 0.0 110.625 166.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -111.0 129.03 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.436 1.094 . . . . 0.0 109.835 169.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -97.65 143.73 28.02 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.025 1.73 . . . . 0.0 111.301 173.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.3 mt -104.55 157.35 17.23 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 127.094 2.158 . . . . 0.0 110.317 -176.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.3 t -66.88 -23.6 66.02 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -173.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.7 t -66.84 -20.05 65.85 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.251 -0.905 . . . . 0.0 113.415 167.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 108.13 -5.52 34.08 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 127.575 2.512 . . . . 0.0 115.71 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -82.85 161.07 22.05 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.166 1.387 . . . . 0.0 110.831 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 65.2 p -141.46 159.83 41.41 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 24.3 tp -129.41 138.89 51.74 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.461 1.904 . . . . 0.0 110.324 177.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -111.22 121.63 45.79 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.876 1.27 . . . . 0.0 112.113 177.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.12 153.41 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.728 1.611 . . . . 0.0 112.85 -166.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.2 p -68.55 148.57 98.11 Favored Pre-proline 0 N--CA 1.472 0.64 0 O-C-N 120.944 -1.098 . . . . 0.0 112.573 173.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -60.84 -30.32 89.9 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 123.069 2.513 . . . . 0.0 114.366 -168.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 95.9 p -85.19 -6.56 59.27 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -61.5 119.21 44.75 Favored Pre-proline 0 CA--C 1.544 0.747 0 CA-C-N 119.635 1.107 . . . . 0.0 111.548 -177.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -73.47 127.38 11.75 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.415 2.077 . . . . 0.0 113.097 178.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.1 t -109.38 141.04 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.389 1.876 . . . . 0.0 109.374 174.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 20.2 tp -84.12 116.06 22.71 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.935 -0.478 . . . . 0.0 110.369 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.4 mp -115.67 148.28 39.88 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.961 1.704 . . . . 0.0 111.358 -173.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -107.0 81.54 1.56 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.877 0.846 . . . . 0.0 112.662 -173.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -119.0 78.81 1.32 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.691 1.196 . . . . 0.0 110.055 -169.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.6 t70 64.54 -14.79 0.09 Allowed 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 128.697 2.799 . . . . 0.0 115.602 -160.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.58 179.45 43.32 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 126.471 1.986 . . . . 0.0 111.506 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 73.0 mt -71.49 127.38 32.36 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.501 1.12 . . . . 0.0 109.981 178.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -153.33 144.93 23.34 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.902 0.881 . . . . 0.0 112.387 174.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -89.83 128.13 36.11 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.163 0.985 . . . . 0.0 110.879 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.0 t -131.65 128.94 21.93 Favored Pre-proline 0 N--CA 1.473 0.698 0 C-N-CA 124.584 1.154 . . . . 0.0 110.801 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -65.21 144.57 81.61 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.08 1.854 . . . . 0.0 110.974 175.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.44 -29.9 17.72 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 176.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.81 -23.0 67.19 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 173.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -108.83 0.76 20.49 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.302 1.841 . . . . 0.0 112.178 178.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.7 t -78.37 142.92 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.478 1.111 . . . . 0.0 110.014 166.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.74 154.94 73.24 Favored Pre-proline 0 N--CA 1.469 0.478 0 C-N-CA 126.202 1.801 . . . . 0.0 111.127 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.412 ' HD3' HG22 ' A' ' 142' ' ' VAL . 64.2 Cg_endo -63.69 122.5 10.62 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.188 1.926 . . . . 0.0 109.978 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 102.08 5.27 50.23 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 124.355 0.979 . . . . 0.0 115.316 -176.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -64.38 165.08 10.23 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 118.956 1.378 . . . . 0.0 112.302 164.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.1 p -113.48 125.03 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.171 1.388 . . . . 0.0 111.744 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.3 t -101.64 142.92 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 127.938 2.495 . . . . 0.0 110.652 -173.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 43.8 t -99.99 143.35 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.842 1.257 . . . . 0.0 112.314 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -162.9 -152.12 6.67 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.826 1.679 . . . . 0.0 112.63 175.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.4 p -138.82 157.01 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 127.519 2.328 . . . . 0.0 108.873 -177.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -59.85 125.82 25.15 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.068 0.547 . . . . 0.0 110.815 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -54.3 -34.11 60.23 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.227 1.011 . . . . 0.0 112.663 -172.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -47.22 -48.16 24.2 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.897 1.279 . . . . 0.0 114.328 174.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.6 p -71.0 -22.14 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-N 120.9 1.682 . . . . 0.0 113.582 -174.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -85.03 -35.44 21.92 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.624 1.169 . . . . 0.0 111.547 172.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 52.1 ttt85 -100.64 -45.92 5.35 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 -164.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -169.68 102.28 0.32 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 127.108 2.163 . . . . 0.0 110.43 177.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 33.8 ttt-85 -155.29 165.27 37.18 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 125.99 1.716 . . . . 0.0 111.747 175.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.64 142.61 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.831 1.252 . . . . 0.0 109.76 155.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 44.9 pt -58.25 139.83 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -172.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 79.3 p -159.52 177.47 10.89 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.56 1.944 . . . . 0.0 111.363 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -135.05 168.88 18.32 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.206 1.402 . . . . 0.0 112.174 166.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.96 -3.18 85.91 Favored Glycine 0 CA--C 1.537 1.425 0 N-CA-C 119.438 2.535 . . . . 0.0 119.438 162.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -89.0 70.27 8.51 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.186 1.493 . . . . 0.0 113.637 -168.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 98.8 mt -66.03 138.98 58.16 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.003 1.721 . . . . 0.0 113.838 -177.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -131.11 149.88 52.4 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.439 1.496 . . . . 0.0 112.98 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -130.95 136.13 48.28 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.895 0.878 . . . . 0.0 113.142 -170.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -125.9 142.41 51.53 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.42 1.088 . . . . 0.0 111.297 -175.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -88.99 138.46 31.38 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.55 0.74 . . . . 0.0 110.894 174.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 71.9 t -72.41 126.26 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 O-C-N 120.705 -1.247 . . . . 0.0 110.115 172.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 28.2 t -77.71 -48.55 16.43 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.412 1.485 . . . . 0.0 111.629 172.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.72 170.54 20.57 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.412 -0.805 . . . . 0.0 111.588 176.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.412 HG22 ' HD3' ' A' ' 112' ' ' PRO . 11.1 m -132.81 155.24 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.772 1.229 . . . . 0.0 110.255 169.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -153.9 153.9 32.89 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.201 1.001 . . . . 0.0 112.391 168.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 96.3 mt -94.14 135.99 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.949 1.3 . . . . 0.0 108.091 168.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 28.2 pt -132.56 148.21 31.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 125.147 1.379 . . . . 0.0 111.029 -178.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -84.39 96.01 8.94 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 170.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -74.12 -45.95 45.68 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.096 -1.003 . . . . 0.0 112.105 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 47.12 40.51 9.97 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.559 1.143 . . . . 0.0 112.498 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -148.41 172.3 14.66 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.244 1.418 . . . . 0.0 110.763 -170.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -76.94 142.55 40.0 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 122.052 0.93 . . . . 0.0 112.638 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.36 157.53 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 126.557 1.943 . . . . 0.0 109.344 177.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.422 ' CE1' ' HB2' ' A' ' 2' ' ' PHE . 7.8 p90 -110.51 161.44 15.69 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.973 0.909 . . . . 0.0 112.016 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -137.38 154.03 50.08 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.865 0.866 . . . . 0.0 108.944 158.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.0 tt -129.05 108.99 10.82 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.738 -1.226 . . . . 0.0 108.823 -172.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.7 t -90.87 127.47 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -153.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 28.8 mm -124.18 85.84 54.7 Favored Pre-proline 0 N--CA 1.47 0.571 0 C-N-CA 125.627 1.571 . . . . 0.0 109.705 -172.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -64.65 -16.92 57.74 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.098 1.866 . . . . 0.0 113.816 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -78.45 -45.03 23.18 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.742 1.156 . . . . 0.0 113.089 -176.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 76.6 p -131.65 -8.52 3.62 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.338 1.455 . . . . 0.0 114.288 -172.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 54.73 15.68 1.17 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.555 1.542 . . . . 0.0 114.773 -165.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -143.45 142.48 31.22 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 121.248 1.84 . . . . 0.0 114.951 -175.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -141.74 162.91 34.31 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.383 1.473 . . . . 0.0 112.069 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 95.2 mt -112.29 130.62 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.281 1.032 . . . . 0.0 110.568 -173.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -77.74 160.1 75.18 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 124.151 0.981 . . . . 0.0 111.866 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -62.19 -20.12 68.91 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.577 2.185 . . . . 0.0 112.719 177.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -73.81 -12.21 60.62 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.039 1.336 . . . . 0.0 113.226 175.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 102.61 -22.43 37.38 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.851 1.691 . . . . 0.0 115.446 177.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 72.2 mt -72.14 148.12 45.98 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 119.479 1.639 . . . . 0.0 113.087 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.9 p -99.89 134.38 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.396 1.079 . . . . 0.0 112.48 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 41.4 mt -119.47 133.75 55.54 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.498 1.919 . . . . 0.0 110.913 -171.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 31.6 t-80 -86.23 126.56 34.36 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.606 -0.684 . . . . 0.0 110.379 165.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.471 ' ND2' ' H ' ' A' ' 174' ' ' GLN . 0.0 OUTLIER -73.53 144.75 46.0 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.069 0.948 . . . . 0.0 109.464 170.837 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -110.78 7.76 22.16 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.83 1.418 . . . . 0.0 114.83 -170.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . 0.471 ' H ' ' ND2' ' A' ' 172' ' ' ASN . 45.1 mm-40 . . . . . 0 C--O 1.253 1.255 0 C-N-CA 125.603 1.561 . . . . 0.0 113.194 -172.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.878 0 CA-C-O 121.085 0.469 . . . . 0.0 111.983 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -131.01 160.26 35.1 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 127.014 2.126 . . . . 0.0 111.196 -175.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -55.46 145.86 21.57 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.379 1.071 . . . . 0.0 112.615 175.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -26.26 67.89 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -79.21 -8.26 58.88 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 175.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.0 m -63.11 134.8 56.63 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 121.063 -1.023 . . . . 0.0 111.29 -175.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -76.78 149.32 36.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 122.268 1.033 . . . . 0.0 113.719 175.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.0 p -145.35 152.14 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 124.595 1.158 . . . . 0.0 111.675 -173.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -122.06 143.26 49.62 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.766 2.026 . . . . 0.0 107.284 176.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -150.86 -175.88 5.31 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.427 0.691 . . . . 0.0 111.132 164.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -136.15 142.24 44.18 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.258 1.423 . . . . 0.0 110.624 174.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -164.04 151.21 11.95 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.879 2.071 . . . . 0.0 108.109 176.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.2 t0 50.95 43.18 28.86 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.791 1.237 . . . . 0.0 113.698 -177.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.5 m 56.66 35.18 25.76 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.625 1.57 . . . . 0.0 114.523 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.1 p -154.66 140.8 12.85 Favored Pre-proline 0 CA--C 1.538 0.482 0 O-C-N 120.505 -1.372 . . . . 0.0 112.012 177.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.35 144.87 57.67 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.588 2.192 . . . . 0.0 112.194 173.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -123.34 142.21 51.19 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 128.819 2.848 . . . . 0.0 108.806 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 41.6 ttm -153.29 120.43 5.8 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.678 -0.639 . . . . 0.0 111.634 -175.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -160.44 -172.43 3.55 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.47 1.908 . . . . 0.0 110.56 -176.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.4 m -76.16 150.08 37.21 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 120.639 -1.288 . . . . 0.0 110.541 167.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.2 tp -59.22 -36.36 62.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 O-C-N 121.019 -1.051 . . . . 0.0 111.985 177.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -59.71 -27.64 66.62 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.202 0.91 . . . . 0.0 113.455 173.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -81.46 -47.51 13.08 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.542 0.737 . . . . 0.0 110.194 -176.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.9 ppp? -68.27 -33.26 74.04 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 176.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -58.46 -50.05 75.1 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.428 0.691 . . . . 0.0 111.6 170.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.4 t -66.18 -29.61 69.93 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 121.646 -0.659 . . . . 0.0 111.973 -173.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -69.53 -57.13 5.6 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 126.39 1.876 . . . . 0.0 110.731 173.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -69.7 -34.86 74.51 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.282 -0.886 . . . . 0.0 112.89 -176.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.57 -24.79 64.65 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.303 1.041 . . . . 0.0 113.616 174.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 30.9 t -82.38 -35.27 27.91 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.765 0.712 . . . . 0.0 111.975 172.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 63.8 mtm -77.55 -58.08 3.46 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.85 0.86 . . . . 0.0 111.793 -178.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 47.2 m-20 -98.53 -20.02 17.29 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.828 1.251 . . . . 0.0 112.555 -171.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.7 159.35 33.2 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-O 121.941 0.745 . . . . 0.0 114.008 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -105.01 124.2 49.12 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.223 1.009 . . . . 0.0 110.577 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.6 mp -98.46 151.31 37.41 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 125.225 1.41 . . . . 0.0 110.488 174.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -69.09 156.12 66.05 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.834 2.356 . . . . 0.0 111.624 176.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -140.6 169.54 17.45 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.988 1.715 . . . . 0.0 110.26 174.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -48.93 -49.48 39.99 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -176.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -107.4 -13.43 15.1 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 177.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -161.21 -134.96 1.73 Allowed Glycine 0 CA--C 1.528 0.847 0 O-C-N 121.507 -0.745 . . . . 0.0 113.935 -167.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -140.69 154.72 46.49 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.284 1.034 . . . . 0.0 111.891 -177.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -135.95 145.4 46.17 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.774 1.23 . . . . 0.0 112.454 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 52.1 t -118.53 116.78 34.85 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 125.642 1.577 . . . . 0.0 110.758 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -71.34 138.23 32.54 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 124.091 3.194 . . . . 0.0 111.603 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 82.2 mt -107.18 158.13 17.34 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.974 1.31 . . . . 0.0 112.507 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -139.12 124.37 19.11 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.316 1.446 . . . . 0.0 109.444 174.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 51.33 51.2 17.35 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.797 1.639 . . . . 0.0 113.98 -178.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.4 t -116.41 128.71 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.408 1.483 . . . . 0.0 109.981 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -129.25 158.28 39.5 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.603 1.161 . . . . 0.0 113.364 -170.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.1 m -146.12 152.48 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 126.784 2.034 . . . . 0.0 112.269 176.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -61.7 131.45 49.99 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.402 1.481 . . . . 0.0 110.45 161.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.6 t -134.84 153.09 52.18 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.201 2.2 . . . . 0.0 111.565 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 37.6 tp -106.63 136.2 46.84 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.032 0.933 . . . . 0.0 112.169 -176.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -82.61 93.56 7.35 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.733 1.613 . . . . 0.0 110.173 170.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 31.7 mm -59.92 -21.82 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 O-C-N 120.854 -1.154 . . . . 0.0 112.888 -175.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.26 -50.12 64.84 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.081 -1.012 . . . . 0.0 113.455 175.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -111.91 -15.28 13.37 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.917 0.887 . . . . 0.0 112.652 -168.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.86 36.27 91.93 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.395 0.998 . . . . 0.0 112.105 -172.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -103.67 150.0 24.43 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.529 1.932 . . . . 0.0 111.084 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 mp -95.41 135.47 29.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 124.774 1.23 . . . . 0.0 110.801 -173.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.05 163.5 38.0 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.679 1.592 . . . . 0.0 112.569 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.4 150.19 20.65 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.232 1.413 . . . . 0.0 111.695 172.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.8 t -143.25 165.1 28.39 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.616 1.167 . . . . 0.0 111.787 167.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -91.58 153.38 19.78 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.142 1.377 . . . . 0.0 112.639 172.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -107.39 144.06 34.83 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.397 1.079 . . . . 0.0 111.487 170.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.6 t -97.64 -44.19 6.89 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.699 0.999 . . . . 0.0 113.699 -170.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -153.83 159.13 41.72 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.402 1.081 . . . . 0.0 112.761 173.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.2 mt -90.21 153.02 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.268 1.427 . . . . 0.0 108.398 164.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -137.41 148.42 46.16 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.051 1.34 . . . . 0.0 112.614 -177.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 37.3 ptt85 -138.29 145.89 41.8 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.836 1.254 . . . . 0.0 114.105 174.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -152.63 168.35 25.89 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.942 2.097 . . . . 0.0 110.314 177.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.423 ' HE2' ' HA ' ' A' ' 149' ' ' ASN . 1.0 OUTLIER -110.26 139.56 45.31 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.285 1.434 . . . . 0.0 112.602 -175.252 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.1 m -148.48 146.82 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 124.794 1.238 . . . . 0.0 112.133 -176.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.439 ' HA ' ' H ' ' A' ' 148' ' ' ASN . 6.4 pt-20 -104.32 -25.32 12.91 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 126.188 1.795 . . . . 0.0 112.923 174.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -122.23 118.05 27.63 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.64 1.109 . . . . 0.0 111.021 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.9 tp -128.03 159.15 35.92 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.813 2.045 . . . . 0.0 108.388 -175.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.1 mt -113.37 129.58 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 119.727 1.149 . . . . 0.0 109.146 177.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -103.76 117.24 33.9 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.769 0.828 . . . . 0.0 110.978 170.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.2 mp -102.84 125.58 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 C-N-CA 125.399 1.479 . . . . 0.0 108.241 175.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.4 tttt -95.46 147.75 23.2 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.057 1.343 . . . . 0.0 110.67 171.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 54.3 mt -117.67 160.57 21.09 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.364 1.466 . . . . 0.0 112.149 -172.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.7 t -64.76 -16.86 63.58 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.571 1.148 . . . . 0.0 112.979 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.2 p -70.37 -11.16 60.72 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.974 1.71 . . . . 0.0 114.214 167.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.76 -4.17 84.95 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 126.193 1.854 . . . . 0.0 113.985 -174.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -88.72 165.76 14.52 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.236 1.814 . . . . 0.0 112.151 -175.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.9 p -131.2 152.78 50.14 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 174.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 61.8 tp -127.94 129.28 46.56 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.63 1.972 . . . . 0.0 109.394 178.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -114.09 113.31 24.56 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.262 1.425 . . . . 0.0 111.15 -177.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.9 m -141.72 155.39 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 125.634 1.574 . . . . 0.0 113.036 -170.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.4 p -64.25 147.18 97.22 Favored Pre-proline 0 N--CA 1.469 0.513 0 O-C-N 121.212 -0.93 . . . . 0.0 112.677 175.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -62.83 -29.81 77.01 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.864 2.376 . . . . 0.0 113.589 -170.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.8 p -72.04 -10.93 60.46 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.196 1.798 . . . . 0.0 114.768 174.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -78.38 119.19 76.41 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 119.524 1.056 . . . . 0.0 112.787 -164.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -68.74 137.85 39.66 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.847 2.365 . . . . 0.0 113.207 -177.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.9 t -120.25 140.81 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 126.388 1.875 . . . . 0.0 109.156 175.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 39.5 tp -81.83 110.43 17.13 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 122.848 0.459 . . . . 0.0 110.158 178.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.0 mp -105.12 150.53 24.96 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.972 1.709 . . . . 0.0 111.801 -175.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -108.74 102.06 11.14 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.641 0.776 . . . . 0.0 111.792 171.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 59.0 mtt-85 -139.61 80.52 1.78 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.312 1.045 . . . . 0.0 111.6 174.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.9 t0 64.5 1.05 1.21 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 127.728 2.411 . . . . 0.0 115.148 -167.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 179.32 165.63 33.83 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 124.764 1.173 . . . . 0.0 113.018 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 39.6 mt -72.43 117.58 14.27 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.174 0.99 . . . . 0.0 111.133 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -145.63 137.09 25.06 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.22 1.008 . . . . 0.0 112.609 -176.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -91.79 121.85 33.79 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.209 1.004 . . . . 0.0 110.902 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 71.3 t -134.0 130.27 20.4 Favored Pre-proline 0 N--CA 1.48 1.039 0 C-N-CA 125.472 1.509 . . . . 0.0 109.561 -175.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.05 151.53 77.43 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 122.815 2.343 . . . . 0.0 112.797 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.47 -31.91 16.57 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 174.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.09 -23.31 67.28 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 173.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -106.07 -5.01 19.77 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.027 1.731 . . . . 0.0 112.082 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 89.9 t -69.53 147.07 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.592 1.157 . . . . 0.0 110.26 166.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.53 154.13 80.64 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 127.78 2.432 . . . . 0.0 110.625 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.401 ' HD3' HG22 ' A' ' 142' ' ' VAL . 58.0 Cg_endo -66.56 116.15 3.93 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.431 2.087 . . . . 0.0 111.043 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.414 ' H ' ' HB ' ' A' ' 139' ' ' VAL . . . 113.65 0.37 24.6 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.677 1.132 . . . . 0.0 114.948 -177.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -60.21 157.04 14.08 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 119.682 1.741 . . . . 0.0 112.119 169.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.6 t -95.65 126.05 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.542 1.137 . . . . 0.0 110.574 168.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.1 t -101.08 142.51 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 126.92 2.088 . . . . 0.0 110.09 173.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.1 t -90.63 137.62 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.852 0.861 . . . . 0.0 111.111 175.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -166.48 -150.87 6.54 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.298 0.951 . . . . 0.0 113.533 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.0 p -152.81 172.86 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 127.25 2.22 . . . . 0.0 109.895 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -67.71 122.23 17.64 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.051 1.34 . . . . 0.0 112.7 174.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.29 -39.2 72.32 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.193 0.997 . . . . 0.0 112.948 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -62.24 -27.27 68.88 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 175.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 66.6 t -76.51 -30.69 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-N 119.026 0.83 . . . . 0.0 110.764 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -76.99 -31.41 56.47 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.768 1.227 . . . . 0.0 111.886 171.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 26.9 ttp-105 -82.42 -11.92 58.22 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.596 1.558 . . . . 0.0 114.226 177.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -53.26 150.47 6.16 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.06 1.744 . . . . 0.0 111.993 170.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 69.2 mtt85 -70.55 -32.81 70.4 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 118.657 0.662 . . . . 0.0 112.512 -178.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 10.5 tt -90.57 144.73 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.714 1.206 . . . . 0.0 112.465 176.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 46.6 pt -68.65 121.67 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 121.681 0.753 . . . . 0.0 110.444 172.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 58.2 m -120.07 151.07 39.57 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.903 1.281 . . . . 0.0 111.898 -166.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -136.24 169.64 17.32 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.399 1.48 . . . . 0.0 113.987 -167.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.71 13.31 83.14 Favored Glycine 0 CA--C 1.542 1.77 0 N-CA-C 117.492 1.757 . . . . 0.0 117.492 166.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -120.94 148.94 43.39 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 120.501 2.151 . . . . 0.0 113.011 -176.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 43.4 mt -147.31 154.42 40.92 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.584 1.554 . . . . 0.0 111.968 172.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -149.7 127.75 11.95 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.101 1.76 . . . . 0.0 110.836 177.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -88.14 148.6 24.35 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.309 -0.869 . . . . 0.0 111.54 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -130.2 133.39 46.53 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.925 1.29 . . . . 0.0 109.622 -170.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -90.82 140.77 29.49 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 119.812 1.187 . . . . 0.0 111.847 175.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.414 ' HB ' ' H ' ' A' ' 113' ' ' GLY . 78.4 t -74.8 139.65 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.16 0.984 . . . . 0.0 111.271 175.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.1 t -94.58 -48.27 6.17 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.503 1.921 . . . . 0.0 112.29 175.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 13.1 t -156.61 161.63 39.91 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.352 1.061 . . . . 0.0 111.551 -177.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.401 HG22 ' HD3' ' A' ' 112' ' ' PRO . 5.6 m -139.52 149.38 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 125.365 1.466 . . . . 0.0 111.512 168.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -161.85 168.76 22.49 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 160.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 43.9 mt -93.09 128.06 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.006 1.322 . . . . 0.0 110.004 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 31.6 pt -120.78 154.8 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 127.159 2.184 . . . . 0.0 112.485 -174.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -100.48 75.51 1.78 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.182 1.393 . . . . 0.0 111.159 -168.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -66.97 -47.89 70.17 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.26 -0.9 . . . . 0.0 112.465 -169.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.439 ' H ' ' HA ' ' A' ' 74' ' ' GLU . 1.5 m-80 49.5 41.5 21.23 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.09 1.756 . . . . 0.0 111.941 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.423 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 22.3 t-20 -146.17 176.62 9.61 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.114 1.366 . . . . 0.0 111.34 -171.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -74.42 147.0 42.44 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.008 0.923 . . . . 0.0 112.067 170.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 6.8 m -127.98 150.17 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.087 1.755 . . . . 0.0 109.484 175.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -118.34 156.8 28.29 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.526 0.73 . . . . 0.0 112.74 -173.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -155.64 151.41 27.43 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.481 1.113 . . . . 0.0 109.485 -165.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 38.0 tp -128.68 128.34 43.91 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.067 0.947 . . . . 0.0 111.782 -173.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 59.6 t -98.99 118.95 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.537 0.684 . . . . 0.0 112.742 -166.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 16.2 mm -124.41 86.87 54.63 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 127.451 2.3 . . . . 0.0 108.754 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -64.3 -17.82 61.04 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.837 2.358 . . . . 0.0 114.192 175.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -72.18 -55.62 6.95 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.705 1.139 . . . . 0.0 112.6 -177.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 67.7 p -124.97 -10.18 7.16 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.238 1.415 . . . . 0.0 113.9 -172.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 53.43 29.25 8.57 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -171.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -156.94 147.47 21.41 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 120.024 -1.673 . . . . 0.0 113.562 175.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -150.38 161.15 43.05 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.403 1.081 . . . . 0.0 112.076 176.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.7 mp -101.03 136.56 32.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 123.911 0.885 . . . . 0.0 111.486 -176.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -82.55 159.21 64.56 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 125.745 1.618 . . . . 0.0 112.456 173.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.01 -16.65 40.88 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.91 2.407 . . . . 0.0 113.68 -177.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -79.68 -1.09 36.8 Favored 'General case' 0 CA--C 1.556 1.194 0 O-C-N 121.398 -0.814 . . . . 0.0 112.487 170.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 97.91 -14.52 62.72 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.999 1.761 . . . . 0.0 115.65 175.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 57.9 mt -74.19 145.47 44.16 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.831 1.252 . . . . 0.0 111.953 -177.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.4 p -91.09 137.5 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 118.796 0.725 . . . . 0.0 112.318 174.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 67.5 mt -116.45 155.63 28.24 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.177 2.191 . . . . 0.0 110.78 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -100.87 155.44 17.94 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.935 0.894 . . . . 0.0 111.075 177.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 25.6 t30 -80.51 86.72 5.77 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.051 -1.031 . . . . 0.0 109.336 161.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -152.41 104.7 2.95 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 117.323 -1.322 . . . . 0.0 111.92 153.398 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -132.29 163.9 27.61 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 127.557 2.343 . . . . 0.0 111.183 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.3 145.09 54.69 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.64 1.176 . . . . 0.0 113.587 177.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -61.26 -24.28 66.27 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.545 1.138 . . . . 0.0 113.292 173.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -86.33 4.68 38.12 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.697 1.599 . . . . 0.0 113.658 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.6 m -74.25 141.06 45.39 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.047 0.939 . . . . 0.0 111.915 171.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -81.34 155.75 25.83 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.03 0.932 . . . . 0.0 113.038 169.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.0 p -148.07 155.8 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.957 0.903 . . . . 0.0 111.724 -173.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.47 139.22 54.24 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.151 1.78 . . . . 0.0 108.016 175.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -152.03 -179.06 7.16 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.951 0.9 . . . . 0.0 111.236 167.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -135.23 142.14 45.93 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.211 1.404 . . . . 0.0 111.082 177.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -164.14 159.08 19.92 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 127.618 2.367 . . . . 0.0 107.359 174.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.7 t0 53.49 32.94 15.03 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 m 58.73 33.21 22.91 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.894 1.278 . . . . 0.0 113.399 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.6 p -154.39 140.57 12.77 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 125.133 1.373 . . . . 0.0 112.527 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -70.02 150.85 67.2 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 123.13 2.553 . . . . 0.0 113.489 176.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -130.31 133.12 46.23 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 127.903 2.481 . . . . 0.0 108.744 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 39.9 ttm -145.75 113.11 6.23 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.074 0.95 . . . . 0.0 112.298 -175.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -162.79 -177.07 5.3 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.515 1.526 . . . . 0.0 112.606 -174.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.9 m -69.96 137.81 51.78 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.289 -0.882 . . . . 0.0 110.531 170.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.413 HG12 ' CG ' ' A' ' 152' ' ' TYR . 7.6 tp -55.68 -36.5 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 121.378 -0.826 . . . . 0.0 113.1 -178.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -60.8 -26.93 67.64 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.522 1.129 . . . . 0.0 112.596 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -81.49 -42.83 19.69 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.477 1.111 . . . . 0.0 111.191 178.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.6 ptm -68.65 -32.21 71.9 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.331 0.969 . . . . 0.0 111.591 174.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -57.67 -48.97 78.01 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.562 0.745 . . . . 0.0 110.632 171.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.6 t -62.79 -38.07 89.21 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.629 0.772 . . . . 0.0 111.829 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -64.32 -52.37 58.82 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.004 1.321 . . . . 0.0 110.585 177.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -71.08 -34.3 71.03 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.409 -0.807 . . . . 0.0 113.018 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.21 -35.32 80.7 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.788 0.835 . . . . 0.0 111.535 172.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 66.7 m -74.54 -29.34 61.33 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.115 0.966 . . . . 0.0 112.647 178.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 66.5 mtm -86.86 -47.31 9.14 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.068 1.347 . . . . 0.0 113.237 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -116.92 -13.76 10.66 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.835 1.254 . . . . 0.0 113.825 -165.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.46 163.72 39.56 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 124.4 1.0 . . . . 0.0 114.4 175.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -113.75 126.21 54.97 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.885 1.274 . . . . 0.0 110.452 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.6 mp -105.42 151.33 39.69 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 127.247 2.219 . . . . 0.0 110.54 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -76.91 155.91 34.44 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 123.558 2.839 . . . . 0.0 112.973 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.75 162.92 34.28 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.197 1.399 . . . . 0.0 110.519 163.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.36 -54.1 36.16 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 120.854 -1.154 . . . . 0.0 113.496 -176.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -96.96 -6.91 34.44 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 177.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -163.17 -140.5 2.89 Favored Glycine 0 CA--C 1.534 1.244 0 N-CA-C 116.602 1.401 . . . . 0.0 116.602 -172.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -149.0 157.13 43.18 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.752 1.621 . . . . 0.0 112.958 -171.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.83 148.75 41.07 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.434 1.094 . . . . 0.0 113.531 -176.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 51.4 t -129.18 121.72 20.75 Favored Pre-proline 0 N--CA 1.48 1.056 0 C-N-CA 126.085 1.754 . . . . 0.0 111.534 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -80.55 132.99 9.24 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 124.379 3.386 . . . . 0.0 113.227 -175.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 78.0 mt -97.77 165.76 11.8 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.042 1.337 . . . . 0.0 113.682 179.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -148.97 121.21 8.36 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.94 1.296 . . . . 0.0 111.079 176.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 46.14 52.77 9.97 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.782 1.633 . . . . 0.0 112.823 -173.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.7 t -112.46 128.43 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.44 1.096 . . . . 0.0 108.577 174.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -134.4 161.29 35.41 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -168.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.1 p -152.84 148.66 13.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 124.306 1.042 . . . . 0.0 112.18 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -64.41 133.45 52.58 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 122.348 1.07 . . . . 0.0 109.93 166.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.452 HG23 ' HG3' ' A' ' 61' ' ' LYS . 6.7 t -138.38 153.59 48.92 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.803 2.041 . . . . 0.0 110.49 -171.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.0 tp -113.95 145.02 42.11 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.322 -0.861 . . . . 0.0 111.537 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -96.8 118.02 32.34 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 124.485 1.114 . . . . 0.0 110.845 164.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mp -80.53 -20.65 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 124.135 0.974 . . . . 0.0 112.457 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.65 -36.93 85.12 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.206 1.003 . . . . 0.0 113.459 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.4 m -121.11 -16.97 7.89 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.565 1.146 . . . . 0.0 112.827 173.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.21 23.69 39.82 Favored Glycine 0 N--CA 1.475 1.293 0 C-N-CA 124.173 0.892 . . . . 0.0 113.667 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -100.02 137.75 38.04 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.862 1.665 . . . . 0.0 112.745 -169.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 mp -75.7 144.83 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 125.636 1.575 . . . . 0.0 111.866 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.452 ' HG3' HG23 ' A' ' 52' ' ' THR . 13.7 ptpt -155.6 176.19 12.92 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 127.093 2.157 . . . . 0.0 111.629 -178.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -129.08 141.86 51.08 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 125.14 1.376 . . . . 0.0 111.151 175.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 t -139.83 168.98 18.57 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.398 1.079 . . . . 0.0 113.287 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -92.2 147.95 22.54 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.178 1.391 . . . . 0.0 112.563 173.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.88 138.31 37.13 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.245 1.018 . . . . 0.0 110.311 167.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.0 t -94.28 -48.69 6.06 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -167.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.17 156.03 40.11 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.657 1.183 . . . . 0.0 111.629 175.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.7 mt -89.94 145.05 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.43 1.092 . . . . 0.0 108.414 165.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -128.52 150.65 50.08 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.949 1.7 . . . . 0.0 111.004 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.3 ptt-85 -143.63 151.35 40.02 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.201 1.0 . . . . 0.0 113.578 168.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -147.45 167.89 23.26 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.928 1.691 . . . . 0.0 110.938 175.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.54 146.89 23.8 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.621 0.768 . . . . 0.0 112.131 173.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.8 m -149.15 147.97 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 125.784 1.634 . . . . 0.0 111.522 171.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -100.31 -29.06 12.64 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.788 1.635 . . . . 0.0 112.36 175.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -122.23 128.76 51.54 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.513 1.125 . . . . 0.0 110.582 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 12.2 tp -135.45 160.86 37.13 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.841 1.657 . . . . 0.0 109.503 -174.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.7 mt -109.04 126.65 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 119.836 1.198 . . . . 0.0 109.653 175.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -102.46 119.93 39.66 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.775 1.23 . . . . 0.0 110.792 169.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -105.65 125.01 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.063 1.345 . . . . 0.0 108.478 173.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.6 tttt -92.33 146.54 23.61 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.675 1.19 . . . . 0.0 110.623 172.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 78.5 mt -106.57 160.48 15.4 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.769 1.627 . . . . 0.0 111.475 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.5 t -67.78 -11.42 58.43 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.626 1.17 . . . . 0.0 112.591 -176.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.6 p -81.44 -8.78 59.78 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 128.63 2.772 . . . . 0.0 114.947 168.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.65 -7.9 80.65 Favored Glycine 0 CA--C 1.54 1.632 0 C-N-CA 125.752 1.644 . . . . 0.0 115.362 -173.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -74.04 162.67 28.78 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.544 1.538 . . . . 0.0 111.201 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 86.3 p -140.41 146.02 37.79 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 66.8 tp -121.96 132.51 54.57 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.485 1.914 . . . . 0.0 110.068 176.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -117.03 116.5 27.47 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.871 1.668 . . . . 0.0 111.522 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.5 m -141.61 153.08 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.327 1.451 . . . . 0.0 113.082 -169.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.7 p -68.08 148.97 98.33 Favored Pre-proline 0 N--CA 1.466 0.372 0 O-C-N 121.258 -0.901 . . . . 0.0 111.66 171.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.22 -28.32 83.74 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.409 2.739 . . . . 0.0 114.346 -166.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.8 m -85.21 -4.96 59.34 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.39 1.255 . . . . 0.0 114.39 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 63.8 t60 -65.92 118.53 52.93 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 119.909 1.231 . . . . 0.0 111.918 -176.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -76.36 132.63 13.83 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.758 2.305 . . . . 0.0 113.441 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.3 t -111.33 143.82 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 126.111 1.765 . . . . 0.0 109.798 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 25.6 tp -81.31 102.0 10.14 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.014 0.526 . . . . 0.0 110.78 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.1 mp -98.96 153.64 18.68 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.971 1.709 . . . . 0.0 111.434 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -108.7 107.94 18.59 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.413 0.625 . . . . 0.0 112.593 176.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 36.4 mtp-105 -136.24 80.05 1.8 Allowed 'General case' 0 N--CA 1.479 1.004 0 O-C-N 120.861 -1.149 . . . . 0.0 110.211 -178.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 53.43 -3.25 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 127.657 2.383 . . . . 0.0 115.584 -156.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.81 171.27 44.02 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 125.591 1.567 . . . . 0.0 113.206 -178.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 82.1 mt -76.3 115.16 15.77 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.45 1.9 . . . . 0.0 111.007 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -146.83 147.93 31.36 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -99.4 117.06 32.97 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.183 1.393 . . . . 0.0 111.375 -173.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.4 t -124.49 128.45 24.97 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 123.862 0.865 . . . . 0.0 109.908 -176.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -64.56 147.34 90.22 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.575 2.184 . . . . 0.0 111.419 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.26 -30.78 18.8 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 175.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.54 -21.36 66.16 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 173.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -105.06 4.02 31.09 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.84 2.056 . . . . 0.0 112.436 175.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.6 t -84.12 143.84 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.166 1.386 . . . . 0.0 111.099 169.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.34 155.17 81.07 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 126.995 2.118 . . . . 0.0 111.33 -177.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.52 118.45 5.6 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.006 2.47 . . . . 0.0 111.681 -175.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.74 5.88 35.63 Favored Glycine 0 CA--C 1.538 1.516 0 CA-C-O 119.12 -0.822 . . . . 0.0 115.139 -176.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -61.43 166.11 4.24 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.251 1.421 . . . . 0.0 112.474 166.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.3 p -116.79 131.69 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 125.84 1.656 . . . . 0.0 111.546 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.5 t -117.22 140.67 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 126.147 1.779 . . . . 0.0 110.632 -172.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.1 t -89.03 134.42 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 123.818 0.847 . . . . 0.0 110.943 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -160.05 -151.52 6.2 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 121.674 -0.641 . . . . 0.0 113.66 174.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.3 p -139.52 159.87 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 127.051 2.14 . . . . 0.0 108.981 173.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -64.92 113.29 3.75 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.84 0.856 . . . . 0.0 109.833 173.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . 0.256 0.0 OUTLIER -66.56 -14.49 62.42 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -170.399 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -54.03 -35.24 61.74 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.037 -1.039 . . . . 0.0 112.442 165.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -75.22 -24.95 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 123.582 0.753 . . . . 0.0 112.201 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 59.7 mt -84.87 -21.3 29.82 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.441 1.496 . . . . 0.0 111.779 172.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -90.27 -1.56 57.94 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 126.484 1.914 . . . . 0.0 114.652 174.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 91.0 mtt-85 -67.47 160.01 28.4 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 126.013 1.725 . . . . 0.0 112.454 168.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 64.1 ttp85 -72.87 -36.71 67.44 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.623 0.769 . . . . 0.0 111.47 166.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 46.0 mm -101.98 94.68 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.175 1.39 . . . . 0.0 108.474 167.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.4 pt -71.32 95.07 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 122.275 1.036 . . . . 0.0 110.347 -173.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 55.2 m -86.61 62.46 7.42 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 120.814 -1.178 . . . . 0.0 112.406 -161.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.32 167.43 18.08 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.94 1.696 . . . . 0.0 114.514 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 117.38 4.18 16.03 Favored Glycine 0 CA--C 1.54 1.605 0 C-N-CA 125.336 1.446 . . . . 0.0 114.971 -174.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -129.89 165.56 21.81 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.387 2.275 . . . . 0.0 110.969 176.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 96.0 mt -139.32 163.14 33.28 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.923 1.289 . . . . 0.0 112.84 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -153.66 154.26 33.82 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.824 1.65 . . . . 0.0 112.658 172.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -78.15 153.39 32.11 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 120.961 -1.087 . . . . 0.0 113.848 178.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 43.9 m80 -131.27 158.21 41.21 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.992 1.717 . . . . 0.0 108.385 166.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -120.29 142.24 49.27 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 121.259 -0.901 . . . . 0.0 111.464 -173.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 99.3 t -76.36 132.96 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 121.767 -0.583 . . . . 0.0 110.885 172.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.6 t -91.3 -46.07 8.25 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.89 2.076 . . . . 0.0 111.725 172.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.4 t -158.36 169.54 24.24 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.04 -1.038 . . . . 0.0 111.284 175.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.5 m -133.68 148.95 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.086 1.354 . . . . 0.0 110.745 167.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -154.27 154.82 34.07 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.681 0.792 . . . . 0.0 112.686 167.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 96.9 mt -84.16 130.7 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 166.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 16.3 pt -123.95 158.6 30.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 126.362 1.865 . . . . 0.0 112.299 -174.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -94.46 94.5 8.27 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.127 1.371 . . . . 0.0 112.246 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -83.4 -56.29 3.83 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.459 -0.776 . . . . 0.0 112.771 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 51.82 36.83 18.97 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.081 0.953 . . . . 0.0 112.449 -177.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -150.98 172.97 14.87 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.142 1.377 . . . . 0.0 110.837 -172.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -75.04 138.83 42.44 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.997 0.903 . . . . 0.0 112.962 -176.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 15.5 m -120.25 153.97 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 126.046 1.738 . . . . 0.0 109.57 177.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.413 ' CG ' HG12 ' A' ' 21' ' ' ILE . 1.5 p90 -114.05 160.79 18.5 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.081 0.952 . . . . 0.0 112.568 -175.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -142.63 148.63 37.75 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.612 -0.68 . . . . 0.0 109.856 157.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 55.1 tp -108.5 119.58 39.92 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.684 1.193 . . . . 0.0 109.965 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 50.7 t -88.35 120.25 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -166.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 27.9 mm -118.66 86.93 30.76 Favored Pre-proline 0 N--CA 1.471 0.592 0 C-N-CA 125.833 1.653 . . . . 0.0 109.375 -177.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -70.9 -9.75 26.32 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.271 2.647 . . . . 0.0 113.995 -174.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -81.32 -60.57 2.23 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 118.898 0.772 . . . . 0.0 112.203 175.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 73.7 p -118.61 -10.67 10.0 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -171.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 66.6 m80 53.33 27.36 6.14 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.306 1.442 . . . . 0.0 114.692 -172.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.6 149.96 30.55 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 120.629 -1.294 . . . . 0.0 113.237 178.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -153.01 162.8 40.89 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.358 1.463 . . . . 0.0 111.415 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.8 mp -103.66 137.99 29.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 124.053 0.941 . . . . 0.0 110.945 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.76 156.82 64.51 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 123.944 0.898 . . . . 0.0 111.839 173.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -64.78 -23.76 62.41 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.553 2.169 . . . . 0.0 112.641 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -79.41 3.91 17.0 Favored 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 124.931 1.292 . . . . 0.0 112.711 174.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 105.96 -21.6 33.5 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.645 1.593 . . . . 0.0 116.612 164.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 64.4 mt -77.7 149.33 34.63 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.832 1.816 . . . . 0.0 113.818 -171.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 4.6 t -89.41 123.81 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.175 0.99 . . . . 0.0 110.646 174.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 54.6 mt -116.08 148.48 40.21 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.56 1.944 . . . . 0.0 111.629 -174.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -96.62 136.79 36.64 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.756 0.823 . . . . 0.0 110.873 170.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -71.15 106.67 3.85 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 162.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -79.56 -11.1 59.89 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -163.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 116.671 -1.633 . . . . 0.0 112.967 -163.453 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.686 0 CA-C-O 121.063 0.459 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -140.01 164.78 29.11 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.369 1.468 . . . . 0.0 112.303 -178.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.3 151.3 47.73 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -172.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.65 -22.03 43.36 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 177.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -73.9 -21.63 60.0 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.392 1.477 . . . . 0.0 113.639 177.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.4 m -64.68 126.41 27.81 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.091 0.957 . . . . 0.0 112.017 -166.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -74.14 150.48 40.44 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 174.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.2 p -148.33 153.19 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.114 0.966 . . . . 0.0 111.683 -170.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -126.49 120.77 30.53 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.85 1.66 . . . . 0.0 108.79 -173.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -150.2 168.12 24.92 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -176.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -134.17 144.21 48.37 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.807 1.243 . . . . 0.0 111.041 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -160.92 136.56 8.01 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.175 0.99 . . . . 0.0 111.172 176.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.7 t70 54.53 47.62 22.31 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.1 1.36 . . . . 0.0 113.541 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.9 m 60.47 38.88 18.92 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 127.538 2.335 . . . . 0.0 114.127 176.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.4 p -154.12 140.18 12.57 Favored Pre-proline 0 CA--C 1.547 0.858 0 O-C-N 121.098 -1.001 . . . . 0.0 112.025 173.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -83.31 151.69 13.71 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 124.818 3.679 . . . . 0.0 113.625 175.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -133.91 145.5 49.66 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.472 2.309 . . . . 0.0 111.514 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 43.4 ttm -147.67 95.95 2.59 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.823 0.849 . . . . 0.0 111.503 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -148.64 -178.71 6.49 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.647 1.579 . . . . 0.0 111.952 -171.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.3 m -71.23 148.48 47.19 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 120.74 -1.225 . . . . 0.0 110.238 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.4 tp -57.17 -35.48 48.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 O-C-N 121.368 -0.832 . . . . 0.0 112.418 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -65.68 -29.76 70.36 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.577 1.08 . . . . 0.0 112.792 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -74.86 -42.83 57.15 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.316 1.046 . . . . 0.0 110.037 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -71.93 -40.2 68.92 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.56 -0.713 . . . . 0.0 111.666 176.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -54.27 -48.57 71.05 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.745 0.818 . . . . 0.0 110.939 175.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.0 t -66.59 -32.04 73.12 Favored 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -174.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.2 ttpt -65.53 -50.73 64.16 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.192 0.997 . . . . 0.0 110.131 177.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -70.38 -33.98 72.05 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.607 -0.683 . . . . 0.0 112.287 177.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.52 -22.46 63.58 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.226 -0.921 . . . . 0.0 113.198 173.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.7 m -92.88 -14.96 26.96 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.332 1.453 . . . . 0.0 113.475 176.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 72.6 mtm -97.06 -57.91 2.15 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.068 1.747 . . . . 0.0 112.005 174.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -94.27 -27.49 16.11 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.638 1.575 . . . . 0.0 111.985 -170.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.95 158.85 13.37 Favored Glycine 0 C--N 1.341 0.837 0 C-N-CA 125.248 1.404 . . . . 0.0 114.07 -177.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -104.91 150.49 24.83 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.683 1.193 . . . . 0.0 111.851 -170.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.2 mp -121.97 145.02 42.57 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 127.026 2.13 . . . . 0.0 111.569 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.32 156.35 37.19 Favored 'Trans proline' 0 C--O 1.24 0.616 0 C-N-CA 124.718 3.612 . . . . 0.0 112.848 -176.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -145.85 165.85 27.69 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -177.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -47.56 -53.81 13.48 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.5 1.92 . . . . 0.0 114.054 177.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -106.55 0.71 24.78 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 115.051 1.501 . . . . 0.0 115.051 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 177.78 -122.49 0.83 Allowed Glycine 0 CA--C 1.53 1.019 0 N-CA-C 115.966 1.146 . . . . 0.0 115.966 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -145.36 159.84 42.44 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.025 1.73 . . . . 0.0 111.28 -177.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.68 154.27 48.6 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.076 1.351 . . . . 0.0 111.998 -178.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 67.9 t -127.87 118.12 20.94 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 125.133 1.373 . . . . 0.0 110.44 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.49 138.55 42.5 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.986 3.124 . . . . 0.0 111.34 177.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 87.4 mt -111.49 157.84 19.84 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.673 1.189 . . . . 0.0 112.559 175.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -142.0 129.57 21.44 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.993 1.317 . . . . 0.0 111.023 169.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 59.97 33.03 21.38 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 126.692 1.997 . . . . 0.0 114.673 -177.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.1 t -100.19 137.74 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 O-C-N 120.359 -1.463 . . . . 0.0 111.309 176.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -132.99 154.53 50.42 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.328 1.851 . . . . 0.0 112.851 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.8 m -141.06 162.6 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 126.714 2.006 . . . . 0.0 110.84 174.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -89.36 145.86 25.07 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.328 -0.858 . . . . 0.0 111.847 172.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.5 t -148.47 152.16 36.44 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.259 1.824 . . . . 0.0 111.311 -167.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 48.3 tp -102.22 138.63 38.91 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.773 1.229 . . . . 0.0 109.963 173.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -87.92 130.69 34.85 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.794 0.837 . . . . 0.0 111.347 161.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 43.8 mm -77.21 -25.46 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 120.941 -1.099 . . . . 0.0 112.546 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.99 -42.68 31.94 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -169.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.4 m -112.99 -9.5 13.59 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.928 1.291 . . . . 0.0 112.861 174.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.05 28.71 66.01 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 123.659 0.647 . . . . 0.0 113.987 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -89.51 136.52 32.98 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.999 1.319 . . . . 0.0 110.685 -177.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 mp -88.54 126.85 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 174.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -147.92 169.74 19.19 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.612 1.165 . . . . 0.0 112.661 -173.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.5 ttmt -92.7 149.35 21.37 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.42 1.488 . . . . 0.0 110.438 174.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.1 t -146.21 158.93 43.91 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.199 1.0 . . . . 0.0 111.171 171.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.73 159.91 22.46 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 121.27 -0.894 . . . . 0.0 112.83 177.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.28 135.56 54.96 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.285 0.634 . . . . 0.0 111.38 168.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.8 t -88.78 -46.28 9.1 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.565 1.146 . . . . 0.0 112.676 -167.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -155.25 157.31 37.09 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.494 1.518 . . . . 0.0 111.398 174.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.4 mt -88.81 151.41 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.772 1.229 . . . . 0.0 108.53 167.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -140.27 149.82 43.31 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.857 1.263 . . . . 0.0 112.426 -175.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.9 ptp85 -132.39 155.73 47.94 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.696 1.198 . . . . 0.0 112.714 171.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -150.29 163.26 38.77 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.803 1.241 . . . . 0.0 110.338 167.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -96.94 145.21 26.12 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.351 1.06 . . . . 0.0 110.973 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.4 m -150.13 141.08 16.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 124.862 1.265 . . . . 0.0 110.297 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -83.1 -34.41 26.13 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.955 1.302 . . . . 0.0 110.921 171.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -131.93 132.35 43.48 Favored 'General case' 0 C--N 1.345 0.393 0 C-N-CA 123.942 0.897 . . . . 0.0 112.33 -169.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.5 tp -131.88 164.95 24.95 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.311 1.844 . . . . 0.0 109.678 -173.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.1 mt -112.16 123.83 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 119.587 1.085 . . . . 0.0 109.167 175.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -96.08 123.32 39.65 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.416 0.686 . . . . 0.0 111.489 166.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -108.77 123.18 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.083 1.353 . . . . 0.0 108.621 170.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.1 tttt -92.86 147.87 22.49 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.664 1.586 . . . . 0.0 109.952 173.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 87.8 mt -118.91 158.32 25.93 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.615 1.566 . . . . 0.0 112.337 -175.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.7 t -66.93 -10.41 48.69 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.694 1.198 . . . . 0.0 113.264 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 88.6 p -77.62 0.59 22.6 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 127.625 2.37 . . . . 0.0 114.899 165.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.58 -3.1 56.28 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 125.126 1.346 . . . . 0.0 114.522 -173.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -76.81 163.95 26.3 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.041 1.736 . . . . 0.0 111.957 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 60.4 p -142.2 144.67 33.5 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 165.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.8 tp -118.29 131.55 56.34 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.449 1.899 . . . . 0.0 110.02 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -111.23 114.93 28.49 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.385 1.474 . . . . 0.0 111.515 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.2 m -138.01 153.83 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 126.337 1.855 . . . . 0.0 112.215 -171.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.2 p -67.27 150.48 97.87 Favored Pre-proline 0 N--CA 1.471 0.618 0 O-C-N 120.906 -1.121 . . . . 0.0 112.354 171.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -60.21 -31.38 93.0 Favored 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 123.103 2.535 . . . . 0.0 114.32 -168.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.2 m -84.07 -0.96 53.9 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 49.5 t60 -73.85 117.11 58.43 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.927 1.291 . . . . 0.0 111.177 -175.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -68.35 132.06 24.81 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.04 2.494 . . . . 0.0 112.892 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.0 t -110.74 137.0 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 126.078 1.751 . . . . 0.0 109.422 174.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.13 112.39 19.77 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.7 mp -105.58 149.68 26.06 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.802 1.641 . . . . 0.0 112.212 -175.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -101.99 112.01 24.5 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.033 0.933 . . . . 0.0 112.454 172.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -143.49 80.43 1.67 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.645 1.178 . . . . 0.0 111.024 170.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 59.74 -15.16 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 128.203 2.601 . . . . 0.0 116.759 -164.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -162.67 168.06 37.39 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 126.026 1.775 . . . . 0.0 113.89 177.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.5 mt -72.01 116.11 12.03 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.104 1.762 . . . . 0.0 110.98 -176.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -144.87 139.79 27.92 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.65 0.78 . . . . 0.0 112.786 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -96.53 123.64 40.26 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.251 1.02 . . . . 0.0 112.052 -177.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 57.3 t -128.2 129.84 23.62 Favored Pre-proline 0 N--CA 1.48 1.044 0 C-N-CA 124.928 1.291 . . . . 0.0 109.738 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -64.68 148.37 90.24 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.856 2.371 . . . . 0.0 112.057 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.67 -32.14 18.35 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.28 -25.48 67.88 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 173.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -107.85 -1.34 20.89 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.777 1.631 . . . . 0.0 113.158 178.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 74.9 t -70.1 144.17 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 124.368 1.067 . . . . 0.0 109.655 166.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.86 156.95 77.01 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 127.098 2.159 . . . . 0.0 110.324 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -65.48 125.3 14.18 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.74 1.627 . . . . 0.0 110.776 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 103.22 0.42 47.57 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.649 1.119 . . . . 0.0 114.931 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -57.95 153.73 13.75 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.176 0.991 . . . . 0.0 111.309 167.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.4 t -97.64 122.2 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.062 0.945 . . . . 0.0 109.957 172.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.2 t -94.12 141.48 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 126.68 1.992 . . . . 0.0 110.016 173.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 59.4 t -92.62 131.59 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.959 0.904 . . . . 0.0 110.399 172.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -155.08 -150.86 5.67 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.028 1.299 . . . . 0.0 111.644 176.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.8 p -143.8 169.28 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.227 1.411 . . . . 0.0 111.118 177.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 -69.48 122.6 19.33 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 127.332 2.253 . . . . 0.0 110.153 177.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -57.82 -37.16 73.31 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.712 0.687 . . . . 0.0 112.326 178.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -55.08 -47.26 75.13 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.066 0.848 . . . . 0.0 113.045 -175.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.6 p -75.8 -16.1 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.393 1.077 . . . . 0.0 112.821 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 17.0 tp -88.58 -32.65 18.01 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.55 1.14 . . . . 0.0 112.331 174.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 94.7 mtt-85 -98.57 -38.21 9.24 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -171.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.4 ttp85 -158.2 -33.35 0.07 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 116.882 2.178 . . . . 0.0 116.882 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 16.2 tpt85 -67.58 160.36 27.94 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 125.821 1.648 . . . . 0.0 112.711 -172.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 40.3 mm -39.26 121.19 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 126.067 1.747 . . . . 0.0 112.032 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.7 tp -63.88 131.18 29.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 122.263 1.03 . . . . 0.0 112.721 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 34.6 t -146.11 135.0 22.49 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.084 1.354 . . . . 0.0 109.784 170.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -96.78 159.96 14.63 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.645 1.978 . . . . 0.0 114.857 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 77.47 20.21 74.98 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 114.096 -1.411 . . . . 0.0 115.266 160.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -120.97 155.4 34.38 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.336 1.854 . . . . 0.0 111.796 174.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 97.0 mt -136.9 157.47 46.66 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.689 1.596 . . . . 0.0 112.062 -172.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -132.66 132.78 42.79 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.372 1.469 . . . . 0.0 112.007 174.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -87.49 143.61 27.13 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.593 1.157 . . . . 0.0 112.518 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -131.11 136.57 48.5 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.739 1.616 . . . . 0.0 110.115 -174.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -85.36 137.12 33.15 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.97 -1.081 . . . . 0.0 112.828 176.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 97.6 t -69.93 122.51 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.101 0.961 . . . . 0.0 111.372 163.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.4 t -81.77 -53.04 6.53 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.791 1.636 . . . . 0.0 112.329 176.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.5 m -154.92 156.3 35.84 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.346 1.058 . . . . 0.0 111.921 177.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.4 m -128.63 148.13 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.043 0.937 . . . . 0.0 111.33 176.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -157.93 156.13 30.76 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.849 0.86 . . . . 0.0 112.015 169.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 74.6 mt -80.58 145.43 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 160.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 44.8 pt -131.25 153.49 39.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 126.515 1.926 . . . . 0.0 110.076 177.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -88.29 108.02 19.11 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 122.581 1.182 . . . . 0.0 109.904 169.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -83.35 -50.48 8.31 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.363 1.865 . . . . 0.0 112.355 174.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 42.23 51.5 4.54 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.847 1.659 . . . . 0.0 111.76 -172.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -155.84 177.28 11.58 Favored 'General case' 0 CA--C 1.552 1.037 0 O-C-N 121.257 -0.902 . . . . 0.0 113.099 -175.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -77.65 134.95 38.06 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.182 1.393 . . . . 0.0 112.928 174.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 5.9 m -114.29 153.63 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.34 1.456 . . . . 0.0 109.664 175.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -119.81 159.62 24.21 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -171.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -155.04 157.59 37.81 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 113.614 -1.63 . . . . 0.0 110.289 -172.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 41.5 tp -134.82 119.07 17.69 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.92 0.888 . . . . 0.0 109.391 -175.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 51.9 t -86.93 118.03 32.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.154 0.502 . . . . 0.0 111.749 -165.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 29.7 mm -115.29 94.09 38.1 Favored Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 124.944 1.297 . . . . 0.0 109.194 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.4 -12.47 33.66 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.732 2.288 . . . . 0.0 113.339 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -79.45 -64.04 1.28 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 119.039 0.836 . . . . 0.0 112.586 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 76.0 p -114.48 -13.7 12.19 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.174 1.39 . . . . 0.0 114.459 -173.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 63.05 15.01 8.1 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -169.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -150.79 151.93 33.05 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 120.21 1.368 . . . . 0.0 113.257 -175.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -152.55 179.67 8.38 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.788 1.235 . . . . 0.0 112.241 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 85.1 mt -123.62 138.88 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.689 1.196 . . . . 0.0 111.473 -170.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -93.32 154.6 41.4 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.931 1.292 . . . . 0.0 112.302 173.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -66.76 -16.21 49.58 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.789 2.992 . . . . 0.0 114.054 -174.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -72.42 -3.55 24.86 Favored 'General case' 0 CA--C 1.556 1.179 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 170.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.9 -8.92 68.18 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.555 1.55 . . . . 0.0 114.919 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 66.9 mt -79.55 144.66 33.7 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.886 1.274 . . . . 0.0 111.99 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.2 p -89.86 139.07 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.135 0.974 . . . . 0.0 111.035 173.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 74.1 mt -118.19 152.21 36.11 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.855 2.062 . . . . 0.0 111.114 178.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -120.33 148.56 43.58 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.89 0.876 . . . . 0.0 112.93 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -120.24 -34.97 3.54 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.112 0.965 . . . . 0.0 113.47 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 54.98 22.79 4.59 Favored 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 -175.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . 0.253 45.2 tt0 . . . . . 0 C--O 1.253 1.257 0 C-N-CA 126.59 1.956 . . . . 0.0 113.393 -170.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.93 0 N-CA-C 110.763 -0.088 . . . . 0.0 110.763 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.03 162.57 33.78 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.775 1.23 . . . . 0.0 112.615 -173.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -55.91 145.3 25.37 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.946 1.699 . . . . 0.0 113.317 176.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.0 ppt_? -63.75 -22.71 67.04 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 172.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -83.19 3.66 30.03 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.6 m -69.75 150.97 46.35 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.797 1.239 . . . . 0.0 112.883 170.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -101.52 155.35 18.13 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.16 1.784 . . . . 0.0 113.169 174.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 p -148.15 158.35 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.511 0.724 . . . . 0.0 112.484 -168.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -127.34 126.36 42.4 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.387 1.875 . . . . 0.0 108.698 -174.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -153.32 173.41 15.64 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -128.15 144.43 51.12 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.588 1.155 . . . . 0.0 111.378 168.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -165.19 154.01 12.19 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.62 1.568 . . . . 0.0 110.052 174.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.9 t70 48.98 44.38 22.5 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.83 1.252 . . . . 0.0 114.181 -175.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.9 m 58.06 37.32 26.51 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.544 1.538 . . . . 0.0 114.023 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.2 p -157.7 142.47 11.96 Favored Pre-proline 0 CA--C 1.551 0.992 0 O-C-N 120.562 -1.336 . . . . 0.0 112.964 176.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.24 152.31 39.53 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 124.567 3.511 . . . . 0.0 113.516 174.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -136.62 142.63 43.28 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.742 2.017 . . . . 0.0 111.371 -175.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 52.2 ttm -147.35 86.39 1.62 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.208 1.003 . . . . 0.0 110.979 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -137.46 -179.2 5.59 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.532 1.533 . . . . 0.0 112.491 -174.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.9 m -73.17 140.91 47.33 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 120.759 -1.213 . . . . 0.0 110.637 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.42 HG12 ' CD2' ' A' ' 152' ' ' TYR . 9.3 tp -58.0 -36.12 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 O-C-N 121.303 -0.873 . . . . 0.0 112.958 -178.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.01 -24.77 68.07 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.758 -0.589 . . . . 0.0 112.455 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -79.09 -49.25 12.93 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.028 0.931 . . . . 0.0 109.916 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 20.7 ptm -65.85 -33.0 74.84 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.606 -0.684 . . . . 0.0 112.114 175.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -54.88 -49.87 70.12 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.295 0.952 . . . . 0.0 111.207 172.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 39.9 t -61.29 -39.48 90.59 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.348 1.059 . . . . 0.0 111.486 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -65.32 -53.46 43.43 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.319 1.447 . . . . 0.0 110.932 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -72.84 -31.5 64.81 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.249 -0.907 . . . . 0.0 112.473 -177.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.43 -32.26 73.52 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.129 -0.982 . . . . 0.0 111.907 170.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 60.4 m -79.2 -26.03 42.63 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.664 0.786 . . . . 0.0 112.864 178.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 61.2 mtm -91.53 -46.61 7.87 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.24 1.416 . . . . 0.0 113.264 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -112.22 -13.91 13.43 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.034 1.334 . . . . 0.0 113.572 -169.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.9 163.75 35.94 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.849 1.214 . . . . 0.0 114.573 178.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -111.38 134.85 52.67 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.189 1.395 . . . . 0.0 110.014 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.5 mp -116.75 148.46 42.07 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 126.14 1.776 . . . . 0.0 111.617 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -70.65 143.44 46.55 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.38 2.72 . . . . 0.0 111.349 175.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -130.07 169.53 15.18 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.876 1.67 . . . . 0.0 111.149 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.91 -52.8 62.83 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 120.975 -1.078 . . . . 0.0 113.538 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -99.86 -8.86 23.56 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.98 -134.25 1.76 Allowed Glycine 0 CA--C 1.53 0.994 0 CA-C-N 119.137 0.88 . . . . 0.0 114.235 -172.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -135.27 151.3 50.45 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.14 1.776 . . . . 0.0 112.066 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.25 142.59 39.89 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.4 1.08 . . . . 0.0 112.784 -174.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.9 t -116.38 111.62 41.99 Favored Pre-proline 0 N--CA 1.474 0.74 0 C-N-CA 126.653 1.981 . . . . 0.0 109.638 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -65.17 139.69 61.72 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.867 3.044 . . . . 0.0 110.931 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.0 mt -110.06 165.13 11.98 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.601 1.16 . . . . 0.0 111.941 176.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -144.16 127.0 16.28 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.75 1.62 . . . . 0.0 110.123 169.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 50.5 46.81 25.01 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.387 1.075 . . . . 0.0 113.306 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.8 t -111.4 116.92 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.18 0.992 . . . . 0.0 108.797 173.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -113.63 151.8 31.24 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -167.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.6 m -135.82 154.13 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.494 1.518 . . . . 0.0 111.565 174.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -66.74 133.25 49.78 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 161.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.0 t -135.52 145.28 46.9 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.737 1.615 . . . . 0.0 110.54 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.4 tp -99.87 136.51 39.68 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.792 0.837 . . . . 0.0 110.351 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -85.46 91.43 8.22 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.755 1.222 . . . . 0.0 109.422 171.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.7 mm -58.97 -25.22 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 119.372 0.987 . . . . 0.0 112.282 -171.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.69 -45.92 87.86 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.63 1.172 . . . . 0.0 114.108 175.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 m -107.67 -22.75 12.38 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.632 1.173 . . . . 0.0 112.61 -173.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.44 25.16 66.26 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.642 1.592 . . . . 0.0 113.281 -169.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -90.49 141.39 28.8 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.177 1.391 . . . . 0.0 112.061 -175.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.2 mp -90.83 122.41 42.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 125.042 1.337 . . . . 0.0 110.681 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -146.91 179.23 7.74 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.773 1.629 . . . . 0.0 112.093 -177.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -110.89 152.27 26.91 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.886 1.674 . . . . 0.0 111.358 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.3 t -147.65 162.08 39.87 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.61 -0.681 . . . . 0.0 110.852 165.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -94.41 142.78 27.03 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.091 0.957 . . . . 0.0 112.335 173.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.41 143.8 26.77 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.555 0.742 . . . . 0.0 111.311 174.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 84.4 p -84.5 -48.34 9.69 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.437 1.095 . . . . 0.0 112.454 -172.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -151.86 159.95 43.69 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.306 1.842 . . . . 0.0 112.191 173.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.5 mt -86.73 146.98 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 160.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -132.9 148.11 52.29 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 125.246 1.418 . . . . 0.0 110.927 -175.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -146.13 150.23 35.51 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 165.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -146.99 165.97 28.23 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.183 1.793 . . . . 0.0 110.878 173.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.45 146.78 23.84 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.194 -0.941 . . . . 0.0 112.8 -177.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.1 m -147.53 151.36 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.366 1.066 . . . . 0.0 112.299 173.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -113.36 -5.37 13.56 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.988 2.115 . . . . 0.0 113.184 177.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -138.43 119.21 14.14 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.792 1.637 . . . . 0.0 109.992 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.6 tp -133.24 159.35 40.46 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.812 1.645 . . . . 0.0 109.601 -175.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 13.5 mt -110.48 127.72 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 119.245 0.93 . . . . 0.0 109.492 176.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -98.68 127.63 44.67 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.406 1.082 . . . . 0.0 111.048 167.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.8 mp -112.9 126.07 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.152 1.381 . . . . 0.0 109.77 172.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -91.68 143.41 26.58 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.662 1.585 . . . . 0.0 110.48 171.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 83.9 mt -113.32 156.45 23.36 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.091 1.357 . . . . 0.0 112.113 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.1 t -59.55 -26.4 65.34 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.251 1.42 . . . . 0.0 112.005 174.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 94.2 p -64.57 -16.72 63.11 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.207 1.403 . . . . 0.0 114.477 171.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.33 4.04 74.55 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 125.919 1.723 . . . . 0.0 114.505 -174.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -85.22 158.73 20.27 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.889 1.675 . . . . 0.0 110.729 172.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 84.5 p -137.66 142.64 41.13 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 165.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.8 tp -121.48 140.62 51.94 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.73 2.012 . . . . 0.0 110.09 -172.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -121.16 116.56 25.19 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.189 1.396 . . . . 0.0 112.165 -174.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.1 m -139.81 154.78 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.286 1.434 . . . . 0.0 112.899 -167.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.1 p -65.79 148.1 98.41 Favored Pre-proline 0 N--CA 1.471 0.598 0 O-C-N 120.912 -1.117 . . . . 0.0 111.572 173.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.08 -29.47 87.16 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.166 2.578 . . . . 0.0 113.535 -173.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 32.9 p -84.62 0.2 51.03 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.178 2.191 . . . . 0.0 114.875 177.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -73.95 116.47 52.49 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 119.89 1.223 . . . . 0.0 112.023 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -77.9 127.13 8.41 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.681 2.254 . . . . 0.0 112.468 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 38.4 t -107.0 142.08 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 126.095 1.758 . . . . 0.0 109.43 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 22.4 tp -80.68 113.29 18.78 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 122.588 0.355 . . . . 0.0 110.693 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.8 mp -109.38 147.54 32.59 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.655 1.582 . . . . 0.0 112.701 -172.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -96.18 95.21 7.98 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.55 1.54 . . . . 0.0 109.569 170.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -130.35 71.88 1.47 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.288 1.435 . . . . 0.0 109.662 174.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.9 t70 63.37 -15.88 0.07 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 128.712 2.805 . . . . 0.0 115.866 -163.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -168.51 159.34 32.46 Favored Glycine 0 CA--C 1.522 0.524 0 O-C-N 121.189 -0.945 . . . . 0.0 114.09 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 59.6 mt -61.21 112.72 2.24 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.786 1.634 . . . . 0.0 110.95 -175.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -145.85 145.33 30.71 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -93.15 119.62 32.55 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.571 1.148 . . . . 0.0 110.895 -178.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 57.7 t -127.61 130.08 23.72 Favored Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 124.073 0.949 . . . . 0.0 110.081 -178.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -65.37 147.88 87.72 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.872 2.382 . . . . 0.0 111.82 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.1 -31.89 20.63 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 174.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.52 -18.42 65.36 Favored 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 173.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -108.57 2.09 21.86 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.237 1.815 . . . . 0.0 112.477 173.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.5 t -78.26 143.32 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 120.875 -1.141 . . . . 0.0 109.993 168.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.65 151.54 78.23 Favored Pre-proline 0 N--CA 1.471 0.596 0 C-N-CA 127.505 2.322 . . . . 0.0 110.682 -177.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -65.22 116.19 3.73 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.418 2.079 . . . . 0.0 110.798 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.7 2.22 34.69 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 124.571 1.082 . . . . 0.0 115.543 -173.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -56.59 159.94 3.54 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.804 1.302 . . . . 0.0 111.912 162.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.6 t -116.78 125.4 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 123.936 0.894 . . . . 0.0 110.042 175.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.6 t -100.78 145.19 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 126.774 2.03 . . . . 0.0 110.279 -178.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 44.1 t -86.05 135.99 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.818 1.247 . . . . 0.0 109.926 175.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -166.68 -149.56 6.02 Favored Glycine 0 CA--C 1.529 0.915 0 O-C-N 121.952 -0.468 . . . . 0.0 113.837 178.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.3 p -151.07 162.43 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 125.403 1.481 . . . . 0.0 110.579 175.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 42.4 mtm105 -67.33 121.0 14.77 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.696 1.198 . . . . 0.0 111.065 172.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -64.64 -24.78 67.7 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -175.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -52.72 -29.54 27.44 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 169.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 24.1 t -79.96 -45.31 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 118.612 0.642 . . . . 0.0 110.479 178.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -62.52 -23.31 66.89 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.699 1.199 . . . . 0.0 112.677 174.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 35.3 ttt180 -97.2 -4.18 39.51 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.346 1.458 . . . . 0.0 114.135 174.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . 0.282 3.5 mpt_? 55.05 41.19 32.0 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.829 1.651 . . . . 0.0 113.851 -176.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -81.07 -25.68 36.88 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.672 1.589 . . . . 0.0 111.098 157.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 52.0 mt -123.17 142.89 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.025 1.33 . . . . 0.0 107.66 153.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 4.1 mt -112.0 89.95 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 118.9 0.773 . . . . 0.0 109.953 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 79.9 p -139.21 158.82 43.49 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.903 2.081 . . . . 0.0 112.538 -176.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.21 160.5 38.83 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.858 1.263 . . . . 0.0 113.778 174.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.67 18.29 73.48 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 123.527 0.584 . . . . 0.0 113.411 -177.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -112.7 143.44 43.9 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.742 1.617 . . . . 0.0 111.898 -171.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 91.3 mt -140.46 163.49 32.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.219 1.807 . . . . 0.0 111.73 -177.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -146.35 161.8 39.55 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.443 1.897 . . . . 0.0 111.882 -176.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -107.12 149.17 27.94 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.924 0.89 . . . . 0.0 112.096 170.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -128.48 119.05 24.15 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.354 1.061 . . . . 0.0 108.497 173.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -85.22 144.19 28.29 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 120.94 -1.1 . . . . 0.0 111.786 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 97.1 t -76.36 142.87 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 125.418 1.487 . . . . 0.0 111.027 174.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 26.0 t -100.76 -50.03 3.98 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.438 1.895 . . . . 0.0 112.506 174.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 13.9 m -149.5 156.37 41.88 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.134 1.373 . . . . 0.0 111.035 -175.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.4 m -134.97 147.09 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.893 0.877 . . . . 0.0 111.97 169.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -154.99 156.87 36.76 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 176.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 90.9 mt -92.27 138.42 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.69 1.196 . . . . 0.0 108.499 168.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 16.0 pt -132.83 155.87 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 126.388 1.875 . . . . 0.0 111.587 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -96.07 94.54 7.61 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 122.122 0.963 . . . . 0.0 112.491 173.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -72.34 -43.47 64.03 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 8.0 m120 49.22 38.79 14.18 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.849 1.66 . . . . 0.0 113.583 -178.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -154.15 175.62 13.24 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.627 1.171 . . . . 0.0 111.109 -170.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -72.28 141.53 48.89 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.157 0.983 . . . . 0.0 113.218 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.8 m -122.53 153.96 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 126.465 1.906 . . . . 0.0 109.614 173.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.42 ' CD2' HG12 ' A' ' 21' ' ' ILE . 3.4 p90 -113.59 164.66 13.38 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -174.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -140.07 159.98 40.96 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.547 151.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.1 tt -127.06 98.86 5.47 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.182 0.993 . . . . 0.0 108.796 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 98.9 t -82.73 128.25 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -148.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 23.3 mm -116.59 100.61 53.54 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 124.767 1.227 . . . . 0.0 109.445 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -73.16 -13.33 25.87 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.356 2.037 . . . . 0.0 113.101 176.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 76.7 tt0 -74.0 -67.76 0.58 Allowed 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.815 1.188 . . . . 0.0 111.97 174.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 68.6 p -109.83 -7.97 14.95 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.928 1.291 . . . . 0.0 114.215 -169.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 56.42 21.23 5.36 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.929 1.291 . . . . 0.0 114.468 -169.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.37 145.56 26.18 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 -178.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -138.66 166.84 23.33 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.04 1.336 . . . . 0.0 112.416 176.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.8 mp -110.21 135.45 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.731 1.212 . . . . 0.0 111.634 177.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -86.5 156.62 56.32 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.091 0.956 . . . . 0.0 112.568 171.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -67.3 -11.99 34.22 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.826 3.017 . . . . 0.0 113.875 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -70.27 -17.82 63.11 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 121.767 -0.583 . . . . 0.0 112.443 168.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 115.23 -24.69 10.42 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 126.46 1.981 . . . . 0.0 115.069 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 50.0 mt -68.73 151.82 46.16 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.807 1.643 . . . . 0.0 113.63 -170.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 4.1 t -104.02 122.82 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 124.977 1.311 . . . . 0.0 111.96 176.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.8 144.27 43.77 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.355 1.862 . . . . 0.0 112.868 -170.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 62.7 t60 -96.61 150.48 20.61 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.136 0.975 . . . . 0.0 113.183 169.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -71.47 169.64 14.98 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 115.533 1.679 . . . . 0.0 115.533 177.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -89.2 -3.58 58.52 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.708 2.003 . . . . 0.0 113.079 170.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 . . . . . 0 C--O 1.25 1.111 0 C-N-CA 127.171 2.188 . . . . 0.0 111.476 -176.268 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.7 166.51 22.77 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.446 1.898 . . . . 0.0 111.772 -174.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.45 146.88 54.06 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.244 1.418 . . . . 0.0 114.608 -176.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -67.85 -21.22 65.19 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.748 1.219 . . . . 0.0 113.96 175.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -84.76 -3.66 58.7 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 174.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.2 m -65.16 141.65 58.61 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 119.363 0.983 . . . . 0.0 113.233 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -79.35 147.89 32.25 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.581 1.152 . . . . 0.0 112.917 170.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 p -146.39 156.77 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.498 1.119 . . . . 0.0 112.328 -172.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -126.28 135.19 51.24 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.844 2.058 . . . . 0.0 108.088 177.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -153.59 176.09 12.47 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.493 0.717 . . . . 0.0 112.249 169.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -131.85 140.98 49.29 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.148 1.379 . . . . 0.0 110.819 174.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -162.12 166.19 26.06 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.713 2.005 . . . . 0.0 108.328 174.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.4 t70 58.99 24.73 12.98 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 120.176 1.353 . . . . 0.0 113.2 170.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 63.55 29.81 15.22 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.158 1.783 . . . . 0.0 114.8 -171.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.8 p -152.78 141.75 14.31 Favored Pre-proline 0 CA--C 1.548 0.884 0 O-C-N 119.678 -1.889 . . . . 0.0 113.473 -176.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.33 152.96 50.38 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.713 2.942 . . . . 0.0 112.595 173.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -135.75 142.59 44.99 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.033 2.133 . . . . 0.0 109.96 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 35.9 ttm -153.24 106.21 2.96 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.035 0.534 . . . . 0.0 111.555 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -157.14 -179.54 8.3 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.444 1.898 . . . . 0.0 111.682 -172.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.7 m -67.73 138.49 56.29 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.219 -0.926 . . . . 0.0 110.013 170.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.6 tp -55.9 -37.33 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -176.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -69.53 -16.67 63.48 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.84 1.2 . . . . 0.0 112.755 -178.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -80.44 -46.55 15.75 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.416 1.086 . . . . 0.0 109.836 177.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -67.92 -34.62 76.96 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 122.015 -0.428 . . . . 0.0 112.079 173.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -58.59 -49.97 75.52 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.497 0.719 . . . . 0.0 110.835 172.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.5 t -68.99 -30.3 68.68 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.263 0.625 . . . . 0.0 111.513 -176.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -64.67 -54.04 37.89 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.43 1.492 . . . . 0.0 110.514 172.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -69.4 -33.85 73.63 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.203 -0.936 . . . . 0.0 112.347 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.33 -19.1 64.64 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 121.104 -0.997 . . . . 0.0 113.309 174.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.0 m -96.04 -7.64 35.69 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.874 1.669 . . . . 0.0 113.855 174.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 59.2 mtm -113.08 -49.51 2.92 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.756 1.623 . . . . 0.0 112.895 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -102.33 -19.59 14.94 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.175 1.79 . . . . 0.0 112.021 -174.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.96 166.59 42.33 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.589 1.09 . . . . 0.0 114.103 174.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -112.89 130.19 56.2 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.731 1.212 . . . . 0.0 110.465 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.2 mp -119.38 148.87 46.44 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 126.431 1.893 . . . . 0.0 110.808 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -72.06 162.31 42.18 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.452 2.768 . . . . 0.0 113.977 -173.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -145.45 170.07 17.1 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.047 1.739 . . . . 0.0 110.847 175.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -60.03 -58.23 9.42 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.546 1.138 . . . . 0.0 113.151 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -90.56 -3.87 57.28 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 176.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.93 -128.31 1.15 Allowed Glycine 0 CA--C 1.534 1.239 0 CA-C-N 120.322 1.419 . . . . 0.0 116.504 -177.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -139.56 161.07 38.39 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.092 1.757 . . . . 0.0 111.668 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.6 159.74 41.54 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.571 1.148 . . . . 0.0 112.691 177.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 81.6 t -127.17 113.47 21.63 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 125.782 1.633 . . . . 0.0 109.855 176.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -65.71 142.42 70.18 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 124.25 3.3 . . . . 0.0 111.263 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.2 mt -116.12 151.97 34.58 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 122.608 1.194 . . . . 0.0 112.853 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -133.84 129.74 36.9 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.824 1.249 . . . . 0.0 110.581 170.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 57.84 33.68 23.49 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.209 1.404 . . . . 0.0 114.157 176.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.3 t -101.68 133.7 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.492 1.517 . . . . 0.0 110.031 174.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -132.39 154.18 50.06 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.927 1.691 . . . . 0.0 112.912 -174.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.3 m -146.68 158.6 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 127.725 2.41 . . . . 0.0 110.542 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -79.32 149.06 31.87 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.013 -1.054 . . . . 0.0 112.232 170.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.0 t -148.24 157.17 43.34 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.904 1.682 . . . . 0.0 111.81 -169.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 38.6 tp -112.35 134.22 54.01 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.05 1.34 . . . . 0.0 110.226 176.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -83.46 104.12 13.36 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 163.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 mm -63.32 -29.94 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-N 120.935 1.698 . . . . 0.0 111.546 -177.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.77 -45.31 90.36 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.071 1.348 . . . . 0.0 113.241 -177.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.8 m -101.84 -20.24 14.98 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.918 0.887 . . . . 0.0 112.465 177.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.25 37.72 81.16 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.981 1.277 . . . . 0.0 112.42 -170.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -103.01 136.33 43.02 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.393 1.877 . . . . 0.0 110.644 -177.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 mp -93.7 127.69 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.7 pttt -144.86 169.65 17.64 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.987 1.315 . . . . 0.0 112.072 -177.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -103.5 143.46 32.69 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.959 0.904 . . . . 0.0 110.887 175.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.6 t -142.44 162.08 36.38 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.017 1.327 . . . . 0.0 112.62 -175.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -81.74 151.73 27.34 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 173.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -107.69 138.66 43.51 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.778 0.831 . . . . 0.0 110.942 164.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.9 t -91.86 -46.83 7.65 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.978 1.311 . . . . 0.0 113.255 -169.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -150.73 158.49 44.21 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.868 1.267 . . . . 0.0 111.559 172.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.1 mt -87.25 153.22 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 162.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -139.05 149.65 44.87 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.304 1.441 . . . . 0.0 111.715 -175.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 21.6 ptt-85 -139.12 150.5 45.74 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.769 1.228 . . . . 0.0 113.547 169.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -144.53 159.56 42.57 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.152 1.781 . . . . 0.0 109.445 172.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -102.91 136.43 42.74 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.133 0.879 . . . . 0.0 110.788 -176.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.9 m -144.87 145.48 20.97 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-O 122.324 1.059 . . . . 0.0 111.962 -176.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -97.48 -28.64 13.89 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 125.987 1.715 . . . . 0.0 111.867 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -120.28 128.69 53.54 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.544 1.138 . . . . 0.0 110.385 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.8 tp -131.89 160.69 34.97 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.342 1.457 . . . . 0.0 109.781 178.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.0 mt -113.4 126.21 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 119.858 1.208 . . . . 0.0 109.123 175.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -97.15 120.6 37.81 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.465 1.106 . . . . 0.0 111.119 169.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -109.55 122.22 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.496 1.518 . . . . 0.0 109.266 173.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -90.68 146.09 24.3 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.254 1.822 . . . . 0.0 110.601 175.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.6 mt -115.92 158.63 22.72 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.497 1.519 . . . . 0.0 111.74 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.5 t -61.71 -20.0 63.02 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.396 1.079 . . . . 0.0 113.561 -176.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 78.1 p -85.3 4.76 33.51 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.27 1.828 . . . . 0.0 115.619 172.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.78 10.04 86.49 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 124.306 0.955 . . . . 0.0 114.652 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -76.52 152.82 35.91 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.996 1.319 . . . . 0.0 109.829 166.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 80.5 p -135.68 135.62 40.26 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 165.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.9 tp -109.42 137.22 47.6 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.906 1.682 . . . . 0.0 109.755 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt -119.64 117.83 29.33 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.86 1.264 . . . . 0.0 111.105 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.5 m -139.15 153.49 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.994 1.318 . . . . 0.0 112.479 -168.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.8 p -64.87 145.66 98.9 Favored Pre-proline 0 N--CA 1.468 0.462 0 O-C-N 121.098 -1.001 . . . . 0.0 111.003 170.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -59.09 -24.81 75.4 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.381 2.721 . . . . 0.0 113.322 -173.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 61.7 p -76.3 -12.77 60.13 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 128.033 2.533 . . . . 0.0 115.539 175.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -70.96 116.68 48.92 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 124.344 1.058 . . . . 0.0 111.886 -174.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -78.52 120.81 4.93 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 123.253 2.636 . . . . 0.0 111.966 177.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.2 t -92.89 142.95 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 126.689 1.996 . . . . 0.0 110.124 178.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.74 101.08 6.5 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.534 0.683 . . . . 0.0 109.395 173.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.6 tp -98.76 152.77 19.32 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.015 1.726 . . . . 0.0 111.735 -173.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -111.85 113.2 25.4 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.056 0.542 . . . . 0.0 111.932 167.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -130.67 77.47 1.79 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.876 0.871 . . . . 0.0 109.274 165.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.2 t70 62.99 -7.92 0.14 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 128.634 2.774 . . . . 0.0 116.335 -166.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -165.32 163.36 36.5 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 125.628 1.585 . . . . 0.0 112.722 -177.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 78.2 mt -70.28 119.35 14.33 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.627 1.571 . . . . 0.0 110.594 -174.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -149.63 149.86 31.3 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -103.16 121.82 43.44 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.427 1.091 . . . . 0.0 111.028 -177.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 54.4 t -136.59 129.47 17.53 Favored Pre-proline 0 N--CA 1.481 1.104 0 C-N-CA 124.185 0.994 . . . . 0.0 110.87 -174.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -66.31 146.71 81.68 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.081 2.521 . . . . 0.0 112.811 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.11 -32.05 21.37 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 175.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.29 -19.43 65.41 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 173.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -107.8 -3.88 18.61 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.29 1.836 . . . . 0.0 112.824 177.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 92.6 t -73.47 146.23 10.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 C-N-CA 124.987 1.315 . . . . 0.0 110.479 168.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.78 159.26 72.03 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 127.762 2.425 . . . . 0.0 109.387 177.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -65.64 127.78 18.7 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 121.637 1.558 . . . . 0.0 110.724 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 99.14 7.81 54.41 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.238 0.923 . . . . 0.0 114.756 -178.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -67.15 165.65 15.55 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 118.301 1.05 . . . . 0.0 112.21 162.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.56 132.37 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 124.242 1.017 . . . . 0.0 111.211 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.0 t -107.26 134.1 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 126.367 1.867 . . . . 0.0 110.521 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 49.5 t -91.26 143.02 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.905 0.882 . . . . 0.0 111.355 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -169.1 -149.38 6.2 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.424 1.488 . . . . 0.0 111.846 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.6 p -136.88 162.99 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 125.388 1.475 . . . . 0.0 111.096 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -64.48 103.22 0.63 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.705 2.002 . . . . 0.0 110.427 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -62.65 -27.64 69.37 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -173.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -61.0 -28.16 68.84 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 173.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.7 t -85.96 -30.52 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.194 0.998 . . . . 0.0 110.394 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 47.7 tp -77.38 -26.51 51.92 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.667 1.587 . . . . 0.0 112.926 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -67.02 -18.25 65.29 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.582 1.553 . . . . 0.0 113.568 173.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -66.65 159.15 28.26 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.275 1.43 . . . . 0.0 112.844 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 55.4 mtt85 -71.86 -42.08 67.31 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.63 0.772 . . . . 0.0 112.438 174.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 42.1 mt -95.43 142.52 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.31 1.044 . . . . 0.0 110.13 168.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 42.0 mm -101.74 140.33 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.824 1.249 . . . . 0.0 111.305 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 40.1 t -116.02 134.77 54.61 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.017 1.727 . . . . 0.0 110.783 171.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -93.58 165.84 12.54 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -173.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 81.64 25.83 52.38 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 116.783 1.473 . . . . 0.0 116.783 165.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -117.7 155.21 30.35 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.619 1.568 . . . . 0.0 111.319 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.1 mt -146.83 153.36 40.08 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.221 1.009 . . . . 0.0 113.508 -177.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -135.8 151.47 50.11 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.156 1.782 . . . . 0.0 113.11 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -124.16 130.57 52.77 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.989 1.715 . . . . 0.0 110.701 -175.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -129.43 126.48 38.85 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.075 0.95 . . . . 0.0 110.411 -164.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -84.71 134.03 34.36 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.322 0.965 . . . . 0.0 112.152 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 75.0 t -67.41 129.41 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 124.142 0.977 . . . . 0.0 110.259 170.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.0 t -88.48 -42.94 11.8 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.412 1.485 . . . . 0.0 113.059 176.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.8 t -159.84 161.17 34.43 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.834 0.854 . . . . 0.0 111.426 -177.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 10.7 m -136.92 154.99 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.639 1.175 . . . . 0.0 112.555 170.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -162.36 162.11 27.73 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.428 1.091 . . . . 0.0 112.809 156.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 64.9 mt -76.05 141.34 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.953 0.901 . . . . 0.0 108.827 163.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 35.8 pt -130.67 156.67 42.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 126.988 2.115 . . . . 0.0 111.16 176.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -100.15 85.84 3.1 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 122.354 1.073 . . . . 0.0 111.382 -175.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -72.12 -46.45 56.57 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 121.308 -0.87 . . . . 0.0 112.862 -173.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 48.21 37.54 8.45 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.468 1.507 . . . . 0.0 113.097 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -145.47 174.52 11.08 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.503 1.121 . . . . 0.0 111.165 -170.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -74.64 132.81 42.03 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 123.553 0.741 . . . . 0.0 111.826 173.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 5.7 m -102.24 170.78 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.945 1.298 . . . . 0.0 109.474 169.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -123.0 161.47 24.2 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.973 0.909 . . . . 0.0 112.6 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -144.48 154.99 43.5 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.628 0.771 . . . . 0.0 110.184 158.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 40.8 tp -116.27 122.69 45.69 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.013 1.325 . . . . 0.0 110.232 175.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 99.7 t -91.83 121.25 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -165.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 25.1 mm -118.08 88.58 32.33 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 125.747 1.619 . . . . 0.0 110.227 -176.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -68.29 -13.69 38.43 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.47 2.113 . . . . 0.0 113.547 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -76.53 -46.39 26.73 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.326 0.966 . . . . 0.0 112.637 -177.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 81.3 p -138.78 -4.02 1.61 Allowed 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 126.077 1.751 . . . . 0.0 114.782 -169.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 31.0 m170 60.39 18.45 8.13 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 -177.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.15 148.51 25.02 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 120.095 -1.628 . . . . 0.0 113.582 177.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -132.66 170.9 14.56 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.939 1.696 . . . . 0.0 112.365 176.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 81.1 mt -121.54 132.99 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.471 1.108 . . . . 0.0 110.925 -175.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -80.36 161.74 63.76 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 125.102 1.361 . . . . 0.0 113.439 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.44 -18.35 62.71 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 122.869 2.379 . . . . 0.0 112.158 174.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.74 10.85 10.27 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.116 0.966 . . . . 0.0 113.181 172.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.21 -14.43 27.94 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.6 1.571 . . . . 0.0 116.559 176.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 78.6 mt -69.65 144.94 52.77 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 118.947 1.373 . . . . 0.0 112.833 -177.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 19.7 t -85.23 132.21 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.732 0.813 . . . . 0.0 110.629 171.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 77.1 mt -118.15 138.22 52.43 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.957 2.103 . . . . 0.0 110.061 177.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 42.3 t60 -137.76 141.85 40.93 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -168.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -159.73 151.5 20.29 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.977 1.311 . . . . 0.0 111.078 158.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -128.67 30.48 5.11 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.593 1.557 . . . . 0.0 114.59 -174.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 . . . . . 0 C--O 1.253 1.261 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -177.046 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.835 0 CA-C-O 119.474 -0.298 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.0 162.18 25.86 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.358 1.463 . . . . 0.0 112.238 -178.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.72 148.94 41.18 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.901 1.28 . . . . 0.0 113.697 177.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -12.54 31.98 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.047 1.339 . . . . 0.0 113.724 171.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.79 -24.19 64.38 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.187 2.195 . . . . 0.0 111.411 175.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.4 m -66.64 139.28 57.86 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.429 1.092 . . . . 0.0 113.62 -170.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -88.34 152.26 22.05 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.929 1.291 . . . . 0.0 113.427 171.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 p -148.17 153.3 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.122 0.969 . . . . 0.0 112.543 -169.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -132.88 127.22 33.92 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.175 1.79 . . . . 0.0 107.767 -173.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -153.0 177.7 10.49 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.111 0.964 . . . . 0.0 111.562 -175.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -134.48 141.79 46.87 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.036 -1.04 . . . . 0.0 111.275 173.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -154.51 162.38 41.17 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.774 1.63 . . . . 0.0 108.72 171.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.9 t70 51.28 29.74 5.28 Favored 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -174.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.1 m 57.34 39.74 28.14 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.703 1.601 . . . . 0.0 113.675 -171.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.0 p -153.58 141.13 13.53 Favored Pre-proline 0 CA--C 1.545 0.785 0 O-C-N 120.395 -1.441 . . . . 0.0 112.452 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.18 143.87 45.15 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.526 2.817 . . . . 0.0 113.871 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.5 m80 -128.45 141.67 51.33 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 128.294 2.637 . . . . 0.0 109.194 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 52.6 ttm -149.55 106.31 3.55 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.054 -1.029 . . . . 0.0 111.48 -174.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -153.95 179.39 8.95 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.115 0.966 . . . . 0.0 112.514 -171.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.9 m -74.86 141.08 44.25 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.028 -1.045 . . . . 0.0 109.479 168.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.425 HG12 ' CG ' ' A' ' 152' ' ' TYR . 8.4 tp -53.63 -36.28 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -176.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -63.44 -27.27 69.18 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.198 0.908 . . . . 0.0 112.564 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -74.85 -44.09 50.97 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.506 -0.746 . . . . 0.0 110.426 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 20.2 ptm -69.32 -37.44 77.74 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 119.371 -0.347 . . . . 0.0 111.3 172.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -59.78 -52.16 66.64 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.093 0.86 . . . . 0.0 110.874 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.7 t -65.51 -28.47 69.21 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.851 1.261 . . . . 0.0 111.773 -175.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -72.04 -56.78 5.03 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 127.373 2.269 . . . . 0.0 111.378 171.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -71.72 -33.77 69.02 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 120.919 -1.113 . . . . 0.0 112.791 -175.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.33 -23.07 65.59 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 121.288 -0.883 . . . . 0.0 112.663 172.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.2 t -89.67 -23.88 21.76 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.156 0.982 . . . . 0.0 113.316 174.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 70.5 mtm -86.44 -52.09 5.8 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.0 0.92 . . . . 0.0 112.013 176.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -106.65 -18.44 13.95 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.344 1.458 . . . . 0.0 112.724 -168.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.95 161.75 35.57 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.303 0.954 . . . . 0.0 114.05 176.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -109.42 126.89 53.94 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.954 0.902 . . . . 0.0 111.104 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.5 mp -98.6 144.94 29.04 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 125.32 1.448 . . . . 0.0 110.589 176.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -72.91 146.19 41.63 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 123.838 3.026 . . . . 0.0 112.199 -177.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.41 154.37 49.98 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.114 1.366 . . . . 0.0 111.941 178.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -52.55 -46.67 66.89 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.649 1.18 . . . . 0.0 113.745 -177.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -88.81 -9.98 49.77 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 172.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 173.81 -123.3 0.96 Allowed Glycine 0 CA--C 1.532 1.099 0 N-CA-C 116.958 1.543 . . . . 0.0 116.958 -168.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -142.7 159.25 42.59 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.007 1.723 . . . . 0.0 111.953 -177.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.25 150.66 46.91 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.522 1.529 . . . . 0.0 111.997 176.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.9 t -125.79 118.27 24.24 Favored Pre-proline 0 N--CA 1.486 1.34 0 C-N-CA 125.302 1.441 . . . . 0.0 111.29 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.62 140.89 40.41 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 124.186 3.257 . . . . 0.0 112.157 -178.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 73.3 mt -111.1 165.79 11.6 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.084 1.354 . . . . 0.0 112.568 176.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -145.59 124.09 12.43 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.881 1.272 . . . . 0.0 111.534 169.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 51.18 44.66 28.63 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.421 1.889 . . . . 0.0 113.856 -177.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.7 t -106.81 130.75 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.857 1.663 . . . . 0.0 109.884 173.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -130.15 159.19 37.57 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.948 1.299 . . . . 0.0 113.014 -169.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.5 m -144.78 150.63 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.951 1.7 . . . . 0.0 112.13 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -65.31 132.57 49.37 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.962 1.305 . . . . 0.0 108.027 164.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.461 HG21 ' HB ' ' A' ' 63' ' ' THR . 6.4 t -141.37 154.9 45.9 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.335 1.054 . . . . 0.0 112.005 -169.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 56.8 tp -115.64 133.41 56.06 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.957 1.303 . . . . 0.0 110.785 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.462 ' HB2' ' HE3' ' A' ' 61' ' ' LYS . 8.2 t0 -79.51 117.02 20.08 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.223 0.609 . . . . 0.0 111.255 163.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.4 mm -70.15 -16.64 20.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 O-C-N 121.056 -1.028 . . . . 0.0 113.261 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.48 -46.87 24.92 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.545 -1.347 . . . . 0.0 113.92 -177.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.0 m -121.36 -8.73 9.14 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 179.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.4 29.06 54.27 Favored Glycine 0 CA--C 1.535 1.291 0 O-C-N 121.388 -0.82 . . . . 0.0 114.016 -176.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -77.83 131.59 37.63 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.142 0.971 . . . . 0.0 110.933 175.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 mp -81.74 139.57 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 170.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.462 ' HE3' ' HB2' ' A' ' 54' ' ' ASP . 5.9 mttt -141.12 173.13 11.78 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.567 1.547 . . . . 0.0 110.485 174.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -111.53 128.53 56.05 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.476 0.71 . . . . 0.0 110.433 162.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.461 ' HB ' HG21 ' A' ' 52' ' ' THR . 2.9 t -131.41 164.54 25.48 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.202 1.001 . . . . 0.0 112.601 -174.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.8 ppt_? -86.09 139.59 30.99 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.231 1.013 . . . . 0.0 112.772 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -93.8 144.01 25.81 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.063 0.945 . . . . 0.0 109.587 166.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.7 t -101.01 -45.88 5.27 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -172.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -153.78 155.55 36.06 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.767 1.227 . . . . 0.0 112.551 175.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.9 mt -87.23 159.88 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.855 1.262 . . . . 0.0 108.85 167.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -142.54 151.03 41.19 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.178 1.791 . . . . 0.0 111.106 -176.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 42.9 ptt85 -145.5 159.41 43.14 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 167.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -152.09 159.42 43.67 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.333 1.853 . . . . 0.0 110.663 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -97.28 140.95 30.98 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.632 1.173 . . . . 0.0 112.526 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.1 m -148.12 141.62 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.073 0.949 . . . . 0.0 113.25 -176.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -99.66 -24.34 14.75 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.269 1.428 . . . . 0.0 113.226 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -127.86 126.83 42.33 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.451 1.101 . . . . 0.0 110.994 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.7 tp -136.84 167.11 22.08 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.947 2.099 . . . . 0.0 109.29 -173.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 20.2 mt -119.82 126.95 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.75 1.22 . . . . 0.0 108.816 176.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -99.31 116.63 31.93 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.917 0.887 . . . . 0.0 111.073 170.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.0 mp -101.4 122.33 53.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 125.175 1.39 . . . . 0.0 108.416 172.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -90.37 148.91 22.52 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.782 1.233 . . . . 0.0 110.791 174.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 65.2 mt -116.38 157.78 24.52 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.436 1.494 . . . . 0.0 111.831 178.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.1 t -64.65 -27.17 68.75 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.665 -0.647 . . . . 0.0 112.469 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 84.3 p -59.82 -22.43 62.22 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.374 1.469 . . . . 0.0 114.354 172.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 86.27 19.0 58.09 Favored Glycine 0 CA--C 1.537 1.452 0 O-C-N 121.284 -0.885 . . . . 0.0 113.806 -167.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -93.67 158.32 15.74 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.082 0.941 . . . . 0.0 111.062 161.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 83.8 p -138.21 137.53 37.66 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.52 1.528 . . . . 0.0 110.785 177.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.6 tp -115.97 130.65 56.91 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.93 1.292 . . . . 0.0 109.79 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -111.53 113.53 26.01 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.484 1.514 . . . . 0.0 109.929 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.8 m -137.41 153.82 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.16 1.384 . . . . 0.0 113.504 -169.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.6 p -66.71 143.25 98.0 Favored Pre-proline 0 N--CA 1.472 0.644 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 176.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -62.43 -22.26 73.83 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.713 2.942 . . . . 0.0 113.454 -178.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.6 p -88.55 -1.67 58.18 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.324 1.85 . . . . 0.0 114.215 176.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -87.74 124.28 67.69 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 119.158 0.89 . . . . 0.0 112.583 -175.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -70.97 129.75 16.79 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.607 2.872 . . . . 0.0 111.215 176.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.1 t -108.03 140.35 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 125.679 1.591 . . . . 0.0 110.337 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 51.9 tp -81.51 104.67 12.1 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.493 0.717 . . . . 0.0 110.812 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.1 mp -104.5 158.38 16.52 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.431 1.893 . . . . 0.0 112.119 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -106.14 127.02 52.91 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 169.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 72.4 mtp85 -138.23 74.87 1.49 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.981 0.912 . . . . 0.0 111.009 162.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 50.97 21.14 0.92 Allowed 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 125.44 1.496 . . . . 0.0 113.173 -164.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 179.27 149.02 8.06 Favored Glycine 0 CA--C 1.521 0.455 0 O-C-N 120.536 -1.352 . . . . 0.0 111.447 -170.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 60.6 mt -75.01 120.89 21.15 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.34 1.456 . . . . 0.0 109.523 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -150.34 151.68 33.27 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -177.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -105.76 121.12 43.37 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.458 1.103 . . . . 0.0 112.106 -172.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 78.5 t -139.07 132.56 15.92 Favored Pre-proline 0 N--CA 1.484 1.257 0 C-N-CA 124.916 1.286 . . . . 0.0 110.563 -178.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -66.82 145.29 74.38 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.827 2.352 . . . . 0.0 113.333 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.01 -34.03 19.89 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 175.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.84 -23.99 67.56 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 174.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -98.02 -15.49 20.03 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.552 1.141 . . . . 0.0 112.94 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.7 t -63.02 149.95 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.565 1.546 . . . . 0.0 111.416 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.8 154.3 81.02 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 126.094 1.757 . . . . 0.0 111.389 178.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -65.98 130.3 24.09 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.311 2.007 . . . . 0.0 111.513 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.62 4.09 54.88 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.775 1.179 . . . . 0.0 114.073 -176.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -65.06 168.76 6.15 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.668 1.187 . . . . 0.0 112.291 165.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.3 t -115.54 124.23 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.949 1.3 . . . . 0.0 111.069 -173.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.0 t -95.71 143.38 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.74 1.616 . . . . 0.0 110.31 175.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.5 t -89.56 133.71 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.706 0.803 . . . . 0.0 110.507 177.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -158.28 -158.52 9.05 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.139 0.876 . . . . 0.0 113.053 178.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.732 HG22 ' H ' ' A' ' 120' ' ' ARG . 4.1 p -141.38 -179.71 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 126.589 1.955 . . . . 0.0 111.746 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.732 ' H ' HG22 ' A' ' 119' ' ' VAL . 64.8 mtt-85 -78.74 98.71 6.36 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.489 1.916 . . . . 0.0 111.459 -175.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -58.8 -30.11 67.36 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.175 0.99 . . . . 0.0 112.227 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -63.01 -37.84 88.81 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.065 -1.022 . . . . 0.0 113.605 174.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 22.0 t -75.42 -39.94 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 13.1 tp -63.49 -14.59 52.42 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.52 1.528 . . . . 0.0 113.522 176.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 83.1 mtm-85 -80.45 -21.29 42.24 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.838 1.655 . . . . 0.0 115.056 169.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 11.8 mpt_? -77.87 169.05 18.93 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 119.821 1.191 . . . . 0.0 111.063 171.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 60.1 ttt-85 -91.36 71.35 6.09 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.629 1.172 . . . . 0.0 109.891 174.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 20.7 tt -142.8 152.39 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.054 1.341 . . . . 0.0 112.525 -164.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 71.6 mt -81.33 102.81 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.111 0.964 . . . . 0.0 108.655 162.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.3 m -77.71 61.57 2.43 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.175 0.99 . . . . 0.0 111.883 -176.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.26 151.52 43.42 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -170.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 67.24 -1.99 5.92 Favored Glycine 0 CA--C 1.536 1.376 0 N-CA-C 119.838 2.695 . . . . 0.0 119.838 162.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -107.79 152.96 23.67 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 120.257 2.028 . . . . 0.0 114.335 -169.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 92.5 mt -138.41 159.74 41.3 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.71 2.004 . . . . 0.0 111.353 168.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -150.73 127.05 10.65 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.473 2.309 . . . . 0.0 110.452 174.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -84.67 146.37 27.49 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.401 1.08 . . . . 0.0 112.227 -177.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 52.0 m80 -129.63 137.89 50.92 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.297 1.039 . . . . 0.0 111.479 -174.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -89.48 136.61 32.93 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.293 1.037 . . . . 0.0 113.529 -174.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 77.5 t -74.27 120.0 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.407 1.083 . . . . 0.0 111.379 171.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.8 t -87.68 -29.62 21.0 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.034 1.733 . . . . 0.0 114.105 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.1 m -164.93 164.54 20.73 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.693 1.197 . . . . 0.0 111.291 172.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.9 m -132.79 145.69 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.235 1.014 . . . . 0.0 111.221 165.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -151.21 154.56 37.08 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.78 1.232 . . . . 0.0 112.281 170.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 97.0 mt -76.59 141.89 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 160.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 24.7 pt -131.05 159.37 43.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 125.288 1.435 . . . . 0.0 110.898 169.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -98.54 101.49 12.94 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.731 0.776 . . . . 0.0 111.942 169.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -80.21 -47.71 14.23 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.609 -0.682 . . . . 0.0 112.281 -177.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 55.66 32.51 19.43 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.346 1.058 . . . . 0.0 113.095 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -144.65 178.2 8.15 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.0 1.32 . . . . 0.0 111.814 -170.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -80.51 139.94 36.12 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.115 1.366 . . . . 0.0 112.753 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.8 m -125.88 154.7 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 125.841 1.656 . . . . 0.0 110.063 177.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.425 ' CG ' HG12 ' A' ' 21' ' ' ILE . 1.6 p90 -115.67 162.92 16.56 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -171.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -140.87 150.78 43.67 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 125.8 1.64 . . . . 0.0 108.633 160.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 56.5 tp -119.19 115.26 23.85 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.326 -1.484 . . . . 0.0 109.677 175.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 35.0 t -86.0 120.47 35.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -163.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 13.1 mm -119.6 84.64 30.71 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 125.384 1.474 . . . . 0.0 109.424 -177.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -65.77 -8.14 18.68 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.777 2.984 . . . . 0.0 114.371 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -84.56 -42.15 15.74 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.03 1.332 . . . . 0.0 113.212 177.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 68.9 p -142.26 -11.93 0.83 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -170.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . 0.25 92.0 m-70 57.36 24.13 9.72 Favored 'General case' 0 CA--C 1.553 1.079 0 N-CA-C 116.782 2.141 . . . . 0.0 116.782 -176.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -157.36 150.53 23.64 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 119.929 -1.732 . . . . 0.0 114.169 175.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -148.18 142.69 26.44 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.526 1.53 . . . . 0.0 112.43 -174.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.8 mp -92.7 137.04 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 O-C-N 120.477 -1.389 . . . . 0.0 112.162 -175.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -91.97 159.42 37.91 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 126.698 1.999 . . . . 0.0 113.386 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.25 -13.76 33.81 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.95 3.1 . . . . 0.0 113.885 -177.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -72.85 -7.69 52.0 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.28 0.632 . . . . 0.0 112.049 168.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 98.54 -20.17 51.49 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 126.749 2.119 . . . . 0.0 113.902 -177.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 74.7 mt -69.72 144.57 52.75 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.043 1.422 . . . . 0.0 112.844 -174.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 56.8 t -74.49 125.73 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 165.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 47.0 mt -106.53 166.27 10.67 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.081 1.752 . . . . 0.0 110.487 167.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -132.31 155.04 49.07 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.153 0.981 . . . . 0.0 112.446 -157.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -117.19 122.01 42.82 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.268 1.027 . . . . 0.0 111.499 172.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -154.45 51.11 0.64 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.061 1.344 . . . . 0.0 112.684 -178.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 . . . . . 0 C--O 1.248 0.994 0 C-N-CA 124.639 1.175 . . . . 0.0 113.724 171.66 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.948 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -140.02 156.58 46.55 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.044 1.737 . . . . 0.0 111.239 -171.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.88 146.33 55.06 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 120.491 -1.381 . . . . 0.0 114.21 -177.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.87 -14.49 15.55 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.226 1.411 . . . . 0.0 114.605 165.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -69.87 -14.9 62.96 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.167 0.987 . . . . 0.0 112.24 170.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.8 m -80.5 143.55 33.23 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -170.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -80.17 152.69 29.06 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.604 1.562 . . . . 0.0 112.741 168.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.6 p -146.99 158.35 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.505 1.122 . . . . 0.0 112.534 -172.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -124.92 137.59 54.27 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.621 1.968 . . . . 0.0 108.749 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -156.27 177.13 11.79 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 118.863 0.756 . . . . 0.0 111.96 168.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -135.78 144.71 45.93 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.037 1.335 . . . . 0.0 110.206 171.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -150.77 -63.31 0.19 Allowed 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 176.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -76.6 45.07 0.38 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.815 1.246 . . . . 0.0 112.722 -175.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.4 m 49.56 45.12 24.37 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.321 1.448 . . . . 0.0 110.706 -168.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.9 p -165.98 144.23 4.8 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 127.021 2.128 . . . . 0.0 110.126 -173.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.2 161.3 23.21 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 124.013 3.142 . . . . 0.0 113.855 175.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -142.23 143.93 33.11 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.57 2.348 . . . . 0.0 111.337 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 40.7 ttm -145.83 120.34 9.72 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.15 1.38 . . . . 0.0 110.02 172.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -165.77 -179.03 5.09 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.217 1.407 . . . . 0.0 110.628 -172.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.7 m -76.82 142.94 40.09 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 120.83 -1.168 . . . . 0.0 110.635 171.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.436 HG12 ' CG ' ' A' ' 152' ' ' TYR . 8.4 tp -56.0 -36.64 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -177.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -69.71 -18.0 63.5 Favored 'General case' 0 CA--C 1.549 0.909 0 O-C-N 121.673 -0.642 . . . . 0.0 112.529 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -75.3 -46.9 30.53 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.156 -0.965 . . . . 0.0 110.465 172.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.7 ptm -71.95 -35.83 69.7 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -57.93 -53.59 56.54 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 118.921 0.782 . . . . 0.0 110.709 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.2 t -64.68 -33.68 76.52 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.318 1.047 . . . . 0.0 111.509 -176.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -65.12 -52.66 53.99 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.209 1.404 . . . . 0.0 110.683 175.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -70.1 -32.38 70.4 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.321 -0.862 . . . . 0.0 112.671 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.01 -27.68 67.63 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.999 0.92 . . . . 0.0 113.176 172.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.7 t -79.86 -35.46 38.11 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.469 1.107 . . . . 0.0 112.073 173.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 46.0 mtm -85.13 -43.47 13.83 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.157 0.983 . . . . 0.0 113.395 -174.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -107.5 -31.86 7.95 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.289 1.435 . . . . 0.0 111.404 -172.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 102.05 165.36 26.82 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.016 1.293 . . . . 0.0 113.508 -177.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -114.44 135.65 53.87 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.675 1.59 . . . . 0.0 111.136 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.6 mp -100.43 148.29 34.74 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 125.878 1.671 . . . . 0.0 109.833 166.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -75.79 159.34 38.56 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.328 2.685 . . . . 0.0 111.615 175.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -135.59 161.36 35.75 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.461 1.505 . . . . 0.0 109.861 164.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -42.9 -48.55 5.84 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -117.14 3.94 12.69 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -160.89 -145.64 4.36 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 115.515 0.966 . . . . 0.0 115.515 -172.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -150.53 155.53 39.65 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.388 1.875 . . . . 0.0 112.378 -175.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.72 143.43 41.22 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.459 1.504 . . . . 0.0 112.095 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 86.7 t -125.71 111.65 25.16 Favored Pre-proline 0 N--CA 1.484 1.233 0 C-N-CA 125.16 1.384 . . . . 0.0 110.787 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.63 127.74 13.5 Favored 'Trans proline' 0 C--N 1.351 0.686 1 C-N-CA 125.348 4.032 . . . . 0.0 112.307 -174.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 68.6 mt -106.64 156.4 18.65 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.183 0.993 . . . . 0.0 113.152 -177.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -134.98 132.66 38.63 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.91 1.684 . . . . 0.0 111.046 168.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 50.13 45.84 25.23 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.347 1.859 . . . . 0.0 113.244 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 49.1 t -109.07 127.76 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.69 0.796 . . . . 0.0 109.604 175.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -127.99 155.34 44.44 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.268 1.027 . . . . 0.0 113.471 -168.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.5 m -141.94 151.88 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 126.543 1.937 . . . . 0.0 112.25 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -72.25 136.35 46.3 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.298 1.839 . . . . 0.0 108.137 169.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.2 t -151.33 154.65 37.12 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.186 -0.946 . . . . 0.0 113.323 -170.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 60.2 tp -107.09 129.04 54.88 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.758 1.623 . . . . 0.0 110.579 177.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -79.78 102.35 9.01 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.602 -0.686 . . . . 0.0 109.876 168.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.5 mm -59.31 -23.36 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.318 1.047 . . . . 0.0 112.586 -175.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.81 -39.77 69.6 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.428 1.891 . . . . 0.0 114.746 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.3 m -108.4 -24.65 11.35 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.971 1.309 . . . . 0.0 112.94 -173.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.13 29.4 68.8 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.234 1.397 . . . . 0.0 113.161 -169.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -103.38 137.23 41.76 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.69 1.596 . . . . 0.0 111.386 -176.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.464 HD12 ' N ' ' A' ' 60' ' ' ILE . 1.3 mp -93.33 135.58 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.111 0.965 . . . . 0.0 109.088 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -153.27 172.2 17.37 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.796 1.638 . . . . 0.0 111.192 -176.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt -90.58 144.11 26.09 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.842 0.857 . . . . 0.0 111.146 165.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.8 t -136.48 166.38 23.64 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.056 1.342 . . . . 0.0 111.41 170.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.6 ptp85 -97.64 146.88 24.88 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.773 1.229 . . . . 0.0 112.939 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -103.13 146.21 28.74 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.468 1.107 . . . . 0.0 111.19 170.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.7 t -98.13 -43.35 7.05 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -174.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -153.9 159.01 41.58 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.062 0.945 . . . . 0.0 112.789 173.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.8 mt -89.42 151.48 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.08 0.952 . . . . 0.0 108.465 164.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -137.46 146.71 44.62 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.778 1.631 . . . . 0.0 110.31 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -144.07 151.55 39.78 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 119.833 1.197 . . . . 0.0 113.482 166.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -152.05 169.99 21.02 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.013 1.725 . . . . 0.0 110.597 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -103.35 140.13 37.84 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.689 1.195 . . . . 0.0 111.605 -175.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.1 m -146.88 142.22 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.649 1.18 . . . . 0.0 111.795 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.453 ' HA ' ' H ' ' A' ' 148' ' ' ASN . 11.6 pt-20 -104.99 -11.15 16.78 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.639 1.575 . . . . 0.0 113.451 175.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -123.75 121.21 34.86 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.969 1.308 . . . . 0.0 109.908 173.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.0 tp -136.9 161.03 37.14 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.43 1.492 . . . . 0.0 109.419 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.4 mt -114.5 128.11 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 120.982 -1.074 . . . . 0.0 109.348 178.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -100.6 113.61 26.58 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.559 1.143 . . . . 0.0 110.518 171.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.2 mp -100.79 122.11 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.174 1.39 . . . . 0.0 108.526 172.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -91.6 148.75 22.05 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.548 1.139 . . . . 0.0 111.108 176.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 82.8 mt -115.34 158.74 21.98 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.876 1.27 . . . . 0.0 112.822 -176.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.8 t -66.31 -39.71 89.5 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.993 1.317 . . . . 0.0 112.205 -175.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.7 m -75.29 0.28 17.19 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 172.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 105.99 -2.53 38.28 Favored Glycine 0 CA--C 1.534 1.268 0 N-CA-C 117.089 1.596 . . . . 0.0 117.089 162.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -81.48 171.64 14.47 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.529 1.664 . . . . 0.0 111.654 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 85.2 p -139.73 135.55 33.24 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.993 0.917 . . . . 0.0 112.926 174.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 68.4 tp -105.41 126.0 51.62 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.126 1.77 . . . . 0.0 109.468 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -114.52 110.62 20.1 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.422 1.489 . . . . 0.0 110.54 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.6 m -140.69 154.09 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.586 1.554 . . . . 0.0 112.34 -167.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.49 150.36 97.32 Favored Pre-proline 0 N--CA 1.468 0.427 0 C-N-CA 123.761 0.824 . . . . 0.0 113.115 177.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -63.51 -35.58 59.31 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.598 2.198 . . . . 0.0 114.951 -167.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.7 m -89.5 3.06 53.63 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -67.65 119.36 65.49 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 124.539 1.135 . . . . 0.0 110.928 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -80.12 126.47 6.35 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.914 2.409 . . . . 0.0 112.347 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.6 t -106.32 146.23 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 125.938 1.695 . . . . 0.0 109.537 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 21.6 tp -78.8 105.17 9.92 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.081 0.467 . . . . 0.0 110.221 177.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.6 mp -104.19 158.94 16.1 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.475 1.51 . . . . 0.0 111.508 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -103.35 122.81 45.6 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.186 0.594 . . . . 0.0 112.202 168.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 44.9 mtp180 -143.36 85.42 1.85 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.528 1.531 . . . . 0.0 109.366 170.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 54.56 -3.72 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 127.464 2.305 . . . . 0.0 115.855 -160.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -175.21 174.81 46.99 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 126.933 2.206 . . . . 0.0 113.059 -178.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 37.1 mt -64.58 122.33 16.56 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.965 1.706 . . . . 0.0 110.673 173.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -151.94 152.04 32.0 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.08 0.952 . . . . 0.0 113.4 170.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -97.96 118.48 34.64 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.297 1.439 . . . . 0.0 111.126 -173.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.3 t -130.09 130.59 23.11 Favored Pre-proline 0 N--CA 1.48 1.046 0 C-N-CA 124.001 0.921 . . . . 0.0 110.872 -172.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -65.71 140.36 61.59 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.67 2.246 . . . . 0.0 111.877 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.36 -31.52 14.88 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 176.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.25 -29.28 69.75 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 174.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -101.32 -2.71 30.38 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.241 1.416 . . . . 0.0 112.169 178.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 89.9 t -72.95 142.9 14.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 O-C-N 121.064 -1.022 . . . . 0.0 110.328 167.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.46 154.57 76.98 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 127.108 2.163 . . . . 0.0 109.804 -177.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.432 ' HD3' HG22 ' A' ' 142' ' ' VAL . 60.7 Cg_endo -66.21 136.07 42.61 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.778 1.652 . . . . 0.0 111.147 -170.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 93.37 3.65 64.84 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.812 1.196 . . . . 0.0 114.222 -176.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -62.54 158.64 17.53 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.441 1.096 . . . . 0.0 111.096 164.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.0 t -106.05 119.24 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.997 1.319 . . . . 0.0 110.16 -177.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.6 t -91.88 140.47 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.158 1.383 . . . . 0.0 109.694 174.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 38.2 t -90.64 135.67 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 123.739 0.816 . . . . 0.0 110.644 177.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -164.44 -145.29 4.34 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 114.268 0.467 . . . . 0.0 114.268 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.9 p -156.07 169.77 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 126.263 1.825 . . . . 0.0 109.545 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 74.1 mtm-85 -62.88 109.31 1.41 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.18 1.392 . . . . 0.0 111.946 175.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -65.02 -25.89 68.04 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 178.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -64.54 -39.27 93.45 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.37 0.986 . . . . 0.0 113.038 176.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.0 p -80.57 -29.04 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 119.227 0.921 . . . . 0.0 111.582 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 17.6 tp -70.76 -17.67 62.79 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 121.381 -0.824 . . . . 0.0 112.613 171.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.8 mtt85 -95.75 9.51 40.16 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 127.226 2.21 . . . . 0.0 114.329 171.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -86.35 154.82 20.93 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.129 1.372 . . . . 0.0 110.182 158.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -75.85 -25.83 56.56 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 119.755 1.161 . . . . 0.0 112.401 172.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 59.1 mt -85.73 81.64 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 162.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.542 HD13 ' H ' ' A' ' 129' ' ' ILE . 0.2 OUTLIER -71.15 113.39 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.935 0.894 . . . . 0.0 111.019 177.256 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 38.4 t -78.16 129.69 35.45 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.422 0.689 . . . . 0.0 112.054 -175.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -97.22 165.76 11.89 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.018 0.927 . . . . 0.0 113.123 170.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 93.31 6.16 63.09 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 125.244 1.402 . . . . 0.0 116.194 171.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -129.2 152.38 48.84 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.969 1.708 . . . . 0.0 112.326 -177.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.3 mt -140.76 160.28 40.38 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.622 1.569 . . . . 0.0 112.103 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -144.05 165.15 28.61 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.409 1.484 . . . . 0.0 111.248 174.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -110.73 152.28 26.77 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.727 1.211 . . . . 0.0 111.91 174.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 64.1 m-70 -135.36 137.81 42.73 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.493 1.117 . . . . 0.0 109.635 -176.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -103.52 135.29 45.4 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.453 -0.78 . . . . 0.0 112.475 -169.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 91.4 t -73.86 125.64 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 121.631 0.729 . . . . 0.0 111.352 177.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 21.2 t -88.28 -37.77 15.75 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.734 1.614 . . . . 0.0 113.403 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.2 m -154.47 159.67 41.15 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.824 1.25 . . . . 0.0 111.327 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.432 HG22 ' HD3' ' A' ' 112' ' ' PRO . 4.5 m -138.2 148.94 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 123.434 0.693 . . . . 0.0 111.193 163.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -163.16 159.65 23.25 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.309 1.044 . . . . 0.0 113.41 165.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 89.9 mt -79.22 135.57 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 164.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 16.3 pt -124.54 163.49 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 127.589 2.355 . . . . 0.0 109.828 173.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . 0.328 1.6 p-10 -114.13 65.98 0.67 Allowed 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 -172.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -56.27 -39.93 73.42 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.794 1.637 . . . . 0.0 115.335 -160.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.453 ' H ' ' HA ' ' A' ' 74' ' ' GLU . 6.1 m-80 47.9 36.02 5.57 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.81 2.044 . . . . 0.0 113.461 -175.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -146.48 175.52 10.5 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 120.841 -1.162 . . . . 0.0 112.458 -170.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -67.21 133.74 50.33 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 122.396 1.093 . . . . 0.0 113.433 -176.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.7 m -114.45 150.83 16.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.437 164.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.436 ' CG ' HG12 ' A' ' 21' ' ' ILE . 2.8 p90 -111.78 163.88 13.67 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.987 1.315 . . . . 0.0 111.656 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -143.84 147.99 34.87 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.348 0.659 . . . . 0.0 109.844 160.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 34.6 tp -107.15 122.18 45.99 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.687 1.195 . . . . 0.0 110.271 174.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 36.1 t -87.47 118.04 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 O-C-N 121.948 -0.47 . . . . 0.0 111.911 -168.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 12.7 mm -123.19 84.78 51.53 Favored Pre-proline 0 N--CA 1.472 0.66 0 C-N-CA 125.29 1.436 . . . . 0.0 110.416 -176.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -70.04 -12.08 31.68 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 122.646 2.231 . . . . 0.0 113.835 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -74.34 -40.5 62.12 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.066 1.346 . . . . 0.0 113.83 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 70.9 p -139.73 -13.9 1.09 Allowed 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -170.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 77.4 m80 56.11 20.69 4.58 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.984 1.713 . . . . 0.0 115.179 -164.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -150.13 151.0 32.45 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.618 -1.301 . . . . 0.0 114.476 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -145.87 173.84 11.77 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.307 1.843 . . . . 0.0 111.065 177.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 79.4 mt -122.26 138.29 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.01 0.924 . . . . 0.0 110.534 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -89.0 158.18 47.43 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 124.087 0.955 . . . . 0.0 112.438 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -65.7 -18.69 59.05 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.136 2.557 . . . . 0.0 112.751 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -74.57 7.92 2.66 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.868 1.267 . . . . 0.0 112.812 170.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 91.55 -25.11 16.78 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 126.968 2.223 . . . . 0.0 115.644 175.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 41.3 mt -75.19 144.37 42.72 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.553 1.176 . . . . 0.0 113.79 -166.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.9 t -86.1 127.66 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.012 0.925 . . . . 0.0 111.079 174.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 52.9 mt -117.29 150.35 38.94 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.113 2.165 . . . . 0.0 112.169 -174.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -109.24 145.52 35.76 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.632 1.173 . . . . 0.0 112.809 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -84.22 76.34 10.11 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 121.21 -0.931 . . . . 0.0 111.811 169.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -154.58 146.47 23.48 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.951 1.301 . . . . 0.0 111.865 172.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 . . . . . 0 C--O 1.256 1.44 0 C-N-CA 127.459 2.303 . . . . 0.0 113.515 -170.332 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.638 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -135.04 162.04 33.59 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.673 1.989 . . . . 0.0 111.098 -174.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.46 141.7 57.5 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.1 0.96 . . . . 0.0 111.673 172.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -11.58 38.66 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 176.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -81.43 -13.11 58.62 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.565 1.946 . . . . 0.0 113.306 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.3 m -64.47 136.92 57.55 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.153 0.981 . . . . 0.0 112.253 -177.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -81.32 151.64 27.93 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.662 0.744 . . . . 0.0 112.073 171.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 p -144.14 160.68 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 123.611 0.764 . . . . 0.0 111.038 -170.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -132.09 124.78 29.85 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.167 1.387 . . . . 0.0 108.929 -175.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -149.58 174.87 12.06 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 118.921 0.782 . . . . 0.0 112.73 176.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -131.03 142.43 50.32 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.117 1.367 . . . . 0.0 110.879 170.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -162.91 141.98 8.73 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.996 1.319 . . . . 0.0 110.533 174.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.2 t70 61.34 38.21 16.45 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.38 1.472 . . . . 0.0 113.448 -173.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.8 m 59.41 40.6 20.66 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.317 1.447 . . . . 0.0 112.651 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.2 p -158.85 140.51 9.8 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 124.866 1.266 . . . . 0.0 110.873 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -75.46 155.82 40.89 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 123.791 2.994 . . . . 0.0 113.806 176.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 39.1 m-70 -137.0 142.99 42.53 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 127.072 2.149 . . . . 0.0 110.767 176.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 43.1 ttm -154.29 82.64 1.12 Allowed 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.764 0.792 . . . . 0.0 112.432 -170.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -143.49 -176.34 4.91 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.238 1.415 . . . . 0.0 112.085 -173.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.9 m -69.37 138.47 53.7 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 120.955 -1.091 . . . . 0.0 110.755 174.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.5 tp -55.06 -36.34 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -66.73 -17.91 65.1 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.338 -0.851 . . . . 0.0 113.127 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -75.43 -51.76 12.31 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.354 1.061 . . . . 0.0 109.927 172.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 22.2 ptm -68.08 -36.21 79.46 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.43 -0.794 . . . . 0.0 112.034 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -56.17 -51.83 66.58 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.5 0.72 . . . . 0.0 111.299 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.1 m -57.27 -40.16 77.16 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 125.324 1.449 . . . . 0.0 111.727 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -69.51 -50.93 40.43 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.017 0.927 . . . . 0.0 111.173 178.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -68.19 -33.66 74.84 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 121.338 -0.851 . . . . 0.0 112.213 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.68 -23.46 65.31 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.59 0.756 . . . . 0.0 112.782 172.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.57 -11.94 38.54 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.957 1.303 . . . . 0.0 114.112 174.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 67.0 mtm -103.66 -52.2 3.03 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.103 1.361 . . . . 0.0 111.669 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -105.14 -16.53 14.76 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.972 1.309 . . . . 0.0 112.346 -171.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.36 161.97 32.21 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 124.234 0.921 . . . . 0.0 113.271 175.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -104.96 140.58 37.97 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.913 0.885 . . . . 0.0 109.845 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.3 mp -118.51 149.09 45.47 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 126.375 1.87 . . . . 0.0 110.611 176.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -81.44 151.24 17.43 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.074 3.183 . . . . 0.0 112.222 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -138.9 163.35 32.54 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.308 1.843 . . . . 0.0 111.097 -175.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -50.76 -55.88 14.66 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.844 1.258 . . . . 0.0 113.573 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -95.54 -7.45 37.91 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.47 -134.23 1.84 Allowed Glycine 0 CA--C 1.533 1.167 0 N-CA-C 115.507 0.963 . . . . 0.0 115.507 -170.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -138.98 160.23 40.26 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.623 1.969 . . . . 0.0 111.05 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.98 155.71 45.45 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.205 1.002 . . . . 0.0 113.311 176.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.8 t -126.46 115.97 23.13 Favored Pre-proline 0 N--CA 1.48 1.059 0 C-N-CA 126.09 1.756 . . . . 0.0 110.457 175.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.95 139.3 29.87 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 124.63 3.554 . . . . 0.0 112.296 -176.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 78.4 mt -107.76 163.98 12.63 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.65 1.18 . . . . 0.0 112.752 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -147.93 128.41 14.04 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.686 1.594 . . . . 0.0 109.345 168.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 55.04 41.31 31.9 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.865 1.666 . . . . 0.0 114.264 -176.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.4 t -108.32 118.43 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 O-C-N 121.308 -0.87 . . . . 0.0 109.618 175.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -114.52 148.33 38.07 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.458 1.103 . . . . 0.0 112.166 -171.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.9 m -139.44 153.97 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.091 1.357 . . . . 0.0 111.431 175.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -76.27 147.21 38.42 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.726 0.775 . . . . 0.0 111.557 172.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.6 t -154.96 167.08 31.53 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.69 1.596 . . . . 0.0 111.316 -165.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 36.9 tp -124.76 139.11 54.15 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.453 1.501 . . . . 0.0 110.326 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -87.14 112.96 22.46 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.363 1.065 . . . . 0.0 109.652 164.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.1 mm -71.62 -21.39 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 121.049 -1.032 . . . . 0.0 112.513 -175.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.47 -45.62 21.66 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -174.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.2 m -101.89 -15.63 16.81 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.266 1.027 . . . . 0.0 112.681 173.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.55 23.33 75.62 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.045 0.831 . . . . 0.0 113.524 -174.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -82.41 133.66 35.22 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.501 1.12 . . . . 0.0 111.519 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.3 mp -80.67 136.06 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 174.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -142.92 171.08 14.54 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.444 1.898 . . . . 0.0 111.528 -174.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -117.56 144.98 44.58 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.911 1.684 . . . . 0.0 110.118 167.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.7 t -143.68 153.29 42.32 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.221 1.008 . . . . 0.0 112.492 -174.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.3 137.07 37.88 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.362 1.065 . . . . 0.0 112.198 172.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.83 136.78 36.89 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.16 0.984 . . . . 0.0 110.984 172.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 91.4 p -89.02 -47.25 8.25 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.862 0.865 . . . . 0.0 113.267 -167.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -154.12 156.97 38.21 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.393 1.477 . . . . 0.0 112.356 173.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.7 mt -87.19 153.57 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 124.683 1.193 . . . . 0.0 107.941 164.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -138.6 152.61 48.29 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.858 1.663 . . . . 0.0 111.581 -173.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -146.52 152.88 39.69 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 164.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -150.39 167.22 27.72 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 127.453 2.301 . . . . 0.0 110.574 177.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -106.33 138.63 42.16 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.079 1.351 . . . . 0.0 113.779 -173.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.8 m -145.97 145.28 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 C-N-CA 124.764 1.226 . . . . 0.0 111.881 -176.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -96.22 -30.86 13.24 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 125.867 1.667 . . . . 0.0 112.26 175.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -129.41 133.25 47.25 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.144 0.978 . . . . 0.0 111.822 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.9 tp -136.39 158.45 44.4 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.15 2.18 . . . . 0.0 109.161 -170.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.2 mt -110.17 127.66 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 O-C-N 121.241 -0.912 . . . . 0.0 109.617 176.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -102.91 119.08 38.21 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.321 1.048 . . . . 0.0 111.648 168.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -104.86 123.65 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.694 1.598 . . . . 0.0 108.547 174.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -91.54 143.93 26.07 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.431 1.092 . . . . 0.0 111.142 173.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.4 mt -109.73 151.94 26.29 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.231 1.812 . . . . 0.0 110.706 175.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.9 t -66.53 -22.8 66.16 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -168.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.9 m -76.9 -10.29 59.27 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.863 1.265 . . . . 0.0 114.159 172.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 107.03 2.28 36.19 Favored Glycine 0 CA--C 1.54 1.634 0 N-CA-C 116.731 1.452 . . . . 0.0 116.731 175.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -80.86 153.81 27.43 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.41 1.484 . . . . 0.0 110.841 172.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 39.1 p -131.06 144.32 51.35 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 168.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 60.0 tp -111.72 126.35 54.95 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.168 2.187 . . . . 0.0 109.566 177.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -118.61 107.8 14.17 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.823 1.649 . . . . 0.0 110.556 -173.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.3 m -143.42 151.49 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.83 1.252 . . . . 0.0 113.174 -161.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.4 p -67.9 149.07 98.37 Favored Pre-proline 0 N--CA 1.467 0.402 0 O-C-N 121.43 -0.794 . . . . 0.0 111.93 174.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -59.5 -29.81 90.93 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 123.144 2.563 . . . . 0.0 114.09 -168.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.3 p -81.04 -9.42 59.83 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 55.6 t60 -69.38 120.81 79.39 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 119.717 1.144 . . . . 0.0 111.637 -178.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -79.31 129.49 8.65 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.019 2.479 . . . . 0.0 113.687 178.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.4 t -103.95 143.13 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 126.112 1.765 . . . . 0.0 109.544 175.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.05 109.32 15.51 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.181 0.515 . . . . 0.0 110.729 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.4 mp -106.23 153.84 21.57 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.417 1.887 . . . . 0.0 111.33 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -108.65 107.72 18.3 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 40.8 mtp180 -139.83 89.71 2.33 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 120.9 -1.125 . . . . 0.0 109.842 174.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 59.76 -13.84 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 128.154 2.581 . . . . 0.0 116.049 -163.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -174.2 -176.36 42.53 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 126.163 1.839 . . . . 0.0 113.329 174.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 95.1 mt -72.37 117.51 14.11 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.796 2.038 . . . . 0.0 111.738 -174.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -146.59 141.84 27.35 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -95.96 120.92 37.09 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.428 1.491 . . . . 0.0 111.225 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 83.9 t -123.5 128.03 25.35 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 123.652 0.781 . . . . 0.0 109.945 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -62.87 142.93 90.42 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.283 1.989 . . . . 0.0 111.147 176.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.0 -31.89 19.46 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 176.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.42 -11.29 57.43 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 174.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -112.71 -4.62 14.03 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.144 1.378 . . . . 0.0 113.552 171.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.4 t -71.63 149.35 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.067 1.347 . . . . 0.0 111.712 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.14 152.04 79.47 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 126.26 1.824 . . . . 0.0 111.747 178.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -67.56 125.24 13.04 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.271 2.647 . . . . 0.0 111.093 -175.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 96.93 9.58 55.99 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-O 119.673 -0.515 . . . . 0.0 114.266 -173.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -65.52 161.37 20.28 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 118.183 0.991 . . . . 0.0 111.587 159.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.4 p -106.59 126.96 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.617 1.567 . . . . 0.0 111.604 178.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.9 t -106.2 136.41 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.791 1.636 . . . . 0.0 111.199 -177.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.3 t -89.78 134.74 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.081 0.952 . . . . 0.0 110.9 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -158.49 -153.11 6.64 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.533 1.064 . . . . 0.0 111.522 172.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.408 HG22 ' H ' ' A' ' 120' ' ' ARG . 3.6 p -131.88 162.5 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.766 1.226 . . . . 0.0 110.294 167.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.408 ' H ' HG22 ' A' ' 119' ' ' VAL . 40.3 mtt-85 -60.15 107.61 0.67 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.47 1.908 . . . . 0.0 112.556 -165.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -64.13 -31.04 72.09 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -176.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -62.09 -22.21 65.62 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 173.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 57.4 t -85.51 -53.74 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 173.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 16.2 tp -65.43 -15.66 62.85 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.99 1.716 . . . . 0.0 114.611 -172.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -95.3 -15.58 23.04 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 171.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.3 ttm180 -146.13 -8.66 0.53 Allowed 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 -162.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -137.93 176.0 9.09 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.924 1.29 . . . . 0.0 112.592 -174.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 16.0 tt -48.37 141.2 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 126.234 1.814 . . . . 0.0 111.178 159.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 10.9 pt -78.4 117.7 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 120.959 -1.088 . . . . 0.0 111.627 -174.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 59.9 p -81.44 72.95 8.49 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 120.978 -1.076 . . . . 0.0 111.698 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.45 148.45 48.54 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 121.366 -0.834 . . . . 0.0 111.748 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 89.87 11.34 63.67 Favored Glycine 0 CA--C 1.538 1.519 0 N-CA-C 116.0 1.16 . . . . 0.0 116.0 -177.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -127.9 158.81 36.79 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.257 1.423 . . . . 0.0 112.313 174.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.7 mt -137.94 158.56 44.09 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.276 1.83 . . . . 0.0 111.4 173.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -142.02 150.41 41.27 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.429 1.492 . . . . 0.0 112.339 177.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -91.52 148.87 21.98 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.944 1.697 . . . . 0.0 113.25 176.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -137.09 139.4 41.24 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.438 1.495 . . . . 0.0 109.911 -177.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -91.5 130.21 37.36 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.844 0.747 . . . . 0.0 111.843 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 71.1 t -67.94 125.47 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 O-C-N 121.498 -0.751 . . . . 0.0 109.758 168.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.4 t -85.62 -42.64 14.15 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.944 1.698 . . . . 0.0 112.635 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.5 t -159.93 165.41 32.16 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.602 1.161 . . . . 0.0 111.108 174.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.9 m -135.11 149.94 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.671 1.188 . . . . 0.0 110.936 168.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -156.02 160.31 39.91 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.964 0.906 . . . . 0.0 112.65 167.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 87.8 mt -81.67 143.44 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 161.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 43.2 pt -131.91 152.33 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.949 2.1 . . . . 0.0 111.383 173.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -87.12 97.21 10.62 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.004 -1.06 . . . . 0.0 110.769 174.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -76.94 -46.63 23.48 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.554 -1.341 . . . . 0.0 112.59 177.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 50.84 31.94 6.65 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.59 1.156 . . . . 0.0 114.077 -176.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -139.19 172.59 12.61 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.808 -1.183 . . . . 0.0 111.61 -176.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -71.18 141.35 50.7 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.34 1.056 . . . . 0.0 111.562 173.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.9 m -123.53 153.26 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 126.219 1.808 . . . . 0.0 109.551 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -109.72 161.92 14.94 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.169 0.587 . . . . 0.0 112.258 -173.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -143.19 157.59 44.37 Favored 'General case' 0 CA--C 1.55 0.949 0 O-C-N 121.722 -0.612 . . . . 0.0 111.366 158.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 44.1 tp -114.76 127.88 55.99 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.056 1.342 . . . . 0.0 110.555 174.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 37.8 t -98.26 132.73 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 121.689 0.757 . . . . 0.0 112.415 -169.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 20.8 mm -132.66 92.61 26.59 Favored Pre-proline 0 N--CA 1.47 0.535 0 C-N-CA 126.08 1.752 . . . . 0.0 108.599 -173.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -70.41 -13.25 32.86 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.404 2.069 . . . . 0.0 113.469 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -72.88 -45.66 57.03 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 118.725 0.693 . . . . 0.0 112.368 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 82.5 p -140.74 -10.21 1.04 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.807 1.643 . . . . 0.0 114.55 -171.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 45.8 m80 55.66 21.46 4.6 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 -169.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -143.7 148.57 35.93 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 120.74 -1.225 . . . . 0.0 113.955 177.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -143.3 167.62 21.72 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.346 1.458 . . . . 0.0 112.449 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 92.5 mt -115.18 131.12 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.416 1.486 . . . . 0.0 110.501 -172.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -81.31 160.23 65.69 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 123.914 0.886 . . . . 0.0 112.543 177.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.92 -12.34 32.4 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.741 2.294 . . . . 0.0 113.421 174.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -94.11 24.13 4.54 Favored 'General case' 0 CA--C 1.555 1.141 0 CA-C-N 118.785 0.72 . . . . 0.0 111.576 165.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 83.42 -23.31 6.45 Favored Glycine 0 CA--C 1.528 0.905 0 O-C-N 120.051 -1.655 . . . . 0.0 117.102 166.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 72.7 mt -61.84 142.03 57.59 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.897 1.348 . . . . 0.0 112.797 -175.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.2 t -98.02 124.95 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.96 0.904 . . . . 0.0 110.525 174.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 27.4 mt -119.37 139.69 51.58 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.856 1.662 . . . . 0.0 111.77 -168.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -97.87 139.75 33.26 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.007 0.923 . . . . 0.0 112.794 172.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -67.81 121.53 16.17 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.705 1.202 . . . . 0.0 111.883 176.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -134.06 85.26 2.18 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.977 0.911 . . . . 0.0 112.511 -176.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.253 1.288 0 C-N-CA 127.158 2.183 . . . . 0.0 112.462 173.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -137.42 155.78 48.95 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.422 1.889 . . . . 0.0 110.988 -172.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -55.28 141.46 35.53 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.203 1.001 . . . . 0.0 112.364 174.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -59.92 -21.09 60.65 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.012 0.925 . . . . 0.0 113.367 172.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -77.53 -3.68 41.84 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.493 1.517 . . . . 0.0 112.635 175.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.8 m -79.22 145.0 33.85 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 122.443 1.116 . . . . 0.0 112.689 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -73.64 158.74 34.19 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.726 1.61 . . . . 0.0 114.112 171.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.3 p -149.2 153.64 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 124.325 1.05 . . . . 0.0 111.599 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -122.91 130.71 53.18 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.69 1.996 . . . . 0.0 107.466 175.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -150.61 179.49 8.14 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.994 0.917 . . . . 0.0 111.287 169.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -140.77 143.69 35.05 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.447 1.499 . . . . 0.0 110.565 178.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -158.28 -39.95 0.06 Allowed 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -100.01 41.1 1.18 Allowed 'General case' 0 N--CA 1.479 1.023 0 O-C-N 120.999 -1.063 . . . . 0.0 112.936 -172.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.6 m 53.26 33.49 15.58 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.247 1.419 . . . . 0.0 112.434 -167.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.6 p -159.44 146.32 12.62 Favored Pre-proline 0 C--O 1.24 0.559 0 C-N-CA 126.8 2.04 . . . . 0.0 107.799 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -74.1 161.01 41.78 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.282 2.655 . . . . 0.0 111.596 171.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -137.75 125.33 22.18 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 126.416 1.886 . . . . 0.0 109.58 -175.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -127.75 112.78 15.17 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.458 1.503 . . . . 0.0 109.023 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -155.45 -175.64 5.54 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.293 1.437 . . . . 0.0 110.704 -177.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.5 m -78.07 148.05 34.44 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 120.9 -1.125 . . . . 0.0 110.045 168.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.472 HG12 ' CG ' ' A' ' 152' ' ' TYR . 7.3 tp -58.05 -38.71 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 O-C-N 121.508 -0.745 . . . . 0.0 111.831 177.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -61.09 -20.1 62.22 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 178.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -85.34 -46.07 11.32 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.87 1.268 . . . . 0.0 111.217 175.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -73.29 -33.59 65.3 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 121.202 -0.936 . . . . 0.0 112.158 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -59.95 -46.96 87.7 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.795 0.838 . . . . 0.0 111.1 176.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.9 t -63.04 -36.03 82.2 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.41 1.084 . . . . 0.0 111.551 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -65.23 -53.61 41.82 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.342 1.457 . . . . 0.0 110.395 175.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -72.29 -34.13 67.94 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.006 -1.059 . . . . 0.0 113.382 -178.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.16 -28.01 66.92 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.964 0.906 . . . . 0.0 112.748 176.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 51.3 m -75.89 -41.89 50.7 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.406 0.682 . . . . 0.0 111.479 172.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 45.5 mtm -78.71 -45.02 22.2 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.44 1.096 . . . . 0.0 113.006 -172.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 23.5 m-20 -111.44 -26.36 9.14 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.124 1.37 . . . . 0.0 112.238 -170.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.19 163.47 27.55 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.85 1.214 . . . . 0.0 114.424 176.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -110.79 126.6 54.79 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.575 1.15 . . . . 0.0 111.167 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.3 mp -95.69 147.68 33.39 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 127.077 2.151 . . . . 0.0 110.988 174.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -73.1 151.15 49.27 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.243 2.629 . . . . 0.0 111.125 174.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -133.73 160.67 36.88 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.318 1.447 . . . . 0.0 111.155 165.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -46.76 -49.03 20.38 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.058 1.343 . . . . 0.0 113.852 177.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -101.18 -5.93 24.94 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 177.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.49 -129.64 1.28 Allowed Glycine 0 CA--C 1.528 0.865 0 CA-C-N 119.75 1.159 . . . . 0.0 115.148 -173.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -144.64 156.32 44.05 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.684 1.194 . . . . 0.0 112.738 -174.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.34 150.45 47.74 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.547 1.139 . . . . 0.0 111.814 177.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.5 t -126.01 120.18 23.96 Favored Pre-proline 0 N--CA 1.48 1.065 0 C-N-CA 125.437 1.495 . . . . 0.0 110.027 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -76.05 139.19 21.42 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 124.13 3.22 . . . . 0.0 111.482 -176.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.3 mt -108.36 155.6 20.36 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.56 0.744 . . . . 0.0 112.516 178.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -138.11 132.5 32.11 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.098 1.359 . . . . 0.0 110.056 167.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 57.5 33.89 23.87 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.503 1.521 . . . . 0.0 113.896 -178.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.8 t -107.88 127.84 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 121.074 -1.016 . . . . 0.0 111.473 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -132.79 160.95 35.38 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.08 1.352 . . . . 0.0 113.905 -172.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.9 p -151.5 155.83 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 125.8 1.64 . . . . 0.0 112.467 -178.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.515 ' CE1' HG23 ' A' ' 60' ' ' ILE . 1.1 t80 -65.51 132.41 48.84 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.841 0.856 . . . . 0.0 110.153 168.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.8 t -132.81 140.17 47.85 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.711 1.605 . . . . 0.0 109.937 173.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.5 tp -91.15 134.1 34.81 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 171.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -79.73 105.32 10.94 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 164.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 23.2 mm -63.29 -24.74 36.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 O-C-N 121.647 -0.658 . . . . 0.0 111.566 -174.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -81.47 -37.21 28.31 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.307 1.843 . . . . 0.0 115.784 -178.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.0 m -106.13 -18.53 13.99 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.658 1.183 . . . . 0.0 112.483 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.4 25.73 73.67 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 125.324 1.44 . . . . 0.0 113.52 -168.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -79.52 131.28 35.99 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.899 1.68 . . . . 0.0 111.093 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.515 HG23 ' CE1' ' A' ' 51' ' ' TYR . 2.8 mp -92.37 113.47 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 173.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -138.38 172.81 12.35 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.079 1.352 . . . . 0.0 112.019 -174.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -103.9 148.05 26.61 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.66 1.184 . . . . 0.0 111.009 173.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.6 t -140.66 151.85 44.91 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.393 1.077 . . . . 0.0 111.178 173.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -72.89 157.58 37.17 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.252 1.021 . . . . 0.0 111.967 171.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -115.81 143.4 45.45 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.308 1.443 . . . . 0.0 110.942 168.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -88.67 -48.5 7.49 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.229 1.012 . . . . 0.0 112.933 -173.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -157.35 157.35 33.95 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.686 1.194 . . . . 0.0 112.043 177.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.5 mt -88.1 153.14 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 124.918 1.287 . . . . 0.0 108.265 166.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -135.22 151.31 50.5 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.025 1.73 . . . . 0.0 111.27 -178.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 26.8 ptt-85 -147.34 156.65 43.1 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 167.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -152.36 163.07 40.23 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.508 1.923 . . . . 0.0 108.945 176.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.17 143.44 26.37 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.36 -0.838 . . . . 0.0 110.577 176.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.0 m -143.28 143.81 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 122.417 1.103 . . . . 0.0 111.641 175.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -101.82 -15.23 16.98 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.657 1.183 . . . . 0.0 113.009 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -132.22 125.44 31.13 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.549 1.54 . . . . 0.0 110.903 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.1 tp -140.26 159.85 41.27 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.012 1.725 . . . . 0.0 109.538 -173.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.2 mt -112.53 128.52 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.372 1.069 . . . . 0.0 109.177 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -102.51 119.67 39.22 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.225 1.01 . . . . 0.0 110.696 169.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -104.16 127.9 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 124.821 1.249 . . . . 0.0 108.556 173.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -94.19 148.35 22.27 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.865 1.266 . . . . 0.0 110.719 172.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 70.6 mt -114.87 156.89 24.12 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.545 1.938 . . . . 0.0 111.367 -177.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 36.3 t -68.38 -20.1 64.67 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -163.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 37.2 m -93.86 4.76 53.45 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 173.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 102.08 11.57 36.52 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.129 1.347 . . . . 0.0 116.254 171.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -96.23 167.99 10.86 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.977 1.311 . . . . 0.0 111.706 177.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 97.1 p -142.46 157.76 44.41 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -176.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.1 tp -135.8 127.8 29.62 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.989 1.716 . . . . 0.0 110.337 177.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -108.7 115.81 30.79 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.491 1.516 . . . . 0.0 111.949 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.4 m -142.33 153.55 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.721 1.608 . . . . 0.0 113.142 -169.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.2 p -67.56 147.96 98.67 Favored Pre-proline 0 N--CA 1.465 0.314 0 O-C-N 121.308 -0.87 . . . . 0.0 112.305 174.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -55.5 -33.77 87.38 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.673 2.916 . . . . 0.0 114.102 -174.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.9 p -81.76 -6.96 59.52 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 30.1 t60 -76.27 120.18 80.54 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 124.737 1.215 . . . . 0.0 112.333 -174.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -75.65 129.78 12.06 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.869 2.379 . . . . 0.0 113.436 176.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.72 144.98 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 126.499 1.92 . . . . 0.0 109.256 174.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 21.2 tp -80.88 106.62 13.02 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.343 0.519 . . . . 0.0 110.561 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.5 mp -107.49 165.63 11.26 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.859 2.063 . . . . 0.0 112.272 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -119.86 119.43 33.52 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.447 1.099 . . . . 0.0 113.05 176.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 33.6 mtm180 -132.59 77.86 1.77 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.176 1.39 . . . . 0.0 108.486 164.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.2 t70 59.23 8.49 1.11 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 126.862 2.065 . . . . 0.0 115.501 -169.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.34 169.01 42.12 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.953 1.739 . . . . 0.0 111.228 -174.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 71.7 mt -76.58 119.23 20.12 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.512 1.125 . . . . 0.0 110.639 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -133.55 131.76 40.12 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.127 0.971 . . . . 0.0 110.915 -176.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -88.32 122.29 31.67 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 172.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 67.0 t -132.2 127.11 20.79 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 123.87 0.868 . . . . 0.0 110.301 -175.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -65.89 142.72 70.31 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.378 2.052 . . . . 0.0 111.239 176.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.97 -30.85 16.07 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 176.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.08 -18.44 65.31 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 173.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -111.74 -3.97 14.81 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.151 1.38 . . . . 0.0 112.248 175.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 89.3 t -71.16 144.49 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.833 1.253 . . . . 0.0 110.316 169.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.12 156.66 78.92 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 126.407 1.883 . . . . 0.0 110.895 -177.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.36 126.24 13.99 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.337 2.025 . . . . 0.0 112.404 -172.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 108.07 -2.85 33.4 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.03 1.3 . . . . 0.0 114.814 -178.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -59.81 160.38 7.66 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.938 1.295 . . . . 0.0 113.221 174.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.8 t -102.56 118.35 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.139 1.375 . . . . 0.0 109.975 177.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.4 t -93.79 141.55 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.698 1.599 . . . . 0.0 110.058 173.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.5 t -91.38 138.66 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.259 1.024 . . . . 0.0 110.555 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -164.7 -149.13 5.7 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 123.402 0.525 . . . . 0.0 114.339 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.7 p -150.33 159.44 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 127.008 2.123 . . . . 0.0 108.573 175.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -59.11 124.45 20.0 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.91 0.884 . . . . 0.0 112.249 176.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -59.38 -31.81 69.57 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -64.22 -21.8 66.71 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 175.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 86.9 t -80.13 -31.39 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 118.906 0.776 . . . . 0.0 111.075 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -85.2 -16.17 41.21 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.28 1.832 . . . . 0.0 113.154 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 70.2 mtt-85 -69.92 -14.14 62.58 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 166.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 10.4 mmp_? -80.16 145.4 32.35 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.55 1.14 . . . . 0.0 111.74 -176.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -72.66 -26.55 61.68 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 177.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 70.6 mt -98.7 127.94 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.836 1.255 . . . . 0.0 108.599 165.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 48.6 mm -102.64 116.33 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.81 1.244 . . . . 0.0 109.917 -176.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 9.5 t -87.86 149.36 24.16 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -101.32 169.66 8.75 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.044 1.738 . . . . 0.0 113.357 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.95 2.51 88.69 Favored Glycine 0 CA--C 1.54 1.619 0 N-CA-C 117.545 1.778 . . . . 0.0 117.545 167.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -125.11 148.37 48.58 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 119.62 1.71 . . . . 0.0 113.556 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 96.7 mt -139.58 174.25 10.7 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 127.864 2.465 . . . . 0.0 111.907 -177.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -142.25 170.85 14.94 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 127.437 2.295 . . . . 0.0 110.604 169.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -126.04 147.0 49.67 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.103 1.761 . . . . 0.0 110.805 172.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -135.76 134.79 39.37 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.257 1.023 . . . . 0.0 110.313 -168.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -95.13 138.95 32.15 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.523 -0.736 . . . . 0.0 112.916 -174.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 71.0 t -74.15 132.67 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.351 1.06 . . . . 0.0 111.012 174.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 36.1 t -91.64 -40.36 11.35 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.211 1.804 . . . . 0.0 113.082 176.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.5 t -162.08 165.97 26.45 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.18 0.992 . . . . 0.0 110.643 176.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.2 m -131.93 148.23 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.491 1.116 . . . . 0.0 109.986 166.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -152.0 154.46 36.05 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.377 1.071 . . . . 0.0 112.766 172.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 87.7 mt -94.32 129.21 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.414 1.086 . . . . 0.0 108.537 169.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 16.8 pt -123.02 165.4 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 126.393 1.877 . . . . 0.0 112.131 -177.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -108.24 68.21 0.69 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.463 1.905 . . . . 0.0 112.509 -173.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -62.21 -43.88 97.84 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 121.097 -1.002 . . . . 0.0 113.24 -164.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 50.97 33.27 8.59 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.338 1.455 . . . . 0.0 113.894 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -141.5 177.64 7.99 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.853 1.261 . . . . 0.0 111.962 -174.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -77.65 142.07 39.06 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.161 0.985 . . . . 0.0 113.055 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 14.8 m -126.76 151.04 33.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 125.666 1.586 . . . . 0.0 109.671 177.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.472 ' CG ' HG12 ' A' ' 21' ' ' ILE . 1.2 p90 -111.04 164.18 13.08 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.678 0.791 . . . . 0.0 112.463 -175.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -144.31 155.4 43.8 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 122.439 0.296 . . . . 0.0 110.761 154.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 46.6 tp -107.49 124.39 49.83 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.568 1.147 . . . . 0.0 110.329 175.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 23.1 t -91.98 117.44 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 121.768 0.794 . . . . 0.0 111.887 -171.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 13.7 mm -120.73 83.25 35.52 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 126.396 1.879 . . . . 0.0 109.063 -177.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -63.24 -19.31 68.21 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.123 1.882 . . . . 0.0 113.808 178.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -76.13 -30.38 58.16 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 120.533 -1.355 . . . . 0.0 113.944 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 69.7 p -141.43 -18.1 0.79 Allowed 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . 0.253 75.6 m80 56.82 21.89 6.47 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.077 2.151 . . . . 0.0 115.165 -168.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -147.32 145.66 29.42 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.618 1.099 . . . . 0.0 113.767 -179.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -148.66 164.79 33.27 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.085 1.354 . . . . 0.0 111.709 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.2 mp -111.39 136.3 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.296 1.038 . . . . 0.0 111.466 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -81.88 157.64 68.82 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 124.033 0.933 . . . . 0.0 112.374 175.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -64.92 -22.71 62.67 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.815 2.344 . . . . 0.0 112.76 178.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -77.27 -5.48 49.58 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.559 0.744 . . . . 0.0 112.856 173.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 112.55 -21.68 18.65 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 125.955 1.74 . . . . 0.0 116.566 165.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 58.3 mt -76.87 149.89 36.09 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.097 1.448 . . . . 0.0 113.88 -171.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.9 t -96.78 123.84 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.761 1.224 . . . . 0.0 111.818 -178.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 25.4 mt -117.47 142.88 46.63 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.323 1.849 . . . . 0.0 112.577 -169.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -102.72 140.42 37.02 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.266 1.026 . . . . 0.0 112.369 170.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -66.89 133.94 51.04 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.944 0.897 . . . . 0.0 111.649 174.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -142.85 113.89 7.68 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.08 0.952 . . . . 0.0 113.487 -176.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 . . . . . 0 C--O 1.253 1.273 0 C-N-CA 127.164 2.185 . . . . 0.0 111.774 -177.858 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.676 0 CA-C-O 120.832 0.349 . . . . 0.0 111.481 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.11 161.75 32.51 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.702 2.401 . . . . 0.0 110.684 -177.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.84 141.68 56.85 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.338 1.055 . . . . 0.0 112.59 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.2 ppt_? -56.54 -28.55 60.33 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.016 1.327 . . . . 0.0 113.166 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -81.74 -6.89 59.45 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.725 2.01 . . . . 0.0 114.599 -177.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.1 m -69.02 144.04 54.17 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.159 1.384 . . . . 0.0 112.856 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -82.06 152.02 26.8 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.438 1.495 . . . . 0.0 113.88 171.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.7 p -148.19 162.57 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.698 1.599 . . . . 0.0 111.685 -173.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -134.89 130.02 35.28 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.685 1.594 . . . . 0.0 109.823 -173.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -157.3 -178.53 7.42 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 118.924 0.784 . . . . 0.0 112.793 175.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -135.3 138.86 43.87 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.399 1.479 . . . . 0.0 111.43 172.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -169.0 146.92 3.8 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.139 1.376 . . . . 0.0 111.374 174.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.5 t0 62.92 36.93 12.38 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 115.321 1.601 . . . . 0.0 115.321 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 m 62.59 37.51 13.0 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.579 1.552 . . . . 0.0 113.504 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.8 p -157.29 137.08 8.58 Favored Pre-proline 0 CA--C 1.543 0.703 0 O-C-N 121.329 -0.857 . . . . 0.0 111.499 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.26 147.4 32.94 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.962 3.108 . . . . 0.0 111.111 171.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -127.35 135.97 51.26 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.812 1.245 . . . . 0.0 112.02 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 52.1 ttm -143.79 88.29 1.97 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.736 1.215 . . . . 0.0 109.789 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -146.31 -176.42 5.16 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.729 2.012 . . . . 0.0 111.645 -168.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -73.64 150.98 40.96 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.472 -1.392 . . . . 0.0 111.893 176.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.8 tp -58.34 -37.25 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 O-C-N 121.527 -0.733 . . . . 0.0 111.927 173.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -64.5 -30.44 71.47 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.215 0.916 . . . . 0.0 113.003 174.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -73.76 -41.39 62.51 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.587 -0.696 . . . . 0.0 110.301 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 20.0 ptm -69.47 -39.51 77.67 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.654 171.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -57.41 -52.41 65.49 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.975 0.807 . . . . 0.0 111.756 -178.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.8 t -71.55 -29.13 64.4 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 122.718 0.407 . . . . 0.0 111.503 -173.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -65.19 -53.01 51.17 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.363 1.465 . . . . 0.0 110.634 173.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -68.26 -32.77 73.18 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.376 -0.827 . . . . 0.0 112.015 177.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.74 -28.54 66.9 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.495 1.118 . . . . 0.0 113.658 174.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.4 t -83.83 -31.49 25.79 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.416 -0.802 . . . . 0.0 111.736 174.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 67.1 mtm -81.33 -42.75 20.09 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -114.27 -23.11 9.59 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.193 1.397 . . . . 0.0 113.875 -171.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.98 161.74 37.01 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.836 1.208 . . . . 0.0 114.647 -178.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -112.83 128.43 56.44 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.566 1.547 . . . . 0.0 110.406 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.8 mp -105.54 142.56 25.01 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 125.393 1.477 . . . . 0.0 111.789 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.24 146.27 40.25 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 124.04 3.16 . . . . 0.0 112.349 -177.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -141.12 159.55 41.98 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.083 1.753 . . . . 0.0 111.346 -178.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -61.42 -52.07 66.12 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 120.203 -1.56 . . . . 0.0 114.578 -178.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -79.84 -15.34 57.59 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 172.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -179.05 -125.99 0.98 Allowed Glycine 0 CA--C 1.539 1.549 0 N-CA-C 117.177 1.631 . . . . 0.0 117.177 -175.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -143.6 161.89 37.32 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.897 1.679 . . . . 0.0 111.003 178.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.19 148.52 41.7 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.952 1.301 . . . . 0.0 112.486 -176.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 54.5 t -124.11 120.99 26.28 Favored Pre-proline 0 N--CA 1.481 1.113 0 C-N-CA 125.756 1.623 . . . . 0.0 110.861 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -75.9 141.91 24.65 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 124.245 3.297 . . . . 0.0 112.317 -178.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.3 mt -106.45 164.58 11.93 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.52 1.128 . . . . 0.0 113.692 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -146.65 125.71 12.87 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.297 1.439 . . . . 0.0 111.009 173.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 54.46 32.96 17.74 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 125.758 1.623 . . . . 0.0 114.251 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.2 t -96.31 122.38 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 120.849 -1.157 . . . . 0.0 110.179 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -124.12 155.04 39.14 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.488 1.115 . . . . 0.0 113.508 -174.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.5 p -150.49 152.19 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.663 1.185 . . . . 0.0 111.976 -176.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.412 ' CE1' HG23 ' A' ' 60' ' ' ILE . 1.2 t80 -63.31 129.83 41.95 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 122.026 0.917 . . . . 0.0 110.228 167.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.405 HG21 ' HB ' ' A' ' 63' ' ' THR . 5.2 t -131.22 152.17 50.76 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.624 1.97 . . . . 0.0 111.248 178.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.6 tp -105.0 135.0 47.15 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.428 1.091 . . . . 0.0 110.211 175.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -80.8 116.04 20.59 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.769 0.828 . . . . 0.0 110.404 164.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 39.4 mm -71.9 -21.43 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.634 0.774 . . . . 0.0 112.473 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.8 -43.11 31.61 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.91 0.884 . . . . 0.0 113.305 -176.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -107.28 -23.67 12.16 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.405 1.082 . . . . 0.0 111.882 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.9 34.25 38.95 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.519 1.056 . . . . 0.0 113.272 -170.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -99.27 147.18 25.43 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.747 1.274 . . . . 0.0 113.502 -175.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.412 HG23 ' CE1' ' A' ' 51' ' ' TYR . 3.4 mp -91.95 130.88 40.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 C-N-CA 125.999 1.72 . . . . 0.0 110.025 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -157.5 171.43 20.37 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.367 1.467 . . . . 0.0 112.374 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -102.86 141.65 35.32 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.075 1.35 . . . . 0.0 111.047 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.405 ' HB ' HG21 ' A' ' 52' ' ' THR . 1.1 t -141.5 166.44 24.74 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.094 0.958 . . . . 0.0 112.373 176.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -93.61 150.79 20.13 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.941 1.296 . . . . 0.0 112.809 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.56 139.16 46.07 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.563 1.145 . . . . 0.0 111.556 173.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 93.1 p -91.0 -51.93 5.1 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -165.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -155.07 159.56 40.35 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.494 1.517 . . . . 0.0 112.95 177.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.3 mt -96.66 151.59 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 125.803 1.641 . . . . 0.0 109.117 170.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -137.6 148.5 45.9 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.347 1.459 . . . . 0.0 111.569 -174.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.51 149.12 52.38 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.399 1.48 . . . . 0.0 112.423 176.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -155.6 162.41 40.64 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.945 1.298 . . . . 0.0 110.386 176.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -101.74 140.92 35.38 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.08 0.952 . . . . 0.0 110.983 -176.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.8 m -149.05 144.47 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 124.527 1.131 . . . . 0.0 111.522 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -93.01 -36.16 12.88 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 126.278 1.831 . . . . 0.0 111.384 170.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -118.38 130.61 56.09 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.355 1.062 . . . . 0.0 110.981 -171.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.3 tp -139.02 159.14 42.86 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.648 1.979 . . . . 0.0 109.403 -173.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.4 mt -113.07 126.05 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.884 0.874 . . . . 0.0 109.209 176.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -97.03 127.82 43.38 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.08 0.952 . . . . 0.0 111.268 167.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -113.79 133.02 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.467 1.507 . . . . 0.0 109.474 173.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -103.78 146.47 28.58 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 126.753 2.021 . . . . 0.0 111.957 -179.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 68.2 mt -119.48 156.72 29.7 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.785 1.634 . . . . 0.0 113.08 -173.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.9 t -57.45 -29.39 64.16 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.312 1.445 . . . . 0.0 113.913 -178.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 55.7 m -75.44 1.38 14.17 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 173.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.63 43.26 19.4 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-N 119.608 1.095 . . . . 0.0 112.596 -178.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -130.48 152.78 49.5 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.15 1.78 . . . . 0.0 109.667 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 54.3 p -132.37 149.68 52.3 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 174.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 67.3 tp -122.19 134.18 54.72 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 126.501 1.92 . . . . 0.0 110.791 176.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -113.26 117.29 31.44 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.286 1.435 . . . . 0.0 111.962 -178.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.0 m -140.59 158.33 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.275 1.43 . . . . 0.0 112.913 -174.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.6 p -65.61 147.56 98.63 Favored Pre-proline 0 N--CA 1.471 0.61 0 O-C-N 120.975 -1.078 . . . . 0.0 112.766 174.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -59.5 -32.7 96.69 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.385 2.723 . . . . 0.0 113.763 -172.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 64.6 p -75.66 -1.64 25.66 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.774 2.03 . . . . 0.0 114.9 177.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 53.6 t60 -91.07 122.11 66.98 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 124.497 1.119 . . . . 0.0 113.022 -165.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 93' ' ' HIS . 17.3 Cg_exo -73.22 142.28 33.67 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.929 2.419 . . . . 0.0 114.425 -177.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.2 t -125.89 143.14 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 126.73 2.012 . . . . 0.0 109.479 174.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.1 tt -81.21 105.52 12.48 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.703 0.763 . . . . 0.0 110.087 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.8 mp -99.73 159.58 14.95 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.335 1.854 . . . . 0.0 111.381 177.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -113.54 133.31 55.32 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.675 -0.641 . . . . 0.0 111.89 174.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -153.46 96.86 2.08 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.942 1.697 . . . . 0.0 110.224 155.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 56.27 -3.33 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 127.328 2.251 . . . . 0.0 116.898 -167.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.83 163.43 34.52 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.372 1.463 . . . . 0.0 113.333 177.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 67.5 mt -67.93 115.16 7.14 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.066 2.146 . . . . 0.0 110.943 -177.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -141.73 139.81 32.97 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -178.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -98.37 124.53 43.09 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.919 0.887 . . . . 0.0 112.157 -175.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 62.1 t -131.58 131.28 22.74 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 125.196 1.398 . . . . 0.0 110.258 -172.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.43 145.62 77.67 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.583 2.188 . . . . 0.0 111.878 177.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.57 -30.95 14.4 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 176.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.27 -25.93 68.27 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 173.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -102.59 -4.95 24.45 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.032 1.733 . . . . 0.0 112.737 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 98.5 t -69.69 148.76 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.024 0.929 . . . . 0.0 109.647 166.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.92 155.22 71.09 Favored Pre-proline 0 N--CA 1.471 0.585 0 C-N-CA 127.252 2.221 . . . . 0.0 109.987 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.403 ' HD3' HG22 ' A' ' 142' ' ' VAL . 55.6 Cg_endo -65.89 119.48 6.51 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.041 1.827 . . . . 0.0 111.577 -177.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.42 ' H ' ' HB ' ' A' ' 139' ' ' VAL . . . 107.24 6.87 33.45 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.158 1.361 . . . . 0.0 114.705 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -61.15 155.62 20.22 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.275 1.037 . . . . 0.0 111.654 163.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.6 t -93.04 128.46 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.421 1.088 . . . . 0.0 110.071 169.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 28.0 t -103.03 139.03 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 126.381 1.872 . . . . 0.0 109.695 171.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.6 t -91.68 141.34 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.531 0.732 . . . . 0.0 110.772 176.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -168.38 -150.52 6.66 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 121.728 -0.607 . . . . 0.0 114.188 -177.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 120' ' ' ARG . 9.4 p -140.33 168.36 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 126.253 1.821 . . . . 0.0 109.979 175.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.41 ' H ' HG22 ' A' ' 119' ' ' VAL . 35.9 mtp180 -62.02 112.62 2.41 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.584 1.554 . . . . 0.0 112.607 -175.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -63.58 -21.38 66.32 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.083 1.353 . . . . 0.0 113.085 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -83.09 -31.12 27.46 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 173.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 46.6 t -86.29 -40.88 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.488 0.715 . . . . 0.0 110.972 -174.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 42.2 tp -65.9 -28.64 69.09 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.535 0.734 . . . . 0.0 112.2 178.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 36.5 mtp-105 -95.07 28.59 2.73 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.698 1.599 . . . . 0.0 113.082 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 71.1 mtt85 -138.09 157.98 45.23 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 127.699 2.4 . . . . 0.0 109.64 170.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -70.19 147.68 49.54 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.027 0.931 . . . . 0.0 112.04 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 91.4 mt 60.09 114.0 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 127.07 2.148 . . . . 0.0 112.486 -162.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.5 mp -86.13 134.34 27.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 123.975 0.91 . . . . 0.0 108.973 167.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 41.3 t -79.89 130.38 35.26 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.381 0.673 . . . . 0.0 109.7 167.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.3 ptpt -91.39 144.0 26.03 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.505 1.122 . . . . 0.0 111.866 -172.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 74.32 24.49 73.07 Favored Glycine 0 CA--C 1.54 1.597 0 N-CA-C 114.985 0.754 . . . . 0.0 114.985 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -121.97 136.72 54.94 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.293 1.437 . . . . 0.0 112.658 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 60.9 mt -128.93 174.18 9.74 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.652 1.981 . . . . 0.0 112.297 178.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -140.05 169.53 17.53 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.885 2.474 . . . . 0.0 109.279 171.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -135.5 156.18 49.32 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 119.992 -1.693 . . . . 0.0 111.627 164.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.29 140.09 52.07 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.589 1.156 . . . . 0.0 110.862 -172.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -89.28 133.69 34.36 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.51 0.724 . . . . 0.0 110.985 170.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.42 ' HB ' ' H ' ' A' ' 113' ' ' GLY . 79.4 t -72.15 122.58 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 123.433 0.693 . . . . 0.0 110.229 174.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 47.9 t -77.76 -41.98 35.68 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.652 1.181 . . . . 0.0 112.478 174.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.7 t -160.8 164.67 31.26 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.458 -0.777 . . . . 0.0 112.376 -177.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.403 HG22 ' HD3' ' A' ' 112' ' ' PRO . 5.7 m -135.72 150.71 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.485 1.114 . . . . 0.0 110.999 167.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -152.68 155.94 38.24 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.397 1.079 . . . . 0.0 112.943 173.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 80.5 mt -93.01 130.82 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 168.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 36.3 pt -122.33 149.37 25.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 124.63 1.172 . . . . 0.0 112.371 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.53 102.47 12.88 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.421 1.088 . . . . 0.0 110.069 168.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -84.34 -50.38 7.87 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.211 0.604 . . . . 0.0 111.715 172.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 44.57 57.17 4.62 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.978 1.311 . . . . 0.0 112.504 -173.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -151.63 175.71 12.08 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.712 0.805 . . . . 0.0 112.176 -177.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -67.67 144.42 55.5 Favored 'General case' 0 N--CA 1.463 0.189 0 O-C-N 121.727 -0.608 . . . . 0.0 110.79 162.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.1 m -122.5 152.16 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.521 1.128 . . . . 0.0 109.466 169.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -114.47 157.2 23.25 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 121.781 0.801 . . . . 0.0 112.09 -178.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -155.59 153.94 30.89 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.777 0.831 . . . . 0.0 109.784 -165.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 32.3 tp -136.51 139.44 42.27 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.174 -0.954 . . . . 0.0 111.788 -170.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 28.9 t -113.17 130.04 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.763 0.825 . . . . 0.0 112.608 -168.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 11.0 mm -134.08 85.55 39.51 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 125.728 1.611 . . . . 0.0 109.535 -175.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.98 -13.71 39.08 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.006 2.471 . . . . 0.0 113.766 -177.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -79.43 -40.18 30.58 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.383 0.882 . . . . 0.0 113.383 -177.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 59.1 p -140.14 -6.41 1.24 Allowed 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -171.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 58.01 13.35 2.15 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.203 1.801 . . . . 0.0 115.851 -174.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.03 147.55 24.15 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 120.96 1.709 . . . . 0.0 114.983 -176.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -146.85 159.24 43.76 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.369 1.068 . . . . 0.0 113.539 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.7 mp -99.7 137.96 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.466 1.106 . . . . 0.0 112.643 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -91.0 156.26 44.32 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 126.664 1.986 . . . . 0.0 112.428 172.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -67.75 -19.83 46.85 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.763 2.976 . . . . 0.0 113.74 -174.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 47.6 p30 -73.18 -0.94 15.67 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.063 1.345 . . . . 0.0 113.418 171.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.2 -5.63 68.28 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 126.391 1.948 . . . . 0.0 115.385 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 66.8 mt -84.94 153.54 22.76 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.231 1.516 . . . . 0.0 111.846 -175.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.7 p -110.55 133.04 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.785 0.834 . . . . 0.0 111.798 175.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 24.4 mt -116.2 154.33 30.26 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.831 2.052 . . . . 0.0 110.844 -172.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 8.3 t-80 -111.64 149.75 31.09 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.081 0.952 . . . . 0.0 112.86 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -60.47 137.07 58.21 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.474 0.709 . . . . 0.0 111.161 162.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -91.71 -3.57 56.1 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 -171.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 . . . . . 0 C--O 1.247 0.957 0 C-N-CA 125.101 1.36 . . . . 0.0 112.042 -168.622 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.608 0 CA-C-O 120.819 0.343 . . . . 0.0 111.6 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.12 156.32 45.37 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.704 1.602 . . . . 0.0 110.748 -169.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.08 145.3 31.3 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.825 1.25 . . . . 0.0 114.203 -177.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -60.64 -23.39 64.73 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.474 1.509 . . . . 0.0 114.216 177.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -92.79 4.37 53.93 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.792 0.837 . . . . 0.0 112.973 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.8 m -71.47 140.14 49.89 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.027 -1.045 . . . . 0.0 111.603 174.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -65.67 155.61 35.44 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.241 1.417 . . . . 0.0 113.648 167.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.7 p -148.11 151.93 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.331 1.052 . . . . 0.0 111.341 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -128.08 126.22 40.78 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.544 1.538 . . . . 0.0 108.254 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -156.92 176.98 12.03 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.396 0.678 . . . . 0.0 111.616 -177.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -134.83 138.36 44.15 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.683 1.193 . . . . 0.0 110.08 178.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -161.66 158.79 26.61 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.425 1.09 . . . . 0.0 110.213 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.3 t0 50.27 37.87 16.14 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.063 0.945 . . . . 0.0 113.26 -175.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.7 m 53.39 41.85 32.07 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.398 1.079 . . . . 0.0 113.372 -176.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.0 p -157.92 142.19 11.61 Favored Pre-proline 0 CA--C 1.545 0.753 0 O-C-N 120.968 -1.083 . . . . 0.0 111.216 174.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.14 149.26 64.21 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 123.003 2.468 . . . . 0.0 112.604 174.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -137.11 139.82 41.5 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 127.209 2.203 . . . . 0.0 109.629 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 42.6 ttm -153.08 106.1 2.98 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.361 -0.837 . . . . 0.0 110.775 -174.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -159.55 -179.3 7.78 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.006 1.322 . . . . 0.0 111.963 -165.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.4 m -71.03 138.02 49.51 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.099 -1.0 . . . . 0.0 110.565 169.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.466 HG12 ' CG ' ' A' ' 152' ' ' TYR . 6.6 tp -55.13 -38.75 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 O-C-N 121.251 -0.906 . . . . 0.0 112.606 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -66.29 -16.78 64.31 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.389 0.995 . . . . 0.0 113.104 -177.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -87.2 -41.13 13.97 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.846 1.258 . . . . 0.0 111.178 173.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 2.1 ppp? -73.4 -36.93 66.09 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 120.914 -1.116 . . . . 0.0 112.062 176.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -55.42 -45.7 76.73 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.447 1.099 . . . . 0.0 110.673 175.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.2 t -60.98 -34.67 75.14 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.1 0.96 . . . . 0.0 111.156 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -65.47 -53.08 47.78 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.457 1.103 . . . . 0.0 110.513 174.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -73.28 -35.36 66.15 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 121.495 -0.753 . . . . 0.0 112.739 -173.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.01 -35.67 80.45 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.262 0.625 . . . . 0.0 110.686 172.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 54.5 m -76.9 -24.08 52.51 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 121.049 -1.032 . . . . 0.0 113.538 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 33.1 mtm -90.54 -52.98 4.63 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.844 1.258 . . . . 0.0 112.062 177.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -100.31 -21.33 15.49 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.34 1.456 . . . . 0.0 112.049 -167.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.84 161.09 31.58 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.632 1.111 . . . . 0.0 113.049 -177.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -102.76 138.38 39.73 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.663 1.185 . . . . 0.0 111.155 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.6 mp -107.4 148.21 36.73 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 128.925 2.89 . . . . 0.0 110.212 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.85 155.68 43.68 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 123.516 2.811 . . . . 0.0 112.53 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -142.46 175.95 9.38 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.857 1.263 . . . . 0.0 112.524 169.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.61 -55.96 25.95 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.555 1.142 . . . . 0.0 112.119 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -105.94 -4.19 20.91 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -175.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -169.7 -135.69 1.95 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 114.61 0.604 . . . . 0.0 114.61 -172.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -144.65 165.37 28.23 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.086 1.754 . . . . 0.0 111.334 -175.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.29 159.33 42.33 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.687 1.595 . . . . 0.0 111.617 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 54.2 t -131.52 117.18 16.47 Favored Pre-proline 0 N--CA 1.48 1.061 0 C-N-CA 125.747 1.619 . . . . 0.0 111.102 178.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -82.46 123.3 3.81 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 124.233 3.289 . . . . 0.0 112.664 -172.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 90.5 mt -97.74 157.48 16.04 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -171.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -134.49 127.04 30.62 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.731 1.613 . . . . 0.0 112.588 171.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 52.32 40.95 30.23 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.246 1.418 . . . . 0.0 113.578 178.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.7 t -104.26 126.62 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.974 1.31 . . . . 0.0 109.543 172.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -126.46 158.74 35.26 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.927 1.291 . . . . 0.0 112.305 -175.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.8 m -143.09 150.18 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 126.334 1.853 . . . . 0.0 111.457 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -69.56 133.07 47.21 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 122.925 1.345 . . . . 0.0 109.666 164.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.3 t -137.13 164.68 27.87 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.7 2.4 . . . . 0.0 110.345 -173.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.3 tp -119.22 135.37 54.72 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.389 1.076 . . . . 0.0 109.194 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -79.1 105.99 10.83 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 163.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.2 mm -70.62 -24.63 25.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.685 0.794 . . . . 0.0 111.579 -175.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.97 -47.56 71.2 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.439 1.496 . . . . 0.0 113.391 -177.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.1 m -107.98 -19.27 13.56 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.599 1.16 . . . . 0.0 112.745 178.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.62 36.87 15.14 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.018 0.818 . . . . 0.0 112.318 -176.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -101.63 134.5 44.67 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.875 1.67 . . . . 0.0 112.591 -177.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 mp -76.64 136.53 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 O-C-N 121.798 -0.564 . . . . 0.0 109.934 178.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.1 ptpt -146.94 168.09 22.36 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.559 1.544 . . . . 0.0 111.781 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -116.05 147.71 40.98 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.414 1.486 . . . . 0.0 109.349 170.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.3 t -147.12 161.3 41.15 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.714 0.806 . . . . 0.0 111.866 -178.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -83.75 137.92 33.51 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.727 1.211 . . . . 0.0 112.027 175.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.34 132.18 44.03 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.229 1.011 . . . . 0.0 109.707 169.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.3 t -94.63 -41.09 9.48 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -163.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -150.51 156.23 41.03 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.923 1.289 . . . . 0.0 110.842 173.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.4 mt -88.49 149.4 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 162.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -126.95 149.2 49.96 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 126.324 1.85 . . . . 0.0 109.742 175.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.52 142.67 47.09 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.661 1.184 . . . . 0.0 111.71 167.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -141.98 153.22 44.13 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.595 1.158 . . . . 0.0 109.868 171.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.5 mmtt -84.06 144.36 29.12 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.813 -0.555 . . . . 0.0 110.661 171.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 20.5 m -143.09 140.51 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 122.457 1.122 . . . . 0.0 111.883 173.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -102.05 -9.11 20.87 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.594 1.558 . . . . 0.0 112.453 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -139.46 131.3 27.6 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.076 1.35 . . . . 0.0 109.952 175.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 13.0 tp -139.52 160.28 40.22 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.996 1.318 . . . . 0.0 109.513 -176.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.9 mt -111.63 127.5 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.851 0.861 . . . . 0.0 109.451 179.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -98.51 120.02 38.21 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.091 0.956 . . . . 0.0 110.786 167.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.4 mp -102.16 127.47 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.316 1.046 . . . . 0.0 108.473 168.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -97.12 151.05 20.16 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.071 1.348 . . . . 0.0 110.838 173.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 59.9 mt -117.21 159.97 21.8 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.263 1.825 . . . . 0.0 112.864 -172.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.7 t -58.8 -25.1 62.8 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.721 1.608 . . . . 0.0 113.368 177.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.8 p -67.33 -11.5 57.8 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.204 1.801 . . . . 0.0 115.236 172.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.78 -1.42 83.52 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 125.193 1.378 . . . . 0.0 114.664 -170.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -95.92 173.12 7.6 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.247 1.819 . . . . 0.0 112.835 -175.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.7 p -143.36 164.25 30.79 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 17.5 tp -139.09 137.07 35.87 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.331 1.452 . . . . 0.0 111.204 174.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.7 mtmt -113.69 117.72 32.33 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.023 1.329 . . . . 0.0 112.803 -176.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.2 m -143.48 153.93 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 125.868 1.667 . . . . 0.0 113.08 -163.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.6 p -70.16 149.76 96.09 Favored Pre-proline 0 N--CA 1.475 0.813 0 O-C-N 120.731 -1.231 . . . . 0.0 112.824 176.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -60.86 -22.76 75.01 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.692 2.928 . . . . 0.0 114.069 -174.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 58.9 p -88.81 -11.49 44.68 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.882 1.673 . . . . 0.0 115.02 177.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -65.74 121.78 77.27 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-N 119.332 0.969 . . . . 0.0 110.887 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -77.35 128.24 9.54 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.709 2.272 . . . . 0.0 112.789 177.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.0 t -100.0 137.55 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 C-N-CA 126.425 1.89 . . . . 0.0 109.692 176.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.33 108.35 13.86 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.6 mp -103.4 146.65 28.17 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.346 1.458 . . . . 0.0 111.904 -177.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -96.92 96.74 8.73 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.181 0.515 . . . . 0.0 111.518 170.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -124.73 73.73 1.29 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 122.808 1.289 . . . . 0.0 110.148 -178.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.4 t70 60.38 4.03 0.64 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 128.165 2.586 . . . . 0.0 114.79 -162.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -177.66 174.63 47.05 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 126.566 2.032 . . . . 0.0 111.28 -175.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.0 mt -76.5 123.36 25.92 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.748 1.219 . . . . 0.0 110.376 174.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -155.09 159.46 40.25 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.007 1.323 . . . . 0.0 112.492 176.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -107.16 131.76 53.79 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.901 0.88 . . . . 0.0 112.367 -175.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 97.1 t -132.72 129.39 21.26 Favored Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 124.099 0.96 . . . . 0.0 110.829 175.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -62.21 144.65 95.87 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.741 2.294 . . . . 0.0 111.944 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.68 -31.57 26.38 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.32 -25.61 67.24 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 172.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -108.37 -2.85 18.79 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.924 1.69 . . . . 0.0 112.945 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 89.6 t -70.0 139.2 20.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 O-C-N 121.542 -0.724 . . . . 0.0 109.563 162.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.18 154.96 74.38 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 126.187 1.795 . . . . 0.0 110.113 -177.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.69 121.14 8.03 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.194 1.93 . . . . 0.0 110.641 -175.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.37 4.95 34.89 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.377 0.989 . . . . 0.0 114.609 -174.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -65.87 175.79 1.84 Allowed 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 118.897 1.349 . . . . 0.0 113.08 168.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.5 p -125.16 123.26 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 125.069 1.348 . . . . 0.0 111.945 -176.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 26.0 t -115.9 131.9 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 125.652 1.581 . . . . 0.0 111.923 -167.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.0 t -88.18 140.88 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 122.063 0.935 . . . . 0.0 111.659 -178.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -170.07 -144.35 4.27 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.906 1.717 . . . . 0.0 111.845 -176.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.3 p -150.49 163.88 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 126.722 2.009 . . . . 0.0 109.131 173.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -62.66 121.19 12.76 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.635 0.774 . . . . 0.0 111.887 169.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -67.9 -29.25 68.3 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -169.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -56.31 -33.97 66.08 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 172.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 23.8 t -75.03 -40.01 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.812 0.815 . . . . 0.0 110.202 176.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 23.1 tp -72.8 -29.85 63.6 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.086 0.954 . . . . 0.0 112.922 -177.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 90.7 mtt-85 -84.79 15.84 3.67 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.995 1.718 . . . . 0.0 112.394 172.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 19.6 mmm-85 60.1 9.73 1.96 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 128.595 2.758 . . . . 0.0 116.324 176.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -66.85 -22.22 66.0 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 119.626 1.103 . . . . 0.0 113.208 -178.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 14.3 tt -141.0 153.99 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 125.621 1.568 . . . . 0.0 110.099 170.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 30.5 pt -93.91 126.79 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.171 0.989 . . . . 0.0 111.822 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 2.0 t -167.06 122.74 1.11 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.769 1.627 . . . . 0.0 109.177 172.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -99.91 143.7 29.82 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.484 1.114 . . . . 0.0 113.474 -174.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 63.65 26.44 69.82 Favored Glycine 0 CA--C 1.535 1.328 0 N-CA-C 117.535 1.774 . . . . 0.0 117.535 168.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -109.62 165.31 11.77 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 119.891 1.845 . . . . 0.0 114.478 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 97.0 mt -138.92 176.94 8.26 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 128.404 2.682 . . . . 0.0 112.321 -178.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -155.63 159.76 39.88 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.963 2.105 . . . . 0.0 111.535 169.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -107.44 151.2 25.87 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.63 1.172 . . . . 0.0 113.0 169.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -135.69 136.79 41.17 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.037 1.335 . . . . 0.0 110.704 -167.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -85.08 134.14 34.2 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.507 -0.745 . . . . 0.0 111.878 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 70.3 t -73.89 126.17 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.167 0.587 . . . . 0.0 110.279 171.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.6 t -81.35 -49.56 10.54 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.146 1.778 . . . . 0.0 112.461 175.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.4 m -156.09 161.34 40.4 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.709 1.204 . . . . 0.0 110.633 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.5 m -134.14 144.35 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.077 0.951 . . . . 0.0 110.337 167.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -152.24 155.79 38.43 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 173.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 85.9 mt -86.81 139.95 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 167.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 21.9 pt -130.52 148.82 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 125.958 1.703 . . . . 0.0 110.94 174.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -86.64 89.72 8.02 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.391 -0.818 . . . . 0.0 109.825 177.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -71.87 -44.0 64.51 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -172.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 51.61 26.8 3.53 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 126.544 1.938 . . . . 0.0 114.832 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 -139.65 175.56 9.47 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.694 1.198 . . . . 0.0 111.662 -173.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -74.19 140.81 45.37 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 124.006 0.922 . . . . 0.0 112.617 177.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 15.0 m -122.68 154.95 27.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 126.131 1.772 . . . . 0.0 109.079 172.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.466 ' CG ' HG12 ' A' ' 21' ' ' ILE . 3.2 p90 -110.34 159.32 17.54 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.558 0.743 . . . . 0.0 112.217 -177.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -137.9 143.84 41.04 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 122.639 0.376 . . . . 0.0 110.356 158.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 60.4 tp -111.39 103.59 11.97 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.526 1.13 . . . . 0.0 110.223 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.0 t -81.05 122.95 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -158.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 24.2 mm -112.42 96.33 35.4 Favored Pre-proline 0 N--CA 1.469 0.513 0 C-N-CA 125.464 1.506 . . . . 0.0 110.035 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.38 -14.77 37.83 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.022 1.815 . . . . 0.0 113.553 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -73.16 -65.34 0.82 Allowed 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 119.145 0.884 . . . . 0.0 111.735 177.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 67.7 p -114.88 -10.72 12.3 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.296 1.439 . . . . 0.0 114.04 -171.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 59.06 18.86 6.71 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.46 1.504 . . . . 0.0 114.243 -167.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -146.63 145.66 30.14 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -175.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -146.46 163.76 34.66 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.62 1.568 . . . . 0.0 112.596 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.0 mp -102.14 134.94 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 O-C-N 121.261 -0.9 . . . . 0.0 111.715 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.32 154.24 54.14 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 124.956 1.302 . . . . 0.0 112.307 170.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.09 -17.05 54.34 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.705 2.937 . . . . 0.0 114.736 -173.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -73.07 -6.01 42.74 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 169.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 111.66 -20.87 22.07 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 126.359 1.933 . . . . 0.0 115.221 172.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 54.4 mt -81.92 145.51 30.28 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 120.1 1.95 . . . . 0.0 113.842 -166.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.5 t -89.26 123.87 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.954 0.902 . . . . 0.0 110.603 176.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 20.8 mt -115.73 137.93 51.61 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.644 1.578 . . . . 0.0 111.184 -174.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -101.16 145.26 29.02 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.149 0.979 . . . . 0.0 111.016 168.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -59.62 164.94 3.23 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.411 1.084 . . . . 0.0 112.06 170.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -127.26 14.18 7.2 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 116.678 2.103 . . . . 0.0 116.678 -175.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 . . . . . 0 N--CA 1.484 1.228 0 CA-C-N 121.108 1.776 . . . . 0.0 114.979 -176.758 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.58 159.9 41.19 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.867 1.667 . . . . 0.0 112.09 -168.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.27 146.48 39.21 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.177 1.391 . . . . 0.0 113.015 175.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.03 -22.72 64.83 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.098 1.359 . . . . 0.0 114.521 177.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -87.4 -2.54 58.69 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.7 m -65.02 134.87 54.82 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.902 0.881 . . . . 0.0 111.628 175.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -75.07 153.29 38.43 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.009 0.924 . . . . 0.0 112.882 172.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 p -145.56 158.96 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.287 1.035 . . . . 0.0 112.389 -174.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -127.82 133.52 49.41 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.018 1.727 . . . . 0.0 109.456 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -156.28 168.93 25.78 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 170.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -132.91 143.72 49.68 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.321 1.448 . . . . 0.0 111.52 -178.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -157.86 136.41 11.2 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.071 1.349 . . . . 0.0 109.566 175.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.5 t0 50.48 46.91 24.87 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.397 1.479 . . . . 0.0 113.972 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.7 m 61.86 42.4 10.47 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 176.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.1 p -155.05 140.51 12.46 Favored Pre-proline 0 CA--C 1.548 0.871 0 O-C-N 121.027 -1.046 . . . . 0.0 111.514 167.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -91.21 157.42 3.8 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 124.981 3.787 . . . . 0.0 114.802 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 33.1 m80 -136.74 138.17 40.68 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.63 1.972 . . . . 0.0 110.553 -173.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 41.6 ttm -144.64 107.82 4.55 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.666 0.787 . . . . 0.0 111.809 176.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -156.8 -179.97 8.71 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.287 1.435 . . . . 0.0 111.746 -174.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.3 m -67.34 136.81 55.39 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.376 -0.828 . . . . 0.0 110.023 171.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.451 HG12 ' CG ' ' A' ' 152' ' ' TYR . 7.8 tp -54.85 -36.53 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 121.173 -0.954 . . . . 0.0 112.924 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -62.36 -17.96 60.29 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -82.24 -54.44 5.25 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.3 1.44 . . . . 0.0 110.37 174.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -65.26 -32.63 74.39 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.63 -0.669 . . . . 0.0 112.013 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -60.4 -51.12 70.83 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.33 0.652 . . . . 0.0 111.454 169.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.0 t -61.23 -38.07 85.31 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.667 0.787 . . . . 0.0 111.001 -177.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -62.71 -52.72 62.16 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 125.328 1.451 . . . . 0.0 110.845 174.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -72.17 -32.68 67.07 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.199 -0.938 . . . . 0.0 113.2 -176.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.46 -31.22 68.28 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.971 0.908 . . . . 0.0 112.547 174.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.8 t -78.6 -20.65 50.0 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.969 1.308 . . . . 0.0 112.322 176.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 46.4 mtm -96.62 -58.61 2.01 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.913 1.685 . . . . 0.0 113.601 177.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -100.0 -15.14 18.38 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.427 1.491 . . . . 0.0 113.611 -170.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 87.49 162.89 38.37 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 124.433 1.016 . . . . 0.0 114.515 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -110.65 134.45 52.42 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.976 1.311 . . . . 0.0 110.017 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.7 mp -120.75 148.34 48.06 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 125.531 1.532 . . . . 0.0 111.522 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.05 150.6 60.64 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.841 3.028 . . . . 0.0 112.762 -177.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -134.05 168.0 19.61 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.422 1.489 . . . . 0.0 111.653 177.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.19 -50.58 37.41 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.066 1.347 . . . . 0.0 113.886 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -111.44 -2.51 15.54 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.802 1.641 . . . . 0.0 114.18 -175.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.04 -137.16 2.37 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 121.423 -0.798 . . . . 0.0 114.116 -173.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -136.0 161.12 36.55 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.311 1.845 . . . . 0.0 111.516 176.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.95 158.06 44.48 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.323 1.049 . . . . 0.0 112.168 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 84.6 t -126.64 117.01 22.71 Favored Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 125.919 1.688 . . . . 0.0 109.904 176.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.0 130.76 17.11 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 123.993 3.129 . . . . 0.0 112.617 -174.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 89.4 mt -102.05 162.2 13.09 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.179 0.992 . . . . 0.0 113.294 176.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -144.86 124.83 13.51 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.225 1.01 . . . . 0.0 112.235 173.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 47.82 52.56 12.64 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.652 1.581 . . . . 0.0 112.777 -174.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.9 t -113.46 132.87 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 125.059 1.344 . . . . 0.0 110.079 175.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -132.26 151.18 51.95 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.499 1.12 . . . . 0.0 112.899 -166.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.6 m -140.41 153.53 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 126.24 1.816 . . . . 0.0 111.912 177.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -68.13 132.05 46.51 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.134 0.974 . . . . 0.0 109.948 168.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.5 t -134.33 153.56 51.82 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.762 2.025 . . . . 0.0 111.175 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 49.0 tp -103.05 129.33 49.81 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.25 1.02 . . . . 0.0 109.637 175.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -77.23 97.56 4.85 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.678 0.791 . . . . 0.0 109.157 173.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 30.5 mm -59.25 -25.68 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 O-C-N 120.877 -1.14 . . . . 0.0 112.907 -170.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.49 -39.73 31.4 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -176.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.3 m -110.99 -6.36 14.68 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.23 1.012 . . . . 0.0 113.214 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.82 29.24 74.66 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.558 1.551 . . . . 0.0 113.649 177.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -96.37 139.28 32.72 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.772 1.629 . . . . 0.0 112.142 -178.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 mp -80.26 130.03 36.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 125.552 1.541 . . . . 0.0 108.974 173.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -151.6 169.11 22.92 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.976 1.71 . . . . 0.0 111.278 -177.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -100.06 147.67 25.39 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.536 1.134 . . . . 0.0 110.552 170.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.3 t -142.0 168.73 19.05 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.817 0.847 . . . . 0.0 112.085 173.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 -102.01 145.95 28.58 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.492 1.117 . . . . 0.0 113.535 -174.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -108.07 139.18 43.1 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.236 1.414 . . . . 0.0 111.228 178.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.86 -47.02 7.85 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.565 0.746 . . . . 0.0 112.733 -170.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -153.58 156.89 38.85 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.998 1.319 . . . . 0.0 110.834 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.7 mt -86.17 154.39 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 163.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -138.87 151.15 46.74 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.464 1.505 . . . . 0.0 112.264 -175.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -144.63 152.78 40.98 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.003 1.321 . . . . 0.0 113.301 170.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -155.25 160.25 40.67 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.014 1.326 . . . . 0.0 110.586 173.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp -87.78 143.71 27.0 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.278 1.431 . . . . 0.0 111.546 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.5 m -147.13 146.0 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 124.983 1.313 . . . . 0.0 111.556 176.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -95.31 -34.27 12.23 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.539 1.536 . . . . 0.0 111.596 170.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -113.16 119.24 37.12 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.377 1.471 . . . . 0.0 109.421 -169.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.0 tp -133.99 162.09 33.03 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.379 1.472 . . . . 0.0 109.524 -178.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.5 mt -120.5 129.3 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.351 1.061 . . . . 0.0 108.742 177.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -99.28 125.68 44.95 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.346 0.658 . . . . 0.0 110.798 168.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -109.81 127.56 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.821 1.248 . . . . 0.0 109.471 170.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -94.16 146.38 24.03 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.443 1.497 . . . . 0.0 110.92 171.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 49.2 mt -112.73 162.16 16.06 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.597 1.559 . . . . 0.0 111.95 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.0 t -63.74 -16.09 60.26 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.917 1.287 . . . . 0.0 113.3 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 77.9 p -77.89 -9.74 59.22 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.249 2.22 . . . . 0.0 115.167 170.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 83.65 0.69 89.98 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.957 1.265 . . . . 0.0 114.869 -171.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -77.42 148.47 35.44 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.773 1.229 . . . . 0.0 110.635 175.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 93.3 p -122.66 143.26 49.89 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.457 1.103 . . . . 0.0 112.689 173.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.5 tp -127.53 132.13 49.96 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.973 1.709 . . . . 0.0 110.528 178.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.0 mtpt -118.31 115.72 25.28 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.036 1.334 . . . . 0.0 111.751 -171.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.5 m -143.93 154.5 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.131 1.372 . . . . 0.0 113.665 -164.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 21.3 p -66.77 147.96 98.9 Favored Pre-proline 0 N--CA 1.471 0.615 0 O-C-N 121.163 -0.96 . . . . 0.0 112.397 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -57.82 -29.01 84.59 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.199 2.599 . . . . 0.0 113.086 -177.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.2 p -71.83 -20.96 61.75 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.457 2.303 . . . . 0.0 115.782 176.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -71.62 119.65 75.3 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.254 1.022 . . . . 0.0 112.052 -168.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -75.68 129.0 11.37 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.713 2.276 . . . . 0.0 112.341 175.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.0 t -108.95 144.44 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 126.112 1.765 . . . . 0.0 109.113 176.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.21 104.95 12.03 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.141 0.496 . . . . 0.0 109.992 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.7 mp -104.22 160.99 14.42 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.692 1.597 . . . . 0.0 111.541 -178.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -112.38 119.21 37.47 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 176.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.8 mtp-105 -136.89 81.78 1.9 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.098 0.959 . . . . 0.0 110.448 161.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 58.62 10.3 1.38 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.694 1.998 . . . . 0.0 115.515 -170.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 177.67 163.25 29.16 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.892 1.234 . . . . 0.0 113.22 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 46.0 mt -64.01 116.53 5.96 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.725 1.61 . . . . 0.0 111.612 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -144.62 144.46 31.28 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 178.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -95.27 129.82 42.26 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.139 0.976 . . . . 0.0 110.79 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.8 t -133.66 127.96 19.75 Favored Pre-proline 0 N--CA 1.476 0.848 0 C-N-CA 123.891 0.876 . . . . 0.0 110.438 -178.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -65.58 141.04 65.17 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.326 2.017 . . . . 0.0 111.084 177.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.99 -30.4 14.99 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 176.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.04 -17.89 63.81 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 174.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -108.5 -14.83 14.57 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.098 1.359 . . . . 0.0 112.793 175.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 87.2 t -63.47 140.78 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.823 1.249 . . . . 0.0 110.434 173.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.86 153.56 78.77 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 125.93 1.692 . . . . 0.0 110.866 -174.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.435 ' HD3' HG22 ' A' ' 142' ' ' VAL . 50.8 Cg_endo -68.86 116.1 4.29 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.644 2.229 . . . . 0.0 111.543 -169.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 115.29 0.36 22.2 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 124.416 1.008 . . . . 0.0 115.1 -176.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -63.4 156.74 25.07 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 118.583 1.191 . . . . 0.0 111.351 169.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.6 t -97.56 132.32 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 124.539 1.135 . . . . 0.0 110.875 173.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.2 t -106.63 143.5 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 127.308 2.243 . . . . 0.0 110.285 176.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.5 t -95.44 140.85 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.274 1.029 . . . . 0.0 111.153 176.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -165.65 -150.87 6.43 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.551 1.072 . . . . 0.0 112.887 176.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.6 p -134.29 163.0 38.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 127.676 2.39 . . . . 0.0 108.258 173.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 38.9 mtt180 -50.99 119.14 3.67 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.623 1.169 . . . . 0.0 109.894 172.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -60.3 -26.27 66.39 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 118.664 0.665 . . . . 0.0 112.415 -176.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -68.79 -27.21 65.67 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 172.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.11 -27.55 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-N 120.941 1.7 . . . . 0.0 111.828 -176.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 70.5 mt -84.85 -18.48 34.71 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.316 1.446 . . . . 0.0 112.933 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 44.5 ttt180 -116.97 -25.47 7.21 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 -170.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -87.88 155.99 19.59 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.666 1.186 . . . . 0.0 111.77 176.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 58.9 ttt-85 -63.31 -28.96 70.36 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.184 1.393 . . . . 0.0 113.138 174.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 70.8 mt -78.7 120.63 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.371 1.069 . . . . 0.0 109.077 169.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 21.3 tt -124.39 152.76 30.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 125.698 1.599 . . . . 0.0 111.457 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 33.8 t -140.81 161.58 37.47 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.075 1.75 . . . . 0.0 111.282 -178.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.8 ptpt -125.02 149.44 47.76 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.416 1.886 . . . . 0.0 113.221 -176.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 73.25 20.02 79.8 Favored Glycine 0 CA--C 1.537 1.41 0 N-CA-C 115.304 0.882 . . . . 0.0 115.304 175.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -116.22 147.42 41.47 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.481 1.513 . . . . 0.0 111.608 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 80.3 mt -137.64 161.81 35.47 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.972 1.709 . . . . 0.0 111.161 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -144.08 130.32 19.72 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.726 1.21 . . . . 0.0 113.306 -177.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -79.66 144.38 33.79 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.226 1.41 . . . . 0.0 112.099 175.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -134.05 141.46 47.2 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.068 1.347 . . . . 0.0 110.631 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -102.65 139.25 38.48 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.126 -0.984 . . . . 0.0 112.855 -175.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 78.6 t -76.11 134.71 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.912 0.885 . . . . 0.0 111.491 175.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.9 t -99.06 -39.13 8.67 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.873 2.069 . . . . 0.0 113.525 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 26.2 t -157.41 160.32 38.27 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.58 1.152 . . . . 0.0 110.918 175.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.435 HG22 ' HD3' ' A' ' 112' ' ' PRO . 3.4 m -136.51 147.79 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.599 1.159 . . . . 0.0 110.028 164.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 31.7 ptt-85 -158.41 159.58 35.92 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 162.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 45.6 mt -85.03 134.29 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.065 0.946 . . . . 0.0 108.685 173.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 19.0 pt -126.99 156.27 38.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 125.396 1.478 . . . . 0.0 112.524 -177.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.94 96.79 10.84 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.749 1.22 . . . . 0.0 111.737 173.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -78.46 -53.12 7.59 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.232 -0.917 . . . . 0.0 112.316 176.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 46.53 47.94 14.19 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.513 1.525 . . . . 0.0 112.434 -172.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -151.97 178.52 9.35 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.702 0.801 . . . . 0.0 112.732 -176.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -80.01 139.27 37.04 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.708 1.203 . . . . 0.0 113.042 177.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.5 m -121.25 160.63 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.526 1.93 . . . . 0.0 110.084 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.451 ' CG ' HG12 ' A' ' 21' ' ' ILE . 0.7 OUTLIER -113.78 161.83 17.06 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.988 0.915 . . . . 0.0 112.87 -178.357 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -144.03 163.37 33.7 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.571 0.748 . . . . 0.0 111.156 154.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 46.4 tp -115.17 122.93 47.56 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.277 1.431 . . . . 0.0 109.927 172.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 58.6 t -87.52 121.88 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 O-C-N 121.276 -0.89 . . . . 0.0 111.919 -171.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 20.5 mm -119.56 89.95 41.92 Favored Pre-proline 0 N--CA 1.47 0.531 0 C-N-CA 125.836 1.655 . . . . 0.0 109.371 -177.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -66.21 -23.19 52.72 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.331 2.02 . . . . 0.0 112.524 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 -81.76 -29.57 32.75 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -171.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 69.1 p -140.5 -22.33 0.82 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -177.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 65.33 15.86 10.24 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 127.113 2.165 . . . . 0.0 115.507 -171.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.49 150.52 26.67 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 120.735 -1.228 . . . . 0.0 114.144 -177.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -150.92 170.38 19.45 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.102 1.361 . . . . 0.0 113.09 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.1 mp -106.98 137.42 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.648 1.179 . . . . 0.0 111.937 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.91 157.99 50.9 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.684 1.194 . . . . 0.0 113.097 173.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -66.06 -18.07 56.14 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.302 2.668 . . . . 0.0 113.989 -175.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -83.83 6.07 22.77 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 171.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 107.04 -23.69 26.83 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 126.106 1.813 . . . . 0.0 116.954 165.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 75.2 mt -83.3 151.42 25.6 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 120.252 2.026 . . . . 0.0 114.46 -169.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.0 t -93.83 129.0 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.657 1.183 . . . . 0.0 111.93 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 25.5 mt -119.69 141.74 49.11 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.77 2.028 . . . . 0.0 111.552 -170.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -102.36 134.83 45.02 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 119.206 0.912 . . . . 0.0 112.681 171.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -92.16 81.06 5.02 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.43 1.092 . . . . 0.0 111.733 -169.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -145.21 152.82 40.59 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.854 1.662 . . . . 0.0 112.869 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 8.5 mp0 . . . . . 0 C--O 1.252 1.212 0 C-N-CA 125.887 1.675 . . . . 0.0 113.287 -177.798 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -142.58 163.64 32.27 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.082 1.353 . . . . 0.0 112.389 -167.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.13 146.05 48.85 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.629 1.572 . . . . 0.0 112.821 175.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.6 ppt_? -63.48 -21.49 66.34 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 176.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -83.79 0.36 47.69 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 176.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.6 m -66.45 147.7 52.92 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.613 1.165 . . . . 0.0 113.112 174.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -88.62 156.28 19.13 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.844 1.657 . . . . 0.0 114.423 175.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.425 HG11 ' SD ' ' A' ' 24' ' ' MET . 3.5 p -145.82 150.66 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.948 0.899 . . . . 0.0 113.217 -172.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -128.42 121.98 30.29 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.788 2.035 . . . . 0.0 107.679 175.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -139.74 174.44 10.51 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.209 1.004 . . . . 0.0 111.422 173.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -131.23 134.46 46.46 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.053 -1.029 . . . . 0.0 111.393 170.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -159.33 166.53 30.97 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.483 1.913 . . . . 0.0 108.257 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.0 t70 55.5 22.42 5.09 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 120.083 1.311 . . . . 0.0 113.093 -167.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.2 m 56.84 36.17 27.34 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.646 1.978 . . . . 0.0 114.185 -170.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.2 p -152.82 143.77 15.89 Favored Pre-proline 0 CA--C 1.547 0.85 0 O-C-N 120.534 -1.354 . . . . 0.0 112.141 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -70.03 140.98 42.94 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.74 2.96 . . . . 0.0 113.622 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -129.16 137.05 50.94 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 127.519 2.328 . . . . 0.0 110.339 -178.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 45.4 mtp -143.76 119.2 10.3 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.266 1.426 . . . . 0.0 112.093 -174.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -164.43 -173.51 3.1 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.617 1.567 . . . . 0.0 112.709 -172.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 65.4 m -74.53 141.57 44.83 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.089 -1.007 . . . . 0.0 111.127 167.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.451 HG12 ' CG ' ' A' ' 152' ' ' TYR . 7.4 tp -57.53 -38.21 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 121.256 -0.903 . . . . 0.0 112.857 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -60.92 -28.41 68.91 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.733 0.697 . . . . 0.0 111.913 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -80.49 -43.91 20.04 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 124.135 0.974 . . . . 0.0 110.974 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.425 ' SD ' HG11 ' A' ' 8' ' ' VAL . 12.9 ptm -65.19 -35.14 80.16 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.322 0.964 . . . . 0.0 111.625 173.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -60.83 -48.48 81.62 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.356 0.662 . . . . 0.0 110.557 173.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.1 t -59.78 -39.55 85.27 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.815 1.246 . . . . 0.0 111.39 177.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.3 ttmm -61.31 -56.73 17.21 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.414 1.486 . . . . 0.0 110.793 174.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -74.6 -33.05 62.53 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.108 -0.995 . . . . 0.0 112.564 -172.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.63 -19.91 62.78 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.975 0.91 . . . . 0.0 112.522 172.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 51.0 m -90.02 -18.98 24.97 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.252 1.421 . . . . 0.0 113.678 171.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 72.0 mtm -98.27 -44.91 6.38 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.893 1.277 . . . . 0.0 113.334 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -112.11 -23.77 10.26 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.592 1.557 . . . . 0.0 112.962 -169.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.32 162.98 38.97 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.693 1.616 . . . . 0.0 114.172 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -107.53 133.78 51.5 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.256 1.022 . . . . 0.0 110.94 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.3 mp -118.51 150.83 48.78 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 126.921 2.088 . . . . 0.0 110.936 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -75.53 148.03 32.76 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.693 2.929 . . . . 0.0 112.429 177.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -131.21 169.3 16.13 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.518 1.927 . . . . 0.0 111.595 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.58 -56.34 7.36 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.569 1.548 . . . . 0.0 114.613 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -105.33 -6.57 19.51 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -168.37 -137.84 2.33 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 123.716 0.674 . . . . 0.0 113.918 -170.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -131.84 155.89 47.02 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.51 1.524 . . . . 0.0 111.498 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.31 148.77 41.88 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.041 0.936 . . . . 0.0 112.214 -177.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 84.2 t -118.38 111.14 38.49 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 125.593 1.557 . . . . 0.0 109.476 176.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.58 140.23 51.25 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 124.569 3.513 . . . . 0.0 111.231 -177.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.5 mt -107.5 163.42 13.08 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.153 0.981 . . . . 0.0 113.528 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -137.63 116.34 12.2 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 127.58 2.352 . . . . 0.0 110.238 176.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 52.69 38.66 26.76 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 126.83 2.052 . . . . 0.0 115.133 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.6 t -99.92 133.71 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.18 1.392 . . . . 0.0 110.857 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -127.95 159.88 33.6 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.275 1.83 . . . . 0.0 113.319 -175.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.8 m -138.32 161.2 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 127.257 2.223 . . . . 0.0 111.593 174.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.464 ' CE1' HG23 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -76.38 131.05 38.9 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 122.02 0.914 . . . . 0.0 108.933 163.115 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.8 t -132.32 151.25 51.93 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.116 1.766 . . . . 0.0 111.054 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.6 tp -109.51 136.29 49.15 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.574 1.15 . . . . 0.0 109.546 174.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -85.38 115.9 23.39 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 118.57 -0.729 . . . . 0.0 109.762 160.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.2 mm -66.36 -28.5 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 119.685 1.129 . . . . 0.0 112.331 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.43 -47.86 31.09 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -168.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 64.3 m -96.06 -17.77 20.68 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.247 -0.908 . . . . 0.0 112.075 169.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.84 32.37 33.11 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.552 1.072 . . . . 0.0 112.856 -176.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -88.35 119.79 29.1 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 118.246 1.023 . . . . 0.0 111.865 -172.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.464 HG23 ' CE1' ' A' ' 51' ' ' TYR . 3.2 mp -72.98 125.64 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 167.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -152.15 175.39 12.63 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.658 1.183 . . . . 0.0 112.178 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -99.1 148.76 23.72 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.363 1.465 . . . . 0.0 110.601 172.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.7 t -143.93 158.72 43.51 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 118.547 0.612 . . . . 0.0 111.554 165.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.7 ptt85 -67.21 156.04 37.29 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.862 0.865 . . . . 0.0 112.576 170.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -112.99 138.34 50.02 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.704 0.802 . . . . 0.0 110.198 160.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.9 t -88.71 -47.62 8.11 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.282 1.033 . . . . 0.0 112.697 -167.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -154.46 156.59 37.02 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.141 1.776 . . . . 0.0 111.549 173.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.4 mt -86.01 153.35 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 165.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -133.93 148.14 51.17 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.43 1.492 . . . . 0.0 112.113 -172.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -142.77 149.08 38.21 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 165.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -146.13 162.5 37.84 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.937 1.695 . . . . 0.0 110.23 171.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.51 147.26 23.14 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.75 0.82 . . . . 0.0 112.965 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.5 m -149.05 145.96 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.505 1.522 . . . . 0.0 111.653 177.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -93.54 -31.13 14.66 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.823 1.249 . . . . 0.0 112.395 173.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -128.0 137.11 52.09 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 122.147 0.975 . . . . 0.0 112.648 -176.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.4 tp -137.79 165.45 26.43 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.715 2.006 . . . . 0.0 110.333 -174.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.6 mt -119.15 127.82 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.555 1.142 . . . . 0.0 109.532 175.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -95.25 124.52 39.34 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.809 0.843 . . . . 0.0 111.293 163.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -106.62 127.77 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 125.574 1.55 . . . . 0.0 108.835 168.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -96.59 145.77 25.44 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.075 1.35 . . . . 0.0 111.075 173.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 81.8 mt -104.92 162.29 13.46 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.538 1.935 . . . . 0.0 111.59 -178.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.3 t -60.03 -28.86 68.1 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.346 1.458 . . . . 0.0 111.915 177.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 97.3 p -63.27 -12.81 31.9 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.707 1.603 . . . . 0.0 114.646 169.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.1 2.47 89.39 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.695 1.616 . . . . 0.0 114.06 -170.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -88.86 173.26 8.62 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.494 1.518 . . . . 0.0 111.891 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 86.8 p -143.0 148.82 37.41 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 -171.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 61.3 tp -120.7 131.65 54.66 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 127.577 2.351 . . . . 0.0 109.787 174.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -122.89 113.24 18.86 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.15 1.38 . . . . 0.0 111.697 -176.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.9 m -145.06 155.46 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 125.081 1.353 . . . . 0.0 113.286 -163.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.2 p -68.08 147.05 98.39 Favored Pre-proline 0 N--CA 1.473 0.709 0 O-C-N 121.404 -0.81 . . . . 0.0 112.417 176.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -60.79 -33.99 92.17 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.775 2.317 . . . . 0.0 113.265 -170.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.4 p -78.83 -7.48 57.91 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.829 1.651 . . . . 0.0 114.946 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -86.99 124.75 68.31 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.373 1.069 . . . . 0.0 113.353 -168.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -72.66 143.55 37.98 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.337 2.691 . . . . 0.0 115.479 -178.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.7 t -122.77 146.87 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 126.777 2.031 . . . . 0.0 109.693 174.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 31.0 tp -84.68 114.6 22.14 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.285 0.634 . . . . 0.0 111.358 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.7 mp -113.87 153.66 28.82 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.285 1.834 . . . . 0.0 112.686 -172.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -103.34 101.63 11.55 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.804 1.641 . . . . 0.0 110.733 171.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 76.5 mtt-85 -136.17 74.14 1.49 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.535 1.134 . . . . 0.0 110.722 173.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 61.7 2.4 0.71 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 126.486 1.914 . . . . 0.0 115.748 -167.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -176.3 167.89 39.73 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.456 1.503 . . . . 0.0 112.115 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 75.6 mt -81.96 108.58 15.58 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.132 1.373 . . . . 0.0 110.727 -178.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -140.71 144.02 35.36 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.527 0.731 . . . . 0.0 112.765 -168.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -96.57 120.59 37.17 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.673 1.189 . . . . 0.0 111.118 -176.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 62.1 t -130.08 131.99 23.81 Favored Pre-proline 0 N--CA 1.482 1.162 0 C-N-CA 124.777 1.231 . . . . 0.0 110.43 -176.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -67.42 146.99 76.62 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.344 2.696 . . . . 0.0 112.257 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.41 -31.71 23.74 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 176.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.8 -23.39 66.69 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 173.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -104.35 0.89 29.63 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.02 1.728 . . . . 0.0 112.053 174.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 84.0 t -74.88 141.37 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 O-C-N 120.796 -1.19 . . . . 0.0 109.773 167.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.52 154.39 81.63 Favored Pre-proline 0 N--CA 1.472 0.649 0 C-N-CA 127.334 2.254 . . . . 0.0 110.436 -176.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.417 ' HD3' HG22 ' A' ' 142' ' ' VAL . 59.6 Cg_endo -66.27 115.03 3.27 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 121.664 1.576 . . . . 0.0 109.613 177.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.37 3.41 24.18 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.745 1.164 . . . . 0.0 115.542 -177.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -60.13 161.89 6.42 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 118.65 1.225 . . . . 0.0 111.85 161.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 24.5 t -118.22 128.7 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.5 1.52 . . . . 0.0 110.225 174.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.0 t -104.09 145.11 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 127.16 2.184 . . . . 0.0 110.606 -175.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 43.7 t -87.77 137.76 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.376 1.07 . . . . 0.0 111.112 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -167.32 -146.65 4.97 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 115.262 0.865 . . . . 0.0 115.262 179.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.8 p -155.75 165.04 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 126.658 1.983 . . . . 0.0 108.639 176.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -56.77 126.66 27.89 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.871 1.268 . . . . 0.0 111.773 176.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -60.83 -38.07 84.19 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.966 0.906 . . . . 0.0 111.361 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -67.04 -28.67 68.41 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 28.3 t -71.93 -31.03 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 O-C-N 121.329 -0.857 . . . . 0.0 110.552 177.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 25.6 mt -78.18 -16.53 57.81 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.519 1.128 . . . . 0.0 113.304 169.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.87 -24.65 35.62 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 172.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 57.7 ttt85 -61.78 136.77 58.12 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.971 0.908 . . . . 0.0 109.388 170.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 84.0 mtt85 -69.72 -25.66 63.96 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -175.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 96.6 mt -88.61 126.35 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.311 1.445 . . . . 0.0 108.737 157.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 96.3 mt -102.91 112.1 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.877 0.871 . . . . 0.0 109.568 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 31.2 t -66.28 134.87 53.53 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -173.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -96.76 139.58 32.6 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.168 1.387 . . . . 0.0 112.419 175.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.26 19.22 55.85 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 125.154 1.359 . . . . 0.0 114.8 177.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -123.8 136.36 54.35 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.983 1.713 . . . . 0.0 111.529 176.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 85.8 mt -149.0 151.46 34.59 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.767 2.027 . . . . 0.0 112.561 -174.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -136.5 171.63 14.2 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.208 1.803 . . . . 0.0 111.386 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -131.01 157.06 44.03 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 120.631 -1.293 . . . . 0.0 112.724 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -138.34 123.83 19.56 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.576 1.15 . . . . 0.0 110.2 -167.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -84.67 145.63 27.88 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.952 -1.092 . . . . 0.0 112.307 -178.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.5 t -77.55 133.1 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.285 1.034 . . . . 0.0 111.699 175.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 26.9 t -87.16 -46.31 9.87 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.625 1.97 . . . . 0.0 112.405 171.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 29.6 t -157.26 160.72 38.91 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.42 0.688 . . . . 0.0 111.788 -173.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.417 HG22 ' HD3' ' A' ' 112' ' ' PRO . 4.0 m -135.36 145.73 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.285 1.034 . . . . 0.0 111.61 167.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -152.73 151.23 30.28 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.551 1.14 . . . . 0.0 113.344 172.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 75.4 mt -89.0 138.86 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.953 1.301 . . . . 0.0 109.051 169.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 44.9 pt -131.65 146.62 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.936 1.694 . . . . 0.0 111.62 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -80.07 104.92 10.96 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.668 -0.645 . . . . 0.0 109.549 165.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -81.62 -49.01 11.01 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.077 -1.015 . . . . 0.0 113.518 174.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 44.33 52.71 7.16 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.069 1.348 . . . . 0.0 111.989 -173.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -150.02 176.85 10.41 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.808 0.843 . . . . 0.0 111.97 -177.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -75.52 146.94 40.15 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.565 -0.709 . . . . 0.0 111.638 168.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 6.8 m -126.23 158.22 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.799 1.64 . . . . 0.0 109.47 172.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.451 ' CG ' HG12 ' A' ' 21' ' ' ILE . 0.6 OUTLIER -110.89 160.75 16.49 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.294 0.637 . . . . 0.0 112.577 -175.753 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -141.91 163.17 33.63 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.914 0.886 . . . . 0.0 110.22 157.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 54.8 tp -123.98 123.92 41.44 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.502 -1.374 . . . . 0.0 110.235 176.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 42.4 t -90.6 122.13 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -165.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 42.1 mm -124.1 84.31 55.39 Favored Pre-proline 0 N--CA 1.47 0.539 0 C-N-CA 126.196 1.798 . . . . 0.0 108.832 -172.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -66.83 -17.57 52.09 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.759 2.306 . . . . 0.0 113.752 -176.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -83.8 -32.78 25.16 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -174.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 80.9 p -140.74 -12.46 0.99 Allowed 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 -174.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 60.6 m80 56.23 26.23 10.15 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 -173.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.31 148.23 25.59 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 120.557 -1.34 . . . . 0.0 113.21 178.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -148.8 163.34 37.67 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.914 1.286 . . . . 0.0 112.211 -178.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.5 mp -112.67 137.73 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.864 0.866 . . . . 0.0 111.973 -176.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.89 157.34 51.77 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 125.38 1.472 . . . . 0.0 113.15 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.14 -17.87 50.78 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.549 2.833 . . . . 0.0 113.748 -176.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -74.58 -10.3 59.41 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 171.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 112.91 -24.66 12.6 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 125.743 1.64 . . . . 0.0 115.798 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.43 139.92 49.88 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.625 1.712 . . . . 0.0 113.799 -167.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 20.3 t -87.09 123.99 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.02 0.928 . . . . 0.0 110.958 173.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 33.5 mt -115.86 150.26 37.31 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.141 1.776 . . . . 0.0 111.709 -173.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -88.76 159.86 17.57 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.583 0.753 . . . . 0.0 110.79 170.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -98.26 118.47 34.97 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.141 -0.974 . . . . 0.0 109.601 163.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 52.36 -127.4 2.43 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.376 1.471 . . . . 0.0 112.857 -177.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 15.0 tm0? . . . . . 0 C--O 1.255 1.356 0 C-N-CA 126.1 1.76 . . . . 0.0 110.891 177.958 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -139.72 163.32 32.91 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.636 1.974 . . . . 0.0 111.082 -172.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.03 146.16 51.04 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.86 1.264 . . . . 0.0 113.383 -177.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -62.91 -19.88 64.63 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.929 1.292 . . . . 0.0 113.426 174.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -75.55 -10.44 59.45 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.248 1.819 . . . . 0.0 112.953 176.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.8 m -70.96 144.39 50.55 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 121.142 -0.974 . . . . 0.0 113.316 -175.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -91.72 150.88 20.9 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.055 1.742 . . . . 0.0 113.305 176.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.3 p -148.74 156.3 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 124.202 1.001 . . . . 0.0 113.484 -167.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -136.95 125.99 24.41 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.522 1.929 . . . . 0.0 109.042 -174.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -150.86 175.49 11.97 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 119.741 1.155 . . . . 0.0 113.154 -177.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -130.07 144.56 51.41 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.111 1.365 . . . . 0.0 112.933 171.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -161.97 162.43 29.0 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.749 2.02 . . . . 0.0 109.666 168.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.5 t0 53.77 28.74 8.61 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.372 1.469 . . . . 0.0 114.292 -177.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.8 m 59.33 38.0 23.23 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.431 1.892 . . . . 0.0 114.571 -172.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.6 p -151.98 140.63 13.66 Favored Pre-proline 0 CA--C 1.544 0.728 0 O-C-N 120.501 -1.375 . . . . 0.0 112.609 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -72.1 151.03 55.07 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 123.336 2.69 . . . . 0.0 113.106 175.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -134.44 140.63 46.39 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.281 2.232 . . . . 0.0 110.708 -176.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 36.7 ttm -141.75 121.9 13.83 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.396 1.078 . . . . 0.0 110.776 179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -163.83 -177.01 4.88 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.487 1.515 . . . . 0.0 112.983 -179.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.6 m -77.04 144.26 38.74 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.005 -1.06 . . . . 0.0 110.146 167.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.447 HG12 ' CG ' ' A' ' 152' ' ' TYR . 9.3 tp -57.31 -38.22 60.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -61.43 -24.18 66.36 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -76.5 -51.06 12.45 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.909 1.283 . . . . 0.0 110.862 175.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 19.9 ptm -68.86 -32.69 72.54 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.753 -0.592 . . . . 0.0 112.361 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -59.84 -51.04 71.44 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.216 0.606 . . . . 0.0 110.701 173.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.0 t -66.54 -34.86 78.85 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.412 0.551 . . . . 0.0 111.264 -176.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -61.12 -54.45 44.42 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.124 1.37 . . . . 0.0 110.305 174.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -70.68 -36.42 73.31 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.367 -0.833 . . . . 0.0 112.763 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.4 -33.01 74.75 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.971 0.908 . . . . 0.0 112.337 176.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.1 t -75.9 -32.27 59.57 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.923 0.889 . . . . 0.0 112.463 176.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 37.9 mtm -85.62 -47.21 10.05 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.308 1.443 . . . . 0.0 113.728 -177.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 48.3 m-20 -109.97 -20.39 12.75 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.49 1.516 . . . . 0.0 113.455 -171.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.13 163.97 39.52 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 122.247 0.915 . . . . 0.0 114.603 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -110.4 133.24 53.46 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.278 1.831 . . . . 0.0 110.175 -178.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.2 mp -116.05 146.92 38.16 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 126.79 2.036 . . . . 0.0 111.691 -176.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.65 141.55 19.73 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 124.589 3.526 . . . . 0.0 114.29 -173.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -133.97 166.18 23.31 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.669 1.988 . . . . 0.0 111.839 -177.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.45 -52.67 35.89 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.719 1.208 . . . . 0.0 114.036 -177.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -105.87 -4.78 20.33 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -173.25 -132.75 1.57 Allowed Glycine 0 CA--C 1.529 0.92 0 O-C-N 120.758 -1.214 . . . . 0.0 115.335 -174.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -141.04 153.58 45.57 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.266 1.427 . . . . 0.0 112.658 -173.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -132.59 153.84 50.63 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.389 1.476 . . . . 0.0 112.18 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.2 t -125.08 118.33 25.46 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 125.393 1.477 . . . . 0.0 110.86 177.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.57 136.88 24.32 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 124.521 3.481 . . . . 0.0 112.331 -175.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 70.6 mt -104.17 166.58 10.32 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.413 1.085 . . . . 0.0 112.514 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -141.45 118.68 11.38 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.519 1.928 . . . . 0.0 109.703 177.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 51.31 51.63 16.48 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 126.031 1.732 . . . . 0.0 114.095 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.1 t -113.54 133.06 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.761 1.224 . . . . 0.0 112.021 -177.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -127.94 157.29 40.97 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.882 1.273 . . . . 0.0 113.755 -175.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.2 m -144.11 164.12 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 127.46 2.304 . . . . 0.0 111.634 177.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.486 ' CE1' HG23 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -82.94 133.71 35.1 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.681 1.192 . . . . 0.0 110.102 171.461 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.2 t -131.8 153.62 49.94 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 127.395 2.278 . . . . 0.0 112.104 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 32.9 tp -106.09 133.61 50.53 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.177 0.991 . . . . 0.0 110.973 169.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -90.42 95.6 10.25 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.549 1.539 . . . . 0.0 111.501 175.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.4 mm -61.12 -18.75 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 124.8 1.24 . . . . 0.0 113.43 -174.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.56 -37.13 84.31 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.615 1.566 . . . . 0.0 114.334 172.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.6 p -127.56 -26.82 2.94 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.778 1.231 . . . . 0.0 113.545 -167.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.13 29.1 65.11 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.905 1.241 . . . . 0.0 113.38 -167.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -77.54 125.04 28.72 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.312 1.056 . . . . 0.0 110.615 167.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.486 HG23 ' CE1' ' A' ' 51' ' ' TYR . 1.9 mp -79.71 123.9 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 165.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -148.71 167.78 24.64 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -173.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -92.93 145.13 24.61 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.271 1.428 . . . . 0.0 110.005 174.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.5 t -144.49 155.43 43.7 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.522 1.129 . . . . 0.0 111.65 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.56 137.55 32.24 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.92 143.94 29.56 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.526 1.13 . . . . 0.0 110.666 171.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.6 t -99.2 -50.17 4.23 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.636 1.174 . . . . 0.0 112.885 -170.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -154.41 157.74 38.96 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.246 1.018 . . . . 0.0 112.286 176.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.7 mt -84.42 150.18 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 165.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -138.6 150.76 46.63 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.351 1.46 . . . . 0.0 111.731 -175.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -143.18 154.4 43.83 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 168.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -143.06 166.01 25.82 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.868 1.667 . . . . 0.0 109.789 172.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.7 tmtp? -100.68 136.57 40.34 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.209 0.603 . . . . 0.0 111.062 178.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.6 m -142.76 144.69 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 122.614 1.197 . . . . 0.0 111.021 178.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -93.5 -33.96 13.57 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 125.228 1.411 . . . . 0.0 111.148 173.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -121.17 137.35 54.71 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 124.418 1.087 . . . . 0.0 110.34 -173.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.4 tp -141.53 159.97 41.11 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 125.386 1.474 . . . . 0.0 109.191 -175.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.5 mt -109.36 124.25 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 175.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -93.5 125.92 38.36 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.891 0.877 . . . . 0.0 110.169 166.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.2 mp -110.84 124.84 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 124.512 1.125 . . . . 0.0 108.372 168.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -92.31 144.52 25.3 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.826 1.25 . . . . 0.0 110.202 173.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 59.9 mt -103.58 155.67 18.37 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 126.659 1.984 . . . . 0.0 110.263 178.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.8 t -66.37 -20.54 66.1 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.175 0.99 . . . . 0.0 112.949 -176.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 86.8 p -63.02 -18.48 63.38 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.111 1.765 . . . . 0.0 114.184 165.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 99.78 -7.35 59.19 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 126.254 1.883 . . . . 0.0 114.523 -174.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -86.18 171.12 11.55 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.475 1.51 . . . . 0.0 111.573 -178.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 95.2 p -142.81 157.6 44.46 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -177.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 14.3 tp -128.59 138.88 52.44 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.918 1.687 . . . . 0.0 109.969 171.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -120.78 116.97 26.26 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.242 1.417 . . . . 0.0 111.54 -176.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.4 m -140.21 153.29 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.058 1.343 . . . . 0.0 112.566 -164.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.9 p -67.79 146.68 98.48 Favored Pre-proline 0 N--CA 1.469 0.476 0 O-C-N 121.125 -0.985 . . . . 0.0 111.832 172.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -58.68 -18.69 41.97 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 124.279 3.319 . . . . 0.0 114.702 -175.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.7 p -88.81 -8.44 54.36 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.242 1.817 . . . . 0.0 114.987 177.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -71.61 120.96 82.97 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 119.526 1.057 . . . . 0.0 111.589 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -79.17 122.74 5.34 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.152 2.568 . . . . 0.0 112.537 176.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 40.1 t -93.72 141.17 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.927 1.691 . . . . 0.0 110.04 177.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 32.7 tp -80.01 104.65 10.73 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.518 0.599 . . . . 0.0 111.091 176.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -92.69 157.65 16.35 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.474 1.51 . . . . 0.0 112.323 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -121.17 71.1 0.94 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.684 0.754 . . . . 0.0 111.203 -177.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 73.0 mtp85 -119.65 74.08 0.99 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.651 1.18 . . . . 0.0 110.888 -169.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 58.22 6.07 0.49 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 127.337 2.255 . . . . 0.0 115.212 -166.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -178.35 157.9 22.16 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 125.693 1.616 . . . . 0.0 112.437 -177.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 48.4 mt -76.25 115.16 15.72 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.82 0.848 . . . . 0.0 109.871 177.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -146.0 141.74 27.96 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.946 0.898 . . . . 0.0 111.859 -173.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -101.32 111.82 24.16 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.777 0.831 . . . . 0.0 110.857 -175.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 54.1 t -117.85 127.78 26.41 Favored Pre-proline 0 N--CA 1.478 0.952 0 C-N-CA 123.953 0.901 . . . . 0.0 109.646 -173.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -64.44 143.79 83.41 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.192 1.928 . . . . 0.0 111.123 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.23 -31.63 21.4 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 175.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.17 -14.88 62.58 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 174.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -114.16 3.35 15.17 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.444 1.497 . . . . 0.0 112.22 175.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.2 t -78.2 149.06 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 125.185 1.394 . . . . 0.0 110.169 168.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.64 156.8 79.18 Favored Pre-proline 0 N--CA 1.47 0.527 0 C-N-CA 128.409 2.684 . . . . 0.0 108.857 178.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.401 ' HD3' HG22 ' A' ' 142' ' ' VAL . 60.5 Cg_endo -67.81 138.9 46.15 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.098 1.865 . . . . 0.0 111.765 -177.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 102.5 -1.6 49.65 Favored Glycine 0 N--CA 1.47 0.923 0 C-N-CA 124.452 1.025 . . . . 0.0 115.418 175.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.67 177.68 8.71 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 118.526 1.163 . . . . 0.0 114.116 176.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.3 p -122.54 122.5 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -168.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.8 t -102.84 144.05 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 127.426 2.29 . . . . 0.0 110.877 -177.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.8 t -89.17 142.95 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.472 1.109 . . . . 0.0 111.563 175.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -160.87 -152.48 6.61 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.369 0.985 . . . . 0.0 113.879 177.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.9 p -141.39 157.66 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.938 1.695 . . . . 0.0 110.058 172.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -60.64 117.6 5.54 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.995 0.918 . . . . 0.0 111.052 176.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -66.46 -14.71 62.6 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -173.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -65.84 -40.26 91.57 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.86 0.864 . . . . 0.0 112.643 166.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 83.0 t -64.78 -34.31 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 121.042 -1.037 . . . . 0.0 111.005 -177.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 58.5 mt -75.13 -5.07 42.33 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -119.41 -15.01 9.13 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 115.807 1.781 . . . . 0.0 115.807 169.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 74.9 mtt180 -63.58 155.45 29.54 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.816 1.246 . . . . 0.0 112.454 175.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -79.59 -12.37 59.84 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 125.295 1.438 . . . . 0.0 114.355 -177.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.2 tt -115.94 148.22 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 125.133 1.373 . . . . 0.0 109.95 165.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 18.7 tt -140.22 129.55 27.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.095 0.958 . . . . 0.0 111.51 175.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.4 t -124.76 115.56 20.91 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.744 1.218 . . . . 0.0 111.094 -177.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -62.08 157.48 18.89 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.886 1.275 . . . . 0.0 112.895 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 91.58 21.34 34.63 Favored Glycine 0 CA--C 1.541 1.712 0 N-CA-C 116.276 1.27 . . . . 0.0 116.276 173.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -120.67 150.76 40.43 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.226 1.411 . . . . 0.0 112.579 169.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 89.7 mt -143.61 163.71 32.46 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.83 1.652 . . . . 0.0 113.15 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -131.94 171.87 13.04 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 128.214 2.605 . . . . 0.0 110.742 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -135.24 158.43 44.39 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.836 -1.165 . . . . 0.0 113.496 169.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -134.92 136.14 42.08 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.544 1.538 . . . . 0.0 109.975 -174.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -99.41 138.79 36.0 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.282 1.033 . . . . 0.0 112.019 -177.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 93.8 t -77.18 126.95 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 O-C-N 121.062 -1.024 . . . . 0.0 111.614 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 12.3 t -83.24 -44.7 14.68 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.559 1.944 . . . . 0.0 113.022 175.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 31.0 t -158.57 161.24 37.25 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.941 1.296 . . . . 0.0 110.039 -177.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.401 HG22 ' HD3' ' A' ' 112' ' ' PRO . 5.4 m -133.92 147.86 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.117 0.967 . . . . 0.0 110.306 166.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -154.87 154.58 32.91 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.417 0.687 . . . . 0.0 112.247 169.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 66.8 mt -86.06 135.01 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 165.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 23.6 pt -123.64 166.79 18.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 125.773 1.629 . . . . 0.0 111.305 -177.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -103.74 98.7 8.53 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.011 1.325 . . . . 0.0 110.975 175.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -80.47 -57.22 3.69 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.463 -0.773 . . . . 0.0 112.016 177.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 45.7 51.59 10.1 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.326 1.05 . . . . 0.0 112.135 -172.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -150.21 173.91 13.4 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.921 1.289 . . . . 0.0 111.651 174.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -71.06 136.76 48.47 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.06 0.944 . . . . 0.0 112.502 173.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.3 m -117.23 155.47 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 125.673 1.589 . . . . 0.0 110.093 174.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.447 ' CG ' HG12 ' A' ' 21' ' ' ILE . 0.7 OUTLIER -112.1 160.68 17.29 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -172.834 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -143.17 160.31 40.68 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.527 0.731 . . . . 0.0 110.34 156.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 56.0 tp -124.3 109.59 13.55 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.874 1.269 . . . . 0.0 110.106 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 85.8 t -83.79 123.54 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -159.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 11.6 mm -116.86 88.88 27.35 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.197 1.399 . . . . 0.0 110.33 -176.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -65.5 -16.44 53.96 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.871 2.381 . . . . 0.0 113.25 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -78.11 -45.51 23.18 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.016 -1.052 . . . . 0.0 113.19 178.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 76.8 p -140.54 -2.9 1.35 Allowed 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -171.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 42.0 m-70 59.23 7.09 0.82 Allowed 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -149.2 145.52 27.18 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 120.886 -1.134 . . . . 0.0 112.235 -175.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -146.23 151.5 37.68 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.759 1.224 . . . . 0.0 112.476 -176.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.9 mp -99.97 140.01 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.053 0.941 . . . . 0.0 111.789 -176.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -91.04 157.99 42.26 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 126.482 1.913 . . . . 0.0 112.949 176.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.99 -19.24 57.92 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.785 2.99 . . . . 0.0 113.487 -176.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -80.86 3.77 21.5 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.036 1.334 . . . . 0.0 113.682 174.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.89 -17.94 58.36 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 126.233 1.873 . . . . 0.0 116.029 175.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 54.8 mt -77.78 148.29 34.88 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.387 1.594 . . . . 0.0 112.899 -175.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.8 p -96.41 136.92 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.284 1.034 . . . . 0.0 112.394 174.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 40.5 mt -115.54 145.91 42.21 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 127.236 2.215 . . . . 0.0 110.155 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -134.43 130.0 36.13 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.802 1.241 . . . . 0.0 111.12 -174.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -58.41 122.54 13.56 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.707 0.803 . . . . 0.0 112.374 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -103.89 5.77 35.96 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 -174.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 . . . . . 0 C--O 1.253 1.267 0 C-N-CA 125.724 1.61 . . . . 0.0 111.439 -177.949 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 110.854 -0.054 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.44 159.0 43.19 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.36 1.464 . . . . 0.0 111.446 -168.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.22 147.74 46.91 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.879 0.872 . . . . 0.0 113.02 177.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -58.01 -23.9 56.01 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 174.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -82.96 0.54 44.1 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.3 m -72.74 142.46 48.15 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.356 -0.84 . . . . 0.0 112.407 176.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -79.89 158.61 26.65 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.08 -1.013 . . . . 0.0 113.38 169.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.6 p -147.98 157.13 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.887 0.875 . . . . 0.0 111.842 -174.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -126.51 135.84 51.83 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.358 1.863 . . . . 0.0 108.853 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -155.23 179.99 8.62 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.946 0.898 . . . . 0.0 112.057 174.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -135.31 143.21 46.06 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.732 1.213 . . . . 0.0 109.618 171.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -156.66 152.68 27.43 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.385 1.474 . . . . 0.0 109.221 178.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.1 t0 53.94 35.06 20.96 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.669 1.122 . . . . 0.0 113.304 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.0 m 53.8 37.61 26.75 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.736 1.615 . . . . 0.0 114.241 -172.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.3 p -148.7 138.57 12.81 Favored Pre-proline 0 CA--C 1.549 0.924 0 O-C-N 120.033 -1.667 . . . . 0.0 112.131 177.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.42 153.88 69.87 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.756 2.971 . . . . 0.0 113.187 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 47.0 m80 -138.78 138.91 38.04 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.189 2.196 . . . . 0.0 110.464 -175.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 40.1 ttm -152.96 114.67 4.29 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.536 1.134 . . . . 0.0 110.987 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -160.26 -179.49 7.77 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.976 1.31 . . . . 0.0 111.661 -175.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 m -67.43 138.3 56.54 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.065 -1.022 . . . . 0.0 110.135 169.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.9 tp -58.03 -36.44 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 121.256 -0.903 . . . . 0.0 112.269 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -61.72 -23.02 65.87 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.521 0.729 . . . . 0.0 112.909 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -83.4 -49.39 9.38 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.657 0.783 . . . . 0.0 110.014 177.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -66.02 -34.66 78.6 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.586 -0.696 . . . . 0.0 112.336 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -59.75 -51.81 68.16 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.769 0.828 . . . . 0.0 111.346 169.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.6 t -61.3 -36.13 79.24 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.514 0.726 . . . . 0.0 111.266 -178.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -63.46 -55.74 21.73 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.494 1.517 . . . . 0.0 111.206 172.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -72.15 -32.47 66.91 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 121.147 -0.971 . . . . 0.0 112.68 -173.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.43 -28.93 68.99 Favored 'General case' 0 CA--C 1.551 1.014 0 O-C-N 121.498 -0.752 . . . . 0.0 112.347 171.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.4 t -83.01 -25.64 31.98 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.841 1.256 . . . . 0.0 112.993 175.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 50.7 mtm -88.85 -48.19 7.65 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.859 1.263 . . . . 0.0 113.446 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 -110.55 -20.73 12.46 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.325 1.45 . . . . 0.0 113.681 -170.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.99 159.54 35.45 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.626 1.108 . . . . 0.0 114.853 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -103.36 131.02 50.78 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.772 1.229 . . . . 0.0 110.479 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.3 mp -110.12 142.57 26.21 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 126.447 1.899 . . . . 0.0 110.271 175.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.12 159.0 44.94 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.687 2.925 . . . . 0.0 111.366 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -140.13 173.07 11.88 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.239 1.415 . . . . 0.0 111.505 -176.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -55.31 -57.16 12.96 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.413 1.085 . . . . 0.0 113.014 176.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -105.08 -0.01 27.11 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -172.41 -128.44 1.05 Allowed Glycine 0 CA--C 1.536 1.379 0 N-CA-C 115.982 1.153 . . . . 0.0 115.982 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -137.51 161.29 36.79 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 126.623 1.969 . . . . 0.0 110.772 175.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.87 159.45 42.16 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.323 1.449 . . . . 0.0 112.148 177.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 98.1 t -128.48 117.89 20.05 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 125.972 1.709 . . . . 0.0 109.498 174.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.24 142.14 54.33 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 124.065 3.177 . . . . 0.0 111.456 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 74.3 mt -118.13 152.67 35.17 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.398 1.079 . . . . 0.0 112.855 175.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -137.42 125.23 22.51 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.385 1.874 . . . . 0.0 110.167 178.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 51.63 54.85 10.28 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.145 0.978 . . . . 0.0 112.286 -174.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.4 t -123.22 119.23 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 124.603 1.161 . . . . 0.0 109.632 173.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -113.16 158.94 19.79 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.577 1.551 . . . . 0.0 112.642 -176.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.0 m -140.64 152.25 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 126.113 1.765 . . . . 0.0 111.609 170.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -65.58 130.47 43.43 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.495 0.718 . . . . 0.0 109.139 163.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.0 t -133.48 148.07 51.7 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.514 1.926 . . . . 0.0 110.786 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 45.3 tp -99.53 140.17 34.11 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.768 0.827 . . . . 0.0 111.542 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -85.81 117.79 24.9 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.133 -0.979 . . . . 0.0 110.488 158.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.0 mm -74.45 -22.53 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 CA-C-N 119.084 0.856 . . . . 0.0 112.19 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.64 -33.52 64.56 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -173.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.2 m -121.45 -10.95 8.8 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.931 1.292 . . . . 0.0 112.919 169.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.51 39.46 56.42 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 -173.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -97.53 138.02 35.59 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.153 1.781 . . . . 0.0 111.715 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.1 mp -91.62 130.9 40.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 124.549 1.14 . . . . 0.0 109.669 -177.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -152.6 171.34 18.3 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.612 1.165 . . . . 0.0 111.509 -177.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -106.08 150.45 25.76 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.479 1.112 . . . . 0.0 111.242 176.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.8 t -139.58 153.11 47.33 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.466 1.106 . . . . 0.0 110.977 170.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 72.4 mtt85 -87.01 133.5 33.58 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.914 0.885 . . . . 0.0 110.303 172.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -87.12 149.64 24.54 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.196 0.998 . . . . 0.0 111.733 176.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.7 t -88.76 -54.19 4.27 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.834 1.254 . . . . 0.0 112.508 -169.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -157.63 160.03 37.63 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.672 1.589 . . . . 0.0 111.028 178.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.0 mt -84.8 150.42 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 162.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -139.76 152.42 46.59 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.529 1.531 . . . . 0.0 111.099 -176.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.8 ptt-85 -139.74 152.44 46.63 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.058 0.943 . . . . 0.0 113.321 166.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -146.41 168.93 19.93 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.811 2.045 . . . . 0.0 110.115 175.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -112.11 136.92 50.88 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 120.661 -1.274 . . . . 0.0 112.859 -170.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.2 m -144.51 142.04 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 122.796 1.284 . . . . 0.0 113.327 -176.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -97.63 -28.61 13.85 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 127.196 2.199 . . . . 0.0 111.745 178.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -120.85 127.92 52.35 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.606 1.562 . . . . 0.0 110.646 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.4 tp -136.95 161.26 36.53 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.469 1.508 . . . . 0.0 110.115 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.4 mt -117.7 126.0 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.356 1.062 . . . . 0.0 109.455 177.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 68.7 tt0 -100.09 117.15 33.73 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.156 0.982 . . . . 0.0 111.876 169.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.7 mp -108.42 129.26 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.365 1.466 . . . . 0.0 109.415 175.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -96.88 148.68 22.69 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.937 1.695 . . . . 0.0 111.4 176.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 59.6 mt -116.67 165.32 13.41 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.933 1.693 . . . . 0.0 112.483 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.6 t -71.06 -13.28 61.92 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 77.8 p -70.76 -15.58 62.69 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 120.428 -1.42 . . . . 0.0 113.59 165.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.49 -1.93 84.43 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.085 1.326 . . . . 0.0 114.178 -170.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -72.33 153.7 41.35 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.702 1.251 . . . . 0.0 110.605 174.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 95.1 p -130.01 143.23 50.69 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 167.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.2 tp -113.06 135.86 53.33 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.414 1.486 . . . . 0.0 109.768 173.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -115.25 110.85 20.05 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.28 1.832 . . . . 0.0 110.176 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.3 m -137.23 158.84 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.37 1.068 . . . . 0.0 113.083 -168.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.0 p -68.99 146.76 97.55 Favored Pre-proline 0 N--CA 1.467 0.413 0 O-C-N 121.692 -0.63 . . . . 0.0 112.541 175.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.52 -30.69 86.76 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.776 2.317 . . . . 0.0 113.294 -171.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.0 p -77.3 -7.09 55.44 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.367 1.867 . . . . 0.0 114.649 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -73.31 116.95 56.15 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 119.936 1.244 . . . . 0.0 112.97 -174.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -76.07 135.45 17.18 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.899 2.399 . . . . 0.0 113.782 178.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.5 t -118.91 143.81 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 126.655 1.982 . . . . 0.0 108.953 176.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 17.3 tp -82.51 114.57 21.01 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.569 -0.707 . . . . 0.0 110.44 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.5 mp -115.86 159.78 21.06 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.675 1.99 . . . . 0.0 111.499 -176.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -112.72 101.84 9.92 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.875 0.87 . . . . 0.0 113.073 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 68.9 mtp85 -125.82 81.56 1.99 Allowed 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 122.426 1.108 . . . . 0.0 108.799 174.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 59.79 -4.39 0.1 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 128.388 2.675 . . . . 0.0 115.282 -167.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -168.06 170.73 42.13 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 128.701 3.048 . . . . 0.0 111.242 -175.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 62.8 mt -83.57 115.21 22.01 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.395 1.478 . . . . 0.0 111.83 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -128.84 137.15 51.32 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.837 1.255 . . . . 0.0 112.107 -171.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -87.9 110.34 20.47 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.504 0.322 . . . . 0.0 111.413 172.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 52.3 t -121.56 126.34 26.49 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 124.723 1.209 . . . . 0.0 109.892 -172.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -66.96 149.48 82.91 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.576 2.184 . . . . 0.0 111.837 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.79 -31.21 26.19 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.19 -21.47 66.77 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 172.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -99.7 -6.76 26.58 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.048 1.739 . . . . 0.0 112.575 172.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.1 t -73.39 142.42 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 O-C-N 121.041 -1.037 . . . . 0.0 110.125 171.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.32 155.75 67.63 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 127.549 2.34 . . . . 0.0 110.197 -175.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.9 123.37 10.31 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.992 1.794 . . . . 0.0 111.891 -170.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 103.91 1.68 45.67 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.636 1.113 . . . . 0.0 114.738 -175.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -58.65 155.41 12.62 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.468 1.134 . . . . 0.0 113.148 170.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.3 p -107.55 119.21 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 126.243 1.817 . . . . 0.0 111.055 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 38.7 t -113.04 134.33 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 125.92 1.688 . . . . 0.0 110.927 -167.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.7 t -88.44 134.92 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 O-C-N 121.267 -0.896 . . . . 0.0 111.376 -172.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -169.12 -147.16 5.31 Favored Glycine 0 CA--C 1.529 0.935 0 O-C-N 121.796 -0.565 . . . . 0.0 112.872 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.2 p -135.58 161.31 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 127.384 2.274 . . . . 0.0 108.475 171.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 68.8 mtp85 -64.99 117.6 7.87 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.73 -0.606 . . . . 0.0 110.775 173.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -61.84 -26.79 68.34 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -176.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -58.39 -25.64 62.32 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 174.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.4 t -85.78 -37.76 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 123.911 0.884 . . . . 0.0 110.511 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 21.2 tp -68.96 -27.96 66.2 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.346 1.459 . . . . 0.0 111.883 175.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -94.98 17.17 14.4 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 127.201 2.201 . . . . 0.0 112.955 174.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -95.7 159.56 14.93 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.944 2.098 . . . . 0.0 110.589 168.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -73.06 -45.23 58.59 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.24 1.016 . . . . 0.0 113.001 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 39.5 mm -97.22 102.78 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.936 1.294 . . . . 0.0 108.704 166.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 58.2 mt -82.19 90.24 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 49.4 m -69.71 78.11 0.44 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.94 1.696 . . . . 0.0 111.489 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -82.69 164.41 20.73 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 126.969 2.108 . . . . 0.0 113.915 -165.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 101.91 20.42 12.86 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 115.389 -0.823 . . . . 0.0 113.176 -172.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -127.48 160.27 32.01 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.519 1.527 . . . . 0.0 113.21 173.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 96.8 mt -138.07 166.49 23.97 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 127.013 2.125 . . . . 0.0 112.136 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -154.38 148.43 25.75 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.463 1.905 . . . . 0.0 111.084 167.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -94.62 143.42 26.45 Favored 'General case' 0 CA--C 1.548 0.87 0 O-C-N 120.889 -1.132 . . . . 0.0 112.423 172.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -122.63 160.27 26.13 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.495 1.918 . . . . 0.0 110.926 -170.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -111.33 130.11 55.78 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -168.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 84.4 t -73.01 136.67 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 121.599 0.714 . . . . 0.0 110.674 171.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 12.3 t -94.42 -49.54 5.64 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.966 2.106 . . . . 0.0 112.537 176.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.4 t -157.48 162.06 38.89 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.216 1.006 . . . . 0.0 111.433 -176.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.7 m -135.19 148.34 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 124.435 1.094 . . . . 0.0 112.066 172.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -152.47 155.18 36.99 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.659 1.183 . . . . 0.0 112.914 170.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 89.2 mt -91.79 133.39 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.359 1.064 . . . . 0.0 108.642 167.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 44.3 pt -126.78 154.28 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 126.09 1.756 . . . . 0.0 111.83 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -96.26 98.91 10.67 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.393 0.677 . . . . 0.0 109.71 178.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -78.62 -53.06 7.58 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 51.88 36.65 18.71 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.648 1.179 . . . . 0.0 113.26 -174.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -144.16 171.7 13.93 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 120.888 -1.132 . . . . 0.0 111.464 -173.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -77.39 134.49 38.42 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.566 1.146 . . . . 0.0 111.794 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 14.1 m -117.64 152.46 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 125.704 1.602 . . . . 0.0 109.993 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -106.56 160.48 15.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.686 0.755 . . . . 0.0 112.942 -173.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.35 140.24 27.57 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.482 1.113 . . . . 0.0 109.098 166.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 64.9 tp -109.33 115.93 30.91 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 120.456 -1.403 . . . . 0.0 110.129 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 57.3 t -86.24 123.07 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -158.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 42.6 mm -118.4 92.32 43.08 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 126.569 1.948 . . . . 0.0 109.451 -176.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.88 -18.99 41.04 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 123.071 2.514 . . . . 0.0 113.736 176.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -78.74 -50.83 10.7 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 120.207 1.367 . . . . 0.0 112.81 -174.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 76.9 p -128.6 -7.01 5.15 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.496 1.518 . . . . 0.0 114.417 -169.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 74.9 m-70 57.22 19.49 4.95 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -170.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -140.9 149.61 42.13 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 120.892 1.678 . . . . 0.0 114.136 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -141.52 154.63 45.61 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.232 1.013 . . . . 0.0 111.316 168.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.4 mp -102.46 132.45 48.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.118 0.967 . . . . 0.0 110.926 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.46 158.79 62.78 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.62 1.168 . . . . 0.0 112.518 175.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.44 -16.82 52.41 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.227 2.618 . . . . 0.0 113.274 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 33.0 p30 -70.07 -2.26 12.32 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 124.702 1.201 . . . . 0.0 113.565 169.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.33 -10.95 69.32 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 126.831 2.157 . . . . 0.0 115.893 176.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 52.4 mt -96.34 150.28 20.75 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 120.317 2.059 . . . . 0.0 113.663 -169.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.2 p -97.54 133.16 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.261 1.024 . . . . 0.0 113.023 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 31.7 mt -119.46 132.81 55.86 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.03 1.732 . . . . 0.0 111.112 -169.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -88.42 118.44 28.05 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.056 0.843 . . . . 0.0 111.937 175.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -81.65 140.09 34.59 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 120.949 -1.095 . . . . 0.0 113.393 -172.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 59.7 14.43 4.06 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.458 2.303 . . . . 0.0 116.995 167.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 . . . . . 0 C--O 1.253 1.246 0 C-N-CA 125.992 1.717 . . . . 0.0 113.422 167.429 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.687 0 CA-C-O 120.897 0.38 . . . . 0.0 111.572 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.61 161.56 38.18 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.657 1.583 . . . . 0.0 110.724 -169.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.81 141.03 50.31 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.511 1.124 . . . . 0.0 112.949 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.02 -22.48 49.93 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.511 1.524 . . . . 0.0 114.198 176.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -78.39 -17.31 56.62 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 177.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.6 m -58.6 136.75 57.69 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 119.347 0.976 . . . . 0.0 113.504 -169.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.33 150.65 47.1 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.12 0.968 . . . . 0.0 113.378 175.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.2 p -146.06 155.67 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.894 1.277 . . . . 0.0 112.141 -171.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -128.98 137.62 51.47 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.449 1.9 . . . . 0.0 108.744 176.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -153.83 168.39 26.49 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.214 0.916 . . . . 0.0 113.256 168.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -130.13 146.02 51.75 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.309 1.443 . . . . 0.0 111.026 177.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -163.0 145.03 10.17 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.217 1.407 . . . . 0.0 109.151 174.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.3 t70 53.76 39.02 29.78 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.349 1.059 . . . . 0.0 113.033 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.2 m 67.41 16.3 10.0 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.331 1.852 . . . . 0.0 114.979 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.0 p -133.67 133.47 22.48 Favored Pre-proline 0 CA--C 1.554 1.1 0 O-C-N 120.175 -1.578 . . . . 0.0 113.229 -177.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -85.72 153.06 10.14 Favored 'Trans proline' 0 CA--C 1.539 0.742 1 C-N-CA 125.593 4.195 . . . . 0.0 114.713 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -135.42 144.87 46.74 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.353 2.261 . . . . 0.0 111.156 -178.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 50.7 ttm -149.37 111.23 4.57 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.784 0.834 . . . . 0.0 110.904 -176.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -158.98 -168.8 2.47 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.81 1.244 . . . . 0.0 112.302 -169.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.4 m -85.71 143.99 28.05 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.098 -1.001 . . . . 0.0 111.36 166.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.43 HG12 ' CG ' ' A' ' 152' ' ' TYR . 8.4 tp -56.81 -38.23 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -177.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -61.75 -22.58 65.52 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.608 0.763 . . . . 0.0 112.848 179.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -80.41 -49.4 11.51 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.302 1.041 . . . . 0.0 111.235 176.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 19.3 ptm -65.77 -31.48 72.49 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 122.062 -0.399 . . . . 0.0 111.589 176.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -57.92 -51.63 68.81 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.603 0.638 . . . . 0.0 111.031 172.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.9 t -67.68 -29.98 69.39 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.148 0.579 . . . . 0.0 111.679 -177.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -66.71 -53.19 36.13 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.323 1.449 . . . . 0.0 111.04 172.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -71.72 -30.82 66.05 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.004 -1.06 . . . . 0.0 112.805 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.48 -31.36 71.46 Favored 'General case' 0 CA--C 1.552 1.054 0 O-C-N 121.51 -0.744 . . . . 0.0 111.992 171.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.0 t -80.07 -22.74 41.93 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 120.668 -1.27 . . . . 0.0 113.095 174.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 55.9 mtm -92.13 -49.7 6.06 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.543 1.137 . . . . 0.0 113.43 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -109.21 -24.09 11.29 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.356 1.462 . . . . 0.0 112.612 -169.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 87.26 164.5 40.2 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 125.556 1.551 . . . . 0.0 114.787 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -109.18 143.57 38.42 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.969 1.308 . . . . 0.0 111.392 -173.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.4 mp -117.33 140.72 27.64 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 126.146 1.778 . . . . 0.0 111.181 172.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.25 141.77 18.56 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 124.469 3.446 . . . . 0.0 111.784 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -126.36 156.16 40.92 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.632 1.573 . . . . 0.0 111.459 -177.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.87 -46.92 16.09 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.387 1.475 . . . . 0.0 114.056 178.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -97.73 -16.58 19.84 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 176.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.26 -126.83 0.95 Allowed Glycine 0 CA--C 1.538 1.504 0 N-CA-C 116.585 1.394 . . . . 0.0 116.585 -168.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -144.54 155.08 43.5 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.61 1.564 . . . . 0.0 112.538 -178.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.48 154.73 50.67 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.759 1.224 . . . . 0.0 113.15 175.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.9 t -130.45 115.75 17.3 Favored Pre-proline 0 N--CA 1.481 1.097 0 C-N-CA 126.125 1.77 . . . . 0.0 110.606 177.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.52 138.64 27.24 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 125.057 3.838 . . . . 0.0 112.52 -176.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.8 mt -112.69 160.98 17.38 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.874 1.27 . . . . 0.0 113.125 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -146.34 128.29 15.48 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.606 1.162 . . . . 0.0 111.349 168.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 55.39 40.39 31.36 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.6 1.56 . . . . 0.0 113.839 -173.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.4 t -107.71 113.3 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 O-C-N 121.109 -0.994 . . . . 0.0 109.346 175.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -113.79 152.0 31.23 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.144 1.378 . . . . 0.0 113.59 -166.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.0 m -143.18 154.35 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 127.119 2.168 . . . . 0.0 111.119 175.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.487 ' CE1' HG23 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -72.08 135.67 46.36 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.744 0.818 . . . . 0.0 109.873 166.541 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.0 t -133.35 153.49 51.54 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.131 1.772 . . . . 0.0 112.842 -179.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 50.3 tp -100.13 133.89 43.86 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.512 1.125 . . . . 0.0 109.861 168.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -84.59 119.39 25.15 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.94 1.296 . . . . 0.0 110.407 164.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.8 mm -76.38 -19.48 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 119.569 1.077 . . . . 0.0 112.265 -179.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.44 -41.03 48.88 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -174.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.3 m -110.57 -11.76 14.42 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.695 1.198 . . . . 0.0 112.814 172.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.5 36.82 68.93 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-N 118.42 0.555 . . . . 0.0 112.037 -173.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -96.69 136.8 36.71 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.222 1.809 . . . . 0.0 111.769 -175.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.487 HG23 ' CE1' ' A' ' 51' ' ' TYR . 1.9 mp -85.84 130.6 36.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 124.504 1.121 . . . . 0.0 107.992 172.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.3 pttt -154.91 168.46 26.85 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.803 1.241 . . . . 0.0 112.913 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -89.56 146.7 24.4 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.574 0.749 . . . . 0.0 111.183 172.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.7 t -143.25 164.13 31.06 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.108 0.963 . . . . 0.0 111.645 172.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -99.88 142.85 30.81 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.241 1.016 . . . . 0.0 112.077 174.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.73 137.39 32.37 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.262 0.625 . . . . 0.0 110.109 167.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 22.8 t -86.97 -46.38 9.91 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.427 1.491 . . . . 0.0 112.334 -172.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -152.89 155.45 37.06 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.618 0.723 . . . . 0.0 112.356 174.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.9 mt -85.12 147.36 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 163.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -136.25 147.78 47.72 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 125.747 1.619 . . . . 0.0 110.839 -175.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 30.6 ptt-85 -143.92 153.95 42.82 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.052 0.941 . . . . 0.0 113.424 167.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -154.82 172.43 18.0 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.846 1.259 . . . . 0.0 110.728 169.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -95.39 147.27 23.7 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.646 0.778 . . . . 0.0 111.943 177.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.1 m -143.74 144.55 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 125.18 1.392 . . . . 0.0 110.481 171.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -94.18 -29.05 15.32 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 124.888 1.275 . . . . 0.0 111.469 175.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -121.01 134.27 55.29 Favored 'General case' 0 C--N 1.344 0.358 0 C-N-CA 125.17 1.388 . . . . 0.0 109.416 -176.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.5 tp -143.53 159.69 41.96 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.164 1.386 . . . . 0.0 109.966 -177.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.6 mt -111.21 128.49 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 O-C-N 121.246 -0.909 . . . . 0.0 109.632 177.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -102.67 112.98 26.0 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.363 1.465 . . . . 0.0 110.261 173.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.2 mp -106.92 131.13 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.608 1.163 . . . . 0.0 109.376 174.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.2 tttt -100.96 147.63 25.94 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.678 1.591 . . . . 0.0 111.51 175.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 61.5 mt -107.75 164.39 12.28 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 126.83 2.052 . . . . 0.0 111.195 -178.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.7 t -75.02 -1.53 23.18 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -178.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.8 p -79.06 -15.09 58.68 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.954 1.702 . . . . 0.0 113.766 160.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.78 -3.63 84.89 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 125.73 1.633 . . . . 0.0 114.199 -169.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -74.54 151.37 39.48 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.451 1.625 . . . . 0.0 111.45 177.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.7 p -128.68 138.63 52.26 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 178.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 14.7 tp -117.01 140.02 49.98 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.995 1.718 . . . . 0.0 110.538 177.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.6 mtmm -118.49 116.38 26.55 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.687 1.195 . . . . 0.0 112.402 -175.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.1 m -141.61 152.49 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 125.204 1.402 . . . . 0.0 113.031 -163.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.7 p -68.39 148.3 98.18 Favored Pre-proline 0 N--CA 1.474 0.73 0 O-C-N 121.031 -1.043 . . . . 0.0 112.433 174.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.79 -17.63 60.31 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.594 2.862 . . . . 0.0 113.728 -175.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 36.3 p -86.35 -10.94 53.4 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.949 2.1 . . . . 0.0 114.48 176.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -72.46 122.17 86.76 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-N 119.699 1.136 . . . . 0.0 111.736 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -80.35 125.06 5.57 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 123.711 2.941 . . . . 0.0 113.113 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.3 t -94.52 141.09 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.686 1.595 . . . . 0.0 109.848 175.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 17.4 tp -83.86 107.23 16.13 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.103 0.561 . . . . 0.0 110.664 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.9 mp -100.15 144.34 29.3 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.756 1.622 . . . . 0.0 111.755 -176.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -104.29 90.23 3.49 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.933 0.893 . . . . 0.0 112.244 -177.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 46.6 mtm180 -133.91 81.43 1.92 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.865 0.866 . . . . 0.0 110.841 -177.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.7 t70 66.3 -17.94 0.11 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 128.09 2.556 . . . . 0.0 115.888 -167.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.48 167.26 39.87 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 126.171 1.843 . . . . 0.0 113.258 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 77.3 mt -62.94 113.83 3.31 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.493 1.917 . . . . 0.0 111.392 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -141.94 142.83 33.03 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.646 0.778 . . . . 0.0 112.847 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -97.56 122.14 40.28 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.877 1.271 . . . . 0.0 110.768 -175.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 71.2 t -128.45 126.69 23.57 Favored Pre-proline 0 N--CA 1.477 0.914 0 C-N-CA 124.289 1.036 . . . . 0.0 110.007 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -64.71 148.65 90.3 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.301 2.001 . . . . 0.0 112.014 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.59 -31.98 17.42 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 173.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.93 -17.89 63.68 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 173.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -111.82 -0.61 15.84 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.568 1.547 . . . . 0.0 112.989 174.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 71.3 t -72.12 148.67 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 120.679 -1.263 . . . . 0.0 110.833 171.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.96 157.09 75.36 Favored Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 127.369 2.268 . . . . 0.0 111.129 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.59 113.42 3.16 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.715 2.277 . . . . 0.0 112.003 -175.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 111.91 6.09 24.87 Favored Glycine 0 CA--C 1.537 1.449 0 CA-C-O 118.691 -1.061 . . . . 0.0 115.264 -175.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -62.86 161.31 12.95 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 118.946 1.373 . . . . 0.0 112.403 163.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 5.8 p -109.45 129.52 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.384 1.474 . . . . 0.0 111.747 178.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.1 t -107.55 137.07 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 126.729 2.012 . . . . 0.0 110.2 -175.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 51.8 t -87.25 134.39 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.744 0.817 . . . . 0.0 110.31 172.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -157.82 -153.91 6.91 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.53 1.062 . . . . 0.0 112.49 176.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.1 p -145.22 176.86 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 126.415 1.886 . . . . 0.0 108.492 174.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -80.91 139.42 35.9 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.071 -1.018 . . . . 0.0 113.067 175.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.58 -39.37 80.13 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.792 0.837 . . . . 0.0 112.859 173.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -61.44 -26.72 68.06 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 178.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 55.8 t -78.74 -41.49 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.069 0.948 . . . . 0.0 110.335 178.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -65.37 -33.47 76.05 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.909 1.283 . . . . 0.0 111.922 173.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -88.11 9.65 21.94 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.709 1.603 . . . . 0.0 113.443 170.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.4 mtt-85 49.89 22.64 0.89 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 127.375 2.27 . . . . 0.0 116.411 175.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -56.25 -39.28 72.33 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.052 -1.03 . . . . 0.0 110.485 175.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.4 tp -133.84 144.0 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 128.845 2.858 . . . . 0.0 107.393 168.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 7.0 tp -81.64 134.48 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.228 1.011 . . . . 0.0 111.162 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.3 t -154.43 132.16 11.46 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.829 -0.544 . . . . 0.0 111.926 165.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -132.75 140.81 48.23 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.929 1.292 . . . . 0.0 111.736 169.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.94 -2.31 59.94 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 124.801 1.191 . . . . 0.0 115.646 177.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -123.92 153.03 41.76 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.15 1.38 . . . . 0.0 112.563 -169.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 89.9 mt -131.04 165.21 23.71 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.858 2.063 . . . . 0.0 111.741 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -131.59 157.17 44.36 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.739 1.616 . . . . 0.0 110.912 173.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -113.28 142.89 45.3 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.608 1.163 . . . . 0.0 111.587 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -133.54 156.24 48.15 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.606 1.562 . . . . 0.0 110.544 -173.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 57.4 tt0 -114.68 137.79 51.48 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.128 -0.983 . . . . 0.0 112.288 -170.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 92.2 t -73.79 133.32 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 122.003 0.906 . . . . 0.0 110.622 173.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 27.5 t -87.11 -59.64 2.2 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.941 1.697 . . . . 0.0 111.748 173.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 59.2 m -149.61 158.88 44.58 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.259 1.424 . . . . 0.0 110.901 -170.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.2 m -136.37 152.86 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 124.126 0.97 . . . . 0.0 111.925 173.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 9.4 ptp85 -158.14 159.48 36.24 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.74 1.216 . . . . 0.0 112.684 168.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 76.3 mt -99.03 129.92 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.935 0.894 . . . . 0.0 109.211 170.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 13.2 pt -121.15 156.58 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.574 1.55 . . . . 0.0 111.908 -174.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -92.7 97.96 11.11 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.754 0.787 . . . . 0.0 110.957 170.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -76.63 -47.89 20.8 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 44.39 39.46 3.13 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.576 1.15 . . . . 0.0 113.826 -174.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 -144.31 174.71 10.67 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.17 0.988 . . . . 0.0 111.392 -174.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -77.27 137.88 39.06 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 124.588 1.155 . . . . 0.0 112.466 -177.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.2 m -119.8 152.74 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 125.084 1.353 . . . . 0.0 109.97 176.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.43 ' CG ' HG12 ' A' ' 21' ' ' ILE . 1.4 p90 -112.1 160.53 17.45 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.08 0.952 . . . . 0.0 112.278 -178.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -141.3 156.06 45.9 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.052 0.541 . . . . 0.0 110.069 156.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 65.2 tp -128.69 103.0 6.83 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.767 1.227 . . . . 0.0 110.051 -175.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 87.8 t -86.63 124.12 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -151.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 20.8 mm -110.71 98.27 36.78 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 125.27 1.428 . . . . 0.0 109.681 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.5 -16.73 38.81 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.512 2.142 . . . . 0.0 113.193 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -74.51 -61.28 1.92 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.784 0.834 . . . . 0.0 112.363 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 54.9 p -122.82 -7.95 8.43 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -171.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 61.37 15.38 6.5 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.086 1.754 . . . . 0.0 115.657 -175.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.81 148.52 30.03 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.082 -1.011 . . . . 0.0 113.532 -178.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -145.9 158.93 43.84 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.746 1.218 . . . . 0.0 112.385 177.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.3 mp -102.39 137.22 31.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 123.975 0.91 . . . . 0.0 111.377 -177.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -88.56 160.24 45.1 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 125.938 1.695 . . . . 0.0 113.088 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.36 -19.46 61.62 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.299 2.666 . . . . 0.0 113.989 -176.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 50.6 p30 -86.18 -2.26 58.2 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.961 1.304 . . . . 0.0 113.551 175.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 102.12 -15.04 56.88 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 126.628 2.061 . . . . 0.0 116.756 173.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 66.7 mt -74.09 145.39 44.43 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.425 1.613 . . . . 0.0 111.965 -178.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.1 p -91.36 135.76 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.528 0.731 . . . . 0.0 111.304 171.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 39.6 mt -113.61 142.09 46.41 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.156 1.783 . . . . 0.0 109.792 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -127.54 127.01 43.22 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.279 1.432 . . . . 0.0 110.146 -177.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -60.46 129.7 42.9 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.912 0.885 . . . . 0.0 112.696 -174.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -154.96 124.94 6.63 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.453 0.701 . . . . 0.0 112.593 175.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 . . . . . 0 C--O 1.252 1.186 0 C-N-CA 124.846 1.259 . . . . 0.0 114.198 -179.29 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.566 0 CA-C-O 120.62 0.248 . . . . 0.0 111.504 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.54 156.99 47.01 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.247 1.419 . . . . 0.0 111.063 -170.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.54 143.97 33.4 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.346 1.458 . . . . 0.0 113.901 -178.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -61.11 -26.09 67.43 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.494 1.117 . . . . 0.0 113.241 174.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -83.03 -1.46 52.73 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.312 1.045 . . . . 0.0 113.803 176.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.4 m -68.59 143.51 54.83 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 119.845 1.202 . . . . 0.0 111.77 174.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -74.68 159.22 32.34 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.205 -0.934 . . . . 0.0 112.817 167.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 p -149.0 156.26 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.049 0.94 . . . . 0.0 111.867 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -121.26 141.8 50.55 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.638 1.975 . . . . 0.0 108.134 176.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -156.44 -178.28 7.22 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.666 0.786 . . . . 0.0 111.128 164.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -136.6 143.13 43.41 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.564 1.545 . . . . 0.0 110.216 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -154.96 -45.68 0.08 Allowed 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 174.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -83.24 37.1 0.54 Allowed 'General case' 0 N--CA 1.481 1.097 0 O-C-N 120.65 -1.281 . . . . 0.0 112.857 -175.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.2 m 61.0 24.92 14.99 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 126.007 1.723 . . . . 0.0 112.915 -167.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.2 p -158.61 149.89 16.57 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 126.412 1.885 . . . . 0.0 109.276 -170.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.45 160.53 32.05 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.974 3.116 . . . . 0.0 114.306 176.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -140.48 151.16 44.6 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 128.029 2.532 . . . . 0.0 110.561 -173.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 34.8 ttm -149.48 126.14 11.03 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.485 -0.759 . . . . 0.0 112.148 177.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -160.89 -178.17 6.64 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.528 1.531 . . . . 0.0 111.75 178.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.52 143.12 51.76 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 121.017 -1.052 . . . . 0.0 109.433 171.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.45 HG12 ' CG ' ' A' ' 152' ' ' TYR . 8.1 tp -56.55 -38.54 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 O-C-N 121.24 -0.913 . . . . 0.0 112.002 179.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -60.56 -24.51 65.47 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.359 0.982 . . . . 0.0 112.566 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -81.6 -46.95 13.68 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.499 1.12 . . . . 0.0 111.402 179.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -70.71 -34.07 71.54 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.441 -0.787 . . . . 0.0 111.6 176.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -58.58 -52.6 64.99 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 124.196 0.998 . . . . 0.0 110.591 172.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.8 t -67.58 -30.4 70.01 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 122.661 0.384 . . . . 0.0 111.043 -174.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -64.69 -52.91 54.69 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.043 1.337 . . . . 0.0 110.969 172.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -71.57 -31.01 66.5 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.074 -1.016 . . . . 0.0 113.14 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.93 -30.44 67.84 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.99 0.916 . . . . 0.0 111.305 172.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.4 m -74.21 -35.21 63.89 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 120.398 -1.439 . . . . 0.0 112.081 172.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 42.5 mtm -86.79 -42.95 12.88 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.366 1.066 . . . . 0.0 113.664 -173.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -114.55 -21.16 10.43 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.803 1.241 . . . . 0.0 112.639 -171.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.95 155.64 21.69 Favored Glycine 0 C--N 1.341 0.816 0 C-N-CA 125.441 1.496 . . . . 0.0 114.38 176.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -98.15 139.15 34.38 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.404 1.081 . . . . 0.0 110.645 -177.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.4 mp -106.86 143.91 28.01 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 127.331 2.252 . . . . 0.0 110.89 175.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.52 145.97 34.15 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.905 3.07 . . . . 0.0 112.415 176.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -142.12 157.52 44.79 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.856 1.662 . . . . 0.0 111.322 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.14 -52.66 58.01 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 120.63 -1.294 . . . . 0.0 113.997 -177.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -84.53 -16.0 43.84 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 176.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -178.65 -131.82 1.63 Allowed Glycine 0 CA--C 1.53 1.002 0 N-CA-C 115.626 1.01 . . . . 0.0 115.626 -165.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -143.59 159.3 42.69 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.284 1.434 . . . . 0.0 111.803 -178.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.06 149.4 45.97 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.862 1.265 . . . . 0.0 112.853 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.4 t -125.63 113.37 25.14 Favored Pre-proline 0 N--CA 1.484 1.263 0 C-N-CA 125.472 1.509 . . . . 0.0 111.933 177.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -68.73 134.72 31.0 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 124.235 3.29 . . . . 0.0 111.02 178.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 96.9 mt -99.65 164.25 12.14 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.884 1.274 . . . . 0.0 112.665 -177.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -133.71 120.65 20.86 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.224 1.01 . . . . 0.0 110.514 172.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 48.15 42.47 17.31 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.342 1.457 . . . . 0.0 113.593 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 97.7 t -100.88 123.76 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 O-C-N 121.488 -0.757 . . . . 0.0 109.734 178.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -126.23 161.18 28.32 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.419 1.088 . . . . 0.0 112.99 -172.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.8 m -148.09 153.32 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.927 2.091 . . . . 0.0 111.321 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -60.29 132.24 53.31 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 122.144 0.974 . . . . 0.0 109.611 155.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.3 t -134.6 147.58 50.25 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.175 1.79 . . . . 0.0 110.901 176.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 61.9 tp -98.16 137.01 37.55 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.244 1.017 . . . . 0.0 109.725 175.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -80.9 106.98 13.33 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.549 0.739 . . . . 0.0 110.404 167.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 46.0 mm -66.13 -23.0 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 O-C-N 120.774 -1.204 . . . . 0.0 112.286 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.66 -43.13 76.87 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.455 1.102 . . . . 0.0 113.973 -175.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.1 m -128.82 -8.01 5.0 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.94 35.13 22.49 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.321 0.962 . . . . 0.0 114.024 178.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -90.68 135.95 33.38 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.062 1.345 . . . . 0.0 112.204 176.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 mp -85.46 127.14 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 124.876 1.27 . . . . 0.0 109.43 176.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -147.15 169.91 18.32 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.582 1.153 . . . . 0.0 111.838 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -99.13 147.4 25.12 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.14 0.976 . . . . 0.0 110.535 170.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.2 t -146.53 167.96 22.39 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.689 0.796 . . . . 0.0 112.441 174.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 50.5 ptt85 -94.07 150.83 19.98 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.639 1.576 . . . . 0.0 112.75 177.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -105.82 132.87 51.41 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.601 1.161 . . . . 0.0 110.921 168.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.2 t -85.96 -45.55 11.38 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.732 1.213 . . . . 0.0 112.379 -171.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -152.25 162.11 41.63 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.394 1.078 . . . . 0.0 112.828 173.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.9 mt -89.7 155.01 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 125.094 1.357 . . . . 0.0 108.407 162.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -137.6 148.85 46.18 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.986 1.715 . . . . 0.0 110.448 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -138.46 149.56 45.57 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.867 1.267 . . . . 0.0 113.174 171.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -148.79 164.26 34.95 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.736 1.614 . . . . 0.0 110.09 170.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.5 mmtp -93.18 148.79 21.72 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.508 1.123 . . . . 0.0 111.047 176.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.1 m -148.38 144.77 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.683 1.193 . . . . 0.0 111.074 172.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -94.05 -31.33 14.27 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.66 1.184 . . . . 0.0 112.069 173.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -121.76 129.57 52.79 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.68 1.192 . . . . 0.0 110.457 -174.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.3 tp -136.52 162.34 33.36 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.392 1.877 . . . . 0.0 109.676 -172.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.9 mt -115.02 125.52 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.707 1.203 . . . . 0.0 109.274 176.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -96.97 123.74 40.77 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.148 0.979 . . . . 0.0 110.198 168.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.9 mp -111.18 126.96 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.846 1.258 . . . . 0.0 109.488 172.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.6 tttt -93.9 146.42 23.91 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.355 1.862 . . . . 0.0 110.672 174.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 80.9 mt -116.56 158.49 23.59 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.773 1.629 . . . . 0.0 111.869 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 18.8 t -59.36 -30.82 68.68 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.677 1.191 . . . . 0.0 112.699 -178.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.0 p -62.66 -15.96 54.74 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 173.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.0 7.0 68.7 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 124.749 1.166 . . . . 0.0 113.825 -171.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -81.33 159.52 24.39 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.726 1.211 . . . . 0.0 111.722 171.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 77.2 p -142.03 143.15 33.0 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.988 0.915 . . . . 0.0 112.739 169.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.1 tp -121.7 142.21 50.39 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.767 1.627 . . . . 0.0 110.858 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -120.41 110.36 16.42 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.224 1.809 . . . . 0.0 111.093 -172.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.0 m -141.06 154.37 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.029 1.332 . . . . 0.0 112.927 -165.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.4 p -68.43 150.43 97.7 Favored Pre-proline 0 N--CA 1.47 0.552 0 O-C-N 120.65 -1.281 . . . . 0.0 113.19 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -61.73 -29.65 83.72 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.678 2.252 . . . . 0.0 112.395 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 38.8 p -83.37 10.17 9.31 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 128.054 2.542 . . . . 0.0 114.859 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -99.1 109.52 54.51 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 124.748 1.219 . . . . 0.0 112.237 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -63.57 124.16 13.25 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.258 2.639 . . . . 0.0 113.841 164.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.5 t -101.27 146.67 9.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 127.433 2.293 . . . . 0.0 109.0 176.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.29 107.57 11.0 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.998 -0.438 . . . . 0.0 110.052 177.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.1 mp -110.22 155.69 21.67 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.541 1.537 . . . . 0.0 111.992 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -96.72 117.45 31.05 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.17 0.588 . . . . 0.0 112.359 174.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 73.4 mtp85 -136.15 78.75 1.73 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.607 1.163 . . . . 0.0 109.791 168.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 56.57 0.42 0.07 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 128.175 2.59 . . . . 0.0 115.78 -164.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -172.68 173.62 45.5 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 126.44 1.971 . . . . 0.0 111.341 -178.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 63.4 mt -70.15 125.72 27.59 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.434 1.494 . . . . 0.0 110.171 177.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -157.13 155.81 31.65 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 173.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -103.73 120.82 41.73 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.217 1.007 . . . . 0.0 112.639 -172.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 49.0 t -129.59 127.01 22.93 Favored Pre-proline 0 N--CA 1.482 1.147 0 C-N-CA 124.905 1.282 . . . . 0.0 110.698 -175.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -64.32 140.41 70.24 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.077 2.518 . . . . 0.0 112.225 -179.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.08 -32.38 15.54 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 176.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.76 -20.95 66.16 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 173.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -106.84 -9.56 16.33 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.61 1.564 . . . . 0.0 113.17 177.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 78.1 t -68.45 145.48 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.696 1.598 . . . . 0.0 109.969 172.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.63 157.93 75.03 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 125.697 1.599 . . . . 0.0 111.62 -178.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.416 ' HD3' HG22 ' A' ' 142' ' ' VAL . 42.9 Cg_endo -64.81 122.11 9.84 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 121.986 1.791 . . . . 0.0 111.32 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 108.11 0.16 33.54 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 124.565 1.078 . . . . 0.0 115.377 -178.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -63.34 162.25 12.61 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.872 1.269 . . . . 0.0 112.372 169.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -109.07 122.73 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 125.35 1.46 . . . . 0.0 111.332 177.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.45 135.86 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 126.324 1.85 . . . . 0.0 110.102 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.9 t -85.79 143.8 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 119.522 1.055 . . . . 0.0 111.733 -176.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -168.21 -149.4 6.11 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 124.794 1.188 . . . . 0.0 114.174 -177.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.1 p -156.97 165.55 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 127.287 2.235 . . . . 0.0 107.767 -174.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -58.62 109.29 0.77 Allowed 'General case' 0 N--CA 1.479 0.993 0 O-C-N 121.095 -1.003 . . . . 0.0 112.84 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -59.53 -30.38 68.55 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.539 0.736 . . . . 0.0 112.865 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -65.61 -29.74 70.37 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 178.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -84.64 -36.36 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-N 119.362 0.983 . . . . 0.0 111.08 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -62.48 -24.07 67.26 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.007 1.323 . . . . 0.0 113.057 173.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 20.3 mtt85 -87.44 5.44 38.89 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.739 1.615 . . . . 0.0 114.91 172.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -132.41 -169.14 2.17 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 125.915 1.686 . . . . 0.0 112.763 -175.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 51.5 ttp85 -56.73 -34.41 67.47 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 127.611 2.364 . . . . 0.0 116.209 -166.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 63.5 mt -124.15 142.67 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 CA-C-N 119.665 1.12 . . . . 0.0 111.587 -171.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 48.6 mt -95.73 115.0 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 160.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 64.1 m -74.86 128.39 35.45 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.333 0.653 . . . . 0.0 112.756 -172.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -79.64 145.08 33.23 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.022 0.929 . . . . 0.0 111.791 176.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 68.11 24.52 74.63 Favored Glycine 0 CA--C 1.539 1.538 0 N-CA-C 116.644 1.418 . . . . 0.0 116.644 174.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -127.79 139.75 52.46 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.081 1.441 . . . . 0.0 112.681 -177.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 59.7 mt -149.56 156.48 42.02 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.222 1.409 . . . . 0.0 113.522 -176.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -142.62 167.21 22.62 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.657 1.983 . . . . 0.0 111.199 -179.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -128.15 156.93 42.09 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 120.348 -1.47 . . . . 0.0 113.945 158.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -116.15 136.31 53.14 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 128.116 2.566 . . . . 0.0 109.159 -173.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -89.11 131.78 35.1 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.965 0.802 . . . . 0.0 111.936 178.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 93.8 t -69.91 127.8 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 123.421 0.688 . . . . 0.0 110.734 171.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.3 t -88.27 -45.1 10.34 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.528 1.931 . . . . 0.0 112.091 175.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.2 t -157.67 163.54 38.1 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.443 1.097 . . . . 0.0 111.404 177.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.416 HG22 ' HD3' ' A' ' 112' ' ' PRO . 4.9 m -136.63 148.54 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 124.81 1.244 . . . . 0.0 111.193 171.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -158.18 155.98 30.02 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 172.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 74.3 mt -86.81 131.8 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.549 1.14 . . . . 0.0 109.061 168.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 25.1 pt -127.0 161.77 33.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 126.611 1.964 . . . . 0.0 112.257 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -95.91 99.06 10.89 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.777 1.631 . . . . 0.0 111.976 177.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -85.63 -51.95 6.13 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 177.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 48.37 41.18 16.1 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.325 1.05 . . . . 0.0 113.164 -175.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 33.9 t-20 -145.41 167.84 21.95 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.684 1.193 . . . . 0.0 110.38 -176.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -68.87 145.44 53.7 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.32 1.048 . . . . 0.0 112.149 177.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.1 m -128.77 152.8 37.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 126.069 1.748 . . . . 0.0 109.422 177.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.45 ' CG ' HG12 ' A' ' 21' ' ' ILE . 2.3 p90 -111.43 160.42 17.12 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -174.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -146.39 127.89 15.05 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.334 1.053 . . . . 0.0 109.299 170.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 32.7 tp -93.06 134.9 34.74 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 120.336 -1.478 . . . . 0.0 112.315 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 23.1 t -99.25 119.67 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 121.545 0.688 . . . . 0.0 112.822 -172.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 20.2 mm -125.96 96.57 37.12 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 126.914 2.085 . . . . 0.0 107.969 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.79 -18.14 22.27 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 122.623 2.216 . . . . 0.0 113.285 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -82.58 -34.48 27.71 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -172.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 44.5 p -139.02 -10.93 1.29 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.615 1.166 . . . . 0.0 113.474 -175.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . 0.306 51.7 m-70 55.37 26.08 8.33 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.09 1.756 . . . . 0.0 115.635 -173.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -154.19 158.96 41.11 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 120.795 -1.191 . . . . 0.0 113.68 173.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -147.06 166.18 27.67 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.544 1.538 . . . . 0.0 112.209 176.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.0 mp -107.96 139.28 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.085 0.954 . . . . 0.0 111.588 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.94 157.16 63.65 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.483 1.113 . . . . 0.0 112.52 174.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.01 -13.98 41.92 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.897 2.398 . . . . 0.0 113.165 177.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -85.94 7.87 22.59 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 124.438 1.095 . . . . 0.0 113.104 171.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 94.4 -23.92 29.81 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 126.24 1.876 . . . . 0.0 116.47 173.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 65.7 mt -70.17 146.27 50.9 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.906 1.353 . . . . 0.0 113.497 -174.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 4.1 t -90.46 128.51 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 123.748 0.819 . . . . 0.0 111.685 174.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 47.3 mt -117.79 160.6 21.09 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 127.598 2.359 . . . . 0.0 111.919 -176.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.31 166.17 11.11 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 -175.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -99.15 144.97 27.68 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.672 1.589 . . . . 0.0 109.972 148.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -138.26 26.78 2.62 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.625 1.17 . . . . 0.0 113.84 172.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 . . . . . 0 C--O 1.251 1.156 0 C-N-CA 126.345 1.858 . . . . 0.0 111.784 178.757 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 111.365 0.135 . . . . 0.0 111.365 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -129.01 159.91 34.4 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.555 1.942 . . . . 0.0 111.151 -177.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.95 145.87 34.34 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.25 0.62 . . . . 0.0 111.268 173.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.92 -24.2 50.66 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 178.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -74.24 -15.4 60.99 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.721 1.608 . . . . 0.0 112.633 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.0 m -68.94 144.02 54.28 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.021 0.929 . . . . 0.0 112.46 -170.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -78.98 156.62 28.38 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 176.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 p -146.17 154.33 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.296 1.438 . . . . 0.0 111.878 -175.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -130.22 127.26 39.28 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 126.293 1.837 . . . . 0.0 108.493 177.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -153.85 171.91 18.21 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.588 0.755 . . . . 0.0 112.133 175.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -130.81 148.82 52.63 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.731 1.213 . . . . 0.0 111.27 171.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -152.59 140.16 19.75 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.528 1.131 . . . . 0.0 110.061 172.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.1 t0 49.13 49.17 20.0 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.01 1.324 . . . . 0.0 113.967 170.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.0 m 62.05 35.42 15.95 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.741 2.016 . . . . 0.0 114.636 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.5 p -152.39 138.42 11.74 Favored Pre-proline 0 CA--C 1.546 0.826 0 O-C-N 120.838 -1.164 . . . . 0.0 113.054 167.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.41 154.95 28.26 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 124.543 3.495 . . . . 0.0 113.814 174.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -133.21 142.51 48.62 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.856 2.062 . . . . 0.0 110.81 172.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 47.1 ttm -145.16 90.65 2.06 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.094 1.358 . . . . 0.0 109.404 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -139.21 -168.72 2.5 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.695 1.998 . . . . 0.0 111.094 -168.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 m -79.03 151.32 31.57 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 121.0 -1.062 . . . . 0.0 111.477 168.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.3 tp -57.64 -37.65 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 O-C-N 121.607 -0.683 . . . . 0.0 111.829 173.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -61.59 -29.68 70.19 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.484 1.038 . . . . 0.0 112.781 175.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -80.74 -35.87 32.8 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.592 0.757 . . . . 0.0 111.674 -175.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 21.6 ptm -71.11 -35.26 71.72 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.207 0.458 . . . . 0.0 111.115 169.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -60.27 -51.53 69.16 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.695 0.798 . . . . 0.0 111.559 176.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.9 t -61.68 -39.62 92.07 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.309 1.044 . . . . 0.0 110.956 -176.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -63.71 -52.97 58.18 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 124.872 1.269 . . . . 0.0 110.851 177.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -72.7 -32.1 65.52 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.297 -0.877 . . . . 0.0 113.179 -178.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.54 -32.17 72.77 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.186 0.995 . . . . 0.0 111.892 173.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.1 m -81.61 -27.05 34.38 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.27 1.028 . . . . 0.0 112.463 176.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 70.2 mtm -80.17 -55.09 5.17 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.314 1.046 . . . . 0.0 112.25 174.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -108.22 -20.58 13.1 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.073 1.349 . . . . 0.0 114.13 -167.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.27 157.6 33.6 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 124.779 1.18 . . . . 0.0 114.216 -176.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -102.02 128.51 48.44 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.455 1.102 . . . . 0.0 108.414 174.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.3 mp -104.39 143.09 25.98 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 125.684 1.594 . . . . 0.0 110.23 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.69 149.13 54.25 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 123.725 2.95 . . . . 0.0 111.884 -176.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -144.14 161.82 37.88 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.995 1.318 . . . . 0.0 111.563 -175.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -51.33 -55.3 19.15 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.461 1.505 . . . . 0.0 113.505 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -90.78 -7.04 53.5 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 177.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 174.73 -124.75 1.04 Allowed Glycine 0 CA--C 1.53 0.978 0 CA-C-N 119.856 1.207 . . . . 0.0 115.55 -174.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -141.57 158.97 43.17 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.7 1.6 . . . . 0.0 111.126 177.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.94 149.12 44.41 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.817 1.247 . . . . 0.0 112.121 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.0 t -119.12 117.8 33.19 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 125.249 1.42 . . . . 0.0 110.625 178.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -74.69 140.49 26.44 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 124.421 3.414 . . . . 0.0 112.315 -177.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 64.2 mt -107.34 170.51 7.92 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.575 1.15 . . . . 0.0 113.604 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -152.63 135.18 15.24 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 127.225 2.21 . . . . 0.0 109.295 166.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 51.43 47.01 25.64 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.278 1.431 . . . . 0.0 113.162 -178.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 56.8 t -115.3 129.37 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.874 0.869 . . . . 0.0 110.637 176.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -126.93 149.0 50.03 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.748 1.219 . . . . 0.0 111.828 -170.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.0 m -137.25 150.42 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.011 1.324 . . . . 0.0 110.793 175.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -77.58 144.45 37.52 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.956 0.884 . . . . 0.0 111.006 168.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.1 t -151.81 151.77 31.78 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.581 1.152 . . . . 0.0 111.055 -165.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.4 tp -98.11 129.01 44.94 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.322 0.649 . . . . 0.0 109.573 171.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -69.88 101.88 1.84 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 162.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.0 mm -64.15 -26.83 41.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 O-C-N 120.951 -1.093 . . . . 0.0 111.279 -174.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.42 -42.15 18.95 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.67 1.188 . . . . 0.0 113.938 -174.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.2 m -101.29 -16.78 16.83 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.075 0.95 . . . . 0.0 112.308 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.45 20.67 79.51 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.461 1.505 . . . . 0.0 114.288 -176.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -79.24 123.95 27.91 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.138 1.375 . . . . 0.0 110.524 177.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.9 mp -72.9 124.24 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 165.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -142.85 174.03 11.02 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.762 1.225 . . . . 0.0 112.707 -178.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -105.5 139.42 40.14 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.99 1.316 . . . . 0.0 110.517 172.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.7 t -135.44 166.59 22.81 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.642 1.177 . . . . 0.0 112.152 176.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -100.92 137.06 39.8 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.613 1.165 . . . . 0.0 113.78 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -94.11 149.28 21.38 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.139 1.376 . . . . 0.0 112.422 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 85.4 p -99.47 -54.1 3.03 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.144 0.978 . . . . 0.0 113.563 -173.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -150.73 156.36 41.14 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.033 1.124 . . . . 0.0 114.033 176.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.0 mt -89.59 152.52 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.264 1.425 . . . . 0.0 108.685 168.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -140.66 144.04 35.47 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.169 -0.957 . . . . 0.0 112.229 -172.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -131.77 142.75 49.84 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.072 1.349 . . . . 0.0 111.882 175.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -149.92 164.18 36.1 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.112 1.365 . . . . 0.0 109.746 175.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -97.55 143.35 28.33 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 123.989 0.916 . . . . 0.0 111.419 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.1 m -147.03 145.46 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.842 1.257 . . . . 0.0 111.427 173.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -94.53 -32.97 13.24 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.867 1.667 . . . . 0.0 112.184 175.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -122.68 134.38 54.48 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 124.093 0.957 . . . . 0.0 110.68 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.8 tp -132.49 160.99 34.89 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.66 1.584 . . . . 0.0 109.299 -176.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.2 mt -115.6 122.88 70.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 121.232 -0.917 . . . . 0.0 109.401 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -93.82 115.92 28.35 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.387 1.075 . . . . 0.0 111.294 169.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 mp -103.75 124.98 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 124.471 1.108 . . . . 0.0 108.721 170.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -91.93 146.11 24.01 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.487 1.515 . . . . 0.0 110.336 172.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 60.4 mt -106.86 160.92 15.15 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.486 1.914 . . . . 0.0 110.939 -178.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.6 t -65.11 -18.74 65.56 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.168 -0.958 . . . . 0.0 113.06 -178.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.7 p -69.02 -17.08 63.86 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.46 1.504 . . . . 0.0 114.572 167.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 83.73 7.43 85.94 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 126.458 1.98 . . . . 0.0 114.907 -170.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -80.44 167.45 20.15 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 118.771 1.285 . . . . 0.0 109.811 168.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 91.9 p -144.79 158.46 43.78 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 120.953 -1.092 . . . . 0.0 113.582 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 61.1 tp -130.64 133.53 46.2 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.383 1.873 . . . . 0.0 110.007 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -113.61 113.66 25.36 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.782 1.233 . . . . 0.0 111.65 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.4 m -139.67 157.08 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 125.721 1.608 . . . . 0.0 112.598 -169.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.9 p -68.25 149.72 97.99 Favored Pre-proline 0 N--CA 1.468 0.442 0 O-C-N 121.262 -0.899 . . . . 0.0 112.514 177.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -57.11 -33.61 96.15 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.642 2.228 . . . . 0.0 112.015 -178.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.7 m -89.54 21.63 3.34 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.526 1.93 . . . . 0.0 114.551 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -102.82 115.95 63.38 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 125.139 1.375 . . . . 0.0 111.072 176.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -72.93 142.43 34.94 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.895 2.396 . . . . 0.0 114.213 177.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 39.9 t -121.54 143.27 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 126.954 2.101 . . . . 0.0 109.298 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 25.8 tp -79.0 113.73 17.36 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.403 0.547 . . . . 0.0 110.292 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.43 159.58 18.6 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.222 2.609 . . . . 0.0 110.27 -172.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -124.18 121.13 34.26 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 174.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -138.63 89.45 2.37 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.822 0.849 . . . . 0.0 110.595 165.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 56.5 -0.17 0.06 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.995 2.118 . . . . 0.0 115.206 -163.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -176.47 167.23 38.64 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 125.627 1.584 . . . . 0.0 112.344 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 38.0 mt -64.38 128.54 36.21 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 126.001 1.721 . . . . 0.0 110.909 178.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -152.59 144.57 23.74 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.54 1.136 . . . . 0.0 112.727 175.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -94.39 130.1 40.85 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.109 0.964 . . . . 0.0 110.643 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 47.9 t -133.72 127.4 19.44 Favored Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 124.047 0.939 . . . . 0.0 110.527 -177.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -65.81 143.79 74.96 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.698 2.265 . . . . 0.0 111.434 175.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.27 -31.7 22.07 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.44 -16.46 62.46 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 173.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -113.15 -7.94 13.59 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.485 1.514 . . . . 0.0 113.042 177.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.4 t -67.06 150.24 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.1 1.36 . . . . 0.0 110.522 168.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.36 157.78 71.88 Favored Pre-proline 0 N--CA 1.475 0.799 0 C-N-CA 126.71 2.004 . . . . 0.0 111.246 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -68.2 122.27 9.31 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.598 2.199 . . . . 0.0 111.806 -173.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 104.62 5.49 42.11 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.309 0.957 . . . . 0.0 114.647 -176.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -67.43 166.68 14.11 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.557 1.143 . . . . 0.0 112.166 168.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.2 p -117.11 118.46 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.133 0.973 . . . . 0.0 112.052 -176.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.0 t -89.75 139.03 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 125.474 1.51 . . . . 0.0 110.008 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.3 t -91.57 139.04 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 123.731 0.812 . . . . 0.0 110.243 174.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -160.65 -155.88 7.97 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.011 0.815 . . . . 0.0 113.284 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.4 p -137.22 161.76 34.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 128.279 2.632 . . . . 0.0 107.919 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -62.08 103.42 0.37 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.761 0.824 . . . . 0.0 112.301 -173.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.18 -29.31 70.12 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.817 0.847 . . . . 0.0 113.018 -175.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -66.2 -29.64 69.95 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.289 1.036 . . . . 0.0 113.792 172.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 76.2 t -85.89 -40.97 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 123.682 0.793 . . . . 0.0 109.825 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.5 tp -60.98 -21.35 63.44 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.753 1.221 . . . . 0.0 112.765 176.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 42.9 ttm105 -76.61 -15.38 59.85 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 127.072 2.149 . . . . 0.0 114.738 174.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -81.13 153.15 27.43 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.7 1.2 . . . . 0.0 110.925 -178.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -66.38 -36.64 83.36 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 118.362 0.528 . . . . 0.0 110.931 177.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 92.6 mt -88.49 108.96 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.37 1.468 . . . . 0.0 109.767 164.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 62.9 mt -91.72 90.57 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.493 1.117 . . . . 0.0 109.907 -176.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 44.9 m -77.88 70.51 4.26 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.735 1.214 . . . . 0.0 111.803 178.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.19 -176.05 0.51 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 127.267 2.227 . . . . 0.0 114.639 -173.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.04 -2.97 61.89 Favored Glycine 0 CA--C 1.535 1.33 0 N-CA-C 116.512 1.365 . . . . 0.0 116.512 172.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -120.49 99.9 6.83 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 118.803 1.302 . . . . 0.0 111.477 -168.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 96.4 mt -67.36 146.18 54.33 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.813 0.845 . . . . 0.0 112.514 -175.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -140.18 123.89 17.27 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.422 1.489 . . . . 0.0 110.459 176.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -87.2 146.09 26.14 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 122.991 0.516 . . . . 0.0 111.367 176.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 23.9 m80 -129.08 128.4 43.47 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.666 1.587 . . . . 0.0 108.545 -173.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -88.31 141.01 28.9 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 120.944 -1.098 . . . . 0.0 112.494 -178.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 76.6 t -67.78 136.39 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 124.755 1.222 . . . . 0.0 110.078 171.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 29.6 t -90.18 -53.11 4.61 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.81 1.644 . . . . 0.0 111.506 171.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.6 m -156.97 159.87 38.49 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 121.194 -0.941 . . . . 0.0 111.121 -174.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.8 m -134.96 152.5 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.158 0.983 . . . . 0.0 111.813 174.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -162.56 159.84 25.24 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.386 1.074 . . . . 0.0 112.481 168.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 83.4 mt -82.66 144.41 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 166.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 44.4 pt -133.82 155.02 39.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.981 1.713 . . . . 0.0 111.074 174.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -93.78 95.96 9.47 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.739 0.816 . . . . 0.0 111.108 -177.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -76.95 -56.72 4.34 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.193 0.997 . . . . 0.0 112.842 179.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 44.82 51.08 8.61 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.046 1.338 . . . . 0.0 112.783 -171.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -152.09 172.02 16.97 Favored 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 124.929 1.292 . . . . 0.0 112.451 -175.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -72.27 135.35 45.98 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 120.739 -1.226 . . . . 0.0 112.144 172.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 4.0 m -111.14 152.14 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.839 1.256 . . . . 0.0 109.645 172.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -115.77 156.17 26.5 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 122.129 0.966 . . . . 0.0 112.105 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -158.59 164.88 35.64 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.22 1.408 . . . . 0.0 109.206 -163.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 44.1 tp -143.02 141.97 31.47 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.712 1.205 . . . . 0.0 110.103 -170.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.9 t -112.4 128.58 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.097 0.959 . . . . 0.0 111.534 -172.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.9 mm -135.09 83.28 39.94 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 126.445 1.898 . . . . 0.0 108.743 -176.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -64.27 -16.77 56.88 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.825 2.35 . . . . 0.0 113.303 -178.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -74.88 -32.29 61.82 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.014 1.726 . . . . 0.0 113.348 -175.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 59.7 p -141.87 -25.82 0.67 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -173.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 56.6 31.27 18.82 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.945 1.698 . . . . 0.0 115.339 -161.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -159.15 152.91 23.06 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.026 1.285 . . . . 0.0 114.137 171.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -148.07 175.69 10.8 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.914 1.686 . . . . 0.0 112.278 175.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 91.2 mt -117.94 128.95 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.731 1.212 . . . . 0.0 110.69 -174.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -80.71 156.95 72.6 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 123.173 0.589 . . . . 0.0 111.636 173.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.9 -20.91 64.53 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.555 2.17 . . . . 0.0 112.673 178.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -74.86 8.12 2.68 Favored 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 124.457 1.103 . . . . 0.0 112.872 172.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 93.09 -25.21 21.19 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 127.319 2.39 . . . . 0.0 115.621 171.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 40.6 mt -75.07 146.02 41.83 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 118.715 1.257 . . . . 0.0 113.121 -170.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.8 t -88.61 125.89 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.514 0.726 . . . . 0.0 110.632 174.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 32.0 mt -113.31 148.83 34.9 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.973 1.709 . . . . 0.0 111.193 -177.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -91.05 153.24 20.27 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.844 0.857 . . . . 0.0 112.315 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -118.81 81.1 1.64 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.875 0.87 . . . . 0.0 111.656 178.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -148.52 144.14 27.13 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.904 1.281 . . . . 0.0 111.962 170.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.28 0 C-N-CA 126.514 1.926 . . . . 0.0 111.766 173.821 . . . . . . . . 1 1 . 1 stop_ save_